PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dong, H; Tian, L; Li, R; Pei, C; Fu, Y; Dong, X; Xia, F; Wang, C; Li, W; Guo, X; Gu, C; Li, B; Liu, A; Ren, H; Wang, C; Xu, H				Dong, H.; Tian, L.; Li, R.; Pei, C.; Fu, Y.; Dong, X.; Xia, F.; Wang, C.; Li, W.; Guo, X.; Gu, C.; Li, B.; Liu, A.; Ren, H.; Wang, C.; Xu, H.			IFNg-induced Irgm1 promotes tumorigenesis of melanoma via dual regulation of apoptosis and Bif-1-dependent autophagy	ONCOGENE			English	Article							INTERFERON-GAMMA; BIF-1/ENDOPHILIN B1; CELL-PROLIFERATION; TUMOR-DEVELOPMENT; FACTOR (IRF)-1; GTPASE IRGM1; T-CELL; GROWTH; EXPRESSION; MYCOBACTERIA	Interferon gamma (IFNg) has been known as the regulator for both tumor immune surveillance and tumorgenesis. However, mechanisms underlying the resistance of tumor cell to IFNg have yet been fully understood. In the current study, we showed that immunity-related GTPase family member 1 (mouse: Irgm1; human: IRGM) is essential for IFNg-mediated regulation of tumor cell growth in melanoma. IRGM/Irgm1 was highly expressed in human and mouse melanoma. IFNg and starvation synergistically induced Irgm1 expression in melanoma B16 cells. In vivo, injection of Irgm1-siRNA-treated cells significantly reduced the number of tumor nodules and prolonged the mice survival. In vitro, knockdown endogenous or IFNg-induced Irgm1 significantly decreases the proliferation and increases apoptosis of B16 cells. In addition, suppressing Irgm1 decreased the IFNg/starvation-induced autophagy, while overexpressing Irgm1 significantly increased autophagy and rescued starvation-challenged cells. Moreover, IFNg and starvation-induced the co-localization of Irgm1 with Bax-interacting factor 1 (Bif-1). Knockdown of Bif-1 decreased Irgm1-mediated tumor cell autophagy. Taken together, these data reveal an Irgm1-dependent mechanism that promotes the tumorigenesis of melanoma via dual regulation of apoptosis and Bif-1-dependent autophagy.	[Dong, H.; Tian, L.; Pei, C.; Fu, Y.; Dong, X.; Xia, F.; Wang, C.; Li, W.; Guo, X.; Gu, C.; Li, B.; Ren, H.; Xu, H.] Harbin Med Univ, Dept Immunol, Heilongjiang Prov Key Lab Infect & Immun, Harbin 150086, Heilongjiang, Peoples R China; [Dong, H.; Wang, C.] Fujian Med Univ, Dept Neurol, Affiliated Sanming Hosp 1, Sanming, Fujian, Peoples R China; [Li, R.] McGill Univ, Neuroinflammat Unit, Montreal Neurol Inst, Montreal, PQ, Canada; [Liu, A.] Harbin Med Univ, Dept Hematol, Affiliated Tumor Hosp, Harbin, Peoples R China	Harbin Medical University; Fujian Medical University; McGill University; Harbin Medical University	Xu, H (corresponding author), Harbin Med Univ, Dept Immunol, Heilongjiang Prov Key Lab Infect & Immun, 157 Baojian Rd, Harbin 150086, Heilongjiang, Peoples R China.	cdongwang01@126.com; hongwei56@hotmail.com	Li, Rui/O-7397-2016; Xu, Hongwei/S-3865-2018; Ren, Huan/O-5727-2017	Li, Rui/0000-0002-7210-8358; Ren, Huan/0000-0001-7114-2012; Xu, Hongwei/0000-0001-5763-3894	National Natural Science Foundation Projects [81071949, 31371080]; Heilongjiang Provincial Natural Science Foundation [D201004]; National Natural Science Foundation Project [81371320]	National Natural Science Foundation Projects(National Natural Science Foundation of China (NSFC)); Heilongjiang Provincial Natural Science Foundation(Natural Science Foundation of Heilongjiang Province); National Natural Science Foundation Project(National Natural Science Foundation of China (NSFC))	We thank Dr Zhiheng Xu and Professor Hulun Li for project discussion and technical support. These studies were funded by the National Natural Science Foundation Projects (Nos. 81071949 and 31371080) and Heilongjiang Provincial Natural Science Foundation (D201004) to Dr Hongwei Xu and the National Natural Science Foundation Project (No. 81371320) to Dr Chaodong Wang.	Altman BJ, 2009, AUTOPHAGY, V5, P569, DOI 10.4161/auto.5.4.8254; Bernabei P, 2001, J LEUKOCYTE BIOL, V70, P950; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BROWN TJ, 1987, J IMMUNOL, V139, P2977; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Feng CG, 2008, NAT IMMUNOL, V9, P1279, DOI 10.1038/ni.1653; Feng CG, 2008, CELL STEM CELL, V2, P83, DOI 10.1016/j.stem.2007.10.007; Guo JY, 2013, CELL, V155, P1216, DOI 10.1016/j.cell.2013.11.019; He SY, 2012, AUTOPHAGY, V8, P1621, DOI 10.4161/auto.21561; He YF, 2005, CANCER IMMUNOL IMMUN, V54, P891, DOI 10.1007/s00262-004-0654-1; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; LOLLINI PL, 1993, INT J CANCER, V55, P320, DOI 10.1002/ijc.2910550224; Overwijk W W, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2001s39; Seliger B, 2008, ADV CANCER RES, V101, P249, DOI 10.1016/S0065-230X(08)00407-7; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Takahashi Y, 2009, CELL DEATH DIFFER, V16, P947, DOI 10.1038/cdd.2009.19; Takahashi Y, 2008, AUTOPHAGY, V4, P121, DOI 10.4161/auto.5265; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; TANIGUCHI K, 1987, P NATL ACAD SCI USA, V84, P3405, DOI 10.1073/pnas.84.10.3405; Taylor GA, 1996, J BIOL CHEM, V271, P20399, DOI 10.1074/jbc.271.34.20399; Tiwari S, 2009, NAT IMMUNOL, V10, P907, DOI 10.1038/ni.1759; Wang Y, 2007, CANCER RES, V67, P2535, DOI 10.1158/0008-5472.CAN-06-3530; Xia FC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01867; Xu HW, 2010, FASEB J, V24, P1583, DOI 10.1096/fj.09-137323; Yi Y, 2013, ANN SURG ONCOL, V20, P267, DOI 10.1245/s10434-012-2487-z; Yin XC, 2011, EMBO REP, V12, P727, DOI 10.1038/embor.2011.79; Zaidi MR, 2011, NATURE, V469, P548, DOI 10.1038/nature09666	34	18	18	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 16	2015	34	42					5363	5371		10.1038/onc.2014.459	http://dx.doi.org/10.1038/onc.2014.459			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU4EI	25619828				2022-12-26	WOS:000363479200006
J	Dupoiron, S; Zischek, C; Ligat, L; Carbonne, J; Boulanger, A; de Bernonville, TD; Lautier, M; Rival, P; Arlat, M; Jamet, E; Lauber, E; Albenne, C				Dupoiron, Stephanie; Zischek, Claudine; Ligat, Laetitia; Carbonne, Julien; Boulanger, Alice; de Bernonville, Thomas Duge; Lautier, Martine; Rival, Pauline; Arlat, Matthieu; Jamet, Elisabeth; Lauber, Emmanuelle; Albenne, Cecile			The N-Glycan Cluster from Xanthomonas campestris pv. campestris A TOOLBOX FOR SEQUENTIAL PLANT N-GLYCAN PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-PYOGENES; ENTEROCOCCUS-FAECALIS; MEDIATES GROWTH; GLYCOSYLATION; PROTEIN; PATHOGENICITY; SECRETION; ENDOS; ACETYLGLUCOSAMINE; ENDOGLYCOSIDASE	N-Glycans are widely distributed in living organisms but represent only a small fraction of the carbohydrates found in plants. This probably explains why they have not previously been considered as substrates exploited by phytopathogenic bacteria during plant infection. Xanthomonas campestris pv. campestris, the causal agent of black rot disease of Brassica plants, possesses a specific system for GlcNAc utilization expressed during host plant infection. This system encompasses a cluster of eight genes (nixE to nixL) encoding glycoside hydrolases (GHs). In this paper, we have characterized the enzymatic activities of these GHs and demonstrated their involvement in sequential degradation of a plant N-glycan using a N-glycopeptide containing two GlcNAcs, three mannoses, one fucose, and one xylose (N2M3FX) as a substrate. The removal of the alpha-1,3-mannose by the alpha-mannosidase NixK (GH92) is a prerequisite for the subsequent action of the beta-xylosidase NixI (GH3), which is involved in the cleavage of the beta-1,2-xylose, followed by the alpha-mannosidase NixJ (GH125), which removes the alpha-1,6-mannose. These data, combined to the subcellular localization of the enzymes, allowed us to propose a model of N-glycopeptide processing by X. campestris pv. campestris. This study constitutes the first evidence suggesting N-glycan degradation by a plant pathogen, a feature shared with human pathogenic bacteria. Plant N-glycans should therefore be included in the repertoire of molecules putatively metabolized by phytopathogenic bacteria during their life cycle.	[Dupoiron, Stephanie; Ligat, Laetitia; Carbonne, Julien; Rival, Pauline; Jamet, Elisabeth; Albenne, Cecile] Univ Toulouse, Lab Rech Sci Vegetales, UMR 5546, F-31326 Castanet Tolosan, France; [Dupoiron, Stephanie; Ligat, Laetitia; Carbonne, Julien; Rival, Pauline; Jamet, Elisabeth; Albenne, Cecile] CNRS, Lab Rech Sci Vegetales, UMR 5546, F-31326 Castanet Tolosan, France; [Zischek, Claudine; Boulanger, Alice; de Bernonville, Thomas Duge; Lautier, Martine; Rival, Pauline; Arlat, Matthieu; Lauber, Emmanuelle] INRA, F-31326 Castanet Tolosan, France; [Zischek, Claudine; Boulanger, Alice; de Bernonville, Thomas Duge; Lautier, Martine; Rival, Pauline; Arlat, Matthieu; Lauber, Emmanuelle] CNRS, Lab Interact Plantes Microorganismes, UMR 2594, F-31326 Castanet Tolosan, France; [Lautier, Martine; Arlat, Matthieu] Univ Toulouse, UPS, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Dupoiron, S (corresponding author), Lab Interact Plantes Microorganismes, UMR 2594 441, Chemin Borde Rouge,CS52627, F-31326 Castanet Tolosan, France.	emmanuelle.lauber@toulouse.inra.fr	Lauber, Emmanuelle/ABB-3077-2021; Rival, Pauline/HGU-3018-2022; Jamet, Elisabeth/Z-2476-2019; Arlat, Matthieu/CAH-3310-2022; Boulanger, Alice/E-6279-2019	Lauber, Emmanuelle/0000-0001-5933-4476; Boulanger, Alice/0000-0001-5918-9547; ALBENNE, Cecile/0000-0001-9856-9745; Arlat, Matthieu/0000-0001-6196-4856; Duge de Bernonville, Thomas/0000-0002-2205-2886	French Agence Nationale de la Recherche [ANR-08-BLAN-0193-01]; local Federation de Recherche Agrobiosciences, Interactions et Biodiversite; Universite Paul Sabatier; Centre National de la Recherche Scientifique; Institut National de la Recherche Agronomique; French Ministry of Research and Technology	French Agence Nationale de la Recherche(French National Research Agency (ANR)); local Federation de Recherche Agrobiosciences, Interactions et Biodiversite; Universite Paul Sabatier; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Recherche Agronomique; French Ministry of Research and Technology	This work was supported by French Agence Nationale de la Recherche Grant ANR-08-BLAN-0193-01, the local Federation de Recherche Agrobiosciences, Interactions et Biodiversite, the Universite Paul Sabatier, the Centre National de la Recherche Scientifique, the Institut National de la Recherche Agronomique, and the French Ministry of Research and Technology (to A.B.).	AMES GF, 1984, J BACTERIOL, V160, P1181, DOI 10.1128/JB.160.3.1181-1183.1984; An HJ, 2010, METHODS MOL BIOL, V600, P199, DOI 10.1007/978-1-60761-454-8_14; ARLAT M, 1991, MOL PLANT MICROBE IN, V4, P593, DOI 10.1094/MPMI-4-593; Berger S, 1995, BIOCHIMIE, V77, P751, DOI 10.1016/0300-9084(96)88193-4; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; Boulanger A, 2014, MBIO, V5, DOI 10.1128/mBio.01527-14; Boulanger A, 2010, J BACTERIOL, V192, P1487, DOI 10.1128/JB.01418-09; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Byers HL, 1999, GLYCOBIOLOGY, V9, P469, DOI 10.1093/glycob/9.5.469; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cao YL, 2014, P NATL ACAD SCI USA, V111, P12901, DOI 10.1073/pnas.1407344111; Collin M, 2004, J BIOL CHEM, V279, P22558, DOI 10.1074/jbc.M402156200; Collin M, 2002, INFECT IMMUN, V70, P6646, DOI 10.1128/IAI.70.12.6646-6651.2002; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Dejean G, 2013, NEW PHYTOL, V198, P899, DOI 10.1111/nph.12187; Faye L, 2005, VACCINE, V23, P1770, DOI 10.1016/j.vaccine.2004.11.003; Garbe J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091035; Garrido D, 2012, MOL CELL PROTEOMICS, V11, P775, DOI 10.1074/mcp.M112.018119; Gregg KJ, 2011, J BIOL CHEM, V286, P15586, DOI 10.1074/jbc.M111.223172; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Horsch M, 1997, PHARMACOL THERAPEUT, V76, P187, DOI 10.1016/S0163-7258(97)00110-1; Jarrell KF, 2014, MICROBIOL MOL BIOL R, V78, P304, DOI 10.1128/MMBR.00052-13; Jefferson R A, 1987, EMBO J, V6, P3901; Katta S, 2013, FEMS MICROBIOL LETT, V348, P19, DOI 10.1111/1574-6968.12237; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Ladeveze S, 2013, J BIOL CHEM, V288, P32370, DOI 10.1074/jbc.M113.483628; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mally M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000164; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Messner P, 1997, FEMS MICROBIOL REV, V20, P25, DOI 10.1016/S0168-6445(97)00041-7; Meyer D, 2005, MOL PLANT PATHOL, V6, P327, DOI 10.1111/j.1364-3703.2005.00287.x; Miller JH., 1992, SHORT COURSE BACTERI; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Nakayama-Imaohji H, 2012, J MED INVESTIG, V59, P79, DOI 10.2152/jmi.59.79; Nihira T, 2013, J BIOL CHEM, V288, P27366, DOI 10.1074/jbc.M113.469080; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Renzi F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002118; Roberts G, 2000, J BACTERIOL, V182, P882, DOI 10.1128/JB.182.4.882-890.2000; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Suits MDL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009006; Szczesny R, 2010, NEW PHYTOL, V187, P983, DOI 10.1111/j.1469-8137.2010.03312.x; Tailford LE, 2007, J BIOL CHEM, V282, P11291, DOI 10.1074/jbc.M610964200; Thompson AJ, 2012, P NATL ACAD SCI USA, V109, P781, DOI 10.1073/pnas.1111482109; TURNER P, 1985, MOL GEN GENET, V199, P338, DOI 10.1007/BF00330277; Wang LF, 2008, MOL PLANT MICROBE IN, V21, P555, DOI 10.1094/MPMI-21-5-0555; Yokouchi D, 2013, GLYCOCONJUGATE J, V30, P463, DOI 10.1007/s10719-012-9441-y; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]	53	25	25	4	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6022	6036		10.1074/jbc.M114.624593	http://dx.doi.org/10.1074/jbc.M114.624593			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25586188	Green Published, hybrid			2022-12-26	WOS:000350732500014
J	Maruyama, Y; Oiki, S; Takase, R; Mikami, B; Murata, K; Hashimoto, W				Maruyama, Yukie; Oiki, Sayoko; Takase, Ryuichi; Mikami, Bunzo; Murata, Kousaku; Hashimoto, Wataru			Metabolic Fate of Unsaturated Glucuronic/Iduronic Acids from Glycosaminoglycans MOLECULAR IDENTIFICATION AND STRUCTURE DETERMINATION OF STREPTOCOCCAL ISOMERASE AND DEHYDROGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCURONYL HYDROLASE; CRYSTAL-STRUCTURE; GENOME SEQUENCE; SPECIFICITY; PNEUMONIAE; DEGRADATION; PATHOGEN; BACTERIA; STRAIN; DNA	Glycosaminoglycans in mammalian extracellular matrices are degraded to their constituents, unsaturated uronic (glucuronic/iduronic) acids and amino sugars, through successive reactions of bacterial polysaccharide lyase and unsaturated glucuronyl hydrolase. Genes coding for glycosaminoglycan-acting lyase, unsaturated glucuronyl hydrolase, and the phosphotransferase system are assembled into a cluster in the genome of pathogenic bacteria, such as streptococci and clostridia. Here, we studied the streptococcal metabolic pathway of unsaturated uronic acids and the structure/function relationship of its relevant isomerase and dehydrogenase. Two proteins (gbs1892 and gbs1891) of Streptococcus agalactiae strain NEM316 were overexpressed in Escherichia coli, purified, and characterized. 4-Deoxy-L-threo-5-hexosulose-uronate (Dhu) nonenzymatically generated from unsaturated uronic acids was converted to 2-keto-3-deoxy-D-gluconate via 3-deoxy-D-glycero-2,5-hexodiulosonate through successive reactions of gbs1892 isomerase (DhuI) and gbs1891 NADH-dependent reductase/dehydrogenase (DhuD). DhuI and DhuD enzymatically corresponded to 4-deoxy-L-threo-5-hexosulose-uronate ketolisomerase (KduI) and 2-keto-3-deoxy-D-gluconate dehydrogenase (KduD), respectively, involved in pectin metabolism, although no or low sequence identity was observed between DhuI and KduI or between DhuD and KduD, respectively. Genes for DhuI and DhuD were found to be included in the streptococcal genetic cluster, whereas KduI and KduD are encoded in clostridia. Tertiary and quaternary structures of DhuI and DhuD were determined by x-ray crystallography. Distinct from KduI beta-barrels, DhuI adopts an alpha/beta/alpha-barrel structure as a basic scaffold similar to that of ribose 5-phosphateisomerase. The structure of DhuD is unable to accommodate the substrate/cofactor, suggesting that conformational changes are essential to trigger enzyme catalysis. This is the first report on the bacterial metabolism of glycosaminoglycan-derived unsaturated uronic acids by isomerase and dehydrogenase.	[Maruyama, Yukie; Oiki, Sayoko; Takase, Ryuichi; Murata, Kousaku; Hashimoto, Wataru] Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Lab Appl Struct Biol, Div Appl Life Sci, Grad Sch Agr, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Hashimoto, W (corresponding author), Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan.	whasimot@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science; Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Mizutani Foundation for Glycoscience	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Mizutani Foundation for Glycoscience	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science (to K. M. and W. H.); the Targeted Proteins Research Program (to W. H.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; and a research grant (to W. H.) from the Mizutani Foundation for Glycoscience.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; Brinkkotter A, 2000, MOL MICROBIOL, V37, P125, DOI 10.1046/j.1365-2958.2000.01969.x; CONDEMINE G, 1991, MOL MICROBIOL, V5, P2191, DOI 10.1111/j.1365-2958.1991.tb02149.x; CONDEMINE G, 1984, J GEN MICROBIOL, V130, P2839; Couchman JR, 2012, J HISTOCHEM CYTOCHEM, V60, P885, DOI 10.1369/0022155412464638; Crowther RL, 2005, PROTEINS, V61, P680, DOI 10.1002/prot.20598; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Edwards Thomas E, 2011, BMC Struct Biol, V11, P39, DOI 10.1186/1472-6807-11-39; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Hashimoto W, 1997, ARCH BIOCHEM BIOPHYS, V339, P17, DOI 10.1006/abbi.1996.9851; Hashimoto W, 1999, ARCH BIOCHEM BIOPHYS, V368, P367, DOI 10.1006/abbi.1999.1305; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; HUGOUVIEUXCOTTEPATTAT N, 1994, MOL MICROBIOL, V11, P67, DOI 10.1111/j.1365-2958.1994.tb00290.x; Imberty A, 2007, CARBOHYD RES, V342, P430, DOI 10.1016/j.carres.2006.12.019; Jung J, 2011, APPL MICROBIOL BIOT, V90, P517, DOI 10.1007/s00253-011-3095-8; Kawada-Matsuo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033382; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; Maruyama Y, 2009, J BIOL CHEM, V284, P18059, DOI 10.1074/jbc.M109.005660; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Nakamichi Y, 2014, J BIOL CHEM, V289, P4787, DOI 10.1074/jbc.M113.522573; Nakamichi Y, 2011, J BIOL CHEM, V286, P6262, DOI 10.1074/jbc.M110.182618; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Persson B, 2008, CELL MOL LIFE SCI, V65, P3879, DOI 10.1007/s00018-008-8587-z; Persson B, 2013, CHEM-BIOL INTERACT, V202, P111, DOI 10.1016/j.cbi.2012.11.009; PREISS J, 1963, J BIOL CHEM, V238, P1577; PREISS J, 1962, J BIOL CHEM, V237, P317; Preiss J., 1966, METHOD ENZYMOL, DOI [10.1016/0076-6879(66)09121-3, DOI 10.1016/0076-6879(66)09121-3]; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Rodionov DA, 2004, MICROBIOL-SGM, V150, P3571, DOI 10.1099/mic.0.27041-0; Rothe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056906; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sawitzky D, 1996, MED MICROBIOL IMMUN, V184, P155, DOI 10.1007/BF02456129; Starr CR, 2006, INFECT IMMUN, V74, P40, DOI 10.1128/IAI.74.1.40-48.2006; Stern AL, 2011, FEBS J, V278, P793, DOI 10.1111/j.1742-4658.2010.07999.x; Takase R., 2012, ANN M JAP SOC BIOSC, P110; Takase R, 2010, BBA-PROTEINS PROTEOM, V1804, P1925, DOI 10.1016/j.bbapap.2010.05.010; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang RG, 2003, J MOL BIOL, V332, P1083, DOI 10.1016/j.jmb.2003.08.009	52	16	16	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6281	6292		10.1074/jbc.M114.604546	http://dx.doi.org/10.1074/jbc.M114.604546			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605731	hybrid, Green Published			2022-12-26	WOS:000350732500034
J	Yang, SP; Zhang, L; Chen, XC; Chen, YH; Dong, JX				Yang, Shuping; Zhang, Lin; Chen, Xingcheng; Chen, Yuanhong; Dong, Jixin			Oncoprotein YAP Regulates the Spindle Checkpoint Activation in a Mitotic Phosphorylation-dependent Manner through Up-regulation of BubR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; YES-ASSOCIATED PROTEIN; HIPPO PATHWAY; GENE-EXPRESSION; CDK1 PHOSPHORYLATION; PHOSPHATASE CDC14A; TISSUE-GROWTH; SIZE-CONTROL; ORGAN SIZE; KINASE	The transcriptional co-activator YAP (Yes-associated protein) functions as an oncogene; however, it is largely unclear how YAP exerts its oncogenic role. In this study, we further explored the functional significance of YAP and its mitotic phosphorylation in the spindle checkpoint. We found that the dynamic mitotic phosphorylation of YAP was CDC14-dependent. We also showed that YAP was required for the spindle checkpoint activation induced by spindle poisons. Mitotic phosphorylation of YAP was required for activation of the spindle checkpoint. Furthermore, enhanced expression of active YAP hyperactivated the spindle checkpoint and induced mitotic defects in a mitotic phosphorylation-dependent manner. Mechanistically, we documented that mitotic phosphorylation of YAP controlled transcription of genes associated with the spindle checkpoint. YAP constitutively associated with BubR1 (BUB1-related protein kinase), and knockdown of BubR1 relieved YAP-driven hyperactivation of the spindle checkpoint. Finally, we demonstrated that YAP promoted epithelial cell invasion via both mitotic phosphorylation and BubR1-dependent mechanisms. Together, our results reveal a novel link between YAP and the spindle checkpoint and indicate a potential mechanism underlying the oncogenic function of YAP through dysregulation of the spindle checkpoint.	[Yang, Shuping] Shandong Univ, Shandong Prov Hosp, Dept Oncol, Jinan 250021, Shandong, Peoples R China; [Yang, Shuping; Zhang, Lin; Chen, Xingcheng; Chen, Yuanhong; Dong, Jixin] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Nebraska System; University of Nebraska Medical Center	Dong, JX (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	dongj@unmc.edu	Chen, Xingcheng/AAL-3210-2020		National Institutes of Health [5P30 GM106397, R01 GM109066]; Department of Defense Health Program through the Prostate Cancer Research Program [W81XWH-14-1-0150]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109066, P30GM106397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Health Program through the Prostate Cancer Research Program(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5P30 GM106397 and R01 GM109066 (to J. D.). This work was also supported by Grant W81XWH-14-1-0150 from the Department of Defense Health Program through the Prostate Cancer Research Program (to J. D.).	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Bembenek J, 2001, J BIOL CHEM, V276, P48237, DOI 10.1074/jbc.M108126200; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; Cui Y, 2008, ONCOGENE, V27, P3122, DOI 10.1038/sj.onc.1210972; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Esteban V, 2006, CELL CYCLE, V5, P2894, DOI 10.4161/cc.5.24.3566; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Florindo C, 2012, J CELL SCI, V125, P3085, DOI 10.1242/jcs.097147; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gray CH, 2003, EMBO J, V22, P3524, DOI 10.1093/emboj/cdg348; Hansen CA, 2008, CELL CYCLE, V7, P325, DOI 10.4161/cc.7.3.5354; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hergovich A, 2009, CURR BIOL, V19, P1692, DOI 10.1016/j.cub.2009.09.020; Ji M, 2012, BIOCHEM J, V447, P93, DOI 10.1042/BJ20120751; Jia LY, 2013, TRENDS BIOCHEM SCI, V38, P302, DOI 10.1016/j.tibs.2013.03.004; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lanzetti L, 2007, J BIOL CHEM, V282, P15258, DOI 10.1074/jbc.M700914200; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lee KM, 2005, LAB INVEST, V85, P1003, DOI 10.1038/labinvest.3700298; Li LW, 2000, J BIOL CHEM, V275, P2410, DOI 10.1074/jbc.275.4.2410; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Mardin BR, 2010, NAT CELL BIOL, V12, P1166, DOI 10.1038/ncb2120; Oh HJ, 2010, CURR BIOL, V20, P416, DOI 10.1016/j.cub.2009.12.054; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park HW, 2013, TRENDS PHARMACOL SCI, V34, P581, DOI 10.1016/j.tips.2013.08.006; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Ricke RM, 2011, J CELL BIOL, V193, P1049, DOI 10.1083/jcb.201012035; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Schvartzman JM, 2011, CANCER CELL, V19, P701, DOI 10.1016/j.ccr.2011.04.017; Shimizu T, 2008, GENETICS, V178, P957, DOI 10.1534/genetics.107.081570; Siegel JJ, 2012, ANNU REV CELL DEV BI, V28, P189, DOI 10.1146/annurev-cellbio-101011-155807; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Tumurbaatar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014711; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Vazquez-Novelle MD, 2010, J BIOL CHEM, V285, P40544, DOI 10.1074/jbc.M110.133009; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Xiao L, 2011, J BIOL CHEM, V286, P36304, DOI 10.1074/jbc.M111.246850; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yabuta N, 2007, J BIOL CHEM, V282, P19259, DOI 10.1074/jbc.M608562200; Yamamoto Y, 2007, CANCER GENET CYTOGEN, V174, P42, DOI 10.1016/j.cancergencyto.2006.11.012; Yang SP, 2014, CELL SIGNAL, V26, P343, DOI 10.1016/j.cellsig.2013.11.012; Yang SP, 2013, CANCER RES, V73, P6722, DOI 10.1158/0008-5472.CAN-13-2049; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang L, 2012, J BIOL CHEM, V287, P34069, DOI 10.1074/jbc.M112.385518; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	59	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6191	6202		10.1074/jbc.M114.624411	http://dx.doi.org/10.1074/jbc.M114.624411			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605730	hybrid, Green Published			2022-12-26	WOS:000350732500027
J	Menden, H; Welak, S; Cossette, S; Ramchandran, R; Sampath, V				Menden, Heather; Welak, Scott; Cossette, Stephanie; Ramchandran, Ramani; Sampath, Venkatesh			Lipopolysaccharide (LPS)-mediated Angiopoietin-2-dependent Autocrine Angiogenesis Is Regulated by NADPH Oxidase 2 (Nox2) in Human Pulmonary Microvascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG INJURY; BRONCHOPULMONARY DYSPLASIA; GROWTH-FACTORS; MESSENGER-RNA; EXPRESSION; ANGIOPOIETINS; MODEL; TIE2; GENE; ACTIVATION	Sepsis-mediated endothelial Angiopoeitin-2 (Ang2) signaling may contribute to microvascular remodeling in the developing lung. The mechanisms by which bacterial cell wall components such as LPS mediate Ang2 signaling in human pulmonary microvascular endothelial cells (HPMECs) remain understudied. In HPMEC, LPS-induced Ang2, Tie2, and VEGF-A protein expression was preceded by increased superoxide formation. NADPH oxidase 2 (Nox2) inhibition, but not Nox4 or Nox1 inhibition, attenuated LPS-induced superoxide formation and Ang2, Tie2, and VEGF-A expression. Nox2 silencing, but not Nox4 or Nox1 silencing, inhibited LPS-mediated inhibitor of kappa-B kinase beta (IKK beta) and p38 phosphorylation and nuclear translocation of NF-kappa B and AP-1. In HPMECs, LPS increased the number of angiogenic tube and network formations in Matrigel by >3-fold. Conditioned media from LPS-treated cells also induced angiogenic tube and network formation in the presence of Toll-like receptor 4 blockade but not in the presence of Ang2 and VEGF blockade. Nox2 inhibition or conditioned media from Nox2-silenced cells attenuated LPS-induced tube and network formation. Ang2 and VEGF-A treatment rescued angiogenesis in Nox2-silenced cells. We propose that Nox2 regulates LPS-mediated Ang2-dependent autocrine angiogenesis in HPMECs through the IKK beta/NF-kappa B and MAPK/AP-1 pathways.	[Menden, Heather; Welak, Scott; Cossette, Stephanie; Ramchandran, Ramani; Sampath, Venkatesh] Med Coll Wisconsin, Childrens Res Inst, Dept Pediat, Milwaukee, WI 53226 USA; [Ramchandran, Ramani] Med Coll Wisconsin, Childrens Res Inst, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Sampath, V (corresponding author), Childrens Corp Ctr, Dept Pediat, Suite 410,999 N 92nd St, Wauwatosa, WI 53226 USA.	vsampath@mcw.edu			National Institutes of Health [1R03HD062693-01A1, 8KL2TR000056, HL102745]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD062693] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123338, R01HL102745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R03HD062693-01A1 and 8KL2TR000056 (to V. S.) and HL102745 (to S. C. and R. R.).	Abman SH, 2001, AM J RESP CRIT CARE, V164, P1755, DOI 10.1164/ajrccm.164.10.2109111c; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494; Bhandarkar SS, 2009, J CLIN INVEST, V119, P2359, DOI 10.1172/JCI33877; Blanchetot C, 2008, CRIT REV EUKAR GENE, V18, P35, DOI 10.1615/CritRevEukarGeneExpr.v18.i1.30; Brigelius-Flohe R, 2011, ANTIOXID REDOX SIGN, V15, P2335, DOI 10.1089/ars.2010.3534; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carnesecchi S, 2012, CELL MOL LIFE SCI, V69, P2373, DOI 10.1007/s00018-012-1013-6; Chen J.-X., 2006, AM J PHYSIOL-HEART C, V291, pH1563; Cifuentes-Pagano E, 2014, ANTIOXID REDOX SIGN, V20, P2741, DOI 10.1089/ars.2013.5620; Cordero L, 1997, PEDIATR INFECT DIS J, V16, P18, DOI 10.1097/00006454-199701000-00005; David S, 2011, AM J PHYSIOL-LUNG C, V300, pL851, DOI 10.1152/ajplung.00459.2010; Fakler CR, 2000, INFLAMM RES, V49, P63, DOI 10.1007/s000110050560; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Hato T, 2009, BIOCHEM BIOPH RES CO, V381, P218, DOI 10.1016/j.bbrc.2009.02.030; Hayes AJ, 1999, MICROVASC RES, V58, P224, DOI 10.1006/mvre.1999.2179; Hegen A, 2004, ARTERIOSCL THROM VAS, V24, P1803, DOI 10.1161/01.ATV.0000140819.81839.0e; Hewett PW, 1998, BIOCHEM BIOPH RES CO, V252, P546, DOI 10.1006/bbrc.1998.9690; Jobe AJ, 1999, PEDIATR RES, V46, P641, DOI 10.1203/00006450-199912000-00007; Josko J, 2004, MED SCI MONITOR, V10, pRA89; Kallopur SG, 2006, ARCH DIS CHILD-FETAL, V91, pF132, DOI 10.1136/adc.2004.068544; Karmpaliotis D, 2002, AM J PHYSIOL-LUNG C, V283, pL585, DOI 10.1152/ajplung.00048.2002; Kumpers P, 2009, CRIT CARE, V13, DOI 10.1186/cc7866; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Loukili N, 2010, J BIOL CHEM, V285, P15746, DOI 10.1074/jbc.M110.103259; Medford ARL, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-27; Medhora M, 2008, AM J PHYSIOL-LUNG C, V294, pL676, DOI 10.1152/ajplung.00496.2007; Menden H, 2013, AM J PHYSIOL-LUNG C, V304, pL445, DOI 10.1152/ajplung.00261.2012; Miyoshi T, 2010, IMMUNOLOGY, V131, P331, DOI 10.1111/j.1365-2567.2010.03303.x; Mofarrahi M, 2008, AM J PHYSIOL-LUNG C, V294, pL955, DOI 10.1152/ajplung.00449.2007; Oh YT, 2008, NEUROSCI LETT, V431, P155, DOI 10.1016/j.neulet.2007.11.033; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Park HS, 2006, CARDIOVASC RES, V72, P447, DOI 10.1016/j.cardiores.2006.09.012; Patel DN, 2006, BIOCHEM BIOPH RES CO, V347, P1113, DOI 10.1016/j.bbrc.2006.07.015; Peng TQ, 2004, FASEB J, V18, P293, DOI 10.1096/fj.04-2289fje; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Takac I, 2012, CURR HYPERTENS REP, V14, P70, DOI 10.1007/s11906-011-0238-3; Teng RJ, 2009, AM J PHYSIOL-LUNG C, V297, pL184, DOI 10.1152/ajplung.90455.2008; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; Thomas W, 2011, PEDIATR PULM, V46, P777, DOI 10.1002/ppul.21435; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P2517, DOI [10.1089/ars.2009.2582, 10.1089/ARS.2009.2582]; van der Heijden M, 2010, SHOCK, V33, P263, DOI 10.1097/SHK.0b013e3181b2f978; van Meurs M, 2009, CRIT CARE, V13, DOI 10.1186/cc7153; Veronese FM, 2002, ADV DRUG DELIVER REV, V54, P587, DOI 10.1016/S0169-409X(02)00029-7; Willam C, 2000, CIRC RES, V87, P370; Wu F, 2008, J CELL PHYSIOL, V217, P207, DOI 10.1002/jcp.21495; Yang J, 2010, CHIN J TRAUMATOL, V13, P308, DOI 10.3760/cma.j.issn.1008-1275.2010.05.011; Ziegler T, 2013, J CLIN INVEST, V123, P3436, DOI 10.1172/JCI66549	52	52	52	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5449	5461		10.1074/jbc.M114.600692	http://dx.doi.org/10.1074/jbc.M114.600692			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568324	Green Published, hybrid			2022-12-26	WOS:000350044200018
J	Rouget, R; Sharma, G; LeBlanc, AC				Rouget, Raphael; Sharma, Gyanesh; LeBlanc, Andrea C.			Cyclin-dependent Kinase 5 Phosphorylation of Familial Prion Protein Mutants Exacerbates Conversion into Amyloid Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; NEURONAL CDK5 ACTIVATOR; N-TERMINAL REGION; CONFORMATIONAL-CHANGE; Y145STOP VARIANT; APLYSIA CPEB; IN-VITRO; SCRAPIE; DISEASES; ISOFORM	Familial prion protein (PrP) mutants undergo conversion from soluble and protease-sensitive to insoluble and partially protease-resistant proteins. Cyclin-dependent kinase 5 (Cdk5) phosphorylation of wild type PrP (pPrP) at serine 43 induces a conversion of PrP into aggregates and fibrils. Here, we investigated whether familial PrP mutants are predisposed to Cdk5 phosphorylation and whether phosphorylation of familial PrP mutants increases conversion. PrP mutants representing three major familial PrP diseases and different PrP structural domains were studied. We developed a novel in vitro kinase reaction coupled with Thioflavin T binding to amyloid structure assay to monitor phosphorylation-dependent amyloid conversion. Although non-phosphorylated full-length wild type or PrP mutants did not convert into amyloid, Cdk5 phosphorylation rapidly converted these into Thioflavin T-positive structures following first order kinetics. Dephosphorylation partially reversed conversion. Phosphorylation-dependent conversion of PrP from alpha-helical structures into beta-sheet structures was confirmed by circular dichroism. Relative to wild type pPrP, most PrP mutants showed increased rate constants of conversion. In contrast, non-phosphorylated truncated PrP Y145X (where X represents a stop codon) and Q160X mutants converted spontaneously into Thioflavin T-positive fibrils after a lag phase of over 20 h, indicating nucleation-dependent polymerization. Phosphorylation reduced the lag phase by over 50% and thus accelerated the formation of the nucleating event. Consistently, phosphorylated Y145X and phosphorylated Q160X exacerbated conversion in a homologous seeding reaction, whereas WT pPrP could not seed WT PrP. These results demonstrate an influence of both the N terminus and the C terminus of PrP on conversion. We conclude that post-translational modifications of the flexible N terminus of PrP can cause or exacerbate PrP mutant conversion.	[Rouget, Raphael; Sharma, Gyanesh; LeBlanc, Andrea C.] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Dept Neurol & Neurosurg, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Sharma, Gyanesh; LeBlanc, Andrea C.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	Lady Davis Institute; McGill University; McGill University	LeBlanc, AC (corresponding author), Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, 3755 Ch Cote St Catherine, Montreal, PQ H3T 1E2, Canada.	andrea.leblanc@mcgill.ca			National Institutes of Health [1R21NS06114]; Canadian Institutes of Health Research [MOP89376, MOP 102738]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21NS06114 (to A. L. B.). This work was also supported by Canadian Institutes of Health Research Operating Grants MOP89376 and MOP 102738 (to A. L. B.).	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Asada A, 2012, J CELL SCI, V125, P3421, DOI 10.1242/jcs.100503; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Baron GS, 2003, J BIOL CHEM, V278, P14883, DOI 10.1074/jbc.M210840200; Blanch EW, 2004, J MOL BIOL, V343, P467, DOI 10.1016/j.jmb.2004.08.058; Capellari S, 2011, ACTA NEUROPATHOL, V121, P21, DOI 10.1007/s00401-010-0760-4; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Ehrnhoefer DE, 2011, NEUROSCIENTIST, V17, P475, DOI 10.1177/1073858410390378; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Fournier JG, 2008, CELL TISSUE RES, V332, P1, DOI 10.1007/s00441-007-0565-5; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frankenfield KN, 2005, PROTEIN SCI, V14, P2154, DOI 10.1110/ps.051434005; Fu XR, 2006, J BIOL CHEM, V281, P39014, DOI 10.1074/jbc.M512663200; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Garai K, 2013, P NATL ACAD SCI USA, V110, P3321, DOI 10.1073/pnas.1222478110; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; Giannopoulos PN, 2009, J NEUROSCI, V29, P8743, DOI 10.1523/JNEUROSCI.2294-09.2009; Gilbert NC, 2012, FASEB J, V26, P3222, DOI 10.1096/fj.12-205286; Gilch S, 2003, J BIOL CHEM, V278, P18524, DOI 10.1074/jbc.M210723200; Gill AC, 2000, EMBO J, V19, P5324, DOI 10.1093/emboj/19.20.5324; Gomes MPB, 2008, J BIOL CHEM, V283, P19616, DOI 10.1074/jbc.M802102200; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Helmus JJ, 2011, J AM CHEM SOC, V133, P13934, DOI 10.1021/ja206469q; Helmus JJ, 2010, J AM CHEM SOC, V132, P2393, DOI 10.1021/ja909827v; Heske J, 2004, J BIOL CHEM, V279, P5435, DOI 10.1074/jbc.M309570200; Jodoin J, 2007, J NEUROSCI, V27, P5081, DOI 10.1523/JNEUROSCI.0957-07.2007; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Jones EM, 2011, J BIOL CHEM, V286, P42777, DOI 10.1074/jbc.M111.302539; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kelleher I, 2007, J NEUROCHEM, V103, P2256, DOI 10.1111/j.1471-4159.2007.04930.x; Kretzschmar H, 2013, BRAIN PATHOL, V23, P321, DOI 10.1111/bpa.12045; Kumar S, 2011, EMBO J, V30, P2255, DOI 10.1038/emboj.2011.138; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Ladner-Keay CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098753; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; Liebl J, 2011, CELL SIGNAL, V23, P1698, DOI 10.1016/j.cellsig.2011.06.020; Liebl J, 2010, J BIOL CHEM, V285, P35932, DOI 10.1074/jbc.M110.126177; Lorenz H, 2002, J BIOL CHEM, V277, P8508, DOI 10.1074/jbc.M110197200; Magzoub M, 2006, BIOCHEM BIOPH RES CO, V348, P379, DOI 10.1016/j.bbrc.2006.07.065; Maji S. K., 2009, SCIENCE, V325, P328; Masujin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058013; Miller MB, 2013, STRUCTURE, V21, P2061, DOI 10.1016/j.str.2013.08.025; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Negro A, 2000, BIOCHEM BIOPH RES CO, V271, P337, DOI 10.1006/bbrc.2000.2628; Nishina K, 2004, BIOCHEMISTRY-US, V43, P2613, DOI 10.1021/bi035889l; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Qu DB, 2002, J BIOL CHEM, V277, P7324, DOI 10.1074/jbc.M107270200; Querfurth C, 2011, MOL CELL, V43, P713, DOI 10.1016/j.molcel.2011.06.033; Rahaman H, 2012, BIOCHEMISTRY-US, V51, P5521, DOI 10.1021/bi300380h; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Raveendra BL, 2013, NAT STRUCT MOL BIOL, V20, P495, DOI 10.1038/nsmb.2503; Schmitz M, 2014, NEUROBIOL AGING, V35, P1177, DOI 10.1016/j.neurobiolaging.2013.11.010; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; TATEISHI J, 1995, BRAIN PATHOL, V5, P53, DOI 10.1111/j.1750-3639.1995.tb00577.x; Turnbaugh JA, 2012, J NEUROSCI, V32, P8817, DOI 10.1523/JNEUROSCI.1103-12.2012; Tweedie-Cullen RY, 2009, J PROTEOME RES, V8, P4966, DOI 10.1021/pr9003739; Walmsley AR, 2003, J BIOL CHEM, V278, P37241, DOI 10.1074/jbc.M302036200; Wang F, 2010, BIOCHEMISTRY-US, V49, P8169, DOI 10.1021/bi101146v; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wang GR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-86; Watt B, 2009, J BIOL CHEM, V284, P35543, DOI 10.1074/jbc.M109.047449; Watzlawik J, 2006, J BIOL CHEM, V281, P30242, DOI 10.1074/jbc.M605141200; Yoshikawa D, 2008, J BIOL CHEM, V283, P24202, DOI 10.1074/jbc.M804212200; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396; Zhang J, 2008, P NATL ACAD SCI USA, V105, P8772, DOI 10.1073/pnas.0711355105	74	3	3	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5759	5771		10.1074/jbc.M114.630699	http://dx.doi.org/10.1074/jbc.M114.630699			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25572400	Green Published, hybrid			2022-12-26	WOS:000350044200043
J	Vallabhaneni, H; Zhou, F; Maul, RW; Sarkar, J; Yin, JH; Lei, M; Harrington, L; Gearhart, PJ; Liu, Y				Vallabhaneni, Haritha; Zhou, Fang; Maul, Robert W.; Sarkar, Jaya; Yin, Jinhu; Lei, Ming; Harrington, Lea; Gearhart, Patricia J.; Liu, Yie			Defective Repair of Uracil Causes Telomere Defects in Mouse Hematopoietic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID EXCHANGE; BASE EXCISION-REPAIR; SINGLE-STRANDED-DNA; REVERSE-TRANSCRIPTASE; LENGTH REGULATOR; FRAGILE SITES; POT1; TRF1; PROTEIN; DAMAGE	Calcium transients in the cell nucleus evoked by synaptic activity in hippocampal neurons function as a signaling end point in synapse-to-nucleus communication. As an important regulator of neuronal gene expression, nuclear calcium is involved in the conversion of synaptic stimuli into functional and structural changes of neurons. Here we identify two synaptic organizers, Lrrtm1 and Lrrtm2, as targets of nuclear calcium signaling. Expression of both Lrrtm1 and Lrrtm2 increased in a synaptic NMDA receptor- and nuclear calcium-dependent manner in hippocampal neurons within 2-4 h after the induction of action potential bursting. Induction of Lrrtm1 and Lrrtm2 occurred independently of the need for new protein synthesis and required calcium/calmodulin-dependent protein kinases and the nuclear calcium signaling target CREB-binding protein. Analysis of reporter gene constructs revealed a functional cAMP response element in the proximal promoter of Lrrtm2, indicating that at least Lrrtm2 is regulated by the classical nuclear Ca2+ /calmodulin-dependent protein kinase IV-CREB/CREB-binding protein pathway. These results suggest that one mechanism by which nuclear calcium signaling controls neuronal network function is by regulating the expression of Lrrtm1 and Lrrtm2.	[Vallabhaneni, Haritha; Zhou, Fang; Sarkar, Jaya; Yin, Jinhu; Liu, Yie] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Maul, Robert W.; Gearhart, Patricia J.] NIA, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA; [Lei, Ming] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai,State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Harrington, Lea] Univ Montreal, Inst Res Immunol & Canc, Dept Med, Montreal, PQ H3C 3J7, Canada	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Universite de Montreal	Gearhart, PJ (corresponding author), NIA, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA.	gearhartp@mail.nih.gov; liuyie@mail.nih.gov	Maul, Robert W./Y-6818-2019; Liu, Yie/AAO-2092-2020; Gearhart, Patricia/Y-7227-2019		Intramural Research Program of the National Institutes of Health, NIA; NATIONAL INSTITUTE ON AGING [ZIAAG000744, ZIAAG000777] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported entirely by the Intramural Research Program of the National Institutes of Health, NIA.	Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370; Badie S, 2010, NAT STRUCT MOL BIOL, V17, P1461, DOI 10.1038/nsmb.1943; Bailey SM, 2004, CYTOGENET GENOME RES, V107, P14, DOI 10.1159/000079565; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; COLLINS K, 1995, EMBO J, V14, P5422, DOI 10.1002/j.1460-2075.1995.tb00226.x; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Drosopoulos WC, 2007, NUCLEIC ACIDS RES, V35, P1155, DOI 10.1093/nar/gkm002; Frescas D, 2014, J BIOL CHEM, V289, P24180, DOI 10.1074/jbc.M114.592592; Frescas D, 2014, MOL CELL BIOL, V34, P1349, DOI 10.1128/MCB.01052-13; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Gomez M, 2006, MOL BIOL CELL, V17, P1686, DOI 10.1091/mbc.E05-07-0672; Gu PL, 2012, EMBO J, V31, P2309, DOI 10.1038/emboj.2012.96; Hammond PW, 1997, NUCLEIC ACIDS RES, V25, P3698, DOI 10.1093/nar/25.18.3698; HARRINGTON L, 1995, J BIOL CHEM, V270, P8893, DOI 10.1074/jbc.270.15.8893; He H, 2006, EMBO J, V25, P5180, DOI 10.1038/sj.emboj.7601294; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Huard S, 2004, NUCLEIC ACIDS RES, V32, P2171, DOI 10.1093/nar/gkh546; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Kavli B, 2002, J BIOL CHEM, V277, P39926, DOI 10.1074/jbc.M207107200; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Liu Y, 2000, CURR BIOL, V10, P1459, DOI 10.1016/S0960-9822(00)00805-8; Liu Y, 2012, MURINE MODELS DYSFUN; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Lu J, 2010, EMBO J, V29, P398, DOI 10.1038/emboj.2009.355; Lue NF, 2013, NAT STRUCT MOL BIOL, V20, P10, DOI 10.1038/nsmb.2483; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Maul RW, 2011, NAT IMMUNOL, V12, P70, DOI 10.1038/ni.1970; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; McNees CJ, 2010, J CELL BIOL, V188, P639, DOI 10.1083/jcb.200908136; Morrish TA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000357; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Nilsen H, 2003, ONCOGENE, V22, P5381, DOI 10.1038/sj.onc.1206860; Opresko PL, 2005, NUCLEIC ACIDS RES, V33, P1230, DOI 10.1093/nar/gki273; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Oulton R, 2004, MOL BIOL CELL, V15, P3244, DOI 10.1091/mbc.E04-03-0178; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Ramsay AJ, 2013, NAT GENET, V45, P526, DOI 10.1038/ng.2584; Rhee DB, 2010, HUM MOL GENET, V19, P879, DOI 10.1093/hmg/ddp556; Robles-Espinoza CD, 2014, NAT GENET, V46, P478, DOI 10.1038/ng.2947; Seow WJ, 2014, CANCER RES, V74, P4090, DOI 10.1158/0008-5472.CAN-14-0459; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Shi JX, 2014, NAT GENET, V46, P482, DOI 10.1038/ng.2941; Skordalakes E., 2012, TERT STRUCTURE FUNCT; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Taboski MAS, 2012, CELL REP, V1, P91, DOI 10.1016/j.celrep.2011.12.004; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Tzfati Y., 2012, TELOMERASE RNA STRUC; Vallabhaneni H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003639; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wan BB, 2013, CELL REP, V4, P861, DOI 10.1016/j.celrep.2013.08.017; Wang F, 2012, CELL RES, V22, P757, DOI 10.1038/cr.2011.201; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang YS, 2005, P NATL ACAD SCI USA, V102, P10256, DOI 10.1073/pnas.0504635102; Wang YS, 2005, CELL CYCLE, V4, P1320, DOI 10.4161/cc.4.10.2075; Wang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000951; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zhao Y, 2009, CELL, V138, P463, DOI 10.1016/j.cell.2009.05.026; Zheng YL, 2014, CELL CYCLE, V13, DOI 10.4161/cc.28705	68	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5502	5511		10.1074/jbc.M114.607101	http://dx.doi.org/10.1074/jbc.M114.607101			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25572391	Green Published, hybrid			2022-12-26	WOS:000350044200022
J	Sadegh, MK; Ekman, M; Krawczyk, K; Svensson, D; Goransson, O; Dahan, D; Nilsson, BO; Albinsson, S; Uvelius, B; Sward, K				Sadegh, Mardjaneh Karbalaei; Ekman, Mari; Krawczyk, Katarzyna; Svensson, Daniel; Goransson, Olga; Dahan, Diana; Nilsson, Bengt-Olof; Albinsson, Sebastian; Uvelius, Bengt; Sward, Karl			Detrusor Induction of miR-132/212 following Bladder Outlet Obstruction: Association with MeCP2 Repression and Cell Viability	PLOS ONE			English	Article							INDUCED MICRORNA; CIRCADIAN-CLOCK; EXPRESSION; DIFFERENTIATION; HYPERTROPHY; HYPERPLASIA; PLASTICITY; COMPLEX; CREB; RAT	The microRNAs (miRNAs) miR-132 and miR-212 have been found to regulate synaptic plasticity and cholinergic signaling and recent work has demonstrated roles outside of the CNS, including in smooth muscle. Here, we examined if miR-132 and miR-212 are induced in the urinary bladder following outlet obstruction and whether this correlates with effects on gene expression and cell growth. Three to seven-fold induction of miR-132/212 was found at 10 days of obstruction and this was selective for the detrusor layer. We cross-referenced putative binding sites in the miR-132/212 promoter with transcription factors that were predicted to be active in the obstruction model. This suggested involvement of Creb and Ahr in miR-132/212 induction. Creb phosphorylation (S-133) was not increased, but the number of Ahr positive nuclei increased. Moreover, we found that serum stimulation and protein kinase C activation induced miR-132/212 in human detrusor cells. To identify miR-132/212 targets, we correlated the mRNA levels of validated targets with the miRNA levels. Significant correlations between miR-132/212 and MeCP2, Ep300, Pnkd and Jarid1a were observed, and the protein levels of MeCP2, Pnkd and Ache were reduced after obstruction. Reduction of Ache however closely matched a 90% reduction of synapse density arguing that its repression was unrelated to miR-132/212 induction. Importantly, transfection of antimirs and mimics in cultured detrusor cells increased and decreased, respectively, the number of cells and led to changes in MeCP2 expression. In all, these findings show that obstruction of the urethra increases miR-132 and miR-212 in the detrusor and suggests that this influences gene expression and limits cell growth.	[Sadegh, Mardjaneh Karbalaei; Ekman, Mari; Krawczyk, Katarzyna; Svensson, Daniel; Goransson, Olga; Dahan, Diana; Nilsson, Bengt-Olof; Albinsson, Sebastian; Sward, Karl] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Uvelius, Bengt] Lund Univ, Dept Clin Sci, Lund, Sweden; [Ekman, Mari] Lund Univ, Dept Biol, Lund, Sweden	Lund University; Lund University; Lund University	Sward, K (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	karl.sward@med.lu.se	Svensson, Daniel/D-4497-2015; Svensson, Daniel/C-6279-2014; Albinsson, Sebastian/B-4105-2010	Svensson, Daniel/0000-0001-6670-2142; Svensson, Daniel/0000-0001-6670-2142; Albinsson, Sebastian/0000-0001-6936-3967; Goransson, Olga/0000-0002-7209-8022; Uvelius, Bengt/0000-0003-0201-8928; Sward, Karl/0000-0002-7255-5510	Swedish Research Council; Greta and Johan Kock's Foundation; Crafoord Foundation; Medical Faculty at Lund University; Gosta Jonsson's foundation; Olle Engkvist Byggmastare's foundation; Swedish National Health Service (ALF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Greta and Johan Kock's Foundation; Crafoord Foundation; Medical Faculty at Lund University; Gosta Jonsson's foundation; Olle Engkvist Byggmastare's foundation; Swedish National Health Service (ALF)	This study was financially supported by The Swedish Research Council, The Greta and Johan Kock's Foundation, The Crafoord Foundation, The Medical Faculty at Lund University, Gosta Jonsson's foundation, Olle Engkvist Byggmastare's foundation and a clinical grant from the Swedish National Health Service (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018869; Alvarez-Saavedra M, 2011, HUM MOL GENET, V20, P731, DOI 10.1093/hmg/ddq519; Alvarez-Saavedra M, 2010, HUM MOL GENET, V19, P2177, DOI 10.1093/hmg/ddq096; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Cambronne XA, 2012, P NATL ACAD SCI USA, V109, P20473, DOI 10.1073/pnas.1218887109; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chang AY, 2011, AM J PHYSIOL-RENAL, V301, pF813, DOI 10.1152/ajprenal.00586.2010; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cheng TL, 2014, DEV CELL, V28, P547, DOI 10.1016/j.devcel.2014.01.032; Choe N, 2013, ATHEROSCLEROSIS, V229, P348, DOI 10.1016/j.atherosclerosis.2013.05.009; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Ekman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082308; Eskildsen TV, 2013, INT J MOL SCI, V14, P11190, DOI 10.3390/ijms140611190; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; GABELLA G, 1990, CELL TISSUE RES, V262, P67, DOI 10.1007/BF00327747; Gheinani AH, 2014, 29 ANN EAU C STOCKH; Hu B, 2011, AM J PATHOL, V178, P1500, DOI 10.1016/j.ajpath.2011.01.002; Im HI, 2010, NAT NEUROSCI, V13, P1120, DOI 10.1038/nn.2615; Jin W, 2012, J BIOL CHEM, V287, P15672, DOI 10.1074/jbc.M111.322669; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; LINDNER P, 1988, J UROLOGY, V140, P642, DOI 10.1016/S0022-5347(17)41746-0; Mellios N, 2011, NAT NEUROSCI, V14, P1240, DOI 10.1038/nn.2909; Nakahama T, 2013, P NATL ACAD SCI USA, V110, P11964, DOI 10.1073/pnas.1311087110; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Sadegh MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035882; Sadegh MK, 2011, BRIT J PHARMACOL, V162, P1156, DOI 10.1111/j.1476-5381.2010.01115.x; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Tognini P, 2011, NAT NEUROSCI, V14, P1237, DOI 10.1038/nn.2920; Turczynska KM, 2012, J BIOL CHEM, V287, P19199, DOI 10.1074/jbc.M112.341073; Ucar A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2090; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151	34	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116784	10.1371/journal.pone.0116784	http://dx.doi.org/10.1371/journal.pone.0116784			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617893	gold, Green Published, Green Submitted			2022-12-26	WOS:000350336000026
J	Asghar, MS; Pereira, MP; Werner, MU; Martensson, J; Larsson, HBW; Dahl, JB				Asghar, Mohammad Sohail; Pereira, Manuel Pedro; Werner, Mads Utke; Martensson, Johan; Larsson, Henrik B. W.; Dahl, Jorgen Berg			Secondary Hyperalgesia Phenotypes Exhibit Differences in Brain Activation during Noxious Stimulation	PLOS ONE			English	Article							CENTRAL SENSITIZATION; CAUDATE-NUCLEUS; HEAT INJURY; PAIN; MODEL; SEGMENTATION; MODULATION; DEPRESSION; PREDICTION; NETWORK	Noxious stimulation of the skin with either chemical, electrical or heat stimuli leads to the development of primary hyperalgesia at the site of injury, and to secondary hyperalgesia in normal skin surrounding the injury. Secondary hyperalgesia is inducible in most individuals and is attributed to central neuronal sensitization. Some individuals develop large areas of secondary hyperalgesia (high-sensitization responders), while others develop small areas (low-sensitization responders). The magnitude of each area is reproducible within individuals, and can be regarded as a phenotypic characteristic. To study differences in the propensity to develop central sensitization we examined differences in brain activity and anatomy according to individual phenotypical expression of secondary hyperalgesia by magnetic resonance imaging. Forty healthy volunteers received a first-degree burn-injury (47 degrees C, 7 min, 9 cm(2)) on the non-dominant lower-leg. Areas of secondary hyperalgesia were assessed 100 min after the injury. We measured neuronal activation by recording bloodoxygen- level-dependent-signals (BOLD-signals) during mechanical noxious stimulation before burn injury and in both primary and secondary hyperalgesia areas after burn-injury. In addition, T1-weighted images were used to measure differences in gray-matter density in cortical and subcortical regions of the brain. We found significant differences in neuronal activity between high-and low-sensitization responders at baseline (before application of the burn-injury) (p < 0.05). After the burn-injury, we found significant differences between responders during noxious stimulation of both primary (p < 0.01) and secondary hyperalgesia (p = 0.04) skin areas. A decreased volume of the right (p = 0.001) and left caudate nucleus (p = 0.01) was detected in high-sensitization responders in comparison to low-sensitization responders. These findings suggest that brain-structure and neuronal activation to noxious stimulation differs according to secondary hyperalgesia phenotype. This indicates differences in central sensitization according to phenotype, which may have predictive value on the susceptibility to development of high-intensity acute and persistent pain.	[Asghar, Mohammad Sohail; Pereira, Manuel Pedro; Dahl, Jorgen Berg] Copenhagen Univ Hosp, Rigshosp, Ctr Head & Orthopaed, Dept Anaesthesia, Copenhagen, Denmark; [Werner, Mads Utke] Copenhagen Univ Hosp, Rigshosp, Ctr Neurosci, Ctr Multidisciplinary Pain, Copenhagen, Denmark; [Martensson, Johan] Max Planck Inst Human Dev, Berlin, Germany; [Martensson, Johan] Lund Univ, Dept Psychol, Lund, Sweden; [Larsson, Henrik B. W.] Copenhagen Univ Hosp, Glostrup Hosp, Funct Imaging Unit, Glostrup, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Max Planck Society; Lund University; University of Copenhagen	Asghar, MS (corresponding author), Copenhagen Univ Hosp, Rigshosp, Ctr Head & Orthopaed, Dept Anaesthesia, Copenhagen, Denmark.	sohail@dadlnet.dk	Pereira, Manuel Pedro/AAP-8484-2020	Werner, Mads/0000-0003-1540-8845	Danish Society for Anaesthesiology and Intensive Medicine (DASAIM); Sofus Johannesens Foundation; Torben and Alice Frimodts Foundation; Aase and Einar Danielsens Foundation	Danish Society for Anaesthesiology and Intensive Medicine (DASAIM); Sofus Johannesens Foundation; Torben and Alice Frimodts Foundation; Aase and Einar Danielsens Foundation	The study was supported by grants from Danish Society for Anaesthesiology and Intensive Medicine (DASAIM), The Sofus Johannesens Foundation, Torben and Alice Frimodts Foundation, and Aase and Einar Danielsens Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author had full access to all the study data and had the final responsibility to submit for publication.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Baum C, 2011, PERCEPT MOTOR SKILL, V112, P926, DOI 10.2466/02.09.22.PMS.112.3.926-946; Bromm B, 2001, NEWS PHYSIOL SCI, V16, P244; Brooks J, 2005, TCE-THE CHEM ENG, P19; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; CHUDLER EH, 1995, PAIN, V60, P3, DOI 10.1016/0304-3959(94)00172-B; Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; DAHL JB, 1993, PAIN, V53, P43, DOI 10.1016/0304-3959(93)90054-S; de Lange FP, 2004, BRAIN, V127, P1948, DOI 10.1093/brain/awh225; Dirks J, 2002, ANESTHESIOLOGY, V97, P102, DOI 10.1097/00000542-200207000-00015; DIXON WJ, 1991, NEUROSCI BIOBEHAV R, V15, P47, DOI 10.1016/S0149-7634(05)80090-9; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Emerson NM, 2013, PAIN SENSITIVITY IS; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Iannetti GD, 2005, P NATL ACAD SCI USA, V102, P18195, DOI 10.1073/pnas.0506624102; Koppert W, 2001, ANESTHESIOLOGY, V95, P395, DOI 10.1097/00000542-200108000-00022; KRISHNAN KRR, 1992, ARCH GEN PSYCHIAT, V49, P553; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lautenbacher S, 2010, PAIN, V151, P722, DOI 10.1016/j.pain.2010.08.041; Martinez V, 2012, PAIN, V153, P1478, DOI 10.1016/j.pain.2012.04.004; MOINICHE S, 1993, BRIT J ANAESTH, V71, P201, DOI 10.1093/bja/71.2.201; MOUNTZ JM, 1995, ARTHRITIS RHEUM, V38, P926, DOI 10.1002/art.1780380708; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Oshiro Y, 2007, J NEUROSCI, V27, P3388, DOI 10.1523/JNEUROSCI.5128-06.2007; Paulus MP, 2005, NEUROIMAGE, V25, P607, DOI 10.1016/j.neuroimage.2004.12.055; Petersen KL, 1999, NEUROREPORT, V10, P1511, DOI 10.1097/00001756-199905140-00022; Petersen KL, 2001, ANESTHESIOLOGY, V94, P15, DOI 10.1097/00000542-200101000-00008; Peyron R, 2004, NEUROLOGY, V63, P1838, DOI 10.1212/01.WNL.0000144177.61125.85; Pleger B, 2004, EXP BRAIN RES, V155, P115, DOI 10.1007/s00221-003-1738-4; Ravn Pernille, 2012, J Pain Res, V5, P313, DOI 10.2147/JPR.S33925; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Reyns N, 2013, CLIN NEUROPHYSIOL, V124, P761, DOI 10.1016/j.clinph.2012.10.011; Rijpkema M, 2012, HUM BRAIN MAPP, V33, P1246, DOI 10.1002/hbm.21283; ROBINSON D, 1995, ARCH GEN PSYCHIAT, V52, P393; Salengros JC, 2010, J CARDIOTHOR VASC AN, V24, P608, DOI 10.1053/j.jvca.2009.10.006; Salomons TV, 2014, PAIN, V155, P1446, DOI 10.1016/j.pain.2014.02.012; SKULLERUD K, 1985, ACTA NEUROL SCAND, V71, P5; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tang TY, 2013, NEUROSCI LETT, V556, P79, DOI 10.1016/j.neulet.2013.09.060; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069; Veldhuijzen DS, 2009, PAIN, V141, P104, DOI 10.1016/j.pain.2008.10.027; Werner MU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062733; Werner MU, 2004, ANESTHESIOLOGY, V100, P115, DOI 10.1097/00000542-200401000-00020; Wiech K, 2005, NEUROIMAGE, V27, P59, DOI 10.1016/j.neuroimage.2005.03.044; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Wunderlich Arthur P, 2011, Open Neuroimag J, V5, P1, DOI 10.2174/1874440001105010001; Yan B, 2005, NEUROSCI LETT, V383, P236, DOI 10.1016/j.neulet.2005.04.021; Zambreanu L, 2005, PAIN, V114, P397, DOI 10.1016/j.pain.2005.01.005	56	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0114840	10.1371/journal.pone.0114840	http://dx.doi.org/10.1371/journal.pone.0114840			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615578	Green Published, Green Submitted, gold			2022-12-26	WOS:000349122100005
J	Kwon, JY; Park, BS; Kim, YH; Kim, YD; Kim, CH; Yoon, Y; Yoon, JU				Kwon, Jae-Young; Park, Bong-Soo; Kim, Yong-Ho; Kim, Yong-Deok; Kim, Cheul-Hong; Yoon, Young; Yoon, Ji-Uk			Remifentanil Protects Human Keratinocytes against Hypoxia-Reoxygenation Injury through Activation of Autophagy	PLOS ONE			English	Article							ATG16L1; MOUSE; CELLS	The proliferation, differentiation, and migration of keratinocytes are essential in the early stages of wound healing. Hypoxia-Reoxygenation (H/R) injury to keratinocytes can occur in various stressful environments such as surgery, trauma, and various forms of ulcers. The effects of remifentanil on human keratinocytes under hypoxia-reoxygenation have not been fully studied. Therefore, we investigated the effects of remifentanil on the proliferation, apoptosis, and autophagic activation of human keratinocytes during hypoxic-reoxygenation. Human keratinocytes were cultured under 1% oxygen tension for 24 h. The cells were then treated with various concentrations of remifentanil (0.01, 0.1, 0.5, and 1 ng/mL) for 2 h. Thereafter, the cells were reoxygenated for 12 h at 37 degrees C. We measured cell viability via MTT assay. Using quantitative real-time PCR and western blot analysis, we measured the expression levels of proteins associated with apoptosis and autophagy. Quantification of apoptotic cells was performed using flow cytometer analysis and autophagic vacuoles were observed under a fluorescence microscope. Remifentanil treatment brought about an increase in the proliferation of human keratinocytes damaged by hypoxia-reoxygenation and decreased the apoptotic cell death, enhancing autophagic activity. However, the autophagy pathway inhibitor 3-MA inhibited the protective effect of remifentanil in hypoxiareoxygenation injury. In conclusion, the current study demonstrated that remifentanil treatment stimulated autophagy and reduced apoptotic cell death in a hypoxiareoxygenation model of human keratinocytes. Our results provide additional insights into the relationship between apoptosis and autophagy.	[Kwon, Jae-Young; Yoon, Ji-Uk] Pusan Natl Univ, Sch Med, Dept Anesthesia & Pain Med, Yangsan, South Korea; [Park, Bong-Soo; Kim, Yong-Ho] Pusan Natl Univ, Sch Dent, Dept Oral Anat, Yangsan, South Korea; [Kim, Yong-Deok] Pusan Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Yangsan, South Korea; [Kim, Cheul-Hong; Yoon, Young] Pusan Natl Univ, Sch Dent, Dept Dent Anesthesia & Pain Med, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Yoon, JU (corresponding author), Pusan Natl Univ, Sch Med, Dept Anesthesia & Pain Med, Yangsan, South Korea.	jiuk@pusan.ac.kr		Kim, Cheul Hong/0000-0003-1536-9460	medical Research Institute Grant, Pusan National University Hospital, Korea [2009-18]	medical Research Institute Grant, Pusan National University Hospital, Korea	This study was supported by medical Research Institute Grant (2009-18), Pusan National University Hospital, Korea [www.pnuh.co.kr]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cepero E, 2005, ONCOGENE, V24, P6354, DOI 10.1038/sj.onc.1208793; Coulombe PA, 2003, J INVEST DERMATOL, V121, P219, DOI 10.1046/j.1523-1747.2003.12387.x; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lazarides M K, 2007, Int J Low Extrem Wounds, V6, P254, DOI 10.1177/1534734607306878; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mustoe TA, 2006, PLAST RECONSTR SURG, V117, p35S, DOI 10.1097/01.prs.0000225431.63010.1b; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; Schwarten M, 2009, AUTOPHAGY, V5, P690, DOI 10.4161/auto.5.5.8494; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Wong GTC, 2010, J CARDIOTHOR VASC AN, V24, P790, DOI 10.1053/j.jvca.2009.09.012; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu WL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-24; Zhang ZZ, 2010, MOL BIOL REP, V37, P2803, DOI 10.1007/s11033-009-9828-4	23	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116982	10.1371/journal.pone.0116982	http://dx.doi.org/10.1371/journal.pone.0116982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615605	Green Submitted, Green Published, gold			2022-12-26	WOS:000349122100051
J	Nie, ZY; Kang, GJ; Li, Y; Dai, LJ; Zeng, RZ				Nie Zhiyi; Kang Guijuan; Li Yu; Dai Longjun; Zeng Rizhong			Whole-Transcriptome Survey of the Putative ATP-Binding Cassette (ABC) Transporter Family Genes in the Latex-Producing Laticifers of Hevea brasiliensis	PLOS ONE			English	Article							FUNCTIONAL CLASSIFICATION; RUBBER BIOSYNTHESIS; ARABIDOPSIS; PROTEIN; ACID; RESISTANCE; TRAFFICKING; EXPRESSION; MEMBRANE; OVEREXPRESSION	The ATP-binding cassette (ABC) proteins or transporters constitute a large protein family in plants and are involved in many different cellular functions and processes, including solute transportation, channel regulation and molecular switches, etc. Through transcriptome sequencing, a transcriptome-wide survey and expression analysis of the ABC protein genes were carried out using the laticiferous latex from Hevea brasiliensis (rubber tree). A total of 46 putative ABC family proteins were identified in the H. brasiliensis latex. These consisted of 12 'full-size', 21 'half-size' and 13 other putative ABC proteins, and all of them showed strong conservation with their Arabidopsis thaliana counterparts. This study indicated that all eight plant ABC protein paralog subfamilies were identified in the H. brasiliensis latex, of which ABCB, ABCG and ABCI were the most abundant. Real-time quantitative reverse transcription-polymerase chain reaction assays demonstrated that gene expression of several latex ABC proteins was regulated by ethylene, jasmonic acid or bark tapping (a wound stress) stimulation, and that HbABCB15, HbABCB19, HbABCD1 and HbABCG21 responded most significantly of all to the abiotic stresses. The identification and expression analysis of the latex ABC family proteins could facilitate further investigation into their physiological involvement in latex metabolism and rubber biosynthesis by H. brasiliensis.	[Zeng Rizhong] Chinese Acad Trop Agr Sci, Key Lab Biol & Genet Resources Rubber Tree, Minist Agr, Danzhou 571737, Hainan, Peoples R China; Chinese Acad Trop Agr Sci, Rubber Res Inst, Danzhou 571737, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Tropical Agricultural Sciences	Zeng, RZ (corresponding author), Chinese Acad Trop Agr Sci, Key Lab Biol & Genet Resources Rubber Tree, Minist Agr, Danzhou 571737, Hainan, Peoples R China.	hnzrz@aliyun.com			National Natural Science Foundation;  [31070607];  [31270713]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); ; 	This work was supported by the National Natural Science Foundation with the website of (http://www.nsfc.gov.cn). The grant numbers are 31070607 and 31270713, which were received by the authors of NZY and ZRZ, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMALOU Z, 1992, PLANT PHYSIOL, V98, P1270, DOI 10.1104/pp.98.4.1270; Awai K, 2006, P NATL ACAD SCI USA, V103, P10817, DOI 10.1073/pnas.0602754103; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernard DG, 2009, PLANT PHYSIOL, V151, P590, DOI 10.1104/pp.109.143651; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Bouige P, 2002, CURR PROTEIN PEPT SC, V3, P541, DOI 10.2174/1389203023380486; Boursiac Y, 2013, TRENDS PLANT SCI, V18, P325, DOI 10.1016/j.tplants.2013.01.007; Burla B, 2013, PLANT PHYSIOL, V163, P1446, DOI 10.1104/pp.113.222547; Cakir B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078860; CARCIA O, 2004, J MOL BIOL, V343, P249, DOI DOI 10.1016/J.JMB.2004.07.093; CHAO CJ, 2012, MOL MED, V18, P149; Cho M, 2012, PLANT PHYSIOL, V159, P642, DOI 10.1104/pp.112.196139; Chow KS, 2012, J EXP BOT, V63, P1863, DOI 10.1093/jxb/err363; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cornish K, 1999, PLANTA, V210, P85, DOI 10.1007/s004250050657; Cornish K, 2001, PHYTOCHEMISTRY, V57, P1123, DOI 10.1016/S0031-9422(01)00097-8; d'Auzac J, 1989, PHYSL RUBBER TREE LA, P89; Dai LJ, 2013, PLANT MOL BIOL, V82, P155, DOI 10.1007/s11103-013-0047-y; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; DAUZAC J, 1995, PLANT PHYSIOL BIOCH, V33, P765; De Faiy E., 1989, PHYSL RUBBER TREE LA, P15; de Fay E, 1989, PHYSL RUBBER TREE LA, P3, DOI DOI 10.1111/J.1432-2277.2005.00166.X.; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Duan C, 2010, TREE PHYSIOL, V30, P1349, DOI 10.1093/treephys/tpq066; Dusotoit-Coucaud A, 2009, ANN BOT-LONDON, V104, P635, DOI 10.1093/aob/mcp150; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichhorn H, 2006, J EXP BOT, V57, P2193, DOI 10.1093/jxb/erj179; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Footitt S, 2002, EMBO J, V21, P2912, DOI 10.1093/emboj/cdf300; Francisco RM, 2013, PLANT CELL, V25, P1840, DOI 10.1105/tpc.112.102152; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grec S, 2003, PLANT J, V35, P237, DOI 10.1046/j.1365-313X.2003.01792.x; Green P, 1996, PHRAP DOCUMENTATION; Hao BZ, 2000, ANN BOT-LONDON, V85, P37, DOI 10.1006/anbo.1999.0995; HASMA H, 1986, Journal of Natural Rubber Research, V1, P30; Herman E, 2004, PLANT PHYSIOL, V136, P3440, DOI 10.1104/pp.104.051722; Hillebrand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041874; Kaneda M, 2011, J EXP BOT, V62, P2063, DOI 10.1093/jxb/erq416; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; KEKWICK RGO, 1989, PHYSL RUBBER TREE LA, P146; Kim DY, 2010, PHYSIOL PLANTARUM, V139, P170, DOI 10.1111/j.1399-3054.2010.01353.x; Kim S, 2013, P NATL ACAD SCI USA, V110, P773, DOI 10.1073/pnas.1214159110; Klein M, 2006, FEBS LETT, V580, P1112, DOI 10.1016/j.febslet.2005.11.056; Kuromori T, 2010, P NATL ACAD SCI USA, V107, P2361, DOI 10.1073/pnas.0912516107; Le Hir R, 2013, PLANT J, V76, P811, DOI 10.1111/tpj.12334; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Lee M, 2008, NAT CELL BIOL, V10, P1217, DOI 10.1038/ncb1782; Lu BB, 2007, J BIOL CHEM, V282, P35945, DOI 10.1074/jbc.M704063200; Mantello CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102665; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Marin E, 2006, PLANT SCI, V171, P84, DOI 10.1016/j.plantsci.2006.02.014; Mendiondo GM, 2014, J EXP BOT, V65, P4833, DOI 10.1093/jxb/eru243; Mentewab A, 2005, NAT BIOTECHNOL, V23, P1177, DOI 10.1038/nbt1134; Pang KY, 2013, GENE, V526, P411, DOI 10.1016/j.gene.2013.05.051; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Post J, 2012, PLANT PHYSIOL, V158, P1406, DOI 10.1104/pp.111.187880; Rayapuram N, 2007, J BIOL CHEM, V282, P21015, DOI 10.1074/jbc.M704091200; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Schmitz G, 2000, CURR OPIN LIPIDOL, V11, P493, DOI 10.1097/00041433-200010000-00007; Shimoni-Shor E, 2010, PLANT CELL ENVIRON, V33, P1029, DOI 10.1111/j.1365-3040.2010.02124.x; Stukkens Y, 2005, PLANT PHYSIOL, V139, P341, DOI 10.1104/pp.105.062372; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang CR, 2010, PLANT CELL ENVIRON, V33, P1708, DOI 10.1111/j.1365-3040.2010.02175.x; Tang CK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060038, 10.1371/journal.pone.0075307, 10.1371/journal.pone.0061093]; Teschner J, 2010, PLANT CELL, V22, P468, DOI 10.1105/tpc.109.068478; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI [10.1016/S0005-2736(00)00132-2, 10.1199/tab.0153]; Theodoulou FL, 2006, FEBS LETT, V580, P1139, DOI 10.1016/j.febslet.2005.12.095; Theodoulou FL, 2005, PLANT PHYSIOL, V137, P835, DOI 10.1104/pp.105.059352; Titapiwatanakun B, 2009, J EXP BOT, V60, P1093, DOI 10.1093/jxb/ern240; Tupy J., 1989, PHYSL RUBBER TREE LA, P179; van Beilen JB, 2007, TRENDS BIOTECHNOL, V25, P522, DOI 10.1016/j.tibtech.2007.08.009; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Xu CC, 2005, PLANT CELL, V17, P3094, DOI 10.1105/tpc.105.035592; Xu CC, 2003, EMBO J, V22, P2370, DOI 10.1093/emboj/cdg234; Xu XM, 2005, J BIOL CHEM, V280, P6648, DOI 10.1074/jbc.M413082200; Xu XM, 2004, P NATL ACAD SCI USA, V101, P9143, DOI 10.1073/pnas.0400799101; Xu YX, 2014, PLANT J, V79, P106, DOI 10.1111/tpj.12544; Yazaki K, 2006, FEBS LETT, V580, P1183, DOI 10.1016/j.febslet.2005.12.009; Yazaki K, 2009, INT REV CEL MOL BIO, V276, P263, DOI 10.1016/S1937-6448(09)76006-X; Zeng RZ, 2009, PLANT SCI, V176, P602, DOI 10.1016/j.plantsci.2009.01.009; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550	86	13	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116857	10.1371/journal.pone.0116857	http://dx.doi.org/10.1371/journal.pone.0116857			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615936	Green Published, gold, Green Submitted			2022-12-26	WOS:000349122100046
J	Funakoshi, S; Shimizu, T; Numata, O; Ato, M; Melchers, F; Ohnishi, K				Funakoshi, Shuichi; Shimizu, Takeyuki; Numata, Osamu; Ato, Manabu; Melchers, Fritz; Ohnishi, Kazuo			BILL-Cadherin/Cadherin-17 Contributes to the Survival of Memory B Cells	PLOS ONE			English	Article							LIVER-INTESTINE CADHERIN; BONE-MARROW; EPITHELIAL-CELLS; ADHESION; EXPRESSION; INTEGRIN; LOCALIZATION; HOMEOSTASIS; MARKER	Memory B cells (MBCs) and long-lived plasma cells (LLPCs) are responsible for immunological "memory", which can last for many years. The long-term survival niche for LLPCs in the bone marrow is well characterized; however, the corresponding niche for MBCs is unclear. BILL-cadherin/cadherin-17 (CDH17) is the only member of the cadherin superfamily that is expressed on mouse B lymphocytes in a spatiotemporally regulated manner. Here, we show that half of all MBCs regain expression of CDH17 during the later stage of development. The maintenance of high affinity antigen-specific serum antibodies was impaired in CDH17(-/-)mice and the number of antigen-specific MBCs was reduced as compared to wildtype mice (WT). Also, specific responses to secondary antigens were ablated in CDH17(-/-)mice, whereas primary antibody responses were the same as those in WT mice. Cell cycle analysis revealed a decline in the proliferation of CDH17-MBCs as compared to CDH17(+) MBCs. In addition, we identified a subpopulation of splenic stromal cells, MAdCAM-1(+) blood endothelial cells (BEC), which was CDH17(+). Taken together, these results suggest that CDH17 plays a role in the long-term survival of MBCs, presumably via an "MBC niche" comprising, at least in part, BEC in the spleen.	[Funakoshi, Shuichi] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki, Japan; [Shimizu, Takeyuki] Kochi Univ, Dept Immunol, Kochi Med Sch, Kochi 780, Japan; [Numata, Osamu] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki, Japan; [Melchers, Fritz] Max Planck Inst Infect Biol, Res Grp Lymphocyte Dev, Berlin, Germany; [Funakoshi, Shuichi; Ato, Manabu; Ohnishi, Kazuo] Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan	University of Tsukuba; Kochi University; University of Tsukuba; Max Planck Society; National Institute of Infectious Diseases (NIID)	Ohnishi, K (corresponding author), Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan.	ohnishik@nih.go.jp	Ato, Manabu/K-6452-2019	Ato, Manabu/0000-0002-3178-2645	Health Science Foundation in the Ministry of Health, Labor and Welfare, Japan [KHC1015, KHC1218, H26-Shinkoujitsuyouka-Ippan-017]	Health Science Foundation in the Ministry of Health, Labor and Welfare, Japan	This work was supported by grants from the Health Science Foundation in the Ministry of Health, Labor and Welfare, Japan (to K.O., KHC1015, KHC1218; to M.A., H26-Shinkoujitsuyouka-Ippan-017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Angres B, 2001, DEV DYNAM, V221, P182, DOI 10.1002/dvdy.1146; Bartolome RA, 2014, ONCOGENE, V33, P1658, DOI 10.1038/onc.2013.117; Baumgartner W, 2008, J MOL BIOL, V378, P44, DOI 10.1016/j.jmb.2008.02.023; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; BERNDORFF D, 1994, J CELL BIOL, V125, P1353, DOI 10.1083/jcb.125.6.1353; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; BRUGGEMANN M, 1986, EMBO J, V5, P1561, DOI 10.1002/j.1460-2075.1986.tb04397.x; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; DUNNWALTERS DK, 1995, J EXP MED, V182, P559, DOI 10.1084/jem.182.2.559; Fairfax KA, 2008, SEMIN IMMUNOL, V20, P49, DOI 10.1016/j.smim.2007.12.002; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Hutcheson J, 2008, IMMUNITY, V28, P206, DOI 10.1016/j.immuni.2007.12.015; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Jones D, 2000, BLOOD, V95, P627, DOI 10.1182/blood.V95.2.627; KARECLA PI, 1995, EUR J IMMUNOL, V25, P852, DOI 10.1002/eji.1830250333; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; KRAAL G, 1995, AM J PATHOL, V147, P763; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lee NP, 2010, BBA-REV CANCER, V1806, P138, DOI 10.1016/j.bbcan.2010.05.002; Liu LX, 2009, HEPATOLOGY, V50, P1453, DOI 10.1002/hep.23143; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Ohnishi K, 2000, J BIOL CHEM, V275, P31134, DOI 10.1074/jbc.M005901200; Ohnishi K, 2005, EUR J IMMUNOL, V35, P957, DOI 10.1002/eji.200425853; Qiu HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056959; Su MC, 2008, MODERN PATHOL, V21, P1379, DOI 10.1038/modpathol.2008.107; Takamura M, 2004, CANCER LETT, V212, P253, DOI 10.1016/j.canlet.2004.03.016; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Tokoyoda K, 2010, NAT REV IMMUNOL, V10, P193, DOI 10.1038/nri2727; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Wendeler MW, 2007, J MOL BIOL, V370, P220, DOI 10.1016/j.jmb.2007.04.062; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440	46	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0117566	10.1371/journal.pone.0117566	http://dx.doi.org/10.1371/journal.pone.0117566			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25612318	Green Published, gold, Green Submitted			2022-12-26	WOS:000348562900036
J	Caley, P; Ramsey, DSL; Barry, SC				Caley, Peter; Ramsey, David S. L.; Barry, Simon C.			Inferring the Distribution and Demography of an Invasive Species from Sighting Data: The Red Fox Incursion into Tasmania	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; VULPES-VULPES; MODEL SELECTION; UNCERTAINTY; POPULATION; EXTINCTION; PARAMETER; RECORDS	A recent study has inferred that the red fox (Vulpes vulpes) is now widespread in Tasmania as of 2010, based on the extraction of fox DNA from predator scats. Heuristically, this inference appears at first glance to be at odds with the lack of recent confirmed discoveries of either road-killed foxes-the last of which occurred in 2006, or hunter killed foxes-the most recent in 2001. This paper demonstrates a method to codify this heuristic analysis and produce inferences consistent with assumptions and data. It does this by formalising the analysis in a transparent and repeatable manner to make inference on the past, present and future distribution of an invasive species. It utilizes Approximate Bayesian Computation to make inferences. Importantly, the method is able to inform management of invasive species within realistic time frames, and can be applied widely. We illustrate the technique using the Tasmanian fox data. Based on the pattern of carcass discoveries of foxes in Tasmania, we infer that the population of foxes in Tasmania is most likely extinct, or restricted in distribution and demographically weak as of 2013. It is possible, though unlikely, that that population is widespread and/or demographically robust. This inference is largely at odds with the inference from the predator scat survey data. Our results suggest the chances of successfully eradicating the introduced red fox population in Tasmania may be significantly higher than previously thought.	[Caley, Peter; Barry, Simon C.] Commonwealth Sci & Ind Res Org, Canberra, ACT, Australia; [Ramsey, David S. L.] Arthur Rylah Inst, Dept Sustainabil & Environm, Victoria, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Caley, P (corresponding author), Commonwealth Sci & Ind Res Org, Canberra, ACT, Australia.	peter.caley@csiro.au	Caley, Peter/D-8638-2011	Caley, Peter/0000-0002-8077-6460	Australian Pest Animal Research Program Round 3 [GMS1520]; CSIRO Biosecurity Flagship	Australian Pest Animal Research Program Round 3; CSIRO Biosecurity Flagship	Funding was provided by the Australian Pest Animal Research Program Round 3 2011-12 (Project GMS1520) and the CSIRO Biosecurity Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Blackman D, 2013, ARE THERE REALLY FOX; Caley P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095857; Catterall S, 2012, ECOGRAPHY, V35, P901, DOI 10.1111/j.1600-0587.2011.07190.x; COMAN BJ, 1991, WILDLIFE RES, V18, P215, DOI 10.1071/WR9910215; Field SA, 2005, WILDLIFE RES, V32, P253, DOI 10.1071/WR05010; Fisher DO, 2012, CONSERV BIOL, V26, P57, DOI 10.1111/j.1523-1739.2011.01797.x; Gilks WR, 1996, MARKOV CHAIN MONTE C; Heydon MJ, 2000, J ZOOL, V251, P237, DOI 10.1111/j.1469-7998.2000.tb00607.x; Hijmans RJ, 2014, INTRO RASTER PACKAGE; Keith JM, 2013, P NATL ACAD SCI USA, V110, P13428, DOI 10.1073/pnas.1216146110; Kirkwood R, 2005, PROTECTING PENGUINS, P177; Marion G, 2012, J BIOGEOGR, V39, P2225, DOI 10.1111/j.1365-2699.2012.02772.x; Marks CA, 2014, J APPL ECOL, V51, P1033, DOI 10.1111/1365-2664.12278; McCallum H, 2007, ECOHEALTH, V4, P318, DOI 10.1007/s10393-007-0118-0; O'Hara RB, 2002, ECOLOGY, V83, P2408, DOI 10.1890/0012-9658(2002)083[2408:BAOMD]2.0.CO;2; Pagel J, 2012, GLOBAL ECOL BIOGEOGR, V21, P293, DOI 10.1111/j.1466-8238.2011.00663.x; Petzoldt T, 2007, SIMECOL OBJECT ORIEN; R Development Core Team, 2014, R LANG ENV STAT COMP; Rasmussen R, 2012, ENVIRON MODELL SOFTW, V29, P1, DOI 10.1016/j.envsoft.2011.10.005; Reynolds JC, 2003, MAMMAL REV, V33, P69, DOI 10.1046/j.1365-2907.2003.00002.x; Roberts DL, 2006, BIOL CONSERV, V128, P285, DOI 10.1016/j.biocon.2005.09.033; Rolls EC, 1984, THEY ALL RAN WILD AN; Sarre SD, 2013, J APPL ECOL, V50, P459, DOI 10.1111/1365-2664.12011; Saunders G., 2006, FOXES TASMANIA REPOR; Saunders G., 1995, MANAGING VERTEBRATE; Sisson SA, 2007, P NATL ACAD SCI USA, V104, P1760, DOI 10.1073/pnas.0607208104; Snow NP, 2012, J WILDLIFE MANAGE, V76, P243, DOI 10.1002/jwmg.247; Solow A, 2008, J APPL ECOL, V45, P424, DOI 10.1111/j.1365-2664.2007.01446.x; Statham M, 1991, ADELAIDE, P169; Toni T, 2010, BIOINFORMATICS, V26, P104, DOI 10.1093/bioinformatics/btp619; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Van Dyk DA, 2001, J COMPUTATIONAL GRAP, V10; Willson JD, 2011, BIOL INVASIONS, V13, P1493, DOI 10.1007/s10530-010-9908-3	34	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116631	10.1371/journal.pone.0116631	http://dx.doi.org/10.1371/journal.pone.0116631			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602618	Green Submitted, Green Published, gold			2022-12-26	WOS:000348203500030
J	Chen, YJ; Roohani-Esfahani, SI; Lu, ZF; Zreiqat, H; Dunstan, CR				Chen, Yongjuan; Roohani-Esfahani, Seyed-Iman; Lu, Zufu; Zreiqat, Hala; Dunstan, Colin R.			Zirconium Ions Up-Regulate the BMP/SMAD Signaling Pathway and Promote the Proliferation and Differentiation of Human Osteoblasts	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; IN-VITRO BIOCOMPATIBILITY; ALPHA-2-BETA-1 INTEGRIN; PHOSPHATE COATINGS; ALUMINA CERAMICS; CELLS; EXPRESSION; TITANIUM; SURFACE; OSTEOCONDUCTIVITY	Zirconium (Zr) is an element commonly used in dental and orthopedic implants either as zirconia (ZrO2) or in metal alloys. It can also be incorporated into calcium silicate-based ceramics. However, the effects of in vitro culture of human osteoblasts (HOBs) with soluble ionic forms of Zr have not been determined. In this study, primary culture of human osteoblasts was conducted in the presence of medium containing either ZrCl4 or Zirconium (IV) oxynitrate (ZrO(NO3)(2)) at concentrations of 0, 5, 50 and 500 mu M, and osteoblast proliferation, differentiation and calcium deposition were assessed. Incubation of human osteoblast cultures with Zr ions increased the proliferation of human osteoblasts and also gene expression of genetic markers of osteoblast differentiation. In 21 and 28 day cultures, Zr ions at concentrations of 50 and 500 mu M increased the deposition of calcium phosphate. In addition, the gene expression of BMP2 and BMP receptors was increased in response to culture with Zr ions and this was associated with increased phosphorylation of SMAD1/5. Moreover, Noggin suppressed osteogenic gene expression in HOBs co-treated with Zr ions. In conclusion, Zr ions appear able to induce both the proliferation and the differentiation of primary human osteoblasts. This is associated with up-regulation of BMP2 expression and activation of BMP signaling suggesting this action is, at least in part, mediated by BMP signaling.	[Chen, Yongjuan; Roohani-Esfahani, Seyed-Iman; Lu, Zufu; Zreiqat, Hala; Dunstan, Colin R.] Univ Sydney, Sch AMME, Biomat & Tissue Engn Res Unit, Sydney, NSW 2006, Australia	University of Sydney	Dunstan, CR (corresponding author), Univ Sydney, Sch AMME, Biomat & Tissue Engn Res Unit, Sydney, NSW 2006, Australia.	colin.dunstan@sydney.edu.au	Dunstan, Colin/G-6214-2013	Dunstan, Colin/0000-0001-7586-4071; Lu, ZuFu/0000-0003-4843-4441; Zreiqat, Hala/0000-0003-0521-7711; Roohani, Iman/0000-0001-6618-8577	National Health and Medical Research Council of Australia; National Health and Medical Research Council [632654]; Rebecca Cooper Medical Research Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Rebecca Cooper Medical Research Foundation	The work was supported by the following: National Health and Medical Research Council of Australia; Project grant 632654, National Health and Medical Research Council https://www.nhmrc.gov.au and Rebecca Cooper Medical Research Foundation http://cooperfoundation.org.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair JH, 1997, MATER RES SOC SYMP P, V432, P101, DOI 10.1557/PROC-432-101; Carinci F, 2004, BIOMATERIALS, V25, P215, DOI 10.1016/S0142-9612(03)00486-1; GHOSH S, 1992, BIOL TRACE ELEM RES, V35, P247, DOI 10.1007/BF02783770; Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47; GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408; Hallab N, 2006, J ASTM INT, V3, P1, DOI [10.1520/JAI1281710.1002/(SICI)1097-4636(19991215)47:4%3C481::AID-JBM4%3E3.0.CO;2-Y, DOI 10.1520/JAI1281710.1002/(SICI)1097-4636(19991215)47:4%3C481::AID-JBM4%3E3.0.CO;2]; Josset Y, 1999, J BIOMED MATER RES, V47, P481, DOI 10.1002/(SICI)1097-4636(19991215)47:4<481::AID-JBM4>3.0.CO;2-Y; KASSEM M, 1994, EUR J ENDOCRINOL, V130, P381, DOI 10.1530/eje.0.1300381; Kim HW, 2004, J BIOMED MATER RES A, V68A, P522, DOI 10.1002/jbm.a.20094; Knabe C, 2004, BIOMATERIALS, V25, P4911, DOI 10.1016/j.biomaterials.2004.01.059; Kohal RJ, 2009, CLIN ORAL IMPLAN RES, V20, P1265, DOI 10.1111/j.1600-0501.2009.01735.x; Kulakov O B, 2005, Morfologiia, V127, P52; Lecanda F, 1997, J CELL BIOCHEM, V67, P386, DOI 10.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.3.CO;2-5; LU Z, 2013, TISSUE ENG A; Lu ZF, 2013, J CELL PHYSIOL, V228, P1737, DOI 10.1002/jcp.24330; Lu ZF, 2012, NANOMED-NANOTECHNOL, V8, P507, DOI 10.1016/j.nano.2011.07.012; Lu ZL, 2010, TISSUE ENG PT A, V16, P3075, DOI 10.1089/ten.tea.2010.0204; Lu ZF, 2010, BIOCHEM BIOPH RES CO, V394, P323, DOI 10.1016/j.bbrc.2010.02.178; Oum'hamed Z, 2004, J BIOMED MATER RES A, V68A, P114, DOI 10.1002/jbm.a.20001; Ramaswamy Y, 2008, BIOMATERIALS, V29, P4392, DOI 10.1016/j.biomaterials.2008.08.006; Randeniya L, 2010, ACTA BIOMATER, V6, P4154, DOI 10.1016/j.actbio.2010.04.014; Roohani-Esfahani SI, 2012, ACTA BIOMATER, V8, P4162, DOI 10.1016/j.actbio.2012.07.036; Saldana L, 2007, BIOMATERIALS, V28, P4343, DOI 10.1016/j.biomaterials.2007.06.015; Sherepo KM, 2004, BIOMED ENG, V38, P77, DOI DOI 10.1023/B:BIEN.0000035726.31175.F8; Sollazzo V, 2008, J BIOMED MATER RES B, V84B, P550, DOI 10.1002/jbm.b.30903; Verberckmoes SC, 2003, KIDNEY INT, V64, P534, DOI 10.1046/j.1523-1755.2003.00123.x; Verron E, 2010, BRIT J PHARMACOL, V159, P1681, DOI 10.1111/j.1476-5381.2010.00665.x; Wang GC, 2010, ACTA BIOMATER, V6, P990, DOI 10.1016/j.actbio.2009.09.021; Zhou FY, 2013, J BIOMED MATER RES B, V101B, P237, DOI 10.1002/jbm.b.32833; Zreiqat H, 2005, BIOMATERIALS, V26, P7579, DOI 10.1016/j.biomaterials.2005.05.024	30	28	28	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0113426	10.1371/journal.pone.0113426	http://dx.doi.org/10.1371/journal.pone.0113426			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602473	Green Published, gold, Green Submitted			2022-12-26	WOS:000348203500002
J	Kajala, I; Shi, Q; Nyyssola, A; Maina, NH; Hou, YX; Katina, K; Tenkanen, M; Juvonen, R				Kajala, Ilkka; Shi, Qiao; Nyyssola, Antti; Maina, Ndegwa Henry; Hou, Yaxi; Katina, Kati; Tenkanen, Maija; Juvonen, Riikka			Cloning and Characterization of a Weissella confusa Dextransucrase and Its Application in High Fibre Baking	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; WHEAT BRAN; MOLECULAR CHARACTERIZATION; GLUCANSUCRASE; GENES; EXOPOLYSACCHARIDES; LACTOBACILLUS; CIBARIA; OPTIMIZATION; SPECIFICITY	Wheat bran offers health benefits as a baking ingredient, but is detrimental to bread textural quality. Dextran production by microbial fermentation improves sourdough bread volume and freshness, but extensive acid production during fermentation may negate this effect. Enzymatic production of dextran in wheat bran was tested to determine if dextran-containing bran could be used in baking without disrupting bread texture. The Weissella confusa VTT E-90392 dextransucrase gene was sequenced and His-tagged dextransucrase Wc392-rDSR was produced in Lactococcus lactis. Purified enzyme was characterized using C-14-sucrose radioisotope and reducing value-based assays, the former yielding K-m and V-max values of 14.7 mM and 8.2 mu mol/(mg min), respectively, at the pH optimum of 5.4. The structure and size of in vitro dextran product was similar to dextran produced in vivo. Dextran (8.1% dry weight) was produced in wheat bran in 6 h using Wc392-rDSR. Bran with and without dextran was used in wheat baking at 20% supplementation level. Dextran presence improved bread softness and neutralized bran-induced volume loss, clearly demonstrating the potential of using dextransucrases in bran bioprocessing for use in baking.	[Kajala, Ilkka; Nyyssola, Antti; Juvonen, Riikka] VTT, Tech Res Ctr Finland, Espoo, Finland; [Shi, Qiao; Maina, Ndegwa Henry; Hou, Yaxi; Katina, Kati; Tenkanen, Maija] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland	VTT Technical Research Center Finland; University of Helsinki	Kajala, I (corresponding author), VTT, Tech Res Ctr Finland, Espoo, Finland.	ilkka.kajala@vtt.fi	Tenkanen, Maija/F-9080-2016	Katina, Kati/0000-0002-8147-3146; Nyyssola, Antti/0000-0002-8195-3967; Juvonen, Riikka/0000-0001-8145-3359; Tenkanen, Maija/0000-0003-2883-2717; Maina, Ndegwa/0000-0001-8955-2458	Academy of Finland via the WISE-Dextran project [255755]; ABS Graduate School via a PhD scholarship	Academy of Finland via the WISE-Dextran project; ABS Graduate School via a PhD scholarship	This study was supported by the Academy of Finland (contract number 255755) via the WISE-Dextran project and the ABS Graduate School via a PhD scholarship to Qiao Shi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amari M, 2013, APPL MICROBIOL BIOT, V97, P5413, DOI 10.1007/s00253-012-4447-8; BASEDOW A, 1979, J POLYM SCI       PS, V66, P101, DOI DOI 10.1002/POLC.5070660113; Bejar W, 2013, INT J BIOL MACROMOL, V52, P125, DOI 10.1016/j.ijbiomac.2012.09.014; Bounaix MS, 2009, J AGR FOOD CHEM, V57, P10889, DOI 10.1021/jf902068t; Clarke CI, 2005, ADV FOOD NUTR RES, V49, P137, DOI 10.1016/S1043-4526(05)49004-X; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Di Cagno R, 2006, J AGR FOOD CHEM, V54, P9873, DOI 10.1021/jf061393+; Freitas F, 2011, TRENDS BIOTECHNOL, V29, P388, DOI 10.1016/j.tibtech.2011.03.008; Galle S, 2012, INT J FOOD MICROBIOL, V155, P105, DOI 10.1016/j.ijfoodmicro.2012.01.009; Galle S, 2010, J AGR FOOD CHEM, V58, P5834, DOI 10.1021/jf1002683; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Holo H, 1995, Methods Mol Biol, V47, P195; Irague R, 2012, BIOMACROMOLECULES, V13, P187, DOI 10.1021/bm201453r; Kaditzky S, 2008, EUR FOOD RES TECHNOL, V228, P291, DOI 10.1007/s00217-008-0934-7; Kang HK, 2009, FEMS MICROBIOL LETT, V292, P33, DOI 10.1111/j.1574-6968.2008.01460.x; Katina K, 2012, CEREAL CHEM, V89, P126, DOI 10.1094/CCHEM-08-11-0106; Katina K, 2009, FOOD MICROBIOL, V26, P734, DOI 10.1016/j.fm.2009.07.008; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kralj S, 2004, MICROBIOL-SGM, V150, P3681, DOI 10.1099/mic.0.27321-0; Kralj S, 2003, BIOCATAL BIOTRANSFOR, V21, P181, DOI 10.1080/10242420310001618519; Lacaze G, 2007, FOOD MICROBIOL, V24, P155, DOI 10.1016/j.fm.2006.07.015; Leemhuis H, 2013, J BIOTECHNOL, V163, P250, DOI 10.1016/j.jbiotec.2012.06.037; LILJA S, 1993, EFFECTS NACL ACIDITY, P3946; Maina NH, 2008, CARBOHYD RES, V343, P1446, DOI 10.1016/j.carres.2008.04.012; Maina NH, 2014, CARBOHYD POLYM, V99, P199, DOI 10.1016/j.carbpol.2013.08.021; Maina NH, 2011, BIOMACROMOLECULES, V12, P409, DOI 10.1021/bm1011536; Malik A, 2009, FEMS MICROBIOL LETT, V300, P131, DOI 10.1111/j.1574-6968.2009.01772.x; McIntyre AP, 2013, CARBOHYD RES, V380, P118, DOI 10.1016/j.carres.2013.06.008; Nelson N, 1944, J BIOL CHEM, V153, P375; Pakarinen A, 2011, BIOMASS BIOENERG, V35, P3071, DOI 10.1016/j.biombioe.2011.04.022; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pruckler M, 2014, LWT-FOOD SCI TECHNOL, V56, P211, DOI 10.1016/j.lwt.2013.12.004; Rantanen H, 2007, CARBOHYD POLYM, V68, P350, DOI 10.1016/j.carbpol.2006.11.022; Rao TJM, 2013, PREP BIOCHEM BIOTECH, V43, P329, DOI 10.1080/10826068.2012.737400; Sandra C, 2012, J CEREAL SCI, V56, P531, DOI 10.1016/j.jcs.2012.07.001; Seegers JFML, 2000, MICROBIOL-UK, V146, P435, DOI 10.1099/00221287-146-2-435; Shukla S, 2014, CARBOHYD POLYM, V101, P554, DOI 10.1016/j.carbpol.2013.09.087; Shukla Shraddha, 2011, Enzyme Res, V2011, P250842, DOI 10.4061/2011/250842; SOMOGYI M, 1945, J BIOL CHEM, V160, P61; Stevenson L, 2012, INT J FOOD SCI NUTR, V63, P1001, DOI 10.3109/09637486.2012.687366; Van der Meulen R, 2007, INT J FOOD MICROBIOL, V118, P250, DOI 10.1016/j.ijfoodmicro.2007.07.014; Vettori MHPB, 2011, CARBOHYD RES, V346, P1077, DOI 10.1016/j.carres.2011.02.015; Vujicic-Zagar A, 2010, P NATL ACAD SCI USA, V107, P21406, DOI 10.1073/pnas.1007531107; Zhang D, 1999, J SCI FOOD AGR, V79, P805, DOI 10.1002/(SICI)1097-0010(19990501)79:6<805::AID-JSFA285>3.0.CO;2-E	45	28	30	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116418	10.1371/journal.pone.0116418	http://dx.doi.org/10.1371/journal.pone.0116418			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603169	Green Submitted, Green Published, gold			2022-12-26	WOS:000348203500024
J	Minias, AE; Brzostek, AM; Minias, P; Dziadek, J				Minias, Alina E.; Brzostek, Anna M.; Minias, Piotr; Dziadek, Jaroslaw			The Deletion of rnhB in Mycobacterium smegmatis Does Not Affect the Level of RNase HII Substrates or Influence Genome Stability	PLOS ONE			English	Article							DNA-POLYMERASE-I; H-DEFECTIVE-MUTANTS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; BACILLUS-SUBTILIS; REPLICATION; RIBONUCLEOTIDES; TUBERCULOSIS; GENES; GROWTH	RNase HII removes RNA from RNA/DNA hybrids, such as single ribonucleotides and RNA primers generated during DNA synthesis. Both, RNase HII substrates and RNase HII deficiency have been associated with genome instability in several organisms, and genome instability is a major force leading to the acquisition of drug resistance in bacteria. Understanding the mechanisms that underlie this phenomenon is one of the challenges in identifying efficient methods to combat bacterial pathogens. The aim of the present study was set to investigate the role of rnhB, presumably encoding RNase HII, in maintaining genome stability in the M. tuberculosis model organism Mycobacterium smegmatis. We performed gene replacement through homologous recombination to obtain mutant strains of Mycobacterium smegmatis lacking the rnhB gene. The mutants did not present an altered phenotype, according to the growth rate in liquid culture or susceptibility to hydroxyurea, and did not show an increase in the spontaneous mutation rate, determined using the Luria-Delbru fluctuation test for streptomycin resistance in bacteria. The mutants also did not present an increase in the level of RNase HII substrates, measured as the level of alkaline degradation of chromosomal DNA or determined through immunodetection. We conclude that proteins other than RnhB proteins efficiently remove RNase HII substrates in M. smegmatis. These results highlight differences in the basic biology between Mycobacteria and eukaryotes and between different species of bacteria.	[Minias, Alina E.; Brzostek, Anna M.; Dziadek, Jaroslaw] Polish Acad Sci, Inst Med Biol, Dept Genet & Physiol Mycobacterium, Lodz, Poland; [Minias, Alina E.] Univ Lodz, Dept Microbiol Biotechnol & Immunol, PL-90131 Lodz, Poland; [Minias, Piotr] Univ Lodz, Dept Teacher Training & Biodivers Studies, PL-90131 Lodz, Poland	Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; University of Lodz; University of Lodz	Minias, AE (corresponding author), Polish Acad Sci, Inst Med Biol, Dept Genet & Physiol Mycobacterium, Lodz, Poland.	alinagrna@gmail.pl; jdziadek@cbm.pan.pl		Dziadek, Jaroslaw/0000-0003-1427-884X; Minias, Alina/0000-0002-3210-6737; Minias, Piotr/0000-0002-7742-6750	Innovative Economy Operational Programme [POIG.01.01.02-10-107/09]; Polish National Center of Science [2011/01/N/NZ6/04186]	Innovative Economy Operational Programme; Polish National Center of Science	The study was supported by POIG.01.01.02-10-107/09 project implemented under Innovative Economy Operational Programme, years 2007-2013 "Studies of the molecular mechanisms at the interface the human organism-the pathogen-environmental factors." and by grant of Polish National Center of Science 2011/01/N/NZ6/04186 "Identification of a novel mechanism of initiation of DNA replication in Mycobacterium smegmatis".	Arudchandran A, 2000, GENES CELLS, V5, P789, DOI 10.1046/j.1365-2443.2000.00373.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bayliss CD, 2005, NUCLEIC ACIDS RES, V33, P400, DOI 10.1093/nar/gki180; Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; Chen JJZ, 2000, NUCLEIC ACIDS RES, V28, P3649, DOI 10.1093/nar/28.18.3649; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DELUCIA P, 1969, NATURE, V224, P1164, DOI 10.1038/2241164a0; Dziadek J, 2002, J BACTERIOL, V184, P3848, DOI 10.1128/JB.184.14.3848-3855.2002; EDER PS, 1993, BIOCHIMIE, V75, P123, DOI 10.1016/0300-9084(93)90033-O; Fukushima S, 2007, J BACTERIOL, V189, P8575, DOI 10.1128/JB.00653-07; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Ghodgaonkar MM, 2013, MOL CELL, V50, P323, DOI 10.1016/j.molcel.2013.03.019; Ginno PA, 2013, GENOME RES, V23, P1590, DOI 10.1101/gr.158436.113; Gordhan BG, 1996, GENE, V178, P125, DOI 10.1016/0378-1119(96)00350-2; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; HORIUCHI T, 1984, MOL GEN GENET, V195, P17, DOI 10.1007/BF00332717; HUANG L, 1994, J BIOL CHEM, V269, P25922; Itaya M, 1999, J BACTERIOL, V181, P2118, DOI 10.1128/JB.181.7.2118-2123.1999; JOYCE CM, 1984, J BACTERIOL, V158, P636, DOI 10.1128/JB.158.2.636-643.1984; KANAYA S, 1984, P NATL ACAD SCI-BIOL, V81, P3447, DOI 10.1073/pnas.81.11.3447; KELLEY WS, 1980, GENETICS, V95, P15; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; KLENOW H, 1970, P NATL ACAD SCI USA, V65, P168, DOI 10.1073/pnas.65.1.168; Kochiwa H, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-128; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Lazzaro F, 2012, MOL CELL, V45, P99, DOI 10.1016/j.molcel.2011.12.019; Le Laz S, 2010, J BACTERIOL, V192, P3689, DOI 10.1128/JB.00268-10; LEHMAN IR, 1976, SCIENCE, V193, P963, DOI 10.1126/science.781842; Liang RB, 2007, MICROBIOL-SGM, V153, P787, DOI 10.1099/mic.0.2006/003434-0; LU AL, 1987, J BACTERIOL, V169, P1254, DOI 10.1128/jb.169.3.1254-1259.1987; Luria SE, 1943, GENETICS, V28, P491; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; Murante RS, 1998, P NATL ACAD SCI USA, V95, P2244, DOI 10.1073/pnas.95.5.2244; Murdeshwar MS, 2012, J BACTERIOL, V194, P4003, DOI 10.1128/JB.00258-12; Nagata Y, 2002, GENETICS, V160, P13; OGAWA T, 1984, MOL GEN GENET, V193, P231, DOI 10.1007/BF00330673; Ohtani N, 1999, BIOCHEMISTRY-US, V38, P605, DOI 10.1021/bi982207z; OKAZAKI R, 1971, P NATL ACAD SCI USA, V68, P2954, DOI 10.1073/pnas.68.12.2954; OLIVERA BM, 1974, NATURE, V250, P513, DOI 10.1038/250513a0; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pawelczyk J, 2011, J BACTERIOL, V193, P6960, DOI 10.1128/JB.05638-11; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; RICCHETTI M, 1993, EMBO J, V12, P387, DOI 10.1002/j.1460-2075.1993.tb05670.x; Rumbaugh JA, 1997, J BIOL CHEM, V272, P22591, DOI 10.1074/jbc.272.36.22591; Sato A, 2003, BIOCHEM BIOPH RES CO, V309, P247, DOI 10.1016/j.bbrc.2003.08.003; Spies FS, 2011, J CLIN MICROBIOL, V49, P2625, DOI 10.1128/JCM.00168-11; TORREY TA, 1984, MOL GEN GENET, V196, P350, DOI 10.1007/BF00328070; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803; Vaisman A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003878; Villellas C, 2013, J CLIN MICROBIOL, V51, P2124, DOI 10.1128/JCM.01944-12; Wahba L, 2013, ELIFE, V2, DOI 10.7554/eLife.00505; Watkins HA, 2010, J BACTERIOL, V192, P2878, DOI 10.1128/JB.01615-09; WINDER FG, 1973, J GEN MICROBIOL, V76, P189, DOI 10.1099/00221287-76-1-189; Yao NY, 2013, P NATL ACAD SCI USA, V110, P12942, DOI 10.1073/pnas.1309506110; Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	58	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0115521	10.1371/journal.pone.0115521	http://dx.doi.org/10.1371/journal.pone.0115521			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603150	gold, Green Published, Green Submitted			2022-12-26	WOS:000348203500015
J	Gauci, PJ; McAllister, J; Mitchell, IR; Boyle, DB; Bulach, DM; Weir, RP; Melville, LF; Gubala, AJ				Gauci, Penelope J.; McAllister, Jane; Mitchell, Ian R.; Boyle, David B.; Bulach, Dieter M.; Weir, Richard P.; Melville, Lorna F.; Gubala, Aneta J.			Genomic Characterisation of Three Mapputta Group Viruses, a Serogroup of Australian and Papua New Guinean Bunyaviruses Associated with Human Disease	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN NSS; SEQUENCE DETERMINATION; NUCLEOCAPSID PROTEIN; FAMILY BUNYAVIRIDAE; RNA SEGMENT; MAIN-DRAIN; ARBOVIRUSES; MOSQUITOS; QUEENSLAND; VALLEY	The Mapputta serogroup tentatively contains the mosquito-associated viruses Mapputta, Maprik, Trubanaman and Gan Gan. Interestingly, this serogroup has previously been associated with an acute epidemic polyarthritis-like illness in humans; however, there has been no ensuing genetic characterisation. Here we report the complete genome sequences of Mapputta and Maprik viruses, and a new Mapputta group candidate, Buffalo Creek virus, previously isolated from mosquitoes and detected by serology in a hospitalised patient. Phylogenetic analyses indicate that the group is one of the earliest diverged groups within the genus Orthobunyavirus of the family Bunyaviridae. Analyses show that these three viruses are related to the recently sequenced Australian bunyaviruses from mosquitoes, Salt Ash and Murrumbidgee. A notable feature of the Mapputta group viruses is the absence of the NSs (non-structural) ORF commonly found on the S segment of other orthobunya-viruses. Viruses of the Mapputta group have been isolated from geographically diverse regions ranging from tropical Papua New Guinea to the semi-arid climate of south-eastern Australia. The relevance of this group to human health in the region merits further investigation.	[Gauci, Penelope J.; McAllister, Jane; Mitchell, Ian R.; Gubala, Aneta J.] Def Sci & Technol Org, Land Div, Fishermans Bend, Vic, Australia; [Boyle, David B.; Bulach, Dieter M.] Commonwealth Sci & Ind Res Org, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Weir, Richard P.; Melville, Lorna F.] Berrimah Vet Labs, Dept Primary Ind & Fisheries, Berrimah, NT, Australia	Defence Science & Technology; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Gauci, PJ (corresponding author), Def Sci & Technol Org, Land Div, Fishermans Bend, Vic, Australia.	Penny.Gauci@dsto.defence.gov.au	Bulach, Dieter M/D-5793-2011	Bulach, Dieter M/0000-0001-9823-6078				Akashi H, 1997, J GEN VIROL, V78, P2847, DOI 10.1099/0022-1317-78-11-2847; Aquino VH, 2003, ARCH VIROL, V148, P19, DOI 10.1007/s00705-002-0913-4; Barr JN, 2004, J VIROL, V78, P1129, DOI 10.1128/JVI.78.3.1129-1138.2004; Barr JN, 2003, VIROLOGY, V311, P326, DOI 10.1016/S0042-6822(03)00130-2; Beer M, 2013, EPIDEMIOL INFECT, V141, P1, DOI 10.1017/S0950268812002245; BISHOP DHL, 1980, INTERVIROLOGY, V14, P125, DOI 10.1159/000149174; Blakqori G, 2007, J VIROL, V81, P4991, DOI 10.1128/JVI.01933-06; BOUGHTON CR, 1990, AUST NZ J MED, V20, P51, DOI 10.1111/j.1445-5994.1990.tb00371.x; BOWEN MD, 1995, J GEN VIROL, V76, P559, DOI 10.1099/0022-1317-76-3-559; Boyle DB, 2012, J VIROL, V86, P6724, DOI 10.1128/JVI.00182-12; BRANDT WE, 1967, AM J TROP MED HYG, V16, P339, DOI 10.4269/ajtmh.1967.16.339; Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; Briese T, 2007, ARCH VIROL, V152, P2237, DOI 10.1007/s00705-007-1069-z; Briese T, 2004, J GEN VIROL, V85, P3071, DOI 10.1099/vir.0.80122-0; Briese T, 2013, VIROLOGY, V446, P207, DOI 10.1016/j.virol.2013.07.030; Chowdhary R, 2012, J GEN VIROL, V93, P1023, DOI 10.1099/vir.0.039479-0; Coffey LL, 2014, VIROLOGY, V448, P146, DOI 10.1016/j.virol.2013.09.026; DOHERTY RL, 1973, T ROY SOC TROP MED H, V67, P536, DOI 10.1016/0035-9203(73)90084-9; DOHERTY RL, 1970, T ROY SOC TROP MED H, V64, P748, DOI 10.1016/0035-9203(70)90017-9; DOHERTY RL, 1968, T ROY SOC TROP MED H, V62, P430, DOI 10.1016/0035-9203(68)90095-3; DOHERTY RL, 1963, AUST J EXP BIOL MED, V41, P17, DOI 10.1038/icb.1963.2; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; DUNN EF, 1995, VIROLOGY, V211, P133, DOI 10.1006/viro.1995.1386; DUNN EF, 1994, J GEN VIROL, V75, P597, DOI 10.1099/0022-1317-75-3-597; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eifan SA, 2009, J VIROL, V83, P11307, DOI 10.1128/JVI.01460-09; Elliott RM, 2011, BUNYAVIRIDAE: MOLECULAR AND CELLULAR BIOLOGY, P1; FAZAKERLEY JK, 1988, VIROLOGY, V167, P422, DOI 10.1016/0042-6822(88)90104-3; GARD G, 1973, AM J TROP MED HYG, V22, P551, DOI 10.4269/ajtmh.1973.22.551; Gubala AJ, 2008, VIROLOGY, V376, P13, DOI 10.1016/j.virol.2008.03.004; Hooper PT, 1997, B I PASTEUR, V95, P209, DOI 10.1016/S0020-2452(97)83529-5; Huppatz C, 2009, COMMUN DIS INTELL, V33, P192; Huppatz C, 2009, EMERG INFECT DIS, V15, P1359, DOI 10.3201/eid1509.081540; KARABATSOS N, 1985, THE AMERICAN COMMITT; Kohl A, 2004, J GEN VIROL, V85, P3269, DOI 10.1099/vir.0.80407-0; MARSHALL ID, 1982, AUST J EXP BIOL MED, V60, P457, DOI 10.1038/icb.1982.51; Mir MA, 2004, J VIROL, V78, P8281, DOI 10.1128/jvi.78.15.8281-8288.2004; Mohamed M, 2009, J VIROL, V83, P7612, DOI 10.1128/JVI.02080-08; MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345; NEWTON SE, 1983, AUST J EXP BIOL MED, V61, P201, DOI 10.1038/icb.1983.19; Nunes MRT, 2005, J VIROL, V79, P10561, DOI 10.1128/JVI.79.16.10561-10570.2005; Osborne JC, 2000, J VIROL, V74, P9946, DOI 10.1128/JVI.74.21.9946-9952.2000; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plyusnin A, 2012, VIRUS TAXONOMY, P725; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rost B, 2003, CELL MOL LIFE SCI, V60, P2637, DOI 10.1007/s00018-003-3114-8; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Saeed MF, 2000, J GEN VIROL, V81, P743, DOI 10.1099/0022-1317-81-3-743; Savji N, 2011, J GEN VIROL, V92, P1676, DOI 10.1099/vir.0.028308-0; Shi XH, 2005, J VIROL, V79, P13725, DOI 10.1128/JVI.79.21.13725-13734.2005; STANDFAST HA, 1984, AUST J BIOL SCI, V37, P351, DOI 10.1071/BI9840351; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Weber F, 2002, J VIROL, V76, P7949, DOI 10.1128/JVI.76.16.7949-7955.2002; WEIR R, 2002, THESIS U SYDNEY; Yanase T, 2003, VIRUS RES, V93, P63, DOI 10.1016/S0168-1702(03)00066-2; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	59	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116561	10.1371/journal.pone.0116561	http://dx.doi.org/10.1371/journal.pone.0116561			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25588016	Green Published, gold, Green Submitted			2022-12-26	WOS:000347928300017
J	Xavier, R; Faria, PJ; Paladini, G; van Oosterhout, C; Johnson, M; Cable, J				Xavier, Raquel; Faria, Patricia J.; Paladini, Giuseppe; van Oosterhout, Cock; Johnson, Mireille; Cable, Jo			Evidence for Cryptic Speciation in Directly Transmitted Gyrodactylid Parasites of Trinidadian Guppies	PLOS ONE			English	Article							MITOCHONDRIAL-DNA EVOLUTION; N.-SP MONOGENEA; POECILIA-RETICULATA; EXPERIMENTAL INFECTIONS; NATURAL-POPULATIONS; WILD POPULATIONS; RIBOSOMAL DNA; MATE CHOICE; PLATYHELMINTHES; HISTORY	Cryptic species complexes are common among parasites, which tend to have large populations and are subject to rapid evolution. Such complexes may arise through host-parasite co-evolution and/or host switching. For parasites that reproduce directly on their host, there might be increased opportunities for sympatric speciation, either by exploiting different hosts or different micro-habitats within the same host. The genus Gyrodactylus is a specious group of viviparous monogeneans. These ectoparasites transfer between teleosts during social contact and cause significant host mortality. Their impact on the guppy ( Poecilia reticulata), an iconic evolutionary and ecological model species, is well established and yet the population genetics and phylogenetics of these parasites remains understudied. Using mtDNA sequencing of the host and its parasites, we provide evidence of cryptic speciation in Gyrodactylus bullatarudis, G. poeciliae and G. turnbulli. For the COII gene, genetic divergence of lineages within each parasite species ranged between 5.7 and 17.2%, which is typical of the divergence observed between described species in this genus. Different lineages of G. turnbulli and G. poeciliae appear geographically isolated, which could imply allopatric speciation. In addition, for G. poeciliae, co-evolution with a different host species cannot be discarded due to its host range. This parasite was originally described on P. caucana, but for the first time here it is also recorded on the guppy. The two cryptic lineages of G. bullatarudis showed considerable geographic overlap. G. bullatarudis has a known wide host range and it can also utilize a killifish (Anablepsoides hartii) as a temporary host. This killifish is capable of migrating overland and it could act as a transmission vector between otherwise isolated populations. Additional genetic markers are needed to confirm the presence of these cryptic Gyrodactylus species complexes, potentially leading to more in-depth genetic, ecological and evolutionary analyses on this multi-host-parasite system.	[Xavier, Raquel; Faria, Patricia J.; Johnson, Mireille; Cable, Jo] Cardiff Univ, Sch Biol Sci, Cardiff CF10 3AX, S Glam, Wales; [Xavier, Raquel] Univ Porto, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, P-4485661 Vairao, Portugal; [Paladini, Giuseppe] Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling FK9 4LA, Scotland; [van Oosterhout, Cock] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	Cardiff University; Universidade do Porto; University of Stirling; University of East Anglia	Cable, J (corresponding author), Cardiff Univ, Sch Biol Sci, Cardiff CF10 3AX, S Glam, Wales.	cablej@cardiff.ac.uk	Cable, Joanne/A-4360-2010; Xavier, Raquel/A-8393-2012	Cable, Joanne/0000-0002-8510-7055; Xavier, Raquel/0000-0001-8800-3924; Paladini, Giuseppe/0000-0003-4944-0499; van Oosterhout, Cock/0000-0002-5653-738X	European Community [MTKD-CT-2005-030018]; FEDER (COMPETE); Fundacao para a Ciencia e a Tecnologia (FCT) [EXPL/MAR-BIO/1034/2012]; FCT [SFRH/BPD/75851/2011]; Earth and Life Systems Alliance (ELSA)	European Community(European Commission); FEDER (COMPETE)(European Commission); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Earth and Life Systems Alliance (ELSA)	This study was funded by a European Community Framework Programme 6 Marie Curie Host Fellowship for transfer of knowledge (MTKD-CT-2005-030018) coordinated by JC, by FEDER (COMPETE program), and Fundacao para a Ciencia e a Tecnologia (FCT) funds through the project EXPL/MAR-BIO/1034/2012. RX is currently supported by a post-doctoral grant awarded by FCT (SFRH/BPD/75851/2011) and CvO by the Earth and Life Systems Alliance (ELSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKE TA, 1990, J FISH BIOL, V37, P577, DOI 10.1111/j.1095-8649.1990.tb05890.x; BAKKE TA, 2007, ADV PARASIT, V64, P459; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barson M, 2010, PARASITOLOGY, V137, P1585, DOI 10.1017/S0031182010000302; Barson NJ, 2009, J EVOLUTION BIOL, V22, P485, DOI 10.1111/j.1420-9101.2008.01675.x; Bueno-Silva M, 2014, FOLIA PARASIT, V61, P213, DOI 10.14411/fp.2014.028; Cable J, 2007, INT J PARASITOL, V37, P1449, DOI 10.1016/j.ijpara.2007.04.013; Cable J, 2007, BIOL J LINN SOC, V90, P647, DOI 10.1111/j.1095-8312.2006.00755.x; Cable J, 1996, TISSUE CELL, V28, P515, DOI 10.1016/S0040-8166(96)80054-1; Cable J, 1999, CAN J ZOOL, V77, P1439, DOI 10.1139/cjz-77-9-1439; Cable J, 2005, SYST PARASITOL, V60, P159, DOI 10.1007/s11230-004-6348-4; Cable J, 1998, MICROSC RES TECHNIQ, V42, P186, DOI 10.1002/(SICI)1097-0029(19980801)42:3<186::AID-JEMT3>3.0.CO;2-R; Cable J, 2013, PARASITOLOGY, V140, P1138, DOI 10.1017/S003118201300067X; Crispo E, 2006, MOL ECOL, V15, P49, DOI 10.1111/j.1365-294X.2005.02764.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dowton M, 1995, J MOL EVOL, V41, P958, DOI 10.1007/BF00173176; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAJEN A, 1992, EVOLUTION, V46, P1457, DOI 10.1111/j.1558-5646.1992.tb01136.x; Faria PJ, 2011, CONSERV GENET RESOUR, V3, P177, DOI 10.1007/s12686-010-9317-z; Faria PJ, 2010, BIOL CONSERV, V143, P35, DOI 10.1016/j.biocon.2009.06.002; HAFNER MS, 1995, PHILOS T R SOC B, V349, P77, DOI 10.1098/rstb.1995.0093; Hansen H, 2007, TRENDS PARASITOL, V23, P363, DOI 10.1016/j.pt.2007.06.007; Harris PD, 1999, J PARASITOL, V85, P188, DOI 10.2307/3285617; Harris PD, 2000, SYST PARASITOL, V47, P79, DOI 10.1023/A:1006413804061; Harris PD, 2008, TRENDS PARASITOL, V24, P109, DOI 10.1016/j.pt.2007.12.004; Hoberg EP, 2008, J BIOGEOGR, V35, P1533, DOI 10.1111/j.1365-2699.2008.01951.x; Hughes J, 2007, SYST BIOL, V56, P232, DOI 10.1080/10635150701311370; Huyse T, 2005, TRENDS PARASITOL, V21, P469, DOI 10.1016/j.pt.2005.08.009; Huyse T, 2002, INT J PARASITOL, V32, P907, DOI 10.1016/S0020-7519(02)00026-7; Huyse T, 2008, GENE, V417, P27, DOI 10.1016/j.gene.2008.03.008; Jeswiet SB, 2011, ANIM BEHAV, V81, P639, DOI 10.1016/j.anbehav.2010.12.013; Johnson MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022634; Jorge F, 2011, SYST PARASITOL, V80, P53, DOI 10.1007/s11230-011-9311-1; KENNEDY CEJ, 1987, BEHAV ECOL SOCIOBIOL, V21, P291, DOI 10.1007/BF00299966; King TA, 2007, INT J PARASITOL, V37, P663, DOI 10.1016/j.ijpara.2006.11.015; King TA, 2009, PARASITOL INT, V58, P249, DOI 10.1016/j.parint.2009.04.005; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kolluru GR, 2009, BEHAV ECOL, V20, P131, DOI 10.1093/beheco/arn124; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Light JE, 2007, MOL PHYLOGENET EVOL, V45, P997, DOI 10.1016/j.ympev.2007.09.001; MALMBERG G, 1970, ARK ZOOL, V23, P1; Page RDM, 1998, MOL PHYLOGENET EVOL, V9, P276, DOI 10.1006/mpev.1997.0458; Paladini G, 2009, VET PARASITOL, V165, P290, DOI 10.1016/j.vetpar.2009.07.025; Pariselle Antoine, 2011, International Journal of Evolutionary Biology, V2011, P1, DOI 10.4061/2011/471480; Perez-Jvostov F, 2012, OECOLOGIA, V170, P77, DOI 10.1007/s00442-012-2289-9; Peterson KR, 2010, MYCOLOGIA, V102, P1417, DOI 10.3852/10-048; Plaisance L, 2007, MOL BIOCHEM PARASIT, V154, P190, DOI 10.1016/j.molbiopara.2007.04.012; Poulin R, 2000, Q REV BIOL, V75, P277, DOI 10.1086/393500; Reznick D, 1996, NETH J ZOOL, V46, P172, DOI 10.1163/156854295X00140; Richards EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013285; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SCOTT ME, 1985, J FISH DIS, V8, P495, DOI 10.1111/j.1365-2761.1985.tb00964.x; SHAW PW, 1991, J FISH BIOL, V39, P203, DOI 10.1111/j.1095-8649.1991.tb05084.x; SHIELDS GF, 1991, EVOLUTION, V45, P218, DOI 10.1111/j.1558-5646.1991.tb05279.x; Shinn AP, 2004, FOLIA PARASIT, V51, P239, DOI 10.14411/fp.2004.029; Simkova A, 2004, EVOLUTION, V58, P1001, DOI 10.1111/j.0014-3820.2004.tb00434.x; STEPHENSON JF, 2014, ECOLOGY IN PRESS; Suk HY, 2009, HEREDITY, V102, P425, DOI 10.1038/hdy.2009.7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Van Oosterhout C, 2007, CONSERV BIOL, V21, P1573, DOI 10.1111/j.1523-1739.2007.00809.x; van Oosterhout C, 2006, EVOLUTION, V60, P2562, DOI 10.1111/j.0014-3820.2006.tb01890.x; Willing EM, 2010, MOL ECOL, V19, P968, DOI 10.1111/j.1365-294X.2010.04528.x; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Zietara MS, 2010, ACTA PARASITOL, V55, P20, DOI 10.2478/s11686-010-0016-4; Zwickl DJ., 2006, GENETIC ALGORITHM AP	69	23	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0117096	10.1371/journal.pone.0117096	http://dx.doi.org/10.1371/journal.pone.0117096			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25574955	Green Accepted, Green Published, gold			2022-12-26	WOS:000348168100011
J	Tsiavaliaris, G; Itel, F; Hedfalk, K; Al-Samir, S; Meier, W; Gros, G; Endeward, V				Tsiavaliaris, Georgios; Itel, Fabian; Hedfalk, Kristina; Al-Samir, Samer; Meier, Wolfgang; Gros, Gerolf; Endeward, Volker			Low CO2 permeability of cholesterol-containing liposomes detected by stopped-flow fluorescence spectroscopy	FASEB JOURNAL			English	Article						phospholipid vesicles; carbonic anhydrase; aquaporin 1; BCECF; carboxyfluorescein	CARBON-DIOXIDE PERMEABILITY; CELL-MEMBRANES; EPITHELIAL MEMBRANE; AQUAPORIN-1; DIFFUSION; WATER; TRANSPORT; CHANNEL; BLOOD; PROTEIN	Here we ask the following: 1) what is the CO2 permeability (Pco(2)) of unilamellar liposomes composed of l--phosphatidylcholine (PC)/l--phosphatidylserine (PS) = 4:1 and containing cholesterol (Chol) at levels often occurring in biologic membranes (50 mol%), and 2) does incorporation of the CO2 channel aquaporin (AQP)1 cause a significant increase in membrane Pco(2)? Presently, a drastic discrepancy exists between the answers to these two questions obtained from mass-spectrometric O-18-exchange measurements (Chol reduces Pco(2) 100-fold, AQP1 increases Pco(2) 10-fold) vs. from stopped-flow approaches observing CO2 uptake (no effects of either Chol or AQP1). A novel theory of CO2 uptake by vesicles predicts that in a stopped-flow apparatus this fast process can only be resolved temporally and interpreted quantitatively, if 1) a very low CO2 partial pressure (pCO(2)) is used (e.g., 18 mmHg), and 2) intravesicular carbonic anhydrase (CA) activity is precisely known. With these prerequisites fulfilled, we find by stopped-flow that 1) Chol-containing vesicles possess a Pco(2) = 0.01cm/s, and Chol-free vesicles exhibit approximate to 1 cm/s, and 2) the Pco(2) of 0.01 cm/s is increased 10-fold by AQP1. Both results agree with previous mass-spectrometric results and thus resolve the apparent discrepancy between the two techniques. We confirm that biologic membranes have an intrinsically low Pco(2) that can be raised when functionally necessary by incorporating protein-gas channels such as AQP1.Tsiavaliaris, G., Itel, F., Hedfalk, K., Al-Samir, S., Meier, W., Gros, G., Endeward, V. Low CO2 permeability of cholesterol-containing liposomes detected by stopped-flow fluorescence spectroscopy.	[Tsiavaliaris, Georgios] Hannover Med Sch, Inst Mol & Zellphysiol, D-30625 Hannover, Germany; [Itel, Fabian; Meier, Wolfgang] Univ Basel, Dept Chem, Basel, Switzerland; [Hedfalk, Kristina] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Al-Samir, Samer; Gros, Gerolf; Endeward, Volker] Hannover Med Sch, Inst Mol & Zellphysiol, AG Vegetat Physiol, D-30625 Hannover, Germany	Hannover Medical School; University of Basel; University of Gothenburg; Hannover Medical School	Gros, G (corresponding author), Hannover Med Sch, Inst Mol & Zellphysiol, AG Vegetat Physiol 4220,Carl Neuberg Str 1, D-30625 Hannover, Germany.	gros.gerolf@mh-hannover.de	Itel, Fabian/AAU-2465-2021	Itel, Fabian/0000-0002-4161-2383	Deutsche Forschungsgemeinschaft [EN-908/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank the Deutsche Forschungsgemeinschaft for their support of this project (Grant EN-908/2-1). They also acknowledge the Swiss National Science Foundation and the National Center of Competence in Molecular Systems Engineering (NCCR-MSE). F.I. thanks the Zentrum fur Mikroskopie (ZMB), University of Basel, for access to the electron microscopy facility.	Bienert GP, 2014, BBA-GEN SUBJECTS, V1840, P1596, DOI 10.1016/j.bbagen.2013.09.017; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; Borisova MM, 2012, BBA-BIOENERGETICS, V1817, P1314, DOI 10.1016/j.bbabio.2012.02.036; Boron WF, 2011, CHEMPHYSCHEM, V12, P1017, DOI 10.1002/cphc.201100034; CORVERA E, 1992, BIOCHIM BIOPHYS ACTA, V1107, P261, DOI 10.1016/0005-2736(92)90413-G; Crank J., 1964, MATH DIFFUSION, V1956th; Duttingdorf HDMZ, 1999, ANAL BIOCHEM, V269, P45, DOI 10.1006/abio.1998.3075; Echevarria M, 2007, J BIOL CHEM, V282, P30207, DOI 10.1074/jbc.M702639200; Endeward V, 2006, FASEB J, V20, P1974, DOI 10.1096/fj.04-3300com; Endeward V, 2006, TRANSFUS CLIN BIOL, V13, P123, DOI 10.1016/j.tracli.2006.02.007; Endeward V, 2005, J PHYSIOL-LONDON, V567, P253, DOI 10.1113/jphysiol.2005.085761; Endeward V, 2008, FASEB J, V22, P64, DOI 10.1096/fj.07-9097com; Endeward V, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00382; Endeward V, 2012, J APPL PHYSIOL, V112, P1466, DOI 10.1152/japplphysiol.00835.2011; Endeward V, 2009, J PHYSIOL-LONDON, V587, P1153, DOI 10.1113/jphysiol.2008.165027; Erbakan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086830; Forster R. E., 1969, NASA, P275; Forster RE, 1998, P NATL ACAD SCI USA, V95, P15815, DOI 10.1073/pnas.95.26.15815; Geyer RR, 2013, J MEMBRANE BIOL, V246, P915, DOI 10.1007/s00232-013-9593-0; GROS G, 1976, J GEN PHYSIOL, V67, P773, DOI 10.1085/jgp.67.6.773; Gros G., 1976, THESIS U REGENSBURG; GUTKNECHT J, 1977, J GEN PHYSIOL, V69, P779; HANSSON GC, 1986, EMBO J, V5, P483, DOI 10.1002/j.1460-2075.1986.tb04237.x; Hasselblatt P, 2000, PFLUG ARCH EUR J PHY, V441, P118, DOI 10.1007/s004240000377; Herrera M, 2007, AM J PHYSIOL-RENAL, V292, pF1443, DOI 10.1152/ajprenal.00353.2006; Herrera M, 2006, HYPERTENSION, V48, P157, DOI 10.1161/01.HYP.0000223652.29338.77; Herrera M, 2011, PFLUG ARCH EUR J PHY, V462, P623, DOI 10.1007/s00424-011-1002-x; Hill WG, 2000, J BIOL CHEM, V275, P30176, DOI 10.1074/jbc.M003494200; HOLLAND RAB, 1985, RESP PHYSIOL, V59, P71, DOI 10.1016/0034-5687(85)90020-9; Hub JS, 2010, J AM CHEM SOC, V132, P13251, DOI 10.1021/ja102133x; Hulikova A, 2014, FASEB J, V28, P2762, DOI 10.1096/fj.13-241752; Itel F, 2012, FASEB J, V26, P5182, DOI 10.1096/fj.12-209916; KORN ED, 1969, ANNU REV BIOCHEM, V38, P263, DOI 10.1146/annurev.bi.38.070169.001403; LANDE MB, 1995, J GEN PHYSIOL, V106, P67, DOI 10.1085/jgp.106.1.67; Missner A, 2008, J BIOL CHEM, V283, P25340, DOI 10.1074/jbc.M800096200; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; Nyblom M, 2007, PROTEIN EXPRES PURIF, V56, P110, DOI 10.1016/j.pep.2007.07.007; OBRIEN JS, 1967, J THEOR BIOL, V15, P307, DOI 10.1016/0022-5193(67)90140-3; Prasad GVR, 1998, J BIOL CHEM, V273, P33123, DOI 10.1074/jbc.273.50.33123; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; Segel IH, 1976, BIOCH CALCULATIONS; Siggaard-Andersen O, 1974, ACID BASE STATUS BLO; Swenson ER, 2002, CLIN SCI, V103, P567, DOI 10.1042/cs1030567; Tanford C., 1961, PHYS CHEM MACROMOLEC; Trandum C, 2000, BIOPHYS J, V78, P2486, DOI 10.1016/S0006-3495(00)76793-2; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; Uehlein N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00538; WAISBREN SJ, 1994, NATURE, V368, P332, DOI 10.1038/368332a0; Wunder MA, 1998, ISOT ENVIRON HEALT S, V34, P303, DOI 10.1080/10256019808234064; Yang BX, 2000, J BIOL CHEM, V275, P2686, DOI 10.1074/jbc.275.4.2686	51	16	16	0	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1780	1793		10.1096/fj.14-263988	http://dx.doi.org/10.1096/fj.14-263988			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25609423				2022-12-26	WOS:000354114600015
J	Schmidt, A; Dietrich, S; Steuer, A; Weltmann, KD; von Woedtke, T; Masur, K; Wende, K				Schmidt, Anke; Dietrich, Stephan; Steuer, Anna; Weltmann, Klaus-Dieter; von Woedtke, Thomas; Masur, Kai; Wende, Kristian			Non-thermal Plasma Activates Human Keratinocytes by Stimulation of Antioxidant and Phase II Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATMOSPHERIC-PRESSURE PLASMA; GROWTH-FACTOR SYNTHESIS; HEME OXYGENASE-1; OXIDATIVE STRESS; REDOX REGULATION; TRANSCRIPTIONAL REPRESSOR; HACAT KERATINOCYTES; NUCLEAR EXPORT; IN-VITRO; C-JUN	Non-thermal atmospheric pressure plasma provides a novel therapeutic opportunity to control redox-based processes, e.g. wound healing, cancer, and inflammatory diseases. By spatial and time-resolved delivery of reactive oxygen and nitrogen species, it allows stimulation or inhibition of cellular processes in biological systems. Our data show that both gene and protein expression is highly affected by non-thermal plasma. Nuclear factor erythroid-related factor 2 (NRF2) and phase II enzyme pathway components were found to act as key controllers orchestrating the cellular response in keratinocytes. Additionally, glutathione metabolism, which is a marker for NRF2-related signaling events, was affected. Among the most robustly increased genes and proteins, heme oxygenase 1, NADPH-quinone oxidoreductase 1, and growth factors were found. The roles of NRF2 targets, investigated by siRNA silencing, revealed that NRF2 acts as an important switch for sensing oxidative stress events. Moreover, the influence of non-thermal plasma on the NRF2 pathway prepares cells against exogenic noxae and increases their resilience against oxidative species. Via paracrine mechanisms, distant cells benefit from cell-cell communication. The finding that non-thermal plasma triggers hormesis-like processes in keratinocytes facilitates the understanding	[Schmidt, Anke; Dietrich, Stephan; Masur, Kai; Wende, Kristian] Ctr Innovat Competence ZIK Plasmatis, D-17489 Greifswald, Germany; [Schmidt, Anke; Steuer, Anna; Weltmann, Klaus-Dieter; von Woedtke, Thomas] Leibniz Inst Plasma Sci & Technol, D-17489 Greifswald, Germany	Leibniz Institut fur Plasmaforschung und Technologie	Schmidt, A (corresponding author), INF Greifswald, Dept Plasma Bioengn, Felix Hausdorff Str 2, D-17489 Greifswald, Germany.	anke.schmidt@inp-greifswald.de	von Woedtke, Thomas/U-3604-2018; Wende, Kristian/AAE-8810-2020	von Woedtke, Thomas/0000-0002-1097-4832; Wende, Kristian/0000-0001-5217-0683; Dietrich, Stephan/0000-0002-0753-9266	German Federal Ministry of Education and Research [03Z2DN11]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	We thank L. Kuntz for distinguished technical support: For critical reading of the manuscript; we thank J. C. Schmidt. This work was realized within the framework of the multi-disciplinary research center ZIK plasmatis, which is funded by German Federal Ministry of Education and Research Grant 03Z2DN11.	Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Arndt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079325; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Barton A., 2014, PLASMA MED, V3, P125, DOI [10.1615/PlasmaMed.2014008540, DOI 10.1615/PLASMAMED.2014008540]; Behmoaras J, 2008, NAT GENET, V40, P553, DOI 10.1038/ng.137; Bekeschus S, 2013, PLASMA PROCESS POLYM, V10, P706, DOI 10.1002/ppap.201300008; Blackert S, 2013, J DERMATOL SCI, V70, P173, DOI 10.1016/j.jdermsci.2013.01.012; Boxhammer V, 2013, MUTAT RES-GEN TOX EN, V753, P23, DOI 10.1016/j.mrgentox.2012.12.015; Brandenburg R, 2009, IEEE T PLASMA SCI, V37, P877, DOI 10.1109/TPS.2009.2019657; Bundscherer L, 2013, IMMUNOBIOLOGY, V218, P1248, DOI 10.1016/j.imbio.2013.04.015; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Christman SA, 2005, FEBS LETT, V579, P6705, DOI 10.1016/j.febslet.2005.10.066; Correa-Costa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049569; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Daeschlein G, 2012, J HOSP INFECT, V81, P177, DOI 10.1016/j.jhin.2012.02.012; Daeschlein G, 2010, PLASMA PROCESS POLYM, V7, P224, DOI 10.1002/ppap.200900059; DARR D, 1994, J INVEST DERMATOL, V102, P671, DOI 10.1111/1523-1747.ep12374036; Dulak J, 2002, ANTIOXID REDOX SIGN, V4, P229, DOI 10.1089/152308602753666280; Emmert S, 2013, CLIN PLASMA MED, V1, P24, DOI 10.1016/j.cpme.2012.11.002; FRANK S, 1995, J BIOL CHEM, V270, P12607, DOI 10.1074/jbc.270.21.12607; Fridman G, 2007, PLASMA CHEM PLASMA P, V27, P163, DOI 10.1007/s11090-007-9048-4; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Green GH, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1302; Grochot-Przeczek A, 2014, ANTIOXID REDOX SIGN, V20, P1677, DOI 10.1089/ars.2013.5426; Haertel B, 2012, CELL BIOL INT, V36, P1217, DOI 10.1042/CBI20120139; Haertel B, 2012, IMMUNOBIOLOGY, V217, P628, DOI 10.1016/j.imbio.2011.10.017; Hanselmann C, 2001, BIOCHEM J, V353, P459, DOI 10.1042/0264-6021:3530459; Heinlin J, 2011, J EUR ACAD DERMATOL, V25, P1, DOI 10.1111/j.1468-3083.2010.03702.x; Hirakawa S, 2011, J IMMUNOL, V186, P4762, DOI 10.4049/jimmunol.1000791; Hirota A, 2005, J INVEST DERMATOL, V124, P825, DOI 10.1111/j.0022-202X.2005.23670.x; Huang BW, 2013, FASEB J, V27, P3763, DOI 10.1096/fj.12-226043; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; Isbary G, 2010, BRIT J DERMATOL, V163, P78, DOI 10.1111/j.1365-2133.2010.09744.x; Isbary G, 2011, ARCH DERMATOL, V147, P388, DOI 10.1001/archdermatol.2011.57; Ishikawa M, 2005, FREE RADICAL BIO MED, V38, P1344, DOI 10.1016/j.freeradbiomed.2005.01.021; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jazwa A, 2006, FREE RADICAL BIO MED, V40, P1250, DOI 10.1016/j.freeradbiomed.2005.11.016; Jurzak M, 2013, ACTA POL PHARM, V70, P205; Kaushik AK, 2014, J PROTEOME RES, V13, P1088, DOI 10.1021/pr401106h; Kayahara M, 2005, MOL CELL BIOL, V25, P3784, DOI 10.1128/MCB.25.9.3784-3792.2005; Kondo N, 2006, ANTIOXID REDOX SIGN, V8, P1881, DOI 10.1089/ars.2006.8.1881; Kramer A, 2013, CLIN PLASMA MED, V1, P11, DOI 10.1016/j.cpme.2013.03.002; Lichtenfels R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041345; Loo AEK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049215; Lukes P, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/1/015019; Mann A, 2001, J INVEST DERMATOL, V117, P1382, DOI 10.1046/j.0022-202x.2001.01600.x; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Metelmann HR, 2013, CLIN PLASMA MED, V1, P30, DOI 10.1016/j.cpme.2012.12.001; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Pekovic-Vaughan V, 2014, GENE DEV, V28, P548, DOI 10.1101/gad.237081.113; Pham RT, 2002, MAR ENVIRON RES, V54, P291, DOI 10.1016/S0141-1136(02)00179-4; Reichard JF, 2008, J BIOL CHEM, V283, P22363, DOI 10.1074/jbc.M801784200; Reuter S, 2012, IEEE T PLASMA SCI, V40, P2986, DOI 10.1109/TPS.2012.2207130; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Roman M, 2014, METALLOMICS, V6, P25, DOI 10.1039/c3mt00185g; Schmidt A., 2013, PLASMA MED, V3, P15, DOI [DOI 10.1615/PLASMAMED.2014008535, 10.1615/PlasmaMed.2014008535]; Schmidt A, 2013, FREE RADICAL RES, V47, P577, DOI 10.3109/10715762.2013.804623; Sen CK, 2009, WOUND REPAIR REGEN, V17, P1, DOI 10.1111/j.1524-475X.2008.00436.x; Sen CK, 2003, WOUND REPAIR REGEN, V11, P431, DOI 10.1046/j.1524-475X.2003.11607.x; Sen CK, 1998, BIOCHEM PHARMACOL, V55, P1747, DOI 10.1016/S0006-2952(97)00672-2; Shibata T, 2008, GASTROENTEROLOGY, V135, P1358, DOI 10.1053/j.gastro.2008.06.082; Siegel D, 2001, MOL PHARMACOL, V59, P263, DOI 10.1124/mol.59.2.263; Soneja A, 2005, PHARMACOL REP, V57, P108; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Sun Z, 2007, MOL CELL BIOL, V27, P6334, DOI 10.1128/MCB.00630-07; Suzuki H, 2003, J BIOL CHEM, V278, P49246, DOI 10.1074/jbc.M306764200; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Valencia A, 2008, J INVEST DERMATOL, V128, P214, DOI 10.1038/sj.jid.5700960; Vesely PW, 2009, MUTAT RES-REV MUTAT, V682, P7, DOI 10.1016/j.mrrev.2009.01.001; VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607; von Woedtke T, 2014, CONTRIB PLASM PHYS, V54, P104, DOI 10.1002/ctpp.201310068; von Woedtke T, 2013, PHYS REP, V530, P291, DOI 10.1016/j.physrep.2013.05.005; von Woedtke T, 2008, PLASMA PROCESS POLYM, V5, P534, DOI 10.1002/ppap.200800013; Wagener FADTG, 2010, CURR DRUG TARGETS, V11, P1571; Weltmann KD, 2009, CONTRIB PLASM PHYS, V49, P631, DOI 10.1002/ctpp.200910067; Wende K., 2013, PLASMA MED, V3, P81, DOI DOI 10.1615/PLASMAMED.2014009690; Wende K, 2014, CELL BIOL INT, V38, P412, DOI 10.1002/cbin.10200; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Winter J, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/28/285401; WINTER J, 2014, J PHYS D, P46; Zhao R, 2012, ENVIRON HEALTH PERSP, V120, P583, DOI 10.1289/ehp.1104580	87	95	96	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6731	6750		10.1074/jbc.M114.603555	http://dx.doi.org/10.1074/jbc.M114.603555			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25589789	hybrid, Green Published			2022-12-26	WOS:000350991500007
J	Sutthangkul, J; Amparyup, P; Charoensapsri, W; Senapin, S; Phiwsaiya, K; Tassanakajon, A				Sutthangkul, Jantiwan; Amparyup, Piti; Charoensapsri, Walaiporn; Senapin, Saengchan; Phiwsaiya, Kornsunee; Tassanakajon, Anchalee			Suppression of Shrimp Melanization during White Spot Syndrome Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPHENOLOXIDASE-ACTIVATING ENZYME; LITOPENAEUS-VANNAMEI; SYSTEM; PHENOLOXIDASE; CRUSTACEAN; CRAYFISH; IDENTIFICATION; EXPRESSION; INHIBITOR; HEMOCYTES	The melanization cascade, activated by the prophenoloxidase (proP0) system, plays a key role in the production of cytotoxic intermediates, as well as melanin products for microbial sequestration in invertebrates. Here, we show that the proPO system is an important component of the Penaeus inonodon shrimp immune defense toward a major viral pathogen, white spot syndrome virus (WSSV). Gene silencing of PmproP0(s) resulted in increased cumulative shrimp mortality after WSSV infection, whereas incubation of WSSV with an in vitro melanization reaction prior to injection into shrimp significantly increased the shrimp survival rate. The hemolymph phenoloxidase (PO) activity of WSSV-infected shrimp was extremely reduced at days 2 and 3 post-injection compared with uninftcted shrimp but was fully restored after the addition of exogenous trypsin, suggesting that WSSV probably inhibits the activity of some proteinases in the proPO cascade. Using yeast two-hybrid screening and co-immunoprecipitation assays, the viral protein WSSV453 was found to interact with the proP0-activating enzyme 2 (Pm1PAE2) of P. nionodon. Gene silencing of WSSV453 showed a significant increase of PO activity in WSSV-infected shrimp, whereas co-silencing of WSSV453 and PmPPAE2 did not, sug- gesting that silencing of WSSV453 partially restored the PO activity via PmPPAE2 in WSSV-infected shrimp. Moreover, the activation of PO activity in shrimp plasma by PmPPAE2 was significantly decreased by preincubation with recombinant WSSV453. These results suggest that the inhibition of the shrimp proPO system by WSSV partly occurs via the PmPPAE2-inhibiting activity of WSSV453.	[Sutthangkul, Jantiwan; Amparyup, Piti; Tassanakajon, Anchalee] Chulalongkorn Univ, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, Fac Sci, Bangkok 10330, Thailand; [Amparyup, Piti; Charoensapsri, Walaiporn; Senapin, Saengchan; Phiwsaiya, Kornsunee] Natl Ctr Genet Engn & Biotechnol, Natl Sci & Technol, Dev Agcy, Klongluang 12120, Pathumthani, Thailand; [Charoensapsri, Walaiporn; Senapin, Saengchan; Phiwsaiya, Kornsunee] Mahidol Univ, Ctr Excellence Shrimp Mol Biol & Biotechnol, Bangkok 10400, Thailand	Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Tassanakajon, A (corresponding author), Chulalongkorn Univ, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, Fac Sci, 254 Phayathai Rd, Bangkok 10330, Thailand.	anchalee.k@chula.ac.th	Senapin, Saengchan/F-1323-2011	Senapin, Saengchan/0000-0002-5599-4343; Charoensapsri, Walaiporn/0000-0002-8651-383X; Phiwsaiya, Kornsunee/0000-0003-3876-6450	Thailand Research Fund Senior Scholar [RTA5580008]; Thailand Research Fund; National Center for Genetic Engineering and Biotechnology; National Science and Technology Development Agency [RSA5580046]; Higher Education Research Promotion and National Research University Project of Thailand; Office of the Higher Education Commission Grant [WCU-017-FW-57]; Japan Science and Technology Agency (JST)/the Japan International Cooperation Agency (JICA); Science and Technology Research Partnership for Sustainable Development (SATREPS); Japan Society for the Promotion of Science (JSPS) core University Program; Royal Golden Jubilee Ph.D. Program; Chulalongkorn University; 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund)	Thailand Research Fund Senior Scholar; Thailand Research Fund(Thailand Research Fund (TRF)); National Center for Genetic Engineering and Biotechnology; National Science and Technology Development Agency; Higher Education Research Promotion and National Research University Project of Thailand; Office of the Higher Education Commission Grant; Japan Science and Technology Agency (JST)/the Japan International Cooperation Agency (JICA); Science and Technology Research Partnership for Sustainable Development (SATREPS); Japan Society for the Promotion of Science (JSPS) core University Program; Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Chulalongkorn University(Chulalongkorn University); 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund)(Chulalongkorn University)	This work was supported by Thailand Research Fund Senior Scholar Grant RTA5580008 (to A.T.), the Thailand Research Fund and National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency Grant RSA5580046 (to P. A.), Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission Grant WCU-017-FW-57, the Japan Science and Technology Agency (JST)/the Japan International Cooperation Agency (JICA), Science and Technology Research Partnership for Sustainable Development (SATREPS), and a visiting fellowship under the Japan Society for the Promotion of Science (JSPS) core University Program.; Recipient of a student fellowship from the Royal Golden Jubilee Ph.D. Program, Joint Funding of the Thailand Research Fund and Chulalongkorn University and the 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund).	Ai HS, 2009, DEV COMP IMMUNOL, V33, P59, DOI 10.1016/j.dci.2008.07.017; Ai HS, 2008, FISH SHELLFISH IMMUN, V25, P28, DOI 10.1016/j.fsi.2007.12.002; Amparyup P, 2009, DEV COMP IMMUNOL, V33, P247, DOI 10.1016/j.dci.2008.09.003; Amparyup P, 2008, DEV COMP IMMUNOL, V32, P1497, DOI 10.1016/j.dci.2008.06.005; Amparyup P, 2013, FISH SHELLFISH IMMUN, V34, P990, DOI 10.1016/j.fsi.2012.08.019; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Binggeli O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004067; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2003, CELL MICROBIOL, V5, P353, DOI 10.1046/j.1462-5822.2003.00282.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Cerenius L, 2010, J INVERTEBR PATHOL, V103, P21, DOI 10.1016/j.jip.2009.09.006; Charoensapsri W, 2014, DEV COMP IMMUNOL, V47, P150, DOI 10.1016/j.dci.2014.07.010; Charoensapsri W, 2011, DEV COMP IMMUNOL, V35, P115, DOI 10.1016/j.dci.2010.09.002; Charoensapsri W, 2009, DEV COMP IMMUNOL, V33, P811, DOI 10.1016/j.dci.2009.01.006; Eleftherianos I, 2007, P NATL ACAD SCI USA, V104, P2419, DOI 10.1073/pnas.0610525104; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; Fagutao FF, 2009, FEBS J, V276, P5298, DOI 10.1111/j.1742-4658.2009.07225.x; Gao HW, 2009, MOL BIOL REP, V36, P1159, DOI 10.1007/s11033-008-9292-6; Jang IK, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-70; Jiravanichpaisal P, 2006, FISH SHELLFISH IMMUN, V20, P718, DOI 10.1016/j.fsi.2005.09.002; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058627, 10.1371/journal.pone.0076131]; Lightner, 1996, HDB SHRIMP PATHOLOGY, P304; Lin SW, 2012, J INFECTION, V64, P325, DOI 10.1016/j.jinf.2011.11.023; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Liu YC, 2009, FISH SHELLFISH IMMUN, V26, P345, DOI 10.1016/j.fsi.2008.08.016; Liu YJ, 2014, DEV COMP IMMUNOL, V43, P35, DOI 10.1016/j.dci.2013.10.012; Lu Z, 2008, J BIOL CHEM, V283, P21325, DOI 10.1074/jbc.M801593200; Lu ZQ, 2010, INSECT BIOCHEM MOLEC, V40, P497, DOI 10.1016/j.ibmb.2010.04.009; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977; Sanchez-Paz A, 2010, VET RES, V41, DOI 10.1051/vetres/2010015; Sangsuriya P, 2014, MOL CELL PROTEOMICS, V13, P269, DOI 10.1074/mcp.M113.029199; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Sritunyalucksana K, 2000, AQUACULTURE, V191, P53, DOI 10.1016/S0044-8486(00)00411-7; Stentiford GD, 2012, J INVERTEBR PATHOL, V110, P141, DOI 10.1016/j.jip.2012.03.013; Yassine H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003029; Yeh SP, 2009, FISH SHELLFISH IMMUN, V26, P582, DOI 10.1016/j.fsi.2008.09.010; Zeng Y, 2009, FISH SHELLFISH IMMUN, V26, P646, DOI 10.1016/j.fsi.2008.11.005; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001; Zhao PC, 2011, INSECT BIOCHEM MOLEC, V41, P645, DOI 10.1016/j.ibmb.2011.04.006	45	46	46	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6470	6481		10.1074/jbc.M114.605568	http://dx.doi.org/10.1074/jbc.M114.605568			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25572398	hybrid, Green Published			2022-12-26	WOS:000350732500050
J	Benazza, A; Selleslagh, J; Breton, E; Rabhi, K; Cornille, V; Bacha, M; Lecuyer, E; Amara, R				Benazza, Achwak; Selleslagh, Jonathan; Breton, Elsa; Rabhi, Khalef; Cornille, Vincent; Bacha, Mahmoud; Lecuyer, Eric; Amara, Rachid			Environmental Control on Fish and Macrocrustacean Spring Community-Structure, on an Intertidal Sandy Beach	PLOS ONE			English	Article							EASTERN ENGLISH-CHANNEL; PLAICE PLEURONECTES-PLATESSA; SHRIMP CRANGON-CRANGON; WESTERN WADDEN SEA; SURF ZONE; MACROFAUNA COMMUNITIES; POPULATION-DYNAMICS; SPECIES COMPOSITION; SEASONAL PATTERNS; COASTAL WATERS	The inter-annual variability of the fish and macrocrustacean spring community on an intertidal sandy beach near the Canche estuary (North of France) was studied from 2000 to 2013 based on weekly spring sampling over an 11-year period. Twenty-eight species representing 21 families were collected during the course of the study. The community was dominated by a few abundant species accounting for > 99% of the total species densities. Most individuals caught were young-of-the-year indicating the importance of this ecosystem for juvenile fishes and macrocrustaceans. Although standard qualitative community ecology metrics (species composition, richness, diversity, evenness and similarity) indicated notable stability over the study period, community structure showed a clear change since 2009. Densities of P. platessa, P. microps and A. tobianus decreased significantly since 2009, whereas over the period 2010-2013, the contribution of S. sprattus to total species density increased 4-fold. Co-inertia and generalised linear model analyses identified winter NAO index, water temperature, salinity and suspended particular matter as the major environmental factors explaining these changes. Although the recurrent and dense spring blooms of the Prymnesiophyte Phaeocystis globosa is one of the main potential threats in shallow waters of the eastern English Channel, no negative impact of its temporal change was detected on the fish and macrocrustacean spring community structure.	[Benazza, Achwak; Selleslagh, Jonathan; Breton, Elsa; Rabhi, Khalef; Cornille, Vincent; Bacha, Mahmoud; Amara, Rachid] Univ Littoral, UMR LOG 8187, F-62930 Wimereux, France; [Benazza, Achwak; Selleslagh, Jonathan; Breton, Elsa; Rabhi, Khalef; Cornille, Vincent; Bacha, Mahmoud; Lecuyer, Eric; Amara, Rachid] CNRS, UMR LOG 8187, F-62930 Wimereux, France; [Selleslagh, Jonathan] Univ Bordeaux, CNRS, UMR EPOC 5805, Stn Marine Arcachon, F-33120 Arcachon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite du Littoral-Cote-d'Opale; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux	Amara, R (corresponding author), Univ Littoral, UMR LOG 8187, F-62930 Wimereux, France.	rachid.amara@univ-littoral.fr	RACHID, AMARA/E-2525-2012; elsa, Breton/J-4996-2013	AMARA, Rachid/0000-0002-7183-1333; Breton, Elsa/0000-0002-9569-5436	French Ministere des Affaires Etrangeres et Europeennes (MAEE)	French Ministere des Affaires Etrangeres et Europeennes (MAEE)	This research was funded by a doctoral grant to AB by the French Ministere des Affaires Etrangeres et Europeennes (MAEE) as part of the "programme de cooperation decentralisee des territoires Dunkerquois et Annabis". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara R, 2004, HYDROBIOLOGIA, V518, P23, DOI 10.1023/B:HYDR.0000025053.62966.cd; Amara R, 2013, AQUACULTURE, V414, P149, DOI 10.1016/j.aquaculture.2013.07.048; Amara R, 2003, ESTUAR COAST SHELF S, V56, P807, DOI 10.1016/S0272-7714(02)00315-3; Amara R, 2000, OCEANOL ACTA, V23, P469, DOI 10.1016/S0399-1784(00)00134-1; Attrill MJ, 2002, NATURE, V417, P275, DOI 10.1038/417275a; Banikas EM, 2012, ESTUAR COAST, V35, P1346, DOI 10.1007/s12237-012-9517-8; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; BEUKEMA JJ, 1992, NETH J SEA RES, V30, P73, DOI 10.1016/0077-7579(92)90047-I; Beyst B, 2001, ESTUAR COAST SHELF S, V53, P877, DOI 10.1006/ecss.2001.0808; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Breton E, 2006, LIMNOL OCEANOGR, V51, P1401, DOI 10.4319/lo.2006.51.3.1401; Brown A.C., 1990, ECOLOGY SANDY SHORES; Brylinski JM, 1991, OCEANOL ACTA, V11, P197; Campos J, 2010, MAR ECOL PROG SER, V405, P203, DOI 10.3354/meps08493; CHANG FH, 1984, NEW ZEAL J MAR FRESH, V18, P303, DOI 10.1080/00288330.1984.9516052; Clark BM, 1996, MAR ECOL PROG SER, V131, P35, DOI 10.3354/meps131035; Clarke K., 2001, PRIMER V5 USER MANUA; Cornelius C, 2001, CONSERV BIOL, V15, P1396, DOI 10.1046/j.1523-1739.2001.00163.x; Costa-Dias S, 2010, MAR POLLUT BULL, V61, P240, DOI 10.1016/j.marpolbul.2010.02.020; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Defeo O, 2013, GEOMORPHOLOGY, V199, P106, DOI 10.1016/j.geomorph.2013.04.013; Desroy N, 2004, MAR ECOL PROG SER, V270, P41, DOI 10.3354/meps270041; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; EDWARDS R, 1968, Journal of Experimental Marine Biology and Ecology, V2, P215, DOI 10.1016/0022-0981(68)90017-8; Faria C, 1999, MAR ECOL PROG SER, V184, P197, DOI 10.3354/meps184197; Gibson R.N., 1999, P264, DOI 10.1016/B978-012356040-7/50014-7; GIBSON RN, 1993, MAR ECOL PROG SER, V98, P89, DOI 10.3354/meps098089; Gibson RN, 1996, MAR ECOL PROG SER, V130, P1, DOI 10.3354/meps130001; Gibson RN, 2002, MAR ECOL PROG SER, V229, P233, DOI 10.3354/meps229233; Grioche A, 1997, ICES J MAR SCI, V54, P93, DOI 10.1006/jmsc.1996.0162; Hamed KH, 1998, J HYDROL, V204, P182, DOI 10.1016/S0022-1694(97)00125-X; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; Henderson PA, 2011, J EXP MAR BIOL ECOL, V400, P78, DOI 10.1016/j.jembe.2011.02.028; Henderson PA, 2006, J MAR BIOL ASSOC UK, V86, P287, DOI 10.1017/S0025315406013142; Herborg LM, 2003, HYDROBIOLOGIA, V503, P21, DOI 10.1023/B:HYDR.0000008483.63314.3c; Jackson G, 1999, MAR ECOL PROG SER, V182, P253, DOI 10.3354/meps182253; KAISER MJ, 1994, MAR ECOL PROG SER, V106, P131, DOI 10.3354/meps106131; KENDALL MG, 1955, BIOMETRICS, V11, P43, DOI 10.2307/3001479; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Kroncke I, 2013, ESTUAR COAST SHELF S, V119, P79, DOI 10.1016/j.ecss.2012.12.024; Lazzari MA, 1999, ESTUARIES, V22, P636, DOI 10.2307/1353051; McLachlan A, 1996, REV CHILENA HIST NAT, V69; Oh CW, 2001, MAR ECOL PROG SER, V214, P211, DOI 10.3354/meps214211; Philippart CJM, 1996, ICES J MAR SCI, V53, P1120, DOI 10.1006/jmsc.1996.0138; PIHL L, 1990, HYDROBIOLOGIA, V195, P79, DOI 10.1007/BF00026815; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; POXTON MG, 1992, P ROY SOC EDINB B, V100, P141, DOI 10.1017/S0269727000011118; Riley J.D., 1966, ANN REP MAR BIOL STN, V78, P51; ROSS ST, 1987, ESTUAR COAST SHELF S, V25, P391, DOI 10.1016/0272-7714(87)90033-3; SANTOS RS, 1995, ESTUAR COAST SHELF S, V41, P579, DOI 10.1016/0272-7714(95)90028-4; Schoemann V, 2005, J SEA RES, V53, P43, DOI 10.1016/j.seares.2004.01.008; Schuckel U, 2013, ESTUAR COAST SHELF S, V117, P210, DOI 10.1016/j.ecss.2012.11.008; Selleslagh J, 2009, ESTUAR COAST SHELF S, V81, P149, DOI 10.1016/j.ecss.2008.10.008; Selleslagh J, 2008, ESTUAR COAST SHELF S, V79, P507, DOI 10.1016/j.ecss.2008.05.006; Selleslagh J, 2008, ESTUAR COAST SHELF S, V77, P721, DOI 10.1016/j.ecss.2007.11.004; Short A.D, 1999, HDB BEACH SHOREFACE; Spilmont N, 2009, MAR POLLUT BULL, V58, P55, DOI 10.1016/j.marpolbul.2008.09.007; THIEL R, 1995, J FISH BIOL, V46, P47, DOI 10.1111/j.1095-8649.1995.tb05946.x; Tulp I, 2012, MAR ECOL PROG SER, V458, P141, DOI 10.3354/meps09743; van der Veer HW, 2000, ICES J MAR SCI, V57, P202, DOI 10.1006/jmsc.1999.0523; VANDERVEER HW, 1993, MAR ECOL PROG SER, V101, P81, DOI 10.3354/meps101081; VANDERVEER HW, 1987, MAR ECOL PROG SER, V35, P203, DOI 10.3354/meps035203; VANDERVEER HW, 1991, MAR ECOL PROG SER, V73, P141, DOI 10.3354/meps073141	64	2	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117220	10.1371/journal.pone.0117220	http://dx.doi.org/10.1371/journal.pone.0117220			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617852	Green Published, Green Submitted, gold			2022-12-26	WOS:000350336000041
J	Matsushita, M; Ozaki, Y; Hasegawa, Y; Terada, F; Tabata, N; Shiheido, H; Yanagawa, H; Oikawa, T; Matsuo, K; Du, WL; Yamada, T; Hozumi, M; Ichikawa, D; Hattori, Y				Matsushita, Maiko; Ozaki, Yoshie; Hasegawa, Yuka; Terada, Fukiko; Tabata, Noriko; Shiheido, Hirokazu; Yanagawa, Hiroshi; Oikawa, Tsukasa; Matsuo, Koichi; Du, Wenlin; Yamada, Taketo; Hozumi, Masashi; Ichikawa, Daiju; Hattori, Yutaka			A Novel Phthalimide Derivative, TC11, Has Preclinical Effects on High-Risk Myeloma Cells and Osteoclasts	PLOS ONE			English	Article							REFRACTORY MULTIPLE-MYELOMA; 2013 UPDATE; NUCLEOPHOSMIN; TARGET; LENALIDOMIDE; POMALIDOMIDE; MANAGEMENT; LEUKEMIA; CANCER; STRATIFICATION	Despite the recent advances in the treatment of multiple myeloma (MM), MM patients with high-risk cytogenetic changes such as t(4;14) translocation or deletion of chromosome 17 still have extremely poor prognoses. With the goal of helping these high-risk MM patients, we previously developed a novel phthalimide derivative, TC11. Here we report the further characterization of TC11 including anti-myeloma effects in vitro and in vivo, a pharmacokinetic study in mice, and anti-osteoclastogenic activity. Intraperitoneal injections of TC11 significantly delayed the growth of subcutaneous tumors in human myeloma-bearing SCID mice. Immunohistochemical analyses showed that TC11 induced apoptosis of MM cells in vivo. In the pharmacokinetic analyses, the C-max was 2.1 mu M at 1 h after the injection of TC11, with 1.2 h as the half-life. TC11 significantly inhibited the differentiation and function of tartrate-resistant acid phosphatase (TRAP)-positive multinucleated osteoclasts in mouse osteoclast cultures using M-CSF and RANKL. We also revealed that TC11 induced the apoptosis of myeloma cells accompanied by alpha-tubulin fragmentation. In addition, TC11 and lenalidomide, another phthalimide derivative, directly bound to nucleophosmin 1 (NPM1), whose role in MM is unknown. Thus, through multiple molecular interactions, TC11 is a potentially effective drug for high-risk MM patients with bone lesions. The present results suggest the possibility of the further development of novel thalidomide derivatives by drug designing.	[Matsushita, Maiko; Ozaki, Yoshie; Hasegawa, Yuka; Terada, Fukiko; Hozumi, Masashi; Ichikawa, Daiju; Hattori, Yutaka] Keio Univ, Fac Pharm, Tokyo, Japan; [Tabata, Noriko; Shiheido, Hirokazu; Yanagawa, Hiroshi] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan; [Oikawa, Tsukasa; Matsuo, Koichi] Keio Univ, Sch Med, Tokyo, Japan; [Du, Wenlin; Yamada, Taketo] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan	Keio University; Keio University; Keio University; Keio University	Hattori, Y (corresponding author), Keio Univ, Fac Pharm, Tokyo, Japan.	hattori-yt@pha.keio.ac.jp	Matsuo, Koichi/K-5695-2012; Oikawa, Tsukasa/B-7718-2013	Matsuo, Koichi/0000-0002-1490-8955; Oikawa, Tsukasa/0000-0003-2694-2699; Hattori, Yutaka/0000-0003-1080-9738; Shiheido, Hirokazu/0000-0002-1415-2019	Private University Strategic Research Base Development Program of MEXT (Ministry of Education, Culture, Sports, Science and Technology) of Japan; Keio Gijuku Academic development Funds; Japan Leukemia Research Fund	Private University Strategic Research Base Development Program of MEXT (Ministry of Education, Culture, Sports, Science and Technology) of Japan; Keio Gijuku Academic development Funds; Japan Leukemia Research Fund(Japan Leukemia Research Fund (JLRF))	This work was supported in part by a Grant-in-Aid for Scientific Research (Y. Hattori, MM) and a grant from the Private University Strategic Research Base Development Program (Y. Hattori) of MEXT (the Ministry of Education, Culture, Sports, Science and Technology) of Japan, Keio Gijuku Academic development Funds (Y. Hattori) and Japan Leukemia Research Fund (Y. Hattori, MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparartion of the manuscript.	Avet-Loiseau H, 2012, J CLIN ONCOL, V30, P1949, DOI 10.1200/JCO.2011.36.5726; Balusu R, 2011, BLOOD, V118, P3096, DOI 10.1182/blood-2010-09-309674; Bergsagel PL, 2013, BLOOD, V121, P884, DOI 10.1182/blood-2012-05-432203; Bird JM, 2011, BRIT J HAEMATOL, V154, P32, DOI 10.1111/j.1365-2141.2011.08573.x; Chang H, 2010, LEUKEMIA LYMPHOMA, V51, P2084, DOI 10.3109/10428194.2010.524325; Chesi M, 2013, INT J HEMATOL, V97, P313, DOI 10.1007/s12185-013-1291-2; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Du WL, 2007, BLOOD, V109, P3042, DOI 10.1182/blood-2006-02-003103; Ebert BL, 2011, SEMIN ONCOL, V38, P621, DOI 10.1053/j.seminoncol.2011.04.010; Estey EH, 2013, AM J HEMATOL, V88, P317, DOI 10.1002/ajh.23404; Falini B, 2009, LEUKEMIA, V23, P1731, DOI 10.1038/leu.2009.124; Falini B, 2011, BLOOD REV, V25, P247, DOI 10.1016/j.blre.2011.06.001; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hattori Y, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.13; Ito T, 2011, CELL MOL LIFE SCI, V68, P1569, DOI 10.1007/s00018-010-0619-9; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Lacy MQ, 2011, CURR HEMATOL MALIG R, V6, P120, DOI 10.1007/s11899-011-0077-y; Lee HH, 2007, PROTEINS, V69, P672, DOI 10.1002/prot.21504; Li J, 2006, J BIOL CHEM, V281, P16536, DOI 10.1074/jbc.M601386200; Lindstrom MS, 2011, BIOCH RES INT, V2011, P195; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Mateos MV, 2011, BLOOD, V118, P4547, DOI 10.1182/blood-2011-04-345801; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; McCurdy AR, 2013, THER ADV HEMATOL, V4, P211, DOI 10.1177/2040620713480155; Modi ND, 2012, LEUKEMIA, V26, P589, DOI 10.1038/leu.2011.282; NAMBA M, 1989, IN VITRO CELL DEV B, V25, P723; Oikawa T, 2012, J CELL BIOL, V197, P553, DOI 10.1083/jcb.201111116; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Pan BQ, 2012, PHARMACOL THERAPEUT, V136, P56, DOI 10.1016/j.pharmthera.2012.07.004; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Qi W, 2008, ONCOGENE, V27, P4210, DOI 10.1038/onc.2008.54; Raje N, 2011, CLIN CANCER RES, V17, P1278, DOI 10.1158/1078-0432.CCR-10-1804; Rajkumar SV, 2013, AM J HEMATOL, V88, P225, DOI 10.1002/ajh.23390; Sawyer JR, 2011, CANCER GENET-NY, V204, P3, DOI 10.1016/j.cancergencyto.2010.11.002; Shiheido H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038878; Siegel DS, 2012, SEMIN HEMATOL, V49, pS3, DOI 10.1053/j.seminhematol.2012.05.005; Spagnuolo PA, 2010, BLOOD, V115, P4824, DOI 10.1182/blood-2009-09-243055; Terpos E, 2013, ONCOTARGETS THER, V6, P531, DOI 10.2147/OTT.S34498; Weinhold N, 2010, GENE CHROMOSOME CANC, V49, P333, DOI 10.1002/gcc.20745; Zangari M, 2012, CANCER TREAT REV, V38, P968, DOI 10.1016/j.ctrv.2011.12.007; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	41	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116135	10.1371/journal.pone.0116135	http://dx.doi.org/10.1371/journal.pone.0116135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617756	Green Published, gold, Green Submitted			2022-12-26	WOS:000350336000008
J	Musto, AE; Walker, CP; Petasis, NA; Bazan, NG				Musto, Alberto E.; Walker, Chelsey P.; Petasis, Nicos A.; Bazan, Nicolas G.			Hippocampal Neuro-Networks and Dendritic Spine Perturbations in Epileptogenesis Are Attenuated by Neuroprotectin D1	PLOS ONE			English	Article							EPILEPTIFORM ACTIVITY; PILOCARPINE MODEL; SPONTANEOUS SEIZURES; EPILEPSY; INHIBITION; SUSCEPTIBILITY; EXPRESSION; CELLS	Purpose Limbic epileptogenesis triggers molecular and cellular events that foster the establishment of aberrant neuronal networks that, in turn, contribute to temporal lobe epilepsy (TLE). Here we have examined hippocampal neuronal network activities in the pilocarpine post-status epilepticus model of limbic epileptogenesis and asked whether or not the docosahexaenoic acid (DHA)-derived lipid mediator, neuroprotectin D1 (NPD1), modulates epileptogenesis. Methods Status epilepticus (SE) was induced by intraperitoneal administration of pilocarpine in adult male C57BL/6 mice. To evaluate simultaneous hippocampal neuronal networks, local field potentials were recorded from multi-microelectrode arrays (silicon probe) chronically implanted in the dorsal hippocampus. NPD1 (570 mu g/kg) or vehicle was administered intraperitoneally daily for five consecutive days 24 hours after termination of SE. Seizures and epileptiform activity were analyzed in freely-moving control and treated mice during epileptogenesis and epileptic periods. Then hippocampal dendritic spines were evaluated using Golgi-staining. Results We found brief spontaneous microepileptiform activity with high amplitudes in the CA1 pyramidal and stratum radiatum in epileptogenesis. These aberrant activities were attenuated following systemic NPD1 administration, with concomitant hippocampal dendritic spine protection. Moreover, NPD1 treatment led to a reduction in spontaneous recurrent seizures. Conclusions Our results indicate that NPD1 displays neuroprotective bioactivity on the hippocampal neuronal network ensemble that mediates aberrant circuit activity during epileptogenesis. Insight into the molecular signaling mediated by neuroprotective bioactivity of NPD1 on neuronal network dysfunction may contribute to the development of anti-epileptogenic therapeutic strategies.	[Musto, Alberto E.; Walker, Chelsey P.; Bazan, Nicolas G.] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA 70112 USA; [Petasis, Nicos A.] Univ So Calif, Dept Chem, Loker Hydrocarbon Res Inst, Los Angeles, CA 90089 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Southern California	Musto, AE (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA 70112 USA.	amusto@lsuhsc.edu; nbazan@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020; Petasis, Nicos/B-3162-2009	Bazan, Nicolas/0000-0002-9243-5444; Petasis, Nicos/0000-0002-8864-4446	NIH/NIGMS [P30-GM103340]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103340] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by funds from NIH/NIGMS Grant P30-GM103340. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre V, 2001, HIPPOCAMPUS, V11, P452, DOI 10.1002/hipo.1060.abs; Barros CS, 2009, P NATL ACAD SCI USA, V106, P4507, DOI 10.1073/pnas.0900355106; Bazan NG, 2012, BASIC NEUROCHEMISTRY: PRINCIPLES OF MOLECULAR, CELLULAR, AND MEDICAL NEUROBIOLOGY, 8THEDITION, P610; Bazan NG, 2012, BASIC NEUROCHEMISTRY: PRINCIPLES OF MOLECULAR, CELLULAR, AND MEDICAL NEUROBIOLOGY, 8THEDITION, P643; Bazan NG, 2011, MOL NEUROBIOL, V44, P216, DOI 10.1007/s12035-011-8200-6; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Bazan NG, 2010, J LIPID RES, V51, P2018, DOI 10.1194/jlr.R001131; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; Bertram EH, 2013, EXP NEUROL, V244, P67, DOI 10.1016/j.expneurol.2012.01.028; Bialer M, 2013, EPILEPSY RES, V103, P2, DOI 10.1016/j.eplepsyres.2012.10.001; Bragin A, 2011, EPILEPSIA, V52, P45, DOI 10.1111/j.1528-1167.2010.02896.x; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; CHATT AB, 1982, BRAIN RES, V241, P382, DOI 10.1016/0006-8993(82)91084-8; Chen J, 2005, NEUROSCI LETT, V375, P192, DOI 10.1016/j.neulet.2004.11.008; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Danzer E, 2010, NEUROPEDIATRICS, V41, P140, DOI 10.1055/s-0030-1263164; Dichter MA, 2009, ARCH NEUROL-CHICAGO, V66, P443, DOI 10.1001/archneurol.2009.10; Dinocourt C, 2003, J COMP NEUROL, V459, P407, DOI 10.1002/cne.10622; Dudek FE, 2011, EPILEPSY RES, V97, P324, DOI 10.1016/j.eplepsyres.2011.10.017; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; Galvez R, 2006, J NEUROSCI, V26, P6062, DOI 10.1523/JNEUROSCI.5582-05.2006; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Grabenstatter HL, 2014, NEUROBIOL DIS, V62, P73, DOI 10.1016/j.nbd.2013.09.003; Helgager J, 2013, J COMP NEUROL, V521, P499, DOI 10.1002/cne.23225; Jette N, 2013, CURR OPIN NEUROL, V26, P201, DOI 10.1097/WCO.0b013e32835ef345; Jiang JX, 2013, P NATL ACAD SCI USA, V110, P3591, DOI 10.1073/pnas.1218498110; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kohling R, 2011, EPILEPSY RES, V97, P318, DOI 10.1016/j.eplepsyres.2011.03.006; Kurz JE, 2008, EPILEPSIA, V49, P1696, DOI 10.1111/j.1528-1167.2008.01616.x; Mani R, 2011, NEUROSCI LETT, V497, P251, DOI 10.1016/j.neulet.2011.03.010; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Marx M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00167; Mattson MP, 1999, J NEUROSCI RES, V58, P152, DOI 10.1002/(SICI)1097-4547(19991001)58:1<152::AID-JNR15>3.0.CO;2-V; Mazzuferi M, 2013, ANN NEUROL, V74, P560, DOI 10.1002/ana.23940; McAuliffe JJ, 2011, HIPPOCAMPUS, V21, P93, DOI 10.1002/hipo.20726; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13152, DOI 10.1073/pnas.0705949104; Muldoon SF, 2013, P NATL ACAD SCI USA, V110, P3567, DOI 10.1073/pnas.1216958110; Musto AE, 2011, EPILEPSIA, V52, P1601, DOI 10.1111/j.1528-1167.2011.03081.x; Musto AE, 2009, EPILEPSY RES, V85, P199, DOI 10.1016/j.eplepsyres.2009.02.020; Osawa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060928; Pitkanen A, 2011, BIOMARK MED, V5, P629, DOI [10.2217/BMM.11.67, 10.2217/bmm.11.67]; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rusan ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101117; Schevon CA, 2008, J CLIN NEUROPHYSIOL, V25, P321, DOI 10.1097/WNP.0b013e31818e8010; Seo J, 2012, EXP NEUROL, VS0014-4886, P441; Sfondouris JL, 2012, COMPUT BIOL MED, V42, P129, DOI 10.1016/j.compbiomed.2011.10.017; Sheets KG, 2010, MOL VIS, V16, P320; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; Sloviter RS, 2013, NEUROPHARMACOLOGY, V69, P3, DOI 10.1016/j.neuropharm.2012.01.022; Soussi R, 2015, BRAIN STRUCT FUNCT, V220, P2449, DOI 10.1007/s00429-014-0800-2; Stead M, 2010, BRAIN, V133, P2789, DOI 10.1093/brain/awq190; Takahashi N, 2012, SCIENCE, V335, P353, DOI 10.1126/science.1210362; Timofeev I, 2002, NEUROSCIENCE, V114, P1115, DOI 10.1016/S0306-4522(02)00300-7; Trevelyan AJ, 2006, J NEUROSCI, V26, P12447, DOI 10.1523/JNEUROSCI.2787-06.2006; Tu B, 2003, EXP NEUROL, V179, P167, DOI 10.1016/S0014-4886(02)00019-5; Vandecasteele M, 2012, JOVE-J VIS EXP, DOI 10.3791/3568; Young C, 2000, SYNAPSE, V37, P90, DOI 10.1002/1098-2396(200008)37:2&lt;90::AID-SYN2&gt;3.0.CO;2-Z; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024	58	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116543	10.1371/journal.pone.0116543	http://dx.doi.org/10.1371/journal.pone.0116543			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617763	Green Submitted, Green Published, gold			2022-12-26	WOS:000350336000016
J	Shivaprasad, PV; Hohn, T; Akbergenov, R				Shivaprasad, Padubidri V.; Hohn, Thomas; Akbergenov, Rashid			Biochemical Requirements for Two Dicer-Like Activities from Wheat Germ	PLOS ONE			English	Article							BINDING-PROTEIN HYL1; RNA-BINDING; FUNCTIONAL DIVERSIFICATION; SIRNA BIOGENESIS; MICRO-RNA; PRI-MIRNA; ARABIDOPSIS; DCL4; RIBONUCLEASE; INTERFERENCE	RNA silencing pathways were first discovered in plants. Through genetic analysis, it has been established that the key silencing components called Dicer-like (DCL) genes have been shown to cooperatively process RNA substrates of multiple origin into distinct 21, 22 and 24 nt small RNAs. However, only few detailed biochemical analysis of the corresponding complexes has been carried out in plants, mainly due to the large unstable complexes that are hard to obtain or reconstitute in heterologous systems. Reconstitution of activity needs thorough understanding of all protein partners in the complex, something that is still an ongoing process in plant systems. Here, we use biochemical analysis to uncover properties of two previously identified native dicer-like activities from wheat germ. We find that standard wheat germ extract contains Dicer-like enzymes that convert double-stranded RNA (dsRNA) into two classes of small interfering RNAs of 21 and 24 nt in size. The 21 nt dicing activity, likely an siRNA producing complex known as DCL4, is 950 kDa-1.2 mDa in size and is highly unstable during purification processes but has a rather vast range for activity. On the contrary, the 24 nt dicing complex, likely the DCL3 activity, is relatively stable and comparatively smaller in size, but has stricter conditions for effective processing of dsRNA substrates. While both activities could process completely complementary dsRNA albeit with varying abilities, we show that DCL3-like 24 nt producing activity is equally good in processing incompletely complementary RNAs.	[Shivaprasad, Padubidri V.] Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Hohn, Thomas] Univ Basel, Inst Bot, Dept Plant Physiol, CH-4056 Basel, Switzerland; [Akbergenov, Rashid] Univ Zurich, Inst Med Microbiol, Zurich, Switzerland	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Basel; University of Zurich	Shivaprasad, PV (corresponding author), Natl Ctr Biol Sci, GKVK Campus, Bangalore, Karnataka, India.	shivaprasad@ncbs.res.in; rashidakber@yahoo.com		Shivaprasad, Padubidri/0000-0002-9296-4848	Marie Curie Actions	Marie Curie Actions(European Commission)	Support was provided by Marie Curie Actions (http://ec. europa. eu/research/mariecurieactions/) to RA; National Centre for Biological Sciences (http://www. ncbs. res. in/) to PVS; Ramanujan Fellowship, Department of Science and Technology, Government of India (http://www. snf. ch/en/Pages/default. aspx) to TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbergenov R, 2006, NUCLEIC ACIDS RES, V34, P462, DOI 10.1093/nar/gkj447; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; ANDERSON CW, 1983, METHOD ENZYMOL, V101, P635; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Cho SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000314; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Du QS, 2007, J VIROL, V81, P9142, DOI 10.1128/JVI.02885-06; Dugas DV, 2004, CURR OPIN PLANT BIOL, V7, P512, DOI 10.1016/j.pbi.2004.07.011; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Eamens AL, 2012, PLANT SIGNAL BEHAV, V7, P1224, DOI 10.4161/psb.21518; Fu DQ, 2006, MOL CELLS, V21, P153; Fukudome A, 2011, RNA, V17, P750, DOI 10.1261/rna.2455411; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Grigg SP, 2005, NATURE, V437, P1022, DOI 10.1038/nature04052; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hiraguri A, 2005, PLANT MOL BIOL, V57, P173, DOI 10.1007/s11103-004-6853-5; Ho T, 2008, BIOCHEM BIOPH RES CO, V368, P433, DOI 10.1016/j.bbrc.2008.01.110; Hohjoh H, 1997, J MOL BIOL, V271, P7, DOI 10.1006/jmbi.1997.1159; Iwata Y, 2013, NUCLEIC ACIDS RES, V41, P9129, DOI 10.1093/nar/gkt667; Jin ZG, 2007, CURR BIOL, V17, P539, DOI 10.1016/j.cub.2007.01.050; Kapoor M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-451; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Li HL, 1996, EMBO J, V15, P1421, DOI 10.1002/j.1460-2075.1996.tb00484.x; Liu B, 2007, PLANT CELL, V19, P2705, DOI 10.1105/tpc.107.052209; Liu QP, 2009, FUNCT INTEGR GENOMIC, V9, P277, DOI 10.1007/s10142-009-0111-5; LOBBES D, 2006, EMBO REP IN PRESS; Lu C, 2000, PLANT CELL, V12, P2351, DOI 10.1105/tpc.12.12.2351; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Manavella PA, 2012, CELL, V151, P859, DOI 10.1016/j.cell.2012.09.039; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Nagano H, 2014, NUCLEIC ACIDS RES, V42, P1845, DOI 10.1093/nar/gkt1077; Nakazawa Y, 2007, PLANT MOL BIOL, V63, P777, DOI 10.1007/s11103-006-9125-8; Papp I, 2003, PLANT PHYSIOL, V132, P1382, DOI 10.1104/pp.103.021980; Pouch-Pelissier MN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000096; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Ren GD, 2012, P NATL ACAD SCI USA, V109, P12817, DOI 10.1073/pnas.1204915109; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Sandoval PY, 2014, DEV CELL, V28, P174, DOI 10.1016/j.devcel.2013.12.010; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Song L, 2010, CURR BIOL, V20, P37, DOI 10.1016/j.cub.2009.10.076; SONG X, 2011, PLANT J IN PRINT; Song XW, 2012, PLANT J, V69, P462, DOI 10.1111/j.1365-313X.2011.04805.x; Szittya G, 2003, EMBO J, V22, P633, DOI 10.1093/emboj/cdg74; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Tang Guiliang, 2004, Methods Mol Biol, V257, P223, DOI 10.1385/1-59259-750-5:223; Ueki S, 2001, PLANT J, V28, P283, DOI 10.1046/j.1365-313X.2001.01145.x; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wei LY, 2014, P NATL ACAD SCI USA, V111, P3877, DOI 10.1073/pnas.1318131111; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; YANG L, 2006, PLANT J IN PRESS; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zhong SH, 2013, P NATL ACAD SCI USA, V110, P9171, DOI 10.1073/pnas.1219655110; Zhu HL, 2013, NAT STRUCT MOL BIOL, V20, P1106, DOI 10.1038/nsmb.2646	69	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116736	10.1371/journal.pone.0116736	http://dx.doi.org/10.1371/journal.pone.0116736			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615604	gold, Green Submitted, Green Published			2022-12-26	WOS:000349122100040
J	Jiang, XX; Hardy, LL; Baur, LA; Ding, D; Wang, L; Shi, HJ				Jiang, Xiaoxiao; Hardy, Louise L.; Baur, Louise A.; Ding, Ding; Wang, Ling; Shi, Huijing			Sleep Duration, Schedule and Quality among Urban Chinese Children and Adolescents: Associations with Routine After-School Activities	PLOS ONE			English	Article							AGED CHILDREN; PATTERNS; HABITS; HEALTH; IMPACT; TIME; DISORDERS; OBESITY; MEDIA	Background With rapid urbanization accompanied by lifestyle changes, children and adolescents living in metropolitan areas are faced with many time use choices that compete with sleep. This study reports on the sleep hygiene of urban Chinese school students, and investigates the relationship between habitual after-school activities and sleep duration, schedule and quality on a regular school day. Methods Cross-sectional, school-based survey of school children (Grades 4-8) living in Shanghai, China, conducted in 2011. Self-reported data were collected on students' sleep duration and timing, sleep quality, habitual after-school activities (i.e. homework, leisure-time physical activity, recreational screen time and school commuting time), and potential correlates. Results Mean sleep duration of this sample (mean age: 11.5-years; 48.6% girls) was 9 hours. Nearly 30% of students reported daytime tiredness. On school nights, girls slept less (p<0.001) and went to bed later (p<0.001), a sex difference that was more pronounced in older students. Age by sex interactions were observed for both sleep duration (p=0.005) and bedtime (p=0.002). Prolonged time spent on homework and mobile phone playing was related to shorter sleep duration and later bedtime. Adjusting for all other factors, with each additional hour of mobile phone playing, the odds of daytime tiredness and having difficulty maintaining sleep increased by 30% and 27% among secondary students, respectively. Conclusion There are sex differences in sleep duration, schedule and quality. Habitual activities had small but significant associations with sleep hygiene outcomes especially among secondary school students. Intervention strategies such as limiting children's use of electronic screen devices after school are implicated.	[Jiang, Xiaoxiao; Wang, Ling; Shi, Huijing] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Jiang, Xiaoxiao; Wang, Ling; Shi, Huijing] Fudan Univ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Jiang, Xiaoxiao; Hardy, Louise L.; Baur, Louise A.; Ding, Ding] Univ Sydney, Prevent Res Collaborat, Sch Publ Hlth, Sydney, NSW 2006, Australia	Fudan University; Fudan University; University of Sydney	Shi, HJ (corresponding author), Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China.	hjshi@fudan.edu.cn	Ding, Ding/AAF-9985-2021; Hardy, Louise L./E-7043-2010; Baur, Louise/AAE-3413-2021; Shi, Huijing/GRR-8564-2022	Ding, Ding/0000-0001-9850-9224; Hardy, Louise L./0000-0001-8656-6758; Baur, Louise/0000-0002-4521-9482	Shanghai Municipal Committee of Education; Shanghai Municipal Health Bureau [12GWZX0301]; China Scholarship Council (CSC); University of Sydney	Shanghai Municipal Committee of Education; Shanghai Municipal Health Bureau; China Scholarship Council (CSC)(China Scholarship Council); University of Sydney(University of Sydney)	The study is mainly funded by the Shanghai Municipal Committee of Education and also sponsored by Shanghai Municipal Health Bureau (Award Number: 12GWZX0301). The authors also thank the China Scholarship Council (CSC) for funding Xiaoxiao Jiang's doctoral scholarship in joint-PhD program with University of Sydney and this analysis, which is part of the requirements for her PhD studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Biggs SN, 2013, SLEEP MED, V14, P1304, DOI 10.1016/j.sleep.2013.06.014; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Chahal H, 2013, PEDIATR OBES, V8, P42, DOI 10.1111/j.2047-6310.2012.00085.x; Chen MY, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-59; Chen Wen-juan, 2011, Zhonghua Er Ke Za Zhi, V49, P333; Chen XL, 2008, OBESITY, V16, P265, DOI 10.1038/oby.2007.63; Chung KF, 2008, SLEEP, V31, P185, DOI 10.1093/sleep/31.2.185; Chung KF, 2013, BIOL RHYTHM RES, V44, P169, DOI 10.1080/09291016.2012.656247; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cortese S, 2013, J AM ACAD CHILD PSY, V52, P784, DOI 10.1016/j.jaac.2013.06.001; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Dworak M, 2007, PEDIATRICS, V120, P978, DOI 10.1542/peds.2007-0476; Firouzi S, 2013, SLEEP BIOL RHYTHMS, V11, P185, DOI 10.1111/sbr.12020; Foti KE, 2011, AM J PREV MED, V41, P596, DOI 10.1016/j.amepre.2011.08.009; *GLOB MOB STAT, 2013, MOB SUBSCR HANDS MAR; Guo XF, 2011, CLIN CARDIOL, V34, P774, DOI 10.1002/clc.20976; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Lee YJ, 2012, SLEEP, V35, P455, DOI 10.5665/sleep.1722; Li SH, 2007, SLEEP, V30, P361, DOI 10.1093/sleep/30.3.361; Li SH, 2010, SLEEP MED, V11, P907, DOI 10.1016/j.sleep.2010.03.018; Liu XC, 2005, PEDIATRICS, V115, P241, DOI 10.1542/peds.2004-0815F; Loessl B, 2008, CHILD CARE HLTH DEV, V34, P549, DOI 10.1111/j.1365-2214.2008.00845.x; Matricciani L, 2012, SLEEP MED REV, V16, P203, DOI 10.1016/j.smrv.2011.03.005; Matricciani LA, 2012, PEDIATRICS, V129, P548, DOI 10.1542/peds.2011-2039; McKnight-Eily LR, 2011, PREV MED, V53, P271, DOI 10.1016/j.ypmed.2011.06.020; Merrill RM, 2007, J NUTR HEALTH AGING, V11, P242; Nuutinen T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-684; Olds T, 2010, SLEEP MED REV, V14, P371, DOI 10.1016/j.smrv.2009.12.002; Ortega FB, 2010, EUR J APPL PHYSIOL, V110, P563, DOI 10.1007/s00421-010-1536-1; Owens JA, 2010, ARCH PEDIAT ADOL MED, V164, P608, DOI 10.1001/archpediatrics.2010.96; Paavonen EJ, 2002, EUR CHILD ADOLES PSY, V11, P10, DOI 10.1007/s007870200002; Passos GS, 2011, SLEEP MED, V12, P1018, DOI 10.1016/j.sleep.2011.02.007; Russo PM, 2007, J SLEEP RES, V16, P163, DOI 10.1111/j.1365-2869.2007.00584.x; Sadeh A, 2007, SLEEP MED CLIN, V2, P513, DOI 10.1016/j.jsmc.2007.05.012; Smaldone A, 2007, PEDIATRICS, V119, pS29, DOI 10.1542/peds.2006-2089F; Tagaya H, 2004, SLEEP BIOL RHYTHMS, V2, P57, DOI [10.1111/j.1479-8425.2003.00079.x, DOI 10.1111/J.1479-8425.2003.00079.X]; Tao F., 2008, CHIN J DIS CONTROL P, V12, P309, DOI [10.3969/j.issn.1674-3679.2008.04.003, DOI 10.3969/J.ISSN.1674-3679.2008.04.003]; Tie LJ, 2010, BIOL RHYTHM RES, V41, P183, DOI 10.1080/09291011003687957; Van den Bulck J, 2007, SLEEP, V30, P1220, DOI 10.1093/sleep/30.9.1220; Wang GH, 2013, SLEEP MED, V14, P45, DOI 10.1016/j.sleep.2012.09.022; Wolfson Amy R, 2007, Behav Sleep Med, V5, P194; Wolfson AR, 2003, SLEEP, V26, P213, DOI 10.1093/sleep/26.2.213; Yang CK, 2005, PEDIATRICS, V115, P250, DOI 10.1542/peds.2004-0815G; Yang QZ, 2009, J PAEDIATR CHILD H, V45, P414, DOI 10.1111/j.1440-1754.2009.01530.x; Yen CF, 2008, SLEEP, V31, P1515, DOI 10.1093/sleep/31.11.1515; Zhang Zhi-Qiang, 2011, Zootaxa, V3148, P1, DOI 10.11646/zootaxa.3703.1.1	47	46	49	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0115326	10.1371/journal.pone.0115326	http://dx.doi.org/10.1371/journal.pone.0115326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UU	25611973	gold, Green Published, Green Submitted			2022-12-26	WOS:000348562900007
J	Mandler, M; Santic, R; Gruber, P; Cinar, Y; Pichler, D; Funke, SA; Willbold, D; Schneeberger, A; Schmidt, W; Mattner, F				Mandler, Markus; Santic, Radmila; Gruber, Petra; Cinar, Yeliz; Pichler, Dagmar; Funke, Susanne Aileen; Willbold, Dieter; Schneeberger, Achim; Schmidt, Walter; Mattner, Frank			Tailoring the Antibody Response to Aggregated A beta Using Novel Alzheimer-Vaccines	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; MOUSE MODEL; TRANSGENIC MICE; SECRETED FORM; DISEASE; APP; IMMUNOTHERAPY; PATHOLOGY; PEPTIDE; BRAIN	Recent evidence suggests Alzheimer-Disease (AD) to be driven by aggregated A beta. Capitalizing on the mechanism of molecular mimicry and applying several selection layers, we screened peptide libraries for moieties inducing antibodies selectively reacting with A beta-aggregates. The technology identified a pool of peptide candidates; two, AFFITOPES AD01 and AD02, were assessed as vaccination antigens and compared to A beta 1-6, the targeted epitope. When conjugated to Keyhole Limpet Hemocyanin (KLH) and adjuvanted with aluminum, all three peptides induced A beta-targeting antibodies (Abs). In contrast to A beta 1-6, AD01- or AD02-induced Abs were characterized by selectivity for aggregated forms of A beta and absence of reactivity with related molecules such as Amyloid Precursor Protein (APP)/secreted APP-alpha (sAPPa). Administration of AFFITOPE-vaccines to APP-transgenic mice was found to reduce their cerebral amyloid burden, the associated neuropathological alterations and to improve their cognitive functions. Thus, the AFFITOME-technology delivers vaccines capable of inducing a distinct Ab response. Their features may be beneficial to AD-patients, a hypothesis currently tested within a phase-II-study.	[Mandler, Markus; Santic, Radmila; Gruber, Petra; Pichler, Dagmar; Schneeberger, Achim; Schmidt, Walter; Mattner, Frank] AFFiRiS AG, A-1030 Vienna, Austria; [Cinar, Yeliz; Funke, Susanne Aileen; Willbold, Dieter] Forschungszentrum Julich, Inst Struct Biochem, Inst Complex Syst 6, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Mandler, M (corresponding author), AFFiRiS AG, Karl Farkas Gasse 22, A-1030 Vienna, Austria.	markus.mandler@affiris.com; achim.schneeberger@affiris.com	Willbold, Dieter/A-6280-2013	Willbold, Dieter/0000-0002-0065-7366	AFFiRiS AG, Vienna; Austrian Science promotion agency [807619, 809649, 811169]; FFG	AFFiRiS AG, Vienna; Austrian Science promotion agency; FFG	AFFiRiS AG (www.affiris.com), Vienna, and Austrian Science promotion agency (www.ffg.at; Grant numbers: 807619, 809649 and 811169) provided the study funding. FFG-Funding was provided for MM, RS and PG. AFFiRiS Funding was provided to employees (MM, RS, PG, AS, FM and WS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Chen Y, 2009, CELL DEATH DIFFER, V16, P386, DOI 10.1038/cdd.2008.94; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Freir DB, 2011, NEUROBIOL AGING, V32, P2211, DOI 10.1016/j.neurobiolaging.2010.01.001; Fujinami RS, 2006, CLIN MICROBIOL REV, V19, P80, DOI 10.1128/CMR.19.1.80-94.2006; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; HAYASHI Y, 1994, BIOCHEM BIOPH RES CO, V205, P936, DOI 10.1006/bbrc.1994.2755; Heber S, 2000, J NEUROSCI, V20, P7951; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Ishida A, 1997, NEUROREPORT, V8, P2133, DOI 10.1097/00001756-199707070-00009; Johansson AS, 2006, FEBS J, V273, P2618, DOI 10.1111/j.1742-4658.2006.05263.x; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Le Poole I. Caroline, 2008, V10, P227, DOI 10.1159/000131485; Lemere CA, 2003, NEUROBIOL DIS, V14, P10, DOI 10.1016/S0969-9961(03)00044-5; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Liu B, 2013, J NEUROSCI, V33, P7027, DOI 10.1523/JNEUROSCI.5924-12.2013; Lyketsos CG, 2006, AM J GERIAT PSYCHIAT, V14, P561, DOI 10.1097/01.JGP.0000221334.65330.55; Mandler M, 2014, ACTA NEUROPATHOL, V127, P861, DOI 10.1007/s00401-014-1256-4; Mandler M, 2012, J ALZHEIMERS DIS, V28, P783, DOI 10.3233/JAD-2011-111208; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Muhs A, 2007, P NATL ACAD SCI USA, V104, P9810, DOI 10.1073/pnas.0703137104; Ohsawa I, 1999, EUR J NEUROSCI, V11, P1907, DOI 10.1046/j.1460-9568.1999.00601.x; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Oyarbide-Valencia K, 2006, AUTOIMMUN REV, V5, P486, DOI 10.1016/j.autrev.2006.03.012; Pride M, 2008, NEURODEGENER DIS, V5, P194, DOI 10.1159/000113700; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Reed MN, 2011, NEUROBIOL AGING, V32, P1784, DOI 10.1016/j.neurobiolaging.2009.11.007; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; Rogers DC, 1999, BEHAV BRAIN RES, V105, P207, DOI 10.1016/S0166-4328(99)00072-8; Rosenfeld MR, 2010, SEMIN NEUROL, V30, P320, DOI 10.1055/s-0030-1255223; Schneeberger A, 2010, HUM VACCINES, V6, P948, DOI 10.4161/hv.6.11.13217; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SMALL DH, 1994, J NEUROSCI, V14, P2117; Sotthibundhu A, 2009, NEUROBIOL AGING, V30, P1975, DOI 10.1016/j.neurobiolaging.2008.02.004; Taylor CJ, 2008, NEUROBIOL DIS, V31, P250, DOI 10.1016/j.nbd.2008.04.011; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Wang CY, 2007, VACCINE, V25, P3041, DOI 10.1016/j.vaccine.2007.01.031; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wiessner C, 2011, J NEUROSCI, V31, P9323, DOI 10.1523/JNEUROSCI.0293-11.2011; Wilcock DM, 2007, NEUROSCIENCE, V144, P950, DOI 10.1016/j.neuroscience.2006.10.020; Wilcock DM, 2009, J NEUROSCI, V29, P7957, DOI 10.1523/JNEUROSCI.1339-09.2009; Wilcock DM, 2009, CNS NEUROL DISORD-DR, V8, P50, DOI 10.2174/187152709787601858; Wimo A, 2010, WORLD ALZHEIMER REPO; YANKNER BA, 1990, P NATL ACAD SCI USA, V87, P9020, DOI 10.1073/pnas.87.22.9020	54	24	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0115237	10.1371/journal.pone.0115237	http://dx.doi.org/10.1371/journal.pone.0115237			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611858	gold, Green Published			2022-12-26	WOS:000348562900006
J	Xie, J; Tong, A; Kim, SC				Xie, Jing; Tong, Angela; Kim, Seoyoung C.			Patterns of Bisphosphonates Utilization in Patients under Age 45 in a Large Cohort of Commercial Insurance Beneficiaries in the United States	PLOS ONE			English	Article							GLUCOCORTICOID-INDUCED OSTEOPOROSIS; POSTMENOPAUSAL OSTEOPOROSIS; WOMEN; ALENDRONATE; FRACTURES; RISK; RISEDRONATE; PREVENTION; THERAPY; TRIAL	Background The effectiveness and safety of bisphosphonates treatment used in the young population have not been well studied. Despite insufficient data on effectiveness and safety of bisphosphonates in young patients, bisphosphonates are still considered in younger patients at high risk for osteoporosis or fracture. The objectives of this study were to identify bisphosphonate initiators aged 10-45 years and describe their clinical characteristics and to assess time trends of bisphosphonate use over the past decade in a large U.S. population-based cohort. Methods Using the medical and pharmacy claims data from a U.S. commercial insurance (20032012), patients aged 10-45 years without malignancy who initiated an oral or intravenous bisphosphonate after at least 1 year of insurance enrollment were selected. Baseline demographics, comorbidities, medications and health care utilization were assessed in the year prior to initiating a bisphosphonate. The trend of bisphosphonate use over time was examined. Results There were 9,082 bisphosphonate initiators (0.02% of the same age group in the population). The mean age was 38.1 years and 79.6% female. Osteoporosis was the most common diagnosis (41.2%). At baseline, 10.8% had a diagnosis of fracture and 29.0% had a bone mineral density measured. Of those who used glucocorticoids (39%) at baseline, the mean 1-year cumulative prednisone-equivalent dose was 2,669 milligrams. The use of bisphosphonates in the young population significantly decreased over the past decade (p < 0.001). Conclusions Among young patients aged 10-45, the use of bisphosphonates was uncommon and significantly decreased over the past decade in the U.S. While most patients initiating bisphosphonates had a diagnosis of osteoporosis and fracture in the preceding year, some had no recorded claims with a diagnosis of fracture, osteoporosis, or long-term glucocorticoids use at baseline. Future research is needed to examine the effectiveness and safety of bisphosphonates in young patients at risk for osteoporosis.	[Xie, Jing; Tong, Angela; Kim, Seoyoung C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Kim, Seoyoung C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kim, SC (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA.	skim62@partners.org	Kim, Seoyoung/L-6561-2019	Kim, Seoyoung/0000-0002-2517-3579	NIH [K23 AR059677]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR059677] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Dr. Kim is supported by the NIH grant K23 AR059677. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Boskey AL, 2009, OSTEOPOROSIS INT, V20, P793, DOI 10.1007/s00198-008-0725-9; Boyce AM, 2014, PM&R, V6, P427, DOI 10.1016/j.pmrj.2013.10.009; da Fonseca MA, 2011, PEDIATR DENT, V33, P241; Feldstein AC, 2005, OSTEOPOROSIS INT, V16, P2168, DOI 10.1007/s00198-005-2016-z; Grossman JM, 2010, ARTHRIT CARE RES, V62, P1515, DOI 10.1002/acr.20295; Hansen KE, 2011, J BONE MINER RES, V26, P1989, DOI 10.1002/jbmr.362; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Khan SA, 1997, J BONE MINER RES, V12, P1700, DOI 10.1359/jbmr.1997.12.10.1700; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Patlas N, 1999, TERATOLOGY, V60, P68, DOI 10.1002/(SICI)1096-9926(199908)60:2<68::AID-TERA10>3.0.CO;2-H; Pazianas M, 2012, OSTEOPOROSIS INT, V23, P2873, DOI 10.1007/s00198-012-1952-7; Ro C, 2013, CURR OSTEOPOROS REP, V11, P45, DOI 10.1007/s11914-012-0129-9; Suresh E, 2014, RHEUMATOLOGY, V53, P19, DOI 10.1093/rheumatology/ket236; Whyte MP, 2003, NEW ENGL J MED, V349, P457, DOI 10.1056/NEJMoa023110	15	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0115091	10.1371/journal.pone.0115091	http://dx.doi.org/10.1371/journal.pone.0115091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611596	Green Published, gold, Green Submitted			2022-12-26	WOS:000348562900004
J	Fujita, T; Kitaura, F; Fujii, H				Fujita, Toshitsugu; Kitaura, Fusako; Fujii, Hodaka			A Critical Role of the Thy28-MYH9 Axis in B Cell-Specific Expression of the Pax5 Gene in Chicken B Cells	PLOS ONE			English	Article							RNA-POLYMERASE-II; BRUTONS TYROSINE KINASE; GENOMIC REGIONS; CHROMATIN IMMUNOPRECIPITATION; STIMULATED TRANSCRIPTION; NEUROENDOCRINE CELLS; EFFICIENT ISOLATION; MYOSIN-I; PROTEIN; DIFFERENTIATION	Accumulating evidence suggests that Pax5 plays essential roles in B cell lineage commitment. However, molecular mechanisms of B cell-specific expression of Pax5 are not fully understood. Here, we applied insertional chromatin immunoprecipitation iChIP) combined with stable isotope labeling using amino acids in cell culture (SILAC) (iChIP-SILAC) to direct identification of proteins interacting with the promoter region of the endogenous single-copy chicken Pax5 gene. By comparing B cells with macrophage-like cells trans-differentiated by ectopic expression of C/EBP beta, iChIP-SILAC detected B cell-specific interaction of a nuclear protein, Thy28/Thyn1, with the Pax5 1A promoter. Trans-differentiation of B cells into macrophage- like cells caused down-regulation of Thy28 expression. Loss-of-function of Thy28 induced decrease in Pax5 expression and recruitment of myosin-9 (MYH9), one of Thy28-interacting proteins, to the Pax5 1A promoter. Loss-of-function of MYH9 also induced decrease in Pax5 expression. Thus, our analysis revealed that Thy28 is functionally required for B cell-specific expression of Pax5 via recruitment of MYH9 to the Pax5 locus in chicken B cells.	[Fujita, Toshitsugu; Kitaura, Fusako; Fujii, Hodaka] Osaka Univ, Microbial Dis Res Inst, Chromatin Biochem Res Grp, Combined Program Microbiol & Immunol, Suita, Osaka, Japan	Osaka University	Fujii, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, Chromatin Biochem Res Grp, Combined Program Microbiol & Immunol, Suita, Osaka, Japan.	hodaka@biken.osaka-u.ac.jp	Fujii, Hodaka/A-2420-2008; FUJITA, Toshitsugu/ABH-5101-2020; Fujita, Toshitsugu/AAB-4964-2022; Fujii, Hodaka/N-9792-2019	Fujii, Hodaka/0000-0003-1296-4256; FUJITA, Toshitsugu/0000-0002-9536-9999; Fujii, Hodaka/0000-0003-1296-4256	Tokyo Biochemical Research Foundation; Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering; Asahi Glass Foundation; Uehara Memorial Foundation; Takeda Science Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP) by the Japan Science and Technology Agency (JST) [AS242Z00789Q]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23118516, 23114707, 25118512]; Program for Combined Research Fields from Immunology Frontier Research Center, Osaka University;  [22710185];  [25830131]	Tokyo Biochemical Research Foundation; Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering; Asahi Glass Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kurata Memorial Hitachi Science and Technology Foundation; Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP) by the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Combined Research Fields from Immunology Frontier Research Center, Osaka University; ; 	This work was supported by the Tokyo Biochemical Research Foundation, Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering (T.F.), the Asahi Glass Foundation, the Uehara Memorial Foundation (H.F.), Takeda Science Foundation, the Kurata Memorial Hitachi Science and Technology Foundation (T.F. and H.F.), Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP) by the Japan Science and Technology Agency (JST) (#AS242Z00789Q) (T.F.), Grant-in-Aid for Young Scientists (B) (#22710185 and #25830131) (T.F.), Grant-in-Aid for Scientific Research on Innovative Areas "Cell Fate" (#23118516) (T.F.), "The Genofield" (#23114707), " Transcription Cycle" (#25118512) (H. F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Program for Combined Research Fields from Immunology Frontier Research Center, Osaka University (H.F.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Balduini CL, 2011, BRIT J HAEMATOL, V154, P161, DOI 10.1111/j.1365-2141.2011.08716.x; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Chen CMA, 2000, MECH DEVELOP, V90, P293; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Compton MM, 2001, APOPTOSIS, V6, P299, DOI 10.1023/A:1011339626128; de Lanerolle P, 2011, NAT CELL BIOL, V13, P1282, DOI 10.1038/ncb2364; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; FUJII H, 1995, P NATL ACAD SCI USA, V92, P5482, DOI 10.1073/pnas.92.12.5482; Fujita T, 2012, ADV BIOSCI BIOTECHNO, V3, P626, DOI [10.4236/abb.2012.35081., DOI 10.4236/ABB.2012.35081]; Fujita T, 2008, MOL CELL BIOL, V28, P1630, DOI 10.1128/MCB.01767-07; Fujita T, 2007, NUCLEIC ACIDS RES, V35, P1007, DOI 10.1093/nar/gkl1138; Fujita T, 2014, BMC MOL BIOL, V15, DOI 10.1186/s12867-014-0026-0; Fujita T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103084; Fujita Toshitsugu, 2013, ISRN Biochem, V2013, P913273, DOI 10.1155/2013/913273; Fujita T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03171; Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013; Fujita T, 2012, MOL BIOL REP, V39, P9613, DOI 10.1007/s11033-012-1825-3; Fujita T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026109; Fujita T, 2011, GENE, V477, P24, DOI 10.1016/j.gene.2011.01.008; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Harrison MM, 2014, GENE DEV, V28, P1859, DOI 10.1101/gad.248252.114; Hirano M, 2004, INT IMMUNOL, V16, P747, DOI 10.1093/intimm/dxh076; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Hofmann WA, 2006, J CELL BIOCHEM, V99, P1001, DOI 10.1002/jcb.21035; Hoshino A, 2009, J BIOSCI BIOENG, V108, P446, DOI 10.1016/j.jbiosc.2009.05.005; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Jiang XZ, 2003, APOPTOSIS, V8, P509, DOI 10.1023/A:1025594409056; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Miyaji H, 2002, GENE, V297, P189, DOI 10.1016/S0378-1119(02)00886-7; Munemasa Y, 2008, MOL CELL BIOL, V28, P1171, DOI 10.1128/MCB.01396-07; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337; Saint Fleur S, 2009, BLOOD, V114, P1355, DOI 10.1182/blood-2008-11-189118; Schaniel C, 2002, BLOOD, V99, P472, DOI 10.1182/blood.V99.2.472; Toyota H, 2012, CELL MOL BIOL LETT, V17, P36, DOI 10.2478/s11658-011-0034-8; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Vreugde S, 2006, MOL CELL, V23, P749, DOI 10.1016/j.molcel.2006.07.005; Webb CF, 2000, J IMMUNOL, V165, P6956, DOI 10.4049/jimmunol.165.12.6956; Woolner S, 2009, TRENDS CELL BIOL, V19, P245, DOI 10.1016/j.tcb.2009.03.003; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yang WC, 2000, INT IMMUNOL, V12, P1547, DOI 10.1093/intimm/12.11.1547; Yu F, 2009, ACTA CRYSTALLOGR D, V65, P212, DOI 10.1107/S0907444908041474	46	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116579	10.1371/journal.pone.0116579	http://dx.doi.org/10.1371/journal.pone.0116579			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607658	Green Submitted, gold, Green Published			2022-12-26	WOS:000348205300029
J	Kubesova, A; Tejkalova, H; Syslova, K; Kacer, P; Vondrousova, J; Tyls, F; Fujakova, M; Palenicek, T; Horacek, J				Kubesova, Anna; Tejkalova, Hana; Syslova, Kamila; Kacer, Petr; Vondrousova, Jana; Tyls, Filip; Fujakova, Michaela; Palenicek, Tomas; Horacek, Jiri			Biochemical, Histopathological and Morphological Profiling of a Rat Model of Early Immune Stimulation: Relation to Psychopathology	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; GAMMA-AMINOBUTYRIC-ACID; NEONATAL EXPOSURE; MICROGLIAL ACTIVATION; PLASMA TRYPTOPHAN; QUINOLINIC ACID; LATER-LIFE; BRAIN; LIPOPOLYSACCHARIDE; SCHIZOPHRENIA	Perinatal immune challenge leads to neurodevelopmental dysfunction, permanent immune dysregulation and abnormal behaviour, which have been shown to have translational validity to findings in human neuropsychiatric disorders (e.g. schizophrenia, mood and anxiety disorders, autism, Parkinson's disease and Alzheimer's disease). The aim of this animal study was to elucidate the influence of early immune stimulation triggered by systemic postnatal lipopolysaccharide administration on biochemical, histopathological and morphological measures, which may be relevant to the neurobiology of human psychopathology. In the present study of adult male Wistar rats we examined the brain and plasma levels of monoamines (dopamine, serotonin), their metabolites, the levels of the main excitatory and inhibitory neurotransmitters glutamate and Y-aminobutyric acid and the levels of tryptophan and its metabolites from the kynurenine catabolic pathway. Further, we focused on histopathological and morphological markers related to pathogenesis of brain diseases - glial cell activation, neurodegeneration, hippocampal volume reduction and dopaminergic synthesis in the substantia nigra. Our results show that early immune stimulation in adult animals alters the levels of neurotransmitters and their metabolites, activates the kynurenine pathway of tryptophan metabolism and leads to astrogliosis, hippocampal volume reduction and a decrease of tyrosine hydroxylase immunoreactivity in the substantia nigra. These findings support the crucial pathophysiological role of early immune stimulation in the above mentioned neuropsychiatric disorders.	[Kubesova, Anna; Tejkalova, Hana; Tyls, Filip; Fujakova, Michaela; Palenicek, Tomas; Horacek, Jiri] Prague Psychiat Ctr, Prague, Czech Republic; [Kubesova, Anna; Tejkalova, Hana; Tyls, Filip; Fujakova, Michaela; Palenicek, Tomas; Horacek, Jiri] Natl Inst Mental Hlth, Klecany, Czech Republic; [Kubesova, Anna; Tyls, Filip; Fujakova, Michaela; Palenicek, Tomas; Horacek, Jiri] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Syslova, Kamila; Kacer, Petr; Vondrousova, Jana] Inst Chem Technol, CR-16628 Prague, Czech Republic	National Institute of Mental Health - Czech Republic; Charles University Prague; University of Chemistry & Technology, Prague	Kubesova, A (corresponding author), Prague Psychiat Ctr, Prague, Czech Republic.	kubesova@pcp.lf3.cuni.cz	Horacek, Jiri/X-6851-2018; Kacer, Petr/AAW-2355-2021; Horacek, Jiri/M-7054-2019; Palenicek, Tomas/AAA-2549-2021; Tyls, Filip/C-4542-2018	Horacek, Jiri/0000-0003-0114-7306; Horacek, Jiri/0000-0003-0114-7306; Palenicek, Tomas/0000-0002-3109-9539; Tyls, Filip/0000-0002-8337-6999; Kacer, Petr/0000-0002-5905-3516	Ministry of Health of the Czech Republic - Internal Grant Agency, Development of Research Organization (PCP) [NT13843, 00023752]; Charles University in Prague - Specific Academic Research, Charles University Research Development Schemes [260045/SVV/2014, PRVOUK P34]; Ministry of Education, Youth and Sports of the Czech Republic - National Programme of Sustainability (NPU I (LO)	Ministry of Health of the Czech Republic - Internal Grant Agency, Development of Research Organization (PCP); Charles University in Prague - Specific Academic Research, Charles University Research Development Schemes; Ministry of Education, Youth and Sports of the Czech Republic - National Programme of Sustainability (NPU I (LO)	The study was supported by The Ministry of Health of the Czech Republic (www.mzcr.cz) - Internal Grant Agency (NT13843), Development of Research Organization (PCP, 00023752); Charles University in Prague (www.cuni.cz) - Specific Academic Research (260045/SVV/2014), Charles University Research Development Schemes (PRVOUK P34); The Ministry of Education, Youth and Sports of the Czech Republic (www.msmt.cz) - The National Programme of Sustainability (NPU I (LO)	Almeida-Montes LG, 2000, J PSYCHIATR NEUROSCI, V25, P371; Bell C, 2001, BRIT J PSYCHIAT, V178, P399, DOI 10.1192/bjp.178.5.399; Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009; Bohmer C, 2005, BIOCHEM J, V389, P745; Brambilla Paolo, 2008, Curr Psychiatry Rep, V10, P505; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Brisch R, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00047; Bsibsi M, 2006, GLIA, V53, P688, DOI 10.1002/glia.20328; Cai ZW, 2013, DEV NEUROSCI-BASEL, V35, P155, DOI 10.1159/000346156; Campbell BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00012; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Catts VS, 2014, AUST NZ J PSYCHIAT, V48, P722, DOI 10.1177/0004867414531078; Chung DW, 2010, CELL MOL NEUROBIOL, V30, P531, DOI 10.1007/s10571-009-9477-0; Craig A, 2003, EXP NEUROL, V181, P231, DOI 10.1016/S0014-4886(03)00032-3; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Doosti MH, 2013, PROG NEURO-PSYCHOPH, V43, P55, DOI 10.1016/j.pnpbp.2012.12.003; Fan LW, 2011, NEUROBIOL DIS, V44, P304, DOI 10.1016/j.nbd.2011.07.011; Fan LW, 2011, BRAIN BEHAV IMMUN, V25, P286, DOI 10.1016/j.bbi.2010.09.020; Feleder C, 2010, BIOL PSYCHIAT, V67, P386, DOI 10.1016/j.biopsych.2009.09.028; FORNO LS, 1992, PROG BRAIN RES, V94, P429; Gauthier C, 2014, PSYCHONEUROENDOCRINO, V39, P170, DOI 10.1016/j.psyneuen.2013.09.009; Guillemin GJ, 2012, FEBS J, V279, P1356, DOI 10.1111/j.1742-4658.2012.08485.x; Gulyas B, 2011, NEUROCHEM INT, V58, P60, DOI 10.1016/j.neuint.2010.10.013; Haukvik Unn Kristin, 2013, Tidsskr Nor Laegeforen, V133, P850, DOI 10.4045/tidsskr.12.1084; Huang F, 2014, J NEUROSCI METH, V229, P8, DOI 10.1016/j.jneumeth.2014.04.004; ISSA F, 1994, PSYCHIAT RES, V52, P237, DOI 10.1016/0165-1781(94)90069-8; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kirsten TB, 2012, J NEUROSCI RES, V90, P1903, DOI 10.1002/jnr.23089; Krystal JH, 2002, MOL PSYCHIATR, V7, pS71, DOI 10.1038/sj.mp.4001021; Laakso MP, 1996, NEUROLOGY, V46, P678, DOI 10.1212/WNL.46.3.678; Lee M, 2011, PSYCHIAT RES, V185, P328, DOI 10.1016/j.psychres.2010.07.013; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; Linderholm KR, 2012, SCHIZOPHRENIA BULL, V38, P426, DOI 10.1093/schbul/sbq086; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P702, DOI 10.1016/j.pnpbp.2010.12.017; Meyer-Franke A, 1999, MOL CELL NEUROSCI, V14, P385, DOI 10.1006/mcne.1999.0788; Meyerhoff DJ, 2014, SLEEP, V37, P893, DOI 10.5665/sleep.3654; Miller CL, 2008, NEUROCHEM INT, V52, P1297, DOI 10.1016/j.neuint.2008.01.013; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Najmanova V, 2011, CHROMATOGRAPHIA, V73, pS143, DOI 10.1007/s10337-011-1959-9; Okada Kazumasa, 2005, Journal of UOEH, V27, P161; Ong LK, 2012, NEUROCHEM RES, V37, P1938, DOI 10.1007/s11064-012-0812-3; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Pang Y, 2003, DEV BRAIN RES, V140, P205, DOI 10.1016/S0165-3806(02)00606-5; Patro N, 2013, INDIAN J EXP BIOL, V51, P606; PAXINOS G, 2007, RAT BRAIN STREREOTAC; Pollack MH, 2008, PROG NEURO-PSYCHOPH, V32, P739, DOI 10.1016/j.pnpbp.2007.11.023; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; PRATT OE, 1979, J NEURAL TRANSM S, V29; Quaak I, 2013, INT J ENV RES PUB HE, V10, P3384, DOI 10.3390/ijerph10083384; Rajkowska G, 2013, CURR DRUG TARGETS, V14, P1225; Ratnayake U, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00180; Ravikumar A, 2000, NEUROL INDIA, V48, P231; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Schmitt A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00019; Schwarcz R, 2001, BIOL PSYCHIAT, V50, P521, DOI 10.1016/S0006-3223(01)01078-2; SHANKS N, 1995, J NEUROSCI, V15, P376, DOI 10.1523/jneurosci.15-01-00376.1995; Shanks N, 2000, P NATL ACAD SCI USA, V97, P5645, DOI 10.1073/pnas.090571897; Smith PLP, 2014, DEV NEUROSCI-BASEL, V36, P119, DOI 10.1159/000359950; Sominsky L, 2012, BEHAV BRAIN RES, V226, P351, DOI 10.1016/j.bbr.2011.08.038; Sominsky L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057700; Spencer SJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE11, DOI 10.1152/ajpendo.00516.2010; St'astny F, 2000, BRAIN RES BULL, V53, P415, DOI 10.1016/S0361-9230(00)00368-3; Stone TW, 2012, FEBS J, V279, P1386, DOI 10.1111/j.1742-4658.2012.08487.x; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; TEJKALOVA H, 2010, PSYCHIATRIE, V14, P19; TEJKALOVA H, 2008, PSYCHIATRIE, V12, P68; Tejkalova H., 2007, PSYCHIATRIE, V11, P12; Terrazzino S, 2002, J NEUROIMMUNOL, V124, P45, DOI 10.1016/S0165-5728(02)00013-9; VANBEMMELEN FJ, 1985, J NEUROCHEM, V45, P1471; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Wang KC, 2013, NEUROSCIENCE, V234, P146, DOI 10.1016/j.neuroscience.2012.12.049; Wang XY, 2006, SEMIN FETAL NEONAT M, V11, P343, DOI 10.1016/j.siny.2006.04.002; WHITE HL, 1981, MOL CELL BIOCHEM, V39, P253, DOI 10.1007/BF00232578; WISNIEWSKI HM, 1991, NEUROBIOL AGING, V12, P593, DOI 10.1016/0197-4580(91)90091-W; Woon FL, 2010, PROG NEURO-PSYCHOPH, V34, P1181, DOI 10.1016/j.pnpbp.2010.06.016; Zhu FR, 2014, BRAIN BEHAV IMMUN, V38, P166, DOI 10.1016/j.bbi.2014.01.017	77	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0115439	10.1371/journal.pone.0115439	http://dx.doi.org/10.1371/journal.pone.0115439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602957	gold, Green Published, Green Submitted			2022-12-26	WOS:000348203500014
J	Jones, SP; Dwyer, DM; Lewis, MB				Jones, Scott P.; Dwyer, Dominic M.; Lewis, Michael B.			Learning Faces: Similar Comparator Faces Do Not Improve Performance	PLOS ONE			English	Article							RECOGNITION MEMORY; UNFAMILIAR FACES; UNIFIED ACCOUNT; FLAVOR AVERSION; PERCEPTION; FAMILIAR; RACE; DISTINCTIVENESS; INHIBITION; INVERSION	Recent evidence indicates that comparison of two similar faces can aid subsequent discrimination between them. However, the fact that discrimination between two faces is facilitated by comparing them directly does not demonstrate that comparison produces a general improvement in the processing of faces. It remains an open question whether the opportunity to compare a "target" face to similar faces can facilitate the discrimination of the exposed target face from other nonexposed faces. In Experiment 1, selection of a target face from an array of novel foils was not facilitated by intermixed exposure to the target and comparators of the same sex. Experiment 2 also found no advantage for similar comparators (morphed towards the target) over unmorphed same sex comparators, or over repeated target exposure alone. But all repeated exposure conditions produced better performance than a single brief presentation of the target. Experiment 3 again demonstrated that repeated exposure produced equivalent learning in same sex and different sex comparator conditions, and also showed that increasing the number of same sex or different sex comparators failed to improve identification. In all three experiments, exposure to a target alongside similar comparators failed to support selection of the target from novel test stimuli to a greater degree than exposure alongside dissimilar comparators or repeated target exposure alone. The current results suggest that the facilitatory effects of comparison during exposure may be limited to improving discrimination between exposed stimuli, and thus our results do not support the idea that providing the opportunity for comparison is a practical means for improving face identification.	[Jones, Scott P.] Anglia Ruskin Univ, Dept Psychol, Cambridge, England; [Dwyer, Dominic M.; Lewis, Michael B.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales; [Dwyer, Dominic M.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	Anglia Ruskin University; Cardiff University; University of New South Wales Sydney	Jones, SP (corresponding author), Anglia Ruskin Univ, Dept Psychol, Cambridge, England.	scott.jones@anglia.ac.uk	Dwyer, Dominic Michael/D-1498-2009; Lewis, Michael/D-1488-2009	Dwyer, Dominic Michael/0000-0001-8069-5508; Lewis, Michael/0000-0002-5735-5318; Jones, Scott/0000-0001-5516-4385	School of Psychology, Cardiff University [EP/P504864/1]; EPSRC [EP/P504864/1]	School of Psychology, Cardiff University; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was funded by a PhD studentship awarded to SJ. This was jointly funded by the School of Psychology, Cardiff University, and the EPSRC Doctoral Training Grant (EP/P504864/1) awarded to Cardiff University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHRICK HP, 1975, J EXP PSYCHOL GEN, V104, P54, DOI 10.1037/0096-3445.104.1.54; BIEDERMAN I, 1987, J EXP PSYCHOL LEARN, V13, P640, DOI 10.1037/0278-7393.13.4.640; Bindemann M, 2011, PERCEPTION, V40, P625, DOI 10.1068/p7008; Blair CAJ, 2003, J EXP PSYCHOL-ANIM B, V29, P39, DOI 10.1037//0097-7403.29.1.39; Blanz V, 1999, MORPHABLE MODEL SYNT, P178; Bonner L, 2003, VIS COGN, V10, P527, DOI 10.1080/13506280244000168; Brogden WJ, 1939, J EXP PSYCHOL, V25, P323, DOI 10.1037/h0058944; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; BRUCE V, 1982, BRIT J PSYCHOL, V73, P105, DOI 10.1111/j.2044-8295.1982.tb01795.x; Burton AM, 1999, PSYCHOL SCI, V10, P243, DOI 10.1111/1467-9280.00144; Buttle H, 2003, PERCEPT PSYCHOPHYS, V65, P1296, DOI 10.3758/BF03194853; Clutterbuck R, 2005, EUR J COGN PSYCHOL, V17, P97, DOI 10.1080/09541440340000439; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dwyer DM, 2009, VIS COGN, V17, P334, DOI 10.1080/13506280701757577; Dwyer DM, 2011, J EXP PSYCHOL ANIM B, V37, P300, DOI 10.1037/a0023078; Dwyer DM, 2009, Q J EXP PSYCHOL, V62, P2055, DOI 10.1080/17470210802661736; ELLIS HD, 1979, PERCEPTION, V8, P431, DOI 10.1068/p080431; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FLEISHMAN JJ, 1976, PERCEPT MOTOR SKILL, V43, P709, DOI 10.2466/pms.1976.43.3.709; GIBSON EJ, 1963, ANNU REV PSYCHOL, V14, P29, DOI 10.1146/annurev.ps.14.020163.000333; Gibson Eleanor Jack, 1969, PRINCIPLES PERCEPTUA; Hall G, 2003, J EXP PSYCHOL GEN, V132, P266, DOI 10.1037/0096-3445.132.2.266; Hancock PJB, 2000, TRENDS COGN SCI, V4, P330, DOI 10.1016/S1364-6613(00)01519-9; Hancock PJB, 1996, MEM COGNITION, V24, P26, DOI 10.3758/BF03197270; Hill H, 1997, COGNITION, V62, P201, DOI 10.1016/S0010-0277(96)00785-8; Hill H, 1996, J EXP PSYCHOL HUMAN, V22, P986, DOI 10.1037/0096-1523.22.4.986; HONEY RC, 1994, Q J EXP PSYCHOL-B, V47, P83; Jeffreys H., 1961, THEORY PROBABILITY; Johnston RA, 2009, MEMORY, V17, P577, DOI 10.1080/09658210902976969; Kemp R, 1997, APPL COGNITIVE PSYCH, V11, P211; Kemp R, 1996, PERCEPTION, V25, P37, DOI 10.1068/p250037; Lewis MB, 2004, VIS COGN, V11, P29, DOI 10.1080/13506280344000194; LIGHT LL, 1979, J EXP PSYCHOL-HUM L, V5, P212, DOI 10.1037/0278-7393.5.3.212; LOGIE RH, 1987, APPL COGNITIVE PSYCH, V1, P53, DOI 10.1002/acp.2350010108; Longmore CA, 2008, J EXP PSYCHOL HUMAN, V34, P77, DOI 10.1037/0096-1523.34.1.77; McLaren IPL, 2002, ANIM LEARN BEHAV, V30, P177, DOI 10.3758/BF03192828; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Mitchell C, 2008, J EXP PSYCHOL-ANIM B, V34, P475, DOI 10.1037/0097-7403.34.4.475; Mundy ME, 2007, J EXP PSYCHOL ANIM B, V33, P124, DOI 10.1037/0097-7403.33.2.124; Mundy ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101011; Mundy ME, 2009, NEUROREPORT, V20, P1397, DOI 10.1097/WNR.0b013e32832f81f4; Mundy ME, 2006, J EXP PSYCHOL ANIM B, V32, P178, DOI 10.1037/0097-7403.32.2.178; O'Donnell C, 2001, PERCEPTION, V30, P755, DOI 10.1068/p3027; OTOOLE AJ, 1994, MEM COGNITION, V22, P208, DOI 10.3758/BF03208892; PATTERSON KE, 1977, J EXP PSYCHOL-HUM L, V3, P406, DOI 10.1037/0278-7393.3.4.406; Robbins R, 2003, COGNITION, V88, P79, DOI 10.1016/S0010-0277(03)00020-9; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; SHAPIRO PN, 1986, PSYCHOL BULL, V100, P139, DOI 10.1037/0033-2909.100.2.139; Solomon GEA, 1997, J LEARN SCI, V6, P41, DOI 10.1207/s15327809jls0601_3; Sowden PT, 2000, J EXP PSYCHOL HUMAN, V26, P379, DOI 10.1037/0096-1523.26.1.379; Stevenage SV, 1998, BRIT J PSYCHOL, V89, P39, DOI 10.1111/j.2044-8295.1998.tb02672.x; SYMONDS M, 1995, LEARN MOTIV, V26, P203, DOI 10.1016/0023-9690(95)90005-5; VALENTINE T, 1986, ACTA PSYCHOL, V61, P259, DOI 10.1016/0001-6918(86)90085-5; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Vetter T, 1997, IEEE T PATTERN ANAL, V19, P733, DOI 10.1109/34.598230; White D, 2014, PSYCHON B REV, V21, P100, DOI 10.3758/s13423-013-0475-3; YOUNG AW, 1985, BRIT J PSYCHOL, V76, P495, DOI 10.1111/j.2044-8295.1985.tb01972.x; Yu T, 2014, HUM BRAIN MAPP, V35, P1297, DOI 10.1002/hbm.22253	58	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116707	10.1371/journal.pone.0116707	http://dx.doi.org/10.1371/journal.pone.0116707			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9HN	25590574	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000350679400021
J	Corbisier, J; Gales, C; Huszagh, A; Parmentier, M; Springael, JY				Corbisier, Jenny; Gales, Celine; Huszagh, Alexandre; Parmentier, Marc; Springael, Jean-Yves			Biased Signaling at Chemokine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN RECRUITMENT; FUNCTIONAL SELECTIVITY; DRUG DISCOVERY; CC-CHEMOKINES; ACTIVATION; LIGANDS; PHOSPHORYLATION; INTERNALIZATION; TRANSDUCTION	The ability of G protein-coupled receptors (GPCRs) to activate selective signaling pathways according to the conformation stabilized by bound ligands (signaling bias) is a challenging concept in the GPCR field. Signaling bias has been documented for several GPCRs, including chemokine receptors. However, most of these studies examined the global signaling bias between G protein- and arrestin-de pendent pathways, leaving unaddressed the potential bias between particular G protein subtypes. Here, we investigated the coupling selectivity of chemokine receptors CCR2, CCR5, and CCR7 in response to various ligands with G protein subtypes by using bioluminescence resonance energy transfer biosensors monitoring directly the activation of G proteins. We also compared data obtained with the G protein biosensors with those obtained with other functional readouts, such as beta-arrestin-2 recruitment, cAMP accumulation, and calcium mobilization assays. We showed that the binding of chemokines to CCR2, CCR5, and CCR7 activated the three G alpha(i) subtypes (G alpha(i1); G alpha(i2), and G alpha(i3)) and the two G alpha(o) isoforms (G alpha(oa) and G alpha(ob)) with potencies that generally correlate to their binding affinities. In addition, we showed that the binding of chemokines to CCR5 and CCR2 also activated Ga-12, but not Ga-13. For each receptor, we showed that the relative potency of various agonist chemokines was not identical in all assays, supporting the notion that signaling bias exists at chemokine receptors.	[Corbisier, Jenny; Huszagh, Alexandre; Parmentier, Marc; Springael, Jean-Yves] Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, Campus Erasme,808 Route Lennik, B-1070 Brussels, Belgium; [Parmentier, Marc] Univ Libre Bruxelles, Welbio, B-1070 Brussels, Belgium; [Gales, Celine] Univ Toulouse 3, Inst Natl Sante & Rech Med, Inst Malad Metab & Cardiovasc, F-31432 Toulouse, France	Universite Libre de Bruxelles; Universite Libre de Bruxelles; WELBIO; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Springael, JY (corresponding author), Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, Campus Erasme,808 Route Lennik, B-1070 Brussels, Belgium.	jyspring@ulb.ac.be	soler, martha maricel m gomez/L-6025-2014	soler, martha maricel m gomez/0000-0002-4412-8108; GALES, Celine/0000-0002-4938-1583	Fonds de la Recherche Scientifique Medicale of Belgium; Actions de Recherche Concertees; Interuniversity Attraction Poles Programme, Belgian State, Belgian Science Policy [P7-14]; Belgian Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture	Fonds de la Recherche Scientifique Medicale of Belgium(Fonds de la Recherche Scientifique - FNRS); Actions de Recherche Concertees(University of Liege); Interuniversity Attraction Poles Programme, Belgian State, Belgian Science Policy(Belgian Federal Science Policy Office); Belgian Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Fonds de la Recherche Scientifique Medicale of Belgium, the Actions de Recherche Concertees, and the Interuniversity Attraction Poles Programme (P7-14), Belgian State, Belgian Science Policy.r Recipient of a a studentship from the Belgian Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture.	Barak LS, 2008, MOL PHARMACOL, V74, P585, DOI 10.1124/mol.108.048884; Berchiche YA, 2011, MOL PHARMACOL, V79, P488, DOI 10.1124/mol.110.068486; Berg KA, 1998, ANN NY ACAD SCI, V861, P104, DOI 10.1111/j.1749-6632.1998.tb10180.x; Blanpain C, 1999, BLOOD, V94, P1899; Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Byers MA, 2008, J IMMUNOL, V181, P4723, DOI 10.4049/jimmunol.181.7.4723; El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624; Ferain T, 2011, J PHARMACOL EXP THER, V337, P655, DOI 10.1124/jpet.111.179622; Fuxe K, 2010, J RECEPT SIG TRANSD, V30, P271, DOI 10.3109/10799893.2010.507367; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kenakin TP, 2012, BRIT J PHARMACOL, V165, P1659, DOI 10.1111/j.1476-5381.2011.01749.x; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Kuroumalis A, 2005, J IMMUNOL, V175, P5403, DOI 10.4049/jimmunol.175.8.5403; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Mottola DM, 2002, J PHARMACOL EXP THER, V301, P1166, DOI 10.1124/jpet.301.3.1166; Oppermann M, 1999, J BIOL CHEM, V274, P8875, DOI 10.1074/jbc.274.13.8875; Rajagopal S, 2013, J BIOL CHEM, V288, P35039, DOI 10.1074/jbc.M113.479113; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Saita Y, 2006, J IMMUNOL, V177, P3116, DOI 10.4049/jimmunol.177.5.3116; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Strange PG, 2008, CURR OPIN DRUG DISC, V11, P196; Tian Y, 2004, EUR J IMMUNOL, V34, P785, DOI 10.1002/eji.200324166; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	31	83	83	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9542	9554		10.1074/jbc.M114.596098	http://dx.doi.org/10.1074/jbc.M114.596098			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25614627	Green Published, hybrid			2022-12-26	WOS:000352729400021
J	Parhar, A; Gao, ZW; Heffernan, C; Ahmed, R; Egedahl, ML; Long, R				Parhar, Anu; Gao, Zhiwei; Heffernan, Courtney; Ahmed, Rabia; Egedahl, Mary Lou; Long, Richard			Is Early Tuberculosis Death Associated with Increased Tuberculosis Transmission?	PLOS ONE			English	Article							ACTIVE PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; RISK-FACTORS; FOREIGN-BORN; MORTALITY; ADULTS; RECOMMENDATIONS; EPIDEMIOLOGY; POPULATIONS; INFECTION	Introduction Tuberculosis (TB) is now a relatively uncommon disease in high income countries. As such, its diagnosis may be missed or delayed resulting in death before or shortly after the introduction of treatment. Whether early TB death is associated with increased TB transmission is unknown. To determine the transmission risk attributable to early TB death we undertook a case-control study. Methods All adults who were: (1) diagnosed with culture-positive pulmonary TB in the Province of Alberta, Canada between 1996 and 2012, and (2) died a TB-related death before or within the first 60 days of treatment, were identified. For each of these "cases" two sets of "controls" were randomly selected from among culture-positive pulmonary TB cases that survived beyond 60 days of treatment. "Controls" were matched by age, sex, population group, +/- smear status. Secondary cases of "cases" and "controls" were identified using conventional and molecular epidemiologic tools and compared. In addition, new infections were identified and compared in contacts of "cases" that died before treatment and contacts of their smearmatched "controls". Conditional logistic regression was used to find associations in both univariate and multivariate analysis. Results "Cases" were as, but not more, likely than "controls" to transmit. This was so whether transmission was measured in terms of the number of "cases" and smear-unmatched or -matched "controls" that had a secondary case, the number of secondary cases that they had or the number of new infections found in contacts of "cases" that died before treatment and their smear-matched "controls". Conclusion In a low TB incidence/low HIV prevalence country, pulmonary TB patients that die a TB-related death before or in the initial phase of treatment and pulmonary TB patients that survive beyond the initial phase of treatment are equally likely to transmit.	[Parhar, Anu; Gao, Zhiwei; Heffernan, Courtney; Ahmed, Rabia; Egedahl, Mary Lou; Long, Richard] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Long, Richard] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Gao, Zhiwei] Mem Univ Canada, Dept Med, St John, NF, Canada	University of Alberta; University of Alberta; Memorial University Newfoundland	Long, R (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	richard.long@ualberta.ca	Heffernan, Courtney E/G-5296-2016					Bailey WC, 2002, JAMA-J AM MED ASSOC, V287, P996, DOI 10.1001/jama.287.8.996; Borgdorff MW, 2001, AM J EPIDEMIOL, V154, P934, DOI 10.1093/aje/154.10.934; *CAN LUNG ASS PUBL, 2007, CANADIAN TUBERCULOSI; CATANZARO A, 1982, AM REV RESPIR DIS, V125, P559, DOI 10.1164/arrd.1982.125.5.559; *CDC, 2013, REPORTED TUBERCULOSI; CULLINAN P, 1991, THORAX, V46, P347, DOI 10.1136/thx.46.5.347; Dale JW, 2001, INT J TUBERC LUNG D, V5, P216; DeRiemer K, 1999, INT J TUBERC LUNG D, V3, P488; Dewan PK, 2004, INT J TUBERC LUNG D, V8, P598; ENARSON DA, 1978, CAN MED ASSOC J, V118, P1520; Erbes R, 2006, EUR RESPIR J, V27, P1223, DOI 10.1183/09031936.06.00088105; Fielder JF, 2002, INT J TUBERC LUNG D, V6, P1114; *GOV CAN STAT CAN, POSTAL CODE; Jensen M, 2012, INT J TUBERC LUNG D, V16, P43, DOI 10.5588/ijtld.11.0374; Jones-Lopez EC, 2013, AM J RESP CRIT CARE, V187, P1007, DOI 10.1164/rccm.201208-1422OC; KATZ I, 1985, CHEST, V87, P770, DOI 10.1378/chest.87.6.770; KHAN MA, 1977, AM J MED, V62, P31, DOI 10.1016/0002-9343(77)90346-1; Kourbatova EV, 2006, INT J TUBERC LUNG D, V10, P1224; Kunimoto D, 2004, INT J TUBERC LUNG D, V8, P1213; Long R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098993; Long R, 2013, CAN J PUBLIC HEALTH, V104, pE22, DOI 10.1007/BF03405649; Lubart E, 2007, ISR MED ASSOC J, V9, P870; Madhi F, 2002, PEDIATR PULM, V34, P159, DOI 10.1002/ppul.10153; Mathew TA, 2006, INT J TUBERC LUNG D, V10, P857; MILLER W T, 1978, AJR (American Journal of Roentgenology), V130, P867; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Murray J, 2007, AIDS, V21, pS97, DOI 10.1097/01.aids.0000299416.61808.24; NAALSUND A, 1994, J INTERN MED, V236, P137, DOI 10.1111/j.1365-2796.1994.tb01275.x; Oursler KK, 2002, CLIN INFECT DIS, V34, P752, DOI 10.1086/338784; Perez-Guzman Carlos, 1999, Chest, V116, P961, DOI 10.1378/chest.116.4.961; *PUBL HLTH AG CAN, 2013, TUBERCULOSIS IN CANA; Rao VK, 1998, CHEST, V114, P1244, DOI 10.1378/chest.114.5.1244; Shen X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-95; STEAD WW, 1981, ANN INTERN MED, V94, P606, DOI 10.7326/0003-4819-94-5-606; STEAD WW, 1985, NEW ENGL J MED, V312, P1483, DOI 10.1056/NEJM198506063122304; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; XIE HJ, 1992, TUBERCLE LUNG DIS, V73, P77, DOI 10.1016/0962-8479(92)90059-S; Yen YF, 2013, INT J TUBERC LUNG D, V17, P1310, DOI [10.5588/ijtld.12.0888, 10.5588/ijtid.12.0888]; Zahar JR, 2001, INTENS CARE MED, V27, P513, DOI 10.1007/s001340000849	40	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117036	10.1371/journal.pone.0117036	http://dx.doi.org/10.1371/journal.pone.0117036			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25622038	Green Published, Green Submitted, gold			2022-12-26	WOS:000348470400015
J	Hagman, A; Piskur, J				Hagman, Arne; Piskur, Jure			A Study on the Fundamental Mechanism and the Evolutionary Driving Forces behind Aerobic Fermentation in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GLUCOSE-TRANSPORT; RESPIRATORY CAPACITY; KLUYVEROMYCES-LACTIS; GROWTH; GENE; DUPLICATION; NETWORK; ABILITY; COMPLEX	Baker's yeast Saccharomyces cerevisiae rapidly converts sugars to ethanol and carbon dioxide at both anaerobic and aerobic conditions. The later phenomenon is called Crabtree effect and has been described in two forms, long-term and short-term effect. We have previously studied under fully controlled aerobic conditions forty yeast species for their central carbon metabolism and the presence of long-term Crabtree effect. We have also studied ten steady-state yeast cultures, pulsed them with glucose, and followed the central carbon metabolism and the appearance of ethanol at dynamic conditions. In this paper we analyzed those wet laboratory data to elucidate possible mechanisms that determine the fate of glucose in different yeast species that cover approximately 250 million years of evolutionary history. We determine overflow metabolism to be the fundamental mechanism behind both long-and short-term Crabtree effect, which originated approximately 125-150 million years ago in the Saccharomyces lineage. The "invention" of overflow metabolism was the first step in the evolution of aerobic fermentation in yeast. It provides a general strategy to increase energy production rates, which we show is positively correlated to growth. The "invention" of overflow has also simultaneously enabled rapid glucose consumption in yeast, which is a trait that could have been selected for, to "starve" competitors in nature. We also show that glucose repression of respiration is confined mainly among S. cerevisiae and closely related species that diverged after the whole genome duplication event, less than 100 million years ago. Thus, glucose repression of respiration was apparently "invented" as a second step to further increase overflow and ethanol production, to inhibit growth of other microbes. The driving force behind the initial evolutionary steps was most likely competition with other microbes to faster consume and convert sugar into biomass, in niches that were semi-anaerobic.	[Hagman, Arne; Piskur, Jure] Lund Univ, Dept Biol, Lund, Sweden	Lund University	Hagman, A (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	arne.hagman@biol.lu.se			Swedish Research Council (VR); Crafoord Foundation; Fysiografen Foundation; Sorensen Foundation; Lindstrom Foundation	Swedish Research Council (VR)(Swedish Research Council); Crafoord Foundation; Fysiografen Foundation; Sorensen Foundation; Lindstrom Foundation	This work was supported by the Swedish Research Council (VR), Crafoord, Fysiografen, Sorensen, and Lindstrom Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MA, 1990, ENZYME MICROB TECH, V12, P2, DOI 10.1016/0141-0229(90)90173-N; BARFORD JP, 1981, BIOTECHNOL BIOENG, V23, P1735, DOI 10.1002/bit.260230806; Billard P, 1996, J BACTERIOL, V178, P5860, DOI 10.1128/jb.178.20.5860-5866.1996; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; CHEN XJ, 1992, MOL GEN GENET, V233, P97, DOI 10.1007/BF00587566; Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149; Dujon B, 2010, NAT REV GENET, V11, P512, DOI 10.1038/nrg2811; Gojkovic Z, 2004, MOL GENET GENOMICS, V271, P387, DOI 10.1007/s00438-004-0995-7; Hagman A, 2014, FEBS J, V281, P4805, DOI 10.1111/febs.13019; Hagman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068734; Huberts DHEW, 2012, FEMS YEAST RES, V12, P118, DOI 10.1111/j.1567-1364.2011.00767.x; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Kim JH, 2013, BBA-GEN SUBJECTS, V1830, P5204, DOI 10.1016/j.bbagen.2013.07.025; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Lin ZG, 2011, MOL BIOL EVOL, V28, P131, DOI 10.1093/molbev/msq184; Marcet-Houben M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-295; Merico A, 2007, FEBS J, V274, P976, DOI 10.1111/j.1742-4658.2007.05645.x; Moller K, 2001, J BACTERIOL, V183, P2485, DOI 10.1128/JB.183.8.2485-2489.2001; PETRIK M, 1983, J GEN MICROBIOL, V129, P43; Piskur J, 2006, TRENDS GENET, V22, P183, DOI 10.1016/j.tig.2006.02.002; POSTMA E, 1989, APPL ENVIRON MICROB, V55, P468, DOI 10.1128/AEM.55.2.468-477.1989; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; RIEGER M, 1983, J GEN MICROBIOL, V129, P653; SONNLEITNER B, 1986, BIOTECHNOL BIOENG, V28, P927, DOI 10.1002/bit.260280620; VANURK H, 1989, J GEN MICROBIOL, V135, P2399; VONMEYEN HK, 1969, ARCH MIKROBIOL, V66, P289; Westergaard SL, 2007, BIOTECHNOL BIOENG, V96, P134, DOI 10.1002/bit.21135; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	30	64	65	2	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116942	10.1371/journal.pone.0116942	http://dx.doi.org/10.1371/journal.pone.0116942			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617754	Green Submitted, Green Published, gold			2022-12-26	WOS:000350336000032
J	Silvis, A; Ford, WM; Britzke, ER				Silvis, Alexander; Ford, W. Mark; Britzke, Eric R.			Effects of Hierarchical Roost Removal on Northern Long-Eared Bat (Myotis septentrionalis) Maternity Colonies	PLOS ONE			English	Article							BROWN BATS; NETWORK ANALYSIS; PRESCRIBED FIRE; SOCIAL NETWORKS; SOUTH-CAROLINA; INDIANA BATS; FOREST BATS; HABITAT USE; SELECTION; FEMALE	Forest roosting bats use a variety of ephemeral roosts such as snags and declining live trees. Although conservation of summer maternity habitat is considered critical for forest-roosting bats, bat response to roost loss still is poorly understood. To address this, we monitored 3 northern long-eared bat (Myotis septentrionalis) maternity colonies on Fort Knox Military Reservation, Kentucky, USA, before and after targeted roost removal during the dormant season when bats were hibernating in caves. We used 2 treatments: removal of a single highly used (primary) roost and removal of 24% of less used (secondary) roosts, and an un-manipulated control. Neither treatment altered the number of roosts used by individual bats, but secondary roost removal doubled the distances moved between sequentially used roosts. However, overall space use by and location of colonies was similar pre- and post-treatment. Patterns of roost use before and after removal treatments also were similar but bats maintained closer social connections after our treatments. Roost height, diameter at breast height, percent canopy openness, and roost species composition were similar pre- and post-treatment. We detected differences in the distribution of roosts among decay stages and crown classes pre- and post-roost removal, but this may have been a result of temperature differences between treatment years. Our results suggest that loss of a primary roost or <= 20% of secondary roosts in the dormant season may not cause northern long-eared bats to abandon roosting areas or substantially alter some roosting behaviors in the following active season when tree-roosts are used. Critically, tolerance limits to roost loss may be dependent upon local forest conditions, and continued research on this topic will be necessary for conservation of the northern long-eared bat across its range.	[Silvis, Alexander; Ford, W. Mark] Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Ford, W. Mark] US Geol Survey, Virginia Cooperat Fish & Wildlife Res Unit, Blacksburg, VA USA; [Britzke, Eric R.] US Army, Engn Res & Dev Ctr, Environm Lab, Vicksburg, MS USA	Virginia Polytechnic Institute & State University; United States Department of the Interior; United States Geological Survey; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Silvis, A (corresponding author), Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.	silvis@vt.edu			United States Army	United States Army(United States Department of DefenseUnited States Army)	Funding for this research was provided through a United States Army 6.1 basic science grant. One of the authors in this manuscript works for the United States Army Corps of Engineers, but we have no conflicts of interest with the United States Army. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was conducted on an active military installation, and accordingly, our field sites were positioned within areas of the installation that were not used for active training. We, the authors, selected these sites from a list of several safe operation zones on the installation.	[Anonymous], 2002, OAK FOREST; [Anonymous], 2012, INT J FOREST RES, DOI DOI 10.1155/2012/148106; Arms ELP, 1979, SOIL SURVEY HARDIN L; Bagne KE, 2008, FOREST ECOL MANAG, V255, P99, DOI 10.1016/j.foreco.2007.08.024; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Borgatti SP, 1997, SOC NETWORKS, V19, P243, DOI 10.1016/S0378-8733(96)00301-2; Borkin KM, 2011, BIODIVERS CONSERV, V20, P3537, DOI 10.1007/s10531-011-0144-7; Boyles JG, 2006, FOREST ECOL MANAG, V222, P108, DOI 10.1016/j.foreco.2005.09.024; Braun E.L, 1950, SOIL SCI, V71, P155, DOI [10.1097/00010694-195102000-00012, DOI 10.1097/00010694-195102000-00012]; BRIGHAM RM, 1986, CAN J ZOOL, V64, P1128, DOI 10.1139/z86-169; Broders HG, 2006, J WILDLIFE MANAGE, V70, P1174, DOI 10.2193/0022-541X(2006)70[1174:REASSF]2.0.CO;2; Brooks RT, 2005, NORTHEAST NAT, V12, P447, DOI 10.1656/1092-6194(2005)012[0447:BAIAFL]2.0.CO;2; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Carter TC, 2005, FOREST ECOL MANAG, V219, P259, DOI 10.1016/j.foreco.2005.08.049; Chaverri G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028821; CLINE SP, 1980, J WILDLIFE MANAGE, V44, P773, DOI 10.2307/3808305; Copenheaver CA, 2006, NORTHEAST NAT, V13, P477, DOI 10.1656/1092-6194(2006)13[477:FSDPIT]2.0.CO;2; CRANFILL R, 1991, Castanea, V56, P228; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Davison AC, 1997, BOOTSTRAP METHODS TH; Dixon MD, 2013, J FISH WILDL MANAG, V4, P406, DOI 10.3996/122012-JFWM-106; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; ERDOS P, 1960, B INT STATIST INST, V38, P343; Fenton MB, 1997, J MAMMAL, V78, P1, DOI 10.2307/1382633; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Ford WM, 2006, J WILDLIFE MANAGE, V70, P1200, DOI 10.2193/0022-541X(2006)70[1200:PAAOBA]2.0.CO;2; Ford WM, 2006, NORTHEAST NAT, V13, P15, DOI 10.1656/1092-6194(2006)13[15:RPBLAD]2.0.CO;2; Ford WM, 2005, BIOL CONSERV, V126, P528, DOI 10.1016/j.biocon.2005.07.003; Fortuna MA, 2009, ECOLOGY, V90, P934, DOI 10.1890/08-0174.1; Foster RW, 1999, J MAMMAL, V80, P659, DOI 10.2307/1383310; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; Garroway CJ, 2008, ECOSCIENCE, V15, P89, DOI 10.2980/1195-6860(2008)15[89:DRCONL]2.0.CO;2; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Goodreau SM, 2009, DEMOGRAPHY, V46, P103, DOI 10.1353/dem.0.0045; GRINDAL SD, 1992, AM MIDL NAT, V128, P339, DOI 10.2307/2426468; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Hutchinson TF, 2008, CAN J FOREST RES, V38, P1184, DOI 10.1139/X07-216; James R, 2009, BEHAV ECOL SOCIOBIOL, V63, P989, DOI 10.1007/s00265-009-0742-5; Johnson JS, 2012, J MAMMAL, V93, P1545, DOI 10.1644/12-MAMM-A-097.1; Johnson JB, 2012, FOREST ECOL MANAG, V266, P223, DOI 10.1016/j.foreco.2011.11.032; Johnson JB, 2010, J FISH WILDL MANAG, V1, P111, DOI 10.3996/042010-JFWM-007; Johnson JB, 2009, FOREST ECOL MANAG, V258, P233, DOI 10.1016/j.foreco.2009.04.008; Jung TS, 1999, J WILDLIFE MANAGE, V63, P1306, DOI 10.2307/3802849; Kerth G, 2001, OECOLOGIA, V126, P1, DOI 10.1007/s004420000489; Kunz TH, 2003, BAT ECOLOGY, P3; Lacki MJ, 2009, J MAMMAL, V90, P1165, DOI 10.1644/08-MAMM-A-349.1; Lacki MJ, 2001, J WILDLIFE MANAGE, V65, P482, DOI 10.2307/3803101; LEWIS SE, 1995, J MAMMAL, V76, P481, DOI 10.2307/1382357; Loeb SC, 2006, J WILDLIFE MANAGE, V70, P1210, DOI 10.2193/0022-541X(2006)70[1210:HUBFBI]2.0.CO;2; Lorimer CG, 2003, FOREST ECOL MANAG, V185, P41, DOI 10.1016/S0378-1127(03)00245-7; Menzel MA, 2002, FOREST ECOL MANAG, V155, P107, DOI 10.1016/S0378-1127(01)00551-5; Menzel MA, 2002, FOREST ECOL MANAG, V162, P209, DOI 10.1016/S0378-1127(01)00516-3; Metheny JD, 2008, BEHAV ECOL SOCIOBIOL, V62, P1043, DOI 10.1007/s00265-007-0531-y; Moorman CE, 1999, FOREST ECOL MANAG, V118, P37, DOI 10.1016/S0378-1127(98)00482-4; Morris AD, 2010, J WILDLIFE MANAGE, V74, P26, DOI 10.2193/2008-471; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; NEILSON AL, 1994, WILDLIFE SOC B, V22, P8; Nyland R., 2002, SILVICULTURE CONCEPT; Olson CR, 2013, CAN J ZOOL, V91, P149, DOI 10.1139/cjz-2012-0267; Opsahl T., 2009, STRUCTURE EVOLUTION; Owen SF, 2004, NORTH J APPL FOR, V21, P154, DOI 10.1093/njaf/21.3.154; Patriquin KJ, 2013, BEHAV ECOL, V24, P949, DOI 10.1093/beheco/art012; Patriquin KJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P899, DOI 10.1007/s00265-010-0905-4; Perry RW, 2007, FOREST ECOL MANAG, V247, P220, DOI 10.1016/j.foreco.2007.04.041; Perry RW, 2011, J FISH WILDL MANAG, V2, P112, DOI 10.3996/082010-JFWM-030; Popa-Lisseanu AG, 2008, ANIM BEHAV, V75, P471, DOI 10.1016/j.anbehav.2007.05.011; R Development Core Team, 2014, R LANG ENV STAT COMP; Rhodes M, 2006, CONSERV BIOL, V20, P861, DOI 10.1111/j.1523-1739.2006.00415.x; Signell SA, 2005, FOREST ECOL MANAG, V218, P146, DOI 10.1016/j.foreco.2005.07.006; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Silvis A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096937; Silvis A, 2014, BEHAV PROCESS, V103, P283, DOI 10.1016/j.beproc.2014.01.016; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Stone EL, 2013, CONSERV BIOL, V27, P1324, DOI 10.1111/cobi.12154; Timpone JC, 2010, AM MIDL NAT, V163, P115, DOI 10.1674/0003-0031-163.1.115; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weller Theodore J., 2009, Endangered Species Research, V8, P129, DOI 10.3354/esr00149; Willis CKR, 2005, CAN J ZOOL, V83, P871, DOI 10.1139/Z05-074; Wisdom MJ, 2008, FOREST ECOL MANAG, V255, P2085, DOI 10.1016/j.foreco.2007.12.027; Womack KM, 2013, J WILDLIFE MANAGE, V77, P707, DOI 10.1002/jwmg.498; Zahn A, 1999, J ZOOL, V247, P275, DOI 10.1111/j.1469-7998.1999.tb00991.x; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115	87	22	22	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116356	10.1371/journal.pone.0116356	http://dx.doi.org/10.1371/journal.pone.0116356			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611060	gold, Green Submitted, Green Published			2022-12-26	WOS:000348562900013
J	Cerna, L; Munzbergova, Z				Cerna, Lucie; Muenzbergova, Zuzana			Conditions in Home and Transplant Soils Have Differential Effects on the Performance of Diploid and Allotetraploid Anthericum Species	PLOS ONE			English	Article							LOCAL ADAPTATION; NICHE DIFFERENTIATION; POPULATION BIOLOGY; GENETIC-VARIATION; PERENNIAL HERB; PLANT; PLASTICITY; POLYPLOIDY; COMPETITION; LEVEL	Due to increased levels of heterozygosity, polyploids are expected to have a greater ability to adapt to different environments than their diploid ancestors. While this theoretical pattern has been suggested repeatedly, studies comparing adaptability to changing conditions in diploids and polyploids are rare. The aim of the study was to determine the importance of environmental conditions of origin as well as target conditions on performance of two Anthericum species, allotetraploid A. liliago and diploid A. ramosum and to explore whether the two species differ in the ability to adapt to these environmental conditions. Specifically, we performed a common garden experiment using soil from 6 localities within the species' natural range, and we simulated the forest and open environments in which they might occur. We compared the performance of diploid A. ramosum and allotetraploid A. liliago originating from different locations in the different soils. The performance of the two species was not affected by simulated shading but differed strongly between the different target soils. Growth of the tetraploids was not affected by the origin of the plants. In contrast, diploids from the most nutrient poor soil performed best in the richest soil, indicating that diploids from deprived environments have an increased ability to acquire nutrients when available. They are thus able to profit from transfer to novel nutrient rich environments. Therefore, the results of the study did not support the general expectation that the polyploids should have a greater ability than the diploids to adapt to a wide range of conditions. In contrast, the results are in line with the observation that diploids occupy a wider range of environments than the allotetraploids in our system.	[Cerna, Lucie; Muenzbergova, Zuzana] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Muenzbergova, Zuzana] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Munzbergova, Z (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.	zuzmun@natur.cuni.cz	Münzbergová, Zuzana/F-6321-2013; Černá, Lucie/GSJ-0030-2022	Münzbergová, Zuzana/0000-0002-4026-6220; 	Grant agency of the Czech Republic (GACR) [13-2048S]; Developmental project of the Academy of Sciences [RVO 67985939]; Ministry of education (MSMT)	Grant agency of the Czech Republic (GACR)(Grant Agency of the Czech Republic); Developmental project of the Academy of Sciences; Ministry of education (MSMT)	The study was supported by a project of the Grant agency of the Czech Republic (GACR 13-2048S) and also in part by the Developmental project of the Academy of Sciences (RVO 67985939) and an institutional research project provided by the Ministry of education (MSMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela-Hofbauerova I, 2011, FLORA, V206, P1012, DOI 10.1016/j.flora.2011.07.007; Allen RM, 2008, AM NAT, V171, P225, DOI 10.1086/524952; Baack EJ, 2005, EVOLUTION, V59, P1936; Bever JD, 2012, ANNU REV MICROBIOL, V66, P265, DOI 10.1146/annurev-micro-092611-150107; Bischoff A, 2013, AM J BOT, V100, P1162, DOI 10.3732/ajb.1200500; BRETAGNOLLE F, 1995, EUPHYTICA, V84, P197, DOI 10.1007/BF01681812; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; Bucharova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045855; Bucharova A, 2010, AM J BOT, V97, P1260, DOI 10.3732/ajb.0900351; Buggs RJA, 2007, EVOLUTION, V61, P125, DOI 10.1111/j.1558-5646.2007.00010.x; Burkle LA, 2010, J ECOL, V98, P705, DOI 10.1111/j.1365-2745.2010.01648.x; Castro S, 2011, EVOL ECOL, V25, P795, DOI 10.1007/s10682-010-9439-5; Cerna L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075563; Chun YJ, 2011, MOL ECOL, V20, P1378, DOI 10.1111/j.1365-294X.2011.05013.x; D'Hertefeldt T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085407; Dostalek T, 2013, FOLIA GEOBOT, V48, P75, DOI 10.1007/s12224-012-9132-2; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Ehrenberger F., 1973, METHODEN ORG ELEMENT; Eliasova A, 2014, ANN BOT-LONDON, V113, P159, DOI 10.1093/aob/mct252; Ellenberg H., 1988, VEGETATION ECOLOGY C; FelberGirard M, 1996, NEW PHYTOL, V133, P531, DOI 10.1111/j.1469-8137.1996.tb01921.x; Flegrova M, 1999, FOLIA GEOBOT, V34, P19, DOI 10.1007/BF02803074; Francis B., 1993, STAT SYSTEM GEN LINE; Freville H, 2004, ECOLOGY, V85, P694, DOI 10.1890/03-0119; Galloway LF, 2000, EVOLUTION, V54, P1173, DOI 10.1111/j.0014-3820.2000.tb00552.x; Godsoe W, 2013, AM J BOT, V100, P496, DOI 10.3732/ajb.1200275; GRANT V, 1994, P NATL ACAD SCI USA, V91, P3, DOI 10.1073/pnas.91.1.3; Hahn MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050284; Heinken-Smidova A, 2012, FOLIA GEOBOT, V47, P193, DOI 10.1007/s12224-011-9116-7; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Hulber K, 2011, ALPINE BOT, V121, P123, DOI 10.1007/s00035-011-0091-7; Husband BC, 2000, P ROY SOC B-BIOL SCI, V267, P217, DOI 10.1098/rspb.2000.0990; JAIN SK, 1966, HEREDITY, V21, P407, DOI 10.1038/hdy.1966.42; Jersakova J, 2010, EVOL ECOL, V24, P1199, DOI 10.1007/s10682-010-9356-7; Jolivet C, 2007, ANN BOT-LONDON, V100, P119, DOI 10.1093/aob/mcm088; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Laine AL, 2007, J EVOLUTION BIOL, V20, P1665, DOI 10.1111/j.1420-9101.2007.01359.x; Lankau RA, 2013, ECOLOGY, V94, P32, DOI 10.1890/12-0675.1; Latzel V, 2010, OIKOS, V119, P1700, DOI 10.1111/j.1600-0706.2010.18737.x; Latzel V, 2009, OIKOS, V118, P1669, DOI 10.1111/j.1600-0706.2009.17767.x; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lembicz M, 2011, FLORA, V206, P158, DOI 10.1016/j.flora.2010.09.006; Lenssen JPM, 2004, J ECOL, V92, P696, DOI 10.1111/j.0022-0477.2004.00895.x; Levin D. A, 2002, OX ECOL EV; LEVIN DA, 1983, AM NAT, V122, P1, DOI 10.1086/284115; LEWIS HARLAN, 1967, TAXON, V16, P267, DOI 10.2307/1216373; Munzbergova Z, 2007, ANN BOT-LONDON, V100, P1259, DOI 10.1093/aob/mcm204; Macel M, 2007, ECOLOGY, V88, P424, DOI 10.1890/0012-9658(2007)88[424:CVSFIL]2.0.CO;2; Manzaneda AJ, 2012, NEW PHYTOL, V193, P797, DOI 10.1111/j.1469-8137.2011.03988.x; Marques I, 2007, AM J BOT, V94, P1352, DOI 10.3732/ajb.94.8.1352; Martin SL, 2013, EVOLUTION, V67, P1780, DOI 10.1111/evo.12065; Martina JP, 2013, PLANT ECOL, V214, P1443, DOI 10.1007/s11258-013-0265-z; MCNEILLY T, 1968, EVOLUTION, V22, P108, DOI [10.1111/j.1558-5646.1968.tb03454.x, 10.2307/2406655]; Meeus S, 2012, AM J BOT, V99, P1809, DOI 10.3732/ajb.1200223; Muenzbergova Z, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082806, DOI 10.1371/JOURNAL.PONE.0082806]; Munzbergova Z, 2007, BIOL J LINN SOC, V92, P211, DOI 10.1111/j.1095-8312.2007.00820.x; Munzbergova Z, 2005, AM J BOT, V92, P1987, DOI 10.3732/ajb.92.12.1987; Munzbergova Z, 2005, FLORA, V200, P275, DOI 10.1016/j.flora.2004.08.002; Munzbergova Z, 2004, J ECOL, V92, P854, DOI 10.1111/j.0022-0477.2004.00919.x; Munzbergova Z, 2010, FLORA, V205, P552, DOI 10.1016/j.flora.2010.04.001; Nuismer SL, 2005, EVOLUTION, V59, P1928; Oberprieler C, 2012, FLORA, V207, P862, DOI 10.1016/j.flora.2012.09.012; Oleksyn J, 2003, OECOLOGIA, V136, P220, DOI 10.1007/s00442-003-1265-9; Olsen R., 1954, US DEP AGR CIRCULAR, V939, P1; Pankova H, 2008, OECOLOGIA, V157, P211, DOI 10.1007/s00442-008-1064-4; Pankova H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093967; Pankova H, 2011, AM J BOT, V98, P850, DOI 10.3732/ajb.0900350; Parisod C, 2010, NEW PHYTOL, V186, P5, DOI 10.1111/j.1469-8137.2009.03142.x; Petit C, 1997, HEREDITY, V79, P31, DOI 10.1038/hdy.1997.120; Raabova J, 2008, OECOLOGIA, V158, P463, DOI 10.1007/s00442-008-1156-1; Raabova J, 2007, BIOL CONSERV, V139, P348, DOI 10.1016/j.biocon.2007.07.007; Raabova J, 2011, BASIC APPL ECOL, V12, P152, DOI 10.1016/j.baae.2011.01.001; Reckinger C, 2010, RESTOR ECOL, V18, P904, DOI 10.1111/j.1526-100X.2009.00522.x; Rosquist G, 2002, PLANT SYST EVOL, V236, P55, DOI 10.1007/s00606-002-0238-5; Schlaepfer DR, 2010, OECOLOGIA, V163, P661, DOI 10.1007/s00442-010-1595-3; Skalicky V, 1959, ACTA U CAROLINAE BIO, V2, P117; Skalova H, 2005, FOLIA GEOBOT, V40, P77, DOI 10.1007/BF02803046; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Smidova A, 2011, FLORA, V206, P151, DOI 10.1016/j.flora.2010.03.003; Soltis DE, 2010, TAXON, V59, P1387, DOI 10.1002/tax.595006; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Sterck FJ, 2013, J ECOL, V101, P971, DOI 10.1111/1365-2745.12076; SYMEONIDIS L, 1985, NEW PHYTOL, V101, P317, DOI 10.1111/j.1469-8137.1985.tb02838.x; Tajek P, 2011, ACTA OECOL, V37, P495, DOI 10.1016/j.actao.2011.06.009; van Kleunen M, 2007, J EVOLUTION BIOL, V20, P2126, DOI 10.1111/j.1420-9101.2007.01431.x; Weiner J, 2009, J ECOL, V97, P1220, DOI 10.1111/j.1365-2745.2009.01559.x; Weisshuhn K, 2012, BASIC APPL ECOL, V13, P551, DOI 10.1016/j.baae.2012.07.004; Wright JW, 2006, EVOL ECOL RES, V8, P1; Xu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035873; Zhang ST, 2011, ANN BOT-LONDON, V107, P437, DOI 10.1093/aob/mcq259	90	8	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116992	10.1371/journal.pone.0116992	http://dx.doi.org/10.1371/journal.pone.0116992			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607545	Green Submitted, Green Published, gold			2022-12-26	WOS:000348205300046
J	Nathalang, O; Intharanut, K; Siriphanthong, K; Nathalang, S; Leetrakool, N				Nathalang, Oytip; Intharanut, Kamphon; Siriphanthong, Kanokpol; Nathalang, Siriporn; Leetrakool, Nipapan			Risk Estimation of HNA-3 Incompatibility and Alloimmunization in Thai Populations	PLOS ONE			English	Article							HUMAN NEUTROPHIL ALLOANTIGENS; BLOOD-DONORS; GENOTYPE FREQUENCIES; TRALI; GENE; 5B	Severe transfusion-related acute lung injury (TRALI) is often due to antibodies in blood components directed against human neutrophil antigen (HNA)-3a. This study aimed to report the genotype frequencies of the HNA-3 system and to estimate the potential risk of HNA-3 incompatibility and alloimmunization in two Thai populations. Eight hundred DNA samples obtained from 500 unrelated healthy blood donors at the National Blood Centre, Thai Red Cross Society, Bangkok and 300 samples from the Blood Bank, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand were included. HNA-3 genotyping was performed using an in-house polymerase chain reaction with sequence-specific primer (PCR-SSP) technique. The observed frequencies of the HNA-3a/3a, HNA-3a/3b, and HNA3b/3b genotypes were 0.528, 0.380, and 0.092 in central Thais and 0.600, 0.350, and 0.050 in northern Thais, respectively. The frequencies were used to estimate HNA-3 incompatibility and risk of HNA-3a alloimmunization. The HNA-3 incompatibility in central Thais (33.28%) was higher than northern Thais (28.75%), corresponding to a significantly higher probability of HNA-3a alloimmunization (P<0.05) similar to Japanese and Chinese populations. This study showed the high risk of HNA-3 incompatibility and alloimmunization, especially in central Thai blood donors. A molecular-based identification of the HNA-3 genotype of female donors is suggested to reduce the risk of TRALI following plasma and whole blood allogeneic transfusion.	[Nathalang, Oytip; Intharanut, Kamphon; Siriphanthong, Kanokpol] Thammasat Univ, Fac Allied Hlth Sci, Grad Program Biomed Sci, Pathum Thani, Thailand; [Nathalang, Siriporn] Red Cross Soc, Natl Blood Ctr, Bangkok, Thailand; [Leetrakool, Nipapan] Chiang Mai Univ, Fac Med, Blood Bank Sect, Chiang Mai 50000, Thailand	Thammasat University; Thai Red Cross Society; Chiang Mai University	Nathalang, O (corresponding author), Thammasat Univ, Fac Allied Hlth Sci, Grad Program Biomed Sci, Pathum Thani, Thailand.	oytipntl@hotmail.com		Intharanut, Kamphon/0000-0002-2978-1432	Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission	Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission	This work was supported by grants of the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bux J, 2008, VOX SANG, V94, P277, DOI 10.1111/j.1423-0410.2007.01031.x; Cardoso SP, 2013, VOX SANG, V105, P65, DOI 10.1111/vox.12016; Changsri K, 2014, BLOOD TRANSFUS-ITALY, V12, pS286, DOI 10.2450/2013.0161-12; Chapman CE, 2008, TRANSFUS MED HEMOTH, V35, P93, DOI 10.1159/000119116; Curtis BR, 2010, BLOOD, V115, P2073, DOI 10.1182/blood-2009-11-248336; Davoren A, 2003, TRANSFUSION, V43, P641, DOI 10.1046/j.1537-2995.2003.00374.x; Flesch BK, 2011, TRANSFUSION, V51, P2391, DOI 10.1111/j.1537-2995.2011.03155.x; Greinacher A, 2010, NAT MED, V16, P45, DOI 10.1038/nm.2070; Hauck B, 2011, TISSUE ANTIGENS, V78, P416, DOI 10.1111/j.1399-0039.2011.01779.x; He JJ, 2014, BLOOD TRANSFUS-ITALY, V12, pS292, DOI 10.2450/2013.0308-12; Huvard MJ, 2012, TRANSFUSION, V52, P1106, DOI 10.1111/j.1537-2995.2011.03396.x; Lopes LB, 2014, TRANSFUSION, V54, P1619, DOI 10.1111/trf.12493; Matsuhashi M, 2012, TISSUE ANTIGENS, V80, P336, DOI 10.1111/j.1399-0039.2012.01930.x; Miller AS, 1988, NUCLEIC ACIDS RES, V16, P1215; Nielsen KR, 2012, TISSUE ANTIGENS, V80, P249, DOI 10.1111/j.1399-0039.2012.01912.x; Reil A, 2011, TRANSFUSION, V51, P18, DOI 10.1111/j.1537-2995.2010.02751.x; Xia WJ, 2011, TRANSFUSION, V51, P1271, DOI 10.1111/j.1537-2995.2010.02979.x	17	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116905	10.1371/journal.pone.0116905	http://dx.doi.org/10.1371/journal.pone.0116905			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25608003	Green Published, gold, Green Submitted			2022-12-26	WOS:000348205300042
J	Jeanray, N; Maree, R; Pruvot, B; Stern, O; Geurts, P; Wehenkel, L; Muller, M				Jeanray, Nathalie; Maree, Raphael; Pruvot, Benoist; Stern, Olivier; Geurts, Pierre; Wehenkel, Louis; Muller, Marc			Phenotype Classification of Zebrafish Embryos by Supervised Learning	PLOS ONE			English	Article							SCREENS	Zebrafish is increasingly used to assess biological properties of chemical substances and thus is becoming a specific tool for toxicological and pharmacological studies. The effects of chemical substances on embryo survival and development are generally evaluated manually through microscopic observation by an expert and documented by several typical photographs. Here, we present a methodology to automatically classify brightfield images of wildtype zebrafish embryos according to their defects by using an image analysis approach based on supervised machine learning. We show that, compared to manual classification, automatic classification results in 90 to 100% agreement with consensus voting of biological experts in nine out of eleven considered defects in 3 days old zebrafish larvae. Automation of the analysis and classification of zebrafish embryo pictures reduces the workload and time required for the biological expert and increases the reproducibility and objectivity of this classification.	[Jeanray, Nathalie; Pruvot, Benoist; Muller, Marc] Univ Liege, GIGA Dev Stem Cells & Regenerat Med, Liege, Belgium; [Jeanray, Nathalie; Stern, Olivier; Geurts, Pierre; Wehenkel, Louis] Univ Liege, GIGA Syst Biol & Chem Biol, Dept EE & CS, Liege, Belgium; [Maree, Raphael; Wehenkel, Louis] Univ Liege, GIGA Bioinformat Core Facil, Liege, Belgium	University of Liege; University of Liege; University of Liege	Muller, M (corresponding author), Univ Liege, GIGA Dev Stem Cells & Regenerat Med, Liege, Belgium.	m.muller@ulg.ac.be		Maree, Raphael/0000-0002-9587-1954	Walloon Region (FEDER); European Interreg Program Almain-silico (AIS); European Space Agency (ESA); Fonds National de la Recherche Scientifique (F.N.R.S.)	Walloon Region (FEDER); European Interreg Program Almain-silico (AIS); European Space Agency (ESA)(European Space Agency); Fonds National de la Recherche Scientifique (F.N.R.S.)(Fonds de la Recherche Scientifique - FNRS)	This study was suppported by The Walloon Region (FEDER. GIGA2 Bioindustry support: (www.wallonie.be), The European Interreg Program Almain-silico (AIS): (www.euregio-mr.com), The European Space Agency (ESA): (http://www.esa.int/ESA), The Fonds National de la Recherche Scientifique (F.N.R.S.): (www.fnrs.be), M.M. is a "Chercheur Qualifie du F.N.R.S." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshut R, 2010, LECT NOTES ARTIF INT, V6359, P219, DOI 10.1007/978-3-642-16111-7_25; Arslanova D, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-24; Cao Y, 2009, P NATL ACAD SCI USA, V106, P21819, DOI 10.1073/pnas.0911987106; Chang TY, 2012, LAB CHIP, V12, P711, DOI 10.1039/c1lc20849g; Chen YH, 2012, REPROD TOXICOL, V33, P233, DOI 10.1016/j.reprotox.2011.12.008; David A, 2009, J APPL TOXICOL, V29, P597, DOI 10.1002/jat.1446; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Fraysse B, 2006, ECOTOX ENVIRON SAFE, V63, P253, DOI 10.1016/j.ecoenv.2004.10.015; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Gurvich N, 2005, FASEB J, V19, P1166, DOI 10.1096/fj.04-3425fje; JEANRAY N, 2011, 20TH ANNUAL BELGIAN; JIANGFEI C, 2012, NEUROTOXICOLOGY AND, V34, P581, DOI DOI 10.1016/J.NTT.2012.09.001; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kucukoglu M, 2013, TURK J BIOL, V37, P158, DOI 10.3906/biy-1203-27; Liu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035014; LIXIN Y, 2010, TOXICOL SCI, V115, P379; Love DR, 2004, CURR OPIN BIOTECH, V15, P564, DOI 10.1016/j.copbio.2004.09.004; MAREE R, 2013, PROC 12TH EUROPEAN C, P526; Maree R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-S1-S2; Mikut R, 2013, ZEBRAFISH, V10, P401, DOI 10.1089/zeb.2013.0886; OECD, 2013, OECD GUIDELINES FOR; Pardo-Martin C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2475; Peter ALJ, 2005, ENVIRON INT, V31, P493, DOI 10.1016/j.envint.2004.09.003; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Pruvot B, 2012, REPROD TOXICOL, V34, P568, DOI 10.1016/j.reprotox.2012.07.010; Shamir L, 2011, J MICROSC-OXFORD, V243, P284, DOI 10.1111/j.1365-2818.2011.03502.x; Shamir L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000974; Spitsbergen Jan M., 2003, Toxicologic Pathology, V31, P62, DOI 10.1080/01926230309774; STERN O, 2011, PROCEEDINGS OF THE 6; TAT J, 2012, DRUG DISCOVERY TODAY; Teraoka Hiroki, 2003, Congenital Anomalies, V43, P123, DOI 10.1111/j.1741-4520.2003.tb01036.x; Teresa G, 2002, TOXICOL LETT, V132, P57, DOI 10.1016/S0378-4274(02)00066-8; Tornova E, 2008, J ENVIRON BIOL, V29, P897; Vogt A, 2009, DEV DYNAM, V238, P656, DOI 10.1002/dvdy.21892; Weigt S, 2010, TOXICOLOGY, V275, P36, DOI 10.1016/j.tox.2010.05.012; Westerfield M., 2007, THE ZEBRAFISH BOOK	36	25	25	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0116989	10.1371/journal.pone.0116989	http://dx.doi.org/10.1371/journal.pone.0116989			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25574849	Green Submitted, Green Published, gold			2022-12-26	WOS:000348168100010
J	Musahl, AS; Huang, X; Rusakiewicz, S; Ntini, E; Marsico, A; Kroemer, G; Kepp, O; Orom, UA				Musahl, A-S; Huang, X.; Rusakiewicz, S.; Ntini, E.; Marsico, A.; Kroemer, G.; Kepp, O.; Orom, U. A.			A long non-coding RNA links calreticulin-mediated immunogenic cell removal to RB1 transcription	ONCOGENE			English	Article							BIDIRECTIONAL PROMOTERS; DIVERGENT TRANSCRIPTION; HUMAN GENOME; GENE-EXPRESSION; MAJOR SOURCE; CHROMATIN; REVEALS; ELEMENTS; CANCER; SITE	A subset of promoters bidirectionally expresses long non-coding RNAs (ncRNAs) of unknown function and protein-coding genes (PCGs) in parallel. Here, we define a set of 1107 highly conserved human bidirectional promoters that mediate the linked expression of long ncRNAs and PCGs. Depletion of the long ncRNA expressed from the RB1 promoter, ncRNA-RB1, reveals regulatory effects different from the RB1-controlled transcriptional program. ncRNA-RB1 positively regulates the expression of calreticulin (CALR) that in response to certain therapeutic interventions can translocate from the endoplasmic reticulum to the cell surface, hence activating anticancer immune responses. Knockdown of ncRNA-RB1 in tumor cells reduced expression of CALR, impaired the translocation of the protein to the cell surface upon treatment with anthracylines and consequently inhibited the cellular uptake by macrophages. In conclusion, co-transcription of ncRNA-RB1 and RB1 provides a positive link between the expression of the two tumor suppressors RB1 and the immune-relevant CALR protein. This regulatory interplay exemplifies disease-relevant co-regulation of two distinct gene products, in which loss of expression of one oncosuppressor protein entails the abolition of additional tumor-inhibitory mechanisms.	[Musahl, A-S; Ntini, E.; Orom, U. A.] Max Planck Inst Mol Genet, Noncoding RNA Res Grp, D-14195 Berlin, Germany; [Huang, X.; Kroemer, G.; Kepp, O.] INSERM, Cordeliers Res Canc, U1138, Team11,Equipe Labellisee Ligue Canc, Paris, France; [Huang, X.; Kroemer, G.; Kepp, O.] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Huang, X.; Kroemer, G.; Kepp, O.] Gustave Roussy Comprehens Canc Ctr, Cell Biol & Metabol Platforms, Villejuif, France; [Rusakiewicz, S.] Gustave Roussy, Villejuif, France; [Rusakiewicz, S.] INSERM, U1015, CICBT507, Villejuif, France; [Marsico, A.] Max Planck Inst Mol Genet, Dept Computat Biol, D-14195 Berlin, Germany; [Marsico, A.] Max Planck Inst Mol Genet, RNA Bioinformat Grp, D-14195 Berlin, Germany; [Marsico, A.] Free Univ Berlin, Berlin, Germany; [Kroemer, G.] Univ Paris 06, Paris, France; [Kroemer, G.] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Max Planck Society; Max Planck Society; Free University of Berlin; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Orom, UA (corresponding author), Max Planck Inst Mol Genet, Warburg Labs, Ihnestr 63, D-14195 Berlin, Germany.	Oerom@molgen.mpg.de	Marsico, Annalisa/AFU-3262-2022; Kepp, Oliver/GPX-8627-2022; KROEMER, Guido/B-4263-2013; Kroemer, Guido/AAY-9859-2020; Kepp, Oliver/N-2763-2017; 黄, 星/AAB-2241-2019	KROEMER, Guido/0000-0002-9334-4405; Kepp, Oliver/0000-0002-6081-9558; 黄, 星/0000-0002-8886-2777; Ntini, Evgenia/0000-0002-4649-6051; Orom, Ulf/0000-0002-0643-0592	Ligue contre le Cancer (equipe labelisee); Agence National de la Recherche (ANR); Association pour la recherche sur le cancer (ARC); Canceropole Ile-de-France; AXA Chair for Longevity Research; Institut National du Cancer (INCa); Fondation Bettencourt-Schueller; Fondation de France; Fondation pour la Recherche Medicale (FRM); European Commission (ArtForce); European Research Council (ERC); LabEx Immuno-Oncology; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI); German Ministry of education and research through the Alexander von Humboldt Foundation Sofja Kovalevskaja Award	Ligue contre le Cancer (equipe labelisee)(Ligue nationale contre le cancer); Agence National de la Recherche (ANR)(French National Research Agency (ANR)); Association pour la recherche sur le cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Canceropole Ile-de-France(Region Ile-de-France); AXA Chair for Longevity Research(AXA Research Fund); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Fondation Bettencourt-Schueller; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Commission (ArtForce)(European CommissionEuropean Commission Joint Research Centre); European Research Council (ERC)(European Research Council (ERC)European Commission); LabEx Immuno-Oncology; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI); German Ministry of education and research through the Alexander von Humboldt Foundation Sofja Kovalevskaja Award	Work in the laboratories of GK and OK are suppported by the Ligue contre le Cancer (equipe labelisee); Agence National de la Recherche (ANR); Association pour la recherche sur le cancer (ARC); Canceropole Ile-de-France; AXA Chair for Longevity Research; Institut National du Cancer (INCa); Fondation Bettencourt-Schueller; Fondation de France; Fondation pour la Recherche Medicale (FRM); the European Commission (ArtForce); the European Research Council (ERC); the LabEx Immuno-Oncology; the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); and the Paris Alliance of Cancer Research Institutes (PACRI). Work in the laboratory of UAO is supported by the German Ministry of education and research through the Alexander von Humboldt Foundation Sofja Kovalevskaja Award.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Chao MP, 2012, NAT REV CANCER, V12, P58, DOI 10.1038/nrc3171; Chao MP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001375; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; GILL RM, 1994, CELL GROWTH DIFFER, V5, P467; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; HAMEL PA, 1992, MOL CELL BIOL, V12, P3431, DOI 10.1128/MCB.12.8.3431; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Manning AL, 2011, TRENDS CELL BIOL, V21, P433, DOI 10.1016/j.tcb.2011.05.003; Marquardt S, 2014, CELL, V157, P1712, DOI 10.1016/j.cell.2014.04.036; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Orom UA, 2013, CELL, V154, P1190, DOI 10.1016/j.cell.2013.08.028; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Polson A, 2014, GENE, V538, P138, DOI 10.1016/j.gene.2013.12.046; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; SAKAI T, 1991, NATURE, V353, P83, DOI 10.1038/353083a0; SAVOYSKY E, 1994, ONCOGENE, V9, P1839; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; SHAN B, 1994, MOL CELL BIOL, V14, P299, DOI 10.1128/MCB.14.1.299; SHIIO Y, 1992, P NATL ACAD SCI USA, V89, P5206, DOI 10.1073/pnas.89.12.5206; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Sowa Y, 1997, CANCER RES, V57, P3145; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trimarchi T, 2014, CELL, V158, P593, DOI 10.1016/j.cell.2014.05.049; Uesaka M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-35; Wakano C, 2012, BBA-GENE REGUL MECH, V1819, P688, DOI 10.1016/j.bbagrm.2012.02.006; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wu XB, 2013, CELL, V155, P990, DOI 10.1016/j.cell.2013.10.048; Yang MQ, 2007, PLOS COMPUT BIOL, V3, P733, DOI 10.1371/journal.pcbi.0030072; Zhang L, 2013, MOL CELL BIOCHEM, V382, P237, DOI 10.1007/s11010-013-1739-y; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	57	36	37	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 24	2015	34	39					5046	5054		10.1038/onc.2014.424	http://dx.doi.org/10.1038/onc.2014.424			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR9RC	25579178	Green Published			2022-12-26	WOS:000361693300005
J	Bjerregaard, H; Severinsen, K; Said, S; Wiborg, O; Sinning, S				Bjerregaard, Henriette; Severinsen, Kasper; Said, Saida; Wiborg, Ove; Sinning, Steffen			A Dualistic Conformational Response to Substrate Binding in the Human Serotonin Transporter Reveals a High Affinity State for Serotonin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cholesterol; Membrane Protein; Monoamine Transporter; Neurotransmitter; Neurotransmitter Transport; Protein Conformation; Serotonin; Serotonin Transporter; Transport; LeuT	CYSTEINE-SCANNING MUTAGENESIS; BACTERIAL HOMOLOG; DOPAMINE TRANSPORTER; LIGAND-BINDING; MECHANISM; 5-HYDROXYTRYPTAMINE; EXPRESSION; CLONING; LEUT; INHIBITOR	Background: The serotonin transporter (SERT) mediates neuronal reuptake of serotonin and is inhibited by most antidepressants. Results: A dualistic conformational response in SERT reveals a high affinity state in response to serotonin. Conclusion: Membrane cholesterol modulates the dualistic conformational response to serotonin in SERT. Significance: The interplay between the conformational responses in SERT and cholesterol is important for understanding an important pharmaceutical target in depression. Serotonergic neurotransmission is modulated by the membrane-embedded serotonin transporter (SERT). SERT mediates the reuptake of serotonin into the presynaptic neurons. Conformational changes in SERT occur upon binding of ions and substrate and are crucial for translocation of serotonin across the membrane. Our understanding of these conformational changes is mainly based on crystal structures of a bacterial homolog in various conformations, derived homology models of eukaryotic neurotransmitter transporters, and substituted cysteine accessibility method of SERT. However, the dynamic changes that occur in the human SERT upon binding of ions, the translocation of substrate, and the role of cholesterol in this interplay are not fully elucidated. Here we show that serotonin induces a dualistic conformational response in SERT. We exploited the substituted cysteine scanning method under conditions that were sensitized to detect a more outward-facing conformation of SERT. We found a novel high affinity outward-facing conformational state of the human SERT induced by serotonin. The ionic requirements for this new conformational response to serotonin mirror the ionic requirements for translocation. Furthermore, we found that membrane cholesterol plays a role in the dualistic conformational response in SERT induced by serotonin. Our results indicate the existence of a subpopulation of SERT responding differently to serotonin binding than hitherto believed and that membrane cholesterol plays a role in this subpopulation of SERT.	[Bjerregaard, Henriette; Severinsen, Kasper; Said, Saida; Wiborg, Ove; Sinning, Steffen] Aarhus Univ, Aarhus Univ Hosp, Dept Clin Med, Translat Neuropsychiat Unit, DK-8240 Risskov, Denmark	Aarhus University	Sinning, S (corresponding author), Aarhus Univ, Aarhus Univ Hosp, Dept Clin Med, Translat Neuropsychiat Unit, Skovagervej 2, DK-8240 Risskov, Denmark.	steffen.sinning@clin.au.dk		Sinning, Steffen/0000-0001-6971-6929	Lundbeck Foundation; Lundbeck Foundation [R34-2011-3868, R126-2012-12576] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by a grant from the Lundbeck Foundation.	Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; Androutsellis-Theotokis A, 2002, J NEUROSCI, V22, P8370; Androutsellis-Theotokis A, 2001, J BIOL CHEM, V276, P45933, DOI 10.1074/jbc.M107462200; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Carlsson A, 1968, J Pharm Pharmacol, V20, P150; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; CERRITO F, 1979, EUR J PHARMACOL, V57, P427, DOI 10.1016/0014-2999(79)90506-5; Chang AS, 1996, MOL BRAIN RES, V43, P185, DOI 10.1016/S0169-328X(96)00172-6; Chang JC, 2012, J NEUROSCI, V32, P8919, DOI 10.1523/JNEUROSCI.0048-12.2012; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; GU H, 1994, J BIOL CHEM, V269, P7124; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; HUMPHREYS CJ, 1994, BIOCHEMISTRY-US, V33, P9118, DOI 10.1021/bi00197a014; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Keller PC, 2004, BIOCHEMISTRY-US, V43, P8510, DOI 10.1021/bi035971g; Koldso H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002246; Koldso H, 2010, J AM CHEM SOC, V132, P1311, DOI 10.1021/ja906923j; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2004, EUR J NEUROSCI, V19, P1513, DOI 10.1111/j.1460-9568.2004.03202.x; LINGJAERDE O, 1969, FEBS LETT, V3, P103, DOI 10.1016/0014-5793(69)80108-0; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; MARSHALL EF, 1960, BRIT J PHARM CHEMOTH, V15, P35, DOI 10.1111/j.1476-5381.1960.tb01207.x; Ni YG, 2001, J BIOL CHEM, V276, P30942, DOI 10.1074/jbc.M104653200; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; RUDNICK G, 1977, J BIOL CHEM, V252, P2170; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; RUDNICK G, 1978, BIOCHEMISTRY-US, V17, P4739, DOI 10.1021/bi00615a021; Sato Y, 2004, J BIOL CHEM, V279, P22926, DOI 10.1074/jbc.M312194200; Scanlon SM, 2001, BIOCHEMISTRY-US, V40, P10507, DOI 10.1021/bi010730z; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Severinsen K, 2008, J NEUROCHEM, V105, P1794, DOI 10.1111/j.1471-4159.2008.05285.x; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; SIWERS B, 1977, CLIN PHARMACOL THER, V21, P194; STACEY RS, 1961, BRIT J PHARM CHEMOTH, V16, P284, DOI 10.1111/j.1476-5381.1961.tb01087.x; Tavoulari S, 2009, J NEUROSCI, V29, P9635, DOI 10.1523/JNEUROSCI.0440-09.2009; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhang YW, 2005, J BIOL CHEM, V280, P30807, DOI 10.1074/jbc.M504087200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	52	19	19	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7747	7755		10.1074/jbc.M114.573477	http://dx.doi.org/10.1074/jbc.M114.573477			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25614630	hybrid, Green Published			2022-12-26	WOS:000351613600035
J	Sun, GQ; Yu, X; Bao, C; Wang, L; Li, M; Gan, JH; Qu, D; Ma, JB; Chen, L				Sun, Guiqin; Yu, Xiang; Bao, Celimuge; Wang, Lei; Li, Meng; Gan, Jianhua; Qu, Di; Ma, Jinbiao; Chen, Li			Identification and Characterization of a Novel Prokaryotic Peptide N-GLYCOSIDASE FROM ELIZABETHKINGIA MENINGOSEPTICA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Crystal Structure; Enzyme; Glycoprotein; N-Linked Glycosylation; Peptide:N-Glycosidase (PNGase); PNGase F; Glycosylation; Deglycosylation; Glycoprotein; Crystal Structure	PEPTIDE-N-4-(N-ACETYL-BETA-D-GLUCOSAMINYL)ASPARAGINE AMIDASE-F; MASS-SPECTROMETRY; BINDING MODULE; PNGASE-F; GLYCANASE; CELLS; OLIGOSACCHARIDES; DEGLYCOSYLATION; DEGRADATION; MATRIX	Background: A putative peptide:N-glycosidase (PNGase), distinct from the well characterized PNGase F, was identified in Elizabethkingia meningoseptica. Results: The candidate protein possesses PNGase activity and a distinct substrate spectrum and domain structure. Conclusion: The candidate (named PNGase F-II) is a novel PNGase. Significance: Characterization of PNGase F-II may provide an alternative tool for glycobiology. Peptide:N-glycosidase (PNGase) F, the first PNGase identified in prokaryotic cells, catalyzes the removal of intact asparagine-linked oligosaccharide chains from glycoproteins and/or glycopeptides. Since its discovery in 1984, PNGase F has remained as the sole prokaryotic PNGase. Recently, a novel gene encoding a protein with a predicted PNGase domain was identified from a clinical isolate of Elizabethkingia meningoseptica. In this study, the candidate protein was expressed in vitro and was subjected to biochemical and structural analyses. The results revealed that it possesses PNGase activity and has substrate specificity different from that of PNGase F. The crystal structure of the protein was determined at 1.9 resolution. Structural comparison with PNGase F revealed a relatively larger glycan-binding groove in the catalytic domain and an additional bowl-like domain with unknown function at the N terminus of the candidate protein. These structural and functional analyses indicated that the candidate protein is a novel prokaryotic N-glycosidase. The protein has been named PNGase F-II.	[Sun, Guiqin; Bao, Celimuge; Wang, Lei; Li, Meng; Qu, Di; Chen, Li] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Educ & Hlth, Shanghai 200032, Peoples R China; [Yu, Xiang; Ma, Jinbiao] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai 200438, Peoples R China; [Gan, Jianhua] Fudan Univ, Sch Life Sci, Dept Physiol & Biophys, Shanghai 200433, Peoples R China; [Sun, Guiqin] Zhejiang Chinese Med Univ, Hangzhou 310053, Zhejiang, Peoples R China	Fudan University; Fudan University; Fudan University; Zhejiang Chinese Medical University	Ma, JB (corresponding author), Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai 200438, Peoples R China.	majb@fudan.edu.cn; lichen_bk@fudan.edu.cn		Chen, Li/0000-0002-7006-4443	Fudan University [EZF101507]; Ministry of Science and Technology of China [2012CB910502, 2011CB966304]; National Science and Technology Major Project of China [2012ZX10003008-010]	Fudan University; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science and Technology Major Project of China	This work was supported in part by Fudan University Grant EZF101507. A part of this work was performed under the National Science and Technology Major Project of China (2012ZX10003008-010). This work was also supported in part by Ministry of Science and Technology of China Grants 2012CB910502 and 2011CB966304.	Allen MD, 2006, J BIOL CHEM, V281, P25502, DOI 10.1074/jbc.M601173200; ALTMANN F, 1995, GLYCOCONJUGATE J, V12, P84, DOI 10.1007/BF00731873; Berger S, 1995, BIOCHIMIE, V77, P751, DOI 10.1016/0300-9084(96)88193-4; Cai Y, 2013, ANALYST, V138, P6270, DOI 10.1039/c3an01228j; Chantret I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011734; Chiba Y, 1998, J BIOL CHEM, V273, P26298, DOI 10.1074/jbc.273.41.26298; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan JQ, 1997, J BIOL CHEM, V272, P27058, DOI 10.1074/jbc.272.43.27058; KITAJIMA K, 1995, ARCH BIOCHEM BIOPHYS, V319, P393, DOI 10.1006/abbi.1995.1309; KUHN P, 1994, BIOCHEMISTRY-US, V33, P11699, DOI 10.1021/bi00205a005; KUHN P, 1995, J BIOL CHEM, V270, P29493, DOI 10.1074/jbc.270.49.29493; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NORRIS GE, 1994, STRUCTURE, V2, P1049, DOI 10.1016/S0969-2126(94)00108-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PLUMMER T H JR, 1991, Glycobiology, V1, P257, DOI 10.1093/glycob/1.3.257; PLUMMER TH, 1987, EUR J BIOCHEM, V163, P167, DOI 10.1111/j.1432-1033.1987.tb10751.x; PLUMMER TH, 1984, J BIOL CHEM, V259, P700; SEKO A, 1991, J BIOL CHEM, V266, P22110; SUGIYAMA K, 1983, BIOCHEM BIOPH RES CO, V112, P155, DOI 10.1016/0006-291X(83)91810-7; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V304, P326, DOI 10.1016/S0006-291X(03)00600-4; SUZUKI T, 1993, BIOCHEM BIOPH RES CO, V194, P1124, DOI 10.1006/bbrc.1993.1938; Suzuki T, 2007, SEMIN CELL DEV BIOL, V18, P762, DOI 10.1016/j.semcdb.2007.09.010; TAKAHASHI N, 1977, BIOCHEM BIOPH RES CO, V76, P1194, DOI 10.1016/0006-291X(77)90982-2; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; VANHOEK AN, 1995, BIOCHEMISTRY-US, V34, P2212, DOI 10.1021/bi00007a015; Yang BY, 1996, CARBOHYD RES, V287, P203, DOI 10.1016/0008-6215(96)00073-0; Zhang W, 2011, ANAL CHEM, V83, P4975, DOI 10.1021/ac200753e; Zhao G, 2006, J BIOL CHEM, V281, P13751, DOI 10.1074/jbc.M600137200; Zhou XK, 2006, P NATL ACAD SCI USA, V103, P17214, DOI 10.1073/pnas.0602954103	31	21	23	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7452	7462		10.1074/jbc.M114.605493	http://dx.doi.org/10.1074/jbc.M114.605493			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25614628	Green Published, hybrid			2022-12-26	WOS:000351613600014
J	Genetet, S; Ripoche, P; Le Van Kim, C; Colin, Y; Lopez, C				Genetet, Sandrine; Ripoche, Pierre; Le Van Kim, Caroline; Colin, Yves; Lopez, Claude			Evidence of a Structural and Functional Ammonium Transporter RhBG center dot Anion Exchanger 1 center dot Ankyrin-G Complex in Kidney Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN-G; CYTOPLASMIC DOMAIN; CARDIAC-ARRHYTHMIA; CRYSTAL-STRUCTURE; MEMBRANE BILAYER; SODIUM-CHANNEL; IN-SITU; BINDING; BAND-3; IDENTIFICATION	The renal ammonium transporter RhBG and anion exchanger 1 kAE1 colocalize in the basolateral domain of a-intercalated cells in the distal nephron. Although we have previously shown that RhBG is linked to the spectrin-based skeleton through ankyrin-G and that its NH3 transport activity is dependent on this association, there is no evidence for an interaction of kAE1 with this adaptor protein. We report here that the kAE1 cytoplasmic N terminus actually binds to ankyrin-G, both in yeast two-hybrid analysis and by coimmunoprecipitation in situ in HEK293 cells expressing recombinant kAE1. A site-directed mutagenesis study allowed the identification of three dispersed regions on kAE1 molecule linking the third and fourth repeat domains of ankyrin-G. One secondary docking site corresponds to a major interacting loop of the erythroid anion exchanger 1 (eAE1) with ankyrin-R, whereas the main binding region of kAE1 does not encompass any eAE1 determinant. Stopped flow spectrofluorometry analysis of recombinant HEK293 cells revealed that the Cl-/HCO3- exchange activity of a kAE1 protein mutated on the ankyrin-G binding site was abolished. This disruption impaired plasma membrane expression of kAE1 leading to total retention on cytoplasmic structures in polarized epithelial Madin-Darby canine kidney cell transfectants. kAE1 also directly interacts with RhBG without affecting its surface expression and NH3 transport function. This is the first description of a structural and functional RhBGIAEl center dot ankyrin-G complex at the plasma membrane of kidney epithelial cells, comparable with the well known Rh center dot eAE1.ankyrin-R complex in the red blood cell membrane. This renal complex could participate in the regulation of acid-base homeostasis.	[Genetet, Sandrine; Ripoche, Pierre; Le Van Kim, Caroline; Colin, Yves; Lopez, Claude] INSERM, U1134, F-75739 Paris, France; [Genetet, Sandrine; Ripoche, Pierre; Le Van Kim, Caroline; Colin, Yves; Lopez, Claude] Univ Paris Diderot, Sorbonne Paris Cite, UMR S1134, F-75739 Paris, France; [Genetet, Sandrine; Ripoche, Pierre; Le Van Kim, Caroline; Colin, Yves; Lopez, Claude] Inst Natl Transfus Sanguine, F-75739 Paris, France; [Genetet, Sandrine; Ripoche, Pierre; Le Van Kim, Caroline; Colin, Yves; Lopez, Claude] Lab Excellence GR Ex, F-75238 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Lopez, C (corresponding author), INSERM, INTS, UMR S1134, 6 Rue Alexandre Cabanel, F-75015 Paris, France.	claude.lopez@inserm.fr	colin, yves/O-1910-2017; le van kim, caroline/O-7030-2017	colin, yves/0000-0001-5196-4254; GENETET, Sandrine/0000-0001-8497-0087; le van kim, caroline/0000-0002-3251-1310	INSERM [U1134]; Institut National de la Transfusion Sanguine; Laboratory of Excellence GR-Ex Grant [ANR-11-LABX-0051]; program Investissements d'Avenir of the French National Research Agency [ANR-11-IDEX-0005-02]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut National de la Transfusion Sanguine; Laboratory of Excellence GR-Ex Grant; program Investissements d'Avenir of the French National Research Agency(French National Research Agency (ANR))	This work was supported by institutional funding to the INSERM U1134 and Institut National de la Transfusion Sanguine. This study was supported by Laboratory of Excellence GR-Ex Grant ANR-11-LABX-0051. The labex GR-Ex is funded by the program Investissements d'Avenir of the French National Research Agency through Grant ANR-11-IDEX-0005-02.	Alper SL, 2009, J EXP BIOL, V212, P1672, DOI 10.1242/jeb.029454; ALPER SL, 1989, P NATL ACAD SCI USA, V86, P5429, DOI 10.1073/pnas.86.14.5429; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; BROSIUS FC, 1989, J BIOL CHEM, V264, P7784; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Bustos SP, 2011, BIOCHEM J, V433, P313, DOI 10.1042/BJ20101375; Chang SH, 2003, J BIOL CHEM, V278, P6879, DOI 10.1074/jbc.M211137200; Chung HJ, 2006, P NATL ACAD SCI USA, V103, P8870, DOI 10.1073/pnas.0603376103; Cordat E, 2006, TRAFFIC, V7, P117, DOI 10.1111/j.1600-0854.2005.00366.x; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; DING Y, 1994, J BIOL CHEM, V269, P32201; Frumence E, 2013, AM J PHYSIOL-CELL PH, V305, pC654, DOI 10.1152/ajpcell.00142.2013; Grey JL, 2012, BIOCHEMISTRY-US, V51, P6838, DOI 10.1021/bi300693k; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kim S, 2011, J BIOL CHEM, V286, P20746, DOI 10.1074/jbc.M111.230326; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Koos B, 2014, CURR TOP MICROBIOL, V377, P111, DOI 10.1007/82_2013_334; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI B, 1993, FASEB J, V7, P957, DOI 10.1096/fasebj.7.10.8344494; Li JD, 2010, J BIOL CHEM, V285, P28723, DOI 10.1074/jbc.M110.147868; Liu Z, 2001, J BIOL CHEM, V276, P1424, DOI 10.1074/jbc.M007528200; Lopez C, 2005, J BIOL CHEM, V280, P8221, DOI 10.1074/jbc.M413351200; MICHAELY P, 1995, J BIOL CHEM, V270, P22050, DOI 10.1074/jbc.270.37.22050; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Mohler PJ, 2002, J CELL SCI, V115, P1565; Nicolas V, 2003, J BIOL CHEM, V278, P25526, DOI 10.1074/jbc.M302816200; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Pang AJ, 2008, BIOCHEMISTRY-US, V47, P4510, DOI 10.1021/bi702149b; Quentin F, 2003, J AM SOC NEPHROL, V14, P545, DOI 10.1097/01.ASN.0000050413.43662.55; Rasmussen HB, 2007, J CELL SCI, V120, P953, DOI 10.1242/jcs.03396; Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101; Shirahata E, 2006, J NEUROPHYSIOL, V96, P1347, DOI 10.1152/jn.01264.2005; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sohet F, 2008, J BIOL CHEM, V283, P26557, DOI 10.1074/jbc.M803120200; SRINIVASAN Y, 1992, J BIOL CHEM, V267, P7483; Su Y, 2015, J AM SOC NEPHROL, V26, P400, DOI 10.1681/ASN.2013101063; Thevananther S, 1998, J BIOL CHEM, V273, P23952, DOI 10.1074/jbc.273.37.23952; Toye AM, 2004, J CELL SCI, V117, P1399, DOI 10.1242/jcs.00974; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; WANG CC, 1995, J BIOL CHEM, V270, P17892, DOI 10.1074/jbc.270.30.17892; Williamson RC, 2008, J CELL SCI, V121, P3422, DOI 10.1242/jcs.035584; Zhang DC, 2000, BLOOD, V96, P2925; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295; Zidi-Yahiaoui N, 2005, BIOCHEM J, V391, P33, DOI 10.1042/BJ20050657	51	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6925	6936		10.1074/jbc.M114.610048	http://dx.doi.org/10.1074/jbc.M114.610048			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25616663	Green Published, hybrid			2022-12-26	WOS:000350991500027
J	Rosenberg, J; Dickmanns, A; Neumann, P; Gunka, K; Arens, J; Kaever, V; Stulke, J; Ficner, R; Commichau, FM				Rosenberg, Jonathan; Dickmanns, Achim; Neumann, Piotr; Gunka, Katrin; Arens, Johannes; Kaever, Volkhard; Stuelke, Joerg; Ficner, Ralf; Commichau, Fabian M.			Structural and Biochemical Analysis of the Essential Diadenylate Cyclase CdaA from Listeria monocytogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-DI-AMP; PROTEIN HOMOLOGY DETECTION; BACILLUS-SUBTILIS; CHECKPOINT PROTEIN; DNA INTEGRITY; IDENTIFICATION; GMP; BACTERIA; CAMP; ANTIBIOTICS	The recently identified second messenger cyclic di-AMP (c-di-AMP) is involved in several important cellular processes, such as cell wall metabolism, maintenance of DNA integrity, ion transport, transcription regulation, and allosteric regulation of enzyme function. Interestingly, c-di-AMP is essential for growth of the Gram-positive model bacterium Bacillus subtilis. Although the genome of B. subtilis encodes three c-di-AMPproducing diadenlyate cyclases that can functionally replace each other, the phylogenetically related human pathogens like Listeria nionocytogenes and Staphylococcus aureus possess only one enzyme, the diadenlyate cydase CdaA. Because CdaA is also essential for growth of these bacteria, the enzyme is a promising target for the development of novel antibiotics. Here we present the first crystal structure of the L. monocytogenes CdaA diadenylate cydase domain that is conserved in many human pathogens. Moreover, biochemical characterization of the cyclase revealed an unusual metal cofactor requirement.	[Rosenberg, Jonathan; Gunka, Katrin; Stuelke, Joerg; Commichau, Fabian M.] Univ Gottingen, Inst Microbiol & Genet, Dept Gen Microbiol, D-37077 Gottingen, Germany; [Dickmanns, Achim; Neumann, Piotr; Arens, Johannes; Ficner, Ralf] Univ Gottingen, Inst Microbiol & Genet, Dept Mol Struct Biol, D-37077 Gottingen, Germany; [Kaever, Volkhard] Hannover Med Sch, Res Core Unit Metabol, D-30625 Hannover, Germany	University of Gottingen; University of Gottingen; Hannover Medical School	Commichau, FM (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Gen Microbiol, D-37077 Gottingen, Germany.	fcommic1@gwdg.de	Stülke, Jörg/AAD-1600-2021; Kaever, Volkhard/G-3280-2013; Commichau, Fabian/A-9664-2018	Stulke, Jorg/0000-0001-5881-5390; Commichau, Fabian/0000-0003-0323-7479	Deutsche Forschungsgemeinschaft (DFG) [SFB 860]; DFG [CO 1139/1-1]; Fonds der Chemischen Industrie; Max-Buchner-Forschungsstiftung [MBFSt-Kennziffer 3381]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Max-Buchner-Forschungsstiftung	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant SFB 860 (to R. F. and J. S.) and by grants of the DFG (CO 1139/1-1), the Fonds der Chemischen Industrie, and the Max-Buchner-Forschungsstiftung (MBFSt-Kennziffer 3381) (to F. M. C.).	Abel S, 2011, MOL CELL, V43, P550, DOI 10.1016/j.molcel.2011.07.018; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agranoff DD, 1998, MOL MICROBIOL, V28, P403, DOI 10.1046/j.1365-2958.1998.00790.x; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; Bai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035206; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bassetti M, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-22; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Bi WL, 1997, NUCLEIC ACIDS RES, V25, P2949, DOI 10.1093/nar/25.14.2949; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Bumann D, 2008, CURR OPIN MICROBIOL, V11, P387, DOI 10.1016/j.mib.2008.08.002; Campos SS, 2014, J BACTERIOL, V196, P568, DOI 10.1128/JB.01259-13; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; de Alda JAGO, 2000, J BACTERIOL, V182, P3839, DOI 10.1128/JB.182.13.3839-3842.2000; Dengler V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073512; Diep BA, 2008, ANN INTERN MED, V148, P249, DOI 10.7326/0003-4819-148-4-200802190-00204; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gancedo JM, 2013, BIOL REV, V88, P645, DOI 10.1111/brv.12020; Gao A, 2014, NAT CHEM BIOL, V10, P787, DOI [10.1038/NCHEMBIO.1607, 10.1038/nchembio.1607]; Gomelsky M, 2011, MOL MICROBIOL, V79, P562, DOI 10.1111/j.1365-2958.2010.07514.x; Gundlach J, 2015, J BIOL CHEM, V290, P3069, DOI 10.1074/jbc.M114.619619; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1976, J MOL BIOL, V100, P283, DOI 10.1016/S0022-2836(76)80064-2; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Manikandan K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086096; Mehne FMP, 2014, J BIOL CHEM, V289, P21098, DOI 10.1074/jbc.M114.562066; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Merzbacher M, 2004, EUR J BIOCHEM, V271, P367, DOI 10.1046/j.1432-1033.2003.03935.x; Monk IR, 2008, APPL ENVIRON MICROB, V74, P3921, DOI 10.1128/AEM.00314-08; Nelson JW, 2013, NAT CHEM BIOL, V9, P834, DOI [10.1038/NCHEMBIO.1363, 10.1038/nchembio.1363]; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Sambrook J., 2001, MOL CLONING LAB MANU; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Song JH, 2005, MOL CELLS, V19, P365; Spangler C, 2010, J MICROBIOL METH, V81, P226, DOI 10.1016/j.mimet.2010.03.020; Sureka K, 2014, CELL, V158, P1389, DOI 10.1016/j.cell.2014.07.046; Tschowri N, 2014, CELL, V158, P1136, DOI 10.1016/j.cell.2014.07.022; Underwood AJ, 2014, J MICROBIOL METH, V107, P58, DOI 10.1016/j.mimet.2014.08.026; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Zhang L, 2013, J BIOL CHEM, V288, P3085, DOI 10.1074/jbc.M112.428110; Zheng C, 2013, ENZYME MICROB TECH, V52, P319, DOI 10.1016/j.enzmictec.2013.03.007; Zheng Y, 2014, CHEM COMMUN, V50, P11234, DOI 10.1039/c4cc02916j; Zhou J, 2014, ANAL CHEM, V86, P2412, DOI 10.1021/ac403203x	70	44	48	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6596	6606		10.1074/jbc.M114.630418	http://dx.doi.org/10.1074/jbc.M114.630418			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605729	hybrid, Green Published			2022-12-26	WOS:000350732500061
J	Pandey, VG; Jain, S; Rana, A; Puri, N; Arudra, KC; Mopidevi, B; Kaw, M; Nasjletti, A; Kumar, A				Pandey, Varunkumar G.; Jain, Sudhir; Rana, Anita; Puri, Nitin; Arudra, Krishna C.; Mopidevi, Brahmaraju; Kaw, Meenakshi; Nasjletti, Alberto; Kumar, Ashok			Dexamethasone Promotes Hypertension by Allele-specific Regulation of the Human Angiotensinogen Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-PRESSURE; TRANSGENIC MICE; C/EBP BETA; POLYMORPHISMS; RENIN; TRANSCRIPTION; HERITABILITY; PREECLAMPSIA; INDUCTION; SECRETION	The human angiotensinogen (hAGT) gene has polymorphisms in its 2.5-kb promoter that form two haplotype (Hap) blocks: -6A/G (-1670A/G, -1562C/T, and -1561T/C) and -217A/G (-532T/C, -793A/G, -1074T/C, and -1178G/A). Hap -6A/-217A is associated with human hypertension, whereas Hap -6G/-217G reduces cardiovascular risk. Hap -6A/-217A has increased promoter activity with enhanced transcription factor binding, including to the glucocorticoid receptor (GR). Glucocorticoid therapy frequently causes hypertension, the mechanisms for which are incompletely understood. We have engineered double transgenic (TG) mice containing the human renin gene with either Hap of the hAGT gene and examined the physiological significance of glucocorticoid-mediated allele-specific regulation of the hAGT gene. We have also studied the consequential effects on the renin angiotensin system and blood pressure. TG mice with Hap -6A and -6G were treated with and without a low dose of a GR agonist, dexamethasone (2.5 mu g/ml), for 72 h. We found greater chromatin-GR binding with increased GR agonist-induced hAGT expression in liver and renal tissues of Hap -6A mice. Additionally, dexamethasone treatment increased circulating hAGT and angiotensin II levels in Hap -6A mice, as compared with -6G mice. Importantly, GR agonist significantly increased blood pressure and redox markers in TG mice with Hap-6A of the hAGT gene. Taken together, our results show, for the first time, that glucocorticoids affect hAGT expression in a haplotype-dependent fashion with SNPs in Hap -6A favoring agonist-induced GR binding. This leads to increased expression of the hAGT, up-regulation of the renin angiotensin system, and increased blood pressure and oxidative stress in Hap -6A mice.	[Pandey, Varunkumar G.; Jain, Sudhir; Rana, Anita; Puri, Nitin; Mopidevi, Brahmaraju; Kaw, Meenakshi; Nasjletti, Alberto; Kumar, Ashok] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Arudra, Krishna C.] Univ Toledo, Coll Med, Dept Pathol, Toledo, OH 43614 USA; [Pandey, Varunkumar G.] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA	University of Toledo; University of Toledo; New York Medical College	Kumar, A (corresponding author), Univ Toledo, Dept Physiol & Pharmacol, Rm 351,3000 Arlington Ave,MS 1008,Hlth Sci Campus, Toledo, OH 43614 USA.	ashok.kumar2@utoledo.edu	Mopidevi, Brahmaraju/D-6003-2015	Mopidevi, Brahmaraju/0000-0003-1231-7796	National Institutes of Health [HL81752, HL105113, HL092558]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081752, R01HL105113, R01HL092558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL81752, HL105113, and HL092558 (to A. K.).	Aubert J, 1997, BIOCHEM J, V328, P701, DOI 10.1042/bj3280701; BAUMANN H, 1992, J BIOL CHEM, V267, P19744; CLOUSTON WM, 1989, EMBO J, V8, P3337, DOI 10.1002/j.1460-2075.1989.tb08495.x; Gotoh T, 1997, J BIOL CHEM, V272, P3694, DOI 10.1074/jbc.272.6.3694; GOULD AB, 1971, CARDIOVASC RES, V5, P86, DOI 10.1093/cvr/5.1.86; GRIENDLING KK, 1993, CIRCULATION, V87, P1816, DOI 10.1161/01.CIR.87.6.1816; HACKENTHAL E, 1993, J STEROID BIOCHEM, V45, P33, DOI 10.1016/0960-0760(93)90119-H; Hottenga JJ, 2005, TWIN RES HUM GENET, V8, P499, DOI 10.1375/183242705774310123; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; Jain S, 2005, J MOL MED, V83, P121, DOI 10.1007/s00109-004-0621-5; Jain S, 2010, J BIOL CHEM, V285, P41172, DOI 10.1074/jbc.M110.167585; Jain S, 2008, AM J PHYSIOL-REG I, V295, pR1849, DOI 10.1152/ajpregu.90637.2008; Jenkins LD, 2008, REPROD SCI, V15, P696, DOI 10.1177/1933719108316984; Kim HS, 2002, P NATL ACAD SCI USA, V99, P4602, DOI 10.1073/pnas.072083799; KLETT C, 1992, ENDOCRINOLOGY, V130, P3660, DOI 10.1210/en.130.6.3660; Kupper N, 2005, HYPERTENSION, V45, P80, DOI 10.1161/01.HYP.0000149952.84391.54; MANTERO F, 1992, J STEROID BIOCHEM, V43, P409, DOI 10.1016/0960-0760(92)90077-V; Markovic D, 2005, HUM HERED, V60, P89, DOI 10.1159/000088657; Masuzaki H, 2003, J CLIN INVEST, V112, P83, DOI 10.1172/JCI17845; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Matsuno F, 1996, J BIOCHEM-TOKYO, V119, P524; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; MATTSON DL, 1991, AM J PHYSIOL, V260, pR1200, DOI 10.1152/ajpregu.1991.260.6.R1200; Moritz KM, 2002, ENDOCRINOLOGY, V143, P4455, DOI 10.1210/en.2002-220534; Sachse A, 2007, J AM SOC NEPHROL, V18, P2439, DOI 10.1681/ASN.2007020149; Suh DS, 1997, MOL ENDOCRINOL, V11, P1822, DOI 10.1210/me.11.12.1822; WARD K, 1993, NAT GENET, V4, P59, DOI 10.1038/ng0593-59; Watkins WS, 2010, J HYPERTENS, V28, P65, DOI 10.1097/HJH.0b013e328332031a	28	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5749	5758		10.1074/jbc.M114.601922	http://dx.doi.org/10.1074/jbc.M114.601922			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568318	hybrid, Green Published			2022-12-26	WOS:000350044200042
J	Yuan, SF; Wu, TH; Lee, HL; Hsieh, HY; Lin, WL; Yang, B; Chang, CK; Li, Q; Gao, J; Huang, CH; Ho, MC; Guo, RT; Liang, PH				Yuan, Shuo-Fu; Wu, Tzu-Hui; Lee, Hsiao-Lin; Hsieh, Han-Yu; Lin, Wen-Ling; Yang, Barbara; Chang, Chih-Kang; Li, Qian; Gao, Jian; Huang, Chun-Hsiang; Ho, Meng-Chiao; Guo, Rey-Ting; Liang, Po-Huang			Biochemical Characterization and Structural Analysis of a Bifunctional Cellulase/Xylanase from Clostridium thermocellum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROLASE FAMILY 5; SUBSTRATE-SPECIFICITY; THERMOTOGA-MARITIMA; CRYSTAL-STRUCTURE; GLYCOSYL HYDROLASES; ENDOGLUCANASE; COMPLEX; POLYSACCHARIDES; CLASSIFICATION; CELLOTETRAOSE	We expressed an active form of CtCel5E (a bifunctional cellulase/xylanase from Clostridium thermocellum), performed biochemical characterization, and determined its apo- and ligand-bound crystal structures. From the structures, Asn-93, His-168, His-169, Asn-208, Trp-347, and Asn-349 were shown to provide hydrogen-bonding/hydrophobic interactions with both ligands. Compared with the structures of TmCel5A, a bifunctional cellulase/mannanase homolog from Thermotoga maritima, a flexible loop region in CtCel5E is the key for discriminating substrates. Moreover, site-directed mutagenesis data confirmed that His-168 is essential for xylanase activity, and His-169 is more important for xylanase activity, whereas Asn-93, Asn-208, Tyr-270, Trp-347, and Asn-349 are critical for both activities. In contrast, F267A improves enzyme activities.	[Lee, Hsiao-Lin; Lin, Wen-Ling; Chang, Chih-Kang; Ho, Meng-Chiao; Liang, Po-Huang] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Yuan, Shuo-Fu; Hsieh, Han-Yu; Yang, Barbara; Ho, Meng-Chiao; Liang, Po-Huang] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan; [Wu, Tzu-Hui] Natl Taiwan Univ, Inst Biotechnol, Taipei 10617, Taiwan; [Li, Qian; Gao, Jian; Huang, Chun-Hsiang; Guo, Rey-Ting] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Ind Enzymes Natl Engn Lab, Tianjin 300308, Peoples R China	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Ho, MC (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan.	joeho@gate.sinica.edu.tw; guo_rt@tib.cas.cn; phliang@gate.sinica.edu.tw	Liang, Po-Huang/H-6610-2015; Ho, Meng-Chiao/H-2448-2015	Liang, Po-Huang/0000-0003-1207-5256; Ho, Meng-Chiao/0000-0002-5424-4524; Guo, Rey-Ting/0000-0003-2942-7246; Wu, Tzu-Hui/0000-0001-6926-5814; LEE, Hsiao-Lin/0000-0002-4828-3383; Yuan, Shuo-Fu/0000-0002-5530-8702	National Science Council, Taiwan [101-3113-P-008-001]; National Core Facility Program for Biotechnology, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Core Facility Program for Biotechnology, Taiwan	This work was supported by National Science Council, Taiwan, Grant 101-3113-P-008-001. Portions of this research were carried out at the National Synchrotron Radiation Research Center, a national user facility supported by the National Science Council of Taiwan. The Synchrotron Radiation Protein Crystallography Facility is supported by the National Core Facility Program for Biotechnology, Taiwan.	Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; Chang JJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-53; Chhabra SR, 2002, APPL ENVIRON MICROB, V68, P545, DOI 10.1128/AEM.68.2.545-554.2002; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DUCROS V, 1995, STRUCTURE, V3, P939, DOI 10.1016/S0969-2126(01)00228-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GILKES NR, 1991, EUR J BIOCHEM, V202, P367, DOI 10.1111/j.1432-1033.1991.tb16384.x; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hilge M, 1998, STRUCTURE, V6, P1433, DOI 10.1016/S0969-2126(98)00142-7; Karita S, 1996, J FERMENT BIOENG, V81, P553, DOI 10.1016/0922-338X(96)81479-6; Lee HL, 2012, PROTEIN ENG DES SEL, V25, P733, DOI 10.1093/protein/gzs073; Lee HL, 2011, BIORESOURCE TECHNOL, V102, P3973, DOI 10.1016/j.biortech.2010.11.114; Lo Leggio L, 2002, FEBS LETT, V523, P103, DOI 10.1016/S0014-5793(02)02954-X; Lynd LR, 1999, BIOTECHNOL PROGR, V15, P777, DOI 10.1021/bp990109e; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Notenboom V, 1998, BIOCHEMISTRY-US, V37, P4751, DOI 10.1021/bi9729211; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pereira JH, 2010, J STRUCT BIOL, V172, P372, DOI 10.1016/j.jsb.2010.06.018; Sakon J, 1996, BIOCHEMISTRY-US, V35, P10648, DOI 10.1021/bi9604439; Schagerlof U, 2007, BIOMACROMOLECULES, V8, P2358, DOI 10.1021/bm0701200; Taylor EJ, 2005, J BIOL CHEM, V280, P32761, DOI 10.1074/jbc.M506580200; Vlasenko E, 2010, BIORESOURCE TECHNOL, V101, P2405, DOI 10.1016/j.biortech.2009.11.057; Wang HM, 2009, BIOTECHNOL PROGR, V25, P1582, DOI 10.1002/btpr.274; Wu TH, 2011, BBA-PROTEINS PROTEOM, V1814, P1832, DOI 10.1016/j.bbapap.2011.07.020; YAGUE E, 1990, GENE, V89, P61, DOI 10.1016/0378-1119(90)90206-7; Zhang YHP, 2006, BIOMACROMOLECULES, V7, P644, DOI 10.1021/bm050799c; Zhang ZQ, 2007, ANAL BIOCHEM, V371, P118, DOI 10.1016/j.ab.2007.07.003	31	47	48	1	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5739	5748		10.1074/jbc.M114.604454	http://dx.doi.org/10.1074/jbc.M114.604454			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25575592	Green Published, hybrid			2022-12-26	WOS:000350044200041
J	Fedele, C; Singh, A; Zerlanko, BJ; Iozzo, RV; Languino, LR				Fedele, Carmine; Singh, Amrita; Zerlanko, Brad J.; Iozzo, Renato V.; Languino, Lucia R.			The alpha(v)beta(6) Integrin Is Transferred Intercellularly via Exosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-V-BETA-6 INTEGRIN; CANCER-CELLS; IN-VIVO; PROSTATE; PROMOTES; MICROVESICLES; IDENTIFICATION; PROLIFERATION; METASTASIS; SECRETION	Exosomes, cell-derived vesicles of endosomal origin, are continuously released in the extracellular environment and play a key role in intercellular crosstalk. In this study, we have investigated whether transfer of integrins through exosomes between prostate cancer (PrCa) cells occurs and whether transferred integrins promote cell adhesion and migration. Among others, we have focused on the alpha(v)beta(6) integrin, which is not detectable in normal human prostate but is highly expressed in human primary PrCa as well as murine PrCa in Pten(pc-/-) mice. After confirming the fidelity of the exosome preparations by electron microscopy, density gradient, and immunoblotting, we determined that the alpha(v)beta(6) integrin is actively packaged into exosomes isolated from PC3 and RWPE PrCa cell lines. We also demonstrate that alpha(v)beta(6) is efficiently transferred via exosomes from a donor cell to an alpha(v)beta(6)-negative recipient cell and localizes to the cell surface. De novo alpha(v)beta(6) expression in an alpha(v)beta(6)-negative recipient cell is not a result of a change in mRNA levels but is a consequence of exosome-mediated transfer of this integrin between different PrCa cells. Recipient cells incubated with exosomes containing alpha(v)beta(6) migrate on an alpha(v)beta(6) specific substrate, latency-associated peptide-TGF beta, to a greater extent than cells treated with exosomes in which alpha(v)beta(6) is stably or transiently down-regulated by shRNA or siRNA, respectively. Overall, this study shows that exosomes from PrCa cells may contribute to a horizontal propagation of integrin-associated phenotypes, which would promote cell migration, and consequently, metastasis in a paracrine fashion.	[Fedele, Carmine; Singh, Amrita; Zerlanko, Brad J.; Languino, Lucia R.] Thomas Jefferson Univ, Prostate Canc Discovery & Dev Program, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Fedele, Carmine; Singh, Amrita; Zerlanko, Brad J.; Iozzo, Renato V.; Languino, Lucia R.] Thomas Jefferson Univ, Dept Canc Biol, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University	Languino, LR (corresponding author), 233 S 10th St,BLSB 506, Philadelphia, PA 19107 USA.	Lucia.Languino@jefferson.edu	Iozzo, Renato/AAS-1980-2020; Singh, Amrita/J-3106-2019	Languino, Lucia/0000-0001-9011-7031; Singh, Amrita/0000-0001-8023-0807	NCI, National Institutes of Health [P30CA056036]; NATIONAL CANCER INSTITUTE [R01CA089720, R56CA089720, P30CA056036, R01CA109874, P01CA140043] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Bodil Tuma for assistance in the transmission electron microscopy analysis; and A. Sayeed, H. Lu, T. De Angelis, L. Riddell, A. N. Duffy, and R. M. De Rita (from the Languino laboratory); Jeffrey L. Benovic; K. Komolov, and X. Tifan (from the J. L. Benovic laboratory); M. J. Root; and C. Wirblich (from the M. J. Schnell laboratory) for constructive suggestions. Also, we are thankful to Y. Covarrubias and J. H. Keen for constructive suggestions and technical support in bioimaging experiments. The Sidney Kimmel Cancer Center Bioimaging and Flow Cytometry Facilities were supported by the NCI, National Institutes of Health, under Award P30CA056036. We also thank S. Violette and P. Weinreb for providing antibodies to alpha<INF>v</INF>beta<INF>6</INF>.	Agrez M, 1999, INT J CANCER, V81, P90, DOI 10.1002/(SICI)1097-0215(19990331)81:1<90::AID-IJC16>3.0.CO;2-K; AGREZ M, 1994, J CELL BIOL, V127, P547, DOI 10.1083/jcb.127.2.547; Atay S, 2014, P NATL ACAD SCI USA, V111, P711, DOI 10.1073/pnas.1310501111; Azare J, 2007, MOL CELL BIOL, V27, P4444, DOI 10.1128/MCB.02404-06; Bijnsdorp Irene V, 2013, J Extracell Vesicles, V2, DOI 10.3402/jev.v2i0.22097; Brocks D, 2014, CELL REP, V8, P798, DOI 10.1016/j.celrep.2014.06.053; Chen X, 2011, J LEUKOCYTE BIOL, V90, P751, DOI 10.1189/jlb.1210696; Clayton A, 2004, FASEB J, V18, P977, DOI 10.1096/fj.03-1094fje; Deng XY, 2014, CANCER TREAT REV, V40, P730, DOI 10.1016/j.ctrv.2014.04.003; Dixit RB, 1996, J BIOL CHEM, V271, P25976, DOI 10.1074/jbc.271.42.25976; Dutta A, 2014, CANCER RES, V74, P1598, DOI 10.1158/0008-5472.CAN-13-1796; Garlick DS, 2012, AM J TRANSL RES, V4, P165; Gerlinger M, 2015, EUR UROL, V67, P729, DOI 10.1016/j.eururo.2014.04.014; Goel HL, 2008, ENDOCR-RELAT CANCER, V15, P657, DOI 10.1677/ERC-08-0019; Hecht JL, 2008, APPL IMMUNOHISTO M M, V16, P543, DOI 10.1097/PAI.0b013e31816bc5ee; Hosseini-Beheshti E, 2012, MOL CELL PROTEOMICS, V11, P863, DOI 10.1074/mcp.M111.014845; Kahlert C, 2014, J BIOL CHEM, V289, P3869, DOI 10.1074/jbc.C113.532267; Lee HD, 2014, EUR J IMMUNOL, V44, P1156, DOI 10.1002/eji.201343660; Li XW, 2003, J BIOL CHEM, V278, P41646, DOI 10.1074/jbc.M306274200; Martin SK, 2012, ONCOL REP, V28, P409, DOI 10.3892/or.2012.1832; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Ports MO, 2009, CANCER RES, V69, P5007, DOI 10.1158/0008-5472.CAN-09-0354; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Sandvig K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012914; Sayeed A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076513; Sheppard D, 2000, MATRIX BIOL, V19, P203, DOI 10.1016/S0945-053X(00)00065-2; Shin SJ, 2013, P NATL ACAD SCI USA, V110, P19414, DOI 10.1073/pnas.1309720110; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sorkin A, 2010, CURR PROTOC CELL BIO, DOI [10. 1002/0471143030. cb1514s46, DOI 10.1002/0471143030.CB1514S46]; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thompson CA, 2013, J BIOL CHEM, V288, P10093, DOI 10.1074/jbc.C112.444562; Trerotola M, 2013, CANCER RES, V73, P3155, DOI 10.1158/0008-5472.CAN-12-3266; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Aarsen LAK, 2008, CANCER RES, V68, P561, DOI 10.1158/0008-5472.CAN-07-2307; Weinreb PH, 2004, J BIOL CHEM, V279, P17875, DOI 10.1074/jbc.M312103200; Wu XY, 2013, ENDOCR-RELAT CANCER, V20, pR155, DOI 10.1530/ERC-12-0285; Yang GY, 2008, CANCER SCI, V99, P879, DOI 10.1111/j.1349-7006.2008.00762.x	42	115	117	5	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4545	4551		10.1074/jbc.C114.617662	http://dx.doi.org/10.1074/jbc.C114.617662			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25568317	Green Published, hybrid			2022-12-26	WOS:000350042000002
J	Ye, X; Zhang, L; Wang, H; Chen, Y; Zhang, WW; Zhu, RR; Fang, CP; Deng, AM; Qian, BH				Ye, Xin; Zhang, Lei; Wang, Hui; Chen, Yan; Zhang, Weiwei; Zhu, Rongrong; Fang, Chaoping; Deng, Anmei; Qian, Baohua			The Role of IL-23/Th17 Pathway in Patients with Primary Immune Thrombocytopenia	PLOS ONE			English	Article							HIGH-DOSE DEXAMETHASONE; T-CELLS; THERAPEUTIC TARGET; AUTOIMMUNE; CYTOKINE; TH17; PATHOGENESIS; EXPRESSION; DIFFERENTIATION; INTERLEUKIN-17	Background Primary immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with an unclear etiology. This study aims to investigate the role of IL-23/Th17 pathway in patients with ITP. Method The gene expressions of IL-17, IL-23 and their receptors in ITP patients and healthy controls were analyzed by quantitative real-time PCR. ELISA was used to test the IL-17 and IL-23 levels in plasma. Flow cytometry was used to detect the frequency of Th17 cells. The correlation between plasma IL-23 and IL-17 levels, Th17 cells, platelets were analyzed. The level of Th17-related cytokines was measured by ELISA following stimulation with IL-23. Subsequently, the IL-23 and IL-17 levels were measured in patients post-treatment. Results The PBMCs of ITP patients showed increased mRNA expression levels in each of the following: IL-23p19, IL-12p40, IL-23R, IL-12R beta 1, IL-17A, IL-17F, and RORC. In addition, elevated Th17 cells and plasma IL-17, IL-23 levels were also observed in these ITP patients. Furthermore, it was found that IL-23 levels in plasma are positively correlated with IL-17 levels and Th17 cells, yet negatively correlated with platelet count. Following IL-23 stimulation in vitro, IL-17 levels showed significant elevation. Furthermore, both IL-23 and IL-17 levels decreased after effective treatment. Conclusion The IL-23/Th17 pathway may be involved in the pathogenesis of ITP through enhancement of the Th17 response. Moreover, our results suggest that the IL-23/Th17 pathway is a potential therapeutic target in future attempts of ITP treatment.	[Ye, Xin; Qian, Baohua] Second Mil Med Univ, Changhai Hosp, Dept Transfus Med, Shanghai 200433, Peoples R China; [Zhang, Lei; Wang, Hui; Chen, Yan; Zhang, Weiwei; Zhu, Rongrong; Fang, Chaoping; Deng, Anmei] Second Mil Med Univ, Changhai Hosp, Dept Lab Diag, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University	Deng, AM (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Lab Diag, 168 Changhai Rd, Shanghai 200433, Peoples R China.	amdeng70@163.com; qianbh1963@163.com	Ye, Xin/ABC-6619-2020; Zhang, Lei/ABD-4003-2020	Zhang, Lei/0000-0003-3189-4118	973 Foundation [2013CB531606]; National Science Foundation of China [81273282, 81202353, 81371786, 81302579]; Shanghai Municipal Commission for Science and Technology [11JC1410902]; Changhai Hospital [CH125530300]; Grant of Nanjing District [12MA056]; Educational reform fund of SMMU; The master's fund of SMMU graduate school	973 Foundation(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission for Science and Technology; Changhai Hospital; Grant of Nanjing District; Educational reform fund of SMMU; The master's fund of SMMU graduate school	This research was supported by grants from 973 Foundation (2013CB531606), National Science Foundation of China (81273282, 81202353, 81371786, 81302579), Shanghai Municipal Commission for Science and Technology (11JC1410902), Changhai Hospital (CH125530300), Grant of Nanjing District (12MA056), The Educational reform fund of SMMU, The master's fund of SMMU graduate school. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballantine LE, 2014, PEDIATR RHEUMATOL, V12, DOI 10.1186/1546-0096-12-4; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brentano F, 2009, ANN RHEUM DIS, V68, P143, DOI 10.1136/ard.2007.082081; Rocha AMC, 2011, HAEMATOL-HEMATOL J, V96, P1560, DOI 10.3324/haematol.2011.046417; Christensen JR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-215; Coopamah MD, 2003, TRANSFUS MED REV, V17, P69, DOI 10.1053/tmrv.2003.50004; Cooper N, 2006, BRIT J HAEMATOL, V133, P364, DOI 10.1111/j.1365-2141.2006.06024.x; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Fahey AJ, 2006, J LEUKOCYTE BIOL, V80, P133, DOI 10.1189/jlb.0605296; Fransen K, 2014, INFLAMM BOWEL DIS, V20, P777, DOI 10.1097/MIB.0000000000000013; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Gomez-Almaguer D, 2013, EUR J HAEMATOL, V90, P494, DOI 10.1111/ejh.12102; Guo CS, 2007, J CLIN IMMUNOL, V27, P557, DOI 10.1007/s10875-007-9111-1; Hu Y, 2012, HUM IMMUNOL, V73, P629, DOI 10.1016/j.humimm.2012.04.015; Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Ji LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050909; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Kuhne T, 2013, PEDIATR BLOOD CANCER, V60, pS15, DOI 10.1002/pbc.24342; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li JQ, 2013, IMMUNOL LETT, V154, P42, DOI 10.1016/j.imlet.2013.08.006; Liu HY, 2013, THROMB RES, V132, P196, DOI 10.1016/j.thromres.2013.04.025; Liu XG, 2011, BLOOD, V117, P2061, DOI 10.1182/blood-2010-07-295477; Lubberts E, 2008, CYTOKINE, V41, P84, DOI 10.1016/j.cyto.2007.09.014; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McKenzie CGJ, 2013, BRIT J HAEMATOL, V163, P10, DOI 10.1111/bjh.12480; Mottaghi A, 2014, SCAND J IMMUNOL, DOI [10.1111/sji.12260, DOI 10.1111/SJI.12260]; Noack M, 2014, AUTOIMMUN REV, V13, P668, DOI 10.1016/j.autrev.2013.12.004; Pappu R, 2011, IMMUNOLOGY, V134, P8, DOI 10.1111/j.1365-2567.2011.03465.x; Paradowska-Gorycka A, 2010, SCAND J IMMUNOL, V71, P134, DOI 10.1111/j.1365-3083.2009.02361.x; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Qian C, 2013, CYTOKINE, V64, P172, DOI 10.1016/j.cyto.2013.07.005; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Roeleveld DM, 2013, BIODRUGS, V27, P439, DOI 10.1007/s40259-013-0035-4; Romagnani S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2392; Semple JW, 2012, CURR OPIN HEMATOL, V19, P357, DOI 10.1097/MOH.0b013e3283567541; Semple JW, 2010, CURR OPIN HEMATOL, V17, P590, DOI 10.1097/MOH.0b013e32833eaef3; Toussirot Eric, 2012, Inflammation & Allergy Drug Targets, V11, P159; Wang JD, 2011, PEDIATR BLOOD CANCER, V57, P636, DOI 10.1002/pbc.22984; Wang X, 2014, SCAND J IMMUNOL, DOI [10.1111/sji.12260, DOI 10.1111/SJI.12260]; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhan YX, 2014, IMMUNOL LETT, V160, P33, DOI 10.1016/j.imlet.2014.03.002; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu XJ, 2010, J CLIN IMMUNOL, V30, P253, DOI 10.1007/s10875-009-9353-1	46	22	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117704	10.1371/journal.pone.0117704	http://dx.doi.org/10.1371/journal.pone.0117704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25621490	gold, Green Published, Green Submitted			2022-12-26	WOS:000348470400026
J	Chang, KV; Hung, CY; Li, CM; Lin, YH; Wang, TG; Tsai, KS; Han, DS				Chang, Ke-Vin; Hung, Chen-Yu; Li, Chia-Ming; Lin, Yu-Hung; Wang, Tyng-Guey; Tsai, Keh-Sung; Han, Der-Sheng			Reduced Flexibility Associated with Metabolic Syndrome in Community-Dwelling Elders	PLOS ONE			English	Article							MUSCLE STRENGTH; PHYSICAL-ACTIVITY; SKELETAL-MUSCLE; AEROBIC FITNESS; OLDER-ADULTS; RISK; INFLAMMATION; WOMEN; MASS; MEN	Background The ageing process may lead to reductions in physical fitness, a known risk factor in the development of metabolic syndrome. The purpose of the current study was to evaluate cross-sectional and combined associations of metabolic syndrome with body composition and physical fitness in a community based geriatric population. Methods A total of 628 community-dwelling elders attending a geriatric health examination were enrolled in the study. The diagnosis of metabolic syndrome was based on the modified National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criterion with Asian cutoff of waist girth was adopted in this study. Body composition was obtained using bioimpedance analysis, and physical fitness was evaluated through the measurement of muscle strength (handgrip force), lower extremity muscle endurance (sit-to-stand test), flexibility (sit-and-reach test), and cardiorespiratory endurance (2-minute step test). Multivariable logistic regression and correlation analysis were performed to determine the association of metabolic syndrome with body composition and functionality variables. Results Metabolic syndrome was associated with increased skeletal muscle index (SMI) (odds ratio (OR), 1.61, 95% confidence interval (CI), 1.25-2.07) and decreased flexibility (OR, 0.97, 95% CI, 0.95-0.99) compared with those without metabolic syndrome. When body mass index was accounted for in the analysis, the association of SMI with metabolic syndrome was reduced. Waist circumference was positively correlated with SMI but negatively correlated with flexibility, whereas high density lipoprotein was positively correlated with flexibility but negatively correlated with SMI. Conclusion Reduced flexibility was positively associated with metabolic syndrome independent of age, gender, body composition, and functionality measurements in a community based geriatric population. Significant associations between metabolic syndrome with muscle strength and cardiorespiratory fitness in the elderly were not observed. Furthermore, flexibility should be included in the complete evaluation for metabolic syndrome.	[Chang, Ke-Vin; Han, Der-Sheng] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Bei Hu Branch, Taipei, Taiwan; [Chang, Ke-Vin; Li, Chia-Ming; Wang, Tyng-Guey; Tsai, Keh-Sung; Han, Der-Sheng] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Hung, Chen-Yu] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Chu Tung Branch, Hsinchu, Taiwan; [Li, Chia-Ming] Natl Taiwan Univ Hosp, Dept Family Med, Bei Hu Branch, Taipei, Taiwan; [Lin, Yu-Hung] Natl Taiwan Univ Hosp, Dept Social Work, Bei Hu Branch, Taipei, Taiwan; [Wang, Tyng-Guey] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Tsai, Keh-Sung] Natl Taiwan Univ Hosp, Dept Internal Med, Bei Hu Branch, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Han, DS (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Bei Hu Branch, Taipei, Taiwan.	dshan1121@yahoo.com.tw	LI, CHIAMING/AAC-4034-2020	HAN, DER-SHENG/0000-0001-7642-8060; WANG, TYNG-GUEY/0000-0003-3298-4916; TSAI, KEH-SUNG/0000-0001-8528-1566	Ministry of Science and Technology [MOST103-2314-B-002-010]; National Taiwan University Hospital [101-S1919]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Taiwan University Hospital(National Taiwan University)	This research was supported by grants from the Ministry of Science and Technology (MOST103-2314-B-002-010) and National Taiwan University Hospital (101-S1919). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio VA, 2013, EUR J CARDIOVASC NUR; Barzilay JI, 2009, DIABETES CARE, V32, P736, DOI 10.2337/dc08-1781; Brinkley TE, 2009, J GERONTOL A-BIOL, V64, P455, DOI 10.1093/gerona/gln038; Chang CL, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-60; Chang KV, 2014, ULTRASOUND MED BIOL, V40, P313, DOI 10.1016/j.ultrasmedbio.2013.10.002; Choi M, 2013, NURS HEALTH SCI, V15, P379, DOI 10.1111/nhs.12045; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DESROSIERS J, 1995, AM J OCCUP THER, V49, P637, DOI 10.5014/ajot.49.7.637; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Farias DL, 2013, EINSTEIN-SAO PAULO, V11, P174, DOI 10.1590/S1679-45082013000200007; Gottlieb MG, 2014, METAB SYNDR RELAT DI; Hageman PA, 2012, J OBES, V2012, DOI 10.1155/2012/618728; Han DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108230; Jurca R, 2004, MED SCI SPORT EXER, V36, P1301, DOI 10.1249/01.MSS.0000135780.88930.A9; Kao Feng-Chun, 2014, Biomed J, V37, P78, DOI 10.4103/2319-4170.113182; Kim M, 2013, EUR J CLIN NUTR, V67, P395, DOI 10.1038/ejcn.2013.9; Laursen AH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001711; Lee SC., 2008, J SPORT RECREATION M, V5, P35, DOI [10.6214/JSRM.200806_5(1).0003, DOI 10.6214/JSRM.200806_5(1).0003]; Lee W. L., 2007, J HUMANITIES SOCIAL, V3, P27, DOI [10.7118/JHSS.200712.0027, DOI 10.7118/JHSS.200712.0027]; Vieira DCL, 2013, CLIN INTERV AGING, V8, P1377, DOI 10.2147/CIA.S50333; Miyatake N, 2004, DIABETES RES CLIN PR, V64, P173, DOI 10.1016/j.diabres.2003.11.004; Morrell JS, 2013, METAB SYNDR RELAT D, V11, P370, DOI 10.1089/met.2013.0011; Park BS, 2013, DIABETES METAB J, V37, P458, DOI 10.4093/dmj.2013.37.6.458; Pedrosa R, 2009, BRAZ J PHYS THER, V13, P252, DOI 10.1590/S1413-35552009005000030; Rikli RE, 2001, HUMAN KINETICS; Ruggero CR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-182; Shin JA, 2013, J DIABETES INVEST, V4, P334, DOI 10.1111/jdi.12075; Silva G, 2013, INT J SPORTS MED, V34, P912, DOI 10.1055/s-0033-1334967; Wang CY, 2002, ARCH PHYS MED REHAB, V83, P811, DOI 10.1053/apmr.2002.32743; Wijndaele K, 2007, MED SCI SPORT EXER, V39, P233, DOI 10.1249/01.mss.0000247003.32589.a6; Yang JZ, 2014, PROG MOL BIOL TRANSL, V121, P133, DOI 10.1016/B978-0-12-800101-1.00005-3; Zhang P, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/729194	33	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117167	10.1371/journal.pone.0117167	http://dx.doi.org/10.1371/journal.pone.0117167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25614984	gold, Green Published, Green Submitted			2022-12-26	WOS:000349122100058
J	Olsen, RR; Mary-Sinclair, MN; Yin, ZR; Freeman, KW				Olsen, Rachelle R.; Mary-Sinclair, Michelle N.; Yin, Zhirong; Freeman, Kevin W.			Antagonizing Bcl-2 Family Members Sensitizes Neuroblastoma and Ewing's Sarcoma to an Inhibitor of Glutamine Metabolism	PLOS ONE			English	Article							CANCER; BIOLOGY; GLYCOLYSIS	Neuroblastomas (NBL) and Ewing's sarcomas (EWS) together cause 18% of all pediatric cancer deaths. Though there is growing interest in targeting the dysregulated metabolism of cancer as a therapeutic strategy, this approach has not been fully examined in NBL and EWS. In this study, we first tested a panel of metabolic inhibitors and identified the glutamine antagonist 6-diazo-5-oxo-L-norleucine (DON) as the most potent chemotherapeutic across all NBL and EWS cell lines tested. Myc, a master regulator of metabolism, is commonly overexpressed in both of these pediatric malignancies and recent studies have established that Myc causes cancer cells to become "addicted" to glutamine. We found DON strongly inhibited tumor growth of multiple tumor lines in mouse xenograft models. In vitro, inhibition of caspases partially reversed the effects of DON in high Myc expressing cell lines, but not in low Myc expressing lines. We further showed that induction of apoptosis by DON in Myc-overexpressing cancers is via the pro-apoptotic factor Bax. To relieve inhibition of Bax, we tested DON in combination with the Bcl-2 family antagonist navitoclax (ABT-263). In vitro, this combination caused an increase in DON activity across the entire panel of cell lines tested, with synergistic effects in two of the N-Myc amplified neuroblastoma cell lines. Our study supports targeting glutamine metabolism to treat Myc overexpressing cancers, such as NBL and EWS, particularly in combination with Bcl-2 family antagonists.	[Olsen, Rachelle R.; Mary-Sinclair, Michelle N.; Yin, Zhirong; Freeman, Kevin W.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Freeman, KW (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	kevin.freeman@stjude.org			American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding by American Lebanese Syrian Associated Charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros PF, 2009, BRIT J CANCER, V100, P1471, DOI 10.1038/sj.bjc.6605014; Biswas S, 2012, CANCER METAST REV, V31, P689, DOI 10.1007/s10555-012-9384-6; Bodur C, 2012, CURR MED CHEM, V19, P1804, DOI 10.2174/092986712800099839; Chin YR, 2014, CANC DISCOV; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Dang CV, 2011, COLD SH Q B, V76, P369, DOI 10.1101/sqb.2011.76.011296; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DUNN T, 1994, CANCER GENET CYTOGEN, V76, P19, DOI 10.1016/0165-4608(94)90063-9; Galluzzi L, 2013, NAT REV DRUG DISCOV, V12, P829, DOI 10.1038/nrd4145; Ganapathy-Kanniappan S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-152; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Howlader N, 2011, SEER CANC STAT REV 1; KISNER DL, 1980, RECENT RES CANCER, V74, P258; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Ordonez JL, 2009, CANCER RES, V69, P7140, DOI 10.1158/0008-5472.CAN-08-4041; Morrish F, 2009, ONCOGENE, V28, P2485, DOI 10.1038/onc.2009.112; Novick SJ, 2013, STAT MED, V32, P5145, DOI 10.1002/sim.5905; Qing GL, 2012, CANCER CELL, V22, P631, DOI 10.1016/j.ccr.2012.09.021; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Saqcena M, 2014, ONCOGENE; SULLIVAN MP, 1988, CANCER CHEMOTH PHARM, V21, P78, DOI 10.1007/BF00262746; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003	31	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116998	10.1371/journal.pone.0116998	http://dx.doi.org/10.1371/journal.pone.0116998			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615615	gold, Green Submitted, Green Published			2022-12-26	WOS:000349122100052
J	Shiau, CE; Kaufman, Z; Meireles, AM; Talbot, WS				Shiau, Celia E.; Kaufman, Zoe; Meireles, Ana M.; Talbot, William S.			Differential Requirement for irf8 in Formation of Embryonic and Adult Macrophages in Zebrafish	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; IN-VIVO; B-CELL; MICROGLIA; ICSBP; INFLAMMATION; EXPRESSION; RESPONSES; MUTATION; RECEPTOR	Interferon regulatory factor 8 (Irf8) is critical for mammalian macrophage development and innate immunity, but its role in teleost myelopoiesis remains incompletely understood. In particular, genetic tools to analyze the role of Irf8 in zebrafish macrophage development at larval and adult stages are lacking. We generated irf8 null mutants in zebrafish using TALEN-mediated targeting. Our analysis defines different requirements for irf8 at different stages. irf8 is required for formation of all macrophages during primitive and transient definitive hematopoiesis, but not during adult-phase definitive hematopoiesis starting at 5-6 days postfertilization. At early stages, irf8 mutants have excess neutrophils and excess cell death in pu.1-expressing myeloid cells. Macrophage fates were recovered in irf8 mutants after wildtype irf8 expression in neutrophil and macrophage lineages, suggesting that irf8 regulates macrophage specification and survival. In juvenile irf8 mutant fish, mature macrophages are present, but at numbers significantly reduced compared to wildtype, indicating an ongoing requirement for irf8 after embryogenesis. As development progresses, tissue macrophages become apparent in zebrafish irf8 mutants, with the possible exception of microglia. Our study defines distinct requirement for irf8 in myelopoiesis before and after transition to the adult hematopoietic system.	[Shiau, Celia E.; Kaufman, Zoe; Meireles, Ana M.; Talbot, William S.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University	Shiau, CE (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.	shiauc@ornl.gov; wtalbot@stanford.edu	Shiau, Celia/C-7679-2015	, William/0000-0002-2048-7472; Kaufman, Zoe/0000-0001-7745-1000; Shiau, Celia/0000-0002-9347-9158	NIH NRSA fellowship [5F32NS067754]; ORNL Liane Russell Fellowship; Stanford Undergraduate VPUE funds; EMBO fellowship [ALTF 1125-2011]; NIH [R01 NS065787, R56 HL125040]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL125040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065787, F32NS067754] Funding Source: NIH RePORTER	NIH NRSA fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ORNL Liane Russell Fellowship; Stanford Undergraduate VPUE funds; EMBO fellowship(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	C.E.S. was supported by NIH NRSA fellowship 5F32NS067754 and ORNL Liane Russell Fellowship, Z.K. was supported by Stanford Undergraduate VPUE funds, and A.M.M. was supported by EMBO fellowship ALTF 1125-2011. This work was supported by NIH grants R01 NS065787 and R56 HL125040 to W.S.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Chen AT, 2009, J CELL BIOCHEM, V108, P35, DOI 10.1002/jcb.22251; Ellett Felix, 2011, Blood, V117, pe49, DOI 10.1182/blood-2010-10-314120; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gordy C, 2011, BLOOD, V117, P618, DOI 10.1182/blood-2010-01-265959; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Li L, 2011, BLOOD, V117, P1359, DOI 10.1182/blood-2010-06-290700; Marquis JF, 2009, J IMMUNOL, V182, P3008, DOI 10.4049/jimmunol.0800680; Novoa B, 2012, ADV EXP MED BIOL, V946, P253, DOI 10.1007/978-1-4614-0106-3_15; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Pogosova-Agadjanyan EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070812; Qi CF, 2009, IMMUNOL RES, V45, P62, DOI 10.1007/s12026-008-8032-2; Redd MJ, 2006, CELL MOTIL CYTOSKEL, V63, P415, DOI 10.1002/cm.20133; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Richards DM, 2013, CANCER MICROENVIRON, V6, P179, DOI 10.1007/s12307-012-0123-x; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Scheller M, 1999, BLOOD, V94, P3764, DOI 10.1182/blood.V94.11.3764.423k03_3764_3771; Schiavoni G, 2004, BLOOD, V103, P2221, DOI 10.1182/blood-2003-09-3007; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Shiau CE, 2013, CELL REP, V5, P1342, DOI 10.1016/j.celrep.2013.11.004; Stachura DL, 2011, METHOD CELL BIOL, V101, P75, DOI 10.1016/B978-0-12-387036-0.00004-9; Svahn AJ, 2013, DEV NEUROBIOL, V73, P60, DOI 10.1002/dneu.22039; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; TERRY RL, 2014, CELL IMMUNOL, DOI DOI 10.1016/J.CELLIMM.2014.12.004; Tsujimura H, 2002, J IMMUNOL, V169, P1261, DOI 10.4049/jimmunol.169.3.1261; Turcotte K, 2007, J IMMUNOL, V179, P2467, DOI 10.4049/jimmunol.179.4.2467; WANG H, 2014, J IMMUNOL; Wang HS, 2008, BLOOD, V112, P4028, DOI 10.1182/blood-2008-01-129049; Yoshida Y, 2014, IMMUNITY, V40, P187, DOI 10.1016/j.immuni.2013.11.022	43	79	81	10	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117513	10.1371/journal.pone.0117513	http://dx.doi.org/10.1371/journal.pone.0117513			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615614	Green Published, Green Submitted, gold			2022-12-26	WOS:000349122100063
J	Sagova-Mareckova, M; Daniel, O; Omelka, M; Kristufek, V; Divis, J; Kopecky, J				Sagova-Mareckova, Marketa; Daniel, Ondrej; Omelka, Marek; Kristufek, Vaclav; Divis, Jiri; Kopecky, Jan			Determination of Factors Associated with Natural Soil Suppressivity to Potato Common Scab	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; STREPTOMYCES; DISEASES; POPULATIONS; MANAGEMENT; CULTIVARS; ELEMENTS; TUBERS; GROWTH; PH	Common scab of potatoes is a disease, which is difficult to manage due to complex interactions of the pathogenic bacteria (Streptomyces spp.) with soil, microbial community and potato plants. In Bohemian-Moravian Highlands in the Czech Republic two sites (Vyklantice and Zdirec) were selected for a study of common scab disease suppressivity. At both sites, a field with low disease severity occurs next to one with high severity and the situation was regularly observed over four decades although all four fields undergo a crop rotation. In the four fields, quantities of bacteria, actinobacteria and the gene txtB from the biosynthetic gene cluster of thaxtomin, the main pathogenicity factor of common scab, were analyzed by real-time PCR. Microbial community structure was compared by terminal fragment length polymorphism analysis. Soil and potato periderm were characterized by contents of carbon, nitrogen, phosporus, sulphur, calcium, magnesium, and iron. Quality of organic matter was assessed by high performance liquid chromatography of soil extracts. The study demonstrated that the suppressive character of the fields is locally specific. At Zdirec, the suppressivity was associated with low txtB gene copies in bulk soil, while at Vyklantice site it was associated with low txtB gene copies in the tuberosphere. The differences were discussed with respect to the effect of abiotic conditions at Zdirec and interaction between potato plant and soil microbial community at Vyklantice. Soil pH, Ca soil content or cation concentrations, although different were not in the range to predict the disease severity. Low severity of common scab was associated with low content of soil C, N, C/N, Ca and Fe suggesting that oligotrophic conditions may be favorable to common scab suppression.	[Sagova-Mareckova, Marketa; Daniel, Ondrej; Kopecky, Jan] Crop Res Inst, Dept Epidemiol & Ecol Microorganisms, Prague, Czech Republic; [Omelka, Marek] Charles Univ Prague, Dept Probabil & Math Stat, Fac Math & Phys, Prague, Czech Republic; [Kristufek, Vaclav] Acad Sci Czech Republ, Inst Soil Biol, Ctr Biol, Vvi, CR-37005 Ceske Budejovice, Czech Republic; [Divis, Jiri] Univ South Bohemia, Dept Plant Prod, Fac Agr, Ceske Budejovice, Czech Republic	Czech Crop Research Institute (CRI); Charles University Prague; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Sagova-Mareckova, M (corresponding author), Crop Res Inst, Dept Epidemiol & Ecol Microorganisms, Prague, Czech Republic.	sagova@vurv.cz	Omelka, Marek/I-2447-2014; Mareckova, Marketa/AAD-7361-2021; Krištůfek, Václav/G-3846-2014; Mareckova, Marketa/D-9898-2017; Omelka, Marek/AAG-9535-2019; Kopecky, Jan/C-7400-2013	Omelka, Marek/0000-0002-0396-9373; Mareckova, Marketa/0000-0002-0331-8570; Mareckova, Marketa/0000-0002-0331-8570; Kopecky, Jan/0000-0002-3437-257X	Ministry of Agriculture of the Czech Republic [QJ1210359, MZe RO0414]; Czech Science Foundation [P201/11/P290]	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	The study was supported by the Ministry of Agriculture of the Czech Republic, grant No. QJ1210359 and project MZe RO0414 (http://www.mze.cz), and Czech Science Foundation, grant No. P201/11/P290 (http://www.gacr.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almario J, 2013, PLANT SOIL, V371, P397, DOI 10.1007/s11104-013-1677-1; [Anonymous], 2014, R LANG ENV STAT COMP; ARCHULETA JG, 1981, AM POTATO J, V58, P385, DOI 10.1007/BF02852950; Bailey KL, 2003, SOIL TILL RES, V72, P169, DOI 10.1016/S0167-1987(03)00086-2; BAKER KF, 1974, BIOL CONTROL PLANT P, P34217, DOI DOI 10.2307/3758248; Bonanomi G, 2007, J PLANT PATHOL, V89, P311; Cermak L, 2008, APPL SOIL ECOL, V40, P348, DOI 10.1016/j.apsoil.2008.06.001; DAVIS JR, 1976, PHYTOPATHOLOGY, V66, P1236, DOI 10.1094/Phyto-66-1236; DAVIS JR, 1976, PHYTOPATHOLOGY, V66, P1404, DOI DOI 10.1094/PHYTO-66-1236; Dees MW, 2012, POTATO RES, V55, P249, DOI 10.1007/s11540-012-9206-9; Errakhi R, 2008, J EXP BOT, V59, P4259, DOI 10.1093/jxb/ern267; Gijbels I, 2013, BIOMETRICS, V69, P137, DOI 10.1111/j.1541-0420.2012.01797.x; Hiltunen LH, 2006, J AGR FOOD CHEM, V54, P3372, DOI 10.1021/jf060270m; Kers JA, 2005, MOL MICROBIOL, V55, P1025, DOI 10.1111/j.1365-2958.2004.04461.x; Kinkel LL, 2011, ANNU REV PHYTOPATHOL, V49, P47, DOI 10.1146/annurev-phyto-072910-095232; KOPACEK J, 1995, COMMUN SOIL SCI PLAN, V26, P1935, DOI 10.1080/00103629509369419; Kristufek V, 2000, POTATO RES, V43, P107, DOI 10.1007/BF02357951; KYSELKOVA M, 2012, SUSTAINABLE AGR REV, V9, P93, DOI DOI 10.1007/978-94-007-4113-3_5; Kyselkova M, 2008, ANTON LEEUW INT J G, V94, P439, DOI 10.1007/s10482-008-9261-z; Kyselkova M, 2014, ENV MICROBIOL REP, V6, P346, DOI 10.1111/1758-2229.12131; Lacey MJ, 2001, J PHYTOPATHOL, V149, P679, DOI 10.1046/j.1439-0434.2001.00693.x; Lambert DH, 2005, AM J POTATO RES, V82, P309, DOI 10.1007/BF02871961; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lazarovits G, 2007, PHYTOPATHOLOGY, V97, P1071, DOI 10.1094/PHYTO-97-9-1071; Lorang JM, 1989, AM POTATO J, V66, P531; Mazzola M, 2002, ANTON LEEUW INT J G, V81, P557, DOI 10.1023/A:1020557523557; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MEERA MS, 1995, EUR J PLANT PATHOL, V101, P421, DOI 10.1007/BF01874856; Meng QX, 2012, PLANT DIS, V96, P712, DOI 10.1094/PDIS-05-11-0441; Merchant SS, 2010, PLANT PHYSIOL, V154, P512, DOI 10.1104/pp.110.161810; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Noble R, 2005, BIOCONTROL SCI TECHN, V15, P3, DOI 10.1080/09583150400015904; Omelka M, 2012, J STAT PLAN INFER, V142, P1396, DOI 10.1016/j.jspi.2011.12.018; Qu XS, 2008, PHYTOPATHOLOGY, V98, P405, DOI 10.1094/PHYTO-98-4-0405; Rosenzweig N, 2012, PLANT DIS, V96, P718, DOI 10.1094/PDIS-07-11-0571; Sagova-Mareckova M, 2008, APPL ENVIRON MICROB, V74, P2902, DOI 10.1128/AEM.02161-07; Schlatter DC, 2013, MICROB ECOL, V66, P961, DOI 10.1007/s00248-013-0280-6; Stach JEM, 2003, ENVIRON MICROBIOL, V5, P828, DOI 10.1046/j.1462-2920.2003.00483.x; Tokala RK, 2002, APPL ENVIRON MICROB, V68, P2161, DOI 10.1128/AEM.68.5.2161-2171.2002; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Weinert N, 2010, FEMS MICROBIOL ECOL, V74, P114, DOI 10.1111/j.1574-6941.2010.00936.x; Wenzl H., 1967, PFLANZENARZT, V20, P77; Yergeau E, 2010, ENVIRON MICROBIOL, V12, P2096, DOI 10.1111/j.1462-2920.2009.02053.x	43	29	29	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116291	10.1371/journal.pone.0116291	http://dx.doi.org/10.1371/journal.pone.0116291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25612311	Green Submitted, Green Published, gold			2022-12-26	WOS:000348562900011
J	Iglesias-Bexiga, M; Castillo, F; Cobos, ES; Oka, T; Sudol, M; Luque, I				Iglesias-Bexiga, Manuel; Castillo, Francisco; Cobos, Eva S.; Oka, Tsutomu; Sudol, Marius; Luque, Irene			WWDomains of the Yes-Kinase-AssociatedProtein (YAP) Transcriptional Regulator Behave as Independent Units with Different Binding Preferences for PPxY MotifContaining Ligands	PLOS ONE			English	Article							WW DOMAIN; STRUCTURAL-CHARACTERIZATION; TUMOR-SUPPRESSOR; HEAT-CAPACITY; SH3 DOMAINS; ORGAN SIZE; PROLINE; SPECIFICITY; PATHWAY; RECOGNITION	YAP is a WW domain-containing effector of the Hippo tumor suppressor pathway, and the object of heightened interest as a potent oncogene and stemness factor. YAP has two major isoforms that differ in the number ofWWdomains they harbor. Elucidating the degree of co-operation between these WW domains is important for a full understanding of the molecular function of YAP. We present here a detailed biophysical study of the structural stability and binding properties of the two YAP WW domains aimed at investigating the relationship between both domains in terms of structural stability and partner recognition. We have carried out a calorimetric study of the structural stability of the two YAP WW domains, both isolated and in a tandem configuration, and their interaction with a set of functionally relevant ligands derived from PTCH1 and LATS kinases. We find that the two YAP WW domains behave as independent units with different binding preferences, suggesting that the presence of the second WW domain might contribute to modulate target recognition between the two YAP isoforms. Analysis of structural models and phage-display studies indicate that electrostatic interactions play a critical role in binding specificity. Together, these results are relevant to understand of YAP function and open the door to the design of highly specific ligands of interest to delineate the functional role of each WW domain in YAP signaling.	[Iglesias-Bexiga, Manuel; Castillo, Francisco; Cobos, Eva S.; Luque, Irene] Univ Granada, Fac Sci, Dept Phys Chem, E-18071 Granada, Spain; [Iglesias-Bexiga, Manuel; Castillo, Francisco; Cobos, Eva S.; Luque, Irene] Univ Granada, Fac Sci, Inst Biotechnol, E-18071 Granada, Spain; [Oka, Tsutomu; Sudol, Marius] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA	University of Granada; University of Granada	Luque, I (corresponding author), Univ Granada, Fac Sci, Dept Phys Chem, E-18071 Granada, Spain.	iluque@ugr.es	S. Cobos, Eva/H-7703-2015; Luque, Irene/K-4758-2012	S. Cobos, Eva/0000-0002-4622-8698; Luque, Irene/0000-0003-2757-4779; Iglesias Bexiga, Manuel/0000-0001-5737-1601; Castillo Correa, Francisco Jose/0000-0001-5587-9612	Spanish Ministry of Education and Science [BIO2009-13261-CO2]; Spanish Ministry of Economy and Competitivity including FEDER [BIO2012-39922-CO2]; Governement of Andalusia [CVI-5915]; PA Breast Cancer Coalition plus the Geisinger Clinic [60707, 920093]	Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of Economy and Competitivity including FEDER; Governement of Andalusia; PA Breast Cancer Coalition plus the Geisinger Clinic	This work was supported by the Spanish Ministry of Education and Science [grant BIO2009-13261-CO2], the Spanish Ministry of Economy and Competitivity [grant BIO2012-39922-CO2] including FEDER (European Funds for Regional Development) funds and the Governement of Andalusia [grant CVI-5915]. Marius Sudol was supported by PA Breast Cancer Coalition Grants (# 60707 and # 920093) plus the Geisinger Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon E, 2012, STRUCTURE, V20, P1726, DOI 10.1016/j.str.2012.07.014; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chen HJ, 2011, DEV BIOL, V357, P370, DOI 10.1016/j.ydbio.2011.07.003; Chong PA, 2010, P NATL ACAD SCI USA, V107, P18404, DOI 10.1073/pnas.1003023107; Cobos ES, 2009, BIOCHEMISTRY-US, V48, P8712, DOI 10.1021/bi9007758; Cordier F, 2000, J MOL BIOL, V304, P497, DOI 10.1006/jmbi.2000.4274; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Ferreon JC, 2004, BIOCHEMISTRY-US, V43, P7787, DOI 10.1021/bi049752m; Freire E, 2008, DRUG DISCOV TODAY, V13, P869, DOI 10.1016/j.drudis.2008.07.005; Freire E, 2009, CHEM BIOL DRUG DES, V74, P468, DOI 10.1111/j.1747-0285.2009.00880.x; Gaffney CJ, 2012, GENE, V509, P215, DOI 10.1016/j.gene.2012.08.025; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOMEZ J, 1995, PROTEINS, V22, P404, DOI 10.1002/prot.340220410; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Klett J, 2012, J CHEM THEORY COMPUT, V8, P3395, DOI 10.1021/ct300497z; Klippel S, 2011, J BIOL CHEM, V286, P38478, DOI 10.1074/jbc.M111.265710; Koepf EK, 1999, PROTEIN SCI, V8, P841, DOI 10.1110/ps.8.4.841; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lin YT, 2012, EXP CELL RES, V318, P1877, DOI 10.1016/j.yexcr.2012.05.005; Linn H, 1997, BIOL CHEM, V378, P531, DOI 10.1515/bchm.1997.378.6.531; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Martin-Garcia JM, 2012, BIOCHEM J, V442, P443, DOI 10.1042/BJ20111089; McDonald CB, 2012, J MOL BIOL, V422, P58, DOI 10.1016/j.jmb.2012.05.015; Morales B, 2007, STRUCTURE, V15, P473, DOI 10.1016/j.str.2007.03.005; Ng CA, 2008, BBA-PROTEINS PROTEOM, V1784, P1208, DOI 10.1016/j.bbapap.2008.04.026; Oka T, 2012, ONCOGENE, V31, P128, DOI 10.1038/onc.2011.216; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Palencia A, 2004, J MOL BIOL, V336, P527, DOI 10.1016/j.jmb.2003.12.030; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Piana S, 2011, J MOL BIOL, V405, P43, DOI 10.1016/j.jmb.2010.10.023; Pires JR, 2001, J MOL BIOL, V314, P1147, DOI 10.1006/jmbi.2000.5199; PRIVALOV PL, 1990, J MOL BIOL, V213, P385, DOI 10.1016/S0022-2836(05)80198-6; Ramirez-Espain X, 2007, J MOL BIOL, V373, P1255, DOI 10.1016/j.jmb.2007.08.052; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schleinkofer K, 2004, J MOL BIOL, V344, P865, DOI 10.1016/j.jmb.2004.09.063; Schlundt A, 2009, MOL CELL PROTEOMICS, V8, P2474, DOI 10.1074/mcp.M800337-MCP200; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Sudol M, 2005, IUBMB LIFE, V57, P773, DOI 10.1080/15216540500389039; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sudol M, 2013, HIPPO SIGNALING PATH, P53; SUDOL M, 2004, MODULAR PROTEIN DOMA, P59; Sudol M, 2012, STRUCTURE, V20, P1619, DOI 10.1016/j.str.2012.09.007; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Varelas X, 2013, HIPPO SIGNALING PATH, P327; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; VIGUERA AR, 1994, BIOCHEMISTRY-US, V33, P2142, DOI 10.1021/bi00174a022; Wang CY, 2001, J MOL BIOL, V313, P873, DOI 10.1006/jmbi.2001.5083; Webb C, 2011, BIOCHEMISTRY-US, V50, P3300, DOI 10.1021/bi2001888; Yu JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001761; Zarrinpar A, 2000, NAT STRUCT BIOL, V7, P611, DOI 10.1038/77891; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015	66	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0113828	10.1371/journal.pone.0113828	http://dx.doi.org/10.1371/journal.pone.0113828			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607641	Green Published, gold, Green Submitted			2022-12-26	WOS:000348205300002
J	Klumpers, UMH; Veltman, DJ; van Tol, MJ; Kloet, RW; Boellaard, R; Lammertsma, AA; Hoogendijk, WJG				Klumpers, Ursula M. H.; Veltman, Dick J.; van Tol, Marie-Jose; Kloet, Reina W.; Boellaard, Ronald; Lammertsma, Adriaan A.; Hoogendijk, Witte J. G.			Neurophysiological Effects of Sleep Deprivation in Healthy Adults, a Pilot Study	PLOS ONE			English	Article							UNDER-THE-CURVE; GO/NO-GO TASK; DOPAMINE-D-2 RECEPTOR; NEGATIVE AFFECT; NEURAL BASIS; PET; PERFORMANCE; BINDING; IMAGES; ACTIVATION	Total sleep deprivation (TSD) may induce fatigue, neurocognitive slowing and mood changes, which are partly compensated by stress regulating brain systems, resulting in altered dopamine and cortisol levels in order to stay awake if needed. These systems, however, have never been studied in concert. At baseline, after a regular night of sleep, and the next morning after TSD, 12 healthy subjects performed a semantic affective classification functional magnetic resonance imaging (fMRI) task, followed by a [C-11]raclopride positron emission tomography (PET) scan. Saliva cortisol levels were acquired at 7 time points during both days. Affective symptoms were measured using Beck Depression Inventory (BDI), Spielberger State Trait Anxiety Index (STAI) and visual analogue scales. After TSD, perceived energy levels, concentration, and speed of thought decreased significantly, whereas mood did not. During fMRI, response speed decreased for neutral words and positive targets, and accuracy decreased trendwise for neutral words and for positive targets with a negative distracter. Following TSD, processing of positive words was associated with increased left dorsolateral prefrontal activation. Processing of emotional words in general was associated with increased insular activity, whereas contrasting positive vs. negative words showed subthreshold increased activation in the (para) hippocampal area. Cortisol secretion was significantly lower after TSD. Decreased voxel-by-voxel [C-11]raclopride binding potential (BPND) was observed in left caudate. TSD induces widespread cognitive, neurophysiologic and endocrine changes in healthy adults, characterized by reduced cognitive functioning, despite increased regional brain activity. The blunted HPA-axis response together with altered [C-11]raclopride binding in the basal ganglia indicate that sustained wakefulness requires involvement of additional adaptive biological systems.	[Klumpers, Ursula M. H.; Veltman, Dick J.; Hoogendijk, Witte J. G.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Kloet, Reina W.; Boellaard, Ronald; Lammertsma, Adriaan A.] Vrije Univ Amsterdam Med Ctr, Dept Nucl Med, Amsterdam, Netherlands; [Kloet, Reina W.; Boellaard, Ronald; Lammertsma, Adriaan A.] Vrije Univ Amsterdam Med Ctr, PET Res, Amsterdam, Netherlands; [Klumpers, Ursula M. H.; Veltman, Dick J.; Kloet, Reina W.; Boellaard, Ronald; Lammertsma, Adriaan A.; Hoogendijk, Witte J. G.] Vrije Univ Amsterdam Med Ctr, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [van Tol, Marie-Jose] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, NL-9713 AV Groningen, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Groningen	Klumpers, UMH (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands.	u.klumpers@vumc.nl		Boellaard, Ronald/0000-0002-0313-5686; Lammertsma, Adriaan/0000-0003-1237-2891	ZONMW (Dutch Organization for Health Research and Development), The Netherlands [016.066.309]	ZONMW (Dutch Organization for Health Research and Development), The Netherlands	This study was supported in part by ZONMW (Dutch Organization for Health Research and Development), The Netherlands, grant no. 016.066.309, to Dr. Ronald Boellaard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali N, 2010, J COGNITIVE NEUROSCI, V22, P2369, DOI 10.1162/jocn.2009.21352; Balbo M, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/759234; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Boellaard R, 2006, NEUROIMAGE, V31, pT62, DOI 10.1016/j.neuroimage.2006.04.053; Born J, 1999, NATURE, V397, P29, DOI 10.1038/16166; BOROWSKY B, 1992, NEUROPHARMACOLOGY, V31, P671, DOI 10.1016/0028-3908(92)90145-F; Brody AL, 2010, PSYCHIAT RES-NEUROIM, V183, P218, DOI 10.1016/j.pscychresns.2009.06.004; Buckley TM, 2005, J CLIN ENDOCR METAB, V90, P3106, DOI 10.1210/jc.2004-1056; Chee MWL, 2006, NEUROIMAGE, V31, P419, DOI 10.1016/j.neuroimage.2005.12.001; Chee MWL, 2010, NEUROIMAGE, V51, P835, DOI 10.1016/j.neuroimage.2010.02.031; Cizek J, 2004, NEUROIMAGE, V22, P434, DOI 10.1016/j.neuroimage.2004.01.016; Colombo C, 1999, PSYCHIAT RES, V86, P267, DOI 10.1016/S0165-1781(99)00036-0; Cook NR, 2004, STAT MED, V23, P3421, DOI 10.1002/sim.1921; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Defrise M, 1997, IEEE T MED IMAGING, V16, P145, DOI 10.1109/42.563660; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Egerton A, 2009, NEUROSCI BIOBEHAV R, V33, P1109, DOI 10.1016/j.neubiorev.2009.05.005; Elliott R, 2004, BIOL PSYCHIAT, V55, P1163, DOI 10.1016/j.biopsych.2004.03.007; Elliott R, 2002, ARCH GEN PSYCHIAT, V59, P597, DOI 10.1001/archpsyc.59.7.597; Elliott R, 2000, NEUROREPORT, V11, P1739, DOI 10.1097/00001756-200006050-00028; Elmenhorst D, 2012, J NUCL MED, V53, P1723, DOI 10.2967/jnumed.112.105114; FADDA P, 1992, NEUROCHEM INT, V20, pS153; Garcao P, 2013, BRIT J PHARMACOL, V169, P1600, DOI 10.1111/bph.12234; Giedke H, 2002, SLEEP MED REV, V6, P361, DOI 10.1053/smrv.2002.0235; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Huettel SA, 2009, FUNCTIONAL MAGNETIC; Huettel SA, 2012, NEUROIMAGE, V62, P1152, DOI 10.1016/j.neuroimage.2011.08.113; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Isaac SO, 2003, J PHARMACOL EXP THER, V307, P386, DOI 10.1124/jpet.103.053918; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Laruelle M, 1997, NEUROPSYCHOPHARMACOL, V17, P162, DOI 10.1016/S0893-133X(97)00043-2; Levens SM, 2010, J COGNITIVE NEUROSCI, V22, P2790, DOI 10.1162/jocn.2010.21428; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McNair D.M., 1971, MANUAL PROFILES MOOD; Murphy FC, 1999, PSYCHOL MED, V29, P1307, DOI 10.1017/S0033291799001233; Narendran R, 2006, SYNAPSE, V60, P485, DOI 10.1002/syn.20325; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Qu WM, 2010, J NEUROSCI, V30, P4382, DOI 10.1523/JNEUROSCI.4936-09.2010; SIBLEY DR, 1982, J BIOL CHEM, V257, P6351; Spielberger C.D., 1970, STAI MANUAL; Stalder T, 2010, PSYCHONEUROENDOCRINO, V35, P209, DOI 10.1016/j.psyneuen.2009.06.006; Svarer C, 2005, NEUROIMAGE, V24, P969, DOI 10.1016/j.neuroimage.2004.10.017; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Tops M, 2003, PSYCHOPHYSIOLOGY, V40, P167, DOI 10.1111/1469-8986.00018; van Aken MO, 2003, CLIN CHEM, V49, P1408, DOI 10.1373/49.8.1408; van Vliet I M, 2007, Tijdschr Psychiatr, V49, P393; Vgontzas AN, 1999, CLIN ENDOCRINOL, V51, P205, DOI 10.1046/j.1365-2265.1999.00763.x; Volkow ND, 2008, J NEUROSCI, V28, P8454, DOI 10.1523/JNEUROSCI.1443-08.2008; Volkow ND, 2012, J NEUROSCI, V32, P6711, DOI 10.1523/JNEUROSCI.0045-12.2012; Vreeburg SA, 2009, PSYCHONEUROENDOCRINO, V34, P1109, DOI 10.1016/j.psyneuen.2009.04.024; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wilhelm I, 2007, PSYCHONEUROENDOCRINO, V32, P358, DOI 10.1016/j.psyneuen.2007.01.008; WU JC, 1991, SLEEP, V14, P155; Wust Stefan, 2000, Noise Health, V2, P79	60	32	33	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116906	10.1371/journal.pone.0116906	http://dx.doi.org/10.1371/journal.pone.0116906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25608023	Green Published, Green Submitted, gold			2022-12-26	WOS:000348205300043
J	Feliu, J; Salud, A; Safont, MJ; Garcia-Giron, C; Aparicio, J; Losa, F; Bosch, C; Escudero, P; Casado, E; Jorge, M; Bohn, U; Perez-Carrion, R; Carmona, A; Custodio, AB; Maurel, J				Feliu, Jaime; Salud, Antonieta; Safont, Maria J.; Garcia-Giron, Carlos; Aparicio, Jorge; Losa, Ferran; Bosch, Carlos; Escudero, Pilar; Casado, Enrique; Jorge, Monica; Bohn, Uriel; Perez-Carrion, Ramon; Carmona, Alberto; Custodio, Ana B.; Maurel, Joan			Correlation of Hypertension and Proteinuria with Outcome in Elderly Bevacizumab-Treated Patients with Metastatic Colorectal Cancer	PLOS ONE			English	Article							PACLITAXEL PLUS BEVACIZUMAB; ENDOTHELIAL GROWTH-FACTOR; 1ST-LINE TREATMENT; BREAST-CANCER; PHASE-II; CAPECITABINE; CHEMOTHERAPY; ASSOCIATION; OXALIPLATIN; BIOMARKER	Background Studies suggest a relationship between hypertension and outcome in bevacizumab-treated patients with metastatic colorectal cancer (mCRC). We performed a retrospective analysis of two phase II studies (BECA and BECOX) to determine if hypertension and proteinuria predict outcome in elderly patients with mCRC treated with bevacizumab. Patients and Methods Patients >= 70 years of age received either capecitabine 1250 mg/m(2) bid days 1-14 + bevacizumab 7.5 mg/kg day 1 every 21 days (BECA study) or capecitabine 1000 mg/m(2) bid days 1-14 with bevacizumab 7.5 mg/kg and oxaliplatin 130 mg/m(2) day 1 (BECOX study). The primary objective was to correlate hypertension and proteinuria with overall response rate (ORR), time to progression (TTP) and overall survival (OS). Secondary objectives included identification of risk factors associated with the development of hypertension and proteinuria and determining whether development of hypertension or proteinuria in the first 2 cycles was related to ORR, disease-control rate (DCR), TTP or OS. Results In total, 127 patients (median age 75.5 years) were included in the study. Hypertension correlated with DCR and OS; proteinuria correlated with ORR and DCR. Proteinuria or hypertension in the first 2 cycles did not correlate with efficacy. Risk factors for hypertension were female gender (odds ratio [OR] 0.241; P = 0.011) and more bevacizumab cycles (OR 1.112; P = 0.002); risk factors for proteinuria were diabetes (OR 3.869; P = 0.006) and more bevacizumab cycles (OR 1.181; P<0.0001). Multivariate analysis identified as having prognostic value: baseline lactate dehydrogenase, haemoglobin, number of metastatic lesions and DCR. Conclusion This analysis of two phase II studies suggests that hypertension is significantly correlated with OS but not with ORR and TTP, whereas proteinuria is correlated with ORR but not with OS and TTP. Both hypertension and proteinuria are associated with the duration of bevacizumab treatment and do not represent an independent prognostic factor.	[Feliu, Jaime; Custodio, Ana B.] Hosp Univ La Paz, Serv Oncol Med, Madrid, Spain; [Salud, Antonieta] Hosp Arnau Vilanova, Serv Oncol Med, Lleida, Spain; [Safont, Maria J.] Hosp Univ Clinico Valencia, Serv Oncol Med, Valencia, Spain; [Garcia-Giron, Carlos] Hosp Gen Yague, Serv Oncol Med, Burgos, Spain; [Aparicio, Jorge] Hosp La Fe Valencia, Serv Oncol Med, Valencia, Spain; [Losa, Ferran] Hosp La Creu Roja Hosp, Serv Oncol Med, Barcelona, Spain; [Bosch, Carlos] Hosp Gen Valencia, Serv Oncol Med, Valencia, Spain; [Escudero, Pilar] Univ Lozano Blesa, Hosp Clin, Serv Oncol Med, Zaragoza, Spain; [Casado, Enrique] Hosp Infanta Sofia, Serv Oncol Med, Madrid, Spain; [Jorge, Monica] Complejo Hosp Xeral Cies, Serv Oncol Med, Vigo, Spain; [Bohn, Uriel] Hosp Univ Gran Canaria Doctor Negrin, Serv Oncol Med, Las Palmas Gran Canaria, Spain; [Perez-Carrion, Ramon] Hosp Univ Quiron Madrid, Serv Oncol Med, Madrid, Spain; [Carmona, Alberto] Univ Morales Messeguer, Serv Hematol & Oncol Med, Gen Hosp, Murcia, Spain; [Maurel, Joan] Hosp Clin Prov Barcelona, Serv Oncol Med, Barcelona, Spain	Hospital Universitario La Paz; University Hospital Arnau de Vilanova; Hospital General Yague; Hospital Universitari i Politecnic La Fe; Lozano Blesa University Clinical Hospital; Complexo Hospitalario Universitario de Vigo; University of Barcelona; Hospital Clinic de Barcelona	Feliu, J (corresponding author), Hosp Univ La Paz, Serv Oncol Med, Madrid, Spain.	jaime.feliu@salud.madrid.org	García-Girón, Carlos/ABH-3045-2020	Carmona-Bayonas, Alberto/0000-0002-1930-9660; salud, antonia/0000-0002-7399-7484	Hoffmann-La Roche, Nutley, USA; BECOX study - Grupo Espanol Multidisciplinario del Cancer Digestivo, Spain	Hoffmann-La Roche, Nutley, USA; BECOX study - Grupo Espanol Multidisciplinario del Cancer Digestivo, Spain	The BECA study was supported by Hoffmann-La Roche, Nutley, USA, and the BECOX study was sponsored by Grupo Espanol Multidisciplinario del Cancer Digestivo, Spain. Support for third-party writing assistance for this manuscript was provided by Roche Farma, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berruti A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-184; Cancer Research UK, BOW CANC INC STAT; Dahlberg SE, 2010, J CLIN ONCOL, V28, P949, DOI 10.1200/JCO.2009.25.4482; De Stefano A, 2011, CANCER CHEMOTH PHARM, V68, P1207, DOI 10.1007/s00280-011-1604-1; Dewdney A, 2012, BRIT J CANCER, V106, P1718, DOI 10.1038/bjc.2012.152; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Feliu J, 2014, BRIT J CANCER, V111, P241, DOI 10.1038/bjc.2014.346; Feliu J, 2010, BRIT J CANCER, V102, P1468, DOI 10.1038/sj.bjc.6605663; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Garcia-Donas J, 2011, LANCET ONCOL, V12, P1143, DOI 10.1016/S1470-2045(11)70266-2; Hurwitz HI, 2013, ONCOLOGIST, V18, P273, DOI 10.1634/theoncologist.2012-0339; Iwasa S, 2013, ANTICANCER RES, V33, P309; Kabbinavar FF, 2009, J CLIN ONCOL, V27, P199, DOI 10.1200/JCO.2008.17.7931; Karachaliou N, 2010, ANN ONCOL, V21, P1729, DOI 10.1093/annonc/mdq328; Lambrechts D, 2012, LANCET ONCOL, V13, P724, DOI 10.1016/S1470-2045(12)70231-0; Laskin J, 2012, J THORAC ONCOL, V7, P203, DOI 10.1097/JTO.0b013e3182370e02; McKibbin T, 2008, ONCOLOGIST, V13, P876, DOI 10.1634/theoncologist.2008-0061; Mir O, 2011, ONCOLOGIST, V16, P1325, DOI 10.1634/theoncologist.2010-0002; Morita S, 2013, CANCER CHEMOTH PHARM, V71, P405, DOI 10.1007/s00280-012-2028-2; Osterlund P, 2011, BRIT J CANCER, V104, P599, DOI 10.1038/bjc.2011.2; Quipourt V, 2011, J AM GERIATR SOC, V59, P694, DOI 10.1111/j.1532-5415.2011.03334.x; Robinson ES, 2010, HYPERTENSION, V56, P1131, DOI 10.1161/HYPERTENSIONAHA.110.160481; Rosati G, 2013, CANCER CHEMOTH PHARM, V71, P257, DOI 10.1007/s00280-012-2004-x; Saloustros E, 2010, CASE REP ONCOL, V3, P368, DOI 10.1159/000321630; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Schneider BP, 2008, J CLIN ONCOL, V26, P4672, DOI 10.1200/JCO.2008.16.1612; Schuster C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038364; Tahover E, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0327-4	28	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116527	10.1371/journal.pone.0116527	http://dx.doi.org/10.1371/journal.pone.0116527			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602286	Green Submitted, Green Published, gold			2022-12-26	WOS:000348203500027
J	Guisoni, N; Ferrero, P; Layana, C; Diambra, L				Guisoni, Nara; Ferrero, Paola; Layana, Carla; Diambra, Luis			Abortive and Propagating Intracellular Calcium Waves: Analysis from a Hybrid Model	PLOS ONE			English	Article							XENOPUS-LAEVIS OOCYTES; CA2+ WAVES; INOSITOL TRISPHOSPHATE; ENDOPLASMIC-RETICULUM; CYTOSOLIC CALCIUM; GATED CHANNELS; IP3 RECEPTORS; RELEASE; COORDINATION; OSCILLATIONS	The functional properties of inositol(1,4,5)-triphosphate (IP3) receptors allow a variety of intracellular Ca2+ phenomena. In this way, global phenomena, such as propagating and abortive Ca2+ waves, as well as local events such as puffs, have been observed. Several experimental studies suggest that many features of global phenomena (e. g., frequency, amplitude, speed wave) depend on the interplay of biophysical processes such as diffusion, buffering, efflux and influx rates, which in turn depend on parameters such as buffer concentration, Ca2+ pump density, cytosolic IP3 level, and intercluster distance. Besides, it is known that cells are able to modify some of these parameters in order to regulate the Ca2+ signaling. By using a hybrid model, we analyzed different features of the hierarchy of calcium events as a function of two relevant parameters for the calcium signaling, the intercluster distance and the pump strength or intensity. In the space spanned by these two parameters, we found two modes of calcium dynamics, one dominated by abortive calcium waves and the other by propagating waves. Smaller distances between the release sites promote propagating calcium waves, while the increase of the efflux rate makes the transition from propagating to abortive waves occur at lower values of intercluster distance. We determined the frontier between these two modes, in the parameter space defined by the intercluster distance and the pump strength. Furthermore, we found that the velocity of simulated calcium waves accomplishes Luther's law, and that an effective rate constant for autocatalytic calcium production decays linearly with both the intercluster distance and the pump strength.	[Guisoni, Nara] Univ Nacl La Plata, CONICET, CCT La Plata, Inst Fis Liquidos & Sistemas Biol IFLYSIB, RA-1900 La Plata, Argentina; [Ferrero, Paola] Fac Ciencias Med, Ctr Invest Cardiovasc, RA-1900 La Plata, Argentina; [Layana, Carla; Diambra, Luis] Univ Nacl La Plata, CREG, RA-1900 La Plata, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of La Plata	Guisoni, N (corresponding author), Univ Nacl La Plata, CONICET, CCT La Plata, Inst Fis Liquidos & Sistemas Biol IFLYSIB, Calle 59-789, RA-1900 La Plata, Argentina.	naraguisoni@conicet.gov.ar; ldiambra@gmail.com	L, Diambra/F-6319-2015; Guisoni, Nara/AAV-8107-2020	L, Diambra/0000-0001-8052-4880; Guisoni, Nara/0000-0002-2025-7765; Ferrero, Paola/0000-0002-5582-642X; layana, carla/0000-0002-2313-2028	CONICET [PIP 0143]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research has been partially supported by CONICET (Grant: PIP 0143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar M, 2000, PHYS REV LETT, V84, P5664, DOI 10.1103/PhysRevLett.84.5664; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BEZPROZVANNY I, 1994, CELL CALCIUM, V16, P151, DOI 10.1016/0143-4160(94)90019-1; Bugrim AE, 1997, BIOPHYS J, V73, P2897, DOI 10.1016/S0006-3495(97)78318-8; Callamaras N, 1998, J PHYSIOL-LONDON, V509, P81, DOI 10.1111/j.1469-7793.1998.081bo.x; CAMACHO P, 1995, CELL, V82, P765, DOI 10.1016/0092-8674(95)90473-5; CAMACHO P, 1993, SCIENCE, V260, P226, DOI 10.1126/science.8385800; Chang JB, 2013, NATURE, V500, P603, DOI 10.1038/nature12321; Coombes S, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021915; Diambra L, 2005, CELL CALCIUM, V37, P321, DOI 10.1016/j.ceca.2004.12.001; Diambra L, 2011, BIOPHYS J, V100, P822, DOI 10.1016/j.bpj.2011.01.003; Diambra L, 2009, CHAOS, V19, DOI 10.1063/1.3147425; DUPONT G, 1994, BIOPHYS J, V67, P2191, DOI 10.1016/S0006-3495(94)80705-2; Falcke M, 2003, BIOPHYS J, V85, P1474, DOI 10.1016/S0006-3495(03)74580-9; Guisoni N, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061910; Guisoni N, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.061905; JAFFE LF, 1991, P NATL ACAD SCI USA, V88, P9883, DOI 10.1073/pnas.88.21.9883; Jaffe LF, 2008, PHILOS T R SOC B, V363, P1311, DOI 10.1098/rstb.2007.2249; Keizer J, 1998, BIOPHYS J, V75, P595, DOI 10.1016/S0006-3495(98)77550-2; Kupferman R, 1997, BIOPHYS J, V72, P2430, DOI 10.1016/S0006-3495(97)78888-X; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; Lechleiter JD, 1998, BIOPHYS CHEM, V72, P123, DOI 10.1016/S0301-4622(98)00128-8; Lopez L, 2014, BIOPHYS J, V106, p531A, DOI 10.1016/j.bpj.2013.11.2967; Lopez L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00350; Luther R, 1906, Z ELKTROCHEM ANGEW P, V12, P596, DOI 10.1002/bbpc.19060123208; Marchant J, 1999, EMBO J, V18, P5285, DOI 10.1093/emboj/18.19.5285; Marchant JS, 1997, CURR BIOL, V7, P510, DOI 10.1016/S0960-9822(06)00222-3; Nguyen T, 1998, NATURE, V395, P908, DOI 10.1038/27686; NOVAK B, 1993, J THEOR BIOL, V165, P101, DOI 10.1006/jtbi.1993.1179; OTHMER HG, 1993, OSCILLATIONS WAVES M, P277; Parker I, 1996, J PHYSIOL-LONDON, V491, P663, DOI 10.1113/jphysiol.1996.sp021247; Pencea CS, 2000, PHYS REV E, V62, P8420, DOI 10.1103/PhysRevE.62.8420; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHOWALTER K, 1987, J CHEM EDUC, V64, P742, DOI 10.1021/ed064p742; Solovey G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008997; Taylor CW, 2004, TRENDS BIOCHEM SCI, V29, P210, DOI 10.1016/j.tibs.2004.02.010; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Ur-Rahman T., 2009, NATURE, V458, P655, DOI [10.1038/nature07763, DOI 10.1038/NATURE07763]; YAO Y, 1995, J PHYSIOL-LONDON, V482, P533, DOI 10.1113/jphysiol.1995.sp020538; Zhao Q, 2009, PHYSICA A, V388, P4105, DOI 10.1016/j.physa.2009.06.033	40	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0115187	10.1371/journal.pone.0115187	http://dx.doi.org/10.1371/journal.pone.0115187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602295	Green Published, gold			2022-12-26	WOS:000348203500010
J	Hamashima, K; Mori, M; Andachi, Y; Tomita, M; Kohara, Y; Kanai, A				Hamashima, Kiyofumi; Mori, Masaru; Andachi, Yoshiki; Tomita, Masaru; Kohara, Yuji; Kanai, Akio			Analysis of Genetic Code Ambiguity Arising from Nematode-Specific Misacylated tRNAs	PLOS ONE			English	Article							AMINO-ACID; CAENORHABDITIS-ELEGANS; PROTEIN-SYNTHESIS; UNIFORM BINDING; SYNTHETASE; MISTRANSLATION; TRNA(LEU); LEUCINE; NEURODEGENERATION; RECOGNITION	The faithful translation of the genetic code requires the highly accurate aminoacylation of transfer RNAs (tRNAs). However, it has been shown that nematode-specific V-arm-containing tRNAs (nev-tRNAs) are misacylated with leucine in vitro in a manner that transgresses the genetic code. nev-tRNA(Gly) (CCC) and nev-tRNA(lle) (UAU), which are the major nev-tRNA isotypes, could theoretically decode the glycine (GGG) codon and isoleucine (AUA) codon as leucine, causing GGG and AUA codon ambiguity in nematode cells. To test this hypothesis, we investigated the functionality of nev-tRNAs and their impact on the proteome of Caenorhabditis elegans. Analysis of the nucleotide sequences in the 3' end regions of the nev-tRNAs showed that they had matured correctly, with the addition of CCA, which is a crucial post-transcriptional modification required for tRNA aminoacylation. The nuclear export of nev-tRNAs was confirmed with an analysis of their subcellular localization. These results show that nev-tRNAs are processed to their mature forms like common tRNAs and are available for translation. However, a whole-cell proteome analysis found no detectable level of nev-tRNA-induced mistranslation in C. elegans cells, suggesting that the genetic code is not ambiguous, at least under normal growth conditions. Our findings indicate that the translational fidelity of the nematode genetic code is strictly maintained, contrary to our expectations, although deviant tRNAs with misacylation properties are highly conserved in the nematode genome.	[Hamashima, Kiyofumi; Mori, Masaru; Tomita, Masaru; Kanai, Akio] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Hamashima, Kiyofumi; Mori, Masaru; Tomita, Masaru; Kanai, Akio] Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan; [Andachi, Yoshiki; Kohara, Yuji] Natl Inst Genet, Genome Biol Lab, Mishima, Shizuoka 411, Japan; [Andachi, Yoshiki; Kohara, Yuji] SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan; [Tomita, Masaru; Kanai, Akio] Keio Univ, Fac Environm & Informat Studies, Fujisawa, Kanagawa, Japan	Keio University; Keio University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Keio University	Kanai, A (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	akio@sfc.keio.ac.jp	Kanai, Akio/C-4921-2014	Kanai, Akio/0000-0002-6362-2419	Yamagata Prefectural Government and Tsuruoka City, Japan; Japan Society for the Promotion of Science; STFC [ST/K000853/1] Funding Source: UKRI	Yamagata Prefectural Government and Tsuruoka City, Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This research was supported, in part, by research funds from the Yamagata Prefectural Government and Tsuruoka City, Japan, and by a research grant from the Japan Society for the Promotion of Science (to KH). The funding bodies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, NUCLEIC ACIDS RES, V39, pD210, DOI 10.1093/nar/gkq1007; Bezerra AR, 2013, P NATL ACAD SCI USA, V110, P11079, DOI 10.1073/pnas.1302094110; BREITSCHOPF K, 1995, NUCLEIC ACIDS RES, V23, P3633, DOI 10.1093/nar/23.18.3633; BRENNER S, 1974, GENETICS, V77, P71; Creasy DM, 2002, PROTEOMICS, V2, P1426, DOI 10.1002/1615-9861(200210)2:10<1426::AID-PROT1426>3.0.CO;2-5; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Dunn JG, 2013, ELIFE, V2, DOI 10.7554/eLife.01179; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Fahlman RP, 2004, MOL CELL, V16, P799, DOI 10.1016/j.molcel.2004.10.030; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Hamashima Kiyofumi, 2013, Biomol Concepts, V4, P309, DOI 10.1515/bmc-2013-0002; Hamashima K, 2012, NUCLEIC ACIDS RES, V40, P3653, DOI 10.1093/nar/gkr1226; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Harris RP, 2014, CURR OPIN BIOTECH, V30, P45, DOI 10.1016/j.copbio.2014.05.003; Iben JR, 2012, RNA, V18, P1358, DOI 10.1261/rna.032151.111; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749; Javid B, 2014, P NATL ACAD SCI USA, V111, P1132, DOI 10.1073/pnas.1317580111; Jones TE, 2011, P NATL ACAD SCI USA, V108, P6933, DOI 10.1073/pnas.1019033108; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; MCCLAIN WH, 1993, J MOL BIOL, V234, P257, DOI 10.1006/jmbi.1993.1582; MITANI S, 1995, DEV GROWTH DIFFER, V37, P551; Moura GR, 2010, FEBS LETT, V584, P334, DOI 10.1016/j.febslet.2009.11.066; Moura GR, 2009, CURR OPIN MICROBIOL, V12, P631, DOI 10.1016/j.mib.2009.09.004; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Pan T, 2013, ANNU REV GENET, V47, P121, DOI 10.1146/annurev-genet-111212-133522; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Reynolds NM, 2010, NAT REV MICROBIOL, V8, P849, DOI 10.1038/nrmicro2472; de Pouplana LR, 2014, TRENDS BIOCHEM SCI, V39, P355, DOI 10.1016/j.tibs.2014.06.002; Santos MAS, 1999, MOL MICROBIOL, V31, P937, DOI 10.1046/j.1365-2958.1999.01233.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SOLL D, 1988, NATURE, V331, P662; Soma A, 1999, J MOL BIOL, V293, P1029, DOI 10.1006/jmbi.1999.3219; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Sugita T, 1999, SYST APPL MICROBIOL, V22, P79, DOI 10.1016/S0723-2020(99)80030-7; Wiltrout E, 2012, NUCLEIC ACIDS RES, V40, P10494, DOI 10.1093/nar/gks805; Yu XC, 2009, ANAL CHEM, V81, P9282, DOI 10.1021/ac901541h; Zhang ZQ, 2013, BIOCHEMISTRY-US, V52, P8165, DOI 10.1021/bi401002c; Zisoulis DG, 2012, NATURE, V486, P541, DOI 10.1038/nature11134	45	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116981	10.1371/journal.pone.0116981	http://dx.doi.org/10.1371/journal.pone.0116981			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602944	gold, Green Published, Green Submitted			2022-12-26	WOS:000348203500039
J	Kanageswaran, N; Demond, M; Nagel, M; Schreiner, BSP; Baumgart, S; Scholz, P; Altmuller, J; Becker, C; Doerner, JF; Conrad, H; Oberland, S; Wetzel, CH; Neuhaus, EM; Hatt, H; Gisselmann, G				Kanageswaran, Ninthujah; Demond, Marilen; Nagel, Maximilian; Schreiner, Benjamin S. P.; Baumgart, Sabrina; Scholz, Paul; Altmueller, Janine; Becker, Christian; Doerner, Julia F.; Conrad, Heike; Oberland, Sonja; Wetzel, Christian H.; Neuhaus, Eva M.; Hatt, Hanns; Gisselmann, Guenter			Deep Sequencing of the Murine Olfactory Receptor Neuron Transcriptome	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; EXCHANGER REGULATORY FACTOR; MAMMALIAN ODORANT RECEPTORS; PROTEIN-COUPLED RECEPTORS; NUCLEOTIDE-GATED CHANNELS; BETA-GAMMA-SUBUNITS; G-ALPHA-OLF; SENSORY NEURONS; SIGNAL-TRANSDUCTION; RNA-SEQ	The ability of animals to sense and differentiate among thousands of odorants relies on a large set of olfactory receptors (OR) and a multitude of accessory proteins within the olfactory epithelium (OE). ORs and related signaling mechanisms have been the subject of intensive studies over the past years, but our knowledge regarding olfactory processing remains limited. The recent development of next generation sequencing (NGS) techniques encouraged us to assess the transcriptome of the murine OE. We analyzed RNA from OEs of female and male adult mice and from fluorescence-activated cell sorting (FACS)-sorted olfactory receptor neurons (ORNs) obtained from transgenic OMP-GFP mice. The Illumina RNA-Seq protocol was utilized to generate up to 86 million reads per transcriptome. In OE samples, nearly all OR and trace amine-associated receptor (TAAR) genes involved in the perception of volatile amines were detectably expressed. Other genes known to participate in olfactory signaling pathways were among the 200 genes with the highest expression levels in the OE. To identify OE-specific genes, we compared olfactory neuron expression profiles with RNA-Seq transcriptome data from different murine tissues. By analyzing different transcript classes, we detected the expression of non-olfactory GPCRs in ORNs and established an expression ranking for GPCRs detected in the OE. We also identified other previously undescribed membrane proteins as potential new players in olfaction. The quantitative and comprehensive transcriptome data provide a virtually complete catalogue of genes expressed in the OE and present a useful tool to uncover candidate genes involved in, for example, olfactory signaling, OR trafficking and recycling, and proliferation.	[Kanageswaran, Ninthujah; Demond, Marilen; Nagel, Maximilian; Schreiner, Benjamin S. P.; Baumgart, Sabrina; Scholz, Paul; Doerner, Julia F.; Conrad, Heike; Hatt, Hanns; Gisselmann, Guenter] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany; [Demond, Marilen] Univ Duisburg Essen, Inst Med Radiat Biol, Essen, Germany; [Altmueller, Janine; Becker, Christian] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Conrad, Heike] Cluster Excellence, Gottingen, Germany; [Conrad, Heike] DFG Res Ctr Nanoscale Microscopy & Mol Physiol Br, Gottingen, Germany; [Oberland, Sonja; Neuhaus, Eva M.] Univ Hosp Jena, Pharmacol & Toxicol, D-07747 Jena, Germany; [Oberland, Sonja; Neuhaus, Eva M.] Charite, Cluster Excellence NeuroCure, D-10117 Berlin, Germany; [Wetzel, Christian H.] Univ Regensburg, Dept Psychiat & Psychotherapy, Mol Neurosci, D-93053 Regensburg, Germany	Ruhr University Bochum; University of Duisburg Essen; University of Cologne; Friedrich Schiller University of Jena; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Regensburg	Kanageswaran, N (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Univ Str 150, Bochum, Germany.	ninthujah@hotmail.com	Wetzel, Christian/F-1366-2018; Wetzel, Christian/C-2501-2009; Neuhaus, Eva M./L-1428-2015; Wetzel, Christian H/N-9880-2017	Wetzel, Christian/0000-0002-5762-0003; Neuhaus, Eva M./0000-0003-3363-1231; Wetzel, Christian H/0000-0002-5762-0003; Altmuller, Janine/0000-0003-4372-1521	DFG [Sonderforschungsbereich 642]	DFG(German Research Foundation (DFG))	Hanns Hatt was funded by the DFG-Sonderforschungsbereich 642 "GTP- and ATP dependent membrane processes". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ache BW, 2010, CHEM SENSES, V35, P533, DOI 10.1093/chemse/bjq045; Ango F, 2000, J NEUROSCI, V20, P8710; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; ANHOLT RRH, 1987, BIOCHEMISTRY-US, V26, P788, DOI 10.1021/bi00377a020; Armstrong A, 2011, J NEUROSCI, V31, P2371, DOI 10.1523/JNEUROSCI.4243-10.2011; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Barbour J, 2008, J PROTEOME RES, V7, P1594, DOI 10.1021/pr7005796; Barros SA, 2003, GENE, V307, P191, DOI 10.1016/S0378-1119(03)00465-7; Bassani S, 2012, NEURON, V73, P1143, DOI 10.1016/j.neuron.2012.01.021; Bates-Withers C, 2011, ADV EXP MED BIOL, V704, P173, DOI 10.1007/978-94-007-0265-3_9; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; BOEKHOFF I, 1994, J BIOL CHEM, V269, P37; BOEKHOFF I, 1992, P NATL ACAD SCI USA, V89, P471, DOI 10.1073/pnas.89.2.471; Bruch RC, 1996, COMP BIOCHEM PHYS B, V113, P451, DOI 10.1016/0305-0491(95)02040-3; Brunert D, 2010, CHEM SENSES, V35, P301, DOI 10.1093/chemse/bjq020; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cao SL, 2006, BIOCHEM BIOPH RES CO, V345, P310, DOI 10.1016/j.bbrc.2006.04.091; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chadli A, 2006, MOL CELL BIOL, V26, P1722, DOI 10.1128/MCB.26.5.1722-1730.2006; Chang JT, 2012, DEV BIOL, V368, P312, DOI 10.1016/j.ydbio.2012.05.034; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Chaudhari N, 2009, AM J CLIN NUTR, V90, p738S, DOI 10.3945/ajcn.2009.27462H; CHERRY JA, 1995, J NEUROBIOL, V28, P102, DOI 10.1002/neu.480280109; Cintron NS, 2006, J BIOL CHEM, V281, P26235, DOI 10.1074/jbc.M605417200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cote RH, 2004, INT J IMPOT RES, V16, pS28, DOI 10.1038/sj.ijir.3901212; Cote Rick H., 2005, V307, P141; CUNNINGHAM AM, 1993, NEUROSCIENCE, V57, P339, DOI 10.1016/0306-4522(93)90067-P; Cygnar KD, 2009, NAT NEUROSCI, V12, P454, DOI 10.1038/nn.2289; DAVIS RL, 1995, MOL CELL BIOCHEM, V149, P271, DOI 10.1007/BF01076588; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; DeMaria S, 2010, J CELL BIOL, V191, P443, DOI 10.1083/jcb.201008163; Dooley R, 2009, FEBS J, V276, P7279, DOI 10.1111/j.1742-4658.2009.07435.x; Dubacq C, 2009, J NEUROSCI, V29, P10184, DOI 10.1523/JNEUROSCI.2443-09.2009; Eldstrom J, 2002, FEBS LETT, V531, P529, DOI 10.1016/S0014-5793(02)03572-X; Elsaesser R, 2005, EUR J NEUROSCI, V21, P2692, DOI 10.1111/j.1460-9568.2005.04108.x; Engel KMY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029400; FADOOL DA, 1992, NEURON, V9, P907, DOI 10.1016/0896-6273(92)90243-7; FIRESTEIN S, 1990, J PHYSIOL-LONDON, V430, P135, DOI 10.1113/jphysiol.1990.sp018286; Fried HU, 2010, CELL TISSUE RES, V339, P463, DOI 10.1007/s00441-009-0904-9; FULLE HJ, 1995, P NATL ACAD SCI USA, V92, P3571, DOI 10.1073/pnas.92.8.3571; Garitaonandia I, 2009, J RECEPT SIG TRANSD, V29, P67, DOI 10.1080/10799890902729456; Geisert EE, 2009, MOL VIS, V15, P1730; Gloriam DE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-338; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Goldstein BJ, 2003, JARO-J ASSOC RES OTO, V4, P74, DOI 10.1007/s10162-002-2039-5; GRAZIADEI GAM, 1979, J NEUROCYTOL, V8, P197; Hagendorf S, 2009, J NEUROSCI, V29, P206, DOI 10.1523/JNEUROSCI.3656-08.2009; Hague C, 2004, MOL INTERV, V4, P321, DOI 10.1124/mi.4.6.4; Hahn Y, 2009, INT J MOL MED, V24, P51, DOI 10.3892/ijmm_00000205; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hardman RM, 2009, J PHYSIOL-LONDON, V587, P2487, DOI 10.1113/jphysiol.2009.170548; Harr B, 2010, MOL ECOL, V19, P228, DOI 10.1111/j.1365-294X.2009.04490.x; Hass N, 2008, CELL TISSUE RES, V334, P187, DOI 10.1007/s00441-008-0677-6; Heldens L, 2010, CELL MOL LIFE SCI, V67, P4035, DOI 10.1007/s00018-010-0430-7; Hengl T, 2010, P NATL ACAD SCI USA, V107, P6052, DOI 10.1073/pnas.0909032107; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Huard JMT, 1998, J COMP NEUROL, V400, P469; Hwang JI, 2000, J BIOL CHEM, V275, P16632, DOI 10.1074/jbc.M001410200; Irmer H, 1997, J BIOL CHEM, V272, P2230; Jacobsson JA, 2007, GENOMICS, V90, P595, DOI 10.1016/j.ygeno.2007.03.017; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Jin J, 2012, P NATL ACAD SCI USA, V109, pE225, DOI 10.1073/pnas.1120033109; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Juilfs DM, 1997, P NATL ACAD SCI USA, V94, P3388, DOI 10.1073/pnas.94.7.3388; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; KALINOSKI DL, 1992, BIOCHEM J, V281, P449, DOI 10.1042/bj2810449; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; Kelliher KR, 2003, P NATL ACAD SCI USA, V100, P4299, DOI 10.1073/pnas.0736071100; Kerr DS, 2008, MOL CELL NEUROSCI, V38, P341, DOI 10.1016/j.mcn.2008.03.006; Kerstein PC, 2013, J NEUROSCI, V33, P273, DOI 10.1523/JNEUROSCI.2142-12.2013; Keydar I, 2013, HUM MUTAT, V34, P32, DOI 10.1002/humu.22212; Khan M, 2011, CELL, V147, P907, DOI 10.1016/j.cell.2011.09.049; Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Klasen K, 2010, CELL SIGNAL, V22, P150, DOI 10.1016/j.cellsig.2009.09.026; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Klimmeck D, 2008, NEUROSCIENCE, V151, P901, DOI 10.1016/j.neuroscience.2007.11.023; Kolmakov NN, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-429; KREAM RM, 1984, J NEUROSCI, V4, P868; Kurtenbach S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-234; Lai Peter C., 2008, Journal of Structural and Functional Genomics, V9, P29, DOI 10.1007/s10969-008-9043-x; Langenhan T, 2010, ADV EXP MED BIOL, V706, P37; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lesage F, 2000, J BIOL CHEM, V275, P28398, DOI 10.1074/jbc.M002822200; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Li YR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001230; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Lin W, 2007, P NATL ACAD SCI USA, V104, P2471, DOI 10.1073/pnas.0610201104; Ling GY, 2004, CHEM-BIOL INTERACT, V147, P247, DOI 10.1016/j.cbi.2004.02.003; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Liu L, 2008, J BIOL CHEM, V283, P13185, DOI 10.1074/jbc.M800757200; Madsen CP, 2012, AM J PHYSIOL-CELL PH, V303, pC625, DOI 10.1152/ajpcell.00287.2011; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MARGOLIS FL, 1991, PROG BRAIN RES, V89, P97; Mashukova A, 2006, J NEUROSCI, V26, P9902, DOI 10.1523/JNEUROSCI.2897-06.2006; Mast TG, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-61; Mayer U, 2008, CHEM SENSES, V33, P145, DOI 10.1093/chemse/bjm073; Mayer U, 2009, PROTEOMICS, V9, P322, DOI 10.1002/pmic.200800149; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; MENINI A, 1995, BIOPHYS CHEM, V55, P185, DOI 10.1016/0301-4622(94)00153-B; Menini A, 1999, CURR OPIN NEUROBIOL, V9, P419, DOI 10.1016/S0959-4388(99)80063-4; Michalakis S, 2006, J BIOL CHEM, V281, P35156, DOI 10.1074/jbc.M606409200; Michibata H, 2009, STEM CELLS DEV, V18, P629, DOI 10.1089/scd.2008.0215; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munger SD, 2000, J BIOL CHEM, V275, P20450, DOI 10.1074/jbc.M001989200; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Nancy V, 2002, J BIOL CHEM, V277, P15076, DOI 10.1074/jbc.M109983200; Nepravishta R, 2012, METALLOMICS, V4, P480, DOI 10.1039/c2mt20035j; Neuhaus EM, 2006, CHEM SENSES, V31, P445, DOI 10.1093/chemse/bjj049; Neuhaus EM, 2006, J CELL SCI, V119, P3047, DOI 10.1242/jcs.03046; Nickell MD, 2012, J COMP NEUROL, V520, P2608, DOI 10.1002/cne.23052; Nickell WT, 2007, J PHYSIOL-LONDON, V583, P1005, DOI 10.1113/jphysiol.2007.129601; Niedernberg A, 2003, CELL SIGNAL, V15, P435, DOI 10.1016/S0898-6568(02)00119-5; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Nikolova S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-146; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Nisar SP, 2012, J BIOL CHEM, V287, P24505, DOI 10.1074/jbc.M112.347104; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Ohmoto M, 2008, MOL CELL NEUROSCI, V38, P505, DOI 10.1016/j.mcn.2008.04.011; Olianas MC, 1999, BIOCHEM PHARMACOL, V57, P649, DOI 10.1016/S0006-2952(98)00326-8; Oort PJ, 2007, MOL CELL ENDOCRINOL, V276, P24, DOI 10.1016/j.mce.2007.06.005; Palty R, 2012, CELL, V149, P425, DOI 10.1016/j.cell.2012.01.055; Peppel K, 1997, J BIOL CHEM, V272, P25425, DOI 10.1074/jbc.272.41.25425; PES D, 1995, COMP BIOCHEM PHYS B, V112, P471, DOI 10.1016/0305-0491(95)00063-1; Pho V, 2005, BEHAV BRAIN RES, V161, P245, DOI 10.1016/j.bbr.2005.02.011; Pifferi S, 2006, FEBS LETT, V580, P2853, DOI 10.1016/j.febslet.2006.03.086; Pifferi S, 2009, J PHYSIOL-LONDON, V587, P4265, DOI 10.1113/jphysiol.2009.176131; Pluznick JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019694; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Priest CA, 2004, J NEUROBIOL, V60, P154, DOI 10.1002/neu.20011; Radhakrishnan K, 2011, CELL PHYSIOL BIOCHEM, V28, P603, DOI 10.1159/000335756; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Rengaraj D, 2011, DEV DYNAM, V240, P850, DOI 10.1002/dvdy.22575; RESTREPO D, 1992, AM J PHYSIOL, V263, pC667, DOI 10.1152/ajpcell.1992.263.3.C667; RESTREPO D, 1990, SCIENCE, V249, P1166, DOI 10.1126/science.2168580; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Sammeta N, 2007, J COMP NEUROL, V502, P1138, DOI 10.1002/cne.21365; Sammeta N, 2010, MOL CELL NEUROSCI, V45, P398, DOI 10.1016/j.mcn.2010.07.013; Savigner A, 2009, J NEUROPHYSIOL, V101, P2898, DOI 10.1152/jn.91169.2008; SCHLEICHER S, 1993, P NATL ACAD SCI USA, V90, P1420, DOI 10.1073/pnas.90.4.1420; Schobel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048005; SCHULTZ J, 1990, MOL CELL BIOL, V10, P4744, DOI 10.1128/MCB.10.9.4744; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shiao MS, 2012, GENOME BIOL EVOL, V4, P703, DOI 10.1093/gbe/evs039; SIKORSKI RS, 1991, COLD SH Q B, V56, P663; Spehr M, 2002, NEURON, V33, P731, DOI 10.1016/S0896-6273(02)00610-4; Sreedharan S, 2011, FEBS J, V278, P4881, DOI 10.1111/j.1742-4658.2011.08388.x; Stephan AB, 2012, NAT NEUROSCI, V15, P131, DOI 10.1038/nn.2943; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Storch U, 2012, J BIOL CHEM, V287, P3530, DOI 10.1074/jbc.M111.283218; Sugasawa T, 2001, GENE, V273, P227, DOI 10.1016/S0378-1119(01)00587-X; Takami S, 2001, CHEM SENSES, V26, P517, DOI 10.1093/chemse/26.5.517; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Tillerson JL, 2006, BEHAV BRAIN RES, V172, P97, DOI 10.1016/j.bbr.2006.04.025; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trifonov S, 2012, EUR J NEUROSCI, V35, P711, DOI 10.1111/j.1460-9568.2012.08001.x; Ukhanov K, 2011, J NEUROSCI, V31, P273, DOI 10.1523/JNEUROSCI.3698-10.2011; Ukhanov K, 2010, J NEUROPHYSIOL, V103, P1114, DOI 10.1152/jn.00980.2009; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; Von Dannecker LEC, 2005, J NEUROSCI, V25, P3793, DOI 10.1523/JNEUROSCI.4595-04.2005; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Wakabayashi Y, 2002, CHEM SENSES, V27, P207, DOI 10.1093/chemse/27.3.207; Wei J, 1996, J BIOL CHEM, V271, P24231, DOI 10.1074/jbc.271.39.24231; Weiss J, 2011, NATURE, V472, P186, DOI 10.1038/nature09975; Wheeler D, 2008, MOL ENDOCRINOL, V22, P1163, DOI 10.1210/me.2007-0461; Xiang MH, 2005, J BIOL CHEM, V280, P11608, DOI 10.1074/jbc.M413116200; Xu FQ, 2005, J COMP NEUROL, V489, P491, DOI 10.1002/cne.20652; YAN C, 1995, P NATL ACAD SCI USA, V92, P9677, DOI 10.1073/pnas.92.21.9677; Yan C, 1996, J BIOL CHEM, V271, P25699, DOI 10.1074/jbc.271.41.25699; Yu HMI, 2010, DEV DYNAM, V239, P2102, DOI 10.1002/dvdy.22336; Yu TT, 2005, J COMP NEUROL, V483, P251, DOI 10.1002/cne.20429; Zhainazarov AB, 2001, J NEUROPHYSIOL, V85, P2537, DOI 10.1152/jn.2001.85.6.2537; Zhang XF, 2010, NAT NEUROSCI, V13, P1056, DOI 10.1038/nn.2610; Zhao J, 2008, MOL VIS, V14, P1623; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zou AR, 2003, AM J PHYSIOL-CELL PH, V285, pC1356, DOI 10.1152/ajpcell.00179.2003; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473; Zufall F, 2005, Naunyn Schmiedebergs Arch Pharmacol, V371, P245, DOI 10.1007/s00210-005-1028-8; Zufall F, 2002, MICROSC RES TECHNIQ, V58, P251, DOI 10.1002/jemt.10152	201	53	55	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0113170	10.1371/journal.pone.0113170	http://dx.doi.org/10.1371/journal.pone.0113170			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590618	Green Published, Green Submitted, gold			2022-12-26	WOS:000350679400001
J	Beasley, JC; Atwood, TC; Byrne, ME; Vercauteren, KC; Johnson, SR; Rhodes, OE				Beasley, James C.; Atwood, Todd C.; Byrne, Michael E.; Vercauteren, Kurt C.; Johnson, Shylo R.; Rhodes, Olin E., Jr.			A Behaviorally-Explicit Approach for Delivering Vaccine Baits to Mesopredators to Control Epizootics in Fragmented Landscapes	PLOS ONE			English	Article							ORAL RABIES VACCINATION; STRIPED SKUNKS; HABITAT SELECTION; ONRAB(R) BAITS; RHODAMINE-B; RACCOONS; FOXES; ATTRIBUTES; DENSITY; POPULATION	Despite the widespread use of aerial baiting to manage epizootics among free-ranging populations, particularly in rabies management, bait acceptance and seroconversion rates often are lower than required to eliminate spread of disease. Our objectives in this study, therefore, were to evaluate the performance of stratified bait distribution models derived from resource selection functions (RSF) on uptake of placebo rabies baits by raccoons (Procyon lotor) and Virginia opossums (Didelphis virginiana), as well as the probability of bait uptake as a function of proximity to bait distribution areas in fragmented agricultural ecosystems. Among 478 raccoons and 108 opossums evaluated for presence of Rhodamine B (RB) across 8 sites, only 26% of raccoons and 20% of opossums exhibited marking consistent with bait consumption 14-24 days post-baiting. The effective area treated, based on 90% kernel density estimators of marked individuals, ranged from 99-240 ha larger than bait distribution zones, with RB marked individuals captured up to 753m beyond the bait zone. Despite incorporation of RSF data into bait distribution models, no differences in uptake rates were observed between treatment and control sites. These data likely reflect the underlying constraints imposed by the loss and fragmentation of habitat on animal movement in heterogeneous landscapes, forcing individuals to optimize movements at coarse (i.e., patch-level) rather than fine spatial scales in highly fragmented environments. Our data also confirm that the probability of bait acceptance decreases with increasing distance from bait zone interiors, even within the zone itself. Thus, although bait acceptance was confirmed beyond bait zone boundaries, the proportion of vaccinated individuals may comprise a small minority of the population at increasing distances from baiting interiors. These data suggest focal baiting creates a buffered area of treated individuals around bait zones or bait stations, but repeated treatments may be needed to achieve sufficient uptake to eradicate disease.	[Beasley, James C.; Byrne, Michael E.; Rhodes, Olin E., Jr.] Univ Georgia, Savannah River Ecol Lab, Aiken, SC 29802 USA; [Atwood, Todd C.; Vercauteren, Kurt C.; Johnson, Shylo R.] USDA, APHIS Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA	United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA)	Beasley, JC (corresponding author), Univ Georgia, Savannah River Ecol Lab, Aiken, SC 29802 USA.	beasley@srel.uga.edu			U.S. Department of Agriculture, Animal Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center; U.S. Department of Agriculture, Animal Plant Health Inspection Service, Wildlife Services, National Rabies Management Program; Department of Forestry and Natural Resources at Purdue University; U.S. Department of Energy [DE-FC09-07SR22506]	U.S. Department of Agriculture, Animal Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center; U.S. Department of Agriculture, Animal Plant Health Inspection Service, Wildlife Services, National Rabies Management Program; Department of Forestry and Natural Resources at Purdue University; U.S. Department of Energy(United States Department of Energy (DOE))	Funding for this research was provided by the U.S. Department of Agriculture, Animal Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center (http://www.aphis.usda.gov/wildlife_damage/nwrc), the U.S. Department of Agriculture, Animal Plant Health Inspection Service, Wildlife Services, National Rabies Management Program, the Department of Forestry and Natural Resources at Purdue University, and the U.S. Department of Energy under Award Number DE-FC09-07SR22506 to the University of Georgia Research Foundation. Researchers at the USDA-APHIS National Wildlife Research Center participated in the design of this study and preparation of the manuscript.	Atwood TC, 2009, J WILDLIFE MANAGE, V73, P647, DOI 10.2193/2008-215; Beasley JC, 2010, CAN J ZOOL, V88, P161, DOI 10.1139/Z09-137; Beasley JC, 2007, J WILDLIFE MANAGE, V71, P1125, DOI 10.2193/2006-228; Beasley JC, 2007, J WILDLIFE MANAGE, V71, P844, DOI 10.2193/2006-022; Beasley JC, 2012, J WILDLIFE MANAGE, V76, P1290, DOI 10.1002/jwmg.379; Beasley JC, 2011, LANDSCAPE ECOL, V26, P937, DOI 10.1007/s10980-011-9619-x; Beatty WS, 2014, CAN J ZOOL, V92, P41, DOI 10.1139/cjz-2013-0225; Blancou J, 2008, DEV BIOLOGICALS, V131, P3; Blanton JD, 2011, JAVMA-J AM VET MED A, V239, P773, DOI 10.2460/javma.239.6.773; Boyer JP, 2011, J WILDLIFE DIS, V47, P593, DOI 10.7589/0090-3558-47.3.593; Burnham K. P., 2002, MODEL SELECTION AND; Byrne ME, 2012, ANIM BEHAV, V84, P593, DOI 10.1016/j.anbehav.2012.06.012; Cagnacci F, 2007, WILDLIFE RES, V34, P454, DOI 10.1071/WR07026; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cliquet F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001535; Fehlner-Gardiner C, 2012, J WILDLIFE DIS, V48, P157, DOI 10.7589/0090-3558-48.1.157; Freuling CM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0142; Fry Tricia L., 2010, Human-Wildlife Interactions, V4, P275; Gehrt S. D., 2003, WILD MAMMALS N AM BI, P611; Gross J, 2012, URBAN ECOSYST, V15, P667, DOI 10.1007/s11252-011-0218-z; Hegglin D, 2003, EMERG INFECT DIS, V9, P1266; Hegglin D, 2008, EMERG INFECT DIS, V14, P1626, DOI 10.3201/eid1410.080522; Henner CM, 2004, J WILDLIFE MANAGE, V68, P179, DOI 10.2193/0022-541X(2004)068[0179:AMAORD]2.0.CO;2; Hosmer DW, 1997, STAT MED, V16, P965; Houle M, 2011, CAN J ZOOL, V89, P1107, DOI [10.1139/Z11-085, 10.1139/z11-085]; Kelly DJ, 2011, EUR J WILDLIFE RES, V57, P767, DOI 10.1007/s10344-010-0485-7; Konig A, 2012, WILDLIFE RES, V39, P488, DOI 10.1071/WR11077; Linhart SB, 2002, J WILDLIFE DIS, V38, P363, DOI 10.7589/0090-3558-38.2.363; Mainguy J, 2012, J WILDLIFE DIS, V48, P979, DOI 10.7589/2011-12-316; Mulatti P, 2011, GEOSPATIAL HEALTH, V5, P217, DOI 10.4081/gh.2011.174; Page K, 2011, EMERG INFECT DIS, V17, P90, DOI 10.3201/eid1701.100876; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; R Development Core Team, 2014, R LANG ENV STAT COMP; Ramey PC, 2008, J WILDLIFE DIS, V44, P553, DOI 10.7589/0090-3558-44.3.553; Recuenco S, 2009, ZOONOSES PUBLIC HLTH, V56, P16, DOI 10.1111/j.1863-2378.2008.01168.x; Rosatte RC, 2011, J WILDLIFE DIS, V47, P459, DOI 10.7589/0090-3558-47.2.459; Rosatte RC, 2009, J WILDLIFE DIS, V45, P363, DOI 10.7589/0090-3558-45.2.363; Sattler AC, 2009, VACCINE, V27, P7187, DOI 10.1016/j.vaccine.2009.09.035; Selhorst T, 2012, BERL MUNCH TIERARZTL, V125, P191, DOI 10.2376/0005-9366-125-191; Sidwa TJ, 2005, JAVMA-J AM VET MED A, V227, P785, DOI 10.2460/javma.2005.227.785; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Slate D, 2005, VIRUS RES, V111, P68, DOI 10.1016/j.virusres.2005.03.012; Slate D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000549; Smyser TJ, 2013, J WILDLIFE MANAGE, V77, P1372, DOI 10.1002/jwmg.585; Smyser TJ, 2010, J WILDLIFE MANAGE, V74, P1405, DOI 10.2193/2009-299; Sterner RT, 2009, EMERG INFECT DIS, V15, P1176, DOI 10.3201/eid1508.081061; Thulke HH, 2008, DEV BIOLOGICALS, V131, P291; Tinline R. R., 2007, ONTARIO RABIES MODEL; Tsukada H, 2002, PARASITOLOGY, V125, P119, DOI 10.1017/S0031182002001968; Vos A, 2004, BERL MUNCH TIERARZTL, V117, P360; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	51	9	9	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0113206	10.1371/journal.pone.0113206	http://dx.doi.org/10.1371/journal.pone.0113206			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587900	gold, Green Published, Green Submitted			2022-12-26	WOS:000347928300002
J	Cerbini, T; Funahashl, R; Luo, YQ; Liu, CY; Park, K; Rao, M; Malik, N; Zou, JH				Cerbini, Trevor; Funahashl, Ray; Luo, Yongquan; Liu, Chengyu; Park, Kyeyoon; Rao, Mahendra; Malik, Nasir; Zou, Jizhong			Transcription Activator-Like Effector Nuclease (TALEN)-Mediated CLYBL Targeting Enables Enhanced Transgene Expression and One-Step Generation of Dual Reporter Human Induced Pluripotent Stem Cell (iPSC) and Neural Stem Cell (NSC) Lines	PLOS ONE			English	Article							GENE CORRECTION; DISEASE; TALEN; SPECIFICITY; MUTATIONS; CLONES; CAS9	Targeted genome engineering to robustly express transgenes is an essential methodology for stem cell-based research and therapy. Although designer nucleases have been used to drastically enhance gene editing efficiency, targeted addition and stable expression of transgenes to date is limited at single gene/locus and mostly PPP1R12C/AAVS1 in human stem cells. Here we constructed transcription activator-like effector nucleases (TALENs) targeting the safe-harbor like gene CLYBL to mediate reporter gene integration at 38%-58% efficiency, and used both AAVS1-TALENs and CLYBL-TALENs to simultaneously knock-in multiple reporter genes at dual safe-harbor loci in human induced pluripotent stem cells (iPSCs) and neural stem cells (NSCs). The CLYBL-TALEN engineered cell lines maintained robust reporter expression during self-renewal and differentiation, and revealed that CLYBL targeting resulted in stronger transgene expression and less perturbation on local gene expression than PPP1R12C/AAVS1. TALEN-mediated CLYBL engineering provides improved transgene expression and options for multiple genetic modification in human stem cells.	[Cerbini, Trevor; Funahashl, Ray; Luo, Yongquan; Rao, Mahendra; Malik, Nasir; Zou, Jizhong] NIAMSD, NIH, Ctr Regenerat Med, Lab Stem Cell Biol, Bethesda, MD 20892 USA; [Liu, Chengyu; Zou, Jizhong] NHLBI, Ctr Mol Med, Div Intramural Res, Bethesda, MD 20892 USA; [Park, Kyeyoon] NINDS, Stem Cell Unit, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Zou, JH (corresponding author), NIAMSD, NIH, Ctr Regenerat Med, Lab Stem Cell Biol, Bethesda, MD 20892 USA.	zouj2@mail.nih.gov		Zou, Jizhong/0000-0003-1021-0549	National Institutes of Health Common Fund; National Heart, Lung, and Blood Institute; National Institute of Neurological Disorders and Stroke; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005907, ZICHL006145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZICNS003008] Funding Source: NIH RePORTER	National Institutes of Health Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institutes of Health Common Fund and Intramural Research Programs of the National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown AJ, 2013, NAT METHODS, V10, P638, DOI 10.1038/nmeth.2516; Chen SJ, 2013, NUCLEIC ACIDS RES, V41, P2769, DOI 10.1093/nar/gks1356; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Du ZW, 2009, STEM CELLS, V27, P1032, DOI 10.1002/stem.38; Eyquem J, 2013, BIOTECHNOL BIOENG, V110, P2225, DOI 10.1002/bit.24892; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Grau J, 2013, BIOINFORMATICS, V29, P2931, DOI 10.1093/bioinformatics/btt501; Guilinger JP, 2014, NAT METHODS, V11, P429, DOI 10.1038/nmeth.2845; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Liu Y, 2009, STEM CELLS DEV, V18, P1459, DOI 10.1089/scd.2009.0047; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Luo YQ, 2014, STEM CELL TRANSL MED, V3, P821, DOI 10.5966/sctm.2013-0212; Ma AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065259; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Papapetrou EP, 2011, NAT BIOTECHNOL, V29, P73, DOI 10.1038/nbt.1717; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Swistowski A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006233; Thyagarajan B, 2008, STEM CELLS, V26, P119, DOI 10.1634/stemcells.2007-0283; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang YM, 2012, CIRC RES, V111, P1494, DOI 10.1161/CIRCRESAHA.112.274969; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554; Zou JZ, 2011, BLOOD, V117, P5561, DOI 10.1182/blood-2010-12-328161; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	32	46	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116032	10.1371/journal.pone.0116032	http://dx.doi.org/10.1371/journal.pone.0116032			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587899	Green Published, gold, Green Submitted			2022-12-26	WOS:000347928300008
J	Sorensen, MCH; Gencay, YE; Birk, T; Baldvinsson, SB; Jackel, C; Hammerl, JA; Vegge, CS; Neve, H; Brondsted, L				Sorensen, Martine C. Holst; Gencay, Yilmaz Emre; Birk, Tina; Baldvinsson, Signe Berg; Jaeckel, Claudia; Hammerl, Jens A.; Vegge, Christina S.; Neve, Horst; Brondsted, Lone			Primary Isolation Strain Determines Both Phage Type and Receptors Recognised by Campylobacter jejuni Bacteriophages	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; FREE-RANGE; CHICKEN SKIN; COLI; INFECTION; DIVERSITY; SURFACE; GENOME; LIPOOLIGOSACCHARIDE; IDENTIFICATION	In this study we isolated novel bacteriophages, infecting the zoonotic bacterium Campylobacter jejuni. These phages may be used in phage therapy of C. jejuni colonized poultry to prevent spreading of the bacteria to meat products causing disease in humans. Many C. jejuni phages have been isolated using NCTC12662 as the indicator strain, which may have biased the selection of phages. A large group of C. jejuni phages rely on the highly diverse capsular polysaccharide (CPS) for infection and recent work identified the O-methyl phosphoramidate modification (MeOPN) of CPS as a phage receptor. We therefore chose seven C. jejuni strains each expressing different CPS structures as indicator strains in a large screening for phages in samples collected from free-range poultry farms. Forty-three phages were isolated using C. jejuni NCTC12658, NCTC12662 and RM1221 as host strains and 20 distinct phages were identified based on host range analysis and genome restriction profiles. Most phages were isolated using C. jejuni strains NCTC12662 and RM1221 and interestingly phage genome size (140 kb vs. 190 kb), host range and morphological appearance correlated with the isolation strain. Thus, according to C. jejuni phage grouping, NCTC12662 and NCTC12658 selected for CP81-type phages, while RM1221 selected for CP220-type phages. Furthermore, using acapsular Delta kpsM mutants we demonstrated that phages isolated on NCTC12658 and NCTC12662 were dependent on the capsule for infection. In contrast, CP220-type phages isolated on RM1221 were unable to infect non-motile Delta motA mutants, hence requiring motility for successful infection. Hence, the primary phage isolation strain determines both phage type (CP81 or CP220) as well as receptors (CPS or flagella) recognised by the isolated phages.	[Sorensen, Martine C. Holst; Gencay, Yilmaz Emre; Baldvinsson, Signe Berg; Vegge, Christina S.; Brondsted, Lone] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark; [Birk, Tina] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark; [Jaeckel, Claudia; Hammerl, Jens A.] Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany; [Neve, Horst] Fed Res Inst Nutr & Food, Max Rubner Inst, Dept Microbiol & Biotechnol, Kiel, Germany	University of Copenhagen; Technical University of Denmark; Federal Institute for Risk Assessment	Brondsted, L (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark.	lobr@sund.ku.dk	Gencay, Yilmaz Emre/A-6746-2011; Hammerl, Jens Andre/Y-6406-2018	Gencay, Yilmaz Emre/0000-0002-2154-9663; Hammerl, Jens Andre/0000-0002-6930-4358; Brondsted, Lone/0000-0002-7930-5725; Birk, Tina/0000-0001-7186-0575; Sorensen, Martine Camilla Holst/0000-0001-8900-3176	Danish Research Council for Technology and Production Sciences [09-070555]	Danish Research Council for Technology and Production Sciences	This work was supported by the Danish Research Council for Technology and Production Sciences by grant 09-070555 (http://ufm.dk/en/research-and-innovation/councils-and-commissions/thedanish- council-for-independent-research/the-council1/the-danish-council-for-independent-research-technology-and-production-sciences). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann Hans-W., 2009, V501, P113, DOI 10.1007/978-1-60327-164-6_12; Atterbury RJ, 2005, APPL ENVIRON MICROB, V71, P4885, DOI 10.1128/AEM.71.8.4885-4887.2005; Atterbury RJ, 2003, APPL ENVIRON MICROB, V69, P6302, DOI 10.1128/AEM.69.10.6302-6306.2003; Atterbury RJ, 2003, APPL ENVIRON MICROB, V69, P4511, DOI 10.1128/AEM.69.8.4511-4518.2003; Baldvinsson SB, 2014, APPL ENVIRON MICROB, V80, P7096, DOI 10.1128/AEM.02057-14; Bigwood T, 2009, LETT APPL MICROBIOL, V48, P343, DOI 10.1111/j.1472-765X.2008.02538.x; Bigwood T, 2008, FOOD MICROBIOL, V25, P400, DOI 10.1016/j.fm.2007.11.003; Brathwaite KJ, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00969-13; Carrillo CML, 2007, ANTON LEEUW INT J G, V92, P275, DOI 10.1007/s10482-007-9156-4; Carrillo CL, 2005, APPL ENVIRON MICROB, V71, P6554, DOI 10.1128/AEM.71.11.6554-6563.2005; Carvalho C, 2010, LETT APPL MICROBIOL, V50, P192, DOI 10.1111/j.1472-765X.2009.02774.x; Carvalho CM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-35; Carvalho CM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-232; Chen YH, 2008, CARBOHYD RES, V343, P1034, DOI 10.1016/j.carres.2008.02.024; Choi Y, 2013, APPL ENVIRON MICROB, V79, P4829, DOI 10.1128/AEM.00706-13; Connerton PL, 2011, J APPL MICROBIOL, V111, P255, DOI 10.1111/j.1365-2672.2011.05012.x; Connerton PL, 2004, APPL ENVIRON MICROB, V70, P3877, DOI 10.1128/AEM.70.7.3877-3883.2004; Coward C, 2006, APPL ENVIRON MICROB, V72, P4638, DOI 10.1128/AEM.00184-06; El-Shibiny A, 2005, APPL ENVIRON MICROB, V71, P1259, DOI 10.1128/AEM.71.3.1259-1266.2005; El-Shibiny A, 2009, J FOOD PROTECT, V72, P733, DOI 10.4315/0362-028X-72.4.733; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Fischer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078543; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Frost JA, 1999, EPIDEMIOL INFECT, V123, P47, DOI 10.1017/S095026889900254X; Gilbert M, 2007, CHEMBIOCHEM, V8, P625, DOI 10.1002/cbic.200600508; Goode D, 2003, APPL ENVIRON MICROB, V69, P5032, DOI 10.1128/AEM.69.8.5032-5036.2003; GRAJEWSKI BA, 1985, J CLIN MICROBIOL, V22, P13, DOI 10.1128/JCM.22.1.13-18.1985; Hammerl JA, 2012, J VIROL, V86, P8896, DOI 10.1128/JVI.01252-12; Hammerl JA, 2011, J VIROL, V85, P8597, DOI 10.1128/JVI.00395-11; Hansen VM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-90; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Hwang S, 2009, MICROBIOL IMMUNOL, V53, P559, DOI 10.1111/j.1348-0421.2009.00163.x; Javed MA, 2014, ARCH VIROL, V159, P181, DOI 10.1007/s00705-013-1788-2; Kanipes MI, 2008, J BACTERIOL, V190, P1568, DOI 10.1128/JB.01696-07; Kanipes MI, 2006, J BACTERIOL, V188, P3273, DOI 10.1128/JB.188.9.3273-3279.2006; Karlyshev AV, 2005, MOL MICROBIOL, V55, P90, DOI 10.1111/j.1365-2958.2004.04374.x; KHAKHRIA R, 1992, EPIDEMIOL INFECT, V108, P403, DOI 10.1017/S0950268800049918; Kropinski AM, 2011, APPL ENVIRON MICROB, V77, P8265, DOI 10.1128/AEM.05562-11; McKay D, 2001, J CLIN MICROBIOL, V39, P1917, DOI 10.1128/JCM.39.5.1917-1921.2001; McNally DJ, 2007, J BIOL CHEM, V282, P28566, DOI 10.1074/jbc.M704413200; McNally DJ, 2006, FEBS J, V273, P3975, DOI 10.1111/j.1742-4658.2006.05401.x; McNally DJ, 2005, FEBS J, V272, P4407, DOI 10.1111/j.1742-4658.2005.04856.x; Muldoon J, 2002, CARBOHYD RES, V337, P2223, DOI 10.1016/S0008-6215(02)00182-9; Orquera Stefanie, 2012, J Mol Genet Med, V6, P273; Owens J, 2013, VET MICROBIOL, V162, P144, DOI 10.1016/j.vetmic.2012.08.017; Penner JL, 1997, J INFECT DIS, V176, pS135, DOI 10.1086/513778; Rakhuba DV, 2010, POL J MICROBIOL, V59, P145, DOI 10.33073/pjm-2010-023; Sails AD, 1998, J MED MICROBIOL, V47, P123, DOI 10.1099/00222615-47-2-123; SALAMA S, 1989, LETT APPL MICROBIOL, V8, P5, DOI 10.1111/j.1472-765X.1989.tb00211.x; Scott AE, 2007, PLOS PATHOG, V3, P1142, DOI 10.1371/journal.ppat.0030119; Scott AE, 2007, ENVIRON MICROBIOL, V9, P2341, DOI 10.1111/J.1462-2920.2007.01351.x; Shin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043392; Sorensen MCH, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00011; Sorensen MCH, 2011, J BACTERIOL, V193, P6742, DOI 10.1128/JB.05276-11; SORENSEN MCH, 2011, THESIS U COPENHAGEN; ST MF, 2002, EUR J BIOCHEM, V269, P5119, DOI DOI 10.1046/J.1432-1033.2002.03201.X; Szymanski CM, 2003, J BIOL CHEM, V278, P24509, DOI 10.1074/jbc.M301273200; Tsuei AC, 2007, INT J FOOD MICROBIOL, V116, P121, DOI 10.1016/j.ijfoodmicro.2006.12.028; van Alphen LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087051; Wagenaar JA, 2005, VET MICROBIOL, V109, P275, DOI 10.1016/j.vetmic.2005.06.002; Yen JY, 2012, APPL ENVIRON MICROB, V78, P7216, DOI 10.1128/AEM.01082-12	61	55	58	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0116287	10.1371/journal.pone.0116287	http://dx.doi.org/10.1371/journal.pone.0116287			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OG	25585385	Green Submitted, Green Published, gold			2022-12-26	WOS:000348201300007
J	Froy, H; Lewis, S; Catry, P; Bishop, CM; Forster, IP; Fukuda, A; Higuchi, H; Phalan, B; Xavier, JC; Nussey, DH; Phillips, RA				Froy, Hannah; Lewis, Sue; Catry, Paulo; Bishop, Charles M.; Forster, Isaac P.; Fukuda, Akira; Higuchi, Hiroyoshi; Phalan, Ben; Xavier, Jose C.; Nussey, Daniel H.; Phillips, Richard A.			Age-Related Variation in Foraging Behaviour in the Wandering Albatross at South Georgia: No Evidence for Senescence	PLOS ONE			English	Article							DIOMEDEA-EXULANS; NATURAL-POPULATIONS; BIRD-ISLAND; HABITAT USE; PERFORMANCE; PATTERNS; SUCCESS; LIFE; IMPROVEMENT; EXPERIENCE	Age-related variation in demographic rates is now widely documented in wild vertebrate systems, and has significant consequences for population and evolutionary dynamics. However, the mechanisms underpinning such variation, particularly in later life, are less well understood. Foraging efficiency is a key determinant of fitness, with implications for individual life history trade-offs. A variety of faculties known to decline in old age, such as muscular function and visual acuity, are likely to influence foraging performance. We examine age-related variation in the foraging behaviour of a long-lived, wide-ranging oceanic seabird, the wandering albatross Diomedea exulans. Using miniaturised tracking technologies, we compared foraging trip characteristics of birds breeding at Bird Island, South Georgia. Based on movement and immersion data collected during the incubation phase of a single breeding season, and from extensive tracking data collected in previous years from different stages of the breeding cycle, we found limited evidence for age-related variation in commonly reported trip parameters, and failed to detect signs of senescent decline. Our results contrast with the limited number of past studies that have examined foraging behaviour in later life, since these have documented changes in performance consistent with senescence. This highlights the importance of studies across different wild animal populations to gain a broader perspective on the processes driving variation in ageing rates.	[Froy, Hannah; Lewis, Sue; Nussey, Daniel H.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Froy, Hannah; Phillips, Richard A.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Catry, Paulo] ISPA Inst Univ, Marine & Environm Sci Ctr, Lisbon, Portugal; [Bishop, Charles M.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Forster, Isaac P.] Univ Tasmania, Australian Antarctic Div, Kingston, Tas, Australia; [Fukuda, Akira] Shizuoka Univ, Shizuoka, Japan; [Higuchi, Hiroyoshi] Keio Univ, Fujisawa, Kanagawa, Japan; [Phalan, Ben] Univ Cambridge, Dept Zool, Cambridge, England; [Xavier, Jose C.] Univ Coimbra, Marine & Environm Sci Ctr, Coimbra, Portugal	University of Edinburgh; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Instituto Superior Psicologia Aplicada (ISPA); Bangor University; Australian Antarctic Division; University of Tasmania; Shizuoka University; Keio University; University of Cambridge; Universidade de Coimbra	Froy, H (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	hannah.froy@ed.ac.uk	Phalan, Ben/A-5783-2009; Nussey, Daniel H/F-4155-2010; Lewis, Sue/D-3380-2012; Catry, Paulo/I-5408-2013	Phalan, Ben/0000-0001-7876-7226; /0000-0002-9621-6660; Froy, Hannah/0000-0003-2965-3526; Catry, Paulo/0000-0003-3000-0522	George Macdougal Mackintosh Scholarship; Natural Environment Research Council; Biotechnology and Biological Sciences Research Council; British Antarctic Survey Polar Science for Planet Earth Programme; BBSRC [BB/H021868/1] Funding Source: UKRI; NERC [bas0100025, NE/E012906/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H021868/1] Funding Source: researchfish; Natural Environment Research Council [NE/E012906/1, bas0100025] Funding Source: researchfish	George Macdougal Mackintosh Scholarship; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Antarctic Survey Polar Science for Planet Earth Programme; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	HF was funded by a George Macdougal Mackintosh Scholarship. SL was supported by a Natural Environment Research Council postdoctoral fellowship (www.nerc.ac.uk) and DHN was supported by a Biotechnology and Biological Sciences Research Council David Phillips fellowship (www.bbsrc.ac.uk). The fieldwork in 2012 was funded by the Natural Environment Research Council Collaborative Gearing Scheme, and the British Antarctic Survey Polar Science for Planet Earth Programme (www.antarctica.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Berrow SD, 2001, CONDOR, V103, P230, DOI 10.1650/0010-5422(2001)103[0230:PRAAPO]2.0.CO;2; Brunet-Rossinni A.K., 2006, HDB BIOL AGING, V6, P243; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Caswell H, 2000, MATRIX POPULATION MO, V2nd; Catry P, 2006, P ROY SOC B-BIOL SCI, V273, P1625, DOI 10.1098/rspb.2006.3482; Catry P, 2011, J ORNITHOL, V152, P549, DOI 10.1007/s10336-010-0616-7; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; CROXALL JP, 1990, J ANIM ECOL, V59, P775, DOI 10.2307/4895; Daunt F, 2007, FUNCT ECOL, V21, P561, DOI 10.1111/j.1365-2435.2007.01260.x; Delord K, 2008, BIOL CONSERV, V141, P1840, DOI 10.1016/j.biocon.2008.05.001; DESROCHERS A, 1992, ANIM BEHAV, V43, P885, DOI 10.1016/0003-3472(92)90002-Q; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Froy H, 2013, ECOL LETT, V16, P642, DOI 10.1111/ele.12092; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Hassrick JL, 2013, FUNCT ECOL, V27, P1055, DOI 10.1111/1365-2435.12108; Hindle AG, 2009, J EXP BIOL, V212, P790, DOI 10.1242/jeb.025387; HOLMES DJ, 1995, J GERONTOL A-BIOL, V50, pB59, DOI 10.1093/gerona/50A.2.B59; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; Lecomte VJ, 2010, P NATL ACAD SCI USA, V107, P6370, DOI 10.1073/pnas.0911181107; Lewis S, 2012, OIKOS, V121, P2061, DOI 10.1111/j.1600-0706.2012.20293.x; Limmer B, 2009, ANIM BEHAV, V77, P1095, DOI 10.1016/j.anbehav.2009.01.015; LIND AJ, 1994, ANIM BEHAV, V48, P1261, DOI 10.1006/anbe.1994.1362; MacNulty DR, 2009, ECOL LETT, V12, P1347, DOI 10.1111/j.1461-0248.2009.01385.x; Montgomery RA, 2013, J ANIM ECOL, V82, P301, DOI 10.1111/1365-2656.12000; Nel DC, 2002, IBIS, V144, pE141, DOI 10.1046/j.1474-919X.2002.00092.x; Nevoux M, 2007, J ANIM ECOL, V76, P159, DOI 10.1111/j.1365-2656.2006.01191.x; Nevoux M, 2010, ECOLOGY, V91, P2416, DOI 10.1890/09-0143.1; Newton I, 1989, LIFETIME REPROD BIRD; Nisbet ICT, 2001, EXP GERONTOL, V36, P833, DOI 10.1016/S0531-5565(00)00244-8; Noren SR, 2001, J COMP PHYSIOL B, V171, P127, DOI 10.1007/s003600000161; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Nussey DH, 2013, AGEING RES REV, V12, P214, DOI 10.1016/j.arr.2012.07.004; Nussey DH, 2011, ECOLOGY, V92, P1936, DOI 10.1890/11-0308.1; Palacios MG, 2011, ECOLOGY, V92, P952, DOI 10.1890/10-0662.1; Phalan B, 2007, MAR ECOL PROG SER, V340, P271, DOI 10.3354/meps340271; Phillips RA, 2007, AQUAT CONSERV, V17, pS6, DOI 10.1002/aqc.906; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Phillips RA, 2009, MAR ECOL PROG SER, V391, P279, DOI 10.3354/meps08028; PRINCE PA, 1992, ANTARCT SCI, V4, P31, DOI 10.1017/S0954102092000075; PROMISLOW DEL, 1991, EVOLUTION, V45, P1869, DOI 10.1111/j.1558-5646.1991.tb02693.x; Rebke M, 2010, P NATL ACAD SCI USA, V107, P7841, DOI 10.1073/pnas.1002645107; Reed TE, 2008, AM NAT, V171, pE89, DOI 10.1086/524957; Riotte-Lambert L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1434; Rutz C, 2006, P ROY SOC B-BIOL SCI, V273, P579, DOI 10.1098/rspb.2005.3353; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; Shaffer SA, 2001, FUNCT ECOL, V15, P203, DOI 10.1046/j.1365-2435.2001.00514.x; Stephens D., 2007, FORAGING BEHAV ECOLO; Tanaka H, 2003, J APPL PHYSIOL, V95, P2152, DOI 10.1152/japplphysiol.00320.2003; Tuck GN, 2001, J APPL ECOL, V38, P1182, DOI 10.1046/j.0021-8901.2001.00661.x; Weimerskirch H, 2005, ECOLOGY, V86, P2611, DOI 10.1890/04-1866; Weimerskirch H, 1997, MAR ECOL PROG SER, V151, P245, DOI 10.3354/meps151245; Weimerskirch H, 2000, POLAR BIOL, V23, P733, DOI 10.1007/s003000000144; WEIMERSKIRCH H, 1993, AUK, V110, P325; WEIMERSKIRCH H, 1995, OECOLOGIA, V102, P37, DOI 10.1007/BF00333308; Weimerskirch H, 2014, J EXP MAR BIOL ECOL, V450, P68, DOI 10.1016/j.jembe.2013.10.021; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; WOOLLER RD, 1992, TRENDS ECOL EVOL, V7, P111, DOI 10.1016/0169-5347(92)90143-Y; WUNDERLE JM, 1991, CURR ORNITHOL, V8, P273; Xavier Jose C., 2005, P74; Yoda K, 2004, P ROY SOC B-BIOL SCI, V271, pS240, DOI 10.1098/rsbl.2003.0157; Zimmer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016098	65	27	27	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0116415	10.1371/journal.pone.0116415	http://dx.doi.org/10.1371/journal.pone.0116415			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25574995	Green Published, Green Accepted, gold			2022-12-26	WOS:000348168100005
J	Zhao, X; Parpart, S; Takai, A; Roessler, S; Budhu, A; Yu, Z; Blank, M; Zhang, YE; Jia, HL; Ye, QH; Qin, LX; Tang, ZY; Thorgeirsson, SS; Wang, XW				Zhao, X.; Parpart, S.; Takai, A.; Roessler, S.; Budhu, A.; Yu, Z.; Blank, M.; Zhang, Y. E.; Jia, H-L; Ye, Q-H; Qin, L-X; Tang, Z-Y; Thorgeirsson, S. S.; Wang, X. W.			Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM(+) AFP(+) hepatocellular carcinoma	ONCOGENE			English	Article							H2B UBIQUITYLATION; SOMATIC MUTATIONS; H3 METHYLATION; CANCER; TUMOR; PREDICTION; GENES; CLASSIFICATION; PROGRESSION; LANDSCAPE	Identification of key drivers and new therapeutic targets is important given the poor prognosis for hepatocellular carcinoma (HCC) patients, particularly those ineligible for surgical resection or liver transplant. However, the approach to identify such driver genes is facing significant challenges due to the genomically heterogenous nature of HCC. Here we tested whether the integrative genomic profiling of a well-defined HCC subset that is classified by an extreme EpCAM(+) AFP(+) gene expression signature and associated with poor prognosis, all attributes of a stem cell-like phenotype, could uncover survival-related driver genes in HCC. Following transcriptomic analysis of the well-defined HCC cases, a Gene Set Enrichment Analysis coupled with genomic copy number alteration assessment revealed that YY1-associated protein 1 (YY1AP1) is a critical oncoprotein specifically activated in EpCAM(+) AFP+ HCC. YY1AP1 silencing eliminates oncogene addiction by altering the chromatin landscape and triggering massive apoptosis in vitro and tumor suppression in vivo. YY1AP1 expression promotes HCC proliferation and is required for the maintenance of stem cell features. We revealed that YY1AP1 cooperates with YY1 to alter the chromatin landscape and activate transcription of stemness regulators. Thus YY1AP1 may serve as a key molecular target for EpCAM(+) AFP(+) HCC subtype. Our results demonstrate the feasibility and power of a new strategy by utilizing well-defined patient samples and integrative genomics to uncover critical pathways linked to HCC subtypes with prognostic impact.	[Zhao, X.; Parpart, S.; Takai, A.; Roessler, S.; Budhu, A.; Yu, Z.; Wang, X. W.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Blank, M.; Zhang, Y. E.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, Bethesda, MD 20892 USA; [Jia, H-L; Ye, Q-H; Qin, L-X; Tang, Z-Y] Fudan Univ, Liver Canc Inst, Shanghai 200433, Peoples R China; [Thorgeirsson, S. S.] NCI, Lab Expt Carcinogenesis, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fudan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wang, XW (corresponding author), NCI, Human Carcinogenesis Lab, Liver Carcinogenesis Sect, Ctr Canc Res, Bldg 37,Room 3044A,37 Convent Dr, Bethesda, MD 20892 USA.	xw3u@nih.gov	Roessler, Stephanie/J-8432-2019; Zhao, Xuelian/Q-1370-2017; Zhang, Ying E/G-3657-2015; Wang, Xin Wei/B-6162-2009	Roessler, Stephanie/0000-0002-5333-5942; Zhao, Xuelian/0000-0003-2964-3184; Zhang, Ying E/0000-0003-2753-7601; Wang, Xin Wei/0000-0001-9735-606X	Intramural Research Grants of the Center for Cancer Research; US National Cancer Institute [Z01 BC 010313, Z01 BC 010877, Z01 BC 010876]; NATIONAL CANCER INSTITUTE [Z01BC010313, Z01BC010876, Z01BC010877, ZIABC011168] Funding Source: NIH RePORTER	Intramural Research Grants of the Center for Cancer Research; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Curtis Harris for critical reading of the manuscript, Dr Zheng-Gang Liu for advice on apoptosis study, Dominic Esposito at the Advanced Technology Program of SAIC-Frederick, Inc., for the help in designing the Tet-C2 inducible construct and Liver Tissue Cell Distribution System (LTCDS) at the University of Minnesota (Minneapolis, MN, USA) for generous donation of normal liver specimens. We also thank Karen Yarrick for the bibliographic assistance. This work was supported by the Intramural Research Grants of the Center for Cancer Research and the US National Cancer Institute Z01 BC 010313, Z01 BC 010877 and Z01 BC 010876.	Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Budhu A, 2013, GASTROENTEROLOGY, V144, P1066, DOI 10.1053/j.gastro.2013.01.054; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Cuddapah S, 2011, MOL CELL BIOL, V31, P700, DOI 10.1128/MCB.00740-10; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Guo MZ, 2004, CLIN CANCER RES, V10, P5131, DOI 10.1158/1078-0432.CCR-03-0763; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji JF, 2012, SEMIN ONCOL, V39, P461, DOI 10.1053/j.seminoncol.2012.05.011; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kuryshev VY, 2006, GENOMICS, V88, P143, DOI 10.1016/j.ygeno.2006.02.002; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Oishi N, 2012, HEPATOLOGY, V56, P1792, DOI 10.1002/hep.25890; Roessler S, 2012, GASTROENTEROLOGY, V142, P957, DOI 10.1053/j.gastro.2011.12.039; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Rotili Dante, 2011, Genes Cancer, V2, P663, DOI 10.1177/1947601911417976; Sankpal NV, 2009, CANCER RES, V69, P753, DOI 10.1158/0008-5472.CAN-08-2708; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Wang CY, 2004, J BIOL CHEM, V279, P17750, DOI 10.1074/jbc.M310532200; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang EB, 1997, CANCER LETT, V117, P93, DOI 10.1016/S0304-3835(97)00206-1; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Zhang K, 2005, CLIN CANCER RES, V11, P7532, DOI 10.1158/1078-0432.CCR-05-0400; Zhou XD, 2001, CANCER-AM CANCER SOC, V91, P1479, DOI 10.1002/1097-0142(20010415)91:8<1479::AID-CNCR1155>3.0.CO;2-0	44	31	34	0	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 24	2015	34	39					5095	5104		10.1038/onc.2014.438	http://dx.doi.org/10.1038/onc.2014.438			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR9RC	25597408	Green Accepted			2022-12-26	WOS:000361693300009
J	La Sala, G; Marazziti, D; Di Pietro, C; Golini, E; Matteoni, R; Tocchini-Valentini, GP				La Sala, Gina; Marazziti, Daniela; Di Pietro, Chiara; Golini, Elisabetta; Matteoni, Rafaele; Tocchini-Valentini, Glauco P.			Modulation of Dhh signaling and altered Sertoli cell function in mice lacking the GPR37-prosaposin receptor	FASEB JOURNAL			English	Article						G-protein-coupled receptor; Ptch1; testis; spermatogenesis	COUPLED PEPTIDE RECEPTOR; ANDROGEN RECEPTOR; DEFECTIVE SPERMATOGENESIS; MOLECULAR-CLONING; MALE REPRODUCTION; GENE-EXPRESSION; LEYDIG-CELLS; RAT TESTIS; IN-VIVO; MOUSE	The mammalian G-protein-coupled receptor 37 (GPR37) is expressed in brain, in adult testis, and during the early phase of gonad differentiation. Somatic Sertoli cells (SCs) are located within the seminiferous tubules where they support the germinal epithelium. An adequate number of SCs is required for the complete prepubertal differentiation of germ cells and adult fertility. This study shows that Gpr37 and its ligand prosaposin are both postnatally expressed by SCs, whose proliferation and maturation are affected in Gpr37-null mutant mice during postnatal testicular development. Mutant pups show a delayed timing in sperm cell development, with a partial arrest of spermatocytes at the meiotic pachytene (e.g., 1.5-fold increase in Gpr37(-/-) P21 pups) and their increased apoptosis (e.g., 1.8-fold and 3.5-fold increase in Gpr37(-/-) P21 and adult mice, respectively). Mutant adults have reduced testis weight (wild type, 299 +/- 5 mg; knockout, 258 +/- 16 mg; P < 0.05) and epididymal sperm count and motility (e.g., 1.5-fold and 1.45-fold decrease in Gpr37(-/-) mice, respectively). Lack of Gpr37 results in the reduction in androgen receptor levels during prepubertal testis development, alongside the altered expression of SC maturation markers. It also affects the prepubertal testis expression of desert hedgehog (Dhh) mitogenic cascade components (Dhh, 1.3-fold increase in Gpr37(-/-) P10 and P21 pups; Gli2, 1.4-fold and 1.6-fold increase in Gpr37(-/-) P10 and P21 pups, respectively) including patched homolog 1 (1.3-fold increase in Gpr37(-/-) P10 and P21 pups), which is found localized in prepubertal SCs and is associated with Gpr37 in cultured primary SC samples. These results indicate that Gpr37 is a specific modulator of murine testis Dhh mitogenic signaling and SC proliferation and maturation.	[La Sala, Gina; Marazziti, Daniela; Di Pietro, Chiara; Golini, Elisabetta; Matteoni, Rafaele; Tocchini-Valentini, Glauco P.] CNR, Emma Infrafrontier Impc, Ist Biol Cellulare & Neurobiol, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR)	Tocchini-Valentini, GP (corresponding author), Emma Infrafrontier Impc, Campus A Buzzati Traverso,Via E Ramarini 32, I-00015 Rome, Italy.	gtocchini@emma.cnr.it	LA SALA, GINA/AAF-5414-2021; Di Pietro, Chiara/AAA-7161-2021; Daniela, Marazziti/AAC-1062-2022; Golini, Elisabetta/AAX-2849-2020; , Elisabetta/D-9095-2015	LA SALA, GINA/0000-0002-1907-5948; Daniela, Marazziti/0000-0002-1582-9271; , Elisabetta/0000-0002-9323-7124; MATTEONI, RAFAELE/0000-0002-0314-5948; DI PIETRO, CHIARA/0000-0002-2680-1821	Consiglio Nazionale delle Ricerche Progetto d'Interesse Strategico Invecchiamento; European Union	Consiglio Nazionale delle Ricerche Progetto d'Interesse Strategico Invecchiamento; European Union(European Commission)	The authors thank G. Bolasco and E. Perlas for assistance with microscopy and histology; G. Di Franco, G. D'Erasmo, and A. Ventrera for excellent technical assistance; P. Grimaldi for assistance with SC primary cultures; S. Dolci for helpful discussions; and A. Ferrara and T. Cuccurullo for secretarial work. This work was supported in part by Consiglio Nazionale delle Ricerche Progetto d'Interesse Strategico Invecchiamento 2012-2014 and European Union Framework Programmes 6-7 (EUCOMM, EUCOMMTools grants). The authors declare no conflicts of interest.	BARTKE A, 1973, ENDOCRINOLOGY, V92, P1223, DOI 10.1210/endo-92-4-1223; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Beardsley A, 2006, J ENDOCRINOL, V190, P759, DOI 10.1677/joe.1.06867; Beau C, 2000, MOL REPROD DEV, V56, P124, DOI 10.1002/(SICI)1098-2795(200006)56:2&lt;124::AID-MRD2&gt;3.0.CO;2-J; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; Carpenter D, 1998, P NATL ACAD SCI USA, V95, P13630, DOI 10.1073/pnas.95.23.13630; Chang CS, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109132; Chang CS, 2004, P NATL ACAD SCI USA, V101, P6876, DOI 10.1073/pnas.0307306101; Clark AM, 2000, BIOL REPROD, V63, P1825, DOI 10.1095/biolreprod63.6.1825; COLLARD MW, 1988, BIOCHEMISTRY-US, V27, P4557, DOI 10.1021/bi00412a050; CORTES D, 1987, INT J ANDROL, V10, P589, DOI 10.1111/j.1365-2605.1987.tb00358.x; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; De Gendt K, 2012, MOL CELL ENDOCRINOL, V352, P13, DOI 10.1016/j.mce.2011.08.008; Franco HL, 2012, CHROMOSOME RES, V20, P247, DOI 10.1007/s10577-011-9254-z; Godmann M, 2008, DEV BIOL, V315, P552, DOI 10.1016/j.ydbio.2007.12.018; GRIMALDI P, 1993, MOL ENDOCRINOL, V7, P1217, DOI 10.1210/me.7.9.1217; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; Holdcraft RW, 2004, INT J ANDROL, V27, P335, DOI 10.1111/j.1365-2605.2004.00502.x; IGDOURA SA, 1995, MOL REPROD DEV, V40, P91, DOI 10.1002/mrd.1080400112; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jahnukainen K, 2004, BIOL REPROD, V70, P290, DOI 10.1095/biolreprod.103.018390; Koochekpour S, 2007, PROSTATE, V67, P178, DOI 10.1002/pros.20513; Kroft TL, 2001, BIOL REPROD, V65, P1663, DOI 10.1095/biolreprod65.6.1663; Latendresse JR, 2002, TOXICOL PATHOL, V30, P524, DOI 10.1080/01926230290105721; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucas TFG, 2010, BIOL REPROD, V83, P307, DOI 10.1095/biolreprod.110.084160; Marazziti D, 2004, P NATL ACAD SCI USA, V101, P10189, DOI 10.1073/pnas.0403661101; Marazziti D, 1998, GENOMICS, V53, P315, DOI 10.1006/geno.1998.5433; Marazziti D, 1997, GENOMICS, V45, P68, DOI 10.1006/geno.1997.4900; Marazziti D, 2007, P NATL ACAD SCI USA, V104, P9846, DOI 10.1073/pnas.0703368104; Marazziti D, 2013, P NATL ACAD SCI USA, V110, P16486, DOI 10.1073/pnas.1314819110; Mark M, 2004, P NATL ACAD SCI USA, V101, P4453, DOI 10.1073/pnas.0400234101; Mei H, 2011, REPRODUCTION, V141, P357, DOI 10.1530/REP-10-0432; Meyer RC, 2013, P NATL ACAD SCI USA, V110, P9529, DOI 10.1073/pnas.1219004110; Moens PB, 2000, J CELL SCI, V113, P663; Morales CR, 2009, MICROSC RES TECHNIQ, V72, P809, DOI 10.1002/jemt.20733; Morales CR, 1998, J ANDROL, V19, P156; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Notini AJ, 2012, SEX DEV, V6, P223, DOI 10.1159/000339723; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Print CG, 2000, BIOESSAYS, V22, P423, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;423::AID-BIES4&gt;3.0.CO;2-0; Rey R, 1998, TRENDS ENDOCRIN MET, V9, P271, DOI 10.1016/S1043-2760(98)00069-1; Sanz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066179; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; STEINBERGER A, 1971, BIOL REPROD, V4, P84, DOI 10.1093/biolreprod/4.1.84; SYLVESTER SR, 1989, BIOL REPROD, V41, P941, DOI 10.1095/biolreprod41.5.941; Tan KAL, 2005, ENDOCRINOLOGY, V146, P2674, DOI 10.1210/en.2004-1630; Tsai MY, 2006, P NATL ACAD SCI USA, V103, P18975, DOI 10.1073/pnas.0608565103; Valdenaire O, 1998, FEBS LETT, V424, P193, DOI 10.1016/S0014-5793(98)00170-7; Xu QQ, 2007, ENDOCRINE, V32, P96, DOI 10.1007/s12020-007-9015-0; Yao HHC, 2002, GENE DEV, V16, P1433, DOI 10.1101/gad.981202; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Zhang CX, 2006, P NATL ACAD SCI USA, V103, P17718, DOI 10.1073/pnas.0608556103	55	15	15	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					2059	2069		10.1096/fj.14-269209	http://dx.doi.org/10.1096/fj.14-269209			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25609427				2022-12-26	WOS:000354114600038
J	Smith, AD; Wilks, A				Smith, Aaron D.; Wilks, Angela			Differential Contributions of the Outer Membrane Receptors PhuR and HasR to Heme Acquisition in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Surface Receptor; Heme; Iron Metabolism; Mass Spectrometry (MS); Membrane Transport	GRAM-NEGATIVE BACTERIA; BINDING PROTEIN PHUS; SERRATIA-MARCESCENS; UPTAKE SYSTEM; SHIGELLA-DYSENTERIAE; STAPHYLOCOCCUS-AUREUS; TRAFFICKING PROTEIN; HEMOGLOBIN RECEPTOR; CRYSTAL-STRUCTURE; OXYGENASE HEMO	Background:Pseudomonas aeruginosa utilizes extracellular heme as a source of iron on infection of the host. Results: Both PhuR and HasR are required for efficient utilization of heme by P. aeruginosa. Conclusion: Non-redundant outer membrane receptors allow for heme acquisition across a range of physiological conditions. Significance: PhuR and HasR have complimentary roles in heme acquisition and utilization. Pseudomonas aeruginosa PAO1 encodes two outer membrane receptors, PhuR (Pseudomonasheme uptake) and HasR (heme assimilation system). The HasR and PhuR receptors have distinct heme coordinating ligands and substrate specificities. HasR is encoded in an operon with a secreted hemophore, HasAp. In contrast the non-hemophore-dependent PhuR is encoded within an operon along with proteins required for heme translocation into the cytoplasm. Herein we report on the contributions of the HasR and PhuR receptors to heme uptake and utilization. Employing bacterial genetics and isotopic [C-13]heme labeling studies we have shown both PhuR and HasR are required for optimal heme utilization. However, the unique His-Tyr-ligated PhuR plays a major role in the acquisition of heme. In contrast the HasR receptor plays a primary role in the sensing of extracellular heme and a supplementary role in heme uptake. We propose PhuR and HasR represent non-redundant heme receptors, capable of accessing heme across a wide range of physiological conditions on colonization of the host.	[Smith, Aaron D.; Wilks, Angela] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Wilks, A (corresponding author), HSF 2,20 Penn St, Baltimore, MD 21201 USA.	awilks@rx.umaryland.edu	Smith, Aaron/AAS-5716-2021	Smith, Aaron/0000-0001-8864-1934	National Institutes of Health [AI 102883]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI 102883 (to A. W.).	Barker KD, 2012, J BIOL CHEM, V287, P18342, DOI 10.1074/jbc.M112.359265; Barkovits K, 2008, FEMS MICROBIOL LETT, V280, P160, DOI 10.1111/j.1574-6968.2007.01058.x; Benevides-Matos N, 2010, MICROBIOL-SGM, V156, P1749, DOI 10.1099/mic.0.034405-0; Biville F, 2004, MOL MICROBIOL, V53, P1267, DOI 10.1111/j.1365-2958.2004.04207.x; Block DR, 2007, BIOCHEMISTRY-US, V46, P14391, DOI 10.1021/bi701509n; Bracken CS, 1999, J BACTERIOL, V181, P6063, DOI 10.1128/JB.181.19.6063-6072.1999; Burkhard KA, 2007, J BIOL CHEM, V282, P15126, DOI 10.1074/jbc.M611121200; Caignan GA, 2002, J AM CHEM SOC, V124, P14879, DOI 10.1021/ja0274960; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; Cobessi D, 2010, PROTEINS, V78, P286, DOI 10.1002/prot.22539; Contreras H, 2014, CURR OPIN CHEM BIOL, V19, P34, DOI 10.1016/j.cbpa.2013.12.014; Cornelis P, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00075; Cornelis P, 2010, APPL MICROBIOL BIOT, V86, P1637, DOI 10.1007/s00253-010-2550-2; Czjzek M, 2007, J MOL BIOL, V365, P1176, DOI 10.1016/j.jmb.2006.10.063; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Deniau C, 2003, BIOCHEMISTRY-US, V42, P10627, DOI 10.1021/bi030015k; Eakanunkul S, 2005, BIOCHEMISTRY-US, V44, P13179, DOI 10.1021/bi050422r; Friedman J, 2004, BIOCHEMISTRY-US, V43, P5239, DOI 10.1021/bi049687g; Fuhrhop J. H., 1975, PORPHYRINS METALLOPO, P804; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Ghigo JM, 1997, J BACTERIOL, V179, P3572, DOI 10.1128/jb.179.11.3572-3579.1997; Grigg JC, 2011, J MOL BIOL, V413, P684, DOI 10.1016/j.jmb.2011.08.047; HENDERSON DP, 1994, J BACTERIOL, V176, P3269, DOI 10.1128/jb.176.11.3269-3277.1994; Ho WW, 2007, J BIOL CHEM, V282, P35796, DOI 10.1074/jbc.M706761200; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Izadi-Pruneyre N, 2006, J BIOL CHEM, V281, P25541, DOI 10.1074/jbc.M603698200; Jepkorir G, 2010, J AM CHEM SOC, V132, P9857, DOI 10.1021/ja103498z; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; Lansky IB, 2006, J BIOL CHEM, V281, P13652, DOI 10.1074/jbc.M600824200; Letoffe S, 1996, EMBO J, V15, P5804, DOI 10.1002/j.1460-2075.1996.tb00967.x; Letoffe S, 2004, J BACTERIOL, V186, P4067, DOI 10.1128/JB.186.13.4067-4074.2004; Marvig RL, 2014, MBIO, V5, DOI 10.1128/mBio.00966-14; Mokry DZ, 2014, BBA-GEN SUBJECTS, V1840, P3058, DOI 10.1016/j.bbagen.2014.06.009; Nguyen AT, 2014, J BACTERIOL, V196, P2265, DOI 10.1128/JB.01491-14; O'Neill MJ, 2013, ACS CHEM BIOL, V8, P1794, DOI 10.1021/cb400165b; O'Neill MJ, 2012, P NATL ACAD SCI USA, V109, P5639, DOI 10.1073/pnas.1121549109; Ochsner UA, 1996, P NATL ACAD SCI USA, V93, P4409, DOI 10.1073/pnas.93.9.4409; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Payne SM, 2006, BIOMETALS, V19, P173, DOI 10.1007/s10534-005-4577-x; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; RIVERA M, 1995, ANAL BIOCHEM, V230, P295, DOI 10.1006/abio.1995.1477; Rossi MS, 2003, MOL MICROBIOL, V48, P1467, DOI 10.1046/j.1365-2958.2003.03516.x; Rossi MS, 2001, INFECT IMMUN, V69, P6707, DOI 10.1128/IAI.69.11.6707-6717.2001; Schrodinger L, 2012, PYMOL MOL GRAPHICS S; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; STOJILJKOVIC I, 1995, MOL MICROBIOL, V15, P531, DOI 10.1111/j.1365-2958.1995.tb02266.x; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Wegele R, 2004, J BIOL CHEM, V279, P45791, DOI 10.1074/jbc.M408303200; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Wilks A, 2011, HANDB PORPHYR SCI, V15, P357; Yukl ET, 2010, BIOCHEMISTRY-US, V49, P6646, DOI 10.1021/bi100692f	51	43	43	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7756	7766		10.1074/jbc.M114.633495	http://dx.doi.org/10.1074/jbc.M114.633495			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25616666	Green Published, hybrid			2022-12-26	WOS:000351613600036
J	Pituch, KC; Moyano, AL; Lopez-Rosas, A; Marottoli, FM; Li, GN; Hu, CQ; van Breemen, R; Mansson, JE; Givogri, MI				Pituch, Katarzyna C.; Moyano, Ana L.; Lopez-Rosas, Aurora; Marottoli, Felecia M.; Li, Guannan; Hu, Chenqi; van Breemen, Richard; Mansson, Jan E.; Givogri, Maria I.			Dysfunction of Platelet-derived Growth Factor Receptor a (PDGFR alpha) Represses the Production of Oligodendrocytes from Arylsulfatase A-deficient Multipotential Neural Precursor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD OLIGODENDROCYTES; METACHROMATIC LEUKODYSTROPHY; PROGENITOR CELLS; MYELIN MEMBRANE; SONIC HEDGEHOG; LIPID RAFTS; INTRACELLULAR TRAFFICKING; MULTIVESICULAR ENDOSOMES; RETICULOCYTE MATURATION	The membrane-bound receptor for platelet-derived growth factor A (PDGFR alpha) is crucial for controlling the production of oligodendrocytes (OLs) for myelination, but regulation of its activity during OL differentiation is largely unknown. We have examined the effect of increased sulfated content of galactosylceramides (sulfatides) on the regulation of PDGTR alpha in multipotential neural precursors (NPs) that are deficient in arylsulfatase A (ASA) activity. This enzyme is responsible for the lysosomal hydrolysis of sulfatides. We show that sulfatide accumulation significantly impacts the formation of OLs via deregulation of PDGFR alpha function. PDGFR alpha is less associated with detergent-resistant membranes in ASA-deficient cells and showed a significant decrease in AKT phosphorylation Rescue experiments with ASA showed a normalization of the ratio of long versus short sulfatides, restored PDGTRa levels, corrected its localization to detergent-resistant membranes, increased AKT phosphorylation, and normalized the production of OLs in ASA-deficient NPs. Moreover, our studies identified a novel mechanism that regulates the secretion of PDGFR alpha in NPs, in glial cells, and in the brain cortex via exosomal shedding. Our study provides a first step in understanding the role of sulfatides in regulating PDGFR alpha levels in OLs and its impact in myelination.	[Pituch, Katarzyna C.; Moyano, Ana L.; Lopez-Rosas, Aurora; Marottoli, Felecia M.; Givogri, Maria I.] Univ Illinois, Dept Anat & Cell Biol, Coll Med, Chicago, IL 60612 USA; [Li, Guannan; Hu, Chenqi; van Breemen, Richard] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA; [Mansson, Jan E.] Univ Gothenburg, Sahlgren Acad, Dept Clin Chem, SE-41345 Gothenburg, Sweden	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Gothenburg	Givogri, MI (corresponding author), Univ Illinois, Dept Anat & Cell Biol, Coll Med, 808 S Wood St,M-C 512, Chicago, IL 60612 USA.	mgivogri@uic.edu	van Breemen, Richard/AAO-2875-2020; Li, Guannan/J-4474-2019	Li, Guannan/0000-0002-9533-7524; van Breemen, Richard/0000-0003-2016-0063; Moyano, Ana Lis/0000-0002-1089-8542	National Institutes of Health Ruth L. Kirschstein National Research Service Award [F31]; National Multiple Sclerosis Society [PP1516, RG 4439-A-2]; Department of Defense [W81XWH-11-1-0198]	National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Department of Defense(United States Department of Defense)	This work was supported, in whole or in part, by National Institutes of Health Ruth L. Kirschstein National Research Service Award F31 (to K. P. C.). This work was also supported by National Multiple Sclerosis Society Grants PP1516 and RG 4439-A-2 and by Department of Defense Contract W81XWH-11-1-0198 (to M. I. G.).	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Alberta JA, 2001, MOL CELL NEUROSCI, V18, P434, DOI 10.1006/mcne.2001.1026; [Anonymous], 2006, NOVART FDN SYMP; [Anonymous], 2006, NOVART FDN SYMP; [Anonymous], 2006, NOVART FDN SYMP; [Anonymous], 2006, NOVART FDN SYMP; Baer AS, 2009, BRAIN, V132, P465, DOI 10.1093/brain/awn334; Bakhti M, 2011, J BIOL CHEM, V286, P787, DOI 10.1074/jbc.M110.190009; Bansal R, 1999, J NEUROSCI, V19, P7913; BANSAL R, 1989, P NATL ACAD SCI USA, V86, P6181, DOI 10.1073/pnas.86.16.6181; Baron W, 2000, MOL CELL NEUROSCI, V15, P314, DOI 10.1006/mcne.1999.0827; Baron W, 2003, CURR BIOL, V13, P151, DOI 10.1016/S0960-9822(02)01437-9; Baron W, 2002, EMBO J, V21, P1957, DOI 10.1093/emboj/21.8.1957; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Bhat NR, 1996, J NEUROCHEM, V66, P1986; Blanc L, 2010, CURR OPIN HEMATOL, V17, P177, DOI 10.1097/MOH.0b013e328337b4e3; Blomqvist M, 2002, GLYCOCONJUGATE J, V19, P403, DOI 10.1023/B:GLYC.0000004012.14438.e6; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Bodennec J, 2000, METHOD ENZYMOL, V312, P101; Bosio A, 1996, P NATL ACAD SCI USA, V93, P13280, DOI 10.1073/pnas.93.23.13280; Bosio A, 1998, J NEUROCHEM, V70, P308; BURKART T, 1981, DEV BIOL, V83, P42, DOI 10.1016/S0012-1606(81)80006-1; Butt AM, 1997, MOL CELL NEUROSCI, V8, P311, DOI 10.1006/mcne.1996.0590; Cafferty WBJ, 2010, J NEUROSCI, V30, P6825, DOI 10.1523/JNEUROSCI.6239-09.2010; Carayon K, 2011, J BIOL CHEM, V286, P34426, DOI 10.1074/jbc.M111.257444; Chesley A, 2000, CIRC RES, V87, P1172, DOI 10.1161/01.RES.87.12.1172; Chojnacki A, 2011, J NEUROSCI, V31, P9503, DOI 10.1523/JNEUROSCI.1531-11.2011; Chong SYC, 2010, J CELL BIOL, V188, P305, DOI 10.1083/jcb.200905111; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; COLLARINI EJ, 1991, J CELL SCI, P117; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; de Laurentiis Angela, 2007, Open Biochem J, V1, P12, DOI 10.2174/1874091X00701010012; Decker L, 2004, BIOCHEM SOC T, V32, P426, DOI 10.1042/BST0320426; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Du H, 2005, AM J HUM GENET, V77, P1061, DOI 10.1086/498652; DYER CA, 1988, J NEUROSCI, V8, P4307; Flores AI, 2000, J NEUROSCI, V20, P7622; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Gieselmann V, 2003, ACTA PAEDIATR, V92, P74, DOI 10.1080/08035320310000528; Givogri MI, 2008, DEV NEUROSCI-BASEL, V30, P340, DOI 10.1159/000150127; Givogri MI, 2006, DEV NEUROSCI-BASEL, V28, P81, DOI 10.1159/000090755; Givogri MI, 2001, J NEUROSCI RES, V66, P679, DOI 10.1002/jnr.10031; Givogri MI, 2006, J NEUROSCI, V26, P3109, DOI 10.1523/JNEUROSCI.4366-05.2006; Gonnord P, 2012, SEMIN CELL DEV BIOL, V23, P154, DOI 10.1016/j.semcdb.2011.11.002; Gonzalez-Gaitan M, 2008, DEV CELL, V15, P172, DOI 10.1016/j.devcel.2008.07.001; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Haghighi S, 2012, ACTA NEUROL SCAND, V125, P64, DOI 10.1111/j.1600-0404.2011.01554.x; Hall A, 1996, DEVELOPMENT, V122, P4085; HART IK, 1989, J CELL BIOL, V109, P3411, DOI 10.1083/jcb.109.6.3411; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Hill MM, 2002, CURR BIOL, V12, P1251, DOI 10.1016/S0960-9822(02)00973-9; Hirahara Y, 2004, GLIA, V45, P269, DOI 10.1002/glia.10327; HIRAIWA N, 1990, CANCER RES, V50, P2917; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; Kotter MR, 2001, GLIA, V35, P204, DOI 10.1002/glia.1085; Kramer-Albers EM, 2007, PROTEOM CLIN APPL, V1, P1446, DOI 10.1002/prca.200700522; Lai CPK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00228; LOUIS JC, 1992, GLIA, V6, P30, DOI 10.1002/glia.440060105; Luca T, 2005, MOL THER, V12, P669, DOI 10.1016/j.ymthe.2005.06.438; Marsching C, 2011, ANAL BIOANAL CHEM, V401, P53, DOI 10.1007/s00216-011-4802-0; Marsh M, 2008, SCIENCE, V319, P1191, DOI 10.1126/science.1155750; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCKINNON RD, 1991, ANN NY ACAD SCI, V638, P378, DOI 10.1111/j.1749-6632.1991.tb49048.x; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Mitsuda T, 2002, J BIOL CHEM, V277, P11239, DOI 10.1074/jbc.M107756200; Morichika H, 1996, CANCER, V78, P43, DOI 10.1002/(SICI)1097-0142(19960701)78:1<43::AID-CNCR8>3.3.CO;2-2; Moyano AL, 2013, J NEUROCHEM, V127, P600, DOI 10.1111/jnc.12341; Moyano AL, 2014, ANAL BIOCHEM, V467, P31, DOI 10.1016/j.ab.2014.08.033; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Orentas DM, 1999, DEVELOPMENT, V126, P2419; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; PORTER MT, 1969, P NATL ACAD SCI USA, V62, P887, DOI 10.1073/pnas.62.3.887; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; Rafalski VA, 2013, NAT CELL BIOL, V15, P614, DOI 10.1038/ncb2735; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Raiker SJ, 2010, J NEUROSCI, V30, P12432, DOI 10.1523/JNEUROSCI.0895-10.2010; Reis-Sobreiro M, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.15; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Richardson WD, 1997, DEV NEUROSCI-BASEL, V19, P58, DOI 10.1159/000111186; SAKAKIBARA N, 1991, CANCER LETT, V57, P187, DOI 10.1016/0304-3835(91)90155-B; SANDHOFF K, 1994, FEBS LETT, V346, P103, DOI 10.1016/0014-5793(94)00282-7; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Strauss K, 2010, J BIOL CHEM, V285, P26279, DOI 10.1074/jbc.M110.134775; Takahashi T, 2012, J BIOCHEM, V152, P373, DOI 10.1093/jb/mvs080; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; THOMPSON TE, 1985, ANNU REV BIOPHYS BIO, V14, P361, DOI 10.1146/annurev.biophys.14.1.361; Trajkovic K, 2006, J CELL BIOL, V172, P937, DOI 10.1083/jcb.200509022; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Verweij Frederik J, 2012, Commun Integr Biol, V5, P88; Vidal M, 1997, J CELL SCI, V110, P1867; WARF BC, 1991, J NEUROSCI, V11, P2477; White AB, 2011, J NEUROSCI RES, V89, P352, DOI 10.1002/jnr.22564; White AB, 2009, J NEUROSCI, V29, P6068, DOI 10.1523/JNEUROSCI.5597-08.2009; Yaghootfam A, 2005, EUR J NEUROSCI, V21, P711, DOI 10.1111/j.1460-9568.2005.03891.x	102	29	29	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7040	7053		10.1074/jbc.M115.636498	http://dx.doi.org/10.1074/jbc.M115.636498			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605750	Green Published, hybrid			2022-12-26	WOS:000350991500037
J	Chen, XD; Khajeh, JA; Ju, JH; Gupta, YK; Stanley, CB; Do, C; Heller, WT; Aggarwal, AK; Callaway, DJE; Bu, ZM				Chen, Xiaodong; Khajeh, Jahan Ali; Ju, Jeong Ho; Gupta, Yogesh K.; Stanley, Christopher B.; Do, Changwoo; Heller, William T.; Aggarwal, Aneel K.; Callaway, David J. E.; Bu, Zimei			Phosphatidylinositol 4,5-Bisphosphate Clusters the Cell Adhesion Molecule CD44 and Assembles a Specific CD44-Ezrin Heterocomplex, as Revealed by Small Angle Neutron Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; TRANSMEMBRANE CONDUCTANCE REGULATOR; SCAFFOLDING PROTEIN NHERF1; BREAST-CANCER CELLS; N-TERMINAL DOMAIN; ERM PROTEINS; BIOLOGICAL MACROMOLECULES; PROSPECTIVE IDENTIFICATION; SEDIMENTATION EQUILIBRIUM; CYTOPLASMIC DOMAIN	The cell adhesion molecule CD44 regulates diverse cellular functions, including cell-cell and cell-matrix interaction, cell motility, migration, differentiation, and growth. In cells, CD44 co-localizes with the membrane-cytoskeleton adapter protein Ezrin that links the CD44 assembled receptor signaling complexes to the cytoskeletal actin network, which organizes the spatial and temporal localization of signaling events. Here we report that the cytoplasmic tail of CD44 (CD44ct) is largely disordered. Upon binding to the signaling lipid phosphatidylinositol 4,5-bisphosphate (PI12), CD44ct clusters into aggregates. Further, contrary to the generally accepted model, CD44ct does not bind directly to the FERM domain of Ezrin or to the fulllength Ezrin but only forms a complex with FERM or with the full-length Ezrin in the presence of PIP2. Using contrast variation small angle neutron scattering, we show that PIP2 mediates the assembly of a specific heterotetramer complex of CD44ct with Ezrin. This study reveals the role of PIP2 in clustering CD44 and in assembling multimeric CD44-Ezrin complexes. We hypothesize that polyvalent electrostatic interactions are responsible for the assembly of CD44 clusters and the multimeric PIP2-('D44-Ezrin complexes.	[Chen, Xiaodong; Khajeh, Jahan Ali; Ju, Jeong Ho; Callaway, David J. E.; Bu, Zimei] CUNY, Dept Chem & Biochem, New York, NY 10031 USA; [Chen, Xiaodong] Jiangxi Univ Tradit Chinese Med, Sch Pharm, Nanchang 330004, Jiangxi, Peoples R China; [Gupta, Yogesh K.; Aggarwal, Aneel K.] Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, New York, NY 10029 USA; [Stanley, Christopher B.; Do, Changwoo; Heller, William T.] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA	City University of New York (CUNY) System; Jiangxi University of Traditional Chinese Medicine; Icahn School of Medicine at Mount Sinai; United States Department of Energy (DOE); Oak Ridge National Laboratory	Bu, ZM (corresponding author), CUNY, Dept Chem, 160 Convent Ave, New York, NY 10031 USA.	zbu@ccny.cuny.edu	chen, xia/GYR-3948-2022; Do, Changwoo/ABG-6709-2020; Gupta, Yogesh K/B-6949-2009; Heller, William/ABE-1104-2020; chen, xia/GXM-5435-2022; chen, xi/GXH-3653-2022; Gupta, Yogesh/AFH-5204-2022; Do, Changwoo/A-9670-2011; Stanley, Christopher/AAC-2732-2022	Do, Changwoo/0000-0001-8358-8417; Gupta, Yogesh K/0000-0001-6372-5007; Heller, William/0000-0001-6456-2975; Gupta, Yogesh/0000-0001-6372-5007; Do, Changwoo/0000-0001-8358-8417; Stanley, Christopher/0000-0002-4226-7710	National Institutes of Health [R01HL086496]; National Center for Research Resources [2G12 RR003060]; Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086496] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL086496 (to Z. B.) and 2G12 RR003060 from the National Center for Research Resources (to City College of New York). This work was also supported by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy and the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Momany A, 2014, J CELL SCI, V127, P5164, DOI 10.1242/jcs.147744; Allaire M, 2011, J SYNCHROTRON RADIAT, V18, P41, DOI 10.1107/S0909049510036022; Babina IS, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3614; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Bhattacharya S, 2013, J MOL BIOL, V425, P2509, DOI 10.1016/j.jmb.2013.04.001; Bhattacharya S, 2010, J BIOL CHEM, V285, P9981, DOI 10.1074/jbc.M109.074005; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bu ZM, 2011, ADV PROTEIN CHEM STR, V83, P163, DOI 10.1016/B978-0-12-381262-9.00005-7; Bu ZM, 1999, BIOPHYS J, V77, P1064, DOI 10.1016/S0006-3495(99)76956-0; Bu ZM, 1998, J APPL CRYSTALLOGR, V31, P533, DOI 10.1107/S0021889897015422; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Donatello S, 2012, AM J PATHOL, V181, P2172, DOI 10.1016/j.ajpath.2012.08.025; Farago B, 2010, BIOPHYS J, V99, P3473, DOI 10.1016/j.bpj.2010.09.058; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Glatter O., 1982, SMALL ANGLE X RAY SC; Grover JR, 2015, J VIROL, V89, P454, DOI 10.1128/JVI.02178-14; Hanono A, 2006, J CELL BIOL, V175, P803, DOI 10.1083/jcb.200604046; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Ho DL, 2004, J BIOL CHEM, V279, P39146, DOI 10.1074/jbc.M404565200; JACROT B, 1981, BIOPOLYMERS, V20, P2413, DOI 10.1002/bip.1981.360201110; Jayasundar JJ, 2012, J BIOL CHEM, V287, P37119, DOI 10.1074/jbc.M112.380972; Khajeh JA, 2014, J MOL BIOL, V426, P2755, DOI 10.1016/j.jmb.2014.05.011; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Li JQ, 2009, J MOL BIOL, V392, P166, DOI 10.1016/j.jmb.2009.07.005; Li JQ, 2005, J BIOL CHEM, V280, P37634, DOI 10.1074/jbc.M502305200; Li QZ, 2007, J MOL BIOL, V365, P1446, DOI 10.1016/j.jmb.2006.10.075; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mellor L, 2013, J BIOL CHEM, V288, P25838, DOI 10.1074/jbc.M113.494872; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; NEAME SJ, 1995, J CELL SCI, V108, P3127; Niggli V, 2005, ANNU REV CELL DEV BI, V21, P57, DOI 10.1146/annurev.cellbio.21.021704.102317; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Olsson E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-418; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; PERSCHL A, 1995, EUR J IMMUNOL, V25, P495, DOI 10.1002/eji.1830250228; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Roch F, 2010, J CELL SCI, V123, P2057, DOI 10.1242/jcs.064550; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Smith WJ, 2003, J BIOL CHEM, V278, P4949, DOI 10.1074/jbc.M210601200; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; STUHRMANN HB, 1974, J APPL CRYSTALLOGR, V7, P173, DOI 10.1107/S0021889874009071; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Thorne RF, 2004, J CELL SCI, V117, P373, DOI 10.1242/jcs.00954; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WIGNALL GD, 1987, J APPL CRYSTALLOGR, V20, P28, DOI 10.1107/S0021889887087181; Wobus M, 2002, APPL IMMUNOHISTO M M, V10, P34, DOI 10.1097/00022744-200203000-00006; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869; Yang L, 2013, J SYNCHROTRON RADIAT, V20, P211, DOI 10.1107/S0909049512048984; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zhao JK, 2010, J APPL CRYSTALLOGR, V43, P1068, DOI 10.1107/S002188981002217X; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023; Zwaenepoel I, 2012, MOL BIOL CELL, V23, P1080, DOI 10.1091/mbc.E11-07-0588	74	23	23	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6639	6652		10.1074/jbc.M114.589523	http://dx.doi.org/10.1074/jbc.M114.589523			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25572402	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000350732500065
J	Corrigan, RM; Bowman, L; Willis, AR; Kaever, V; Grundling, A				Corrigan, Rebecca M.; Bowman, Lisa; Willis, Alexandra R.; Kaever, Volkhard; Gruendling, Angelika			Cross-talk between Two Nucleotide-signaling Pathways in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-DI-AMP; BETA-LACTAM RESISTANCE; BACILLUS-SUBTILIS; STRINGENT RESPONSE; STREPTOCOCCUS-PNEUMONIAE; ALLELIC REPLACEMENT; LACTOCOCCUS-LACTIS; STRESS RESISTANCE; ESCHERICHIA-COLI; ESSENTIAL GENES	Nucleotide-signaling pathways are found in all kingdoms of life and are utilized to coordinate a rapid response to external stimuli. The stringent response alarmones guanosine tetra-(ppGpp) and pentaphosphate (pppGpp) control a global response allowing cells to adapt to starvation conditions such as amino acid depletion. One more recently discovered signaling nucleotide is the secondary messenger cyclic diadenosine monophosphate (c-di-AMP). Here, we demonstrate that this signaling nucleotide is essential for the growth of Staphylococcus aureus, and its increased production during late growth phases indicates that c-di-AMP controls processes that are important for the survival of cells in stationary phase. By examining the transcriptional profile of cells with high levels of c-diAMP, we reveal a significant overlap with a stringent response transcription signature. Examination of the intracellular nucleotide levels under stress conditions provides further evidence that high levels of c-di-AMP lead to an activation of the stringent response through a RelA/SpoT homologue (RSH) enzyme-dependent increase in the (p) ppGpp levels. This activation is shown to be indirect as c-di-AMP does not interact directly with the RSH protein. Our data extend this interconnection further by showing that the S. aureus c-di-AMP phosphodiesterase enzyme GdpP is inhibited in a dose-dependent manner by ppGpp, which itself is not a substrate for this enzyme. Altogether, these findings add a new layer of complexity to our understanding of nucleotide signaling in bacteria as they highlight intricate interconnections between different nucleotide-signaling networks.	[Corrigan, Rebecca M.; Bowman, Lisa; Willis, Alexandra R.; Gruendling, Angelika] Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, London SW7 2AZ, England; [Corrigan, Rebecca M.; Bowman, Lisa; Willis, Alexandra R.; Gruendling, Angelika] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Bacteriol & Infect, MRC, London SW7 2AZ, England; [Kaever, Volkhard] Hannover Med Sch, Res Core Unit Metabol, D-306625 Hannover, Germany	Imperial College London; Imperial College London; Hannover Medical School	Grundling, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, Flowers Bldg,RM 3-21, London SW7 2AZ, England.	a.grundling@imperial.ac.uk	Corrigan, Rebecca M/H-7249-2019; Kaever, Volkhard/G-3280-2013	Corrigan, Rebecca M/0000-0002-6031-1148; Grundling, Angelika/0000-0002-6235-8687	European Research Council [260371]; Wellcome Trust [100289]; Medical Research Council Centre for Molecular Bacteriology and Infection (MRC CMBI) studentship; Medical Research Council [MR/J006874/1, MR/J006874/1B] Funding Source: researchfish; MRC [MR/J006874/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Centre for Molecular Bacteriology and Infection (MRC CMBI) studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by European Research Council Grant 260371 and Wellcome Trust Grant 100289 (to A. G.).; Supported by a Medical Research Council Centre for Molecular Bacteriology and Infection (MRC CMBI) studentship.	An SQ, 2013, EMBO J, V32, P2430, DOI 10.1038/emboj.2013.165; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; Bai YL, 2013, J BACTERIOL, V195, P5123, DOI 10.1128/JB.00769-13; Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; CASHEL M, 1969, J BIOL CHEM, V244, P3133; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; FIIL NP, 1972, J MOL BIOL, V71, P769; Fong JCN, 2008, J BACTERIOL, V190, P6646, DOI 10.1128/JB.00466-08; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; Gao W, 2013, J INFECT DIS, V207, P929, DOI 10.1093/infdis/jis772; Gao W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000944; Geiger T, 2014, J BACTERIOL, V196, P894, DOI 10.1128/JB.01201-13; Geiger T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003016; Geiger T, 2010, INFECT IMMUN, V78, P1873, DOI 10.1128/IAI.01439-09; Gentry D, 2000, J BACTERIOL, V182, P4995, DOI 10.1128/JB.182.17.4995-4997.2000; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Griffiths JM, 2012, ANTIMICROB AGENTS CH, V56, P579, DOI 10.1128/AAC.05148-11; Grundling A, 2007, J BACTERIOL, V189, P2521, DOI 10.1128/JB.01683-06; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Jenvert RMK, 2005, FEBS J, V272, P685, DOI 10.1111/j.1742-4658.2004.04502.x; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Lemos JAC, 2004, INFECT IMMUN, V72, P1431, DOI 10.1128/IAI.72.3.1431-1440.2004; Leski TA, 2005, J BACTERIOL, V187, P1815, DOI 10.1128/JB.187.5.1815-1824.2005; Lu D, 2009, P NATL ACAD SCI USA, V106, P1584, DOI 10.1073/pnas.0809020106; Lund E., 1972, FEBS, V28, P316; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Memmi G, 2008, ANTIMICROB AGENTS CH, V52, P3955, DOI 10.1128/AAC.00049-08; Miller HK, 2012, J BACTERIOL, V194, P4342, DOI 10.1128/JB.00484-12; Mwangi MM, 2013, MICROB DRUG RESIST, V19, P153, DOI 10.1089/mdr.2013.0053; Nagarajan V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-351; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; Nelson JW, 2013, NAT CHEM BIOL, V9, P834, DOI [10.1038/NCHEMBIO.1363, 10.1038/nchembio.1363]; OCHI K, 1981, J BIOL CHEM, V256, P6866; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Rallu F, 2000, MOL MICROBIOL, V35, P517, DOI 10.1046/j.1365-2958.2000.01711.x; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; RUDIN L, 1974, J BACTERIOL, V118, P155, DOI 10.1128/JB.118.1.155-164.1974; Smith WM, 2012, APPL ENVIRON MICROB, V78, P7753, DOI 10.1128/AEM.02316-12; Song JH, 2005, MOL CELLS, V19, P365; Sureka K, 2014, CELL, V158, P1389, DOI 10.1016/j.cell.2014.07.046; Thomaides HB, 2001, GENE DEV, V15, P1662, DOI 10.1101/gad.197501; Webb AJ, 2009, MOL MICROBIOL, V74, P299, DOI 10.1111/j.1365-2958.2009.06829.x; Witney AA, 2005, APPL ENVIRON MICROB, V71, P7504, DOI 10.1128/AEM.71.11.7504-7514.2005; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801	62	78	80	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5826	5839		10.1074/jbc.M114.598300	http://dx.doi.org/10.1074/jbc.M114.598300			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25575594	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000350044200048
J	Haldar, S; Tripathi, A; Qian, J; Beserra, A; Suda, S; McElwee, M; Turner, J; Hopfer, U; Singh, N				Haldar, Swati; Tripathi, Ajai; Qian, Juan; Beserra, Amber; Suda, Srinivas; McElwee, Matthew; Turner, Jerrold; Hopfer, Ulrich; Singh, Neena			Prion Protein Promotes Kidney Iron Uptake via Its Ferrireductase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE PATHOGENESIS; VESICULAR TRANSPORT; PROXIMAL TUBULE; HUMAN URINE; METABOLISM; CELLS; LOCALIZATION; TRANSFERRIN; BRAIN; DEFERIPRONE	Brain iron-dyshomeostasis is an important cause of neurotoxicity in prion disorders, a group of neurodegenerative conditions associated with the conversion of prion protein (PrPC) from its normal conformation to an aggregated, PrP-scrapie (PrPSc) isoform. Alteration of iron homeostasis is believed to result from impaired function of PrPC in neuronal iron uptake via its ferrireductase activity. However, unequivocal evidence supporting the ferrireductase activity of PrPC is lacking. Kidney provides a relevant model for this evaluation because PrPC is expressed in the kidney, and similar to 370 in of iron are reabsorbed daily from the glomerular filtrate by kidney proximal tubule cells (PT), requiring ferrireductase activity. Here, we report that PrPC promotes the uptake of transferrin (Tf) and non-if-bound iron (NTBI) by the kidney in vivo and mainly NTBI by PT cells in vitro. Thus, uptake of Fe-59 administered by gastric gavage, intravenously, or intraperitoneally was significantly lower in PrP-knock-out (PrP-/-) kidney relative to PrP+/+ controls. Selective in vivo radiolabeling of plasma NTBI with Fe-59 revealed similar results. Expression of exogenous PrPC in immortalized PT cells showed localization on the plasma membrane and intracellular vesicles and increased transepithelial transport of Fe-59-NTBI and to a smaller extent Fe-59-Tf from the apical to the basolateral domain. Notably, the ferrireductase-deficient mutant of PrP (PrP Delta(51-89)) lacked this activity. Furthermore, excess NTBI and hemin caused aggregation of PrPC to a detergent-insoluble form, limiting iron uptake. Together, these observations suggest that PrPC promotes retrieval of iron from the glomerular filtrate via its ferrireductase activity and modulates kidney iron metabolism.	[Haldar, Swati; Tripathi, Ajai; Qian, Juan; Beserra, Amber; Suda, Srinivas; McElwee, Matthew; Singh, Neena] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA; [Hopfer, Ulrich] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Turner, Jerrold] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; University of Chicago	Singh, N (corresponding author), Case Western Reserve Univ, Dept Pathol, 2103 Cornell Rd, Cleveland, OH 44106 USA.	neena.singh@case.edu	Tripathi, Ajai/I-1983-2019; Haldar, Swati/AAH-5388-2021; Turner, Jerrold/H-1502-2019	Tripathi, Ajai/0000-0002-5070-2567; Suda, Srinivas/0000-0003-0860-0169; Haldar, Swati/0000-0002-1566-1907; McElwee, Matthew/0000-0003-1659-6112	National Institutes of Health [DK 088390, NS 076139, NS NS077438]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS077438, R21NS076139] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 088390, NS 076139 (NINDS), and NS NS077438 (to N. S.).	Abbaspour N, 2014, J RES MED SCI, V19, P164; Abouhamed M, 2006, AM J PHYSIOL-RENAL, V290, pF1525, DOI 10.1152/ajprenal.00359.2005; Aguzzi A, 2013, NAT REV IMMUNOL, V13, P888, DOI 10.1038/nri3553; [Anonymous], 2010, PLOS ONE, V19, P5; Ashe KH, 2013, PRION, V7, P55, DOI 10.4161/pri.23061; Aydinok Y, 2007, HAEMATOLOGICA, V92, P1599, DOI 10.3324/haematol.11414; Basu S, 2007, MOL BIOL CELL, V18, P3302, DOI 10.1091/mbc.E07-04-0317; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Caughey B, 1991, Curr Top Microbiol Immunol, V172, P93; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Christoforidis A, 2007, J PEDIAT HEMATOL ONC, V29, P598, DOI 10.1097/MPH.0b013e318142b51e; CRAVEN CM, 1987, P NATL ACAD SCI USA, V84, P3457, DOI 10.1073/pnas.84.10.3457; Dagdanova A, 2010, J BIOL CHEM, V285, P30489, DOI 10.1074/jbc.M110.161794; Ddorizz G., 2015, J CELL BIOL, V135, P39; Fournier JG, 1998, CELL TISSUE RES, V292, P77, DOI 10.1007/s004410051036; Gu YP, 2003, NEUROBIOL DIS, V12, P133, DOI 10.1016/S0969-9961(02)00014-1; Gu YP, 2003, J NEUROCHEM, V84, P10, DOI 10.1046/j.1471-4159.2003.01255.x; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; hierse D., 2015, PLOS ONE, V6; Kozyraki R, 2001, P NATL ACAD SCI USA, V98, P12491, DOI 10.1073/pnas.211291398; Lee KS, 2007, J BIOL CHEM, V282, P36525, DOI 10.1074/jbc.M705620200; Linder MC, 2006, BIOL RES, V39, P143, DOI 10.4067/S0716-97602006000100016; Martines AMF, 2013, NAT REV NEPHROL, V9, P385, DOI 10.1038/nrneph.2013.98; Mckie AT, 2008, BIOCHEM SOC T, V36, P1239, DOI 10.1042/BST0361239; Mishra RS, 2004, J NEUROSCI, V24, P11280, DOI 10.1523/JNEUROSCI.2864-04.2004; Mishra RS, 2002, J BIOL CHEM, V277, P24554, DOI 10.1074/jbc.M200213200; Moriya M, 2006, AM J PHYSIOL-GASTR L, V290, pG301, DOI 10.1152/ajpgi.00029.2005; Moulouel B, 2013, KIDNEY INT, V84, P756, DOI 10.1038/ki.2013.142; Narang HK, 2005, EXP BIOL MED, V230, P343, DOI 10.1177/153537020523000508; Nestel FP, 2000, BLOOD, V96, P1836, DOI 10.1182/blood.V96.5.1836.h8001836_1836_1843; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Parkin E.T., 2004, J BIOL CHEM, V279, P1170; Peralta OA, 2009, PRION, V3, P161, DOI 10.4161/pri.3.3.9772; Peters PJ, 2003, J CELL BIOL, V162, P703, DOI 10.1083/jcb.200304140; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SEARS DA, 1966, BLOOD-J HEMATOL, V28, P708, DOI 10.1182/blood.V28.5.708.708; Singh A, 2013, J ALZHEIMERS DIS, V35, P541, DOI 10.3233/JAD-130218; Singh A, 2012, NEUROBIOL DIS, V45, P930, DOI 10.1016/j.nbd.2011.12.012; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006115; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000336; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004468; Singh N, 1997, J BIOL CHEM, V272, P28461, DOI 10.1074/jbc.272.45.28461; Singh N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004335; Singh N, 2014, ANTIOXID REDOX SIGN, V20, P1324, DOI 10.1089/ars.2012.4931; Smith CP, 2009, BBA-GEN SUBJECTS, V1790, P724, DOI 10.1016/j.bbagen.2008.10.010; Wang EI, 2000, TRAFFIC, V1, P480, DOI 10.1034/j.1600-0854.2000.010606.x; Wareing M, 2000, J PHYSIOL-LONDON, V524, P581, DOI 10.1111/j.1469-7793.2000.00581.x; Woost PG, 2007, IN VITRO CELL DEV-AN, V43, P352, DOI 10.1007/s11626-007-9061-1; Zhang DL, 2007, J AM SOC NEPHROL, V18, P401, DOI 10.1681/ASN.2006080908; Zhang X, 2013, FREE RADICAL BIO MED, V63, P243, DOI 10.1016/j.freeradbiomed.2013.05.004; Zhao HX, 2006, VIRUS RES, V115, P43, DOI 10.1016/j.virusres.2005.07.004	51	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5512	5522		10.1074/jbc.M114.607507	http://dx.doi.org/10.1074/jbc.M114.607507			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25572394	Green Published, hybrid			2022-12-26	WOS:000350044200023
J	Qin, Y; Ke, JY; Gu, X; Fang, JP; Wang, WC; Cong, QF; Li, J; Tan, JZ; Brunzelle, JS; Zhang, CH; Jiang, Y; Melcher, K; Li, JP; Xu, HE; Ding, K				Qin, Yi; Ke, Jiyuan; Gu, Xin; Fang, Jianping; Wang, Wucheng; Cong, Qifei; Li, Jie; Tan, Jinzhi; Brunzelle, Joseph S.; Zhang, Chenghai; Jiang, Yi; Melcher, Karsten; Li, Jin-ping; Xu, H. Eric; Ding, Kan			Structural and Functional Study of D-Glucuronyl C5-epimerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-IDURONIC ACID; CAPSULAR POLYSACCHARIDE; HEPARIN/HEPARAN SULFATE; BIOSYNTHESIS; ENZYME; C-5-EPIMERASE; 2-O-SULFOTRANSFERASE; SPECIFICITY; DISRUPTION; EPIMERASE	Heparan sulfate (HS) is a glycosaminoglycan present on the cell surface and in the extracellular matrix, which interacts with diverse signal molecules and is essential for many physiological processes including embryonic development, cell growth, inflammation, and blood coagulation. D-Glucuronyl C5-epimerase (Glce) is a crucial enzyme in HS synthesis, converting D-glucuronic acid to L-iduronic acid to increase HS flexibility. This modification of HS is important for protein ligand recognition. We have determined the crystal structures of Glce in apo-form (unliganded) and in complex with heparin hexasaccharide (product of Glce following O-sulfation), both in a stable dimer conformation. A Glce dimer contains two catalytic sites, each at a positively charged cleft in C-terminal alpha-helical domains binding one negatively charged hexasaccharide. Based on the structural and mutagenesis studies, three tyrosine residues, Tyr(468), Tyr(528), and Tyr(546), in the active site were found to be crucial for the enzymatic activity. The complex structure also reveals the mechanism of product inhibition (i.e. 2-O- and 6-O-sulfation of HS keeps the C5 carbon of L-iduronic acid away from the active-site tyrosine residues). Our structural and functional data advance understanding of the key modification in HS biosynthesis.	[Qin, Yi; Fang, Jianping; Wang, Wucheng; Cong, Qifei; Li, Jie; Ding, Kan] Chinese Acad Sci, Shanghai Inst Mat Med, Glycochemistry & Glycobiol Lab, Shanghai 201203, Peoples R China; [Qin, Yi; Tan, Jinzhi; Zhang, Chenghai; Jiang, Yi; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, VARI SIMM Ctr,Ctr Struct & Funct Drug Targets, Shanghai 201203, Peoples R China; [Ke, Jiyuan; Gu, Xin; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Ctr Struct Biol & Drug Discovery, Grand Rapids, MI 49503 USA; [Fang, Jianping; Li, Jin-ping] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Brunzelle, Joseph S.] Northwestern Univ, Life Sci Collaborat Access Team, Synchrotron Res Ctr, Argonne, IL 60439 USA	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Van Andel Institute; Uppsala University; Northwestern University	Ke, JY (corresponding author), Van Andel Res Inst, Lab Struct Sci, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	Jiyuan.Ke@vai.org; Eric.Xu@vai.org; dingkan@simm.ac.cn	Xu, H. Eric/ABD-7487-2021; Melcher, Karsten/AAZ-3861-2020	Melcher, Karsten/0000-0002-9125-4027; Ding, Kan/0000-0002-8140-9259; Xu, H. Eric/0000-0002-6829-8144; Cong, Qifei/0000-0002-4446-7222	National Natural Science Foundation of China (NSFC) [31230022]; National Science Fund for Distinguished Young Scholars [81125025]; New Drug Creation and Manufacturing Program [2012ZX09301001-003]; Swedish Research Council; Swedish Cancer Foundation; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant [085P1000817]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); New Drug Creation and Manufacturing Program; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant	This work was supported by National Natural Science Foundation of China (NSFC) Grant 31230022, National Science Fund for Distinguished Young Scholars Grant 81125025, New Drug Creation and Manufacturing Program Grant 2012ZX09301001-003, the Swedish Research Council and Swedish Cancer Foundation (to J. P. L.), the Michigan Economic Development Corporation, and Michigan Technology Tri-Corridor Grant 085P1000817.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; CAMPBELL P, 1983, ANAL BIOCHEM, V131, P146, DOI 10.1016/0003-2697(83)90146-X; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Dejima K, 2013, J BIOL CHEM, V288, P34384, DOI 10.1074/jbc.M113.499269; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feyerabend TB, 2006, NAT CHEM BIOL, V2, P195, DOI 10.1038/nchembio777; Grigorieva EV, 2011, BRIT J CANCER, V105, P74, DOI 10.1038/bjc.2011.170; Hagner-McWhirter A, 2000, BIOCHEM J, V347, P69, DOI 10.1042/0264-6021:3470069; Hagner-McWhirter A, 2004, J BIOL CHEM, V279, P14631, DOI 10.1074/jbc.M313760200; Hagner-McWhirter A, 2000, GLYCOBIOLOGY, V10, P159, DOI 10.1093/glycob/10.2.159; Hallak LK, 2000, VIROLOGY, V271, P264, DOI 10.1006/viro.2000.0293; Hannesson HH, 1996, BIOCHEM J, V313, P589, DOI 10.1042/bj3130589; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JACOBSSON I, 1984, J BIOL CHEM, V259, P1056; Jerga A, 2006, BIOCHEMISTRY-US, V45, P9138, DOI 10.1021/bi060748f; Jia J, 2009, J BIOL CHEM, V284, P15942, DOI 10.1074/jbc.M809577200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Ke JY, 2013, GENE DEV, V27, P2305, DOI 10.1101/gad.228544.113; Kuberan B, 2003, NAT BIOTECHNOL, V21, P1343, DOI 10.1038/nbt885; Li J, 2014, BIOCHEM J, V459, P405, DOI 10.1042/BJ20131360; Li JP, 2010, PROG MOL BIOL TRANSL, V93, P59, DOI 10.1016/S1877-1173(10)93004-4; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Li K, 2010, J BIOL CHEM, V285, P11106, DOI 10.1074/jbc.M109.081059; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pacheco B, 2009, J BIOL CHEM, V284, P1741, DOI 10.1074/jbc.M805479200; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Prudnikova TY, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-27; Raedts J, 2013, J BIOL CHEM, V288, P24332, DOI 10.1074/jbc.M113.476440; Reijmers RM, 2011, BLOOD, V117, P6162, DOI 10.1182/blood-2010-12-325522; Reijmers RM, 2010, J IMMUNOL, V184, P3656, DOI 10.4049/jimmunol.0902200; Rozeboom HJ, 2008, J BIOL CHEM, V283, P23819, DOI 10.1074/jbc.M804119200; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sheng JZ, 2012, J BIOL CHEM, V287, P20996, DOI 10.1074/jbc.M112.359885; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478	37	28	32	1	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4620	4630		10.1074/jbc.M114.602201	http://dx.doi.org/10.1074/jbc.M114.602201			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25568314	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000350042000008
J	Li, SJ; Sun, QZ; Wei, XY; Klena, JD; Wang, JP; Liu, Y; Tian, KC; Luo, X; Ye, CY; Xu, JG; Wang, DM; Tang, GP				Li, Shijun; Sun, Qiangzheng; Wei, Xiaoyu; Klena, John D.; Wang, Jianping; Liu, Ying; Tian, Kecheng; Luo, Xia; Ye, Changyun; Xu, Jianguo; Wang, Dingming; Tang, Guangpeng			Genetic Characterization of Shigella flexneri Isolates in Guizhou Province, China	PLOS ONE			English	Article							TANDEM-REPEAT ANALYSIS; ASIAN COUNTRIES; DISEASE BURDEN; SALMONELLA; PULSENET; SONNEI	Shigella flexneri is one of the major etiologic causes of shigellosis in Guizhou Province, China. However, the genetic characteristics of circulating isolates are unknown. Phenotypic and molecular profiles of 60 S. flexneri isolates recovered in Guizhou between 1972 to 1982 and 2008 to 2010 were determined. Nine serotypes (1a, 2a, 3a, 1b, 2b, X, Y, 4av and Yv) were identified. Multi-locus sequence typing differentiated the isolates into 20 sequence types (STs); 18 were novel. Four STs, ST 129, ST 100, ST 126 and ST 18, were most abundant, accounting for 65% of the isolates. Thirty-nine NotI-pulsed field gel electrophoresis patterns (pulsotypes, PTs) were observed; eight PTs were represented by more than one isolate with six isolates sharing the PT 13 profile. Multi-locus variable-nucleotide tandem-repeat analysis recognized 44 different types (MTs); seven MTs were represented by more than one isolate and MT 1 was most commonly encountered. Correlation between genetic relationships and serotypes was observed among the isolates studied; the majority of isolates belonging to the same serotype from different years clustered together based on the molecular data. These clustered isolates were also from similar geographical origins. These results enhance our understanding of genetic relationships between S. flexneri in Guizhou Province and can be used to help understand the changing etiology of shigellosis in China.	[Li, Shijun; Wei, Xiaoyu; Liu, Ying; Tian, Kecheng; Wang, Dingming; Tang, Guangpeng] Guizhou Prov Ctr Dis Control & Prevent, Inst Communicable Dis Control & Prevent, Guiyang 550004, Guizhou, Peoples R China; [Sun, Qiangzheng; Wang, Jianping; Luo, Xia; Ye, Changyun; Xu, Jianguo] China CDC, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Klena, John D.] US Ctr Dis Control & Prevent, Int Emerging Infect Program, Beijing, Peoples R China; [Klena, John D.] Ctr Dis Control & Prevent, Global Dis Detect Branch, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Centers for Disease Control & Prevention - USA	Li, SJ (corresponding author), Guizhou Prov Ctr Dis Control & Prevent, Inst Communicable Dis Control & Prevent, 101 Bageyan Rd, Guiyang 550004, Guizhou, Peoples R China.	zjumedjun@163.com			grant of national science and technology major project of China [2009ZX10602-12]; Talent Base Funds for Infectious Disease Control and Prevention in Guizhou Provincial Government [Qian Ren Ling Fa [2013]15]; National Natural Science Foundation of China [81271788, 81290345]; National Basic Research Priorities Program [2011CB504901]; National Key Program for Infectious Diseases of China [2013ZX10004221, 013ZX10004216-001-002, 2ZX10004215]	grant of national science and technology major project of China; Talent Base Funds for Infectious Disease Control and Prevention in Guizhou Provincial Government; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Priorities Program(National Basic Research Program of China); National Key Program for Infectious Diseases of China	This work was supported by the grant of national science and technology major project of China (No. 2009ZX10602-12), Talent Base Funds for Infectious Disease Control and Prevention in Guizhou Provincial Government (No. Qian Ren Ling Fa [2013]15), National Natural Science Foundation of China (No. 81271788 and 81290345), National Basic Research Priorities Program (No. 2011CB504901) and National Key Program for Infectious Diseases of China (No. 2013ZX10004221, 013ZX10004216-001-002 and 2ZX10004215. We acknowledge the use of the EcMLST database which is operated by the Microbial Evolution Laboratory at Michigan State University. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2014, INT J FOOD MICROBIOL, V168, P57, DOI 10.1016/j.ijfoodmicro.2013.10.014; [Anonymous], J MODERN LAB MED, V24, P3; Cao Y, 2012, INT J MOL EPIDEMIOL, V3, P321; Chen WWJ, 2006, MODERN PREVENTIVE ME, V33, P2; Chiou CS, 2009, J CLIN MICROBIOL, V47, P1149, DOI 10.1128/JCM.01607-08; Choi SY, 2007, J MED MICROBIOL, V56, P1460, DOI 10.1099/jmm.0.47322-0; Gorge O, 2008, J CLIN MICROBIOL, V46, P1026, DOI 10.1128/JCM.02027-07; Hyytia-Trees E, 2006, FOODBORNE PATHOG DIS, V3, P118, DOI 10.1089/fpd.2006.3.118; Islam MA, 2013, J MED MICROBIOL, V62, P62, DOI 10.1099/jmm.0.048066-0; Izumiya H, 2009, J MED MICROBIOL, V58, P1486, DOI 10.1099/jmm.0.011809-0; Knirel YA, 2013, GLYCOBIOLOGY, V23, P475, DOI 10.1093/glycob/cws222; Liu J MY, 2011, OCCUPATION HLTH, V27, P3; Niyogi SK, 2005, J MICROBIOL, V43, P133; Qiu SF, 2013, EMERG INFECT DIS, V19, P1147, DOI 10.3201/eid1907.111221; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Ru WHL, 2011, CHINESE J PRACTICAL, V38, P4; Sun QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070238; Sun QZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046095; Sun QZ, 2011, J CLIN MICROBIOL, V49, P3766, DOI 10.1128/JCM.01259-11; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353; Wang XY, 2006, B WORLD HEALTH ORGAN, V84, P561, DOI 10.2471/BLT.05.023853; Wang YW, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-278; Wei XY., 2012, PRACT PREV MED, V19, P1185; Xia SL, 2011, J CLIN MICROBIOL, V49, P232, DOI 10.1128/JCM.01508-10; Xu Y, 2009, ANAL COMMUNITY ACQUI; Ye CY, 2010, J CLIN MICROBIOL, V48, P419, DOI 10.1128/JCM.00614-09; Zhu Li TQ, 2013, J PREVENTIVE MED, V24, P3	27	3	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116708	10.1371/journal.pone.0116708	http://dx.doi.org/10.1371/journal.pone.0116708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617838	Green Published, gold			2022-12-26	WOS:000350336000021
J	Fumis, RRL; Ranzani, OT; Martins, PS; Schettino, G				Lins Fumis, Renata Rego; Ranzani, Otavio T.; Martins, Paulo Sergio; Schettino, Guilherme			Emotional Disorders in Pairs of Patients and Their Family Members during and after ICU Stay	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; POSTTRAUMATIC STRESS SYMPTOMS; ILL CANCER-PATIENTS; DEPRESSION SYMPTOMS; CRITICAL ILLNESS; VISITING POLICY; ANXIETY; SPIRITUALITY; RELATIVES; COMMUNICATION	Introduction Patients and family members undergo different experiences of suffering from emotional disorders during ICU stay and after ICU discharge. The purpose of this study was to compare the incidence of anxiety, depression and post-traumatic stress disorder (PTSD) symptoms in pairs (patient and respective family member), during stay at an open visit ICU and at 30 and 90-days post-ICU discharge. We hypothesized that there was a positive correlation with the severity of symptoms among pairs and different patterns of suffering over time. Methods A prospective study was conducted in a 22-bed adult general ICU including patients with >48 hours stay. The Hospital Anxiety and Depression Scale (HADS) was completed by the pairs (patients/respective family member). Interviews were made by phone at 30 and 90-days post-ICU discharge using the Impact of Event Scale (IES) and the HADS. Multivariate models were constructed to predict IES score at 30 days for patients and family members. Results Four hundred and seventy one family members and 289 patients were interviewed in the ICU forming 184 pairs for analysis. Regarding HADS score, patients presented less symptoms than family members of patients who survived and who deceased at 30 and 90-days (p<0.001). However, family members of patients who deceased scored higher anxiety and depression symptoms (p = 0.048) at 90-days when compared with family members of patients who survived. Patients and family members at 30-days had a similar IES score, but it was higher in family members at 90-days (p = 0.019). For both family members and patients, age and symptoms of anxiety and depression during ICU were the major determinants for PTSD at 30-days. Conclusions Anxiety, depression and PTSD symptoms were higher in family members than in the patients. Furthermore, these symptoms in family members persisted at 3 months, while they decreased in patients.	[Lins Fumis, Renata Rego; Martins, Paulo Sergio; Schettino, Guilherme] Hosp Sirio Libanes, Intens Care Unit, BR-01308050 Sao Paulo, Brazil; [Ranzani, Otavio T.] Univ Sao Paulo, Hosp Clin, Inst Heart, Resp Intens Care Unit,Pulm Div, BR-05403900 Sao Paulo, Brazil	Universidade de Sao Paulo	Fumis, RRL (corresponding author), Hosp Sirio Libanes, Intens Care Unit, Rua Dona Adma Jafet 91, BR-01308050 Sao Paulo, Brazil.	regolins@uol.com.br	Ranzani, Otavio T./K-1196-2012; Fumis, R R/J-6993-2015	Ranzani, Otavio T./0000-0002-4677-6862; Fumis, Renata/0000-0003-4780-704X	'Fundacao de Amparo a Pesquisa do Estado de Sao Paulo' - FAPESP [11/05672-1]	'Fundacao de Amparo a Pesquisa do Estado de Sao Paulo' - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study is supported by 'Fundacao de Amparo a Pesquisa do Estado de Sao Paulo' - FAPESP - Process no 11/05672-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Azoulay Elie, 2003, Curr Opin Crit Care, V9, P545; Berwick DM, 2004, JAMA-J AM MED ASSOC, V292, P736, DOI 10.1001/jama.292.6.736; Boscaglia N, 2005, INT J GYNECOL CANCER, V15, P755, DOI 10.1111/j.1525-1438.2005.00248.x; Botega NJ, 1995, REV SAUDE PUBL, V29, P355, DOI 10.1590/S0034-89101995000500004; Curtis JR, 2002, J CRIT CARE, V17, P147, DOI 10.1053/jcrc.2002.35929; da Silva Ramos Fernando Jose, 2013, Ann Intensive Care, V3, P34, DOI 10.1186/2110-5820-3-34; Davidson JE, 2007, CRIT CARE MED, V35, P605, DOI 10.1097/01.CCM.0000254067.14607.EB; de Miranda S, 2011, CRIT CARE MED, V39, P112, DOI 10.1097/CCM.0b013e3181feb824; Fumagalli S, 2006, CIRCULATION, V113, P946, DOI 10.1161/CIRCULATIONAHA.105.572537; Fumis RR, 2013, INTENS CARE MED, V39, P324; Fumis RRL, 2006, INTENS CARE MED, V32, P124, DOI 10.1007/s00134-005-2857-0; Garrouste-Orgeas M, 2008, CRIT CARE MED, V36, P30, DOI 10.1097/01.CCM.0000295310.29099.F8; Jackson JC, 2007, CRIT CARE, V11, DOI 10.1186/cc5707; Janiszewska J, 2013, INT UROL NEPHROL, V45, P1379, DOI 10.1007/s11255-012-0326-6; Jones C, 2007, INTENS CARE MED, V33, P978, DOI 10.1007/s00134-007-0600-8; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Lee MD, 2007, CRIT CARE MED, V35, P497, DOI 10.1097/01.CCM.0000254338.87182.AC; Fumis RRL, 2009, INTENS CARE MED, V35, P899, DOI 10.1007/s00134-009-1406-7; McCoubrie R, 2006, SUPPORT CARE CANCER, V14, P379, DOI 10.1007/s00520-005-0892-6; McKercher C, 2013, NEPHROLOGY, V18, P585, DOI 10.1111/nep.12138; Myhren H, 2010, CRIT CARE, V14, DOI 10.1186/cc8870; Paparrigopoulos T, 2014, INT J PSYCHIAT CLIN, V18, P25, DOI 10.3109/13651501.2013.855793; Peris A, 2011, CRIT CARE, V15, DOI 10.1186/cc10003; Pochard F, 2005, J CRIT CARE, V20, P90, DOI 10.1016/j.jcrc.2004.11.004; Pochard F, 2001, CRIT CARE MED, V29, P1893, DOI 10.1097/00003246-200110000-00007; Rosendahl J, 2013, CRIT CARE MED, V41, P69, DOI 10.1097/CCM.0b013e31826766b0; Schleder LP, 2013, ACTA PAUL ENFERM, V26, P71, DOI 10.1590/S0103-21002013000100012; Silva Adriana Cardoso de Oliveira e, 2010, Rev. psiquiatr. Rio Gd. Sul, V32, P86, DOI 10.1590/S0101-81082010000300005; Steyerberg E., 2009, CLIN PREDICTION MODE; Sukantarat K, 2007, BRIT J HEALTH PSYCH, V12, P65, DOI 10.1348/135910706X94096; Tramm R, 2014, AUST CRIT CARE; Vandijck DM, 2010, HEART LUNG, V39, P137, DOI 10.1016/j.hrtlng.2009.06.001; Wall RJ, 2007, CHEST, V132, P1425, DOI 10.1378/chest.07-0419; Young E, 2005, INTENS CARE MED, V31, P86, DOI 10.1007/s00134-004-2495-y	35	61	66	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115332	10.1371/journal.pone.0115332	http://dx.doi.org/10.1371/journal.pone.0115332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25616059	gold, Green Published, Green Submitted			2022-12-26	WOS:000349122100011
J	Hayford, BL; Caires, AM; Chandra, S; Girdner, SF				Hayford, Barbara L.; Caires, Andrea M.; Chandra, Sudeep; Girdner, Scott F.			Patterns in Benthic Biodiversity Link Lake Trophic Status to Structure and Potential Function of Three Large, Deep Lakes	PLOS ONE			English	Article							SPECIES RICHNESS; CRATER LAKE; NUTRIENT ENRICHMENT; FRESH-WATER; 4 DECADES; EUTROPHICATION; CHIRONOMIDAE; HOVSGOL; OREGON; COMMUNITIES	Relative to their scarcity, large, deep lakes support a large proportion of the world's freshwater species. This biodiversity is threatened by human development and is in need of conservation. Direct comparison of biodiversity is the basis of biological monitoring for conservation but is difficult to conduct between large, insular ecosystems. The objective of our study was to conduct such a comparison of benthic biodiversity between three of the world's largest lakes: Lake Tahoe, USA; Lake Hovsgol, Mongolia; and Crater Lake, USA. We examined biodiversity of common benthic organism, the non-biting midges (Chironomidae) and determined lake trophic status using chironomid-based lake typology, tested whether community structure was similar between the three lakes despite geographic distance; and tested whether chironomid diversity would show significant variation within and between lakes. Typology analysis indicated that Lake Hovsgol was ultra-oligotrophic, Crater Lake was oligotrophic, and Lake Tahoe was borderline oligotrophic/mesotrophic. These results were similar to traditional pelagic measures of lake trophic status for Lake Hovsgol and Crater Lake but differed for Lake Tahoe, which has been designated as ultra-oligotrophic by traditional pelagic measures such as transparency found in the literature. Analysis of similarity showed that Lake Tahoe and Lake Hovsgol chironomid communities were more similar to each other than either was to Crater Lake communities. Diversity varied between the three lakes and spatially within each lake. This research shows that chironomid communities from these large lakes were sensitive to trophic conditions. Chironomid communities were similar between the deep environments of Lake Hovsgol and Lake Tahoe, indicating that chironomid communities from these lakes may be useful in comparing trophic state changes in large lakes. Spatial variation in Lake Tahoe's diversity is indicative of differential response of chironomid communities to nutrient enrichment which may be an indication of changes in trophic state within and across habitats.	[Hayford, Barbara L.] Wayne State Coll, Dept Life Sci, Wayne, NE 68787 USA; [Caires, Andrea M.; Chandra, Sudeep] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Girdner, Scott F.] Crater Lake Natl Pk, Crater Lake, OR USA	Nebraska State College System; Wayne State College; Nevada System of Higher Education (NSHE); University of Nevada Reno	Hayford, BL (corresponding author), Wayne State Coll, Dept Life Sci, Wayne, NE 68787 USA.	bahayfo1@wsc.edu			California Tahoe Conservancy; Cooperative Ecosystems Studies Unit at the University of Nevada; Crater Lake National Park [J8R07080010]; US National Science Foundation, Division of International Studies [9504867]	California Tahoe Conservancy; Cooperative Ecosystems Studies Unit at the University of Nevada; Crater Lake National Park; US National Science Foundation, Division of International Studies	This work was supported by funding provided by the California Tahoe Conservancy (http://tahoe.ca.gov/) to G. Schladow at UC Davis and SC, a cooperative agreement between the Cooperative Ecosystems Studies Unit at the University of Nevada (http://environment.unr.edu/gbcesu/) and Crater Lake National Park (http://www.nps.gov/crla/) (Agreement # J8R07080010) to SC, and by the US National Science Foundation (www.nsf.gov), Division of International Studies grant (INT # 9504867) to BH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RO, 1959, LIMNOL OCEANOGR, V4, P223, DOI 10.4319/lo.1959.4.2.0223; Blumenshine SC, 1997, J N AM BENTHOL SOC, V16, P466, DOI 10.2307/1468138; Brinkhurst RO., 1974, BENTHOS LAKES, DOI 10.1007/978-1-349-15556-9; Caires AM, 2013, FRESHW SCI, V32, P692, DOI 10.1899/12-064.1; Chandra S, 2005, LIMNOL OCEANOGR, V50, P1368, DOI 10.4319/lo.2005.50.5.1368; Crawford GB, 2007, HYDROBIOLOGIA, V574, P47, DOI 10.1007/s10750-006-0345-3; Cuffney TE, 2007, J N AM BENTHOL SOC, V26, P286, DOI 10.1899/0887-3593(2007)26[286:ATEOTC]2.0.CO;2; Dodson SI, 2000, ECOLOGY, V81, P2662, DOI 10.1890/0012-9658(2000)081[2662:TRILCB]2.0.CO;2; Donohue I, 2009, ECOLOGY, V90, P3470, DOI 10.1890/09-0415.1; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Evans-White MA, 2009, J N AM BENTHOL SOC, V28, P855, DOI 10.1899/08-113.1; Ferrington LC, 2008, INTRO AQUATIC INSECT, P847; Ferrington LC, 2008, HYDROBIOLOGIA, V595, P447, DOI 10.1007/s10750-007-9130-1; Goldman CR, 2000, INT VER THEOR ANGEW, V27, P7; GOLDMAN CR, 1981, VERH INT VER LIMNOL, V21, P45; Goulden CE, 2006, BIO INL WAT, P1; Hammer O, 2012, REFERENCE MANUAL; Hayford B, 2006, BIO INL WAT, P433; Hayford Barbara, 2013, Journal of Species Research, V2, P159; HERDENDORF C E, 1982, Journal of Great Lakes Research, V8, P379, DOI 10.1016/S0380-1330(82)71982-3; HEYVAERT A.C., 2013, LAKE TAHOE NEARSHORE; Hintze J, 2007, NUMBER CRUNCHER STAT; Jeppesen E, 2000, FRESHWATER BIOL, V45, P201, DOI 10.1046/j.1365-2427.2000.00675.x; Jyvasjarvi J, 2014, FRESHW SCI, V33, P995, DOI 10.1086/676914; Kalbe Lothar, 1996, Limnologica, V26, P293; Larson GL, 2007, HYDROBIOLOGIA, V574, P69, DOI 10.1007/s10750-006-0346-2; Larson GL, 2007, HYDROBIOLOGIA, V574, P1, DOI 10.1007/s10750-006-0342-6; Mykra H, 2007, GLOBAL ECOL BIOGEOGR, V16, P149, DOI 10.1111/j.1466-8238.2006.00272.x; Nyman MT, 2005, BOREAL ENVIRON RES, V10, P239; Pilotto F, 2012, FUND APPL LIMNOL, V180, P101, DOI 10.1127/1863-9135/2012/0206; PINDER LCV, 1986, ANNU REV ENTOMOL, V31, P1, DOI 10.1146/annurev.en.31.010186.000245; Rosenberg D.M., 1992, NETHERLANDS J AQUATI, V26, P101, DOI DOI 10.1007/BF02255231; Rossaro Bruno, 2012, Fauna Norvegica, V31, P95, DOI 10.5324/fn.v31i0.1364; SAETHER O A, 1979, Holarctic Ecology, V2, P65; Suther, 1975, VERH INT VER LIMNOL, V19, P3127, DOI DOI 10.1080/03680770.1974.11896422; Vadeboncoeur Y, 2011, BIOSCIENCE, V61, P526, DOI 10.1525/bio.2011.61.7.7; WIEDERHOLM T, 1980, J WATER POLLUT CON F, V52, P537; WIEDERHOLM T, 1983, ENTOMOLOGICA SCAND S, V19; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011	39	5	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2015	10	1							e0117024	10.1371/journal.pone.0117024	http://dx.doi.org/10.1371/journal.pone.0117024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OS	25594516	Green Submitted, Green Published, gold			2022-12-26	WOS:000348202900006
J	Arellano, CJ; McDermott, WJ; Kram, R; Grabowski, AM				Arellano, Christopher J.; McDermott, William J.; Kram, Rodger; Grabowski, Alena M.			Effect of Running Speed and Leg Prostheses on Mediolateral Foot Placement and Its Variability	PLOS ONE			English	Article							GROUND REACTION FORCES; STIFFNESS	This study examined the effects of speed and leg prostheses on mediolateral (ML) foot placement and its variability in sprinters with and without transtibial amputations. We hypothesized that ML foot placement variability would: 1. increase with running speed up to maximum speed and 2. be symmetrical between the legs of non-amputee sprinters but asymmetrically greater for the affected leg of sprinters with a unilateral transtibial amputation. We measured the midline of the body (kinematic data) and center of pressure (kinetic data) in the ML direction while 12 non-amputee sprinters and 7 Paralympic sprinters with transtibial amputations (6 unilateral, 1 bilateral) ran across a range of speeds up to maximum speed on a high-speed force measuring treadmill. We quantified ML foot placement relative to the body's midline and its variability. We interpret our results with respect to a hypothesized relation between ML foot placement variability and lateral balance. We infer that greater ML foot placement variability indicates greater challenges with maintaining lateral balance. In non-amputee sprinters, ML foot placement variability for each leg increased substantially and symmetrically across speed. In sprinters with a unilateral amputation, ML foot placement variability for the affected and unaffected leg also increased substantially, but was asymmetric across speeds. In general, ML foot placement variability for sprinters with a unilateral amputation was within the range observed in non-amputee sprinters. For the sprinter with bilateral amputations, both affected legs exhibited the greatest increase in ML foot placement variability with speed. Overall, we find that maintaining lateral balance becomes increasingly challenging at faster speeds up to maximum speed but was equally challenging for sprinters with and without a unilateral transtibial amputation. Finally, when compared to all other sprinters in our subject pool, maintaining lateral balance appears to be the most challenging for the Paralympic sprinter with bilateral transtibial amputations.	[Arellano, Christopher J.; Kram, Rodger; Grabowski, Alena M.] Univ Colorado, Integrat Physiol Dept, Boulder, CO 80309 USA; [McDermott, William J.] Orthoped Specialty Hosp, Biomech Lab, Murray, UT USA; [Grabowski, Alena M.] Eastern Colorado Healthcare Syst, Denver, CO USA	University of Colorado System; University of Colorado Boulder	Arellano, CJ (corresponding author), Brown Univ, Ecol & Evolutionary Biol Dept, Providence, RI 02912 USA.	christopher_arellano@brown.edu		GRABOWSKI, ALENA/0000-0002-4432-618X	Colorado Diversity Initiative	Colorado Diversity Initiative	Funding from the Colorado Diversity Initiative awarded to CJA supported the preparation of this manuscript. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Arellano CJ, 2012, J APPL PHYSIOL, V112, P427, DOI 10.1152/japplphysiol.00554.2011; Arellano CJ, 2011, J BIOMECH, V44, P1291, DOI 10.1016/j.jbiomech.2011.01.002; Buckley JG, 1999, ARCH PHYS MED REHAB, V80, P501, DOI 10.1016/S0003-9993(99)90189-2; Buckley JG, 2000, CLIN BIOMECH, V15, P352, DOI 10.1016/S0268-0033(99)00094-7; CAVANAGH PR, 1980, J BIOMECH, V13, P397, DOI 10.1016/0021-9290(80)90033-0; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dietz V, 2002, NAT REV NEUROSCI, V3, P781, DOI 10.1038/nrn939; ENOKA RM, 1982, AM J PHYS MED REHAB, V61, P66; Ferris DP, 1998, P ROY SOC B-BIOL SCI, V265, P989, DOI 10.1098/rspb.1998.0388; Grabowski AM, 2010, BIOL LETTERS, V6, P201, DOI 10.1098/rsbl.2009.0729; Hanavan EP, 1964, MATH MODEL HUMAN BOD, P1; Jordan K, 2009, HUM MOVEMENT SCI, V28, P113, DOI 10.1016/j.humov.2008.09.001; Look N, 2013, CHAOS, V23, DOI 10.1063/1.4837095; MCCLAY IS, 1994, CLIN BIOMECH, V9, P117, DOI 10.1016/0268-0033(94)90034-5; McGowan CP, 2012, J R SOC INTERFACE, V9, P1975, DOI 10.1098/rsif.2011.0877; MERO A, 1992, SPORTS MED, V13, P376, DOI 10.2165/00007256-199213060-00002; PRINCE F, 1992, PROSTHET ORTHOT INT, V16, P19; Sanderson DJ, 1996, ARCH PHYS MED REHAB, V77, P1279, DOI 10.1016/S0003-9993(96)90193-8; SMITH PJ, 1982, TECHNOMETRICS, V24, P123, DOI 10.2307/1268489; Weyand PG, 2009, J APPL PHYSIOL, V107, P903, DOI 10.1152/japplphysiol.00174.2009	20	11	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0115637	10.1371/journal.pone.0115637	http://dx.doi.org/10.1371/journal.pone.0115637			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590634	gold, Green Submitted, Green Published			2022-12-26	WOS:000350679400010
J	Holzknecht, BJ; Franck, KT; Nielsen, RT; Bottiger, B; Fischer, TK; Fonager, J				Holzknecht, Barbara Juliane; Franck, Kristina Traeholt; Nielsen, Rikke Thoft; Bottiger, Blenda; Fischer, Thea Kolsen; Fonager, Jannik			Sequence Analysis of the Capsid Gene during a Genotype II. 4 Dominated Norovirus Season in One University Hospital: Identification of Possible Transmission Routes	PLOS ONE			English	Article							P2 DOMAIN; GASTROENTERITIS; OUTBREAKS; EPIDEMIOLOGY; EVOLUTION; DYNAMICS; PRIMERS; VIRUSES; SPREAD	Norovirus (NoV) is a leading cause of gastroenteritis and genotype II. 4 (GII. 4) is responsible for the majority of nosocomial NoV infections. Our objective was to examine whether sequencing of the capsid gene might be a useful tool for the hospital outbreak investigation to define possible transmission routes. All NoV positive samples submitted from one university hospital during the 2007/8 season were selected. Genotyping of selected samples by partial polymerase gene sequencing had shown that the majority belonged to the GII. 4 variant Den Haag 2006b and had identical polymerase sequences. Sequences of the capsid gene (1412 nucleotides) were obtained from the first available sample from 55 patients. From six immunocompromised patients with persistent infections a second sample was also included. As a control for a point-source outbreak, five samples from a foodborne outbreak caused by the same GII. 4 variant were analyzed. Forty-seven of the inpatients (85%) were infected with the GII. 4 variant Den Haag 2006b. Phylogenetic analysis of the Den Haag 2006b sequences identified four distinct outbreaks in different departments and a fifth outbreak with possible inter-department spread. In addition, a more heterogeneous cluster with evidence of repeated introductions from the community, but also possible inter-department spread was observed. In all six patients with paired sequences, evidence for in vivo evolution of the virus was found. Capsid gene sequencing showed substantial sequence variation among NoV GII. 4 variant Den Haag 2006b strains from one single institution during a nine months' period. This method proved useful to understand the local epidemiology and, when used promptly, has the potential to make infection control measures more targeted.	[Holzknecht, Barbara Juliane; Franck, Kristina Traeholt; Bottiger, Blenda; Fischer, Thea Kolsen; Fonager, Jannik] Statens Serum Inst, Dept Microbiol Diagnost & Virol, DK-2300 Copenhagen, Denmark; [Holzknecht, Barbara Juliane; Nielsen, Rikke Thoft] Univ Copenhagen, Herlev Hosp, Dept Clin Microbiol, DK-2730 Herlev, Denmark; [Franck, Kristina Traeholt] Univ Southern Denmark, Res Unit Clin Microbiol, Odense, Denmark; [Nielsen, Rikke Thoft] Odense Univ Hosp, Dept Clin Microbiol, DK-5000 Odense, Denmark; [Bottiger, Blenda] Lund Univ, Dept Lab Med Malmo, Med Microbiol, Malmo, Sweden	Statens Serum Institut; University of Copenhagen; Herlev & Gentofte Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Lund University	Holzknecht, BJ (corresponding author), Statens Serum Inst, Dept Microbiol Diagnost & Virol, DK-2300 Copenhagen, Denmark.	barbarah@web.de	Fischer, Thea K/AAH-9892-2019; Fonager, Jannik/AAJ-8292-2020	Fischer, Thea K/0000-0003-4812-980X; Fonager, Jannik/0000-0003-1688-1482; Traeholt Franck, Kristina/0000-0001-8375-3443				Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Barclay L, 2014, CLIN MICROBIOL INFEC, V20, P731, DOI 10.1111/1469-0691.12674; Bok K, 2012, NEW ENGL J MED, V367, P2126, DOI 10.1056/NEJMra1207742; Bull RA, 2012, J VIROL, V86, P3219, DOI 10.1128/JVI.06712-11; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831; Debbink K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002921; Dingle KE, 2004, J CLIN MICROBIOL, V42, P3950, DOI 10.1128/JCM.42.9.3950-3957.2004; Fonager J, 2013, EURO SURVEILL, V18; Franck KT, 2014, EMERG INFECT DIS, V20, P1123, DOI 10.3201/eid2007.130781; Gallimore CI, 2005, INT J FOOD MICROBIOL, V103, P323, DOI 10.1016/j.ijfoodmicro.2005.02.003; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hoebe CJPA, 2004, J INFECT DIS, V189, P699, DOI 10.1086/381534; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Kundu S, 2013, CLIN INFECT DIS, V57, P407, DOI 10.1093/cid/cit287; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lopman B, 2012, CURR OPIN VIROL, V2, P96, DOI 10.1016/j.coviro.2011.11.005; Nilsson M, 2003, J VIROL, V77, P13117, DOI 10.1128/JVI.77.24.13117-13124.2003; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Rahamat-Langendoen JC, 2013, J CLIN VIROL, V58, P245, DOI 10.1016/j.jcv.2013.06.034; Schreier E, 2000, ARCH VIROL, V145, P443, DOI 10.1007/s007050050038; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Sukhrie FHA, 2013, J CLIN VIROL, V56, P286, DOI 10.1016/j.jcv.2012.12.006; Sukhrie FHA, 2011, J CLIN MICROBIOL, V49, P602, DOI 10.1128/JCM.01443-10; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tu ETV, 2008, CLIN INFECT DIS, V46, P413, DOI 10.1086/525259; van Beek J, 2013, EUROSURVEILLANCE, V18, P8; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Vennema H, 2002, J CLIN VIROL, V25, P233, DOI 10.1016/S1386-6532(02)00126-9; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Xerry J, 2008, J CLIN MICROBIOL, V46, P947, DOI 10.1128/JCM.02240-07; Xerry J, 2009, J MED VIROL, V81, P1298, DOI 10.1002/jmv.21517; Zakikhany K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041625	38	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0115331	10.1371/journal.pone.0115331	http://dx.doi.org/10.1371/journal.pone.0115331			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590635	Green Submitted, gold, Green Published			2022-12-26	WOS:000350679400003
J	Ruiz-Saenz, A; Sandhu, M; Carrasco, Y; Maglathlin, RL; Taunton, J; Moasser, MM				Ruiz-Saenz, A.; Sandhu, M.; Carrasco, Y.; Maglathlin, R. L.; Taunton, J.; Moasser, M. M.			Targeting HER3 by interfering with its Sec61-mediated cotranslational insertion into the endoplasmic reticulum	ONCOGENE			English	Article							FACTOR-RECEPTOR MUTATIONS; BREAST-CANCER; GENE AMPLIFICATION; PHOSPHATIDYLINOSITOL 3-KINASE; MONOCLONAL-ANTIBODY; TYROSINE KINASE; ERBB3 ANTIBODY; ONCOGENIC UNIT; UP-REGULATION; COLON-CANCER	There is increasing evidence implicating human epidermal growth factor receptor 3 (HER3) in several types of cancer. However, the development of targeted therapies to inactivate HER3 function has been a challenging endeavor. Its kinase domain functions in allostery not catalysis, and the classical ATP-analog class of tyrosine kinase inhibitors fail to inactivate it. Here we describe a novel approach that eliminates HER3 expression. The small-molecule cotransin CT8 binds the Sec61 translocon and prevents the signal peptide of the nascent HER3 protein from initiating its cotranslational translocation, resulting in the degradation of HER3 but not the other HER proteins. CT8 treatment suppresses the induction of HER3 that accompanies lapatinib treatment of HER2-amplified cancers and synergistically enhances the apoptotic effects of lapatinib. The target selectivities of cotransins are highly dependent on their structure and the signal sequence of targeted proteins and can be narrowed through structure-function studies. Targeting Sec61-dependent processing identifies a novel strategy to eliminate HER3 function.	[Ruiz-Saenz, A.; Sandhu, M.; Moasser, M. M.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Med, San Francisco, CA 94143 USA; [Carrasco, Y.; Maglathlin, R. L.; Taunton, J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Taunton, J.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Moasser, MM (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Med, UCSF Box 1387,2340 Sutter St,Room N-144, San Francisco, CA 94143 USA.	mark.moasser@ucsf.edu	Sandhu, Manbir/AAI-2124-2019; Ruiz-Saenz, Ana/U-3220-2017	Sandhu, Manbir/0000-0003-1182-7268; Ruiz-Saenz, Ana/0000-0001-6033-6153	National Institutes of Health [CA122216, CA112970]; Howard Hughes Medical Institute; Fundacion Ramon Areces Fellowship; NATIONAL CANCER INSTITUTE [U54CA112970, R01CA122216] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Fundacion Ramon Areces Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health CA122216 and CA112970 (to MMM), Howard Hughes Medical Institute (to JT) and a Fundacion Ramon Areces Fellowship (to ARS).	Abel EV, 2013, J CLIN INVEST, V123, P2155, DOI 10.1172/JCI65780; Amin DN, 2012, BIOCHEM J, V447, P417, DOI 10.1042/BJ20120724; Amin DN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000389; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Beji A, 2012, CLIN CANCER RES, V18, P956, DOI 10.1158/1078-0432.CCR-11-1186; Besemer J, 2005, NATURE, V436, P290, DOI 10.1038/nature03670; Blackburn E, 2012, BREAST CANCER RES TR, V134, P53, DOI 10.1007/s10549-011-1908-1; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Chen Y, 2002, J AM CHEM SOC, V124, P5431, DOI 10.1021/ja020166v; Fattore L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-180; Foreman PK, 2012, MOL CANCER THER, V11, P1411, DOI 10.1158/1535-7163.MCT-12-0068; Frederick L, 2000, CANCER RES, V60, P1383; Garner AP, 2013, CANCER RES, V73, P6024, DOI 10.1158/0008-5472.CAN-13-1198; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Garrison JL, 2005, NATURE, V436, P285, DOI 10.1038/nature03821; Gerbin CS, 2010, CELL STRESS CHAPERON, V15, P529, DOI 10.1007/s12192-009-0166-1; Gespach C, 2012, CLIN CANCER RES, V18, P917, DOI 10.1158/1078-0432.CCR-11-3143; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; GIARETTI W, 1994, METHOD CELL BIOL, V41, P389; Harant H, 2006, J BIOL CHEM, V281, P30492, DOI 10.1074/jbc.M607243200; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Hulleman JD, 2013, J BIOMOL SCREEN, V18, P647, DOI 10.1177/1087057112469405; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kugel CH, 2014, CANCER RES, V74, P4122, DOI 10.1158/0008-5472.CAN-14-0464; Lee H, 1998, ONCOGENE, V16, P3243, DOI 10.1038/sj.onc.1201866; Lee H, 2001, CANCER RES, V61, P4467; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Licitra L, 2011, ANN ONCOL, V22, P1078, DOI 10.1093/annonc/mdq588; Littlefield P, 2014, CHEM BIOL, V21, P453, DOI 10.1016/j.chembiol.2014.02.011; Lopez-Gines C, 2005, CLIN NEUROPATHOL, V24, P209; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MacKinnon AL, 2007, J AM CHEM SOC, V129, P14560, DOI 10.1021/ja076250y; MacKinnon AL, 2014, ELIFE, V3, DOI 10.7554/eLife.01483; Maifeld SV, 2011, CHEM BIOL, V18, P1082, DOI 10.1016/j.chembiol.2011.06.015; McDonagh CF, 2012, MOL CANCER THER, V11, P582, DOI 10.1158/1535-7163.MCT-11-0820; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Reschke M, 2008, CLIN CANCER RES, V14, P5188, DOI 10.1158/1078-0432.CCR-08-0186; Santin AD, 2005, CANCER-AM CANCER SOC, V104, P1391, DOI 10.1002/cncr.21308; Schoeberl B, 2010, CANCER RES, V70, P2485, DOI 10.1158/0008-5472.CAN-09-3145; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; Tao JJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005125; Vaught DB, 2012, CANCER RES, V72, P2672, DOI 10.1158/0008-5472.CAN-11-3594; Yano T, 2006, ONCOL REP, V15, P65; Yao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078086; Zhang L, 2014, MOL CANCER THER, V13, P1345, DOI 10.1158/1535-7163.MCT-13-1033	52	18	18	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2015	34	41					5288	5294		10.1038/onc.2014.455	http://dx.doi.org/10.1038/onc.2014.455			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CT1QL	25619841	Green Accepted, Green Submitted			2022-12-26	WOS:000362575400008
J	Lewis, CA; Brault, C; Peck, B; Bensaad, K; Griffiths, B; Mitter, R; Chakravarty, P; East, P; Dankworth, B; Alibhai, D; Harris, AL; Schulze, A				Lewis, C. A.; Brault, C.; Peck, B.; Bensaad, K.; Griffiths, B.; Mitter, R.; Chakravarty, P.; East, P.; Dankworth, B.; Alibhai, D.; Harris, A. L.; Schulze, A.			SREBP maintains lipid biosynthesis and viability of cancer cells under lipid- and oxygen-deprived conditions and defines a gene signature associated with poor survival in glioblastoma multiforme	ONCOGENE			English	Article							ELEMENT-BINDING PROTEIN; STEAROYL-COA DESATURASE; UNSATURATED FATTY-ACIDS; SMALL-MOLECULE; TUMOR-CELLS; HYPOXIA; METABOLISM; EXPRESSION; GROWTH; LIPOGENESIS	Oxygen and nutrient limitation are common features of the tumor microenvironment and are associated with cancer progression and induction of metastasis. The inefficient vascularization of tumor tissue also limits the penetration of other serum-derived factors, such as lipids and lipoproteins, which can be rate limiting for cell proliferation and survival. Here we have investigated the effect of hypoxia and serum deprivation on sterol regulatory element-binding protein (SREBP) activity and the expression of lipid metabolism genes in human glioblastoma multiforme (GBM) cancer cells. We found that SREBP transcriptional activity was induced by serum depletion both in normoxic and hypoxic cells and that activation of SREBP was required to maintain the expression of fatty acid and cholesterol metabolism genes under hypoxic conditions. Moreover, expression of stearoyl-CoA desaturase, the enzyme required for the generation of mono-unsaturated fatty acids, and fatty acid-binding protein 7, a regulator of glioma stem cell function, was strongly dependent on SREBP function. Inhibition of SREBP function blocked lipid biosynthesis in hypoxic cancer cells and impaired cell survival under hypoxia and in a three-dimensional spheroid model. Finally, gene expression analysis revealed that SREBP defines a gene signature that is associated with poor survival in glioblastoma.	[Lewis, C. A.; Peck, B.; Griffiths, B.; Schulze, A.] Canc Res UK London Res Inst, Gene Express Anal Lab, London WC2A 3PX, England; [Brault, C.; Dankworth, B.; Schulze, A.] Theodor Boveri Inst, Bioctr, D-97074 Wurzburg, Bavaria, Germany; [Bensaad, K.; Harris, A. L.] Univ Oxford, CRUK Growth Factor Grp, Weatherall Inst Mol Med, Oxford, England; [Mitter, R.; Chakravarty, P.; East, P.] Canc Res UK London Res Inst, Bioinformat & Biostat Serv, London WC2A 3PX, England; [Alibhai, D.] Canc Res UK London Res Inst, Light Microscopy Core, London WC2A 3PX, England; [Schulze, A.] Comprehens Canc Ctr Mainfranken Wurzburg, Wurzburg, Germany	Cancer Research UK; University of Wurzburg; University of Oxford; Cancer Research UK; Cancer Research UK	Schulze, A (corresponding author), Theodor Boveri Inst, Dept Biochem & Mol Biol, Bioctr, D-97074 Wurzburg, Bavaria, Germany.	almut.schulze@uni-wuerzburg.de	Harris, Adrian L/ABA-3343-2020; Schulze, Almut/AAX-8257-2020	Harris, Adrian L/0000-0003-1376-8409; Schulze, Almut/0000-0002-8199-6422; chakravarty, probir/0000-0003-1146-8824; Peck, Barrie/0000-0002-6687-8495; Mitter, Richard/0000-0002-1279-3760	Cancer Research UK; Cancer Research UK [18974, 11359, 16466] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish; The Francis Crick Institute [10002] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); The Francis Crick Institute	We thank the LRI Research Services for help with experiments and Charles Mein and Lia Di Faveri (Genome Center Bart's and The London School of Medicine and Dentistry) for microarray analysis. We also thank Barbara Bauer (Department of Biochemistry and Molecular Biology, University of Wurzburg, Wurzburg, Germany) for histological analyses. This work was supported by Cancer Research UK.	Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Belanger AJ, 2007, BIOCHEM BIOPH RES CO, V364, P567, DOI 10.1016/j.bbrc.2007.10.062; Bengoechea-Alonso MT, 2007, CURR OPIN CELL BIOL, V19, P215, DOI 10.1016/j.ceb.2007.02.004; Bensaad K, 2014, CELL REP, V9, P349, DOI 10.1016/j.celrep.2014.08.056; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; CASCIARI JJ, 1992, J CELL PHYSIOL, V151, P386, DOI 10.1002/jcp.1041510220; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clendening JW, 2010, P NATL ACAD SCI USA, V107, P15051, DOI 10.1073/pnas.0910258107; Currie E, 2013, CELL METAB; Discher DJ, 1998, J BIOL CHEM, V273, P26087, DOI 10.1074/jbc.273.40.26087; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Favaro E, 2011, GENOME MED, V3, DOI 10.1186/gm271; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; Furuta E, 2008, CANCER RES, V68, P1003, DOI 10.1158/0008-5472.CAN-07-2489; GORDON GB, 1977, AM J PATHOL, V88, P663; Griffiths B, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-3; Guo DL, 2011, CANCER DISCOV, V1, P442, DOI 10.1158/2159-8290.CD-11-0102; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hess D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011394; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Jung SY, 2012, J CELL BIOCHEM, V113, P3730, DOI 10.1002/jcb.24247; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Krycer JR, 2012, BIOCHEM J, V446, P191, DOI 10.1042/BJ20120545; Laurenti G, 2011, J CELL BIOCHEM, V112, P3891, DOI 10.1002/jcb.23323; Lee CYS, 2009, EMBO J, V28, P135, DOI 10.1038/emboj.2008.271; Li JG, 2006, PHYSIOL GENOMICS, V25, P450, DOI 10.1152/physiolgenomics.00293.2005; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu RZ, 2012, BIOCHEM BIOPH RES CO, V422, P482, DOI 10.1016/j.bbrc.2012.05.019; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Mazzatti D, 2012, ARCH PHYSIOL BIOCHEM, V118, P112, DOI 10.3109/13813455.2012.654611; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mita R, 2010, J BIOL CHEM, V285, P37005, DOI 10.1074/jbc.M110.170076; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Ntambi JM, 2004, LIPIDS, V39, P1061, DOI 10.1007/s11745-004-1331-2; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Qiang L, 2012, CELL DEATH DIFFER, V19, P284, DOI 10.1038/cdd.2011.95; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Roongta UV, 2011, MOL CANCER RES, V9, P1551, DOI 10.1158/1541-7786.MCR-11-0126; Rysman E, 2010, CANCER RES, V70, P8117, DOI 10.1158/0008-5472.CAN-09-3871; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Schonfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029; Shai R, 2003, ONCOGENE, V22, P4918, DOI 10.1038/sj.onc.1206753; Storch J, 2010, J BIOL CHEM, V285, P32679, DOI 10.1074/jbc.R110.135210; Swietach P, 2008, J BIOL CHEM, V283, P20473, DOI 10.1074/jbc.M801330200; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Therneau T.M., 2000, MODELING SURVIVAL DA; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Ward C, 2013, CANCER TREAT REV, V39, P171, DOI 10.1016/j.ctrv.2012.08.004; WHITMER JT, 1978, J BIOL CHEM, V253, P4305; Williams KJ, 2013, CANCER RES, V73, P2850, DOI 10.1158/0008-5472.CAN-13-0382-T; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Yang LQ, 2012, EXP CELL RES, V318, P2417, DOI 10.1016/j.yexcr.2012.07.017; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Yoshii Y, 2009, CANCER SCI, V100, P821, DOI 10.1111/j.1349-7006.2009.01099.x; Young RM, 2013, GENE DEV, V27, P1115, DOI 10.1101/gad.198630.112	68	120	124	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 1	2015	34	40					5128	5140		10.1038/onc.2014.439	http://dx.doi.org/10.1038/onc.2014.439			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CS6ZP	25619842				2022-12-26	WOS:000362233400003
J	Sauler, M; Zhang, Y; Min, JN; Leng, L; Shan, PY; Roberts, S; Jorgensen, WL; Bucala, R; Lee, PJ				Sauler, Maor; Zhang, Yi; Min, Jin-Na; Leng, Lin; Shan, Peiying; Roberts, Scott; Jorgensen, William L.; Bucala, Richard; Lee, Patty J.			Endothelial CD74 mediates macrophage migration inhibitory factor protection in hyperoxic lung injury	FASEB JOURNAL			English	Article						apoptosis; endothelium; H2AX; MIF	RESPIRATORY-DISTRESS-SYNDROME; D-DOPACHROME TAUTOMERASE; PULMONARY ARTERIAL-HYPERTENSION; DNA-DAMAGE; OXIDATIVE STRESS; FACTOR MIF; HISTONE H2AX; CELL-CYCLE; MOLECULAR-MECHANISMS; INDUCED APOPTOSIS	Exposure to hyperoxia results in acute lung injury. A pathogenic consequence of hyperoxia is endothelial injury. Macrophage migration inhibitory factor (MIF) has a cytoprotective effect on lung endothelial cells; however, the mechanism is uncertain. We postulate that the MIF receptor CD74 mediates this protective effect. Using adult wild-type (WT), MIF-deficient (Mif(-/-)), CD74-deficient (Cd74(-/-)) mice and MIF receptor inhibitor treated mice, we report that MIF deficiency or inhibition of MIF receptor binding results in increased sensitivity to hyperoxia. Mif(-/-) and Cd74(-/-) mice demonstrated decreased median survival following hyperoxia compared to WT mice. Mif(-/-) mice demonstrated an increase in bronchoalveolar protein (48%) and lactate dehydrogenase (LDH) (68%) following 72 hours of hyperoxia. Similarly, treatment with MIF receptor antagonist resulted in a 59% and 91% increase in bronchoalveolar lavage protein and LDH, respectively. Inhibition of CD74 in primary murine lung endothelial cells (MLECs) abrogated the protective effect of MIF, including decreased hyperoxia-mediated AKT phosphorylation and a 20% reduction in the antiapoptotic effect of exogenous MIF. Treatment with MIF decreased hyperoxia-mediated H2AX phosphorylation in a CD74-dependent manner. These data suggest that therapeutic manipulation of the MIF-CD74 axis in lung endothelial cells may be a novel approach to protect against acute oxidative stress.	[Sauler, Maor; Zhang, Yi; Min, Jin-Na; Shan, Peiying; Lee, Patty J.] Yale Univ, Sch Med, Sect Pulm, Crit Care & Sleep Med, New Haven, CT 06520 USA; [Leng, Lin; Roberts, Scott; Bucala, Richard] Yale Univ, Sch Med, Rheumatol Sect, New Haven, CT 06520 USA; [Jorgensen, William L.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Lee, PJ (corresponding author), Yale Univ, Sch Med, Sect Pulm, Crit Care & Sleep Med, 333 Cedar St,POB 208057, New Haven, CT 06520 USA.	patty.lee@yale.edu	/AAW-1187-2021	Leng, Lin/0000-0002-0605-358X	U.S. National Institutes of Health [T32007778, R01AI043210, R01HL090660, R01HL071595]; FAMRI Clinical Investigator Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090660, R01HL071595] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAMRI Clinical Investigator Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were funded by the following grants from the U.S. National Institutes of Health: T32007778 (to M.S.), R01AI043210 (to R.B.), and R01HL090660, R01HL071595, and FAMRI Clinical Investigator Award (to P.J.L.).	Ahmad A, 2006, FREE RADICAL BIO MED, V40, P1108, DOI 10.1016/j.freeradbiomed.2005.10.045; Arjona A, 2007, J CLIN INVEST, V117, P3059, DOI 10.1172/JCI32218; Barzilai A, 2004, DNA REPAIR, V3, P1109, DOI 10.1016/j.dnarep.2004.03.002; Becker-Herman S, 2005, MOL BIOL CELL, V16, P5061, DOI 10.1091/mbc.E05-04-0327; Beswick EJ, 2005, INFECT IMMUN, V73, P2736, DOI 10.1128/IAI.73.5.2736-2743.2005; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; COLLINS T, 1984, P NATL ACAD SCI-BIOL, V81, P4917, DOI 10.1073/pnas.81.15.4917; Dai G, 2007, CIRC RES, V101, P723, DOI 10.1161/CIRCRESAHA.107.152942; Damico RL, 2008, AM J RESP CELL MOL, V39, P77, DOI 10.1165/rcmb.2007-0248OC; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Gonzalez JE, 2012, ANAL QUANT CYTOL, V34, P66; Fallica J, 2014, AM J RESP CELL MOL, V51, P94, DOI 10.1165/rcmb.2013-0371OC; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Fingerle-Rowson G, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-22; FISHER AB, 1980, AM REV RESPIR DIS, V122, P61, DOI 10.1164/arrd.1980.122.5P2.61; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Gao L, 2007, TRANSL RES, V150, P18, DOI 10.1016/j.trsl.2007.02.007; Guo Yubiao, 2002, Zhonghua Jiehe He Huxi Zazhi, V25, P337; Hare AA, 2010, BIOORG MED CHEM LETT, V20, P5811, DOI 10.1016/j.bmcl.2010.07.129; Hirakawa H, 2007, AM J RESP CRIT CARE, V176, P778, DOI 10.1164/rccm.200704-519OC; Ivashkevich A, 2012, CANCER LETT, V327, P123, DOI 10.1016/j.canlet.2011.12.025; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kulkarni A, 2008, AM J PHYSIOL-LUNG C, V294, pL998, DOI 10.1152/ajplung.00004.2008; Lai KN, 2003, J PATHOL, V199, P496, DOI 10.1002/path.1291; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Leng L, 2011, J IMMUNOL, V186, P527, DOI 10.4049/jimmunol.1001767; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Marsh LM, 2009, AM J PHYSIOL-LUNG C, V296, pL442, DOI 10.1152/ajplung.00525.2007; MARTINS EAL, 1991, MUTAT RES, V250, P95, DOI 10.1016/0027-5107(91)90166-L; Mathew B, 2013, AM J RESP CELL MOL, V49, P269, DOI 10.1165/rcmb.2012-0291OC; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Meduri GU, 2007, CHEST, V131, P954, DOI 10.1378/chest.06-2100; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Min JN, 2013, CELL RES, V23, P1396, DOI 10.1038/cr.2013.113; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Montani D, 2014, PHARMACOL THERAPEUT, V141, P172, DOI 10.1016/j.pharmthera.2013.10.002; Nguyen MT, 2003, J IMMUNOL, V170, P3337, DOI 10.4049/jimmunol.170.6.3337; O'Reilly MA, 2001, AM J PHYSIOL-LUNG C, V281, pL291, DOI 10.1152/ajplung.2001.281.2.L291; Paine R, 2012, CRIT CARE MED, V40, P90, DOI 10.1097/CCM.0b013e31822d7bf0; Pasupuleti V, 2014, J BIOL CHEM, V289, P3713, DOI 10.1074/jbc.M113.500694; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; PERO RW, 1990, CANCER RES, V50, P4619; Petrenko O, 2005, MOL CELL, V17, P225, DOI 10.1016/j.molcel.2004.11.052; Qi DK, 2014, J CLIN INVEST, V124, P3540, DOI 10.1172/JCI73061; Rabinovitch M, 2014, CIRC RES, V115, P165, DOI 10.1161/CIRCRESAHA.113.301141; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sauler M, 2014, AM J PHYSIOL-LUNG C, V306, pL487, DOI 10.1152/ajplung.00284.2013; Schwartz V, 2012, EUR J CELL BIOL, V91, P435, DOI 10.1016/j.ejcb.2011.08.006; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Sun HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060560; Sun HX, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-27; Wang ZD, 2000, J EXP MED, V192, P1587, DOI 10.1084/jem.192.11.1587; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Xin D, 2010, MOL CANCER RES, V8, P1601, DOI 10.1158/1541-7786.MCR-10-0101; Zhang XC, 2005, J IMMUNOL, V175, P4834, DOI 10.4049/jimmunol.175.8.4834; Zhang Y, 2014, J IMMUNOL, V192, P5296, DOI 10.4049/jimmunol.1400653; Zhang Y, 2013, FASEB J, V27, P4041, DOI 10.1096/fj.13-231225; Zhang Y, 2013, J IMMUNOL, V191, P1393, DOI 10.4049/jimmunol.1300052	68	24	25	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1940	1949		10.1096/fj.14-260299	http://dx.doi.org/10.1096/fj.14-260299			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25609432	Green Published			2022-12-26	WOS:000354114600028
J	Ziegler, K; Tumova, S; Kerimi, A; Williamson, G				Ziegler, Kerstin; Tumova, Sarka; Kerimi, Asimina; Williamson, Gary			Cellular Asymmetric Catalysis by UDP-glucuronosyltransferase 1A8 Shows Functional Localization to the Basolateral Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Polarity; Fatty Acid; Flavonoid; Intestinal Metabolism; Membrane Enzyme; Polyunsaturated Fatty Acid (PUFA); Uridine 5'-Diphosphoglucuronosyltransferase (UDP-glucuronosyltransferase); Xenobiotic	TANDEM MASS-SPECTROMETRY; ACTIVATED RECEPTORS ALPHA; FATTY-ACIDS; RAT-LIVER; ENDOPLASMIC-RETICULUM; HYDROXYCINNAMIC ACIDS; MICROSOMAL ENZYMES; EXPRESSION LEVELS; SIGNAL SEQUENCE; SMALL-INTESTINE	Background: Conjugating enzymes such as UDP-glucuronosyltransferases (UGTs) determine small molecule bioavailability. Results: UGT1A8 is induced by certain fatty acids and functionally localizes in the basolateral plasmalemma in HT29-MTX goblet cells. Conclusion: The conjugation pattern is asymmetric, suggesting association of UGT1A8 with membrane transporters. Significance: The enzyme localization allows the cell to carry out conjugation without the small molecule entering into the interior of the cell. UDP-glucuronosyltransferases (UGTs) are highly expressed in liver, intestine and kidney, and catalyze the glucuronic acid conjugation of both endogenous compounds and xenobiotics. Using recombinant human UGT isoforms, we show that glucuronic acid conjugation of the model substrate, (-)-epicatechin, is catalyzed mainly by UGT1A8 and UGT1A9. In HepG2 cells, pretreatment with polyunsaturated fatty acids increased substrate glucuronidation. In the intestinal Caco-2/HT29-MTX co-culture model, overall relative glucuronidation rates were much higher than in HepG2 cells, and (-)-epicatechin was much more readily conjugated when applied to the basolateral side of the cell monolayer. Under these conditions, 95% of the conjugated product was effluxed back to the site of application, and none of the other phase 2-derived metabolites followed this distribution pattern. HT29-MTX cells contained >1000-fold higher levels of UGT1A8 mRNA than Caco-2 or HepG2 cells. Gene expression of UGT1A8 increased after treatment of cells with docosahexaenoic acid, as did UGT1A protein levels. Immunofluorescence staining and Western blotting showed the presence of UGT1A in the basal and lateral parts of the plasma membrane of HT29-MTX cells. These results suggest that some of the UGT1A8 enzyme is not residing in the endoplasmic reticulum but spans the plasma membrane, resulting in increased accessibility to compounds outside the cell. This facilitates more efficient conjugation of substrate and is additionally coupled with rapid efflux by functionally associated basolateral transporters. This novel molecular strategy allows the cell to carry out conjugation without the xenobiotic entering into the interior of the cell.	[Ziegler, Kerstin; Tumova, Sarka; Kerimi, Asimina; Williamson, Gary] Univ Leeds, Fac Math & Phys Sci, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Williamson, G (corresponding author), Univ Leeds, Fac Math & Phys Sci, Leeds LS2 9JT, W Yorkshire, England.	g.williamson@leeds.ac.uk	Tumova, Sarka/AAD-6353-2019; Williamson, Gary/AAE-9665-2019	Tumova, Sarka/0000-0003-2044-4998; Williamson, Gary/0000-0002-5624-6267; Ziegler, Kerstin/0000-0001-8146-8905	Nestle Research Center, Lausanne (Switzerland); European Research Council [322467]	Nestle Research Center, Lausanne (Switzerland); European Research Council(European Research Council (ERC)European Commission)	Recipient of a Ph.D. studentship from The Nestle Research Center, Lausanne (Switzerland).; Supported by European Research Council Advanced Grant POLYTRUE? 322467.	Abumrad NA, 2012, PHYSIOL REV, V92, P1061, DOI 10.1152/physrev.00019.2011; Actis-Goretta L, 2012, FREE RADICAL BIO MED, V53, P787, DOI 10.1016/j.freeradbiomed.2012.05.023; ANTOINE B, 1983, BIOCHEM PHARMACOL, V32, P2629, DOI 10.1016/0006-2952(83)90037-0; ANTOINE B, 1984, XENOBIOTICA, V14, P575, DOI 10.3109/00498258409151451; Auger C, 2008, J NUTR, V138, P1535; Barbier O, 2003, J BIOL CHEM, V278, P13975, DOI 10.1074/jbc.M300749200; Barre L, 2005, FEBS J, V272, P1063, DOI 10.1111/j.1742-4658.2005.04548.x; Campbell BJ, 2001, GLYCOBIOLOGY, V11, P385, DOI 10.1093/glycob/11.5.385; Cheng ZQ, 1999, DRUG METAB DISPOS, V27, P1165; CHOWDHURY JR, 1985, P NATL ACAD SCI USA, V82, P2990, DOI 10.1073/pnas.82.9.2990; Clarke KA, 2014, J CHROMATOGR B, V972, P29, DOI 10.1016/j.jchromb.2014.09.035; Court MH, 2012, XENOBIOTICA, V42, P266, DOI 10.3109/00498254.2011.618954; Croix JA, 2011, EXP BIOL MED, V236, P1402, DOI 10.1258/ebm.2011.011186; DANNENBERG AJ, 1993, BIOCHIM BIOPHYS ACTA, V1210, P8, DOI 10.1016/0005-2760(93)90042-8; DANNENBERG AJ, 1992, BIOCHEM PHARMACOL, V44, P335, DOI 10.1016/0006-2952(92)90017-D; DANNENBERG AJ, 1992, J NUTR, V122, P1607, DOI 10.1093/jn/122.8.1607; Fallon JK, 2013, J PROTEOME RES, V12, P4402, DOI 10.1021/pr4004213; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FORSTNER J, 1991, EXP MOL PATHOL, V54, P129, DOI 10.1016/0014-4800(91)90026-T; Gill KL, 2012, DRUG METAB DISPOS, V40, P825, DOI 10.1124/dmd.111.043984; Grosse L, 2013, BASIC CLIN PHARMACOL, V113, P92, DOI 10.1111/bcpt.12071; Hanioka N, 2012, CHEMOSPHERE, V89, P526, DOI 10.1016/j.chemosphere.2012.05.039; Harbourt DE, 2012, ANAL CHEM, V84, P98, DOI 10.1021/ac201704a; HAUSER SC, 1984, J BIOL CHEM, V259, P4527; Huang YH, 2002, PHARMACOGENETICS, V12, P287, DOI 10.1097/00008571-200206000-00004; Izukawa T, 2009, DRUG METAB DISPOS, V37, P1759, DOI 10.1124/dmd.109.027227; Jenkinson Carl, 2013, Front Endocrinol (Lausanne), V4, P80, DOI 10.3389/fendo.2013.00080; Jimenez R, 2012, J AGR FOOD CHEM, V60, P8823, DOI 10.1021/jf205370q; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Kato J, 2003, J HEALTH SCI, V49, P105, DOI 10.1248/jhs.49.105; Kato Y, 2008, DRUG METAB DISPOS, V36, P51, DOI 10.1124/dmd.107.018184; Kimura R, 2013, J LIPID RES, V54, P3258, DOI 10.1194/jlr.M034942; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; LESUFFLEUR T, 1990, CANCER RES, V50, P6334; Leung HY, 2007, TOXICOLOGY, V242, P153, DOI 10.1016/j.tox.2007.09.027; Levesque B, 1999, PHARMACOGENETICS, V9, P207; MAGDALOU J, 1982, ENZYME, V28, P41, DOI 10.1159/000459083; Malfatti MA, 2005, MUTAT RES-FUND MOL M, V570, P205, DOI 10.1016/j.mrfmmm.2004.11.007; Meech R, 2012, PHARMACOL THERAPEUT, V134, P200, DOI 10.1016/j.pharmthera.2012.01.009; Mojarrabi B, 1998, BIOCHEM BIOPH RES CO, V247, P704, DOI 10.1006/bbrc.1998.8843; Ng SP, 2005, J PHARM PHARM SCI, V8, P1; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; Ohno S, 2009, DRUG METAB DISPOS, V37, P32, DOI 10.1124/dmd.108.023598; Okamura K, 2006, BIOCHEM BIOPH RES CO, V345, P1649, DOI 10.1016/j.bbrc.2006.05.089; Ouzzine M, 1999, FEBS LETT, V454, P187, DOI 10.1016/S0014-5793(99)00797-8; Ouzzine M, 1999, J BIOL CHEM, V274, P31401, DOI 10.1074/jbc.274.44.31401; Rouleau M, 2013, BIOCHEM J, V450, P107, DOI 10.1042/BJ20121594; Rowland A, 2013, INT J BIOCHEM CELL B, V45, P1121, DOI 10.1016/j.biocel.2013.02.019; Sato Y, 2014, DRUG METAB DISPOS, V42, P885, DOI 10.1124/dmd.113.056291; Shibuya A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02903; Singh R, 2011, J AGR FOOD CHEM, V59, P7452, DOI 10.1021/jf1041454; SPECIAN RD, 1991, AM J PHYSIOL, V260, pC183, DOI 10.1152/ajpcell.1991.260.2.C183; Stalmach A, 2010, MOL NUTR FOOD RES, V54, P323, DOI 10.1002/mnfr.200900194; Strassburg CP, 1999, GASTROENTEROLOGY, V116, P149, DOI 10.1016/S0016-5085(99)70239-8; Strassburg CP, 2000, J BIOL CHEM, V275, P36164, DOI 10.1074/jbc.M002180200; Thibaudeau J, 2006, CANCER RES, V66, P125, DOI 10.1158/0008-5472.CAN-05-2857; Trottier J, 2006, HEPATOLOGY, V44, P1158, DOI 10.1002/hep.21362; Tsoutsikos P, 2004, BIOCHEM PHARMACOL, V67, P191, DOI 10.1016/j.bcp.2003.08.025; Vaidyanathan JB, 2002, DRUG METAB DISPOS, V30, P897, DOI 10.1124/dmd.30.8.897; VESSEY DA, 1971, J BIOL CHEM, V246, P4649; Wang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057045; Wong CC, 2011, MOL NUTR FOOD RES, V55, P979, DOI 10.1002/mnfr.201000652; Wong CC, 2010, J NUTR BIOCHEM, V21, P1060, DOI 10.1016/j.jnutbio.2009.09.001; Wu BJ, 2011, J PHARM SCI-US, V100, P3655, DOI 10.1002/jps.22568; Xu L, 2006, DRUG METAB DISPOS, V34, P1406, DOI 10.1124/dmd.106.009399; ZAKIM D, 1973, EUR J BIOCHEM, V38, P59, DOI 10.1111/j.1432-1033.1973.tb03033.x; ZAKIM D, 1970, J BIOL CHEM, V245, P4953; ZALESKI J, 1982, CAN J BIOCHEM CELL B, V60, P972, DOI 10.1139/o82-125	68	7	7	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7622	7633		10.1074/jbc.M114.634428	http://dx.doi.org/10.1074/jbc.M114.634428			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25586184	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000351613600025
J	Haldar, S; Dru, C; Choudhury, D; Mishra, R; Fernandez, A; Biondi, S; Liu, ZQ; Shimada, K; Arditi, M; Bhowmick, NA				Haldar, Subhash; Dru, Christopher; Choudhury, Diptiman; Mishra, Rajeev; Fernandez, Ana; Biondi, Shea; Liu, Zhenqiu; Shimada, Kenichi; Arditi, Moshe; Bhowmick, Neil A.			Inflammation and Pyroptosis Mediate Muscle Expansion in an Interleukin-1 beta (IL-1 beta)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOPHOSPHAMIDE-INDUCED CYSTITIS; HEMORRHAGIC CYSTITIS; NLRP3 INFLAMMASOME; BLADDER INFLAMMATION; MITOCHONDRIAL-DNA; OXIDATIVE STRESS; CELL-DEATH; OGG1 GENE; METHYLATION; ACROLEIN	Muscle inflammation is often associated with its expansion. Bladder smooth muscle inflammation-induced cell death is accompanied by hyperplasia and hypertrophy as the primary cause for poor bladder function. In mice, DNA damage initiated by chemotherapeutic drug cydophosphamide activated caspase 1 through the formation of the NINP3 complex resulting in detrusor hyperplasia. A cyclophosphamide metabolite, acrolein, caused global DNA methylation and accumulation of DNA damage in a mouse model of bladder inflammation and in cultured bladder muscle cells. In correlation, global DNA methylation and NLRP:3 expression was up-regulated in human chronic bladder inflammatory tissues. The epigenetic silencing of DNA damage repair gene, Oggl, could be reversed by the use of demethylating agents. In mice, demethylating agents reversed cydophosphamide-induced bladder inflammation and detrusor expansion. The transgenic knock-out olOgg1 in as few as 10% of the detrusor cells tripled the proliferation of the remaining wild type counterparts in an in vitro co-culture titration experiment. Antagonizing IL-1 beta with Anakinra, a rheumatoid arthritis therapeutic, prevented detrusor proliferation in conditioned media experiments as well as in a mouse model of bladder inflammation. Radiation treatment validated the role of DNA damage in the NLRP3-associated caspase 1-mediated IL-1 beta secretory phenotype. A protein array analysis identified IGF1 to be downstream of IL-1 beta signaling. IL-1 beta-induced detrusor proliferation and hypertrophy could be reversed with the use of Anakinra as well as an IGT1 neutralizing antibody. IL-1 beta antagonists in current clinical practice can exploit the revealed mechanism for DNA damage-mediated muscular expansion.	[Haldar, Subhash; Dru, Christopher; Choudhury, Diptiman; Mishra, Rajeev; Fernandez, Ana; Biondi, Shea; Liu, Zhenqiu; Bhowmick, Neil A.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Choudhury, Diptiman; Fernandez, Ana; Biondi, Shea; Bhowmick, Neil A.] Greater Los Angeles Vet Adm, Los Angeles, CA USA; [Shimada, Kenichi; Arditi, Moshe] Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center	Bhowmick, NA (corresponding author), Cedars Sinai Med Ctr, Dept Med, 8750 Beverly Blvd,Atrium 103, Los Angeles, CA 90048 USA.	bhowmickn@cshs.org	Bhowmick, Neil/AAA-7302-2019; Mishra, Rajeev/AEX-2208-2022; Mishra, Rajeev/T-4216-2017	Bhowmick, Neil/0000-0001-8747-5989; Mishra, Rajeev/0000-0002-7411-4022; Haldar, Subhash/0000-0002-1230-1770	National Institutes of Health [R01CA108646]; NATIONAL CANCER INSTITUTE [R01CA108646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA108646 (NCI).	AHLUWALIA A, 1994, BRIT J PHARMACOL, V111, P1017, DOI 10.1111/j.1476-5381.1994.tb14845.x; Ando M, 2014, BREAST CANCER RES TR, V145, P401, DOI 10.1007/s10549-014-2947-1; Auge C, 2013, EUR J PHARMACOL, V707, P32, DOI 10.1016/j.ejphar.2013.03.008; Banerjee J, 2014, ONCOGENE, V33, P4924, DOI 10.1038/onc.2013.431; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bechis SK, 2014, J UROLOGY, V192, P16, DOI 10.1016/j.juro.2014.01.114; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; Boudes M, 2011, NEUROUROL URODYNAM, V30, P1659, DOI 10.1002/nau.21180; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Burgio G, 2010, BBA-GENE REGUL MECH, V1799, P671, DOI 10.1016/j.bbagrm.2010.05.007; Ceballos-Olvera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002452; Chen HJC, 2011, MOL NUTR FOOD RES, V55, P1391, DOI 10.1002/mnfr.201100185; Christmas TJ, 1996, BRIT J UROL, V78, P862, DOI 10.1046/j.1464-410X.1996.02599.x; Conklin DJ, 2009, J PHARMACOL EXP THER, V331, P456, DOI 10.1124/jpet.109.156513; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; COX PJ, 1979, BIOCHEM PHARMACOL, V28, P2045, DOI 10.1016/0006-2952(79)90222-3; de Souza-Pinto NC, 2001, CANCER RES, V61, P5378; DEVRIES CR, 1990, J UROLOGY, V143, P1; EFROS M, 1990, J UROLOGY, V144, P1231, DOI 10.1016/S0022-5347(17)39702-1; FRIEDMAN J, 1977, NUCLEIC ACIDS RES, V4, P3483, DOI 10.1093/nar/4.10.3483; Geisler CH, 2014, BLOOD, V123, P3255, DOI 10.1182/blood-2014-01-547737; Hartman KG, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt366; HASELBERGER MB, 1995, ANN PHARMACOTHER, V29, P918, DOI 10.1177/106002809502900914; He X, 2014, CELL PROLIFERAT, V47, P161, DOI 10.1111/cpr.12091; Hu RQ, 2008, RHEUMATOL INT, V28, P1161, DOI 10.1007/s00296-008-0581-0; Junttila Ilkka, 2013, Duodecim, V129, P705; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kiskowski MA, 2011, CANCER RES, V71, P3459, DOI 10.1158/0008-5472.CAN-10-2999; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; LEVINE LA, 1993, J UROLOGY, V149, P719, DOI 10.1016/S0022-5347(17)36192-X; Lewis SA, 2000, AM J PHYSIOL-RENAL, V278, pF867; Li X, 2008, ONCOGENE, V27, P7118, DOI 10.1038/onc.2008.293; Li XH, 2012, MOL CANCER RES, V10, P494, DOI 10.1158/1541-7786.MCR-11-0506; Mankan AK, 2012, EUR J IMMUNOL, V42, P710, DOI 10.1002/eji.201141921; Martinez-Ferrer M, 2008, AM J PATHOL, V172, P59, DOI 10.2353/ajpath.2008.070529; Martinez-Ferrer M, 2010, AM J PATHOL, V176, P98, DOI 10.2353/ajpath.2010.090283; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Maryanovich M, 2013, TRENDS CELL BIOL, V23, P129, DOI 10.1016/j.tcb.2012.09.007; Miao CG, 2013, CELL SIGNAL, V25, P875, DOI 10.1016/j.cellsig.2012.12.017; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; O'Toole TE, 2009, TOXICOL APPL PHARM, V236, P194, DOI 10.1016/j.taap.2009.01.024; Obtulowicz T, 2010, MUTAGENESIS, V25, P463, DOI 10.1093/mutage/geq028; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Shimada K, 2012, MICROBES INFECT, V14, P1301, DOI 10.1016/j.micinf.2012.08.004; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Smit SG, 2010, NAT REV UROL, V7, P206, DOI 10.1038/nrurol.2010.23; Starkman JS, 2008, J UROLOGY, V179, P2440, DOI 10.1016/j.juro.2008.01.082; Takahashi M, 2014, INT HEART J, V55, P101, DOI 10.1536/ihj.13-388; Terado M, 2005, ENDOCRINE, V26, P55, DOI 10.1385/ENDO:26:1:055; Tian YJ, 2014, BRIT J NUTR, V111, P1594, DOI 10.1017/S0007114513004054; Ulanovskaya OA, 2013, NAT CHEM BIOL, V9, P300, DOI [10.1038/NCHEMBIO.1204, 10.1038/nchembio.1204]; Wang HT, 2013, CARCINOGENESIS, V34, P220, DOI 10.1093/carcin/bgs323; Wu M, 2011, INFECT IMMUN, V79, P75, DOI 10.1128/IAI.00815-10	54	36	39	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6574	6583		10.1074/jbc.M114.617886	http://dx.doi.org/10.1074/jbc.M114.617886			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25596528	Green Published, hybrid			2022-12-26	WOS:000350732500059
J	Liu, ZH; Li, FD; Zhang, BB; Li, S; Wu, JH; Shi, YY				Liu, Zhonghua; Li, Fudong; Zhang, Beibei; Li, Sai; Wu, Jihui; Shi, Yunyu			Structural Basis of Plant Homeodomain Finger 6 (PHF6) Recognition by the Retinoblastoma Binding Protein 4 (RBBP4) Component of the Nucleosome Remodeling and Deacetylase (NuRD) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORJESON-FORSSMAN-LEHMANN; HISTONE DEACETYLASE; MI-2/NURD COMPLEX; MUTATIONS; RECRUITMENT; INSIGHTS; FEATURES; FEMALES; FOG-1	The NuRD complex is a conserved transcriptional coregulator that contains both chromatin-remodeling and histone deacetylase activities. Mutations of PHF6 are found in patients with Biirjeson-Forssman-Lehmann syndrome, T-cell acute lymphoblastic leukemia, or acute myeloid leukemia. Recently, PHF6 was identified to interact with the NuRD complex, and this interaction is mediated by the RBBP4 component. However, little is known about the molecular basis for the interaction. Here, we present the crystal structure of the complex of the NuRD subunit RBBP4 bound to the 1HF6 peptide (residues 162-170). The PHF6 peptide binds to the top surface of the RBBP4 beta-propeller. A pair of positively charged residues of the PHF6 peptide insert into the negatively charged pocket of RBBP4, which is critical for the interaction between PHF6 and RBBP4. Corresponding PHF6 mutants impair this interaction in vitro and in vivo. Structural comparison shows that the PHF6binding pocket overlaps with LOGI and histone H3 on RBBP4/ Nur155, but it is distinct from the pocket recognizing histone H4, Su(z)12, and MTAL We further show that the middle disordered region (residues 145-207, containing the RBBP4-binding motif) is sufficient for the transcriptional repression mediated by Pl4F6 on the GAL4 reporter, and knockdown of.RBBP4 diminished the PHI6-mediated repression. Our RBBP4-PHI6 complex structure provides insights into the molecular basis of PHF6-NuRD complex interaction and implicates a role for PHF6 in chromatin structure modulation and gene regulation.	[Wu, Jihui] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, JH (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	wujihui@ustc.edu.cn; yyshi@ustc.edu.cn	Shi, Yunyu/B-3240-2009	Shi, Yunyu/0000-0002-1348-4759	National Basic Research Program of China 973 Program [2011CB966302, 2012CB917201, 2011CB911104]; Chinese National Natural Science Foundation [31170693, 31330018]; Chinese Academy of Sciences [KJZD-EW-L05]; Strategic Priority Research Program [XDB08010101, XDB08030302]	National Basic Research Program of China 973 Program(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Strategic Priority Research Program(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China 973 Program Grants 2011CB966302, 2012CB917201, and 2011CB911104; Chinese National Natural Science Foundation Grants 31170693 and 31330018; and Chinese Academy of Sciences Grant KJZD-EW-L05 and Strategic Priority Research Program Grants XDB08010101 and XDB08030302.	Alqarni SSM, 2014, J BIOL CHEM, V289, P21844, DOI 10.1074/jbc.M114.558940; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BORJESON M, 1962, ACTA MED SCAND, V171, P13; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Brackertz M, 2002, J BIOL CHEM, V277, P40958, DOI 10.1074/jbc.M207467200; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; Conomos D, 2014, NAT STRUCT MOL BIOL, V21, P760, DOI 10.1038/nsmb.2877; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feng Q, 2002, MOL CELL BIOL, V22, P536, DOI 10.1128/MCB.22.2.536-546.2002; Gao ZG, 2010, EMBO J, V29, P457, DOI 10.1038/emboj.2009.368; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Kosho T, 2014, AM J MED GENET C, V166, P241, DOI 10.1002/ajmg.c.31415; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Lejon S, 2011, J BIOL CHEM, V286, P1196, DOI 10.1074/jbc.M110.195842; Liu ZH, 2014, J BIOL CHEM, V289, P10069, DOI 10.1074/jbc.M113.535351; Lower KM, 2002, NAT GENET, V32, P661, DOI 10.1038/ng1040; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Pavlopoulos E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006373; Ramirez J, 2009, EPIGENETICS-US, V4, P532, DOI 10.4161/epi.4.8.10108; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Todd MAM, 2012, J PROTEOME RES, V11, P4326, DOI 10.1021/pr3004369; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Turner G, 2004, CLIN GENET, V65, P226, DOI 10.1111/j.0009-9163.2004.00215.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Van Vlierberghe P, 2011, LEUKEMIA, V25, P130, DOI 10.1038/leu.2010.247; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Visootsak J, 2004, J PEDIATR-US, V145, P819, DOI 10.1016/j.jpeds.2004.07.041; Voss AK, 2007, GENE EXPR PATTERNS, V7, P858, DOI 10.1016/j.modgep.2007.06.007; Wang JD, 2013, J BIOL CHEM, V288, P3174, DOI 10.1074/jbc.M112.414839; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zweier C, 2014, AM J MED GENET C, V166, P290, DOI 10.1002/ajmg.c.31408	37	26	29	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6630	6638		10.1074/jbc.M114.610196	http://dx.doi.org/10.1074/jbc.M114.610196			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25601084	Green Published, hybrid			2022-12-26	WOS:000350732500064
J	Petrosyan, A; Ali, MF; Cheng, PW				Petrosyan, Armen; Ali, Mohamed F.; Cheng, Pi-Wan			Keratin 1 Plays a Critical Role in Golgi Localization of Core 2 N-Acetylglucosaminyltransferase M via Interaction with Its Cytoplasmic Tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-SPANNING DOMAIN; NONMUSCLE MYOSIN IIA; ENDOPLASMIC-RETICULUM; INTERMEDIATE-FILAMENTS; MUCIN BIOSYNTHESIS; MOLECULAR-CLONING; BREFELDIN-A; IN-VITRO; GLYCOSYLTRANSFERASES; PROTEIN	Core 2 N-acetylglucosaminyltransferase 2/M (C2GnT-M) synthesizes all three beta 6GlcNAc branch structures found in secreted mucins. Loss of C2GnT-M leads to development of colitis and colon cancer. Recently we have shown that C2GnT-M targets the Golgi at the Giantin site and is recycled by binding to non-muscle myosin IIA, a motor protein, via the cytoplasmic tail (CT). But how this enzyme is retained in the Golgi is not known. Proteomics analysis identifies keratin type II cytoskeletal 1 (KRT1) as a protein pulled down with anti-c-Myc antibody or C2GnT-M CT from the lysate of Panc1 cells expressing bC2GnT-M tagged with c-Myc. Yeast two-hybrid analysis shows that the rod domain of KRT1 interacts directly with the WKR6 motif in the C2GnT-M CT. Knockdown of KRT1 does not affect Golgi morphology but increases the interaction of C2GnT-M with non-muscle myosin IIA and its transportation to the endoplasmic reticulum, ubiquitination, and degradation. During Golgi recovery after brefeldin A treatment, C2GnT-M forms a complex with Giantin before KRT1, demonstrating CT-mediated sequential events of Golgi targeting and retention of C2GnT-M. In HeLa cells transiently expressing C2GnT-M-GFP, knockdown of KRT1 does not affect Golgi morphology but leaves C2GnT-M outside of the Golgi, resulting in the formation of sialyl-T antigen. Interaction of C2GnT-M and KRT1 was also detected in the goblet cells of human colon epithelial tissue and primary culture of colonic epithelial cells. The results indicate that glycosylation and thus the function of glycoconjugates can be regulated by a protein that helps retain a glycosyltransferase in the Golgi.	[Petrosyan, Armen; Ali, Mohamed F.; Cheng, Pi-Wan] VA Nebraska Western Iowa Hlth Care Syst, Dept Res Serv, Omaha, NE 68105 USA; [Petrosyan, Armen; Ali, Mohamed F.; Cheng, Pi-Wan] Univ Nebraska, Coll Med, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Cheng, Pi-Wan] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska System; University of Nebraska Medical Center	Cheng, PW (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	pcheng@unmc.edu	Petrosyan, Armen/T-7071-2018	Petrosyan, Armen/0000-0003-3895-3993	Office of Research and Development, Department of Veterans Affairs [VA 1I1BX000985]; National Institutes of Health [R21 HL097238]; State of Nebraska [LB506]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA022979] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000985] Funding Source: NIH RePORTER	Office of Research and Development, Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Nebraska; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by the Office of Research and Development, Department of Veterans Affairs (VA 1I1BX000985), the National Institutes of Health Grant R21 HL097238, and the State of Nebraska (LB506).	Ali MF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.346528; AOKI D, 1992, P NATL ACAD SCI USA, V89, P4319, DOI 10.1073/pnas.89.10.4319; BURGESS TL, 1991, CELL MOTIL CYTOSKEL, V20, P289, DOI 10.1002/cm.970200405; BURKE J, 1994, J BIOL CHEM, V269, P12049; Cheng PW, 2011, ADV EXP MED BIOL, V705, P465, DOI 10.1007/978-1-4419-7877-6_25; CHIPEV CC, 1992, CELL, V70, P821, DOI 10.1016/0092-8674(92)90315-4; Choi KH, 2005, GLYCOCONJUGATE J, V22, P63, DOI 10.1007/s10719-005-0326-1; Choi KH, 2004, AM J RESP CELL MOL, V30, P710, DOI 10.1165/rcmb.2003-0202OC; Chu PG, 2000, MODERN PATHOL, V13, P962, DOI 10.1038/modpathol.3880175; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Dabelsteen E, 1996, J PATHOL, V179, P358; Dalziel M, 2001, J BIOL CHEM, V276, P11007, DOI 10.1074/jbc.M006523200; Eklund Erik A, 2006, NeuroRx, V3, P254; El-Battari A, 2006, METHOD ENZYMOL, V416, P102, DOI 10.1016/S0076-6879(06)16007-3; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; England K, 2002, CELL SIGNAL, V14, P529, DOI 10.1016/S0898-6568(01)00277-7; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Gao YS, 2001, J CELL BIOL, V152, P877, DOI 10.1083/jcb.152.5.877; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; HATZFELD M, 1985, J CELL BIOL, V101, P1826, DOI 10.1083/jcb.101.5.1826; HATZFELD M, 1990, J CELL BIOL, V110, P1199, DOI 10.1083/jcb.110.4.1199; HENDRICKS LC, 1992, P NATL ACAD SCI USA, V89, P7242, DOI 10.1073/pnas.89.15.7242; Huang MC, 2006, ONCOGENE, V25, P3267, DOI 10.1038/sj.onc.1209350; Jiang S, 2005, MOL BIOL CELL, V16, P2586, DOI 10.1091/mbc.e04-10-0861; JOHNSON LD, 1985, P NATL ACAD SCI USA, V82, P1896, DOI 10.1073/pnas.82.7.1896; KARTASOVA T, 1993, J CELL BIOL, V120, P1251, DOI 10.1083/jcb.120.5.1251; Kreplak L, 2007, BIOESSAYS, V29, P26, DOI 10.1002/bies.20514; Kumar R, 1996, BLOOD, V88, P3872, DOI 10.1182/blood.V88.10.3872.bloodjournal88103872; Kumemura H, 2004, CELL MOTIL CYTOSKEL, V57, P37, DOI 10.1002/cm.10152; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lin YR, 2008, DEV DYNAM, V237, P3703, DOI 10.1002/dvdy.21775; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; May JA, 1998, PLATELETS, V9, P227, DOI 10.1080/09537109876744; Nakamura M, 1998, J BIOL CHEM, V273, P26779, DOI 10.1074/jbc.273.41.26779; Nilsson T, 1996, J CELL SCI, V109, P1975; Okamoto M, 2008, EUKARYOT CELL, V7, P310, DOI 10.1128/EC.00333-07; Osman N, 1996, J BIOL CHEM, V271, P33105, DOI 10.1074/jbc.271.51.33105; Pellett PA, 2013, ELIFE, V2, DOI 10.7554/eLife.01296; Pereira NA, 2014, J BIOL CHEM, V289, P14762, DOI 10.1074/jbc.M114.548305; Petrosyan A, 2014, MOL CANCER RES, V12, P1704, DOI 10.1158/1541-7786.MCR-14-0291-T; Petrosyan A, 2014, CELL STRESS CHAPERON, V19, P241, DOI 10.1007/s12192-013-0450-y; Petrosyan A, 2013, GLYCOBIOLOGY, V23, P690, DOI 10.1093/glycob/cwt009; Petrosyan A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.C112.403006; Petrosyan A, 2012, INT J BIOCHEM CELL B, V44, P1153, DOI 10.1016/j.biocel.2012.04.004; Quintero CA, 2008, BIOCHEM J, V412, P19, DOI 10.1042/BJ20071725; Quintero CA, 2010, J BIOL CHEM, V285, P30340, DOI 10.1074/jbc.M110.128868; Rhee SW, 2005, TRAFFIC, V6, P978, DOI 10.1111/j.1600-0854.2005.00333.x; ROPP PA, 1991, J BIOL CHEM, V266, P23863; Roth W, 2012, J CELL SCI, V125, P5269, DOI 10.1242/jcs.116574; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Schwientek T, 2000, J BIOL CHEM, V275, P11106, DOI 10.1074/jbc.275.15.11106; St Hill C. A., 2011, PLOS ONE, V6; Stone EL, 2009, MOL CELL BIOL, V29, P3770, DOI 10.1128/MCB.00204-09; Styers ML, 2005, TRAFFIC, V6, P359, DOI 10.1111/j.1600-0854.2005.00286.x; Tal O, 2005, CLIN EXP DERMATOL, V30, P64, DOI 10.1111/j.1365-2230.2004.01661.x; Todorow Z, 2000, P NATL ACAD SCI USA, V97, P13643, DOI 10.1073/pnas.250472397; Toivola DM, 2008, AM J PATHOL, V172, P882, DOI 10.2353/ajpath.2008.070830; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Tu LN, 2010, CELL MOL LIFE SCI, V67, P29, DOI 10.1007/s00018-009-0126-z; TURNER JR, 1989, J CELL BIOL, V109, P2081, DOI 10.1083/jcb.109.5.2081; Varki A., 2009, ESSENTIALS GLYCOBIOL; Virtanen M, 2003, J INVEST DERMATOL, V121, P1013, DOI 10.1046/j.1523-1747.2003.12534.x; Wang C, 2002, BIOCHEM J, V361, P461, DOI 10.1042/0264-6021:3610461; Wassler MJ, 2001, J CELL SCI, V114, P2291; Weber KL, 2002, J CELL SCI, V115, P1373; Whitehouse C, 1997, J CELL BIOL, V137, P1229, DOI 10.1083/jcb.137.6.1229; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; YANG JM, 1994, J INVEST DERMATOL, V102, P17, DOI 10.1111/1523-1747.ep12371725; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215; Zerfaoui M, 2002, GLYCOBIOLOGY, V12, P15, DOI 10.1093/glycob/12.1.15	73	19	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6256	6269		10.1074/jbc.M114.618702	http://dx.doi.org/10.1074/jbc.M114.618702			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605727	hybrid, Green Published			2022-12-26	WOS:000350732500032
J	Padmanabhan, J; Brown, KR; Padilla, A; Shelanski, ML				Padmanabhan, Jaya; Brown, Kristy R.; Padilla, Amelia; Shelanski, Michael L.			Functional Role of RNA Polymerase II and P70 S6 Kinase in KCl Withdrawal-induced Cerebellar Granule Neuron Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; PROGRAMMED CELL-DEATH; DNA-DAMAGING AGENTS; ALZHEIMERS-DISEASE; CORTICAL-NEURONS; NERVOUS-SYSTEM; MESSENGER-RNAS; HISTONE H3; IN-VITRO; P-TEFB	KCl withdrawal-induced apoptosis in cerebellar granule neurons is associated with aberrant cell cycle activation, and treatment with cyclin-dependent kinase (Cdk) inhibitors protects cells from undergoing apoptosis. Because the Cdk inhibitor flavopiridol is known to inhibit RNA polymerase II (Pol II)-dependent transcription elongation by inhibiting the positive transcription elongation factor b (P-TEFb, a complex of CDK9 and cyclin T), we examined whether inhibition of RNA Pol II protects neurons from apoptosis. Treatment of neurons with 5, 6-dichloro-1-beta-D-ribobenzimidazole (DRB), an RNA Pol II-dependent transcription elongation inhibitor, and flavopiridol inhibited phosphorylation and activation of Pol II and protected neurons from undergoing apoptosis. In addition to Pol II, neurons subjected to KCl withdrawal showed increased phosphorylation and activation of p70 S6 kinase, which was inhibited by both DRB and flavopiridol. Immunostaining analysis of the neurons deprived of KCl showed increased nuclear levels of phospho-p70 S6 kinase, and neurons protected with DRB and flavopiridol showed accumulation of the kinase into large spliceosome assembly factor-positive speckle domains within the nuclei. The formation of these foci corresponded with cell survival, and removal of the inhibitors resulted in dispersal of the speckles into smaller foci with subsequent apoptosis induction. Because p70 S6 kinase is known to induce translation of mRNAs containing a 5'-terminal oligopyrimidine tract, our data suggest that transcription and translation of this subset of mRNAs may contribute to KCl withdrawal-induced apoptosis in neurons.	[Padmanabhan, Jaya; Padilla, Amelia] Univ S Florida, USF Hlth Byrd Alzheimers Inst, Dept Mol Med, Tampa, FL 33613 USA; [Brown, Kristy R.; Shelanski, Michael L.] Columbia Univ, Coll Phys & Surg, Taub Ctr Alzheimers Dis, Dept Pathol & Cell Biol, New York, NY 10032 USA	State University System of Florida; University of South Florida; Columbia University	Padmanabhan, J (corresponding author), Univ S Florida, USF Hlth Byrd Alzheimers Inst, Dept Mol Med, 4001 E Fletcher Ave, Tampa, FL 33613 USA.	jpadmana@health.usf.edu	Padmanabhan, Jaya/A-4226-2012	Padmanabhan, Jaya/0000-0003-2019-5135	NINDS/National Institutes of Health Javits Neuroscience Award [NS-15076]; NIA/National Institutes of Health R21 Award [1R21AG031429-01A2]; Alzheimer's Association Investigator Initiated Research Grant [IIRG-08-90842]; Byrd Institute Small Grants Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG031429] Funding Source: NIH RePORTER	NINDS/National Institutes of Health Javits Neuroscience Award; NIA/National Institutes of Health R21 Award; Alzheimer's Association Investigator Initiated Research Grant; Byrd Institute Small Grants Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by NINDS/National Institutes of Health Javits Neuroscience Award NS-15076 (to M. L. S.) and by NIA/National Institutes of Health R21 Award 1R21AG031429-01A2 (to J. P.).This work was also supported by Alzheimer's Association Investigator Initiated Research Grant IIRG-08-90842 (to J. P.) and by the Byrd Institute Small Grants Program (to J. P.).	Alvira D, 2007, NEUROSCIENCE, V146, P350, DOI 10.1016/j.neuroscience.2007.01.042; An WL, 2003, AM J PATHOL, V163, P591, DOI 10.1016/S0002-9440(10)63687-5; Avni D, 1997, NUCLEIC ACIDS RES, V25, P995, DOI 10.1093/nar/25.5.995; BALLOU LM, 1988, P NATL ACAD SCI USA, V85, P7154, DOI 10.1073/pnas.85.19.7154; BAORTO DM, 1992, J CELL BIOL, V117, P357, DOI 10.1083/jcb.117.2.357; BARRATT MJ, 1994, P NATL ACAD SCI USA, V91, P4781, DOI 10.1073/pnas.91.11.4781; Barth-Baus D, 2002, NUCLEIC ACIDS RES, V30, P1919, DOI 10.1093/nar/30.9.1919; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Blagosklonny MV, 2004, CELL CYCLE, V3, P1537, DOI 10.4161/cc.3.12.1278; BREGMAN DB, 1995, J CELL BIOL, V129, P287, DOI 10.1083/jcb.129.2.287; Burek MJ, 1996, BRAIN PATHOL, V6, P427, DOI 10.1111/j.1750-3639.1996.tb00874.x; Carlson BA, 1996, CANCER RES, V56, P2973; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen R, 2005, BLOOD, V106, P2513, DOI 10.1182/blood-2005-04-1678; CHODOSH LA, 1989, J BIOL CHEM, V264, P2250; Cmarko D, 1999, MOL BIOL CELL, V10, P211, DOI 10.1091/mbc.10.1.211; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dennis PB, 1996, MOL CELL BIOL, V16, P6242; DREYER EB, 1995, NEUROREPORT, V6, P942, DOI 10.1097/00001756-199504190-00029; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Dumont F J, 1996, Life Sci, V58, P373; FU XD, 1992, P NATL ACAD SCI USA, V89, P1725, DOI 10.1073/pnas.89.5.1725; GALLI C, 1995, J NEUROSCI, V15, P1172; GALLO V, 1987, J NEUROSCI, V7, P2203; Giovanni A, 2000, J BIOL CHEM, V275, P11553, DOI 10.1074/jbc.275.16.11553; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Greene LA, 2004, CELL DEATH DIFFER, V11, P49, DOI 10.1038/sj.cdd.4401341; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hubert T, 2014, J NEUROSCI, V34, P758, DOI 10.1523/JNEUROSCI.2886-13.2014; Kapasi AJ, 2008, J VIROL, V82, P394, DOI 10.1128/JVI.01681-07; Kim SJ, 1997, BIOCHEM BIOPH RES CO, V234, P681, DOI 10.1006/bbrc.1997.6699; Kole AJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.220; Konishi Y, 2003, J NEUROSCI, V23, P1649; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kumaran RI, 2002, J CELL BIOL, V159, P783, DOI 10.1083/jcb.200204149; Kwon HK, 2002, ARCH PHARM RES, V25, P685, DOI 10.1007/BF02976945; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Liu DX, 2001, NEURON, V32, P425, DOI 10.1016/S0896-6273(01)00495-0; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; Miller TM, 1996, J NEUROSCI, V16, P7487; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; Nowak SJ, 2000, GENE DEV, V14, P3003, DOI 10.1101/gad.848800; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Padmanabhan J, 1999, J NEUROSCI, V19, P8747, DOI 10.1523/JNEUROSCI.19-20-08747.1999; Padmanabhan J, 2007, DEV NEUROBIOL, V67, P818, DOI 10.1002/dneu.20394; Papst PJ, 1998, J BIOL CHEM, V273, P15077, DOI 10.1074/jbc.273.24.15077; Park DS, 1998, J NEUROSCI, V18, P830; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; Park DS, 2000, J NEUROSCI, V20, P3104, DOI 10.1523/JNEUROSCI.20-09-03104.2000; Park DS, 1997, J NEUROSCI, V17, P8975; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Pei JJ, 2008, J ALZHEIMERS DIS, V14, P385; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Rogalinska M, 2010, J CELL BIOCHEM, V109, P217, DOI 10.1002/jcb.22400; Romanelli A, 1999, MOL CELL BIOL, V19, P2921; RUKENSTEIN A, 1991, J NEUROSCI, V11, P2552; Schwab MS, 1999, MOL CELL BIOL, V19, P2485; Schwartz BE, 2003, MOL CELL BIOL, V23, P6876, DOI 10.1128/MCB.23.19.6876-6886.2003; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Stefanis L, 1999, J NEUROSCI, V19, P6235; Tang Z, 2013, J BIOL CHEM, V288, P15556, DOI 10.1074/jbc.M112.435123; Troy CM, 1996, P NATL ACAD SCI USA, V93, P5635, DOI 10.1073/pnas.93.11.5635; VILLA P, 1994, J NEUROCHEM, V62, P1468; Volarevic S, 2001, PROG NUCLEIC ACID RE, V65, P101; WILLIAMS RW, 1988, ANNU REV NEUROSCI, V11, P423, DOI 10.1146/annurev.neuro.11.1.423; Yang K, 2013, BRAIN STRUCT FUNCT, V218, P669, DOI 10.1007/s00429-012-0420-7; Zhou XW, 2008, FEBS LETT, V582, P159, DOI 10.1016/j.febslet.2007.11.078	72	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5267	5279		10.1074/jbc.M114.575225	http://dx.doi.org/10.1074/jbc.M114.575225			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568312	Green Published, hybrid			2022-12-26	WOS:000350044200004
J	Lehri-Boufala, S; Ouidja, MO; Barbier-Chassefiere, V; Henault, E; Raisman-Vozari, R; Garrigue-Antar, L; Papy-Garcia, D; Morin, C				Lehri-Boufala, Sonia; Ouidja, Mohand-Ouidir; Barbier-ChassefiSre, Veronique; Henault, Emilie; Raisman-Vozari, Rita; Garrigue-Antar, Laure; Papy-Garcia, Dulce; Morin, Christophe			New Roles of Glycosaminoglycans in alpha-Synuclein Aggregation in a Cellular Model of Parkinson Disease	PLOS ONE			English	Article							OXIDATIVE STRESS; CATHEPSIN-D; DEGRADATION; PROTEOGLYCANS; EXPRESSION; APOPTOSIS; AUTOPHAGY; SULFATION; MICE	The causes of Parkinson disease (PD) remain mysterious, although some evidence supports mitochondrial dysfunctions and alpha-synuclein accumulation in Lewy bodies as major events. The abnormal accumulation of alpha-synuclein has been associated with a deficiency in the ubiquitin-proteasome system and the autophagy-lysosomal pathway. Cathepsin D ( cathD), the major lysosomal protease responsible of a-synuclein degradation was described to be up-regulated in PD model. As glycosaminoglycans ( GAGs) regulate cathD activity, and have been recently suggested to participate in PD physiopathology, we investigated their role in a-synuclein accumulation by their intracellular regulation of cathD activity. In a classical neuroblastoma cell model of PD induced by MPP+, the genetic expression of GAGs-biosynthetic enzymes was modified, leading to an increase of GAGs amounts whereas intracellular level of a-synuclein increased. The absence of sulfated GAGs increased intracellular cathD activity and limited alpha-synuclein accumulation. GAGs effects on cathD further suggested that specific sequences or sulfation patterns could be responsible for this regulation. The present study identifies, for the first time, GAGs as new regulators of the lysosome degradation pathway, regulating cathD activity and affecting two main biological processes, alpha-synuclein aggregation and apoptosis. Finally, this opens new insights into intracellular GAGs functions and new fields of investigation for glycobiological approaches in PD and neurobiology.	[Lehri-Boufala, Sonia; Ouidja, Mohand-Ouidir; Barbier-ChassefiSre, Veronique; Henault, Emilie; Garrigue-Antar, Laure; Papy-Garcia, Dulce; Morin, Christophe] Univ Paris Est Creteil, Lab CRRET EAC CNRS 7149, F-94010 Creteil, France; [Raisman-Vozari, Rita] Univ Paris 06, CNRS UMR 7225, ICM,Ctr Rech,Inst Cerveau & Moelle Epiniere, Hop Salpetriere Batiment,CRICM, F-75651 Paris, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Morin, C (corresponding author), Univ Paris Est Creteil, Lab CRRET EAC CNRS 7149, 61 Ave Gen Gaulle, F-94010 Creteil, France.	ch.morin@u-pec.fr	Morin, christophe/V-6238-2017; Morin, christophe/O-8796-2019	Morin, christophe/0000-0002-2490-7585; Morin, christophe/0000-0002-2490-7585; Garrigue-Antar, Laure/0000-0001-6331-8882				AVILA JL, 1976, BIOCHEM J, V160, P129, DOI 10.1042/bj1600129; AVILA JL, 1975, BIOCHEM J, V152, P57, DOI 10.1042/bj1520057; Bandopadhyay R, 2010, TRENDS MOL MED, V16, P27, DOI 10.1016/j.molmed.2009.11.004; Barbosa I, 2005, J CELL SCI, V118, P253, DOI 10.1242/jcs.01607; Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082; Barret A, 2005, J BIOL CHEM, V280, P10516, DOI 10.1074/jbc.M412635200; BATES TE, 1994, J NEUROCHEM, V63, P640; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Cullen V, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-5; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Engelender S, 2008, AUTOPHAGY, V4, P372, DOI 10.4161/auto.5604; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Kalivendi SV, 2004, J BIOL CHEM, V279, P15240, DOI 10.1074/jbc.M312497200; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; Huynh MB, 2012, J BIOL CHEM, V287, P11363, DOI 10.1074/jbc.M111.335901; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Nakayama F, 2008, CELL MOL BIOL LETT, V13, P475, DOI 10.2478/s11658-008-0016-7; Nara A, 2012, BRAIN RES, V1466, P1, DOI 10.1016/j.brainres.2012.05.017; Narkiewicz J, 2014, PRION, V8, P19, DOI 10.4161/pri.28125; Okuda T, 2003, J BIOCHEM, V134, P111, DOI 10.1093/jb/mvg118; Papy-Garcia D, 2011, CURR PROTEIN PEPT SC, V12, P258, DOI 10.2174/138920311795860188; Qiao LY, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-17; Rott R, 2013, CNS NEUROL DISORD-DR; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; Sevlever D, 2008, BIOCHEMISTRY-US, V47, P9678, DOI 10.1021/bi800699v; Terman A, 2006, CHEM-BIOL INTERACT, V163, P29, DOI 10.1016/j.cbi.2006.04.013; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; Winder-Rhodes SE, 2012, MOVEMENT DISORD, V27, P312, DOI 10.1002/mds.24029; Xilouri M, 2013, MOL NEUROBIOL, V47, P537, DOI 10.1007/s12035-012-8341-2; Yelamanchili SV, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-52; Yue XL, 2009, CELL DEATH DIFFER, V16, P770, DOI 10.1038/cdd.2009.9; Zhang GL, 2013, J NEUROSCI RES, V91, P273, DOI 10.1002/jnr.23146	44	32	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116641	10.1371/journal.pone.0116641	http://dx.doi.org/10.1371/journal.pone.0116641			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617759	gold, Green Published, Green Submitted			2022-12-26	WOS:000350336000020
J	van Maanen, MA; Papke, RL; Koopman, FA; Koepke, J; Bevaart, L; Clark, R; Lamppu, D; Elbaum, D; LaRosa, GJ; Tak, PP; Vervoordeldonk, MJ				van Maanen, Marjolein A.; Papke, Roger L.; Koopman, Frieda A.; Koepke, Jessica; Bevaart, Lisette; Clark, Roger; Lamppu, Diana; Elbaum, Daniel; LaRosa, Gregory J.; Tak, Paul P.; Vervoordeldonk, Margriet J.			Two Novel alpha 7 Nicotinic Acetylcholine Receptor Ligands: In Vitro Properties and Their Efficacy in Collagen-Induced Arthritis in Mice	PLOS ONE			English	Article							CHOLINERGIC ANTIINFLAMMATORY PATHWAY; POSITIVE ALLOSTERIC MODULATION; TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; VAGUS NERVE; XENOPUS OOCYTES; ACTIVATION; STIMULATION; INFLAMMATION; EXPRESSION	Introduction The cholinergic anti-inflammatory pathway can downregulate inflammation via the release of acetylcholine (ACh) by the vagus nerve. This neurotransmitter binds to the alpha 7 subunit of nicotinic acetylcholine receptors (alpha 7nAChR), expressed on macrophages and other immune cells. We tested the pharmacological and functional profile of two novel compounds, PMP-311 and PMP-072 and investigated their role in modulating collagen-induced arthritis (CIA) in mice. Methods Both compounds were characterized with binding, electrophysiological, and pharmacokinetic studies. For in vivo efficacy studies in the CIA model the compounds were administered daily by oral gavage from day 20 till sacrifice at day 34. Disease progression was monitored by visual clinical scoring and measurement of paw swelling. Inflammation and joint destruction were examined by histology and radiology. Results Treatment with PMP-311 was effective in preventing disease onset, reducing clinical signs of arthritis, and reducing synovial inflammation and bone destruction. PMP-072 also showed a trend in arthritis reduction at all concentrations tested. The data showed that while both compounds bind to a7nAChR with high affinity, PMP-311 acts like a classical agonist of ion channel activity, and PMP-072 can actually act as an ion channel antagonist. Moreover, PMP-072 was clearly distinct from typical competitive antagonists, since it was able to act as a silent agonist. It synergizes with the allosteric modulator PNU-120596, and subsequently activates desensitized alpha 7nAChR. However, PMP-072 was less efficacious than PMP-311 at both channel activation and desensitization, suggesting that both conducting and non-conducting states maybe of importance in driving an anti-inflammatory response. Finally, we found that the anti-arthritic effect can be observed despite limited penetration of the central nervous system. Conclusions These data provide direct evidence that the alpha 7nAChR in immune cells does not require typical ion channel activation to exert its antiinflammatory effects.	[van Maanen, Marjolein A.; Koopman, Frieda A.; Koepke, Jessica; Bevaart, Lisette; Tak, Paul P.; Vervoordeldonk, Margriet J.] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Papke, Roger L.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Koepke, Jessica; Bevaart, Lisette; Vervoordeldonk, Margriet J.] Arthrogen BV, Amsterdam, Netherlands; [Clark, Roger; Lamppu, Diana; LaRosa, Gregory J.] Cornerstone Therapeut Inc, Cary, NC USA; [Elbaum, Daniel] DEC Associates LLC, Newton, MA USA	University of Amsterdam; Academic Medical Center Amsterdam; State University System of Florida; University of Florida	Vervoordeldonk, MJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.j.vervoordeldonk@amc.uva.nl			Dutch Arthritis Association [NR 05-1-102)]; NIH [GM57481]; Cornerstone Therapeutics Inc.; SetPoint Medical and Critical Therapeutics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057481] Funding Source: NIH RePORTER	Dutch Arthritis Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornerstone Therapeutics Inc.; SetPoint Medical and Critical Therapeutics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Dutch Arthritis Association (NR 05-1-102), a NIH grant GM57481 and a research award from Cornerstone Therapeutics Inc. PPT received research support from SetPoint Medical and Critical Therapeutics. The funders SetPoint Medical and Critical Therapeutics had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors Roger Clark, Diana Lamppu and Gregory J. LaRosa were employed by Cornerstone Therapeutics, Inc. during the course of the study. Co-authors Jessica Koepke, Lisette Bevaart and Margriet J. Vervoordeldonk are employed by Arthrogen BV. Co-author Daniel Elbaum is employed by DEC Associates, LLC. Cornerstone Therapeutics Inc., Arthrogen BV. and DEC Associates, LLC provided support in the form of salaries for authors RC, DL, GJLR, JK, LB, MJV and DE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altavilla D, 2006, SHOCK, V25, P500, DOI 10.1097/01.shk.0000209539.91553.82; Arredondo J, 2007, LIFE SCI, V80, P2191, DOI 10.1016/j.lfs.2007.01.013; Bernik TR, 2002, J VASC SURG, V36, P1231, DOI 10.1067/mva.2002.129643; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Borovikova LV, 2000, AUTON NEUROSCI-BASIC, V85, P141, DOI 10.1016/S1566-0702(00)00233-2; Briggs CA, 2009, BRIT J PHARMACOL, V158, P1486, DOI 10.1111/j.1476-5381.2009.00426.x; Chojnacka K, 2013, BIOORG MED CHEM LETT, V23, P4145, DOI 10.1016/j.bmcl.2013.05.039; Clark R, 2007, NOVEL PIPERAZINES PH; Cloez-Tayarani I, 2007, J LEUKOCYTE BIOL, V81, P599, DOI 10.1189/jlb.0906544; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Feldmann M, 2008, IMMUNOL REV, V223, P7, DOI 10.1111/j.1600-065X.2008.00626.x; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Ghia JE, 2006, GASTROENTEROLOGY, V131, P1122, DOI 10.1053/j.gastro.2006.08.016; Giebelen IAJ, 2007, SHOCK, V28, P700, DOI 10.1097/shk.0b013e318054dd89; Giebelen IAJ, 2007, SHOCK, V27, P443, DOI 10.1097/01.shk.0000245016.78493.bb; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Halevi S, 2003, J BIOL CHEM, V278, P34411, DOI 10.1074/jbc.M300170200; Horenstein NA, 2008, MOL PHARMACOL, V74, P1496, DOI 10.1124/mol.108.048892; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Jull BA, 2001, J CANCER RES CLIN, V127, P707; Kageyama-Yahara N, 2008, BIOCHEM BIOPH RES CO, V377, P321, DOI 10.1016/j.bbrc.2008.10.004; Kop EN, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2049; Lopez-Hernandez GY, 2009, MOL PHARMACOL, V76, P652, DOI 10.1124/mol.109.056176; Marrero MB, 2009, BRAIN RES, V1256, P1, DOI 10.1016/j.brainres.2008.11.053; Papke RL, 1998, NEUROSCI LETT, V256, P163, DOI 10.1016/S0304-3940(98)00786-1; Papke RL, 2004, BIOORG MED CHEM LETT, V14, P1849, DOI 10.1016/j.bmcl.2003.09.104; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Papke RL, 2014, J PHARM EXP THER; Papke RL, 2009, J PHARMACOL EXP THER, V329, P791, DOI 10.1124/jpet.108.150151; Parrish WR, 2008, MOL MED, V14, P567, DOI 10.2119/2008-00079.Parrish; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Peng C, 2013, MOL PHARMACOL, V84, P459, DOI 10.1124/mol.113.086462; Shimohama S, 2009, BIOL PHARM BULL, V32, P332, DOI 10.1248/bpb.32.332; Suzuki T, 2006, J NEUROSCI RES, V83, P1461, DOI 10.1002/jnr.20850; Tak PP, 2000, ARTHRITIS RHEUM-US, V43, P2619, DOI 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V; Thomsen MS, 2012, J NEUROIMMUNOL, V251, P65, DOI 10.1016/j.jneuroim.2012.07.006; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; VAN HJ, 2004, ARTHRITIS RES THER, V6, pR239, DOI DOI 10.1186/AR1165; van Holten J, 2004, ARTHRITIS RES THER, V6, pR239, DOI 10.1186/ar1165; van Maanen MA, 2010, ANN RHEUM DIS, V69, P1717, DOI 10.1136/ard.2009.118554; van Maanen MA, 2009, NAT REV RHEUMATOL, V5, P229, DOI 10.1038/nrrheum.2009.31; van Maanen MA, 2009, ARTHRITIS RHEUM-US, V60, P1272, DOI 10.1002/art.24470; van Maanen MA, 2009, ARTHRITIS RHEUM-US, V60, P114, DOI 10.1002/art.24177; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; Villiger Y, 2002, J NEUROIMMUNOL, V126, P86, DOI 10.1016/S0165-5728(02)00057-7; Waldburger JM, 2008, ARTHRITIS RHEUM, V58, P3439, DOI 10.1002/art.23987; Williams DK, 2012, MOL PHARMACOL, V82, P746, DOI 10.1124/mol.112.080317; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Xiao YX, 2006, MOL PHARMACOL, V70, P1454, DOI 10.1124/mol.106.027318; Yoshida S, 2005, J MED CHEM, V48, P7075, DOI 10.1021/jm050209t	52	29	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116227	10.1371/journal.pone.0116227	http://dx.doi.org/10.1371/journal.pone.0116227			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617631	Green Published, Green Submitted, gold			2022-12-26	WOS:000350336000011
J	Rivera-Hoyos, CM; Morales-Alvarez, ED; Poveda-Cuevas, SA; Reyes-Guzman, EA; Poutou-Pinales, RA; Reyes-Montano, EA; Pedroza-Rodriguez, AM; Rodriguez-Vazquez, R; Cardozo-Bernal, AM				Rivera-Hoyos, Claudia M.; Morales-Alvarez, Edwin David; Poveda-Cuevas, Sergio Alejandro; Reyes-Guzman, Edwin Alfredo; Poutou-Pinales, Raul A.; Reyes-Montano, Edgar Antonio; Pedroza-Rodriguez, Aura Marina; Rodriguez-Vazquez, Refugio; Cardozo-Bernal, Angela M.			Computational Analysis and Low-Scale Constitutive Expression of Laccases Synthetic Genes GlLCC1 from Ganoderma lucidum and POXA 1B from Pleurotus ostreatus in Pichia pastoris	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; TRAMETES-VERSICOLOR; SACCHAROMYCES-CEREVISIAE; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; SCORING FUNCTION; MODEL QUALITY; OPTIMIZATION; DEGRADATION; SUBSTRATE	Lacasses are multicopper oxidases that can catalyze aromatic and non-aromatic compounds concomitantly with reduction of molecular oxygen to water. Fungal laccases have generated a growing interest due to their biotechnological potential applications, such as lignocellulosic material delignification, biopulping and biobleaching, wastewater treatment, and transformation of toxic organic pollutants. In this work we selected fungal genes encoding for laccase enzymes GlLCC1 in Ganoderma lucidum and POXA 1B in Pleurotus ostreatus. These genes were optimized for codon use, GC content, and regions generating secondary structures. Laccase proposed computational models, and their interaction with ABTS [2, 2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid)] substrate was evaluated by molecular docking. Synthetic genes were cloned under the control of Pichia pastoris glyceraldehyde-3-phosphate dehydrogenase (GAP) constitutive promoter. P. pastoris X-33 was transformed with pGAPZ alpha A-LaccGluc-Stop and pGAPZ alpha A-LaccPost-Stop constructs. Optimization reduced GC content by 47 and 49% for LaccGluc-Stop and LaccPost-Stop genes, respectively. A codon adaptation index of 0.84 was obtained for both genes. 3D structure analysis using SuperPose revealed LaccGluc-Stop is similar to the laccase crystallographic structure 1GYC of Trametes versicolor. Interaction analysis of the 3D models validated through ABTS, demonstrated higher substrate affinity for LaccPost-Stop, in agreement with our experimental results with enzymatic activities of 451.08 +/- 6.46 UL-1 compared to activities of 0.13 +/- 0.028 UL-1 for LaccGluc-Stop. This study demonstrated that G. lucidum GlLCC1 and P. ostreatus POXA 1B gene optimization resulted in constitutive gene expression under GAP promoter and alpha-factor leader in P. pastoris. These are important findings in light of recombinant enzyme expression system utility for environmentally friendly designed expression systems, because of the wide range of substrates that laccases can transform. This contributes to a great gamut of products in diverse settings: industry, clinical and chemical use, and environmental applications.	[Rivera-Hoyos, Claudia M.; Poutou-Pinales, Raul A.; Cardozo-Bernal, Angela M.] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Lab Biotecnol Mol,GBAI, Bogota, DC, Colombia; [Morales-Alvarez, Edwin David; Pedroza-Rodriguez, Aura Marina] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Lab Microbiol Ambiental & Suelos,GBAI, Bogota, DC, Colombia; [Morales-Alvarez, Edwin David] Univ Caldas, Fac Ciencias Exactas & Nat, Grupo Invest Genet Biodiversidad & Manejo Ecosist, Dept Quim, Manizales Caldas, Colombia; [Poveda-Cuevas, Sergio Alejandro] UPTC, Fac Ciencias Basicas, Escuela Ciencias Biol, Tunja Boyaca, Colombia; [Reyes-Guzman, Edwin Alfredo; Pedroza-Rodriguez, Aura Marina] Univ Nacl Colombia UNAL, Fac Ciencias, Dept Quim, Bogota, DC, Colombia; [Rodriguez-Vazquez, Refugio] IPN, Ctr Invest & Estudios Avanzados, Dept Biotecnol & Bioingn, Mexico City, DF, Mexico	Pontificia Universidad Javeriana; Pontificia Universidad Javeriana; Universidad de Caldas; Universidad Pedagogica y Tecnologica de Colombia (UPTC); Universidad Nacional de Colombia; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Poutou-Pinales, RA (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Lab Biotecnol Mol,GBAI, Bogota, DC, Colombia.	rpoutou@javeriana.edu.co; eareyesm@unal.edu.co; apedroza@javeriana.edu.co	Poutou-Piñales, Raúl A./AAF-2962-2019; Marina, Aura/AAF-7657-2019; Poveda Cuevas, Sergio Alejandro Alejandro Poveda/AAX-1132-2021; Rivera-Hoyos, Claudia M./AAF-2954-2019	Poutou-Piñales, Raúl A./0000-0001-8841-2357; Poveda Cuevas, Sergio Alejandro Alejandro Poveda/0000-0002-3087-6674; Morales-Alvarez, Edwin David/0000-0003-2622-2130; Rivera-Hoyos, Claudia Marcela/0000-0003-0915-8229; Reyes Montano, Edgar Antonio/0000-0003-0921-2125	Pontificia Universidad Javeriana, Bogota, D.C. Colombia [00004334, 00004335]; Universidad Nacional de Colombia, Bogota, D.C. Colombia [DIB 12929]	Pontificia Universidad Javeriana, Bogota, D.C. Colombia; Universidad Nacional de Colombia, Bogota, D.C. Colombia	This work was supported by Pontificia Universidad Javeriana, Bogota, D.C. Colombia (Grants 00004334 and 00004335) and by Universidad Nacional de Colombia, Bogota, D.C. Colombia (grant DIB 12929). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Barragan CE, 2005, NOVA, V3, P80; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Bertrand T, 2002, BIOCHEMISTRY-US, V41, P7325, DOI 10.1021/bi0201318; Bleve G, 2008, APPL MICROBIOL BIOT, V79, P731, DOI 10.1007/s00253-008-1479-1; Bulter T, 2003, APPL ENVIRON MICROB, V69, P987, DOI 10.1128/AEM.69.2.987-995.2003; Cambria MT, 2010, J BIOMOL STRUCT DYN, V27, P501, DOI 10.1080/07391102.2010.10507334; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cordoba-Ruiz HA, 2009, AFR J BIOTECHNOL, V8, P1786; Doran PM, 1998, PRINCIPIOS INGENIERI; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Enguita FJ, 2004, J BIOL CHEM, V279, P23472, DOI 10.1074/jbc.M314000200; Fernández Jorge Andrés, 2009, Rev. colomb. biotecnol, V11, P59; Forgacs E, 2004, ENVIRON INT, V30, P953, DOI 10.1016/j.envint.2004.02.001; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Guo M, 2006, APPL MICROBIOL BIOT, V71, P848, DOI 10.1007/s00253-005-0210-8; Helles G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-338; Henao-Jaramillo LM, 2011, INT BIOTECHNOL COLOR, V1, P9; Huang H, 2008, APPL MICROBIOL BIOT, V78, P95, DOI 10.1007/s00253-007-1290-4; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Joo SS, 2008, MOL CELLS, V25, P112; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Ko EM, 2001, APPL MICROBIOL BIOT, V57, P98, DOI 10.1007/s002530100727; Landazuri P, 2009, AFR J BIOTECHNOL, V8, P2871; Loera Corral O., 2006, Advances in agricultural and food biotechnology, P323; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Morozova V, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1136, DOI 10.1134/S0006297907100112; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; O'Callaghan J, 2002, J IND MICROBIOL BIOT, V29, P55, DOI 10.1038/sj.jim.7000268; Palmieri G, 1997, J BIOL CHEM, V272, P31301, DOI 10.1074/jbc.272.50.31301; Pedroza AM, 2007, CHEMOSPHERE, V67, P793, DOI 10.1016/j.chemosphere.2006.10.015; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Piscitelli A, 2005, APPL MICROBIOL BIOT, V69, P428, DOI 10.1007/s00253-005-0004-z; Piscitelli Alessandra, 2010, Bioeng Bugs, V1, P252, DOI 10.4161/bbug.1.4.11438; Plummer DT, 1981, INTRO BIOQUIMICA PRA; Poutou-Pinales RA, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue3-fulltext-8; Poutou-Pinales RA, 2010, AFR J BIOTECHNOL, V9, P2173; Prasad NK, 2011, J MOL MODEL, P1; Rivera-Hoyos CM, 2013, FUNGAL BIOL REV, V27, P67, DOI 10.1016/j.fbr.2013.07.001; Robert V, 2011, CURR GENOMICS, V12, P123, DOI 10.2174/138920211795564340; Rodgers CJ, 2010, TRENDS BIOTECHNOL, V28, P63, DOI 10.1016/j.tibtech.2009.11.001; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Sakurai T, 2007, CELL MOL LIFE SCI, V64, P2642, DOI 10.1007/s00018-007-7183-y; Sambrook J., 2001, MOL CLONING LAB MANU; Santo M, 2013, INT BIODETER BIODEGR, V84, P204, DOI 10.1016/j.ibiod.2012.03.001; Sun J, 2012, MOL BIOL REP, V39, P3807, DOI 10.1007/s11033-011-1158-7; Suresh PS, 2008, J MOL GRAPH MODEL, V26, P845, DOI 10.1016/j.jmgm.2007.05.005; Theerachat M, 2012, BIORESOURCE TECHNOL, V125, P267, DOI 10.1016/j.biortech.2012.07.117; Tinoco R, 2001, LETT APPL MICROBIOL, V32, P331, DOI 10.1046/j.1472-765X.2001.00913.x; Velu C, 2011, J BIOPROCESSING BIOT, V1; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Xie HF, 2013, J MICROBIOL BIOTECHN, V23, P864, DOI 10.4014/jmb.1212.12057; Yu GC, 2006, PROCESS BIOCHEM, V41, P1987, DOI 10.1016/j.procbio.2006.04.008	62	28	30	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116524	10.1371/journal.pone.0116524	http://dx.doi.org/10.1371/journal.pone.0116524			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611746	gold, Green Published, Green Submitted			2022-12-26	WOS:000348562900017
J	Newman, SJ; Easteal, S				Newman, Saul J.; Easteal, Simon			A New Metric of Inclusive Fitness Predicts the Human Mortality Profile	PLOS ONE			English	Article							POSTREPRODUCTIVE LIFE-SPAN; CHILDREN; GROWTH; RATES	Biological species have evolved characteristic patterns of age-specific mortality across their life spans. If these mortality profiles are shaped by natural selection they should reflect underlying variation in the fitness effect of mortality with age. Direct fitness models, however, do not accurately predict the mortality profiles of many species. For several species, including humans, mortality rates vary considerably before and after reproductive ages, during life-stages when no variation in direct fitness is possible. Variation in mortality rates at these ages may reflect indirect effects of natural selection acting through kin. To test this possibility we developed a new two-variable measure of inclusive fitness, which we term the extended genomic output or EGO. Using EGO, we estimate the inclusive fitness effect of mortality at different ages in a small hunter-gatherer population with a typical human mortality profile. EGO in this population predicts 90% of the variation in age-specific mortality. This result represents the first empirical measurement of inclusive fitness of a trait in any species. It shows that the pattern of human survival can largely be explained by variation in the inclusive fitness cost of mortality at different ages. More generally, our approach can be used to estimate the inclusive fitness of any trait or genotype from population data on birth dates and relatedness.	[Newman, Saul J.; Easteal, Simon] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Newman, SJ (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	saul.newman@anu.edu.au		Newman, Saul/0000-0001-9841-1518; Easteal, Simon/0000-0002-0462-502X				CAREY JR, 1992, SCIENCE, V258, P457, DOI 10.1126/science.1411540; Caswell, 2000, MATRIX POPULATION MO; CHARLESWORTH B, 1993, GENETICA, V91, P11, DOI 10.1007/BF01435984; COALE AJ, 1957, POP STUD-J DEMOG, V11, P92, DOI 10.2307/2172513; Cohen AA, 2004, BIOL REV, V79, P733, DOI 10.1017/S1464793103006432; EULER L, 1760, GEN RES MORTALITY MU, P1; Fisher RA, 1930, GENETICAL THEORY NAT; Haldane J.B.S., 1941, NEW PATHS GENETICS; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; HEADLAND J, 2011, AGTA DEMOGRAPHIC DAT, P89023; Jones JH, 2009, EVOL HUM BEHAV, V30, P305, DOI 10.1016/j.evolhumbehav.2009.01.005; Jones OR, 2014, NATURE, V505, P169, DOI 10.1038/nature12789; Lahdenpera M, 2004, NATURE, V428, P178, DOI 10.1038/nature02367; Lotka AJ, 1907, SCIENCE, V26, P21, DOI 10.1126/science.26.653.21-a; Lotka AJ, 1907, AM J SCI, V24, P199; MEDAWAR PB, 1957, UNIQUENESS INDIVIDUA, V36, P89023; RIFFE T, 2013, LOTKA, P89023; Roff DA, 2008, J GENET, V87, P339, DOI 10.1007/s12041-008-0056-9; Rose MR, 2008, J GENET, V87, P363, DOI 10.1007/s12041-008-0059-6; Sear R, 2000, P ROY SOC B-BIOL SCI, V267, P1641, DOI 10.1098/rspb.2000.1190; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; United Nations, 2011, WORLD POP PROSP 2010; Vaupel JW, 2004, THEOR POPUL BIOL, V65, P339, DOI 10.1016/j.tpb.2003.12.003; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Yang QH, 1997, GENET EPIDEMIOL, V14, P493, DOI 10.1002/(SICI)1098-2272(1997)14:5<493::AID-GEPI4>3.0.CO;2-2	28	1	1	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0117019	10.1371/journal.pone.0117019	http://dx.doi.org/10.1371/journal.pone.0117019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607654	Green Submitted, Green Published, gold			2022-12-26	WOS:000348205300047
J	Huang, B; Xu, S; Miao, AJ; Xiao, L; Yang, LY				Huang, Bin; Xu, Shen; Miao, Ai-Jun; Xiao, Lin; Yang, Liu-Yan			Cadmium Toxicity to Microcystis aeruginosa PCC 7806 and Its Microcystin-Lacking Mutant	PLOS ONE			English	Article							HEAVY-METAL DETOXIFICATION; CHLAMYDOMONAS-REINHARDTII; POLYPHOSPHATE METABOLISM; INORGANIC POLYPHOSPHATE; MARINE-PHYTOPLANKTON; NUTRIENT LIMITATION; DIFFERENT PHOSPHATE; COPPER TOXICITY; GREEN-ALGAE; LAKE TAIHU	The adverse effects of microcystin (MC) produced by cyanobacteria have drawn considerable attention from the public. Yet it remains unclear whether MC confers any benefits to the cyanobacteria themselves. One suggested function of MC is complexation, which may influence the bioaccumulation and toxicity of trace metals. To test this hypothesis, we examined Cd toxicity to wild-type Microcystis aeruginosa PCC 7806 (WT) and its MC-lacking mutant (MT) under nutrient-enriched (+ NP), phosphorus-limited (-P), and nitrogen-limited (-N) conditions. The accumulation of Cd and the biochemical parameters associated with its detoxification [total phosphorus (TP), inorganic polyphosphate (Poly-P), and glutathione (GSH) in the cells as well as intra-and extra-cellular carbohydrates] were quantified. Although the -P cyanobacteria accumulated less Cd than their + NP and -N counterparts, the different nutrient-conditioned cyanobacteria were similarly inhibited by similar free ion concentration of Cd in the medium ([Cd2+](F)). Such good toxicity predictability of [Cd2+](F) was ascribed to the synchronous decrease in the intracellular concentrations of Cd and TP. Nevertheless, Cd toxicity was still determined by the intracellular Cd to phosphorus ratio (Cd/P), in accordance with what has been reported in the literature. On the other hand, the concentrations of TP, Poly-P, and carbohydrates went up, but GSH concentration dropped down with the enhancement of [Cd2+](F), indicating their association with Cd detoxification. Although the inactivation of MC peptide synthetase gene had some nutrient and Cd concentration dependent effects on the parameters above, both cyanobacterial strains showed the same Cd accumulation ability and displayed similar Cd sensitivity. These results suggest that MC cannot affect metal toxicity either by regulating metal accumulation or by altering the detoxification ability of the cyanobacteria. Other possible functions of MC need to be further investigated.					Huang, Bin/A-3639-2017; liu, yang/HHY-8583-2022; yang, liu/GVU-8760-2022	Huang, Bin/0000-0002-1025-9775; 	National Natural Science Foundation of China [21237001, 41001338, 41271486]; Agricultural Science and Technology Independent Innovation Foundation of Jiangsu Province [CX(14)2094]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Independent Innovation Foundation of Jiangsu Province	This research was funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (grant numbers: 21237001, 41001338, and 41271486) and by the Agricultural Science and Technology Independent Innovation Foundation of Jiangsu Province (http://home.jaas.ac.cn/) (grant number: CX(14)2094) to AJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNER BA, 1995, LIMNOL OCEANOGR, V40, P649, DOI 10.4319/lo.1995.40.4.0649; ALLEN MM, 1968, J GEN MICROBIOL, V51, P199, DOI 10.1099/00221287-51-2-199; [Anonymous], 1994, METAL SPECIATION BIO; Babica P, 2006, J PHYCOL, V42, P9, DOI 10.1111/j.1529-8817.2006.00176.x; Cobbett CS, 2000, PLANT PHYSIOL, V123, P825, DOI 10.1104/pp.123.3.825; Diaz JM, 2011, INORGANIC POLYPHOSPH; Dittmann E, 1997, MOL MICROBIOL, V26, P779, DOI 10.1046/j.1365-2958.1997.6131982.x; Eixler S, 2005, HYDROBIOLOGIA, V533, P135, DOI 10.1007/s10750-004-2406-9; Frausto da Silva J. J. R., 1993, BIOL CHEM ELEMENTS I, DOI 10.1021/ed069pA326.1; Freire-Nordi CS, 2005, PROCESS BIOCHEM, V40, P2215, DOI 10.1016/j.procbio.2004.09.003; Fujii M, 2011, APPL ENVIRON MICROB, V77, P7068, DOI 10.1128/AEM.05270-11; Harada E, 2004, PHYTOCHEMISTRY, V65, P3179, DOI 10.1016/j.phytochem.2004.09.017; Hassinen VH, 2011, PLANT BIOLOGY, V13, P225, DOI 10.1111/j.1438-8677.2010.00398.x; Haye JM, 2006, ENVIRON CHEM, V3, P172, DOI 10.1071/EN06015; Hesse K, 2001, FEMS MICROBIOL ECOL, V37, P39, DOI 10.1111/j.1574-6941.2001.tb00851.x; HOAGLAND KD, 1993, J PHYCOL, V29, P537, DOI 10.1111/j.0022-3646.1993.00537.x; Kaebernick M, 2000, APPL ENVIRON MICROB, V66, P3387, DOI 10.1128/AEM.66.8.3387-3392.2000; Keyhani S, 1996, MICROBIOS, V88, P105; Kilham SS, 1997, FRESHWATER BIOL, V38, P591, DOI 10.1046/j.1365-2427.1997.00231.x; Kim IG, 2002, BIOTECHNOL LETT, V24, P1299, DOI 10.1023/A:1019812202099; KORNBERG A, 1995, J BACTERIOL, V177, P491, DOI 10.1128/jb.177.3.491-496.1995; Kulaev I, 1999, J BIOSCI BIOENG, V88, P111, DOI 10.1016/S1389-1723(99)80189-3; Lavoie M, 2009, AQUAT TOXICOL, V92, P65, DOI 10.1016/j.aquatox.2008.12.007; Lombardi AT, 1998, PHYCOLOGIA, V37, P34, DOI 10.2216/i0031-8884-37-1-34.1; Lynn SG, 2000, J PHYCOL, V36, P510, DOI 10.1046/j.1529-8817.2000.98251.x; Mason A.Z., 1995, METAL SPECIATION BIO; McIntyre AM, 2013, CHEMOSPHERE, V90, P620, DOI 10.1016/j.chemosphere.2012.08.057; Miao AJ, 2007, ENVIRON SCI TECHNOL, V41, P1777, DOI 10.1021/es0613963; Miao AJ, 2006, MAR ECOL PROG SER, V318, P141, DOI 10.3354/meps318141; Miao AJ, 2006, AQUAT TOXICOL, V78, P114, DOI 10.1016/j.aquatox.2006.02.008; Miao AJ, 2009, ENVIRON POLLUT, V157, P3034, DOI 10.1016/j.envpol.2009.05.047; Miao AJ, 2004, MAR ECOL PROG SER, V275, P103, DOI 10.3354/meps275103; MYKLESTAD S, 1972, Journal of Experimental Marine Biology and Ecology, V9, P125, DOI 10.1016/0022-0981(72)90041-X; MYKLESTAD SM, 1995, SCI TOTAL ENVIRON, V165, P155, DOI 10.1016/0048-9697(95)04549-G; Nishikawa K, 2003, FEMS MICROBIOL ECOL, V44, P253, DOI 10.1016/S0168-6496(03)00049-7; Ou-Yang HL, 2013, ENVIRON TOXICOL CHEM, V32, P2762, DOI 10.1002/etc.2362; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Perales-Vela HV, 2006, CHEMOSPHERE, V64, P1, DOI 10.1016/j.chemosphere.2005.11.024; Pistocchi R, 2000, J APPL PHYCOL, V12, P469, DOI 10.1023/A:1008162812651; Ramanan S, 2000, J CHROMATOGR A, V883, P103, DOI 10.1016/S0021-9673(00)00378-2; Rijstenbil JW, 1998, AQUAT TOXICOL, V42, P187, DOI 10.1016/S0166-445X(97)00091-X; Salgado LT, 2005, PROTOPLASMA, V225, P123, DOI 10.1007/s00709-004-0066-2; Satoh M, 1999, J PHYCOL, V35, P989, DOI 10.1046/j.1529-8817.1999.3550989.x; Shi XL, 2003, MICROBIOL RES, V158, P345, DOI 10.1078/0944-5013-00214; Song LR, 2007, WATER RES, V41, P2853, DOI 10.1016/j.watres.2007.02.013; Tsuji N, 2004, BIOCHEM BIOPH RES CO, V315, P751, DOI 10.1016/j.bbrc.2004.01.122; TWISS MR, 1992, J PHYCOL, V28, P291, DOI 10.1111/j.0022-3646.1992.00291.x; Underwood GJC, 2004, J PHYCOL, V40, P293, DOI 10.1111/j.1529-8817.2004.03076.x; UTKILEN H, 1995, APPL ENVIRON MICROB, V61, P797, DOI 10.1128/AEM.61.2.797-800.1995; Wang NX, 2013, WATER RES, V47, P2497, DOI 10.1016/j.watres.2013.02.034; Wang NX, 2012, WATER RES, V46, P369, DOI 10.1016/j.watres.2011.10.035; Wang WX, 2001, ENVIRON POLLUT, V111, P233, DOI 10.1016/S0269-7491(00)00071-3; Wang WX, 2005, ENVIRON TOXICOL CHEM, V24, P161, DOI 10.1897/04-125R.1; Wang WX, 2006, ENVIRON POLLUT, V142, P303, DOI 10.1016/j.envpol.2005.10.005; Wei LP, 2003, ENVIRON SCI TECHNOL, V37, P3609, DOI 10.1021/es0340026; Xu S, 2013, ECOTOX ENVIRON SAFE, V94, P190, DOI 10.1016/j.ecoenv.2013.05.006; Yu RQ, 2004, AQUAT MICROB ECOL, V35, P163, DOI 10.3354/ame035163; Yu RQ, 2004, ENVIRON POLLUT, V129, P443, DOI 10.1016/j.envpol.2003.11.013; Zeng J, 2009, ENVIRON TOXICOL CHEM, V28, P1618, DOI 10.1897/08-639.1; Zeng J, 2009, AQUAT TOXICOL, V91, P212, DOI 10.1016/j.aquatox.2008.11.004; ZHANG WX, 1994, ENVIRON SCI TECHNOL, V28, P1577, DOI 10.1021/es00058a007; Zhou WB, 2006, CHEMOSPHERE, V65, P1738, DOI 10.1016/j.chemosphere.2006.04.078	62	9	9	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116659	10.1371/journal.pone.0116659	http://dx.doi.org/10.1371/journal.pone.0116659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590420	Green Submitted, gold, Green Published			2022-12-26	WOS:000350679400020
J	Al Khamici, H; Brown, LJ; Hossain, KR; Hudson, AL; Sinclair-Burton, AA; Ng, JPM; Daniel, EL; Hare, JE; Cornell, BA; Curmi, PMG; Davey, MW; Valenzuela, SM				Al Khamici, Heba; Brown, Louise J.; Hossain, Khondker R.; Hudson, Amanda L.; Sinclair-Burton, Alxcia A.; Jane Phui Mun Ng; Daniel, Elizabeth L.; Hare, Joanna E.; Cornell, Bruce A.; Curmi, Paul M. G.; Davey, Mary W.; Valenzuela, Stella M.			Members of the Chloride Intracellular Ion Channel Protein Family Demonstrate Glutaredoxin-Like Enzymatic Activity	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; CRYSTAL-STRUCTURE; MOLECULAR-CLONING; ETHACRYNIC-ACID; MEMBRANE INTERACTION; THIOREDOXIN SYSTEMS; ACTIN CYTOSKELETON; SOLUBLE FORM; CELL-CYCLE; CLIC1	The Chloride Intracellular Ion Channel (CLIC) family consists of six evolutionarily conserved proteins in humans. Members of this family are unusual, existing as both monomeric soluble proteins and as integral membrane proteins where they function as chloride selective ion channels, however no function has previously been assigned to their soluble form. Structural studies have shown that in the soluble form, CLIC proteins adopt a glutathione S-transferase (GST) fold, however, they have an active site with a conserved glutaredoxin monothiol motif, similar to the omega class GSTs. We demonstrate that CLIC proteins have glutaredoxin-like glutathione-dependent oxidoreductase enzymatic activity. CLICs 1, 2 and 4 demonstrate typical glutaredoxin-like activity using 2-hydroxyethyl disulfide as a substrate. Mutagenesis experiments identify cysteine 24 as the catalytic cysteine residue in CLIC1, which is consistent with its structure. CLIC1 was shown to reduce sodium selenite and dehydroascorbate in a glutathione-dependent manner. Previous electrophysiological studies have shown that the drugs IAA-94 and A9C specifically block CLIC channel activity. These same compounds inhibit CLIC1 oxidoreductase activity. This work for the first time assigns a functional activity to the soluble form of the CLIC proteins. Our results demonstrate that the soluble form of the CLIC proteins has an enzymatic activity that is distinct from the channel activity of their integral membrane form. This CLIC enzymatic activity may be important for protecting the intracellular environment against oxidation. It is also likely that this enzymatic activity regulates the CLIC ion channel function.	[Al Khamici, Heba; Hossain, Khondker R.; Hudson, Amanda L.; Sinclair-Burton, Alxcia A.; Jane Phui Mun Ng; Davey, Mary W.; Valenzuela, Stella M.] Univ Technol Sydney, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia; [Valenzuela, Stella M.] Univ Technol Sydney, Ctr Hlth Technol, Sydney, NSW 2007, Australia; [Brown, Louise J.; Daniel, Elizabeth L.; Hare, Joanna E.] Macquarie Univ, Dept Chem & Bimolecular Sci, Sydney, NSW 2109, Australia; [Cornell, Bruce A.] Roseville, Surg Diagnost, Sydney, NSW 2069, Australia; [Curmi, Paul M. G.] Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia; [Curmi, Paul M. G.] St Vincents Hosp, Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Hossain, Khondker R.] Australian Nucl Sci & Technol Org, Bragg Inst, Sydney, NSW 2234, Australia	University of Technology Sydney; University of Technology Sydney; Macquarie University; University of New South Wales Sydney; St Vincents Hospital Sydney; Australian Nuclear Science & Technology Organisation	Valenzuela, SM (corresponding author), Univ Technol Sydney, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia.	Stella.Valenzuela@uts.edu.au	Valenzuela, Stella/R-6387-2019; Curmi, Paul/G-7185-2011; Hossain, Khondker/C-1814-2019; Hossain, Khondker Rufaka/AAR-6301-2020	Valenzuela, Stella/0000-0001-5934-6047; Curmi, Paul/0000-0001-5762-7638; Hossain, Khondker/0000-0003-4506-1491; Hossain, Khondker Rufaka/0000-0003-4506-1491; Brown, Louise/0000-0001-8592-2431; cornell, bruce/0000-0003-4166-3241	Centre for Health Technologies, University of Technology Sydney; Australian Research Council [LP120200078]; Australian Institute of Nuclear Science and Engineering (AINSE)	Centre for Health Technologies, University of Technology Sydney; Australian Research Council(Australian Research Council); Australian Institute of Nuclear Science and Engineering (AINSE)	Funding: The authors thank the following organisations for financial support of this research: the Centre for Health Technologies, University of Technology Sydney (funding support to SMV); the Australian Research Council (grant LP120200078 to SMV and BAC) and the Australian Institute of Nuclear Science and Engineering (AINSE Award to SMV, HA, KRH). ARC website URL: http://www.arc.gov.au/; AINSE website URL: http://www.ainse.edu.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson HJ, 2009, BIOCHEMISTRY-US, V48, P11108, DOI 10.1021/bi901180v; Berryman M, 2000, MOL BIOL CELL, V11, P1509, DOI 10.1091/mbc.11.5.1509; BJORNSTEDT M, 1994, J BIOL CHEM, V269, P29382; BJORNSTEDT M, 1995, METHOD ENZYMOL, V252, P209; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Board PG, 2004, INT J BIOCHEM CELL B, V36, P1599, DOI 10.1016/j.biocel.2004.01.026; Bohman S, 2005, J BIOL CHEM, V280, P42397, DOI 10.1074/jbc.M506724200; BOOTH J, 1961, BIOCHEM J, V79, P516, DOI 10.1042/bj0790516; BROPHY PM, 1989, BIOCHEM J, V262, P939, DOI 10.1042/bj2620939; Caccuri AM, 2002, J BIOL CHEM, V277, P18777, DOI 10.1074/jbc.M201137200; CAMERON AD, 1995, STRUCTURE, V3, P717, DOI 10.1016/S0969-2126(01)00206-4; Chalothorn D, 2009, CIRC RES, V105, P89, DOI 10.1161/CIRCRESAHA.109.197145; Cheng NH, 2011, FEBS J, V278, P2525, DOI 10.1111/j.1742-4658.2011.08178.x; Cromer BA, 2002, EUR BIOPHYS J BIOPHY, V31, P356, DOI 10.1007/s00249-002-0219-1; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; DAS AK, 1988, BIOCHEM CELL BIOL, V66, P460, DOI 10.1139/o88-057; DEVAMANOHARAN PS, 1991, EXP EYE RES, V52, P563, DOI 10.1016/0014-4835(91)90057-L; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Duncan RR, 1997, J BIOL CHEM, V272, P23880, DOI 10.1074/jbc.272.38.23880; Edwards JC, 2010, KIDNEY INT, V78, P831, DOI 10.1038/ki.2010.238; Elter A, 2007, J BIOL CHEM, V282, P8786, DOI 10.1074/jbc.M607241200; Fujimura K, 2012, NUCLEIC ACIDS RES, V40, P8099, DOI 10.1093/nar/gks566; Gagnon LH, 2006, J NEUROSCI, V26, P10188, DOI 10.1523/JNEUROSCI.2166-06.2006; Goodchild SC, 2011, BIOCHEMISTRY-US, V50, P10887, DOI 10.1021/bi2012564; Goodchild SC, 2010, BIOCHEMISTRY-US, V49, P5278, DOI 10.1021/bi100111c; Goodchild SC, 2009, EUR BIOPHYS J BIOPHY, V39, P129, DOI 10.1007/s00249-009-0450-0; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Harrop SJ, 2001, J BIOL CHEM, V276, P44993, DOI 10.1074/jbc.M107804200; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Heiss NS, 1997, GENOMICS, V45, P224, DOI 10.1006/geno.1997.4922; Herrero E, 2007, CELL MOL LIFE SCI, V64, P1518, DOI 10.1007/s00018-007-6554-8; HOLMGREN A, 1988, BIOCHEM SOC T, V16, P95, DOI 10.1042/bst0160095; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Howell S, 1996, FEBS LETT, V390, P207, DOI 10.1016/0014-5793(96)00676-X; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jiang L, 2014, BBA-BIOMEMBRANES, V1838, P643, DOI 10.1016/j.bbamem.2013.05.025; Jiang LL, 2012, J CELL SCI, V125, P5479, DOI 10.1242/jcs.110072; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; KEEN JH, 1978, J BIOL CHEM, V253, P5654; LANDRY DW, 1989, SCIENCE, V244, P1469, DOI 10.1126/science.2472007; Littler DR, 2010, FEBS LETT, V584, P2093, DOI 10.1016/j.febslet.2010.01.027; Littler DR, 2005, FEBS J, V272, P4996, DOI 10.1111/j.1742-4658.2005.04909.x; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; Menon D, 2013, J BIOL CHEM, V288, P25769, DOI 10.1074/jbc.M113.487785; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Nishizawa T, 2000, J BIOL CHEM, V275, P11164, DOI 10.1074/jbc.275.15.11164; Oakley AJ, 1997, BIOCHEMISTRY-US, V36, P576, DOI 10.1021/bi962316i; Pastore A, 2012, EUR J PHARM SCI, V46, P279, DOI 10.1016/j.ejps.2012.03.010; PLOEMEN JHTM, 1993, XENOBIOTICA, V23, P913, DOI 10.3109/00498259309059418; Qian ZJ, 1999, J BIOL CHEM, V274, P1621, DOI 10.1074/jbc.274.3.1621; Qiu MR, 2010, GENESIS, V48, P127, DOI 10.1002/dvg.20590; Redhead C, 1997, MOL BIOL CELL, V8, P691, DOI 10.1091/mbc.8.4.691; Ronnov-Jessen L, 2002, AM J PATHOL, V161, P471, DOI 10.1016/S0002-9440(10)64203-4; Shanks RA, 2002, J BIOL CHEM, V277, P40973, DOI 10.1074/jbc.M112277200; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Singh H, 2010, FEBS LETT, V584, P2112, DOI 10.1016/j.febslet.2010.03.013; Sotirchos IM, 2009, FREE RADICAL BIO MED, V46, P579, DOI 10.1016/j.freeradbiomed.2008.11.009; Suh KS, 2004, J BIOL CHEM, V279, P4632, DOI 10.1074/jbc.M311632200; Tang ZX, 2013, MOL BIOL REP, V40, P5105, DOI 10.1007/s11033-013-2612-5; Tulk BM, 2002, AM J PHYSIOL-CELL PH, V282, pC1103, DOI 10.1152/ajpcell.00402.2001; Ulmasov B, 2009, AM J PATHOL, V174, P1084, DOI 10.2353/ajpath.2009.080625; Valenzuela SM, 2000, J PHYSIOL-LONDON, V529, P541, DOI 10.1111/j.1469-7793.2000.00541.x; Valenzuela SM, 1997, J BIOL CHEM, V272, P12575, DOI 10.1074/jbc.272.19.12575; Valenzuela SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056948; Vlamis-Gardikas A, 2002, METHOD ENZYMOL, V347, P286; Wallenberg M, 2010, BIOCHEM J, V429, P85, DOI 10.1042/BJ20100368; Warton K, 2002, J BIOL CHEM, V277, P26003, DOI 10.1074/jbc.M203666200; WELLS WW, 1990, J BIOL CHEM, V265, P15361	70	53	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2015	10	1							e115699	10.1371/journal.pone.0115699	http://dx.doi.org/10.1371/journal.pone.0115699			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4CF	25581026	Green Published, Green Submitted, gold			2022-12-26	WOS:000348169100002
J	Jang, SY; Shin, YK; Park, SY; Park, JY; Rha, SH; Kim, JK; Lee, HJ; Park, HT				Jang, So Young; Shin, Yoon Kyung; Park, So Young; Park, Joo Youn; Rha, Seo-Hee; Kim, Jong Kuk; Lee, Hye Jeong; Park, Hwan Tae			Autophagy Is Involved in the Reduction of Myelinating Schwann Cell Cytoplasm during Myelin Maturation of the Peripheral Nerve	PLOS ONE			English	Article							MICE; GROWTH; SYSTEM; NEUROPATHY; MTOR; AXON	Peripheral nerve myelination involves dynamic changes in Schwann cell morphology and membrane structure. Recent studies have demonstrated that autophagy regulates organelle biogenesis and plasma membrane dynamics. In the present study, we investigated the role of autophagy in the development and differentiation of myelinating Schwann cells during sciatic nerve myelination. Electron microscopy and biochemical assays have shown that Schwann cells remove excess cytoplasmic organelles during myelination through macroautophagy. Inhibition of autophagy via Schwann cell-specific removal of ATG7, an essential molecule for macroautophagy, using a conditional knockout strategy, resulted in abnormally enlarged abaxonal cytoplasm in myelinating Schwann cells that contained a large number of ribosomes and an atypically expanded endoplasmic reticulum. Small fiber hypermyelination and minor anomalous peripheral nerve functions are observed in this mutant. Rapamycin-induced suppression of mTOR activity during the early postnatal period enhanced not only autophagy but also developmental reduction of myelinating Schwann cells cytoplasm in vivo. Together, our findings suggest that autophagy is a regulatory mechanism of Schwann cells structural plasticity during myelination.	[Jang, So Young; Shin, Yoon Kyung; Park, Joo Youn; Park, Hwan Tae] Mitochondria Hub Regulat Ctr, Dept Physiol, Pusan, South Korea; [Park, So Young; Lee, Hye Jeong] Mitochondria Hub Regulat Ctr, Dept Pharmacol, Pusan, South Korea; [Rha, Seo-Hee] Dong A Univ, Coll Med, Dept Pathol, Pusan, South Korea; [Kim, Jong Kuk] Dong A Univ, Coll Med, Dept Neurol, Pusan, South Korea	Dong A University; Dong A University	Park, HT (corresponding author), Mitochondria Hub Regulat Ctr, Dept Physiol, Pusan, South Korea.	phwantae@dau.ac.kr	Kim, Jong Kuk/C-6426-2018; Kuk, Kim Jong/ABH-5221-2020	Kim, Jong Kuk/0000-0001-9204-3718; Kuk, Kim Jong/0000-0001-9204-3718	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2014-001483, 2014R1A2A2A01002566]	National Research Foundation of Korea (NRF) - Korean government (MSIP)	Funding: This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (2014-001483, 2014R1A2A2A01002566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhti M, 2014, CELL MOL LIFE SCI, V71, P1265, DOI 10.1007/s00018-013-1492-0; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Court FA, 2009, J NEUROSCI, V29, P3908, DOI 10.1523/JNEUROSCI.5672-08.2009; Feltri ML, 1999, ANN NY ACAD SCI, V883, P116, DOI 10.1111/j.1749-6632.1999.tb08574.x; Friedman LG, 2012, J NEUROSCI, V32, P7585, DOI 10.1523/JNEUROSCI.5809-11.2012; Garbay B, 2000, PROG NEUROBIOL, V61, P267, DOI 10.1016/S0301-0082(99)00049-0; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; LOW PA, 1976, J NEUROL SCI, V30, P343, DOI 10.1016/0022-510X(76)90139-8; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Pereira JA, 2012, TRENDS NEUROSCI, V35, P123, DOI 10.1016/j.tins.2011.11.006; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Sherman DL, 2012, J NEUROSCI, V32, P1817, DOI 10.1523/JNEUROSCI.4814-11.2012; Shin YK, 2010, GLIA, V58, P1961, DOI 10.1002/glia.21065; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; WEBSTER HD, 1971, J CELL BIOL, V48, P348, DOI 10.1083/jcb.48.2.348; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	20	32	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2015	10	1							e0116624	10.1371/journal.pone.0116624	http://dx.doi.org/10.1371/journal.pone.0116624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4CF	25581066	Green Published, Green Submitted, gold			2022-12-26	WOS:000348169100004
J	Yen, WY; Cai, B; Yang, JL; Zhang, L; Zeng, M; Tarbell, JM; Fu, BMM				Yen, Wanyi; Cai, Bin; Yang, Jinlin; Zhang, Lin; Zeng, Min; Tarbell, John M.; Fu, Bingmei M.			Endothelial Surface Glycocalyx Can Regulate Flow-Induced Nitric Oxide Production in Microvessels In Vivo	PLOS ONE			English	Article							FLUID SHEAR-STRESS; HEPARAN-SULFATE; NO PRODUCTION; HYDRAULIC CONDUCTIVITY; VASCULAR-PERMEABILITY; INTACT MICROVESSELS; CELL-ADHESION; TUMOR-CELLS; MECHANOTRANSDUCTION; ARTERIES	Due to its unique location, the endothelial surface glycocalyx ( ESG) at the luminal side of the microvessel wall may serve as a mechano-sensor and transducer of blood flow and thus regulate endothelial functions. To examine this role of the ESG, we used fluorescence microscopy to measure nitric oxide ( NO) production in post-capillary venules and arterioles of rat mesentery under reduced ( low) and normal ( high) flow conditions, with and without enzyme pretreatment to remove heparan sulfate ( HS) of the ESG and in the presence of an endothelial nitric oxide synthase ( eNOS) inhibitor, N-G-monomethyl-L-arginine ( L-NMMA). Rats ( SD, 250-300g) were anesthetized. The mesentery was gently taken out from the abdominal cavity and arranged on the surface of a glass coverslip for the measurement. An individual post-capillary venule or arteriole was cannulated and loaded for 45 min with 5 mu M 4, 5-Diaminofluorescein diacetate, a membrane permeable fluorescent indictor for NO, then the NO production was measured for similar to 10 min under a low flow (similar to 300 mu m/s) and for similar to 60 min under a high flow (similar to 1000 mu m/s). In the 15 min after switching to the high flow, DAF-2-NO fluorescence intensity increased to 1.27-fold of its baseline, DAF-2-NO continuously increased under the high flow, to 1.53-fold of its baseline in 60 min. Inhibition of eNOS by 1 mM L-NMMA attenuated the flow-induced NO production to 1.13-fold in 15 min and 1.30-fold of its baseline in 60 min, respectively. In contrast, no significant increase in NO production was observed after switching to the high flow for 60 min when 1 h pretreatment with 50 mU/mL heparanase III to degrade the ESG was applied. Similar NO production was observed in arterioles under low and high flows and under eNOS inhibition. Our results suggest that ESG participates in endothelial cell mechanosensing and transduction through its heparan sulfate to activate eNOS.	[Yen, Wanyi; Cai, Bin; Yang, Jinlin; Zhang, Lin; Zeng, Min; Tarbell, John M.; Fu, Bingmei M.] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Fu, BMM (corresponding author), CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA.	fu@ccny.cuny.edu	Fu, Bingmei M/I-3295-2013		NIH [1R01HL094889-01, SC1CA153325-01]; NATIONAL CANCER INSTITUTE [SC1CA153325] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094889] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NIH 1R01HL094889-01 and NIH SC1CA153325-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER M, 1974, MICROVASC RES, V7, P131, DOI 10.1016/0026-2862(74)90043-0; Barakat AI, 2008, CIRC RES, V102, P747, DOI 10.1161/CIRCRESAHA.108.174839; Becker BF, 2010, BASIC RES CARDIOL, V105, P687, DOI 10.1007/s00395-010-0118-z; Cai B, 2012, J APPL PHYSIOL, V113, P1141, DOI 10.1152/japplphysiol.00479.2012; Chang YS, 2000, ARTERIOSCL THROM VAS, V20, P35, DOI 10.1161/01.ATV.20.1.35; Chappell D, 2008, BIOL CHEM, V389, P79, DOI 10.1515/BC.2008.005; Chappell D, 2011, ANESTHESIOLOGY, V115, P483, DOI 10.1097/ALN.0b013e3182289988; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; COOKE JP, 1990, AM J PHYSIOL, V259, pH804, DOI 10.1152/ajpheart.1990.259.3.H804; Curry FRE, 2010, CARDIOVASC RES, V87, P218, DOI 10.1093/cvr/cvq115; Ebong EE, 2014, INTEGR BIOL-UK, V6, P338, DOI 10.1039/c3ib40199e; Egorova AD, 2012, DIFFERENTIATION, V83, pS56, DOI 10.1016/j.diff.2011.11.007; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Fu BMM, 2013, WIRES SYST BIOL MED, V5, P381, DOI 10.1002/wsbm.1211; Fu BMM, 2004, MICROVASC RES, V68, P51, DOI 10.1016/j.mvr.2004.03.004; Gao LJ, 2010, MICROVASC RES, V80, P394, DOI 10.1016/j.mvr.2010.06.005; Gautam M, 2006, J BIOL CHEM, V281, P36492, DOI 10.1074/jbc.M605866200; Giantsos-Adams KM, 2013, CELL MOL BIOENG, V6, P160, DOI 10.1007/s12195-013-0273-z; Gojova A, 2005, J APPL PHYSIOL, V98, P2355, DOI 10.1152/japplphysiol.01136.2004; Guo P, 2014, BIOMECH MODEL MECHAN, V13, P537, DOI 10.1007/s10237-013-0515-y; Guo X, 2009, ACTA PHYSIOL, V197, P99, DOI 10.1111/j.1748-1716.2009.01999.x; Juffer P, 2014, CELL BIOCHEM BIOPHYS, V69, P411, DOI 10.1007/s12013-013-9812-4; Kang HY, 2011, AM J PHYSIOL-HEART C, V300, pH76, DOI 10.1152/ajpheart.00905.2010; Kojima H, 1998, NEUROREPORT, V9, P3345, DOI 10.1097/00001756-199810260-00001; Koo A, 2013, BIOPHYS J, V104, P2295, DOI 10.1016/j.bpj.2013.03.052; Koo A, 2013, AM J PHYSIOL-CELL PH, V304, pC137, DOI 10.1152/ajpcell.00187.2012; KUCHAN MJ, 1994, AM J PHYSIOL, V266, pC628, DOI 10.1152/ajpcell.1994.266.3.C628; Kumagai R, 2009, FREE RADICAL BIO MED, V47, P600, DOI 10.1016/j.freeradbiomed.2009.05.034; Liu Q, 2008, J BIOMECH, V41, P2726, DOI 10.1016/j.jbiomech.2008.06.013; Lopez-Quintero SV, 2009, AM J PHYSIOL-HEART C, V296, pH1451, DOI 10.1152/ajpheart.00894.2008; Matsui TS, 2011, INTERFACE FOCUS, V1, P754, DOI 10.1098/rsfs.2011.0031; Mochizuki S, 2003, AM J PHYSIOL-HEART C, V285, pH722, DOI 10.1152/ajpheart.00691.2002; Morgan JT, 2011, MOL BIOL CELL, V22, P4324, DOI 10.1091/mbc.E11-04-0287; Mulivor AW, 2009, MICROCIRCULATION, V16, P657, DOI 10.3109/10739680903133714; Padberg JS, 2014, ATHEROSCLEROSIS, V234, P335, DOI 10.1016/j.atherosclerosis.2014.03.016; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; POHL U, 1991, AM J PHYSIOL, V261, pH2016, DOI 10.1152/ajpheart.1991.261.6.H2016; Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307; PRITCHARD KA, 1995, CIRC RES, V77, P510, DOI 10.1161/01.RES.77.3.510; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Reitsma S, 2011, J VASC RES, V48, P297, DOI 10.1159/000322176; Rosenberg RD, 1997, J CLIN INVEST, V100, pS67; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; Shen S, 2010, EXP PHYSIOL, V95, P369, DOI 10.1113/expphysiol.2009.050260; Stevens HY, 2008, DIS MODEL MECH, V1, P175, DOI 10.1242/dmm.000547; Tabouillot T, 2011, CELL MOL BIOENG, V4, P169, DOI 10.1007/s12195-010-0136-9; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; Tarbell JM, 2010, CARDIOVASC RES, V87, P320, DOI 10.1093/cvr/cvq146; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; van Haaren PMA, 2003, AM J PHYSIOL-HEART C, V285, pH2848, DOI 10.1152/ajpheart.00117.2003; VanTeeffelen JWGE, 2007, HYPERTENSION, V50, P261, DOI 10.1161/HYPERTENSIONAHA.107.089250; VanTeeffelen JWGE, 2010, CARDIOVASC RES, V87, P311, DOI 10.1093/cvr/cvq114; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Williams DA, 2007, MICROVASC RES, V73, P48, DOI 10.1016/j.mvr.2006.08.003; Wu QH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.194501; Yamamoto K, 2011, J PHARMACOL SCI, V116, P323, DOI 10.1254/jphs.10R29FM; Yao Y, 2007, AM J PHYSIOL-HEART C, V293, pH1023, DOI 10.1152/ajpheart.00162.2007; Yen WY, 2012, MICROVASC RES, V83, P337, DOI 10.1016/j.mvr.2012.02.005; Yi FX, 2002, AM J PHYSIOL-HEART C, V283, pH2725, DOI 10.1152/ajpheart.00428.2002; Zeng Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086249; Zeng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043168; Zhou XP, 2011, AM J PHYSIOL-HEART C, V301, pH108, DOI 10.1152/ajpheart.00195.2011; Zhu LK, 2005, AM J PHYSIOL-HEART C, V288, pH2869, DOI 10.1152/ajpheart.01080.2004; Ziegler T, 1998, ARTERIOSCL THROM VAS, V18, P686, DOI 10.1161/01.ATV.18.5.686	67	67	69	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0117133	10.1371/journal.pone.0117133	http://dx.doi.org/10.1371/journal.pone.0117133			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25575016	Green Published, gold			2022-12-26	WOS:000348168100012
J	Meissner, AM; Christiansen, F; Martinez, E; Pawley, MDM; Orams, MB; Stockin, KA				Meissner, Anna M.; Christiansen, Fredrik; Martinez, Emmanuelle; Pawley, Matthew D. M.; Orams, Mark B.; Stockin, Karen A.			Behavioural Effects of Tourism on Oceanic Common Dolphins, Delphinus sp., in New Zealand: The Effects of Markov Analysis Variations and Current Tour Operator Compliance with Regulations	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; EAST AUCKLAND CURRENT; TURSIOPS-TRUNCATUS; HAURAKI GULF; HECTORS DOLPHINS; FEEDING PROGRAM; DOUBTFUL SOUND; SOUTH-EAST; BOATS; WHALES	Common dolphins, Delphinus sp., are one of the marine mammal species tourism operations in New Zealand focus on. While effects of cetacean-watching activities have previously been examined in coastal regions in New Zealand, this study is the first to investigate effects of commercial tourism and recreational vessels on common dolphins in an open oceanic habitat. Observations from both an independent research vessel and aboard commercial tour vessels operating off the central and east coast Bay of Plenty, North Island, New Zealand were used to assess dolphin behaviour and record the level of compliance by permitted commercial tour operators and private recreational vessels with New Zealand regulations. Dolphin behaviour was assessed using two different approaches to Markov chain analysis in order to examine variation of responses of dolphins to vessels. Results showed that, regardless of the variance in Markov methods, dolphin foraging behaviour was significantly altered by boat interactions. Dolphins spent less time foraging during interactions and took significantly longer to return to foraging once disrupted by vessel presence. This research raises concerns about the potential disruption to feeding, a biologically critical behaviour. This may be particularly important in an open oceanic habitat, where prey resources are typically widely dispersed and unpredictable in abundance. Furthermore, because tourism in this region focuses on common dolphins transiting between adjacent coastal locations, the potential for cumulative effects could exacerbate the local effects demonstrated in this study. While the overall level of compliance by commercial operators was relatively high, non-compliance to the regulations was observed with time restriction, number or speed of vessels interacting with dolphins not being respected. Additionally, prohibited swimming with calves did occur. The effects shown in this study should be carefully considered within conservation management plans, in order to reduce the risk of detrimental effects on common dolphins within the region.	[Meissner, Anna M.; Martinez, Emmanuelle; Pawley, Matthew D. M.; Orams, Mark B.; Stockin, Karen A.] Massey Univ, Coastal Marine Res Grp, Inst Nat & Math Sci, Auckland, New Zealand; [Christiansen, Fredrik] Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Warrnambool, Vic, Australia; [Christiansen, Fredrik] Murdoch Univ, Cetacean Res Unit, Sch Vet & Life Sci, Murdoch, WA 6150, Australia; [Martinez, Emmanuelle] Pacific Whale Fdn, Wailuku, HI USA; [Orams, Mark B.] Auckland Univ Technol, New Zealand Tourism Res Inst, Sch Hospitality & Tourism, Auckland, New Zealand	Massey University; Deakin University; Murdoch University; Auckland University of Technology	Meissner, AM (corresponding author), Massey Univ, Coastal Marine Res Grp, Inst Nat & Math Sci, Private Bag 102904, Auckland, New Zealand.	anna.meissner@gmail.com	Stockin, Karen A/B-4452-2010; Christiansen, Fredrik/O-3655-2017	Christiansen, Fredrik/0000-0001-9090-8458; Stockin, Karen/0000-0002-2981-3983; Martinez, Emmanuelle/0000-0001-6492-2643; Meissner, Anna/0000-0002-4997-3538	East Coast Bay of Plenty Conservancy of the Department of Conservation; Massey University; Massey University Institute of Natural and Mathematical Sciences Fees Scholarship; Massey University Doctoral Scholarship	East Coast Bay of Plenty Conservancy of the Department of Conservation; Massey University; Massey University Institute of Natural and Mathematical Sciences Fees Scholarship; Massey University Doctoral Scholarship	This project was funded by the East Coast Bay of Plenty Conservancy of the Department of Conservation and Massey University. AMM is the recipient of a Massey University Institute of Natural and Mathematical Sciences Fees Scholarship and a Massey University Doctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arcangeli Antonella, 2009, Journal of Marine Animals and their Ecology, V2, P3; Baker CS, 2010, NEW ZEAL J MAR FRESH, V44, P101, DOI 10.1080/00288330.2010.482970; Barr K, 1997, THESIS U OTAGO; Bearzi G, 2005, AQUAT CONSERV, V15, P243, DOI 10.1002/aqc.667; Bearzi G, 1997, MAR MAMMAL SCI, V13, P650, DOI 10.1111/j.1748-7692.1997.tb00089.x; Bearzi G, 2011, MAR MAMMAL SCI, V27, pE165, DOI 10.1111/j.1748-7692.2010.00448.x; Bejder L, 1999, MAR MAMMAL SCI, V15, P738, DOI 10.1111/j.1748-7692.1999.tb00840.x; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; BOGGS CL, 1992, FUNCT ECOL, V6, P508, DOI 10.2307/2390047; Burgess L, 2006, THESIS MASSEY U; Chen CL, 2011, MAR POLICY, V35, P10, DOI 10.1016/j.marpol.2010.07.002; Christiansen F, 2014, J EXP MAR BIOL ECOL, V459, P96, DOI 10.1016/j.jembe.2014.05.014; Christiansen F, 2013, BEHAV ECOL, V24, P1415, DOI 10.1093/beheco/art086; Christiansen Fredrik, 2010, Endangered Species Research, V11, P91, DOI 10.3354/esr00265; Constantine R, 2001, MAR MAMMAL SCI, V17, P689, DOI 10.1111/j.1748-7692.2001.tb01293.x; Constantine R, 2004, BIOL CONSERV, V117, P299, DOI 10.1016/j.biocon.2003.12.009; Constantine R., 1997, MONITORING COMMERCIA; Courbis S, 2009, MAR MAMMAL SCI, V25, P430, DOI 10.1111/j.1748-7692.2008.00254.x; de la Brosse N, 2010, THESIS MASSEY U; Donaldson R., 2010, Pacific Conservation Biology, V16, P157; Draheim M., 2010, Tourism in Marine Environments, V6, P175, DOI 10.3727/154427310X12764412619046; Dwyer SL, 2014, NEW ZEAL J MAR FRESH, V48, P294, DOI 10.1080/00288330.2013.866578; Dwyer SL, 2014, ENDANGER SPECIES RES, V25, P97, DOI 10.3354/esr00613; Filby NE, 2014, GLOB ECOL CONSERV, V2, P62, DOI 10.1016/j.gecco.2014.08.006; Foroughirad V, 2013, BIOL CONSERV, V160, P242, DOI 10.1016/j.biocon.2013.01.001; Gaborit-Haverkort T, 2011, E COAST BAY PLENTY C; GASKIN DE, 1992, CAN FIELD NAT, V106, P55; Guerra M, 2014, ENDANGER SPECIES RES, V24, P221, DOI 10.3354/esr00598; Hammond, 2008, DELPHINUS DELPHIS IU; Hammond PS, 2008, DELPHINUS CAPENSIS I; Higham J., 2014, WHALE WATCHING SUSTA; Hollingworth K, 2001, DEMOGRAPHY DISPERSIO; Hoyt E., 2001, WHALE WATCHING 2001; Hughes P, 2001, TOURISM MANAGE, V22, P321, DOI 10.1016/S0261-5177(00)00070-4; International Fund for Animal Welfare, 2005, GROWTH NZ WHAL WATCH; International Whaling Commision, 2001, J CET RES MAN SUPPL, V3, P297; InternationalWhaling Commission, 2014, J CETACEAN RES MAN S, V15, P380; Jensen FH, 2009, MAR ECOL PROG SER, V395, P161, DOI 10.3354/meps08204; Lachmuth CL, 2011, MAR POLLUT BULL, V62, P792, DOI 10.1016/j.marpolbul.2011.01.002; Laist DW, 2001, MAR MAMMAL SCI, V17, P35, DOI 10.1111/j.1748-7692.2001.tb00980.x; Dans SL, 2012, CONSERV BIOL, V26, P708, DOI 10.1111/j.1523-1739.2012.01844.x; Luksenburg JA, 2014, AQUAT CONSERV, V24, P135, DOI 10.1002/aqc.2348; Lundquist D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041969; Lusseau D, 2003, CONSERV BIOL, V17, P1785, DOI 10.1111/j.1523-1739.2003.00054.x; Lusseau D, 2004, ECOL SOC, V9; Lusseau D, 2003, MAR ECOL PROG SER, V257, P267, DOI 10.3354/meps257267; Lusseau D, 2006, MAR MAMMAL SCI, V22, P802, DOI 10.1111/j.1748-7692.2006.00052.x; Lusseau David, 2009, Endangered Species Research, V6, P211, DOI 10.3354/esr00154; Mann J, 1999, MAR MAMMAL SCI, V15, P102, DOI 10.1111/j.1748-7692.1999.tb00784.x; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Markowitz T. M., 2009, TOURISM EFFECTS DUSK; Martinez E., 2013, Pacific Conservation Biology, V19, P19; Martinez E, 2010, THESIS MASSEY U; Martinez E, 2011, TOURISM MARINE ENV, V7, P191, DOI [10.3727/154427311X13195453162895, DOI 10.3727/154427311X13195453162895]; Martinez E, 2010, TOUR REV INT, V14, P99, DOI 10.3727/154427211X13044361606379; Martinez E, 2012, MAR MAMMAL SCI, V28, pE295, DOI 10.1111/j.1748-7692.2011.00528.x; Meissner AM, 2014, EFFECTS COMMERCIAL T; Meynier L, 2008, MAR ECOL PROG SER, V354, P277, DOI 10.3354/meps07246; Miller LJ, 2008, J MAR BIOL ASSOC UK, V88, P1139, DOI 10.1017/S0025315408000908; Neumann Dirk R., 2006, Aquatic Mammals, V32, P1, DOI 10.1578/AM.32.1.2006.1; Neumann Dirk R., 2003, Aquatic Mammals, V29, P137, DOI 10.1578/016754203101023997; Neumann Dirk R., 2001, Aquatic Mammals, V27, P121; Neumann DR, 2002, NEW ZEAL J MAR FRESH, V36, P593, DOI 10.1080/00288330.2002.9517115; Neumann DR, 2001, NEW ZEAL J MAR FRESH, V35, P371, DOI 10.1080/00288330.2001.9517007; Neumann DR, 2001, THESIS MASSEY U; Nichols C., 2001, OBSERVATIONS INTERAC; Nowacek SM, 2001, MAR MAMMAL SCI, V17, P673, DOI 10.1111/j.1748-7692.2001.tb01292.x; O'Connor S., 2009, WHALE WATCHING WORLD; Orams M., 2004, Tourism in Marine Environments, V1, P17; Orams MB, 2002, TOURISM MANAGE, V23, P281, DOI 10.1016/S0261-5177(01)00080-2; Orams MB, 1996, MAR MAMMAL SCI, V12, P107, DOI 10.1111/j.1748-7692.1996.tb00308.x; Parsons ECM, 2009, CURR ISSUES TOUR, V12, P397, DOI 10.1080/13683500902730460; Parsons ECM, 2006, J CETACEAN RES MAN S, V8, P249; PARSONS ECM, 2012, J MAR BIOL, V2012, DOI DOI 10.1155/2012/807294; R Core Team, 2021, R LANGUAGE ENV STAT; Rafic M, 1999, J CETACEAN RES MAN S, V1, P230; Samuels Amy, 2004, Journal of Cetacean Research and Management, V6, P69; Scarpaci C, 2013, J CETACEAN RES MANAG, P1; Scarpaci Carol, 2000, Journal of Cetacean Research and Management, V2, P183; Schaffar-Delaney A, 2004, THESIS MASSEY U; Shane S.H., 1990, P245; Sharples J, 1997, CONT SHELF RES, V17, P835, DOI 10.1016/S0278-4343(96)00060-X; Smith H, 2008, TOURISM MANAGE, V29, P994, DOI 10.1016/j.tourman.2008.01.001; Stamation KA, 2010, MAR MAMMAL SCI, V26, P98, DOI 10.1111/j.1748-7692.2009.00320.x; Stanton BR, 1997, NEW ZEAL J MAR FRESH, V31, P537, DOI 10.1080/00288330.1997.9516787; Steckenreuter A, 2012, J ENVIRON MANAGE, V97, P14, DOI 10.1016/j.jenvman.2011.11.002; Stensland E, 2007, MAR ECOL PROG SER, V332, P225, DOI 10.3354/meps332225; Stockin KA, 2007, SCI TOTAL ENVIRON, V387, P333, DOI 10.1016/j.scitotenv.2007.05.016; Stockin K.A., 2009, J CETACEAN RES MANAG, VSC/61/SM20, P1; Stockin KA, 2011, 19 BIENN C BIOL MAR; Stockin KA, 2008, MAR ECOL PROG SER, V355, P287, DOI 10.3354/meps07386; Stockin Karen A., 2009, Pacific Conservation Biology, V15, P217; Stockin KA, 2009, MAR MAMMAL SCI, V25, P283, DOI 10.1111/j.1748-7692.2008.00262.x; Stockin Karen A., 2008, Aquatic Mammals, V34, P200, DOI 10.1578/AM.34.2.2008.200; Suisted R, 2004, DEP CONSERVATION MAR; Thompson PM, 2000, CONSERV BIOL, V14, P1253, DOI 10.1046/j.1523-1739.2000.00099-410.x; Tilburg CE, 2001, J PHYS OCEANOGR, V31, P2917, DOI 10.1175/1520-0485(2001)031<2917:TDOTEA>2.0.CO;2; Townsend A.J., 2008, NZ THREAT CLASSIFICA; Waltzek TB, 2012, ZOONOSES PUBLIC HLTH, V59, P521, DOI 10.1111/j.1863-2378.2012.01492.x; Wells RS, 1997, MAR MAMMAL SCI, V13, P475, DOI 10.1111/j.1748-7692.1997.tb00654.x; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010; Williams Rob, 2009, Endangered Species Research, V6, P199, DOI 10.3354/esr00150; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; Young DD, 1995, Z SAUGETIERKD, V60, P343; YOUNG DD, 1994, J ZOOL, V234, P41, DOI 10.1111/j.1469-7998.1994.tb06055.x; Zaeschmar JR, 2014, MAR MAMMAL SCI, V30, P594, DOI 10.1111/mms.12065	107	59	63	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2015	10	1							e0116962	10.1371/journal.pone.0116962	http://dx.doi.org/10.1371/journal.pone.0116962			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4BS	25565523	gold, Green Submitted, Green Published			2022-12-26	WOS:000348167900006
J	Wang, N; Ding, H; Liu, C; Li, X; Wei, L; Yu, J; Liu, M; Ying, M; Gao, W; Jiang, H; Wang, Y				Wang, N.; Ding, H.; Liu, C.; Li, X.; Wei, L.; Yu, J.; Liu, M.; Ying, M.; Gao, W.; Jiang, H.; Wang, Y.			A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk	ONCOGENE			English	Article							DNA-DAMAGE CHECKPOINT; OVARIAN-CANCER; HEREDITARY BREAST; CHK2 KINASE; P53; SUSCEPTIBILITY; GENES; FAMILIES; VARIANT; BRCA1	Certain predisposition factors such as BRCA1/2 and CHEK2 mutations cause familial breast cancers that occur early. In China, breast cancers are diagnosed at relatively younger age, and higher percentage of patients are diagnosed before 40 years, than that in Caucasians. However, the prevalence for BRCA1/2 mutations and reported CHEK2 germline mutations is much lower or absent in Chinese population, arguing for the need to study other novel risk alleles among Chinese breast cancer patients. In this study, we searched for CHEK2 mutations in young, high-risk breast cancer patients in China and detected a missense variant Y390C (1169A4G) in 12 of 150 patients (8.0%) and 2 in 250 healthy controls (0.8%, P = 0.0002). Four of the Y390C carriers have family history of breast and/or ovarian cancer. In patients without family history, Y390C carriers tend to develop breast cancer early, before 35 years of age. The codon change at Y390, a highly conserved residue located in CHEK2's kinase domain, appeared to significantly impair CHEK2 activity. Functional analysis suggested that the CHEK2 Y390C mutation is deleterious as judged by the mutant protein's inability to inactivate CDC25A or to activate p53 after DNA damage. Cells expressing the CHEK2 Y390C variant showed impaired p21 and Puma expression after DNA damage, and the deregulated cell cycle checkpoint and apoptotic response may help conserve mutations and therefore contribute to tumorigeneisis. Taken together, our results not only identified a novel CHEK2 allele that is associated with cancer families and confers increased breast cancer risk, but also showed that this allele significantly impairs CHEK2 function during DNA damage response. Our results provide further insight on how the function of such an important cancer gene may be impaired by existing mutations to facilitate tumorigenesis. It also offers a new subject for breast cancer monitoring, prevention and management.	[Wang, N.; Liu, C.; Wei, L.; Ying, M.; Gao, W.; Wang, Y.] Second Mil Med Univ, Dept Oncol, Changhai Hosp, Shanghai, Peoples R China; [Ding, H.; Liu, C.; Li, X.; Yu, J.; Liu, M.; Jiang, H.] Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Key Lab Syst Biol,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Wei, L.] PLA, Hosp 401, Dept Oncol, Qingdao, Peoples R China; [Wang, Y.] Shanghai Jiao Tong Univ, Xinhua Canc Ctr, Sch Med, Xinhua Hosp, Shanghai 200030, Peoples R China	Naval Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Jiang, H (corresponding author), Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Key Lab Syst Biol,Shanghai Inst Biol Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	hai@sibcb.ac.cn; yajiewao459@163.com		jiang, hai/0000-0002-2508-5413; Ding, Hongyu/0000-0002-7531-4771	major scientific research project [2013CB910404]; Natural Science Foundation of the People's Republic of China [81372854, 31371418, 81202096, 81102010]; Shanghai Science and Technology Committee [114119a7500, 06DZ19505, 13NM1401504]	major scientific research project; Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This study was supported by the major scientific research project (2013CB910404), Natural Science Foundation of the People's Republic of China (No. 81372854; 31371418; 81202096; 81102010), and Shanghai Science and Technology Committee (No. 114119a7500, No. 06DZ19505 and No. 13NM1401504). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. We thank Dr Qingpeng Kong of the Kunming Institute of Zoology, Chinese Academy of Sciences for his help in analysis of the 1000 human genome project.	Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Apostolou P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/747318; Baloch AH, 2014, MOL BIOL REP, V41, P1103, DOI 10.1007/s11033-013-2956-x; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Baysal BE, 2004, GYNECOL ONCOL, V95, P62, DOI 10.1016/j.ygyno.2004.07.015; Brinkman H, 2006, CLIN GENET, V70, P526, DOI 10.1111/j.1399-0004.2006.00711.x; Brown AL, 1999, P NATL ACAD SCI USA, V96, P3745, DOI 10.1073/pnas.96.7.3745; Cai Z, 2009, MOL CELL, V35, P818, DOI 10.1016/j.molcel.2009.09.007; Cao AY, 2010, BREAST CANCER RES TR, V120, P271, DOI 10.1007/s10549-009-0598-4; Chehab NH, 2000, GENE DEV, V14, P278; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Cybulski C, 2011, J CLIN ONCOL, V29, P3747, DOI 10.1200/JCO.2010.34.0778; de Miranda NFCC, 2013, J EXP MED, V210, P1729, DOI 10.1084/jem.20122842; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Gonzalez-Hormazabal P, 2008, BREAST CANCER RES TR, V110, P543, DOI 10.1007/s10549-007-9743-0; Gutierrez-Enriquez S, 2014, INT J CANCER, V134, P2088, DOI 10.1002/ijc.28540; Jiang H, 2011, NAT CHEM BIOL, V7, P92, DOI 10.1038/NCHEMBIO.503; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Kwong A, 2008, WORLD J SURG, V32, P2554, DOI 10.1007/s00268-008-9589-6; Lacroix M, 2005, BREAST CANCER RES TR, V89, P297, DOI 10.1007/s10549-004-2172-4; Liede A, 2002, HUM MUTAT, V20, P413, DOI 10.1002/humu.10154; Liu C, 2012, ASIAN PAC J CANCER P, V13, P1355, DOI 10.7314/APJCP.2012.13.4.1355; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Novak DJ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-239; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Osorio A, 2012, HUM MOL GENET, V21, P2889, DOI 10.1093/hmg/dds115; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Shieh SY, 2000, GENE DEV, V14, P289; Sodha N, 2002, HUM MUTAT, V19, P173, DOI 10.1002/humu.10031; Song QK, 2014, ASIAN PAC J CANCER P, V15, P10021, DOI 10.7314/APJCP.2014.15.22.10021; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Takacova S, 2012, CANCER CELL, V21, P517, DOI 10.1016/j.ccr.2012.01.021; Vahteristo P, 2002, AM J HUM GENET, V71, P432, DOI 10.1086/341943; Vahteristo P, 2001, CANCER RES, V61, P5718; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Wang C, 2008, ADV THER, V25, P496, DOI 10.1007/s12325-008-0057-3; Weischer M, 2008, J CLIN ONCOL, V26, P542, DOI 10.1200/JCO.2007.12.5922; Wu XL, 2001, J BIOL CHEM, V276, P2971, DOI 10.1074/jbc.M009727200	44	21	22	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 1	2015	34	40					5198	5205		10.1038/onc.2014.443	http://dx.doi.org/10.1038/onc.2014.443			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CS6ZP	25619829				2022-12-26	WOS:000362233400009
J	Bufe, B; Schumann, T; Kappl, R; Bogeski, I; Kummerow, C; Podgorska, M; Smola, S; Hoth, M; Zufall, F				Bufe, Bernd; Schumann, Timo; Kappl, Reinhard; Bogeski, Ivan; Kummerow, Carsten; Podgorska, Marta; Smola, Sigrun; Hoth, Markus; Zufall, Frank			Recognition of Bacterial Signal Peptides by Mammalian Formyl Peptide Receptors A NEW MECHANISM FOR SENSING PATHOGENS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Imaging; Chemical Biology; G-protein-coupled Receptor (GPCR); Innate Immunity; Molecular Pharmacology; Pathogen-associated Molecular Pattern (PAMP); Pattern Recognition Receptor (PRR); Vomeronasal Organ (VNO)	VOMERONASAL SENSORY NEURONS; GENERAL SECRETORY PATHWAY; STAPHYLOCOCCUS-AUREUS; HUMAN NEUTROPHILS; HOST-DEFENSE; LISTERIA-MONOCYTOGENES; PROTEIN SECRETION; INFLAMMATION; IDENTIFICATION; RESPONSES	Background: The function of formyl peptide receptors (FPRs) is incompletely understood. Results: We report the identification of bacterial signal peptides as potent activators of mammalian FPRs and innate immune responses and define critical features underlying FPR peptide recognition. Conclusion: These findings identify a molecular signature for FPR activation. Significance: Our results define a novel mechanism for sensing bacteria. Formyl peptide receptors (FPRs) are G-protein-coupled receptors that function as chemoattractant receptors in innate immune responses. Here we perform systematic structure-function analyses of FPRs from six mammalian species using structurally diverse FPR peptide agonists and identify a common set of conserved agonist properties with typical features of pathogen-associated molecular patterns. Guided by these results, we discover that bacterial signal peptides, normally used to translocate proteins across cytoplasmic membranes, are a vast family of natural FPR agonists. N-terminally formylated signal peptide fragments with variable sequence and length activate human and mouse FPR1 and FPR2 at low nanomolar concentrations, thus establishing FPR1 and FPR2 as sensitive and broad signal peptide receptors. The vomeronasal receptor mFpr-rs1 and its sequence orthologue hFPR3 also react to signal peptides but are much more narrowly tuned in signal peptide recognition. Furthermore, all signal peptides examined here function as potent activators of the innate immune system. They elicit robust, FPR-dependent calcium mobilization in human and mouse leukocytes and trigger a range of classical innate defense mechanisms, such as the production of reactive oxygen species, metalloprotease release, and chemotaxis. Thus, bacterial signal peptides constitute a novel class of immune activators that are likely to contribute to mammalian immune defense against bacteria. This evolutionarily conserved detection mechanism combines structural promiscuity with high specificity and enables discrimination between bacterial and eukaryotic signal sequences. With at least 175,542 predicted sequences, bacterial signal peptides represent the largest and structurally most heterogeneous class of G-protein-coupled receptor agonists currently known for the innate immune system.	[Bufe, Bernd; Schumann, Timo; Zufall, Frank] Univ Saarland, Sch Med, Dept Physiol, D-66421 Homburg, Germany; [Kappl, Reinhard; Bogeski, Ivan; Kummerow, Carsten; Hoth, Markus] Univ Saarland, Sch Med, Dept Biophys, D-66421 Homburg, Germany; [Podgorska, Marta; Smola, Sigrun] Univ Saarland, Sch Med, Dept Virol, D-66421 Homburg, Germany	Saarland University; Saarland University; Saarland University	Bufe, B (corresponding author), Univ Saarland, Sch Med, Dept Physiol, Kirrbergerstr Bldg 58, D-66424 Homburg, Germany.	bernd.bufe@uks.eu	Bogeski, Ivan/ABA-2141-2021; Zufall, Frank/AAE-5290-2021; Bufe, Bernd/N-6685-2018	Bogeski, Ivan/0000-0001-9879-7174; Zufall, Frank/0000-0002-4383-8618; Hoth, Markus/0000-0001-7080-4643; Bufe, Bernd/0000-0003-1610-0658; Kappl, Reinhard/0000-0003-0223-6642; Kummerow, Carsten/0000-0001-5667-2293	Deutsche Forschungsgemeinschaft [INST 256/271-1 FUGG, Sonderforschungsbereich 894/A1, Sonderforschungsbereich 894/A17, Sonderforschungsbereich 1027/A2, Sonderforschungsbereich 1027/C4, Schwerpunktprogramm 1392]; University of Saarland	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Saarland	This work was supported by Deutsche Forschungsgemeinschaft Grants INST 256/271-1 FUGG (to F. Z. and B. B), Sonderforschungsbereich 894/A1 (to M. H.) and A17 (to F. Z.), Sonderforschungsbereich 1027/A2 and C4 (to M. H. and I. B.), and Schwerpunktprogramm 1392 (to F. Z.). This work was also supported by the University of Saarland through HOMFORexcellent Grants 2011 (to B. B.) and 2013 (to I. B.) and a graduate scholarship (GradUS) (to T. S.).	Back M, 2014, BRIT J PHARMACOL, V171, P3551, DOI 10.1111/bph.12665; Bae GH, 2012, EXP MOL MED, V44, P130, DOI 10.3858/emm.2012.44.2.008; Baek SH, 1996, J BIOL CHEM, V271, P8170, DOI 10.1074/jbc.271.14.8170; Benelli D, 2009, RES MICROBIOL, V160, P493, DOI 10.1016/j.resmic.2009.06.003; Bogeski I, 2011, CELL CALCIUM, V50, P407, DOI 10.1016/j.ceca.2011.07.006; BOULAY F, 1990, BIOCHEM BIOPH RES CO, V168, P1103, DOI 10.1016/0006-291X(90)91143-G; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bufe B, 2012, J BIOL CHEM, V287, P33644, DOI 10.1074/jbc.M112.375774; Chamero P, 2012, TRENDS NEUROSCI, V35, P597, DOI 10.1016/j.tins.2012.04.011; Chamero P, 2011, P NATL ACAD SCI USA, V108, P12898, DOI 10.1073/pnas.1107770108; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Dalbey RE, 2012, MICROBIOL MOL BIOL R, V76, P311, DOI 10.1128/MMBR.05019-11; de Souza GA, 2011, J PROTEOMICS, V75, P502, DOI 10.1016/j.jprot.2011.08.016; Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Gear ARL, 2003, MICROCIRCULATION, V10, P335, DOI 10.1038/sj.mn.7800198; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KEMMERICH B, 1988, J LEUKOCYTE BIOL, V43, P125, DOI 10.1002/jlb.43.2.125; Kretschmer D, 2012, J INNATE IMMUN, V4, P201, DOI 10.1159/000332142; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; LACY M, 1995, J NEUROIMMUNOL, V61, P71, DOI 10.1016/0165-5728(95)00075-D; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Le YY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-02-j0003.2001; Leinders-Zufall T, 2014, J NEUROSCI, V34, P5121, DOI 10.1523/JNEUROSCI.0186-14.2014; Leinders-Zufall T, 2009, NAT NEUROSCI, V12, P1551, DOI 10.1038/nn.2452; Li YS, 2013, J MOL MED, V91, P781, DOI 10.1007/s00109-013-1005-5; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; MARASCO WA, 1984, J BIOL CHEM, V259, P5430; Martner A, 2008, INFECT IMMUN, V76, P4079, DOI 10.1128/IAI.01747-07; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Mollica Adriano, 2012, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V11, P20; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; Panaro MA, 2006, IMMUNOPHARM IMMUNOT, V28, P103, DOI 10.1080/08923970600625975; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Rabiet MJ, 2005, EUR J IMMUNOL, V35, P2486, DOI 10.1002/eji.200526338; Ravipaty S, 2010, MOL CELL PROTEOMICS, V9, P1898, DOI 10.1074/mcp.M900494-MCP200; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Rienstra CM, 2002, P NATL ACAD SCI USA, V99, P10260, DOI 10.1073/pnas.152346599; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Ruiz-Gomez G, 2010, CHEM REV, V110, pPR1, DOI 10.1021/cr900344w; Sagan L, 1967, J Theor Biol, V14, P255; Schepetkin IA, 2013, BIOCHEM PHARMACOL, V85, P404, DOI 10.1016/j.bcp.2012.11.015; SCHIFFMANN E, 1975, P NATL ACAD SCI USA, V72, P1059, DOI 10.1073/pnas.72.3.1059; Schwartz K, 2014, INFECT IMMUN, V82, P3837, DOI 10.1128/IAI.02111-14; Selvatici R, 2006, EUR J PHARMACOL, V534, P1, DOI 10.1016/j.ejphar.2006.01.034; Shao GH, 2011, AM J RESP CELL MOL, V44, P264, DOI 10.1165/rcmb.2010-0246RC; SHAWAR SM, 1995, BIOCHEM BIOPH RES CO, V211, P812, DOI 10.1006/bbrc.1995.1884; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wentworth CC, 2011, J BIOL CHEM, V286, P38448, DOI 10.1074/jbc.M111.268938; YARMOLINSKY MB, 1995, SCIENCE, V267, P836, DOI 10.1126/science.7846528; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Ying GG, 2004, J IMMUNOL, V172, P7078, DOI 10.4049/jimmunol.172.11.7078	57	68	69	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7369	7387		10.1074/jbc.M114.626747	http://dx.doi.org/10.1074/jbc.M114.626747			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25605714	hybrid, Green Published			2022-12-26	WOS:000351613600007
J	Richards, EJ; Zhang, G; Li, ZP; Permuth-Wey, J; Challa, S; Li, YJ; Kong, W; Dan, S; Bui, MM; Coppola, D; Mao, WM; Sellers, TA; Cheng, JQ				Richards, Edward J.; Zhang, Gu; Li, Zhu-Peng; Permuth-Wey, Jennifer; Challa, Sridevi; Li, Yajuan; Kong, William; Dan, Su; Bui, Marilyn M.; Coppola, Domenico; Mao, Wei-Min; Sellers, Thomas A.; Cheng, Jin Q.			Long Non-coding RNAs (LncRNA) Regulated by Transforming Growth Factor (TGF) beta LncRNA-HIT-MEDIATED TGF beta-INDUCED EPITHELIAL TO MESENCHYMAL TRANSITION IN MAMMARY EPITHELIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; METASTASIS; CHROMATIN; CONSERVATION; CELLS; CONTRIBUTES; PROMOTES	Long noncoding RNAs (lncRNAs) are emerging as key regulators in various biological processes. Epithelial-to-mesenchymal transition (EMT) is a developmental process hijacked by tumor cells to depart from the primary tumor site, invade surrounding tissue, and establish distant metastases. Transforming growth factor beta(TGF beta) signaling has been shown to be a major inducer of EMT and to facilitate breast cancer metastasis. However, the role of lncRNAs in this process remains largely unknown. Here we report a genome-wide lncRNA profile in mouse mammary epithelial NMuMG cells upon TGF beta induction of EMT. Among 10,802 lncRNAs profiled, over 600 were up-regulated and down-regulated during the EMT, respectively. Furthermore, we identify that lncRNA-HIT (HOXA transcript induced by TGF beta mediates TGF beta function, i.e. depletion of lncRNA-HIT inhibits TGF beta-induced migration, invasion, and EMT in NMuMG. LncRNA-HIT is also significantly elevated in the highly metastatic 4T1 cells. Knockdown of lncRNA-HIT in 4T1 results in decrease of cell migration, invasion, tumor growth, and metastasis. E-cadherin was identified as a major target of lncRNA-HIT. Moreover, lncRNA-HIT is conserved in humans and elevated expression associates with more invasive human primary breast carcinoma. Collectively, these data suggest that a subset of lncRNAs such as lncRNA-HIT play a significant role in regulation of EMT and breast cancer invasion and metastasis, and could be potential therapeutic targets in breast cancers.	[Richards, Edward J.; Challa, Sridevi; Li, Yajuan; Kong, William; Cheng, Jin Q.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Permuth-Wey, Jennifer; Sellers, Thomas A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33612 USA; [Bui, Marilyn M.; Coppola, Domenico] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol Anat, Tampa, FL 33612 USA; [Zhang, Gu; Li, Zhu-Peng; Dan, Su; Mao, Wei-Min] Zhejiang Canc Hosp, Hangzhou 310022, Zhejiang, Peoples R China; [Zhang, Gu; Li, Zhu-Peng; Dan, Su; Mao, Wei-Min] Zhejiang Canc Res Inst, Hangzhou 310022, Zhejiang, Peoples R China	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital	Cheng, JQ (corresponding author), 12902 Magnolia Dr,SRB3, Tampa, FL 33612 USA.	jin.cheng@moffitt.org			National Institutes of Health [CA137041, CA160455, CA114343-03S1]; National Natural Science Foundation of China [81172081]; NATIONAL CANCER INSTITUTE [R25CA174664, R01CA114343, P30CA076292, R01CA160455, R01CA137041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA137041, CA160455 (to J. Q. C.), and CA114343-03S1 (to T. A. S.) and the National Natural Science Foundation of China, Grant 81172081 (to W. M. M.).	Allred DC, 1998, MODERN PATHOL, V11, P155; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Chau YM, 2002, J CLIN ENDOCR METAB, V87, P2674, DOI 10.1210/jc.87.6.2674; Diederichs S, 2014, TRENDS GENET, V30, P121, DOI 10.1016/j.tig.2014.01.004; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hacisuleyman E, 2014, NAT STRUCT MOL BIOL, V21, P198, DOI 10.1038/nsmb.2764; Johnsson P, 2014, BBA-GEN SUBJECTS, V1840, P1063, DOI 10.1016/j.bbagen.2013.10.035; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Manzanares M, 2000, NATURE, V408, P854, DOI 10.1038/35048570; Nam JS, 2006, CANCER RES, V66, P6327, DOI 10.1158/0008-5472.CAN-06-0068; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Quagliata L, 2014, HEPATOLOGY, V59, P911, DOI 10.1002/hep.26740; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Xie W, 2002, CANCER RES, V62, P497; Yang F, 2013, MOL CELL, V49, P1083, DOI 10.1016/j.molcel.2013.01.010; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	29	124	133	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6857	6867		10.1074/jbc.M114.610915	http://dx.doi.org/10.1074/jbc.M114.610915			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605728	hybrid, Green Published			2022-12-26	WOS:000350991500021
J	Deming, PB; Campbell, SL; Stone, JB; Rivard, RL; Mercier, AL; Howe, AK				Deming, Paula B.; Campbell, Shirley L.; Stone, Jamie B.; Rivard, Robert L.; Mercier, Alison L.; Howe, Alan K.			Anchoring of Protein Kinase A by ERM (Ezrin-Radixin-Moesin) Proteins Is Required for Proper Netrin Signaling through DCC (Deleted in Colorectal Cancer)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH CONE GUIDANCE; ADENOSINE A2B RECEPTOR; FOCAL ADHESION KINASE; CELL-MIGRATION; AXON OUTGROWTH; CYCLIC-AMP; NEUROBLASTOMA-CELLS; FILOPODIA FORMATION; ENA/VASP PROTEINS; PLASMA-MEMBRANE	Netrin-1, acting through its principal receptor DCC (deleted in colorectal cancer), serves as an axon guidance cue during neural development and also contributes to vascular morphogenesis, epithelial migration, and the pathogenesis of some tumors. Several lines of evidence suggest that netrin-DCC signaling can regulate and be regulated by the cAMP-dependent protein kinase, PKA, although the molecular details of this relationship are poorly understood. Specificity in PKA signaling is often achieved through differential subcellular localization of the enzyme by interaction with protein kinase A anchoring proteins (AKAPs). Here, we show that AKAP function is required for DCC-mediated activation of PKA and phosphorylation of cytoskeletal regulatory proteins of the Mena/VASP (vasodilator-stimulated phosphoprotein) family. Moreover, we show that DCC and PKA physically interact and that this association is mediated by the ezrin-radixin-moesin (ERM) family of plasma membrane-actin cytoskeleton cross-linking proteins. Silencing of ERM protein expression inhibits DCC-PKA interaction, DCC-mediated PKA activation, and phosphorylation of Mena/VASP proteins as well as growth cone morphology and neurite outgrowth. Finally, although expression of wild-type radixin partially rescued growth cone morphology and tropism toward netrin in ERM-knockdown cells, expression of an AKAP-deficient mutant of radixin did not fully rescue growth cone morphology and switched netrin tropism from attraction to repulsion. These data support a model in which ERM-mediated anchoring of PKA activity to DCC is required for proper netrin/DCC-mediated signaling.	[Deming, Paula B.] Univ Vermont, Coll Med, Dept Med Lab & Radiat Sci, Burlington, VT 05405 USA; [Campbell, Shirley L.; Stone, Jamie B.; Rivard, Robert L.; Mercier, Alison L.; Howe, Alan K.] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; [Deming, Paula B.; Campbell, Shirley L.; Howe, Alan K.] Univ Vermont, Coll Med, Ctr Canc, Burlington, VT 05405 USA; [Campbell, Shirley L.] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada	University of Vermont; University of Vermont; University of Vermont; Universite de Montreal	Howe, AK (corresponding author), Univ Vermont, Coll Med, Dept Pharmacol, 149 Beaumont Ave,HSRF Room 322, Burlington, VT 05405 USA.	Alan.Howe@uvm.edu		Deming, Paula/0000-0003-3278-1705	National Institutes of Health [R01GM074204, R01GM097495]; National Institutes of Health (COBRE (Centers of Biomedical Research Excellence)) [P20RR016435]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074204, R01GM097495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (COBRE (Centers of Biomedical Research Excellence)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM074204 and R01GM097495 (to A. K. H.) and P20RR016435 (to R. Parsons and A. K. H., COBRE (Centers of Biomedical Research Excellence) Project 1).	Abrahamsen H, 2003, J BIOL CHEM, V278, P17170, DOI 10.1074/jbc.M211426200; Antoine-Bertrand J, 2011, MOL BIOL CELL, V22, P3734, DOI 10.1091/mbc.E10-11-0917; Arakawa H, 2004, NAT REV CANCER, V4, P978, DOI 10.1038/nrc1504; Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; BIRGBAUER E, 1991, J NEUROSCI RES, V30, P232; Bouchard JF, 2004, J NEUROSCI, V24, P3040, DOI 10.1523/JNEUROSCI.4934-03.2004; Castelo L, 1999, MOL BIOL CELL, V10, P1511, DOI 10.1091/mbc.10.5.1511; Chedotal A, 2007, PROG EXP TUMOR RES, V39, P78, DOI 10.1159/000100048; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; Delloye-Bourgeois C, 2009, J EXP MED, V206, P833, DOI 10.1084/jem.20082299; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Evans GJO, 2003, BIOCHEM SOC T, V31, P824, DOI 10.1042/bst0310824; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Feoktistov I, 2000, MOL PHARMACOL, V58, P903, DOI 10.1124/mol.58.5.903; Finci LI, 2014, NEURON, V83, P839, DOI 10.1016/j.neuron.2014.07.010; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; Gomez TM, 2014, J NEUROCHEM, V129, P221, DOI 10.1111/jnc.12506; GonzalezAgosti C, 1996, CELL MOTIL CYTOSKEL, V34, P122, DOI 10.1002/(SICI)1097-0169(1996)34:2<122::AID-CM4>3.0.CO;2-D; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; Gronholm M, 2003, J BIOL CHEM, V278, P41167, DOI 10.1074/jbc.M306149200; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; GUPTA M, 1985, DEV BRAIN RES, V19, P21, DOI 10.1016/0165-3806(85)90227-5; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Hochbaum D, 2011, J BIOL CHEM, V286, P859, DOI 10.1074/jbc.M110.163816; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2000, NAT CELL BIOL, V2, P593, DOI 10.1038/35023536; Howe AK, 2002, J BIOL CHEM, V277, P38121, DOI 10.1074/jbc.M205379200; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Howe AK, 2011, CURR OPIN CELL BIOL, V23, P554, DOI 10.1016/j.ceb.2011.05.006; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jarnaess E, 2008, J BIOL CHEM, V283, P33708, DOI 10.1074/jbc.M804807200; Kennedy Timothy E., 1995, Current Opinion in Neurobiology, V5, P83, DOI 10.1016/0959-4388(95)80091-3; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Manitt C, 2004, J NEUROSCI RES, V77, P690, DOI 10.1002/jnr.20199; Martin M, 2006, EUR J CELL BIOL, V85, P769, DOI 10.1016/j.ejcb.2006.02.013; McClatchey AI, 2009, TRENDS CELL BIOL, V19, P198, DOI 10.1016/j.tcb.2009.02.006; McKenzie AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026552; Mehlen P, 2005, CELL MOL LIFE SCI, V62, P2599, DOI 10.1007/s00018-005-5191-3; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Meriane M, 2004, J CELL BIOL, V167, P687, DOI 10.1083/jcb.200405053; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Moore SW, 2006, J NEUROSCI, V26, P2419, DOI 10.1523/JNEUROSCI.5419-05.2006; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Murray AJ, 2009, J NEUROSCI, V29, P15434, DOI 10.1523/JNEUROSCI.3071-09.2009; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Nicol X, 2011, P NATL ACAD SCI USA, V108, P13776, DOI 10.1073/pnas.1100247108; Nikolopoulos SN, 2005, CELL CYCLE, V4, P429, DOI 10.4161/cc.4.3.1547; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; Paglini G, 1998, J CELL BIOL, V143, P443, DOI 10.1083/jcb.143.2.443; PARK D, 1992, MOL CELL BIOL, V12, P5816, DOI 10.1128/MCB.12.12.5816; Paulucci-Holthauzen AA, 2009, J BIOL CHEM, V284, P5956, DOI 10.1074/jbc.M805606200; Petrie RJ, 2009, BIOL CELL, V101, P77, DOI 10.1042/BC20070108; Poongodi GL, 2002, J BIOL CHEM, V277, P28200, DOI 10.1074/jbc.M202731200; Ralevic V, 1998, PHARMACOL REV, V50, P413; Ramesh V, 2004, NAT REV NEUROSCI, V5, P462, DOI 10.1038/nrn1407; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Rivard RL, 2009, CELL MOTIL CYTOSKEL, V66, P693, DOI 10.1002/cm.20399; ROSSINO P, 1991, CELL REGUL, V2, P1021, DOI 10.1091/mbc.2.12.1021; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; Ruppelt A, 2007, J IMMUNOL, V179, P5159, DOI 10.4049/jimmunol.179.8.5159; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Semenova I, 2009, TRAFFIC, V10, P153, DOI 10.1111/j.1600-0854.2008.00852.x; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Shekarabi M, 2005, J NEUROSCI, V25, P3132, DOI 10.1523/JNEUROSCI.1920-04.2005; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Shewan D, 2002, NAT NEUROSCI, V5, P955, DOI 10.1038/nn919; Sitaraman SV, 2002, J BIOL CHEM, V277, P33188, DOI 10.1074/jbc.M202522200; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Sun F, 2000, J BIOL CHEM, V275, P14360, DOI 10.1074/jbc.275.19.14360; Xu K, 2014, SCIENCE, V344, P1275, DOI 10.1126/science.1255149; Yang F, 1999, ANAL BIOCHEM, V266, P167, DOI 10.1006/abio.1998.2885; Yeo MG, 2011, J CELL PHYSIOL, V226, P236, DOI 10.1002/jcp.22335	86	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5783	5796		10.1074/jbc.M114.628644	http://dx.doi.org/10.1074/jbc.M114.628644			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25575591	Green Published, hybrid			2022-12-26	WOS:000350044200045
J	Lara, E; Holmfeldt, K; Solonenko, N; Sa, EL; Ignacio-Espinoza, JC; Cornejo-Castillo, FM; Verberkmoes, NC; Vaque, D; Sullivan, MB; Acinas, SG				Lara, Elena; Holmfeldt, Karin; Solonenko, Natalie; Laia Sa, Elisabet; Ignacio-Espinoza, J. Cesar; Cornejo-Castillo, Francisco M.; Verberkmoes, Nathan C.; Vaque, Dolors; Sullivan, Matthew B.; Acinas, Silvia G.			Life-Style and Genome Structure of Marine Pseudoalteromonas Siphovirus B8b Isolated from the Northwestern Mediterranean Sea	PLOS ONE			English	Article							CONTAINING BACTERIAL-VIRUS; PLASMID-LIKE PROPHAGE; HOST-RANGE; EVOLUTIONARY RELATIONSHIPS; BACTERIOPHAGE-LAMBDA; VIRAL ASSEMBLAGES; ESCHERICHIA-COLI; OCEAN VIRUSES; GENE-TRANSFER; DNA VIRUSES	Marine viruses (phages) alter bacterial diversity and evolution with impacts on marine biogeochemical cycles, and yet few well-developed model systems limit opportunities for hypothesis testing. Here we isolate phage B8b from the Mediterranean Sea using Pseudoalteromonas sp. QC-44 as a host and characterize it using myriad techniques. Morphologically, phage B8b was classified as a member of the Siphoviridae family. One-step growth analyses showed that this siphovirus had a latent period of 70 min and released 172 new viral particles per cell. Host range analysis against 89 bacterial host strains revealed that phage B8b infected 3 Pseudoalteromonas strains (52 tested, >99.9% 16S rRNA gene nucleotide identity) and 1 non-Pseudoaltermonas strain belonging to Alteromonas sp. (37 strains from 6 genera tested), which helps bound the phylogenetic distance possible in a phage-mediated horizontal gene transfer event. The Pseudoalteromonas phage B8b genome size was 42.7 kb, with clear structural and replication modules where the former were delineated leveraging identification of 16 structural genes by virion structural proteomics, only 4 of which had any similarity to known structural proteins. In nature, this phage was common in coastal marine environments in both photic and aphotic layers (found in 26.5% of available viral metagenomes), but not abundant in any sample (average per sample abundance was 0.65% of the reads). Together these data improve our understanding of siphoviruses in nature, and provide foundational information for a new 'rare virosphere' phage-host model system.	[Lara, Elena; Laia Sa, Elisabet; Cornejo-Castillo, Francisco M.; Vaque, Dolors; Acinas, Silvia G.] CSIC, Inst Ciencia Mar, Dept Marine Biol & Oceanog, E-08003 Barcelona, Spain; [Holmfeldt, Karin; Solonenko, Natalie; Sullivan, Matthew B.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Ignacio-Espinoza, J. Cesar; Sullivan, Matthew B.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Verberkmoes, Nathan C.] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Arizona; University of Arizona; United States Department of Energy (DOE); Oak Ridge National Laboratory	Acinas, SG (corresponding author), CSIC, Inst Ciencia Mar, Dept Marine Biol & Oceanog, Passeig Maritim Barceloneta 37-49, E-08003 Barcelona, Spain.	sacinas@icm.csic.es	Sullivan, Matthew B/H-3256-2011; Acinas, Silvia/F-7462-2016; Vaque, Dolors/H-6973-2018	Sullivan, Matthew B/0000-0003-4040-9831; Acinas, Silvia/0000-0002-3439-0428; Cornejo-Castillo, Francisco M./0000-0001-8431-9278; Holmfeldt, Karin/0000-0002-6887-6661; Lara, Elena/0000-0002-4625-348X; Ignacio Espinoza, J. Cesar/0000-0001-9303-7504; Vaque, Dolors/0000-0002-0420-5914	FPI-predoc fellowship from the Spanish Ministry of Science and Innovation (MICINN); Ramon y Cajal contract from MICINN; MicroB3; Swedish Research Council [623-2010-6548]; MICROVIS from the MICINN [CTM2007-62140]; MEFISTO from the MICINN [CTM2013-43767-P]; MICRODIVERSITY from the MICINN [CGL2008-00762/BOS]; PANGENOMICS from the MICINN [CGL2011-26848/BOS]; Gordon and Betty Moore Foundation [2631]	FPI-predoc fellowship from the Spanish Ministry of Science and Innovation (MICINN); Ramon y Cajal contract from MICINN; MicroB3; Swedish Research Council(Swedish Research CouncilEuropean Commission); MICROVIS from the MICINN; MEFISTO from the MICINN; MICRODIVERSITY from the MICINN; PANGENOMICS from the MICINN; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	EL was a recipient of the FPI-predoc fellowship from the Spanish Ministry of Science and Innovation (MICINN). SGA was supported by a Ramon y Cajal contract from MICINN and by MicroB3 (FP7-OCEAN-2011). KH was supported by a postdoctoral fellowship from the Swedish Research Council (623-2010-6548). This work was supported by grants MICROVIS (CTM2007-62140) and MEFISTO (CTM2013-43767-P) to DV, MICRODIVERSITY (CGL2008-00762/BOS) and PANGENOMICS (CGL2011-26848/BOS) to SGA from the MICINN, a Gordon and Betty Moore Foundation (grant #2631) to MBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Allers E, 2013, ENVIRON MICROBIOL, V15, P2306, DOI 10.1111/1462-2920.12100; Angly F, 2009, ENVIRON MICROBIOL, V11, P2863, DOI 10.1111/j.1462-2920.2009.02021.x; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Baudoux AC, 2012, ENVIRON MICROBIOL, V14, P2071, DOI 10.1111/j.1462-2920.2011.02685.x; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; Boras JA, 2009, ENVIRON MICROBIOL, V11, P1181, DOI 10.1111/j.1462-2920.2008.01849.x; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805; Breitbart M, 2007, OCEANOGRAPHY, V20, P135, DOI 10.5670/oceanog.2007.58; Brum JR, 2013, ISME J, V7, P1738, DOI 10.1038/ismej.2013.67; Brussaard CPD, 2008, ISME J, V2, P575, DOI 10.1038/ismej.2008.31; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Casjens SR, 2005, CURR OPIN MICROBIOL, V8, P451, DOI 10.1016/j.mib.2005.06.014; CATALANO CE, 1995, MOL MICROBIOL, V16, P1075, DOI 10.1111/j.1365-2958.1995.tb02333.x; Chang HW, 2011, J MICROBIOL, V49, P927, DOI 10.1007/s12275-011-1577-0; Chen F, 1996, VIROLOGY, V219, P170, DOI 10.1006/viro.1996.0234; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Comeau AM, 2004, J VIROL METHODS, V118, P95, DOI 10.1016/j.jviromet.2004.01.020; Comeau AM, 2006, ENVIRON MICROBIOL, V8, P1164, DOI 10.1111/j.1462-2920.2006.01006.x; Comeau AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040102; Crespo BG, 2013, MICROBIOLOGYOPEN, V2, P541, DOI 10.1002/mbo3.92; Cui ZL, 2012, J VIROL, V86, P13843, DOI 10.1128/JVI.02435-12; Danovaro R, 2011, FEMS MICROBIOL REV, V35, P993, DOI 10.1111/j.1574-6976.2010.00258.x; Deng L, 2014, NATURE, V513, P242, DOI 10.1038/nature13459; Desiere F, 2001, VIROLOGY, V288, P325, DOI 10.1006/viro.2001.1085; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Duhaime Melissa B, 2012, Environ Microbiol, V14, P2526, DOI 10.1111/j.1462-2920.2012.02791.x; Duhaime MB, 2012, VIROLOGY, V434, P181, DOI 10.1016/j.virol.2012.09.036; Duhaime MB, 2011, ISME J, V5, P107, DOI 10.1038/ismej.2010.94; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Erickson AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049138; Ferrera I, 2011, APPL ENVIRON MICROB, V77, P7451, DOI 10.1128/AEM.00208-11; Filee J, 2002, J MOL EVOL, V54, P763, DOI 10.1007/s00239-001-0078-x; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Garcia P, 2008, APPL ENVIRON MICROB, V74, P7552, DOI 10.1128/AEM.01709-08; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; GEORGOPOULOS CP, 1973, J MOL BIOL, V76, P45, DOI 10.1016/0022-2836(73)90080-6; Goodridge L, 2003, APPL ENVIRON MICROB, V69, P5364, DOI 10.1128/AEM.69.9.5364-5371.2003; Haber JE, 1999, NATURE, V398, P665, DOI 10.1038/19423; Hadas H, 1997, MICROBIOL-UK, V143, P179, DOI 10.1099/00221287-143-1-179; HALL SD, 1994, P NATL ACAD SCI USA, V91, P3205, DOI 10.1073/pnas.91.8.3205; Hardies SC, 2013, J VIROL, V87, P9189, DOI 10.1128/JVI.01521-13; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Henn MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009083; Hingamp P, 2013, ISME J, V7, P1678, DOI 10.1038/ismej.2013.59; Holmfeldt K, 2007, APPL ENVIRON MICROB, V73, P6730, DOI 10.1128/AEM.01399-07; Holmfeldt K, 2014, ENVIRON MICROBIOL, V16, P2501, DOI 10.1111/1462-2920.12391; Holmfeldt K, 2013, P NATL ACAD SCI USA, V110, P12798, DOI 10.1073/pnas.1305956110; Hopkins M, 2014, ISME J, V8, P2093, DOI 10.1038/ismej.2014.43; Huang SJ, 2012, ENVIRON MICROBIOL, V14, P540, DOI 10.1111/j.1462-2920.2011.02667.x; Hurwitz BL, 2015, ISME J, V9, P472, DOI 10.1038/ismej.2014.143; Hurwitz BL, 2014, P NATL ACAD SCI USA, V111, P10714, DOI 10.1073/pnas.1319778111; Hurwitz BL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r123; Hurwitz BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057355; Hurwitz BL, 2013, ENVIRON MICROBIOL, V15, P1428, DOI 10.1111/j.1462-2920.2012.02836.x; Ignacio-Espinoza JC, 2013, CURR OPIN VIROL, V3, P566, DOI 10.1016/j.coviro.2013.07.004; Ignacio-Espinoza JC, 2012, ENVIRON MICROBIOL, V14, P2113, DOI 10.1111/j.1462-2920.2012.02704.x; Jensen EC, 1998, APPL ENVIRON MICROB, V64, P575; Jiang SC, 1998, APPL ENVIRON MICROB, V64, P2780; Joh RI, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002006; John SG, 2011, ENV MICROBIOL REP, V3, P195, DOI 10.1111/j.1758-2229.2010.00208.x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kang I, 2013, P NATL ACAD SCI USA, V110, P12343, DOI 10.1073/pnas.1219930110; Keppel F, 2002, EMBO REP, V3, P893, DOI 10.1093/embo-reports/kvf176; Kim M, 2011, APPL ENVIRON MICROB, V77, P2042, DOI 10.1128/AEM.02504-10; Kivela HM, 1999, VIROLOGY, V262, P364, DOI 10.1006/viro.1999.9838; Kogoma T, 1996, CELL, V85, P625, DOI 10.1016/S0092-8674(00)81229-5; KOURILSKY P, 1973, MOL GEN GENET, V122, P183, DOI 10.1007/BF00435190; Kurochkina LP, 2012, J VIROL, V86, P10103, DOI 10.1128/JVI.00940-12; Labonte JM, 2013, ISME J, V7, P2169, DOI 10.1038/ismej.2013.110; Lan SF, 2009, APPL ENVIRON MICROB, V75, P2659, DOI 10.1128/AEM.02483-08; LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI DOI 10.1093/BI0INF0RMATICS/BTM404; Lohr JE, 2005, APPL ENVIRON MICROB, V71, P1598, DOI 10.1128/AEM.71.3.1598-1609.2005; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Mannisto RH, 1999, VIROLOGY, V262, P355, DOI 10.1006/viro.1999.9837; MATSUZAKI S, 1992, MICROBIOL IMMUNOL, V36, P93, DOI 10.1111/j.1348-0421.1992.tb01645.x; Mobberley JM, 2008, J VIROL, V82, P6618, DOI 10.1128/JVI.00140-08; MOEBUS K, 1992, HELGOLANDER MEERESUN, V46, P275, DOI 10.1007/BF02367099; Paul JH, 2005, APPL ENVIRON MICROB, V71, P3311, DOI 10.1128/AEM.71.6.3311-3320.2005; Paul JH, 2005, CURR OPIN BIOTECH, V16, P299, DOI 10.1016/j.copbio.2005.03.007; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Rohwer F, 2003, CELL, V113, P141, DOI 10.1016/S0092-8674(03)00276-9; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Roux S, 2014, ELIFE, V3, DOI 10.7554/eLife.03125; Ruiz-Gonzalez C, 2012, LIMNOL OCEANOGR, V57, P1376, DOI 10.4319/lo.2012.57.5.1376; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SAMBROOK J, 2000, MOL CLONING LAB MANU; Seguritan V, 2003, J BACTERIOL, V185, P6434, DOI 10.1128/JB.185.21.6434-6447.2003; Serwer P, 2004, VIROLOGY, V329, P412, DOI 10.1016/j.virol.2004.08.021; Sharon I, 2011, ISME J, V5, P1178, DOI 10.1038/ismej.2011.2; Solonenko SA, 2013, METHOD ENZYMOL, V531, P143, DOI 10.1016/B978-0-12-407863-5.00008-3; Solonenko SA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-320; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Steward GF, 2000, LIMNOL OCEANOGR, V45, P1697, DOI 10.4319/lo.2000.45.8.1697; Steward GF, 2001, METHOD MICROBIOL, V30, P85, DOI 10.1016/S0580-9517(01)30041-7; Steward GF, 2013, ISME J, V7, P672, DOI 10.1038/ismej.2012.121; STEWART FM, 1984, THEOR POPUL BIOL, V26, P93, DOI 10.1016/0040-5809(84)90026-1; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sullivan MB, 2009, ENVIRON MICROBIOL, V11, P2935, DOI 10.1111/j.1462-2920.2009.02081.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; SUTTLE CA, 1993, MAR ECOL PROG SER, V92, P99, DOI 10.3354/meps092099; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tapia P, 2012, J VIROL, V86, P12452, DOI 10.1128/JVI.02261-12; Thomas T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003252; van Regenmortel MHV, 2000, ARCH VIROL, V145, P2227, DOI 10.1007/s007050070053; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Weinbauer MG, 2003, LIMNOL OCEANOGR, V48, P1457, DOI 10.4319/lo.2003.48.4.1457; WEISS BD, 1994, J BACTERIOL, V176, P3354, DOI 10.1128/jb.176.11.3354-3359.1994; Weitz JS, 2013, TRENDS MICROBIOL, V21, P82, DOI 10.1016/j.tim.2012.11.003; Wichels A, 1998, APPL ENVIRON MICROB, V64, P4128; Wichels A, 2002, AQUAT MICROB ECOL, V27, P233, DOI 10.3354/ame027233; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Winget DM, 2008, APPL ENVIRON MICROB, V74, P2612, DOI 10.1128/AEM.02829-07; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Xie BB, 2012, J BACTERIOL, V194, P2746, DOI 10.1128/JB.00265-12; YASUIKE M, 2013, GENOME ANNOUNC, V1, DOI DOI 10.1128/GENOMEA.00248-12; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhao YL, 2013, NATURE, V494, P357, DOI 10.1038/nature11921	129	9	9	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0114829	10.1371/journal.pone.0114829	http://dx.doi.org/10.1371/journal.pone.0114829			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587991	Green Submitted, gold, Green Published			2022-12-26	WOS:000347928300004
J	Rydzak, J; Kaczmarek, R; Czerwinski, M; Lukasiewicz, J; Tyborowska, J; Szewczyk, B; Jaskiewicz, E				Rydzak, Joanna; Kaczmarek, Radoslaw; Czerwinski, Marcin; Lukasiewicz, Jolanta; Tyborowska, Jolanta; Szewczyk, Boguslaw; Jaskiewicz, Ewa			The Baculovirus-Expressed Binding Region of Plasmodium falciparum EBA-140 Ligand and Its Glycophorin C Binding Specificity	PLOS ONE			English	Article							MURINE MONOCLONAL-ANTIBODIES; ERYTHROCYTE INVASION; RECEPTOR SPECIFICITY; MOLECULAR-BASIS; RECOMBINANT FORMS; ANTI-GLYCOPHORIN; MALARIA; PROTEINS; BAEBL; ACID	The erythrocyte binding ligand 140 (EBA-140) is a member of the Plasmodium falciparum DBL family of erythrocyte binding proteins, which are considered as prospective candidates for malaria vaccine development. The EBA-140 ligand is a paralogue of the well-characterized P. falciparum EBA-175 protein. They share homology of domain structure, including Region II, which consists of two homologous F1 and F2 domains and is responsible for ligand-erythrocyte receptor interaction during invasion. In this report we describe, for the first time, the glycophorin C specificity of the recombinant, baculovirus-expressed binding region (Region II) of P. falciparum EBA-140 ligand. It was found that the recombinant EBA-140 Region II binds to the endogenous and recombinant glycophorin C, but does not bind to Gerbich-type glycophorin C, neither normal nor recombinant, which lacks amino acid residues 36-63 of its polypeptide chain. Our results emphasize the crucial role of this glycophorin C region in EBA-140 ligand binding. Moreover, the EBA-140 Region II did not bind either to glycophorin D, the truncated form of glycophorin C lacking the N-glycan or to desialylated GPC. These results draw attention to the role of glycophorin C glycans in EBA-140 binding. The full identification of the EBA-140 binding site on glycophorin C molecule, consisting most likely of its glycans and peptide backbone, may help to design therapeutics or vaccines that target the erythrocyte binding merozoite ligands.	[Rydzak, Joanna; Kaczmarek, Radoslaw; Czerwinski, Marcin; Lukasiewicz, Jolanta; Jaskiewicz, Ewa] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland; [Czerwinski, Marcin] Opole Univ Technol, Fac Physiotherapy & Phys Educ, Opole, Poland; [Tyborowska, Jolanta; Szewczyk, Boguslaw] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Recombinant Vaccines, PL-80952 Gdansk, Poland; [Tyborowska, Jolanta; Szewczyk, Boguslaw] Med Univ Gdansk, Gdansk, Poland; [Jaskiewicz, Ewa] Univ Zielona Gora, Dept Mol Biol, Zielona Gora, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Opole University of Technology; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; University of Zielona Gora	Jaskiewicz, E (corresponding author), Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland.	jaskiew@iitd.pan.wroc.pl		Szewczyk, Boguslaw/0000-0003-4957-4059; Kaczmarek, Radoslaw/0000-0001-8084-1958; Lukasiewicz, Jolanta/0000-0001-8081-7261; Czerwinski, Marcin/0000-0003-2859-3699	Ministry of Science and Higher Education of Poland [N N302 281436]; National Centre of Science [2012/05/N/NZ6/00667]	Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland); National Centre of Science	The research was supported by grants No N N302 281436 from the Ministry of Science and Higher Education of Poland and grant No 2012/05/N/NZ6/00667 from National Centre of Science.	Adams JH, 2001, TRENDS PARASITOL, V17, P297, DOI 10.1016/S1471-4922(01)01948-1; Bei AK, 2012, INT J PARASITOL, V42, P575, DOI 10.1016/j.ijpara.2012.03.006; CARTRON JP, 1993, SEMIN HEMATOL, V30, P152; Chiu PCN, 2004, BIOL REPROD, V70, P1710, DOI 10.1095/biolreprod.103.023259; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Gaur D, 2011, CURR OPIN MICROBIOL, V14, P422, DOI 10.1016/j.mib.2011.07.018; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; Ja kiewicz E, 2007, POST PY HIG MED DO W, V61, P718; Jaskiewicz E, 2002, TRANSFUS CLIN BIOL, V9, P121, DOI 10.1016/S1246-7820(02)00233-1; Jaskiewicz E, 2002, TRANSFUSION MED, V12, P141, DOI 10.1046/j.1365-3148.2002.00361.x; JASKIEWICZ E, 1994, BLOOD, V84, P2340; Jiang LB, 2009, MOL BIOCHEM PARASIT, V168, P49, DOI 10.1016/j.molbiopara.2009.06.006; Kim CLV, 1996, BLOOD, V88, P2364, DOI 10.1182/blood.V88.6.2364.bloodjournal8862364; Kobayashi K, 2010, J BIOL CHEM, V285, P1716, DOI 10.1074/jbc.M109.021576; KUSNIERZ-ALEJSKA G, 1990, Materia Medica Polona, V22, P8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin DH, 2012, J BIOL CHEM, V287, P36830, DOI 10.1074/jbc.M112.409276; LISOWSKA E, 1987, MOL IMMUNOL, V24, P605, DOI 10.1016/0161-5890(87)90041-1; Lisowska E, 1988, Adv Exp Med Biol, V228, P265; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; LOIRAT MJ, 1994, TRANSFUSION MED, V4, P147, DOI 10.1111/j.1365-3148.1994.tb00256.x; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Maier AG, 2009, INFECT IMMUN, V77, P1689, DOI 10.1128/IAI.01331-08; Malpede BM, 2013, J BIOL CHEM, V288, P12406, DOI 10.1074/jbc.M113.450643; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; Mayer DCG, 2006, P NATL ACAD SCI USA, V103, P2358, DOI 10.1073/pnas.0510648103; Mayer DCG, 2002, J EXP MED, V196, P1523, DOI 10.1084/jem.20020750; Narum DL, 2002, MOL BIOCHEM PARASIT, V119, P159, DOI 10.1016/S0166-6851(01)00428-5; Ockenhouse CF, 2001, MOL BIOCHEM PARASIT, V113, P9, DOI 10.1016/S0166-6851(00)00375-3; Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6; REID ME, 1987, BIOCHEM J, V244, P123, DOI 10.1042/bj2440123; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Rydzak J, 2013, POSTEP HIG MED DOSW, V67, P1331, DOI 10.5604/17322693.1081865; Rydzak J, 2012, ACTA BIOCHIM POL, V59, P685; Salinas ND, 2014, PROTEIN EXPRES PURIF, V95, P188, DOI 10.1016/j.pep.2013.12.008; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Walker P S, 2010, Immunohematology, V26, P60; Zhang DM, 2005, INFECT IMMUN, V73, P6530, DOI 10.1128/IAI.73.10.6530-6536.2005	42	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0115437	10.1371/journal.pone.0115437	http://dx.doi.org/10.1371/journal.pone.0115437			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25588042	gold, Green Published, Green Submitted			2022-12-26	WOS:000347928300006
J	Perez-Cruz, C; Delgado, L; Lopez-Iglesias, C; Mercade, E				Perez-Cruz, Carla; Delgado, Lidia; Lopez-Iglesias, Carmen; Mercade, Elena			Outer-Inner Membrane Vesicles Naturally Secreted by Gram-Negative Pathogenic Bacteria	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; CRYOELECTRON TOMOGRAPHY; PROTEOME ANALYSIS; ESCHERICHIA-COLI; VIRULENCE; DNA; BIOGENESIS; MECHANISM; PROTEINS; RELEASE	Outer-inner membrane vesicles (O-IMVs) were recently described as a new type of membrane vesicle secreted by the Antarctic bacterium Shewanella vesiculosa M7T. Their formation is characterized by the protrusion of both outer and plasma membranes, which pulls cytoplasmic components into the vesicles. To demonstrate that this is not a singular phenomenon in a bacterium occurring in an extreme environment, the identification of O-IMVs in pathogenic bacteria was undertaken. With this aim, a structural study by Transmission Electron Microscopy (TEM) and Cryo-transmission electron microscopy (Cryo-TEM) was carried out, confirming that O-IMVs are also secreted by Gram-negative pathogenic bacteria such as Neisseria gonorrhoeae, Pseudomonas aeruginosa PAO1 and Acinetobacter baumannii AB41, in which they represent between 0.23% and 1.2% of total vesicles produced. DNA and ATP, which are components solely found in the cell cytoplasm, were identified within membrane vesicles of these strains. The presence of DNA inside the O-IMVs produced by N. gonorrhoeae was confirmed by gold DNA immunolabeling with a specific monoclonal IgM against double-stranded DNA. A proteomic analysis of N. gonorrhoeae-derived membrane vesicles identified proteins from the cytoplasm and plasma membrane. This confirmation of O-IMV extends the hitherto uniform definition of membrane vesicles in Gram-negative bacteria and explains the presence of components in membrane vesicles such as DNA, cytoplasmic and inner membrane proteins, as well as ATP, detected for the first time. The production of these O-IMVs by pathogenic Gram-negative bacteria opens up new areas of study related to their involvement in lateral gene transfer, the transfer of cytoplasmic proteins, as well as the functionality and role of ATP detected in these new vesicles.	[Perez-Cruz, Carla; Mercade, Elena] Univ Barcelona, Fac Farm, Microbiol Lab, E-08028 Barcelona, Spain; [Delgado, Lidia; Lopez-Iglesias, Carmen] Univ Barcelona, Ctr Cient & Tecnol, Barcelona, Spain	University of Barcelona; University of Barcelona	Mercade, E (corresponding author), Univ Barcelona, Fac Farm, Microbiol Lab, E-08028 Barcelona, Spain.	mmercade@ub.edu	DELGADO, LIDIA/H-7939-2015; Mercade, Elena/L-5218-2014; Perez-Cruz, Carla/AAB-3540-2020	DELGADO, LIDIA/0000-0001-7351-6188; Mercade, Elena/0000-0001-7828-2210; 	Government of Spain (CICYT) [CTQ 2010-21183-C02-01/PPQ]; Autonomous Government of Catalonia [2009SGR1212]; University of Barcelona [FFAR2012.3]	Government of Spain (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Autonomous Government of Catalonia(Generalitat de Catalunya); University of Barcelona	Funding: This work received funding from the following sources: Government of Spain (CICYT grant CTQ 2010-21183-C02-01/PPQ)EM CP-C, Autonomous Government of Catalonia (grant 2009SGR1212)EM CL-I, and Fellowship FFAR2012.3 from the University of Barcelona (CP-C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera L, 2014, PROTEOMICS, V14, P222, DOI 10.1002/pmic.201300328; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Choi DS, 2011, PROTEOMICS, V11, P3424, DOI 10.1002/pmic.201000212; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Deatherage BL, 2009, MOL MICROBIOL, V72, P1395, DOI 10.1111/j.1365-2958.2009.06731.x; Delgado L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073297; DORWARD DW, 1990, APPL ENVIRON MICROB, V56, P1960, DOI 10.1128/AEM.56.6.1960-1962.1990; DORWARD DW, 1989, J BACTERIOL, V171, P2499, DOI 10.1128/jb.171.5.2499-2505.1989; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Hironaka I, 2013, APPL ENVIRON MICROB, V79, P2328, DOI 10.1128/AEM.03871-12; Hurbain I, 2011, BIOL CELL, V103, P405, DOI 10.1042/BC20110015; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; Koning RI, 2013, RES MICROBIOL, V164, P397, DOI 10.1016/j.resmic.2013.02.007; Kudryashev M, 2009, MOL MICROBIOL, V71, P1415, DOI 10.1111/j.1365-2958.2009.06613.x; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Kwon SO, 2009, FEMS MICROBIOL LETT, V297, P150, DOI 10.1111/j.1574-6968.2009.01669.x; Lappann M, 2013, J BACTERIOL, V195, P4425, DOI 10.1128/JB.00625-13; Lee EY, 2008, MASS SPECTROM REV, V27, P535, DOI 10.1002/mas.20175; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Lee JC, 2012, FEMS MICROBIOL LETT, V331, P17, DOI 10.1111/j.1574-6968.2012.02549.x; Li Z, 2009, CURR OPIN MICROBIOL, V12, P333, DOI 10.1016/j.mib.2009.03.007; Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x; McBroom AJ, 2006, J BACTERIOL, V188, P5385, DOI 10.1128/JB.00498-06; Mempin R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-301; Mullaney E, 2009, PROTEOM CLIN APPL, V3, P785, DOI 10.1002/prca.200800192; Perez-Cruz C, 2013, APPL ENVIRON MICROB, V79, P1874, DOI 10.1128/AEM.03657-12; Pierson T, 2011, J PROTEOME RES, V10, P954, DOI 10.1021/pr1009756; Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0; Rumbo C, 2011, ANTIMICROB AGENTS CH, V55, P3084, DOI 10.1128/AAC.00929-10; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharpe SW, 2011, INFECT IMMUN, V79, P4361, DOI 10.1128/IAI.05332-11; Toyofuku M, 2012, J PROTEOME RES, V11, P4906, DOI 10.1021/pr300395j; Unal CM, 2011, SEMIN IMMUNOPATHOL, V33, P395, DOI 10.1007/s00281-010-0231-y; Xi CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013355; Yaron S, 2000, APPL ENVIRON MICROB, V66, P4414, DOI 10.1128/AEM.66.10.4414-4420.2000; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	39	137	139	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2015	10	1							e0116896	10.1371/journal.pone.0116896	http://dx.doi.org/10.1371/journal.pone.0116896			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4CF	25581302	gold, Green Published, Green Submitted			2022-12-26	WOS:000348169100006
J	Visciano, C; Liotti, F; Prevete, N; Cali, G; Franco, R; Collina, F; de Paulis, A; Marone, G; Santoro, M; Melillo, RM				Visciano, C.; Liotti, F.; Prevete, N.; Cali, G.; Franco, R.; Collina, F.; de Paulis, A.; Marone, G.; Santoro, M.; Melillo, R. M.			Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway	ONCOGENE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; EXPRESSION; CARCINOGENESIS; ANGIOGENESIS; PROGRESSION; MECHANISMS; IMMUNITY; ROLES	There is increasing evidence that mast cells (MCs) and their mediators are involved in the remodeling of the tumor microenvironment and promote tumor growth, angiogenesis and metastasis. We have found that an increased density of MCs in thyroid cancer (TC) correlates with enhanced invasiveness. However, the MC-derived factors responsible for this activity and the mechanisms by which they enhance TC invasiveness remain unidentified. Here, we report that MCs, when activated by TC cells, produce soluble factors that induce epithelial-to-mesenchymal transition (EMT) and stemness features of TC cells. We identified CXCL8/interleukin (IL)-8 as the main mediator contained in activated MC conditioned media (CM) capable of inducing both EMT and stemness of TC cells. Mechanistically, MC CM or exogenous IL-8 stimulated Akt phosphorylation and Slug expression in TC cells. The inhibition of the Akt pathway or depletion of the Slug transcription factor by RNA interference, reverted EMT and stemness responses. TC cells stably transfected with exogenous IL-8 underwent EMT, displayed increased stemness and enhanced tumorigenicity with respect to control cells. The analysis of TC surgical specimens by immunohistochemical analysis demonstrated a positive correlation between MC density (Tryptase(+) cells) and stemness features (OCT4 staining). Taken together, our data identify an MC-dependent IL-8-Akt-Slug pathway that sustains EMT/stemness of TC cells. The blockade of this circuit might be exploited for the therapy of advanced TC.	[Visciano, C.; Liotti, F.; Cali, G.; Santoro, M.; Melillo, R. M.] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, CNR G Salvato, Ist Endocrinol & Oncol Sperimentale, I-80131 Naples, Italy; [Prevete, N.; de Paulis, A.; Marone, G.] Univ Naples Federico II, Dipartimento Sci Med Traslaz, Ctr Interdipartimentale Ric Sci Immunol Base & Cl, I-80131 Naples, Italy; [Franco, R.; Collina, F.] Ist Nazl Fis Nucl, Struttura Complessa Anat Patol, Fdn G Pascale, I-80125 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Naples Federico II; IRCCS Fondazione Pascale; Istituto Nazionale di Fisica Nucleare (INFN)	Melillo, RM (corresponding author), Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, CNR G Salvato, Ist Endocrinol & Oncol Sperimentale, Via S Pansini 5, I-80131 Naples, Italy.	rosmelil@unina.it	Collina, Francesca/K-6763-2016; melillo, rosa marina/O-5255-2015; Liotti, Federica/AAC-1614-2019	Collina, Francesca/0000-0001-9862-3668; Liotti, Federica/0000-0002-0145-988X; Franco, Renato/0000-0002-8340-3184; de Paulis, Amato/0000-0003-0347-2540; MELILLO, Rosa Marina/0000-0002-9233-5275	Associazione Italiana per la Ricerca sul Cancro (AIRC) IG grant 'Thyroid cancer and inflammation' [11827]; Italian Health Ministry grant 'Molecular diagnostic and prognostic markers of thyroid neoplasis' [RF-CAM-353005]; Istituto Superiore di Oncologia grant [MIUR PON01_02782/12]; Ministero della Salute; Regione Campania CISI-Lab Project; CREME Project; TIMING Project	Associazione Italiana per la Ricerca sul Cancro (AIRC) IG grant 'Thyroid cancer and inflammation'(Fondazione AIRC per la ricerca sul cancro); Italian Health Ministry grant 'Molecular diagnostic and prognostic markers of thyroid neoplasis'; Istituto Superiore di Oncologia grant; Ministero della Salute(Ministry of Health, Italy); Regione Campania CISI-Lab Project(Regione Campania); CREME Project; TIMING Project	We thank A Cerrato (IEOS, CNR, Naples) for helpful discussions and technical suggestions. We thank S Sequino for assistance in animal maintenance. We are grateful to PB Gupta (Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology, Cambridge, MA, USA) for shSlug plasmids, to M Kajita (Department of Pathology and Laboratory Medicine, Winship Cancer Institute, Atlanta) for the Slug myc plasmid and to BP Zhou (Department of Molecular and Cellular Oncology, Breast Cancer Basic Research Program, The University of Texas M. D. Anderson Cancer Center, Houston, Texas) for the FLAG Snail wt plasmid. Associazione Italiana per la Ricerca sul Cancro (AIRC) IG grant 11827 'Thyroid cancer and inflammation'; Italian Health Ministry grant RF-CAM-353005 'Molecular diagnostic and prognostic markers of thyroid neoplasis'; Istituto Superiore di Oncologia grant (MIUR PON01_02782/12); Ministero della Salute (Ricerca Finalizzata 2009-IZSM RF 2009), Regione Campania CISI-Lab Project, CREME Project and TIMING Project.	Alves CC, 2009, FRONT BIOSCI-LANDMRK, V14, P3041, DOI 10.2741/3433; Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Avilla E, 2011, CANCER RES, V71, P1792, DOI 10.1158/0008-5472.CAN-10-2186; Buehler D, 2013, MODERN PATHOL, V26, P54, DOI 10.1038/modpathol.2012.137; Caillou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022567; Campbell LM, 2013, PHARMACEUTICALS, V6, P929, DOI 10.3390/ph6080929; Carling T, 2014, ANNU REV MED, V65, P125, DOI 10.1146/annurev-med-061512-105739; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Dalton DK, 2012, CANCER IMMUNOL IMMUN, V61, P1511, DOI 10.1007/s00262-012-1246-0; Detoraki A, 2009, J ALLERGY CLIN IMMUN, V123, P1142, DOI 10.1016/j.jaci.2009.01.044; Fang WY, 2014, CARCINOGENESIS, V35, P1780, DOI 10.1093/carcin/bgu060; French JD, 2012, J CLIN ENDOCR METAB, V97, pE934, DOI 10.1210/jc.2011-3428; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Hardy RG, 2007, AM J PATHOL, V171, P1037, DOI 10.2353/ajpath.2007.061211; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kwon MJ, 2013, INT J MOL SCI, V14, P18148, DOI 10.3390/ijms140918148; Lengner CJ, 2008, CELL CYCLE, V7, P725, DOI 10.4161/cc.7.6.5573; Melillo RM, 2010, ONCOGENE, V29, P6203, DOI 10.1038/onc.2010.348; Nehs MA, 2012, ENDOCRINOLOGY, V153, P985, DOI 10.1210/en.2011-1519; Nowak EC, 2012, J EXP MED, V209, P2127, DOI 10.1084/jem.20120408; Palena C, 2012, FUTURE ONCOL, V8, P713, DOI [10.2217/FON.12.59, 10.2217/fon.12.59]; Phay JE, 2013, ENDOCR-RELAT CANCER, V20, pR307, DOI 10.1530/ERC-13-0187; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ryder M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054302; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Salerno P, 2011, J CLIN ENDOCR METAB, V96, pE772, DOI 10.1210/jc.2010-1182; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Shaik S, 2012, J EXP MED, V209, P1289, DOI 10.1084/jem.20112446; Shi Q, 2001, J INTERF CYTOK RES, V21, P553, DOI 10.1089/10799900152547812; Singh JK, 2013, CLIN CANCER RES, V19, P643, DOI 10.1158/1078-0432.CCR-12-1063; Todaro M, 2010, CANCER RES, V70, P8874, DOI 10.1158/0008-5472.CAN-10-1994; Wang YM, 2013, INT J CLIN EXP PATHO, V6, P326; Wasiuk A, 2012, CANCER IMMUNOL IMMUN, V61, P2273, DOI 10.1007/s00262-012-1276-7; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wei Q., 2012, THYROID, V22, P905	39	143	147	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 1	2015	34	40					5175	5186		10.1038/onc.2014.441	http://dx.doi.org/10.1038/onc.2014.441			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CS6ZP	25619830				2022-12-26	WOS:000362233400007
J	Liu, YY; Ayers, S; Milanesi, A; Teng, XC; Rabi, S; Akiba, Y; Brent, GA				Liu, Yan-Yun; Ayers, Stephen; Milanesi, Anna; Teng, Xiaochun; Rabi, Sina; Akiba, Ysutada; Brent, Gregory A.			Thyroid Hormone Receptor Sumoylation Is Required for Preadipocyte Differentiation and Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipogenesis; Cell Proliferation; Peroxisome Proliferator-activated Receptor (PPAR); Sumoylation; Wnt Signaling; 3T3L1; Human Primary Preadipocytes; NCoR; Perilipin1; TR	PPAR-GAMMA; IN-VIVO; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTIONAL REGULATION; LIPID DROPLETS; SUMO CHAINS; NUCLEAR RECEPTOR; PERILIPIN-GENE; STEM-CELLS; ALPHA-GENE	Background: Thyroid hormone receptor (TR) sumoylation is essential for thyroid hormone regulation of gene expression. Results: TR sumoylation mutants impair differentiation though down-regulation of C/EBPs, constitutive interaction with NCoR, interference with PPAR signaling, and disruption of the Wnt canonical signaling pathway important for preadipocyte proliferation. Conclusion: TR sumoylation site mutations impair preadipocyte proliferation and differentiation. Significance: TR sumoylation is required for adipogenesis. Thyroid hormone and thyroid hormone receptor (TR) play an essential role in metabolic regulation. However, the role of TR in adipogenesis has not been established. We reported previously that TR sumoylation is essential for TR-mediated gene regulation and that mutation of either of the two sites in TR or any of the three sites in TR reduces TR sumoylation. Here, we transfected TR sumoylation site mutants into human primary preadiocytes and the mouse 3T3L1 preadipocyte cell line to determine the role of TR sumoylation in adipogenesis. Reduced sumoylation of TR or TR resulted in fewer and smaller lipid droplets and reduced proliferation of preadipocytes. TR sumoylation mutations, compared with wild-type TR, results in reduced C/EBP expression and reduced PPAR(2) mRNA and protein levels. TR sumoylation mutants recruited NCoR and disrupted PPAR-mediated perilipin1 (Plin1) gene expression, associated with impaired lipid droplet formation. Expression of NCoRID, a mutant NCoR lacking the TR interaction domain, partially rescued the delayed adipogenesis and restored Plin1 gene expression and adipogenesis. TR sumoylation site mutants impaired Wnt/-catenin signaling pathways and the proliferation of primary human preadipocytes. Expression of the TR K146Q sumoylation site mutant down-regulated the essential genes required for canonical Wnt signal-mediated proliferation, including Wnt ligands, Fzds, -catenin, LEF1, and CCND1. Additionally, the TR K146Q mutant enhanced the canonical Wnt signaling inhibitor Dickkopf-related protein 1 (DKK1). Our data demonstrate that TR sumoylation is required for activation of the Wnt canonical signaling pathway during preadipocyte proliferation and enhances the PPAR signaling that promotes differentiation.	[Liu, Yan-Yun; Milanesi, Anna; Rabi, Sina; Akiba, Ysutada; Brent, Gregory A.] Vet Affairs Greater Los Angeles Healthcare Syst, Mol Endocrinol Lab, Los Angeles, CA 90073 USA; [Liu, Yan-Yun; Milanesi, Anna; Rabi, Sina; Akiba, Ysutada; Brent, Gregory A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90073 USA; [Liu, Yan-Yun; Milanesi, Anna; Rabi, Sina; Akiba, Ysutada; Brent, Gregory A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90073 USA; [Ayers, Stephen] Methodist Hosp, Res Inst, Genom Med Program, Houston, TX 77030 USA; [Teng, Xiaochun] China Med Univ, Inst Endocrinol, Shenyang 110001, Peoples R China	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; The Methodist Hospital System; The Methodist Hospital - Houston; China Medical University	Liu, YY (corresponding author), VA Greater Los Angeles Healthcare Syst, Bldg 114,Rm 230,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	yyl@ucla.edu; gbrent@ucla.edu		Liu, Yan-Yun/0000-0003-1946-2275	National Institutes of Health [R01DK098576]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098576, K08DK097295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported, in whole or in part, by National Institutes of Health Grant R01DK098576 (to G. A. B.).	Aguilar V, 2010, ENDOCRINOLOGY, V151, P5247, DOI 10.1210/en.2010-0461; Albers J, 2013, J CELL BIOL, V200, P537, DOI 10.1083/jcb.201207142; Albert JS, 2014, NEW ENGL J MED, V370, P2307, DOI 10.1056/NEJMoa1315496; Araki O, 2009, MOL ENDOCRINOL, V23, P308, DOI 10.1210/me.2008-0311; Arimura N, 2004, J BIOL CHEM, V279, P10070, DOI 10.1074/jbc.M308522200; Astapova I, 2011, MOL ENDOCRINOL, V25, P212, DOI 10.1210/me.2010-0462; Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Bucan V, 2012, GENES CELLS, V17, P559, DOI 10.1111/j.1365-2443.2012.01613.x; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Castillo M, 2011, DIABETES, V60, P1082, DOI 10.2337/db10-0758; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Chatonnet F, 2013, P NATL ACAD SCI USA, V110, pE766, DOI 10.1073/pnas.1210626110; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Fan WQ, 2009, J BIOL CHEM, V284, P12188, DOI 10.1074/jbc.M808915200; Florian MC, 2013, NATURE, V503, P392, DOI 10.1038/nature12631; Fozzatti L, 2013, P NATL ACAD SCI USA, V110, P7850, DOI 10.1073/pnas.1222334110; Gandotra S, 2011, J BIOL CHEM, V286, P34998, DOI 10.1074/jbc.M111.278853; Hadjihannas MV, 2012, EMBO REP, V13, P347, DOI 10.1038/embor.2012.12; Hodgson MC, 2008, MOL CANCER THER, V7, P3187, DOI 10.1158/1535-7163.MCT-08-0461; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Langlois D, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-169; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Listenberger L. L., 2007, CURR PROTOC CELL BIO, V24; Liu YY, 2007, ENDOCRINOLOGY, V148, P1206, DOI 10.1210/en.2006-0836; Liu YY, 2012, J BIOL CHEM, V287, P36499, DOI 10.1074/jbc.M112.344317; Liu YY, 2003, J BIOL CHEM, V278, P38913, DOI 10.1074/jbc.M306120200; Lu CX, 2010, J MOL ENDOCRINOL, V44, P143, DOI 10.1677/JME-09-0107; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Menendez-Hurtado A, 2000, ENDOCRINOLOGY, V141, P4164, DOI 10.1210/en.141.11.4164; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Pei H, 2011, CELL DEATH DIFFER, V18, P315, DOI 10.1038/cdd.2010.100; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Pinho S, 2007, DIFFERENTIATION, V75, P957, DOI 10.1111/j.1432-0436.2007.00185.x; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Schupp M, 2009, P NATL ACAD SCI USA, V106, P1105, DOI 10.1073/pnas.0812065106; Seo JB, 2004, J BIOL CHEM, V279, P22108, DOI 10.1074/jbc.M400238200; Shimizu M, 2004, MOL CELL BIOL, V24, P1313, DOI 10.1128/MCB.24.3.1313-1323.2004; Silva JE, 2008, THYROID, V18, P157, DOI 10.1089/thy.2007.0252; Sjogren M, 2007, EMBO J, V26, P4535, DOI 10.1038/sj.emboj.7601882; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Subramanian V, 2004, J LIPID RES, V45, P1983, DOI 10.1194/jlr.M400291-JLR200; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282; Windecker H, 2008, J MOL BIOL, V376, P221, DOI 10.1016/j.jmb.2007.12.008; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Ye JP, 2008, BIOCHEM BIOPH RES CO, V374, P405, DOI 10.1016/j.bbrc.2008.07.068; Yin DT, 2013, ENDOCR-RELAT CANCER, V20, P507, DOI 10.1530/ERC-13-0053; Ying H, 2007, MOL CELL BIOL, V27, P2359, DOI 10.1128/MCB.02189-06	67	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7402	7415		10.1074/jbc.M114.600312	http://dx.doi.org/10.1074/jbc.M114.600312			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25572392	hybrid, Green Published			2022-12-26	WOS:000351613600009
J	Dutta, K; Varshney, AK; Franklin, MC; Goger, M; Wang, XB; Fries, BC				Dutta, Kaushik; Varshney, Avanish K.; Franklin, Matthew C.; Goger, Michael; Wang, Xiaobo; Fries, Bettina C.			Mechanisms Mediating Enhanced Neutralization Efficacy of Staphylococcal Enterotoxin B by Combinations of Monoclonal Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; POLARIZATION TRANSFER; FUSION PROTEIN; IN-VITRO; SUPERANTIGEN; TOXIN; SUBUNIT; COMPLEX; MOLECULES; TOXICITY	Staphylococcal enterotoxin B (SEB) is a superantigen that cross-links the major histocompatibility complex class II and specific V-beta chains of the T-cell receptor, thus forming a ternary complex. Developing neutralizing mAb to disrupt the ternary complex and abrogate the resulting toxicity is a major therapeutic challenge because SEB is effective at very low concentrations. We show that combining two SEB-specific mAbs enhances their efficacy, even though one of the two mAbs by itself has no effect on neutralization. Crystallography was employed for fine-mapping conformational epitopes in binary and ternary complexes between SEB and Fab fragments. NMR spectroscopy was used to validate and identify subtle allosteric changes induced by mAbs binding to SEB. The mapping of epitopes established that a combination of different mAbs can enhance efficacy of mAb-mediated protection from SEB induced lethal shock by two different mechanisms: one mAb mixture promoted clearance of the toxin both in vitro and in vivo by FcR-mediated cross-linking and clearance, whereas the other mAb mixture induced subtle allosteric conformational changes in SEB that perturbed formation of the SEB.T-cell receptor.major histocompatibility complex class II trimer. Finally structural information accurately predicted mAb binding to other superantigens that share conformational epitopes with SEB. Fine mapping of conformational epitopes is a powerful tool to establish the mechanism and optimize the action of synergistic mAb combinations.	[Dutta, Kaushik; Franklin, Matthew C.; Goger, Michael] New York Struct Biol Ctr, New York, NY 10027 USA; [Varshney, Avanish K.; Fries, Bettina C.] SUNY Stony Brook, Dept Med & Mol Genet & Microbiol, Stony Brook, NY 11790 USA; [Varshney, Avanish K.; Wang, Xiaobo; Fries, Bettina C.] Albert Einstein Coll Med, Dept Med Microbiol & Immunol, Bronx, NY 10461 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Yeshiva University; Albert Einstein College of Medicine	Dutta, K (corresponding author), New York Struct Biol Ctr, 89 Convent Ave, New York, NY 10027 USA.	dutta@nysbc.org; Bettina.Fries@stonybrookmedicine.edu			National Institutes of Health [U54 AI057158, P41GM066354]; Department of Defense [W911NF0710053]; New York Division of Science, Technology and Innovation, Office of Research Infrastructure Programs/National Institutes of Health facility improvement [CO6RR015495]; Keck Foundation; New York State Assembly; U.S. Department of Defense; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI114259, U54AI057158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066354, P41GM111244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); New York Division of Science, Technology and Innovation, Office of Research Infrastructure Programs/National Institutes of Health facility improvement; Keck Foundation(W.M. Keck Foundation); New York State Assembly; U.S. Department of Defense(United States Department of Defense); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant U54 AI057158 (to B. C. F. and Prof. W. Ian Lipkin (Principal Investigator), Columbia University). This work was also supported by U.S. Department of Defense Grant W911NF0710053 (to the New York Structural Biology Center), a grant from New York Division of Science, Technology and Innovation, Office of Research Infrastructure Programs/National Institutes of Health facility improvement Grant CO6RR015495. The 900-MHz NMR spectrometers were purchased with funds from National Institutes of Health Grant P41GM066354, the Keck Foundation, New York State Assembly, and the U.S. Department of Defense. Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886.	Abboud N, 2010, J EXP MED, V207, P2395, DOI 10.1084/jem.20100995; Alexandrov A, 2001, BIOTECHNIQUES, V30, P1194, DOI 10.2144/01306bm01; Allende D., 2010, ANTIMICROB AGENTS CH, V54, P239; Andersen LM, 2012, J BIOL CHEM, V287, P8994, DOI 10.1074/jbc.M111.312330; Bakker ABH, 2008, VACCINE, V26, P5922, DOI 10.1016/j.vaccine.2008.08.050; BOUCHER P, 1994, INFECT IMMUN, V62, P449, DOI 10.1128/IAI.62.2.449-456.1994; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043845; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; Davies John Q, 2005, Methods Mol Biol, V290, P91; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demarest SJ, 2010, MABS-AUSTIN, V2, P190, DOI 10.4161/mabs.2.2.11220; Drozdowski Brian, 2010, J Immune Based Ther Vaccines, V8, P9, DOI 10.1186/1476-8518-8-9; Ganesan R, 2009, STRUCTURE, V17, P1614, DOI 10.1016/j.str.2009.09.014; HAMAD ARA, 1994, J EXP MED, V180, P615, DOI 10.1084/jem.180.2.615; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Karauzum H, 2012, J BIOL CHEM, V287, P25203, DOI 10.1074/jbc.M112.364075; Kerschbaumer RJ, 2004, J BIOL CHEM, V279, P40445, DOI 10.1074/jbc.M405966200; Krautz-Peterson G, 2008, INFECT IMMUN, V76, P1931, DOI 10.1128/IAI.01282-07; Larkin EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013253; Lehnert NM, 2001, BIOCHEMISTRY-US, V40, P4222, DOI 10.1021/bi002172e; Lemak A, 2011, J BIOMOL NMR, V49, P27, DOI 10.1007/s10858-010-9458-0; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Lomonte B, 2009, TOXICON, V54, P1012, DOI 10.1016/j.toxicon.2009.03.015; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; MARRACK P, 1990, J EXP MED, V171, P455, DOI 10.1084/jem.171.2.455; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meddeb-Mouelhi F, 2003, TOXICON, V42, P785, DOI 10.1016/j.toxicon.2003.10.021; Migone TS, 2009, NEW ENGL J MED, V361, P135, DOI 10.1056/NEJMoa0810603; MOLLICK JA, 1993, J CLIN INVEST, V92, P710, DOI 10.1172/JCI116641; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; O'Hara JM, 2013, J IMMUNOL METHODS, V395, P71, DOI 10.1016/j.jim.2013.06.004; Papageorgiou AC, 1998, J MOL BIOL, V277, P61, DOI 10.1006/jmbi.1997.1577; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Pettitt J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006608; Pinchuk IV, 2010, TOXINS, V2, P2177, DOI 10.3390/toxins2082177; Prigent J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020166; Riek R, 1999, P NATL ACAD SCI USA, V96, P4918, DOI 10.1073/pnas.96.9.4918; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scarselli M, 2009, J MOL BIOL, V386, P97, DOI 10.1016/j.jmb.2008.12.005; Sepulveda J, 2010, INFECT IMMUN, V78, P756, DOI 10.1128/IAI.01084-09; Slominska-Wojewodzka M, 2006, MOL BIOL CELL, V17, P1664, DOI 10.1091/mbc.E05-10-0961; Smith MJ, 2009, INFECT IMMUN, V77, P2730, DOI 10.1128/IAI.00005-09; STILES BG, 1993, INFECT IMMUN, V61, P5333, DOI 10.1128/IAI.61.12.5333-5338.1993; Tilahun ME, 2010, INFECT IMMUN, V78, P2801, DOI 10.1128/IAI.01121-09; Ulrich RG, 1997, TXB MILITARY MED 1, P621; Varshney A. K., 2009, APPL ENVIRON MICROB, P6839; Varshney AK, 2014, MBIO, V5, DOI 10.1128/mBio.01007-14; Varshney AK, 2014, J INFECT DIS, V210, P973, DOI 10.1093/infdis/jiu198; Varshney AK, 2011, J BIOL CHEM, V286, P9737, DOI 10.1074/jbc.M110.212407; Xia T, 2014, MABS-AUSTIN, V6, P119, DOI 10.4161/mabs.27106; Yermakova A, 2014, MBIO, V5, DOI 10.1128/mBio.00995-13	52	26	27	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6715	6730		10.1074/jbc.M114.630715	http://dx.doi.org/10.1074/jbc.M114.630715			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25572397	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000350991500006
J	Pircher, H; von Grafenstein, S; Diener, T; Metzger, C; Albertini, E; Taferner, A; Unterluggauer, H; Kramer, C; Liedl, KR; Janesn-Durr, P				Pircher, Haymo; von Grafenstein, Susanne; Diener, Thomas; Metzger, Christina; Albertini, Eva; Taferner, Andrea; Unterluggauer, Hermann; Kramer, Christian; Liedl, Klaus R.; Janesn-Duerr, Pidder			Identification of FAH Domain-containing Protein 1 (FAHD1) as Oxaloacetate Decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FUMARYLACETOACETATE HYDROLASE; CRYSTAL-STRUCTURE; MECHANISM; PURIFICATION; ENZYMES	Fumarylacetoacetate hydrolase (FAH) domain-containing proteins occur in both prokaryotes and eukaryotes, where they carry out diverse enzymatic reactions, probably related to structural differences in their respective FAH domains; however, the precise relationship between structure of the FAH domain and the associated enzyme function remains elusive. In mammals, three FAH domain-containing proteins, FAHD1, FAHD2A, and FAHD2B, are known; however, their enzymatic function, if any, remains to be demonstrated. In bacteria, oxaloacetate is subject to enzymatic decarboxylation; however, oxaloacetate decarboxylases (ODx) were so far not identified in eukaryotes. Based on molecular modeling and subsequent biochemical investigations, we identified FAHD1 as a eukaryotic ODx enzyme. The results presented here indicate that dedicated oxaloacetate decarboxylases exist in eukaryotes.	[Pircher, Haymo; Diener, Thomas; Metzger, Christina; Albertini, Eva; Taferner, Andrea; Unterluggauer, Hermann; Janesn-Duerr, Pidder] Univ Innsbruck, Inst Biomed Aging Res, A-6020 Innsbruck, Austria; [Pircher, Haymo; von Grafenstein, Susanne; Diener, Thomas; Metzger, Christina; Albertini, Eva; Taferner, Andrea; Unterluggauer, Hermann; Kramer, Christian; Liedl, Klaus R.; Janesn-Duerr, Pidder] Univ Innsbruck, Ctr Mol Biosci Innsbruck, A-6020 Innsbruck, Austria; [von Grafenstein, Susanne; Kramer, Christian; Liedl, Klaus R.] Univ Innsbruck, Inst Gen Inorgan & Theoret Chem, A-6020 Innsbruck, Austria	University of Innsbruck; University of Innsbruck; University of Innsbruck	Janesn-Durr, P (corresponding author), Univ Innsbruck, Inst Biomed Aging Res, Rennweg 10, A-6020 Innsbruck, Austria.	pidder.jansen-duerr@uibk.ac.at	Liedl, Klaus/ABB-4725-2021; Jansen-Dürr, Pidder/ABG-2466-2020; Albertini, Emidio/F-7393-2014; Liedl, Klaus R/F-3099-2015	Liedl, Klaus/0000-0002-0985-2299; Jansen-Dürr, Pidder/0000-0001-7771-3429; Liedl, Klaus R/0000-0002-0985-2299	Austrian Science Funds (FWF) [NFN 593]; European Union	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); European Union(European Commission)	This work was supported by a grant from the Austrian Science Funds (FWF; NFN 593) (to P. J.-D.) and by the European Union through the FP6 Integrated Project MiMAGE (to P. J.-D.).	BALLARD FJ, 1970, BIOCHEM J, V119, P735, DOI 10.1042/bj1190735; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Brouns SJJ, 2008, J MOL BIOL, V379, P357, DOI 10.1016/j.jmb.2008.03.064; CORWIN LM, 1959, J BIOL CHEM, V234, P1338; DEAN B, 1973, BIOCHEM J, V135, P667, DOI 10.1042/bj1350667; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; HSIANG HH, 1972, BIOCHEMISTRY-US, V11, P2098, DOI 10.1021/bi00761a016; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Klaffl S, 2010, J BACTERIOL, V192, P2604, DOI 10.1128/JB.01678-09; Lietzan AD, 2014, ARCH BIOCHEM BIOPHYS, V544, P75, DOI 10.1016/j.abb.2013.10.014; Manjasetty BA, 2004, BIOL CHEM, V385, P935, DOI 10.1515/BC.2004.122; MITCHELL GA, 2001, METABOLIC MOL BASES, P1777; PARVIN R, 1980, ANAL BIOCHEM, V104, P296, DOI 10.1016/0003-2697(80)90078-0; PHANEUF D, 1991, AM J HUM GENET, V48, P525; Pircher H, 2011, J BIOL CHEM, V286, P36500, DOI 10.1074/jbc.M111.264770; Pollard JR, 1998, EUR J BIOCHEM, V251, P98, DOI 10.1046/j.1432-1327.1998.2510098.x; Ran TT, 2013, BIOCHEM J, V449, P51, DOI 10.1042/BJ20120913; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Tame JRH, 2002, BIOCHEMISTRY-US, V41, P2982, DOI 10.1021/bi015717t; Timm DE, 1999, STRUCTURE, V7, P1023, DOI 10.1016/S0969-2126(99)80170-1; WOJTCZAK AB, 1974, BIOCHIM BIOPHYS ACTA, V347, P168, DOI 10.1016/0005-2728(74)90042-5; Wolfenden R, 2011, J AM CHEM SOC, V133, P5683, DOI 10.1021/ja111457h; Zhou NY, 2001, J BACTERIOL, V183, P700, DOI 10.1128/JB.183.2.700-708.2001	23	24	26	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6755	6762		10.1074/jbc.M114.609305	http://dx.doi.org/10.1074/jbc.M114.609305			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25575590	hybrid, Green Published			2022-12-26	WOS:000350991500012
J	Zhang, Y; Geng, LY; Talmon, G; Wang, J				Zhang, Yang; Geng, Liying; Talmon, Geoffrey; Wang, Jing			MicroRNA-520g Confers Drug Resistance by Regulating p21 Expression in Colorectal Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CISPLATIN RESISTANCE; INDUCED APOPTOSIS; P53; 5-FLUOROURACIL; INHIBITION; MECHANISMS; GROWTH; CHEMOTHERAPY; RESTORATION; PACLITAXEL	Development of drug resistance is one of the major causes of colorectal cancer recurrence, yet mechanistic understanding and therapeutic options remain limited. Here, we show that expression of microRNA (miR)-520g is correlated with drug resistance of colon cancer cells. Ectopic expression of miR-520g conferred resistance to 5-fluorouracil (5-FU)-or oxaliplatin-induced apoptosis in vitro and reduced the effectiveness of 5-FU in the inhibition of tumor growth in a mouse xenograft model in vivo. Further studies indicated that miR-520g mediated drug resistance through down-regulation of p21 expression. Moreover, p53 suppressed miR-520g expression, and deletion of p53 up-regulated miR-520g expression. Inhibition of miR-520g in p53(-/-) cells increased their sensitivity to 5-FU treatment. Importantly, studies of patient samples indicated that expression of miR-520g correlated with chemoresistance in colorectal cancer. These findings indicate that the p53/miR-520g/p21 signaling axis plays an important role in the response of colorectal cancer to chemotherapy. A major implication of our studies is that inhibition of miR-520g or restoration of p21 expression may have considerable therapeutic potential to overcome drug resistance in colorectal cancer patients, especially in those with mutant p53.	[Zhang, Yang; Geng, Liying; Wang, Jing] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Zhang, Yang; Wang, Jing] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Wang, Jing] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Wang, Jing] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Talmon, Geoffrey] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Wang, J (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	jjwang@unmc.edu	Zhang, Yang/H-3299-2018	Zhang, Yang/0000-0003-2315-9009	National Institutes of Health from NCI [R01CA140988-01]; Nebraska Department of Health and Human Services [LB506 (2014-40)]; NATIONAL CANCER INSTITUTE [P30CA036727, R01CA140988, R01CA058755, P30CA013148] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Nebraska Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA140988-01 from NCI. This work was also supported by Nebraska Department of Health and Human Services Grant LB506 (2014-40; to J. W.).	Abukhdeir AM, 2008, P NATL ACAD SCI USA, V105, P288, DOI 10.1073/pnas.0710887105; Aneja R, 2007, CANCER RES, V67, P3862, DOI 10.1158/0008-5472.CAN-06-4282; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Borralho PM, 2009, FEBS J, V276, P6689, DOI 10.1111/j.1742-4658.2009.07383.x; BOYD DD, 1988, CANCER RES, V48, P2469; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chakraborty S, 2014, FEBS LETT, V588, P549, DOI 10.1016/j.febslet.2013.11.040; Chowdhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019335; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ferrandiz N, 2010, CANCER LETT, V292, P133, DOI 10.1016/j.canlet.2009.11.017; Galmarini CM, 2006, INT J CANCER, V119, P60, DOI 10.1002/ijc.21770; Gayet J, 2001, ONCOGENE, V20, P5025, DOI 10.1038/sj.onc.1204611; Geng L, 2014, ONCOGENE, V33, P5332, DOI 10.1038/onc.2013.478; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Grassilli E, 2013, CLIN CANCER RES, V19, P3820, DOI 10.1158/1078-0432.CCR-12-3289; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Kang KH, 1999, EXP CELL RES, V253, P403, DOI 10.1006/excr.1999.4644; Kim CW, 2013, INT J ONCOL, V43, P1495, DOI 10.3892/ijo.2013.2070; Kim SH, 2009, AM J CLIN ONCOL-CANC, V32, P38, DOI 10.1097/COC.0b013e31817be58e; Koster R, 2010, J CLIN INVEST, V120, P3594, DOI 10.1172/JCI41939; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krell J, 2013, EPIGENOMICS-UK, V5, P417, DOI [10.2217/EPI.13.41, 10.2217/epi.13.41]; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang F, 2009, SWISS MED WKLY, V139, P724, DOI smw-12754; Lim HK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/413575; Liu YY, 2001, FASEB J, V15, P719, DOI 10.1096/fj.00-0223com; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Metzinger DS, 2006, CANCER LETT, V236, P302, DOI 10.1016/j.canlet.2005.05.016; MIYASHITA T, 1995, CELL, V80, P293; MOERTEL CG, 1978, NEW ENGL J MED, V299, P1049, DOI 10.1056/NEJM197811092991906; Nefedova Y, 2004, BLOOD, V103, P3503, DOI 10.1182/blood-2003-07-2340; Rougier P, 1998, LANCET, V352, P1407, DOI 10.1016/S0140-6736(98)03085-2; SLICHENMYER WJ, 1993, CANCER RES, V53, P4164; Stoklosa T, 2004, CELL CYCLE, V3, P1463, DOI 10.4161/cc.3.11.1229; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912; Valeri N, 2010, P NATL ACAD SCI USA, V107, P21098, DOI 10.1073/pnas.1015541107; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Yang JY, 2013, ONCOL RES, V21, P43, DOI 10.3727/096504013X13793555706722; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	47	86	89	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6215	6225		10.1074/jbc.M114.620252	http://dx.doi.org/10.1074/jbc.M114.620252			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25616665	Green Published, hybrid			2022-12-26	WOS:000350732500029
J	Tokhtaeva, E; Capri, J; Marcus, EA; Whitelegge, JP; Khuzakhmetova, V; Bukharaeva, E; Deiss-Yehiely, N; Dada, LA; Sachs, G; Fernandez-Salas, E; Vagin, O				Tokhtaeva, Elmira; Capri, Joe; Marcus, Elizabeth A.; Whitelegge, Julian P.; Khuzakhmetova, Venera; Bukharaeva, Ellya; Deiss-Yehiely, Nimrod; Dada, Laura A.; Sachs, George; Fernandez-Salas, Ester; Vagin, Olga			Septin Dynamics Are Essential for Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EVOKED QUANTAL RELEASE; MICROTUBULE ORGANIZATION; NEUROTRANSMITTER RELEASE; ENDOPLASMIC-RETICULUM; BARRIER FUNCTION; ALPHA-SNAP; COMPLEX; FORCHLORFENURON; DISRUPTION; BINDING	Septins are a family of 14 cytoskeletal proteins that dynamically form hetero-oligomers and organize membrane microdomains for protein complexes. The previously reported interactions with SNARE proteins suggested the involvement of septins in exocytosis. However, the contradictory results of up-or down-regulation of septin-5 in various cells and mouse models or septin-4 in mice suggested either an inhibitory or a stimulatory role for these septins in exocytosis. The involvement of the ubiquitously expressed septin-2 or general septin polymerization in exocytosis has not been explored to date. Here, by nano-LC with tandem MS and immunoblot analyses of the septin-2 interactome in mouse brain, we identified not only SNARE proteins but also Munc-18-1 (stabilizes assembled SNARE complexes), N-ethylmaleimide-sensitive factor (NSF) (disassembles SNARE complexes after each membrane fusion event), and the chaperones Hsc70 and synucleins (maintain functional conformation of SNARE proteins after complex disassembly). Importantly, alpha-soluble NSF attachment protein (SNAP), the adaptor protein that mediates NSF binding to the SNARE complex, did not interact with septin-2, indicating that septins undergo reorganization during each exocytosis cycle. Partial depletion of septin-2 by siRNA or impairment of septin dynamics by forchlorfenuron inhibited constitutive and stimulated exocytosis of secreted and transmembrane proteins in various cell types. Forchlorfenuron impaired the interaction between SNAP-25 and its chaperone Hsc70, decreasing SNAP-25 levels in cultured neuroendocrine cells, and inhibited both spontaneous and stimulated acetylcholine secretion in mouse motor neurons. The results demonstrate a stimulatory role of septin-2 and the dynamic reorganization of septin oligomers in exocytosis.	[Sachs, George] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Marcus, Elizabeth A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Tokhtaeva, Elmira; Marcus, Elizabeth A.; Sachs, George; Vagin, Olga] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; [Capri, Joe; Whitelegge, Julian P.] Univ Calif Los Angeles, Pasarow Mass Spectrometry Lab, Semel Inst, Neuropsychiat Inst, Los Angeles, CA 90024 USA; [Khuzakhmetova, Venera; Bukharaeva, Ellya] Russian Acad Sci, Kazan Sci Ctr, Kazan Inst Biochem & Biophys, Kazan 420111, Russia; [Bukharaeva, Ellya] Kazan Fed Univ, Kazan 420008, Russia; [Deiss-Yehiely, Nimrod; Dada, Laura A.] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Fernandez-Salas, Ester] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; Russian Academy of Sciences; Kazan Scientific Centre of the Russian Academy of Sciences; Kazan Institute of Biochemistry & Biophysics; Kazan Federal University; Northwestern University; Feinberg School of Medicine; University of Michigan System; University of Michigan	Vagin, O (corresponding author), Univ Calif Los Angeles, Dept Physiol & Med, VAGLAHS West LA, 11301 Wilshire Blvd,Bldg 113,Rm 324, Los Angeles, CA 90073 USA.	olgav@ucla.edu			National Institutes of Health from the NHLBI [R01HL113350]; National Institutes of Health from the NIDDK [UL1TR000124, K08DK100661-01, P30DK063491]; UCLA Children's Discovery and Innovation Institute; Program of Competitive Growth of Kazan Federal University; Russian Foundation for Basic Research [15-04-02983a]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK100661, P30DK063491, P30DK041301] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health from the NIDDK; UCLA Children's Discovery and Innovation Institute; Program of Competitive Growth of Kazan Federal University(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL113350 from the NHLBI (to L. A. D. and O. V.), UL1TR000124 (to the UCLA Clinical and Translational Science Institute and E. A. M.), and K08DK100661-01 (to E. A. M.) and P30DK063491 from the NIDDK (to J. P. W) This work was also supported by the UCLA Children's Discovery and Innovation Institute (to E. A. M.), the Program of Competitive Growth of Kazan Federal University (to E. B. and V. K.), and Russian Foundation for Basic Research Grant 15-04-02983a (to E. B. and V. K.).	Ageta-Ishihara N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3532; Amin ND, 2008, J NEUROSCI, V28, P3631, DOI 10.1523/JNEUROSCI.0453-08.2008; Angelis D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096390; Beites CL, 2005, BIOCHEM J, V385, P347, DOI 10.1042/BJ20041090; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; Bowen JR, 2011, J CELL BIOL, V194, P187, DOI 10.1083/jcb.201102076; BRIGANT JL, 1982, J PHYSIOL-LONDON, V333, P619, DOI 10.1113/jphysiol.1982.sp014472; Bukcharaeva EA, 1999, J PHYSIOL-LONDON, V517, P879, DOI 10.1111/j.1469-7793.1999.0879s.x; Bukharaeva EA, 2007, J NEUROCHEM, V100, P939, DOI 10.1111/j.1471-4159.2006.04282.x; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Carmosino M, 2000, PFLUG ARCH EUR J PHY, V440, P871, DOI 10.1007/s004240000363; Chailler P, 2005, J CELL PHYSIOL, V202, P263, DOI 10.1002/jcp.20124; Cipriano DJ, 2013, J BIOL CHEM, V288, P23436, DOI 10.1074/jbc.M113.476705; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Demay BS, 2010, CYTOSKELETON, V67, P383, DOI 10.1002/cm.20452; Dent J, 2002, P NATL ACAD SCI USA, V99, P3064, DOI 10.1073/pnas.052715199; Done SC, 2002, J BIOL CHEM, V277, P17108, DOI 10.1074/jbc.M201326200; Gerlach RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078912; Ghossoub R, 2013, J CELL SCI, V126, P2583, DOI 10.1242/jcs.111377; Gilden J, 2010, CYTOSKELETON, V67, P477, DOI 10.1002/cm.20461; Han GA, 2010, J NEUROCHEM, V115, P1, DOI 10.1111/j.1471-4159.2010.06900.x; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Heasley LR, 2014, EUKARYOT CELL, V13, P1411, DOI 10.1128/EC.00191-14; Hsu SC, 1999, TRENDS CELL BIOL, V9, P150, DOI 10.1016/S0962-8924(99)01516-0; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Hu QC, 2008, J BIOL CHEM, V283, P29563, DOI 10.1074/jbc.M804962200; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Ito H, 2009, J NEUROCHEM, V108, P867, DOI 10.1111/j.1471-4159.2008.05849.x; Iwase M, 2004, GENES GENET SYST, V79, P199, DOI 10.1266/ggs.79.199; Kaeser PS, 2014, ANNU REV PHYSIOL, V76, P333, DOI 10.1146/annurev-physiol-021113-170338; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P483, DOI 10.1098/rspb.1965.0016; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kinoshita A, 2000, J COMP NEUROL, V428, P223, DOI 10.1002/1096-9861(20001211)428:2<223::AID-CNE3>3.0.CO;2-M; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Mandel-Gutfreund Y, 2011, BIOL CHEM, V392, P783, DOI 10.1515/BC.2011.089; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Mostowy S, 2009, J BIOL CHEM, V284, P11613, DOI 10.1074/jbc.M900231200; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; Nakahira M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013799; Naydenov NG, 2012, J BIOL CHEM, V287, P5928, DOI 10.1074/jbc.M111.278358; Ono R, 2005, MOL CELL BIOL, V25, P10965, DOI 10.1128/MCB.25.24.10965-10978.2005; Padilla-Benavides T, 2010, MOL BIOL CELL, V21, P2217, DOI 10.1091/mbc.E10-01-0081; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rittmeyer EN, 2008, J CELL SCI, V121, P391, DOI 10.1242/jcs.016881; Rizzoli SO, 2014, EMBO J, V33, P788, DOI 10.1002/embj.201386357; Saarikangas J, 2011, EMBO REP, V12, P1118, DOI 10.1038/embor.2011.193; Sharma M, 2012, EMBO J, V31, P829, DOI 10.1038/emboj.2011.467; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Sharma S, 2013, NATURE, V499, P238, DOI 10.1038/nature12229; Sidhaye VK, 2011, AM J RESP CELL MOL, V45, P120, DOI 10.1165/rcmb.2010-0235OC; Smith SM, 2012, CELL CALCIUM, V52, P226, DOI 10.1016/j.ceca.2012.06.001; Spiliotis ET, 2008, J CELL BIOL, V180, P295, DOI 10.1083/jcb.200710039; Spiliotis ET, 2010, CYTOSKELETON, V67, P339, DOI 10.1002/cm.20448; Stanley AC, 2010, PHYSIOLOGY, V25, P218, DOI 10.1152/physiol.00017.2010; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tokhtaeva E, 2012, J BIOL CHEM, V287, P26115, DOI 10.1074/jbc.M112.370734; Tokhtaeva E, 2012, J CELL SCI, V125, P1605, DOI 10.1242/jcs.100149; Tokhtaeva E, 2010, J BIOL CHEM, V285, P39289, DOI 10.1074/jbc.M110.172858; Tooley AJ, 2009, NAT CELL BIOL, V11, P17, DOI 10.1038/ncb1808; Tsang CW, 2008, MOL CELL BIOL, V28, P7012, DOI 10.1128/MCB.00035-08; Tsang CW, 2011, BIOL CHEM, V392, P739, DOI 10.1515/BC.2011.077; Vagin O, 2014, J CELL SCI, V127, P3294, DOI 10.1242/jcs.146324; Vagin O, 2006, J BIOL CHEM, V281, P39573, DOI 10.1074/jbc.M606507200; Vega IE, 2003, NEUROREPORT, V14, P31, DOI 10.1097/00001756-200301200-00006; Wasik AA, 2012, MOL BIOL CELL, V23, P3370, DOI 10.1091/mbc.E11-12-1010; Xue J, 2004, J NEUROCHEM, V91, P579, DOI 10.1111/j.1471-4159.2004.02755.x; Yang YM, 2010, NEURON, V67, P100, DOI 10.1016/j.neuron.2010.06.003	69	52	52	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5280	5297		10.1074/jbc.M114.616201	http://dx.doi.org/10.1074/jbc.M114.616201			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25575596	Green Published, hybrid			2022-12-26	WOS:000350044200005
J	Willenborg, J; Huber, C; Koczula, A; Lange, B; Eisenreich, W; Valentin-Weigand, P; Goethe, R				Willenborg, Joerg; Huber, Claudia; Koczula, Anna; Lange, Birgit; Eisenreich, Wolfgang; Valentin-Weigand, Peter; Goethe, Ralph			Characterization of the Pivotal Carbon Metabolism of Streptococcus suis Serotype 2 under ex Vivo and Chemically Defined in Vitro Conditions by Isotopologue Profiling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-MENINGITIS; FLUID BARRIER; VIRULENCE; PATHOGENESIS; SERINE; ACID; EPIDEMIOLOGY; TRANSDUCTION; PNEUMONIAE; RESISTANCE	Streptococcus suis is a neglected zoonotic pathogen that has to adapt to the nutritional requirements in the different host niches encountered during infection and establishment of invasive diseases. To dissect the central metabolic activity of S. suis under different conditions of nutrient availability, we performed labeling experiments starting from [C-13]glucose specimens and analyzed the resulting isotopologue patterns in amino acids of S. suis grown under in vitro and ex vivo conditions. In combination with classical growth experiments, we found that S. suis is auxotrophic for Arg, Gln/Glu, His, Leu, and Trp in chemically defined medium. De novo biosynthesis was shown for Ala, Asp, Ser, and Thr at high rates and for Gly, Lys, Phe, Tyr, and Val at moderate or low rates, respectively. Glucose degradation occurred mainly by glycolysis and to a minor extent by the pentose phosphate pathway. Furthermore, the exclusive formation of oxaloacetate by phosphoenolpyruvate (PEP) carboxylation became evident from the patterns in de novo synthesized amino acids. Labeling experiments with S. suis grown ex vivo in blood or cerebrospinal fluid reflected the metabolic adaptation to these host niches with different nutrient availability; however, similar key metabolic activities were identified under these conditions. This points at the robustness of the core metabolic pathways in S. suis during the infection process. The crucial role of PEP carboxylation for growth of S. suis in the host was supported by experiments with a PEP carboxylase-deficient mutant strain in blood and cerebrospinal fluid.	[Willenborg, Joerg; Koczula, Anna; Valentin-Weigand, Peter; Goethe, Ralph] Univ Vet Med Hannover, Inst Microbiol, D-30173 Hannover, Germany; [Huber, Claudia; Lange, Birgit; Eisenreich, Wolfgang] Tech Univ Munich, Lehrstuhl Biochem, D-85747 Garching, Germany	University of Veterinary Medicine Hannover, Foundation; Technical University of Munich	Willenborg, J (corresponding author), Univ Vet Med Hannover, Inst Microbiol, Bischofsholer Damm 15, D-30173 Hannover, Germany.	joerg.willenborg@tiho-hannover.de	Lange, Birgit/X-6514-2019; Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279	Deutsche Forschungsgemeinschaft [GO-983-3/1, EI-384/5-1, SPP1316]; Niedersachsen-Research Network on Neuroinfectiology of the Ministry of Science and Culture of Lower Saxony	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Niedersachsen-Research Network on Neuroinfectiology of the Ministry of Science and Culture of Lower Saxony	This work was supported by Grants GO-983-3/1 and EI-384/5-1 from the Deutsche Forschungsgemeinschaft within the Priority Programme SPP1316 and by the Niedersachsen-Research Network on Neuroinfectiology of the Ministry of Science and Culture of Lower Saxony.	Auzat I, 1999, MOL MICROBIOL, V34, P1018, DOI 10.1046/j.1365-2958.1999.01663.x; Baums Christoph Georg, 2009, Animal Health Research Reviews, V10, P65, DOI 10.1017/S146625230999003X; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; BLAKLEY RL, 1955, BIOCHEM J, V61, P315, DOI 10.1042/bj0610315; Chubukov V, 2014, NAT REV MICROBIOL, V12, P327, DOI 10.1038/nrmicro3238; Eisenreich W, 2006, P NATL ACAD SCI USA, V103, P2040, DOI 10.1073/pnas.0507580103; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Eylert E, 2010, J BIOL CHEM, V285, P22232, DOI 10.1074/jbc.M110.128678; Fittipaldi N, 2007, VACCINE, V25, P3524, DOI 10.1016/j.vaccine.2007.01.084; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Fuchs TM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00023; Fuchs TM, 2012, FEMS MICROBIOL REV, V36, P435, DOI 10.1111/j.1574-6976.2011.00301.x; Garrigues C, 1997, J BACTERIOL, V179, P5282, DOI 10.1128/jb.179.17.5282-5287.1997; Gillmaier N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052378; Gotz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010586; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Gruening P, 2006, J BACTERIOL, V188, P361, DOI 10.1128/JB.188.2.361-369.2006; Hartel T, 2012, J BIOL CHEM, V287, P4260, DOI 10.1074/jbc.M111.304311; HICKMAN R, 1986, EUR SURG RES, V18, P283, DOI 10.1159/000128537; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Hui ACF, 2005, CLIN NEUROL NEUROSUR, V107, P366, DOI 10.1016/j.clineuro.2004.10.006; Kaiser GM, 2007, LAB ANIM-UK, V41, P80, DOI 10.1258/002367707779399509; Koczula A, 2014, J MICROBIOL METH, V107, P80, DOI 10.1016/j.mimet.2014.09.007; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Li M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002080; MONTGOMERY GW, 1980, HORM METAB RES, V12, P304, DOI 10.1055/s-2007-996276; Neijssel O.M., 1997, SOC APPL BACTERIOL S, V26, P125; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Noor E, 2010, MOL CELL, V39, P809, DOI 10.1016/j.molcel.2010.08.031; Okwumabua O, 2001, CLIN DIAGN LAB IMMUN, V8, P251, DOI 10.1128/CDLI.8.2.251-257.2001; Pan XZ, 2009, J BACTERIOL, V191, P2601, DOI 10.1128/JB.01309-08; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; POOLMAN B, 1993, FEMS MICROBIOL REV, V12, P125, DOI 10.1111/j.1574-6976.1993.tb00015.x; Rosenling T, 2009, J PROTEOME RES, V8, P5511, DOI 10.1021/pr9005876; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Schar J, 2010, J BACTERIOL, V192, P1774, DOI 10.1128/JB.01132-09; SCHIRCH V, 1985, J BACTERIOL, V163, P1; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Silva LMG, 2006, VET MICROBIOL, V115, P117, DOI 10.1016/j.vetmic.2005.12.013; SMITH HE, 1995, MICROBIOL-UK, V141, P181, DOI 10.1099/00221287-141-1-181; Sperandio B, 2007, J BACTERIOL, V189, P7032, DOI 10.1128/JB.00703-07; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Tang JKH, 2012, J R SOC INTERFACE, V9, P2767, DOI 10.1098/rsif.2012.0396; Tenenbaum T, 2005, FEMS IMMUNOL MED MIC, V44, P25, DOI 10.1016/j.femsim.2004.12.006; Tenenbaum T, 2009, CELL MICROBIOL, V11, P323, DOI 10.1111/j.1462-5822.2008.01255.x; van Hulst RA, 2003, CLIN PHYSIOL FUNCT I, V23, P143; Varela NP, 2013, ANIM HEALTH RES REV, V14, P68, DOI 10.1017/S1466252313000029; Huong VTL, 2014, EMERG INFECT DIS, V20, P1105, DOI 10.3201/eid2007.131594; Wertheim HFL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005973; Willenborg J, 2011, MICROBIOL-SGM, V157, P1823, DOI 10.1099/mic.0.046417-0; Willenborg J, 2014, MOL MICROBIOL, V92, P61, DOI 10.1111/mmi.12537; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194	55	11	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5840	5854		10.1074/jbc.M114.619163	http://dx.doi.org/10.1074/jbc.M114.619163			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25575595	Green Published, hybrid			2022-12-26	WOS:000350044200049
J	Mani, A; Ravindran, R; Mannepalli, S; Vang, D; Luciw, PA; Hogarth, M; Khan, IH; Krishnan, VV				Mani, Akshay; Ravindran, Resmi; Mannepalli, Soujanya; Vang, Daniel; Luciw, Paul A.; Hogarth, Michael; Khan, Imran H.; Krishnan, Viswanathan V.			Data Mining Strategies to Improve Multiplex Microbead Immunoassay Tolerance in a Mouse Model of Infectious Diseases	PLOS ONE			English	Article							SIMULTANEOUS SERODETECTION; MICE; VIRUS; PARVOVIRUS; CYTOKINES	Multiplex methodologies, especially those with high-throughput capabilities generate large volumes of data. Accumulation of such data (e.g., genomics, proteomics, metabolomics etc.) is fast becoming more common and thus requires the development and implementation of effective data mining strategies designed for biological and clinical applications. Multiplex microbead immunoassay (MMIA), on xMAP or MagPix platform (Luminex), which is amenable to automation, offers a major advantage over conventional methods such as Western blot or ELISA, for increasing the efficiencies in serodiagnosis of infectious diseases. MMIA allows detection of antibodies and/or antigens efficiently for a wide range of infectious agents simultaneously in host blood samples, in one reaction vessel. In the process, MMIA generates large volumes of data. In this report we demonstrate the application of data mining tools on how the inherent large volume data can improve the assay tolerance (measured in terms of sensitivity and specificity) by analysis of experimental data accumulated over a span of two years. The combination of prior knowledge with machine learning tools provides an efficient approach to improve the diagnostic power of the assay in a continuous basis. Furthermore, this study provides an in-depth knowledge base to study pathological trends of infectious agents in mouse colonies on a multivariate scale. Data mining techniques using serodetection of infections in mice, developed in this study, can be used as a general model for more complex applications in epidemiology and clinical translational research.	[Mani, Akshay; Ravindran, Resmi; Vang, Daniel; Luciw, Paul A.; Khan, Imran H.; Krishnan, Viswanathan V.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Mannepalli, Soujanya; Krishnan, Viswanathan V.] Calif State Univ Fresno, Dept Chem, Fresno, CA 93740 USA; [Luciw, Paul A.; Hogarth, Michael; Khan, Imran H.; Krishnan, Viswanathan V.] Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Davis, CA 95616 USA	University of California System; University of California Davis; California State University System; California State University Fresno; University of California System; University of California Davis	Khan, IH (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	Ihkhan@ucdavis.edu; vvkrishnan@ucdavis.edu	Khan, Imran Ali/GVT-0232-2022; Khan, imran/GQQ-2176-2022	Khan, Imran Ali/0000-0002-8774-2896; 	Department of Pathology and Laboratory Medicine's proteomics and informatics initiative at UC Davis Medical Center; NIH [P20 MD 002732, P20 CA 138025]; NATIONAL CANCER INSTITUTE [P20CA138025] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD002732] Funding Source: NIH RePORTER	Department of Pathology and Laboratory Medicine's proteomics and informatics initiative at UC Davis Medical Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Partial funding from Department of Pathology and Laboratory Medicine's proteomics and informatics initiative at UC Davis Medical Center is acknowledged. VVK and SM were supported in part by NIH grants P20 MD 002732 and P20 CA 138025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Amancio DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094137; ANDERSON CA, 1986, J CLIN MICROBIOL, V23, P1152, DOI 10.1128/JCM.23.6.1152-1154.1986; Bishop C.M., 2006, PATTERN RECOGN, V4; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carson RT, 1999, J IMMUNOL METHODS, V227, P41, DOI 10.1016/S0022-1759(99)00069-1; Carugo O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-380; Cheon DJ, 2011, ANNU REV PATHOL-MECH, V6, P95, DOI 10.1146/annurev.pathol.3.121806.154244; Compton SR, 2004, COMPARATIVE MED, V54, P382; Couzin-Frankel J, 2014, SCIENCE, V346, P28, DOI 10.1126/science.346.6205.28; Couzin-Frankel J, 2014, SCIENCE, V344, P24, DOI [10.1126/science.344.6179.24, 10.1126/science.346.6205.24]; Davies MN, 2007, BIOINFORMATICS, V23, P3113, DOI 10.1093/bioinformatics/btm506; DUCATELLE F, 2006, SOFTWARE DATA MINING; DUDA RO, 2001, PATTERN CLASSIFICATI; Fayyad U, 1996, COMMUN ACM, V39, P27, DOI 10.1145/240455.240464; FOSTER HL, 1981, MOUSE BIOMEDICAL RES; FOX RR, 1997, HDB GENETICALLY STAN; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Gunnarsson RK, 2002, STAT MED, V21, P1773, DOI 10.1002/sim.1119; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hu J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-297; IWARSSON K, 1990, ACTA PHYSIOL SCAND, V140, P139; Jacoby RO, 1997, FASEB J, V11, P609, DOI 10.1096/fasebj.11.8.9240962; JEROLMACK C, 2005, QUALITATIVE SOCIOLOG, V3; Khan IH, 2005, CLIN DIAGN LAB IMMUN, V12, P513, DOI 10.1128/CDLI.12.4.513-519.2005; Khan IH, 2009, CYTOM PART B-CLIN CY, V76B, P159, DOI 10.1002/cyto.b.20452; Krishhan VV, 2009, CRIT REV BIOTECHNOL, V29, P29, DOI 10.1080/07388550802688847; KRISHNAN VV, 2014, CYTOMETRY B; Kumar P, 2012, PATTERN DISCOVERY USING SEQUENCE DATA MINING: APPLICATIONS AND STUDIES, P1, DOI 10.4018/978-1-61350-056-9; Liu LY, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-236; Livingston RS, 2002, CLIN DIAGN LAB IMMUN, V9, P1025, DOI 10.1128/CDLI.9.5.1025-1031.2002; LUSSIER G, 1986, LAB ANIM SCI, V36, P145; Marx V, 2013, NATURE, V496, P253, DOI 10.1038/498255a; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; POROPUDAS J, 2007, ANAL AIR COMBAT SIMU; Pullium JK, 2004, CONTEMP TOP LAB ANIM, V43, P8; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; R Core Team, 2021, R LANGUAGE ENV STAT; Ravindran R, 2010, J IMMUNOL METHODS, V363, P51, DOI 10.1016/j.jim.2010.10.003; Selvaraj S, 2011, BIOINFORMATION, V6, P95, DOI 10.6026/97320630006095; SUZUKI E, 1982, JPN J MED SCI BIOL, V35, P249, DOI 10.7883/yoken1952.35.249; *US DEP AGR AAPHIS, 2011, ANN REP AN US FISC Y; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Witten I.H., 2000, DATA MINING PRACTICA; Witten IH, 2011, MOR KAUF D, pXXI; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Wolpert DH, 2005, IEEE T EVOLUT COMPUT, V9, P721, DOI 10.1109/TEVC.2005.856205; Wolpert DH, 1996, PHYS REV E, V54, P6973, DOI 10.1103/PhysRevE.54.6973.2; Wu X, 2009, CH CRC DATA MIN KNOW, P1, DOI 10.1201/9781420089653; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2	53	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116262	10.1371/journal.pone.0116262	http://dx.doi.org/10.1371/journal.pone.0116262			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25614982	Green Published, gold, Green Submitted			2022-12-26	WOS:000349122100025
J	Vijay, V; Han, T; Moland, CL; Kwekel, JC; Fuscoe, JC; Desai, VG				Vijay, Vikrant; Han, Tao; Moland, Carrie L.; Kwekel, Joshua C.; Fuscoe, James C.; Desai, Varsha G.			Sexual Dimorphism in the Expression of Mitochondria-Related Genes in Rat Heart at Different Ages	PLOS ONE			English	Article							GENDER-RELATED DIFFERENCES; MOUSE MODEL; CARDIOMYOPATHY; DYSFUNCTION; APOPTOSIS; DEHYDROGENASE; INJURY; LIVER; HYPERTROPHY; DEFICIENCY	Cardiovascular disease (CVD) is the leading cause of mortality worldwide. Moreover, sex and age are considered major risk factors in the development of CVDs. Mitochondria are vital for normal cardiac function, and regulation of mitochondrial structure and function may impact susceptibility to CVD. To identify potential role of mitochondria in sex-related differences in susceptibility to CVD, we analyzed the basal expression levels of mitochondria-related genes in the hearts of male and female rats. Whole genome expression profiling was performed in the hearts of young (8-week), adult (21-week), and old (78-week) male and female Fischer 344 rats and the expression of 670 unique genes related to various mitochondrial functions was analyzed. A significant (p<0.05) sexual dimorphism in expression levels of 46, 114, and 41 genes was observed in young, adult and old rats, respectively. Gene Ontology analysis revealed the influence of sex on various biological pathways related to cardiac energy metabolism at different ages. The expression of genes involved in fatty acid metabolism was significantly different between the sexes in young and adult rat hearts. Adult male rats also showed higher expression of genes associated with the pyruvate dehydrogenase complex compared to females. In young and adult hearts, sexual dimorphism was not noted in genes encoding oxidative phosphorylation. In old rats, however, a majority of genes involved in oxidative phosphorylation had higher expression in females compared to males. Such basal differences between the sexes in cardiac expression of genes associated with energy metabolism may indicate a likely involvement of mitochondria in susceptibility to CVDs. In addition, female rats showed lower expression levels of apoptotic genes in hearts compared to males at all ages, which may have implications for better preservation of cardiac mass in females than in males.	[Vijay, Vikrant; Han, Tao; Moland, Carrie L.; Kwekel, Joshua C.; Fuscoe, James C.; Desai, Varsha G.] US FDA, Personalized Med Branch, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	US Food & Drug Administration (FDA)	Desai, VG (corresponding author), US FDA, Personalized Med Branch, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	varsha.desai@fda.hhs.gov	Vijay, Vikrant/E-7651-2010	Vijay, Vikrant/0000-0001-8425-1285; Desai, Varsha/0000-0002-5285-3801	FDA Office of Women's Health; U.S. Department of Energy; U.S. Food and Drug Administration	FDA Office of Women's Health; U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Food and Drug Administration	We thank the FDA Office of Women's Health for support of this project. This research was supported in part by an appointment to the Research Participation Program at the National Center for Toxicological Research administered by the Oak Ridge Institute for Science and Education through an inter-agency agreement between the U.S. Department of Energy and the U.S. Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews MT, 2004, BIOCHEM SOC T, V32, P1021, DOI 10.1042/BST0321021; Arieli Y, 2004, J MOL CELL CARDIOL, V37, P507, DOI 10.1016/j.yjmcc.2004.04.023; Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014; BUCHWALD A, 1990, EUR HEART J, V11, P509, DOI 10.1093/oxfordjournals.eurheartj.a059743; Colom B, 2007, CARDIOVASC RES, V74, P456, DOI 10.1016/j.cardiores.2007.02.001; Conner P, 2007, ANN MED, V39, P28, DOI 10.1080/07853890601039842; Czubryt MP, 2006, CAN J PHYSIOL PHARM, V84, P93, DOI 10.1139/Y05-151; Delongchamp R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S11; Desai VG, 2009, MITOCHONDRION, V9, P9, DOI 10.1016/j.mito.2008.09.002; Du XJ, 2004, CARDIOVASC RES, V63, P510, DOI 10.1016/j.cardiores.2004.03.027; Fang H, 2009, METHODS MOL BIOL, V563, P379, DOI 10.1007/978-1-60761-175-2_20; Forman DE, 1997, J AM COLL CARDIOL, V30, P1872, DOI 10.1016/S0735-1097(97)00411-7; Genova ML, 2004, ANN NY ACAD SCI, V1011, P86, DOI 10.1196/annals.1293.010; GERTZ EW, 1988, J CLIN INVEST, V82, P2017, DOI 10.1172/JCI113822; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Griffin M, 2000, MOL CELL BIOCHEM, V215, P21, DOI 10.1023/A:1026585420021; Harris RA, 2001, ADV ENZYME REGUL, V41, P269, DOI 10.1016/S0065-2571(00)00020-0; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Ibdah JA, 2001, J CLIN INVEST, V107, P1403, DOI 10.1172/JCI12590; Jian BX, 2011, MOL MED, V17, P542, DOI 10.2119/molmed.2010.00195; Joseph A, 2009, MITOCHONDRION, V9, P149, DOI 10.1016/j.mito.2009.02.002; KAJSTURA J, 1995, EXP CELL RES, V219, P110, DOI 10.1006/excr.1995.1211; Kashimshetty R, 2009, TOXICOL APPL PHARM, V238, P150, DOI 10.1016/j.taap.2009.05.007; Klinge CM, 2008, J CELL BIOCHEM, V105, P1342, DOI 10.1002/jcb.21936; Kodde IF, 2007, COMP BIOCHEM PHYS A, V146, P26, DOI 10.1016/j.cbpa.2006.09.014; KUKA S, 2013, GEN PHYSL BIOPHYS; Kurdi Mazen, 2011, Congest Heart Fail, V17, P255, DOI 10.1111/j.1751-7133.2011.00269.x; Kwekel JC, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-14; Kwekel JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-675; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Lee TW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S20; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luczak ED, 2009, ANNU REV PHYSIOL, V71, P1, DOI 10.1146/annurev.physiol.010908.163156; Mahmoodzadeh S, 2012, Handb Exp Pharmacol, P23, DOI 10.1007/978-3-642-30726-3_2; MarinGarcia J, 1997, BIOCHEM CELL BIOL, V75, P137, DOI 10.1139/bcb-75-2-137; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Merz CNB, 1996, AM HEART J, V131, P704; Mihl C, 2008, NETH HEART J, V16, P129, DOI 10.1007/BF03086131; Miller VM, 2010, WOMENS HEALTH, V6, P737, DOI [10.2217/whe.10.53, 10.2217/WHE.10.53]; Miller Virginia M, 2011, Sex Reprod Menopause, V9, P21; Mosca L, 1997, CIRCULATION, V96, P2468; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; OLIVETTI G, 1995, J AM COLL CARDIOL, V26, P1068, DOI 10.1016/0735-1097(95)00282-8; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Organization WH, 2011, GLOB STAT REP NONC D; Ostadal B, 2007, RESP PHYSIOL NEUROBI, V158, P224, DOI 10.1016/j.resp.2007.03.005; Ostadal B, 2009, EXP BIOL MED, V234, P1011, DOI 10.3181/0812-MR-362; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Regitz-Zagrosek V, 2010, CIRC J, V74, P1265, DOI 10.1253/circj.CJ-10-0196; ROCCHICCIOLI F, 1990, PEDIATR RES, V28, P657, DOI 10.1203/00006450-199012000-00023; Rosenberg P, 2004, MITOCHONDRION, V4, P621, DOI 10.1016/j.mito.2004.07.016; RUSTIN P, 1994, J PEDIATR-US, V124, P224, DOI 10.1016/S0022-3476(94)70308-6; Sanz A, 2007, EXP GERONTOL, V42, P173, DOI 10.1016/j.exger.2006.10.003; SASS B, 1975, J NATL CANCER I, V54, P1449, DOI 10.1093/jnci/54.6.1449; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Speijer D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0446; Stanley William C, 2002, Heart Fail Rev, V7, P115, DOI 10.1023/A:1015320423577; Tein I, 1999, SEMIN PERINATOL, V23, P125, DOI 10.1016/S0146-0005(99)80046-9; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; VANDERVUSSE GJ, 1992, PHYSIOL REV, V72, P881, DOI 10.1152/physrev.1992.72.4.881; Vassalle C, 2012, GYNECOL ENDOCRINOL, V28, P746, DOI 10.3109/09513590.2011.652720; Wallace DC, 2000, AM HEART J, V139, pS70, DOI 10.1067/mhj.2000.103934; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Yan L, 2004, J MOL CELL CARDIOL, V37, P921, DOI 10.1016/j.yjmcc.2004.06.012; Yu Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4230	67	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117047	10.1371/journal.pone.0117047	http://dx.doi.org/10.1371/journal.pone.0117047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615628	Green Submitted, Green Published, gold			2022-12-26	WOS:000349122100053
J	Yasumoto, Y; Nakao, R; Oishi, K				Yasumoto, Yuki; Nakao, Reiko; Oishi, Katsutaka			Free Access to a Running-Wheel Advances the Phase of Behavioral and Physiological Circadian Rhythms and Peripheral Molecular Clocks in Mice	PLOS ONE			English	Article							GENE-EXPRESSION; VOLUNTARY EXERCISE; SLEEP-WAKE; LIGHT; TIME; SYSTEM; PGC-1-ALPHA; PROTEIN; ALTERS; ALPHA	Behavioral and physiological circadian rhythms are controlled by endogenous oscillators in animals. Voluntary wheel-running in rodents is thought to be an appropriate model of aerobic exercise in humans. We evaluated the effects of chronic voluntary exercise on the circadian system by analyzing temporal profiles of feeding, core body temperature, plasma hormone concentrations and peripheral expression of clock and clock-controlled genes in mice housed under sedentary (SED) conditions or given free access to a running-wheel (RW) for four weeks. Voluntary wheel-running activity advanced the circadian phases of increases in body temperature, food intake and corticosterone secretion in the mice. The circadian expression of clock and clock-controlled genes was tissue-and gene-specifically affected in the RW mice. The temporal expression of E-box-dependent circadian clock genes such as Per1, Per2, Nr1d1 and Dbp were slightly, but significantly phase-advanced in the liver and white adipose tissue, but not in brown adipose tissue and skeletal muscle. Peak levels of Per1, Per2 and Nr1d1 expression were significantly increased in the skeletal muscle of RW mice. The circadian phase and levels of hepatic mRNA expression of the clock-controlled genes that are involved in cholesterol and fatty acid metabolism significantly differed between SED and RW mice. These findings indicated that endogenous clock-governed voluntary wheel-running activity provides feedback to the central circadian clock that systemically governs behavioral and physiological rhythms.	[Yasumoto, Yuki; Nakao, Reiko; Oishi, Katsutaka] Natl Inst Adv Ind Sci & Technol, Biol Clock Res Grp, Biomed Res Inst, Tsukuba, Ibaraki, Japan; [Yasumoto, Yuki; Oishi, Katsutaka] Tokyo Univ Sci, Grad Sch Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan; [Oishi, Katsutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Tokyo University of Science; University of Tokyo	Oishi, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Biol Clock Res Grp, Biomed Res Inst, Tsukuba, Ibaraki, Japan.	k-ooishi@aist.go.jp	Oishi, Katsutaka/L-6906-2018	Oishi, Katsutaka/0000-0002-4870-0837	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [25350179, 24620015]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partly supported by Grants-in-Aid for Scientific Research (C) KAKENHI to K. Oishi (25350179) and R. Nakao (24620015) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamah-Biassi EB, 2013, BEHAV BRAIN RES, V243, P306, DOI 10.1016/j.bbr.2013.01.003; Ando H, 2005, ENDOCRINOLOGY, V146, P5631, DOI 10.1210/en.2005-0771; Ando H, 2011, ENDOCRINOLOGY, V152, P1347, DOI 10.1210/en.2010-1068; Belden WJ, 2008, CELL, V134, P212, DOI 10.1016/j.cell.2008.07.010; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chikahisa S, 2008, ENDOCRINOLOGY, V149, P5262, DOI 10.1210/en.2008-0285; Droste SK, 2003, ENDOCRINOLOGY, V144, P3012, DOI 10.1210/en.2003-0097; EDGAR DM, 1991, PHYSIOL BEHAV, V50, P373, DOI 10.1016/0031-9384(91)90080-8; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Husse J, 2014, FASEB J, V28, P4950, DOI 10.1096/fj.14-256594; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kuroda H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00711; Lakka TA, 2005, HANDB EXP PHARM, V170, P137; Leise TL, 2013, AGE, V35, P2137, DOI 10.1007/s11357-012-9502-y; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Marcheva Biliana, 2013, Handb Exp Pharmacol, P127, DOI 10.1007/978-3-642-25950-0_6; Mendoza J, 2008, J PHYSIOL-LONDON, V586, P5901, DOI 10.1113/jphysiol.2008.159566; Mistlberger RE, 2000, AM J PHYSIOL-REG I, V279, pR813, DOI 10.1152/ajpregu.2000.279.3.R813; Novak CM, 2012, NEUROSCI BIOBEHAV R, V36, P1001, DOI 10.1016/j.neubiorev.2011.12.012; Ohkura N, 2007, CHRONOBIOL INT, V24, P651, DOI 10.1080/07420520701534673; Oike Hideaki, 2014, Curr Nutr Rep, V3, P204; Oishi K, 2013, FEBS OPEN BIO, V3, P192, DOI 10.1016/j.fob.2013.03.005; Oishi K, 2011, BIOCHEM BIOPH RES CO, V412, P396, DOI 10.1016/j.bbrc.2011.07.125; Oishi K, 2009, ARTERIOSCL THROM VAS, V29, P1571, DOI 10.1161/ATVBAHA.109.190140; Pendergast JS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00177; Robinson I, 2014, FEBS LETT, V588, P2477, DOI 10.1016/j.febslet.2014.06.005; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Sakurai T, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/801743; Schroeder AM, 2012, J PHYSIOL-LONDON, V590, P6213, DOI 10.1113/jphysiol.2012.233676; Shibata S, 2010, ADV DRUG DELIVER REV, V62, P918, DOI 10.1016/j.addr.2010.06.003; Shirai H, 2007, BIOCHEM BIOPH RES CO, V357, P679, DOI 10.1016/j.bbrc.2007.04.002; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Terazono H, 2003, P NATL ACAD SCI USA, V100, P6795, DOI 10.1073/pnas.0936797100; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Wolff G, 2012, MED SCI SPORT EXER, V44, P1663, DOI 10.1249/MSS.0b013e318255cf4c; Yamanaka Y, 2014, AM J PHYSIOL-REG I, V307, pR546, DOI 10.1152/ajpregu.00087.2014; Yamanaka Y, 2013, AM J PHYSIOL-REG I, V305, pR1367, DOI 10.1152/ajpregu.00389.2013; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775	44	40	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116476	10.1371/journal.pone.0116476	http://dx.doi.org/10.1371/journal.pone.0116476			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615603	gold, Green Submitted, Green Published			2022-12-26	WOS:000349122100029
J	Tanno, J; Nakano, S; Kasai, T; Ako, J; Nakamura, S; Senbonmatsu, T; Nishimura, S				Tanno, Jun; Nakano, Shintaro; Kasai, Takatoshi; Ako, Junya; Nakamura, Sunao; Senbonmatsu, Takaaki; Nishimura, Shigeyuki			Increase in Ultrasonic Intensity of Blood Speckle across Moderate Coronary Artery Stenosis Is an Independent Predictor of Functional Coronary Artery Stenosis Measured by Fractional Flow Reserve: Pilot Study	PLOS ONE			English	Article							EXPERT CONSENSUS DOCUMENT; ASSOCIATION TASK-FORCE; INTRAVASCULAR ULTRASOUND; MYOCARDIAL PERFUSION; PRACTICE GUIDELINES; EUROPEAN-SOCIETY; ANGIOGRAPHY; ACQUISITION; STANDARDS; SEVERITY	Background and Aims The degree of coronary artery stenosis should be assessed both anatomically and functionally. We observed that the intensity of blood speckle (IBS) on intravascular ultrasound (IVUS) is low proximal to a coronary artery stenosis, and high distal to the stenosis. We defined step-up IBS as the distal minus the proximal IBS, and speculated that this new parameter could be used for the functional evaluation of stenosis on IVUS. The aims of this study were to assess the relationships between step-up IBS and factors that affect coronary blood flow, and between step-up IBS and fractional flow reserve (FFR). Methods and Results This study enrolled 36 consecutive patients with angina who had a single moderate stenosis in the left anterior descending artery. All patients were evaluated by integrated backscatter IVUS and intracoronary pressure measurements. FFR was calculated from measurements using a coronary pressure wire during hyperemia. Conventional gray-scale IVUS images were recorded, and integrated backscatter was measured in three cross-sectional slices proximal and distal to the stenosis. Step-up IBS was calculated as (mean distal integrated backscatter value) - (mean proximal integrated backscatter value). Stepwise multiple linear regression analysis showed that the heart rate (r = 0.45, P = 0.005), ejection fraction (r = -0.39, P = 0.01), and hemoglobin level (r = -0.32, P = 0.04) were independently correlated with step-up IBS, whereas proximal and distal IBS were not associated with these factors. There was a strong inverse correlation between step-up IBS and FFR (r = -0.84, P < 0.001), which remained significant on stepwise multiple linear regression analysis. Conclusions The newly defined parameter of step-up IBS is potentially useful for the functional assessment of coronary artery stenosis.	[Tanno, Jun; Nakano, Shintaro; Senbonmatsu, Takaaki; Nishimura, Shigeyuki] Saitama Med Univ, Int Med Ctr, Dept Cardiol, Saitama, Japan; [Nakamura, Sunao] New Tokyo Hosp, Chiba, Japan; [Kasai, Takatoshi] Juntendo Univ, Sch Med, Dept Cardiol, Tokyo 113, Japan; [Ako, Junya] Kitasato Univ, Sch Med, Dept Cardiovasc Med, Kanagawa, Japan	Saitama Medical University; Juntendo University; Kitasato University	Tanno, J (corresponding author), Saitama Med Univ, Int Med Ctr, Dept Cardiol, Saitama, Japan.	j_tanno@saitama-med.ac.jp						BACHE RJ, 1977, CIRC RES, V41, P648, DOI 10.1161/01.RES.41.5.648; BRAUNWALD E, 1971, AM J CARDIOL, V27, P416, DOI 10.1016/0002-9149(71)90439-5; Cho I, 2012, CIRCULATION, V126, P304, DOI 10.1161/CIRCULATIONAHA.111.081380; Crossman DC, 2004, HEART, V90, P576, DOI 10.1136/hrt.2003.029017; Duncker DJ, 2008, PHYSIOL REV, V88, P1009, DOI 10.1152/physrev.00045.2006; ELLIS AK, 1980, CIRC RES, V46, P68, DOI 10.1161/01.RES.46.1.68; Ercan M, 2003, ANESTH ANALG, V96, P307, DOI 10.1097/00000539-200301000-00073; Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2; Govindaraju K, 2012, PHYS MED; Hillis LD, 2011, CIRCULATION, V124, pE652, DOI 10.1161/CIR.0b013e31823c074e; Jeremias A, 2000, CIRCULATION, V101, P318, DOI 10.1161/01.CIR.101.3.318; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Matsuo H, 2002, CIRCULATION, V105, P1060, DOI 10.1161/hc0902.104719; Mintz GS, 2011, EUROINTERVENTION, V6, P1123, DOI 10.4244/EIJV6I9A195; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Pakkal M, 2011, Br J Radiol, V84 Spec No 3, pS280, DOI 10.1259/bjr/50903757; Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604; Pijls NHJ, 2012, J AM COLL CARDIOL, V59, P1045, DOI 10.1016/j.jacc.2011.09.077; Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tobis J, 2007, J AM COLL CARDIOL, V49, P839, DOI 10.1016/j.jacc.2006.10.055; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; VANDERHEIDEN MS, 1995, ULTRASOUND MED BIOL, V21, P817, DOI 10.1016/0301-5629(95)00012-G	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116727	10.1371/journal.pone.0116727	http://dx.doi.org/10.1371/journal.pone.0116727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607986	gold, Green Published, Green Submitted			2022-12-26	WOS:000348205300033
J	Zhang, CX; Guo, ZX; Liu, HY; Shi, YL; Ge, SL				Zhang, Chengxin; Guo, Zhixiang; Liu, Haiyuan; Shi, Yinglu; Ge, Shenglin			Influence of Levosimendan Postconditioning on Apoptosis of Rat Lung Cells in a Model of Ischemia-Reperfusion Injury	PLOS ONE			English	Article							CONTROLLED OXYGEN REPERFUSION; CARDIOPULMONARY BYPASS; HEART-FAILURE; SURGERY; CHANNELS	Objective To ascertain if levosimendan postconditioning can alleviate lung ischemia-reperfusion injury (LIRI) in rats. Method One hundred rats were divided into five groups: Sham (sham), ischemia-reperfusion group (I/R group), ischemic postconditioning (IPO group), levosimendan postconditioning (Levo group) and combination postconditioning group of levosimendan and 5-Hydroxydecanoic acid (Levo+5-HD group). The apoptotic index (AI) of lung tissue cells was determined using the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Expression of active cysteine aspartate specific protease-3 (active caspase-3), Bcl-2 and Bax in lung tissue was determined by immunohistochemical staining. The morphopathology of lung tissue was observed using light and electron microscopy. Results AI values and expression of active caspase-3, Bcl-2 and Bax of lung tissue in I/R and Levo+5-HD groups were significantly higher than those in the sham group (P<0.05). AI values and expression of active caspase-3 and Bax were significantly lower, whereas that of Bcl-2 was higher significantly in the Levo group, compared with I/R and Levo+5-HD groups (P<0.05). Significant differences were not observed in comparisons between I/R and Levo+5-HD groups as well as IPO and Levo groups. Conclusion LIRI can be alleviated by levosimendan, which simulates an IPO protective function. A postulated lung-protective mechanism of action could involve opening of mitochondrial adenosine triphosphate-sensitive potassium channels, relieving Ca2+ overload, upregulation of expression of Bcl-2, and downregulation of expression of active caspase-3 and Bax.	[Zhang, Chengxin; Guo, Zhixiang; Ge, Shenglin] Anhui Med Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Hefei, Anhui, Peoples R China; [Liu, Haiyuan] An Hui Med Univ, He Fei Hosp Affiliated, Dept Oncol, Hefei, Anhui, Peoples R China; [Shi, Yinglu] Chest Hosp Anhui Prov, Dept Cerebral Surg, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Ge, SL (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Hefei, Anhui, Peoples R China.	aydgsl@sina.com			Anhui Provincial Natural Science Research Projects in Colleges and Universities in China [KJ2013Z108]	Anhui Provincial Natural Science Research Projects in Colleges and Universities in China	This study was funded by grant number KJ2013Z108 from Anhui Provincial Natural Science Research Projects in Colleges and Universities in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakis EE, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-1; Canbaz S, 2003, THORAC CARDIOV SURG, V51, P57, DOI 10.1055/s-2003-38983; Dezfulian C, 2013, TRANSL STROKE RES, V4, P19, DOI 10.1007/s12975-012-0224-3; Ersoy O, 2013, CARDIOVASC J AFR, V24, P260, DOI 10.5830/CVJA-2013-047; Hsiao ST, 2014, PHARMACOL THERAPEUT, V142, P141, DOI 10.1016/j.pharmthera.2013.12.002; Jin CH, 2012, J PHYSIOL SCI, V62, P325, DOI 10.1007/s12576-012-0206-y; Kagawa H, 2010, J THORAC CARDIOV SUR, V139, P174, DOI 10.1016/j.jtcvs.2009.08.036; Kim JC, 2012, CHEST, V142, P467, DOI 10.1378/chest.11-2246; Lin YM, 2008, J CELL SCI, V121, P2382, DOI 10.1242/jcs.021394; Maytin M, 2005, AM J CARDIOL, V96, p26G, DOI 10.1016/j.amjcard.2005.07.018; Mockford KA, 2009, EUR J VASC ENDOVASC, V37, P437, DOI 10.1016/j.ejvs.2008.12.017; Moghtadaei M, 2012, MOL BIOL REP, V39, P11093, DOI 10.1007/s11033-012-2015-z; Mykytenko J, 2008, BASIC RES CARDIOL, V103, P472, DOI 10.1007/s00395-008-0731-2; Ng SC, 2005, EUR RESPIR J, V25, P356, DOI 10.1183/09031936.05.00030304; Oikawa M, 2008, CIRC J, V72, P2081, DOI 10.1253/circj.CJ-08-0098; Robin E, 2011, BRAIN RES, V1375, P137, DOI 10.1016/j.brainres.2010.12.054; Rong J, 2013, ASAIO J, V59, P302, DOI 10.1097/MAT.0b013e318290504e; Rong J, 2012, EXP LUNG RES, V38, P183, DOI 10.3109/01902148.2012.662667; Soeding PF, 2011, EUR J PHARMACOL, V655, P59, DOI 10.1016/j.ejphar.2010.12.035; Tasal A, 2014, J CARDIOL, V63, P418, DOI 10.1016/j.jjcc.2013.10.009; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; Wu Q, 2011, J SURG RES, V169, pE155, DOI 10.1016/j.jss.2010.04.009; Xanthos T, 2009, AM J EMERG MED, V27, P651, DOI 10.1016/j.ajem.2008.05.004; Yapic D, 2008, EUR J ANAESTH, V25, P8, DOI 10.1017/S0265021507002736	24	26	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0114963	10.1371/journal.pone.0114963	http://dx.doi.org/10.1371/journal.pone.0114963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25608001	gold, Green Submitted, Green Published			2022-12-26	WOS:000348205300006
J	De Taeye, L; Pourtois, G; Meurs, A; Boon, P; Vonck, K; Carrette, E; Raedt, R				De Taeye, Leen; Pourtois, Gilles; Meurs, Alfred; Boon, Paul; Vonck, Kristl; Carrette, Evelien; Raedt, Robrecht			Event-Related Potentials Reveal Preserved Attention Allocation but Impaired Emotion Regulation in Patients with Epilepsy and Comorbid Negative Affect	PLOS ONE			English	Article							QUALITY-OF-LIFE; THREAT-RELATED STIMULI; NEURAL MECHANISMS; COGNITIVE-CONTROL; MAJOR DEPRESSION; BRAIN POTENTIALS; FACE; ANXIETY; DISORDER; PICTURES	Patients with epilepsy have a high prevalence of comorbid mood disorders. This study aims to evaluate whether negative affect in epilepsy is associated with dysfunction of emotion regulation. Event-related potentials (ERPs) are used in order to unravel the exact electrophysiological time course and investigate whether a possible dysfunction arises during early (attention) and/or late (regulation) stages of emotion control. Fifty epileptic patients with (n = 25) versus without (n = 25) comorbid negative affect plus twenty-five matched controls were recruited. ERPs were recorded while subjects performed a face-or house-matching task in which fearful, sad or neutral faces were presented either at attended or unattended spatial locations. Two ERP components were analyzed: the early vertex positive potential (VPP) which is normally enhanced for faces, and the late positive potential (LPP) that is typically larger for emotional stimuli. All participants had larger amplitude of the early face-sensitive VPP for attended faces compared to houses, regardless of their emotional content. By contrast, in patients with negative affect only, the amplitude of the LPP was significantly increased for unattended negative emotional expressions. These VPP results indicate that epilepsy with or without negative affect does not interfere with the early structural encoding and attention selection of faces. However, the LPP results suggest abnormal regulation processes during the processing of unattended emotional faces in patients with epilepsy and comorbid negative affect. In conclusion, this ERP study reveals that early object-based attention processes are not compromised by epilepsy, but instead, when combined with negative affect, this neurological disease is associated with dysfunction during the later stages of emotion regulation. As such, these new neurophysiological findings shed light on the complex interplay of epilepsy with negative affect during the processing of emotional visual stimuli and in turn might help to better understand the etiology and maintenance of mood disorders in epilepsy.	[De Taeye, Leen; Meurs, Alfred; Boon, Paul; Vonck, Kristl; Carrette, Evelien; Raedt, Robrecht] Ghent Univ Hosp, LCEN3, Dept Neurol, Ghent, Belgium; [Pourtois, Gilles] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University	De Taeye, L (corresponding author), Ghent Univ Hosp, LCEN3, Dept Neurol, Ghent, Belgium.	leen.detaeye@ugent.be		Carrette, Evelien/0000-0002-9736-7401; Pourtois, Gilles/0000-0002-5109-2801; vonck, kristl/0000-0002-2671-2650; Boon, Paul/0000-0002-4180-8896; De Taeye, Leen/0000-0003-4494-3994; Raedt, Robrecht/0000-0002-8939-0169	Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO); Bijzonder Onderzoeksfonds (BOF) Grant from Ghent University; European Research Council; BOF-ZAP grant from Ghent University Hospital; FWO-Flanders; BOF; Clinical Epilepsy Grant from Ghent University Hospital; BOF-Tenure Track grant from Ghent University	Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO)(FWO); Bijzonder Onderzoeksfonds (BOF) Grant from Ghent University; European Research Council(European Research Council (ERC)European Commission); BOF-ZAP grant from Ghent University Hospital(Ghent University); FWO-Flanders(FWO); BOF; Clinical Epilepsy Grant from Ghent University Hospital(Ghent University); BOF-Tenure Track grant from Ghent University	LDT is supported by a Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO) aspirant grant. GP is supported by a Bijzonder Onderzoeksfonds (BOF) Grant from Ghent University and grants from the European Research Council. KV is supported by a BOF-ZAP grant from Ghent University Hospital. PB is supported by grants from FWO-Flanders, grants from BOF and by the Clinical Epilepsy Grant from Ghent University Hospital. RR is supported by a BOF-Tenure Track grant from Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck AT, 1996, MANUAL FOR THE BECK; Bentley P, 2003, NEUROIMAGE, V20, P58, DOI 10.1016/S1053-8119(03)00302-1; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Bishop SJ, 2004, J NEUROSCI, V24, P10364, DOI 10.1523/JNEUROSCI.2550-04.2004; Blumer D, 2004, EPILEPSY BEHAV, V5, P826, DOI 10.1016/j.yebeh.2004.08.003; BOTZEL K, 1989, EXP BRAIN RES, V77, P349, DOI 10.1007/BF00274992; BOTZEL K, 1995, EXP BRAIN RES, V104, P135, DOI 10.1007/BF00229863; Boylan LS, 2004, NEUROLOGY, V62, P258, DOI 10.1212/01.WNL.0000103282.62353.85; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Dennis TA, 2009, J CHILD PSYCHOL PSYC, V50, P1373, DOI 10.1111/j.1469-7610.2009.02168.x; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Ekman P., 1976, PICTURES OF FACIAL A; Fales CL, 2008, BIOL PSYCHIAT, V63, P377, DOI 10.1016/j.biopsych.2007.06.012; Foti D, 2008, J COGNITIVE NEUROSCI, V20, P977, DOI 10.1162/jocn.2008.20066; Foti D, 2010, DEPRESS ANXIETY, V27, P813, DOI 10.1002/da.20712; George N, 1996, COGNITIVE BRAIN RES, V4, P65, DOI 10.1016/0926-6410(95)00045-3; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Hesdorffer DC, 2012, ANN NEUROL, V72, P184, DOI 10.1002/ana.23601; Hesdorffer DC, 2000, ANN NEUROL, V47, P246, DOI 10.1002/1531-8249(200002)47:2<246::AID-ANA17>3.3.CO;2-5; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Holtzheimer PE, 2011, TRENDS NEUROSCI, V34, P1, DOI 10.1016/j.tins.2010.10.004; Hoppe C, 2011, NAT REV NEUROL, V7, P462, DOI 10.1038/nrneurol.2011.104; JEFFREYS DA, 1989, EXP BRAIN RES, V78, P193; Johnson EK, 2004, EPILEPSIA, V45, P544, DOI 10.1111/j.0013-9580.2004.47003.x; Jones JE, 2003, EPILEPSY BEHAV, V4, pS31, DOI 10.1016/j.yebeh.2003.08.019; Jones JE, 2005, J NEUROPSYCH CLIN N, V17, P172, DOI 10.1176/appi.neuropsych.17.2.172; Kanner AM, 2012, EPILEPSY BEHAV, V24, P156, DOI 10.1016/j.yebeh.2012.01.007; Kanner AM, 2011, EPILEPSIA, V52, P21, DOI 10.1111/j.1528-1167.2010.02907.x; Kanner AM, 2010, EPILEPSIA, V51, P1152, DOI 10.1111/j.1528-1167.2010.02582.x; Kondziella D, 2007, J NEUROCHEM, V103, P2136, DOI 10.1111/j.1471-4159.2007.04926.x; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; MacNamara A, 2009, NEUROPSYCHOLOGIA, V47, P2975, DOI 10.1016/j.neuropsychologia.2009.06.026; Moser JS, 2006, PSYCHOPHYSIOLOGY, V43, P292, DOI 10.1111/j.1469-8986.2006.00402.x; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Pourtois G, 2013, BIOL PSYCHOL, V92, P492, DOI 10.1016/j.biopsycho.2012.02.007; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Rosler J, 2014, CLIN NEUROPHYSIOL, V125, P526, DOI 10.1016/j.clinph.2013.08.015; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Sabatinelli D, 2007, CEREB CORTEX, V17, P1085, DOI 10.1093/cercor/bhl017; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Spielberger CD, 1983, MANUAL FOR THE STATE; VANDERDOES AJW, 2002, HANDLEIDING BIJ DE N; VANDERPLOEG HM, 2000, HANDLEIDING BIJ DE Z; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341; Weinberg A, 2011, PSYCHOPHYSIOLOGY, V48, P842, DOI 10.1111/j.1469-8986.2010.01149.x; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574	54	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116817	10.1371/journal.pone.0116817	http://dx.doi.org/10.1371/journal.pone.0116817			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ0ID	25587987	Green Published, Green Submitted, gold			2022-12-26	WOS:000347928300022
J	Krawczyk, A; Dirks, M; Kasper, M; Buch, A; Dittmer, U; Giebel, B; Wildschutz, L; Busch, M; Goergens, A; Schneweis, KE; Eis-Hubinger, AM; Sodeik, B; Heiligenhaus, A; Roggendorf, M; Bauer, D				Krawczyk, Adalbert; Dirks, Miriam; Kasper, Maren; Buch, Anna; Dittmer, Ulf; Giebel, Bernd; Wildschuetz, Lena; Busch, Martin; Goergens, Andre; Schneweis, Karl E.; Eis-Huebinger, Anna M.; Sodeik, Beate; Heiligenhaus, Arnd; Roggendorf, Michael; Bauer, Dirk			Prevention of Herpes Simplex Virus Induced Stromal Keratitis by a Glycoprotein B-Specific Monoclonal Antibody	PLOS ONE			English	Article							IN-VIVO; PASSIVE-IMMUNIZATION; AMNIOTIC MEMBRANE; CORNEAL INFECTION; CAPSID TRANSPORT; NERVOUS-SYSTEM; OCULAR DISEASE; T-LYMPHOCYTES; TYPE-1; SPREAD	The increasing incidence of acyclovir (ACV) and multidrug-resistant strains in patients with corneal HSV-1 infections leading to Herpetic Stromal Keratitis (HSK) is a major health problem in industrialized countries and often results in blindness. To overcome this obstacle, we have previously developed an HSV-gB-specific monoclonal antibody (mAb 2c) that proved to be highly protective in immunodeficient NOD/SCID-mice towards genital infections. In the present study, we examined the effectivity of mAb 2c in preventing the immunopathological disease HSK in the HSK BALB/c mouse model. Therefore, mice were inoculated with HSV-1 strain KOS on the scarified cornea to induce HSK and subsequently either systemically or topically treated with mAb 2c. Systemic treatment was performed by intravenous administration of mAb 2c 24 h prior to infection (pre-exposure prophylaxis) or 24, 40, and 56 hours after infection (post-exposure immunotherapy). Topical treatment was performed by periodical inoculations (5 times per day) of antibody-containing eye drops as control, starting at 24 h post infection. Systemic antibody treatment markedly reduced viral loads at the site of infection and completely protected mice from developing HSK. The administration of the antiviral antibody prior or post infection was equally effective. Topical treatment had no improving effect on the severity of HSK. In conclusion, our data demonstrate that mAb 2c proved to be an excellent drug for the treatment of corneal HSV-infections and for prevention of HSK and blindness. Moreover, the humanized counterpart (mAb hu2c) was equally effective in protecting mice from HSV-induced HSK when compared to the parental mouse antibody. These results warrant the future development of this antibody as a novel approach for the treatment of corneal HSV-infections in humans.	[Krawczyk, Adalbert; Dirks, Miriam; Dittmer, Ulf; Roggendorf, Michael] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany; [Kasper, Maren; Wildschuetz, Lena; Busch, Martin; Heiligenhaus, Arnd; Bauer, Dirk] St Franziskus Hosp, Dept Ophthalmol, Ophtha Lab, Munster, Germany; [Buch, Anna; Sodeik, Beate] Hannover Med Sch, Inst Virol, Hannover, Germany; [Giebel, Bernd; Goergens, Andre] Univ Hosp Essen, Inst Transfus Med, Essen, Germany; [Schneweis, Karl E.; Eis-Huebinger, Anna M.] Univ Med Ctr Bonn, Inst Virol, Bonn, Germany	University of Duisburg Essen; St. Franziskus-Hospital; Hannover Medical School; University of Duisburg Essen; University of Bonn	Krawczyk, A (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany.	adalbert.krawczyk@uni-due.de	Görgens, André/C-3835-2016; Kasper, Maren/AAS-1716-2021; Krawczyk, Adalbert/ABD-7193-2020; Giebel, Bernd/AAH-1083-2021	Görgens, André/0000-0001-9198-0857; Krawczyk, Adalbert/0000-0001-9502-9903; Giebel, Bernd/0000-0003-2446-948X; Sodeik, Beate/0000-0003-4650-3036; Buch, Anna/0000-0003-1415-4492	"Ernst und Berta Grimmke-Stiftung" Foundation [1/13]; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany	"Ernst und Berta Grimmke-Stiftung" Foundation; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany	This study was funded by the "Ernst und Berta Grimmke-Stiftung" Foundation (grant number 1/13, awarded to AK). Anna Buch and Beate Sodeik are supported by the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLANSMITH M, 1979, INVEST OPHTH VIS SCI, V18, P947; ALLANSMITH MR, 1973, ARCH OPHTHALMOL-CHIC, V89, P36, DOI 10.1001/archopht.1973.01000040038010; Bauer D, 2000, CURR EYE RES, V20, P45; Bauer D, 2009, INVEST OPHTH VIS SCI, V50, P3188, DOI 10.1167/iovs.08-3041; Berdugo M, 2012, ANTIMICROB AGENTS CH, V56, P1390, DOI 10.1128/AAC.05145-11; Choong K, 2010, CLIN EXP OPHTHALMOL, V38, P309, DOI 10.1111/j.1442-9071.2010.02209.x; Cohen J, 2010, SCIENCE, V330, P304, DOI 10.1126/science.330.6002.304; Daumer MP, 2011, MED MICROBIOL IMMUN, V200, P85, DOI 10.1007/s00430-010-0174-x; Dastjerdi MH, 2011, INVEST OPHTH VIS SCI, V52, P8718, DOI 10.1167/iovs.11-7871; Dohner K, 2006, J VIROL, V80, P8211, DOI 10.1128/JVI.02528-05; Dohner K, 2002, MOL BIOL CELL, V13, P2795, DOI 10.1091/mbc.01-07-0348; Duan R, 2008, J INFECT DIS, V198, P659, DOI 10.1086/590668; Duan R, 2009, J INFECT DIS, V200, P1402, DOI 10.1086/606028; DUBIN G, 1990, J VIROL, V64, P2725, DOI 10.1128/JVI.64.6.2725-2731.1990; EISHUBINGER AM, 1993, J GEN VIROL, V74, P379, DOI 10.1099/0022-1317-74-3-379; EISHUBINGER AM, 1991, INTERVIROLOGY, V32, P351, DOI 10.1159/000150219; Erickson AL, 2008, CLIN VACCINE IMMUNOL, V15, P1745, DOI 10.1128/CVI.00247-08; Farooq AV, 2012, SURV OPHTHALMOL, V57, P448, DOI 10.1016/j.survophthal.2012.01.005; Ghiasi H, 1998, IMMUNOLOGY, V95, P352; GROTHE C, 1987, J NEUROSCI RES, V18, P539, DOI 10.1002/jnr.490180406; Heiligenhaus A, 2005, INVEST OPHTH VIS SCI, V46, P4079, DOI 10.1167/iovs.05-0192; Heiligenhaus A, 1999, GRAEF ARCH CLIN EXP, V237, P399, DOI 10.1007/s004170050251; Hennig M, 2012, EXP EYE RES, V105, P43, DOI 10.1016/j.exer.2012.09.003; Hjerling-Leffler J, 2007, J NEUROSCI, V27, P2435, DOI 10.1523/JNEUROSCI.5614-06.2007; Hoffman VF, 2000, EXPERT OPIN INV DRUG, V9, P207, DOI 10.1517/13543784.9.2.207; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Jones Cheryl A, 2004, Herpes, V11, P12; Kaye S, 2006, PROG RETIN EYE RES, V25, P355, DOI 10.1016/j.preteyeres.2006.05.001; Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010; Krawczyk A, 2013, P NATL ACAD SCI USA, V110, P6760, DOI 10.1073/pnas.1220019110; Krawczyk A, 2011, J VIROL, V85, P1793, DOI 10.1128/JVI.01924-10; LAUSCH RN, 1989, CURR EYE RES, V8, P499, DOI 10.3109/02713688909000030; Mabit H, 2002, J VIROL, V76, P9962, DOI 10.1128/JVI.76.19.9962-9971.2002; METCALF JF, 1987, CURR EYE RES, V6, P173, DOI 10.3109/02713688709020086; METCALF JF, 1988, INTERVIROLOGY, V29, P39, DOI 10.1159/000150027; Mikloska Z, 1999, J VIROL, V73, P5934, DOI 10.1128/JVI.73.7.5934-5944.1999; Mott KR, 2007, INVEST OPHTH VIS SCI, V48, P2185, DOI 10.1167/iovs.06-1276; NIEMIALTOWSKI MG, 1992, J IMMUNOL, V149, P3035; Osorio Y, 2002, OCUL IMMUNOL INFLAMM, V10, P105, DOI 10.1076/ocii.10.2.105.13982; PRICE RW, 1979, INFECT IMMUN, V23, P373, DOI 10.1128/IAI.23.2.373-383.1979; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Remeijer L, 2004, OCUL IMMUNOL INFLAMM, V12, P255, DOI 10.1080/092739490500363; Richter ER, 2009, J INFECT DIS, V200, P1901, DOI 10.1086/648474; RUSSELL RG, 1984, INVEST OPHTH VIS SCI, V25, P938; Sanna PP, 1999, J VIROL, V73, P8817, DOI 10.1128/JVI.73.10.8817-8823.1999; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; SHIMELD C, 1990, J GEN VIROL, V71, P681, DOI 10.1099/0022-1317-71-3-681; SIMMONS A, 1984, J VIROL, V52, P816, DOI 10.1128/JVI.52.3.816-821.1984; Snijder B, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.9; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Streilein JW, 1997, IMMUNOL TODAY, V18, P443, DOI 10.1016/S0167-5699(97)01114-6; Su YH, 1996, J VIROL, V70, P1277, DOI 10.1128/JVI.70.2.1277-1281.1996; Tang QZ, 1997, J IMMUNOL, V158, P1275; Tang QZ, 1996, J EXP MED, V184, P1435, DOI 10.1084/jem.184.4.1435; Thiel MA, 2002, CLIN EXP IMMUNOL, V128, P67, DOI 10.1046/j.1365-2249.2002.01808.x; WALZ MA, 1974, SCIENCE, V184, P1185, DOI 10.1126/science.184.4142.1185; Wasmuth S, 2008, GRAEF ARCH CLIN EXP, V246, P443, DOI 10.1007/s00417-007-0707-1; Whitbeck JC, 2014, J VIROL, V88, P7786, DOI 10.1128/JVI.00544-14	58	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116800	10.1371/journal.pone.0116800	http://dx.doi.org/10.1371/journal.pone.0116800			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587898	gold, Green Published, Green Submitted			2022-12-26	WOS:000347928300020
J	Maiorka, PC; Favaron, PO; Mess, AM; dos Santos, CR; Alberto, ML; Meirelles, FV; Miglino, MA				Maiorka, Paulo Cesar; Favaron, Phelipe Oliveira; Mess, Andrea Maria; dos Santos, Caio Rodrigues; Alberto, Miryan Lanca; Meirelles, Flavio Vieira; Miglino, Maria Angelica			Vascular Alterations Underlie Developmental Problems Manifested in Cloned Cattle before or after Birth	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; TRANSFER PREGNANCIES; BOVINE PLACENTOMES; TRANSFER CLONING; FARM-ANIMALS; BOS-INDICUS; CALVES; GESTATION; TERM; PERTURBATIONS	Although assisted reproductive techniques are commonly applied in humans and animals, they are frequently associated with major developmental deficits and reduced viability. To explore abnormalities associated with cloning or nuclear transfer (NT) as the most invasive of these methods, we used a bovine model to characterize abnormalities. Detailed necropsy examinations were done on 13 calves that died soon after birth; in addition, we included data from embryos and fetuses (produced by NT) that terminated prematurely. Bovine clones that survived until the neonatal period differed quantitatively and qualitatively from in-vivo-derived cattle. Although alterations affected a variety of organs (e.g. heart, lung and liver), there was a clear association with abberant vascular developmental during the early intrauterine phase. Therefore, we concluded that vascular problems were key alterations induced by cloning (presumably via epigenetic modifications).	[Maiorka, Paulo Cesar; dos Santos, Caio Rodrigues] Univ Sao Paulo, Sch Vet Med, Dept Pathol, Sao Paulo, Brazil; [Favaron, Phelipe Oliveira; Mess, Andrea Maria; Alberto, Miryan Lanca; Miglino, Maria Angelica] Univ Sao Paulo, Sch Vet Med, Dept Surg, Sao Paulo, Brazil; [Meirelles, Flavio Vieira] Univ Sao Paulo, Fac Anim Sci & Food Engn, Pirassununga, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Miglino, MA (corresponding author), Univ Sao Paulo, Sch Vet Med, Dept Pathol, Sao Paulo, Brazil.	miglino@usp.br	Meirelles, Flavio V/B-5048-2010; Miglino, Maria Angelica/B-9519-2012; Maiorka, Paulo/ABG-1405-2020; CTC USP, CEPID 13 18/J-8951-2014	Meirelles, Flavio V/0000-0003-0372-4920; Miglino, Maria Angelica/0000-0003-4979-115X; Favaron, Phelipe/0000-0002-6431-6886; CTC USP, CEPID 13 18/0000-0002-7123-9524	FAPESP [05/60606-3]; CNPq [477740/2008-1]; NETCEM; CAPES [335/2013]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NETCEM; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by grants from FAPESP and CNPq (Process number: 05/60606-3 and 477740/2008-1, respectively) and NETCEM. In addition, Dr. Andrea Mess received support from CAPES (Process: 335/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto MLV, 2013, REPROD FERT DEVELOP, V25, P907, DOI 10.1071/RD12092; [Anonymous], 2012, HUM FERTIL, V15, P62, DOI 10.3109/14647273.2012.663571; Baruselli P. S., 2003, Brazilian Journal of Veterinary Research and Animal Science, V40, P96; Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235; Bertolini M, 2002, THERIOGENOLOGY, V57, P181, DOI 10.1016/S0093-691X(01)00665-3; BIRGELJUNIOR E.H, 2011, Acta Scientiae Veterinariae, V39, P243; Brisville AC, 2011, J VET INTERN MED, V25, P373, DOI 10.1111/j.1939-1676.2011.0693.x; Campos DB, 2010, GENET MOL RES, V9, P309, DOI 10.4238/vol9-1gmr729; Chavatte-Palmer P, 2012, PLACENTA, V33, pS99, DOI 10.1016/j.placenta.2011.09.012; Cibelli JB, 2002, NAT BIOTECHNOL, V20, P13, DOI 10.1038/nbt0102-13; Constant F, 2006, BIOL REPROD, V75, P122, DOI 10.1095/biolreprod.106.051581; Constant F, 2011, THERIOGENOLOGY, V76, P1006, DOI 10.1016/j.theriogenology.2011.04.029; De Bem THC, 2011, CELL REPROGRAM, V13, P419, DOI 10.1089/cell.2011.0010; Edwards JL, 2003, AM J REPROD IMMUNOL, V50, P113, DOI 10.1034/j.1600-0897.2003.00064.x; Eroglu A, 2012, SEMIN REPROD MED, V30, P92, DOI 10.1055/s-0032-1307417; Garry FB, 1996, THERIOGENOLOGY, V45, P141, DOI 10.1016/0093-691X(95)00363-D; Hill JR, 1999, THERIOGENOLOGY, V51, P1451, DOI 10.1016/S0093-691X(99)00089-8; Hill JR, 2000, BIOL REPROD, V63, P1787, DOI 10.1095/biolreprod63.6.1787; Huang YY, 2013, BIOL OPEN, V2, P1223, DOI 10.1242/bio.20135983; Kohda T, 2013, J HUM GENET, V58, P416, DOI 10.1038/jhg.2013.61; Koot YEM, 2013, CURR OPIN OBSTET GYN, V25, P274, DOI 10.1097/GCO.0b013e3283630d94; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Li N, 2005, BIOL REPROD, V73, P139, DOI 10.1095/biolreprod.104.038018; Lopez-Saucedo J, 2012, ANIM REPROD SCI, V133, P129, DOI 10.1016/j.anireprosci.2012.07.003; Meirelles FV, 2010, REPROD FERT DEVELOP, V22, P88, DOI 10.1071/RD09229; MEIRELLES FV, 2006, ACTA SCI VET, V34, P235; Melo EO, 2007, J APPL GENET, V48, P47, DOI 10.1007/BF03194657; Miglino MA, 2007, THERIOGENOLOGY, V68, P604, DOI 10.1016/j.theriogenology.2007.04.060; Ogonuki N, 2002, NAT GENET, V30, P253, DOI 10.1038/ng841; Panarace M, 2007, THERIOGENOLOGY, V67, P142, DOI 10.1016/j.theriogenology.2006.09.036; PEREIRA FC, 2013, PLOS GENET, V9; REICHENBACH HD, 2003, EMBRIAO, V17, P3; Renard JP, 1999, LANCET, V353, P1489, DOI 10.1016/S0140-6736(98)12173-6; Rhind SM, 2003, NAT BIOTECHNOL, V21, P744, DOI 10.1038/nbt0703-744; Rodriguez-Alvarez L, 2013, IN VITRO CELL DEV-AN, V49, P657, DOI 10.1007/s11626-013-9650-0; Sa MF, 2010, ANIM REPROD SCI, V118, P182, DOI 10.1016/j.anireprosci.2009.10.004; Sangalli JR, 2012, CELL REPROGRAM, V14, P235, DOI 10.1089/cell.2011.0079; SANTOS CR, 2010, BRAZ J VET RES ANIM, V45, P447; Shen CJ, 2013, CELL REPROGRAM, V15, P413, DOI 10.1089/cell.2013.0012; Shimozawa N, 2006, REPRODUCTION, V132, P435, DOI 10.1530/rep.1.00745; Shufaro Y, 2013, FERTIL STERIL, V99, P605, DOI 10.1016/j.fertnstert.2013.01.126; Tanaka S, 2006, AM J REPROD IMMUNOL, V55, P28, DOI 10.1111/j.1600-0897.2005.00319.x; Watanabe S, 2013, ANIM SCI J, V84, P631, DOI 10.1111/asj.12087; Wells DN, 2004, CLONING STEM CELLS, V6, P101, DOI 10.1089/1536230041372300; Wells DN, 1997, BIOL REPROD, V57, P385, DOI 10.1095/biolreprod57.2.385; WILSON JM, 1995, ANIM REPROD SCI, V38, P73, DOI 10.1016/0378-4320(94)01353-N; Woelders H, 2012, REPROD DOMEST ANIM, V47, P264, DOI 10.1111/j.1439-0531.2012.02085.x; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155	48	8	8	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0106663	10.1371/journal.pone.0106663	http://dx.doi.org/10.1371/journal.pone.0106663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OG	25584533	gold, Green Published, Green Submitted			2022-12-26	WOS:000348201300001
J	Bhat, A; Heinzel, A; Mayer, B; Perco, P; Muhlberger, I; Husi, H; Merseburger, AS; Zoidakis, J; Vlahou, A; Schanstra, JP; Mischak, H; Jankowski, V				Bhat, Akshay; Heinzel, Andreas; Mayer, Bernd; Perco, Paul; Muehlberger, Irmgard; Husi, Holger; Merseburger, Axel S.; Zoidakis, Jerome; Vlahou, Antonia; Schanstra, Joost P.; Mischak, Harald; Jankowski, Vera			Protein Interactome of Muscle Invasive Bladder Cancer	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; SYSTEMS BIOLOGY; DATABASE; PATHWAYS; GENE; CYTOSKELETON; ENDOCYTOSIS; METASTASIS; BIOMARKERS; CARCINOMA	Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disruptions and alterations of several molecular pathways that result in heterogeneous phenotypes and variable disease outcome. Combining this disparate knowledge may offer insights for deciphering relevant molecular processes regarding targeted therapeutic approaches guided by molecular signatures allowing improved phenotype profiling. The aim of the study is to characterize muscle invasive bladder carcinoma on a molecular level by incorporating scientific literature screening and signatures from omics profiling. Public domain omics signatures together with molecular features associated with muscle invasive bladder cancer were derived from literature mining to provide 286 unique protein-coding genes. These were integrated in a protein-interaction network to obtain a molecular functional map of the phenotype. This feature map educated on three novel disease-associated pathways with plausible involvement in bladder cancer, namely Regulation of actin cytoskeleton, Neurotrophin signalling pathway and Endocytosis. Systematic integration approaches allow to study the molecular context of individual features reported as associated with a clinical phenotype and could potentially help to improve the molecular mechanistic description of the disorder.	[Bhat, Akshay] Charite, Med Klin 4, D-13353 Berlin, Germany; [Bhat, Akshay; Mischak, Harald] Mosaiques Diagnost GmbH, Hannover, Germany; [Heinzel, Andreas; Mayer, Bernd; Perco, Paul; Muehlberger, Irmgard] Emergentec Biodev GmbH, Vienna, Austria; [Husi, Holger; Mischak, Harald] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Merseburger, Axel S.] Hannover Med Sch, Dept Urol & Urol Oncol, Hannover, Germany; [Zoidakis, Jerome; Vlahou, Antonia] Biomed Res Fdn Acad Athens, Div Biotechnol, Athens, Greece; [Schanstra, Joost P.] Fac Med Toulouse, INSERM, U1048, Inst Cardiovasc & Metab Dis, F-31073 Toulouse, France; [Schanstra, Joost P.] Univ Toulouse 3, F-31062 Toulouse, France; [Jankowski, Vera] Inst Mol Cardiovasc Res IMCAR, Aachen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Mosaiques Diagnostics GmbH (MOS); Emergentec Biodevelopment GmbH; University of Glasgow; Hannover Medical School; Academy of Athens; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Jankowski, V (corresponding author), Inst Mol Cardiovasc Res IMCAR, Aachen, Germany.	vjankowski@ukaachen.de	Zoidakis, Jerome/AAO-8236-2021; Perco, Paul/U-2489-2019; Schanstra, Joost P/X-7724-2018; Zoidakis, Jerome/P-9599-2018	Zoidakis, Jerome/0000-0002-4557-3430; Perco, Paul/0000-0003-2087-5691; Schanstra, Joost P/0000-0002-7471-372X; Zoidakis, Jerome/0000-0002-4557-3430; Vlahou, Antonia/0000-0003-3284-5713; Mischak, Harald/0000-0003-0323-0306	Marie Curie Actions - BCMolMed [FP7-PEOPLE-2012-ITN-EID]; European Community's Seventh Framework Programme [306157]	Marie Curie Actions - BCMolMed; European Community's Seventh Framework Programme	This work was supported by Marie Curie Actions - BCMolMed under grant agreement no. FP7-PEOPLE-2012-ITN-EID and the European Community's Seventh Framework Programme under grant agreement no. 306157. Harald Mischak is the founder and co-owner of Mosaiques Diagnostics, who developed the CE-MS technology for clinical application. Akshay Bhat is an employee of Mosaiques Diagnostics. Bernd Mayer is the managing partner of emergentec biodevelopment GmbH, Austria. Paul Perco, Andreas Heinzel and Irmgard Muhlberger are employees of emergentec. Neither Mosaiques Diagnostics GmbH nor emergentec biodevelopment GmbH were involved in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The companies involved only provided financial support in the form of authors' salaries and/or research materials. The specific roles of these authors are articulated in the 'author contributions' section.	Abu-Asab MS, 2011, OMICS, V15, P105, DOI 10.1089/omi.2010.0023; Alberice JV, 2013, J CHROMATOGR A, V1318, P163, DOI 10.1016/j.chroma.2013.10.002; Assimakopoulou M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-202; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bernthaler A, 2009, MOL BIOSYST, V5, P1720, DOI 10.1039/b903109j; Besaratinia A, 2013, EPIGENETICS-US, V8, P1013, DOI 10.4161/epi.25927; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chihara Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-275; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Dakna M, 2009, J CHROMATOGR B, V877, P1250, DOI 10.1016/j.jchromb.2008.10.048; De Las Rivas J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000807; Di Pierro GB, 2012, CURR GENOMICS, V13, P395, DOI 10.2174/138920212801619232; Emmert-Streib F, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-12; Evelyne CCC, 2011, INDIAN J UROL, V27, P245, DOI 10.4103/0970-1591.82845; Ewald JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055414; Frantzi M, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-7; GeneCards, 2013, HUM GEN COMP; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Henning A, 2013, BJU INT, V112, P68, DOI 10.1111/j.1464-410X.2012.11661.x; Huang HZ, 2011, BIOINFORMATICS, V27, P1190, DOI 10.1093/bioinformatics/btr101; Jing X, 2013, GENET MOL BIOL, V36, P287, DOI 10.1590/S1415-47572013005000015; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Karam JA, 2007, CLIN CANCER RES, V13, P4400, DOI 10.1158/1078-0432.CCR-07-0287; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Koochekpour S, 2010, ASIAN J ANDROL, V12, P639, DOI 10.1038/aja.2010.89; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Krishnamurthy L, 2003, BIOINFORMATICS, V19, P930, DOI 10.1093/bioinformatics/btg113; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Mayer G, 2011, METHODS MOL BIOL, V719, P479, DOI 10.1007/978-1-61779-027-0_22; Mayer P, 2012, NEPHROL DIAL TRANSPL, V27, P3995, DOI 10.1093/ndt/gfs489; McConkey DJ, 2010, UROL ONCOL-SEMIN ORI, V28, P429, DOI 10.1016/j.urolonc.2010.04.008; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mischak H, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001249; Mischak H, 2011, PROTEOM CLIN APPL, V5, P9, DOI 10.1002/prca.201000058; Mitra AP, 2009, ANNU REV PATHOL-MECH, V4, P251, DOI 10.1146/annurev.pathol.4.110807.092230; Mitra AP, 2005, BJU INT, V96, P7, DOI 10.1111/j.1464-410X.2005.05557.x; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Philippi S, 2006, NAT REV GENET, V7, P482, DOI 10.1038/nrg1872; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Price LS, 2001, SEMIN CANCER BIOL, V11, P167, DOI 10.1006/scbi.2000.0367; Raman JD, 2011, UROL ONCOL-SEMIN ORI, V29, P716, DOI 10.1016/j.urolonc.2009.11.007; Rapberger R, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-2; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ru YB, 2011, CURR OPIN UROL, V21, P420, DOI 10.1097/MOU.0b013e32834956d6; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Stein LD, 2003, NAT REV GENET, V4, P337, DOI 10.1038/nrg1065; Thiele CJ, 2009, CLIN CANCER RES, V15, P5962, DOI 10.1158/1078-0432.CCR-08-0651; Vishnu P, 2011, ONCOTARGETS THER, V4, P97, DOI 10.2147/OTT.S22875; Vlahou A, 2013, PROTEOM CLIN APPL, V7, P384, DOI 10.1002/prca.201200121; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Weiss GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076438; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yu L, 2014, ONCOGENE, V33, P690, DOI 10.1038/onc.2013.20; Yuan XL, 2013, CANCER RES, V73, P3625, DOI 10.1158/0008-5472.CAN-12-3879; Zoidakis J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009449	65	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e0116404	10.1371/journal.pone.0116404	http://dx.doi.org/10.1371/journal.pone.0116404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25569276	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000348168000007
J	Lastrucci, C; Baillif, V; Behar, A; Al Saati, T; Dubourdeau, M; Maridonneau-Parini, I; Cougoule, C				Lastrucci, Claire; Baillif, Vincent; Behar, Annie; Al Saati, Talal; Dubourdeau, Marc; Maridonneau-Parini, Isabelle; Cougoule, Celine			Molecular and cellular profiles of the resolution phase in a damage-associated molecular pattern (DAMP)-mediated peritonitis model and revelation of leukocyte persistence in peritoneal tissues	FASEB JOURNAL			English	Article						bioactive lipid mediators; omentum; macrophage polarization	ACUTE-INFLAMMATION; PROMOTE RESOLUTION; LIPID MEDIATORS; MILKY SPOTS; MACROPHAGES; INNATE; POLARIZATION; MIGRATION; PRODUCTS; OMENTUM	Models of microbe-elicited peritonitis have been invaluable to identify mechanisms underlying inflammation resolution, but whether resolution mechanisms differ from an inflammatory agent to another has not been determined. Thus, we analyzed the cellular and molecular components of the resolution phase of non-microbe-induced inflammation. In thioglycollate (TG)-induced peritonitis, resolution started at 12 h (T-max) and displayed a 22 h resolution interval (R-i). During resolution, lipoxin A4, resolvin (Rv) D1 and RvD2, protectin D1 (PD1), and maresin 1 (MaR1) were transiently produced while RvD5 was continually generated. In addition, docosahexaenoic acid (DHA)-derived mediators were produced to a higher extent than in microbial peritonitis. We also investigated leukocyte infiltration and clearance in peritoneal tissues surrounding the inflammatory site. In the omentum, resolution parameters, neutrophil apoptosis, and efferocytosis were similar to those of the peritoneal cavity. However, we noticed long-term persistence of M2-polarized macrophages and B-lymphocytes in the omentum after TG administration, whereas zymosan injection caused M1/M2-macrophage and T-lymphocyte persistence regardless of the magnitude of the inflammatory response. Our study indicates that some aspects of resolution are shaped in a stimulus-specific manner, and it ultimately argues that the tissues surrounding the inflammatory site must also be considered to address the inflammatory response globally.	[Lastrucci, Claire; Behar, Annie; Maridonneau-Parini, Isabelle; Cougoule, Celine] CNRS, IPBS, Dept TB & Infect Biol, Toulouse, France; [Lastrucci, Claire; Behar, Annie; Maridonneau-Parini, Isabelle; Cougoule, Celine] Univ Toulouse 3, Univ Toulouse, UPS, IPBS, F-31062 Toulouse, France; [Baillif, Vincent; Dubourdeau, Marc] Ambiotis SAS, Toulouse, France; [Al Saati, Talal] CHU Purpan, INSERM, Serv Histopathol, CREFRE UPS US006, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Maridonneau-Parini, I (corresponding author), CNRS, IPBS, UMR5089, 205 Route Narbonne,BP64182, F-31077 Toulouse, France.	isabelle.maridonneau-parini@ipbs.fr	Maridonneau-Parini, Isabelle/F-1985-2011; COUGOULE, Céline/ABB-4180-2021	Maridonneau-Parini, Isabelle/0000-0003-0189-0976	Fondation pour la Recherche Medicale [FRM: FDT20130928326]; ARC [8505]; Agence Nationale de la Recherche (ANR) [2010-01301]; FRM [DEQ20110421312]; Region Midi-Pyrenees (Platform TRI);  [HEALTH-F4-2011-282095]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ARC(Australian Research Council); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); Region Midi-Pyrenees (Platform TRI)(Region Occitanie); 	The authors acknowledge Anexplo Genotoul facility at IPBS, F. Capilla and C. Salon of the Service d'Histopathologie for histological slide preparation and scanning, F.-X. Frenois of the Imag'In platform for scanning of histology slides, R. Poincloux for technical assistance with histology slide quantification and confocal microscopy analysis, G. Chene for RT-qPCR on the omentum, C.N. Serhan for PD1 standard, G. Lugo-Villarino and A. Proag for critical reading of the manuscript. C.L. was supported by a fellowship from the Fondation pour la Recherche Medicale (FRM: FDT20130928326). This work was supported in part by ARC 8505 (Platform TRI), Agence Nationale de la Recherche (ANR) 2010-01301, FRM DEQ20110421312, Region Midi-Pyrenees (Platform TRI), and Tarkinaid FP7-2007-2013 under grant agreement HEALTH-F4-2011-282095.	Ajuebor MN, 1999, J IMMUNOL, V162, P1685; Ariel A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00004; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; BARTH MW, 1995, J LEUKOCYTE BIOL, V57, P361, DOI 10.1002/jlb.57.3.361; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Cooper D, 2002, DIS COLON RECTUM, V45, P394, DOI 10.1007/s10350-004-6189-x; Cougoule C, 2012, EUR J CELL BIOL, V91, P938, DOI 10.1016/j.ejcb.2012.07.002; Cougoule C, 2010, BLOOD, V115, P1444, DOI 10.1182/blood-2009-04-218735; Cuzzocrea S, 2004, INTENS CARE MED, V30, P1935, DOI 10.1007/s00134-004-2353-y; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Dalli J, 2013, CHEM BIOL, V20, P188, DOI 10.1016/j.chembiol.2012.11.010; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Fernandez-Boyanapalli R, 2010, BLOOD, V116, P4512, DOI 10.1182/blood-2010-02-272005; Fredman G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00639; Fukatsu K, 1996, J AM COLL SURGEONS, V183, P450; Gautier EL, 2013, BLOOD, V122, P2714, DOI 10.1182/blood-2013-01-478206; Goulding John, 2007, Proc Am Thorac Soc, V4, P618, DOI 10.1513/pats.200706-066TH; Kajikawa M, 2015, DIABETES CARE, V38, P119, DOI 10.2337/dc14-1435; Le Faouder P, 2013, J CHROMATOGR B, V932, P123, DOI 10.1016/j.jchromb.2013.06.014; Lee HN, 2013, SEMIN IMMUNOPATHOL, V35, P151, DOI 10.1007/s00281-013-0363-y; Li YM, 1997, J IMMUNOL METHODS, V201, P183, DOI 10.1016/S0022-1759(96)00224-4; Li YS, 2013, IMMUNITY, V39, P885, DOI 10.1016/j.immuni.2013.10.011; Mallipattu SK, 2014, CURR OPIN NEPHROL HY, V23, P547, DOI 10.1097/MNH.0000000000000062; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Navarro-Xavier RA, 2010, J IMMUNOL, V184, P1516, DOI 10.4049/jimmunol.0902866; Nessim SJ, 2013, NAT REV NEPHROL, V9, P302, DOI 10.1038/nrneph.2013.43; Netea MG, 2013, EUR J CLIN INVEST, V43, P881, DOI 10.1111/eci.12132; Newson J, 2014, BLOOD, V124, P1748, DOI 10.1182/blood-2014-03-562710; Nguyen HH, 2012, J IMMUNOL, V189, P3112, DOI 10.4049/jimmunol.1200360; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Rajakariarl R, 2008, BLOOD, V111, P4184, DOI 10.1182/blood-2007-08-108936; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; Rosas M, 2010, J LEUKOCYTE BIOL, V88, P169, DOI 10.1189/jlb.0809548; Salahuddin P, 2014, CELL MOL BIOL LETT, V19, P407, DOI 10.2478/s11658-014-0205-5; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2013, CURR OPIN PHARMACOL, V13, P632, DOI 10.1016/j.coph.2013.05.012; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shah S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038368; Shen H, 2013, J IMMUNOL, V191, P2857, DOI 10.4049/jimmunol.1301539; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Verollet C., BLOOD; WIJFFELS JFAM, 1992, RES IMMUNOL, V143, P401, DOI 10.1016/S0923-2494(05)80072-0; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; Yamagishi S, 2012, REJUV RES, V15, P564, DOI 10.1089/rej.2012.1335	55	19	19	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1914	1929		10.1096/fj.14-259341	http://dx.doi.org/10.1096/fj.14-259341			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25609430				2022-12-26	WOS:000354114600026
J	Amrutkar, M; Cansby, E; Nunez-Duran, E; Pirazzi, C; Stahlman, M; Stenfeldt, E; Smith, U; Boren, J; Mahlapuu, M				Amrutkar, Manoj; Cansby, Emmelie; Nunez-Duran, Esther; Pirazzi, Carlo; Stahlman, Marcus; Stenfeldt, Elin; Smith, Ulf; Boren, Jan; Mahlapuu, Margit			Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH	FASEB JOURNAL			English	Article						lipid droplets; lipid metabolism; liver inflammation; NAFLD; steatohepatitis	DIFFERENTIATION-RELATED PROTEIN; NONALCOHOLIC FATTY LIVER; ADIPOSE TRIGLYCERIDE LIPASE; HORMONE-SENSITIVE LIPASE; INSULIN-RESISTANCE; ACID OXIDATION; MICE; INFLAMMATION; EXPRESSION; TISSUE	Nonalcoholic fatty liver disease (NAFLD) is the most common form of liver disease, and 10% to 20% of NAFLD patients progress to nonalcoholic steatohepatitis (NASH). The molecular pathways controlling progression to NAFLD/NASH remain poorly understood. We recently identified serine/threonine protein kinase 25 (STK25) as a regulator of whole-body insulin and glucose homeostasis. This study investigates the role of STK25 in liver lipid accumulation and NASH. Stk25 transgenic mice challenged with a high-fat diet displayed a dramatic increase in liver steatosis and hepatic insulin resistance compared to wild-type siblings. Focal fibrosis, hepatocellular damage, and inflammation were readily seen in transgenic but not wild-type livers. Transgenic livers displayed reduced beta-oxidation and triacylglycerol secretion, while lipid uptake and synthesis remained unchanged. STK25 was associated with lipid droplets, colocalizing with the main hepatic lipid droplet-coating protein adipose differentiation-related protein, the level of which was increased 3.8 +/- 0.7-fold in transgenic livers (P < 0.01), while a key hepatic lipase, adipose triacylglycerol lipase, was translocated from the lipid droplets surface to the cytoplasm, providing the likely mechanism underlying the effect of STK25. In summary, STK25 is a lipid droplet-associated protein that promotes NAFLD through control of lipid release from the droplets for beta-oxidation and triacylglycerol secretion. STK25 also drives pathogenesis of NASH.	[Amrutkar, Manoj; Cansby, Emmelie; Nunez-Duran, Esther; Smith, Ulf; Mahlapuu, Margit] Univ Gothenburg, Dept Mol & Clin Med, Lundberg Lab Diabet Res, SE-41345 Gothenburg, Sweden; [Pirazzi, Carlo; Stahlman, Marcus; Stenfeldt, Elin; Boren, Jan] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, SE-41345 Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Mahlapuu, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Lundberg Lab Diabet Res, Dept Mol & Clin Med, Bla Straket 5, SE-41345 Gothenburg, Sweden.	margit.mahlapuu@gu.se	Amrutkar, Manoj/J-2848-2019; StÃhlman, Marcus/M-4597-2019	Amrutkar, Manoj/0000-0002-1868-0249; Mahlapuu, Margit/0000-0001-8740-8874; Henricsson, Marcus/0000-0002-4202-0339	Swedish Research Council; European Foundation for the Study of Diabetes/Lilly Research Program; European Foundation for the Study of Diabetes; Novo Nordisk Partnership for Diabetes Research in Europe (Dusseldorf, Germany); Novo Nordisk Foundation (Hellerup, Denmark); Diabetes Wellness Network Sweden; Swedish Diabetes Foundation; Petrus and Augusta Hedlunds Foundation (Stockholm, Sweden); Ake Wiberg Foundation (Boras, Sweden); Adlerbert Research Foundation (Gothenburg, Sweden); M. Bergvall Foundation (Stockholm, Sweden); Novo Nordisk Fonden [NNF14OC0009667, NNF14OC0010799] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Foundation for the Study of Diabetes/Lilly Research Program; European Foundation for the Study of Diabetes; Novo Nordisk Partnership for Diabetes Research in Europe (Dusseldorf, Germany); Novo Nordisk Foundation (Hellerup, Denmark)(Novo Nordisk Foundation); Diabetes Wellness Network Sweden; Swedish Diabetes Foundation; Petrus and Augusta Hedlunds Foundation (Stockholm, Sweden); Ake Wiberg Foundation (Boras, Sweden); Adlerbert Research Foundation (Gothenburg, Sweden); M. Bergvall Foundation (Stockholm, Sweden); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank Dr. Rosie Perkins for editorial support. This work was supported by grants from the Swedish Research Council, the European Foundation for the Study of Diabetes/Lilly Research Program, the European Foundation for the Study of Diabetes, the Novo Nordisk Partnership for Diabetes Research in Europe (Dusseldorf, Germany), the Novo Nordisk Foundation (Hellerup, Denmark), the Diabetes Wellness Network Sweden, the Swedish Diabetes Foundation, the Petrus and Augusta Hedlunds Foundation (Stockholm, Sweden), the Ake Wiberg Foundation (Boras, Sweden), the Adlerbert Research Foundation (Gothenburg, Sweden), and the M. Bergvall Foundation (Stockholm, Sweden).	Adiels M, 2006, DIABETOLOGIA, V49, P755, DOI 10.1007/s00125-005-0125-z; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Cansby E, 2014, MOL CELL ENDOCRINOL, V393, P143, DOI 10.1016/j.mce.2014.06.014; Cansby E, 2013, FASEB J, V27, P3660, DOI 10.1096/fj.13-228494; Chang BHJ, 2010, J LIPID RES, V51, P2132, DOI 10.1194/jlr.M004515; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Dalen KT, 2006, J LIPID RES, V47, P931, DOI 10.1194/jlr.M500459-JLR200; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; FOLCH J, 1957, J BIOL CHEM, V226, P497; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Imai Y, 2007, GASTROENTEROLOGY, V132, P1947, DOI 10.1053/j.gastro.2007.02.046; Kato M, 2008, SCAND J GASTROENTERO, V43, P1018, DOI 10.1080/00365520802008140; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Magnusson B, 2006, ARTERIOSCL THROM VAS, V26, P1566, DOI 10.1161/01.ATV.0000223345.11820.da; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Motomura W, 2006, BIOCHEM BIOPH RES CO, V340, P1111, DOI 10.1016/j.bbrc.2005.12.121; Nagarajan P, 2012, WORLD J GASTROENTERO, V18, P1141, DOI 10.3748/wjg.v18.i11.1141; Nerstedt A, 2012, DIABETOLOGIA, V55, P1797, DOI 10.1007/s00125-012-2511-7; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Qi KM, 2003, JPEN-PARENTER ENTER, V27, P58, DOI 10.1177/014860710302700158; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Sapiro JM, 2009, J LIPID RES, V50, P1621, DOI 10.1194/jlr.M800614-JLR200; Senthivinayagam S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073696; Sparks JD, 2012, ARTERIOSCL THROM VAS, V32, P2104, DOI 10.1161/ATVBAHA.111.241463; Stahlman M, 2013, BBA-MOL CELL BIOL L, V1831, P1609, DOI 10.1016/j.bbalip.2013.07.009; Sundaram M, 2010, J LIPID RES, V51, P150, DOI [10.1194/jlr.M900346-JLR200, 10.1194/M900346-JLR200]; Sutti S, 2014, HEPATOLOGY, V59, P886, DOI 10.1002/hep.26749; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005; Turpin SM, 2011, DIABETOLOGIA, V54, P146, DOI 10.1007/s00125-010-1895-5; Varela GM, 2008, AM J PHYSIOL-GASTR L, V295, pG621, DOI 10.1152/ajpgi.90204.2008; Wang SP, 2001, OBES RES, V9, P119, DOI 10.1038/oby.2001.15; Wei EH, 2010, CELL METAB, V11, P183, DOI 10.1016/j.cmet.2010.02.005; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	42	56	57	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1564	1576		10.1096/fj.14-264937	http://dx.doi.org/10.1096/fj.14-264937			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25609431	Bronze			2022-12-26	WOS:000354115000040
J	Gheinani, AH; Burkhard, FC; Rehrauer, H; Fournier, CA; Monastyrskaya, K				Gheinani, Ali Hashenni; Burkhard, Fiona C.; Rehrauer, Hubert; Fournier, Catharine Aquino; Monastyrskaya, Katia			MicroRNA MiR-199a-5p Regulates Smooth Muscle Cell Proliferation and Morphology by Targeting WNT2 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLADDER PAIN SYNDROME; DOWN-REGULATION; MYOGENIC DIFFERENTIATION; STEM-CELLS; EXPRESSION; MYOCARDIN; FIBROSIS; DISEASE; CANCER; PATHOGENESIS	MicroRNA miR-199a-5p impairs tight junction formation, leading to increased urothelial permeability in bladder pain syndrome. Now, using transcriptome analysis in urothelial TEU-2 cells, we implicate it in the regulation of cell cycle, cytoskeleton remodeling, TGF, and WNT signaling pathways. MiR-199a-5p is highly expressed in the smooth muscle layer of the bladder, and we altered its levels in bladder smooth muscle cells (SMCs) to validate the pathway analysis. Inhibition of miR-199a-5p with antimiR increased SMC proliferation, reduced cell size, and upregulated miR-199a-5p targets, including WNT2. Overexpression of WNT2 protein or treating SMCs with recombinant WNT2 closely mimicked the miR-199a-5p inhibition, whereas down-regulation of WNT2 in antimiR-expressing SMCs with shRNA restored cell phenotype and proliferation rates. Overexpression of miR-199a-5p in the bladder SMCs significantly increased cell size and up-regulated SM22, SM a-actin, and SM myosin heavy chain mRNA and protein levels. These changes as well as increased expression of ACTG2, TGFB111, and CDKN1A were mediated by up-regulation of the smooth muscle-specific transcriptional activator myocardin at mRNA and protein levels. Myocardin-related transcription factor A downstream targets Id3 and MYL9 were also induced. Up-regulation of myocardin was accompanied by down-regulation of WNT-dependent inhibitory Kruppel-like transcription factor 4 in miR-199a-5p-overexpressing cells. In contrast, Kruppel-like transcription factor 4 was induced in antimiR-expressing cells following the activation of WNT2 signaling, leading to repression of myocardin-dependent genes. MiR-199a-5p plays a critical role in the processes in the smooth muscle and may behave as a key modulator of smooth muscle hypertrophy, which is relevant for organ remodeling.	[Gheinani, Ali Hashenni; Monastyrskaya, Katia] Univ Bern, Dept Clin Res, Urol Res Lab, CH-3010 Bern, Switzerland; [Burkhard, Fiona C.] Univ Hosp Bern, Dept Urol, CH-3010 Bern, Switzerland; [Rehrauer, Hubert; Fournier, Catharine Aquino] Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland	University of Bern; University of Bern; University Hospital of Bern	Monastyrskaya, K (corresponding author), Univ Bern, Dept Clin Res, Urol Res Lab, Murtenstr 35, CH-3010 Bern, Switzerland.	monastyk@dkf.unibe.ch	Gheinani, Ali Hashemi/L-2929-2019; Hashemi Gheinani, Ali/I-5148-2013; Burkhard, Fiona/AAE-4524-2020	Hashemi Gheinani, Ali/0000-0002-9625-6259; Aquino, Catharine/0000-0002-3600-9862; Monastyrskaya, Katia/0000-0003-2042-1139; Burkhard, Fiona/0000-0002-8271-014X	Swiss National Science Foundation [320030_135783]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 320030_135783 (to K. M.).	Adam RM, 2006, NEPHRON EXP NEPHROL, V102, pE1, DOI 10.1159/000088310; Alexander MS, 2013, CELL DEATH DIFFER, V20, P1194, DOI 10.1038/cdd.2013.62; Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Applebaum M, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0053-9; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bowen T, 2013, J PATHOL, V229, P274, DOI 10.1002/path.4119; Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; Chacko S, 2004, SCAND J UROL NEPHROL, V38, P26, DOI 10.1080/03008880410015147; Chan YC, 2012, J BIOL CHEM, V287, P41032, DOI 10.1074/jbc.M112.413294; Cheung HH, 2011, ONCOGENE, V30, P3404, DOI 10.1038/onc.2011.60; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Ekman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082308; Freire VS, 2011, BJU INT, V108, pE126, DOI 10.1111/j.1464-410X.2010.09934.x; Freire VS, 2010, AM J PATHOL, V176, P288, DOI 10.2353/ajpath.2010.090552; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gheinani AH, 2013, CELL MOL LIFE SCI, V70, P3773, DOI 10.1007/s00018-013-1275-7; Goodwin A. M., 2002, Angiogenesis, V5, P1, DOI 10.1023/A:1021563510866; Goss AM, 2011, DEV BIOL, V356, P541, DOI 10.1016/j.ydbio.2011.06.011; Guo Y, 2012, PHYSIOL RES, V61, P337, DOI 10.33549/physiolres.932289; Hsu CY, 2014, J PATHOL, V232, P330, DOI 10.1002/path.4295; Hu YB, 2014, DIGEST DIS SCI, V59, P2163, DOI 10.1007/s10620-014-3136-0; Hypolite JA, 2006, J UROLOGY, V175, P777, DOI 10.1016/S0022-5347(05)00138-2; Imamura M, 2013, J CELL PHYSIOL, V228, P1819, DOI 10.1002/jcp.24333; Iwasaki K, 2008, J BIOL CHEM, V283, P21230, DOI 10.1074/jbc.M710525200; Klumpp DJ, 2001, INFECT IMMUN, V69, P6689, DOI 10.1128/IAI.69.11.6689-6695.2001; Kropp BP, 1999, J UROLOGY, V162, P1779, DOI 10.1016/S0022-5347(05)68237-7; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lu TY, 2013, J MOL CELL CARDIOL, V63, P146, DOI 10.1016/j.yjmcc.2013.07.019; Luo XG, 2014, CANCER LETT, V344, P129, DOI 10.1016/j.canlet.2013.10.026; Martin AF, 2007, AM J PHYSIOL-CELL PH, V293, pC238, DOI 10.1152/ajpcell.00567.2006; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Meng XM, 2013, CLIN SCI, V124, P243, DOI 10.1042/CS20120252; Mohamed JS, 2013, J BIOL CHEM, V288, P24560, DOI 10.1074/jbc.M112.434423; Monastyrskaya K, 2013, AM J PATHOL, V182, P431, DOI 10.1016/j.ajpath.2012.10.020; Monastyrskaya K, 2009, J BIOL CHEM, V284, P17227, DOI 10.1074/jbc.M109.004457; Myers JB, 2009, J UROLOGY, V181, P1926, DOI 10.1016/j.juro.2008.11.077; Onizuka T, 2012, J MOL CELL CARDIOL, V52, P650, DOI 10.1016/j.yjmcc.2011.11.010; Pekow JR, 2012, INFLAMM BOWEL DIS, V18, P187, DOI 10.1002/ibd.21691; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rickard A, 2008, IN VITRO CELL DEV-AN, V44, P261, DOI 10.1007/s11626-008-9116-y; Roncarati R, 2014, J AM COLL CARDIOL, V63, P920, DOI 10.1016/j.jacc.2013.09.041; Sadegh MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035882; Sasaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075010; Shen QL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-227; Slobodov G, 2004, J UROLOGY, V171, P1554, DOI 10.1097/01.ju.0000118938.09119.a5; Song XW, 2010, J CELL PHYSIOL, V225, P437, DOI 10.1002/jcp.22217; Tsaousi A, 2011, CIRC RES, V108, P427, DOI 10.1161/CIRCRESAHA.110.233999; UEKI N, 1987, P NATL ACAD SCI USA, V84, P9049, DOI 10.1073/pnas.84.24.9049; Wang H, 2007, J BIOL CHEM, V282, P782, DOI 10.1074/jbc.M606610200; Wilmott JS, 2011, PATHOLOGY, V43, P657, DOI 10.1097/PAT.0b013e32834a7358; Wu ZY, 2014, GENET MOL RES, V13, P2727, DOI 10.4238/2014.April.14.2; Yang J, 2013, AM J PHYSIOL-LUNG C, V305, pL312, DOI 10.1152/ajplung.00054.2013; Zhang S, 2012, AM J PATHOL, V181, P937, DOI 10.1016/j.ajpath.2012.05.035; Zhang XM, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-15; Zheng XL, 2014, ARCH BIOCHEM BIOPHYS, V543, P48, DOI 10.1016/j.abb.2013.12.015	59	51	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7067	7086		10.1074/jbc.M114.618694	http://dx.doi.org/10.1074/jbc.M114.618694			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25596533	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000350991500039
J	de la Parra, C; Borrero-Garcia, LD; Cruz-Collazo, A; Schneider, RJ; Dharmawardhane, S				de la Parra, Columba; Borrero-Garcia, Luis D.; Cruz-Collazo, Ailed; Schneider, Robert J.; Dharmawardhane, Suranganie			Equol, an Isoflavone Metabolite, Regulates Cancer Cell Viability and Protein Synthesis Initiation via c-Myc and eIF4G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR-ALPHA; INTERNAL RIBOSOME ENTRY; OVARIECTOMIZED ATHYMIC MICE; INFLAMMATORY BREAST-CANCER; IN-VITRO; TRANSLATIONAL CONTROL; GENE-EXPRESSION; MESSENGER-RNAS; TUMOR-CELLS; GROWTH-FACTOR	Epidemiological studies implicate dietary soy isoflavones as breast cancer preventives, especially due to their anti-estrogenic properties. However, soy isoflavones may also have a role in promoting breast cancer, which has yet to be clarified. We previously reported that equol, a metabolite of the soy isoflavone daidzein, may advance breast cancer potential via up-regulation of the eukaryotic initiation factor 4GI (eIF4GI). In estrogen receptor negative (ER-) metastatic breast cancer cells, equol induced elevated levels of eIF4G, which were associated with increased cell viability and the selective translation of mRNAs that use non-canonical means of initiation, including internal ribosome entry site (IRES), ribosome shunting, and eIF4G enhancers. These mRNAs typically code for oncogenic, survival, and cell stress molecules. Among those mRNAs translationally increased by equol was the oncogene and eIF4G enhancer, c-Myc. Here we report that siRNA-mediated knockdown of c-Myc abrogates the increase in cancer cell viability and mammosphere formation by equol, and results in a significant down-regulation of eIF4GI (the major eIF4G isoform), as well as reduces levels of some, but not all, proteins encoded by mRNAs that are translationally stimulated by equol treatment. Knockdown of eIF4GI also markedly reduces an equol-mediated increase in IRES-dependent mRNA translation and the expression of specific oncogenic proteins. However, eIF4GI knockdown did not reciprocally affect c-Myc levels or cell viability. This study therefore implicates c-Myc as a potential regulator of the cancer-promoting effects of equol via up-regulation of eIF4GI and selective initiation of translation on mRNAs that utilize non-canonical initiation, including certain oncogenes.	[de la Parra, Columba; Borrero-Garcia, Luis D.; Cruz-Collazo, Ailed; Dharmawardhane, Suranganie] Univ Puerto Rico, Sch Med, Dept Biochem, San Juan, PR 00936 USA; [de la Parra, Columba; Schneider, Robert J.] NYU, Sch Med, Dept Microbiol & Radiat Oncol, Inst Canc, New York, NY 10016 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; New York University	Dharmawardhane, S (corresponding author), POB 365067, San Juan, PR 00936 USA.	su.d@upr.edu		Borrero-Garcia, Luis D/0000-0002-5256-7581; Schneider, Robert/0000-0001-5807-5564	United States Army/BCRP Grant [W81XWH-11-1-0199]; National Institutes of Health/NIGMS Grant [SC3GM084824]; National Institutes of Health/NIMHHD Grants [G12RR035051, R25GM061838]; Breast Cancer Research Foundation; Avon Foundation; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838, SC3GM084824] Funding Source: NIH RePORTER	United States Army/BCRP Grant; National Institutes of Health/NIGMS Grant; National Institutes of Health/NIMHHD Grants; Breast Cancer Research Foundation; Avon Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by United States Army/BCRP Grant W81XWH-11-1-0199 (to C. D.), National Institutes of Health/NIGMS Grant SC3GM084824 (to S. D.), National Institutes of Health/NIMHHD Grants G12RR035051 and R25GM061838 (to L. D. B.) to UPR MSC, and the Breast Cancer Research Foundation and Avon Foundation (to R. J. S.).	Avdulov S, 2015, CANCER RES, V75, P687, DOI 10.1158/0008-5472.CAN-14-2571; Badve S, 2012, LANCET ONCOL, V13, pE43, DOI 10.1016/S1470-2045(11)70191-7; Bauer C, 2002, INT J CANCER, V98, P181, DOI 10.1002/ijc.10180; Bolca S, 2007, J NUTR, V137, P2242, DOI 10.1093/jn/137.10.2242; Bosviel R, 2012, BRIT J NUTR, V108, P1187, DOI 10.1017/S000711451100657X; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Carreau C, 2009, MOL NUTR FOOD RES, V53, P652, DOI 10.1002/mnfr.200800061; Charalambous C, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-238; Choi EJ, 2008, MOL MED REP, V1, P239; Choi EJ, 2009, CHEM-BIOL INTERACT, V177, P7, DOI 10.1016/j.cbi.2008.09.031; Cuesta R, 2009, PROG MOL BIOL TRANSL, V90, P255, DOI 10.1016/S1877-1173(09)90007-2; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Davison Z, 2011, NEOPLASIA, V13, P504, DOI 10.1593/neo.101590; de la Parra C, 2012, J BIOL CHEM, V287, P41640, DOI 10.1074/jbc.M112.393470; Douglas CC, 2013, ANTI-CANCER AGENT ME, V13, P1178, DOI 10.2174/18715206113139990320; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Frenzel Anna, 2010, Genes Cancer, V1, P660, DOI 10.1177/1947601910377488; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Haron H, 2011, INT J FOOD SCI NUTR, V62, P642, DOI 10.3109/09637486.2011.570742; Hilakivi-Clarke L, 2010, J NUTR, V140, p2326S, DOI 10.3945/jn.110.124230; Jones RM, 1996, MOL CELL BIOL, V16, P4754; Ju YH, 2006, CARCINOGENESIS, V27, P856, DOI 10.1093/carcin/bgi320; Kong J, 2012, NAT REV GENET, V13, P383, DOI 10.1038/nrg3184; Lamartiniere CA, 2002, TOXICOL SCI, V65, P228, DOI 10.1093/toxsci/65.2.228; Lee T, 2012, FUTURE MED CHEM, V4, P19, DOI [10.4155/FMC.11.150, 10.4155/fmc.11.150]; Lewis SM, 2008, NUCLEIC ACIDS RES, V36, P168, DOI 10.1093/nar/gkm1007; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lin CJ, 2008, CANCER RES, V68, P5326, DOI 10.1158/0008-5472.CAN-07-5876; Liu HQ, 2010, J NUTR BIOCHEM, V21, P390, DOI 10.1016/j.jnutbio.2009.01.016; Liu XP, 2012, LIFE SCI, V91, P415, DOI 10.1016/j.lfs.2012.08.022; Magee PJ, 2006, NUTR CANCER, V54, P232, DOI 10.1207/s15327914nc5402_10; Magee PJ, 2004, CANCER LETT, V208, P35, DOI 10.1016/j.canlet.2003.11.012; Magklara A, 2000, BREAST CANCER RES TR, V59, P263, DOI 10.1023/A:1006304518750; Martinez-Montemayor MM, 2010, CLIN EXP METASTAS, V27, P465, DOI 10.1007/s10585-010-9336-x; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Montalvo-Ortiz BL, 2012, J BIOL CHEM, V287, P13228, DOI 10.1074/jbc.M111.334524; Moumen M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-132; Muthyala RS, 2004, BIOORGAN MED CHEM, V12, P1559, DOI 10.1016/j.bmc.2003.11.035; Nair R, 2014, ONCOGENE, V33, P3992, DOI 10.1038/onc.2013.368; Okabe Y, 2011, J SCI FOOD AGR, V91, P658, DOI 10.1002/jsfa.4228; Onoda A, 2011, FOOD CHEM TOXICOL, V49, P2279, DOI 10.1016/j.fct.2011.06.027; Park J, 2005, IMMUNOLOGY, V116, P71, DOI 10.1111/j.1365-2567.2005.02199.x; Pieters T, 2012, FRONT BIOSCI-LANDMRK, V17, P760, DOI 10.2741/3956; Poola I, 2000, J STEROID BIOCHEM, V72, P249, DOI 10.1016/S0960-0760(00)00033-9; Ramirez-Valle F., 2008, J CELL BIOL, V181, P293; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; Setchell KDR, 2010, J NUTR, V140, p1363S, DOI 10.3945/jn.109.119784; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Sherrill KW, 2004, J BIOL CHEM, V279, P29066, DOI 10.1074/jbc.M402727200; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Silvera D, 2009, CELL CYCLE, V8, P3091, DOI 10.4161/cc.8.19.9637; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2009, MOL CELL BIOL, V29, P1565, DOI 10.1128/MCB.01283-08; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Taghizadeh B, 2015, BREAST CANCER-TOKYO, V22, P382, DOI 10.1007/s12282-013-0492-0; Tonetti DA, 2007, NUTR CANCER, V58, P222, DOI 10.1080/01635580701328545; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Wang CY, 2011, MOL ENDOCRINOL, V25, P1527, DOI 10.1210/me.2011-1037; Wang YH, 2005, BREAST CANCER RES, V7, pR220, DOI 10.1186/bcr975; WELSHONS WV, 1987, BREAST CANCER RES TR, V10, P169, DOI 10.1007/BF01810580; Willis AE, 1999, INT J BIOCHEM CELL B, V31, P73, DOI 10.1016/S1357-2725(98)00133-2; Wolf E, 2015, TRENDS CELL BIOL, V25, P241, DOI 10.1016/j.tcb.2014.10.006; Xu Jinhua, 2010, Genes Cancer, V1, P629, DOI 10.1177/1947601910378691; XU X, 1994, J NUTR, V124, P825, DOI 10.1093/jn/124.6.825; Yi TF, 2014, ONCOTARGET, V5, P6028, DOI 10.18632/oncotarget.2112; Yi TF, 2013, J BIOL CHEM, V288, P18732, DOI 10.1074/jbc.M113.471466; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08; Zava DT, 1997, NUTR CANCER, V27, P31, DOI 10.1080/01635589709514498	71	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6047	6057		10.1074/jbc.M114.617415	http://dx.doi.org/10.1074/jbc.M114.617415			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25593313	hybrid, Green Published			2022-12-26	WOS:000350732500016
J	Neidel, S; de Motes, CM; Mansur, DS; Strnadova, P; Smith, GL; Graham, SC				Neidel, Sarah; de Motes, Carlos Maluquer; Mansur, Daniel S.; Strnadova, Pavla; Smith, Geoffrey L.; Graham, Stephen C.			Vaccinia Virus Protein A49 Is an Unexpected Member of the B-cell Lymphoma (Bcl)-2 Protein Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BCL-2 FAMILY; BETA-TRCP; SEQUENCE SIMILARITY; N1L PROTEIN; ACTIVATION; VIRULENCE; COMPLEX; INHIBITOR; KINASE	Vaccinia virus (VACV) encodes several proteins that inhibit activation of the proinflammatory transcription factor nuclear factor kappa B (NF-kappa B). VACV protein A49 prevents translocation of NF-kappa B to the nucleus by sequestering cellular beta-TrCP, a protein required for the degradation of the inhibitor of kappa B. A49 does not share overall sequence similarity with any protein of known structure or function. We solved the crystal structure of A49 from VACV Western Reserve to 1.8 angstrom resolution and showed, surprisingly, that A49 has the same three-dimensional fold as Bcl-2 family proteins despite lacking identifiable sequence similarity. Whereas Bcl-2 family members characteristically modulate cellular apoptosis, A49 lacks a surface groove suitable for binding BH3 peptides and does not bind proapoptotic Bcl-2 family proteins Bax or Bak. The N-terminal 17 residues of A49 do not adopt a single well ordered conformation, consistent with their proposed role in binding beta-TrCP. Whereas pairs of A49 molecules interact symmetrically via a large hydrophobic surface in crystallo, A49 does not dimerize in solution or in cells, and we propose that this hydrophobic interaction surface may mediate binding to a yet undefined cellular partner. A49 represents the eleventh VACV Bcl-2 family protein and, despite these proteins sharing very low sequence identity, structure-based phylogenetic analysis shows that all poxvirus Bcl-2 proteins are structurally more similar to each other than they are to any cellular or herpesvirus Bcl-2 proteins. This is consistent with duplication and diversification of a single BCL2 family gene acquired by an ancestral poxvirus.	[Neidel, Sarah; de Motes, Carlos Maluquer; Strnadova, Pavla; Smith, Geoffrey L.; Graham, Stephen C.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Mansur, Daniel S.] Univ Fed Santa Catarina, Dept Microbiol Immunol & Parasitol, BR-88040900 Florianopolis, SC, Brazil	University of Cambridge; Universidade Federal de Santa Catarina (UFSC)	Graham, SC (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	scg34@cam.ac.uk	Mansur, Daniel/AAQ-8062-2020; de Motes, Carlos Maluquer/AAF-8092-2021	de Motes, Carlos Maluquer/0000-0003-4712-4601; Smith, Geoffrey L/0000-0002-3730-9955; Mansur, Daniel/0000-0001-6773-9334; Graham, Stephen/0000-0003-4547-4034	Wellcome Trust Principal Research Fellowship [090315]; Sir Henry Dale Fellowship - Wellcome Trust [098406/Z/12/Z]; Sir Henry Dale Fellowship - Royal Society [098406/Z/12/Z]; United Kingdom Medical Research Council [G1000099]; MRC [G1000099] Funding Source: UKRI; Medical Research Council [G1000099] Funding Source: researchfish	Wellcome Trust Principal Research Fellowship(Wellcome Trust); Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Sir Henry Dale Fellowship - Royal Society; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust Principal Research Fellowship 090315 (to G. L. S.), Sir Henry Dale Fellowship 098406/Z/12/Z, jointly funded by the Wellcome Trust and the Royal Society (to S. C. G.), and United Kingdom Medical Research Council Grant G1000099 (to David Stuart).	Aoyagi M, 2007, PROTEIN SCI, V16, P118, DOI 10.1110/ps.062454707; Balachandran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002165; Bartlett N, 2002, J GEN VIROL, V83, P1965, DOI 10.1099/0022-1317-83-8-1965; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benfield CTO, 2011, J BIOL CHEM, V286, P20727, DOI 10.1074/jbc.M111.231381; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bour S, 2001, J BIOL CHEM, V276, P15920, DOI 10.1074/jbc.M010533200; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Chen RAJ, 2006, J GEN VIROL, V87, P1451, DOI 10.1099/vir.0.81736-0; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; de Motes CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002430; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Elde NC, 2012, CELL, V150, P831, DOI 10.1016/j.cell.2012.05.049; Ember SWJ, 2012, J GEN VIROL, V93, P2098, DOI 10.1099/vir.0.045070-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FALKNER FG, 1990, J VIROL, V64, P3108, DOI 10.1128/JVI.64.6.3108-3111.1990; Fedosyuk S, 2014, J BIOL CHEM, V289, P3749, DOI 10.1074/jbc.M113.512756; Ferguson BJ, 2013, J GEN VIROL, V94, P2070, DOI 10.1099/vir.0.054114-0; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; French AR, 2004, IMMUNITY, V20, P747, DOI 10.1016/j.immuni.2004.05.006; Gerlic M, 2013, P NATL ACAD SCI USA, V110, P7808, DOI 10.1073/pnas.1215995110; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Gonzalez JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-59; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000128; Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Holyoak T, 2003, ACTA CRYSTALLOGR D, V59, P2356, DOI 10.1107/S0907444903021784; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalverda AP, 2009, J MOL BIOL, V385, P843, DOI 10.1016/j.jmb.2008.09.048; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kelley LA, 1997, PROTEIN SCI, V6, P2628; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; KOTWAL GJ, 1988, VIROLOGY, V167, P524, DOI 10.1016/S0042-6822(88)90115-8; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Kvansakul M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.436; Kvansakul M, 2007, MOL CELL, V25, P933, DOI 10.1016/j.molcel.2007.02.004; Lama D, 2010, BIOCHEMISTRY-US, V49, P2574, DOI 10.1021/bi100029k; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mansur DS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003183; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moss B, 2007, FIELDS VIROLOGY; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oda S, 2009, STRUCTURE, V17, P1528, DOI 10.1016/j.str.2009.09.005; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; PARKINSON JE, 1994, VIROLOGY, V204, P376, DOI 10.1006/viro.1994.1542; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PICKUP DJ, 1984, P NATL ACAD SCI-BIOL, V81, P6817, DOI 10.1073/pnas.81.21.6817; Postigo A, 2006, CELL DEATH DIFFER, V13, P1651, DOI 10.1038/sj.cdd.4401853; Ravantti J, 2013, J STRUCT BIOL, V183, P47, DOI 10.1016/j.jsb.2013.05.007; ROSSMANN MG, 1976, J MOL BIOL, V105, P75, DOI 10.1016/0022-2836(76)90195-9; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; SMITH GL, 1991, J GEN VIROL, V72, P1349, DOI 10.1099/0022-1317-72-6-1349; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW374, DOI 10.1093/nar/gkl195; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Stack J, 2013, J BIOL CHEM, V288, P33642, DOI 10.1074/jbc.M113.485490; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Buuren N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004326; Veyer DL, 2014, J GEN VIROL, V95, P2757, DOI 10.1099/vir.0.068833-0; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walsh SR, 2011, EXPERT REV VACCINES, V10, P1221, DOI [10.1586/ERV.11.79, 10.1586/erv.11.79]; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808; Wang G, 2004, J VIROL, V78, P7097, DOI 10.1128/JVI.78.13.7097-7111.2004; Wang Y, 2013, J BIOL CHEM, V288, P35840, DOI 10.1074/jbc.M113.503680; Wasilenko ST, 2003, P NATL ACAD SCI USA, V100, P14345, DOI 10.1073/pnas.2235583100; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X	84	34	35	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					5991	6002		10.1074/jbc.M114.624650	http://dx.doi.org/10.1074/jbc.M114.624650			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605733	Green Published, hybrid			2022-12-26	WOS:000350732500005
J	Grosjean, K; Mongrand, S; Beney, L; Simon-Plas, F; Gerbeau-Pissot, P				Grosjean, Kevin; Mongrand, Sebastien; Beney, Laurent; Simon-Plas, Francoise; Gerbeau-Pissot, Patricia			Differential Effect of Plant Lipids on Membrane Organization SPECIFICITIES OF PHYTOSPHINGOLIPIDS AND PHYTOSTEROLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIANT UNILAMELLAR VESICLES; RESONANCE ENERGY-TRANSFER; LATERAL PHASE-SEPARATION; CHAIN BASE COMPOSITION; PROGRAMMED CELL-DEATH; LIQUID-ORDERED PHASES; PLASMA-MEMBRANE; MODEL MEMBRANES; COLD-ACCLIMATION; PHOSPHOLIPID-MEMBRANES	The high diversity of the plant lipid mixture raises the question of their respective involvement in the definition of membrane organization. This is particularly the case for plant plasma membrane, which is enriched in specific lipids, such as free and conjugated forms of phytosterols and typical phytosphingolipids, such as glycosylinositolphosphoceramides. This question was here addressed extensively by characterizing the order level of membrane from vesicles prepared using various plant lipid mixtures and labeled with an environment-sensitive probe. Fluorescence spectroscopy experiments showed that among major phytosterols, campesterol exhibits a stronger ability than beta-sitosterol and stigmasterol to order model membranes. Multispectral confocal microscopy, allowing spatial analysis of membrane organization, demonstrated accordingly the strong ability of campesterol to promote ordered domain formation and to organize their spatial distribution at the membrane surface. Conjugated sterol forms, alone and in synergy with free sterols, exhibit a striking ability to order membrane. Plant sphingolipids, particularly glycosylinositolphosphoceramides, enhanced the sterol-induced ordering effect, emphasizing the formation and increasing the size of sterol-dependent ordered domains. Altogether, our results support a differential involvement of free and conjugated phytosterols in the formation of ordered domains and suggest that the diversity of plant lipids, allowing various local combinations of lipid species, could be a major contributor to membrane organization in particular through the formation of sphingolipid-sterol interacting domains.	[Grosjean, Kevin; Gerbeau-Pissot, Patricia] Univ Bourgogne, CNRS, ERL 6300, Agroecol UMR1347, 17 Rue Sully,BP 86510, F-21065 Dijon, France; [Mongrand, Sebastien] CNRS, UMR 5200, LBM, F-33000 Villenave Dornon, France; [Mongrand, Sebastien] Univ Bordeaux, UMR 5200, LBM, F-33000 Villenave Dornon, France; [Beney, Laurent] AgroSup Dijon, Lab Proc Alimentaires & Microbiol, F-21000 Dijon, France; [Simon-Plas, Francoise] INRA, CNRS, Agroecol UMR1347, ERL 6300, F-21065 Dijon, France	Centre National de la Recherche Scientifique (CNRS); Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Gerbeau-Pissot, P (corresponding author), Univ Bourgogne, CNRS, ERL 6300, Agroecol UMR1347, 17 Rue Sully,BP 86510, F-21065 Dijon, France.	pgerbeau@dijon.inra.fr		Laurent, Beney/0000-0002-2757-2506	French Agence Nationale de la Recherche, program blanc, ANR "PANACEA" [NT09_517917]	French Agence Nationale de la Recherche, program blanc, ANR "PANACEA"(French National Research Agency (ANR))	This work was supported by the French Agence Nationale de la Recherche, program blanc, ANR "PANACEA" NT09_517917 (contracts to S. M. and F. S. P.) and platform Metabolome-Lipidome-Fluxome of Bordeaux (contribution toward lipid analysis equipment).	Aguilar LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040254; Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g; Almeida PF, 2011, BIOPHYS J, V100, P420, DOI 10.1016/j.bpj.2010.12.3694; ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; Ariola FS, 2009, BIOPHYS J, V96, P2696, DOI 10.1016/j.bpj.2008.12.3922; Arnqvist L, 2008, PLANTA, V227, P309, DOI 10.1007/s00425-007-0618-8; Bagatolli LA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00457; BARENHOLZ Y, 1980, BIOCHIM BIOPHYS ACTA, V604, P129, DOI 10.1016/0005-2736(80)90572-6; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Beck JG, 2007, FASEB J, V21, P1714, DOI 10.1096/fj.06-7809com; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V506, P265, DOI 10.1016/0005-2736(78)90397-8; Berglund AH, 2002, BBA-BIOMEMBRANES, V1564, P466, DOI 10.1016/S0005-2736(02)00498-4; Bonneau L, 2010, BBA-BIOMEMBRANES, V1798, P2150, DOI 10.1016/j.bbamem.2010.07.026; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; BRUCKDORFER KR, 1968, EUR J BIOCHEM, V4, P512, DOI 10.1111/j.1432-1033.1968.tb00242.x; Bure C, 2014, ANAL BIOANAL CHEM, V406, P995, DOI 10.1007/s00216-013-7130-8; Bure C, 2011, RAPID COMMUN MASS SP, V25, P3131, DOI 10.1002/rcm.5206; Cacas JL, 2013, PHYTOCHEMISTRY, V96, P191, DOI 10.1016/j.phytochem.2013.08.002; Cacas JL, 2012, PROG LIPID RES, V51, P272, DOI 10.1016/j.plipres.2012.04.001; CARTER HE, 1958, J BIOL CHEM, V233, P1309; CARTER HE, 1969, J LIPID RES, V10, P363; Clarke JA, 2006, BIOPHYS J, V90, P2383, DOI 10.1529/biophysj.104.056499; de Joannis J, 2011, J AM CHEM SOC, V133, P3625, DOI 10.1021/ja110425s; DEMEL RA, 1972, BIOCHIM BIOPHYS ACTA, V255, P311, DOI 10.1016/0005-2736(72)90030-2; DEMEL RA, 1972, BIOCHIM BIOPHYS ACTA, V255, P321, DOI 10.1016/0005-2736(72)90031-4; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; DIMITROV DS, 1988, BIOELECTROCH BIOENER, V19, P323, DOI 10.1016/0302-4598(88)80013-8; Dinic J, 2013, BBA-BIOMEMBRANES, V1828, P1102, DOI 10.1016/j.bbamem.2012.12.004; Dinic J, 2011, BBA-BIOMEMBRANES, V1808, P298, DOI 10.1016/j.bbamem.2010.10.002; EDWARDS PA, 1972, FEBS LETT, V20, P97, DOI 10.1016/0014-5793(72)80026-7; Frazier ML, 2007, BIOPHYS J, V92, P2422, DOI 10.1529/biophysj.106.100107; FUJINO Y, 1985, AGR BIOL CHEM TOKYO, V49, P2753, DOI 10.1080/00021369.1985.10867139; Furl F., 2007, PLANT SIGNAL BEHAV, V2, P508; Gandhavadi M, 2002, BIOPHYS J, V82, P1469, DOI 10.1016/S0006-3495(02)75501-X; GEBHARDT C, 1977, Z NATURFORSCH C, V32, P581; Gerbeau-Pissot P, 2014, PLANT PHYSIOL, V164, P273, DOI 10.1104/pp.113.225755; GRANT CWM, 1974, BIOCHIM BIOPHYS ACTA, V363, P151, DOI 10.1016/0005-2736(74)90055-8; Grille S, 2010, PROG LIPID RES, V49, P262, DOI 10.1016/j.plipres.2010.02.001; GUO DA, 1995, LIPIDS, V30, P203, DOI 10.1007/BF02537823; Halling KK, 2004, BBA-BIOMEMBRANES, V1664, P161, DOI 10.1016/j.bbamem.2004.05.006; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hartmann MA, 1998, TRENDS PLANT SCI, V3, P170, DOI 10.1016/S1360-1385(98)01233-3; Heinz E., 1996, PLANT GLYCOLIPIDS ST, V3, P211; Henriksen J, 2006, BIOPHYS J, V90, P1639, DOI 10.1529/biophysj.105.067652; HSIEH TCY, 1981, J BIOL CHEM, V256, P7747; HSIEH TCY, 1978, BIOCHEMISTRY-US, V17, P3575, DOI 10.1021/bi00610a024; Islam MN, 2012, METABOLOMICS, V8, P598, DOI 10.1007/s11306-011-0352-x; Janich P, 2007, FEBS LETT, V581, P1783, DOI 10.1016/j.febslet.2007.03.065; Jimenez-Rojo N, 2014, BBA-BIOMEMBRANES, V1838, P456, DOI 10.1016/j.bbamem.2013.10.010; Jin L, 2006, BIOPHYS J, V90, P2563, DOI 10.1529/biophysj.105.072884; Jin L, 2005, BIOPHYS J, V89, pL4, DOI 10.1529/biophysj.105.064816; Kahya N, 2003, J BIOL CHEM, V278, P28109, DOI 10.1074/jbc.M302969200; KAUL K, 1975, PLANT PHYSIOL, V55, P120, DOI 10.1104/pp.55.1.120; Kim K, 2013, P NATL ACAD SCI USA, V110, pE3054, DOI 10.1073/pnas.1303304110; Kovganko NV, 1999, CHEM NAT COMPD+, V35, P479, DOI 10.1007/BF02323277; Kusumi A, 2005, BBA-MOL CELL RES, V1746, P234, DOI 10.1016/j.bbamcr.2005.10.001; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; Lefebvre B, 2007, PLANT PHYSIOL, V144, P402, DOI 10.1104/pp.106.094102; LENTZ BR, 1976, BIOCHEMISTRY-US, V15, P4529, DOI 10.1021/bi00665a030; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu P, 2009, PLANT J, V60, P303, DOI 10.1111/j.1365-313X.2009.03955.x; Lonnfors M, 2011, BIOPHYS J, V100, P2633, DOI 10.1016/j.bpj.2011.03.066; Lopez-Perez L, 2009, PHYTOCHEMISTRY, V70, P492, DOI 10.1016/j.phytochem.2009.01.014; LYNCH DV, 1987, PLANT PHYSIOL, V83, P761, DOI 10.1104/pp.83.4.761; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Mannock DA, 2010, CHEM PHYS LIPIDS, V163, P403, DOI 10.1016/j.chemphyslip.2010.03.011; Markham JE, 2006, J BIOL CHEM, V281, P22684, DOI 10.1074/jbc.M604050200; Marsh D, 2010, BBA-BIOMEMBRANES, V1798, P688, DOI 10.1016/j.bbamem.2009.12.027; MASSERINI M, 1988, BIOCHEMISTRY-US, V27, P7973, DOI 10.1021/bi00420a057; MASSERINI M, 1986, BIOCHEMISTRY-US, V25, P1043, DOI 10.1021/bi00353a014; MASSERINI M, 1989, BIOCHEMISTRY-US, V28, P5029, DOI 10.1021/bi00438a019; Menger FM, 1998, ACCOUNTS CHEM RES, V31, P789, DOI 10.1021/ar970103v; Millard AC, 2004, BIOPHYS J, V86, P1169, DOI 10.1016/S0006-3495(04)74191-0; Minami A, 2010, PLANT SIGNAL BEHAV, V5, P1115, DOI [10.4161/psb.5.9.12478, 10.4161/psb.5.9. 12478]; Minami A, 2009, PLANT CELL PHYSIOL, V50, P341, DOI 10.1093/pcp/pcn202; Mombelli E, 2003, BIOPHYS J, V84, P1507, DOI 10.1016/S0006-3495(03)74963-7; Mongrand S, 2004, J BIOL CHEM, V279, P36277, DOI 10.1074/jbc.M403440200; MUDD JB, 1980, PLANT PHYSIOL, V65, P78, DOI 10.1104/pp.65.1.78; Obaid AL, 2004, J NEUROSCI METH, V134, P179, DOI 10.1016/j.jneumeth.2003.11.011; Ouimet J, 2004, LANGMUIR, V20, P7474, DOI 10.1021/la0491293; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Owen DM, 2010, MICROSC RES TECHNIQ, V73, P618, DOI 10.1002/jemt.20801; PALTA JP, 1993, PLANT PHYSIOL, V103, P793, DOI 10.1104/pp.103.3.793; Pandit SA, 2004, BIOPHYS J, V87, P1092, DOI 10.1529/biophysj.104.041939; Parasassi T, 1997, BIOPHYS J, V72, P2413, DOI 10.1016/S0006-3495(97)78887-8; PASCHER I, 1976, BIOCHIM BIOPHYS ACTA, V455, P433, DOI 10.1016/0005-2736(76)90316-3; Pata MO, 2010, NEW PHYTOL, V185, P611, DOI 10.1111/j.1469-8137.2009.03123.x; PHILLIPS MC, 1970, CHEM PHYS LIPIDS, V4, P409, DOI 10.1016/0009-3084(70)90039-3; Pinto SN, 2013, BBA-BIOMEMBRANES, V1828, P2099, DOI 10.1016/j.bbamem.2013.05.011; Quartacci MF, 2002, J EXP BOT, V53, P2159, DOI 10.1093/jxb/erf076; Quinn PJ, 2010, PROG LIPID RES, V49, P390, DOI 10.1016/j.plipres.2010.05.002; Quinn PJ, 2009, BBA-BIOMEMBRANES, V1788, P33, DOI 10.1016/j.bbamem.2008.08.005; Ramstedt B, 2006, BBA-BIOMEMBRANES, V1758, P1945, DOI 10.1016/j.bbamem.2006.05.020; RANADIVE GN, 1987, BIOCHEMISTRY-US, V26, P2426, DOI 10.1021/bi00383a005; REINL H, 1992, BIOPHYS J, V61, P1025, DOI 10.1016/S0006-3495(92)81910-0; Roche Y, 2008, FASEB J, V22, P3980, DOI 10.1096/fj.08-111070; Roche Y, 2010, BBA-BIOMEMBRANES, V1798, P1601, DOI 10.1016/j.bbamem.2010.03.024; RUJANAVECH C, 1986, J BIOL CHEM, V261, P7204; Samsonov AV, 2001, BIOPHYS J, V81, P1486, DOI 10.1016/S0006-3495(01)75803-1; Schaller H, 2004, PLANT PHYSIOL BIOCH, V42, P465, DOI 10.1016/j.plaphy.2004.05.012; Scherfeld D, 2003, BIOPHYS J, V85, P3758, DOI 10.1016/S0006-3495(03)74791-2; SCHMIDT CF, 1977, BIOCHEMISTRY-US, V16, P2649, DOI 10.1021/bi00631a011; Schrick K, 2012, LIPIDS, V47, P185, DOI 10.1007/s11745-011-3602-9; SCHULER I, 1991, P NATL ACAD SCI USA, V88, P6926, DOI 10.1073/pnas.88.16.6926; SCHULER I, 1990, BIOCHIM BIOPHYS ACTA, V1028, P82, DOI 10.1016/0005-2736(90)90268-S; Sezgin E, 2012, BBA-BIOMEMBRANES, V1818, P1777, DOI 10.1016/j.bbamem.2012.03.007; SHIMSHICK EJ, 1973, BIOCHEMISTRY-US, V12, P2351, DOI 10.1021/bi00736a026; Sonnino S, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00153; Spassieva SD, 2002, PLANT J, V32, P561, DOI 10.1046/j.1365-313X.2002.01444.x; Sperling P, 2005, PLANT PHYSIOL BIOCH, V43, P1031, DOI 10.1016/j.plaphy.2005.10.004; Stevens MM, 2010, SOFT MATTER, V6, P5882, DOI 10.1039/c0sm00373e; STILLWELL W, 1990, METHOD ENZYMOL, V189, P373; SUBBARAO NK, 1991, BIOCHIM BIOPHYS ACTA, V1063, P147, DOI 10.1016/0005-2736(91)90364-E; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; UEMURA M, 1994, PLANT PHYSIOL, V104, P479, DOI 10.1104/pp.104.2.479; Uline MJ, 2013, FARADAY DISCUSS, V161, P177, DOI 10.1039/c2fd20091k; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Veatch SL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.268101; VERKLEIJ AJ, 1973, BIOCHIM BIOPHYS ACTA, V291, P577, DOI 10.1016/0005-2736(73)90509-9; Wang KR, 2012, PLANT PHYSIOL, V158, P1789, DOI 10.1104/pp.111.189217; Wang WM, 2008, PLANT CELL, V20, P3163, DOI 10.1105/tpc.108.060053; WEBB MS, 1995, BBA-BIOMEMBRANES, V1239, P226, DOI 10.1016/0005-2736(95)00147-U; Wesolowska O, 2009, ACTA BIOCHIM POL, V56, P33; Wewer V, 2011, J LIPID RES, V52, P1039, DOI 10.1194/jlr.D013987; Wojciechowski Z. A., 1991, BIOCH PHYTOSTEROL CO	126	69	70	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5810	5825		10.1074/jbc.M114.598805	http://dx.doi.org/10.1074/jbc.M114.598805			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25575593	Green Published, hybrid			2022-12-26	WOS:000350044200047
J	Makowska-Grzyska, M; Kim, Y; Maltseva, N; Osipiuk, J; Gu, MY; Zhang, MJ; Mandapati, K; Gollapalli, DR; Gorla, SK; Hedstrom, L; Joachimiak, A				Makowska-Grzyska, Magdalena; Kim, Youngchang; Maltseva, Natalia; Osipiuk, Jerzy; Gu, Minyi; Zhang, Minjia; Mandapati, Kavitha; Gollapalli, Deviprasad R.; Gorla, Suresh Kumar; Hedstrom, Lizbeth; Joachimiak, Andrzej			A Novel Cofactor-binding Mode in Bacterial IMP Dehydrogenases Explains Inhibitor Selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE MONOPHOSPHATE DEHYDROGENASE; NICOTINAMIDE ADENINE-DINUCLEOTIDE; 5'-MONOPHOSPHATE DEHYDROGENASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PROTEIN; COMPLEX; INTEGRATION; MECHANISM; SUBSTRATE	The steadily rising frequency of emerging diseases and antibiotic resistance creates an urgent need for new drugs and targets. Inosine 5'-monophosphate dehydrogenase (IMP dehydrogenase or IMPDH) is a promising target for the development of new antimicrobial agents. IMPDH catalyzes the oxidation of IMP to XMP with the concomitant reduction of NAD(+), which is the pivotal step in the biosynthesis of guanine nucleotides. Potent inhibitors of bacterial IMPDHs have been identified that bind in a structurally distinct pocket that is absent in eukaryotic IMPDHs. The physiological role of this pocket was not understood. Here, we report the structures of complexes with different classes of inhibitors of Bacillus anthracis, Campylobacter jejuni, and Clostridium perfringens IMPDHs. These structures in combination with inhibition studies provide important insights into the interactions that modulate selectivity and potency. We also present two structures of the Vibrio cholerae IMPDH in complex with IMP/NAD(+) and XMP/NAD(+). In both structures, the cofactor assumes a dramatically different conformation than reported previously for eukaryotic IMPDHs and other dehydrogenases, with the major change observed for the position of the NAD(+) adenosine moiety. More importantly, this new NAD(+)-binding site involves the same pocket that is utilized by the inhibitors. Thus, the bacterial IMPDH-specific NAD(+) binding mode helps to rationalize the conformation adopted by several classes of prokaryotic IMPDH inhibitors. These findings offer a potential strategy for further ligand optimization.	[Makowska-Grzyska, Magdalena; Kim, Youngchang; Maltseva, Natalia; Osipiuk, Jerzy; Gu, Minyi; Joachimiak, Andrzej] Univ Chicago, Ctr Struct Genom Infect Dis, Chicago, IL 60637 USA; [Makowska-Grzyska, Magdalena; Kim, Youngchang; Maltseva, Natalia; Osipiuk, Jerzy; Gu, Minyi; Joachimiak, Andrzej] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Kim, Youngchang; Osipiuk, Jerzy; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA; [Zhang, Minjia; Mandapati, Kavitha; Gollapalli, Deviprasad R.; Gorla, Suresh Kumar; Hedstrom, Lizbeth] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Hedstrom, Lizbeth] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA	University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; Brandeis University; Brandeis University	Hedstrom, L (corresponding author), Brandeis Univ, Dept Biol & Chem, 415 South St, Waltham, MA 02454 USA.	hedstrom@brandeis.edu; andrzejj@anl.gov		Kim, Youngchang/0000-0002-1610-4889; Joachimiak, Andrzej/0000-0003-2535-6209	United States Department of Energy, Office of Biological and Environmental Research under National Institutes of Health [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093459] Funding Source: NIH RePORTER	United States Department of Energy, Office of Biological and Environmental Research under National Institutes of Health(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The use of Structural Biology Center beamlines was supported by the United States Department of Energy, Office of Biological and Environmental Research under National Institutes of Health Contract DE-AC02-06CH11357, Argonne, a United States Department of Energy Office of Science Laboratory, is operated under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBINI A, 1984, CHEM REV, V84, P43, DOI 10.1021/cr00059a004; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Bell CE, 1997, PROTEIN SCI, V6, P2084; BROWN GB, 1964, BIOCHEMISTRY-US, V3, P880, DOI 10.1021/bi00895a002; Chen LQ, 2010, J MED CHEM, V53, P4768, DOI 10.1021/jm100424m; Colby TD, 1999, P NATL ACAD SCI USA, V96, P3531, DOI 10.1073/pnas.96.7.3531; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felczak K, 2011, BIOORGAN MED CHEM, V19, P1594, DOI 10.1016/j.bmc.2011.01.042; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Gan L, 2003, BIOCHEMISTRY-US, V42, P857, DOI 10.1021/bi0271401; Gan L, 2002, BIOCHEMISTRY-US, V41, P13309, DOI 10.1021/bi0203785; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Giangreco I, 2013, J MED CHEM, V56, P6175, DOI 10.1021/jm400644z; Gollapalli DR, 2010, CHEM BIOL, V17, P1084, DOI 10.1016/j.chembiol.2010.07.014; Gorla SK, 2013, J MED CHEM, V56, P4028, DOI 10.1021/jm400241j; Gorla SK, 2012, J MED CHEM, V55, P7759, DOI 10.1021/jm3007917; Hedstrom L, 2011, CURR MED CHEM, V18, P1909, DOI 10.2174/092986711795590129; Hedstrom L, 2009, CHEM REV, V109, P2903, DOI 10.1021/cr900021w; Johnson CR, 2013, BIOORG MED CHEM LETT, V23, P1004, DOI 10.1016/j.bmcl.2012.12.037; Kerr KM, 2000, BIOCHEMISTRY-US, V39, P9804, DOI 10.1021/bi0005409; Kim Y, 2011, METHODS, V55, P12, DOI 10.1016/j.ymeth.2011.07.010; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024621; Kirubakaran S, 2012, BIOORG MED CHEM LETT, V22, P1985, DOI 10.1016/j.bmcl.2012.01.029; Kuppuraj G, 2011, J PHYS CHEM B, V115, P7932, DOI 10.1021/jp1118663; MacPherson IS, 2010, J AM CHEM SOC, V132, P1230, DOI 10.1021/ja909947a; Makowska-Grzyska M, 2012, BIOCHEMISTRY-US, V51, P6148, DOI 10.1021/bi300511w; Mandapati K, 2014, ACS MED CHEM LETT, V5, P846, DOI 10.1021/ml500203p; Maurya SK, 2009, J MED CHEM, V52, P4623, DOI 10.1021/jm900410u; Michael G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nimmesgern E, 1999, PROTEIN EXPRES PURIF, V17, P282, DOI 10.1006/prep.1999.1136; Pankiewicz KW, 2003, ACS SYM SER, V839, P1; Patton GC, 2011, NAT CHEM BIOL, V7, P950, DOI [10.1038/NCHEMBIO.693, 10.1038/nchembio.693]; Pimkin M, 2008, MOL MICROBIOL, V68, P342, DOI 10.1111/j.1365-2958.2008.06153.x; Prosise GL, 2003, J MOL BIOL, V326, P517, DOI 10.1016/S0022-2836(02)01383-9; Rao VA, 2013, ACTA CRYSTALLOGR F, V69, P243, DOI 10.1107/S1744309113002352; Riera TV, 2011, BIOCHEMISTRY-US, V50, P8508, DOI 10.1021/bi200785s; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Sharling L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000794; Sintchak MD, 1996, CELL, V85, P921, DOI 10.1016/S0092-8674(00)81275-1; Trzhtsinskaya B.V., 1991, SULFUR REP, V10, P389, DOI DOI 10.1080/01961779108048760; Umejiego NN, 2008, CHEM BIOL, V15, P70, DOI 10.1016/j.chembiol.2007.12.010; Usha V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033886; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; World Health Organization, 2013, GLOB TUB REP 2013, P45; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v; Zhang RG, 1999, CURR MED CHEM, V6, P537	53	30	30	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5893	5911		10.1074/jbc.M114.619767	http://dx.doi.org/10.1074/jbc.M114.619767			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25572472	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000350044200053
J	Palchetti, S; Starace, D; De Cesaris, P; Filippini, A; Ziparo, E; Riccioli, A				Palchetti, Sara; Starace, Donatella; De Cesaris, Paola; Filippini, Antonio; Ziparo, Elio; Riccioli, Anna			Transfected Poly(I:C) Activates Different dsRNA Receptors, Leading to Apoptosis or Immunoadjuvant Response in Androgen-independent Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; ACID/CATIONIC LIPOSOME COMPLEX; NF-KAPPA-B; RIG-I; ADAPTER PROTEIN; VIRUS INFECTION; UP-REGULATION; RECOGNITION; BETA; KINASE	Despite the effectiveness of surgery or radiation therapy for the treatment of early-stage prostate cancer (PCa), there is currently no effective strategy for late-stage disease. New therapeutic targets are emerging; in particular, dsRNA receptors Toll-like receptor 3 (TLR3) and cytosolic helicases expressed by cancer cells, once activated, exert a pro-apoptotic effect in different tumors. We previously demonstrated that the synthetic analog of dsRNA poly(I:C) induces apoptosis in the androgen-dependent PCa cell line LNCaP in a TLR3-dependent fashion, whereas only a weak apoptotic effect is observed in the more aggressive and androgen-independent PCa cells PC3 and DU145. In this paper, we characterize the receptors and the signaling pathways involved in the remarkable apoptosis induced by poly(I:C) transfected by Lipofectamine (in-poly(I:C)) compared with the 12-fold higher free poly(I:C) concentration in PC3 and DU145 cells. By using genetic inhibition of different poly(I:C) receptors, we demonstrate the crucial role of TLR3 and Src in in-poly(I:C)-induced apoptosis. Therefore, we show that the increased in-poly(I:C) apoptotic efficacy is due to a higher binding of endosomal TLR3. On the other hand, we show that in-poly(I:C) binding to cytosolic receptors MDA5 and RIG-I triggers IRF3-mediated signaling, leading uniquely to the up-regulation of IFN-beta, which likely in turn induces increased TLR3, MDA5, and RIG-I proteins. In summary, in-poly(I:C) activates two distinct antitumor pathways in PC3 and DU145 cells:one mediated by the TLR3/Src/STAT1 axis, leading to apoptosis, and the other one mediated by MDA5/RIG-I/IRF3, leading to immunoadjuvant IFN-beta expression.	[Palchetti, Sara; Starace, Donatella; Filippini, Antonio; Ziparo, Elio; Riccioli, Anna] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped, Sect Histol & Med Embryol, Ist Pasteur Fdn Cenci Bolognetti, I-00161 Rome, Italy; [De Cesaris, Paola] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; University of L'Aquila	Starace, D (corresponding author), Univ Roma La Sapienza, DAHFMO Unit Histol & Med Embryol, Via Antonio Scarpa 16, I-00161 Rome, Italy.	donatella.starace@uniroma1.it; anna.riccioli@uniroma1.it	Palchetti, Sara/AAF-6645-2020	Palchetti, Sara/0000-0001-9582-953X; filippini, antonio/0000-0001-8453-287X; Ziparo, Elio/0000-0002-8776-3515; DE CESARIS, Paola/0000-0002-3802-9103	Italian Ministry of University and Research (MIUR) [prot.2010MCLPLB]; Fondazione Roma; Ricerca Scientifica Ateneo "Sapienza"	Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Fondazione Roma(Fondazione RomaEuropean Commission); Ricerca Scientifica Ateneo "Sapienza"	This work was supported by the Italian Ministry of University and Research (MIUR) Grant prot.2010MCLPLB, a grant from Fondazione Roma (to E. Z.), and Ricerca Scientifica Ateneo "Sapienza" 2014 (to E. Z.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alonso-Curbelo D, 2010, AUTOPHAGY, V6, P148, DOI 10.4161/auto.6.1.10464; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Chattopadhyay S, 2013, J VIROL, V87, P16, DOI 10.1128/JVI.01853-12; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Chen M, 2002, APOPTOSIS, V7, P313, DOI 10.1023/A:1016167228059; Cheng YS, 2010, CANCER BIOL THER, V10, P1219, DOI 10.4161/cbt.10.12.13450; Chin AI, 2010, CANCER RES, V70, P2595, DOI 10.1158/0008-5472.CAN-09-1162; Cirri P, 1997, BIOCHEM BIOPH RES CO, V239, P493, DOI 10.1006/bbrc.1997.7493; Dempoya J, 2012, J VIROL, V86, P12760, DOI 10.1128/JVI.01881-12; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Faraji AH, 2009, BIOORGAN MED CHEM, V17, P2950, DOI 10.1016/j.bmc.2009.02.043; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujii K, 2010, J PROTEOMICS, V73, P1196, DOI 10.1016/j.jprot.2010.02.009; Galli R, 2013, P NATL ACAD SCI USA, V110, P9812, DOI 10.1073/pnas.1304610110; Gambara G., 2014, J CELL MOL MED; Gatti G, 2013, EUR J IMMUNOL, V43, P1849, DOI 10.1002/eji.201242902; Gil J, 1999, MOL CELL BIOL, V19, P4653; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Hafner AM, 2013, ADV DRUG DELIVER REV, V65, P1386, DOI 10.1016/j.addr.2013.05.013; Harashima N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-217; Hertzog PJ, 2013, CYTOKINE GROWTH F R, V24, P217, DOI 10.1016/j.cytogfr.2013.04.002; Hirabayashi K, 1999, CANCER RES, V59, P4325; Hsieh MY, 2014, J BIOL CHEM, V289, P9208, DOI 10.1074/jbc.M113.508663; Inao T, 2012, BREAST CANCER RES TR, V134, P89, DOI 10.1007/s10549-011-1930-3; Into T, 2005, CELL MICROBIOL, V7, P1305, DOI 10.1111/j.1462-5822.2005.00558.x; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Matsushima-Miyagi T, 2012, CLIN CANCER RES, V18, P6271, DOI 10.1158/1078-0432.CCR-12-1595; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Myskiw C, 2011, VIROLOGY, V413, P183, DOI 10.1016/j.virol.2011.01.034; Palchetti S, 2013, RSC ADV, V3, P24597, DOI 10.1039/c3ra44093a; Paone A, 2008, CARCINOGENESIS, V29, P1334, DOI 10.1093/carcin/bgn149; Paone A, 2010, NEOPLASIA, V12, P539, DOI 10.1593/neo.92106; Peng S, 2009, CANCER SCI, V100, P529, DOI 10.1111/j.1349-7006.2008.01062.x; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Qu J, 2013, INT IMMUNOPHARMACOL, V17, P814, DOI 10.1016/j.intimp.2013.08.013; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Uno T, 2005, MOL CANCER THER, V4, P799, DOI 10.1158/1535-7163.MCT-04-0317; Vacchelli E, 2012, ONCOIMMUNOLOGY, V1, P1557, DOI 10.4161/onci.22428; Van DN, 2012, FASEB J, V26, P3188, DOI 10.1096/fj.11-202333; Vince JE, 2010, EMBO J, V29, P1627, DOI 10.1038/emboj.2010.79; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yount JS, 2007, J VIROL, V81, P7316, DOI 10.1128/JVI.00545-07; Zhou Y, 2013, INNATE IMMUN-LONDON, V19, P184, DOI 10.1177/1753425912459975	59	72	75	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5470	5483		10.1074/jbc.M114.601625	http://dx.doi.org/10.1074/jbc.M114.601625			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568326	Green Published, hybrid			2022-12-26	WOS:000350044200020
J	Acevedo, R; Orench-Rivera, N; Quarles, KA; Showalter, SA				Acevedo, Roderico; Orench-Rivera, Nichole; Quarles, Kaycee A.; Showalter, Scott A.			Helical Defects in MicroRNA Influence Protein Binding by TAR RNA Binding Protein	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; MICROPROCESSOR COMPLEX; KINASE PKR; HUMAN TRBP; CANCER; REGION; DGCR8; MOTIF; INTERFERENCE; RECOGNITION	Background MicroRNAs (miRNAs) are critical post-transcriptional regulators of gene expression. Their precursors have a globally A-form helical geometry, which prevents most proteins from identifying their nucleotide sequence. This suggests the hypothesis that local structural features (e. g., bulges, internal loops) play a central role in specific double-stranded RNA (dsRNA) selection from cellular RNA pools by dsRNA binding domain (dsRBD) containing proteins. Furthermore, the processing enzymes in the miRNA maturation pathway require tandem-dsRBD cofactor proteins for optimal function, suggesting that dsRBDs play a key role in the molecular mechanism for precise positioning of the RNA within these multi-protein complexes. Here, we focus on the tandem-dsRBDs of TRBP, which have been shown to bind dsRNA tightly. Methodology/Principal Findings We present a combination of dsRNA binding assays demonstrating that TRBP binds dsRNA in an RNA-length dependent manner. Moreover, circular dichroism data shows that the number of dsRBD moieties bound to RNA at saturation is different for a tandem-dsRBD construct than for constructs with only one dsRBD per polypeptide, revealing another reason for the selective pressure to maintain multiple domains within a polypeptide chain. Finally, we show that helical defects in precursor miRNA alter the apparent dsRNA size, demonstrating that imperfections in RNA structure influence the strength of TRBP binding. Conclusion/Significance We conclude that TRBP is responsible for recognizing structural imperfections in miRNA precursors, in the sense that TRBP is unable to bind imperfections efficiently and thus is positioned around them. We propose that once positioned around structural defects, TRBP assists Dicer and the rest of the RNA-induced silencing complex (RISC) in providing efficient and homogenous conversion of substrate precursor miRNA into mature miRNA downstream.	[Acevedo, Roderico; Orench-Rivera, Nichole; Quarles, Kaycee A.; Showalter, Scott A.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Acevedo, Roderico; Orench-Rivera, Nichole; Quarles, Kaycee A.; Showalter, Scott A.] Penn State Univ, Ctr RNA Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Showalter, SA (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	sas76@psu.edu	Showalter, Scott A/A-1655-2012	Showalter, Scott A/0000-0001-5179-032X	National Institutes of Health (NIH) [R01GM098451]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098451] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health (NIH) Grant R01GM098451 to SAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benoit MPMH, 2013, BIOMOL NMR ASSIGN, V7, P229, DOI 10.1007/s12104-012-9416-8; Benoit MPMH, 2013, NUCLEIC ACIDS RES, V41, P4241, DOI 10.1093/nar/gkt086; Bloomfield V.A., 2000, NUCL ACIDS STRUCTURE, V1st ed.; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Clemens MJ, 1997, INT J BIOCHEM CELL B, V29, P945, DOI 10.1016/S1357-2725(96)00169-0; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Daniels SM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-38; Daviet L, 2000, EUR J BIOCHEM, V267, P2419, DOI 10.1046/j.1432-1327.2000.01256.x; Dong JT, 2001, PROSTATE, V49, P166, DOI 10.1002/pros.1131; GATIGNOL A, 1993, MOL CELL BIOL, V13, P2193, DOI 10.1128/MCB.13.4.2193; Gredell JA, 2010, BIOCHEMISTRY-US, V49, P3148, DOI 10.1021/bi902189s; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kini HK, 2009, FEBS J, V276, P6576, DOI 10.1111/j.1742-4658.2009.07364.x; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Laraki G, 2008, RNA BIOL, V5, P92, DOI 10.4161/rna.5.2.6069; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Negrini M, 2007, J CELL SCI, V120, P1833, DOI 10.1242/jcs.03450; Nicholson AW, 2014, WIRES RNA, V5, P31, DOI 10.1002/wrna.1195; Parker GS, 2008, J MOL BIOL, V384, P967, DOI 10.1016/j.jmb.2008.10.002; Perron Marjorie P., 2009, V487, P369, DOI 10.1007/978-1-60327-547-7_18; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Quarles KA, 2013, BIOCHEMISTRY-US, V52, P795, DOI 10.1021/bi301452a; Roth BM, 2013, J BIOL CHEM, V288, P26785, DOI 10.1074/jbc.M112.446880; Sanghvi VR, 2011, J VIROL, V85, P12614, DOI 10.1128/JVI.05240-11; Sohn SY, 2007, NAT STRUCT MOL BIOL, V14, P847, DOI 10.1038/nsmb1294; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Ucci JW, 2007, BIOCHEMISTRY-US, V46, P55, DOI 10.1021/bi061531o; Warf MB, 2011, RNA, V17, P563, DOI 10.1261/rna.2432311; Wostenberg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051829; Wostenberg C, 2010, BIOCHEMISTRY-US, V49, P10728, DOI 10.1021/bi1015716; Wostenberg C, 2010, BIOPHYS J, V99, P248, DOI 10.1016/j.bpj.2010.04.010; Yamashita S, 2011, PROTEIN SCI, V20, P118, DOI 10.1002/pro.543; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	41	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116749	10.1371/journal.pone.0116749	http://dx.doi.org/10.1371/journal.pone.0116749			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25608000	Green Published, gold			2022-12-26	WOS:000348205300034
J	Ali, S; Magne, M; Chen, SY; Cote, O; Stare, BG; Obradovic, N; Jamshaid, L; Wang, XH; Belair, G; Moffett, P				Ali, Shawkat; Magne, Maxime; Chen, Shiyan; Cote, Olivier; Stare, Barbara Geric; Obradovic, Natasa; Jamshaid, Lubna; Wang, Xiaohong; Belair, Guy; Moffett, Peter			Analysis of Putative Apoplastic Effectors from the Nematode, Globodera rostochiensis, and Identification of an Expansin-Like Protein That Can Induce and Suppress Host Defenses	PLOS ONE			English	Article							DISEASE RESISTANCE; VIRUS-RESISTANCE; PARASITISM FACTOR; VARIABLE DOMAIN; PECTATE LYASE; COAT PROTEIN; PLANT; GENE; VIRULENCE; BINDING	The potato cyst nematode, Globodera rostochiensis, is an important pest of potato. Like other pathogens, plant parasitic nematodes are presumed to employ effector proteins, secreted into the apoplast as well as the host cytoplasm, to alter plant cellular functions and successfully infect their hosts. We have generated a library of ORFs encoding putative G. rostochiensis putative apoplastic effectors in vectors for expression in planta. These clones were assessed for morphological and developmental effects on plants as well as their ability to induce or suppress plant defenses. Several CLAVATA3/ESR-like proteins induced developmental phenotypes, whereas predicted cell wall-modifying proteins induced necrosis and chlorosis, consistent with roles in cell fate alteration and tissue invasion, respectively. When directed to the apoplast with a signal peptide, two effectors, an ubiquitin extension protein (GrUBCEP12) and an expansin-like protein (GrEXPB2), suppressed defense responses including NB-LRR signaling induced in the cytoplasm. GrEXPB2 also elicited defense response in species-and sequence-specific manner. Our results are consistent with the scenario whereby potato cyst nematodes secrete effectors that modulate host cell fate and metabolism as well as modifying host cell walls. Furthermore, we show a novel role for an apoplastic expansin-like protein in suppressing intra-cellular defense responses.	[Ali, Shawkat; Magne, Maxime; Cote, Olivier; Obradovic, Natasa; Jamshaid, Lubna; Moffett, Peter] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Ali, Shawkat; Belair, Guy] Agr & Agri Food Canada, Hort R&D Ctr, St Jean, PQ, Canada; [Chen, Shiyan; Wang, Xiaohong] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14853 USA; [Stare, Barbara Geric] Agr Inst Slovenia, Dept Plant Protect, SI-1000 Ljubljana, Slovenia; [Wang, Xiaohong] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA	University of Sherbrooke; Agriculture & Agri Food Canada; Cornell University; Agricultural Institute Slovenia; United States Department of Agriculture (USDA)	Moffett, P (corresponding author), Univ Sherbrooke, Dept Biol, 2500 Blvd Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada.	peter.moffett@usherbrooke.ca	Ali, Shawkat/AAN-2902-2020	Moffett, Peter/0000-0003-0678-4531; Ali, Shawkat/0000-0003-3282-3186; Geric Stare, Barbara/0000-0002-2334-8830	Agriculture and Agri-food Canada Growing Canadian Agri-Innovations Program; National Sciences and Engineering Research Council (NSERC); US Department of Agriculture, Agricultural Research Service; visiting fellowships in government laboratories program (NSERC); Fonds de Recherche Quebecois Nature et Technologie (FRQNT); ARS [ARS-0423113] Funding Source: Federal RePORTER	Agriculture and Agri-food Canada Growing Canadian Agri-Innovations Program(Agriculture & Agri Food Canada); National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); US Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); visiting fellowships in government laboratories program (NSERC); Fonds de Recherche Quebecois Nature et Technologie (FRQNT); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by funds from the Agriculture and Agri-food Canada Growing Canadian Agri-Innovations Program to G.B. and P.M., a discovery grant from the National Sciences and Engineering Research Council (NSERC) to P.M., and funds from the US Department of Agriculture, Agricultural Research Service to X.W.S.A. was supported by the visiting fellowships in government laboratories program (NSERC) and by a postdoctoral fellowship from the Fonds de Recherche Quebecois Nature et Technologie (FRQNT), and this work benefited from links established under CropSustaIn FP7 Project.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Ali S, 2011, CAN J PLANT PATHOL, V33, P425, DOI 10.1080/07060661.2011.625448; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bendahmane A, 1995, PLANT J, V8, P933, DOI 10.1046/j.1365-313X.1995.8060933.x; Bendahmane A, 2002, PLANT J, V32, P195, DOI 10.1046/j.1365-313X.2002.01413.x; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bhattacharjee S, 2009, PLANT J, V58, P940, DOI 10.1111/j.1365-313X.2009.03832.x; Bohlmann H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00089; Boucher AC, 2013, MOL PHYLOGENET EVOL, V69, P75, DOI 10.1016/j.ympev.2013.05.020; Brotman Y, 2008, PLANT PHYSIOL, V147, P779, DOI 10.1104/pp.108.116293; Poch HLC, 2006, PLANT CELL ENVIRON, V29, P1372, DOI 10.1111/j.1365-3040.2006.01517.x; Carpentier J, 2012, MOL PLANT PATHOL, V13, P546, DOI 10.1111/j.1364-3703.2011.00769.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Chronis D, 2013, PLANT J, V74, P185, DOI 10.1111/tpj.12125; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; Cotton JA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r43; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Davis EL, 2000, ANNU REV PHYTOPATHOL, V38, P365, DOI 10.1146/annurev.phyto.38.1.365; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Guo YF, 2011, PLANT PHYSIOL, V157, P476, DOI 10.1104/pp.111.180554; Haegeman A, 2012, GENE, V492, P19, DOI 10.1016/j.gene.2011.10.040; Haegeman A, 2009, MOL BIOCHEM PARASIT, V167, P32, DOI 10.1016/j.molbiopara.2009.04.004; Hemetsberger C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002684; Igarashi D, 2012, PLANT J, V71, P194, DOI 10.1111/j.1365-313X.2012.04950.x; Jaouannet M, 2013, MOL PLANT MICROBE IN, V26, P97, DOI 10.1094/MPMI-05-12-0130-R; Kanneganti TD, 2006, MOL PLANT MICROBE IN, V19, P854, DOI 10.1094/MPMI-19-0854; KELEMU S, 1993, APPL ENVIRON MICROB, V59, P1756, DOI 10.1128/AEM.59.6.1756-1761.1993; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kudla U, 2007, MOL PLANT PATHOL, V8, P293, DOI 10.1111/J.1364-3703.2007.00394.X; Laine MJ, 2000, PHYSIOL MOL PLANT P, V57, P221, DOI 10.1006/pmpp.2000.0301; Laurie JD, 2012, PLANT CELL, V24, P1733, DOI 10.1105/tpc.112.097261; Lozano-Torres JL, 2012, P NATL ACAD SCI USA, V109, P10119, DOI 10.1073/pnas.1202867109; Lu SW, 2008, MOL BIOCHEM PARASIT, V162, P1, DOI 10.1016/j.molbiopara.2008.06.002; Lu SW, 2009, MOL PLANT MICROBE IN, V22, P1128, DOI 10.1094/MPMI-22-9-1128; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Mitchum MG, 2013, NEW PHYTOL, V199, P879, DOI 10.1111/nph.12323; Moffett P, 2011, METHODS MOL BIOL, V712, P9, DOI 10.1007/978-1-61737-998-7_2; Peng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069579; Postma WJ, 2012, PLANT PHYSIOL, V160, P944, DOI 10.1104/pp.112.200188; Qin L, 2004, NATURE, V427, P30, DOI 10.1038/427030a; Qu F, 2003, J VIROL, V77, P511, DOI 10.1128/JVI.77.1.511-522.2003; Qutob D, 2006, TRENDS MICROBIOL, V14, P470, DOI 10.1016/j.tim.2006.09.004; Rairdan GJ, 2008, PLANT CELL, V20, P739, DOI 10.1105/tpc.107.056036; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; Sacco MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000564; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Shabab M, 2008, PLANT CELL, V20, P1169, DOI 10.1105/tpc.107.056325; Song J, 2009, P NATL ACAD SCI USA, V106, P1654, DOI 10.1073/pnas.0809201106; Stam R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059517; Stare Barbara Geric, 2013, Acta Biologica Slovenica, V56, P75; Stare BG, 2012, PHYSIOL MOL PLANT P, V79, P49, DOI 10.1016/j.pmpp.2012.04.002; Tai TH, 1999, P NATL ACAD SCI USA, V96, P14153, DOI 10.1073/pnas.96.24.14153; Takken FLW, 2000, PLANT J, V24, P275, DOI 10.1046/j.1365-313x.2000.00866.x; Tian MY, 2007, PLANT PHYSIOL, V143, P364, DOI 10.1104/pp.106.090050; Tomalova I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038656; van den Burg HA, 2006, MOL PLANT MICROBE IN, V19, P1420, DOI 10.1094/MPMI-19-1420; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; van Esse HP, 2008, PLANT CELL, V20, P1948, DOI 10.1105/tpc.108.059394; van Esse HP, 2007, MOL PLANT MICROBE IN, V20, P1092, DOI 10.1094/MPMI-20-9-1092; Wang JY, 2010, PLANT SIGNAL BEHAV, V5, P1633, DOI 10.4161/psb.5.12.13774; Wang JY, 2011, MOL PLANT PATHOL, V12, P177, DOI 10.1111/j.1364-3703.2010.00660.x; Wang JY, 2010, NEW PHYTOL, V187, P1003, DOI 10.1111/j.1469-8137.2010.03300.x; Wang XH, 2001, MOL PLANT MICROBE IN, V14, P536, DOI 10.1094/MPMI.2001.14.4.536; Win J., 2012, COLD SPRING HARB SYM, V77, P235, DOI [10.1101/sqb.2012.77.015933, DOI 10.1101/SQB.2012.77.015933]; Yennawar NH, 2006, P NATL ACAD SCI USA, V103, P14664, DOI 10.1073/pnas.0605979103	69	43	46	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115042	10.1371/journal.pone.0115042	http://dx.doi.org/10.1371/journal.pone.0115042			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25606855	Green Published, Green Submitted, gold			2022-12-26	WOS:000348205300009
J	Beaz-Hidalgo, R; Hossain, MJ; Liles, MR; Figueras, MJ				Beaz-Hidalgo, Roxana; Hossain, Mohammad J.; Liles, Mark R.; Figueras, Maria-Jose			Strategies to Avoid Wrongly Labelled Genomes Using as Example the Detected Wrong Taxonomic Affiliation for Aeromonas Genomes in the GenBank Database	PLOS ONE			English	Article							SPECIES DEFINITION; VIRULENCE FACTORS; SP NOV.; STRAINS	Around 27,000 prokaryote genomes are presently deposited in the Genome database of GenBank at the National Center for Biotechnology Information (NCBI) and this number is exponentially growing. However, it is not known how many of these genomes correspond correctly to their designated taxon. The taxonomic affiliation of 44 Aeromonas genomes (only five of these are type strains) deposited at the NCBI was determined by a multilocus phylogenetic analysis (MLPA) and by pairwise average nucleotide identity (ANI). Discordant results in relation to taxa assignation were found for 14 (35.9%) of the 39 non-type strain genomes on the basis of both the MLPA and ANI results. Data presented in this study also demonstrated that if the genome of the type strain is not available, a genome of the same species correctly identified can be used as a reference for ANI calculations. Of the three ANI calculating tools compared (ANI calculator, EzGenome and JSpecies), EzGenome and JSpecies provided very similar results. However, the ANI calculator provided higher intra- and inter-species values than the other two tools (differences within the ranges 0.06-0.82% and 0.92-3.38%, respectively). Nevertheless each of these tools produced the same species classification for the studied Aeromonas genomes. To avoid possible misinterpretations with the ANI calculator, particularly when values are at the borderline of the 95% cutoff, one of the other calculation tools (EzGenome or JSpecies) should be used in combination. It is recommended that once a genome sequence is obtained the correct taxonomic affiliation is verified using ANI or a MLPA before it is submitted to the NCBI and that researchers should amend the existing taxonomic errors present in databases.	[Beaz-Hidalgo, Roxana; Figueras, Maria-Jose] Univ Rovira & Virgili, Fac Med & Ciencies Salut, IISPV, Dept Ciences Med Basiques,Unitat Microbiol, E-43201 Reus, Spain; [Hossain, Mohammad J.; Liles, Mark R.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Auburn University System; Auburn University	Figueras, MJ (corresponding author), Univ Rovira & Virgili, Fac Med & Ciencies Salut, IISPV, Dept Ciences Med Basiques,Unitat Microbiol, C St Llorenc 21, E-43201 Reus, Spain.	mariajose.figueras@urv.cat	Hossain, Mohammad J/I-1542-2014	Hossain, Mohammad J/0000-0003-3848-9035; Figueras, Maria J./0000-0002-2268-8980	"Ministerio de Ciencia e Innovacion" (Spain) [AGL2011-30461-C02-02]; European Union [311846]	"Ministerio de Ciencia e Innovacion" (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission)	This work was supported in part by the project with reference AGL2011-30461-C02-02 by the "Ministerio de Ciencia e Innovacion" (Spain) and by funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 311846. The authors are solely responsible for the content of this publication. It does not represent the opinion of the European Commission. The European Commission is not responsible for any use that might be made of data appearing therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravena-Roman M, 2013, INT J SYST EVOL MICR, V63, P2270, DOI 10.1099/ijs.0.040162-0; Beaz-Hidalgo R, 2013, J FISH DIS, V36, P371, DOI 10.1111/jfd.12025; Beaz-Hidalgo R, 2013, SYST APPL MICROBIOL, V36, P171, DOI 10.1016/j.syapm.2012.12.007; Chen PL, 2014, CLIN MICROBIOL INFEC, V20, pO428, DOI 10.1111/1469-0691.12456; Chun J, 2014, INT J SYST EVOL MICR, V64, P316, DOI 10.1099/ijs.0.054171-0; Colston SM, 2014, MBIO, V5, DOI 10.1128/mBio.02136-14; Figueras M.J., 2011, B BISMIS 1, V2, P1; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Grim CJ, 2014, APPL ENVIRON MICROB, V80, P4162, DOI 10.1128/AEM.00486-14; Hossain MJ, 2014, MBIO, V5, DOI 10.1128/mBio.00848-14; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jimenez G, 2013, SYST APPL MICROBIOL, V36, P383, DOI 10.1016/j.syapm.2013.04.008; Figueras MJ, 2015, AEROMONAS, P65; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Konstantinidis KT, 2006, APPL ENVIRON MICROB, V72, P7286, DOI 10.1128/AEM.01398-06; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Konstantinidis KT, 2014, MICROBE, V9, P111, DOI [10.1128/microbe.9.111.1, DOI 10.1128/MICROBE.9.111.1]; Martens M, 2008, INT J SYST EVOL MICR, V58, P200, DOI 10.1099/ijs.0.65392-0; Martinez-Murcia A, 2013, CURR MICROBIOL, V66, P197, DOI 10.1007/s00284-012-0253-x; Martinez-Murcia AJ, 2011, SYST APPL MICROBIOL, V34, P189, DOI 10.1016/j.syapm.2010.11.014; Pascual J, 2010, INT J SYST EVOL MICR, V60, P154, DOI 10.1099/ijs.0.010702-0; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Serrano W, 2010, SYST APPL MICROBIOL, V33, P116, DOI 10.1016/j.syapm.2009.12.003; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; Wu CJ, 2013, INT J ANTIMICROB AG, V42, P456, DOI 10.1016/j.ijantimicag.2013.08.002	28	55	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115813	10.1371/journal.pone.0115813	http://dx.doi.org/10.1371/journal.pone.0115813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607802	gold, Green Published, Green Submitted			2022-12-26	WOS:000348205300021
J	Copik, AJ; Baldys, A; Nguyen, K; Sahdeo, S; Ho, H; Kosaka, A; Dietrich, PJ; Fitch, B; Raymond, JR; Ford, APDW; Button, D; Milla, ME				Copik, Alicja J.; Baldys, Aleksander; Nguyen, Khanh; Sahdeo, Sunil; Ho, Hoangdung; Kosaka, Alan; Dietrich, Paul J.; Fitch, Bill; Raymond, John R.; Ford, Anthony P. D. W.; Button, Donald; Milla, Marcos E.			Isoproterenol Acts as a Biased Agonist of the Alpha-1A-Adrenoceptor that Selectively Activates the MAPK/ERK Pathway	PLOS ONE			English	Article							PROTEIN-KINASE PATHWAYS; PAROTID ACINAR-CELLS; ALPHA(1)-ADRENERGIC RECEPTOR SUBTYPES; BETA-ADRENERGIC-RECEPTORS; TRANSFECTED PC12 CELLS; BETA(2)-ADRENERGIC RECEPTOR; ALPHA(1A)-ADRENERGIC RECEPTORS; INTERNALIZATION PROPERTIES; SYMPATHOMIMETIC AMINES; FUNCTIONAL SELECTIVITY	The alpha(1A)-AR is thought to couple predominantly to the G alpha(q)/PLC pathway and lead to phosphoinositide hydrolysis and calcium mobilization, although certain agonists acting at this receptor have been reported to trigger activation of arachidonic acid formation and MAPK pathways. For several G protein-coupled receptors (GPCRs) agonists can manifest a bias for activation of particular effector signaling output, i.e. not all agonists of a given GPCR generate responses through utilization of the same signaling cascade(s). Previous work with G alpha(q) coupling-defective variants of alpha(1A)-AR, as well as a combination of Ca2+ channel blockers, uncovered cross-talk between alpha(1A)-AR and beta(2)-AR that leads to potentiation of a G alpha(q)-independent signaling cascade in response to alpha(1A)-AR activation. We hypothesized that molecules exist that act as biased agonists to selectively activate this pathway. In this report, isoproterenol (Iso), typically viewed as beta-AR-selective agonist, was examined with respect to activation of alpha(1A)-AR. alpha(1A)-AR selective antagonists were used to specifically block Iso evoked signaling in different cellular backgrounds and confirm its action at alpha(1A)-AR. Iso induced signaling at alpha(1A)-AR was further interrogated by probing steps along the G alpha(q)/PLC, G alpha(s) and MAPK/ERK pathways. In HEK-293/EBNA cells transiently transduced with alpha(1A)-AR, and CHO_alpha(1A)-AR stable cells, Iso evoked low potency ERK activity as well as Ca2+ mobilization that could be blocked by alpha(1A)-AR selective antagonists. The kinetics of Iso induced Ca2+ transients differed from typical G alpha(q)-mediated Ca2+ mobilization, lacking both the fast IP3R mediated response and the sustained phase of Ca2+ re-entry. Moreover, no inositol phosphate (IP) accumulation could be detected in either cell line after stimulation with Iso, but activation was accompanied by receptor internalization. Data are presented that indicate that Iso represents a novel type of alpha(1A)-AR partial agonist with signaling bias toward MAPK/ERK signaling cascade that is likely independent of coupling to G alpha(q).	[Copik, Alicja J.; Sahdeo, Sunil; Ford, Anthony P. D. W.; Button, Donald; Milla, Marcos E.] Roche Palo Alto LLC, Biochem Pharmacol Inflammat Discovery, Palo Alto, CA 94304 USA; [Nguyen, Khanh; Ho, Hoangdung; Kosaka, Alan; Dietrich, Paul J.; Fitch, Bill] Roche Palo Alto LLC, Discovery Technol, Palo Alto, CA 94304 USA; [Baldys, Aleksander; Raymond, John R.] Med Univ S Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA; [Baldys, Aleksander; Raymond, John R.] Ralph H Johnson Vet Affairs Med Ctr, Med & Res Serv, Charleston, SC 29425 USA	Roche Holding; Roche Holding; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Milla, ME (corresponding author), Roche Palo Alto LLC, Biochem Pharmacol Inflammat Discovery, 3401 Hillview Dr, Palo Alto, CA 94304 USA.	mmilla22@its.jnj.com		Copik, Alicja/0000-0003-4109-5539	Department of Veterans Affairs Merit and Research Enhancement Award Program grants; National Institutes of Health [DK052448, GM063909]; Medical University of South Carolina Division of Nephrology, and Dialysis Clinics, Inc.; Roche Palo Alto LLC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052448, R01DK052448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063909] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit and Research Enhancement Award Program grants; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical University of South Carolina Division of Nephrology, and Dialysis Clinics, Inc.; Roche Palo Alto LLC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Most of this work was performed at Roche Palo Alto LLC. Immunofluorescence microscopy studies were performed with support from the Department of Veterans Affairs Merit and Research Enhancement Award Program grants, by National Institutes of Health Grants DK052448 and GM063909, by laboratory endowment jointly supported by the Medical University of South Carolina Division of Nephrology, and Dialysis Clinics, Inc. (to JRR). Roche Palo Alto LLC, the funder, provided support in the form of salaries for authors AJC, KN, SS, HH, AK, PJD, BF, APDWF, DB and MEM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AHLQUIST RP, 1948, AM J PHYSIOL, V153, P586, DOI 10.1152/ajplegacy.1948.153.3.586; ARCH JRS, 1984, NATURE, V309, P163, DOI 10.1038/309163a0; BERTHELSEN S, 1977, LIFE SCI, V21, P595, DOI 10.1016/0024-3205(77)90066-2; Berts A, 1999, MOL PHARMACOL, V55, P296, DOI 10.1124/mol.55.2.296; BORDA ES, 1981, PHARMACOL RES COMMUN, V13, P487, DOI 10.1016/S0031-6989(81)80075-6; BRISTOL JA, 1994, TRENDS ENDOCRIN MET, V5, P402, DOI 10.1016/1043-2760(95)92522-K; BYLUND DB, 1992, MOL PHARMACOL, V42, P1; Chalothorn D, 2002, MOL PHARMACOL, V61, P1008, DOI 10.1124/mol.61.5.1008; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Copik AJ, 2009, MOL PHARMACOL, V75, P713, DOI 10.1124/mol.108.050765; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; DeArcangelis V, 2008, MOL PHARM; Del Carmine R, 2002, BRIT J PHARMACOL, V135, P1715, DOI 10.1038/sj.bjp.0704622; DOREVITCH N, 1968, ARCH INT PHARMACOD T, V174, P98; FLEISCH JH, 1970, CIRC RES, V26, P151, DOI 10.1161/01.RES.26.2.151; FORD APDW, 1994, TRENDS PHARMACOL SCI, V15, P167, DOI 10.1016/0165-6147(94)90136-8; Ford APDW, 1997, BRIT J PHARMACOL, V121, P1127, DOI 10.1038/sj.bjp.0701207; FURCHGOTT RF, 1959, PHARMACOL REV, V11, P429; FURCHGOTT RF, 1953, J PHARMACOL EXP THER, V108, P129; Galandrin S, 2008, MOL PHARMACOL, V74, P162, DOI 10.1124/mol.107.043893; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; GIUDICELLI R, 1967, CR SOC BIOL, V161, P284; Grisanti LA, 2014, J MOL CELL CARDIOL, V72, P39, DOI 10.1016/j.yjmcc.2014.02.009; Guimaraes S, 2001, PHARMACOL REV, V53, P319; Hilal-Dandan R, 2000, J MOL CELL CARDIOL, V32, P1211, DOI 10.1006/jmcc.2000.1156; Hoffmann C, 2008, BRIT J PHARMACOL, V153, pS358, DOI 10.1038/sj.bjp.0707615; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; HORN VJ, 1988, J BIOL CHEM, V263, P12454; Huang Y, 2007, CIRCULATION, V115, P763, DOI 10.1161/CIRCULATIONAHA.106.664862; Iwai-Kanai E, 1999, CIRCULATION, V100, P305, DOI 10.1161/01.CIR.100.3.305; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; LANDS AM, 1967, NATURE, V214, P597, DOI 10.1038/214597a0; LANGER SZ, 1974, BIOCHEM PHARMACOL, V23, P1793, DOI 10.1016/0006-2952(74)90187-7; Lee D, 2003, J PHARMACOL EXP THER, V306, P471, DOI 10.1124/jpet.103.050500; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liu F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021520; Liu XD, 2009, RAPID COMMUN MASS SP, V23, P705, DOI 10.1002/rcm.3923; Lohse MJ, 2008, BRIT J PHARMACOL, V153, pS125, DOI 10.1038/sj.bjp.0707656; Mailman RB, 2007, TRENDS PHARMACOL SCI, V28, P390, DOI 10.1016/j.tips.2007.06.002; MINNEMAN KP, 1988, PHARMACOL REV, V40, P87; Morris DP, 2008, J BIOL CHEM, V283, P2973, DOI 10.1074/jbc.M705795200; Morris DP, 2004, MOL PHARMACOL, V66, P843, DOI 10.1124/mol.104.000430; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; O'Connell TD, 2006, J CLIN INVEST, V116, P1005, DOI 10.1172/JCI22811; Oganesian A, 2011, P NATL ACAD SCI USA, V108, P19796, DOI 10.1073/pnas.1116271108; Perez DM, 2011, J RECEPT SIG TRANSD, V31, P98, DOI 10.3109/10799893.2010.550008; Perez DM., 2005, ADRENERGIC RECEPTORS; Perez-Aso M, 2013, BBA-MOL CELL RES, V1833, P2322, DOI 10.1016/j.bbamcr.2013.06.013; Sabri A, 2000, CIRC RES, V86, P1047, DOI 10.1161/01.RES.86.10.1047; Sakata Y, 1998, CIRCULATION, V97, P1488; Simmons MA, 2005, MOL INTERV, V5, P154, DOI 10.1124/mi.5.3.4; Simpson PC, 2011, J MOL CELL CARDIOL, V51, P435, DOI 10.1016/j.yjmcc.2011.08.005; Stanasila L, 2008, MOL PHARMACOL, V74, P562, DOI 10.1124/mol.107.043422; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; SUTTER MC, 1965, BRIT J PHARM CHEMOTH, V24, P742, DOI 10.1111/j.1476-5381.1965.tb01630.x; TAKEMURA H, 1985, BIOCHEM BIOPH RES CO, V131, P1048, DOI 10.1016/0006-291X(85)90196-2; TANIMURA A, 1990, BIOCHIM BIOPHYS ACTA, V1055, P273, DOI 10.1016/0167-4889(90)90043-D; Tojyo Y, 1998, EUR J PHARMACOL, V360, P73, DOI 10.1016/S0014-2999(98)00651-7; TURLAPATY PDMV, 1975, J PHARMACOL EXP THER, V192, P372; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; WALZ DT, 1960, J PHARMACOL EXP THER, V129, P200; Waugh DJJ, 1999, J PHARMACOL EXP THER, V291, P1164; Williams NG, 1998, J BIOL CHEM, V273, P24624, DOI 10.1074/jbc.273.38.24624; Williams TJ, 1999, BRIT J PHARMACOL, V127, P252, DOI 10.1038/sj.bjp.0702541; Zhang XY, 2013, CIRC RES, V112, P498, DOI 10.1161/CIRCRESAHA.112.273896; Zhong HY, 1999, J NEUROCHEM, V72, P2388, DOI 10.1046/j.1471-4159.1999.0722388.x; Zou YZ, 1999, J BIOL CHEM, V274, P9760, DOI 10.1074/jbc.274.14.9760	69	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115701	10.1371/journal.pone.0115701	http://dx.doi.org/10.1371/journal.pone.0115701			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25606852	Green Submitted, gold, Green Published			2022-12-26	WOS:000348205300018
J	Cornelius, RJ; Wen, DH; Li, HQ; Yuan, Y; Wang-France, J; Warner, PC; Sansom, SC				Cornelius, Ryan J.; Wen, Donghai; Li, Huaqing; Yuan, Yang; Wang-France, Jun; Warner, Paige C.; Sansom, Steven C.			Low Na, High K Diet and the Role of Aldosterone in BK-Mediated K Excretion	PLOS ONE			English	Article							POTASSIUM SECRETION; DISTAL NEPHRON; DIFFERENTIAL REGULATION; DEPENDENT REGULATION; BETA-1 SUBUNIT; ION-TRANSPORT; CHANNEL; SODIUM; BICARBONATE; EXPRESSION	A low Na, high K diet (LNaHK) is associated with a low rate of cardiovascular (CV) disease in many societies. Part of the benefit of LNaHK relies on its diuretic effects; however, the role of aldosterone (aldo) in the diuresis is not understood. LNaHK mice exhibit an increase in renal K secretion that is dependent on the large, Ca-activated K channel, (BK-alpha with accessory BK-beta 4; BK-alpha/beta 4). We hypothesized that aldo causes an osmotic diuresis by increasing BK-alpha/beta-mediated K secretion in LNaHK mice. We found that the plasma aldo concentration (P[aldo]) was elevated by 10-fold in LNaHK mice compared with control diet (Con) mice. We subjected LNaHK mice to either sham surgery (sham), adrenalectomy (ADX) with low aldo replacement (ADX-LA), or ADX with high aldo replacement (ADX-HA). Compared to sham, the urinary flow, K excretion rate, transtubular K gradient (TTKG), and BK-alpha and BK-beta 4 expressions, were decreased in ADX-LA, but not different in ADX-HA. BK-beta 4 knockout (beta 4KO) and WT mice exhibited similar K clearance and TTKG in the ADX-LA groups; however, in sham and ADX-HA, the K clearance and TTKG of beta 4KO were less than WT. In response to amiloride treatment, the osmolar clearance was increased in WT Con, decreased in WT LNaHK, and unchanged in beta 4KO LNaHK. These data show that the high P[aldo] of LNaHK mice is necessary to generate a high rate of BK-alpha/beta 4-mediated K secretion, which creates an osmotic diuresis that may contribute to a reduction in CV disease.	[Cornelius, Ryan J.; Wen, Donghai; Li, Huaqing; Yuan, Yang; Wang-France, Jun; Warner, Paige C.; Sansom, Steven C.] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Sansom, SC (corresponding author), Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE 68198 USA.	ssansom@unmc.edu			National Institute of Diabetes and Digestive and Kidney Diseases [RO1 DK071014, RO1 DK73070]; American Heart Association MWA Affiliate [11PRE7530018]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092474, R01DK071014, R01DK073070] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association MWA Affiliate(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was funded by National Institute of Diabetes and Digestive and Kidney Diseases Grants RO1 DK071014 and RO1 DK73070 (SCS), and a fellowship (#11PRE7530018) from the American Heart Association MWA Affiliate (RJC).	Amberg GC, 2003, J CLIN INVEST, V112, P717, DOI 10.1172/JC1200318684; Bailey MA, 2006, KIDNEY INT, V70, P51, DOI 10.1038/sj.ki.5000388; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Cornelius RJ, 2012, AM J PHYSIOL-RENAL, V303, pF1563, DOI 10.1152/ajprenal.00490.2012; Dijkink L, 1999, PFLUG ARCH EUR J PHY, V438, P354, DOI 10.1007/s004240050920; Dooley R, 2012, MOL CELL ENDOCRINOL, V350, P223, DOI 10.1016/j.mce.2011.07.019; Dunn SR, 2004, KIDNEY INT, V65, P1959, DOI 10.1111/j.1523-1755.2004.00600.x; EATON SB, 1985, NEW ENGL J MED, V312, P283, DOI 10.1056/NEJM198501313120505; Fernandez-Fernandez JM, 2004, J CLIN INVEST, V113, P1032, DOI 10.1172/JCI200420347; FIELD MJ, 1984, J CLIN INVEST, V74, P1792, DOI 10.1172/JCI111598; Frassetto L, 2001, EUR J NUTR, V40, P200, DOI 10.1007/s394-001-8347-4; Frindt G, 2009, AM J PHYSIOL-RENAL, V297, pF389, DOI 10.1152/ajprenal.90528.2008; Gamliel-Lazarovich A, 2013, EUR J GASTROEN HEPAT, V25, P1086, DOI 10.1097/MEG.0b013e328360554a; GARG LC, 1981, AM J PHYSIOL, V240, pF536, DOI 10.1152/ajprenal.1981.240.6.F536; GARG LC, 1987, PFLUG ARCH EUR J PHY, V409, P126, DOI 10.1007/BF00584759; Gertner RA, 2004, J AM SOC NEPHROL, V15, P558, DOI 10.1097/01.ASN.0000113244.37857.AC; GORDON RD, 1994, CLIN EXP PHARMACOL P, V21, P315, DOI 10.1111/j.1440-1681.1994.tb02519.x; GREEN HH, 1970, J CLIN INVEST, V49, P1724, DOI 10.1172/JCI106390; Grimm PR, 2010, KIDNEY INT, V78, P956, DOI 10.1038/ki.2010.272; Grimm PR, 2009, P NATL ACAD SCI USA, V106, P11800, DOI 10.1073/pnas.0904635106; Grimm PR, 2009, AM J PHYSIOL-RENAL, V297, pF420, DOI 10.1152/ajprenal.00191.2009; Hebert SC, 2005, PHYSIOL REV, V85, P319, DOI 10.1152/physrev.00051.2003; Holtzclaw JD, 2011, AM J PHYSIOL-RENAL, V300, pF1319, DOI 10.1152/ajprenal.00112.2011; Holtzclaw JD, 2010, J AM SOC NEPHROL, V21, P634, DOI 10.1681/ASN.2009080817; Huang DY, 2004, J AM SOC NEPHROL, V15, P885, DOI 10.1097/01.ASN.0000120368.59693.A8; Keith NM, 1935, J AMER MED ASSOC, V105, P1584; Kim GH, 1998, P NATL ACAD SCI USA, V95, P14552, DOI 10.1073/pnas.95.24.14552; Kobayashi M, 2011, CLIN EXP NEPHROL, V15, P355, DOI 10.1007/s10157-011-0414-4; Mancilha-Carvalho Jairo de Jesus, 2003, Arq. Bras. Cardiol., V80, P295, DOI 10.1590/S0066-782X2003000300005; Manolopoulou J, 2008, J ENDOCRINOL, V196, P215, DOI 10.1677/JOE-07-0134; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Nesterov V, 2012, AM J PHYSIOL-RENAL, V303, pF1289, DOI 10.1152/ajprenal.00247.2012; NICKERSON PA, 1969, AM J PATHOL, V57, P335; OLIVER WJ, 1975, CIRCULATION, V52, P146, DOI 10.1161/01.CIR.52.1.146; Onogawa Toshiyuki, 2011, Cardiovasc Drugs Ther, V25 Suppl 1, pS67, DOI 10.1007/s10557-011-6350-4; Arroyo JP, 2011, PHYSIOLOGY, V26, P115, DOI 10.1152/physiol.00049.2010; Pluger S, 2000, CIRC RES, V87, pE53, DOI 10.1161/01.RES.87.11.e53; Rengarajan S, 2014, AM J PHYSIOL-RENAL, V306, pF1059, DOI 10.1152/ajprenal.00015.2014; Sansom SC, 2007, KIDNEY INT, V72, P529, DOI 10.1038/sj.ki.5002438; SANSOM SC, 1985, AM J PHYSIOL, V248, pF858, DOI 10.1152/ajprenal.1985.248.6.F858; Sorensen MV, 2013, KIDNEY INT, V83, P811, DOI 10.1038/ki.2013.14; STOKES JB, 1982, J CLIN INVEST, V70, P219, DOI 10.1172/JCI110609; TODKAR A, 2014, J AM SOC NEPHROL; TREASURE J, 1983, HYPERTENSION, V5, P864, DOI 10.1161/01.HYP.5.6.864; Tsuchiya K, 1996, AM J PHYSIOL-RENAL, V271, pF7, DOI 10.1152/ajprenal.1996.271.1.F7; Vasan RS, 2004, NEW ENGL J MED, V351, P33, DOI 10.1056/NEJMoa033263; Velazquez H, 1996, AM J PHYSIOL-RENAL, V270, pF211, DOI 10.1152/ajprenal.1996.270.1.F211; Wade JB, 2011, AM J PHYSIOL-RENAL, V300, pF1385, DOI 10.1152/ajprenal.00592.2010; Wang XF, 2003, NAT CELL BIOL, V5, P902, DOI 10.1038/ncb1047; Welling PA, 2013, SEMIN NEPHROL, V33, P215, DOI 10.1016/j.semnephrol.2013.04.002; Wen DH, 2014, KIDNEY INT, V86, P139, DOI 10.1038/ki.2014.14; Wen DH, 2014, CURR OPIN PHARMACOL, V15, P28, DOI 10.1016/j.coph.2013.11.001; Wen DH, 2013, AM J PHYSIOL-RENAL, V305, pF463, DOI 10.1152/ajprenal.00171.2013; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200	55	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115515	10.1371/journal.pone.0115515	http://dx.doi.org/10.1371/journal.pone.0115515			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607984	gold, Green Submitted, Green Published			2022-12-26	WOS:000348205300015
J	Xu, XF; Zhang, XW				Xu, Xiaofei; Zhang, Xuewu			Lentinula edodes-Derived Polysaccharide Alters the Spatial Structure of Gut Microbiota in Mice	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; DIETARY RESISTANT; WEANED PIGLETS; OAT CULTIVARS; INFLAMMATION; EXPRESSION; INTESTINE; RESPONSES; HEALTH; BARLEY	Lentinula edodes-derived polysaccharides possess many therapeutic characteristics, including anti-tumor and immuno-modulation. The gut microbes play a critical role inmodulation of immune function. However, the impact of Lentinula edodes-derived polysaccharides on the gut microbes have not yet been explored. In this study, high-throughput pyrosequencing technique was employed to investigate the effects of a new heteropolysaccharide L2 from Lentinula edodes on microbiota diversity and composition of small intestine, cecum, colon and distal end of colon (feces) in mice. The results demonstrated that along mouse intestine the microbiota exhibit distinctly different space distribution. L2 treatment reduced the diversity and evenness of gut microbiota along the intestine, especially in the cecum and colon. In the fecal microbial communities, the decrease of Bacteroidetes by significantly increasing Proteobacteria were observed, which were characterized by the increased Helicobacteraceae and reduced S24-7 at family level. Some OTUs, corresponding to Bacteroides acidifaciens, Alistipes and Helicobacter suncus, were found to be significantly increased in L2 treatedmice. In particular, 4 phyla Chloroflexi, Gemmatimonadetes, Nitrospirae and Planctomycetes are exclusively present in L2-treated mice. This is helpful for further demonstrating healthy action mechanism of Lentinula edodes-derived polysaccharide L2.	[Xu, Xiaofei; Zhang, Xuewu] S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Zhang, XW (corresponding author), S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China.	snow_dance@sina.com						Abell GCJ, 2011, BRIT J NUTR, V105, P1480, DOI 10.1017/S0007114510005349; Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Aida FMNA, 2009, TRENDS FOOD SCI TECH, V20, P567, DOI 10.1016/j.tifs.2009.07.007; Bisen PS, 2010, CURR MED CHEM, V17, P2419, DOI 10.2174/092986710791698495; Bolam DN, 2011, GUT MICROBES, V2, P86, DOI 10.4161/gmic.2.2.15232; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; Chou WT, 2013, J FOOD SCI, V78, pM1041, DOI 10.1111/1750-3841.12160; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Finimundy T. C., 2014, Food and Nutrition Sciences, V5, P1095; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Gribar SC, 2008, MOL MED, V14, P645, DOI 10.2119/2008-00035.Gribar; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Jeffery IB, 2013, NUTRIENTS, V5, P234, DOI 10.3390/nu5010234; Jha R, 2010, ANIMAL, V4, P724, DOI 10.1017/S1751731109991510; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Lavelle A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078835; Li F, 2009, J NUTR, V139, P1685, DOI 10.3945/jn.109.108191; Low D, 2013, DRUG DES DEV THER, V7, P1341, DOI 10.2147/DDDT.S40107; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046; Mirpuri J, 2014, GUT MICROBES, V5, P28, DOI 10.4161/gmic.26489; Mizoguchi A, 2010, CURR OPIN PHARMACOL, V10, P578, DOI 10.1016/j.coph.2010.05.007; Mizuno M, 2009, BIOSCI BIOTECH BIOCH, V73, P2324, DOI 10.1271/bbb.90326; Nihira T, 2013, J BIOL CHEM, V288, P27366, DOI 10.1074/jbc.M113.469080; Nishitani Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062441; Pieper R, 2008, FEMS MICROBIOL ECOL, V66, P556, DOI 10.1111/j.1574-6941.2008.00605.x; Pieper R, 2009, APPL ENVIRON MICROB, V75, P7006, DOI 10.1128/AEM.01343-09; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ramakers JD, 2007, MOL NUTR FOOD RES, V51, P211, DOI 10.1002/mnfr.200600149; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Tachon S, 2013, FEMS MICROBIOL ECOL, V83, P299, DOI 10.1111/j.1574-6941.2012.01475.x; Volman JJ, 2010, MOL NUTR FOOD RES, V54, P268, DOI 10.1002/mnfr.200900009; Wang CL, 2014, INFLAMMATION, V37, P83, DOI 10.1007/s10753-013-9714-z; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu WZ, 2013, APPL MICROBIOL BIOT, V97, P2725, DOI 10.1007/s00253-012-4110-4; Xu XF, 2014, CRIT REV FOOD SCI, V54, P474, DOI 10.1080/10408398.2011.587616; Xu XF, 2013, BIOTECHNOL ADV, V31, P318, DOI 10.1016/j.biotechadv.2012.12.009; Xu XF, 2012, J AGR FOOD CHEM, V60, P11560, DOI 10.1021/jf304364c; Yanagibashi T, 2013, IMMUNOBIOLOGY, V218, P645, DOI 10.1016/j.imbio.2012.07.033	49	55	57	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115037	10.1371/journal.pone.0115037	http://dx.doi.org/10.1371/journal.pone.0115037			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25608087	Green Published, Green Submitted, gold			2022-12-26	WOS:000348205300008
J	Gale, SD; Erickson, LD; Brown, BL; Hedges, DW				Gale, Shawn D.; Erickson, Lance D.; Brown, Bruce L.; Hedges, Dawson W.			Interaction between Helicobacter pylori and Latent Toxoplasmosis and Demographic Variables on Cognitive Function in Young to Middle-Aged Adults	PLOS ONE			English	Article							GONDII INFECTION; HEALTH; ASSOCIATION; DEFICIENCY; PERFORMANCE; GASTRITIS; DISEASE; IRON	Helicobacter pylori and latent toxoplasmosis are widespread diseases that have been associated with cognitive deficits and Alzheimer's disease. We sought to determine whether interactions between Helicobacter pylori and latent toxoplasmosis, age, race-ethnicity, educational attainment, economic status, and general health predict cognitive function in young and middle-aged adults. To do so, we used multivariable regression and multivariate models to analyze data obtained from the United States' National Health and Nutrition Examination Survey from the Centers for Disease Control and Prevention, which can be weighted to represent the US population. In this sample, we found that 31.6 percent of women and 36.2 percent of men of the overall sample had IgG Antibodies against Helicobacter pylori, although the seroprevalence of Helicobacter pylori varied with sociodemographic variables. There were no main effects for Helicobacter pylori or latent toxoplasmosis for any of the cognitive measures in models adjusting for age, sex, race-ethnicity, educational attainment, economic standing, and self-rated health predicting cognitive function. However, interactions between Helicobacter pylori and race-ethnicity, educational attainment, latent toxoplasmosis in the fully adjusted models predicted cognitive function. People seropositive for both Helicobacter pylori and latent toxoplasmosis - both of which appear to be common in the general population - appear to be more susceptible to cognitive deficits than are people seropositive for either Helicobacter pylori and or latent toxoplasmosis alone, suggesting a synergistic effect between these two infectious diseases on cognition in young to middle-aged adults.	[Gale, Shawn D.; Brown, Bruce L.; Hedges, Dawson W.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Gale, Shawn D.; Hedges, Dawson W.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Erickson, Lance D.] Brigham Young Univ, Dept Sociol, Provo, UT 84602 USA	Brigham Young University; Brigham Young University; Brigham Young University	Gale, SD (corresponding author), Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA.	shawn_gale@byu.edu	Gale, Shawn/M-3144-2013	Gale, Shawn/0000-0002-8989-0964; Brown, Bruce L./0000-0002-5952-6475				Aiello AE, 2006, J AM GERIATR SOC, V54, P1046, DOI 10.1111/j.1532-5415.2006.00796.x; BAKER EL, 1985, NEUROBEH TOXICOL TER, V7, P369; Berenreiterova M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028925; Beydoun MA, 2013, PSYCHOSOM MED, V75, P486, DOI 10.1097/PSY.0b013e31829108c3; BLASER MJ, 1995, CANCER RES, V55, P2111; Brown B. L., 2012, MULTIVARIATE ANAL BI; Cardenas VM, 2006, AM J EPIDEMIOL, V163, P127, DOI 10.1093/aje/kwj018; [Centers for Disease Control and Prevention (CDC) NCfHS Services USDoHaH], 2012, SERV USDOHAH; Chen Y, 2012, J INFECT DIS, V205, P1195, DOI 10.1093/infdis/jis106; Ellawanda F, 2013, EPIDEMIOL REV, V35, P161, DOI 10.1093/epirev/mxs007; Flegr J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090203; Gale SD, 2015, PARASITOLOGY, V142, P557, DOI 10.1017/S0031182014001577; Gunter E.W., 1996, LAB METHODS USED THI, P1988; Havlicek J, 2001, PARASITOLOGY, V122, P515, DOI 10.1017/S0031182001007624; Henriquez SA, 2009, NEUROIMMUNOMODULAT, V16, P122, DOI 10.1159/000180267; Hinze-Selch D, 2007, SCHIZOPHRENIA BULL, V33, P782, DOI 10.1093/schbul/sbm010; Katan M, 2013, NEUROLOGY, V80, P1209, DOI 10.1212/WNL.0b013e3182896e79; Keppel KG, 2007, AM J EPIDEMIOL, V166, P97, DOI 10.1093/aje/kwm044; Kountouras J, 2007, EUR J NEUROL, V14, P976, DOI 10.1111/j.1468-1331.2007.01827.x; Kountouras J, 2006, NEUROLOGY, V66, P938, DOI 10.1212/01.wnl.0000203644.68059.5f; Kountouras J, 2007, AM J CLIN NUTR, V86, P805, DOI 10.1093/ajcn/86.3.805; Kountouras J, 2010, COGN BEHAV NEUROL, V23, P199, DOI 10.1097/WNN.0b013e3181df3034; Krieg EF, 2001, NEUROTOXICOL TERATOL, V23, P569, DOI 10.1016/S0892-0362(01)00177-5; Kusbeci OY, 2011, ALZ DIS ASSOC DIS, V25, P1, DOI 10.1097/WAD.0b013e3181f73bc2; Letz RE, 1988, NES 2 NEUROBEHAVIORA; Lovheim H, 2015, ALZHEIMERS DEMENT, V11, P587, DOI 10.1016/j.jalz.2014.07.157; Lurain NS, 2013, J INFECT DIS, V208, P564, DOI 10.1093/infdis/jit210; Malaguarnera Mariano, 2004, Eur J Intern Med, V15, P381, DOI 10.1016/j.ejim.2004.05.008; MARSHALL BJ, 1984, LANCET, V1, P1311; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Muhsen K, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-43; Murray-Kolb LE, 2013, CURR OPIN CLIN NUTR, V16, P703, DOI 10.1097/MCO.0b013e3283653ef8; O'Connor JPA, 2012, IMMUNOGASTROENTEROLO, V1, P5, DOI [10.7178/ig.1.1.3, DOI 10.7178/IG.1.1.3]; Pearce BD, 2014, SOC PSYCH PSYCH EPID, V49, P1001, DOI 10.1007/s00127-014-0820-5; Peleteiro B, 2014, DIGEST DIS SCI, V59, P1698, DOI 10.1007/s10620-014-3063-0; Rencher A.C., 2012, METHODS MULTIVARIATE, DOI DOI 10.1002/9781118391686; RENCHER AC, 1990, COMMUN STAT SIMULAT, V19, P535, DOI 10.1080/03610919008812874; Serin E, 2002, HELICOBACTER, V7, P337, DOI 10.1046/j.1523-5378.2002.00106.x; Timm NH, 1997, COMMUN STAT-THEOR M, V26, P1083; Torrey EF, 2013, TRENDS PARASITOL, V29, P380, DOI 10.1016/j.pt.2013.06.001; Wang XL, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00066; Xiao J, 2012, NEUROSCIENCE, V206, P39, DOI 10.1016/j.neuroscience.2011.12.051; Zajacova A, 2011, AM J EPIDEMIOL, V174, P977, DOI 10.1093/aje/kwr204	43	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116874	10.1371/journal.pone.0116874	http://dx.doi.org/10.1371/journal.pone.0116874			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9HN	25590622	Green Published, gold, Green Submitted			2022-12-26	WOS:000350679400024
J	Didham, RK; Barker, GM; Bartlam, S; Deakin, EL; Denmead, LH; Fisk, LM; Peters, JMR; Tylianakis, JM; Wright, HR; Schipper, LA				Didham, Raphael K.; Barker, Gary M.; Bartlam, Scott; Deakin, Elizabeth L.; Denmead, Lisa H.; Fisk, Louise M.; Peters, Jennifer M. R.; Tylianakis, Jason M.; Wright, Hannah R.; Schipper, Louis A.			Agricultural Intensification Exacerbates Spillover Effects on Soil Biogeochemistry in Adjacent Forest Remnants	PLOS ONE			English	Article							NEW-ZEALAND AGRICULTURE; LAND-USE INTENSITY; FARMLAND BIODIVERSITY; WATER-QUALITY; MICROCLIMATE; COMMUNITIES; MANAGEMENT; CADMIUM; IMPACTS; INSECT	Land-use intensification is a central element in proposed strategies to address global food security. One rationale for accepting the negative consequences of land-use intensification for farmland biodiversity is that it could 'spare' further expansion of agriculture into remaining natural habitats. However, in many regions of the world the only natural habitats that can be spared are fragments within landscapes dominated by agriculture. Therefore, land-sparing arguments hinge on land-use intensification having low spillover effects into adjacent protected areas, otherwise net conservation gains will diminish with increasing intensification. We test, for the first time, whether the degree of spillover from farmland into adjacent natural habitats scales in magnitude with increasing land-use intensity. We identified a continuous land-use intensity gradient across pastoral farming systems in New Zealand (based on 13 components of farmer input and soil biogeochemistry variables), and measured cumulative off-site spillover effects of fertilisers and livestock on soil biogeochemistry in 21 adjacent forest remnants. Ten of 11 measured soil properties differed significantly between remnants and intact-forest reference sites, for both fenced and unfenced remnants, at both edge and interior. For seven variables, the magnitude of effects scaled significantly with magnitude of surrounding land-use intensity, through complex interactions with fencing and edge effects. In particular, total C, total N, delta N-15, total P and heavy-metal contaminants of phosphate fertilizers (Cd and U) increased significantly within remnants in response to increasing land-use intensity, and these effects were exac(erbated in unfenced relative to fenced remnants. This suggests movement of livestock into surrounding natural habitats is a significant component of agricultural spillover, but pervasive changes in soil biogeochemistry still occur through nutrient spillover channels alone, even in fenced remnants set aside for conservation. These results have important implications for the viability of land sparing as a strategy for balancing landscape-level conservation and production goals in agricultural landscapes.	[Didham, Raphael K.; Denmead, Lisa H.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Didham, Raphael K.] CSIRO Land & Water Flagship, Perth, WA, Australia; [Barker, Gary M.; Bartlam, Scott] Landcare Res, Hamilton, New Zealand; [Deakin, Elizabeth L.; Tylianakis, Jason M.] Univ Canterbury, Ctr Integrat Ecol, Sch Biol Sci, Christchurch 1, New Zealand; [Deakin, Elizabeth L.] CIFOR Ctr Int Forestry Res, Forests & Livelihoods Programme, Bogor, Indonesia; [Denmead, Lisa H.] Univ Gottingen, Dept Crop Sci, D-37073 Gottingen, Germany; [Fisk, Louise M.] Univ Western Australia, Inst Agr, Sch Earth & Environm, Perth, WA 6009, Australia; [Peters, Jennifer M. R.] Dept Conservat, Sci & Capabil Grp, Christchurch, New Zealand; [Tylianakis, Jason M.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot, Berks, England; [Wright, Hannah R.; Schipper, Louis A.] Univ Waikato, Sch Sci, Hamilton, New Zealand; [Wright, Hannah R.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England	University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Landcare Research - New Zealand; CGIAR; Center for International Forestry Research (CIFOR); University of Gottingen; University of Western Australia; Imperial College London; University of Waikato; Lancaster University	Didham, RK (corresponding author), Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia.	raphael.didham@uwa.edu.au	Didham, Raphael K/B-5953-2011; Barker, Gary M/C-9974-2011; Schipper, Louis A/F-1605-2010	Barker, Gary M/0000-0002-0049-9804; Schipper, Louis A/0000-0001-9899-1276; Denmead, Lisa/0000-0001-7634-8335; Peters, Jennifer/0000-0003-4627-7788	Royal Society of New Zealand Marsden [UOC0803]; Australian Research Council Future Fellowship [FT100100040]; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Royal Society of New Zealand Marsden(Royal Society of New ZealandMarsden Fund (NZ)); Australian Research Council Future Fellowship(Australian Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for the study was provided by the Royal Society of New Zealand Marsden grant UOC0803. RKD was supported during the writing of the manuscript by an Australian Research Council Future Fellowship FT100100040. JMT was supported during the writing of this manuscript by a Rutherford Discovery Fellowship, administered by the Royal Society of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; [Anonymous], 2004, ETH SUST AGR INT; Baird D.B., 1996, P NZ GRASSL ASS, P123, DOI [10.33584/jnzg.1996.58.2233, DOI 10.33584/JNZG.1996.58.2233]; Barton K., 2013, MUMIN MULTIMODEL INF; Baskaran R, 2009, NEW ZEAL J AGR RES, V52, P377, DOI 10.1080/00288230909510520; Baudron F, 2014, BIOL CONSERV, V170, P232, DOI 10.1016/j.biocon.2013.12.009; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Benton TG, 2002, J APPL ECOL, V39, P673, DOI 10.1046/j.1365-2664.2002.00745.x; Berka C, 2001, WATER AIR SOIL POLL, V127, P389, DOI 10.1023/A:1005233005364; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; Blakemore LC, 1987, METHODS CHEM ANAL SO; Blitzer EJ, 2012, AGR ECOSYST ENVIRON, V146, P34, DOI 10.1016/j.agee.2011.09.005; Bluthgen N, 2012, BASIC APPL ECOL, V13, P207, DOI 10.1016/j.baae.2012.04.001; Boutin C, 1998, ECOL APPL, V8, P544, DOI 10.1890/1051-0761(1998)008[0544:IOAPAE]2.0.CO;2; Brady N.C, 2000, NATURE PROPERTIES SO; Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burns BR, 2011, AUSTRAL ECOL, V36, P153, DOI 10.1111/j.1442-9993.2010.02130.x; Cameron M, 2007, AUSTRAL NAT HIST SER, P1; Claessens L, 2009, AGR ECOSYST ENVIRON, V129, P157, DOI 10.1016/j.agee.2008.08.008; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; Colombo S, 2005, J AGR ECON, V56, P81, DOI 10.1111/j.1477-9552.2005.tb00123.x; Cornforth IS, 1984, FERTILISER LIME RECO, P24; Cornforth IS, 1980, SOILS FERTILISERS SO; Cunningham SA, 2013, AGR ECOSYST ENVIRON, V173, P20, DOI 10.1016/j.agee.2013.04.007; Davies-Colley RJ, 2000, NEW ZEAL J ECOL, V24, P111; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; de Klein CAM, 1997, NEW ZEAL J AGR RES, V40, P541, DOI 10.1080/00288233.1997.9513277; de Sassi C, 2012, PHILOS T R SOC B, V367, P3033, DOI 10.1098/rstb.2012.0233; de Sassi C, 2012, ECOLOGY, V93, P1892, DOI 10.1890/11-1839.1; de Sassi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040557; Didham RK, 2012, LAND USE INTENSIFICATION: EFFECTS ON AGRICULTURE, BIODIVERSITY AND ECOLOGICAL PROCESSES, P73; Didham RK, 2009, NEW ZEAL J ZOOL, V36, P135, DOI 10.1080/03014220909510148; Didham RK, 1999, BIOTROPICA, V31, P17, DOI 10.1111/j.1744-7429.1999.tb00113.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Duncan DH, 2008, LANDSCAPE ECOL, V23, P107, DOI 10.1007/s10980-007-9160-0; Dupouey JL, 2002, ECOLOGY, V83, P2978, DOI 10.1890/0012-9658(2002)083[2978:IIOPLU]2.0.CO;2; Ewers RM, 2006, BIOL CONSERV, V133, P312, DOI 10.1016/j.biocon.2006.06.018; Ewers RM, 2009, GLOBAL CHANGE BIOL, V15, P1716, DOI 10.1111/j.1365-2486.2009.01849.x; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Flinn KM, 2007, ECOL APPL, V17, P452, DOI 10.1890/05-1963; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Frost CM, 2015, ECOLOGY, V96, P193, DOI 10.1890/14-0696.1; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gladbach DJ, 2011, OECOLOGIA, V166, P433, DOI 10.1007/s00442-010-1870-3; Godfray HCJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0273; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gorley C.K., 2006, GETTING STARTED PRIM; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Gucker B, 2009, FRESHWATER BIOL, V54, P2069, DOI 10.1111/j.1365-2427.2008.02069.x; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Havlik P, 2014, P NATL ACAD SCI USA, V111, P3709, DOI 10.1073/pnas.1308044111; Hayward MW, 2009, BIOL CONSERV, V142, P1, DOI 10.1016/j.biocon.2008.09.022; Herzog F, 2006, EUR J AGRON, V24, P165, DOI 10.1016/j.eja.2005.07.006; Hill L, 2010, 122 LANDC RES LTD; Hole DG, 2005, BIOL CONSERV, V122, P113, DOI 10.1016/j.biocon.2004.07.018; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kim N., 2005, 200551 ENV WAIK; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Laliberte E, 2013, OECOLOGIA, V171, P439, DOI 10.1007/s00442-012-2417-6; Laliberte E, 2012, ECOLOGY, V93, P145, DOI 10.1890/11-0338.1; Leathwick JR, 2003, CONSERV BIOL, V17, P1612, DOI 10.1111/j.1523-1739.2003.00469.x; Lee KH, 2000, J ENVIRON QUAL, V29, P1200, DOI 10.2134/jeq2000.2941200x; Lee WG, 2008, NEW ZEAL J AGR RES, V51, P457, DOI 10.1080/00288230809510475; MacLeod CJ, 2006, AGR ECOSYST ENVIRON, V115, P201, DOI 10.1016/j.agee.2006.01.003; Martin T.D., 1994, 2002 US EPA ENV MON; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; McDowell RW, 2013, AGR ECOSYST ENVIRON, V165, P80, DOI 10.1016/j.agee.2012.12.011; McDowell RW, 2012, NEW ZEAL J AGR RES, V55, P133, DOI 10.1080/00288233.2012.662901; Moller H, 2008, NEW ZEAL J AGR RES, V51, P461, DOI 10.1080/00288230809510476; Moller H, 2008, NEW ZEAL J AGR RES, V51, P253, DOI 10.1080/00288230809510453; Mudge PL, 2013, SOIL SCI SOC AM J, V77, P830, DOI 10.2136/sssaj2012.0333; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Norris V., 1993, Water Resources Management, V7, P257, DOI 10.1007/BF00872284; Norton David A., 2000, Ecological Management & Restoration, V1, P26; Olsen S., 1954, ESTIMATION AVAILABLE; Parn J, 2012, ECOL INDIC, V22, P4, DOI 10.1016/j.ecolind.2011.10.002; Parfitt RL, 2006, BIOGEOCHEMISTRY, V80, P71, DOI 10.1007/s10533-006-0002-y; Parkyn S, 2004, 200405 MAF, DOI [10.1007/s00267-003-2913-x, DOI 10.1007/S00267-003-2913-X]; PCE, 2004, GROW GOOD INT FARM S; Phalan B, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0285; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Pinheiro J, 2013, NLME LINEAR NONLINEA; Polyakov Viktor, 2005, Environmental Reviews, V13, P129, DOI 10.1139/a05-010; Quinn JM, 2002, NEW ZEAL J MAR FRESH, V36, P409, DOI 10.1080/00288330.2002.9517097; R Core Team, 2016, R FDN STAT COMP; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Risser P. G., 1989, Ecology of arable land-perspectives and challenges. Proceedings of an International Symposium, 9-12 June 1987, Swedish Univ. Agric. Sci., Uppsala, Sweden., P247; Rowarth JS, 2008, NEW ZEAL J AGR RES, V51, P451, DOI 10.1080/00288230809510474; Rowarth JS, 2006, CLEAN AIR ENV QUALIT, V40, P33; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Schipper LA, 2014, AGR ECOSYST ENVIRON, V184, P67, DOI 10.1016/j.agee.2013.11.012; Schipper LA, 2011, AGR ECOSYST ENVIRON, V144, P95, DOI 10.1016/j.agee.2011.08.002; Schipper LA, 2004, SOIL USE MANAGE, V20, P281, DOI 10.1079/SUM2004255; Smale MC, 2008, NEW ZEAL J ECOL, V32, P57; Sparling G, 2004, AGR ECOSYST ENVIRON, V104, P545, DOI 10.1016/j.agee.2003.11.014; Sparling GP, 2004, AGR ECOSYST ENVIRON, V104, P523, DOI 10.1016/j.agee.2004.01.021; Sparling GP, 2002, J ENVIRON QUAL, V31, P1848, DOI 10.2134/jeq2002.1848; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Stevenson BA, 2010, AGR ECOSYST ENVIRON, V139, P736, DOI 10.1016/j.agee.2010.10.020; Stevenson BA, 2004, PLANT SOIL, V262, P317, DOI 10.1023/B:PLSO.0000037050.67578.f0; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tinker PB, 1997, PHILOS T R SOC B, V352, P1023, DOI 10.1098/rstb.1997.0080; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; Tylianakis JM, 2008, PLOS BIOL, V6, P947, DOI 10.1371/journal.pbio.0060122; van Noordwijk M, 2004, AGR ECOSYST ENVIRON, V104, P19, DOI 10.1016/j.agee.2004.01.004; van Noordwijk M, 2014, CURR OPIN ENV SUST, V8, P62, DOI 10.1016/j.cosust.2014.08.008; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wheeler D.M., 2003, P NZ GRASSLAND ASS, V65, P191, DOI DOI 10.33584/JNZG.2003.65; Wheeler DM, 2004, NEW ZEAL J AGR RES, V47, P155, DOI 10.1080/00288233.2004.9513583; Wheeler DM, 1997, NEW ZEAL J AGR RES, V40, P309, DOI 10.1080/00288233.1997.9513250; YOUNG A, 1994, BIOL CONSERV, V67, P63, DOI 10.1016/0006-3207(94)90010-8	121	32	33	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0116474	10.1371/journal.pone.0116474	http://dx.doi.org/10.1371/journal.pone.0116474			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25575017	Green Published, Green Submitted			2022-12-26	WOS:000348168100006
J	Mondal, S; Pahan, K				Mondal, Susanta; Pahan, Kalipada			Cinnamon Ameliorates Experimental Allergic Encephalomyelitis in Mice via Regulatory T Cells: Implications for Multiple Sclerosis Therapy	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; METABOLITE SODIUM BENZOATE; INHIBITS ADOPTIVE TRANSFER; NITRIC-OXIDE; IL-12P40 HOMODIMER; CUTTING EDGE; TH17 CELLS; FOXP3; ACID	Upregulation and/or maintenance of regulatory T cells (Tregs) during an autoimmune insult may have therapeutic efficacy in autoimmune diseases. Although several immunomodulatory drugs and molecules are available, most present significant side effects over long-term use. Cinnamon is a commonly used natural spice and flavoring material used for centuries throughout the world. Here, we have explored a novel use of cinnamon powder in protecting Tregs and treating the disease process of experimental allergic encephalomyelitis (EAE), an animal model of MS. Oral feeding of cinnamon (Cinnamonum verum) powder suppresses clinical symptoms of relapsing-remitting EAE in female PLP-TCR transgenic mice and adoptive transfer mouse model. Cinnamon also inhibited clinical symptoms of chronic EAE in male C57/BL6 mice. Dose-dependent study shows that cinnamon powder at a dose of 50 mg/kg body wt/d or higher significantly suppresses clinical symptoms of EAE in mice. Accordingly, oral administration of cinnamon also inhibited perivascular cuffing, maintained the integrity of blood-brain barrier and blood-spinal cord barrier, suppressed inflammation, normalized the expression of myelin genes, and blocked demyelination in the central nervous system of EAE mice. Interestingly, cinnamon treatment upregulated Tregs via reduction of nitric oxide production. Furthermore, we demonstrate that blocking of Tregs by neutralizing antibodies against CD25 abrogates cinnamon-mediated protection of EAE. Taken together, our results suggest that oral administration of cinnamon powder may be beneficial in MS patients and that no other existing anti-MS therapies could be so economical and trouble-free as this approach.	[Mondal, Susanta; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA	Rush University	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu			NIH [AT6681]; National Center for Complementary & Integrative Health [R01AT006681] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH AT6681. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Mawla AMA, 2001, PLANTA, V212, P288, DOI 10.1007/s004250000394; Brahmachari S, 2007, J IMMUNOL, V179, P275, DOI 10.4049/jimmunol.179.1.275; Brahmachari S, 2010, J IMMUNOL, V184, P1799, DOI 10.4049/jimmunol.0804394; Brahmachari S, 2009, J IMMUNOL, V183, P5917, DOI 10.4049/jimmunol.0803336; Brahmachari S, 2009, J IMMUNOL, V183, P2045, DOI 10.4049/jimmunol.0800276; BRIDGES JW, 1970, BIOCHEM J, V118, P47, DOI 10.1042/bj1180047; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Cohen JA, 2012, LANCET NEUROL, V11, P467, DOI 10.1016/S1474-4422(12)70059-5; Cosmetic Ingredient Review Expert, 2001, INT J TOXICOL, V20, P23; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Dasgupta S, 2003, J IMMUNOL, V170, P3874, DOI 10.4049/jimmunol.170.7.3874; Dasgupta S, 2007, MOL PHARMACOL, V72, P934, DOI 10.1124/mol.106.033787; El-behi M, 2010, J NEUROIMMUNE PHARM, V5, P189, DOI 10.1007/s11481-009-9188-9; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huan J, 2005, J NEUROSCI RES, V81, P45, DOI 10.1002/jnr.20522; Jana A, 2013, J NEUROIMMUNE PHARM, V8, P739, DOI 10.1007/s11481-013-9447-7; Khasnavis S, 2014, J NEUROIMMUNE PHARM, V9, P569, DOI 10.1007/s11481-014-9552-2; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; KUBOTA K, 1991, EUR J CLIN PHARMACOL, V41, P363, DOI 10.1007/BF00314969; Kuerten S, 2011, J INTERF CYTOK RES, V31, P907, DOI 10.1089/jir.2011.0072; Leonard J V, 2002, Semin Neonatol, V7, P27, DOI 10.1053/siny.2001.0085; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; McKee AS, 2004, J IMMUNOL, V173, P1224, DOI 10.4049/jimmunol.173.2.1224; Miller A, 1997, SOUTH MED J, V90, P367, DOI 10.1097/00007611-199704000-00001; Mondal S, 2009, J IMMUNOL, V182, P5013, DOI 10.4049/jimmunol.0801734; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Pahan K, 1997, J CLIN INVEST, V100, P2671, DOI 10.1172/JCI119812; Pahan K, 2011, IMMUNOPHARM IMMUNOT, V33, P586, DOI 10.3109/08923973.2011.561861; Pahan K, 2010, J NEUROIMMUNE PHARM, V5, P165, DOI 10.1007/s11481-010-9219-6; Paust S, 2005, IMMUNOL REV, V204, P195, DOI 10.1111/j.0105-2896.2005.00247.x; Reddy J, 2005, J IMMUNOL, V175, P5591, DOI 10.4049/jimmunol.175.9.5591; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Scaglia F, 2004, MOL GENET METAB, V81, pS79, DOI 10.1016/j.ymgme.2003.11.017; Schrempf W, 2007, AUTOIMMUN REV, V6, P469, DOI 10.1016/j.autrev.2007.02.003; Shi GP, 2008, J IMMUNOL, V181, P7205, DOI 10.4049/jimmunol.181.10.7205; Venken K, 2008, IMMUNOLOGY, V123, P79, DOI 10.1111/j.1365-2567.2007.02690.x; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Waldner H, 2000, P NATL ACAD SCI USA, V97, P3412, DOI 10.1073/pnas.97.7.3412; Xu DM, 2003, J IMMUNOL, V170, P394, DOI 10.4049/jimmunol.170.1.394; Zhu JF, 2010, IMMUNITY, V32, P11, DOI 10.1016/j.immuni.2010.01.001; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	44	33	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e0116566	10.1371/journal.pone.0116566	http://dx.doi.org/10.1371/journal.pone.0116566			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25569428	gold, Green Submitted, Green Published			2022-12-26	WOS:000348168000008
J	Pasula, R; Azad, AK; Gardner, JC; Schlesinger, LS; McCormack, FX				Pasula, Rajamouli; Azad, Abul K.; Gardner, Jason C.; Schlesinger, Larry S.; McCormack, Francis X.			Keratinocyte Growth Factor Administration Attenuates Murine Pulmonary Mycobacterium tuberculosis Infection through Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF)-dependent Macrophage Activation and Phagolysosome Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED LUNG INJURY; GM-CSF; II CELLS; EPITHELIAL-CELLS; TRANSGENIC MICE; SP-A; EXPRESSION; RATS; INSTILLATION; LIPOGENESIS	Augmentation of innate immune defenses is an appealing adjunctive strategy for treatment of pulmonary Mycobacterium tuberculosis infections, especially those caused by drug-resistant strains. The effect of intranasal administration of keratinocyte growth factor (KGF), an epithelial mitogen and differentiation factor, on M. tuberculosis infection in mice was tested in prophylaxis, treatment, and rescue scenarios. Infection of C57131.6 mice with M. tuberculosis resulted in inoculum size-dependent weight loss and mortality. A single dose of KCF given 1 day prior to infection with 105 M. tuberculosis bacilli prevented weight loss and enhanced pulmonary mycobacterial clearance (compared with saline-pretreated mice) for up to 28 days. Similar effects were seen when KGF was delivered intranasally every third day for 15 days, but weight loss and bacillary growth resumed when KGT was withdrawn. For mice with a well established M. tuberculosis infection, KGF given every 3 days beginning on day 15 postinoculation was associated with reversal of weight loss and an increase in M. tuberculosis clearance. In in vitro co-culture experiments, M. tuberculosis-infected macrophages exposed to conditioned medium from KGF-treated alveolar type II cell (MLE-15) monolayers exhibited enhanced GM-CST-dependent killing through mechanisms that included promotion of phagolysosome fusion and induction of nitric oxide, Alveolar macrophages from KGF-treated mice also exhibited enhanced GM-CS F.-dependent phagolysosomal fusion. These results provide evidence that administration of KGF promotes M. tuberculosis clearance through GM-CSF-dependent mechanisms and enhances host defense against M. tuberculosis infection.	[Pasula, Rajamouli; Gardner, Jason C.; McCormack, Francis X.] Univ Cincinnati, Div Pulm Crit Care & Sleep Med, Dept Med, Cincinnati, OH 45267 USA; [Azad, Abul K.; Schlesinger, Larry S.] Ohio State Univ, Ctr Microbial Interface Biol, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	University System of Ohio; University of Cincinnati; University System of Ohio; Ohio State University	McCormack, FX (corresponding author), Univ Cincinnati, Div Pulm Crit Care & Sleep Med, Dept Med, OH MSB 6165,231 Albert Sabin Way,POB 670564, Cincinnati, OH 45267 USA.	frank.mccormack@uc.edu	McCormack, Francis X./ABE-8398-2020	McCormack, Francis X./0000-0001-7168-9464; Gardner, Jason/0000-0002-5924-9201	National Institutes of Health, NCATS [8UL1TR000077-04]; NIH [T32 HL007752-21]; Veterans Affairs Merit Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007752] Funding Source: NIH RePORTER	National Institutes of Health, NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NCATS, Grant 8UL1TR000077-04 and by funding from NIH Grant T32 HL007752-21. This work was also supported by a Veterans Affairs Merit Award (to F. X. M.). Preliminary results from this work have been reported in poster form at the 2011 American Thoracic Society Meeting. Drs. McCormack and Pasula have applied for a patent entitled "Growth Factors for Treatment of Mycobacterial Infection" (PCT/US2013/038206).	Barasch A, 2009, BIOL-TARGETS THER, V3, P111; Blijlevens N, 2007, ANN ONCOL, V18, P817, DOI 10.1093/annonc/mdl332; Chang YS, 2006, AM J RESP CELL MOL, V35, P268, DOI 10.1165/rcmb.2006-0037OC; Charafeddine L, 1999, AM J PHYSIOL-LUNG C, V276, pL105, DOI 10.1152/ajplung.1999.276.1.L105; Deterding RR, 1997, P ASSOC AM PHYSICIAN, V109, P254; Erdag G, 2004, MOL THER, V10, P76, DOI 10.1016/j.ymthe.2004.04.013; Fehrenbach H, 2000, HISTOCHEM CELL BIOL, V114, P49; Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Francisco-Cruz A, 2013, CLIN EXP IMMUNOL, V171, P283, DOI 10.1111/cei.12015; Francisco-Cruz A, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0774-6; Gonzalez-Juarrero M, 2005, J LEUKOCYTE BIOL, V77, P914, DOI 10.1189/jlb.1204723; Gross TJ, 2014, J IMMUNOL, V192, P2326, DOI 10.4049/jimmunol.1301758; Guirado E, 2013, SEMIN IMMUNOPATHOL, V35, P563, DOI 10.1007/s00281-013-0388-2; Guirado E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00098; Higgins DM, 2008, J IMMUNOL, V180, P4892, DOI 10.4049/jimmunol.180.7.4892; IKEDA K, 1994, AM J PHYSIOL, V267, pL309, DOI 10.1152/ajplung.1994.267.3.L309; Mason RJ, 2003, J CLIN INVEST, V112, P244, DOI 10.1172/JCI200316793; Mason RJ, 2002, CHEST, V121, p77S, DOI 10.1378/chest.121.3_suppl.77S; Mueller H, 2008, CYTOKINE, V43, P143, DOI 10.1016/j.cyto.2008.05.002; Nambiar JK, 2010, EUR J IMMUNOL, V40, P153, DOI 10.1002/eji.200939665; PANOS RJ, 1995, J CLIN INVEST, V96, P2026, DOI 10.1172/JCI118250; Pasula R, 1997, AM J RESP CELL MOL, V17, P209, DOI 10.1165/ajrcmb.17.2.2469; Pasula R, 2009, J IMMUNOL, V182, P7102, DOI 10.4049/jimmunol.0803642; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Ryan AA, 2007, J IMMUNOL, V179, P8418, DOI 10.4049/jimmunol.179.12.8418; Sato K, 2002, J INFECT DIS, V185, P1139, DOI 10.1086/340040; Shyamsundar M, 2014, AM J RESP CRIT CARE, V189, P1520, DOI 10.1164/rccm.201310-1892OC; Silver RF, 2009, AM J RESP CELL MOL, V40, P491, DOI 10.1165/rcmb.2008-0219OC; Spielberger R, 2004, NEW ENGL J MED, V351, P2590, DOI 10.1056/NEJMoa040125; Sturrock A, 2012, AM J PHYSIOL-LUNG C, V302, pL343, DOI 10.1152/ajplung.00276.2011; Sundaramurthy V, 2007, MICROBES INFECT, V9, P1671, DOI 10.1016/j.micinf.2007.09.007; Szeliga J, 2008, TUBERCULOSIS, V88, P7, DOI 10.1016/j.tube.2007.08.009; Valdivia-Arenas Ma, 2007, Drug Discov Today Dis Mech, V4, P73, DOI 10.1016/j.ddmec.2007.10.003; Viget NB, 2000, AM J PHYSIOL-LUNG C, V279, pL1199, DOI 10.1152/ajplung.2000.279.6.L1199; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Wu HX, 2011, J BIOL CHEM, V286, P14932, DOI 10.1074/jbc.M110.182170; Xu XS, 1998, AM J RESP CELL MOL, V18, P168, DOI 10.1165/ajrcmb.18.2.2824; Yano T, 1996, AM J RESP CELL MOL, V15, P433, DOI 10.1165/ajrcmb.15.4.8879176; Yano T, 2000, AM J PHYSIOL-LUNG C, V279, pL1146, DOI 10.1152/ajplung.2000.279.6.L1146; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	41	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7151	7159		10.1074/jbc.M114.591891	http://dx.doi.org/10.1074/jbc.M114.591891			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605711	hybrid, Green Published			2022-12-26	WOS:000350991500045
J	Vaughan, AT; Chan, CHT; Klein, C; Glennie, MJ; Beers, SA; Cragg, MS				Vaughan, Andrew T.; Chan, Claude H. T.; Klein, Christian; Glennie, Martin J.; Beers, Stephen A.; Cragg, Mark S.			Activatory and Inhibitory Fc gamma Receptors Augment Rituximab-mediated Internalization of CD20 Independent of Signaling via the Cytoplasmic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; LIPID RAFTS; B-CELLS; MEMBRANE RAFTS; MONOCLONAL-ANTIBODIES; SURFACE EXPRESSION; CALCIUM FLUX; IN-VIVO; RIIA; ASSOCIATION	Type I anti-CD20 mAb such as rituximab and ofatumumab engage with the inhibitory Fc gamma R, Fc gamma RIIb on the surface of B cells, resulting in immunoreceptor tyrosine-based inhibitory motif (ITIM) phosphorylation. Internalization of the CD20 center dot mAb center dot Fc gamma RIIb complex follows, the rate of which correlates with Fc gamma RIIb expression. In contrast, although type II anti-CD20 mAb such as tositumomab and obinutuzumab also interact with and activate Fc gamma RIIb, this interaction fails to augment the rate of CD20 center dot mAb internalization, raising the question of whether ITIM phosphorylation plays any role in this process. We have assessed the molecular requirements for the internalization process and demonstrate that in contrast to internalization of IgG immune complexes, Fc gamma RIIb-augmented internalization of rituximab-ligated CD20 occurs independently of the Fc gamma RIIb ITIM, indicating that signaling downstream of Fc gamma RIIb is not required. In transfected cells, activatory Fc gamma RI, Fc gamma RIIa, and Fc gamma RIIIa augmented internalization of rituximab-ligated CD20 in a similar manner. However, Fc gamma RIIa mediated a slower rate of internalization than cells expressing equivalent levels of the highly homologous Fc gamma RIIb. The difference was maintained in cells expressing Fc gamma RIIa and Fc gamma RIIb lacking cytoplasmic domains and in which the transmembrane domains had been exchanged. This difference may be due to increased degradation of Fc gamma RIIa, which traffics to lysosomes independently of rituximab. We conclude that the cytoplasmic domain of Fc gamma R is not required for promoting internalization of rituximab-ligated CD20. Instead, we propose that Fc gamma R provides a structural role in augmenting endocytosis that differs from that employed during the endocytosis of immune complexes.	[Vaughan, Andrew T.; Chan, Claude H. T.; Glennie, Martin J.; Beers, Stephen A.; Cragg, Mark S.] Univ Southampton, Fac Med, Gen Hosp, Antibody & Vaccine Grp,Canc Sci Unit, Southampton SO16 6YD, Hants, England; [Klein, Christian] Roche Pharmaceut Res & Early Dev, Roche Innovat Ctr Zurich, CH-8952 Schlieren, Switzerland	University of Southampton; Roche Holding	Cragg, MS (corresponding author), Univ Southampton, Fac Med, Gen Hosp, Antibody & Vaccine Grp,Canc Sci Unit, Southampton SO16 6YD, Hants, England.	msc@soton.ac.uk	Cragg, Mark S/E-5965-2010; Klein, Christian/G-1336-2010	Cragg, Mark S/0000-0003-2077-089X; Klein, Christian/0000-0001-7594-7280; chan, claude/0000-0003-0530-9480; Vaughan, Andrew/0000-0001-6076-3649; Beers, Stephen/0000-0002-3765-3342	Leukaemia and Lymphoma Research Grants [09009, 12050]; Roche; BioInvent International	Leukaemia and Lymphoma Research Grants; Roche(Roche Holding); BioInvent International	This work was supported by Leukaemia and Lymphoma Research Grants 09009, 12050, and a research grant from Roche. C. K. is a paid employee of Roche. M. J. G. acts as a consultant to a number of biotech companies to write general antibody expert reports and receives institutional payments and royalties from antibody patents and licenses. M. S. C. serves as a consultant for and received grant funding from BioInvent International and has previously served as an ad hoc consultant for Roche. The remaining authors declare no competing financial interests.	Aman MJ, 2001, J BIOL CHEM, V276, P46371, DOI 10.1074/jbc.M104069200; Beers SA, 2008, BLOOD, V112, P4170, DOI 10.1182/blood-2008-04-149161; Beers SA, 2010, BLOOD, V115, P5191, DOI 10.1182/blood-2010-01-263533; Bournazos S, 2009, J IMMUNOL, V182, P8026, DOI 10.4049/jimmunol.0900107; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; BUDDE P, 1994, J BIOL CHEM, V269, P30636; Chan HTC, 2003, CANCER RES, V63, P5480; Cragg MS, 2004, BLOOD, V103, P2738, DOI 10.1182/blood-2003-06-2031; Cragg MS, 2003, BLOOD, V101, P1045, DOI 10.1182/blood-2002-06-1761; Gamberale R, 2005, LEUKEMIA RES, V29, P1277, DOI 10.1016/j.leukres.2005.04.008; Garcia-Garcia E, 2007, J IMMUNOL, V178, P3048, DOI 10.4049/jimmunol.178.5.3048; Glennie MJ, 2007, MOL IMMUNOL, V44, P3823, DOI 10.1016/j.molimm.2007.06.151; GLENNIE MJ, 1987, J IMMUNOL, V139, P2367; GREENMAN J, 1991, MOL IMMUNOL, V28, P1243, DOI 10.1016/0161-5890(91)90011-8; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; Ivanov A, 2009, J CLIN INVEST, V119, P2143, DOI 10.1172/JCI37884; Kim MK, 2003, BLOOD, V101, P4479, DOI 10.1182/blood.V101.11.4479; Kono H, 2005, HUM MOL GENET, V14, P2881, DOI 10.1093/hmg/ddi320; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Lee CS, 2015, BRIT J HAEMATOL, V168, P145, DOI 10.1111/bjh.13071; Li HD, 2004, J BIOL CHEM, V279, P19893, DOI 10.1074/jbc.M400525200; Li HD, 2003, J BIOL CHEM, V278, P42427, DOI 10.1074/jbc.M308802200; Lim SH, 2011, BLOOD, V118, P2530, DOI 10.1182/blood-2011-01-330357; MIETTINEN HM, 1992, J CELL BIOL, V116, P875, DOI 10.1083/jcb.116.4.875; O'Reilly MK, 2011, J IMMUNOL, V186, P1554, DOI 10.4049/jimmunol.1003005; Polyak MJ, 1998, J IMMUNOL, V161, P3242; Qian L, 2012, BLOOD, V120, P581, DOI 10.1182/blood-2011-08-377242; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Rosman Z, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-88; Su KH, 2007, J IMMUNOL, V178, P3272, DOI 10.4049/jimmunol.178.5.3272; VANDENHERIKOUDIJK IE, 1995, BLOOD, V85, P2202, DOI 10.1182/blood.V85.8.2202.bloodjournal8582202; vanVugt MJ, 1996, BLOOD, V87, P3593, DOI 10.1182/blood.V87.9.3593.bloodjournal8793593; Vaughan AT, 2014, BLOOD, V123, P669, DOI 10.1182/blood-2013-04-490821; Walshe CA, 2008, J BIOL CHEM, V283, P16971, DOI 10.1074/jbc.M708459200; Zhang CY, 2010, J BIOL CHEM, V285, P34250, DOI 10.1074/jbc.M110.143834	35	21	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5424	5437		10.1074/jbc.M114.593806	http://dx.doi.org/10.1074/jbc.M114.593806			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568316	Green Published, hybrid			2022-12-26	WOS:000350044200016
J	Herrera, VL; Pasion, KA; Moran, AM; Zaninello, R; Ortu, MF; Fresu, G; Piras, DA; Argiolas, G; Troffa, C; Glorioso, V; Masala, W; Glorioso, N; Ruiz-Opazo, N				Herrera, Victoria L.; Pasion, Khristine A.; Moran, Ann Marie; Zaninello, Roberta; Ortu, Maria Francesca; Fresu, Giovanni; Piras, Daniela Antonella; Argiolas, Giuseppe; Troffa, Chiara; Glorioso, Valeria; Masala, Wanda; Glorioso, Nicola; Ruiz-Opazo, Nelson			A Functional 12T-Insertion Polymorphism in the ATP1A1 Promoter Confers Decreased Susceptibility to Hypertension in a Male Sardinian Population	PLOS ONE			English	Article							INSERTION-DELETION POLYMORPHISM; NA,K-ATPASE GENE; NFKB1 GENE; SALT; ASSOCIATION; SODIUM; RISK; TRANSPORT; ATTG; NA+,K+-ATPASE	Identification of susceptibility genes for essential hypertension in humans has been a challenge due to its multifactorial pathogenesis complicated by gene-gene and gene-environment interactions, developmental programing and sex specific differences. These concurrent features make identification of causal hypertension susceptibility genes with a single approach difficult, thus requiring multiple lines of evidence involving genetic, biochemical and biological experimentation to establish causal functional mutations. Here we report experimental evidence encompassing genetic, biochemical and in vivo modeling that altogether support ATP1A1 as a hypertension susceptibility gene in males in Sardinia, Italy. ATP1A1 encodes the alpha 1Na, K-ATPase isoform, the sole sodium pump in vascular endothelial and renal tubular epithelial cells. DNA-sequencing detected a 12-nucleotide long thymidine (12T) insertion(ins)/deletion(del) polymorphism within a poly-T sequence (38T vs 26T) in the ATP1A1 5'-regulatory region associated with hypertension in a male Sardinian population. The 12T-insertion allele confers decreased susceptibility to hypertension (P = 0.035; OR = 0.50 [0.28-0.93]) accounting for 12.1 mmHg decrease in systolic BP (P = 0.02) and 6.6 mmHg in diastolic BP (P = 0.046). The ATP1A1 promoter containing the 12T-insertion exhibited decreased transcriptional activity in in vitro reporter-assay systems, indicating decreased a1Na, K-ATPase expression with the 12T-insertion, compared with the 12T-deletion ATP1A1 promoter. To test the effects of decreased a1Na, K-ATPase expression on blood pressure, we measured blood pressure by radiotelemetry in three month-old, highly inbred heterozygous knockout ATP1A1+/- male mice with resultant 58% reduction in ATP1A1 protein levels. Male ATP1A1+/- mice showed significantly lower blood pressure (P < 0.03) than age-matched male wild-type littermate controls. Concordantly, lower ATP1A1 expression is expected to lower Na-reabsorption in the kidney thereby decreasing sodium-associated risk for hypertension and sodium-induced endothelial stiffness and dysfunction. Altogether, data support ATP1A1 as a hypertension susceptibility gene in a male Sardinian population, and mandate further investigation of its involvement in hypertension in the general population.	[Zaninello, Roberta; Ortu, Maria Francesca; Fresu, Giovanni; Piras, Daniela Antonella; Argiolas, Giuseppe; Troffa, Chiara; Glorioso, Valeria; Masala, Wanda; Glorioso, Nicola] Univ Sassari, AOU, Hypertens & Related Dis Ctr, I-07100 Sassari, Sardinia, Italy; [Herrera, Victoria L.; Pasion, Khristine A.; Moran, Ann Marie; Ruiz-Opazo, Nelson] Boston Univ, Sch Med, Dept Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA	University of Sassari; Boston University	Ruiz-Opazo, N (corresponding author), Boston Univ, Sch Med, Dept Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA.	nruizo@bu.edu			National Institutes of Health [HL098939]; "Associazione per la ricerca sull'ipertensione arteriosa e le malattie cardiovascolari" ONLUS, Sassari, Italy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL098939] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Associazione per la ricerca sull'ipertensione arteriosa e le malattie cardiovascolari" ONLUS, Sassari, Italy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by National Institutes of Health grant HL098939 to NR-O. Partial financial support for this project was provided by the "Associazione per la ricerca sull'ipertensione arteriosa e le malattie cardiovascolari" ONLUS, Sassari, Italy to NG, RZ, MFR, GF, DAP, GA, CT, WM, and VG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bussemaker E, 2010, AM J KIDNEY DIS, V55, P1111, DOI 10.1053/j.ajkd.2009.12.022; Cai HZ, 2013, UROL INT, V91, P206, DOI 10.1159/000345630; CANESSA M, 1993, J MEMBRANE BIOL, V134, P107; Cappello N, 1996, ANN HUM GENET, V60, P125, DOI 10.1111/j.1469-1809.1996.tb01183.x; Chen ZQ, 2014, GENET TEST MOL BIOMA, V18, P112, DOI 10.1089/gtmb.2013.0375; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Fukue Y, 2004, NUCLEIC ACIDS RES, V32, P5834, DOI 10.1093/nar/gkh905; Glorioso N, 2001, HYPERTENSION, V38, P204, DOI 10.1161/01.HYP.38.2.204; Glorioso N, 2007, CIRC RES, V100, P1522, DOI 10.1161/01.RES.0000267716.96196.60; Glorioso N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077562; Glorioso N, 2011, PHYSIOL GENOMICS, V43, P1219, DOI 10.1152/physiolgenomics.00012.2011; Herrera VLM, 2006, PHYSIOL GENOMICS, V26, P172, DOI 10.1152/physiolgenomics.00285.2005; HERRERA VLM, 1994, J HYPERTENS, V12, P847; Herrera VLM, 2005, PHYSIOL GENOMICS, V23, P257, DOI 10.1152/physiolgenomics.00144.2005; Herrera VLM, 1998, J CLIN INVEST, V102, P1102, DOI 10.1172/JCI3868; HERRERA VLM, 1990, SCIENCE, V249, P1023, DOI 10.1126/science.1975705; Hoefgen B, 2005, BIOL PSYCHIAT, V57, P247, DOI 10.1016/j.biopsych.2004.11.027; Jaitovich A, 2010, LIFE SCI, V86, P73, DOI 10.1016/j.lfs.2009.10.019; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Kaneko Y, 2005, J HYPERTENS, V23, P745, DOI 10.1097/01.hjh.0000163142.89835.c7; Kava L, 2012, AM J HYPERTENS, V25, P487, DOI 10.1038/ajh.2011.247; Krenek P, 2006, J VASC RES, V43, P502, DOI 10.1159/000095963; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Li PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071604; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Oberleithner H, 2014, NEPHROL DIAL TRANSPL, V29, P240, DOI 10.1093/ndt/gft461; Oberleithner H, 2011, PFLUG ARCH EUR J PHY, V462, P519, DOI 10.1007/s00424-011-0999-1; Oberleithner H, 2011, BLOOD PURIFICAT, V31, P82, DOI 10.1159/000321842; PIAZZA A, 1993, SCIENCE, V260, P1767, DOI 10.1126/science.8511584; Rice T, 2000, CIRCULATION, V102, P1956, DOI 10.1161/01.CIR.102.16.1956; RUIZOPAZO N, 1994, HYPERTENSION, V24, P260, DOI 10.1161/01.HYP.24.3.260; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Suzairi MSM, 2013, CANCER EPIDEMIOL, V37, P634, DOI 10.1016/j.canep.2013.05.007; Vogel U, 2011, ATHEROSCLEROSIS, V219, P200, DOI 10.1016/j.atherosclerosis.2011.06.018; Wang XY, 2009, CURR OPIN NEPHROL HY, V18, P412, DOI 10.1097/MNH.0b013e32832f5775; Wang YB, 2014, J AM SOC NEPHROL, V25, P250, DOI 10.1681/ASN.2013040429	40	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116724	10.1371/journal.pone.0116724	http://dx.doi.org/10.1371/journal.pone.0116724			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615575	gold, Green Submitted, Green Published			2022-12-26	WOS:000349122100038
J	Pavan, A; Greenlee, MW				Pavan, Andrea; Greenlee, Mark W.			Effects of Crowding and Attention on High-Levels of Motion Processing and Motion Adaptation	PLOS ONE			English	Article							CLASSICAL RECEPTIVE-FIELD; OPTIC FLOW STIMULI; CORTICAL AREAS MT; COMPLEX MOTION; VISUAL-MOTION; MST NEURONS; RESPONSE SELECTIVITY; SPATIAL ATTENTION; SPIRAL MOTION; PERCEPTION	The motion after-effect (MAE) persists in crowding conditions, i.e., when the adaptation direction cannot be reliably perceived. The MAE originating from complex moving patterns spreads into non-adapted sectors of a multi-sector adapting display (i.e., phantom MAE). In the present study we used global rotating patterns to measure the strength of the conventional and phantom MAEs in crowded and non-crowded conditions, and when attention was directed to the adapting stimulus and when it was diverted away from the adapting stimulus. The results show that: (i) the phantom MAE is weaker than the conventional MAE, for both non-crowded and crowded conditions, and when attention was focused on the adapting stimulus and when it was diverted from it, (ii) conventional and phantom MAEs in the crowded condition are weaker than in the non-crowded condition. Analysis conducted to assess the effect of crowding on high-level of motion adaptation suggests that crowding is likely to affect the awareness of the adapting stimulus rather than degrading its sensory representation, (iii) for high-level of motion processing the attentional manipulation does not affect the strength of either conventional or phantom MAEs, neither in the non-crowded nor in the crowded conditions. These results suggest that high-level MAEs do not depend on attention and that at high-level of motion adaptation the effects of crowding are not modulated by attention.	[Pavan, Andrea; Greenlee, Mark W.] Univ Regensburg, Inst Psychol, Expt & Clin Neurosci Study Programme, D-93053 Regensburg, Germany; [Pavan, Andrea] Lincoln Univ, Sch Psychol, Brayford Pool LN6 7TS, Lincoln, England	University of Regensburg; University of Lincoln	Pavan, A (corresponding author), Univ Regensburg, Inst Psychol, Expt & Clin Neurosci Study Programme, Univ Str 31, D-93053 Regensburg, Germany.	andrea.pavan@psychologie.uni-regensburg.de	Greenlee, Mark/M-6414-2018	Greenlee, Mark/0000-0003-2305-9286; Pavan, Andrea/0000-0002-7697-6320	Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft (DFG) [GR988/20-2]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was supported by grants from the Alexander von Humboldt Foundation (author AP) and the Deutsche Forschungsgemeinschaft (DFG) (author MWG, GR988/20-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdaee SM, 2005, PERCEPTION, V34, P155, DOI 10.1068/p5298; Aghdaee SM, 2005, VISION RES, V45, P1099, DOI 10.1016/j.visres.2004.11.012; Alais D, 1999, NAT NEUROSCI, V2, P1015, DOI 10.1038/14814; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Anderson EJ, 2012, CURR BIOL, V22, P1199, DOI 10.1016/j.cub.2012.04.063; Anstis S, 1998, TRENDS COGN SCI, V2, P111, DOI 10.1016/S1364-6613(98)01142-5; Bahrami B, 2007, CURR BIOL, V17, P509, DOI 10.1016/j.cub.2007.01.070; Bahrami B, 2008, J VISION, V8, DOI 10.1167/8.3.12; BERKSON J, 1953, J AM STAT ASSOC, V48, P565; Bi TY, 2009, J VISION, V9, DOI 10.1167/9.11.13; Bondarenko V M, 2012, Fiziol Cheloveka, V38, P33; BONNET C, 1972, PERCEPT PSYCHOPHYS, V12, P193, DOI 10.3758/BF03212869; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brascamp JW, 2010, J COGNITIVE NEUROSCI, V22, P2326, DOI 10.1162/jocn.2009.21397; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; Burr DC, 1998, VISION RES, V38, P1731, DOI 10.1016/S0042-6989(97)00346-5; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; Chatterjee S., 2006, REGRESSION ANAL EXAM, DOI DOI 10.1002/0470055464; CHAUDHURI A, 1990, NATURE, V344, P60, DOI 10.1038/344060a0; Chen J, 2014, J NEUROSCI, V34, P10465, DOI 10.1523/JNEUROSCI.1140-14.2014; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Cohen MA, 2012, TRENDS COGN SCI, V16, P411, DOI 10.1016/j.tics.2012.06.013; Culham JC, 2000, NEURON, V28, P607, DOI 10.1016/S0896-6273(00)00137-9; Dakin SC, 2009, J VISION, V9, DOI 10.1167/9.2.13; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1346, DOI 10.1152/jn.1991.65.6.1346; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Ezzati A, 2008, J VISION, V8, DOI 10.1167/8.14.23; Faivre N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00129; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Fang F, 2008, J VISION, V8, DOI 10.1167/8.9.6; Freeman J, 2011, J VISION, V11, DOI 10.1167/11.4.15; Geesaman BJ, 1998, VISION RES, V38, P1223, DOI 10.1016/S0042-6989(97)00279-4; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; Greenlee M W, 2000, Int Rev Neurobiol, V44, P269; Greenwood JA, 2010, CURR BIOL, V20, P496, DOI 10.1016/j.cub.2010.01.023; Harp TD, 2007, J VISION, V7, DOI 10.1167/7.2.15; Haug BA, 1998, NEUROREPORT, V9, P611, DOI 10.1097/00001756-199803090-00009; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Ho C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028814; Huk AC, 2001, NEURON, V32, P161, DOI 10.1016/S0896-6273(01)00452-4; Ikeda H, 2013, J VISION, V13, DOI 10.1167/13.4.20; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Jiang Y, 2006, CURR BIOL, V16, P2023, DOI 10.1016/j.cub.2006.08.084; Kaunitz L, 2011, J VISION, V11, DOI 10.1167/11.13.10; Knapen T, 2009, J VISION, V9, DOI [10.1167/9.13.16, 10.1167/9.5.16]; LAGAE L, 1994, J NEUROPHYSIOL, V71, P1597, DOI 10.1152/jn.1994.71.5.1597; LANKHEET MJM, 1995, VISION RES, V35, P1401, DOI 10.1016/0042-6989(95)98720-T; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Malania M, 2007, J VISION, V7, DOI 10.1167/7.2.1; Manassi M, 2012, J VISION, V12, DOI 10.1167/12.10.13; Mareschal I, 2010, VISION RES, V50, P805, DOI 10.1016/j.visres.2010.01.022; Martin P, 2001, P NATL ACAD SCI USA, V98, P14386, DOI 10.1073/pnas.251530498; Maruya K, 2008, J VISION, V8, DOI 10.1167/8.11.7; Mather G, 2008, TRENDS COGN SCI, V12, P481, DOI 10.1016/j.tics.2008.09.002; Millin R, 2014, CEREB CORTEX, V24, P3107, DOI 10.1093/cercor/bht159; Mineault PJ, 2012, P NATL ACAD SCI USA, V109, pE972, DOI 10.1073/pnas.1115685109; Montaser-Kouhsari L, 2005, VISION RES, V45, P839, DOI 10.1016/j.visres.2004.10.020; Morgan M, 2013, J VISION, V13, DOI 10.1167/13.8.26; Morgan M, 2012, ATTEN PERCEPT PSYCHO, V74, P185, DOI 10.3758/s13414-011-0222-7; Morgan MJ, 2012, VISION RES, V55, P47, DOI 10.1016/j.visres.2011.12.009; Morgan MJ, 2011, VISION RES, V51, P2169, DOI 10.1016/j.visres.2011.07.018; MORGAN MJ, 1980, Q J EXP PSYCHOL, V32, P387, DOI 10.1080/14640748008401833; MORRONE MC, 1995, NATURE, V376, P507, DOI 10.1038/376507a0; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; MURAKAMI I, 1995, VISION RES, V35, P1835, DOI 10.1016/0042-6989(94)00269-R; Nandy AS, 2007, J VISION, V7, DOI 10.1167/7.2.5; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Parkes L, 2001, NAT NEUROSCI, V4, P739, DOI 10.1038/89532; Pavan A, 2013, J VISION, V13, DOI 10.1167/13.6.16; Pelli DG, 2008, CURR OPIN NEUROBIOL, V18, P445, DOI 10.1016/j.conb.2008.09.008; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Petrov Y, 2011, VISION RES, V51, P1117, DOI 10.1016/j.visres.2011.03.001; Petrov Y, 2011, J VISION, V11, DOI 10.1167/11.4.1; Popple AV, 2005, VISION RES, V45, P1085, DOI 10.1016/j.visres.2004.11.008; Price NSC, 2004, VISION RES, V44, P1971, DOI 10.1016/j.visres.2004.04.001; Rajimehr R, 2004, VISION RES, V44, P925, DOI 10.1016/j.visres.2003.11.020; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; REGAN D, 1985, J OPT SOC AM A, V2, P280, DOI 10.1364/JOSAA.2.000280; Rutschmann RM, 2000, EXP BRAIN RES, V134, P533, DOI 10.1007/s002210000502; SAKATA H, 1985, VISION RES, V25, P453, DOI 10.1016/0042-6989(85)90070-7; SAKATA H, 1986, EXP BRAIN RES, V61, P658; Scase MO, 1996, VISION RES, V36, P2579, DOI 10.1016/0042-6989(95)00325-8; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; Smith AT, 2006, EUR J NEUROSCI, V23, P561, DOI 10.1111/j.1460-9568.2005.04526.x; Snowden RJ, 1996, J COGNITIVE NEUROSCI, V8, P435, DOI 10.1162/jocn.1996.8.5.435; Snowden RJ, 1997, CURR BIOL, V7, P717, DOI 10.1016/S0960-9822(06)00329-0; Solomon JA, 2010, J VISION, V10, DOI 10.1167/10.14.19; Spivey MJ, 2000, PERCEPT PSYCHOPHYS, V62, P1525, DOI 10.3758/BF03212153; Strasburger H, 2005, J VISION, V5, P1024, DOI 10.1167/5.11.8; Strasburger H, 2013, J VISION, V13, DOI 10.1167/13.1.24; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; TOET A, 1992, VISION RES, V32, P1349, DOI 10.1016/0042-6989(92)90227-A; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Verstraten FAJ, 2005, VISION RES, V45, P1313, DOI 10.1016/j.visres.2004.11.007; Wade NJ, 1996, VISION RES, V36, P2167, DOI 10.1016/0042-6989(95)00266-9; Wall MB, 2008, EUR J NEUROSCI, V27, P2747, DOI 10.1111/j.1460-9568.2008.06249.x; Wallis TSA, 2011, CURR BIOL, V21, P254, DOI 10.1016/j.cub.2011.01.011; WEISSTEIN N, 1977, SCIENCE, V198, P955, DOI 10.1126/science.929181; Whitney D, 2011, TRENDS COGN SCI, V15, P160, DOI 10.1016/j.tics.2011.02.005; WILLIAMS DW, 1984, VISION RES, V24, P55, DOI 10.1016/0042-6989(84)90144-5; Wohlgemuth A., 1911, AFTER EFFECT SEEN MO, V1; Wu MCK, 2006, ANNU REV NEUROSCI, V29, P477, DOI 10.1146/annurev.neuro.29.051605.113024; Wyart V, 2008, J NEUROSCI, V28, P2667, DOI 10.1523/JNEUROSCI.4748-07.2008; Yeshurun Y, 2010, J VISION, V10, DOI 10.1167/10.10.16	114	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117233	10.1371/journal.pone.0117233	http://dx.doi.org/10.1371/journal.pone.0117233			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UF	25615577	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000349122100060
J	Fan, HF; Liu, ZN; Chow, SY; Lu, YH; Li, H				Fan, Hsiu-Fang; Liu, Zi-Ning; Chow, Sih-Yao; Lu, Yi-Han; Li, Hsin			Histone Chaperone-Mediated Nucleosome Assembly Process	PLOS ONE			English	Article							TETHERED PARTICLE MOTION; SINGLE CHROMATIN FIBERS; PHYSIOLOGICAL IONIC-STRENGTH; CORE PARTICLE; MAGNETIC TWEEZERS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; H3.H4 TETRAMER; DNA MOLECULE; IN-VITRO	A huge amount of information is stored in genomic DNA and this stored information resides inside the nucleus with the aid of chromosomal condensation factors. It has been reported that the repeat nucleosome core particle (NCP) consists of 147-bp of DNA and two copies of H2A, H2B, H3 and H4. Regulation of chromosomal structure is important to many processes inside the cell. In vivo, a group of histone chaperones facilitate and regulate nucleosome assembly. How NCPs are constructed with the aid of histone chaperones remains unclear. In this study, the histone chaperone-mediated nucleosome assembly process was investigated using single-molecule tethered particle motion (TPM) experiments. It was found that Asf1 is able to exert more influence than Nap1 and poly glutamate acid (PGA) on the nucleosome formation process, which highlights Asf1's specific role in tetrasome formation. Thermodynamic parameters supported a model whereby energetically favored nucleosomal complexes compete with non-nucleosomal complexes. In addition, our kinetic findings propose the model that histone chaperones mediate nucleosome assembly along a path that leads to enthalpy-favored products with free histones as reaction substrates.	[Fan, Hsiu-Fang; Chow, Sih-Yao; Lu, Yi-Han] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Fan, Hsiu-Fang; Chow, Sih-Yao; Lu, Yi-Han] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Fan, Hsiu-Fang] Natl Yang Ming Univ, Biophoton Interdisciplinary Res Ctr, Taipei 112, Taiwan; [Liu, Zi-Ning; Li, Hsin] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Fan, HF (corresponding author), Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan.	hffan2@ym.edu.tw	Chow, Sih-Yao/AAD-4236-2022	Chow, Sih-Yao/0000-0001-9994-691X	Ministry of Science and Technology of Taiwan; Yang Ming University	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Yang Ming University	This work is supported by the Ministry of Science and Technology of Taiwan and by Yang Ming University, with support to HFF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; Bancaud A, 2006, NAT STRUCT MOL BIOL, V13, P444, DOI 10.1038/nsmb1087; Bennink ML, 2001, NAT STRUCT BIOL, V8, P606, DOI 10.1038/89646; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; BONNER WM, 1975, J CELL BIOL, V64, P421, DOI 10.1083/jcb.64.2.421; Bowman A, 2011, MOL CELL, V41, P398, DOI 10.1016/j.molcel.2011.01.025; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Campos EI, 2010, NAT STRUCT MOL BIOL, V17, P1343, DOI 10.1038/nsmb.1911; D'Arcy S, 2013, MOL CELL, V51, P662, DOI 10.1016/j.molcel.2013.07.015; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/S0960-9822(03)00869-8; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Dinant C, 2013, MOL CELL, V51, P469, DOI 10.1016/j.molcel.2013.08.007; Dohoney KM, 2001, NATURE, V409, P370, DOI 10.1038/35053124; Donham DC, 2011, NUCLEIC ACIDS RES, V39, P5449, DOI 10.1093/nar/gkr097; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Dutta S, 2001, MOL CELL, V8, P841, DOI 10.1016/S1097-2765(01)00354-9; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Elsasser SJ, 2012, BBA-GENE REGUL MECH, V1819, P211, DOI 10.1016/j.bbagrm.2011.07.007; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Fan HF, 2013, NUCLEIC ACIDS RES, V41, P7031, DOI 10.1093/nar/gkt424; Fan HF, 2012, NUCLEIC ACIDS RES, V40, P6208, DOI 10.1093/nar/gks274; Fan HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021359; Fan HF, 2009, BIOPHYS J, V96, P1875, DOI [10.1016/j.bpj.2008.11.048, 10.1016/j.bpj.2()08.11.048]; Gansen A, 2009, P NATL ACAD SCI USA, V106, P15308, DOI 10.1073/pnas.0903005106; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Gupta P, 2009, BIOPHYS J, V97, P3150, DOI 10.1016/j.bpj.2009.09.032; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Ito T, 1996, MOL CELL BIOL, V16, P3112; JACKSON V, 1988, BIOCHEMISTRY-US, V27, P2109, DOI 10.1021/bi00406a044; JORCANO JL, 1979, BIOCHEMISTRY-US, V18, P768, DOI 10.1021/bi00572a005; Kadyrova LY, 2013, CELL CYCLE, V12, P3286, DOI 10.4161/cc.26310; KLEINSCHMIDT JA, 1990, EMBO J, V9, P1309, DOI 10.1002/j.1460-2075.1990.tb08240.x; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Ladoux B, 2000, P NATL ACAD SCI USA, V97, P14251, DOI 10.1073/pnas.250471597; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; Leuba SH, 2003, P NATL ACAD SCI USA, V100, P495, DOI 10.1073/pnas.0136890100; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lu YW, 2013, BIOCHEMISTRY-US, V52, P7714, DOI 10.1021/bi4010478; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Ma CH, 2013, J MOL BIOL; Mazurkiewicz J, 2006, J BIOL CHEM, V281, P16462, DOI 10.1074/jbc.M511619200; McBryant SJ, 2003, J BIOL CHEM, V278, P44574, DOI 10.1074/jbc.M305636200; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Moshkin YM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003719; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Pascoalino B, 2014, NUCLEIC ACIDS RES, V42, P2906, DOI 10.1093/nar/gkt1267; Perkins TT, 2004, BIOPHYS J, V86, P1640, DOI 10.1016/S0006-3495(04)74232-0; Platonova O, 2011, BIOCHEMISTRY-US, V50, P8078, DOI 10.1021/bi2006652; Pope LH, 2005, BIOPHYS J, V88, P3572, DOI 10.1529/biophysj.104.053074; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; RUIZCARRILLO A, 1979, BIOCHEMISTRY-US, V18, P760, DOI 10.1021/bi00572a004; RUIZCARRILLO A, 1979, P NATL ACAD SCI USA, V76, P3284, DOI 10.1073/pnas.76.7.3284; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; STEIN A, 1979, P NATL ACAD SCI USA, V76, P5000, DOI 10.1073/pnas.76.10.5000; Strick TR, 2000, NATURE, V404, P901, DOI 10.1038/35009144; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tanaka H, 2002, NATURE, V415, P192, DOI 10.1038/415192a; Tomschik M, 2005, P NATL ACAD SCI USA, V102, P3278, DOI 10.1073/pnas.0500189102; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Vlijm R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046306; Wagner G, 2005, BIOPHYS J, V89, P3647, DOI 10.1529/biophysj.105.062786; WILHELM FX, 1978, NUCLEIC ACIDS RES, V5, P505, DOI 10.1093/nar/5.2.505; Winkler DD, 2012, NUCLEIC ACIDS RES, V40, P10139, DOI 10.1093/nar/gks812; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Zhao H, 2012, CELL PHYSIOL BIOCHEM, V30, P1383, DOI 10.1159/000343327; Zhou Z, 2008, NAT STRUCT MOL BIOL, V15, P868, DOI 10.1038/nsmb.1465; Zhou Z, 2011, NATURE, V472, P234, DOI 10.1038/nature09854; Zlatanova J, 2007, FASEB J, V21, P1294, DOI 10.1096/fj.06-7199rev	74	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0115007	10.1371/journal.pone.0115007	http://dx.doi.org/10.1371/journal.pone.0115007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611318	Green Published, Green Submitted, gold			2022-12-26	WOS:000348562900002
J	Nieto, PS; Revelli, JA; Garbarino-Pico, E; Condat, CA; Guido, ME; Tamarit, FA				Nieto, Paula S.; Revelli, Jorge A.; Garbarino-Pico, Eduardo; Condat, Carlos A.; Guido, Mario E.; Tamarit, Francisco A.			Effects of Different PER Translational Kinetics on the Dynamics of a Core Circadian Clock Model	PLOS ONE			English	Article							MESSENGER-RNA; HNRNP Q; RHYTHMS; PROTEIN; PERIOD; EXPRESSION; MECHANISMS	Living beings display self-sustained daily rhythms in multiple biological processes, which persist in the absence of external cues since they are generated by endogenous circadian clocks. The period (per) gene is a central player within the core molecular mechanism for keeping circadian time in most animals. Recently, the modulation PER translation has been reported, both in mammals and flies, suggesting that translational regulation of clock components is important for the proper clock gene expression and molecular clock performance. Because translational regulation ultimately implies changes in the kinetics of translation and, therefore, in the circadian clock dynamics, we sought to study how and to what extent the molecular clock dynamics is affected by the kinetics of PER translation. With this objective, we used a minimal mathematical model of the molecular circadian clock to qualitatively characterize the dynamical changes derived from kinetically different PER translational mechanisms. We found that the emergence of self-sustained oscillations with characteristic period, amplitude, and phase lag (time delays) between per mRNA and protein expression depends on the kinetic parameters related to PER translation. Interestingly, under certain conditions, a PER translation mechanism with saturable kinetics introduces longer time delays than a mechanism ruled by a first-order kinetics. In addition, the kinetic laws of PER translation significantly changed the sensitivity of our model to parameters related to the synthesis and degradation of per mRNA and PER degradation. Lastly, we found a set of parameters, with realistic values, for which our model reproduces some experimental results reported recently for Drosophila melanogaster and we present some predictions derived from our analysis.	[Nieto, Paula S.; Revelli, Jorge A.; Condat, Carlos A.; Tamarit, Francisco A.] UNC, IFEG, CONICET, Cordoba, Argentina; [Nieto, Paula S.; Revelli, Jorge A.; Condat, Carlos A.; Tamarit, Francisco A.] UNC, FaMAF, Cordoba, Argentina; [Garbarino-Pico, Eduardo; Guido, Mario E.] UNC, Fac Ciencias Quim, CIQUIBIC, CONICET, Cordoba, Argentina; [Garbarino-Pico, Eduardo; Guido, Mario E.] UNC, Fac Ciencias Quim, Dept Quim Biol, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba	Nieto, PS (corresponding author), UNC, IFEG, CONICET, Ciudad Univ,CP X5000HUA, Cordoba, Argentina.	pnieto1@famaf.unc.edu.ar			CONICET (Argentina)	CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The authors thank CONICET (Argentina) for support.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Axmann IM, 2007, GENOME INFORM SER, V18, P54; Beersma DGM, 2005, J BIOL RHYTHM, V20, P304, DOI 10.1177/0748730405277388; Bordyugov G, 2013, Handb Exp Pharmacol, P335, DOI 10.1007/978-3-642-25950-0_14; Bradley S, 2012, GENETICS, V192, P943, DOI 10.1534/genetics.112.143248; Brown SA, 2012, DEV CELL, V22, P477, DOI 10.1016/j.devcel.2012.02.007; DIBNER C, 2008, THE EMBO JOURNAL, V28, P123, DOI DOI 10.1038/EMBOJ.2008.262; Dunlap JC, 2006, SCIENCE, V311, P184, DOI 10.1126/science.1122839; Dunlap JC., 2004, CHRONOBIOLOGY BIOLOG; Forger DB, 2005, P NATL ACAD SCI USA, V102, P321, DOI 10.1073/pnas.0408465102; Forger DB, 2003, P NATL ACAD SCI USA, V100, P14806, DOI 10.1073/pnas.2036281100; Garbarino-Pico E, 2007, COLD SPRING HARB SYM, V72, P145, DOI 10.1101/sqb.2007.72.022; Garbarino-Pico E., 2011, CIRCADIAN RHYTHMS BI, P247; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gebauer F, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012245; Gerard C, 2009, PHILOS T R SOC A, V367, P4665, DOI 10.1098/rsta.2009.0133; GOLDBETER A, 1995, P ROY SOC B-BIOL SCI, V261, P319, DOI 10.1098/rspb.1995.0153; Goldbeter A, 2013, FEBS LETT, V587, P2778, DOI 10.1016/j.febslet.2013.07.031; Gonze D, 2006, CHAOS, V16, DOI 10.1063/1.2211767; Gonze D, 2000, CR ACAD SCI III-VIE, V323, P57, DOI 10.1016/S0764-4469(00)00111-6; Gonze D, 2002, J BIOL PHYS, V28, P637, DOI 10.1023/A:1021286607354; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Hafner M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002419; Hardin PE, 2011, ADV GENET, V74, P141, DOI 10.1016/B978-0-12-387690-4.00005-2; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; Jouffe C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001455; Keene JD, 2007, COLD SPRING HARB SYM, V72, P157, DOI 10.1101/sqb.2007.72.013; Kim DY, 2010, NUCLEIC ACIDS RES, V38, P7068, DOI 10.1093/nar/gkq569; Kojima S, 2007, P NATL ACAD SCI USA, V104, P1859, DOI 10.1073/pnas.0607567104; Kojima S, 2012, GENE DEV, V26, P2724, DOI 10.1101/gad.208306.112; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Korencic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046835; Kurosawa G, 2002, J BIOL RHYTHM, V17, P568, DOI 10.1177/0748730402238239; Laurent JM, 2010, PROTEOMICS, V10, P4209, DOI 10.1002/pmic.201000327; Lee KH, 2012, MOL CELL BIOL, V32, P717, DOI 10.1128/MCB.06177-11; Leloup JC, 2004, J THEOR BIOL, V230, P541, DOI 10.1016/j.jtbi.2004.04.040; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Leloup JC, 1998, J BIOL RHYTHM, V13, P70, DOI 10.1177/074873098128999934; Lema MA, 2000, J THEOR BIOL, V204, P565, DOI 10.1006/jtbi.2000.2038; Lim C, 2013, SCIENCE, V340, P875, DOI 10.1126/science.1234785; Lim C, 2011, NATURE, V470, P399, DOI 10.1038/nature09728; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Mirsky HP, 2009, P NATL ACAD SCI USA, V106, P11107, DOI 10.1073/pnas.0904837106; Mohawk JA, 2011, TRENDS NEUROSCI, V34, P349, DOI 10.1016/j.tins.2011.05.003; Nandi A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-45; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Risau-Gusman S, 2012, J THEOR BIOL, V307, P53, DOI 10.1016/j.jtbi.2012.05.003; Roenneberg T, 2008, CURR BIOL, V18, pR826, DOI 10.1016/j.cub.2008.07.017; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stanewsky R, 2002, J BIOL RHYTHM, V17, P293, DOI 10.1177/074873002129002609; Thompson SR, 2012, WIRES RNA, V3, P697, DOI 10.1002/wrna.1129; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Zhang Y, 2013, SCIENCE, V340, P879, DOI 10.1126/science.1234746	55	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115067	10.1371/journal.pone.0115067	http://dx.doi.org/10.1371/journal.pone.0115067			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607544	Green Published, Green Submitted, gold			2022-12-26	WOS:000348205300010
J	Permuth-Wey, J; Chen, YA; Fisher, K; McCarthy, S; Qu, XT; Lloyd, MC; Kasprzak, A; Fournier, M; Williams, VL; Ghia, KM; Yoder, SJ; Hall, L; Georgeades, C; Olaoye, F; Husain, K; Springett, GM; Chen, DT; Yeatman, T; Centeno, A; Klapman, J; Coppola, D; Malafa, M				Permuth-Wey, Jennifer; Chen, Y. Ann; Fisher, Kate; McCarthy, Susan; Qu, Xiaotao; Lloyd, Mark C.; Kasprzak, Agnieszka; Fournier, Michelle; Williams, Vonetta L.; Ghia, Kavita M.; Yoder, Sean J.; Hall, Laura; Georgeades, Christina; Olaoye, Funmilayo; Husain, Kazim; Springett, Gregory M.; Chen, Dung-Tsa; Yeatman, Timothy; Centeno, Ann; Klapman, Jason; Coppola, Domenico; Malafa, Mokenge			A Genome-Wide Investigation of MicroRNA Expression Identifies Biologically-Meaningful MicroRNAs That Distinguish between High-Risk and Low-Risk Intraductal Papillary Mucinous Neoplasms of the Pancreas	PLOS ONE			English	Article							EARLY EVENT; CANCER; MIRNA; PRECURSORS; MANAGEMENT; MARKERS; MIR-155; CYSTS	Background Intraductal papillary mucinous neoplasms (IPMNs) are pancreatic ductal adenocarcinoma (PDAC) precursors. Differentiating between high-risk IPMNs that warrant surgical resection and low-risk IPMNs that can be monitored is a significant clinical problem, and we sought to discover a panel of mi(cro) RNAs that accurately classify IPMN risk status. Methodology/Principal Findings In a discovery phase, genome-wide miRNA expression profiling was performed on 28 surgically-resected, pathologically-confirmed IPMNs (19 high-risk, 9 low-risk) using Taqman MicroRNA Arrays. A validation phase was performed in 21 independent IPMNs (13 high-risk, 8 low-risk). We also explored associations between miRNA expression level and various clinical and pathological factors and examined genes and pathways regulated by the identified miRNAs by integrating data from bioinformatic analyses and microarray analysis of miRNA gene targets. Six miRNAs (miR-100, miR-99b, miR-99a, miR-342-3p, miR-126, miR-130a) were down-regulated in high-risk versus low-risk IPMNs and distinguished between groups (P<10(-3), area underneath the curve (AUC) = 87%). The same trend was observed in the validation phase (AUC = 74%). Low miR-99b expression was associated with main pancreatic duct involvement (P = 0.021), and serum albumin levels were positively correlated with miR-99a (r = 0.52, P = 0.004) and miR-100 expression (r = 0.49, P = 0.008). Literature, validated miRNA: target gene interactions, and pathway enrichment analysis supported the candidate miRNAs as tumor suppressors and regulators of PDAC development. Microarray analysis revealed that oncogenic targets of miR-130a (ATG2B, MEOX2), miR-342-3p (DNMT1), and miR-126 (IRS-1) were up-regulated in high-versus low-risk IPMNs (P<0.10). Conclusions This pilot study highlights miRNAs that may aid in preoperative risk stratification of IPMNs and provides novel insights into miRNA-mediated progression to pancreatic malignancy. The miRNAs identified here and in other recent investigations warrant evaluation in biofluids in a well-powered prospective cohort of individuals newly-diagnosed with IPMNs and other pancreatic cysts and those at increased genetic risk for these lesions.	[Permuth-Wey, Jennifer; Georgeades, Christina; Olaoye, Funmilayo] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Canc Epidemiol, Tampa, FL 33682 USA; [Chen, Y. Ann; Fisher, Kate; Qu, Xiaotao; Chen, Dung-Tsa] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Biostat & Bioinformat, Tampa, FL 33682 USA; [McCarthy, Susan] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Clin Testing Dev, Tampa, FL 33682 USA; [Lloyd, Mark C.; Kasprzak, Agnieszka] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Analyt Microscopy, Tampa, FL 33682 USA; [Fournier, Michelle] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Tissue Core Adm, Tampa, FL 33682 USA; [Williams, Vonetta L.; Ghia, Kavita M.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Informat Shared Serv, Tampa, FL 33682 USA; [Yoder, Sean J.; Hall, Laura] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Mol Genom, Tampa, FL 33682 USA; [Husain, Kazim; Springett, Gregory M.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Gastrointestinal Oncol, Tampa, FL 33682 USA; [Centeno, Ann; Coppola, Domenico] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Anat Pathol, Tampa, FL 33682 USA; [Klapman, Jason] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Gastroenterol, Tampa, FL 33682 USA; [Malafa, Mokenge] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Gastrointestinal Surg Oncol, Tampa, FL 33682 USA; [Yeatman, Timothy] Gibbs Canc Ctr & Res Inst, Dept Surg, Spartanburg, SC USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Permuth-Wey, J (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Dept Canc Epidemiol, Tampa, FL 33682 USA.			Georgeades, Christina/0000-0002-5415-1651; Chen, yian/0000-0003-1468-3490	American Cancer Society [93-032-16]; Programmatic Funds from Moffitt's Gastrointestinal Program; Total Cancer Care Protocol; Information Shared Services, Tissue, Molecular Genomics, Biostatistics, and Cancer Informatics Core Facilities at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center [P30-CA076292]; NATIONAL CANCER INSTITUTE [P30CA076292, R25CA174664] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Programmatic Funds from Moffitt's Gastrointestinal Program; Total Cancer Care Protocol(Total SA); Information Shared Services, Tissue, Molecular Genomics, Biostatistics, and Cancer Informatics Core Facilities at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by Institutional Research Grant number 93-032-16 from the American Cancer Society (PI: J. Permuth-Wey) and Programmatic Funds from Moffitt's Gastrointestinal Program. This work was also supported in part by the Total Cancer Care Protocol and by the Information Shared Services, Tissue, Molecular Genomics, Biostatistics, and Cancer Informatics Core Facilities at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center (P30-CA076292). The content is solely the responsibility of the authors and does not necessarily represent the official views of the American Cancer Society or the H. Lee Moffitt Cancer Center & Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsay NV, 2010, WHO CLASSIFICATION T, P304; Allen PJ, 2010, SURG ONCOL CLIN N AM, V19, P297, DOI 10.1016/j.soc.2009.11.002; American Cancer Society, 2014, CANC FACTS FIG 2014; Bergmann U, 1996, BIOCHEM BIOPH RES CO, V220, P886, DOI 10.1006/bbrc.1996.0500; Brune K, 2006, AM J SURG PATHOL, V30, P1067; Canto MI, 2006, CLIN GASTROENTEROL H, V4, P766, DOI 10.1016/j.cgh.2006.02.005; Caponi S, 2013, ANN ONCOL, V24, P734, DOI 10.1093/annonc/mds513; Correa-Gallego C, 2010, PANCREATOLOGY, V10, P144, DOI 10.1159/000243733; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Dweep H, 2014, METHODS MOL BIOL, V1182, P289, DOI 10.1007/978-1-4939-1062-5_25; Fenstermacher DA, 2011, CANCER J, V17, P528, DOI 10.1097/PPO.0b013e318238216e; Frampton AE, 2012, EXPERT REV ANTICANC, V12, P881, DOI [10.1586/ERA.12.67, 10.1586/era.12.67]; Goggins M, 2007, SEMIN ONCOL, V34, P303, DOI 10.1053/j.seminoncol.2007.05.003; Goswami RS, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-47; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Habbe N, 2009, CANCER BIOL THER, V8, P340, DOI 10.4161/cbt.8.4.7338; Henry JC, 2013, ANN SURG ONCOL; Hines OJ, 2008, CURR OPIN GASTROEN, V24, P603, DOI 10.1097/MOG.0b013e32830b112e; Hruban RH, 2007, GASTROENTEROL CLIN N, V36, P831, DOI 10.1016/j.gtc.2007.08.012; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Jiao LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032068; Lee LS, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2013.18; Li A, 2013, CLIN CANC RES; Li BH, 2011, EUR J CANCER, V47, P2166, DOI 10.1016/j.ejca.2011.04.037; Liu J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-519; Lubezky N, 2013, SURGERY, V153, P663, DOI 10.1016/j.surg.2012.11.016; Maker AV, 2008, ANN SURG ONCOL, V15, P3187, DOI 10.1245/s10434-008-0110-0; Matthaei H, 2012, CLIN CANCER RES, V18, P4713, DOI 10.1158/1078-0432.CCR-12-0035; Matthaei H, 2011, NAT REV GASTRO HEPAT, V8, P141, DOI 10.1038/nrgastro.2011.2; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nissim S, 2012, PANCREAS, V41, P1195, DOI 10.1097/MPA.0b013e3182580fb4; Park Yun Gyoung, 2011, Korean J Gastroenterol, V58, P190; Pelaez-Luna M, 2007, AM J GASTROENTEROL, V102, P1759, DOI 10.1111/j.1572-0241.2007.01224.x; Ryu JK, 2010, PANCREATOLOGY, V10, P66, DOI 10.1159/000231984; Sachs T, 2009, J GASTROINTEST SURG, V13, P405, DOI 10.1007/s11605-008-0788-0; Sahani DV, 2009, CLIN GASTROENTEROL H, V7, P259, DOI 10.1016/j.cgh.2008.11.008; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Song B, 2013, MOL CANCER THER, V12, P58, DOI 10.1158/1535-7163.MCT-12-0632; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Weichert W, 2005, PANCREATOLOGY, V5, P259, DOI 10.1159/000085280; Wong J, 2012, J GASTROINTEST SURG; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zhang DX, 2012, EXP THER MED, V3, P423, DOI 10.3892/etm.2011.412; Zhang JJ, 2012, CLIN TRANSL ONCOL, V14, P116, DOI 10.1007/s12094-012-0770-x	55	32	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116869	10.1371/journal.pone.0116869	http://dx.doi.org/10.1371/journal.pone.0116869			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607660	Green Submitted, gold, Green Published			2022-12-26	WOS:000348205300038
J	Vasquez, D; Scharcanski, J; Wong, A				Vasquez, Dionicio; Scharcanski, Jacob; Wong, Alexander			Automatic Framework for Extraction and Characterization of Wetting Front Propagation Using Tomographic Image Sequences of Water Infiltrated Soils	PLOS ONE			English	Article							NEUTRON-RADIOGRAPHY; TEXTURE ANALYSIS; POROUS-MEDIA; PROFILES	This paper presents a new automatic framework for extracting and characterizing the dynamic shape of the 3D wetting front and its propagation, based in a sequence of tomographic images acquired as water (moisture) infiltrates in unsaturated soils. To the best of the authors' knowledge, the shape of the 3D wetting front and its propagation and progress over time has not been previously produced as a whole by methods in existing literature. The proposed automatic framework is composed two important and integrated modules: i) extraction of the 3D wetting front, and ii) characterization and description of the 3D wetting front to obtain important information about infiltration process. The 3D wetting front surface is segmented from 3D CT imagery provided as input via a 3D stochastic region merging strategy using quadric-regressed bilateral space-scale representations. Based on the 3D segmentation results, the normal directions at local curvature maxima of the wetting front surface are computed for 3D images of soil moisture, and its propagation is analyzed at the local directions in sites of maximal water adsorption, and described using histograms of curvature changes over time in response to sample saturation. These curvature change descriptors provide indirect measurements of moisture infiltration in soils, and soil saturation. Results using a field tomograph equipment specific for soil studies are encouraging, and suggest that the proposed automatic framework can be applied to estimate the infiltration of water in soils in 3D and in time.	[Vasquez, Dionicio; Scharcanski, Jacob] Univ Fed Rio Grande do Sul, Grad Program Comp Sci, BR-91501970 Porto Alegre, RS, Brazil; [Vasquez, Dionicio; Scharcanski, Jacob] Univ Fed Rio Grande do Sul, Grad Program Elect Engn, BR-91501970 Porto Alegre, RS, Brazil; [Wong, Alexander] U Waterloo, Dept Syst Design Engn, Waterloo, ON, Canada	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Scharcanski, J (corresponding author), Univ Fed Rio Grande do Sul, Grad Program Comp Sci, POB 15064, BR-91501970 Porto Alegre, RS, Brazil.	jacobs@inf.ufrgs.br	Scharcanski, Jacob/AAA-4799-2021; Wong, Alexander/GZM-2929-2022	Scharcanski, Jacob/0000-0002-9223-4693; Wong, Alexander/0000-0002-5295-2797	CAPES (Coordenadoria de Aperfeicoamento de Pessoal de Ensino Superior, Brazil); Canada Research Chairs program; Natural Sciences and Engineering Research Council (NSERC) of Canada; Ontario Ministry of Research and Innovation	CAPES (Coordenadoria de Aperfeicoamento de Pessoal de Ensino Superior, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Canada Research Chairs program(Canada Research Chairs); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This work was supported by CAPES (Coordenadoria de Aperfeicoamento de Pessoal de Ensino Superior, Brazil), the Canada Research Chairs program, the Natural Sciences and Engineering Research Council (NSERC) of Canada, and the Ontario Ministry of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARWINI K, 2008, INFORMATION GEOMETRY, P200; CHEN WW, 1993, J AM CERAM SOC, V76, P2086, DOI 10.1111/j.1151-2916.1993.tb08337.x; COHENSTEINER D, 2003, COMP GEOM 2003 19 AC, P312; CRESTANA S, 1985, SOIL SCI, V140, P326, DOI 10.1097/00010694-198511000-00002; Deinert MR, 2004, J HYDROL, V290, P192, DOI 10.1016/j.jhydrol.2003.11.018; Dodson CTJ, 2003, IEEE T SYST MAN CY A, V33, P435, DOI 10.1109/TSMCA.2003.809185; Felipussi SC, 2008, IEEE T INSTRUM MEAS, V57, P2502, DOI 10.1109/TIM.2008.925010; FREDRICH JT, 1995, SCIENCE, V268, P276, DOI 10.1126/science.268.5208.276; Gong YH, 2013, IEEE IMAGE PROC, P534, DOI 10.1109/ICIP.2013.6738110; JASTI JK, 1992, AICHE J, V38, P481, DOI 10.1002/aic.690380402; Jung CR, 2004, J ELECTRON IMAGING, V13, P278, DOI 10.1117/1.1683247; KWIECIEN MJ, 1990, J MICROSC-OXFORD, V159, P343, DOI 10.1111/j.1365-2818.1990.tb03039.x; Liao PS, 2001, J INF SCI ENG, V17, P713; Libardi P. L., 2005, DINAMICA AGUA SOLO; Martin RL, 2012, CHEMPHYSCHEM, V13, P3595, DOI 10.1002/cphc.201200554; Matko V, 2004, SENSOR ACTUAT A-PHYS, V112, P320, DOI 10.1016/j.sna.2003.10.065; MEYER K, 1994, CRYST RES TECHNOL, V29, P903, DOI 10.1002/crat.2170290702; Mohebi A, 2008, IEEE IMAGE PROC, P1312, DOI 10.1109/ICIP.2008.4712004; Naime J.M., 2001, THESIS U SAO PAULO; Scharcanski J, 1996, OPT ENG, V35, P2302, DOI 10.1117/1.600804; SCHARCANSKI J, 1993, IEE PROC-E, V140, P109, DOI 10.1049/ip-e.1993.0016; SCHWARTZMAN M, 1986, J IRRIG DRAIN ENG, V112, P242, DOI 10.1061/(ASCE)0733-9437(1986)112:3(242); Vasquez D, 2013, IEEE IMTC P, P1540; Votrubova J, 2000, GEODERMA, V95, P267, DOI 10.1016/S0016-7061(99)00091-9; Wong A, 2011, IEEE T INF TECHNOL B, V15, P929, DOI 10.1109/TITB.2011.2157829; Wong A, 2009, IEEE T BIO-MED ENG, V56, P2748, DOI 10.1109/TBME.2009.2027225	26	2	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0115218	10.1371/journal.pone.0115218	http://dx.doi.org/10.1371/journal.pone.0115218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602498	Green Published, Green Submitted, gold			2022-12-26	WOS:000348203500011
J	Zhao, XM; Luo, JY; Li, BB; Liu, SG; Li, DT				Zhao, Xiaoming; Luo, Jingyu; Li, Bobo; Liu, Shuguang; Li, Daotang			The Association between Preoperative Serum C-Reactive Protein and Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis B Virus (HBV) Infection-A Retrospective Study	PLOS ONE			English	Article							INTRAHEPATIC RECURRENCE; COLORECTAL-CANCER; RISK-FACTORS; PROGNOSIS; INTERLEUKIN-6; INFLAMMATION; RESECTION; IMPACT; INDICATOR; ELEVATION	The prognosis of the patients with hepatocellular carcinoma (HCC) recurrence following curative hepatectomy is usually dismal. Whether preoperative serum C-reactive protein (CRP) can predict the recurrence of HCC in patients with chronic HBV infection is not clear. Total 232 patients with chronic HBV infection were included in this retrospective study. We investigated the association between detailed preoperative serum CRP levels and early (<= 2 year) and late (> 2 year) HCC recurrence following curative hepatectomy. After adjusting for potential confounders, we found a saturation effect for preoperative serum CRP of 2.1 mg/dl existed for early HCC recurrence (ER). The incidence of ER increased with preoperative serum CRP less than 2.1 mg/dl (OR = 3.5, 95% CI 1.6-7.6, P = 0.001), and higher preoperative serum CRP (> 2.1 mg/dl) did not increase the incidence of ER (OR = 0.8, 95% CI 0.2-2.7, P = 0.703). Whereas there is a linear relationship between preoperative serum CRP and late HCC recurrence (LR) (OR = 0.2, 95% CI, 0.1-0.4) (OR = 1.8, 95% CI, 1.2-2.5, P = 0.002). In addition, the optimal cutoff point for serum CRP level was 1.5 mg/dl, instead of 1.0 mg/dl, in predicting both ER and LR. Patients with higher preoperative serum CRP level (> 1.5 mg/dl) had lower recurrence free survival rates and overall survival rates (P < 0.01). These results suggest that preoperative serum CRP played different roles on ER and LR following curative hepatectomy, thus further predictingthe prognosis in patients with chronic HBV infection.	[Zhao, Xiaoming] Univ Jinan, Sch Med & Life Sci, Jinan 250022, Shandong, Peoples R China; [Zhao, Xiaoming] Shandong Acad Med Sci, Jinan 250022, Shandong, Peoples R China; [Zhao, Xiaoming; Luo, Jingyu; Li, Bobo; Liu, Shuguang; Li, Daotang] Shandong Canc Hosp & Inst, Dept Thorac Surg, Jinan 250117, Shandong, Peoples R China	University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences	Li, DT (corresponding author), Shandong Canc Hosp & Inst, Dept Thorac Surg, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China.	daotang_li@hotmail.com						Alison MR, 2011, RECENT RESULTS CANC, V185, P135, DOI 10.1007/978-3-642-03503-6_8; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Budhu A, 2006, J LEUKOCYTE BIOL, V80, P1197, DOI 10.1189/jlb.0506297; Canna K, 2005, BRIT J CANCER, V92, P651, DOI 10.1038/sj.bjc.6602419; CASTELL JV, 1990, HEPATOLOGY, V12, P1179, DOI 10.1002/hep.1840120517; Chun JM, 2011, J SURG ONCOL, V103, P148, DOI 10.1002/jso.21786; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DEMELLO J, 1983, BRIT J CANCER, V48, P341, DOI 10.1038/bjc.1983.198; Hashimoto K, 2005, CANCER-AM CANCER SOC, V103, P1856, DOI 10.1002/cncr.20976; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Ishizuka M, 2012, AM J SURG, V203, P101, DOI 10.1016/j.amjsurg.2010.09.030; Jang JW, 2012, CYTOKINE, V60, P686, DOI 10.1016/j.cyto.2012.07.017; LEMOINE O, 1994, J HEPATOL, V20, P819; Nozoe T, 1998, AM J SURG, V176, P335, DOI 10.1016/S0002-9610(98)00204-9; Poon D, 2009, LANCET ONCOL, V10, P1111, DOI 10.1016/S1470-2045(09)70241-4; Poon RTP, 2000, CANCER, V89, P500, DOI 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.3.CO;2-F; Porta C, 2008, ANN ONCOL, V19, P353, DOI 10.1093/annonc/mdm448; Sakata J, 2008, EJSO-EUR J SURG ONC, V34, P900, DOI 10.1016/j.ejso.2008.01.031; Shimada H, 2003, J SURG ONCOL, V83, P248, DOI 10.1002/jso.10275; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sieghart W, 2013, HEPATOLOGY, V57, P2224, DOI 10.1002/hep.26057; Taketomi A, 2007, J AM COLL SURGEONS, V204, P580, DOI 10.1016/j.jamcollsurg.2007.01.035; Taura K, 2006, ANN SURG, V244, P265, DOI 10.1097/01.sla.0000217921.28563.55; TILG H, 1992, GASTROENTEROLOGY, V103, P264, DOI 10.1016/0016-5085(92)91122-K; Tsai HT, 2008, INT REV IMMUNOL, V27, P427, DOI 10.1080/08830180802295757; Xavier Pedro, 2006, Archives of Gynecology and Obstetrics, V273, P227, DOI 10.1007/s00404-005-0080-4	27	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116909	10.1371/journal.pone.0116909	http://dx.doi.org/10.1371/journal.pone.0116909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602444	Green Published, Green Submitted, gold			2022-12-26	WOS:000348203500036
J	Huang, CY; Hung, YT; Chang, CM; Juang, SY; Lee, CC				Huang, Chih-Yuan; Hung, Yeh-Ting; Chang, Chun-Ming; Juang, Shiun-Yang; Lee, Ching-Chih			The Association between Individual Income and Aggressive End-of-Life Treatment in Older Cancer Decedents in Taiwan	PLOS ONE			English	Article							ETHNIC-DIFFERENCES; NEW-ZEALAND; LAST YEAR; CARE; DEATH; QUALITY; TRENDS; IMPACT; PLACE; ONTARIO	Objectives To examine the association of individual income and end of life (EOL) care in older cancer decedents in Taiwan. Design Retrospective cohort study. Setting National Health Insurance Research Database (NHIRD) in Taiwan. Participants 28,978 decedents >65 years were diagnosed with cancer and died during 2009-2011 in Taiwan. Of these decedents, 10941, 16535, and 1502 were categorized by individual income as having low, moderate, and high SES, respectively. Main outcome measures Indicators of aggressiveness of EOL care: chemotherapy use before EOL, more than one emergency department (ER) visit, more than one hospital admission, hospital length of stay >4 days, intensive care unit (ICU) admission, and dying in a hospital. Results Low individual income was associated with more aggressive EOL treatment (estimate -0.30 for moderate income, -0.27 for high income, both p<0.01). The major source of aggressiveness was the tendency for older decedents with low income to die in the acute care hospital. The indicators had an increasing trend from 2009 to 2011, except for hospital stay >14 days. Conclusions Low individual income is associated with more aggressive EOL treatment in older cancer decedents. Public health providers should make available appropriate education and hospice resources to these decedents and their families, to reduce the amount of aggressive terminal care such decedents receive.	[Huang, Chih-Yuan] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Internal Med, Div Nephrol, Chiayi, Taiwan; [Huang, Chih-Yuan] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Pediat, Chiayi, Taiwan; [Chang, Chun-Ming] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Surg, Chiayi, Taiwan; [Juang, Shiun-Yang] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan; [Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan; [Huang, Chih-Yuan; Hung, Yeh-Ting; Chang, Chun-Ming; Juang, Shiun-Yang; Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Ctr Clin Epidemiol & Biostatist, Chiayi 622, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Lee, CC (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.	hematcd@hotmail.com						Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044325; Chawla Neetu, 2013, Journal of the National Cancer Institute Monographs, P36, DOI 10.1093/jncimonographs/lgt009; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cohen J, 2010, J CLIN ONCOL, V28, P2267, DOI 10.1200/JCO.2009.23.2850; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Fassbender K, 2009, J PAIN SYMPTOM MANAG, V38, P75, DOI 10.1016/j.jpainsymman.2009.04.007; Felder S, 2000, J HEALTH ECON, V19, P679, DOI 10.1016/S0167-6296(00)00039-4; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hanchate A, 2009, ARCH INTERN MED, V169, P493, DOI 10.1001/archinternmed.2008.616; Hanratty Barbara, 2007, J Health Serv Res Policy, V12, P90, DOI 10.1258/135581907780279585; Ho TH, 2011, J CLIN ONCOL, V29, P1587, DOI 10.1200/JCO.2010.31.9897; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; Hollowell J, 2010, J EVAL CLIN PRACT, V16, P529, DOI 10.1111/j.1365-2753.2009.01154.x; HU W, 2013, J PAIN SYMPTOM MANAG; HUANG WCT, 2009, THESIS NATL DIGITAL; Johnson KS, 2005, J AM GERIATR SOC, V53, P2209, DOI 10.1111/j.1532-5415.2005.00502.x; Kwok J, 2010, CANCER-AM CANCER SOC, V116, P476, DOI 10.1002/cncr.24774; Law HZ, 2011, J ASTHMA, V48, P405, DOI 10.3109/02770903.2011.565849; Lin HC, 2008, STROKE, V39, P2744, DOI 10.1161/STROKEAHA.108.519090; Lin YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062492; Ministry of Health and Welfare, 2013, 2013 STAT CAUS DEATH; Motiwala SS, 2006, CAN J AGING, V25, P363, DOI 10.1353/cja.2007.0019; Nakamura S, 2010, GERIATR GERONTOL INT, V10, P154, DOI 10.1111/j.1447-0594.2009.00570.x; Perelman J, 2011, J HEALTH SERV RES PO, V16, P197, DOI 10.1258/jhsrp.2011.010047; Reyes-Ortiz CA, 2011, CAN J AGING, V30, P143, DOI 10.1017/S0714980810000796; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Saito AM, 2011, BMC PALLIAT CARE, V10, DOI 10.1186/1472-684X-10-14; Tang ST, 2009, ANN ONCOL, V20, P343, DOI 10.1093/annonc/mdn602; Tang ST, 2012, PALLIATIVE MED, V26, P80, DOI 10.1177/0269216311406989; Tang ST, 2009, J CLIN ONCOL, V27, P4613, DOI 10.1200/JCO.2008.20.5096; Tang ST, 2003, CANCER NURS, V26, P245, DOI 10.1097/00002820-200306000-00012; Tang ST, 2002, CANCER NURS, V25, P158, DOI 10.1097/00002820-200204000-00013; Taylor EJ, 2012, PALLIATIVE MED, V26, P342, DOI 10.1177/0269216311412229; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Wang HM, 2011, J PAIN SYMPTOM MANAG, V42, P400, DOI 10.1016/j.jpainsymman.2010.12.011; Wang JY, 2014, INT J CARDIOL, V172, P82, DOI 10.1016/j.ijcard.2013.12.082; 2013, ACTA ONCOL, V52, P1062, DOI DOI 10.3109/0284186X.2012.758872; 1975, 4 FACTOR INDEX SOCIA	41	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0116913	10.1371/journal.pone.0116913	http://dx.doi.org/10.1371/journal.pone.0116913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4OG	25585131	gold, Green Submitted, Green Published			2022-12-26	WOS:000348201300011
J	Saliba, M; Ramalanjaona, N; Gulberti, S; Bertin-Jung, I; Thomas, A; Dahbi, S; Lopin-Bon, C; Jacquinet, JC; Breton, C; Ouzzine, M; Fournel-Gigleux, S				Saliba, Mineem; Ramalanjaona, Nick; Gulberti, Sandrine; Bertin-Jung, Isabelle; Thomas, Aline; Dahbi, Samir; Lopin-Bon, Chrystel; Jacquinet, Jean-Claude; Breton, Christelle; Ouzzine, Mohamed; Fournel-Gigleux, Sylvie			Probing the Acceptor Active Site Organization of the Human Recombinant beta 1,4-Galactosyltransferase 7 and Design of Xyloside-based Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitor; Enzyme Kinetics; Glycosaminoglycan; Glycosyltransferase; Proteoglycan Synthesis; Site-directed Mutagenesis	EHLERS-DANLOS-SYNDROME; GALACTOSYLTRANSFERASE-I BETA-4GALT-7; PROTEIN LINKAGE REGION; HEPARAN-SULFATE BIOSYNTHESIS; BETA-D-XYLOSIDES; CHONDROITIN SULFATE; PROTEOGLYCAN BIOSYNTHESIS; TUMOR ATTENUATION; MOLECULAR-CLONING; PROGEROID FORM	Background: Glycosyltransferase inhibitors have important applications in therapeutics and as chemical biology tools. Results: The human 1,4-galactosyltransferase 7 enzyme active site was mapped by modeling, mutagenesis, and in vitro/in cellulo assays, and novel inhibitors were synthesized. Conclusion: An efficient inhibitor of 1,4-galactosyltransferase 7 and glycosaminoglycan synthesis was obtained. Significance: This inhibitory molecule can be exploited to investigate glycosaminoglycan biology and modulate glycosaminoglycan synthesis in therapeutics. Among glycosaminoglycan (GAG) biosynthetic enzymes, the human 1,4-galactosyltransferase 7 (h4GalT7) is characterized by its unique capacity to take over xyloside derivatives linked to a hydrophobic aglycone as substrates and/or inhibitors. This glycosyltransferase is thus a prime target for the development of regulators of GAG synthesis in therapeutics. Here, we report the structure-guided design of h4GalT7 inhibitors. By combining molecular modeling, in vitro mutagenesis, and kinetic measurements, and in cellulo analysis of GAG anabolism and decorin glycosylation, we mapped the organization of the acceptor binding pocket, in complex with 4-methylumbelliferone-xylopyranoside as prototype substrate. We show that its organization is governed, on one side, by three tyrosine residues, Tyr(194), Tyr(196), and Tyr(199), which create a hydrophobic environment and provide stacking interactions with both xylopyranoside and aglycone rings. On the opposite side, a hydrogen-bond network is established between the charged amino acids Asp(228), Asp(229), and Arg(226), and the hydroxyl groups of xylose. We identified two key structural features, i.e. the strategic position of Tyr(194) forming stacking interactions with the aglycone, and the hydrogen bond between the His(195) nitrogen backbone and the carbonyl group of the coumarinyl molecule to develop a tight binder of h4GalT7. This led to the synthesis of 4-deoxy-4-fluoroxylose linked to 4-methylumbelliferone that inhibited h4GalT7 activity in vitro with a K-i 10 times lower than the K-m value and efficiently impaired GAG synthesis in a cell assay. This study provides a valuable probe for the investigation of GAG biology and opens avenues toward the development of bioactive compounds to correct GAG synthesis disorders implicated in different types of malignancies.	[Saliba, Mineem; Ramalanjaona, Nick; Gulberti, Sandrine; Bertin-Jung, Isabelle; Ouzzine, Mohamed; Fournel-Gigleux, Sylvie] Univ Lorraine, CNRS, Fac Med, UMR 7365,Biopole, F-54505 Vandoeuvre Les Nancy, France; [Thomas, Aline; Breton, Christelle] Univ Grenoble Alpes, CERMAV, F-38041 Grenoble 9, France; [Dahbi, Samir; Lopin-Bon, Chrystel; Jacquinet, Jean-Claude] Univ Orleans, Inst Chim Organ & Analyt, Pole Chim, UMR 7311,CNRS, F-45067 Orleans 02, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lorraine; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Orleans	Fournel-Gigleux, S (corresponding author), Univ Lorraine, CNRS, Fac Med, UMR 7365,Biopole, CS 50184, F-54505 Vandoeuvre Les Nancy, France.	sylvie.fournel-gigleux@univ-lorraine.fr	Ouzzine, Mohamed/G-4368-2013	lopin-bon, chrystel/0000-0002-5146-2905; GULBERTI, Sandrine/0000-0002-9378-4697; OUZZINE, Mohamed/0000-0003-0058-4950	Agence Nationale pour la Recherche (ANR) Meca-GT [ANR-13-BSV8-0011-01]; ANR GAG-Sorting Grant [ANR-13-JS07-0004-01]; Labex SynOrg Grant [ANR-11-LABX-0029]; International Associated Laboratory CNRS-Universite de Lorraine-University of Dundee; SFGEN; Region Lorraine-FEDER (Glyco-Fluo) grant; Region Lorraine; MSEDgenetique association	Agence Nationale pour la Recherche (ANR) Meca-GT(French National Research Agency (ANR)); ANR GAG-Sorting Grant(French National Research Agency (ANR)); Labex SynOrg Grant; International Associated Laboratory CNRS-Universite de Lorraine-University of Dundee; SFGEN; Region Lorraine-FEDER (Glyco-Fluo) grant(Region Grand-Est); Region Lorraine(Region Grand-Est); MSEDgenetique association	This work was supported by Agence Nationale pour la Recherche (ANR) Meca-GT Grant ANR-13-BSV8-0011-01, ANR GAG-Sorting Grant ANR-13-JS07-0004-01, Labex SynOrg Grant ANR-11-LABX-0029, International Associated Laboratory CNRS-Universite de Lorraine-University of Dundee, SFGEN), Region Lorraine-FEDER (Glyco-Fluo) grant, grants from the Region Lorraine (to N. R. and S. F. G.), and the AMSEDgenetique association.	Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Belting M, 2002, P NATL ACAD SCI USA, V99, P371, DOI 10.1073/pnas.012346499; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bui C, 2010, FEBS LETT, V584, P3962, DOI 10.1016/j.febslet.2010.08.001; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Clark SJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00412; Daligault F, 2009, BIOCHEM J, V418, P605, DOI 10.1042/BJ20081093; Eneyskaya EV, 2005, ORG BIOMOL CHEM, V3, P146, DOI 10.1039/b409583a; ESKO JD, 1987, J BIOL CHEM, V262, P12189; FOURNELGIGLEUX S, 1989, FEBS LETT, V243, P119, DOI 10.1016/0014-5793(89)80111-5; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Furukawa K, 2002, BBA-GEN SUBJECTS, V1573, P377, DOI 10.1016/S0304-4165(02)00406-3; Garud DR, 2008, J BIOL CHEM, V283, P28881, DOI 10.1074/jbc.M805939200; Gotte M, 2008, HUM MOL GENET, V17, P996, DOI 10.1093/hmg/ddm372; Gotte M, 2005, BIOCHEM GENET, V43, P65, DOI 10.1007/s10528-005-1068-2; Gulberti S, 2005, J BIOL CHEM, V280, P1417, DOI 10.1074/jbc.M411552200; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Halper J, 2014, ADV EXP MED BIOL, V802, P49, DOI 10.1007/978-94-007-7893-1_4; Honke K, 2002, MED RES REV, V22, P637, DOI 10.1002/med.10020; Kadomatsu K, 2014, ARCH BIOCHEM BIOPHYS, V558, P36, DOI 10.1016/j.abb.2014.06.009; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; KOLSET SO, 1990, BIOCHEM J, V265, P637, DOI 10.1042/bj2650637; LAZARENO S, 1993, BRIT J PHARMACOL, V109, P1110, DOI 10.1111/j.1476-5381.1993.tb13737.x; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; Lugemwa FN, 1996, J BIOL CHEM, V271, P19159, DOI 10.1074/jbc.271.32.19159; Malfait F, 2013, AM J HUM GENET, V92, P935, DOI 10.1016/j.ajhg.2013.04.016; Mani K, 2004, GLYCOBIOLOGY, V14, P387, DOI 10.1093/glycob/cwh035; Mani K, 1998, CANCER RES, V58, P1099; Martin NB, 1996, SEMIN THROMB HEMOST, V22, P247, DOI 10.1055/s-2007-999015; Muto J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025480; Nguyen TKN, 2013, ACS CHEM BIOL, V8, P939, DOI 10.1021/cb400132r; Okajima T, 1999, J BIOL CHEM, V274, P22915, DOI 10.1074/jbc.274.33.22915; Rahuel-Clermont S, 2010, BIOCHEM J, V432, P303, DOI 10.1042/BJ20100921; Ramakrishnan B, 2010, J BIOL CHEM, V285, P15619, DOI 10.1074/jbc.M109.099564; Raman K, 2011, BIOCHEM BIOPH RES CO, V404, P86, DOI 10.1016/j.bbrc.2010.11.069; Repasky Matthew P, 2007, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0812s18; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Sheng JZ, 2012, J BIOL CHEM, V287, P20996, DOI 10.1074/jbc.M112.359885; Siegbahn A, 2014, CHEM SCI, V5, P3501, DOI 10.1039/c4sc01244e; Siegbahn A, 2011, BIOORGAN MED CHEM, V19, P4114, DOI 10.1016/j.bmc.2011.05.007; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Talhaoui I, 2010, J BIOL CHEM, V285, P37342, DOI 10.1074/jbc.M110.151951; Tsutsui Y, 2013, J BIOL CHEM, V288, P31963, DOI 10.1074/jbc.M113.509984; Tsuzuki Y, 2010, BIOORG MED CHEM LETT, V20, P7269, DOI 10.1016/j.bmcl.2010.10.085; Ueno M, 2001, J BIOL CHEM, V276, P29134, DOI 10.1074/jbc.M102089200; Vassal-Stermann E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047933; Wang PP, 2014, PROTEIN PEPTIDE LETT, V21, P1048, DOI 10.2174/0929866521666140626095145; Yada T, 2003, J BIOL CHEM, V278, P30235, DOI 10.1074/jbc.M303657200	51	17	17	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7658	7670		10.1074/jbc.M114.628123	http://dx.doi.org/10.1074/jbc.M114.628123			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25568325	Green Published, hybrid			2022-12-26	WOS:000351613600028
J	Ahmad, F; Shen, WX; Vandeput, F; Szabo-Fresnais, N; Krall, J; Degerman, E; Goetz, F; Klussmann, E; Movsesian, M; Manganiello, V				Ahmad, Faiyaz; Shen, Weixing; Vandeput, Fabrice; Szabo-Fresnais, Nicolas; Krall, Judith; Degerman, Eva; Goetz, Frank; Klussmann, Enno; Movsesian, Matthew; Manganiello, Vincent			Regulation of Sarcoplasmic Reticulum Ca2+ ATPase 2 (SERCA2) Activity by Phosphodiesterase 3A (PDE3A) in Human Myocardium PHOSPHORYLATION-DEPENDENT INTERACTION OF PDE3A1 WITH SERCA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC MYOCYTES; CALCIUM-ATPASE; 3B PDE3B; PROTEIN; HEART; PHOSPHOLAMBAN; INSULIN; ISOFORMS; CONTRACTILITY; ACTIVATION	Cyclic nucleotide phosphodiesterase 3A (PDE3) regulates cAMP-mediated signaling in the heart, and PDE3 inhibitors augment contractility in patients with heart failure. Studies in mice showed that PDE3A, not PDE3B, is the subfamily responsible for these inotropic effects and that murine PDE3A1 associates with sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA2), phospholamban (PLB), and AKAP18 in a multiprotein signalosome in human sarcoplasmic reticulum (SR). Immunohistochemical staining demonstrated that PDE3A co-localizes in Z-bands of human cardiac myocytes with desmin, SERCA2, PLB, and AKAP18. In human SR fractions, cAMPincreased PLB phosphorylation and SERCA2 activity; this was potentiated by PDE3 inhibition but not by PDE4 inhibition. During gel filtration chromatography of solubilized SR membranes, PDE3 activity was recovered in distinct high molecular weight (HMW) and low molecular weight (LMW) peaks. HMW peaks contained PDE3A1 and PDE3A2, whereas LMW peaks contained PDE3A1, PDE3A2, and PDE3A3. Western blotting showed that endogenous HMW PDE3A1 was the principal PKA-phosphorylated isoform. Phosphorylation of endogenous PDE3A by rPKAc increased cAMP-hydrolytic activity, correlated with shift of PDE3A from LMW to HMW peaks, and increased co-immunoprecipitation of SERCA2, cav3, PKAregulatory subunit (PKARII), PP2A, and AKAP18 with PDE3A. In experiments with recombinant proteins, phosphorylation of recombinant human PDE3A isoforms by recombinant PKA catalytic subunit increased co-immunoprecipitation with rSERCA2 and rat rAKAP18 (recombinant AKAP18). Deletion of the recombinant human PDE3A1/PDE3A2 N terminus blocked interactions with recombinant SERCA2. Serine-to-alanine substitutions identified Ser-292/Ser-293, a site unique to human PDE3A1, as the principal site regulating its interaction with SERCA2. These results indicate that phosphorylation of human PDE3A1 at a PKA site in its unique N-terminal extension promotes its incorporation into SERCA2/AKAP18 signalosomes, where it regulates a discrete cAMP pool that controls contractility by modulating phosphorylation-dependent protein-protein interactions, PLB phosphorylation, and SERCA2 activity.	[Ahmad, Faiyaz; Shen, Weixing; Manganiello, Vincent] NHLBI, Cardiovasc Pulm Branch, NIH, Bethesda, MD 20892 USA; [Vandeput, Fabrice; Szabo-Fresnais, Nicolas; Krall, Judith; Movsesian, Matthew] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Vandeput, Fabrice; Szabo-Fresnais, Nicolas; Krall, Judith; Movsesian, Matthew] Univ Utah, Salt Lake City, UT USA; [Degerman, Eva] Lund Univ, Dept Expt Med Sci, Div Diabet Metab & Endocrinol, Lund, Sweden; [Klussmann, Enno] Max Delbrueck Ctr Mol Med Berlin Buch MDC, D-13125 Berlin, Germany; [Klussmann, Enno] German Ctr Cardiovasc Res, DZHK, D-13347 Berlin, Germany	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Lund University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; German Centre for Cardiovascular Research	Ahmad, F (corresponding author), NHLBI, Cardiovasc Pulm Branch, NIH, Bldg 10,Rm 5N311,9000 Rockville Pike, Bethesda, MD 20892 USA.	Ahmadf@nhlbi.nih.gov	Szabo, Nicolas/AAG-1067-2019; Khan, Faiyaz Ahmad/AAW-7944-2021		National Institutes of Health NHLBI Intramural program; Foundation Leducq Grant [06CVD02 cAMP]; American Heart Association; Swedish Research Council [3362]; Deutsche Forschungsgemeinschaft [KL1415-4/2]; Else Kroner-Fresenius-Stiftung [2013_A145]; German-Israeli Foundation [I-1210-286.13/2012]; United States Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006019, ZIAHL002540] Funding Source: NIH RePORTER	National Institutes of Health NHLBI Intramural program; Foundation Leducq Grant; American Heart Association(American Heart Association); Swedish Research Council(Swedish Research CouncilEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung; German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); United States Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health NHLBI Intramural program. This work was also supported by medical research funds from the United States Department of Veterans Affairs and Foundation Leducq Grant 06CVD02 cAMP and an American Heart Association grant-in-aid (to M. M.); by Swedish Research Council Project 3362 (to E.D.); and by Deutsche Forschungsgemeinschaft Grant KL1415-4/2, the Else Kroner-Fresenius-Stiftung (2013_A145), and the German-Israeli Foundation (I-1210-286.13/2012) (to E. K. and F. G.).	Ahmad F, 2007, BIOCHEM J, V404, P257, DOI 10.1042/BJ20060960; Ahmad F, 2009, BIOCHEM J, V424, P399, DOI 10.1042/BJ20090842; [Anonymous], 2011, BASIC RES CARDIOL, V106, P249; Babick AP, 2004, AM J PHYSIOL-CELL PH, V287, pC1202, DOI 10.1152/ajpcell.00155.2004; Beca S, 2013, CIRC RES, V112, P289, DOI 10.1161/CIRCRESAHA.111.300003; Hambleton R, 2005, J BIOL CHEM, V280, P39168, DOI 10.1074/jbc.M506760200; Han SJ, 2006, EMBO J, V25, P5716, DOI 10.1038/sj.emboj.7601431; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Hunter RW, 2009, J BIOL CHEM, V284, P12339, DOI 10.1074/jbc.M807536200; Kawase Y, 2008, NAT CLIN PRACT CARD, V5, P554, DOI 10.1038/ncpcardio1301; KIRCHGESSER M, 1990, J CLIN CHEM CLIN BIO, V28, P407; Kuschel M, 1999, AM J PHYSIOL-HEART C, V276, pH1625, DOI 10.1152/ajpheart.1999.276.5.H1625; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; MANGANIELLO V, 1973, J BIOL CHEM, V248, P7164; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Mishra S, 2005, HEART VESSELS, V20, P23, DOI 10.1007/s00380-004-0792-6; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; Movsesian MA, 2003, J CARD FAIL, V9, P475, DOI 10.1016/S1071-9164(03)00135-0; Nilsson R, 2006, CELL SIGNAL, V18, P1713, DOI 10.1016/j.cellsig.2006.01.010; Onuma H, 2002, DIABETES, V51, P3362, DOI 10.2337/diabetes.51.12.3362; Palmer D, 2007, J BIOL CHEM, V282, P9411, DOI 10.1074/jbc.M606936200; Perino A, 2011, MOL CELL, V42, P84, DOI 10.1016/j.molcel.2011.01.030; Rondinone CM, 2000, J BIOL CHEM, V275, P10093, DOI 10.1074/jbc.275.14.10093; Rubio MP, 2005, BIOCHEM J, V392, P163, DOI 10.1042/BJ20051103; Sande JB, 2002, CARDIOVASC RES, V53, P382, DOI 10.1016/S0008-6363(01)00489-8; Schwoerer AP, 2008, J MOL CELL CARDIOL, V45, P846, DOI 10.1016/j.yjmcc.2008.09.003; Shakur Y, 2000, J BIOL CHEM, V275, P38749, DOI 10.1074/jbc.M001734200; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Singh A, 2011, MOL PHARMACOL, V79, P533, DOI 10.1124/mol.110.065425; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; Sun B, 2007, CELL SIGNAL, V19, P1765, DOI 10.1016/j.cellsig.2007.03.012; Vandeput F, 2007, J BIOL CHEM, V282, P32749, DOI 10.1074/jbc.M703173200; Vandeput F, 2013, P NATL ACAD SCI USA, V110, P19778, DOI 10.1073/pnas.1305427110; Wechsler J, 2002, J BIOL CHEM, V277, P38072, DOI 10.1074/jbc.M203647200; Weninger S, 2014, CELL SIGNAL, V26, P2573, DOI 10.1016/j.cellsig.2014.07.027; Wilson LS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217026; Yan C, 2007, CIRC RES, V100, P489, DOI 10.1161/01.RES.0000258451.44949.d7; Zaccolo M, 2009, BRIT J PHARMACOL, V158, P50, DOI 10.1111/j.1476-5381.2009.00185.x	39	59	61	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6763	6776		10.1074/jbc.M115.638585	http://dx.doi.org/10.1074/jbc.M115.638585			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25593322	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000350991500013
J	Baker, B; Geng, S; Chen, KQ; Diao, N; Yuan, RX; Xu, XG; Dougherty, S; Stephenson, C; Xiong, HB; Chu, HW; Li, LW				Baker, Bianca; Geng, Shuo; Chen, Keqiang; Diao, Na; Yuan, Ruoxi; Xu, Xiguang; Dougherty, Sean; Stephenson, Caroline; Xiong, Huabao; Chu, Hong Wei; Li, Liwu			Alteration of Lysosome Fusion and Low-grade Inflammation Mediated by Super-low-dose Endotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING PROTEIN GENE; NEGATIVE REGULATION; KAPPA-B; AUTOPHAGY; TOLLIP; SUSCEPTIBILITY; MACROPHAGES; LIPOPOLYSACCHARIDE; INDUCTION; VPS34	Subclinical super-low-dose endotoxin I,PS is a risk factor for the establishment of low-grade inflammation during the pathogenesis and progression of chronic diseases. However, the underlying mechanisms are not well understood. At the cellular level, a disruption of lysosome fusion with endosomes or autophagosomes may contribute to the potentiation of low-grade inflammation. In this study, we identified that subclinical super-low-dose endotoxin LPS can potently inhibit the process of endosome acidification and lysosome fusion with endosomes or autophagosomes in primary macrophages. Super-low-dose LPS induced the inhibitory phosphorylation of VPS34, thus leading to the disruption of endosome-lysosome fusion. This effect may depend upon the clearance and relocation of Tollip in macrophages by super-low-dose LPS. Consistent with this notion, Tollip-deficient macrophages had constitutively elevated levels of VPS34 inhibitory phosphorylation and constitutive disruption of endosome-lysosome fusion. By employing a skin excision wound-healing model, we observed that Tollip-deficient mice had significantly elevated levels of cell stress and reduced wound repair. This study reveals a novel mechanism responsible for the modulation of endosome-lysosome fusion and low-grade inflammation in innate macrophages.	[Baker, Bianca; Geng, Shuo; Chen, Keqiang; Diao, Na; Yuan, Ruoxi; Xu, Xiguang; Dougherty, Sean; Stephenson, Caroline; Li, Liwu] Virginia Polytech Inst & State Univ, Lab Inflammat Biol, Dept Biol Sci, Blacksburg, VA 24061 USA; [Xiong, Huabao] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Chu, Hong Wei] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA	Virginia Polytechnic Institute & State University; Icahn School of Medicine at Mount Sinai; National Jewish Health	Li, LW (corresponding author), Virginia Tech, Dept Biol, Life Sci 1 Bldg,Washington St, Blacksburg, VA 24061 USA.	lwli@vt.edu	Geng, Shuo/J-3735-2013	Li, Liwu/0000-0001-8870-5299; Xu, Xiguang/0000-0001-6862-7545; Stephenson, Caroline/0000-0001-5615-4920; Yuan, Ruoxi/0000-0002-8719-341X	National Institutes of Health [R01HL115835, AI106287]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL115835 and AI106287 (to H. W. C. and L. L.).	Andreasen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023999; Cannizzo ES, 2012, CELL REP, V2, P136, DOI 10.1016/j.celrep.2012.06.005; Capelluto DGS, 2012, MICROBES INFECT, V14, P140, DOI 10.1016/j.micinf.2011.08.018; Chang S., 2011, J MED SCI, V31, P191; Chen S, 2012, BRAIN PATHOL, V22, P110, DOI 10.1111/j.1750-3639.2011.00546.x; Devereaux K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076405; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Emanuel R, 2014, ARTERIOSCL THROM VAS, V34, P1942, DOI 10.1161/ATVBAHA.114.303342; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Furuya T, 2010, MOL CELL, V38, P500, DOI 10.1016/j.molcel.2010.05.009; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Katoh Y, 2006, BIOCHEM BIOPH RES CO, V341, P143, DOI 10.1016/j.bbrc.2005.12.156; Katoh Y, 2004, J BIOL CHEM, V279, P24435, DOI 10.1074/jbc.M400059200; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Li T, 2004, MOL IMMUNOL, V41, P85, DOI 10.1016/j.molimm.2004.03.009; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Maitra U, 2012, J IMMUNOL, V189, P1014, DOI 10.4049/jimmunol.1200857; Maitra U, 2009, MOL CELL BIOL, V29, P5989, DOI 10.1128/MCB.00541-09; Mao K, 2011, CIRC RES, V108, P787, DOI 10.1161/RES.0b013e3182194c29; Mayer ML, 2013, J IMMUNOL, V190, P1227, DOI 10.4049/jimmunol.1201404; Mitra S, 2013, J BIOL CHEM, V288, P25780, DOI 10.1074/jbc.M113.484170; Miura K, 2011, INFECT IMMUN, V79, P4947, DOI 10.1128/IAI.05640-11; Montoya-Buelna M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/459169; Morris M, 2012, ARCH IMMUNOL THER EX, V60, P13, DOI 10.1007/s00005-011-0155-9; Noda T, 2010, SEMIN CELL DEV BIOL, V21, P671, DOI 10.1016/j.semcdb.2010.04.002; Noth I, 2013, LANCET RESP MED, V1, P309, DOI 10.1016/S2213-2600(13)70045-6; Parkinson-Lawrence EJ, 2010, PHYSIOLOGY, V25, P102, DOI 10.1152/physiol.00041.2009; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Puri R, 2012, HUM MOL GENET, V21, P175, DOI 10.1093/hmg/ddr452; Schimming TT, 2007, BMC DERMATOL, V7, DOI 10.1186/1471-5945-7-3; Shah JA, 2012, J IMMUNOL, V189, P1737, DOI 10.4049/jimmunol.1103541; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Song ZJ, 2011, CRIT CARE, V15, DOI 10.1186/cc9413; Tumbarello DA, 2012, NAT CELL BIOL, V14, P1024, DOI 10.1038/ncb2589; Wang JH, 2005, J IMMUNOL, V174, P6113, DOI 10.4049/jimmunol.174.10.6113; Wiesner P, 2010, CIRC RES, V107, P56, DOI 10.1161/CIRCRESAHA.110.218420; Wolfe DM, 2013, EUR J NEUROSCI, V37, P1949, DOI 10.1111/ejn.12169; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Yang QA, 2010, APOPTOSIS, V15, P1410, DOI 10.1007/s10495-010-0475-y; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	45	36	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6670	6678		10.1074/jbc.M114.611442	http://dx.doi.org/10.1074/jbc.M114.611442			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25586187	Green Published, hybrid			2022-12-26	WOS:000350732500067
J	Naito, A; Yamamoto, H; Kagawa, Y; Naito, Y; Okuzaki, D; Otani, K; Iwamoto, Y; Maeda, S; Kikuta, J; Nishikawa, K; Uemura, M; Nishimura, J; Hata, T; Takemasa, I; Mizushima, T; Ishii, H; Doki, Y; Mori, M; Ishii, M				Naito, Atsushi; Yamamoto, Hirofumi; Kagawa, Yoshinori; Naito, Yoko; Okuzaki, Daisuke; Otani, Keisuke; Iwamoto, Yoriko; Maeda, Sakae; Kikuta, Junichi; Nishikawa, Keizo; Uemura, Mamoru; Nishimura, Junichi; Hata, Taishi; Takemasa, Ichiro; Mizushima, Tsunekazu; Ishii, Hideshi; Doki, Yuichiro; Mori, Masaki; Ishii, Masaru			RFPL4A Increases the G(1) Population and Decreases Sensitivity to Chemotherapy in Human Colorectal Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; INITIATING CELLS; CYCLE PROGRESSION; P53; 5-FLUOROURACIL; CARCINOMA; EFFICIENT; THERAPY; PROTEIN; GROWTH	Cell cycle-arrested cancer cells are resistant to conventional chemotherapy that acts on the mitotic phases of the cell cycle, although the molecular mechanisms involved in halting cell cycle progression remain unclear. Here, we demonstrated that RFPL4A, an uncharacterized ubiquitin ligase, induced G(1) retention and thus conferred decreased sensitivity to chemotherapy in the human colorectal cancer cell line, HCT116. Long term time lapse observations in HCT116 cells bearing a "fluorescence ubiquitin-based cell cycle indicator" identified a characteristic population that is viable but remains in the G(1) phase for an extended period of time (up to 56 h). Microarray analyses showed that expression of RFPL4A was significantly up-regulated in these G(1)-arrested cells, not only in HCT116 cells but also in other cancer cell lines, and overexpression of RFPL4A increased the G(1) population and decreased sensitivity to chemotherapy. However, knockdown of RFPL4A expression caused the cells to resume mitosis and induced their susceptibility to anti-cancer drugs in vitro and in vivo. These results indicate that RFPL4A is a novel factor that increases the G(1) population and decreases sensitivity to chemotherapy and thus may be a promising therapeutic target for refractory tumor conditions.	[Naito, Atsushi; Kagawa, Yoshinori; Naito, Yoko; Otani, Keisuke; Iwamoto, Yoriko; Maeda, Sakae; Kikuta, Junichi; Nishikawa, Keizo; Ishii, Masaru] Osaka Univ, Grad Sch Med, Dept Immunol & Cell Biol, Suita, Osaka 5650871, Japan; [Naito, Atsushi; Yamamoto, Hirofumi; Kagawa, Yoshinori; Maeda, Sakae; Uemura, Mamoru; Nishimura, Junichi; Hata, Taishi; Takemasa, Ichiro; Mizushima, Tsunekazu; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan; [Ishii, Hideshi] Osaka Univ, Grad Sch Med, Dept Canc Profiling Discovery, Suita, Osaka 5650871, Japan; [Kagawa, Yoshinori; Naito, Yoko; Maeda, Sakae; Kikuta, Junichi; Nishikawa, Keizo; Ishii, Masaru] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Okuzaki, Daisuke] Osaka Univ, DNA Chip Dev Ctr Infect Dis, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Nishikawa, Keizo; Ishii, Masaru] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Mori, M (corresponding author), Osaka Univ, Dept Surg Gastroenterol, Grad Sch Med & Frontier Biosci, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	mmori@gesrug.med.osaka-u.ac.jp; mishii@icb.med.osaka-u.ac.jp	Kikuta, Junichi/HHS-8875-2022; Nishimura, Junichi/K-8390-2015; Ishii, Hideshi/AAV-5317-2020; Okuzaki, Daisuke/AAN-5641-2020; Otani, Keisuke/B-5705-2017	Nishimura, Junichi/0000-0001-8220-3423; Okuzaki, Daisuke/0000-0002-4552-783X; Otani, Keisuke/0000-0002-8275-0651	Ministry of Education, Science, Sports and Culture of Japan [22113007, 25253070]; International Human Frontier Science Program [RGY0077/2011]; Takeda Science Foundation; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [22113007] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Human Frontier Science Program(Human Frontier Science Program); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Grant-in-aid for Scientific Research on Innovative Areas 22113007 and by Grant-in-aid for Scientific Research (A) 25253070 from the Ministry of Education, Science, Sports and Culture of Japan; by International Human Frontier Science Program Grants RGY0077/2011; and by grants from the Takeda Science Foundation and Uehara Memorial Foundation.	Bonnefont J, 2008, AM J HUM GENET, V83, P208, DOI 10.1016/j.ajhg.2008.07.007; Bras-Goncalves RA, 2001, GASTROENTEROLOGY, V120, P874, DOI 10.1053/gast.2001.22440; Bras-Goncalves RA, 2000, BRIT J CANCER, V82, P913, DOI 10.1054/bjoc.1999.1019; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Funato Y, 2010, CURR BIOL, V20, P1945, DOI 10.1016/j.cub.2010.09.065; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Iwahashi S, 2013, SURG TODAY, V43, P654, DOI 10.1007/s00595-012-0437-9; Kagawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083629; Kaminska B, 2013, ADV EXP MED BIOL, V986, P171, DOI 10.1007/978-94-007-4719-7_9; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Rajkovic A, 2002, MECH DEVELOP, V112, P173, DOI 10.1016/S0925-4773(01)00635-9; Roccio M, 2013, DEVELOPMENT, V140, P459, DOI 10.1242/dev.086215; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Salcido CD, 2010, BRIT J CANCER, V102, P1636, DOI 10.1038/sj.bjc.6605668; Satow R, 2010, J BIOL CHEM, V285, P26289, DOI 10.1074/jbc.M109.090597; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shimada H, 2014, SURG TODAY, V44, P1957, DOI 10.1007/s00595-013-0787-y; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sohn KJ, 2004, JNCI-J NATL CANCER I, V96, P134, DOI 10.1093/jnci/djh015; Suzumori N, 2003, P NATL ACAD SCI USA, V100, P550, DOI 10.1073/pnas.0234474100; Takeishi S, 2014, BRIT J CANCER, V111, P1054, DOI 10.1038/bjc.2014.259; Takeishi S, 2013, CANCER CELL, V23, P347, DOI 10.1016/j.ccr.2013.01.026; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wada H, 2007, ONCOL REP, V18, P801; Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598	35	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6326	6337		10.1074/jbc.M114.614859	http://dx.doi.org/10.1074/jbc.M114.614859			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605732	hybrid, Green Published			2022-12-26	WOS:000350732500038
J	Silva, JP; Vetterlein, O; Jose, J; Peters, S; Kirby, H				Silva, John-Paul; Vetterlein, Olivia; Jose, Joby; Peters, Shirley; Kirby, Hishani			The S228P Mutation Prevents in Vivo and in Vitro IgG4 Fab-arm Exchange as Demonstrated using a Combination of Novel Quantitative Immunoassays and Physiological Matrix Preparation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING ASSAYS; IMMUNOGLOBULIN G4; INTERACTION STRENGTH; DISULFIDE BOND; ANTIBODIES; HETEROGENEITY; VALIDATION; MOLECULES; DYNAMICS; ISOTYPE	Human immunoglobulin G isotype 4 (IgG4) antibodies (Abs) are potential candidates for immunotherapy when reduced effector functions are desirable. IgG4 Abs are dynamic molecules able to undergo a process known as Fab arm exchange (FAE). This results in functionally monovalent, bispecific antibodies (bsAbs) with unknown specificity and hence, potentially, reduced therapeutic efficacy. IgG4 FAE is suggested to be an important biological mechanism that provides the basis for the anti-inflammatory activity attributed to IgG4 Abs. To date, the mechanism of FAE is not entirely understood and studies measuring FAE in ex vivo matrices have been hampered by the presence and abundance of endogenous IgG4 wild-type (WT) Abs. Using representative humanized WT IgG4 monoclonal Abs, namely, anti-IL-6 and anti-TNF, and a core-hinge stabilized serine 228 to proline (S228P) anti-IL-6 IgG4 mutant, it is demonstrated for the first time how anti-IgG4 affinity chromatography can be used to prepare physiologically relevant matrices for assessing and quantifying FAE. A novel method for quantifying FAE using a single MSD immunoassay is also reported and confirms previous findings that, dependent on the redox conditions, the S228P mutation can prevent IgG4 FAE to undetectable levels both in vitro and in vivo. Together, the findings and novel methodologies will allow researchers to monitor and quantify FAE of their own IgG4 molecules in physiologically relevant matrices.	[Silva, John-Paul; Vetterlein, Olivia; Jose, Joby; Kirby, Hishani] UCB Pharma, Dept Bioanalyt Sci, Nonclin Dev, Slough SL1 3WE, Berks, England; [Peters, Shirley] UCB Pharma, Dept Antibody Technol & Biol, Slough SL1 3WE, Berks, England	UCB Pharma SA; UCB Pharma SA	Silva, JP (corresponding author), UCB Pharma, Dept Bioanalyt Sci, 208 Bath Rd, Slough SL1 3WE, Berks, England.	john.silva@UCB.com						Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; ANGAL S, 1993, MOL IMMUNOL, V30, P105, DOI 10.1016/0161-5890(93)90432-B; Bloom JW, 1997, PROTEIN SCI, V6, P407; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; Burton DR, 2007, SCIENCE, V317, P1507, DOI 10.1126/science.1148905; Deng L, 2004, BIOTECHNOL APPL BIOC, V40, P261; DeSilva B, 2003, PHARM RES-DORDR, V20, P1885, DOI 10.1023/B:PHAM.0000003390.51761.3d; Divatia M, 2012, YONSEI MED J, V53, P15, DOI 10.3349/ymj.2012.53.1.15; Jones DP, 2009, FREE RADICAL BIO MED, V47, P1329, DOI 10.1016/j.freeradbiomed.2009.08.021; Kabat E. A., 1987, SEQUENCES PROTEINS I, DOI 10.1016/0003-2697(84)90805-4; Kabat EA, 1991, SEQUENCES PROTEINS I; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Labrijn AF, 2008, CURR OPIN IMMUNOL, V20, P479, DOI 10.1016/j.coi.2008.05.010; Labrijn AF, 2013, P NATL ACAD SCI USA, V110, P5145, DOI 10.1073/pnas.1220145110; Labrijn AF, 2011, J IMMUNOL, V187, P3238, DOI 10.4049/jimmunol.1003336; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; Lewis KB, 2009, MOL IMMUNOL, V46, P3488, DOI 10.1016/j.molimm.2009.07.009; MARGNI RA, 1988, ANNU REV IMMUNOL, V6, P535, DOI 10.1146/annurev.iy.06.040188.002535; MILES J, 1994, ANN CLIN BIOCHEM, V31, P245, DOI 10.1177/000456329403100305; Natsume A, 2008, CANCER RES, V68, P3863, DOI 10.1158/0008-5472.CAN-07-6297; Peters SJ, 2012, J BIOL CHEM, V287, P24525, DOI 10.1074/jbc.M112.369744; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; Rispens T, 2014, J BIOL CHEM, V289, P6098, DOI 10.1074/jbc.M113.541813; Rispens T, 2012, MULT SCLER J, V18, P899, DOI 10.1177/1352458511431073; Rispens T, 2011, J AM CHEM SOC, V133, P10302, DOI 10.1021/ja203638y; Rispens T, 2010, MOL IMMUNOL, V47, P1592, DOI 10.1016/j.molimm.2010.02.021; Rose RJ, 2011, STRUCTURE, V19, P1274, DOI 10.1016/j.str.2011.06.016; Salfeld JG, 2007, NAT BIOTECHNOL, V25, P1369, DOI 10.1038/nbt1207-1369; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Shapiro RI, 2011, J PHARMACEUT BIOMED, V55, P168, DOI 10.1016/j.jpba.2011.01.006; Stubenrauch K, 2010, DRUG METAB DISPOS, V38, P84, DOI 10.1124/dmd.109.029751; Unt E, 2008, SCAND J MED SCI SPOR, V18, P360, DOI 10.1111/j.1600-0838.2007.00674.x; Viswanathan CT, 2007, PHARM RES, V24, P1962, DOI 10.1007/s11095-007-9291-7; Wilkinson IC, 2013, MABS-AUSTIN, V5, P406, DOI 10.4161/mabs.23941	35	39	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5462	5469		10.1074/jbc.M114.600973	http://dx.doi.org/10.1074/jbc.M114.600973			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568323	hybrid, Green Published			2022-12-26	WOS:000350044200019
J	Takuma, H; Ushio, N; Minoji, M; Kazayama, A; Shigi, N; Hirata, A; Tomikawa, C; Ochi, A; Hori, H				Takuma, Hiroyuki; Ushio, Natsumi; Minoji, Masayuki; Kazayama, Ai; Shigi, Naoki; Hirata, Akira; Tomikawa, Chie; Ochi, Anna; Hori, Hiroyuki			Substrate tRNA Recognition Mechanism of Eubacterial tRNA (m(1)A58) Methyltransferase (TrmI)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEIC-ACID METHYLASES; PHENYLALANINE TRANSFER-RNA; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; AQUIFEX-AEOLICUS; M(7)G46 METHYLTRANSFERASE; EXTREME THERMOPHILE; IN-VITRO; PURIFICATION; COMPLEX	TrmI generates N-1-methyladenosine at position 58 (m(1)A58) in tRNA. The Thermus thermophilus tRNA(Phe) transcript was methylated efficiently by T. thermophilus TrmI, whereas the yeast tRNA(Phe) transcript was poorly methylated. Fourteen chimeric tRNA transcripts derived from these two tRNAs revealed that TrmI recognized the combination of aminoacyl stem, variable region, and T-loop. This was confirmed by 10 deletion tRNA variants: TrmI methylated transcripts containing the aminoacyl stem, variable region, and T-arm. The requirement for the T-stem itself was confirmed by disrupting the T-stem. Disrupting the interaction between T- and D-arms accelerated the methylation, suggesting that this disruption is included in part of the reaction. Experiments with 17 point mutant transcripts elucidated the positive sequence determinants C56, purine 57, A58, and U60. Replacing A58 with inosine and 2-aminopurine completely abrogated methylation, demonstrating that the 6-amino group in A58 is recognized by TrmI. T. thermophilus tRNA(GGU)(GGU)(Thr)(Thr) contains C60 instead of U60. The tRNA(GGU)(Thr) transcript was poorly methylated by TrmI, and replacing C60 with U increased the methylation, consistent with the point mutation experiments. A gel shift assay revealed that tRNA(GGU)(Thr) had a low affinity for TrmI than tRNA(Phe). Furthermore, analysis of tRNA(GGU)(Thr) purified from the trmI gene disruptant strain revealed that the other modifications in tRNA accelerated the formation of m1A58 by TrmI. Moreover, nucleoside analysis of tRNA(GGU)(Thr) from the wild-type strain indicated that less than 50% of tRNA(GGU)(Thr) contained m(1)A58. Thus, the results from the in vitro experiments were confirmed by the in vivo methylation patterns.	[Takuma, Hiroyuki; Ushio, Natsumi; Minoji, Masayuki; Kazayama, Ai; Hirata, Akira; Tomikawa, Chie; Ochi, Anna; Hori, Hiroyuki] Ehime Univ, Grad Sch Sci & Engn, Dept Mat Sci & Biotechnol, Matsuyama, Ehime 7908577, Japan; [Shigi, Naoki] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Koto Ku, Tokyo 1350064, Japan	Ehime University; National Institute of Advanced Industrial Science & Technology (AIST)	Hori, H (corresponding author), Ehime Univ, Grad Sch Sci & Engn, Dept Mat Sci & Biotechnol, Bunkyo 3, Matsuyama, Ehime 7908577, Japan.	hori@eng.ehime-u.ac.jp	Shigi, Naoki/L-7135-2018; Hori, Hiroyuki/AAB-3911-2021	Shigi, Naoki/0000-0003-4452-8264; 	Japan Society for the Promotion Science [23350081]	Japan Society for the Promotion Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-aid for Science Research 23350081 (to H. H.) from the Japan Society for the Promotion Science.	Alian A, 2008, P NATL ACAD SCI USA, V105, P6876, DOI 10.1073/pnas.0802247105; Anderson J, 2000, P NATL ACAD SCI USA, V97, P5173, DOI 10.1073/pnas.090102597; Anderson J, 1998, GENE DEV, V12, P3650, DOI 10.1101/gad.12.23.3650; Awai T, 2011, J BIOL CHEM, V286, P35236, DOI 10.1074/jbc.M111.253641; Awai T, 2009, J BIOL CHEM, V284, P20467, DOI 10.1074/jbc.M109.020024; Barraud P, 2008, J MOL BIOL, V377, P535, DOI 10.1016/j.jmb.2008.01.041; Chujo T, 2012, RNA, V18, P2269, DOI 10.1261/rna.035600.112; Constantinesco F, 1999, NUCLEIC ACIDS RES, V27, P1308, DOI 10.1093/nar/27.5.1308; Constantinesco F, 1999, J MOL BIOL, V291, P375, DOI 10.1006/jmbi.1999.2976; Droogmans L, 2003, NUCLEIC ACIDS RES, V31, P2148, DOI 10.1093/nar/gkg314; Gehrig S, 2012, J EXP MED, V209, P225, DOI 10.1084/jem.20111044; GLICK JM, 1977, J BIOL CHEM, V252, P4790; GRAWUNDER U, 1992, NUCLEIC ACIDS RES, V20, P137, DOI 10.1093/nar/20.1.137; GROSJEAN H, 1995, NUCLEIC ACIDS RES, V23, P4312, DOI 10.1093/nar/23.21.4312; Grosjean H, 1996, J MOL BIOL, V255, P67, DOI 10.1006/jmbi.1996.0007; GU XG, 1991, BIOCHEMISTRY-US, V30, P2999, DOI 10.1021/bi00226a003; Guelorget A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-48; Guelorget A, 2010, NUCLEIC ACIDS RES, V38, P6206, DOI 10.1093/nar/gkq381; Gupta A, 2001, J MOL BIOL, V312, P381, DOI 10.1006/jmbi.2001.4935; Hamdane D, 2014, NUCLEIC ACIDS RES, V42, P11697, DOI 10.1093/nar/gku820; Hori H, 1998, J BIOL CHEM, V273, P25721, DOI 10.1074/jbc.273.40.25721; Hori H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00144; HORIE N, 1985, BIOCHEMISTRY-US, V24, P5711, DOI 10.1021/bi00342a004; Hoseki J, 1999, J BIOCHEM-TOKYO, V126, P951, DOI 10.1093/oxfordjournals.jbchem.a022539; Hoseki J, 2003, BIOCHEMISTRY-US, V42, P14469, DOI 10.1021/bi034776z; Ishida K, 2011, NUCLEIC ACIDS RES, V39, P2304, DOI 10.1093/nar/gkq1180; Jockel S, 2012, J EXP MED, V209, P235, DOI 10.1084/jem.20111075; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Kaneko T, 2003, EMBO J, V22, P657, DOI 10.1093/emboj/cdg066; Kazayama A, 2015, J BIOCHEM, V157, P411, DOI 10.1093/jb/mvu089; Kempenaers M, 2010, NUCLEIC ACIDS RES, V38, P6533, DOI 10.1093/nar/gkq451; KIM SH, 1974, SCIENCE, V185, P435, DOI 10.1126/science.185.4149.435; KLAGSBRUN M, 1973, J BIOL CHEM, V248, P2606; KRAUS J, 1978, BIOCHEM J, V169, P247, DOI 10.1042/bj1690247; Kuratani Mitsuo, 2014, Journal of Structural and Functional Genomics, V15, P173, DOI 10.1007/s10969-014-9183-0; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Matsumoto K, 2007, FEBS LETT, V581, P1599, DOI 10.1016/j.febslet.2007.03.023; MCFARLANE ES, 1972, BIOCHEM J, V129, P513, DOI 10.1042/bj1290513; MUTZEL R, 1986, EUR J BIOCHEM, V160, P101, DOI 10.1111/j.1432-1033.1986.tb09945.x; Ochi A, 2013, J BIOL CHEM, V288, P25562, DOI 10.1074/jbc.M113.485128; Okamoto H, 2004, J BIOL CHEM, V279, P49151, DOI 10.1074/jbc.M408209200; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Renda MJ, 2001, J VIROL, V75, P9671, DOI 10.1128/JVI.75.20.9671-9678.2001; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; Roovers M, 2004, NUCLEIC ACIDS RES, V32, P465, DOI 10.1093/nar/gkh191; Roovers M, 2008, NUCLEIC ACIDS RES, V36, P3252, DOI 10.1093/nar/gkn169; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Shigi N, 2006, J BIOL CHEM, V281, P2104, DOI 10.1074/jbc.M510771200; Shigi N, 2002, J BIOL CHEM, V277, P39128, DOI 10.1074/jbc.M207323200; Takano Y, 2006, MOL MICROBIOL, V60, P81, DOI 10.1111/j.1365-2958.2006.05080.x; Takeda H, 2006, GENES CELLS, V11, P1353, DOI 10.1111/j.1365-2443.2006.01022.x; Tomikawa C, 2010, NUCLEIC ACIDS RES, V38, P942, DOI 10.1093/nar/gkp1059; Vilardo E, 2012, NUCLEIC ACIDS RES, V40, P11583, DOI 10.1093/nar/gks910; WATANABE K, 1976, BIOCHEM BIOPH RES CO, V72, P1137, DOI 10.1016/S0006-291X(76)80250-1; WIERZBICKA H, 1975, NUCLEIC ACIDS RES, V2, P101, DOI 10.1093/nar/2.1.101; WONG RSL, 1971, J BACTERIOL, V108, P446, DOI 10.1128/JB.108.1.446-450.1971; Yamagami R, 2012, J BIOL CHEM, V287, P42480, DOI 10.1074/jbc.M112.390112; Yokogawa T, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1182	59	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5912	5925		10.1074/jbc.M114.606038	http://dx.doi.org/10.1074/jbc.M114.606038			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25593312	Green Published, hybrid			2022-12-26	WOS:000350044200054
J	Wendell, SG; Golin-Bisello, F; Wenzel, S; Sobol, RW; Holguin, F; Freeman, BA				Wendell, Stacy Gelhaus; Golin-Bisello, Franca; Wenzel, Sally; Sobol, Robert W.; Holguin, Fernando; Freeman, Bruce A.			15-Hydroxyprostaglandin Dehydrogenase Generation of Electrophilic Lipid Signaling Mediators from Hydroxy Omega-3 Fatty Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; DOCOSAHEXAENOIC ACID; LINOLEIC-ACID; IN-VIVO; FATTY; PROTEIN; INHIBITION; SUPPRESSOR; EXPRESSION; ADDUCTION	15-Hydroxyprostaglandin dehydrogenase (15PGDH) is the primary enzyme catalyzing the conversion of hydroxylated arachidonic acid species to their corresponding oxidized metabolites. The oxidation of hydroxylated fatty acids, such as the conversion of prostaglandin (PG) E-2 to 15-ketoPGE(2), by 15PGDH is viewed to inactivate signaling responses. In contrast, the typically electrophilic products can also induce anti-inflammatory and anti-proliferative responses. This study determined that hydroxylated docosahexaenoic acid metabolites (HDoHEs) are substrates for 15PGDH. Examination of 15PGDH substrate specificity was conducted in cell culture (A549 and primary human airway epithelia and alveolar macrophages) using chemical inhibition and shRNA knockdown of 15PGDH. Substrate specificity is broad and relies on the carbon position of the acyl chain hydroxyl group. 14-HDoHE was determined to be the optimal DHA substrate for 15PGDH, resulting in the formation of its electrophilic metabolite, 14-oxoDHA. Consistent with this, 14-HDoHE was detected in bronchoalveolar lavage cells of mild to moderate asthmatics, and the exogenous addition of 14-oxoDHA to primary alveolar macrophages inhibited LPS-induced proinflammatory cytokine mRNA expression. These data reveal that 15PGDH-derived DHA metabolites are biologically active and can contribute to the salutary signaling actions of Omega-3 fatty acids.	[Wendell, Stacy Gelhaus; Golin-Bisello, Franca; Sobol, Robert W.; Freeman, Bruce A.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Wenzel, Sally; Holguin, Fernando] Univ Pittsburgh, Asthma Inst, Pittsburgh, PA 15261 USA; [Wenzel, Sally; Holguin, Fernando] Univ Pittsburgh, Pittsburgh, PA 15261 USA; [Sobol, Robert W.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wendell, SG (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, 200 Lothrop St,Biomed Sci Tower E1340, Pittsburgh, PA 15261 USA.	gstacy@pitt.edu; freerad@pitt.edu	Gelhaus, Stacy/AAF-2570-2019; Sobol, Robert W./E-4125-2013	Sobol, Robert W./0000-0001-7385-3563; Wenzel, Sally/0000-0002-4242-0164	National Institutes of Health Cancer Center Support Grant [CA047904]; NATIONAL CANCER INSTITUTE [R01CA148629, P30CA047904] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL058115, R01HL058115, R01HL064937, P01HL103455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R43ES021116, R44ES021116, R21ES019498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM099213, R43GM087798, R44GM087798] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Meghan Delmastro-Greenwood for critical review of the manuscript. Support for the UPCI Lentiviral Facility was provided by National Institutes of Health Cancer Center Support Grant CA047904.	Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Arnold C, 2010, J BIOL CHEM, V285, P32720, DOI 10.1074/jbc.M110.118406; Bilal S, 2011, BBA-MOL BASIS DIS, V1812, P1164, DOI 10.1016/j.bbadis.2011.05.002; Bonacci G, 2012, J BIOL CHEM, V287, P44071, DOI 10.1074/jbc.M112.401356; Bull AW, 1996, LIFE SCI, V58, P2355, DOI 10.1016/0024-3205(96)00236-6; Charles RL, 2014, P NATL ACAD SCI USA, V111, P8167, DOI 10.1073/pnas.1402965111; Chiang N, 2003, BRIT J PHARMACOL, V139, P89, DOI 10.1038/sj.bjp.0705220; Chu HW, 2004, AM J PATHOL, V165, P1097, DOI 10.1016/S0002-9440(10)63371-8; Clish CB, 2000, J BIOL CHEM, V275, P25372, DOI 10.1074/jbc.M002863200; COHEN AB, 1971, J CLIN INVEST, V50, P1390, DOI 10.1172/JCI106622; Davies John Q, 2005, Methods Mol Biol, V290, P105; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; HAMBERG M, 1967, J BIOL CHEM, V242, P5329; HEMPEL SL, 1994, J CLIN INVEST, V93, P391, DOI 10.1172/JCI116971; Hughes D, 2008, CANCER PREV RES, V1, P241, DOI 10.1158/1940-6207.CAPR-08-0055; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Kansanen E, 2009, J BIOL CHEM, V284, P33233, DOI 10.1074/jbc.M109.064873; Liu XJ, 2011, CHEM RES TOXICOL, V24, P2227, DOI 10.1021/tx200336f; Liu ZX, 2008, CARCINOGENESIS, V29, P1219, DOI 10.1093/carcin/bgm297; Lu D, 2014, ONCOGENE, V33, P1101, DOI 10.1038/onc.2013.69; Lu DD, 2013, J BIOL CHEM, V288, P19484, DOI 10.1074/jbc.M113.453886; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Na HK, 2011, BIOCHEM PHARMACOL, V82, P1352, DOI 10.1016/j.bcp.2011.08.005; O'Flaherty JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045480; Oh JY, 2008, BIOCHEM J, V411, P297, DOI [10.1042/BJ20071189, 10.1042/bj20071189]; PACEASCIAK C, 1975, J BIOL CHEM, V250, P2795; Patel P, 2009, J PHARMACOL EXP THER, V329, P335, DOI 10.1124/jpet.108.143453; Powell WS, 2005, PROG LIPID RES, V44, P154, DOI 10.1016/j.plipres.2005.04.002; Schopfer FJ, 2009, FREE RADICAL BIO MED, V46, P1250, DOI 10.1016/j.freeradbiomed.2008.12.025; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; Schopfer FJ, 2010, J BIOL CHEM, V285, P12321, DOI 10.1074/jbc.M109.091512; Snyder NW, 2015, CHEM-BIOL INTERACT, V234, P144, DOI 10.1016/j.cbi.2014.10.029; Tai HH, 2002, PROSTAG OTH LIPID M, V68-9, P483, DOI 10.1016/S0090-6980(02)00050-3; Tang JB, 2010, MOL CANCER RES, V8, P67, DOI 10.1158/1541-7786.MCR-09-0411; Trudeau J, 2006, J ALLERGY CLIN IMMUN, V117, P1446, DOI 10.1016/j.jaci.2006.01.049; VANROLLINS M, 1984, J BIOL CHEM, V259, P5776; VANROLLINS M, 1984, J LIPID RES, V25, P507; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; Villacorta L, 2013, CARDIOVASC RES, V98, P116, DOI 10.1093/cvr/cvt002; Wei C, 2009, MOL PHARMACOL, V76, P516, DOI 10.1124/mol.109.057489; Yan M, 2004, P NATL ACAD SCI USA, V101, P17468, DOI 10.1073/pnas.0406142101; Zhang JF, 2010, CIRC RES, V107, P540, DOI 10.1161/CIRCRESAHA.110.218404	43	18	18	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5868	5880		10.1074/jbc.M114.635151	http://dx.doi.org/10.1074/jbc.M114.635151			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25586183	hybrid, Green Published			2022-12-26	WOS:000350044200051
J	Zhao, HL; Bauzon, F; Bi, EG; Yu, JJ; Fu, H; Lu, ZL; Cui, JH; Jeon, HJ; Zang, XX; Ye, BH; Zhu, L				Zhao, Hongling; Bauzon, Frederick; Bi, Enguang; Yu, J. Jessica; Fu, Hao; Lu, Zhonglei; Cui, Jinhua; Jeon, Hyungjun; Zang, Xingxing; Ye, B. Hilda; Zhu, Liang			Substituting Threonine 187 with Alanine in p27Kip1 Prevents Pituitary Tumorigenesis by Two-Hit Loss of Rb1 and Enhances Humoral Immunity in Old Age	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; GERMINAL CENTER FORMATION; STEM-CELL QUIESCENCE; T-CELLS; P27 DEGRADATION; MICE LACKING; P27(KIP1); PHOSPHORYLATION; CENTERS; SCFSKP2	p27Kip1 (p27) is an inhibitor of cyclin-dependent kinases. Inhibiting p27 protein degradation is an actively developing cancer therapy strategy. One focus has been to identify small molecule inhibitors to block recruitment of Thr-187-phosphorylated p27 (p27T187p) to SCFSkp2/Cks1 ubiquitin ligase. Since phosphorylation of Thr-187 is required for this recruitment, p27T187A knockin (KI) mice were generated to determine the effects of systemically blocking interaction between p27 and Skp2/Cks1 on tumor susceptibility and other proliferation related mouse physiology. Rb1(+/-) mice develop pituitary tumors with full penetrance and the tumors are invariably Rb1(-/-), modeling tumorigenesis by two-hit loss of RB1 in humans. Immunization induced humoral immunity depends on rapid B cell proliferation and clonal selection in germinal centers (GCs) and declines with age in mice and humans. Here, we show that p27T187A KI prevented pituitary tumorigenesis in Rb1(+/-) mice and corrected decline in humoral immunity in older mice following immunization with sheep red blood cells (SRBC). These findings reveal physiological contexts that depend on p27 ubiquitination by SCFSkp2-Cks1 ubiquitin ligase and therefore help forecast clinical potentials of Skp2/Cks1-p27T187p interaction inhibitors. We further show that GC B cells and T cells use different mechanisms to regulate their p27 protein levels, and propose a T helper cell exhaustion model resembling that of stem cell exhaustion to understand decline in T cell-dependent humoral immunity in older age.	[Zhao, Hongling; Bauzon, Frederick; Fu, Hao; Lu, Zhonglei; Cui, Jinhua; Zhu, Liang] Albert Einstein Comprehens Canc Ctr, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Zhao, Hongling; Bauzon, Frederick; Bi, Enguang; Yu, J. Jessica; Fu, Hao; Lu, Zhonglei; Cui, Jinhua; Jeon, Hyungjun; Zang, Xingxing; Ye, B. Hilda; Zhu, Liang] Albert Einstein Comprehens Canc Ctr, Bronx, NY 10461 USA; Albert Einstein Coll Med, Liver Res Ctr, Bronx, NY 10461 USA	Yeshiva University; Yeshiva University; Yeshiva University; Albert Einstein College of Medicine	Zhu, L (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave,Room U-521, Bronx, NY 10461 USA.	liang.zhu@einstein.yu.edu		Lu, Zhonglei/0000-0002-8915-4828; Zang, Xingxing/0000-0001-5380-1942	NIH [R01CA127901, R01CA131421, R01 CA85573]; Department of Defense PCRP Postdoctoral Fellowship [PC121837]; Irma T. Hirschl Career Scientist Award; NATIONAL CANCER INSTITUTE [R01CA085573, R01CA175495, P30CA013330, R01CA131421, R01CA127901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061153, P30DK041296] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense PCRP Postdoctoral Fellowship(United States Department of Defense); Irma T. Hirschl Career Scientist Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH Grants R01CA127901 and R01CA131421 (to L. Z.), and R01 CA85573 (to B. H. Y.). This work was also supported by a Department of Defense PCRP Postdoctoral Fellowship (PC121837) (to H. Z.), and the Irma T. Hirschl Career Scientist Award (to B. H. Y. and L. Z.).	Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010; CALLAHAN JE, 1993, J IMMUNOL, V151, P6657; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Eaton SM, 2004, J EXP MED, V200, P1613, DOI 10.1084/jem.20041395; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kossatz U, 2004, GENE DEV, V18, P2602, DOI 10.1101/gad.321004; Linterman MA, 2014, IMMUNOL CELL BIOL, V92, P72, DOI 10.1038/icb.2013.77; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Looney RJ, 2001, J CLIN IMMUNOL, V21, P30, DOI 10.1023/A:1006736931381; Lu ZL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4463; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Mountz JD, 2011, DISCOV MED, V11, P76; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Ooi LC, 2013, CANCER SCI, V104, P1461, DOI 10.1111/cas.12246; Peled JU, 2010, CELL RES, V20, P631, DOI 10.1038/cr.2010.55; Sanz-Gonzalez SM, 2006, J CELL BIOCHEM, V97, P735, DOI 10.1002/jcb.20680; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Timmerbeul I, 2006, P NATL ACAD SCI USA, V103, P14009, DOI 10.1073/pnas.0606316103; Tsukiyama T, 2001, J IMMUNOL, V166, P304, DOI 10.4049/jimmunol.166.1.304; Ungermannova D, 2013, J BIOMOL SCREEN, V18, P910, DOI 10.1177/1087057113485789; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Victora G. D., 2014, CELL, V159; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; Wu L, 2012, CHEM BIOL, V19, P1515, DOI 10.1016/j.chembiol.2012.09.015; Yang XH, 1996, J EXP MED, V183, P959, DOI 10.1084/jem.183.3.959; Zhao HL, 2013, CANCER CELL, V24, P645, DOI 10.1016/j.ccr.2013.09.021; Zhu L, 2015, ONCOGENE, V34, P4547, DOI 10.1038/onc.2014.399	43	11	11	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5797	5809		10.1074/jbc.M114.625350	http://dx.doi.org/10.1074/jbc.M114.625350			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25583987	Green Published, hybrid			2022-12-26	WOS:000350044200046
J	Silfver, T; Paaso, U; Rasehorn, M; Rousi, M; Mikola, J				Silfver, Tarja; Paaso, Ulla; Rasehorn, Mira; Rousi, Matti; Mikola, Juha			Genotype x Herbivore Effect on Leaf Litter Decomposition in Betula Pendula Saplings: Ecological and Evolutionary Consequences and the Role of Secondary Metabolites	PLOS ONE			English	Article							SILVER BIRCH; COMMUNITY GENETICS; ECOSYSTEM GENETICS; PHENOLIC-COMPOUNDS; NITROGEN DYNAMICS; INSECT HERBIVORY; PLANT DEFENSE; GROWTH; PUBESCENS; RESISTANCE	Plant genetic variation and herbivores can both influence ecosystem functioning by affecting the quantity and quality of leaf litter. Few studies have, however, investigated the effects of herbivore load on litter decomposition at plant genotype level. We reduced insect herbivory using an insecticide on one half of field-grown Betula Pendula saplings of 17 genotypes, representing random intrapopulation genetic variation, and allowed insects to naturally colonize the other half. We hypothesized that due to induced herbivore defence, saplings under natural herbivory produce litter of higher concentrations of secondary metabolites (terpenes and soluble phenolics) and have slower litter decomposition rate than saplings under reduced herbivory. We found that leaf damage was 89 and 53% lower in the insecticide treated saplings in the summer and autumn surveys, respectively, which led to 73% higher litter production. Litter decomposition rate was also affected by herbivore load, but the effect varied from positive to negative among genotypes and added up to an insignificant net effect at the population level. In contrast to our hypothesis, concentrations of terpenes and soluble phenolics were higher under reduced than natural herbivory. Those genotypes, whose leaves were most injured by herbivores, produced litter of lowest mass loss, but unlike we expected, the concentrations of terpenes and soluble phenolics were not linked to either leaf damage or litter decomposition. Our results show that (1) the genetic and herbivore effects on B. pendula litter decomposition are not mediated through variation in terpene or soluble phenolic concentrations and suggest that (2) the presumably higher insect herbivore pressure in the future warmer climate will not, at the ecological time scale, affect the mean decomposition rate in genetically diverse B. pendula populations. However, (3) due to the significant genetic variation in the response of decomposition to herbivory, evolutionary changes in mean decomposition rate are possible.	[Silfver, Tarja; Paaso, Ulla; Rasehorn, Mira; Mikola, Juha] Univ Helsinki, Dept Environm Sci, FI-15140 Lahti, Finland; [Rousi, Matti] Finnish Forest Res Inst, Vantaa Res Unit, FI-01301 Vantaa, Finland	University of Helsinki; Natural Resources Institute Finland (Luke)	Silfver, T (corresponding author), Univ Helsinki, Dept Environm Sci, Niemenkatu 73, FI-15140 Lahti, Finland.	tarja.h.silfver@gmail.com	Mikola, Juha/A-1630-2015	Mikola, Juha/0000-0002-4336-2648; Silfver, Tarja/0000-0003-0619-5008	Academy of Finland [1122444]	Academy of Finland(Academy of Finland)	The study was funded by the Academy of Finland (decision #1122444). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttila U, 2010, OECOLOGIA, V164, P163, DOI 10.1007/s00442-010-1658-5; ATKINSON MD, 1992, J ECOL, V80, P837, DOI 10.2307/2260870; ATTIWILL PM, 1993, NEW PHYTOL, V124, P561, DOI 10.1111/j.1469-8137.1993.tb03847.x; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; Bardgett RD, 1998, SOIL BIOL BIOCHEM, V30, P1867, DOI 10.1016/S0038-0717(98)00069-8; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Berenbaum MR, 2008, PLANT PHYSIOL, V146, P804, DOI 10.1104/pp.107.113472; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Chapman SK, 2006, OIKOS, V114, P566, DOI 10.1111/j.2006.0030-1299.14676.x; Chapman SK, 2003, ECOLOGY, V84, P2867, DOI 10.1890/02-0046; Cornelissen JHC, 1999, NEW PHYTOL, V143, P191, DOI 10.1046/j.1469-8137.1999.00430.x; Cornelissen JHC, 1997, NEW PHYTOL, V135, P109, DOI 10.1046/j.1469-8137.1997.00628.x; CRAWLEY MJ, 1983, HERBIVORY THE DYNAMI; CYR H, 1993, NATURE, V361, P148, DOI 10.1038/361148a0; Fierer N, 2001, SOIL BIOL BIOCHEM, V33, P1827, DOI 10.1016/S0038-0717(01)00111-0; Findlay S, 1996, ECOL APPL, V6, P269, DOI 10.2307/2269570; Fischer A, 2002, FOLIA GEOBOT, V37, P17, DOI 10.1007/BF02803188; Fritz RS, 1998, OIKOS, V83, P117, DOI 10.2307/3546552; Grime JP, 1996, OIKOS, V77, P489, DOI 10.2307/3545938; Hattenschwiler S, 2000, TRENDS ECOL EVOL, V15, P238, DOI 10.1016/S0169-5347(00)01861-9; Haukioja E, 2003, OECOLOGIA, V136, P161, DOI 10.1007/s00442-003-1238-z; Hersch-Green EI, 2011, PHILOS T R SOC B, V366, P1453, DOI 10.1098/rstb.2010.0331; Hunter MD, 2001, AGR FOREST ENTOMOL, V3, P153, DOI 10.1046/j.1461-9555.2001.00108.x; Hynynen J, 2010, FORESTRY, V83, P103, DOI 10.1093/forestry/cpp035; KARBAN R, 1997, INDUCED RESPONSES TO; Keinanen M, 1999, ECOLOGY, V80, P1970, DOI 10.1890/0012-9658(1999)080[1970:TOIPMO]2.0.CO;2; Keski-Saari S, 2005, GLOBAL CHANGE BIOL, V11, P1180, DOI 10.1111/j.1365-2486.2005.00964.x; Laitinen ML, 2000, J CHEM ECOL, V26, P1609, DOI 10.1023/A:1005582611863; Leroy CJ, 2012, FRESHW SCI, V31, P1244, DOI 10.1899/12-029.1; Madritch M, 2006, ECOSYSTEMS, V9, P528, DOI 10.1007/s10021-006-0008-2; Martemyanov VV, 2012, ARTHROPOD-PLANT INTE, V6, P507, DOI 10.1007/s11829-012-9202-7; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; McNaughton SJ, 1997, SCIENCE, V278, P1798, DOI 10.1126/science.278.5344.1798; Mikola J, 2014, EVOL ECOL, V28, P811, DOI 10.1007/s10682-014-9708-9; Nykanen H, 2004, OIKOS, V104, P247, DOI 10.1111/j.0030-1299.2004.12768.x; Orians CM, 2010, ANNU REV ENTOMOL, V55, P439, DOI 10.1146/annurev-ento-112408-085333; PASTOR J, 1993, ECOLOGY, V74, P467, DOI 10.2307/1939308; Prittinen K, 2003, OECOLOGIA, V137, P572, DOI 10.1007/s00442-003-1384-3; Ritchie ME, 1998, ECOLOGY, V79, P165, DOI 10.1890/0012-9658(1998)079[0165:HEOPAN]2.0.CO;2; ROSENTHAL G, 1992, HERBIVORES THEIR INT, V2; Saikkonen K, 2003, FOREST PATHOL, V33, P215, DOI 10.1046/j.1439-0329.2003.00325.x; Schweitzer JA, 2005, OIKOS, V110, P133, DOI 10.1111/j.0030-1299.2005.13650.x; Silfver T, 2007, OECOLOGIA, V152, P707, DOI 10.1007/s00442-007-0695-1; Silfver Tarja, 2014, F1000Res, V3, P34, DOI 10.12688/f1000research.3-34.v1; Silfver T, 2013, ANN BOT FENN, V50, P337, DOI 10.5735/086.050.0508; Silfver T, 2009, FOREST ECOL MANAG, V257, P2145, DOI 10.1016/j.foreco.2009.02.020; Stark S, 2007, OECOLOGIA, V151, P486, DOI 10.1007/s00442-006-0593-y; Tack AJM, 2012, OIKOS, V121, P481, DOI 10.1111/j.1600-0706.2011.19926.x; Tegelberg R, 2001, GLOBAL CHANGE BIOL, V7, P839, DOI 10.1046/j.1354-1013.2001.00453.x; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; VITOUSEK P, 1982, AM NAT, V119, P553, DOI 10.1086/283931; Wardle DA, 2002, FUNCT ECOL, V16, P585, DOI 10.1046/j.1365-2435.2002.00659.x; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Whitham TG, 2008, SCIENCE, V320, P492, DOI 10.1126/science.1153918; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877	58	18	18	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0116806	10.1371/journal.pone.0116806	http://dx.doi.org/10.1371/journal.pone.0116806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25622034	Green Published, gold, Green Submitted			2022-12-26	WOS:000348470400007
J	Bagchi, D; Andrade, J; Shupnik, MA				Bagchi, Debalina; Andrade, Josefa; Shupnik, Margaret A.			A New Role for Wilms Tumor Protein 1: Differential Activities of plus KTS and -KTS Variants to Regulate LH beta Transcription	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; GROWTH-RESPONSE PROTEIN-1; STEROIDOGENIC FACTOR-I; LUTEINIZING-HORMONE; GENE-EXPRESSION; FRASIER-SYNDROME; SUPPRESSOR GENE; TRANSGENIC MICE; SUBUNIT GENES; BINDING-SITES	Luteinizing hormone (LH) is synthesized and secreted throughout the reproductive cycle from gonadotrope cells in the anterior pituitary, and is required for steroidogenesis and ovulation. LH contains an a-subunit common with FSH, and a unique LH beta subunit that defines biological activity. Basal LH beta transcription is low and stimulated by hypothalamic GnRH, which induces synthesis of early growth response protein-1 (Egr1), and stimulates binding of transcription factors Egr1 and steroidogenic factor-1 (SF1) on the promoter. WT1 (Wilms tumor protein1) is a zinc finger transcription factor with an essential role in urogenital system development, and which regulates several reproductive genes via interactions with SF1 or binding to GC-rich elements such as Egr1 binding sites. We investigated a potential role for WT1 in LH beta transcription in clonal mouse gonadotrope L beta T2 cells. WT1 was present in L beta T2 and mouse pituitary cells, and protein bound to the endogenous LH beta promoter. Interestingly, mRNAs for WT1(+KTS), which contains a three amino-acid insertion between the 3rd and 4th zinc fingers, and the WT1 (-KTS) variant were both expressed at significant levels. WT1 mRNAs and protein were decreased approximately 50% by GnRH treatment, under conditions where Egr1 mRNA and protein, and LH beta transcription, were stimulated. Decreasing expression of mRNA for WT1 (-KTS) decreased stimulation of LH beta and Egr1 by GnRH, whereas decreasing both WT1 (-KTS) and (+KTS) increased endogenous LH beta transcription, and prevented LH beta but not Egr1 stimulation by GnRH, suggesting differing biological activities for the WT1 isoforms. Overexpression of WT1 showed that WT1(-KTS) enhanced LH beta promoter GnRH stimulation 2-to-3-fold and required the 3' Egr1 site, but WT1(+KTS) repressed both basal and GnRH-stimulated LH beta promoter activity by approximately 70%. Our data suggest that WT1 can modulate LH beta transcription, with differential roles for the two WT1 variants; WT1 (-KTS) enhances and WT1 (+KTS) suppresses transcription.	[Bagchi, Debalina] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Andrade, Josefa; Shupnik, Margaret A.] Univ Virginia, Sch Med, Dept Med, Div Endocrinol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Shupnik, MA (corresponding author), Univ Virginia, Sch Med, Dept Med, Div Endocrinol, Charlottesville, VA 22908 USA.	mas3x@virginia.edu			National Institutes of Health as part of the Specialized Cooperative Centers Program in Reproduction Research through both an individual research project [U54 HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER	National Institutes of Health as part of the Specialized Cooperative Centers Program in Reproduction Research through both an individual research project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institutes of Health through cooperative agreement (U54 HD28934) as part of the Specialized Cooperative Centers Program in Reproduction Research through both an individual research project (to MAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade J, 2013, MOL ENDOCRINOL, V27, P828, DOI 10.1210/me.2012-1323; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Benz K, 2006, NEPHROL DIAL TRANSPL, V21, P1716, DOI 10.1093/ndt/gfl023; Bor YC, 2006, GENE DEV, V20, P1597, DOI 10.1101/gad.1402306; Call GB, 2002, MOL CELL ENDOCRINOL, V189, P85, DOI 10.1016/S0303-7207(01)00744-4; Chu ZG, 2009, J NEUROSCI, V29, P5616, DOI 10.1523/JNEUROSCI.0352-09.2009; Crawford PA, 1998, MOL CELL BIOL, V18, P2949, DOI 10.1128/MCB.18.5.2949; Curtin D, 2004, MOL ENDOCRINOL, V18, P1263, DOI 10.1210/me.2003-0221; Dame C, 2006, BLOOD, V107, P4282, DOI 10.1182/blood-2005-07-2889; Dammer EB, 2007, MOL ENDOCRINOL, V21, P415, DOI 10.1210/me.2006-0361; Dorn C, 1999, J BIOL CHEM, V274, P13870, DOI 10.1074/jbc.274.20.13870; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; FALLEST PC, 1995, BIOL REPROD, V53, P103, DOI 10.1095/biolreprod53.1.103; Ferris HA, 2007, BIOL REPROD, V77, P1073, DOI 10.1095/biolreprod.107.064139; Ferris HA, 2006, BIOL REPROD, V74, P993, DOI 10.1095/biolreprod.105.049049; Gannon AM, 2009, J MOL BIOL, V394, P29, DOI 10.1016/j.jmb.2009.09.007; GASHLER AL, 1992, P NATL ACAD SCI USA, V89, P10984, DOI 10.1073/pnas.89.22.10984; GHARIB SD, 1990, ENDOCR REV, V11, P177, DOI 10.1210/edrv-11-1-177; HAISENLEDER DJ, 1991, ENDOCRINOLOGY, V128, P509, DOI 10.1210/endo-128-1-509; Halvorson LM, 1999, MOL ENDOCRINOL, V13, P106, DOI 10.1210/me.13.1.106; HAMILTON TB, 1995, NUCLEIC ACIDS RES, V23, P277, DOI 10.1093/nar/23.2.277; HEWITT SM, 1995, CANCER RES, V55, P5386; Hohenstein P, 2006, HUM MOL GENET, V15, pR196, DOI 10.1093/hmg/ddl196; Huff V, 2011, NAT REV CANCER, V11, P111, DOI 10.1038/nrc3002; Ji SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053140; Kaiser UB, 2000, MOL ENDOCRINOL, V14, P1235, DOI 10.1210/me.14.8.1235; Kim J, 1999, MOL CELL BIOL, V19, P2289; Klamt B, 1998, HUM MOL GENET, V7, P709, DOI 10.1093/hmg/7.4.709; Lee SB, 1999, CELL, V98, P663, DOI 10.1016/S0092-8674(00)80053-7; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Melo KFS, 2002, J CLIN ENDOCR METAB, V87, P2500, DOI 10.1210/jc.87.6.2500; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Oh S, 1999, J BIOL CHEM, V274, P37473, DOI 10.1074/jbc.274.52.37473; Ritchie MF, 2010, J BIOL CHEM, V285, P10591, DOI 10.1074/jbc.M109.083493; SAKAMOTO KM, 1991, ONCOGENE, V6, P867; Schimmer BP, 2010, MOL ENDOCRINOL, V24, P1322, DOI 10.1210/me.2009-0519; SHUPNIK MA, 1990, MOL ENDOCRINOL, V4, P1444, DOI 10.1210/mend-4-10-1444; Tremblay JJ, 1999, MOL CELL BIOL, V19, P2567; Turgeon JL, 1996, MOL ENDOCRINOL, V10, P439, DOI 10.1210/me.10.4.439; Walsh HE, 2009, MOL ENDOCRINOL, V23, P237, DOI 10.1210/me.2008-0098; Webster NJG, 1997, BIOCHEM MOL MED, V62, P139, DOI 10.1006/bmme.1997.2648; Weck J, 2000, MOL ENDOCRINOL, V14, P472, DOI 10.1210/me.14.4.472; Wells J, 2010, MOL CANCER RES, V8, P975, DOI 10.1158/1541-7786.MCR-10-0033; Wilhelm D, 2002, GENE DEV, V16, P1839, DOI 10.1101/gad.220102; Zhao LP, 2001, DEVELOPMENT, V128, P147	45	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116825	10.1371/journal.pone.0116825	http://dx.doi.org/10.1371/journal.pone.0116825			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617744	gold, Green Published, Green Submitted			2022-12-26	WOS:000350336000028
J	Choi, DH; Kim, JH; Lee, KH; Kim, HY; Kim, YS; Choi, WS; Lee, J				Choi, Dong-Hee; Kim, Ji-Hye; Lee, Kyoung-Hee; Kim, Hahn-Young; Kim, Yoon-Seong; Choi, Wahn Soo; Lee, Jongmin			Role of Neuronal NADPH Oxidase 1 in the Peri-Infarct Regions after Stroke	PLOS ONE			English	Article							TABLE STAIR RECOMMENDATIONS; OXIDATIVE STRESS; ISCHEMIC-STROKE; MIGRATION; ADULT; BRAIN; RAT; NEUROPROTECTION; ACTIVATION; THERAPY	The molecular mechanism underlying the selective vulnerability of neurons to oxidative damage caused by ischemia-reperfusion (I/R) injury remains unknown. We sought to determine the role of NADPH oxidase 1 (Nox1) in cerebral I/R-induced brain injury and survival of newborn cells in the ischemic injured region. Male Wistar rats were subjected to 90 min middle cerebral artery occlusion (MCAO) followed by reperfusion. After reperfusion, infarction size, level of superoxide and 8-hydroxy-20-deoxyguanosine (8-oxo-2dG), and Nox1 immunoreactivity were determined. RNAi-mediated knockdown of Nox1 was used to investigate the role of Nox1 in I/R-induced oxidative damage, neuronal death, motor function recovery, and ischemic neurogenesis. After I/R, Nox1 expression and 8-oxo-2dG immunoreactivity was increased in cortical neurons of the peri-infarct regions. Both infarction size and neuronal death in I/R injury were significantly reduced by adeno-associated virus (AAV)-mediated transduction of Nox1 short hairpin RNA (shRNA). AAV-mediated Nox1 knockdown enhanced functional recovery after MCAO. The level of survival and differentiation of newborn cells in the peri-infarct regions were increased by Nox1 inhibition. Our data suggest that Nox-1 may be responsible for oxidative damage to DNA, subsequent cortical neuronal degeneration, functional recovery, and regulation of ischemic neurogenesis in the peri-infarct regions after stroke.	[Choi, Dong-Hee] Konkuk Univ, Sch Med, Dept Med Sci, Seoul, South Korea; [Lee, Jongmin] Konkuk Univ, Sch Med, Dept Rehabil Med, Seoul, South Korea; [Choi, Dong-Hee; Kim, Ji-Hye; Lee, Kyoung-Hee; Kim, Hahn-Young; Lee, Jongmin] Konkuk Univ, Inst Biomed Sci & Technol, Ctr Neurosci Res, Seoul, South Korea; [Kim, Yoon-Seong] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA; [Choi, Wahn Soo] Konkuk Univ, Coll Med, Funct Genom Inst, Dept Immunol & Physiol, Chungju, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Konkuk University; State University System of Florida; University of Central Florida; Konkuk University; Konkuk University Medical Center	Lee, J (corresponding author), Konkuk Univ, Sch Med, Dept Rehabil Med, Seoul, South Korea.	leej@kuh.ac.kr	Lee, Jongmin/Q-4909-2019	Lee, Jongmin/0000-0001-8718-0099	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2010-0025382, 2012R1A1A4A01013749]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A090123]; National Research Foundation of Korea (NRF) grant - Korean government (MEST) [2011-0017016]; US National Institutes of Health [RO1 NS062827]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea (NRF) grant - Korean government (MEST); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0025382 grant to D-HC and 2012R1A1A4A01013749 grant to JL), the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (Grant to DHC, A090123), the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2011-0017016), and the US National Institutes of Health (RO1 NS062827 to Y-SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2005, STROKE, V36, P1040, DOI 10.1161/01.STR.0000163111.05825.0b; Albers GW, 2011, STROKE, V42, P2645, DOI 10.1161/STROKEAHA.111.618850; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Amantea D, 2008, NEUROSCIENCE, V152, P8, DOI 10.1016/j.neuroscience.2007.12.030; Arab L, 2010, ARCH BIOCHEM BIOPHYS, V501, P31, DOI 10.1016/j.abb.2010.03.015; Bein B, 2011, EUR J ANAESTH, V28, P620, DOI 10.1097/EJA.0b013e328349d5f3; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Brennan-Minnella AM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.111; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1378, DOI 10.1038/jcbfm.2011.3; Choi DH, 2012, ANTIOXID REDOX SIGN, V16, P1033, DOI 10.1089/ars.2011.3960; Cook DJ, 2012, NEUROTHERAPEUTICS, V9, P371, DOI 10.1007/s13311-012-0115-z; Cristovao AC, 2009, ANTIOXID REDOX SIGN, V11, P2105, DOI [10.1089/ars.2009.2459, 10.1089/ARS.2009.2459]; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; Desouki MM, 2005, CANCER BIOL THER, V4, P1367, DOI 10.4161/cbt.4.12.2233; Ding YC, 2002, BEHAV BRAIN RES, V132, P29, DOI 10.1016/S0166-4328(01)00405-3; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Girouard H, 2009, J NEUROSCI, V29, P2545, DOI 10.1523/JNEUROSCI.0133-09.2009; Hossmann KA, 2009, FOLIA NEUROPATHOL, V47, P213; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; Jackman KA, 2009, BRAIN RES, V1286, P215, DOI 10.1016/j.brainres.2009.06.056; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Kahles T, 2010, NEUROBIOL DIS, V40, P185, DOI 10.1016/j.nbd.2010.05.023; Katsuyama M, 2005, BIOCHEM J, V386, P255, DOI 10.1042/BJ20041180; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000565, DOI 10.1371/JOURNAL.PBIO.1000565]; Koizumi J Y Y, 1986, JPN J STROKE, V8; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Lee JH, 2013, CARDIOVASC RES, V99, P483, DOI 10.1093/cvr/cvt107; Lee SB, 2006, J BIOL CHEM, V281, P36228, DOI 10.1074/jbc.M606702200; Liu Shimin, 2009, J Exp Stroke Transl Med, V2, P2; Liu ZY, 2007, STROKE, V38, P146, DOI 10.1161/01.STR.0000251791.64910.cd; O'Collins VE, 2011, J CEREBR BLOOD F MET, V31, P962, DOI 10.1038/jcbfm.2010.184; Radermacher KA, 2013, ANTIOXID REDOX SIGN, V18, P1418, DOI 10.1089/ars.2012.4797; Reyes RC, 2012, J NEUROSCI, V32, P12973, DOI 10.1523/JNEUROSCI.1597-12.2012; Saver JL, 2009, STROKE, V40, P2594, DOI 10.1161/STROKEAHA.109.552554; Savitz SI, 2011, STROKE, V42, P825, DOI 10.1161/STROKEAHA.110.601914; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Vallet P, 2005, NEUROSCIENCE, V132, P233, DOI 10.1016/j.neuroscience.2004.12.038; VanGilder RL, 2012, BRAIN RES BULL, V88, P313, DOI 10.1016/j.brainresbull.2012.02.002; Wali B, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/460909; Wang YM, 2013, STROKE, V44, P3529, DOI 10.1161/STROKEAHA.113.003350; Wey HY, 2012, TRANSL STROKE RES, V3, P84, DOI 10.1007/s12975-012-0145-1; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 2005, NEUROSCIENTIST, V11, P408, DOI 10.1177/1073858405278865	45	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116814	10.1371/journal.pone.0116814	http://dx.doi.org/10.1371/journal.pone.0116814			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617620	gold, Green Published, Green Submitted			2022-12-26	WOS:000350336000027
J	Krejcova, T; Smelcova, M; Petr, J; Bodart, JF; Sedmikova, M; Nevoral, J; Dvorakova, M; Vyskocilova, A; Weingartova, I; Kucerova-Chrpova, V; Chmelikova, E; Tumova, L; Jilek, F				Krejcova, Tereza; Smelcova, Miroslava; Petr, Jaroslav; Bodart, Jean-Francois; Sedmikova, Marketa; Nevoral, Jan; Dvorakova, Marketa; Vyskocilova, Alena; Weingartova, Ivona; Kucerova-Chrpova, Veronika; Chmelikova, Eva; Tumova, Lenka; Jilek, Frantisek			Hydrogen Sulfide Donor Protects Porcine Oocytes against Aging and Improves the Developmental Potential of Aged Porcine Oocytes	PLOS ONE			English	Article							CYSTATHIONINE BETA-SYNTHASE; TERMINAL KINASE JNK; INDUCED APOPTOSIS; PIG OOCYTES; INHIBITION; ACTIVATION; CALCIUM; H2S; CARDIOPROTECTION; SULFHYDRATION	Porcine oocytes that have matured in in vitro conditions undergo the process of aging during prolonged cultivation, which is manifested by spontaneous parthenogenetic activation, lysis or fragmentation of aged oocytes. This study focused on the role of hydrogen sulfide (H2S) in the process of porcine oocyte aging. H2S is a gaseous signaling molecule and is produced endogenously by the enzymes cystathionine-beta-synthase (CBS), cystathionine-gamma-lyase (CSE) and 3-mercaptopyruvate sulfurtransferase (MPST). We demonstrated that H2S-producing enzymes are active in porcine oocytes and that a statistically significant decline in endogenous H2S production occurs during the first day of aging. Inhibition of these enzymes accelerates signs of aging in oocytes and significantly increases the ratio of fragmented oocytes. The presence of exogenous H2S from a donor (Na2S.9H(2)O) significantly suppressed the manifestations of aging, reversed the effects of inhibitors and resulted in the complete suppression of oocyte fragmentation. Cultivation of aging oocytes in the presence of H2S donor positively affected their subsequent embryonic development following parthenogenetic activation. Although no unambiguous effects of exogenous H2S on MPF and MAPK activities were detected and the intracellular mechanism underlying H2S activity remains unclear, our study clearly demonstrates the role of H2S in the regulation of porcine oocyte aging.	[Krejcova, Tereza; Smelcova, Miroslava; Sedmikova, Marketa; Nevoral, Jan; Dvorakova, Marketa; Vyskocilova, Alena; Weingartova, Ivona; Kucerova-Chrpova, Veronika; Chmelikova, Eva; Tumova, Lenka; Jilek, Frantisek] Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources, Dept Vet Sci, Prague, Czech Republic; [Petr, Jaroslav] Inst Anim Sci, Prague, Czech Republic; [Bodart, Jean-Francois] Univ Lille 1, Lab Regulat Signaux Div EA 4479, F-59655 Villeneuve Dascq, France	Czech University of Life Sciences Prague; Czech Research Institute of Animal Science; Universite de Lille - ISITE; Universite de Lille	Sedmikova, M (corresponding author), Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources, Dept Vet Sci, Prague, Czech Republic.	sedmikova@af.czu.cz	Chmelíková, Eva/W-8338-2018; Krejcova, Tereza/AAX-1542-2021; Bodart, Jean-François Laurent/AAZ-2075-2021; Sedmíková, Markéta/B-5768-2018	Chmelíková, Eva/0000-0001-8022-2794; Bodart, Jean-François Laurent/0000-0002-6113-7700; Sedmíková, Markéta/0000-0003-0947-4256; Krejcova, Tereza/0000-0001-5840-9499	Ministry of Agriculture of the Czech Republic (NAZV-Project) [QI101A166, MZeRO 0714]; Internal Grant Agency of the Czech University of Life Sciences Prague (CIGA) [CZU20142049]	Ministry of Agriculture of the Czech Republic (NAZV-Project); Internal Grant Agency of the Czech University of Life Sciences Prague (CIGA)	This work was supported by the Ministry of Agriculture of the Czech Republic (NAZV-Project No. QI101A166, MZeRO 0714) and by the Internal Grant Agency of the Czech University of Life Sciences Prague (CIGA) (Project No. CZU20142049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Bian JS, 2006, J PHARMACOL EXP THER, V316, P670, DOI 10.1124/jpet.105.092023; Carson RJ, 2010, EXPERT REV OBSTET GY, V5, P203, DOI [DOI 10.1586/E0G.10.5, 10.1586/eog.10.5]; Du Pasquier D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023672; Elsey DJ, 2010, CELL BIOCHEM FUNCT, V28, P95, DOI 10.1002/cbf.1618; Fang LP, 2009, J HYPERTENS, V27, P2174, DOI 10.1097/HJH.0b013e328330a900; Gadalla MM, 2010, J NEUROCHEM, V113, P14, DOI 10.1111/j.1471-4159.2010.06580.x; Guzman MA, 2006, HUM MOL GENET, V15, P3168, DOI 10.1093/hmg/ddl393; Jeseta M, 2008, ZYGOTE, V16, P145, DOI 10.1017/S0967199408004668; Jeseta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041509; Jiang GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028996; Jilek F, 2001, REPROD DOMEST ANIM, V36, P139, DOI 10.1046/j.1439-0531.2001.d01-27.x; Kikuchi K, 2000, BIOL REPROD, V63, P715, DOI 10.1095/biolreprod63.3.715; Kikuchi Kazuhiro, 2002, Cloning and Stem Cells, V4, P211, DOI 10.1089/15362300260339494; KLINE D, 1992, DEV BIOL, V149, P80, DOI 10.1016/0012-1606(92)90265-I; Li CS, 2014, MOL MED REP, V9, P2467, DOI 10.3892/mmr.2014.2111; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Liang R, 2007, REPROD TOXICOL, V24, P89, DOI 10.1016/j.reprotox.2007.04.002; Liang R, 2006, CHINESE MED J-PEKING, V119, P1877, DOI 10.1097/00029330-200611020-00006; Liang XW, 2012, SCI CHINA LIFE SCI, V55, P670, DOI 10.1007/s11427-012-4354-3; Lowicka E, 2007, PHARMACOL REP, V59, P4; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Nevoral J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099613; Pan TT, 2006, J MOL CELL CARDIOL, V40, P119, DOI 10.1016/j.yjmcc.2005.10.003; Patel P, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-10; Perez GI, 1999, MOL HUM REPROD, V5, P414, DOI 10.1093/molehr/5.5.414; Petrova I, 2004, CZECH J ANIM SCI, V49, P93, DOI 10.17221/4285-CJAS; Petrova I, 2009, J REPROD DEVELOP, V55, P75, DOI 10.1262/jrd.20061; PETTERS RM, 1993, J REPROD FERTIL, P61; Rinaldi L, 2006, LAB INVEST, V86, P391, DOI 10.1038/labinvest.3700391; Sadler KC, 2004, MOL REPROD DEV, V67, P366, DOI 10.1002/mrd.20023; Sedmikova M, 2013, CZECH J ANIM SCI, V58, P535, DOI 10.17221/7088-CJAS; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Smelcova M., 2011, Scientia Agriculturae Bohemica, V42, P188; Srilatha B, 2009, J SEX MED, V6, P1875, DOI 10.1111/j.1743-6109.2009.01291.x; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Tang GH, 2010, CLIN EXP PHARMACOL P, V37, P753, DOI 10.1111/j.1440-1681.2010.05351.x; VITULLO AD, 1992, DEV BIOL, V151, P128, DOI 10.1016/0012-1606(92)90220-B; Wang Q, 2007, REPROD FERT DEVELOP, V19, P1, DOI 10.1071/RD06103; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Whitaker M, 1996, Rev Reprod, V1, P127, DOI 10.1530/ror.0.0010127; Wilcox AJ, 1998, HUM REPROD, V13, P394, DOI 10.1093/humrep/13.2.394; XU Z, 1994, DEVELOPMENT, V120, P1851; Yang GD, 2004, FASEB J, V18, P1782, DOI 10.1096/fj.04-2279fje; Yang Guang-Dong, 2007, Shengli Xuebao, V59, P133; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhang JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064304; Zhao KX, 2014, EMBO REP, V15, P792, DOI 10.1002/embr.201338213; Zhao Y, 2013, ACS CHEM BIOL, V8, P1283, DOI 10.1021/cb400090d	50	9	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116964	10.1371/journal.pone.0116964	http://dx.doi.org/10.1371/journal.pone.0116964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615598	gold, Green Published, Green Submitted			2022-12-26	WOS:000349122100050
J	Ferdinandus; Arai, S; Ishiwata, S; Suzuki, M; Sato, H				Ferdinandus; Arai, Satoshi; Ishiwata, Shin'ichi; Suzuki, Madoka; Sato, Hirotaka			Oral Dosing of Chemical Indicators for In Vivo Monitoring of Ca2+ Dynamics in Insect Muscle	PLOS ONE			English	Article							REMOTE RADIO CONTROL; FREE-FLIGHT; MEMBRANE-POTENTIALS; IMAGING CALCIUM; NEURONS; TRANSMISSION; LOCUST; ELECTROPHYSIOLOGY; DIBAC(4)(3); HAWKMOTH	This paper proposes a remarkably facile staining protocol to visually investigate dynamic physiological events in insect tissues. We attempted to monitor Ca2+ dynamics during contraction of electrically stimulated living muscle. Advances in circuit miniaturization and insect neuromuscular physiology have enabled the hybridization of living insects and man-made electronic components, such as microcomputers, the result of which has been often referred as a Living Machine, Biohybrid, or Cyborg Insect. In order for Cyborg Insects to be of practical use, electrical stimulation parameters need to be optimized to induce desired muscle response (motor action) and minimize the damage in the muscle due to the electrical stimuli. Staining tissues and organs as well as measuring the dynamics of chemicals of interest in muscle should be conducted to quantitatively and systematically evaluate the effect of various stimulation parameters on the muscle response. However, existing staining processes require invasive surgery and/or arduous procedures using genetically encoded sensors. In this study, we developed a non-invasive and remarkably facile method for staining, in which chemical indicators can be orally administered (oral dosing). A chemical Ca2+ indicator was orally introduced into an insect of interest via food containing the chemical indicator and the indicator diffused from the insect digestion system to the target muscle tissue. We found that there was a positive relationship between the fluorescence intensity of the indicator and the frequency of electrical stimulation which indicates the orally dosed indicator successfully monitored Ca2+ dynamics in the muscle tissue. This oral dosing method has a potential to globally stain tissues including neurons, and investigating various physiological events in insects.	[Ferdinandus; Sato, Hirotaka] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore; [Arai, Satoshi; Ishiwata, Shin'ichi; Suzuki, Madoka] WASEDA Biosci Res Inst Singapore WABIOS, Singapore, Singapore; [Ishiwata, Shin'ichi; Suzuki, Madoka] Waseda Univ, Org Univ Res Initiat, Tokyo, Japan; [Ishiwata, Shin'ichi] Waseda Univ, Dept Phys, Fac Sci & Engn, Tokyo 169, Japan	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Waseda University; Waseda University	Sato, H (corresponding author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.	hirosato@ntu.edu.sg	Sato, Hirotaka/D-5203-2014; ARAI, SATOSHI/L-6709-2018; Suzuki, Madoka/E-5420-2013	Sato, Hirotaka/0000-0003-4634-1639; ARAI, SATOSHI/0000-0003-4807-8248; Suzuki, Madoka/0000-0002-3270-1755; , Ferdinandus/0000-0002-7197-3841	Nanyang Assistant Professorship (NAP) [M4080740]; Agency for Science, Technology and Research (A<INF>*</INF>STAR) Public Sector Research Funding (PSF) [M4070190]; A*STAR-JST (The Japan Science and Technology Agency) joint grant [M4070198]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [2306]	Nanyang Assistant Professorship (NAP); Agency for Science, Technology and Research (A<INF>*</INF>STAR) Public Sector Research Funding (PSF); A*STAR-JST (The Japan Science and Technology Agency) joint grant; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This material is based on the work supported by Nanyang Assistant Professorship (NAP, No. M4080740, http://www3.ntu.edu.sg/NAP/index.html) awarded to HS, Agency for Science, Technology and Research (A<INF>*</INF>STAR) Public Sector Research Funding (PSF, No. M4070190) awarded to HS, and A<INF>*</INF>STAR-JST (The Japan Science and Technology Agency) joint grant (No. M4070198) awarded to HS, and a Grant-in-Aid for Scientific Research on Innovative Areas "Nanomedicine Molecular Science" from Ministry of Education, Culture, Sports, Science, and Technology of Japan (No. 2306, http://www.mext.go.jp/english/) awarded to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAT Bioquest Inc, 2013, PHYSIOLOGICAL PROBES; Adrian ED, 1912, J PHYSIOL-LONDON, V44, P68; Ando N, 2004, ZOOL SCI, V21, P123, DOI 10.2108/zsj.21.123; Ando N, 2002, J NEUROSCI METH, V115, P181, DOI 10.1016/S0165-0270(02)00013-4; [Anonymous], 2010, MOL PROBES HDB A GUI, P664; Bozkurt A, 2009, IEEE T BIO-MED ENG, V56, P2304, DOI 10.1109/TBME.2009.2022551; Bozkurt A, 2009, IEEE T BIO-MED ENG, V56, P1727, DOI 10.1109/TBME.2009.2015460; BRAUNER T, 1984, BIOCHIM BIOPHYS ACTA, V771, P208, DOI 10.1016/0005-2736(84)90535-2; Cao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105389; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; CORNELIUS F, 1982, J GEN PHYSIOL, V79, P821, DOI 10.1085/jgp.79.5.821; Daly DC, 2010, IEEE J SOLID-ST CIRC, V45, P153, DOI 10.1109/JSSC.2009.2034433; EPPS DE, 1994, CHEM PHYS LIPIDS, V69, P137, DOI 10.1016/0009-3084(94)90035-3; Falk S, 2009, NEUROSCI LETT, V450, P229, DOI 10.1016/j.neulet.2008.11.042; Fischer H, 1996, J NEUROSCI METH, V64, P39, DOI 10.1016/0165-0270(95)00083-6; Fischer H, 1999, J EXP BIOL, V202, P711; Fox JL, 2010, P NATL ACAD SCI USA, V107, P3840, DOI 10.1073/pnas.0912548107; Galizia CG, 2004, J COMP PHYSIOL A, V190, P21, DOI 10.1007/s00359-003-0469-0; Garaschuk O, 2007, CELL CALCIUM, V42, P351, DOI 10.1016/j.ceca.2007.02.011; Georgakoudi I, 2002, CANCER RES, V62, P682; Gonzalez JE, 1999, DRUG DISCOV TODAY, V4, P431, DOI 10.1016/S1359-6446(99)01383-5; Gordon S, 2006, P NATL ACAD SCI USA, V103, P4311, DOI 10.1073/pnas.0510109103; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Gross M, 2013, CURR BIOL, V23, pR821, DOI 10.1016/j.cub.2013.09.004; Guschlbauer C, 2007, J EXP BIOL, V210, P1092, DOI 10.1242/jeb.02729; Hinterwirth AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052725; Holzer R., 1997, Proceedings of the 1997 IEEE/RSJ International Conference on Intelligent Robot and Systems. Innovative Robotics for Real-World Applications. IROS '97 (Cat. No.97CH36108), P1514, DOI 10.1109/IROS.1997.656559; Houdebine LM, 2002, J BIOTECHNOL, V98, P145, DOI 10.1016/S0168-1656(02)00129-3; Huang M, 2007, ANN BIOMED ENG, V35, P1276, DOI 10.1007/s10439-007-9265-2; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; KUBIN RF, 1982, J LUMIN, V27, P455, DOI 10.1016/0022-2313(82)90045-X; KUTSCH W, 1993, J EXP BIOL, V185, P367; Maharbiz MM, 2010, SCI AM, V303, P94, DOI 10.1038/scientificamerican1210-94; Martin JP, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00159; MAY TE, 1979, J INSECT PHYSIOL, V25, P169, DOI 10.1016/0022-1910(79)90096-9; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Namiki S, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.001.2008; ORCHARD I, 1986, J NEUROBIOL, V17, P359, DOI 10.1002/neu.480170502; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; Piegari E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095860; Plasek J, 1996, J PHOTOCH PHOTOBIO B, V33, P101, DOI 10.1016/1011-1344(96)07283-1; RONOT X, 1986, BIOL CELL, V57, P1; Russell JT, 2011, BRIT J PHARMACOL, V163, P1605, DOI 10.1111/j.1476-5381.2010.00988.x; Sato H, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00199; Sato H, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.024.2009; SZENTGYORGYI AG, 1975, BIOPHYS J, V15, P707, DOI 10.1016/S0006-3495(75)85849-8; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Titushkin IA, 2004, IEEE T PLASMA SCI, V32, P1614, DOI 10.1109/TPS.2004.832625; Tsang WM, 2010, IEEE T BIO-MED ENG, V57, P1757, DOI 10.1109/TBME.2010.2041778; VonSteyern FV, 1996, J HISTOCHEM CYTOCHEM, V44, P267, DOI 10.1177/44.3.8648087; Wang HZ, 2008, J EXP BIOL, V211, P423, DOI 10.1242/jeb.011791; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Webb B, 2004, ARTHROPOD STRUCT DEV, V33, P301, DOI 10.1016/j.asd.2004.05.009; Westneat MW, 2003, SCIENCE, V299, P558, DOI 10.1126/science.1078008; Yamada A, 2001, JPN J PHARMACOL, V86, P342, DOI 10.1254/jjp.86.342	57	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116655	10.1371/journal.pone.0116655	http://dx.doi.org/10.1371/journal.pone.0116655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590329	gold, Green Published			2022-12-26	WOS:000350679400019
J	Barton, R; Palacio, D; Iovine, MK; Berger, BW				Barton, Rachael; Palacio, Danica; Iovine, M. Kathryn; Berger, Bryan W.			A Cytosolic Juxtamembrane Interface Modulates Plexin A3 Oligomerization and Signal Transduction	PLOS ONE			English	Article							AXON GUIDANCE; SEMAPHORINS; RECEPTORS; TRANSMEMBRANE; ZEBRAFISH; PROTEINS; REVEALS; GTPASES; DESIGN; CANCER	Plexins (plxns) are transmembrane (TM) receptors involved in the guidance of vascular, lymphatic vessel, and neuron growth as well as cancer metastasis. Plxn signaling results in cytosolic GTPase-activating protein activity, and previous research implicates dimerization as important for activation of plxn signaling. Purified, soluble plxn extracellular and cytosolic domains exhibit only weak homomeric interactions, suggesting a role for the plxn TM and juxtamembrane regions in homooligomerization. In this study, we consider a heptad repeat in the Danio rerio PlxnA3 cytosolic juxtamembrane domain (JM) for its ability to influence PlxnA3 homooligomerization in TM-domain containing constructs. Site-directed mutagenesis in conjunction with the AraTM assay and bioluminescent energy transfer (BRET2) suggest an interface involving a JM heptad repeat, in particular residue M1281, regulates PlxnA3 homomeric interactions when examined in constructs containing an ectodomain, TM and JM domain. In the presence of a neuropilin-2a co-receptor and semaphorin 3F ligand, disruption to PlxnA3 homodimerization caused by an M1281F mutation is eliminated, suggesting destabilization of the PlxnA3 homodimer in the JM is not sufficient to disrupt co-receptor complex formation. In contrast, enhanced homodimerization of PlxnA3 caused by mutation M1281L remains even in the presence of ligand semaphorin 3F and co-receptor neuropilin-2a. Consistent with this pattern of PlxnA3 dimerization in the presence of ligand and co-receptor, destabilizing mutations to PlxnA3 homodimerization (M1281F) are able to rescue motor patterning defects in sidetracked zebrafish embryos, whereas mutations that enhance PlxnA3 homodimerization (M1281L) are not. Collectively, our results indicate the JM heptad repeat, in particular residue M1281, forms a switchable interface that modulates both PlxnA3 homomeric interactions and signal transduction.	[Barton, Rachael; Berger, Bryan W.] Lehigh Univ, Dept Chem & Biomol Engn, Bethlehem, PA 18015 USA; [Palacio, Danica; Iovine, M. Kathryn] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Berger, Bryan W.] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA	Lehigh University; Lehigh University; Lehigh University	Berger, BW (corresponding author), Lehigh Univ, Dept Chem & Biomol Engn, Bethlehem, PA 18015 USA.	berger@lehigh.edu	Berger, Bryan/D-7985-2014	Berger, Bryan/0000-0002-6135-8677	National Science Foundation [CBET-1227924]; National Institutes of Health [R03 HD070172]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD070172] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1227924] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Funding provided by National Science Foundation (CBET-1227924) to BWB and National Institutes of Health (R03 HD070172) to MKI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aci-Seche S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097779; Balakrishnan A, 2009, HUM MUTAT, V30, P1167, DOI 10.1002/humu.21017; Bell CH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001134; Berger BW, 2010, P NATL ACAD SCI USA, V107, P703, DOI 10.1073/pnas.0910873107; Birely J, 2005, DEV BIOL, V280, P162, DOI 10.1016/j.ydbio.2005.01.012; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; Cirino Patrick C, 2003, Methods Mol Biol, V231, P3; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Feldner J, 2007, J NEUROSCI, V27, P4978, DOI 10.1523/JNEUROSCI.1132-07.2007; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; He HW, 2009, P NATL ACAD SCI USA, V106, P15610, DOI 10.1073/pnas.0906923106; Janssen BJC, 2012, NAT STRUCT MOL BIOL, V19, P1293, DOI 10.1038/nsmb.2416; Janssen BJC, 2010, NATURE, V467, P1118, DOI 10.1038/nature09468; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Negishi M, 2005, CELL MOL LIFE SCI, V62, P1363, DOI 10.1007/s00018-005-5018-2; Palaisa KA, 2007, DEVELOPMENT, V134, P3251, DOI 10.1242/dev.007112; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Roney K, 2013, PROTEIN CELL, V4, P17, DOI 10.1007/s13238-012-2108-4; Su PC, 2012, J BIOL CHEM, V287, P31515, DOI 10.1074/jbc.M112.396895; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Ton QV, 2012, DEV BIOL, V366, P195, DOI 10.1016/j.ydbio.2012.03.020; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Tong YF, 2009, J BIOL CHEM, V284, P35962, DOI 10.1074/jbc.M109.056275; Wang YX, 2013, ELIFE, V2, DOI 10.7554/eLife.01279; WANG YX, 2012, SCI SIGNAL, V5, DOI DOI 10.1126/SCISIGNAL; Wong OGW, 2007, P NATL ACAD SCI USA, V104, P19040, DOI 10.1073/pnas.0702544104; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Xiang X, 2012, NEUROSCI LETT, V530, P127, DOI 10.1016/j.neulet.2012.09.058; Zanata SM, 2002, J NEUROSCI, V22, P471, DOI 10.1523/JNEUROSCI.22-02-00471.2002	35	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2015	10	1							e0116368	10.1371/journal.pone.0116368	http://dx.doi.org/10.1371/journal.pone.0116368			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BS	25565389	Green Submitted, Green Published, gold			2022-12-26	WOS:000348167900005
J	Gomes, LR; Vessoni, AT; Menck, CFM				Gomes, L. R.; Vessoni, A. T.; Menck, C. F. M.			Three-dimensional microenvironment confers enhanced sensitivity to doxorubicin by reducing p53-dependent induction of autophagy	ONCOGENE			English	Article							BREAST-CANCER; CULTURE MODELS; DNA-DAMAGE; CELLS; INHIBITION; P53; EPIRUBICIN; MECHANISMS; APOPTOSIS; SUBTYPES	Preclinical studies of anticancer drugs are typically performed using cancer cell lines maintained in two-dimensional (2D) cultures, ignoring the influences of the extracellular matrix (ECM) and three-dimensional (3D) microenvironment. In this study, we evaluated the microenvironmental control of human breast cancer cells responses to doxorubicin (DOXO) using the 3D laminin-rich ECM (3D lrECM) cell culture model. Under 3D culture conditions, MCF-7 cells displayed drastic morphological alterations, a decrease in proliferation and elevated sensitivity to DOXO. Interestingly, the chemotherapy-mediated activation of autophagy was compromised in the 3D matrix, suggesting an association between the increased cytotoxicity of DOXO and hindered autophagy induction. Indeed, while chloroquine or ATG5 knockdown potentiated DOXO-induced cell death under the 2D culture conditions, the autophagy inducer rapamycin improved the resistance of 3D-cultured cells to this drug. Moreover, in the monolayer-cultured cells, DOXO treatment led to increases in p53 and DRAM-1 expression, which is a p53-dependent activator of autophagy that functions in response to DNA damage. Conversely, p53 and DRAM-1 expression was impaired in 3D-cultured cells. The knockdown of p53 by shRNA blocked DRAM-1 activation, impaired autophagy induction and sensitized only those cells maintained under 2D conditions to DOXO. In addition, 2D-cultured MDA-MB-231 cells (a p53-mutated breast cancer cell line) not only showed increased sensitivity to DOXO compared with MCF-7 cells but also failed to induce DRAM-1 expression or autophagy. Similar to p53 silencing, DRAM-1 knockdown potentiated DOXO cytotoxicity only in 2D-cultured cells. These results suggest that the 3D tissue microenvironment controls tumor cell sensitivity to DOXO treatment by preventing p53-DRAM-autophagy axis activation.	[Gomes, L. R.; Vessoni, A. T.; Menck, C. F. M.] Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Sao Paulo, Brazil	Universidade de Sao Paulo	Menck, CFM (corresponding author), Inst Ciencias Biomed 2, Ave Prof Lineu Prestes 1374, BR-05508900 Sao Paulo, Brazil.	cfmmenck@usp.br	Vessoni, Alexandre T/L-5754-2013; Menck, Carlos FM/G-6321-2011; Gomes, Luciana R/M-3056-2014	Vessoni, Alexandre T/0000-0001-9170-5185; Menck, Carlos FM/0000-0003-1941-0694; 	FAPESP (Sao Paulo, Brazil); CAPES; CNPq (Brasilia, Brazil)	FAPESP (Sao Paulo, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Brasilia, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We thank Professor Maria S. Solengas (Department of Dermatology, University of Michigan Comprehensive Cancer Center) for kindly providing the pEGFP-LC3 construct. We are grateful for the excellent technical assistance provided by the Core Facility for Scientific Research-USP (CEFAP-USP) in conducting the confocal fluorescence microscopy assays. This work was supported by FAPESP (Sao Paulo, Brazil), CAPES and CNPq (Brasilia, Brazil).	Ahn JH, 2011, CANCER LETT, V310, P188, DOI 10.1016/j.canlet.2011.06.034; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Batista LFZ, 2007, CANCER RES, V67, P11886, DOI 10.1158/0008-5472.CAN-07-2964; Beckta JM, 2014, CELL CYCLE, V13, P710, DOI 10.4161/cc.28108; Bertheau P, 2013, BREAST, V22, pS27, DOI 10.1016/j.breast.2013.07.005; Bhana S, 2008, MUTAGENESIS, V23, P43, DOI 10.1093/mutage/gem041; Bissell MJ, 1999, CANCER RES, V59, p1757S; Bramwell VHC, 2002, CLIN CANCER RES, V8, P383; Bristol ML, 2013, J PHARMACOL EXP THER, V344, P544, DOI 10.1124/jpet.112.199802; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Cheng YJ, 2008, INT J CANCER, V123, P1278, DOI 10.1002/ijc.23592; Cortat B, 2013, PHOTOCH PHOTOBIO SCI, V12, P1483, DOI 10.1039/c3pp50023c; Crighton D, 2007, AUTOPHAGY, V3, P72, DOI 10.4161/auto.3438; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Debnath J, 2008, AUTOPHAGY, V4, P351, DOI 10.4161/auto.5523; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; do Amaral JB, 2011, TISSUE ENG PART C-ME, V17, P1097, DOI 10.1089/ten.tec.2011.0260; Edick MJ, 2007, MOL BIOL CELL, V18, P2481, DOI 10.1091/mbc.E06-04-0261; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Ghavami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016523; Gomes LR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-26; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Jackson JG, 2012, CANCER CELL, V21, P793, DOI 10.1016/j.ccr.2012.04.027; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Khasraw M, 2012, BREAST, V21, P142, DOI 10.1016/j.breast.2011.12.012; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045058; Li QW, 2010, J PHARMACOL EXP THER, V332, P821, DOI 10.1124/jpet.109.160390; Liang B, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-213; Lock R, 2008, CURR OPIN CELL BIOL, V20, P583, DOI 10.1016/j.ceb.2008.05.002; Manov I, 2011, FEBS J, V278, P3494, DOI 10.1111/j.1742-4658.2011.08271.x; Mathew R, 2011, COLD SH Q B, V76, P389, DOI 10.1101/sqb.2012.76.011015; Maycotte P, 2014, CANCER RES, V74, P2579, DOI 10.1158/0008-5472.CAN-13-3470; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mohan P, 2010, MOL PHARMACEUT, V7, P1959, DOI 10.1021/mp100269f; Moraes MCS, 2012, CANCER LETT, V314, P108, DOI 10.1016/j.canlet.2011.09.019; Novaro V, 2003, J CELL SCI, V116, P2975, DOI 10.1242/jcs.00523; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Quinet A, 2014, DNA REPAIR, V14, P27, DOI 10.1016/j.dnarep.2013.12.005; Scherz-Shouval R, 2010, P NATL ACAD SCI USA, V107, P18511, DOI 10.1073/pnas.1006124107; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Selvakumaran M, 2013, CLIN CANCER RES, V19, P2995, DOI 10.1158/1078-0432.CCR-12-1542; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Sun WL, 2011, AUTOPHAGY, V7, P1035, DOI 10.4161/auto.7.9.16521; Swenson CE, 2003, ANTI-CANCER DRUG, V14, P239, DOI 10.1097/00001813-200303000-00008; Tasdemir E, 2008, AUTOPHAGY, V4, P810, DOI 10.4161/auto.6486; Tuloup-Minguez V, 2011, AUTOPHAGY, V7, P27, DOI 10.4161/auto.7.1.13851; Valbuena A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017320; Velez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018005; Weaver VM, 1999, J MAMMARY GLAND BIOL, V4, P193, DOI 10.1023/A:1018781325716; Woodley-Cook J, 2006, MOL CANCER THER, V5, P3303, DOI 10.1158/1535-7163.MCT-06-0154	56	36	36	0	24	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 16	2015	34	42					5329	5340		10.1038/onc.2014.461	http://dx.doi.org/10.1038/onc.2014.461			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU4EI	25619836				2022-12-26	WOS:000363479200003
J	Topolska-Wos, AM; Shell, SM; Kilanczyk, E; Szczepanowski, RH; Chazin, WJ; Filipek, A				Topolska-Wos, Agnieszka M.; Shell, Steven M.; Kilanczyk, Ewa; Szczepanowski, Roman H.; Chazin, Walter J.; Filipek, Anna			Dimerization and phosphatase activity of calcyclin-binding protein/Siah-1 interacting protein: the influence of oxidative stress	FASEB JOURNAL			English	Article						CacyBP; SIP; ERK1/2; MAPK phosphatase; protein structure; NB2a cells	STRUCTURAL-ANALYSIS; SOLUTION SCATTERING; ALZHEIMERS-DISEASE; NEUROBLASTOMA NB2A; SELF-ASSOCIATION; BETA-CATENIN; CACYBP/SIP; CELLS; SIAH-1; TARGET	CacyBP/SIP [calcyclin-binding protein/Siah-1 [seven in absentia homolog 1 (Siah E3 ubiquitin protein ligase 1)] interacting protein] is a multifunctional protein whose activity includes acting as an ERK1/2 phosphatase. We analyzed dimerization of mouse CacyBP/SIP in vitro and in mouse neuroblastoma cell line (NB2a) cells, as well as the structure of a full-length protein. Moreover, we searched for the CacyBP/SIP domain important for dimerization and dephosphorylation of ERK2, and we analyzed the role of dimerization in ERK1/2 signaling in NB2a cells. Cell-based assays showed that CacyBP/SIP forms a homodimer in NB2a cell lysate, and biophysical methods demonstrated that CacyBP/SIP forms a stable dimer in vitro. Data obtained using small-angle X-ray scattering supported a model in which CacyBP/SIP occupies an anti-parallel orientation mediated by the N-terminal dimerization domain. Site-directed mutagenesis established that the N-terminal domain is indispensable for full phosphatase activity of CacyBP/SIP. We also demonstrated that the oligomerization state of CacyBP/SIP as well as the level of post-translational modifications and subcellular distribution of CacyBP/SIP change after activation of the ERK1/2 pathway in NB2a cells due to oxidative stress. Together, our results suggest that dimerization is important for controlling phosphatase activity of CacyBP/SIP and for regulating the ERK1/2 signaling pathway.Topolska-Wo, A. M., Shell, S. M., Kilaczyk, E., Szczepanowski, R. H., Chazin, W. J., Filipek, A. Dimerization and phosphatase activity of calcyclin-binding protein/Siah-1 interacting protein: the influence of oxidative stress.	[Topolska-Wos, Agnieszka M.; Kilanczyk, Ewa; Filipek, Anna] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland; [Topolska-Wos, Agnieszka M.; Shell, Steven M.; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37235 USA; [Szczepanowski, Roman H.] Int Inst Mol & Cell Biol, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Vanderbilt University; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Filipek, A (corresponding author), Nencki Inst Expt Biol, 3 Pasteur St, PL-02093 Warsaw, Poland.	walter.j.chazin@vanderbilt.edu; a.filipek@nencki.gov.pl	Kilanczyk, Ewa/C-8209-2018	Kilanczyk, Ewa/0000-0003-4560-0723; Filipek, Anna/0000-0001-9484-9555	European Union [MPD4-502]; U.S. National Institutes of Health, National Institute of General Medical Sciences [R01-GM075156]; National Science Centre Grant [NZ1/00595]; Nencki Institute of Experimental Biology; American Cancer Society [119569-PF-11-271-01-DMC]; U.S. Department of Energy (DOE) program Integrated Diffraction Analysis Technologies (IDAT); European Union - the European Regional Development Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075156] Funding Source: NIH RePORTER	European Union(European Commission); U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Centre Grant(National Science Centre, Poland); Nencki Institute of Experimental Biology; American Cancer Society(American Cancer Society); U.S. Department of Energy (DOE) program Integrated Diffraction Analysis Technologies (IDAT)(United States Department of Energy (DOE)); European Union - the European Regional Development Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. U. Wasik (Nencki Institute of Experimental Biology, Warsaw, Poland) for help with pET28 CacyBP/SIP S22D/T23D plasmid preparation and Prof. A. Dziembowski (Institute of Biochemistry and Biophysics, Warsaw) for equipment support. This work was supported by the European Union through the European Regional Developmental Funds within the scope of the International PhD Studies in Neurobiology MPD4-502 (to A.M.T.W.), U.S. National Institutes of Health, National Institute of General Medical Sciences Grant R01-GM075156 (to W.J.C.), National Science Centre Grant NZ1/00595 (to A.F.), and by statutory funds from the Nencki Institute of Experimental Biology (Warsaw, Poland). S.M.S. is supported by Postdoctoral Fellowship 119569-PF-11-271-01-DMC from the American Cancer Society. The X-ray scattering technology and applications to the determination of macromolecular shapes and conformations were performed at the SIBYLS beamline (12.3.1) at the Advanced Light Source, Lawrence Berkeley National Laboratory, U.S. Department of Energy (DOE) program Integrated Diffraction Analysis Technologies (IDAT). Project subject carried out with use of Centre for Preclinical Research and Technology (CePT) infrastructure financed by the European Union - the European Regional Development Fund within the Operational Programme "Innovative Economy" for 2007-2013.	Behl C, 1999, PROG NEUROBIOL, V57, P301, DOI 10.1016/S0301-0082(98)00055-0; Bhattacharya S, 2005, BIOCHEMISTRY-US, V44, P9462, DOI 10.1021/bi0502689; Brosey CA, 2013, NUCLEIC ACIDS RES, V41, P2313, DOI 10.1093/nar/gks1332; Dimitrova YN, 2010, J BIOL CHEM, V285, P13507, DOI 10.1074/jbc.M109.049411; Filipek A, 1998, J NEUROCHEM, V70, P1793, DOI 10.1046/j.1471-4159.1998.70051793.x; Filipek A, 1996, BIOCHEM J, V320, P585, DOI 10.1042/bj3200585; Filipek A, 2002, J BIOL CHEM, V277, P21103, DOI 10.1074/jbc.M111010200; Filipek A, 2002, J BIOL CHEM, V277, P28848, DOI 10.1074/jbc.M203602200; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gullberg M., 2009, NAT METHODS, V6, P686, DOI [10.1038/nmeth.f.267, DOI 10.1038/NMETH.F.267]; Jastrzebska B, 2000, J HISTOCHEM CYTOCHEM, V48, P1195, DOI 10.1177/002215540004800903; Johs A, 2011, J MOL BIOL, V413, P639, DOI 10.1016/j.jmb.2011.08.042; Jurewicz E, 2013, BBA-MOL CELL RES, V1833, P761, DOI 10.1016/j.bbamcr.2012.12.010; Kilanczyk E, 2012, BIOCHEM CELL BIOL, V90, P558, DOI [10.1139/O2012-011, 10.1139/o2012-011]; Kilanczyk E, 2011, BIOCHEM BIOPH RES CO, V404, P179, DOI 10.1016/j.bbrc.2010.11.088; Kilanczyk E, 2009, BIOCHEM BIOPH RES CO, V380, P54, DOI 10.1016/j.bbrc.2009.01.026; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee YT, 2008, BIOCHEMISTRY-US, V47, P10921, DOI 10.1021/bi801233z; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Luque-Contreras D, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/497802; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Matsuzawa S, 2003, J BIOL CHEM, V278, P1837, DOI 10.1074/jbc.M210263200; Nyarko A, 2007, BIOCHEMISTRY-US, V46, P11331, DOI 10.1021/bi700735t; Peart JR, 2002, P NATL ACAD SCI USA, V99, P10865, DOI 10.1073/pnas.152330599; Pretto DI, 2010, BIOCHEMISTRY-US, V49, P2880, DOI 10.1021/bi9019934; Ruffels J, 2004, EUR J PHARMACOL, V483, P163, DOI 10.1016/j.ejphar.2003.10.032; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Santelli E, 2005, J BIOL CHEM, V280, P34278, DOI 10.1074/jbc.M506707200; Schneider G, 2007, BBA-MOL CELL RES, V1773, P1628, DOI 10.1016/j.bbamcr.2007.07.013; Schneider G, 2010, BBA-MOL CELL RES, V1803, P1308, DOI 10.1016/j.bbamcr.2010.07.003; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Taube M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093313; Wasik U, 2013, NEUROBIOL AGING, V34, P1380, DOI 10.1016/j.neurobiolaging.2012.11.007; Wu J, 2003, J BIOCHEM MOL BIOL, V36, P354	39	16	16	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1711	1724		10.1096/fj.14-264770	http://dx.doi.org/10.1096/fj.14-264770			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25609429	Green Published			2022-12-26	WOS:000354114600010
J	Lin, WC; Zhang, ZQ; Xu, ZC; Wang, B; Li, XQ; Cao, H; Wang, YQ; Zheng, SJJ				Lin, Wencheng; Zhang, Zhiqiang; Xu, Zhichao; Wang, Bin; Li, Xiaoqi; Cao, Hong; Wang, Yongqiang; Zheng, Shijun J.			The Association of Receptor of Activated Protein Kinase C 1(RACK1) with Infectious Bursal Disease Virus Viral Protein VP5 and Voltage-dependent Anion Channel 2 (VDAC2) Inhibits Apoptosis and Enhances Viral Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAFFOLDING PROTEIN; SIGNALING PATHWAY; RACK1 INTERACTS; NONSTRUCTURAL PROTEIN; CELL APOPTOSIS; HOST-CELLS; LIFE-CYCLE; IN-VITRO; CLONING; GENOME	Infectious bursal disease (IBD) is an acute, highly contagious, and immunosuppressive avian disease caused by IBD virus (IBDV). Our previous report indicates that IBDV VP5 induces apoptosis via interaction with voltage-dependent anion channel 2 (VDAC2). However, the underlying molecular mechanism is still unclear. We report here that receptor of activated protein kinase C 1 (RACK1) interacts with both VDAC2 and VP5 and that they could form a complex. We found that overexpression of RACK1 inhibited IBDV-induced apoptosis in DF-1 cells and that knockdown of RACK1 by small interfering RNA induced apoptosis associated with activation of caspases 9 and 3 and suppressed IBDV growth. These results indicate that RACK1 plays an antiapoptotic role during IBDV infection via interaction with VDAC2 and VP5, suggesting that VP5 sequesters RACK1 and VDAC2 in the apoptosis-inducing process.	[Lin, Wencheng; Zhang, Zhiqiang; Xu, Zhichao; Wang, Bin; Li, Xiaoqi; Cao, Hong; Wang, Yongqiang; Zheng, Shijun J.] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Lin, Wencheng; Zhang, Zhiqiang; Xu, Zhichao; Wang, Bin; Li, Xiaoqi; Cao, Hong; Wang, Yongqiang; Zheng, Shijun J.] China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing 100193, Peoples R China; [Lin, Wencheng; Zhang, Zhiqiang; Xu, Zhichao; Wang, Bin; Li, Xiaoqi; Cao, Hong; Wang, Yongqiang; Zheng, Shijun J.] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Wang, YQ (corresponding author), China Agr Univ, Coll Vet Med, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	vetwyq@cau.edu.cn; sjzheng@cau.edu.cn			National Natural Science Foundation of China [31272543, 31430085]; Earmarked Fund for Modern Agro-industry Technology Research System [NYCYTX-41]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for Modern Agro-industry Technology Research System	This work was supported by National Natural Science Foundation of China Grants 31272543 and 31430085 and by Earmarked Fund for Modern Agro-industry Technology Research System Grant NYCYTX-41.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; AZAD AA, 1985, VIROLOGY, V143, P35, DOI 10.1016/0042-6822(85)90094-7; Baumann M, 2000, EUR J BIOCHEM, V267, P3891, DOI 10.1046/j.1432-1327.2000.01430.x; Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Brandon NJ, 1999, J NEUROSCI, V19, P9228; Brandon NJ, 2002, J NEUROSCI, V22, P6353; Busnadiego I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046768; Casanas A, 2008, STRUCTURE, V16, P29, DOI 10.1016/j.str.2007.10.023; Cesar MD, 2004, ARCH BIOCHEM BIOPHYS, V422, P191, DOI 10.1016/j.abb.2003.12.030; Chang BY, 2001, J BIOL CHEM, V276, P20346, DOI 10.1074/jbc.M101375200; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Choi DS, 2003, MOL PHARMACOL, V64, P1541, DOI 10.1124/mol.64.6.1541; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; Daniels CC, 2008, VIROLOGY, V375, P550, DOI 10.1016/j.virol.2008.01.034; Delgui LR, 2013, J VIROL, V87, P8993, DOI 10.1128/JVI.03152-12; DOBOS P, 1979, J VIROL, V32, P593, DOI 10.1128/JVI.32.2.593-605.1979; Escaffre O, 2013, J VIROL, V87, P2767, DOI 10.1128/JVI.02360-12; Hafirassou ML, 2013, J HEPATOL, V58, pS470, DOI 10.1016/S0168-8278(13)61157-5; Haro T, 2004, J IMMUNOL, V173, P1151, DOI 10.4049/jimmunol.173.2.1151; Inayat-Hussain SH, 2009, TOXICOL LETT, V191, P118, DOI 10.1016/j.toxlet.2009.08.012; Isacson CK, 2007, AM J PHYSIOL-CELL PH, V292, pC1459, DOI 10.1152/ajpcell.00322.2006; KIBENGE FSB, 1991, VIROLOGY, V184, P437, DOI 10.1016/0042-6822(91)90865-9; Kubota T, 2002, J VIROL, V76, P12676, DOI 10.1128/JVI.76.24.12676-12682.2002; Li ZH, 2013, J VIROL, V87, P1221, DOI 10.1128/JVI.02421-12; Li ZH, 2012, J VIROL, V86, P1328, DOI 10.1128/JVI.06104-11; Liu MH, 2006, J VIROL, V80, P3369, DOI 10.1128/JVI.80.7.3369-3377.2006; Liu MH, 2004, VIROLOGY, V330, P62, DOI 10.1016/j.virol.2004.09.009; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Luque D, 2007, J VIROL, V81, P6869, DOI 10.1128/JVI.00077-07; MAHARDIKA GNK, 1995, ARCH VIROL, V140, P765, DOI 10.1007/BF01309964; Mamidipudi V, 2009, ONCOGENE, V28, P4421, DOI 10.1038/onc.2009.293; Maraver A, 2003, J VIROL, V77, P6438, DOI 10.1128/JVI.77.11.6438-6449.2003; Mourtacla-Maarabouni M, 2005, J LEUKOCYTE BIOL, V78, P503, DOI 10.1189/jlb.0205070; Muller H, 2003, VET MICROBIOL, V97, P153, DOI 10.1016/j.vetmic.2003.08.005; Mundt E, 1997, J VIROL, V71, P5647, DOI 10.1128/JVI.71.7.5647-5651.1997; Ozaki T, 2003, ONCOGENE, V22, P3231, DOI 10.1038/sj.onc.1206382; Pan JH, 2009, VIROLOGY, V395, P87, DOI 10.1016/j.virol.2009.09.004; Pitcovski J, 2003, VACCINE, V21, P4736, DOI 10.1016/S0264-410X(03)00525-5; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rigas AC, 2003, J BIOL CHEM, V278, P46087, DOI 10.1074/jbc.M306219200; Rodriguez-Lecompte JC, 2005, COMP IMMUNOL MICROB, V28, P321, DOI 10.1016/j.cimid.2005.08.004; Ron D, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-53; Sang NL, 2001, J BIOL CHEM, V276, P27026, DOI 10.1074/jbc.M010346200; Sharma JM, 2000, DEV COMP IMMUNOL, V24, P223, DOI 10.1016/S0145-305X(99)00074-9; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Stricker RLO, 2010, J VIROL, V84, P10592, DOI 10.1128/JVI.02506-09; Tham KM, 1996, AVIAN DIS, V40, P109, DOI 10.2307/1592379; van den Berg TP, 2000, REV SCI TECH OIE, V19, P527; VASCONCELOS AC, 1994, J GEN VIROL, V75, P1803, DOI 10.1099/0022-1317-75-7-1803; Volta V, 2013, CELL MOL LIFE SCI, V70, P1439, DOI 10.1007/s00018-012-1215-y; Wang F, 2011, J BIOL CHEM, V286, P9097, DOI 10.1074/jbc.M110.165605; Wei L, 2011, VIROLOGY, V420, P156, DOI 10.1016/j.virol.2011.08.027; Wei L, 2011, VIROLOGY, V417, P211, DOI 10.1016/j.virol.2011.03.003; Wu YY, 2010, CELL SIGNAL, V22, P1495, DOI 10.1016/j.cellsig.2010.05.018; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Yao K, 2001, VIROLOGY, V285, P50, DOI 10.1006/viro.2001.0947; Yuqi Liu, 2009, BMC Med Genet, V10, P114, DOI 10.1186/1471-2350-10-114; Zhang WZ, 2006, MOL CELL BIOL, V26, P413, DOI 10.1128/MCB.26.2.413-424.2006	59	35	37	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8500	8510		10.1074/jbc.M114.585687	http://dx.doi.org/10.1074/jbc.M114.585687			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25583988	Green Published, hybrid			2022-12-26	WOS:000351662600041
J	Yi, F; Ling, TY; Lu, T; Wang, XL; Li, JC; Claycomb, WC; Shen, WK; Lee, HC				Yi, Fu; Ling, Tian-You; Lu, Tong; Wang, Xiao-Li; Li, Jingchao; Claycomb, William C.; Shen, Win-Kuang; Lee, Hon-Chi			Down-regulation of the Small Conductance Calcium-activated Potassium Channels in Diabetic Mouse Atria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; CARDIOVASCULAR-DISEASE; VENTRICULAR MYOCYTES; FUNCTIONAL ROLES; FIBRILLATION; EXPRESSION; MELLITUS; SK2; ENDOTHELIUM; INHIBITION	The small conductance Ca2+-activated K+ (SK) channels have recently been found to be expressed in the heart, and genomewide association studies have shown that they are implicated in atrial fibrillation. Diabetes mellitus is an independent risk factor of atrial fibrillation, but the ionic mechanism underlying this relationship remains unclear. We hypothesized that SK channel function is abnormal in diabetes mellitus, leading to altered cardiac electrophysiology. We found that in streptozotocin-induced diabetic mice, the expression of SK2 and SK3 isoforms was down-regulated by 85 and 92%, respectively, whereas that of SK1 was not changed. SK currents from isolated diabetic mouse atrial myocytes were significantly reduced compared with controls. The resting potentials of isolated atrial preparations were similar between control and diabetic mice, but action potential durations were significantly prolonged in the diabetic atria. Exposure to apamin significantly prolonged action potential durations in control but not in diabetic atria. Production of reactive oxygen species was significantly increased in diabetic atria and in high glucose-cultured HL-1 cells, whereas exposure of HL-1 cells in normal glucose culture to H2O2 reduced the expression of SK2 and SK3. Tyrosine nitration in SK2 and SK3 was significantly increased by high glucose culture, leading to accelerated channel turnover. Treatment with Tiron prevented these changes. Our results suggest that increased oxidative stress in diabetes results in SK channel-associated electrical remodeling in diabetic atria and may promote arrhythmogenesis.	[Yi, Fu; Ling, Tian-You; Lu, Tong; Wang, Xiao-Li; Li, Jingchao; Lee, Hon-Chi] Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Yi, Fu] Fourth Mil Med Univ, Dept Cardiovasc Dis, Xing Hosp, Xian 710032, Peoples R China; [Ling, Tian-You] Shanghai Jiao Tong Univ, Sch Med, Dept Cardiol, Ruijin Hosp, Shanghai 200025, Peoples R China; [Li, Jingchao] Zhengzhou Univ, Dept Emergency Med, Henan Prov Peoples Hosp, Affiliated Hosp, Zhengzhou 450003, Henan, Peoples R China; [Claycomb, William C.] Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Shen, Win-Kuang] Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, Phoenix, AZ 85255 USA	Mayo Clinic; Air Force Military Medical University; Shanghai Jiao Tong University; Zhengzhou University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Mayo Clinic; Mayo Clinic Phoenix	Lee, HC (corresponding author), Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, 200 First St SW, Rochester, MN 55905 USA.	Lee.honchi@mayo.edu	yi, fu/HGE-6093-2022; Lu, Tong/A-7745-2009	Lu, Tong/0000-0002-2393-7643	National Institutes of Health [HL-080118, HL-074180]; Xijing Hospital, Fourth Military Medical University, Xi'an, China; Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China; National Natural Science Foundation of the Peoples' Republic of China [81000686, 81470479, 81400248]; American Diabetes Association [1-12-BS-119]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL074180, R01HL080118, R01HL074180] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Xijing Hospital, Fourth Military Medical University, Xi'an, China; Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China; National Natural Science Foundation of the Peoples' Republic of China(National Natural Science Foundation of China (NSFC)); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-080118 and HL-074180 (to H.-C. L.). This work was also supported by the Xijing Hospital, Fourth Military Medical University, Xi'an, China; the Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China; National Natural Science Foundation of the Peoples' Republic of China Grants 81000686 and 81470479 (to F. Y.) and 81400248 (to T.-Y. L.); and American Diabetes Association Grant 1-12-BS-119 (to T. L.).	Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Burnham MP, 2002, BRIT J PHARMACOL, V135, P1133, DOI 10.1038/sj.bjp.0704551; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chang PC, 2013, HEART RHYTHM, V10, P1516, DOI 10.1016/j.hrthm.2013.07.003; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Crow JP, 1996, METHOD ENZYMOL, V269, P185; D'hoedt D, 2004, J BIOL CHEM, V279, P12088, DOI 10.1074/jbc.C300382200; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Feletou M, 2009, BRIT J PHARMACOL, V156, P545, DOI 10.1111/j.1476-5381.2009.00052.x; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Jongnarangsin K, 2012, J CARDIOVASC ELECTR, V23, P9, DOI 10.1111/j.1540-8167.2011.02137.x; Kannel WB, 2008, MED CLIN N AM, V92, P17, DOI 10.1016/j.mcna.2007.09.002; Kourliouros A, 2009, AM HEART J, V157, P243, DOI 10.1016/j.ahj.2008.10.009; Lang D, 2000, ARTERIOSCL THROM VAS, V20, P422, DOI 10.1161/01.ATV.20.2.422; Lee HC, 1996, J PHARMACOL EXP THER, V278, P597; Lee HC, 1999, J PHYSIOL-LONDON, V519, P153, DOI 10.1111/j.1469-7793.1999.0153o.x; Li N, 2009, J PHYSIOL-LONDON, V587, P1087, DOI 10.1113/jphysiol.2008.167718; Lu T, 2006, CIRC RES, V99, P607, DOI 10.1161/01.RES.0000243147.41792.93; Lu T, 2010, CIRC RES, V106, P1164, DOI 10.1161/CIRCRESAHA.109.209767; Maylie J, 2004, J PHYSIOL-LONDON, V554, P255, DOI 10.1113/jphysiol.2003.049072; Movahed MR, 2005, INT J CARDIOL, V105, P315, DOI 10.1016/j.ijcard.2005.02.050; Olson TM, 2006, HUM MOL GENET, V15, P2185, DOI 10.1093/hmg/ddl143; Ozgen N, 2007, CARDIOVASC RES, V75, P758, DOI 10.1016/j.cardiores.2007.05.008; Resnick HE, 2002, ANNU REV MED, V53, P245, DOI 10.1146/annurev.med.53.082901.103904; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Turko IV, 2002, PHARMACOL REV, V54, P619, DOI 10.1124/pr.54.4.619; Tuteja D, 2005, AM J PHYSIOL-HEART C, V289, pH2714, DOI 10.1152/ajpheart.00534.2005; VanWagoner DR, 1997, CIRC RES, V80, P772; Xu YF, 2003, J BIOL CHEM, V278, P49085, DOI 10.1074/jbc.M307508200; Zhang DM, 2010, CIRC RES, V107, P1454, DOI 10.1161/CIRCRESAHA.110.228361; Zhang Q, 2008, CIRC RES, V102, P465, DOI 10.1161/CIRCRESAHA.107.161778; Zhou W, 2005, AM J PHYSIOL-HEART C, V288, pH2210, DOI 10.1152/ajpheart.00704.2004	34	34	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7016	7026		10.1074/jbc.M114.607952	http://dx.doi.org/10.1074/jbc.M114.607952			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605734	Green Published, hybrid			2022-12-26	WOS:000350991500035
J	Hortschansky, P; Ando, E; Tuppatsch, K; Arikawa, H; Kobayashi, T; Kato, M; Haas, H; Brakhage, AA				Hortschansky, Peter; Ando, Eriko; Tuppatsch, Katja; Arikawa, Hisashi; Kobayashi, Tetsuo; Kato, Masashi; Haas, Hubertus; Brakhage, Axel A.			Deciphering the Combinatorial DNA-binding Code of the CCAAT-binding Complex and the Iron-regulatory Basic Region Leucine Zipper (bZIP) Transcription Factor HapX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPERGILLUS-NIDULANS; CRYSTAL-STRUCTURE; NF-Y; EXPRESSION; MECHANISM; FOS; HOMEOSTASIS; VIRULENCE; SUBUNIT; AMYLASE	The heterotrimeric CCAAT-binding complex (CBC) is evolutionarily conserved in eukaryotic organisms, including fungi, plants, and mammals. The CBC consists of three subunits, which are named in the filamentous fungus Aspergillus nidulans HapB, HapC, and HapE. HapX, a fourth CBC subunit, was identified exclusively in fungi, except for Saccharomyces cerevisiae and the closely related Saccharomycotina species. The CBC-HapX complex acts as the master regulator of iron homeostasis. HapX belongs to the class of basic region leucine zipper transcription factors. We demonstrated that the CBC and HapX bind cooperatively to bipartite DNA motifs with a general HapX/CBC/DNA 2: 1: 1 stoichiometry in a class of genes that are repressed by HapX-CBC in A. nidulans during iron limitation. This combinatorial binding mode requires protein-protein interaction between the N-terminal domain of HapE and the N-terminal CBC binding domain of HapX as well as sequence-specific DNA binding of both the CBC and HapX. Initial binding of the CBC to CCAAT boxes is mandatory for DNA recognition of HapX. HapX specifically targets the minimal motif 5'-GAT-3 3', which is located at a distance of 11-12 bp downstream of the respective CCAAT box. Single nucleotide substitutions at the 5'- and 3'-end of the GAT motif as well as different spacing between the CBC and HapX DNA-binding sites revealed a remarkable promiscuous DNA-recognition mode of HapX. This flexible DNA-binding code may have evolved as a mechanism for fine-tuning the transcriptional activity of CBC-HapX at distinct target promoters.	[Hortschansky, Peter; Tuppatsch, Katja; Brakhage, Axel A.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Mol & Appl Microbiol, D-07745 Jena, Germany; [Ando, Eriko; Arikawa, Hisashi; Kobayashi, Tetsuo] Nagoya Univ, Dept Biol Mech & Funct, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Kato, Masashi] Meijo Univ, Fac Agr, Nagoya, Aichi 4688502, Japan; [Haas, Hubertus] Med Univ Innsbruck, Bioctr, Div Mol Biol, A-6020 Innsbruck, Austria; [Brakhage, Axel A.] Univ Jena, Inst Microbiol, Dept Microbiol & Mol Biol, D-07743 Jena, Germany	Hans Knoll Institute (HKI); Nagoya University; Meijo University; Medical University of Innsbruck; Friedrich Schiller University of Jena	Brakhage, AA (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol, Dept Mol & Appl Microbiol, Beutenbergstr 11a, D-07745 Jena, Germany.	axel.brakhage@hki-jena.de	Kato, Masashi/AAG-3755-2021; Kobayashi, Tetsuo/I-6901-2014	Kato, Masashi/0000-0002-8951-3640; Kobayashi, Tetsuo/0000-0002-4008-454X	Joint D-A-CH Program; Novel Molecular Mechanisms of Iron Sensing and Homeostasis in Filamentous Fungi; Deutsche Forschungsgemeinschaft [BR 1130/14-1, HO 2596/1-1]; Austrian Science Foundation [I1346-B22]; JSPS KAKENHI [25450116]; NISR	Joint D-A-CH Program; Novel Molecular Mechanisms of Iron Sensing and Homeostasis in Filamentous Fungi; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Foundation(Austrian Science Fund (FWF)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NISR	This work was supported in part by the Joint D-A-CH Program, "Novel Molecular Mechanisms of Iron Sensing and Homeostasis in Filamentous Fungi," Deutsche Forschungsgemeinschaft Grant BR 1130/14-1 (to A. A. B.) and Deutsche Forschungsgemeinschaft Grant HO 2596/1-1 (to P. H.), Austrian Science Foundation Grant I1346-B22 (to H. H.), and JSPS KAKENHI Grant 25450116 and NISR research grants (to M. K.).	Amoutzias GD, 2007, MOL BIOL EVOL, V24, P827, DOI 10.1093/molbev/msl211; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Brakhage AA, 1999, FUNGAL GENET BIOL, V27, P243, DOI 10.1006/fgbi.1999.1136; Chen CB, 2011, CELL HOST MICROBE, V10, P118, DOI 10.1016/j.chom.2011.07.005; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Fleming JD, 2013, GENOME RES, V23, P1195, DOI 10.1101/gr.148080.112; Fujii Y, 2000, NAT STRUCT BIOL, V7, P889; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Gordan R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r125; Gsaller F, 2014, EMBO J, V33, P2261, DOI 10.15252/embj.201489468; Gsaller F, 2012, METALLOMICS, V4, P1262, DOI 10.1039/c2mt20179h; Haas H, 1999, J BIOL CHEM, V274, P4613, DOI 10.1074/jbc.274.8.4613; Haas H, 2014, NAT PROD REP, V31, P1266, DOI 10.1039/c4np00071d; Haas H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00028; Hortschansky P, 2007, EMBO J, V26, P3157, DOI 10.1038/sj.emboj.7601752; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Huber EM, 2012, STRUCTURE, V20, P1757, DOI 10.1016/j.str.2012.07.012; Jung WH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001209; Kato M, 1997, MOL GEN GENET, V254, P119, DOI 10.1007/s004380050399; Kato M, 2002, FEBS LETT, V512, P227, DOI 10.1016/S0014-5793(02)02266-4; Kato N, 2002, CURR GENET, V42, P43, DOI 10.1007/s00294-002-0325-8; Labbe S, 2013, CURR OPIN MICROBIOL, V16, P669, DOI 10.1016/j.mib.2013.07.007; Lopez-Berges MS, 2012, PLANT CELL, V24, P3805, DOI 10.1105/tpc.112.098624; Marui J, 2002, FUNGAL GENET BIOL, V35, P157, DOI 10.1006/fgbi.2001.1321; McNabb DS, 2005, EUKARYOT CELL, V4, P1829, DOI 10.1128/EC.4.11.1829-1839.2005; Miller M, 2009, CURR PROTEIN PEPT SC, V10, P244, DOI 10.2174/138920309788452164; Ogata K., 2003, CURR OPIN STRUC BIOL, V13, P40; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Schrettl M, 2008, MOL MICROBIOL, V70, P27, DOI 10.1111/j.1365-2958.2008.06376.x; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001124; Singh RP, 2011, J BIOL CHEM, V286, P25154, DOI 10.1074/jbc.M111.233569; Steidl S, 2004, J MOL BIOL, V342, P515, DOI 10.1016/j.jmb.2004.07.011; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; Tanaka A, 2002, BBA-GENE STRUCT EXPR, V1576, P176, DOI 10.1016/S0167-4781(02)00286-5; Thon M, 2010, NUCLEIC ACIDS RES, V38, P1098, DOI 10.1093/nar/gkp1091; VANGORCOM RFM, 1986, GENE, V48, P211, DOI 10.1016/0378-1119(86)90079-X; Weidner G, 2001, ARCH MICROBIOL, V175, P122, DOI 10.1007/s002030000246	40	27	28	5	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6058	6070		10.1074/jbc.M114.628677	http://dx.doi.org/10.1074/jbc.M114.628677			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25589790	Green Published, hybrid			2022-12-26	WOS:000350732500017
J	Koliwer, J; Park, M; Bauch, C; von Zastrow, M; Kreienkamp, HJ				Koliwer, Judith; Park, Minjong; Bauch, Carola; von Zastrow, Mark; Kreienkamp, Hans-Juergen			The Golgi-associated PDZ Domain Protein PIST/GOPC Stabilizes the beta 1-Adrenergic Receptor in Intracellular Compartments after Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PLASMA-MEMBRANE EXPRESSION; BETA(1)-ADRENERGIC RECEPTOR; TRAFFICKING; MECHANISM; DEGRADATION; SPECIFICITY; ENDOCYTOSIS; INTERACTS; SEQUENCE	Many G-protein-coupled receptors carry C-terminal ligand motifs for PSD-95/discs large/ZO-1 (PDZ) domains; via interaction with PDZ domain-containing scaffold proteins, this allows for integration of receptors into signaling complexes. However, the presence of PDZ domain proteins attached to intracellular membranes suggests that PDZ-type interactions may also contribute to subcellular sorting of receptors. The protein interacting specifically with Tc10 (PIST; also known as GOPC) is a trans-Golgi-associated protein that interacts through its single PDZ domain with a variety of cell surface receptors. Here we show that PIST controls trafficking of the interacting beta 1-adrenergic receptor both in the anterograde, biosynthetic pathway and during postendocytic recycling. Overexpression and knockdown experiments show that PIST leads to retention of the receptor in the trans-Golgi network (TGN), to the effect that overexpressed PIST reduces activation of the MAPK pathway by beta 1-adrenergic receptor (beta 1AR) agonists. Receptors can be released from retention in the TGN by coexpression of the plasma membrane-associated scaffold PSD-95, which allows for transport of receptors to the plasma membrane. Stimulation of beta 1 receptors and activation of the cAMP pathway lead to relocation of PIST from the TGN to an endosome-like compartment. Here PIST colocalizes with SNX1 and the internalized beta 1AR and protects endocytosed receptors from lysosomal degradation. In agreement, beta 1AR levels are decreased in hippocampi of PIST-deficient mice. Our data suggest that PIST contributes to the fine-tuning of beta 1AR sorting both during biosynthetic and postendocytic trafficking.	[Koliwer, Judith; Bauch, Carola; Kreienkamp, Hans-Juergen] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, D-20246 Hamburg, Germany; [Park, Minjong; von Zastrow, Mark] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94158 USA; [Park, Minjong; von Zastrow, Mark] Univ Calif San Francisco, Sch Med, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kreienkamp, HJ (corresponding author), Univ Krankenhaus Hamburg Eppendorf, Inst Humangenet, Martinistr 52, D-20246 Hamburg, Germany.	Kreienkamp@uke.de		Kreienkamp, Hans-Jurgen/0000-0002-8871-9970	National Institute on Drug Abuse, National Institutes of Health [R37DA010711]; Deutsche Forschungsgemeinschaft [GRK1459]; National Institute on Drug Abuse [T32MH889920]; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154, R37DA010711, R01DA010711, R01DA012864] Funding Source: NIH RePORTER	National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institute on Drug Abuse, National Institutes of Health Grant R37DA010711 (to M. v Z.). This work was also supported by the Deutsche Forschungsgemeinschaft (GRK1459; to H.-J.K.).; Supported by National Institute on Drug Abuse Grant T32MH889920.	BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; Bauch C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088529; Becamel C, 2002, EMBO J, V21, P2332, DOI 10.1093/emboj/21.10.2332; Bockaert J, 2004, BIOCHEM SOC T, V32, P851, DOI 10.1042/BST0320851; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chen AN, 2012, J COMP NEUROL, V520, P889, DOI 10.1002/cne.22774; Cheng J, 2005, J BIOL CHEM, V280, P3731, DOI 10.1074/jbc.M410026200; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Cheng J, 2010, MOL BIOL CELL, V21, P1178, DOI 10.1091/mbc.E09-03-0229; Cheng S, 2010, J NEUROCHEM, V112, P588, DOI 10.1111/j.1471-4159.2009.06454.x; Cushing PR, 2010, ANGEW CHEM INT EDIT, V49, P9907, DOI 10.1002/anie.201005585; Franch HA, 2001, J BIOL CHEM, V276, P19126, DOI 10.1074/jbc.M101777200; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hanyaloglu AC, 2007, J BIOL CHEM, V282, P3095, DOI 10.1074/jbc.M605398200; He JQ, 2004, J BIOL CHEM, V279, P50190, DOI 10.1074/jbc.M404876200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Liang W, 2004, J BIOL CHEM, V279, P46882, DOI 10.1074/jbc.M406501200; Nakagawa T, 2013, J MEMBRANE BIOL, V246, P571, DOI 10.1007/s00232-013-9571-6; ROSA P, 1992, J BIOL CHEM, V267, P12227; Roth A, 1997, DNA CELL BIOL, V16, P111, DOI 10.1089/dna.1997.16.111; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Turvy D N, 2001, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1807s36; Wente W, 2005, J BIOL CHEM, V280, P32419, DOI 10.1074/jbc.M507198200; Xu ZG, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-80; Yao RJ, 2002, P NATL ACAD SCI USA, V99, P11211, DOI 10.1073/pnas.162027899; Zhang JQ, 2008, FEBS LETT, V582, P4117, DOI 10.1016/j.febslet.2008.10.054	30	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6120	6129		10.1074/jbc.M114.605725	http://dx.doi.org/10.1074/jbc.M114.605725			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25614626	hybrid, Green Published			2022-12-26	WOS:000350732500021
J	Yang, F; Hu, Y; Liu, HX; Wan, YJY				Yang, Fan; Hu, Ying; Liu, Hui-Xin; Wan, Yu-Jui Yvonne			MiR-22-silenced Cyclin A Expression in Colon and Liver Cancer Cells Is Regulated by Bile Acid Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESOID-X-RECEPTOR; HUMAN HEPATOCELLULAR-CARCINOMA; NUCLEAR RECEPTOR; LIPID HOMEOSTASIS; VITAMIN-D; BINDING; MICE; MICRORNA-22; PROLIFERATION; ALPHA	Because of the significant tumor-suppressive role of microRNA-22 (miR-22), the current study was designed to understand the regulation of miR-22 and to identify additional downstream miR-22 targets in liver and colon cells. The data showed that miR-22 was transcriptionally regulated by bile acid receptor farnesoid X receptor (FAR) through direct binding to an invert repeat 1 motif located at -1012 to -1025 bp upstream from miR-22. Among the studied primary and secondary bile acids, chenodeoxycholic acid, which has the highest binding affinity to FXR, induced miR-22 level in both Huh7 liver and HCT116 colon cells in a dose- and time-dependent manner. In addition, cyclin A2 (CCNA2) was identified as a miR-22 novel target in liver and colon cancer cells. The sequence of miR-22, which is conserved in mice, rats, humans, and other mammalians, aligns with the sequence of 3'-UTR of CCNA2. Chenodeoxycholic acid treatment and miR-22 mimics reduced CCNA2 protein and increased the number of Cio/G-, Huh7 and HCT116 cells. In FXR KO mice, reduction of miR-22 was accompanied by elevated hepatic and ileal CCNA2 protein, as well as an increased number of hepatic and colonic Ki-67-positive cells. In humans, the expression levels of miR-22 and CCNA2 are inversely correlated in liver and colon cancers. Taken together, our data showed that bile acid-activated FXR stimulates miR-22-silenced CCNA2, a novel pathway for FXR to exert its protective effect in the gastrointestinal tract.	[Yang, Fan; Hu, Ying; Liu, Hui-Xin; Wan, Yu-Jui Yvonne] Univ Calif Davis, Med Ctr, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Yang, Fan; Wan, Yu-Jui Yvonne] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai 201203, Peoples R China	University of California System; University of California Davis; Shanghai University of Traditional Chinese Medicine	Wan, YJY (corresponding author), Univ Calif Davis, Med Ctr, Dept Pathol & Lab Med, Sacramento, CA 95817 USA.	yjywan@ucdavis.edu	Zhu, Ren-Yuan/V-8966-2019; Yang, Fan/GYU-4249-2022	Zhu, Ren-Yuan/0000-0003-3091-7461; Liu, Hui-Xin/0000-0002-8981-9981	National Institutes of Health [DK092100, CA53596]; NATIONAL CANCER INSTITUTE [R01CA053596, R29CA053596, P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK092100 and CA53596 (to Y.-J.Y.W.).	Alvarez-Diaz S, 2012, HUM MOL GENET, V21, P2157, DOI 10.1093/hmg/dds031; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; He YQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-575; Hu Y, 2013, BIOCHEM PHARMACOL, V85, P1007, DOI 10.1016/j.bcp.2013.01.023; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Karpen SJ, 1999, HEPATOLOGY, V30, P1107, DOI 10.1002/hep.510300439; Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249; Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200; Lee CG, 2012, GASTROENTEROLOGY, V142, P1206, DOI 10.1053/j.gastro.2012.01.007; Lee J, 2010, J BIOL CHEM, V285, P12604, DOI 10.1074/jbc.M109.094524; Li J, 2011, MOL CELL BIOCHEM, V357, P31, DOI 10.1007/s11010-011-0872-8; Li J, 2011, MOL PHARMACOL, V80, P191, DOI 10.1124/mol.110.068247; Ling B, 2012, J CANCER RES CLIN, V138, P1355, DOI 10.1007/s00432-012-1194-2; Liu NA, 2012, MOL ENDOCRINOL, V26, P775, DOI 10.1210/me.2011-1383; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; Milovic V, 2002, EUR J CLIN INVEST, V32, P29, DOI 10.1046/j.0014-2972.2001.00938.x; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Sharma R, 2010, BIOORGAN MED CHEM, V18, P6886, DOI 10.1016/j.bmc.2010.07.030; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Su HY, 2012, AM J PHYSIOL-GASTR L, V303, pG1245, DOI 10.1152/ajpgi.00439.2011; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Vallim TQD, 2013, CIRC RES, V112, P1602, DOI 10.1161/CIRCRESAHA.112.300648; Wan YJY, 2000, J BIOL CHEM, V275, P28285; Wan YJY, 2000, MOL CELL BIOL, V20, P4436, DOI 10.1128/MCB.20.12.4436-4444.2000; Wolfe A, 2011, J PHARMACOL EXP THER, V338, P12, DOI 10.1124/jpet.111.179390; Xiong J, 2010, ONCOGENE, V29, P4980, DOI 10.1038/onc.2010.241; Xiong JH, 2010, FEBS J, V277, P1684, DOI 10.1111/j.1742-4658.2010.07594.x; Yamakuchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020291; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Zhan Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050013; Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895	35	53	56	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6507	6515		10.1074/jbc.M114.620369	http://dx.doi.org/10.1074/jbc.M114.620369			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25596928	Green Published, hybrid			2022-12-26	WOS:000350732500053
J	Madhukar, NS; Warmoes, MO; Locasale, JW				Madhukar, Neel S.; Warmoes, Marc O.; Locasale, Jason W.			Organization of Enzyme Concentration across the Metabolic Network in Cancer Cells	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; PROTEIN; GLYCOLYSIS; GLYCINE; IDENTIFICATION; PROLIFERATION; VISUALIZATION; PROTEOMICS; TARGET; SERINE	Rapid advances in mass spectrometry have allowed for estimates of absolute concentrations across entire proteomes, permitting the interrogation of many important biological questions. Here, we focus on a quantitative aspect of human cancer cell metabolism that has been limited by a paucity of available data on the abundance of metabolic enzymes. We integrate data from recent measurements of absolute protein concentration to analyze the statistics of protein abundance across the human metabolic network. At a global level, we find that the enzymes in glycolysis comprise approximately half of the total amount of metabolic proteins and can constitute up to 10% of the entire proteome. We then use this analysis to investigate several outstanding problems in cancer metabolism, including the diversion of glycolytic flux for biosynthesis, the relative contribution of nitrogen assimilating pathways, and the origin of cellular redox potential. We find many consistencies with current models, identify several inconsistencies, and find generalities that extend beyond current understanding. Together our results demonstrate that a relatively simple analysis of the abundance of metabolic enzymes was able to reveal many insights into the organization of the human cancer cell metabolic network.	[Madhukar, Neel S.; Locasale, Jason W.] Cornell Univ, Triinst Program Computat Biol & Med, Ithaca, NY 14850 USA; [Madhukar, Neel S.; Locasale, Jason W.] Weill Cornell Med Coll, New York, NY USA; [Madhukar, Neel S.; Locasale, Jason W.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Madhukar, Neel S.; Warmoes, Marc O.; Locasale, Jason W.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University	Locasale, JW (corresponding author), Cornell Univ, Triinst Program Computat Biol & Med, Ithaca, NY 14850 USA.	Locasale@cornell.edu	Locasale, Jason W/ABE-6505-2020	Locasale, Jason W/0000-0002-7766-3502; Warmoes, Marc/0000-0002-6632-3764	National Institutes of Health [CA168997, AI110613]; International Life Sciences Institute; Tri-Institutional Training Program in Computational Biology and Medicine [1T32GM083937]; NATIONAL CANCER INSTITUTE [R00CA168997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Life Sciences Institute; Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JWL acknowledges support from National Institutes of Health (http://www.nih.gov/) awards CA168997 and AI110613 and the International Life Sciences Institute. NSM was supported by the Tri-Institutional Training Program in Computational Biology and Medicine (http://www.triiprograms.org/cbm/), Program number: 1T32GM083937. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; ARGILES JM, 1990, MED HYPOTHESES, V32, P151, DOI 10.1016/0306-9877(90)90039-H; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Breker M, 2014, NAT REV MOL CELL BIO, V15, P453, DOI 10.1038/nrm3821; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dang CV, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-3; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Henry CS, 2006, BIOPHYS J, V90, P1453, DOI 10.1529/biophysj.105.071720; Hu J, 2013, NAT BIOTECHNOL, V31, P522, DOI 10.1038/nbt.2530; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karnovsky A, 2012, BIOINFORMATICS, V28, P373, DOI 10.1093/bioinformatics/btr661; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Lee K, 2013, ANGEW CHEM INT EDIT, V52, P10286, DOI 10.1002/anie.201304987; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Metallo CM, 2013, MOL CELL, V49, P388, DOI 10.1016/j.molcel.2013.01.018; Milo R, 2013, BIOESSAYS, V35, P1050, DOI 10.1002/bies.201300066; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Noor E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003483; Northrop DB, 1998, ARCH BIOCHEM BIOPHYS, V352, P288, DOI 10.1006/abbi.1997.0589; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Shestov AA, 2014, ELIFE, V3, DOI 10.7554/eLife.03342; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Vazquez A, 2013, CANCER RES, V73, P478, DOI 10.1158/0008-5472.CAN-12-3709; Warmoes M, 2013, MOL CELL PROTEOMICS, V12, P1319, DOI 10.1074/mcp.M112.024182; WARMOES MO, 2014, HETEROGENEITY OF GLY; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934	41	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117131	10.1371/journal.pone.0117131	http://dx.doi.org/10.1371/journal.pone.0117131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25621879	Green Published, Green Submitted, gold			2022-12-26	WOS:000348470400020
J	Vidal, B; Cascao, R; Vale, AC; Cavaleiro, I; Vaz, MF; Brito, JAA; Canhao, H; Fonseca, JE				Vidal, Bruno; Cascao, Rita; Vale, Ana Catarina; Cavaleiro, Ines; Vaz, Maria Fatima; Almeida Brito, Jose Americo; Canhao, Helena; Fonseca, Joao Eurico			Arthritis Induces Early Bone High Turnover, Structural Degradation and Mechanical Weakness	PLOS ONE			English	Article							EARLY RHEUMATOID-ARTHRITIS; BIOMECHANICAL PROPERTIES; RATS; HISTOMORPHOMETRY; DISTURBANCES; ACTIVATION; EXPRESSION; NETWORK; CALCIUM	Background We have previously found in the chronic SKG mouse model of arthritis that long standing (5 and 8 months) inflammation directly leads to high collagen bone turnover, disorganization of the collagen network, disturbed bone microstructure and degradation of bone biomechanical properties. The main goal of the present work was to study the effects of the first days of the inflammatory process on the microarchitecture and mechanical properties of bone. Methods Twenty eight Wistar adjuvant-induced arthritis (AIA) rats were monitored during 22 days after disease induction for the inflammatory score, ankle perimeter and body weight. Healthy non-arthritic rats were used as controls for compar-ison. After 22 days of disease progression rats were sacrificed and bone samples were collected for histomorphometrical, energy dispersive X-ray spectroscopical analysis and 3-point bending. Blood samples were also collected for bone turnover markers. Results AIA rats had an increased bone turnover (as inferred from increased P1NP and CTX1, p = 0.0010 and p = 0.0002, respectively) and this was paralleled by a decreased mineral content (calcium p = 0.0046 and phos-phorus p = 0.0046). Histomorphometry showed a lower trabecular thickness (p = 0.0002) and bone volume (p = 0.0003) and higher trabecular sepa-ration (p = 0.0009) in the arthritic group as compared with controls. In addition, bone mechanical tests showed evidence of fragility as depicted by diminished values of yield stress and ultimate fracture point (p = 0.0061 and p = 0.0279, re-spectively) in the arthritic group. Conclusions We have shown in an AIA rat model that arthritis induc-es early bone high turnover, structural degradation, mineral loss and mechanical weak-ness.	[Vidal, Bruno; Cascao, Rita; Canhao, Helena; Fonseca, Joao Eurico] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal; [Vale, Ana Catarina; Vaz, Maria Fatima] Univ Lisbon, Inst Super Tecn, Inst Ciencia & Engn Mat & Superficies, P-1699 Lisbon, Portugal; [Cavaleiro, Ines; Almeida Brito, Jose Americo] Inst Super Ciencias Saude Egas Moniz, Quinta Da Granja, Caparica, Portugal; [Vaz, Maria Fatima] UL, Inst Super Tecn, Dept Engn Mecan, Lisbon, Portugal; [Canhao, Helena; Fonseca, Joao Eurico] Lisbon Acad Med Ctr, Dept Rheumatol, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico; Instituto Superior de Ciencias da Saude Egas Moniz; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa	Vidal, B (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.	vidal.bmc@gmail.com	Vale, Ana Catarina/B-3771-2016; Canhao, Helena/C-9611-2018; Brito, José/AAM-5150-2020; Vale, Ana/GYQ-5168-2022; Vaz, Fatima/B-8840-2011	Vale, Ana Catarina/0000-0002-1590-6636; Canhao, Helena/0000-0003-1894-4870; Brito, José/0000-0002-8558-6754; Vaz, Fatima/0000-0003-1629-523X	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/81527/2011]; ECTS/Amgen Bone Biology Fellowship from European Calcified Tissue Society	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); ECTS/Amgen Bone Biology Fellowship from European Calcified Tissue Society	This work was supported by a grant SFRH/BD/81527/2011 from Fundacao para a Ciencia e a Tecnologia (FCT) and grant ECTS/Amgen Bone Biology Fellowship 2014 from European Calcified Tissue Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamanos Y, 2005, AUTOIMMUN REV, V4, P130, DOI 10.1016/j.autrev.2004.09.002; Allen MR, 2008, CALCIFIED TISSUE INT, V82, P354, DOI 10.1007/s00223-008-9131-8; Bendele A. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P377; Bonjour JP, 2011, J AM COLL NUTR, V30, p438S, DOI 10.1080/07315724.2011.10719988; Caetano-Lopes J, 2009, CLIN EXP RHEUMATOL, V27, P475; Caetano-Lopes J, 2009, AUTOIMMUN REV, V8, P250, DOI 10.1016/j.autrev.2008.07.038; Caetano-Lopes J, 2014, CLIN REV ALLERG IMMU, V47, P38, DOI 10.1007/s12016-013-8366-y; Caetano-Lopes J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2908; Cascao R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3168; Cortet B, 1998, J RHEUMATOL, V25, P2339; DaSilva JAP, 1996, CLIN EXP RHEUMATOL, V14, P43; Eric-Jan JA, 2000, CLINICAL AND EXPERIM; Fonseca JE, 2005, CLIN EXP RHEUMATOL, V23, P185; Gravallese EM, 2002, ANN RHEUM DIS, V61, P84, DOI 10.1136/ard.61.suppl_2.ii84; Haugeberg G, 2002, ARTHRITIS RHEUM-US, V46, P1720, DOI 10.1002/art.10408; Jiang YB, 1997, J BONE MINER RES, V12, P820, DOI 10.1359/jbmr.1997.12.5.820; Lin YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062926; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Moura RA, 2011, RHEUMATOLOGY, V50, P278, DOI 10.1093/rheumatology/keq338; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PEARSON CM, 1956, P SOC EXP BIOL MED, V91, P95, DOI 10.3181/00379727-91-22179; Schopf KAaBDJ Lisa R., 2006, RAT MODELS OF ARTHRI; Siebuhr AS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-195; van Schaardenburg D, 2011, ANN RHEUM DIS, V70, P1173, DOI 10.1136/ard.2010.135723; Vidal B, 2012, ACTA REUMATOL PORT, V37, P294; Wislowska M, 2009, RHEUMATOL INT, V29, P1403, DOI 10.1007/s00296-009-0867-x; YELIN E, 1995, ARTHRITIS RHEUM, V38, P1351, DOI 10.1002/art.1780381002	27	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117100	10.1371/journal.pone.0117100	http://dx.doi.org/10.1371/journal.pone.0117100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617902	Green Submitted, Green Published, gold			2022-12-26	WOS:000350336000038
J	Jewell, BL; Cremin, I; Pickles, M; Celum, C; Baeten, JM; Delany-Moretlwe, S; Hallett, TB				Jewell, Britta L.; Cremin, Ide; Pickles, Michael; Celum, Connie; Baeten, Jared M.; Delany-Moretlwe, Sinead; Hallett, Timothy B.			Estimating the Cost-Effectiveness of Pre-Exposure Prophylaxis to Reduce HIV-1 and HSV-2 Incidence in HIV-Serodiscordant Couples in South Africa	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; ANTIRETROVIRAL THERAPY; GENITAL HERPES; DISCORDANT COUPLES; MALE CIRCUMCISION; TRANSMISSION; INFECTION; PREVENTION; ACQUISITION; TENOFOVIR	Objective To estimate the cost-effectiveness of daily oral tenofovir-based PrEP, with a protective effect against HSV-2 as well as HIV-1, among HIV-1 serodiscordant couples in South Africa. Methods We incorporated HSV-2 acquisition, transmission, and interaction with HIV-1 into a microsimulation model of heterosexual HIV-1 serodiscordant couples in South Africa, with use of PrEP for the HIV-1 uninfected partner prior to ART initiation for the HIV-1 1infected partner, and for one year thereafter. Results We estimate the cost per disability-adjusted life-year (DALY) averted for two scenarios, one in which PrEP has no effect on reducing HSV-2 acquisition, and one in which there is a 33% reduction. After a twenty-year intervention, the cost per DALY averted is estimated to be $10,383 and $9,757, respectively - a 6% reduction, given the additional benefit of reduced HSV-2 acquisition. If all couples are discordant for both HIV-1 and HSV-2, the cost per DALY averted falls to $ 1,445, which shows that the impact is limited by HSV-2 concordance in couples. Conclusion After a 20-year PrEP intervention, the cost per DALY averted with a reduction in HSV-2 is estimated to be modestly lower than without any effect, providing an increase of health benefits in addition to HIV-1 prevention at no extra cost. The small degree of the effect is in part due to a high prevalence of HSV-2 infection in HIV-1 serodiscordant couples in South Africa.	[Jewell, Britta L.; Cremin, Ide; Pickles, Michael; Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Celum, Connie; Baeten, Jared M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Celum, Connie; Baeten, Jared M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Celum, Connie; Baeten, Jared M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Delany-Moretlwe, Sinead] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa	Imperial College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Witwatersrand	Jewell, BL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	b.jewell@imperial.ac.uk		Pickles, Michael/0000-0002-6754-3945; Cremin, Ide/0000-0003-2560-6247; Hallett, Timothy/0000-0002-9681-0424	Bill & Melinda Gates Foundation via from Georgetown University; National Institute of Mental Health of the US National Institutes of Health [R01MH095507]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095507] Funding Source: NIH RePORTER; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI	Bill & Melinda Gates Foundation via from Georgetown University; National Institute of Mental Health of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	B.L.J., I.C., and T.B.H. would like to thank the Bill & Melinda Gates Foundation for funding this research via a sub-contract from Georgetown University. This analysis was also supported by the National Institute of Mental Health of the US National Institutes of Health (R01MH095507) to J.M.B. The content is the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in the study design and analysis, decision to publish, or preparation of the manuscript.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; AUGENBRAUN M, 1995, ANN INTERN MED, V123, P845, DOI 10.7326/0003-4819-123-11-199512010-00006; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; BENEDETTI J, 1994, ANN INTERN MED, V121, P847, DOI 10.7326/0003-4819-121-11-199412010-00004; Benedetti JK, 1999, ANN INTERN MED, V131, P14, DOI 10.7326/0003-4819-131-1-199907060-00004; BROWN ZA, 1991, NEW ENGL J MED, V324, P1247, DOI 10.1056/NEJM199105023241804; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; CELUM C, 2013, DAILY ORAL TENOFOVIR, DOI DOI 10.1002/JMRI.24478; Celum C, 2014, ANN INTERN MED, V161, P11, DOI 10.7326/M13-2471; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Corey L, 2007, NEW ENGL J MED, V356, P854, DOI 10.1056/NEJMe068302; Curran K, 2012, CURR HIV-AIDS REP, V9, P160, DOI 10.1007/s11904-012-0114-z; Donnell D, 2014, J ACQUIR IMMUNE DEFI; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Glynn JR, 2009, AIDS, V23, P1595, DOI 10.1097/QAD.0b013e32832e15e8; Gomez GB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001401; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Haberer JE, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001511; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; Heffron R, 2012, JAIDS-J ACQ IMM DEF, V61, P116, DOI 10.1097/QAI.0b013e31825da73f; HOLMBERG SD, 1988, JAMA-J AM MED ASSOC, V259, P1048, DOI 10.1001/jama.259.7.1048; Holmes KK, 2004, B WORLD HEALTH ORGAN, V82, P454; Kamali A, 1999, SEX TRANSM INFECT, V75, P98, DOI 10.1136/sti.75.2.98; KARIM QA, 2014, SEX TRANSM INFECT, V2; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; KARIM SS, 2010, 18 INT AIDS C VIENN; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Lingappa JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005272; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Mahy M, 2010, SEX TRANSM INFECT, V86, pI28, DOI 10.1136/sti.2010.044255; Menzies NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048726; Muiru AN, 2013, J INFECT DIS, V208, P1093, DOI 10.1093/infdis/jit303; Mujugira A, 2013, J INFECT DIS, V208, P1366, DOI 10.1093/infdis/jit333; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Naghavi Mohsen, 2009, Popul Health Metr, V7, P9, DOI 10.1186/1478-7954-7-9; Ouedraogo A, 2006, AIDS, V20, P2305, DOI 10.1097/QAD.0b013e328010238d; Phipps W, 2011, J INFECT DIS, V203, P180, DOI 10.1093/infdis/jiq035; Schiffer Joshua T, 2009, Curr Infect Dis Rep, V11, P457, DOI 10.1007/s11908-009-0066-7; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Terris-Prestholt F, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-14; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; *WHO, 2011, GLOB HIV AIDS RESP E, DOI DOI 10.1080/17437199.2011.587961; World Health Organization, CHOOS INT AR COST EF; Zwahlen M, 2008, SEX TRANSM INFECT, V84, pI31, DOI 10.1136/sti.2008.029793	54	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115511	10.1371/journal.pone.0115511	http://dx.doi.org/10.1371/journal.pone.0115511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25616135	Green Published, gold, Green Submitted			2022-12-26	WOS:000349122100013
J	Lopez, S; Aguilar, L; Mercado, L; Bravo, M; Quiroz, W				Lopez, Silvana; Aguilar, Luis; Mercado, Luis; Bravo, Manuel; Quiroz, Waldo			Sb(V) Reactivity with Human Blood Components: Redox Effects	PLOS ONE			English	Article							PENTAVALENT ANTIMONY; SPECIATION ANALYSIS; PARTICULATE MATTER; TRACE-ELEMENTS; GLUTATHIONE; REDUCTION; SB(III); TRYPANOTHIONE; ENVIRONMENT; STABILITY	We assessed the reactivity of Sb(V) in human blood. Sb(V) reactivity was determined using an HPLC-HG-AFS hyphenated system. Sb(V) was partially reduced to Sb(III) in blood incubation experiments; however, Sb(III) was a highly unstable species. The addition of 0.1 mol L-1 EDTA prevented Sb(III) oxidation, thus enabling the detection of the reduction of Sb(V) to Sb (III). The transformation of Sb(V) to Sb(III) in human whole blood was assessed because the reduction of Sb(V) in human blood may likely generate redox side effects. Our results indicate that glutathione was the reducing agent in this reaction and that Sb(V) significantly decreased the GSH/GSSG ratio from 0.32 +/- 0.09 to 0.07 +/- 0.03. Moreover, the presence of 200 ng mL(-1) of Sb(V) increased the activity of superoxide dismutase from 4.4 +/- 0.1 to 7.0 +/- 0.4 U mL(-1) and decreased the activity of glutathione peroxidase from 62 +/- 1 to 34 +/- 2 nmol min(-1) mL(-1).	[Lopez, Silvana; Aguilar, Luis; Bravo, Manuel; Quiroz, Waldo] Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile; [Mercado, Luis] Pontificia Univ Catolica Valparaiso, Inst Biol, Valparaiso, Chile	Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Valparaiso	Quiroz, W (corresponding author), Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile.	waldo.quiroz@ucv.cl		Bravo, Manuel/0000-0002-4548-6265; Mercado, Luis/0000-0003-3883-5188; Aguilar, Luis/0000-0002-6038-3475	FONDECYT [1120203]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	WQ and LA gratefully acknowledge financial support FONDECYT 1120203 (www.fondecyt.cl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariza JLG, 2000, TRAC-TREND ANAL CHEM, V19, P200; Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; Bisacchi D, 2006, ACTA CRYSTALLOGR F, V62, P976, DOI 10.1107/S1744309106033537; De Gregori I, 2005, J CHROMATOGR A, V1091, P94, DOI 10.1016/j.chroma.2005.07.060; De Gregori I, 2007, TALANTA, V73, P458, DOI 10.1016/j.talanta.2007.04.015; Denton H, 2004, BIOCHEM J, V381, P405, DOI 10.1042/BJ20040283; Filella M, 2002, EARTH-SCI REV, V59, P265, DOI 10.1016/S0012-8252(02)00089-2; Frezard F, 2001, ANTIMICROB AGENTS CH, V45, P913, DOI 10.1128/AAC.45.3.913-916.2001; Frezard F, 2009, MOLECULES, V14, P2317, DOI 10.3390/molecules14072317; Furuta N, 2005, J ENVIRON MONITOR, V7, P1155, DOI 10.1039/b513988k; Gao Y, 2002, ATMOS ENVIRON, V36, P1077, DOI 10.1016/S1352-2310(01)00381-8; Ge RG, 2007, ACCOUNTS CHEM RES, V40, P267, DOI 10.1021/ar600001b; Hansen C, 2011, BIOL TRACE ELEM RES, V144, P234, DOI 10.1007/s12011-011-9079-9; Jang H, 2000, WEAR, V239, P229, DOI 10.1016/S0043-1648(00)00314-8; McCallum RI, 2005, J ENVIRON MONITOR, V7, P1245, DOI 10.1039/b509118g; Mukhopadhyay R, 2009, J MOL BIOL, V386, P1229, DOI 10.1016/j.jmb.2008.07.056; Organization W. H, 1990, CONTR LEISHM; Perrin D.D., 1979, CHEM DAT SER, V22, P770; Potin-Gautier M, 2005, ANAL CHIM ACTA, V553, P214, DOI 10.1016/j.aca.2005.07.055; Quiroz W, 2013, MICROCHEM J, V110, P266, DOI 10.1016/j.microc.2013.04.006; Quiroz W, 2013, TALANTA, V115, P902, DOI 10.1016/j.talanta.2013.06.052; Quiroz W, 2011, MICROCHEM J, V97, P78, DOI 10.1016/j.microc.2010.06.015; Quiroz W, 2009, J ENVIRON MONITOR, V11, P1051, DOI 10.1039/b815838j; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Shaked-Mishan P, 2001, J BIOL CHEM, V276, P3971, DOI 10.1074/jbc.M005423200; Sun HZ, 2000, EUR J BIOCHEM, V267, P5450, DOI 10.1046/j.1432-1327.2000.01605.x; Thompson M, 2002, PURE APPL CHEM, V74, P835, DOI 10.1351/pac200274050835; Ulrich N, 2003, CHEM ENG NEWS, V81, P126; von Uexkull O, 2005, J CLEAN PROD, V13, P19, DOI 10.1016/j.jclepro.2003.10.008; Yan SC, 2003, CHEM COMMUN, P266, DOI 10.1039/b210240d; Yan SC, 2003, J BIOL INORG CHEM, V8, P689, DOI 10.1007/s00775-003-0468-1; Zhou Y, 2004, J BIOL CHEM, V279, P37445, DOI 10.1074/jbc.M404383200	32	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0114796	10.1371/journal.pone.0114796	http://dx.doi.org/10.1371/journal.pone.0114796			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615452	Green Published, Green Submitted, gold			2022-12-26	WOS:000349122100004
J	Vincent, G; Ferguson, SA; Tran, J; Larsen, B; Wolkow, A; Aisbett, B				Vincent, Grace; Ferguson, Sally A.; Jacqueline Tran; Larsen, Brianna; Wolkow, Alexander; Aisbett, Brad			Sleep Restriction during Simulated Wildfire Suppression: Effect on Physical Task Performance	PLOS ONE			English	Article							DEPRIVATION; WORK; MODELS; TEMPERATURE; FATIGUE; CAPACITY; DURATION; VALIDITY	Objectives To examine the effects of sleep restriction on firefighters' physical task performance during simulated wildfire suppression. Methods Thirty-five firefighters were matched and randomly allocated to either a control condition (8-hour sleep opportunity, n = 18) or a sleep restricted condition (4-hour sleep opportunity, n = 17). Performance on physical work tasks was evaluated across three days. In addition, heart rate, core temperature, and worker activity were measured continuously. Rate of perceived and exertion and effort sensation were evaluated during the physical work periods. Results There were no differences between the sleep-restricted and control groups in firefighters' task performance, heart rate, core temperature, or perceptual responses during self-paced simulated firefighting work tasks. However, the sleep-restricted group were less active during periods of non-physical work compared to the control group. Conclusions Under self-paced work conditions, 4 h of sleep restriction did not adversely affect firefighters' performance on physical work tasks. However, the sleep-restricted group were less physically active throughout the simulation. This may indicate that sleep-restricted participants adapted their behaviour to conserve effort during rest periods, to subsequently ensure they were able to maintain performance during the firefighter work tasks. This work contributes new knowledge to inform fire agencies of firefighters' operational capabilities when their sleep is restricted during multi-day wildfire events. The work also highlights the need for further research to explore how sleep restriction affects physical performance during tasks of varying duration, intensity, and complexity.	[Vincent, Grace; Larsen, Brianna; Wolkow, Alexander; Aisbett, Brad] Deakin Univ, Ctr Phys Act & Nutr Res, Burwood, Vic 3125, Australia; [Vincent, Grace; Ferguson, Sally A.; Larsen, Brianna; Wolkow, Alexander; Aisbett, Brad] Bushfire Cooperat Res Ctr, East Melbourne, Vic 3002, Australia; [Ferguson, Sally A.] Cent Queensland Univ, Appleton Inst, Wayville, SA 5034, Australia; [Jacqueline Tran] Deakin Univ, Ctr Exercise & Sport Sci, Burwood, Vic 3125, Australia	Deakin University; Central Queensland University; Deakin University	Vincent, G (corresponding author), Deakin Univ, Ctr Phys Act & Nutr Res, Burwood, Vic 3125, Australia.	gvincent@deakin.edu.au	; Aisbett, Brad/E-5178-2011	Tran, Jacqueline/0000-0002-5588-542X; Wolkow, Alexander/0000-0001-7845-3104; Ferguson, Sally/0000-0002-9682-7971; Larsen, Brianna/0000-0003-0885-795X; Vincent, Grace/0000-0002-7036-7823; Aisbett, Brad/0000-0001-8077-0272	Bushfire Co-operative Research Centre	Bushfire Co-operative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This project was funded by the Bushfire Co-operative Research Centre, http://www.bushfirecrc.com/. The funders had no role in the design of the study, data collection, analysis or preparation of the manuscript. Funders have approved the manuscript to be published and provided assistance in participant recruitment.	Abbiss CR, 2011, J APPL PHYSIOL, V110, P1248, DOI 10.1152/japplphysiol.01247.2010; ACSM, 2010, ACSMS GUID EX TEST P; Aisbett B, 2012, APPL ERGON, V43, P916, DOI 10.1016/j.apergo.2011.12.013; Akerstedt T, 2000, J SLEEP RES, V9, P395; American Academy of Sleep Medicine, 2007, AASM MANUAL SCORING; Araujo D, 2007, ECOL PSYCHOL, V19, P69, DOI 10.1080/10407410709336951; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Budd GM, 1997, INT J WILDLAND FIRE, V7, P105, DOI 10.1071/WF9970105; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Byrne C, 2007, BRIT J SPORT MED, V41, P126, DOI 10.1136/bjsm.2006.026344; Cajochen C, 2001, NEUROREPORT, V12, P2277, DOI 10.1097/00001756-200107200-00046; Caldwell JA, 1998, BEHAV RES METH INS C, V30, P651, DOI 10.3758/BF03209483; Carskadon M.A., 2011, PRINC PRACT SLEEP ME, V4, P16, DOI [10.1016/b978-1-4160-6645-3.00002-5, DOI 10.1016/B978-1-4160-6645-3.00002-5]; Cater H, 2007, AUSTR FIR AUTH COUNC; Cuddy JS, 2007, MED SCI SPORT EXER, V39, P1004, DOI 10.1249/mss.0b013e318040b2fb; Darwent D, 2008, APPL ERGON, V39, P614, DOI 10.1016/j.apergo.2008.02.012; Dettoni JL, 2012, J APPL PHYSIOL, V113, P232, DOI 10.1152/japplphysiol.01604.2011; Dinges DF, 2004, AVIAT SPACE ENVIR MD, V75, pA181; Edkins GD, 1997, ACCIDENT ANAL PREV, V29, P533, DOI 10.1016/S0001-4575(97)00033-X; Ferguson S, 2011, DESIGN VALID SIMULAT; Folkard S, 2003, OCCUP MED-OXFORD, V53, P95, DOI 10.1093/occmed/kqg047; Gaskill SE., 2004, HOURS REPORTED SLEEP; Gellish RL, 2007, MED SCI SPORT EXER, V39, P822, DOI 10.1097/mss.0b013e31803349c6; Gibson ASC, 2006, SPORTS MED, V36, P705; Gillberg M, 1998, PHYSIOL BEHAV, V64, P599, DOI 10.1016/S0031-9384(98)00063-8; Havenith G, 2004, APPL ERGON, V35, P3, DOI 10.1016/j.apergo.2003.11.001; Hopkins W., 2006, SPORTSCIENCE, V10, P63; Ingre M, 2004, CHRONOBIOL INT, V21, P973, DOI 10.1081/CBI-200036895; Kachman S, 2000, INTRO GENERALIZED LI, P59; LEGG SJ, 1987, EUR J APPL PHYSIOL O, V56, P64, DOI 10.1007/BF00696378; Lorenzo I, 1995, SLEEP J SLEEP RES SL; MARTIN BJ, 1981, EUR J APPL PHYSIOL O, V47, P345, DOI 10.1007/BF02332962; Mauger AR, 2009, MED SCI SPORT EXER, V41, P451, DOI 10.1249/MSS.0b013e3181854957; Meney I, 1998, CHRONOBIOL INT, V15, P349, DOI 10.3109/07420529808998695; Molenberghs G, 2001, STAT MODEL, V1, P235, DOI 10.1177/1471082X0100100402; Murphy MM, 1984, RELATIONSHIP ANAEROB; MYLES WS, 1985, MED SCI SPORT EXER, V17, P580; MYLES WS, 1987, ERGONOMICS, V30, P1175, DOI 10.1080/00140138708966006; PATTON JF, 1989, WORK STRESS, V3, P69, DOI 10.1080/02678378908256881; Phillips M., 2007, AUSTR FIR AUTH BUSHF; Phillips M, 2011, BUSHF CRC AFAC C SYD; Phillips M, 2012, APPL ERGON, V43, P435, DOI 10.1016/j.apergo.2011.06.018; PLYLEY MJ, 1987, EUR J APPL PHYSIOL O, V56, P338, DOI 10.1007/BF00690902; Rabe-Hesketh S, 2005, J ECONOMETRICS, V128, P301, DOI 10.1016/j.jeconom.2004.08.017; Rabe-Hesketh S, 2002, STATA J, V2, P1, DOI 10.1177/1536867X0200200101; Rama AN, 2006, SLEEP: A COMPREHENSIVE HANDBOOK, P3; RODGERS CD, 1995, SLEEP, V18, P30, DOI 10.1093/sleep/18.1.30; Rodriguez Janeth, 2011, International Journal of Tropical Insect Science, V31, P34, DOI 10.1017/S1742758411000014; RYMAN DH, 1989, WORK STRESS, V3, P57, DOI 10.1080/02678378908256880; SAWKA MN, 1992, MED SCI SPORT EXER, V24, P657; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; SYMONS JD, 1988, MED SCI SPORT EXER, V20, P374, DOI 10.1249/00005768-198808000-00008; Vaara J, 2009, EUR J APPL PHYSIOL, V105, P439, DOI 10.1007/s00421-008-0921-5; Van Dongen HP, 2004, ESSENTIAL NUMERICAL, P225; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2004, SLEEP, V27, P423	57	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115329	10.1371/journal.pone.0115329	http://dx.doi.org/10.1371/journal.pone.0115329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615988	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000349122100010
J	Adam, CL; Williams, PA; Garden, KE; Thomson, LM; Ross, AW				Adam, Clare L.; Williams, Patricia A.; Garden, Karen E.; Thomson, Lynn M.; Ross, Alexander W.			Dose-Dependent Effects of a Soluble Dietary Fibre (Pectin) on Food Intake, Adiposity, Gut Hypertrophy and Gut Satiety Hormone Secretion in Rats	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; GLUCAGON-LIKE PEPTIDE-1; INTESTINAL EPITHELIAL PROLIFERATION; BODY-WEIGHT GAIN; APPETITE REGULATION; CELL PROLIFERATION; INDUCED OBESITY; ENERGY-INTAKE; HEALTH; GLP-2	Soluble fermentable dietary fibre elicits gut adaptations, increases satiety and potentially offers a natural sustainable means of body weight regulation. Here we aimed to quantify physiological responses to graded intakes of a specific dietary fibre (pectin) in an animal model. Four isocaloric semi-purified diets containing 0, 3.3%, 6.7% or 10% w/w apple pectin were offered ad libitum for 8 or 28 days to young adult male rats (n = 8/group). Measurements were made of voluntary food intake, body weight, initial and final body composition by magnetic resonance imaging, final gut regional weights and histology, and final plasma satiety hormone concentrations. In both 8- and 28-day cohorts, dietary pectin inclusion rate was negatively correlated with food intake, body weight gain and the change in body fat mass, with no effect on lean mass gain. In both cohorts, pectin had no effect on stomach weight but pectin inclusion rate was positively correlated with weights and lengths of small intestine and caecum, jejunum villus height and crypt depth, ileum crypt depth, and plasma total glucagon- like peptide-1 (GLP-1) and peptide tyrosine tyrosine (PYY) concentrations, and at 8 days was correlated with weight and length of colon and with caecal mucosal depth. Therefore, the gut's morphological and endocrine adaptations were dose-dependent, occurred within 8 days and were largely sustained for 28 days during continued dietary intervention. Increasing amounts of the soluble fermentable fibre pectin in the diet proportionately decreased food intake, body weight gain and body fat content, associated with proportionately increased satiety hormones GLP-1 and PYY and intestinal hypertrophy, supporting a role for soluble dietary fibre-induced satiety in healthy body weight regulation.	[Adam, Clare L.; Williams, Patricia A.; Garden, Karen E.; Thomson, Lynn M.; Ross, Alexander W.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Obes & Metab Hlth Div, Ingest Behav Grp, Aberdeen AB21 9SB, Scotland	University of Aberdeen	Adam, CL (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Obes & Metab Hlth Div, Ingest Behav Grp, Aberdeen AB21 9SB, Scotland.	c.adam@abdn.ac.uk		Ross, Alexander/0000-0002-1799-1432	Scottish Government's Rural and Environment Science and Analytical Services Division	Scottish Government's Rural and Environment Science and Analytical Services Division	This work was funded by the Scottish Government's Rural and Environment Science and Analytical Services Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam CL, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-36; ALLEN JM, 1984, DIGESTION, V30, P255, DOI 10.1159/000199117; Borg CM, 2007, OBES SURG, V17, P1193, DOI 10.1007/s11695-007-9211-2; BROWN RC, 1979, BRIT J NUTR, V42, P357, DOI 10.1079/BJN19790125; Cani PD, 2004, BRIT J NUTR, V92, P521, DOI 10.1079/BJN20041225; Chelikani PK, 2006, PEPTIDES, V27, P3193, DOI 10.1016/j.peptides.2006.08.001; CHUN W, 1989, DIGESTION, V42, P22, DOI 10.1159/000199821; Clark MJ, 2013, J AM COLL NUTR, V32, P200, DOI 10.1080/07315724.2013.791194; Drucker DJ, 1996, P NATL ACAD SCI USA, V93, P7911, DOI 10.1073/pnas.93.15.7911; Gallwitz Baptist, 2012, Handb Exp Pharmacol, P185, DOI 10.1007/978-3-642-24716-3_8; Ghatei MA, 2001, DIGEST DIS SCI, V46, P1255, DOI 10.1023/A:1010615429639; GOODLAD RA, 1989, GUT, V30, P820, DOI 10.1136/gut.30.6.820; Hansen CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065696; Hansen CF, 2013, AM J TRANSL RES, V5, P347; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Huang XF, 2011, MOL NUTR FOOD RES, V55, P1118, DOI 10.1002/mnfr.201100095; Ichikawa H, 1997, DIGEST DIS SCI, V42, P1598, DOI 10.1023/A:1018884625737; Institute of Medicine of the National Academies of Science IOM, 2005, DIET REF INT EN CARB; Kaji I, 2011, J MOL HISTOL, V42, P27, DOI 10.1007/s10735-010-9304-4; Knapp BK, 2013, NUTRIENTS, V5, P396, DOI 10.3390/nu5020396; KRIPKE SA, 1989, JPEN-PARENTER ENTER, V13, P109, DOI 10.1177/0148607189013002109; le Roux CW, 2010, ANN SURG, V252, P50, DOI 10.1097/SLA.0b013e3181d3d21f; Licht TR, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-13; Lin N, 2013, MOL NUTR FOOD RES, V57, P1291, DOI 10.1002/mnfr.201200695; Maljaars PWJ, 2008, PHYSIOL BEHAV, V95, P271, DOI 10.1016/j.physbeh.2008.07.018; McCullough JS, 1998, GUT, V42, P799, DOI 10.1136/gut.42.6.799; Mudgil D, 2013, INT J BIOL MACROMOL, V61, P1, DOI 10.1016/j.ijbiomac.2013.06.044; Nadkarni PP, 2011, DIABETES OBES METAB, V13, P408, DOI 10.1111/j.1463-1326.2011.01363.x; ORSKOV C, 1986, ENDOCRINOLOGY, V119, P1467, DOI 10.1210/endo-119-4-1467; Parnell JA, 2012, BRIT J NUTR, V107, P601, DOI 10.1017/S0007114511003163; Pedersen C, 2013, APPETITE, V66, P44, DOI 10.1016/j.appet.2013.02.017; SAKATA T, 1983, COMP BIOCHEM PHYS A, V74, P459, DOI 10.1016/0300-9629(83)90631-X; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Sleeth ML, 2010, NUTR RES REV, V23, P135, DOI 10.1017/S0954422410000089; Tazoe H, 2008, J PHYSIOL PHARMACOL, V59, P251; Thulesen J, 2004, CURR PROTEIN PEPT SC, V5, P51, DOI 10.2174/1389203043486946; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Turner ND, 2011, ADV NUTR, V2, P151, DOI 10.3945/an.110.000281; Verdich C, 2001, J CLIN ENDOCR METAB, V86, P4382, DOI 10.1210/jc.86.9.4382; Wanders AJ, 2014, INT J OBESITY, V38, P794, DOI 10.1038/ijo.2013.176; Wikiera A, 2014, POSTEP HIG MED DOSW, V68, P590, DOI 10.5604/17322693.1102342; Willis HJ, 2010, FOOD NUTR RES, V54, DOI 10.3402/fnr.v54i0.5135	42	42	46	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0115438	10.1371/journal.pone.0115438	http://dx.doi.org/10.1371/journal.pone.0115438			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602757	Green Published, gold, Green Submitted			2022-12-26	WOS:000348203500013
J	Gu, Z; Hong, SL; Ke, X; Shen, Y; Wang, XQ; Hu, D; Hu, GH; Kang, HY				Gu, Zheng; Hong, Su-Ling; Ke, Xia; Shen, Yang; Wang, Xiao-Qiang; Hu, Di; Hu, Guo-Hua; Kang, Hou-Yong			FCRL3 Gene Polymorphisms Confer Autoimmunity Risk for Allergic Rhinitis in a Chinese Han Population	PLOS ONE			English	Article							FC RECEPTOR HOMOLOGS; BEHCETS-DISEASE; FCRL3-169T-GREATER-THAN-C POLYMORPHISM; RHEUMATOID-ARTHRITIS; ASSOCIATION; ASTHMA; IMPACT; SUSCEPTIBILITY; IDENTIFICATION; PATHOGENESIS	Background Heredity and environmental exposures may contribute to a predisposition to allergic rhinitis (AR). Autoimmunity may also involve into this pathologic process. FCRL3 (Fc receptor-like 3 gene), a novel immunoregulatory gene, has recently been reported to play a role in autoimmune diseases. Objective This study was performed to evaluate the potential association of FCRL3 polymorphisms with AR in a Chinese Han population. Methods Five single-nucleotide polymorphisms of FCRL3, rs945635, rs3761959, rs7522061, rs10489678 and rs7528684 were genotyped in 540 AR patients and 600 healthy controls using a PCR-restriction fragment length polymorphism assay. Allele, genotype and haplotype frequencies were compared between patients and controls using the X-2 test. The online software platform SHEsis was used to analyze their haplotypes. Results This study identified three strong risk SNPs rs7528684, rs10489678, rs7522061 and one weak risk SNP rs945635 of FCRL3 in Chinese Han AR patients. For rs7528684, a significantly increased prevalence of the AA genotype and A allele in AR patients was recorded. The frequency of the GG genotype and G allele of rs10489678 was markedly higher in AR patients than those in controls. For rs7522061, a higher frequency of the TT genotype, and a lower frequency of the CT genotype were found in AR patients. Concerning rs945635, a lower frequency of the CC genotype, and a higher frequency of G allele were observed in AR patients. According to the analysis of the three strong positive SNPs, the haplotype of AGT increased significantly in AR cases (AR = 38.8%, Controls = 24.3%, P = 8.29x10-14, OR [95% CI] 1.978 [1.652 similar to 2.368]). Conclusions This study found a significant association between the SNPs in FCRL3 gene and AR in Chinese Han patients. The results suggest these gene polymorphisms might be the autoimmunity risk for AR.	[Gu, Zheng; Hong, Su-Ling; Ke, Xia; Shen, Yang; Wang, Xiao-Qiang; Hu, Di; Hu, Guo-Hua; Kang, Hou-Yong] Chongqing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Chongqing, Peoples R China	Chongqing Medical University	Kang, HY (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Chongqing, Peoples R China.	khydoctor@gmail.com			National Natural Science Foundation [81271061]; National key clinic center construction Project, China [[2012]649]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National key clinic center construction Project, China	This work was supported by National Natural Science Foundation Grant (No. 81271061) and National key clinic center construction Project ([2012]649), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2012, J ALLERGY CLIN IMMUN, V130, P1049, DOI 10.1016/j.jaci.2012.07.053; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Chistiakov DA, 2007, HUM IMMUNOL, V68, P375, DOI 10.1016/j.humimm.2007.01.013; Davila I, 2009, J INVEST ALLERG CLIN, V19, P25; Davis RS, 2007, ANNU REV IMMUNOL, V25, P525, DOI 10.1146/annurev.immunol.25.022106.141541; Davis RS, 2001, P NATL ACAD SCI USA, V98, P9772, DOI 10.1073/pnas.171308498; Davis RS, 2002, IMMUNOL REV, V190, P123, DOI 10.1034/j.1600-065X.2002.19009.x; Eyre S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2006; Gaddam SL, 2012, GENET TEST MOL BIOMA, V16, P632, DOI 10.1089/gtmb.2011.0255; Hi G, 2012, AM J RHINOL ALLERGY; Holgate ST, 1999, NATURE, V402, pB2, DOI 10.1038/35037000; Hou SP, 2008, CLIN IMMUNOL, V129, P170, DOI 10.1016/j.clim.2008.06.006; Hou SP, 2012, ARTHRITIS RHEUM-US, V64, P4104, DOI 10.1002/art.37708; Hou SP, 2012, HUM GENET, V131, P1841, DOI 10.1007/s00439-012-1200-4; Hou SP, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3789; Hou SP, 2010, HUM IMMUNOL, V71, P79, DOI 10.1016/j.humimm.2009.09.354; Hu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063858; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Leynaert Benedicte, 2000, Journal of Allergy and Clinical Immunology, V106, pS201; Li K, 2008, MOL VIS, V14, P2136; Martinez A, 2007, J NEUROIMMUNOL, V189, P132, DOI 10.1016/j.jneuroim.2007.06.018; Matesanz F, 2008, J NEUROIMMUNOL, V195, P146, DOI 10.1016/j.jneuroim.2008.01.004; Piotrowski P, 2014, MOD RHEUMATOL, V24, P296, DOI 10.3109/14397595.2013.854066; Shen J, 2011, J HUAZHONG U SCI-MED, V31, P433, DOI 10.1007/s11596-011-0469-1; Shen Y, 2014, HUM IMMUNOL, V75, P991, DOI 10.1016/j.humimm.2014.07.004; Simmonds MJ, 2010, CLIN ENDOCRINOL, V73, P654, DOI 10.1111/j.1365-2265.2010.03843.x; Simmonds MJ, 2006, J CLIN ENDOCR METAB, V91, P1056, DOI 10.1210/jc.2005-1634; Szczepanska M, 2013, ARCH GYNECOL OBSTET, V288, P799, DOI 10.1007/s00404-013-2829-5; Togias A, 2003, J ALLERGY CLIN IMMUN, V111, P1171, DOI 10.1067/mai.2003.1592; Wei P, 2015, EUR ARCH OTO-RHINO-L, V272, P889, DOI 10.1007/s00405-014-3145-9; Xia G, 2010, MOL BIOL REP, V37, P297, DOI 10.1007/s11033-009-9690-4; Yang Y, 2013, AUTOIMMUNITY, V46, P547, DOI 10.3109/08916934.2013.835804; You Y, 2008, J DERMATOL SCI, V52, P118, DOI 10.1016/j.jdermsci.2008.04.011; Young MC, 1998, ALLERGY ASTHMA PROC, V19, P211, DOI 10.2500/108854198778557890; Zhao SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057758	36	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2015	10	1							e0116419	10.1371/journal.pone.0116419	http://dx.doi.org/10.1371/journal.pone.0116419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OS	25594855	gold, Green Submitted, Green Published			2022-12-26	WOS:000348202900001
J	Altun, M; Walter, TS; Kramer, HB; Herr, P; Iphofer, A; Bostrom, J; David, Y; Komsany, A; Ternette, N; Navon, A; Stuart, DI; Ren, JS; Kessler, BM				Altun, Mikael; Walter, Thomas S.; Kramer, Holger B.; Herr, Patrick; Iphoefer, Alexander; Bostrom, Johan; David, Yael; Komsany, Alia; Ternette, Nicola; Navon, Ami; Stuart, David I.; Ren, Jingshan; Kessler, Benedikt M.			The Human Otubain2-Ubiquitin Structure Provides Insights into the Cleavage Specificity of Poly-Ubiquitin-Linkages	PLOS ONE			English	Article							DAMAGE-DEPENDENT UBIQUITINATION; CYSTEINE PROTEASES; CRYSTAL-STRUCTURE; RECOGNITION; INHIBITION; REVEALS; FAMILY	Ovarian tumor domain containing proteases cleave ubiquitin (Ub) and ubiquitin-like polypeptides from proteins. Here we report the crystal structure of human otubain 2 (OTUB2) in complex with a ubiquitin-based covalent inhibitor, Ub-Br2. The ubiquitin binding mode is oriented differently to how viral otubains (vOTUs) bind ubiquitin/ISG15, and more similar to yeast and mammalian OTUs. In contrast to OTUB1 which has exclusive specificity towards Lys48 poly-ubiquitin chains, OTUB2 cleaves different poly-Ub linked chains. N-terminal tail swapping experiments between OTUB1 and OTUB2 revealed how the N-terminal structural motifs in OTUB1 contribute to modulating enzyme activity and Ub-chain selectivity, a trait not observed in OTUB2, supporting the notion that OTUB2 may affect a different spectrum of substrates in Ub-dependent pathways.	[Altun, Mikael; Komsany, Alia; Ternette, Nicola; Kessler, Benedikt M.] Univ Oxford, Nuffield Dept Med, Target Discovery Inst, Oxford OX3 7FZ, England; [Walter, Thomas S.; Stuart, David I.; Ren, Jingshan] Univ Oxford, Nuffield Dept Med, Div Struct Biol, Oxford OX3 7BN, England; [Kramer, Holger B.] Dept Physiol Anat & Genet, Oxford OX1 3DQ, England; [Altun, Mikael; Herr, Patrick; Bostrom, Johan] Karolinska Inst, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, Sci Life Lab, SE-17121 Stockholm, Sweden; [Iphoefer, Alexander] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [David, Yael; Navon, Ami] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	University of Oxford; University of Oxford; Karolinska Institutet; Helmholtz Association; Helmholtz-Center for Infection Research; Weizmann Institute of Science	Ren, JS (corresponding author), Univ Oxford, Nuffield Dept Med, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England.	ren@strubi.ox.ac.uk; benedikt.kessler@ndm.ox.ac.uk	Kessler, Benedikt/AAY-8614-2021; Altun, Mikael/AAI-9527-2020; Kramer, Holger/AAL-4433-2020; Herr, Patrick/ABA-6092-2021; Walter, Thomas/S-8636-2017; Altun, Mikael/AAF-5496-2020; Ren, Jingshan/AAT-7729-2021; Walter, Thomas S/S-5104-2019	Kessler, Benedikt/0000-0002-8160-2446; Altun, Mikael/0000-0002-6937-6124; Kramer, Holger/0000-0002-6400-0945; Herr, Patrick/0000-0003-2945-966X; Walter, Thomas/0000-0002-0030-7235; Ren, Jingshan/0000-0003-4015-1404; Walter, Thomas S/0000-0002-0030-7235; Ternette, Nicola/0000-0002-9283-0743; Stuart, David/0000-0002-3426-4210	Biomedical Research Centre, Oxford, UK; Swedish Medical Research Council; StratNeuro; foundation of Ake Wiberg; foundation of Jeanssons; foundation of Ahlen; foundation of Magnus Bergvalls; foundation of Wenner-Gren; Medical Research Council [G1000099, G0501068, G1100525, MR/N00065X/1] Funding Source: researchfish; MRC [MR/N00065X/1, G0501068, G1000099] Funding Source: UKRI	Biomedical Research Centre, Oxford, UK; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); StratNeuro; foundation of Ake Wiberg; foundation of Jeanssons; foundation of Ahlen; foundation of Magnus Bergvalls; foundation of Wenner-Gren; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Biomedical Research Centre, Oxford, UK (B.M.K.). M.A. is supported as a Hallsten Academy fellow, the Swedish Medical Research Council, StratNeuro, the foundations of Ake Wiberg, Jeanssons, Ahlen, Magnus Bergvalls and Wenner-Gren. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akutsu M, 2011, P NATL ACAD SCI USA, V108, P2228, DOI 10.1073/pnas.1015287108; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Beck A, 2013, DIABETOLOGIA, V56, P1317, DOI 10.1007/s00125-013-2889-x; Borek D, 2010, ACTA CRYSTALLOGR D, V66, P426, DOI 10.1107/S0907444909040177; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Capodagli GC, 2011, J VIROL, V85, P3621, DOI 10.1128/JVI.02496-10; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edelmann MJ, 2010, FEBS J, V277, P2515, DOI 10.1111/j.1742-4658.2010.07665.x; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Goncharov T, 2013, EMBO J, V32, P1103, DOI 10.1038/emboj.2013.62; James TW, 2011, P NATL ACAD SCI USA, V108, P2222, DOI 10.1073/pnas.1013388108; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kato K, 2014, MOL CELL, V53, P617, DOI 10.1016/j.molcel.2014.01.030; Kattenhorn LM, 2005, MOL CELL, V19, P547, DOI 10.1016/j.molcel.2005.07.003; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nanao MH, 2004, EMBO REP, V5, P783, DOI 10.1038/sj.embor.7400201; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Ritorto MS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5763; Ruschak AM, 2011, J NATL CANCER I, V103, P1007, DOI 10.1093/jnci/djr160; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Sun XX, 2011, EMBO J; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/nchembio.426, 10.1038/NCHEMBIO.426]; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808; Wiener R, 2013, NAT STRUCT MOL BIOL, V20, P1033, DOI 10.1038/nsmb.2655; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911	38	25	25	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0115344	10.1371/journal.pone.0115344	http://dx.doi.org/10.1371/journal.pone.0115344			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590432	Green Submitted, Green Published, gold			2022-12-26	WOS:000350679400006
J	Liu, YQ; Huang, LY; Lu, Y; Xi, XE; Huang, XL; Lu, QH; Huang, XM; Li, S; Qin, X				Liu, Yanqiong; Huang, Liying; Lu, Yu; Xi, Xue-E; Huang, Xiu-Li; Lu, Qinghua; Huang, Xiamei; Li, Shan; Qin, Xue			Relationships between the Osteocalcin Gene Polymorphisms, Serum Osteocalcin Levels, and Hepatitis B Virus-Related Hepatocellular Carcinoma in a Chinese Population	PLOS ONE			English	Article							BONE-MINERAL DENSITY; FATTY LIVER-DISEASE; PROSTATE-CANCER; GLA PROTEIN; JAPANESE WOMEN; BREAST-CANCER; RISK-FACTORS; ASSOCIATION; OSTEOPOROSIS; INFECTION	Background Available evidence has demonstrated that osteocalcin may play a role in pathogenesis of cancer, and mutation of the osteocalcin gene may be involved in the cancer development. The aim of this study is to determine whether osteocalcin gene polymorphisms are associated with hepatitis B virus (HBV) related hepatocellular carcinoma (HCC) among Chinese population. Methods A total of 515 subjects were divided into four groups: 129 patients with chronic hepatitis B (CHB), 62 patients with HBV-related liver cirrhosis (LC), 154 patients with HBV-related HCC, and 170 healthy controls. The polymerase chain reaction-restriction fragment length polymorphism strategy was used to detect osteocalcin gene rs1800247 and rs1543297 polymorphisms. Results Compared with healthy controls, the rs1800247 HH and Hh genotypes were associated with a significantly increased susceptibility to HCC (HH versus hh: OR = 6.828, 95% CI 2.620-17.795, P < 0.001; Hh versus hh: OR = 6.306, 95% CI 3.480-11.423, P < 0.001, respectively). Similarly, the subjects bearing the H allele of rs1800247 had more than a 2.4-fold increased risk for development of HCC (OR = 2.484, 95% CI 1.747-3.532, P < 0.001) compared with those bearing the h allele. In addition, we found significant decreased serum osteocalcin levels in HBV-related HCC patients (11.73 +/- 8.18 ng/mL) compared with healthy controls (15.3 +/- 6.06 ng/mL). Furthermore, the serum osteocalcin levels were significantly lower in HCC patients than healthy controls among the individuals with heterozygous Hh genotype (P = 0.003) and CT genotype (P < 0.001). In contrast, there were no significant differences in the genotype and allele of rs1543297 polymorphisms between the groups of patients and healthy controls. Conclusions These findings for the first time suggest that genetic variant in osteocalcin gene rs1800247 polymorphisms may be a risk factor for HBV-related HCC. We also find an inverse association of serum osteocalcin levels with HCC.	[Liu, Yanqiong; Huang, Liying; Lu, Yu; Huang, Xiu-Li; Lu, Qinghua; Huang, Xiamei; Li, Shan; Qin, Xue] Guangxi Med Univ, Dept Clin Lab, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Xi, Xue-E] Nanning Social Welf Hosp, Dept Clin Lab, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Li, S (corresponding author), Guangxi Med Univ, Dept Clin Lab, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.	lis8858@126.com; qinxue919@126.com			National Natural Science Foundation of China [81260302, 81460431]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (No. 81260302 and No. 81460431). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller R, 2011, ANN HEPATOL, V10, P50, DOI 10.1016/S1665-2681(19)31587-X; Aravalli RN, 2013, ARCH TOXICOL, V87, P227, DOI 10.1007/s00204-012-0931-2; Chen CJ, 1997, J GASTROEN HEPATOL, V12, pS294, DOI 10.1111/j.1440-1746.1997.tb00513.x; Chen HY, 2001, J CLIN LAB ANAL, V15, P251, DOI 10.1002/jcla.1036; Chuang SC, 2009, CANCER LETT, V286, P9, DOI 10.1016/j.canlet.2008.10.040; Dohi Y, 1998, J BONE MINER RES, V13, P1633, DOI 10.1359/jbmr.1998.13.10.1633; Elston RC, 1998, GENET EPIDEMIOL, V15, P565, DOI 10.1002/(SICI)1098-2272(1998)15:6<565::AID-GEPI2>3.0.CO;2-J; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Ferlay J, 2013, IARC CANCERBASE; FRANCINI G, 1988, AM J CLIN ONCOL-CANC, V11, pS83, DOI 10.1097/00000421-198801102-00021; Ivaska KK, 2004, J BIOL CHEM, V279, P18361, DOI 10.1074/jbc.M314324200; KAMBY C, 1993, SCAND J CLIN LAB INV, V53, P439, DOI 10.3109/00365519309092538; Kim JG, 2006, MENOPAUSE, V13, P467, DOI 10.1097/01.gme.0000182803.06762.fb; Koeneman KS, 2000, WORLD J UROL, V18, P102, DOI 10.1007/s003450050181; Li S, 2011, INFECT GENET EVOL, V11, P2083, DOI 10.1016/j.meegid.2011.09.025; LIAN JB, 1988, CLIN ORTHOP RELAT R, P267; Liu JJ, 2013, INT J MOL SCI, V14, P19782, DOI 10.3390/ijms141019782; Liu YQ, 2014, INFECT GENET EVOL, V27, P69, DOI 10.1016/j.meegid.2014.07.002; Liu YQ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0200-8; Lu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110061; Mahdy KA, 2007, WORLD J GASTROENTERO, V13, P785, DOI 10.3748/wjg.v13.i5.785; MARCELLINI M, 1992, EUR UROL, V21, P102; Mathew S, 2014, INFECT GENET EVOL, V26, P327, DOI 10.1016/j.meegid.2014.06.014; McGuigan F, 2010, J BONE MINER RES, V25, P1392, DOI 10.1002/jbmr.32; PIETSCHMANN P, 1989, J CANCER RES CLIN, V115, P456, DOI 10.1007/BF00393337; PRICE PA, 1980, J CLIN INVEST, V66, P878, DOI 10.1172/JCI109954; Qin X, 2014, CLIN LAB, V60, P1177, DOI 10.7754/Clin.Lab.2013.130331; Qin X, 2012, DNA CELL BIOL, V31, P1125, DOI 10.1089/dna.2011.1438; Raymond MH, 1999, GENOMICS, V60, P210, DOI 10.1006/geno.1999.5893; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Strohmaier WL, 1996, EUR UROL, V30, P103; Sugiyama T, 2001, J BONE MINER METAB, V19, P146, DOI 10.1007/s007740170034; Tan AH, 2011, METABOLISM, V60, P1186, DOI 10.1016/j.metabol.2011.01.002; Wu HC, 2003, EUR UROL, V43, P197, DOI 10.1016/S0302-2838(02)00541-9; Xi XE, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0355-3; Yamada Y, 2003, J CLIN ENDOCR METAB, V88, P3372, DOI 10.1210/jc.2002-021449; Yeung F, 2002, J BIOL CHEM, V277, P2468, DOI 10.1074/jbc.M105947200; Yilmaz Y, 2011, SCAND J CLIN LAB INV, V71, P631, DOI 10.3109/00365513.2011.604427	38	4	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116479	10.1371/journal.pone.0116479	http://dx.doi.org/10.1371/journal.pone.0116479			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587715	Green Published, gold, Green Submitted			2022-12-26	WOS:000347928300013
J	Takahashi, T; Takase, Y; Yoshino, T; Saito, D; Tadokoro, R; Takahashi, Y				Takahashi, Teruaki; Takase, Yuta; Yoshino, Takashi; Saito, Daisuke; Tadokoro, Ryosuke; Takahashi, Yoshiko			Angiogenesis in the Developing Spinal Cord: Blood Vessel Exclusion from Neural Progenitor Region Is Mediated by VEGF and Its Antagonists	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; CHICKEN EMBRYOS; NERVOUS-SYSTEM; NEUROVASCULAR DEVELOPMENT; ADHERENS JUNCTIONS; TYROSINE KINASE; SOLUBLE FLT-1; DORSAL AORTA; IN-VIVO; CELLS	Blood vessels in the central nervous systemsupply a considerable amount of oxygen via intricate vascular networks. We studied how the initial vasculature of the spinal cord is formed in avian (chicken and quail) embryos. Vascular formation in the spinal cord starts by the ingression of intra-neural vascular plexus (INVP) from the peri-neural vascular plexus (PNVP) that envelops the neural tube. At the ventral region of the PNVP, the INVP grows dorsally in the neural tube, and we observed that these vessels followed the defined path at the interface between the medially positioned and undifferentiated neural progenitor zone and the laterally positioned differentiated zone. When the interface between these two zones was experimentally displaced, INVP faithfully followed a newly formed interface, suggesting that the growth path of the INVP is determined by surrounding neural cells. The progenitor zone expressed mRNA of vascular endothelial growth factor-A whereas its receptor VEGFR2 and FLT-1 (VEGFR1), a decoy for VEGF, were expressed in INVP. By manipulating the neural tube with either VEGF or the soluble form of FLT-1, we found that INVP grew in a VEGF-dependent manner, where VEGF signals appear to be fine-tuned by counteractions with anti-angiogenic activities including FLT-1 and possibly semaphorins. These results suggest that the stereotypic patterning of early INVP is achieved by interactions between these vessels and their surrounding neural cells, where VEGF and its antagonists play important roles.	[Takahashi, Teruaki; Takase, Yuta; Yoshino, Takashi; Tadokoro, Ryosuke; Takahashi, Yoshiko] Kyoto Univ, Grad Sch Sci, Dept Zool, Kyoto, Japan; [Takahashi, Teruaki] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Japan; [Saito, Daisuke] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 980, Japan; [Takahashi, Yoshiko] JST, CREST, Tokyo, Japan	Kyoto University; Nara Institute of Science & Technology; Tohoku University; Japan Science & Technology Agency (JST)	Takahashi, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Zool, Kyoto, Japan.		Saito, Daisuke/AAL-8492-2021	Saito, Daisuke/0000-0002-5999-2505	Ministry of Education, Culture, Sports, Science and Technology of Japan, MEXT, Japan; CREST (JST); Mitsubishi Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan, MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Mitsubishi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, MEXT, Japan, CREST (JST), The Mitsubishi Foundation, and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Atsuta Y, 2013, DEV GROWTH DIFFER, V55, P579, DOI 10.1111/dgd.12047; Bautch VL, 2009, CELL ADHES MIGR, V3, P199, DOI 10.4161/cam.3.2.8397; Bron R, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-21; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chappell JC, 2009, DEV CELL, V17, P377, DOI 10.1016/j.devcel.2009.07.011; Chauvet S, 2013, CELL MOL LIFE SCI, V70, P1685, DOI 10.1007/s00018-013-1278-4; Chen L, 2009, DEV BIOL, V325, P162, DOI 10.1016/j.ydbio.2008.10.023; Christensen CRL, 1998, CANCER RES, V58, P1238; de Almodovar CR, 2011, NEURON, V70, P966, DOI 10.1016/j.neuron.2011.04.014; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Eichmann A, 2005, INT J DEV BIOL, V49, P259, DOI 10.1387/ijdb.041941ae; Eichmann A, 2012, COLD SPRING HARBOR P, V3; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; FEENEY JF, 1946, J MORPHOL, V78, P231, DOI 10.1002/jmor.1050780205; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gerhardt H, 2004, DEV DYNAM, V231, P503, DOI 10.1002/dvdy.20148; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Ghosh S, 2008, P NATL ACAD SCI USA, V105, P335, DOI 10.1073/pnas.0705713105; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hirota S, 2011, DEVELOPMENT, V138, P5157, DOI 10.1242/dev.069153; James JM, 2011, SEMIN CELL DEV BIOL, V22, P1019, DOI 10.1016/j.semcdb.2011.09.010; James JM, 2009, DEVELOPMENT, V136, P833, DOI 10.1242/dev.028845; Katayama KI, 2011, P NATL ACAD SCI USA, V108, P7607, DOI 10.1073/pnas.1101347108; Kim J, 2011, GENE DEV, V25, P1399, DOI 10.1101/gad.2042011; Kurz H, 1996, DEV BIOL, V173, P133, DOI 10.1006/dbio.1996.0012; Kurz H, 2009, CELL ADHES MIGR, V3, P205, DOI 10.4161/cam.3.2.7855; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Ma S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001469; Mackenzie F, 2012, DEVELOPMENT, V139, P1371, DOI 10.1242/dev.072348; Mauti O, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-28; Meadows SM, 2011, CIRC RES, V110, P34; Meadows SM, 2013, DEV DYNAM, V242, P580, DOI 10.1002/dvdy.23949; Meszar Z, 2008, BRAIN RES BULL, V75, P414, DOI 10.1016/j.brainresbull.2007.10.052; Momose T, 1999, DEV GROWTH DIFFER, V41, P335; Morest AK, 2003, GLIA, V43, P6, DOI [10.1002/glia.10288, 10.1002/glia.10238]; Moyon D, 2001, DEVELOPMENT, V128, P3359; Nagase T, 2005, GENES CELLS, V10, P595, DOI 10.1111/j.1365-2443.2005.00861.x; Nimmagadda S, 2004, ANAT EMBRYOL, V208, P219, DOI 10.1007/s00429-004-0396-z; Oh WJ, 2013, NEURON, V80, P458, DOI 10.1016/j.neuron.2013.09.005; Oh WJ, 2013, SEMIN CELL DEV BIOL, V24, P156, DOI 10.1016/j.semcdb.2012.12.001; Ohata E, 2009, DEV BIOL, V335, P33, DOI 10.1016/j.ydbio.2009.08.010; PARDANAUD L, 1987, DEVELOPMENT, V100, P339; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Pouget C, 2006, DEVELOPMENT, V133, P1013, DOI 10.1242/dev.02269; Quaegebeur A, 2011, NEURON, V71, P406, DOI 10.1016/j.neuron.2011.07.013; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Roztocil T, 1997, DEVELOPMENT, V124, P3263; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Ruhrberg C, 2013, CELL MOL LIFE SCI, V70, P1675, DOI 10.1007/s00018-013-1277-5; Saito D, 2012, SCIENCE, V336, P1578, DOI 10.1126/science.1222369; Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09; Sato Y, 2008, DEV CELL, V14, P890, DOI 10.1016/j.devcel.2008.03.024; Sato Y, 2007, DEV BIOL, V305, P616, DOI 10.1016/j.ydbio.2007.01.043; Shibuya M, 2008, BMB REP, V41, P278, DOI 10.5483/BMBRep.2008.41.4.278; Shibuya M, 2013, J BIOCHEM, V153, P13, DOI 10.1093/jb/mvs136; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Stenzel D, 2011, DEVELOPMENT, V138, P4451, DOI 10.1242/dev.071381; Takase Y, 2013, DEV GROWTH DIFFER, V55, P792, DOI 10.1111/dgd.12106; Tonegawa A, 2003, DEV BIOL, V262, P32, DOI 10.1016/S0012-1606(03)00327-0; Vieira JM, 2007, DEVELOPMENT, V134, P1833, DOI 10.1242/dev.002402; Watanabe T, 2007, DEV BIOL, V305, P625, DOI 10.1016/j.ydbio.2007.01.042; Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232; Wolf AM, 2008, J NEUROSCI, V28, P3456, DOI 10.1523/JNEUROSCI.0029-08.2008; Xie ZH, 2011, P NATL ACAD SCI USA, V108, P12119, DOI 10.1073/pnas.1100160108; Yamaguchi S, 2002, BIOCHEM BIOPH RES CO, V291, P554, DOI 10.1006/bbrc.2002.6478; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yokota Y, 2011, DEV BIOL, V353, P382, DOI 10.1016/j.ydbio.2011.02.001; Yoshino T, 2011, DEV GROWTH DIFFER, V53, P378, DOI 10.1111/j.1440-169X.2011.01252.x	78	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0116119	10.1371/journal.pone.0116119	http://dx.doi.org/10.1371/journal.pone.0116119			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OG	25585380	Green Published, gold, Green Submitted			2022-12-26	WOS:000348201300006
J	Kai, M; Ueno, N; Kinoshita, N				Kai, Masatake; Ueno, Naoto; Kinoshita, Noriyuki			Phosphorylation-Dependent Ubiquitination of Paraxial Protocadherin (PAPC) Controls Gastrulation Cell Movements	PLOS ONE			English	Article							BETA-CATENIN PHOSPHORYLATION; NONCANONICAL WNT PATHWAY; CONVERGENT EXTENSION; XENOPUS EMBRYOS; C-CADHERIN; MESODERM; ADHESION; MORPHOGENESIS; SOMITOGENESIS; TARGET	Paraxial protocadherin (PAPC) has been shown to be involved in gastrulation cell movements during early embryogenesis. It is first expressed in the dorsal marginal zone at the early gastrula stage and subsequently restricted to the paraxial mesoderm in Xenopus and zebrafish. Using Xenopus embryos, we found that PAPC is also regulated at the protein level and is degraded and excluded from the plasma membrane in the axial mesoderm by the late gastrula stage. Regulation of PAPC requires poly-ubiquitination that is dependent on phosphorylation. PAPC is phosphorylated by GKS3 in the evolutionarily conserved cytoplasmic domain, and this in turn is necessary for poly-ubiquitination by an E3 ubiquitin ligase beta-TrCP. We also show that precise control of PAPC by phosphorylation/ubiquitination is essential for normal Xenopus gastrulation cell movements. Taken together, our findings unveil a novel mechanism of regulation of a cell adhesion protein and show that this system plays a crucial role in vertebrate embryogenesis.	[Kai, Masatake; Ueno, Naoto; Kinoshita, Noriyuki] Natl Inst Nat Sci, Natl Inst Basic Biol, Dept Dev Biol, Okazaki, Aichi 4448585, Japan; [Ueno, Naoto; Kinoshita, Noriyuki] SOKENDAI, Dept Mol Biomech, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Kinoshita, N (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Dept Dev Biol, 38 Nishigonaka,Myodaiji Cho, Okazaki, Aichi 4448585, Japan.	nkinoshi@nibb.ac.jp		Kinoshita, Noriyuki/0000-0002-1362-4045; Ueno, Naoto/0000-0002-8375-2317	MEXT KAKENHI [23111528]; JSPS KAKENHI [23570262, 12640066]; Grants-in-Aid for Scientific Research [22127007] Funding Source: KAKEN	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: The work was supported by the following: MEXT KAKENHI 23111528 to NK; JSPS KAKENHI 23570262 to NK; and JSPS KAKENHI 12640066 to MK (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bax B, 2001, STRUCTURE, V9, P1143, DOI 10.1016/S0969-2126(01)00679-7; Chen X, 2007, J BIOL CHEM, V282, P32128, DOI 10.1074/jbc.M705337200; Chen X, 2006, J CELL BIOL, V174, P301, DOI 10.1083/jcb.200602062; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Chung HA, 2007, CURR BIOL, V17, P932, DOI 10.1016/j.cub.2007.04.034; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Iioka H, 2004, J CELL BIOL, V164, P169, DOI 10.1083/jcb.200310027; Iioka H, 2007, NAT CELL BIOL, V9, P813, DOI 10.1038/ncb1607; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kim SH, 1998, DEVELOPMENT, V125, P4681; Kim SH, 2000, CURR BIOL, V10, P821, DOI 10.1016/S0960-9822(00)00580-7; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kraft B, 2012, J CELL BIOL, V198, P695, DOI 10.1083/jcb.201110076; Lee RHK, 2007, EMBO J, V26, P3592, DOI 10.1038/sj.emboj.7601781; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Martin BL, 2012, DEV CELL, V22, P223, DOI 10.1016/j.devcel.2011.11.001; Medina A, 2004, EMBO J, V23, P3249, DOI 10.1038/sj.emboj.7600329; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; NIEUWKOOP PD, 1975, NORMAL TABLE OF XENO; Nowotschin S, 2012, DEV BIOL, V367, P1, DOI 10.1016/j.ydbio.2012.04.012; PENG HB, 1991, METHOD CELL BIOL, V36, P657; PIERCE SB, 1995, DEVELOPMENT, V121, P755; Redies C, 2005, CELL MOL LIFE SCI, V62, P2840, DOI 10.1007/s00018-005-5320-z; Rhee J, 2003, DEV BIOL, V254, P248, DOI 10.1016/S0012-1606(02)00085-4; Uemura M, 2007, NAT NEUROSCI, V10, P1151, DOI 10.1038/nn1960; Unterseher F, 2004, EMBO J, V23, P3259, DOI 10.1038/sj.emboj.7600332; Wang Y, 2008, GENE DEV, V22, P878, DOI 10.1101/gad.452908; Weidinger G, 2003, J CELL BIOL, V162, P753, DOI 10.1083/jcb.200307181; Winklbauer R, 2009, INT REV CEL MOL BIO, V278, P215, DOI 10.1016/S1937-6448(09)78005-0; Yamamoto A, 1998, DEVELOPMENT, V125, P3389	34	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2015	10	1							e0115111	10.1371/journal.pone.0115111	http://dx.doi.org/10.1371/journal.pone.0115111			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4CF	25580871	Green Submitted, Green Published, gold			2022-12-26	WOS:000348169100001
J	Catalan, E; Jaime-Sanchez, P; Aguilo, N; Simon, MM; Froelich, CJ; Pardo, J				Catalan, Elena; Jaime-Sanchez, Paula; Aguilo, Nacho; Simon, Markus M.; Froelich, Christopher J.; Pardo, Julian			Mouse Cytotoxic T Cell-derived Granzyme B Activates the Mitochondrial Cell Death Pathway in a Bim-dependent Fashion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; CASPASE ACTIVATION; MEDIATED APOPTOSIS; PROTEIN BIM; ER STRESS; BAX; REQUIRES; DIVERGENT; CLEAVAGE; COMPLEX	Cytotoxic T cells (Tc) use perforin and granzyme B (gzmB) to kill virus-infected cells and cancer cells. Recent evidence suggests that human gzmB primarily induces apoptosis via the intrinsic mitochondrial pathway by either cleaving Bid or activating Bim leading to the activation of Bak/Bax and subsequent generation of active caspase-3. In contrast, mouse gzmB is thought to predominantly induce apoptosis by directly processing pro-caspase-3. However, in certain mouse cell types gzmB-mediated apoptosis mainly occurs via the mitochondrial pathway. To investigate whether Bim is involved under the latter conditions, we have now employed ex vivo virus-immune mouse Tc that selectively kill by using perforin and gzmB (gzmB(+)Tc) as effector cells and wild type as well as Bim- or Bak/Bax-deficient spontaneously (3T9) or virus-(SV40) transformed mouse embryonic fibroblast cells as targets. We show that gzmB(+)Tc-mediated apoptosis (phosphatidylserine translocation, mitochondrial depolarization, cytochrome c release, and caspase-3 activation) was severely reduced in 3T9 cells lacking either Bim or both Bak and Bax. This outcome was related to the ability of c cells to induce the degradation of Mcl-1 and Bcl-X-L, the anti-apoptotic counterparts of Bim. In contrast, gzmB(+)Tc-mediated apoptosis was not affected in SV40-transformed mouse embryonic fibroblast cells lacking Bak/Bax. The data provide evidence that Bim participates in mouse gzmB+Tc-mediated apoptosis of certain targets by activating the mitochondrial pathway and suggest that the mode of cell death depends on the target cell. Our results suggest that the various molecular events leading to transformation and/or immortalization of cells have an impact on their relative resistance to the multiple gzmB(+)Tc-induced death pathways.	[Catalan, Elena; Jaime-Sanchez, Paula; Pardo, Julian] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain; [Catalan, Elena; Jaime-Sanchez, Paula; Pardo, Julian] Univ Zaragoza, Biomed Res Ctr Aragon, IIS Aragon, E-50009 Zaragoza, Spain; [Aguilo, Nacho; Pardo, Julian] Univ Zaragoza, Dept Microbiol Med Prevent & Salud Publ, E-50009 Zaragoza, Spain; [Simon, Markus M.] Max Planck Inst Immunbiol & Epigenet, Metschnikoff Lab, D-79108 Freiburg, Germany; [Froelich, Christopher J.] Univ Chicago, NorthShore Univ Hlth Syst Res Inst, Evanston, IL 60201 USA; [Pardo, Julian] Univ Zaragoza, Nanosci Inst Aragon, Zaragoza 50015, Spain; [Pardo, Julian] Aragon I D Fdn, Zaragoza 50015, Spain	University of Zaragoza; University of Zaragoza; University of Zaragoza; Max Planck Society; NorthShore University Health System; University of Chicago; University of Zaragoza	Pardo, J (corresponding author), Biomed Res Ctr Aragon, Edificio CIBA,Avda San Juan Bosco 13, Zaragoza 50009, Spain.	pardojim@unizar.es	Pardo, Julián/K-6764-2014; AGUILO, NACHO/K-2750-2014; AGUILO, NACHO/GPK-7678-2022	Pardo, Julián/0000-0003-0154-0730; AGUILO, NACHO/0000-0001-7897-9173; AGUILO, NACHO/0000-0001-7897-9173	Spanish Ministry of Science and Innovation and Economy and Competitiveness [SAF2008-02139, SAF2011-25390]	Spanish Ministry of Science and Innovation and Economy and Competitiveness	This work was supported in part by Grants SAF2008-02139 and SAF2011-25390 from the Spanish Ministry of Science and Innovation and Economy and Competitiveness.	Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Alimonti JB, 2001, J BIOL CHEM, V276, P6974, DOI 10.1074/jbc.M008444200; Ashton-Rickardt PG, 2005, CRIT REV IMMUNOL, V25, P161, DOI 10.1615/CritRevImmunol.v25.i3.10; Barry M, 2000, MOL CELL BIOL, V20, P3781, DOI 10.1128/MCB.20.11.3781-3794.2000; Bleackley RC, 2005, BIOCHEM CELL BIOL, V83, P747, DOI 10.1139/O05-146; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Casciola-Rosen L, 2007, J BIOL CHEM, V282, P4545, DOI 10.1074/jbc.M606564200; Cullen SP, 2007, J CELL BIOL, V176, P435, DOI 10.1083/jcb.200612025; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; Goping IS, 2003, IMMUNITY, V18, P355, DOI 10.1016/S1074-7613(03)00032-3; Han J, 2005, J BIOL CHEM, V280, P16383, DOI 10.1074/jbc.M411377200; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; Hoves S, 2010, J LEUKOCYTE BIOL, V87, P237, DOI 10.1189/jlb.0909608; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Hutcheson J, 2005, J EXP MED, V201, P1949, DOI 10.1084/jem.20041484; Joeckel LT, 2011, CELL DEATH DIFFER, V18, P1112, DOI 10.1038/cdd.2011.5; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lieberman J, 2010, IMMUNOL REV, V235, P93, DOI 10.1111/j.0105-2896.2010.00902.x; Lord SJ, 2003, IMMUNOL REV, V193, P31, DOI 10.1034/j.1600-065X.2003.00044.x; Metkar SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024286; Pardo J, 2008, CELL DEATH DIFFER, V15, P567, DOI 10.1038/sj.cdd.4402289; Pardo J, 2004, J CELL BIOL, V167, P457, DOI 10.1083/jcb.200406115; Pardo J, 2002, EUR J IMMUNOL, V32, P1980, DOI 10.1002/1521-4141(200207)32:7<1980::AID-IMMU1980>3.0.CO;2-Z; Pardo J, 2009, MICROBES INFECT, V11, P452, DOI 10.1016/j.micinf.2009.02.004; Pinkoski MJ, 2001, J BIOL CHEM, V276, P12060, DOI 10.1074/jbc.M009038200; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Sarosiek KA, 2013, MOL CELL, V51, P751, DOI 10.1016/j.molcel.2013.08.048; Sutton VR, 2000, J EXP MED, V192, P1403, DOI 10.1084/jem.192.10.1403; Sutton VR, 2003, IMMUNITY, V18, P319, DOI 10.1016/S1074-7613(03)00050-5; Thomas DA, 2001, P NATL ACAD SCI USA, V98, P14985, DOI 10.1073/pnas.261581498; Trapani JA, 2003, CURR OPIN IMMUNOL, V15, P533, DOI 10.1016/S0952-7915(03)00107-9; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Trapani JA, 2008, IMMUNITY, V29, P665, DOI 10.1016/j.immuni.2008.10.002; Vela L, 2013, J BIOL CHEM, V288, P4935, DOI 10.1074/jbc.M112.422204; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Waterhouse NJ, 2003, CELL DEATH DIFFER, V10, P853, DOI 10.1038/sj.cdd.4401263; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Zhu YN, 2004, P NATL ACAD SCI USA, V101, P7681, DOI 10.1073/pnas.0402293101	41	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6868	6877		10.1074/jbc.M114.631564	http://dx.doi.org/10.1074/jbc.M114.631564			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605735	Green Published, hybrid			2022-12-26	WOS:000350991500022
J	Dijksterhuis, JP; Baljinnyam, B; Stanger, K; Sercan, HO; Ji, Y; Andres, O; Rubin, JS; Hannoush, RN; Schulte, G				Dijksterhuis, Jacomijn P.; Baljinnyam, Bolormaa; Stanger, Karen; Sercan, Hakki O.; Ji, Yun; Andres, Osler; Rubin, Jeffrey S.; Hannoush, Rami N.; Schulte, Gunnar			Systematic Mapping of WNT-FZD Protein Interactions Reveals Functional Selectivity by Distinct WNT-FZD Pairs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT/BETA-CATENIN; INTERNATIONAL UNION; FRIZZLED 6; MICROGLIA; RECEPTORS; MEMBRANE; PATHWAY; PHOSPHORYLATION; ACTIVATION; SURVIVAL	The seven-transmembrane-spanning receptors of the FZD1-10 class are bound and activated by the WNT family of lipoglycoproteins, thereby inducing a complex network of signaling pathways. However, the specificity of the interaction between mammalian WNT and FZD proteins and the subsequent signaling cascade downstream of the different WNT-FZD pairs have not been systematically addressed to date. In this study, we determined the binding affinities of various WNTs for different members of the FZD family by using bio-layer interferometry and characterized their functional selectivity in a cell system. Using purified WNTs, we show that different FZD cysteine-rich domains prefer to bind to distinct WNTs with fast on-rates and slow off-rates. In a 32D cell-based system engineered to overexpress FZD(2), FZD(4), or FZD(5), we found that WNT-3A (but not WNT-4, -5A, or -9B) activated the WNT-beta-catenin pathway through FZD(2/4/5) as measured by phosphorylation of LRP6 and beta-catenin stabilization. Surprisingly, different WNT-FZD pairs showed differential effects on phosphorylation of DVL2 and DVL3, revealing a previously unappreciated DVL isoform selectivity by different WNT-FZD pairs in 32D cells. In summary, we present extensive mapping of WNT-FZD cysteine-rich domain interactions complemented by analysis of WNT-FZD pair functionality in a unique cell system expressing individual FZD isoforms. Differential WNT-FZD binding and selective functional readouts suggest that endogenous WNT ligands evolved with an intrinsic natural bias toward different downstream signaling pathways, a phenomenon that could be of great importance in the design of FZD-targeting drugs.	[Dijksterhuis, Jacomijn P.; Schulte, Gunnar] Karolinska Inst, Dept Physiol & Pharmacol, Sect Receptor Biol & Signaling, S-17177 Stockholm, Sweden; [Dijksterhuis, Jacomijn P.; Sercan, Hakki O.; Ji, Yun; Andres, Osler; Rubin, Jeffrey S.] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Stanger, Karen; Hannoush, Rami N.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Schulte, Gunnar] Masaryk Univ, Fac Sci, Inst Expt Biol, CS-61137 Brno, Czech Republic	Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Roche Holding; Genentech; Masaryk University Brno	Hannoush, RN (corresponding author), Genentech Inc, Dept Early Discovery Biochem, 1 DNA Way, San Francisco, CA 94080 USA.	hannoush.rami@gene.com; gunnar.schulte@ki.se		Dijksterhuis, Jacomijn/0000-0002-9214-6255; Schulte, Gunnar/0000-0002-2700-7013	National Institutes of Health NCI Intramural Research Program; Karolinska Institutet; Swedish Research Council [K2008-68P-20810-01-4, K2008-68X-20805-01-4, K2011-67X-20805-05-3]; Swedish Cancer Society [CAN 2008/539, 2011/690]; KI-NIH Joint PhD Program; Signhild Engkvist Foundations; KI-MU Project [CZ.1.07/2.3.00/20.0180]; Czech Research Council [GACR 13-32990S]	National Institutes of Health NCI Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); KI-NIH Joint PhD Program; Signhild Engkvist Foundations; KI-MU Project; Czech Research Council	The work was supported, in whole or in part, by the National Institutes of Health NCI Intramural Research Program. The work also was also supported by the Karolinska Institutet; Swedish Research Council Grants K2008-68P-20810-01-4, K2008-68X-20805-01-4, and K2011-67X-20805-05-3; Swedish Cancer Society Grants CAN 2008/539 and 2011/690; The KI-NIH Joint PhD Program; the Signhild Engkvist Foundations; KI-MU Project Grant CZ.1.07/2.3.00/20.0180; and Czech Research Council (GACR 13-32990S).	Bernard P, 2007, INT J BIOCHEM CELL B, V39, P31, DOI 10.1016/j.biocel.2006.06.007; Bernatik O, 2014, J BIOL CHEM, V289, P23520, DOI 10.1074/jbc.M114.590638; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Bikkavilli Rama Kamesh, 2009, Commun Integr Biol, V2, P46; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Carmon KS, 2010, ANAL BIOCHEM, V401, P288, DOI 10.1016/j.ab.2010.03.009; Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Egger-Adam D, 2008, FRONT BIOSCI-LANDMRK, V13, P4740, DOI 10.2741/3036; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Gao XX, 2011, FEBS LETT, V585, P2501, DOI 10.1016/j.febslet.2011.06.033; Gattinoni L, 2010, CLIN CANCER RES, V16, P4695, DOI 10.1158/1078-0432.CCR-10-0356; Gong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012682; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Halleskog C, 2013, J NEUROCHEM, V125, P803, DOI 10.1111/jnc.12250; Halleskog C, 2013, CELL SIGNAL, V25, P822, DOI 10.1016/j.cellsig.2012.12.006; Halleskog C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-111; Halleskog C, 2011, GLIA, V59, P119, DOI 10.1002/glia.21081; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Kilander MBC, 2011, ACTA PHYSIOL, V203, P363, DOI 10.1111/j.1748-1716.2011.02324.x; Kilander MBC, 2014, CELL SIGNAL, V26, P1943, DOI 10.1016/j.cellsig.2014.05.012; Kilander MBC, 2011, CELL SIGNAL, V23, P550, DOI 10.1016/j.cellsig.2010.11.004; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Liu C, 2008, J NEUROSCI, V28, P5641, DOI 10.1523/JNEUROSCI.1056-08.2008; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; MacDonald BT, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.036; Naz G, 2012, BRIT J DERMATOL, V166, P1088, DOI 10.1111/j.1365-2133.2011.10800.x; Rawal N, 2006, EXP CELL RES, V312, P1626, DOI 10.1016/j.yexcr.2006.01.032; Ring L, 2014, CELL SIGNAL, V26, P260, DOI 10.1016/j.cellsig.2013.11.021; Schulte G, 2005, J NEUROCHEM, V92, P1550, DOI 10.1111/j.1471-4159.2004.03022.x; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Strutt H, 2006, CURR BIOL, V16, P1329, DOI 10.1016/j.cub.2006.04.041; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert Karl H., 2008, V468, P17, DOI 10.1007/978-1-59745-249-6_2	50	92	96	5	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6789	6798		10.1074/jbc.M114.612648	http://dx.doi.org/10.1074/jbc.M114.612648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605717	Green Published, hybrid			2022-12-26	WOS:000350991500015
J	Huang, CX; Wang, JJ; Ma, JH; Jin, CJ; Yu, Q; Zhang, SX				Huang, Chuangxin; Wang, Joshua J.; Ma, Jacey H.; Jin, Chenjin; Yu, Qiang; Zhang, Sarah X.			Activation of the UPR Protects against Cigarette Smoke-induced RPE Apoptosis through Up-Regulation of Nrf2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; INDUCED-OXIDATIVE STRESS; MACULAR DEGENERATION; INDUCIBLE PROTEIN; EPITHELIAL-CELLS; DNA-DAMAGE; EXPRESSION; CHOP; DEFICIENCY; PROLIFERATION	Recent studies have revealed a role of endoplasmic reticulum (ER) stress-induced unfolded protein response (UPR) in the regulation of RPE cell activity and survival. Herein, we examined the mechanisms by which the UPR modulates apoptotic signaling in human RPE cells challenged with cigarette smoking extract (CSE). Our results show that CSE exposure induced a dose-and time-dependent increase in ER stress markers, enhanced reactive oxygen species (ROS), mitochondrial fragmentation, and apoptosis of RPE cells. These changes were prevented by the anti-oxidant NAC or chemical chaperone TMAO, suggesting a close interaction between oxidative and ER stress in CSE-induced apoptosis. To decipher the role of the UPR, overexpression or down-regulation of XBP1 and CHOP genes was manipulated by adenovirus or siRNA. Overexpressing XBP1 protected against CSE-induced apoptosis by reducing CHOP, p-p38, and caspase-3 activation. In contrast, XBP1 knockdown sensitized the cells to CSE-induced apoptosis, which is likely through a CHOP-independent pathway. Surprisingly, knockdown of CHOP reduced p-eIF2 alpha and Nrf2 resulting in a marked increase in caspase-3 activation and apoptosis. Furthermore, Nrf2 inhibition increased ER stress and exacerbated cell apoptosis, while Nrf2 overexpression reduced CHOP and protected RPE cells. Our data suggest that although CHOP may function as a pro-apoptotic gene during ER stress, it is also required for Nrf2 up-regulation and RPE cell survival. In addition, enhancing Nrf2 and XBP1 activity may help reduce oxidative and ER stress and protect RPE cells from cigarette smoke-induced damage.	[Huang, Chuangxin; Wang, Joshua J.; Ma, Jacey H.; Zhang, Sarah X.] SUNY Buffalo, Sch Med & Biomed Sci, Ross Eye Inst, Dept Ophthalmol, Buffalo, NY 14215 USA; [Huang, Chuangxin; Wang, Joshua J.; Ma, Jacey H.; Zhang, Sarah X.] SUNY Buffalo, SUNY Eye Inst, Buffalo, NY 14215 USA; [Huang, Chuangxin; Ma, Jacey H.; Jin, Chenjin; Yu, Qiang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China; [Zhang, Sarah X.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14215 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Sun Yat Sen University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zhang, SX (corresponding author), SUNY Buffalo, Ross Eye Inst, Dept Ophthalmol, 3435 Main St, Buffalo, NY 14214 USA.	xzhang38@buffalo.edu			National Institutes of Health/NEI [EY019949, EY025061]; American Diabetes Association; American Health Assistance Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R21EY025061, R01EY019949] Funding Source: NIH RePORTER	National Institutes of Health/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); American Diabetes Association(American Diabetes Association); American Health Assistance Foundation(BrightFocus Foundation); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in part, by National Institutes of Health/NEI Grants EY019949, EY025061, by grants from American Diabetes Association and American Health Assistance Foundation, and by an Unrestricted Grant to the Dept. of Ophthalmology, SUNY-Buffalo, from Research to Prevent Blindness (all to S. X. Z.).	Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Ariyama Y, 2008, METABOLISM, V57, P1625, DOI 10.1016/j.metabol.2008.06.019; Beazley KE, 2012, ARTERIOSCL THROM VAS, V32, P123, DOI 10.1161/ATVBAHA.111.237834; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Bertram KM, 2009, AM J PHYSIOL-CELL PH, V297, pC1200, DOI 10.1152/ajpcell.00126.2009; Cano M, 2014, FREE RADICAL BIO MED, V69, P1, DOI 10.1016/j.freeradbiomed.2014.01.004; Cano M, 2010, VISION RES, V50, P652, DOI 10.1016/j.visres.2009.08.018; Chang YS, 2007, INVEST OPHTH VIS SCI, V48, P2792, DOI 10.1167/iovs.06-1146; Chen CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040801; Chen C, 2014, ANTIOXID REDOX SIGN, V20, P2091, DOI 10.1089/ars.2013.5240; Chen C, 2013, MOL VIS, V19, P39; Chen HW, 2009, ENVIRON MOL MUTAGEN, V50, P96, DOI 10.1002/em.20441; Chen HW, 2004, CHEM-BIOL INTERACT, V150, P233, DOI 10.1016/j.cbi.2004.09.014; Cheng SE, 2009, FREE RADICAL BIO MED, V46, P948, DOI 10.1016/j.freeradbiomed.2009.01.006; Csiszar A, 2008, AM J PHYSIOL-HEART C, V294, pH2721, DOI 10.1152/ajpheart.00235.2008; Dou GR, 2012, FREE RADICAL BIO MED, V53, P1111, DOI 10.1016/j.freeradbiomed.2012.06.042; Edirisinghe I, 2010, ANTIOXID REDOX SIGN, V12, P1355, DOI 10.1089/ars.2009.2874; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Espinosa-Heidmann DG, 2006, INVEST OPHTH VIS SCI, V47, P729, DOI 10.1167/iovs.05-0719; Esposito V, 2013, AM J PHYSIOL-RENAL, V304, pF440, DOI 10.1152/ajprenal.00487.2011; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Friedman AD, 1996, CANCER RES, V56, P3250; Fujihara M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003119; Geraghty P, 2011, INT J CHRONIC OBSTR, V6, P309, DOI 10.2147/COPD.S19599; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kenche H, 2013, FASEB J, V27, P965, DOI 10.1096/fj.12-216234; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Kim YJ, 2011, BASIC CLIN PHARMACOL, V109, P17, DOI 10.1111/j.1742-7843.2011.00673.x; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; Kroening PR, 2008, J IMMUNOL, V181, P1536, DOI 10.4049/jimmunol.181.2.1536; Kunchithapautham K, 2014, J BIOL CHEM, V289, P14534, DOI 10.1074/jbc.M114.564674; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Li JM, 2011, J BIOL CHEM, V286, P4912, DOI 10.1074/jbc.M110.199729; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Losonczy G, 2011, ACTA OPHTHALMOL, V89, P255, DOI 10.1111/j.1755-3768.2009.01687.x; Min T, 2011, J MOL MED, V89, P577, DOI 10.1007/s00109-011-0732-8; Nashine S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063205; Orosz Z, 2007, AM J PHYSIOL-HEART C, V292, pH130, DOI 10.1152/ajpheart.00599.2006; Pieramici D J, 1998, Curr Opin Ophthalmol, V9, P38, DOI 10.1097/00055735-199806000-00007; Ramkumar HL, 2010, PROG RETIN EYE RES, V29, P169, DOI 10.1016/j.preteyeres.2010.02.002; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Souied EH, 2005, MOL VIS, V11, P1135; Tagawa Y, 2008, FREE RADICAL BIO MED, V45, P50, DOI 10.1016/j.freeradbiomed.2008.03.003; Tamaki N, 2008, AM J PHYSIOL-GASTR L, V294, pG498, DOI 10.1152/ajpgi.00482.2007; Tamakoshi A, 1997, BRIT J OPHTHALMOL, V81, P901, DOI 10.1136/bjo.81.10.901; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang L, 2014, FREE RADICAL BIO MED, V70, P155, DOI 10.1016/j.freeradbiomed.2014.01.015; Wilson GA, 2001, NEW ZEAL MED J, V114, P471; Wu WX, 2011, AM J PHYSIOL-LUNG C, V300, pL821, DOI 10.1152/ajplung.00267.2010; Xu L, 2011, VIRCHOWS ARCH, V459, P415, DOI 10.1007/s00428-011-1141-7; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yang W, 2012, NEOPLASMA, V59, P216, DOI 10.4149/neo_2012_028; Yoon JS, 2013, J ENDOCRINOL, V216, P145, DOI 10.1530/JOE-12-0257; Zeng DX, 2011, J CELL BIOCHEM, V112, P2082, DOI 10.1002/jcb.23131; Zhong YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038616; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	60	51	55	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5367	5380		10.1074/jbc.M114.603738	http://dx.doi.org/10.1074/jbc.M114.603738			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568320	Green Published, hybrid			2022-12-26	WOS:000350044200011
J	Scott, S; Lynch, JW; Keramidas, A				Scott, Suzanne; Lynch, Joseph W.; Keramidas, Angelo			Correlating Structural and Energetic Changes in Glycine Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; X-RAY-STRUCTURE; SINGLE-CHANNEL; HYPEREKPLEXIA MUTATIONS; TRANSMEMBRANE DOMAIN; CYS-LOOP; ACETYLCHOLINE-RECEPTORS; CHLORIDE CONDUCTANCE; AGONIST-BINDING; OPEN STATE	Pentameric ligand-gated ion channels (pLGICs) mediate fast chemoelectrical transduction in the nervous system. The mechanism by which the energy of ligand binding leads to currentconducting receptors is poorly understood and may vary among family members. We addressed these questions by correlating the structural and energetic mechanisms by which a naturally occurring M1 domain mutation (alpha 1(Q-26'E)) enhances receptor activation in homo- and heteromeric glycine receptors. We systematically altered the charge of spatially clustered residues at positions 19' and 24', in the M2 and M2-M3 linker domains, respectively, which are known to be critical to efficient receptor activation, on a background of alpha 1(Q-26'E)]:" Changes in the durations of single receptor activations (clusters) and conductance were used to determine interaction coupling energies, which we correlated with conformational displacements as measured in pLGIC crystal structures. Presence of the alpha 1(Q-26'E) - enhanced cluster durations and reduced channel conductance in homoand heteromeric receptors. Strong coupling between alpha 1(-26') and alpha 1(19') across the subunit interface suggests an important role in receptor activation. A lack of coupling between alpha 1(-26') and alpha 1(24') implies that 24' mutations disrupt activation via other interactions. A similar lack of energetic coupling between al-26' and reciprocal mutations in the beta subunit suggests that this subunit remains relatively static during receptor activation. However, the channel effects of alpha 1(Q-26'E) on alpha 1 beta receptors suggests at least one alpha 1-alpha 1 interface per pentamer. The coupling-energy change between alpha 1(-26') and a1l9' correlates with a local structural rearrangement essential for pLGIC activation, implying it comprises a key energetic pathway in activating glycine receptors and other pLGICs.	[Scott, Suzanne; Lynch, Joseph W.; Keramidas, Angelo] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Lynch, Joseph W.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Keramidas, A (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	a.keramidas@uq.edu.au	Scott, Suzanne/AAY-4374-2020; Keramidas, Angelo/I-1704-2013	Keramidas, Angelo/0000-0003-2846-052X; Scott, Suzanne/0000-0002-5830-8943	National Health and Medical Research Council of Australia; Australian Research Council [DP 1030101702]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the National Health and Medical Research Council of Australia and Australian Research Council Grant DP 1030101702.	Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Auerbach A, 2005, P NATL ACAD SCI USA, V102, P1408, DOI 10.1073/pnas.0406787102; Auerbach A, 2013, J MOL BIOL, V425, P1461, DOI 10.1016/j.jmb.2013.01.027; Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bode A, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-2; Bode A, 2013, J BIOL CHEM, V288, P33745, DOI 10.1074/jbc.M113.509240; Bode A, 2013, J BIOL CHEM, V288, P33760, DOI 10.1074/jbc.M113.513804; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Cadugan DJ, 2010, BIOPHYS J, V99, P798, DOI 10.1016/j.bpj.2010.05.008; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2008, NAT STRUCT MOL BIOL, V15, P389, DOI 10.1038/nsmb.1407; Dreissen YEM, 2012, EPILEPSIA, V53, P3, DOI 10.1111/j.1528-1167.2012.03709.x; Durisic N, 2012, J NEUROSCI, V32, P12915, DOI 10.1523/JNEUROSCI.2050-12.2012; Groot-Kormelink PJ, 2002, J NEUROSCI METH, V113, P207, DOI 10.1016/S0165-0270(01)00500-3; Grosman C, 2000, J GEN PHYSIOL, V115, P621, DOI 10.1085/jgp.115.5.621; Grosman C, 2000, J GEN PHYSIOL, V116, P327, DOI 10.1085/jgp.116.3.327; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; JACKSON MB, 1984, P NATL ACAD SCI-BIOL, V81, P3901, DOI 10.1073/pnas.81.12.3901; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; LANGOSCH D, 1994, EMBO J, V13, P4223, DOI 10.1002/j.1460-2075.1994.tb06742.x; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; Lape R, 2012, J NEUROSCI, V32, P1336, DOI 10.1523/JNEUROSCI.4346-11.2012; Legendre P, 1997, J NEUROPHYSIOL, V77, P2400, DOI 10.1152/jn.1997.77.5.2400; Lewis TM, 1998, J PHYSIOL-LONDON, V507, P25, DOI 10.1111/j.1469-7793.1998.025bu.x; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; Lynch JW, 2001, J NEUROSCI, V21, P2589, DOI 10.1523/JNEUROSCI.21-08-02589.2001; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mohammadi B, 2003, EUR BIOPHYS J BIOPHY, V32, P529, DOI 10.1007/s00249-003-0286-y; Moorhouse AJ, 1999, MOL PHARMACOL, V55, P386, DOI 10.1124/mol.55.2.386; Purohit P, 2014, BIOPHYS J, V107, P88, DOI 10.1016/j.bpj.2014.04.057; Purohit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3984; Purohit P, 2009, P NATL ACAD SCI USA, V106, P115, DOI 10.1073/pnas.0809272106; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; RAJENDRA S, 1995, NEURON, V14, P169, DOI 10.1016/0896-6273(95)90251-1; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Shan Q, 2003, J NEUROCHEM, V86, P498, DOI 10.1046/j.1471-4159.2003.01872.x; Sivilotti LG, 2010, J PHYSIOL-LONDON, V588, P45, DOI 10.1113/jphysiol.2009.178525; Wyllie DJA, 1998, J PHYSIOL-LONDON, V510, P1, DOI 10.1111/j.1469-7793.1998.001bz.x; Yang Z, 2012, BIOCHEMISTRY-US, V51, P5229, DOI 10.1021/bi300063m	51	18	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5621	5634		10.1074/jbc.M114.616573	http://dx.doi.org/10.1074/jbc.M114.616573			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25572390	Green Published, hybrid			2022-12-26	WOS:000350044200032
J	Patra, M; Mukhopadhyay, C; Chakrabarti, A				Patra, Malay; Mukhopadhyay, Chaitali; Chakrabarti, Abhijit			Probing Conformational Stability and Dynamics of Erythroid and Nonerythroid Spectrin: Effects of Urea and Guanidine Hydrochloride	PLOS ONE			English	Article							ALPHA-SPECTRIN; BRAIN SPECTRIN; MULTIDOMAIN PROTEINS; TETRAMERIZATION SITE; CRYSTAL-STRUCTURE; WATER-STRUCTURE; TANDEM REPEATS; IN-VITRO; FLUORESCENCE; DENATURATION	We have studied the conformational stability of the two homologous membrane skeletal proteins, the erythroid and non-erythroid spectrins, in their dimeric and tetrameric forms respectively during unfolding in the presence of urea and guanidine hydrochloride (GuHCl). Fluorescence and circular dichroism (CD) spectroscopy have been used to study the changes of intrinsic tryptophan fluorescence, anisotropy, far UV-CD and extrinsic fluorescence of bound 1-anilinonapthalene-8-sulfonic acid (ANS). Chemical unfolding of both proteins were reversible and could be described as a two state transition. The folded erythroid spectrin and non-erythroid spectrin were directly converted to unfolded monomer without formation of any intermediate. Fluorescence quenching, anisotropy, ANS binding and dynamic light scattering data suggest that in presence of low concentrations of the denaturants (upto 1M) hydrogen bonding network and van der Waals interaction play a role inducing changes in quaternary as well as tertiary structures without complete dissociation of the subunits. This is the first report of two large worm like, multi-domain proteins obeying twofold rule which is commonly found in small globular proteins. The free energy of stabilization (Delta G(u)(2)(H)(0)) for the dimeric spectrin has been 20 kcal/mol lesser than the tetrameric from.	[Patra, Malay; Mukhopadhyay, Chaitali] Univ Calcutta, Dept Chem, Kolkata, W Bengal, India; [Chakrabarti, Abhijit] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, W Bengal, India	University of Calcutta; Saha Institute of Nuclear Physics	Chakrabarti, A (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, W Bengal, India.	abhijit.chakrabarti@saha.ac.in			MSACR project	MSACR project	Funding was obtained from the MSACR project to SINP from Department of Atomic Energy, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel A, 2008, MAT SCI ENG C-BIO S, V28, P594, DOI 10.1016/j.msec.2007.10.004; Akhtar MS, 2002, BIOCHEMISTRY-US, V41, P3819, DOI 10.1021/bi0116700; An XL, 2006, BIOCHEMISTRY-US, V45, P13670, DOI 10.1021/bi061368x; Babbes ARH, 2008, BIOCHEMISTRY-US, V47, P6969, DOI 10.1021/bi800636q; Batey S, 2006, BIOPHYS J, V90, P2120, DOI 10.1529/biophysj.105.072710; Batey S, 2005, J MOL BIOL, V349, P1045, DOI 10.1016/j.jmb.2005.04.028; Batey S, 2006, P NATL ACAD SCI USA, V103, P18113, DOI 10.1073/pnas.0604580103; Begg GE, 1997, BIOCHEMISTRY-US, V36, P6977, DOI 10.1021/bi970186n; BENNETT V, 1982, NATURE, V299, P126, DOI 10.1038/299126a0; Bhattacharyya M, 2004, J BIOL CHEM, V279, P55080, DOI 10.1074/jbc.M406418200; Bhuyan AK, 2002, BIOCHEMISTRY-US, V41, P13386, DOI 10.1021/bi020371n; Bradford MM, 1976, ANAL BIOCHEM, V72, P9781; BRESLOW R, 1990, P NATL ACAD SCI USA, V87, P167, DOI 10.1073/pnas.87.1.167; BUDZYNSKI DM, 1992, BIOCHEMISTRY-US, V31, P3653, DOI 10.1021/bi00129a014; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; CALVERT R, 1980, EUR J BIOCHEM, V107, P363; Chattopadhyay A, 2003, PROTEIN SCI, V12, P2389, DOI 10.1110/ps.03302003; DAVIS J, 1983, J BIOL CHEM, V258, P7757; Del Vecchio P, 2002, BIOCHEM J, V367, P857, DOI 10.1042/BJ20020695; DeSilva TM, 1997, BIOCHEMISTRY-US, V36, P3991, DOI 10.1021/bi962412j; Diakowski W, 2002, BIOCHIM BIOPHYS ACTA, V1564, P13252; Dobson Christopher M., 1999, Current Opinion in Structural Biology, V9, P92, DOI 10.1016/S0959-440X(99)80012-8; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4; DUBIN SB, 1973, BIOCHEMISTRY-US, V12, P714, DOI 10.1021/bi00728a022; Dunbar J, 1997, PROTEIN SCI, V6, P1727, DOI 10.1002/pro.5560060813; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; Fink AL, 1998, FOLD DES, V3, P19, DOI 10.1016/S1359-0278(98)00005-4; Franco G, 2008, BIOCHEMISTRY-US, V47, P7954, DOI 10.1021/bi8002555; GALLAGHER PG, 1993, BLOOD, V82, P2210; GLENNEY JR, 1982, J BIOL CHEM, V257, P9781; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Guidry JJ, 2000, PROTEIN SCI, V9, P2109, DOI 10.1110/ps.9.11.2109; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Haque ME, 1999, EUR J BIOCHEM, V259, P269, DOI 10.1046/j.1432-1327.1999.00062.x; Harper SL, 2013, BLOOD, V122, P3045, DOI 10.1182/blood-2013-02-487702; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Jaenicke R, 2000, ADV PROTEIN CHEM, V53, P329; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; Kloss E, 2008, J MOL BIOL, V383, P1195, DOI 10.1016/j.jmb.2008.08.069; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Lakowicz J.R, 2006, PRINCIPLES FLUORESCE; Lee CT, 2005, BIOCHEMISTRY-US, V44, P524, DOI 10.1021/bi048556c; Lehrer S S, 1978, Methods Enzymol, V49, P222; Li QF, 2009, BIOCHEMISTRY-US, V48, P206, DOI 10.1021/bi8013032; LIU SC, 1984, CELL, V37, P587, DOI 10.1016/0092-8674(84)90389-1; Long F, 2007, PROTEIN SCI, V16, P2519, DOI 10.1110/ps.073115307; MACDONALD RI, 1994, P NATL ACAD SCI USA, V91, P1299, DOI 10.1073/pnas.91.4.1299; MacDonald RI, 2004, P NATL ACAD SCI USA, V101, P1502, DOI 10.1073/pnas.0308059100; MacDonald RI, 2001, BIOCHEMISTRY-US, V40, P3974, DOI 10.1021/bi0025159; Mateu MG, 2002, J MOL BIOL, V318, P519, DOI 10.1016/S0022-2836(02)00091-8; MAYO SL, 1993, SCIENCE, V262, P873, DOI 10.1126/science.8235609; Mehboob S, 2003, BIOCHEMISTRY-US, V42, P14702, DOI 10.1021/bi0353833; Mehboob S, 2010, J BIOL CHEM, V285, P14572, DOI 10.1074/jbc.M109.080028; Menhart N, 1996, J BIOL CHEM, V271, P30410, DOI 10.1074/jbc.271.48.30410; MIKKELSEN A, 1984, BIOCHIM BIOPHYS ACTA, V786, P95, DOI 10.1016/0167-4838(84)90158-4; MOHANDAS N, 1994, ANNU REV BIOPH BIOM, V23, P787, DOI 10.1146/annurev.bb.23.060194.004035; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; MOON RT, 1990, J BIOL CHEM, V265, P4427; MORROW JS, 1981, J CELL BIOL, V88, P463, DOI 10.1083/jcb.88.2.463; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Noppert A, 1996, FEBS LETT, V380, P179, DOI 10.1016/0014-5793(96)00048-8; O'Brien EP, 2007, J AM CHEM SOC, V129, P7346, DOI 10.1021/ja069232+; Pace C N, 1986, Methods Enzymol, V131, P266; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Pace CN, 2000, NAT STRUCT BIOL, V7, P345, DOI 10.1038/75100; Pantazatos DP, 1997, J BIOL CHEM, V272, P21052, DOI 10.1074/jbc.272.34.21052; PARKER W, 1992, BIOPHYS J, V61, P1435, DOI 10.1016/S0006-3495(92)81949-5; Pascual J, 1996, FEBS LETT, V383, P201, DOI 10.1016/0014-5793(96)00251-7; Patra M, 2014, J BIOMOL STRUCT DYN, V32, P852, DOI 10.1080/07391102.2013.793212; PIKE ACW, 1994, PROTEIN SCI, V3, P706; Povarova OI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015035; Prajapati S, 1998, EUR J BIOCHEM, V255, P178, DOI 10.1046/j.1432-1327.1998.2550178.x; Privalov PL, 1996, J MOL BIOL, V258, P707, DOI 10.1006/jmbi.1996.0280; RALSTON GB, 1976, BIOCHIM BIOPHYS ACTA, V455, P163, DOI 10.1016/0005-2736(76)90161-9; Ray S, 2005, J FLUORESC, V15, P61, DOI 10.1007/s10895-005-0214-x; Ray S, 2004, MOL MEMBR BIOL, V21, P93, DOI 10.1080/09687680310001625800; Ray S, 2003, CELL MOTIL CYTOSKEL, V54, P16, DOI 10.1002/cm.10082; Reddy GB, 1999, BIOCHEMISTRY-US, V38, P4462; SAHR KE, 1990, J BIOL CHEM, V265, P4434; Schellman JA, 2002, BIOPHYS CHEM, V96, P91, DOI 10.1016/S0301-4622(02)00009-1; Scott KA, 2002, J MOL BIOL, V315, P819, DOI 10.1006/jmbi.2001.5260; SOSNICK TR, 1992, BIOCHEMISTRY-US, V31, P8329, DOI 10.1021/bi00150a029; SPEICHER DW, 1984, NATURE, V311, P177, DOI 10.1038/311177a0; Sriswasdi S, 2014, P NATL ACAD SCI USA, V111, P1801, DOI 10.1073/pnas.1317620111; Stepanenko OV, 2004, BIOCHEMISTRY-US, V43, P14913, DOI 10.1021/bi048725t; Street TO, 2008, METHOD CELL BIOL, V84, P295, DOI 10.1016/S0091-679X(07)84011-8; SUBBARAO NK, 1994, CELL MOTIL CYTOSKEL, V29, P72, DOI 10.1002/cm.970290107; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; TSE WT, 1990, J CLIN INVEST, V86, P909, DOI 10.1172/JCI114792; Vanzi F, 1998, J AM CHEM SOC, V120, P10748, DOI 10.1021/ja981529n; WILLIAMSON P, 1982, CELL, V30, P725, DOI 10.1016/0092-8674(82)90277-X; WINKELMANN JC, 1990, J BIOL CHEM, V265, P11827; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; YOSHINO H, 1985, BIOCHIM BIOPHYS ACTA, V812, P786, DOI 10.1016/0005-2736(85)90273-1; YOSHINO H, 1984, J BIOL CHEM, V259, P4496; Zhou Z, 2005, BIOCHEMISTRY-US, V44, P12107, DOI 10.1021/bi050785r	100	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116991	10.1371/journal.pone.0116991	http://dx.doi.org/10.1371/journal.pone.0116991			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617632	Green Submitted, gold, Green Published			2022-12-26	WOS:000350336000035
J	Sun, X; Zhang, R; Jiang, F; Tang, SS; Chen, M; Peng, DF; Yan, J; Wang, T; Wang, SY; Bao, YQ; Hu, C; Jia, WP				Sun, Xue; Zhang, Rong; Jiang, Feng; Tang, Shanshan; Chen, Miao; Peng, Danfeng; Yan, Jing; Wang, Tao; Wang, Shiyun; Bao, Yuqian; Hu, Cheng; Jia, Weiping			Common Variants Related to Serum Uric Acid Concentrations Are Associated with Glucose Metabolism and Insulin Secretion in a Chinese Population	PLOS ONE			English	Article							TYPE-2 DIABETES RISK; BETA-CELL FUNCTION; OXIDATIVE STRESS; FASTING GLUCOSE; GOUT; IMPACT; LOCI; GENE; HOMEOSTASIS; RESISTANCE	Background Elevated serum uric acid concentration is an independent risk factor and predictor of type 2 diabetes (T2D). Whether the uric acid-associated genes have an impact on T2D remains unclear. We aimed to investigate the effects of the uric acid-associated genes on the risk of T2D as well as glucose metabolism and insulin secretion. Method We recruited 2,199 normal glucose tolerance subjects from the Shanghai Diabetes Study I and II and 2,999 T2D patients from the inpatient database of Shanghai Diabetes Institute. Fifteen single nucleotide polymorphisms (SNPs) mapped in or near 11 loci (PDZK1, GCKR, LRP2, SLC2A9, ABCG2, LRRC16A, SLC17A1, SLC17A3, SLC22A11, SLC22A12 and SF1) were genotyped and serum biochemical parameters related to uric acid and T2D were determined. Results SF1 rs606458 showed strong association to T2D in both males and females (p = 0.034 and 0.0008). In the males, LRRC16A was associated with 2-h insulin and insulin secretion (p = 0.009 and 0.009). SLC22A11 was correlated with HOMA-B and insulin secretion (p = 0.048 and 0.029). SLC2A9 rs3775948 was associated with 2-h glucose (p = 0.043). In the females, LRP2 rs2544390 and rs1333049 showed correlations with fasting insulin, HOMA-IR and insulin secretion (p = 0.028, 0.033 and 0.052 and p = 0.034, 0.047 and 0.038, respectively). SLC2A9 rs11722228 was correlated with 2-h glucose, 2-h insulin and insulin secretion (p = 0.024, 0.049 and 0.049, respectively). Conclusions Our results indicated that the uric acid-associated genes have an impact on the risk of T2D, glucose metabolism and insulin secretion in a Chinese population.	[Sun, Xue; Zhang, Rong; Jiang, Feng; Tang, Shanshan; Chen, Miao; Peng, Danfeng; Yan, Jing; Wang, Tao; Wang, Shiyun; Bao, Yuqian; Hu, Cheng; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet,Shanghai Key Lab Diabet, Shanghai Diabet Inst,Shanghai Key Clin Ctr Metab, Shanghai 200233, Peoples R China; [Hu, Cheng] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai 201400, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Hu, C (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet,Shanghai Key Lab Diabet, Shanghai Diabet Inst,Shanghai Key Clin Ctr Metab, Shanghai 200233, Peoples R China.	alfredhc@sjtu.edu.cn; wpjia@sjtu.edu.cn	Hu, Cheng/C-3346-2008; Jia, Weiping/B-7483-2012	Hu, Cheng/0000-0003-4314-2386; 	NSFC [81322010]; Excellent Young Medical Expert of Shanghai [XYQ2011041]; Shanghai Rising Star Program [12QH1401700]; Shanghai Talent Development Grant [2012041]; National Program for Support of Top-notch Young Professionals	NSFC(National Natural Science Foundation of China (NSFC)); Excellent Young Medical Expert of Shanghai; Shanghai Rising Star Program; Shanghai Talent Development Grant; National Program for Support of Top-notch Young Professionals	The authors acknowledge grants from NSFC (81322010), Excellent Young Medical Expert of Shanghai (XYQ2011041), Shanghai Rising Star Program (12QH1401700), Shanghai Talent Development Grant (2012041) and National Program for Support of Top-notch Young Professionals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YQ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2249; Bhole V, 2010, AM J MED, V123, P957, DOI 10.1016/j.amjmed.2010.03.027; Cha SH, 2000, J BIOL CHEM, V275, P4507, DOI 10.1074/jbc.275.6.4507; Duplain H, 2001, CIRCULATION, V104, P342, DOI 10.1161/01.CIR.104.3.342; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ekaratanawong S, 2004, J PHARMACOL SCI, V94, P297, DOI 10.1254/jphs.94.297; Evans SA, 2009, ENDOCRINOLOGY, V150, P5302, DOI 10.1210/en.2009-0747; Fan HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067759; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Heni M, 2010, J CLIN ENDOCR METAB, V95, pE479, DOI 10.1210/jc.2010-0860; Heni M, 2010, DIABETES, V59, P3247, DOI 10.2337/db10-0674; Hu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011761; Ishizaka N, 2005, ARTERIOSCL THROM VAS, V25, P1038, DOI 10.1161/01.ATV.0000161274.87407.26; Jia L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078284; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Jia ZT, 2013, DIABETES RES CLIN PR, V101, P88, DOI 10.1016/j.diabres.2013.03.026; Keembiyehetty C, 2006, MOL ENDOCRINOL, V20, P686, DOI 10.1210/me.2005-0010; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Liu WC, 2011, EXP DIABETES RES, DOI 10.1155/2011/527520; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MODAN M, 1987, DIABETOLOGIA, V30, P713, DOI 10.1007/BF00296994; Nakayama A, 2014, RHEUMATOL INT, V34, P473, DOI 10.1007/s00296-013-2924-8; Nath SD, 2007, J AM SOC NEPHROL, V18, P3156, DOI 10.1681/ASN.2007040426; Orlando RA, 1998, J AM SOC NEPHROL, V9, P1759; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roncal CA, 2009, AM J NEPHROL, V30, P399, DOI 10.1159/000235731; Roy D, 1998, AM J PHYSIOL-ENDOC M, V274, pE692, DOI 10.1152/ajpendo.1998.274.4.E692; Sakiyama M, 2014, DRUG METAB PHARMACOK, V29, P208, DOI 10.2133/dmpk.DMPK-13-NT-070; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Simental-Mendia LE, 2009, DIABETES-METAB RES, V25, P535, DOI 10.1002/dmrr.988; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Stumvoll M, 2001, DIABETES CARE, V24, P796, DOI 10.2337/diacare.24.4.796; Sun X, 2014, ACTA PHARMACOL SIN, V35, P1421, DOI 10.1038/aps.2014.87; Tang W, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/709691; Tin A, 2011, HUM MOL GENET, V20, P4056, DOI 10.1093/hmg/ddr307; van der Harst P, 2010, HUM MOL GENET, V19, P387, DOI 10.1093/hmg/ddp489; Wang BB, 2011, RHEUMATOLOGY, V50, P1559, DOI 10.1093/rheumatology/ker135; Zhang YN, 2013, MOL CELL ENDOCRINOL, V375, P89, DOI 10.1016/j.mce.2013.04.027	39	12	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116714	10.1371/journal.pone.0116714	http://dx.doi.org/10.1371/journal.pone.0116714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617895	gold, Green Published, Green Submitted			2022-12-26	WOS:000350336000022
J	Kobler, C; Poulsen, SS; Saber, AT; Jacobsen, NR; Wallin, H; Yauk, CL; Halappanavar, S; Vogel, U; Qvortrup, K; Molhave, K				Kobler, Carsten; Poulsen, Sarah S.; Saber, Anne T.; Jacobsen, Nicklas R.; Wallin, Hakan; Yauk, Carole L.; Halappanavar, Sabina; Vogel, Ulla; Qvortrup, Klaus; Molhave, Kristian			Time-Dependent Subcellular Distribution and Effects of Carbon Nanotubes in Lungs of Mice	PLOS ONE			English	Article							MOUSE LUNG; INHALATION TOXICITY; AIRWAY INFLAMMATION; PULMONARY TOXICITY; RESPONSES; ACCUMULATION; EOSINOPHILS; MECHANISMS; SURFACTANT; PNEUMONIA	Background and Methods Pulmonary deposited carbon nanotubes (CNTs) are cleared very slowly from the lung, but there is limited information on how CNTs interact with the lung tissue over time. To address this, three different multiwalled CNTs were intratracheally instilled into female C57BL/6 mice: one short (850 nm) and tangled, and two longer (4 mu m and 5.7 mu m) and thicker. We assessed the cellular interaction with these CNTs using transmission electron microscopy (TEM) 1, 3 and 28 days after instillation. Results TEM analysis revealed that the three CNTs followed the same overall progression pattern over time. Initially, CNTs were taken up either by a diffusion mechanism or via endocytosis. Then CNTs were agglomerated in vesicles in macrophages. Lastly, at 28 days post-exposure, evidence suggesting CNT escape from vesicle enclosures were found. The longer and thicker CNTs more often perturbed and escaped vesicular enclosures in macrophages compared to the smaller CNTs. Bronchoalveolar lavage (BAL) showed that the CNT exposure induced both an eosinophil influx and also eosinophilic crystalline pneumonia. Conclusion Two very different types of multiwalled CNTs had very similar pattern of cellular interactions in lung tissue, with the longer and thicker CNTs resulting inmore severe effects in terms of eosinophil influx and incidence of eosinophilic crystalline pneumonia (ECP).	[Kobler, Carsten; Vogel, Ulla; Molhave, Kristian] Tech Univ Denmark, DTU Nanotech, DK-2800 Lyngby, Denmark; [Kobler, Carsten] Tech Univ Denmark, DTU CEN, DK-2800 Lyngby, Denmark; [Poulsen, Sarah S.; Saber, Anne T.; Jacobsen, Nicklas R.; Wallin, Hakan; Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Poulsen, Sarah S.] Roskilde Univ, Dept Sci Syst & Models, Roskilde, Denmark; [Wallin, Hakan] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark; [Yauk, Carole L.; Halappanavar, Sabina] Hlth Canada, Environm & Radiat Hlth Sci Directorate, Ottawa, ON, Canada; [Qvortrup, Klaus] Univ Copenhagen, CFIM, Dept Biomed Sci, Copenhagen, Denmark	Technical University of Denmark; Technical University of Denmark; National Research Centre for the Working Environment; Roskilde University; University of Copenhagen; Health Canada; University of Copenhagen	Molhave, K (corresponding author), Tech Univ Denmark, DTU Nanotech, DK-2800 Lyngby, Denmark.	kristian.molhave@nanotech.dtu.dk	Vogel, Ulla B/I-5048-2012; Mølhave, Kristian/AAP-5837-2020; Wallin, Håkan/I-6459-2012; Vogel, Ulla/ABC-2212-2020; Molhave, Kristian/B-9209-2008	Vogel, Ulla B/0000-0001-6807-1524; Mølhave, Kristian/0000-0002-6493-2750; Wallin, Håkan/0000-0001-7716-0166; Vogel, Ulla/0000-0001-6807-1524; Molhave, Kristian/0000-0002-6493-2750; Jacobsen, Nicklas Raun/0000-0002-2504-2229; Yauk, Carole/0000-0002-6725-3454; Yauk, Carole/0000-0003-4919-876X; Qvortrup, Klaus/0000-0001-8811-0260	Danish Centre for Nanosafety from the Danish Working Environment Research Foundation [20110092173/3]; European Community's Seventh Framework Programme (FP7) [247989]; Chemicals Management Plan of Health Canada	Danish Centre for Nanosafety from the Danish Working Environment Research Foundation; European Community's Seventh Framework Programme (FP7); Chemicals Management Plan of Health Canada	Work was supported by the Danish Centre for Nanosafety (20110092173/3) from the Danish Working Environment Research Foundation, and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 247989 (Nanosustain) and Chemicals Management Plan of Health Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jamal KT, 2011, NANOSCALE, V3, P2627, DOI 10.1039/c1nr10080g; ALI-BOUCETTA H., 2013, ANGEW CHEM, V125, P2330, DOI DOI 10.1002/ANGE.201207664; Andon FT, 2013, SMALL, V9, P2721, DOI 10.1002/smll.201202508; Aschberger K, 2010, CRIT REV TOXICOL, V40, P759, DOI 10.3109/10408444.2010.506638; Beamer CA, 2013, NANOTOXICOLOGY, V7, P1070, DOI 10.3109/17435390.2012.702230; Ben-Yehuda C, 2008, EXP LUNG RES, V34, P467, DOI 10.1080/01902140802220625; Bhattacharya K, 2013, ADV DRUG DELIVER REV, V65, P2087, DOI 10.1016/j.addr.2013.05.012; Bourdon JA, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-5; Canton I, 2012, CHEM SOC REV, V41, P2718, DOI 10.1039/c2cs15309b; Donaldson K, 2013, ADV DRUG DELIVER REV, V65, P2078, DOI 10.1016/j.addr.2013.07.014; Elmore SA, 2013, TOXICOL PATHOL, V41, P151, DOI 10.1177/0192623312467102; Erdely A, 2011, J OCCUP ENVIRON MED, V53, pS80, DOI 10.1097/JOM.0b013e31821ad724; Feldmesser M, 2001, INFECT IMMUN, V69, P2723, DOI 10.1128/IAI.69.4.2723-2727.2001; Girtsman TA, 2014, NANOTOXICOLOGY, V8, P17, DOI 10.3109/17435390.2012.744110; Guo L, 2000, J BIOL CHEM, V275, P8032, DOI 10.1074/jbc.275.11.8032; Guo RF, 2001, J IMMUNOL, V166, P5208, DOI 10.4049/jimmunol.166.8.5208; Hamilton RF, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-57; Heath H, 1997, J CLIN INVEST, V99, P178, DOI 10.1172/JCI119145; Hoenerhoff MJ, 2006, VET PATHOL, V43, P682, DOI 10.1354/vp.43-5-682; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Inoue K, 2009, TOXICOL APPL PHARM, V237, P306, DOI 10.1016/j.taap.2009.04.003; Kapralov AA, 2012, ACS NANO, V6, P4147, DOI 10.1021/nn300626q; Kobayashi N, 2010, TOXICOLOGY, V276, P143, DOI 10.1016/j.tox.2010.07.021; KOBLER C, 2014, ANAL BIOANALYTICAL C; Lacerda L, 2012, BIOMATERIALS, V33, P3334, DOI 10.1016/j.biomaterials.2012.01.024; Ma-Hock L, 2009, TOXICOL SCI, V112, P468, DOI 10.1093/toxsci/kfp146; Marangon I, 2012, NANO LETT, V12, P4830, DOI 10.1021/nl302273p; Monthioux M, 2006, CARBON, V44, P1621, DOI 10.1016/j.carbon.2006.03.019; Mu QX, 2009, NANO LETT, V9, P4370, DOI 10.1021/nl902647x; Muller J, 2005, TOXICOL APPL PHARM, V207, P221, DOI 10.1016/j.taap.2005.01.008; Muller J, 2008, CHEM RES TOXICOL, V21, P1698, DOI 10.1021/tx800101p; MURRAY AB, 1990, VET PATHOL, V27, P274, DOI 10.1177/030098589002700409; Nagai H, 2011, P NATL ACAD SCI USA, V108, pE1330, DOI 10.1073/pnas.1110013108; *NAN, 2013, METH DET POT GEN NAN; NIO J, 2004, HISTOCHEMISTRY CELL, V121; Nygaard UC, 2009, TOXICOL SCI, V109, P113, DOI 10.1093/toxsci/kfp057; Pantarotto D, 2004, ANGEW CHEM INT EDIT, V43, P5242, DOI 10.1002/anie.200460437; Pauluhn J, 2010, TOXICOL SCI, V113, P226, DOI 10.1093/toxsci/kfp247; Persson H, 2013, SMALL, V9, P4006, DOI 10.1002/smll.201300644; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Porter DW, 2013, NANOTOXICOLOGY, V7, P1179, DOI 10.3109/17435390.2012.719649; Porter DW, 2010, TOXICOLOGY, V269, P136, DOI 10.1016/j.tox.2009.10.017; Poulsen SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080452; Ronzani C, 2012, ARCH TOXICOL, V86, P137, DOI 10.1007/s00204-011-0741-y; Ross MH., 2011, HISTOLOGY TEXT ATLAS, V6th ed; Ryman-Rasmussen JP, 2009, NAT NANOTECHNOL, V4, P747, DOI [10.1038/nnano.2009.305, 10.1038/NNANO.2009.305]; Saber AT, 2012, NANOTOXICOLOGY, V6, P453, DOI 10.3109/17435390.2011.587900; Saber AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069020; Saber AT, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-4; Sager TM, 2014, NANOTOXICOLOGY, V8, P317, DOI 10.3109/17435390.2013.779757; Teeguarden JG, 2011, TOXICOL SCI, V120, P123, DOI 10.1093/toxsci/kfq363; Treumann S, 2013, TOXICOL SCI, V134, P103, DOI 10.1093/toxsci/kft089; VANZWEITEN M, 1981, IMMUNOLOGICAL TECHNI; Waern I, 2010, MOL IMMUNOL, V47, P1467, DOI 10.1016/j.molimm.2010.02.004; Wang X, 2010, J NANOSCI NANOTECHNO, V10, P8516, DOI 10.1166/jnn.2010.2688; Wang X, 2011, ACS NANO, V5, P9772, DOI 10.1021/nn2033055; Wierzbicki R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053307	57	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116481	10.1371/journal.pone.0116481	http://dx.doi.org/10.1371/journal.pone.0116481			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615613	Green Published, gold, Green Submitted			2022-12-26	WOS:000349122100030
J	Qu, WN; Ge, Y; Xiong, YX; Carciofo, R; Zhao, WG; Zhang, K				Qu, Weina; Ge, Yan; Xiong, Yuexin; Carciofo, Richard; Zhao, Wenguo; Zhang, Kan			Dangerous Driving in a Chinese Sample: Associations with Morningness-Eveningness Preference and Personality	PLOS ONE			English	Article							CIRCADIAN TYPOLOGY; INDIVIDUAL-DIFFERENCES; CHRONOTYPE; TIME; QUESTIONNAIRE; RELIABILITY; SLEEPINESS; VALIDITY; VERSION; RHYTHM	Individual differences in morningness-eveningness preference may influence susceptibility and response to sleepiness. These differences could influence driving performance, but the influence of morningness-eveningness preference on driving behavior and accident risk has not been comprehensively studied. As morningness-eveningness preference is associated with personality characteristics, we also investigated how the interaction between morningness-eveningness preference and personality may be related to dangerous driving behaviors. Two hundred and ninety five drivers completed the reduced Morningness-Eveningness Questionnaire, the Dula Dangerous Driving Index, and personality scales for agreeableness, conscientiousness and neuroticism, and reported demographic information (gender, age, level of education, driving years and annual average driving mileage) and self-reported traffic violations (accidents, penalty points and fines). The results showed that more Risky Driving, Aggressive Driving, Negative Cognitive/Emotional Driving and Drunk Driving, as measured by the Dula Dangerous Driving Index, were all significantly correlated with more eveningness, corresponding to lower scores on the reduced Morningness-Eveningness Questionnaire. Moreover, eveningness was correlated with self-reported traffic accidents, penalty points and fines. Furthermore, a moderation effect was found: eveningness was more strongly associated with risky driving and negative emotional driving in those who scored high for trait agreeableness.	[Qu, Weina; Ge, Yan; Xiong, Yuexin; Carciofo, Richard; Zhao, Wenguo; Zhang, Kan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS	Ge, Y (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	gey@psych.ac.cn			National Natural Science Foundation of China [31100750, 31400886, 91124003]; Basic Project of National Science and Technology of China [2009FY110100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Project of National Science and Technology of China	This study was supported by grants from the National Natural Science Foundation of China (Grants No. 31100750, 31400886 and 91124003), the Basic Project of National Science and Technology of China (No. 2009FY110100). YG received NSFC 31100750, Q received NSFC 31400886, KZ received NSFC 91124003 and 2009FY110100. The URLs of the National Natural Science Foundation of China is http://www.nsfc.gov.cn/. The URLs of the Basic Project of National Science and Technology of China is http://www.most.gov.cn/kjjh/gjkjjh/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAN A, 1991, PERS INDIV DIFFER, V12, P241, DOI 10.1016/0191-8869(91)90110-W; Adan A, 2012, CHRONOBIOL INT, V29, P1153, DOI 10.3109/07420528.2012.719971; Adan A, 2010, CHRONOBIOL INT, V27, P606, DOI 10.3109/07420521003663827; Aiken L. S., 1991, MULTIPLE REGRESSION; Arthur W, 2001, J PREVENTION INTERVE, V22, P35, DOI [10.1080/ 10852350109511209, DOI 10.1080/10852350109511209, 10.1300/J005v22n01_04]; Benfield JA, 2007, PERS INDIV DIFFER, V42, P247, DOI 10.1016/j.paid.2006.06.016; Bergomi M, 2010, Ann Ig, V22, P387; Bone S.A., 2006, J CONSUM BEHAV, V5, P454, DOI DOI 10.1002/(ISSN)1479-1838; Caci H, 2004, EUR PSYCHIAT, V19, P79, DOI 10.1016/j.eurpsy.2003.09.007; Carciofo R, 2012, SLEEP BIOL RHYTHMS, V10, P310, DOI 10.1111/j.1479-8425.2012.00577.x; Cavallera GM, 2008, PERS INDIV DIFFER, V44, P3, DOI 10.1016/j.paid.2007.07.009; Chipman M, 2009, SAFETY SCI, V47, P1364, DOI 10.1016/j.ssci.2009.03.005; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dahlen ER, 2006, PERS INDIV DIFFER, V41, P903, DOI 10.1016/j.paid.2006.03.016; Del Rio-Bermudez C, 2014, CHRONOBIOL INT, V31, P532, DOI 10.3109/07420528.2013.876427; DeYoung CG, 2007, PERS INDIV DIFFER, V43, P267, DOI 10.1016/j.paid.2006.11.030; Di Milia L, 2008, CHRONOBIOL INT, V25, P776, DOI 10.1080/07420520802391098; Di Milia L, 2011, ACCIDENT ANAL PREV, V43, P516, DOI 10.1016/j.aap.2009.12.018; Diaz-Morales JF, 2007, CHRONOBIOL INT, V24, P435, DOI 10.1080/07420520701420659; Dula CS, 2003, J APPL SOC PSYCHOL, V33, P263, DOI 10.1111/j.1559-1816.2003.tb01896.x; Fahrenberg J, 1999, PERS INDIV DIFFER, V26, P641, DOI 10.1016/S0191-8869(98)00160-3; Garbarino S, 2001, SLEEP, V24, P203; Gau SSF, 2007, J BIOL RHYTHM, V22, P268, DOI 10.1177/0748730406298447; Goldstein D, 2007, PERS INDIV DIFFER, V42, P431, DOI 10.1016/j.paid.2006.07.008; HARRIS W, 1977, FATIGUE CIRCADIAN RH, P133; Hirata FC, 2007, CHRONOBIOL INT, V24, P939, DOI 10.1080/07420520701657730; Horne JA, 1976, INT J CHRONOBIOL, V4, P97; John O.P., 1999, HDB PERSONALITY THEO, V1999, P102, DOI DOI 10.1037/A0019265; KERKHOF GA, 1985, BIOL PSYCHOL, V20, P83, DOI 10.1016/0301-0511(85)90019-5; KIRKCALDY B, 2000, STUDIA PSYCHOL; Lajunen T, 2001, PERS INDIV DIFFER, V31, P1365, DOI 10.1016/S0191-8869(00)00230-0; Lenne MG, 1997, ACCIDENT ANAL PREV, V29, P431, DOI 10.1016/S0001-4575(97)00022-5; Li SX, 2011, SLEEP BIOL RHYTHMS, V9, P19, DOI 10.1111/j.1479-8425.2010.00480.x; MATTHEWS G, 1991, PERS INDIV DIFFER, V12, P535, DOI 10.1016/0191-8869(91)90248-A; MECACCI L, 1986, PERS INDIV DIFFER, V7, P911, DOI 10.1016/0191-8869(86)90094-2; Mecacci L, 1998, PERS INDIV DIFFER, V25, P537, DOI 10.1016/S0191-8869(98)00087-7; Natale V, 2002, PERS INDIV DIFFER, V32, P809, DOI 10.1016/S0191-8869(01)00085-X; NEUBAUER AC, 1992, PERS INDIV DIFFER, V13, P125, DOI 10.1016/0191-8869(92)90035-N; Oginska H, 2010, CHRONOBIOL INT, V27, P959, DOI 10.3109/07420528.2010.489412; Paine SJ, 2006, J BIOL RHYTHM, V21, P68, DOI 10.1177/0748730405283154; Qu WN, 2014, ACCIDENT ANAL PREV, V64, P62, DOI 10.1016/j.aap.2013.11.004; Randler C, 2008, SOC INDIC RES, V86, P297, DOI 10.1007/s11205-007-9139-x; Rosekind M.R., 1994, CREW FACTORS FLIGHT; Steele MT, 1999, ACAD EMERG MED, V6, P1050, DOI 10.1111/j.1553-2712.1999.tb01191.x; Stolarski M, 2013, BIOL RHYTHM RES, V44, P181, DOI 10.1080/09291016.2012.656248; Taillard J, 2004, J BIOL RHYTHM, V19, P76, DOI 10.1177/0748730403259849; TANKOVA I, 1994, PERS INDIV DIFFER, V16, P671, DOI 10.1016/0191-8869(94)90209-7; Tonetti L, 2010, EUR PSYCHIAT, V25, P111, DOI 10.1016/j.eurpsy.2009.09.007; Tonetti L, 2009, CHRONOBIOL INT, V26, P337, DOI 10.1080/07420520902750995; TORSVALL L, 1987, ELECTROEN CLIN NEURO, V66, P502, DOI 10.1016/0013-4694(87)90096-4; Wang LL, 2014, J APPL MATH, DOI 10.1155/2014/247836	51	13	13	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116717	10.1371/journal.pone.0116717	http://dx.doi.org/10.1371/journal.pone.0116717			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UF	25615447	gold, Green Published			2022-12-26	WOS:000349122100037
J	Yoshida, K; Nishizawa, D; Ichinomiya, T; Ichinohe, T; Hayashida, M; Fukuda, K; Ikeda, K				Yoshida, Kaori; Nishizawa, Daisuke; Ichinomiya, Takashi; Ichinohe, Tatsuya; Hayashida, Masakazu; Fukuda, Ken-ichi; Ikeda, Kazutaka			Prediction Formulas for Individual Opioid Analgesic Requirements Based on Genetic Polymorphism Analyses	PLOS ONE			English	Article							MAJOR ABDOMINAL-SURGERY; GENOME-WIDE ASSOCIATION; PAIN; SENSITIVITY; MORPHINE; PHARMACOGENETICS; EQUIVALENT; GENOTYPE; DRUGS; TRIAL	Background The analgesic efficacy of opioids is well known to vary widely among individuals, and various factors related to individual differences in opioid sensitivity have been identified. However, a prediction model to calculate appropriate opioid analgesic requirements has not yet been established. The present study sought to construct prediction formulas for individual opioid analgesic requirements based on genetic polymorphisms and clinical data from patients who underwent cosmetic orthognathic surgery and validate the utility of the prediction formulas in patients who underwent major open abdominal surgery. Methods To construct the prediction formulas, we performed multiple linear regression analyses using data from subjects who underwent cosmetic orthognathic surgery. The dependent variable was 24-h postoperative or perioperative fentanyl use, and the independent variables were age, gender, height, weight, pain perception latencies (PPL), and genotype data of five single-nucleotide polymorphisms (SNPs). To examine the utility of the prediction formulas, we performed simple linear regression analyses using subjects who underwent major open abdominal surgery. Actual 24-h postoperative or perioperative analgesic use and the predicted values that were calculated using the multiple regression equations were incorporated as dependent and independent variables, respectively. Results Multiple linear regression analyses showed that the four SNPs, PPL, and weight were retained as independent predictors of 24-h postoperative fentanyl use (R-2 = 0.145, P = 5.66 x 10(-10)) and the two SNPs and weight were retained as independent predictors of perioperative fentanyl use (R-2 = 0.185, P = 1.99 x 10(-15)). Simple linear regression analyses showed that the predicted values were retained as an independent predictor of actual 24-h postoperative analgesic use (R-2 = 0.033, P = 0.030) and perioperative analgesic use (R-2 = 0.100, P = 1.09 x 10(-4)), respectively. Conclusions We constructed prediction formulas, and the possible utility of these prediction formulas was found in another type of surgery.	[Yoshida, Kaori; Nishizawa, Daisuke; Ikeda, Kazutaka] Tokyo Metropolitan Inst Med Sci, Addict Substance Project, Tokyo 113, Japan; [Yoshida, Kaori; Fukuda, Ken-ichi] Tokyo Dent Coll, Dept Dent Anesthesiol, Tokyo, Japan; [Ichinomiya, Takashi] Gifu Univ, Grad Sch Med, Dept Biomed Informat, Gifu, Japan; [Hayashida, Masakazu] Juntendo Univ, Sch Med, Dept Anesthesiol & Pain Med, Tokyo 113, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Dental College; Gifu University; Juntendo University	Ikeda, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Addict Substance Project, Tokyo 113, Japan.	ikeda-kz@igakuken.or.jp	Ichinomiya, Takashi/W-2784-2018	Ichinomiya, Takashi/0000-0002-9173-4514; Ichinohe, Tatsuya/0000-0001-5793-3379	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (Tokyo, Japan) [22790518, 23390377, 24659549, 24790544, 25116532, 26293347, 26860360]; Ministry of Health, Labour and Welfare (MHLW) of Japan (Tokyo, Japan) [H21-3jigan-ippan-011, H22-Iyaku-015, H25-Iyaku-020, H26-Kakushintekigan-ippan-060, 14524680]; Smoking Research Foundation (Tokyo, Japan); Astellas Foundation for Research on Metabolic Disorders (Tokyo, Japan); Grants-in-Aid for Scientific Research [25116532] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (Tokyo, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare (MHLW) of Japan (Tokyo, Japan)(Ministry of Health, Labour and Welfare, Japan); Smoking Research Foundation (Tokyo, Japan); Astellas Foundation for Research on Metabolic Disorders (Tokyo, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (Tokyo, Japan; no. 22790518, 23390377, 24659549, 24790544, 25116532, 26293347, and 26860360), Ministry of Health, Labour and Welfare (MHLW) of Japan (Tokyo, Japan; no. H21-3jigan-ippan-011, H22-Iyaku-015, H25-Iyaku-020, H26-Kakushintekigan-ippan-060, and 14524680), Smoking Research Foundation (Tokyo, Japan), and Astellas Foundation for Research on Metabolic Disorders (Tokyo, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Aoki Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098548; BAHAR M, 1985, ANAESTHESIA, V40, P529; Basar H, 2003, J ENDOUROL, V17, P3, DOI 10.1089/089277903321196706; Bisgaard T, 2001, PAIN, V90, P261, DOI 10.1016/S0304-3959(00)00406-1; BUCHANAN WW, 1986, AM J MED, V80, P145, DOI 10.1016/0002-9343(86)90134-8; Cha PC, 2010, HUM MOL GENET, V19, P4735, DOI 10.1093/hmg/ddq389; Coulbault L, 2006, CLIN PHARMACOL THER, V79, P316, DOI 10.1016/j.clpt.2006.01.007; Fukuda K, 2009, PAIN, V147, P194, DOI 10.1016/j.pain.2009.09.004; Goldstein Frederick J., 2002, Journal of the American Osteopathic Association, V102, pS15; GUINARD JP, 1995, ANESTHESIOLOGY, V82, P377, DOI 10.1097/00000542-199502000-00008; Hayashida M, 2008, PHARMACOGENOMICS, V9, P1605, DOI 10.2217/14622416.9.11.1605; HOSKIN PJ, 1991, DRUGS, V41, P326, DOI 10.2165/00003495-199141030-00002; Ide S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070694; Ikeda K, 2005, TRENDS PHARMACOL SCI, V26, P311, DOI 10.1016/j.tips.2005.04.001; Ip HYV, 2009, ANESTHESIOLOGY, V111, P657, DOI 10.1097/ALN.0b013e3181aae87a; Kasai S, 2008, N-S ARCH PHARMACOL, V377, P269, DOI 10.1007/s00210-007-0205-3; Klepstad P, 2004, ACTA ANAESTH SCAND, V48, P1232, DOI 10.1111/j.1399-6576.2004.00517.x; KLINCK JR, 1982, ANAESTHESIA, V37, P907, DOI 10.1111/j.1365-2044.1982.tb01852.x; Kobayashi D, 2009, PAIN ORIG DIAGN TREA, P101; LOPER KA, 1990, ANESTH ANALG, V70, P72; Maliepaard M, 2013, NAT REV DRUG DISCOV, V12, P103, DOI 10.1038/nrd3931; Martikainen IK, 2004, NEUROSCI LETT, V361, P140, DOI 10.1016/j.neulet.2003.12.060; Nielsen CS, 2008, PAIN, V136, P21, DOI 10.1016/j.pain.2007.06.008; Nishizawa D, 2014, MOL PSYCHIATR, V19, P55, DOI 10.1038/mp.2012.164; Nishizawa D, 2010, METHODS MOL BIOL, V617, P395, DOI 10.1007/978-1-60327-323-7_29; Nishizawa D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007060; Ozcan S, 2002, SCAND J UROL NEPHROL, V36, P281, DOI 10.1080/003655902320248254; PATHAK KS, 1983, ANESTH ANALG, V62, P841; Rogers JF, 2002, AM J MED, V113, P746, DOI 10.1016/S0002-9343(02)01363-3; SUNSHINE S, 1994, TXB PAIN, P923; Zineh I, 2011, PHARMACOTHERAPY, V31, P729, DOI 10.1592/phco.31.8.729	32	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116885	10.1371/journal.pone.0116885	http://dx.doi.org/10.1371/journal.pone.0116885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615449	Green Published, Green Submitted, gold			2022-12-26	WOS:000349122100048
J	Oellrich, A; Collier, N; Smedley, D; Groza, T				Oellrich, Anika; Collier, Nigel; Smedley, Damian; Groza, Tudor			Generation of Silver Standard Concept Annotations from Biomedical Texts with Special Relevance to Phenotypes	PLOS ONE			English	Article							ONTOLOGY; SERVICES	Electronic health records and scientific articles possess differing linguistic characteristics that may impact the performance of natural language processing tools developed for one or the other. In this paper, we investigate the performance of four extant concept recognition tools: the clinical Text Analysis and Knowledge Extraction System (cTAKES), the National Center for Biomedical Ontology (NCBO) Annotator, the Biomedical Concept Annotation System (BeCAS) and MetaMap. Each of the four concept recognition systems is applied to four different corpora: the i2b2 corpus of clinical documents, a PubMed corpus of Medline abstracts, a clinical trails corpus and the ShARe/CLEF corpus. In addition, we assess the individual system performances with respect to one gold standard annotation set, available for the ShARe/CLEF corpus. Furthermore, we built a silver standard annotation set from the individual systems' output and assess the quality as well as the contribution of individual systems to the quality of the silver standard. Our results demonstrate that mainly the NCBO annotator and cTAKES contribute to the silver standard corpora (F1-measures in the range of 21% to 74%) and their quality (best F1-measure of 33%), independent from the type of text investigated. While BeCAS and MetaMap can contribute to the precision of silver standard annotations (precision of up to 42%), the F1-measure drops when combined with NCBO Annotator and cTAKES due to a low recall. In conclusion, the performances of individual systems need to be improved independently from the text types, and the leveraging strategies to best take advantage of individual systems' annotations need to be revised. The textual content of the PubMed corpus, accession numbers for the clinical trials corpus, and assigned annotations of the four concept recognition systems as well as the generated silver standard annotation sets are available from http://purl.org/phenotype/resources. The textual content of the ShARe/CLEF (https://sites.google.com/site/shareclefehealth/data) and i2b2 (https://i2b2.org/NLP/DataSets/) corpora needs to be requested with the individual corpus providers.	[Oellrich, Anika; Smedley, Damian] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Collier, Nigel] EMBL European Bioinformat Inst, Hinxton CB10 1SA, England; [Collier, Nigel] Natl Inst Informat, Tokyo 1018430, Japan; [Groza, Tudor] Univ Queensland, Sch ITEE, St Lucia, Qld 4072, Australia; [Groza, Tudor] Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; University of Queensland; Garvan Institute of Medical Research	Groza, T (corresponding author), Univ Queensland, Sch ITEE, St Lucia, Qld 4072, Australia.	t.groza@garvan.org.au	Smedley, Damian/AAL-8172-2021	Groza, Tudor/0000-0003-2267-8333; Collier, Nigel/0000-0002-7230-4164	European Commission through the Marie Curie International Incoming Fellowship (IIF) programme (Project: Phenominer) [301806]; Wellcome Trust [098051]; National Institutes of Health [1 U54 HG006370-01]; Australian Research Council (ARC) Discovery Early Career Researcher Award (DECRA) [DE120100508]; Western Australian Government Department of Health, IRDiRC; RD-Connect-European Union [305444]; Australian National Health; Medical Research Council under the NHMRC-European Union Collaborative Research Grants scheme [APP1055319]; Education Investment Fund; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006370] Funding Source: NIH RePORTER	European Commission through the Marie Curie International Incoming Fellowship (IIF) programme (Project: Phenominer); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council (ARC) Discovery Early Career Researcher Award (DECRA)(Australian Research Council); Western Australian Government Department of Health, IRDiRC; RD-Connect-European Union; Australian National Health(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council under the NHMRC-European Union Collaborative Research Grants scheme; Education Investment Fund; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Nigel Collier's research is supported by the European Commission through the Marie Curie International Incoming Fellowship (IIF) programme (Project: Phenominer, Ref: 301806). Anika Oellrich and Damian Smedley's work is funded by the Wellcome Trust grant 098051 and National Institutes of Health grant 1 U54 HG006370-01. Tudor Groza's research is funded by the Australian Research Council (ARC) Discovery Early Career Researcher Award (DECRA) -DE120100508. Tudor Groza acknowledges his involvement in the International Rare Disease Research Consortium (IRDiRC) and the support from The Western Australian Government Department of Health as part of its commitment to the goals of the IRDiRC. Furthermore, Tudor Groza gratefully acknowledges the combined financial support-in-part from the RD-Connect-European Union Seventh Framework Programme (HEALTH. 2012.2. 1. 1-1-C) under grant agreement number 305444: RD Connect: An integrated platform connecting databases, registries, biobanks and clinical bioinformatics for rare disease research; and from the Australian National Health and Medical Research Council APP1055319 under the NHMRC-European Union Collaborative Research Grants scheme. The authors acknowledge use of computing resources from the NeCTAR research cloud (http://www.nectar.org.au). NeCTAR is an Australian Government project conducted as part of the Super Science initiative and financed by the Education Investment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Bada M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-161; Baumgartner WA, 2007, BIOINFORMATICS, V23, pI41, DOI 10.1093/bioinformatics/btm229; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Browne AC, 2000, NATL LIB MED TECHNIC, P18; Chapman WW, 2001, J BIOMED INFORM, V34, P301, DOI 10.1006/jbin.2001.1029; *CLEM JONQ NHSMAM, 2009, SUMMIT ON TRANSLATIO, V56; Doms A, 2005, NUCLEIC ACIDS RES, V33, pW783, DOI 10.1093/nar/gki470; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Fluck J, 2014, DRUG DISCOV TODAY, V19, P140, DOI 10.1016/j.drudis.2013.09.012; Funk C, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-59; Groza Tudor, 2013, 2013 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), P481, DOI 10.1109/BIBM.2013.6732541; Hettne KM, 2009, BIOINFORMATICS, V25, P2983, DOI 10.1093/bioinformatics/btp535; Jimeno A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S3-S3; KIM JD, 2003, BIOINFORMATICS S1, V19, P180, DOI DOI 10.1093/BIOINFORMATICS/BTG1023; Li C, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat030; Liu S., 2005, IT Professional, V7, P17, DOI 10.1109/MITP.2005.122; MCCRAY AT, 1993, B MED LIBR ASSOC, V81, P184; McDonald CJ, 2003, CLIN CHEM, V49, P624, DOI 10.1373/49.4.624; Nunes T, 2013, BIOINFORMATICS, V29, P1915, DOI 10.1093/bioinformatics/btt317; Rebholz-Schuhmann D, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-28; Rebholz-Schuhmann Dietrich, 2011, J Biomed Semantics, V2 Suppl 5, pS11, DOI 10.1186/2041-1480-2-S5-S11; Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007; SAGAE K, 2007, EMNLP CONLL; Sasaki Y, 2008, P 3 INT S SEM MIN BI, V3, P109; Schofield PN, 2012, HUM MUTAT, V33, P826, DOI 10.1002/humu.22077; Shah NH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S9-S14; Stearns MQ, 2001, J AM MED INFORM ASSN, P662; Warren S T, 1993, Curr Opin Neurobiol, V3, P752, DOI 10.1016/0959-4388(93)90149-S; Whetzel PL, 2011, NUCLEIC ACIDS RES, V39, pW541, DOI 10.1093/nar/gkr469	30	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116040	10.1371/journal.pone.0116040	http://dx.doi.org/10.1371/journal.pone.0116040			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607983	Green Submitted, gold, Green Published			2022-12-26	WOS:000348205300023
J	Gibertoni, D; Corvaglia, L; Vandini, S; Rucci, P; Savini, S; Alessandroni, R; Sansavini, A; Fantini, MP; Faldella, G				Gibertoni, Dino; Corvaglia, Luigi; Vandini, Silvia; Rucci, Paola; Savini, Silvia; Alessandroni, Rosina; Sansavini, Alessandra; Fantini, Maria Pia; Faldella, Giacomo			Positive Effect of Human Milk Feeding during NICU Hospitalization on 24 Month Neurodevelopment of Very Low Birth Weight Infants: An Italian Cohort Study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; PRETERM INFANTS; BREAST-MILK; COGNITIVE-DEVELOPMENT; GESTATIONAL-AGE; CHILDREN BORN; FIT INDEXES; GROWTH; OUTCOMES; CYTOMEGALOVIRUS	The aim of this study was to determine the effect of human milk feeding during NICU hospitalization on neurodevelopment at 24 months of corrected age in very low birth weight infants. A cohort of 316 very low birth weight newborns (weight <= 1500 g) was prospectively enrolled in a follow-up program on admission to the Neonatal Intensive Care Unit of S. Orsola Hospital, Bologna, Italy, from January 2005 to June 2011. Neurodevelopment was evaluated at 24 months corrected age using the Griffiths Mental Development Scale. The effect of human milk nutrition on neurodevelopment was first investigated using a multiple linear regression model, to adjust for the effects of gestational age, small for gestational age, complications at birth and during hospitalization, growth restriction at discharge and socio-economic status. Path analysis was then used to refine the multiple regression model, taking into account the relationships among predictors and their temporal sequence. Human milk feeding during NICU hospitalization and higher socio-economic status were associated with better neurodevelopment at 24 months in both models. In the path analysis model intraventricular hemorrhage-periventricular leukomalacia and growth restriction at discharge proved to be directly and independently associated with poorer neurodevelopment. Gestational age and growth restriction at birth had indirect significant effects on neurodevelopment, which were mediated by complications that occurred at birth and during hospitalization, growth restriction at discharge and type of feeding. In conclusion, our findings suggest that mother's human milk feeding during hospitalization can be encouraged because it may improve neurodevelopment at 24 months corrected age.	[Gibertoni, Dino; Rucci, Paola; Fantini, Maria Pia] Univ Bologna, Unit Hyg & Biostat, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Corvaglia, Luigi; Vandini, Silvia; Alessandroni, Rosina; Faldella, Giacomo] Univ Bologna, Dept Med & Surg Sci, S Orsola Malpighi Hosp, Neonatol & Neonatal Intens Care Unit, Bologna, Italy; [Savini, Silvia; Sansavini, Alessandra] Univ Bologna, Dept Psychol, Bologna, Italy	University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna	Corvaglia, L (corresponding author), Univ Bologna, Dept Med & Surg Sci, S Orsola Malpighi Hosp, Neonatol & Neonatal Intens Care Unit, Bologna, Italy.	luigi.corvaglia@unibo.it	Gibertoni, Dino/H-4443-2017	Gibertoni, Dino/0000-0002-1722-3724; Rucci, Paola/0000-0002-7704-0831; Sansavini, Alessandra/0000-0002-1991-9864				Aggett PJ, 2006, J PEDIATR GASTR NUTR, V42, P596, DOI 10.1097/01.mpg.0000221915.73264.c7; Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0; Als H, 2004, PEDIATRICS, V113, P846, DOI 10.1542/peds.113.4.846; American Academy of Pediatrics. Committee on Infectious Diseases, 2003, RED BOOK 2003 REPORT; Belfort MB, 2013, JAMA PEDIATR, V167, P836, DOI 10.1001/jamapediatrics.2013.455; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bernard JY, 2013, J PEDIATR-US, V163, P36, DOI 10.1016/j.jpeds.2012.11.090; Bertino E, 2010, J PEDIATR GASTR NUTR, V51, P353, DOI 10.1097/MPG.0b013e3181da213e; Brandt I, 2003, J PEDIATR-US, V142, P463, DOI 10.1067/mpd.2003.149; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Capretti MG, 2009, J PEDIATR-US, V154, P842, DOI 10.1016/j.jpeds.2008.12.046; Cooke R, 2011, ANN NUTR METAB, V58, P32, DOI 10.1159/000323385; Cooke RWI, 2006, ARCH DIS CHILD-FETAL, V91, pF17, DOI 10.1136/adc.2005.077438; Cooke RWI, 2003, ARCH DIS CHILD, V88, P482, DOI 10.1136/adc.88.6.482; Corpeleijn WE, 2012, NEONATOLOGY, V102, P276, DOI 10.1159/000341335; Corvaglia L, 2010, EARLY HUM DEV, V86, P237, DOI 10.1016/j.earlhumdev.2010.04.001; De Curtis M, 2004, ACTA PAEDIATR, V93, P1563, DOI 10.1080/08035250410022198; Dessardo NS, 2012, AM J PERINAT, V29, P133, DOI 10.1055/s-0031-1295654; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Gianni ML, 2007, PEDIATRICS, V120, P1012, DOI 10.1542/peds.2006-3364; Gianni ML, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-74; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Griffiths R., 1996, GRIFFITHS MENTAL DEV; Hamprecht K, 2001, LANCET, V357, P513, DOI 10.1016/S0140-6736(00)04043-5; Haschke F, 2000, J PEDIATR GASTR NUTR, V31, pS60, DOI 10.1097/00005176-200007001-00006; Henderson G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004862.pub2; Hollingshead A. B., 1975, 4 FACTOR INDEX UNPUB; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Isaacs EB, 2010, PEDIATR RES, V67, P357, DOI 10.1203/PDR.0b013e3181d026da; Johnson S, 2006, EARLY HUM DEV, V82, P173, DOI 10.1016/j.earlhumdev.2006.01.008; Kline R.B., 2011, PRINCIPLES PRACTICE; Lanzieri TM, 2013, PEDIATRICS, V131, pE1937, DOI 10.1542/peds.2013-0076; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Lucas A, 1992, RANDOMISED TRIAL NUT; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; McCormick FM, 2010, COCHRANE DATABASE SY; Meinzen-Derr J, 2009, J PERINATOL, V29, P57, DOI 10.1038/jp.2008.117; Mercier CE, 2010, NEONATOLOGY, V97, P329, DOI 10.1159/000260136; Montjaux-Regis N, 2011, ACTA PAEDIATR, V100, P1548, DOI 10.1111/j.1651-2227.2011.02389.x; Morgan JA, 2012, ARCH DIS CHILD-FETAL, V97, pF295, DOI 10.1136/adc.2009.170910; Morley R, 2004, NEURODEVELOPMENT CHI; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; O'Connor DL, 2008, PEDIATRICS, V121, P766, DOI 10.1542/peds.2007-0054; Ostrea EM, 2012, NEUROTOXICOLOGY, V33, P669, DOI 10.1016/j.neuro.2011.11.006; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Potijk MR, 2013, J PEDIATR-US, V163, P1289, DOI 10.1016/j.jpeds.2013.07.001; Quigley MA, 2012, J PEDIATR-US, V160, P25, DOI 10.1016/j.jpeds.2011.06.035; Roze JC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000834; Sansavini A, 2011, CHILD CARE HLTH DEV, V37, P26, DOI 10.1111/j.1365-2214.2010.01143.x; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schanler RJ, 1999, FEEDING STRATEGIES P; Steiger JH, 1980, ANN M PSY CHOM SOC; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Tudehope DI, 2013, J PEDIATR-US, V162, pS17, DOI 10.1016/j.jpeds.2012.11.049; Vohr BR, 2007, PEDIATRICS, V120, pe953, DOI 10.1542/peds.2006-3227; Vohr BR, 2006, PEDIATRICS, V118, pE115, DOI 10.1542/peds.2005-2382; ZIEGLER EE, 1976, GROWTH, V40, P329	57	34	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116552	10.1371/journal.pone.0116552	http://dx.doi.org/10.1371/journal.pone.0116552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9HN	25590630	gold, Green Published, Green Submitted			2022-12-26	WOS:000350679400017
J	Lim, YP; Lin, CL; Lin, YN; Ma, WC; Chen, WC; Hung, DZ; Kao, CH				Lim, Yun-Ping; Lin, Cheng-Li; Lin, Yen-Ning; Ma, Wei-Chih; Chen, Wei-Cheng; Hung, Dong-Zong; Kao, Chia-Hung			Antiarrhythmic Agents and the Risk of Malignant Neoplasm of Liver and Intrahepatic Bile Ducts	PLOS ONE			English	Article							AMIODARONE-INDUCED THYROTOXICOSIS; PROPAFENONE HEPATOTOXICITY; DRUG-THERAPY; TOXICITY; CANCER; RECOMMENDATIONS; PREVENTION; CARCINOMA; UPDATE	Background The objective of this study was to determine the association between the use of antiarrhythmic agents and the risk of malignant neoplasm of liver and intrahepatic bile ducts (MNLIHD). Methods We used the research database of the Taiwan National Health Insurance Program to conduct a population-based, case-control study. We identified 9944 patients with antiarrhythmic history who were first diagnosed as having MNLIHD between 2005 and 2010. We identified an additional 19,497 patients with antiarrhythmic history in the same period who did not develop MNLIHD and were frequency-matched using age, sex, and index year to form a control group. Five commercially available antiarrhythmic agents, amiodarone, mexiletine, propafenone, quinidine, and procainamide, were analyzed. Results The adjusted odds ratio (OR) of MNLIHD was 1.60 (95% confidence interval [CI], 1.45-1.77) for amiodarone users versus nonamiodarone users. In subgroup analysis, amiodarone use was significantly associated with an increased risk of MNLIHD with an adjusted OR of 18.0 (95% CI, 15.7-20.5) for patients with comorbidities compared to an OR of 2.43 (95% CI, 1.92-3.06) for those without comorbidities. After adjustment for age, sex, statins, anti-diabetes medications, non-steroidal antiinflammatory drugs, propafenone use, quinidine use, and comorbidities, the ORs were 1.49, 1.66, and 1.79 for MNLIHD associated with annual mean defined daily doses of <= 30, 31-145, and >145, respectively. Conclusions The results of the present study indicated that amiodarone might be associated with the development of MNLIHD in a dose-dependent manner, particularly among patients with comorbidities.	[Lim, Yun-Ping; Lin, Yen-Ning; Ma, Wei-Chih; Chen, Wei-Cheng; Hung, Dong-Zong] China Med Univ, Coll Pharm, Dept Pharm, Taichung, Taiwan; [Lim, Yun-Ping; Hung, Dong-Zong] China Med Univ Hosp, Dept Emergency, Toxicol Ctr, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chen, Wei-Cheng] Natl Cheng Kung Univ Hosp, Dou Liou Branch, Dept Pharm, Yunlin, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.	d10040@mail.cmuh.org.tw						Arkun A, 2010, J EMERG MED, V38, P337, DOI 10.1016/j.jemermed.2008.01.006; ARNON R, 1988, CHEST, V93, P425, DOI 10.1378/chest.93.2.425; Azzam I, 2006, POSTGRAD MED J, V82, P73, DOI 10.1136/pgmj.2005.040105; Babatin M, 2008, CURR VASC PHARMACOL, V6, P228, DOI 10.2174/157016108784912019; Brambilla G, 2009, MUTAT RES-REV MUTAT, V681, P209, DOI 10.1016/j.mrrev.2008.09.002; CHUANG LC, 1993, ANN PHARMACOTHER, V27, P434, DOI 10.1177/106002809302700407; Cocozzella D, 2003, DIGEST DIS SCI, V48, P354, DOI 10.1023/A:1021943930424; Department of Health, TAIW MAIN CAUS DEATH; Dowman JK, 2014, AM J PATHOL, V184, P1550, DOI 10.1016/j.ajpath.2014.01.034; Farver DK, 1999, ANN PHARMACOTHER, V33, P32, DOI 10.1345/aph.18172; Fuchs BC, 2014, HEPATOLOGY, V59, P1577, DOI 10.1002/hep.26898; Hall MA, 2004, BRIT J DERMATOL, V151, P932, DOI 10.1111/j.1365-2133.2004.06193.x; Higa K, 1997, PAIN, V73, P97, DOI 10.1016/S0304-3959(97)00066-3; Inaba H, 2012, MED PRIN PRACT, V21, P190, DOI 10.1159/000333697; LEWIS JH, 1989, HEPATOLOGY, V9, P679, DOI 10.1002/hep.1840090504; LEWIS JH, 1990, HUM PATHOL, V21, P59, DOI 10.1016/0046-8177(90)90076-H; Malek NP, 2014, DTSCH ARZTEBL INT, V111, P101, DOI 10.3238/arztebl.2014.0101; Maoz KBA, 2009, INT J DERMATOL, V48, P1398, DOI 10.1111/j.1365-4632.2008.03819.x; MASON JW, 1987, NEW ENGL J MED, V316, P455; Mellemgaard A, 1998, THYROID, V8, P751, DOI 10.1089/thy.1998.8.751; MONDARDINI A, 1993, GASTROENTEROLOGY, V104, P1524, DOI 10.1016/0016-5085(93)90365-J; MONK BE, 1995, BRIT J DERMATOL, V133, P148; MORSE RM, 1988, ANN INTERN MED, V109, P838, DOI 10.7326/0003-4819-109-10-838; Piccini JP, 2009, EUR HEART J, V30, P1245, DOI 10.1093/eurheartj/ehp100; PICCIONE W, 1989, ANN THORAC SURG, V47, P918, DOI 10.1016/0003-4975(89)90037-4; Raja K, 2009, SEMIN LIVER DIS, V29, P423, DOI 10.1055/s-0029-1240011; Rodriguez-Garcia J L., 2001, Eur J Intern Med, V12, P372, DOI 10.1016/S0953-6205(01)00127-3; Skanes AC, 2012, CAN J CARDIOL, V28, P125, DOI 10.1016/j.cjca.2012.01.021; Stelfox HT, 2004, CLIN PHARMACOL THER, V75, P110, DOI 10.1016/j.clpt.2003.09.010; Su VYF, 2013, CANCER-AM CANCER SOC, V119, P1699, DOI 10.1002/cncr.27881; TRIP MD, 1991, AM J MED, V91, P507, DOI 10.1016/0002-9343(91)90187-3; US Food and Drug Administration, 2004, NDA 18 972 S 038 039; Waldhauser KM, 2006, J PHARMACOL EXP THER, V319, P1413, DOI 10.1124/jpet.106.108993; Younan L, 2013, SAUDI J GASTROENTERO, V19, P235, DOI 10.4103/1319-3767.118137; Zahno A, 2011, BIOCHEM PHARMACOL, V81, P432, DOI 10.1016/j.bcp.2010.11.002; Zimetbaum P, 2012, CIRCULATION, V125, P381, DOI 10.1161/CIRCULATIONAHA.111.019927	36	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116960	10.1371/journal.pone.0116960	http://dx.doi.org/10.1371/journal.pone.0116960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590332	Green Published, gold, Green Submitted			2022-12-26	WOS:000350679400026
J	Gotts, ZM; Ellis, JG; Deary, V; Barclay, N; Newton, JL				Gotts, Zoe M.; Ellis, Jason G.; Deary, Vincent; Barclay, Nicola; Newton, Julia L.			The Association between Daytime Napping and Cognitive Functioning in Chronic Fatigue Syndrome	PLOS ONE			English	Article							SLEEP; PERFORMANCE; QUALITY; ILLNESS; MOOD; EEG	Objectives The precise relationship between sleep and physical and mental functioning in chronic fatigue syndrome (CFS) has not been examined directly, nor has the impact of daytime napping. This study aimed to examine self-reported sleep in patients with CFS and explore whether sleep quality and daytime napping, specific patient characteristics (gender, illness length) and levels of anxiety and depression, predicted daytime fatigue severity, levels of daytime sleepiness and cognitive functioning, all key dimensions of the illness experience. Methods 118 adults meeting the 1994 CDC case criteria for CFS completed a standardised sleep diary over 14 days. Momentary functional assessments of fatigue, sleepiness, cognition and mood were completed by patients as part of usual care. Levels of daytime functioning and disability were quantified using symptom assessment tools, measuring fatigue (Chalder Fatigue Scale), sleepiness (Epworth Sleepiness Scale), cognitive functioning ( Trail Making Test, Cognitive Failures Questionnaire), and mood ( Hospital Anxiety and Depression Scale). Results Hierarchical Regressions demonstrated that a shorter time since diagnosis, higher depression and longer wake time after sleep onset predicted 23.4% of the variance in fatigue severity ( p <.001). Being male, higher depression and more afternoon naps predicted 25.6% of the variance in objective cognitive dysfunction ( p <.001). Higher anxiety and depression and morning napping predicted 32.2% of the variance in subjective cognitive dysfunction ( p <.001). When patients were classified into groups of mild and moderate sleepiness, those with longer daytime naps, those who mainly napped in the afternoon, and those with higher levels of anxiety, were more likely to be in the moderately sleepy group. Conclusions Napping, particularly in the afternoon is associated with poorer cognitive functioning and more daytime sleepiness in CFS. These findings have clinical implications for symptom management strategies.	[Gotts, Zoe M.; Ellis, Jason G.; Deary, Vincent; Barclay, Nicola] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Newton, Julia L.] Newcastle Univ, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Newton, Julia L.] Newcastle Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Newton, Julia L.] UK NIHR Biomed Res Ctr Ageing, Newcastle Upon Tyne, Tyne & Wear, England	Northumbria University; Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Gotts, ZM (corresponding author), Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.	zoe.gotts@northumbria.ac.uk	; Barclay, Nicola/D-8981-2013; Ellis, Jason/E-7783-2013	Newton, Julia/0000-0002-1249-5253; Gotts, Zoe/0000-0003-0040-1720; Barclay, Nicola/0000-0002-6500-9909; Deary, Vincent/0000-0001-6115-9259; Ellis, Jason/0000-0002-8496-520X	Action for ME; ME Research UK; ME Association Ramsay Research Fund	Action for ME; ME Research UK; ME Association Ramsay Research Fund	This work was supported by Action for ME, ME Research UK, and the ME Association Ramsay Research Fund. The organizations had no role in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Anderson JS, 1997, J NERV MENT DIS, V185, P359, DOI 10.1097/00005053-199706000-00001; Fernandez AA, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-S1-S1; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; CATHEBRAS PJ, 1992, J GEN INTERN MED, V7, P276, DOI 10.1007/BF02598083; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Chellappa SL, 2006, REV BRAS PSIQUIATR, V28, P126, DOI 10.1590/S1516-44462006000200010; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; DIJK DJ, 1989, EUR J PHARMACOL, V171, P207, DOI 10.1016/0014-2999(89)90109-X; Edinger JD, 2004, SLEEP, V27, P1567, DOI 10.1093/sleep/27.8.1567; FEINBERG I, 1985, ELECTROEN CLIN NEURO, V61, P134, DOI 10.1016/0013-4694(85)91051-X; Fossey M, 2004, J BEHAV MED, V27, P581, DOI 10.1007/s10865-004-0004-y; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gotts ZM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002999; Groeger JA, 2011, BEHAV NEUROSCI, V125, P252, DOI 10.1037/a0022692; Hamaguchi M, 2011, CLIN RHEUMATOL, V30, P895, DOI 10.1007/s10067-011-1702-9; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; JASON LA, 2001, J CHRONIC FATIGUE SY, V8, P1, DOI DOI 10.1300/J092V08N03_04; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; KARACAN I, 1970, Biological Psychiatry, V2, P391; Lichstein KL, 1997, BEHAV RES THER, V35, P733, DOI 10.1016/S0005-7967(97)00029-6; Manber R, 2012, J CLIN SLEEP MED, V8, P209, DOI 10.5664/jcsm.1786; Morin CM, 1993, INSOMNIA PSYCHOLOGIC; MORRISS R, 1993, BRIT MED J, V306, P1161, DOI 10.1136/bmj.306.6886.1161; Morriss RK, 2002, PSYCHOPHARMACOLOGY, V163, P166, DOI 10.1007/s00213-002-1129-8; Morriss RK, 1997, J PSYCHOSOM RES, V42, P597, DOI 10.1016/S0022-3999(97)89895-9; MOSSMORRIS R, 2013, HANDB CLINICAL NEURO, P301; *NAT I HLTH CLIN E, 2007, NICE CLINICAL GUIDEL; Neu D, 2008, J SLEEP RES, V17, P427, DOI 10.1111/j.1365-2869.2008.00679.x; Nisenbaum R, 2004, J PSYCHOSOM RES, V56, P171, DOI 10.1016/S0022-3999(03)00039-4; Nisenbaum Rosane, 2003, Health Qual Life Outcomes, V1, P49, DOI 10.1186/1477-7525-1-49; Pigeon WR, 2003, J PSYCHOSOM RES, V54, P61, DOI 10.1016/S0022-3999(02)00542-1; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Santamarina-Perez P, 2011, APPL NEUROPSYCHOL, V18, P216, DOI 10.1080/09084282.2011.595448; Shen JH, 2006, SLEEP MED REV, V10, P63, DOI 10.1016/j.smrv.2005.05.004; SMITH AP, 1993, BRIT J PSYCHOL, V84, P411, DOI 10.1111/j.2044-8295.1993.tb02492.x; Tiersky LA, 2003, J NERV MENT DIS, V191, P324, DOI 10.1097/00005053-200305000-00008; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X; Wearden A, 1997, PSYCHOL MED, V27, P81, DOI 10.1017/S0033291796004035; Werth E, 1996, AM J PHYSIOL-REG I, V271, pR501, DOI 10.1152/ajpregu.1996.271.3.R501; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	19	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0117136	10.1371/journal.pone.0117136	http://dx.doi.org/10.1371/journal.pone.0117136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4BU	25575044	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000348168100013
J	Guo, H; Sa, ZH				Guo, Hong; Sa, Zhihong			Socioeconomic Differentials in Smoking Duration among Adult Male Smokers in China: Result from the 2006 China Health and Nutrition Survey	PLOS ONE			English	Article							LUNG-CANCER; TOBACCO USE; PREVALENCE; CONSUMPTION; CESSATION; EDUCATION; INEQUALITIES; POPULATION; VALIDATION; MORTALITY	Background A smoker's risk of diseases and death from smoking is closely related to his/her smoking duration. But little is known about the average length of smoking and the association between smoking duration and socio-economic status (SES) among Chinese smokers. Methods A sample of male ever smokers (N = 2,637) aged 18+ years was drawn from the 2006 China Health and Nutrition Survey to examine the average length of smoking and socioeconomic differentials in smoking duration. Kaplan-Meier analysis was used to obtain median smoking duration. Log-logistic regression models were employed to estimate the relative duration of smoking, adjusted for demographic characteristics, smoking history, and health status. Results Results showed that Chinese male ever smokers aged 18 years and older had a median duration of smoking of 58 years ( 95% CI: 56-61). Male ever smokers with a lower status job (i.e. farmers, manual and skilled workers, service workers, and office staff) had a significantly longer duration of smoking than those with a professional or administrative job after adjusted for demographic characteristics, smoking history, and health status. Individuals who earned the lowest income and who had no education or were being illiterate smoked for 11% and 14% longer, respectively, relative to those who had the highest income or who had college or above education. Conclusion The findings demonstrated the problem of long smoking duration and a pattern of social disparities in smoking duration among Chinese male smokers. Social disparities in smoking behavior may exacerbate the already existing social inequalities in health. Thus, policies and interventions to promote smoking cessation should pay more attention to disadvantaged social groups.	[Sa, Zhihong] Beijing Normal Univ, Sch Social Dev & Publ Policy, Beijing 100875, Peoples R China	Beijing Normal University	Sa, ZH (corresponding author), Beijing Normal Univ, Sch Social Dev & Publ Policy, Beijing 100875, Peoples R China.	zsa@bnu.edu.cn						Alberg AJ, 2003, CHEST, V123, p21S, DOI 10.1378/chest.123.1_suppl.21S; Burns EK, 2007, NICOTINE TOB RES, V9, P731, DOI 10.1080/14622200701397882; Center for Disease Prevention and Control Chinese Ministry of Health, 2010, GATS CHIN REP; Ceraso M, 2009, PREV CHRONIC DIS, V6; Cleves MA, 2002, INTRO SURVIVAL ANAL; Dikotter F, 2002, BRIT J CRIMINOL, V42, P317, DOI 10.1093/bjc/42.2.317; Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290; Entwisle B, 2002, EUR J POPUL, V18, P99, DOI 10.1023/A:1015507114559; Ferri CP, 2011, INT J GERIATR PSYCH, V26, P1177, DOI 10.1002/gps.2661; Flanders WD, 2003, CANCER RES, V63, P6556; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hu J, 2005, ANN ONCOL, V16, P1605, DOI 10.1093/annonc/mdi312; Huisman M, 2005, PREV MED, V40, P756, DOI 10.1016/j.ypmed.2004.09.022; Islam M S, 2013, Mymensingh Med J, V22, P547; Kendzor DE, 2010, AM J PUBLIC HEALTH, V100, P702, DOI 10.2105/AJPH.2009.172676; Kenkel D, 2009, HEALTH ECON, V18, pS147, DOI 10.1002/hec.1507; Kohrman M, 2007, CHINA J, V58, P85, DOI 10.1086/tcj.58.20066308; Le C, 2009, SE ASIAN J TROP MED, V40, P370; Levy DT, 2006, J EPIDEMIOL COMMUN H, V60, P20, DOI 10.1136/jech.2005.045542; LIU ZY, 1992, INT J EPIDEMIOL, V21, P197, DOI 10.1093/ije/21.2.197; McDonald SP, 2003, AUST NZ J PUBL HEAL, V27, P57, DOI 10.1111/j.1467-842X.2003.tb00380.x; Najman JM, 2006, B WORLD HEALTH ORGAN, V84, P976, DOI 10.2471/BLT.05.028928; Pan ZF, 2004, HEALTH PROMOT INT, V19, P309, DOI 10.1093/heapro/dah304; Pan Z, 2008, J PUBLIC HEALTH POL, V29, P72, DOI 10.1057/palgrave.jphp.3200163; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Sanderson DM, 2005, PREV MED, V41, P757, DOI 10.1016/j.ypmed.2005.06.002; Siahpush M, 2005, PUBLIC HEALTH, V119, P1105, DOI 10.1016/j.puhe.2005.03.004; Siahpush M, 2003, TOB CONTROL, V12, P60, DOI 10.1136/tc.12.1.60; Siahpush M, 2010, J PUBLIC HEALTH-UK, V32, P210, DOI 10.1093/pubmed/fdp104; Siahpush M, 2009, ADDICTION, V104, P1382, DOI 10.1111/j.1360-0443.2009.02599.x; SUADICANI P, 1994, INT J EPIDEMIOL, V23, P293, DOI 10.1093/ije/23.2.293; Tu Shin-Ping, 2000, Asian Am Pac Isl J Health, V8, P46; Vartiainen E, 2002, J EPIDEMIOL COMMUN H, V56, P167, DOI 10.1136/jech.56.3.167; Wang Hong, 2006, Salud pública Méx, V48, ps140, DOI 10.1590/S0036-36342006000700017; Wank D, 2000, CIGARETTES DOMINATIO, P268; WHO, 2008, REP GLOB TOB EP 2008; Wipfli H, 2009, CLIN PHARMACOL THER, V86, P263, DOI 10.1038/clpt.2009.93; World Health Organization, 1999, WORLD HLTH REP 1999; Yan J, 2008, NICOTINE TOB RES, V10, P737, DOI 10.1080/14622200801901930; Yan W, 2004, CHINA PUBLIC HLTH, V20, P2; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Yang Y, 2010, BIOMED ENVIRON SCI, V23, P437, DOI 10.1016/S0895-3988(11)60004-4; Zhang J, 2011, RESPIROLOGY, V16, P1165, DOI 10.1111/j.1440-1843.2011.02062.x; Zhu Zh, 1999, CHINESE MENTAL HLTH, V13, P105	45	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0117354	10.1371/journal.pone.0117354	http://dx.doi.org/10.1371/journal.pone.0117354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4BU	25575097	Green Published, gold, Green Submitted			2022-12-26	WOS:000348168100014
J	Guo, WH; Grewe, F; Mower, JP				Guo, Wenhu; Grewe, Felix; Mower, Jeffrey P.			Variable Frequency of Plastid RNA Editing among Ferns and Repeated Loss of Uridine-to-Cytidine Editing from Vascular Plants	PLOS ONE			English	Article							MITOCHONDRIAL GENOME SEQUENCE; GROUP-II INTRON; CHLOROPLAST GENOME; EQUISETUM-ARVENSE; MESSENGER-RNAS; TRANSCRIPTS; SITES; EVOLUTION; LIVERWORT; LYCOPHYTE	The distinct distribution and abundance of C-to-U and U-to-C RNA editing among land plants suggest that these two processes originated and evolve independently, but the paucity of information from several key lineages limits our understanding of their evolution. To examine the evolutionary diversity of RNA editing among ferns, we sequenced the plastid transcriptomes from two early diverging species, Ophioglossum californicum and Psilotum nudum. Using a relaxed automated approach to minimize false negatives combined with manual inspection to eliminate false positives, we identified 297 C-to-U and three U-to-C edit sites in the O. californicum plastid transcriptome but only 27 C-to-U and no U-to-C edit sites in the P. nudum plastid transcriptome. A broader comparison of editing content with the leptosporangiate fern Adiantum capillus-veneris and the hornwort Anthoceros formosae uncovered large variance in the abundance of plastid editing, indicating that the frequency and type of RNA editing is highly labile in ferns. Edit sites that increase protein conservation among species are more abundant and more efficiently edited than silent and non-conservative sites, suggesting that selection maintains functionally important editing. The absence of U-to-C editing from P. nudum plastid transcripts and other vascular plants demonstrates that U-to-C editing loss is a recurrent phenomenon in vascular plant evolution.	[Guo, Wenhu; Grewe, Felix; Mower, Jeffrey P.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA; [Guo, Wenhu] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Guo, Wenhu] ACGT Inc, Wheeling, IL USA; [Grewe, Felix; Mower, Jeffrey P.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Mower, JP (corresponding author), Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA.	jpmower@unl.edu	Mower, Jeff/P-5893-2019; Mower, Jeff/B-7875-2008; Guo, Wenhu/C-7803-2016	Mower, Jeff/0000-0002-1501-5809; Mower, Jeff/0000-0002-1501-5809; Guo, Wenhu/0000-0002-2515-2161; Grewe, Felix/0000-0002-2805-5930	University of Nebraska-Lincoln; National Science Foundation [IOS-1027529, MCB-1125386]	University of Nebraska-Lincoln; National Science Foundation(National Science Foundation (NSF))	This work was supported by start-up funds from the University of Nebraska-Lincoln and by the National Science Foundation (awards IOS-1027529 and MCB-1125386 to JPM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ACGT, Inc. provided support in the form of salaries for author WG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Begu D, 2009, CURR GENET, V55, P69, DOI 10.1007/s00294-008-0225-7; Begu D, 2011, CURR GENET, V57, P317, DOI 10.1007/s00294-011-0349-z; Bentolila S, 2008, GENETICS, V178, P1693, DOI 10.1534/genetics.107.073585; BORNER GV, 1995, MOL GEN GENET, V246, P739, DOI 10.1007/BF00290721; Carrillo C, 1997, NUCLEIC ACIDS RES, V25, P403, DOI 10.1093/nar/25.2.403; Carrillo C, 2001, MOL GEN GENET, V264, P595, DOI 10.1007/s004380000345; Castandet B, 2010, NUCLEIC ACIDS RES, V38, P7112, DOI 10.1093/nar/gkq591; Chateigner-Boutin AL, 2011, WIRES RNA, V2, P493, DOI 10.1002/wrna.72; Chaw SM, 2008, MOL BIOL EVOL, V25, P603, DOI 10.1093/molbev/msn009; Drescher A, 2002, MOL GENET GENOMICS, V267, P262, DOI 10.1007/s00438-002-0662-9; Duff RJ, 2005, J MOL EVOL, V61, P571, DOI 10.1007/s00239-004-0146-0; Farre JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052644; Finster S, 2012, GENOMICS CHLOROPLAST, P293; Freyer R, 1997, P NATL ACAD SCI USA, V94, P6285, DOI 10.1073/pnas.94.12.6285; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Grewe F, 2014, MITOCHONDRION, V19, P135, DOI 10.1016/j.mito.2014.05.008; Grewe F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-8; Grewe F, 2011, NUCLEIC ACIDS RES, V39, P2890, DOI 10.1093/nar/gkq1227; Grimes BT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-31; Grosche C, 2012, GENOME BIOL EVOL, V4, P1349, DOI 10.1093/gbe/evs114; Groth-Malonek M, 2005, MOL BIOL EVOL, V22, P117, DOI 10.1093/molbev/msh259; Groth-Malonek M, 2007, MOL BIOL EVOL, V24, P1068, DOI 10.1093/molbev/msm026; GUALBERTO JM, 1990, NUCLEIC ACIDS RES, V18, P3771, DOI 10.1093/nar/18.13.3771; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hecht J, 2011, GENOME BIOL EVOL, V3, P344, DOI 10.1093/gbe/evr027; Hepburn NJ, 2012, MOL BIOL EVOL, V29, P3111, DOI 10.1093/molbev/mss130; HIESEL R, 1994, P NATL ACAD SCI USA, V91, P629, DOI 10.1073/pnas.91.2.629; Karcher D, 2002, J BIOL CHEM, V277, P5570, DOI 10.1074/jbc.M107074200; Karol KG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-321; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim HT, 2014, MOL CELLS, V37, P372, DOI 10.14348/molcells.2014.2296; Kugita M, 2003, NUCLEIC ACIDS RES, V31, P2417, DOI 10.1093/nar/gkg327; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li LB, 2009, J MOL EVOL, V68, P665, DOI 10.1007/s00239-009-9240-7; Li-Pook-Than J, 2007, PHYSIOL PLANTARUM, V129, P23, DOI 10.1111/j.1399-3054.2006.00770.x; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035168; Miyata Y, 2004, J PLANT PHYSIOL, V161, P113, DOI 10.1078/0176-1617-01220; Mower JP, 2006, MOL GENET GENOMICS, V276, P285, DOI 10.1007/s00438-006-0139-3; Oldenkott B, 2014, RNA, V20, P1499, DOI 10.1261/rna.045575.114; Ong HC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-55; Picardi E, 2010, NUCLEIC ACIDS RES, V38, P4755, DOI 10.1093/nar/gkq202; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Richardson E, 2014, MOL BIOL EVOL, V31, P2376, DOI 10.1093/molbev/msu189; Rudinger M, 2012, J MOL EVOL, V74, P37, DOI 10.1007/s00239-012-9486-3; Rudinger M, 2009, MOL GENET GENOMICS, V281, P473, DOI 10.1007/s00438-009-0424-z; Ruhfel BR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-23; Ruwe H, 2013, FEBS LETT, V587, P1429, DOI 10.1016/j.febslet.2013.03.022; SCHUSTER W, 1990, MOL CELL BIOL, V10, P2428, DOI 10.1128/MCB.10.5.2428; SCHUSTER W, 1991, NUCLEIC ACIDS RES, V19, P6923, DOI 10.1093/nar/19.24.6923; Sloan DB, 2010, GENETICS, V185, P1369, DOI 10.1534/genetics.110.118000; SPERWHITIS GL, 1994, BBA-GENE STRUCT EXPR, V1218, P218, DOI 10.1016/0167-4781(94)90016-7; Stone JD, 2015, MOL GENET GENOMICS, V290, P1, DOI 10.1007/s00438-014-0905-6; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; van Gurp TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085583; Wakasugi T, 1996, P NATL ACAD SCI USA, V93, P8766, DOI 10.1073/pnas.93.16.8766; Wolf PG, 2011, PLANT MOL BIOL, V76, P251, DOI 10.1007/s11103-010-9706-4; Wolf PG, 2005, GENE, V350, P117, DOI 10.1016/j.gene.2005.01.018; Wolf PG, 2004, GENE, V339, P89, DOI 10.1016/j.gene.2004.06.018; Xue JY, 2010, CURR GENET, V56, P53, DOI 10.1007/s00294-009-0279-1; Yura K, 2008, DNA RES, V15, P309, DOI 10.1093/dnares/dsn016; Zehrmann A, 2008, MITOCHONDRION, V8, P319, DOI 10.1016/j.mito.2008.07.003; Zeng WH, 2007, PLANT CELL PHYSIOL, V48, P362, DOI 10.1093/pcp/pcl058	65	47	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e0117075	10.1371/journal.pone.0117075	http://dx.doi.org/10.1371/journal.pone.0117075			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25568947	Green Published, Green Submitted, gold			2022-12-26	WOS:000348168000011
J	Fan, LC; Shiau, CW; Tai, WT; Hung, MH; Chu, PY; Hsieh, FS; Lin, H; Yu, HC; Chen, KF				Fan, L-C; Shiau, C-W; Tai, W-T; Hung, M-H; Chu, P-Y; Hsieh, F-S; Lin, H.; Yu, H-C; Chen, K-F			SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma	ONCOGENE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GROWTH-FACTOR RECEPTOR; G-ALPHA-I; TGF-BETA; SIGNAL TRANSDUCER; STAT3 ACTIVATION; CELL-CYCLE; MECHANISMS; SORAFENIB; EXPRESSION	Epithelial-to-mesenchymal transition (EMT) is well known to involve in tumor invasion and metastasis. Src homology region 2 domain-containing phosphatase 1 (SHP-1) functions as a potent tumor suppressor and also acts as a negative regulator of p-STAT3(Tyr705) oncogenic signaling. However, little is known about the molecular mechanism(s) through which SHP-1 regulates EMT during hepatocellular carcinoma (HCC) progression. Here we first reported that endogenous SHP-1 protein levels were significantly downregulated in cells with mesenchymal characteristics and negatively correlated with p-STAT3(Tyr705) and vimentin but positively correlated with E-cadherin. SHP-1 overexpression abolished transforming growth factor-beta 1 (TGF-beta 1)-induced p-STAT3(Tyr705) and EMT, as well inhibited migration and invasion but further rescued by signal transducer and activator of transcription factor 3 (STAT3) overexpression. Depletion of SHP-1 could induce a more increase in TGF-beta 1-induced p-STAT3(Tyr-705) and EMT characteristics, further supporting the mechanism that suppression of TGF-beta 1-induced EMT is dependent on SHP-1-mediated STAT3 inactivation. Constitutively overexpressed SHP-1 tyrosine phosphatase activity by D61A-mutated SHP-1 markedly reduced TGF-beta 1-induced p-STAT3(Tyr705) and EMT features but was not altered by C453S catalytic-dead mutant SHP-1. Consequently, SHP-1 acted as a powerful suppressor in preventing EMT by exerting its tyrosine phosphatase activity that directly downregulated p-STAT3(Tyr705). Most notably, we discovered a novel SHP-1 agonist SC-43 better than sorafenib to exert more potent anti-EMT effects in vitro as well as anti-metastatic growth in vivo. In conclusion, SHP-1 is a potent suppressor of HCC EMT and metastasis, thus highlighting that SC-43-SHP-1 axis may serve as a potential therapeutic target that antagonized p-STAT3(Tyr705) and thereby prevented HCC EMT and metastasis.	[Fan, L-C; Tai, W-T; Hsieh, F-S; Lin, H.; Yu, H-C; Chen, K-F] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 100, Taiwan; [Fan, L-C; Tai, W-T; Hsieh, F-S; Lin, H.; Yu, H-C; Chen, K-F] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Taipei 100, Taiwan; [Shiau, C-W] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Hung, M-H] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Hung, M-H] Natl Yang Ming Univ, Sch Life Sci, Program Mol Med, Taipei 112, Taiwan; [Chu, P-Y] Show Chwan Mem Hosp, Dept Pathol, Changhua, Taiwan; [Chu, P-Y] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Show Chwan Memorial Hospital; Fu Jen Catholic University	Chen, KF (corresponding author), Natl Taiwan Univ Hosp, Dept Med Res, 7 Chung Shan South Rd, Taipei 100, Taiwan.	kfchen1970@ntu.edu.tw		Chu, Pei-Yi/0000-0001-7336-2465; Chen, Kuen-Feng/0000-0002-4686-7019	National Science Council [NSC 102-2325-B-002-031, NHRI-EX102-10246B]; National Health Research Institutes, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by grants NSC 102-2325-B-002-031 and NHRI-EX102-10246BI from the National Science Council and the National Health Research Institutes, Taiwan. For SHP-1 and E-cadherin, gene expression levels were assessed by using microarray data deposited in the Gene Expression Omnibus (GEO) database under accession no. GSE25097.	BANVILLE D, 1995, GENOMICS, V27, P165, DOI 10.1006/geno.1995.1020; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chen KF, 2012, EUR J MED CHEM, V55, P220, DOI 10.1016/j.ejmech.2012.07.023; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2010, MOL BIOL CELL, V21, P2338, DOI 10.1091/mbc.E10-01-0028; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Johnston PA, 2011, MOL INTERV, V11, P18, DOI 10.1124/mi.11.1.4; Kang JH, 2008, CANCER LETT, V261, P84, DOI 10.1016/j.canlet.2007.11.006; Lee JH, 2014, CANCER LETT, V345, P140, DOI 10.1016/j.canlet.2013.12.008; Liu CY, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3457; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lopez-Ruiz P, 2011, ANTI-CANCER AGENT ME, V11, P89, DOI 10.2174/187152011794941154; Lu HS, 2014, TUMOR BIOL, V35, P9807, DOI 10.1007/s13277-014-2256-7; Luo F, 2013, TOXICOL APPL PHARM, V273, P27, DOI 10.1016/j.taap.2013.08.025; Mittal Y, 2011, J BIOL CHEM, V286, P32404, DOI 10.1074/jbc.M111.275685; MOK SC, 1995, GYNECOL ONCOL, V57, P299, DOI 10.1006/gyno.1995.1146; Oh J, 2004, CANCER RES, V64, P9062, DOI 10.1158/0008-5472.CAN-04-1981; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Rokavec M, 2014, J CLIN INVEST, V124, P1853, DOI 10.1172/JCI73531; Sainz-Perez A, 2008, J IMMUNOL, V181, P6051, DOI 10.4049/jimmunol.181.9.6051; Simpson D, 2008, DRUGS, V68, P251, DOI 10.2165/00003495-200868020-00007; Tai WT, 2014, HEPATOLOGY, V59, P190, DOI 10.1002/hep.26640; Tai WT, 2011, J HEPATOL, V55, P1041, DOI 10.1016/j.jhep.2011.06.005; Tsui HW, 2002, EUR J BIOCHEM, V269, P3057, DOI 10.1046/j.1432-1033.2002.02986.x; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; Witkiewicz A, 2007, HUM PATHOL, V38, P462, DOI 10.1016/j.humpath.2006.09.012; Wu CY, 2003, J CELL BIOCHEM, V90, P1026, DOI 10.1002/jcb.10727; Wu CY, 2003, GENE, V306, P1, DOI 10.1016/S0378-1119(03)00400-1; Xiong H, 2012, J BIOL CHEM, V287, P5819, DOI 10.1074/jbc.M111.295964; Yang YN, 2006, CANCER RES, V66, P8617, DOI 10.1158/0008-5472.CAN-06-1308; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang Zhuqing, 2013, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V27, P1265	34	37	39	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2015	34	41					5252	5263		10.1038/onc.2014.445	http://dx.doi.org/10.1038/onc.2014.445			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CT1QL	25619838				2022-12-26	WOS:000362575400005
J	Cheruvara, H; Allen-Baume, VL; Kad, NM; Mason, JM				Cheruvara, Harish; Allen-Baume, Victoria L.; Kad, Neil M.; Mason, Jody M.			Intracellular Screening of a Peptide Library to Derive a Potent Peptide Inhibitor of alpha-Synuclein Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alpha-synuclein (-Synuclein); Amyloid; Parkinson Disease; Protein Misfolding; Protein-Protein Interaction; Library Screening; Protein-Fragment Complementation Assay	PROTEIN AGGREGATION; PARKINSONS-DISEASE; CELL-DEATH; IN-VITRO; TOXICITY; NEUROTOXICITY; PREDICTION; FRAGMENT; DETERMINANTS; SELECTION	Background: Deposition of -synuclein into Lewy bodies is considered the primary event in Parkinson disease. Results: A peptide selected via PCA library screening functions by inhibiting fibril formation. Conclusion: A semirational design combined with intracellular PCA is an effective methodology to develop -synuclein aggregation antagonists. Significance: The technique can be applied to a number of diseases from Parkinson to Alzheimer. Aggregation of -synuclein (-syn) into toxic fibrils is a pathogenic hallmark of Parkinson disease (PD). Studies have focused largely on residues 71-82, yet most early-onset mutations are located between residues 46 and 53. A semirationally designed 209,952-member library based entirely on this region was constructed, containing all wild-type residues and changes associated with early-onset PD. Intracellular cell survival screening and growth competition isolated a 10-residue peptide antagonist that potently inhibits -syn aggregation and associated toxicity at a 1:1 stoichiometry. This was verified using continuous growth measurements and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide cytotoxicity studies. Atomic force microscopy and circular dichroism on the same samples showed a random-coil structure and no oligomers. A new region of -syn for inhibitor targeting has been highlighted, together with the approach of using a semirational design and intracellular screening. The peptides can then be used as candidates for modification in drugs capable of slowing or even preventing the onset of PD.	[Cheruvara, Harish; Allen-Baume, Victoria L.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Kad, Neil M.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Mason, Jody M.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Essex; University of Kent; University of Bath	Mason, JM (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	j.mason@bath.ac.uk	Mason, Jody/W-8204-2019	Mason, Jody/0000-0002-4118-1958; Kad, Neil/0000-0002-3491-8595	Parkinson's UK Ph.D. Studentship [H-1001]; Cancer Research UK Career Establishment Award [A11738]; Parkinson&quot;s UK [H-1001] Funding Source: researchfish	Parkinson's UK Ph.D. Studentship; Cancer Research UK Career Establishment Award; Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was supported by Parkinson's UK Ph.D. Studentship H-1001 (to H. C., N. M. K., and J. M. M.) and by Cancer Research UK Career Establishment Award A11738 (to J. M. M.).	Acerra N, 2014, PROTEIN SCI, V23, P1262, DOI 10.1002/pro.2509; Acerra N, 2013, PROTEIN ENG DES SEL, V26, P463, DOI 10.1093/protein/gzt021; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; El-Agnaf OMA, 2004, FASEB J, V18, P1315, DOI 10.1096/fj.03-1346fje; Emadi S, 2004, BIOCHEMISTRY-US, V43, P2871, DOI 10.1021/bi036281f; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Frousios KK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-44; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Hughes E, 2000, J BIOL CHEM, V275, P25109, DOI 10.1074/jbc.M003554200; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Madine J, 2005, BIOCHEM SOC T, V33, P1113, DOI 10.1042/BST0331113; Madine J, 2008, J AM CHEM SOC, V130, P7873, DOI 10.1021/ja075356q; Mason JM, 2006, P NATL ACAD SCI USA, V103, P8989, DOI 10.1073/pnas.0509880103; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x; Rutherford NJ, 2014, J NEUROCHEM, V131, P859, DOI 10.1111/jnc.12806; SHEARMAN MS, 1994, P NATL ACAD SCI USA, V91, P1470, DOI 10.1073/pnas.91.4.1470; Singh PK, 2013, ACS CHEM NEUROSCI, V4, P393, DOI 10.1021/cn3001203; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042	33	32	35	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7426	7435		10.1074/jbc.M114.620484	http://dx.doi.org/10.1074/jbc.M114.620484			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25616660	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000351613600011
J	Kim, Y; Lee, SE; Park, J; Kim, M; Lee, B; Hwang, D; Chang, S				Kim, Yoonju; Lee, Sang-Eun; Park, Joohyun; Kim, Minhyung; Lee, Boyoon; Hwang, Daehee; Chang, Sunghoe			ADP-ribosylation Factor 6 (ARF6) Bidirectionally Regulates Dendritic Spine Formation Depending on Neuronal Maturation and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP-ribosylation Factor (ARF); Dendritic Spine; Phospholipase D; Ras-related C3 Botulinum Toxin Substrate 1 (Rac1); Synaptic Plasticity; ARF6; Rac1; Neuronal Activity	CULTURED HIPPOCAMPAL-NEURONS; NUCLEOTIDE EXCHANGE FACTORS; SYNAPTIC PLASTICITY; PLASMA-MEMBRANE; CEREBRAL-CORTEX; GTPASE; RAC; ACTIVATION; STABILITY; FILOPODIA	Background: Conflicting results regarding the role of ARF6 in dendritic spine development have not been answered. Results: ARF6-mediated Rac1 or RhoA activation via PLD pathway either positively or negatively regulates spine formation. Conclusion: The key factor underlying conversion of the ARF6 effect during development is neuronal activity. Significance: Activity dependence of ARF6-mediated spine formation may play a role in structural plasticity of mature neurons. Recent studies have reported conflicting results regarding the role of ARF6 in dendritic spine development, but no clear answer for the controversy has been suggested. We found that ADP-ribosylation factor 6 (ARF6) either positively or negatively regulates dendritic spine formation depending on neuronal maturation and activity. ARF6 activation increased the spine formation in developing neurons, whereas it decreased spine density in mature neurons. Genome-wide microarray analysis revealed that ARF6 activation in each stage leads to opposite patterns of expression of a subset of genes that are involved in neuronal morphology. ARF6-mediated Rac1 activation via the phospholipase D pathway is the coincident factor in both stages, but the antagonistic RhoA pathway becomes involved in the mature stage. Furthermore, blocking neuronal activity in developing neurons using tetrodotoxin or enhancing the activity in mature neurons using picrotoxin or chemical long term potentiation reversed the effect of ARF6 on each stage. Thus, activity-dependent dynamic changes in ARF6-mediated spine structures may play a role in structural plasticity of mature neurons.	[Kim, Yoonju; Lee, Sang-Eun; Park, Joohyun; Chang, Sunghoe] Seoul Natl Univ, Dept Physiol & Biomed Sci, Coll Med, Seoul 110799, South Korea; [Kim, Yoonju; Park, Joohyun; Chang, Sunghoe] Seoul Natl Univ, Neurosci Res Inst, Coll Med, Med Res Ctr, Seoul 110799, South Korea; [Kim, Yoonju; Lee, Sang-Eun; Park, Joohyun; Chang, Sunghoe] Seoul Natl Univ, Biomembrane Plast Res Ctr, Coll Med, Seoul 110799, South Korea; [Lee, Boyoon; Chang, Sunghoe] Seoul Natl Univ, Interdisciplinary Program Neurosci, Coll Med, Seoul 110799, South Korea; [Kim, Minhyung; Hwang, Daehee] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, Kyungbook, South Korea; [Kim, Minhyung; Hwang, Daehee] Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, Kyungbook, South Korea; [Hwang, Daehee] Daegu Gyeongbuk Inst Sci & Technol, Inst Basic Sci, Ctr Syst Biol Plant Senescence & Life Hist, Daegu 711873, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Daegu Gyeongbuk Institute of Science & Technology (DGIST); Institute for Basic Science - Korea (IBS)	Chang, S (corresponding author), Seoul Natl Univ, Dept Physiol, Coll Med, 309 Biomed Sci Bldg,28 Yeongeon Dong, Seoul 110799, South Korea.	sunghoe@snu.ac.kr		Lee, Sang-Eun/0000-0001-7371-8556; Kim, Yoonju/0000-0003-2657-2923; chang, sunghoe/0000-0002-3446-7288	Biomembrane Plasticity Research Center [20100029395]; Ministry of Science, the Information and Communications Technology, and Future Planning (MSIP); Korea Health Technology Research and Development Project - Ministry of Health and Welfare [A092058]; MSIP [NRF-2013R1A1A2059850]	Biomembrane Plasticity Research Center; Ministry of Science, the Information and Communications Technology, and Future Planning (MSIP); Korea Health Technology Research and Development Project - Ministry of Health and Welfare; MSIP	This work was supported by Biomembrane Plasticity Research Center Grant 20100029395 (to S.C.) from the Ministry of Science, the Information and Communications Technology, and Future Planning (MSIP); Korea Health Technology Research and Development Project Grant A092058 (to S.C.) funded by the Ministry of Health and Welfare; and Research Fellow Grant NRF-2013R1A1A2059850 (to Y.K.) funded by the MSIP.	Albertinazzi C, 2003, MOL BIOL CELL, V14, P1295, DOI 10.1091/mbc.E02-07-0406; Anders N, 2008, CELL MOL LIFE SCI, V65, P3433, DOI 10.1007/s00018-008-8227-7; Asrar S, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.055; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bongmba OYN, 2011, BRAIN RES, V1399, P79, DOI 10.1016/j.brainres.2011.05.020; Bowman AW, 1997, APPL SMOOTHING TECHN; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Chae YC, 2008, MOL BIOL CELL, V19, P3111, DOI 10.1091/mbc.E07-04-0337; Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Choi HJ, 2012, MOL NEUROBIOL, V45, P507, DOI 10.1007/s12035-012-8268-7; Choi S, 2006, J NEUROSCI, V26, P4811, DOI 10.1523/JNEUROSCI.4182-05.2006; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Danglot L, 2012, J NEUROSCI, V32, P9007, DOI 10.1523/JNEUROSCI.3084-11.2012; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Fleming IN, 2004, BIOCHEM J, V382, P857, DOI 10.1042/BJ20040916; Funakoshi Y, 2011, J CELL PHYSIOL, V226, P888, DOI 10.1002/jcp.22482; Gauthier-Campbell C, 2004, MOL BIOL CELL, V15, P2205, DOI 10.1091/mbc.E03-07-0493; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hayashi K, 2007, DEV NEUROBIOL, V67, P655, DOI 10.1002/dneu.20363; Hayashi Y, 2005, NEURON, V46, P529, DOI 10.1016/j.neuron.2005.05.006; Hernandez-Deviez DJ, 2004, MOL BIOL CELL, V15, P111, DOI 10.1091/mbc.E03-06-0410; Hernandez-Deviez DJ, 2002, NAT NEUROSCI, V5, P623, DOI 10.1038/nn865; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hongu Tsunaki, 2014, Advances in Biological Regulation, V54, P59, DOI 10.1016/j.jbior.2013.09.014; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17296, DOI 10.1073/pnas.0508647102; Jaworski J, 2007, EUR J CELL BIOL, V86, P513, DOI 10.1016/j.ejcb.2007.04.007; Kim J, 2004, J NEUROSCI METH, V133, P81, DOI 10.1016/j.jneumeth.2003.09.029; Kim Y, 2013, J BIOL CHEM, V288, P29453, DOI 10.1074/jbc.M113.468801; Kusano K, 1999, MOL CELL BIOCHEM, V190, P133, DOI 10.1023/A:1006962210692; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Miyazaki H, 2005, FEBS LETT, V579, P6834, DOI 10.1016/j.febslet.2005.11.022; Nakamura F, 2013, BIOCHEM J, V453, P17, DOI 10.1042/BJ20130290; Papa M, 1996, NEUROSCIENCE, V71, P1005, DOI 10.1016/0306-4522(95)00490-4; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Raemaekers T, 2012, EMBO J, V31, P3252, DOI 10.1038/emboj.2012.182; Sakagami H, 2008, TOHOKU J EXP MED, V214, P191, DOI 10.1620/tjem.214.191; Segal M, 2000, CURR OPIN NEUROBIOL, V10, P582, DOI 10.1016/S0959-4388(00)00123-9; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Yi CL, 2008, CANCER RES, V68, P7932, DOI 10.1158/0008-5472.CAN-08-0866; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	51	25	25	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7323	7335		10.1074/jbc.M114.634527	http://dx.doi.org/10.1074/jbc.M114.634527			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25605715	Green Published, hybrid			2022-12-26	WOS:000351613600001
J	Ueyama, T; Sakuma, M; Ninoyu, Y; Hamada, T; Dupuy, C; Geiszt, M; Leto, TL; Saito, N				Ueyama, Takehiko; Sakuma, Megumi; Ninoyu, Yuzuru; Hamada, Takeshi; Dupuy, Corinne; Geiszt, Miklos; Leto, Thomas L.; Saito, Naoaki			The Extracellular A-loop of Dual Oxidases Affects the Specificity of Reactive Oxygen Species Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; NADPH OXIDASE; CONGENITAL HYPOTHYROIDISM; HOST-DEFENSE; CLONING; GENE; EVOLUTION; FAMILY; ACTIVATION; EXPRESSION	NADPH oxidase (Nox) family proteins produce superoxide (W) directly by transferring an electron to molecular oxygen. Dual oxidases (Duoxes) also produce an W intermediate, although the final species secreted by mature Duoxes is H2O2, suggesting that intramolecular O-2(center dot)-, dismutation or other mechanisms contribute to H2O2 release. We explored the structural determinants affecting reactive oxygen species formation by Duox enzymes. Duox2 showed O-2(center dot)-, leakage when mismatched with Duox activator 1 (DuoxA1). Duox2 released O-2(center dot)- even in correctly matched combinations, including Duox2 + DuoxA2 and Duox2 + N-terminally tagged DuoxA2 regardless of the type or number of tags. Conversely, Duox1 did not release O-2(center dot)-, in any combination. Chimeric Duox2 possessing the A-loop of Duoxl showed no W. leakage; chimeric Duoxl possessing the A-loop of Duox2 released W. Moreover, Duox2 proteins possessing the A-loops of Noxl or Nox5 co-expressed with DuoxA2 showed enhanced W release, and D uox1 proteins possessing the A-loops of Noxl or Nox5 co-expressed with DuoxAl acquired W leakage. Although we identified Duoxl A-loop residues His(1071), His(1072), and Gly(1074)) important for reducing O-2(center dot)- release, mutations of these residues to those of Duox2 failed to convert Duoxl to an O-2(center dot)--releasing enzyme. Using immunoprecipitation and endoglycosidase H sensitivity assays, we found that the A-loop of Duoxes binds to DuoxA N termini, creating more stable, mature Duox-DuoxA complexes. In conclusion, the A-loops of both Duoxes support H2O2 production through interaction with corresponding activators, but complex formation between the Duoxl A-loop and DuoxAl results in tighter control of H2O2 release by the enzyme complex.	[Ueyama, Takehiko; Sakuma, Megumi; Ninoyu, Yuzuru; Hamada, Takeshi; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Lab Mol Pharmacol, Kobe, Hyogo 6578501, Japan; [Dupuy, Corinne] Univ Paris 11, CNRS, Inst Gustave Roussy, Lab Stabilite Genet & Oncogenese,UMR8200, F-94805 Villejuif, France; [Geiszt, Miklos] Semmelweis Univ, Dept Physiol, Fac Med, H-1444 Budapest, Hungary; [Geiszt, Miklos] Semmelweis Univ, Lendulet Peroxidase Enzyme Res Grp, H-1444 Budapest, Hungary; [Geiszt, Miklos] Hungarian Acad Sci, H-1444 Budapest, Hungary; [Leto, Thomas L.] NIAID, Mol Def Sect, Lab Host Def, NIH, Rockville, MD 20852 USA	Kobe University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Semmelweis University; Semmelweis University; Hungarian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ueyama, T (corresponding author), Kobe Univ, Biosignal Res Ctr, Lab Mol Pharmacol, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	tueyama@kobe-u.ac.jp; naosaito@kobe-u.ac.jp		Ninoyu, Yuzuru/0000-0002-9407-4697	Intramural Research Program of the NIAID, National Institutes of Health; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science; Hungarian Academy of Sciences; Uehara Memorial Foundation; Hyogo Science and Technology Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000614] Funding Source: NIH RePORTER	Intramural Research Program of the NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Uehara Memorial Foundation(Uehara Memorial Foundation); Hyogo Science and Technology Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Intramural Research Program of the NIAID, National Institutes of Health. This work was also supported in part by a grant-in-aid for Scientific Research (C) of the Ministry of Education, Culture, Sports, Science and Technology, Japan, by a grant "Japan-Hungary Research Cooperative Program" from the Japan Society for the Promotion of Science and the Hungarian Academy of Sciences, by the Uehara Memorial Foundation, and by the Hyogo Science and Technology Association.	Ameziane-El-Hassani R, 2005, J BIOL CHEM, V280, P30046, DOI 10.1074/jbc.M500516200; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; De Deken X, 2014, ANTIOXID REDOX SIGN, V20, P2776, DOI 10.1089/ars.2013.5602; Donko A, 2010, FREE RADICAL BIO MED, V49, P2040, DOI 10.1016/j.freeradbiomed.2010.09.027; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Grasberger H, 2013, GASTROENTEROLOGY, V145, P1045, DOI 10.1053/j.gastro.2013.07.011; Grasberger H, 2012, MOL ENDOCRINOL, V26, P481, DOI 10.1210/me.2011-1320; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Hoste C, 2012, EXP CELL RES, V318, P2353, DOI 10.1016/j.yexcr.2012.07.007; Hulur I, 2011, J CLIN ENDOCR METAB, V96, pE841, DOI 10.1210/jc.2010-2321; Johnson KR, 2007, MOL ENDOCRINOL, V21, P1593, DOI 10.1210/me.2007-0085; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Leto TL, 2009, ANTIOXID REDOX SIGN, V11, P2607, DOI [10.1089/ars.2009.2637, 10.1089/ARS.2009.2637]; Maruo Y, 2008, J CLIN ENDOCR METAB, V93, P4261, DOI 10.1210/jc.2008-0856; Matsushima S, 2014, TRENDS CARDIOVAS MED, V24, P202, DOI 10.1016/j.tcm.2014.03.003; Meitzler JL, 2011, ARCH BIOCHEM BIOPHYS, V512, P197, DOI 10.1016/j.abb.2011.05.021; Meitzler JL, 2009, J BIOL CHEM, V284, P18634, DOI 10.1074/jbc.M109.013581; Morand S, 2009, FASEB J, V23, P1205, DOI 10.1096/fj.08-120006; Moreno JC, 2001, GENOMICS, V75, P70, DOI 10.1006/geno.2001.6586; Moskwa P, 2007, AM J RESP CRIT CARE, V175, P174, DOI 10.1164/rccm.200607-1029OC; Nauseef WM, 2014, BBA-GEN SUBJECTS, V1840, P757, DOI 10.1016/j.bbagen.2013.04.040; Pick E, 2014, METHODS MOL BIOL, V1124, P339, DOI 10.1007/978-1-62703-845-4_22; Quinn MT, 2006, CLIN SCI, V111, P1, DOI 10.1042/cs20060059; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Ueyama T, 2007, MOL BIOL CELL, V18, P441, DOI 10.1091/mbc.E06-08-0731; Ueyama T, 2013, J IMMUNOL, V191, P2560, DOI 10.4049/jimmunol.1300209; van der Vliet A, 2011, BBA-GEN SUBJECTS, V1810, P1035, DOI 10.1016/j.bbagen.2011.03.004; Zamproni I, 2008, J CLIN ENDOCR METAB, V93, P605, DOI 10.1210/jc.2007-2020	33	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6495	6506		10.1074/jbc.M114.592717	http://dx.doi.org/10.1074/jbc.M114.592717			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25586178	hybrid, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000350732500052
J	Schween, R; Gehring, D; Gollhofer, A				Schween, Raphael; Gehring, Dominic; Gollhofer, Albert			Immediate Effects of an Elastic Knee Sleeve on Frontal Plane Gait Biomechanics in Knee Osteoarthritis	PLOS ONE			English	Article							RESONANCE ELECTRICAL-STIMULATION; HIP; PROPRIOCEPTION; LOAD; PREVALENCE; ANKLE; POWER	Introduction Osteoarthritis of the knee affects millions of people. Elastic knee sleeves aim at relieving symptoms. While symptomatic improvements have been demonstrated as a consequence of elastic knee sleeves, evidence for biomechanical alterations only exists for the sagittal plane. We therefore asked what effect an elastic knee sleeve would have on frontal plane gait biomechanics. Methods 18 subjects (8 women, 10 men) with osteoarthritis of the medial tibiofemoral joint walked over ground with and without an elastic knee sleeve. Kinematics and forces were recorded and joint moments were calculated using an inverse dynamics approach. Conditions with sleeve and without sleeve were compared with paired t- Tests. Results With the sleeve, knee adduction angle at ground contact was reduced by 1.9 +/- 2.1 degrees (P = 0.006). Peak knee adduction was reduced by 1.5 +/- 1.6 degrees (P = 0.004). The first peak knee adduction moment and positive knee adduction impulse were decreased by 10.1% (0.74 +/- 0.9 Nm.kg-1; P = 0.002) and 12.9% (0.28 +/- 0.3 Nm.s.kg-1; P < 0.004), respectively. Conclusion Our study provides evidence that wearing an elastic knee sleeve during walking can reduce knee adduction angles, moments and impulse in subjects with knee osteoarthritis. As a higher knee adduction moment has previously been identified as a risk factor for disease progression in patients with medial knee osteoarthritis, we speculate that wearing a knee sleeve may be beneficial for this specific subgroup.	[Schween, Raphael; Gehring, Dominic; Gollhofer, Albert] Univ Freiburg, Dept Sport Sci, D-79117 Freiburg, Germany	University of Freiburg	Schween, R (corresponding author), Univ Freiburg, Dept Sport Sci, Schwarzwaldstr 175, D-79117 Freiburg, Germany.	raphael.schween@sport.uni-giessen.de	Gehring, Dominic/F-9680-2013; Albert, Gollhofer/V-3291-2019; Gollhofer, Albert/ABF-5766-2020	Gehring, Dominic/0000-0001-5577-8846; Schween, Raphael/0000-0003-1804-9438	BAUERFEIND AG (Zeulenroda, Germany); German Research Foundation (DFG); Albert Ludwigs University Freiburg; Department of Sport Science of the University of Freiburg	BAUERFEIND AG (Zeulenroda, Germany); German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg; Department of Sport Science of the University of Freiburg	Part of the funding and material (knee sleeves) for the study were provided by the BAUERFEIND AG (Zeulenroda, Germany, www.bauerfeind.com). The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. All other funding was acquired from internal means of the Department of Sport Science (www.sport.unifreiburg.de) of the University of Freiburg (www.unifreiburg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT DS, 1991, J BONE JOINT SURG BR, V73, P53, DOI 10.1302/0301-620X.73B1.1991775; Beaudreuil J, 2009, JOINT BONE SPINE, V76, P629, DOI 10.1016/j.jbspin.2009.02.002; Bennell KL, 2011, ANN RHEUM DIS, V70, P1770, DOI 10.1136/ard.2010.147082; BERRY H, 1992, European Journal of Rheumatology and Inflammation, V12, P30; BORTZ J, 2010, STAT HUMAN SOZIALWIS, DOI DOI 10.1016/J.VASCN.2013.05.004; Bryk FF, 2011, REV BRAS REUMATOL, V51, P434, DOI 10.1590/S0482-50042011000500004; Butler RJ, 2011, PHYS THER, V91, P1235, DOI 10.2522/ptj.20100324; Childs JD, 2004, CLIN BIOMECH, V19, P44, DOI 10.1016/j.clinbiomech.2003.08.007; Chuang SH, 2007, KAOHSIUNG J MED SCI, V23, P405, DOI 10.1016/S0257-5655(07)70004-4; Collins A, 2011, CLIN BIOMECH, V26, P853, DOI 10.1016/j.clinbiomech.2011.04.011; Collins AT, 2011, KNEE, V18, P317, DOI 10.1016/j.knee.2010.07.001; DEGROOT G, 1994, ERGONOMICS, V37, P31, DOI 10.1080/00140139408963620; Draganich L, 2006, J BONE JOINT SURG AM, V88A, P2645, DOI 10.2106/JBJS.D.02787; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Guillemin F, 2011, OSTEOARTHR CARTILAGE, V19, P1314, DOI 10.1016/j.joca.2011.08.004; Henriksen M, 2012, KNEE, V19, P392, DOI 10.1016/j.knee.2011.07.003; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Kamper SJ, 2009, J MAN MANIP THER, V17, P163, DOI 10.1179/jmt.2009.17.3.163; Kean CO, 2012, CLIN BIOMECH, V27, P520, DOI 10.1016/j.clinbiomech.2011.12.007; Keyaki K, 2010, OSTEOARTHR CARTILAGE, V18, pS229, DOI 10.1016/S1063-4584(10)60537-7; Kirkley A, 1999, J BONE JOINT SURG AM, V81A, P539, DOI 10.2106/00004623-199904000-00012; Knoop J, 2011, OSTEOARTHR CARTILAGE, V19, P381, DOI 10.1016/j.joca.2011.01.003; Krohn K, 2005, CURR OPIN RHEUMATOL, V17, P653, DOI 10.1097/01.bor.0000175460.75675.d3; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Morgan WA, 1939, BIOMETRIKA, V31, P13, DOI 10.2307/2334972; Mundermann A, 2005, ARTHRITIS RHEUM-US, V52, P2835, DOI 10.1002/art.21262; Muraki S, 2010, OSTEOARTHR CARTILAGE, V18, P1227, DOI 10.1016/j.joca.2010.06.001; Naal FD, 2009, OSTEOARTHR CARTILAGE, V17, P49, DOI 10.1016/j.joca.2008.05.017; Pagani CHF, 2012, J ORTHOP RES, V30, P1125, DOI 10.1002/jor.22032; Pereira D, 2011, OSTEOARTHR CARTILAGE, V19, P1270, DOI 10.1016/j.joca.2011.08.009; Turcot K, 2013, CLIN BIOMECH, V28, P34, DOI 10.1016/j.clinbiomech.2012.09.004; Weidow J, 2006, J ORTHOP RES, V24, P1890, DOI 10.1002/jor.20194; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Zhao D, 2007, J ORTHOP RES, V25, P789, DOI 10.1002/jor.20379	34	17	19	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0115782	10.1371/journal.pone.0115782	http://dx.doi.org/10.1371/journal.pone.0115782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25621488	Green Published, Green Submitted, gold			2022-12-26	WOS:000348470400002
J	Liu, LL; Zhao, H; Ma, TF; Ge, F; Chen, CS; Zhang, YP				Liu, Lin-Lin; Zhao, Hui; Ma, Teng-Fei; Ge, Fei; Chen, Ce-Shi; Zhang, Ya-Ping			Identification of Valid Reference Genes for the Normalization of RT-qPCR Expression Studies in Human Breast Cancer Cell Lines Treated with and without Transient Transfection	PLOS ONE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE GENE; ENDOGENOUS CONTROL GENES; TIME QUANTITATIVE PCR; MESSENGER-RNA QUANTIFICATION; POLYMERASE-CHAIN-REACTION; HOUSEKEEPING GENES; TUMOR-TISSUES; CARCINOMAS; INTEGRITY; SELECTION	Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) is a powerful technique for examining gene expression changes during tumorigenesis. Target gene expression is generally normalized by a stably expressed endogenous reference gene; however, reference gene expression may differ among tissues under various circumstances. Because no valid reference genes have been documented for human breast cancer cell lines containing different cancer subtypes treated with transient transfection, we identified appropriate and reliable reference genes from thirteen candidates in a panel of 10 normal and cancerous human breast cell lines under experimental conditions with/without transfection treatments with two transfection reagents. Reference gene expression stability was calculated using four algorithms (geNorm, NormFinder, BestKeeper and comparative delta Ct), and the recommended comprehensive ranking was provided using geometric means of the ranking values using the RefFinder tool. GeNorm analysis revealed that two reference genes should be sufficient for all cases in this study. A stability analysis suggests that 18S rRNA-ACTB is the best reference gene combination across all cell lines; ACTB-GAPDH is best for basal breast cancer cell lines; and HSPCB-ACTB is best for ER+ breast cancer cells. After transfection, the stability ranking of the reference gene fluctuated, especially with Lipofectamine 2000 transfection reagent in two subtypes of basal and ER+ breast cell lines. Comparisons of relative target gene (HER2) expression revealed different expressional patterns depending on the reference genes used for normalization. We suggest that identifying the most stable and suitable reference genes is critical for studying specific cell lines under certain circumstances.	[Liu, Lin-Lin; Zhao, Hui; Ma, Teng-Fei; Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming, Peoples R China; [Ge, Fei] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine Surg, Chongqing 400016, Peoples R China; [Ge, Fei; Chen, Ce-Shi] Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China	Yunnan University; Chongqing Medical University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology	Zhang, YP (corresponding author), Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming, Peoples R China.	zhangyp@mail.kiz.ac.cn			National Natural Science Foundation of China [31060302, 31260032]; Natural Science Foundation of Yunnan Province [2010CD010]; Program for Innovative Research Team (in Science and Technology) in University of Yunnan Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); Program for Innovative Research Team (in Science and Technology) in University of Yunnan Province	This work was supported by grants of the National Natural Science Foundation of China (Grant Nos. 31060302 and 31260032) (http://www.nsfc.gov.cn), the Natural Science Foundation of Yunnan Province (Grant No. 2010CD010) (http://www.ynstc.gov.cn) and Program for Innovative Research Team (in Science and Technology) in University of Yunnan Province (http://www.ynjy.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Ceelen L, 2011, BIOCHEM PHARMACOL, V81, P1255, DOI 10.1016/j.bcp.2011.03.004; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; De Spiegelaere W, 2008, ANAL BIOCHEM, V382, P72, DOI 10.1016/j.ab.2008.07.004; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; FEUER EJ, 1993, J NATL CANCER I, V85, P892, DOI 10.1093/jnci/85.11.892; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gur-Dedeoglu B, 2009, ONCOL RES, V17, P353, DOI 10.3727/096504009788428460; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jacobsen LB, 2009, BIOTECHNIQUES, V47, P617, DOI 10.2144/000113132; Kheirelseid EAH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-12; Kilic Y, 2014, CLIN TRANSL ONCOL, V16, P184, DOI 10.1007/s12094-013-1058-5; Kim JW, 1998, GYNECOL ONCOL, V71, P266, DOI 10.1006/gyno.1998.5195; Li YL, 2009, ANAL BIOCHEM, V394, P110, DOI 10.1016/j.ab.2009.07.022; Lyng MB, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-20; Majidzadeh-A Keivan, 2011, BMC Res Notes, V4, P215, DOI 10.1186/1756-0500-4-215; McNeill RE, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-107; Mitri Zahi, 2012, Chemother Res Pract, V2012, P743193, DOI 10.1155/2012/743193; Morse DL, 2005, ANAL BIOCHEM, V342, P69, DOI 10.1016/j.ab.2005.03.034; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Revillion F, 2000, EUR J CANCER, V36, P1038, DOI 10.1016/S0959-8049(00)00051-4; Rho HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-240; Rondinelli RH, 1997, PROSTATE CANCER P D, V1, P66, DOI 10.1038/sj.pcan.4500208; SCHEK N, 1988, CANCER RES, V48, P6354; Shen YM, 2010, ANAL BIOCHEM, V405, P224, DOI 10.1016/j.ab.2010.06.029; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sirover MA, 1997, J CELL BIOCHEM, V66, P133, DOI 10.1002/(SICI)1097-4644(19970801)66:2<133::AID-JCB1>3.3.CO;2-V; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; TOKUNAGA K, 1987, CANCER RES, V47, P5616; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143	36	36	38	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117058	10.1371/journal.pone.0117058	http://dx.doi.org/10.1371/journal.pone.0117058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617865	Green Published, Green Submitted, gold			2022-12-26	WOS:000350336000037
J	Tian, E; Stevens, SR; Guan, Y; Springer, DA; Anderson, SA; Starost, MF; Patel, V; Ten Hagen, KG; Tabak, LA				Tian, E.; Stevens, Sharon R.; Guan, Yu; Springer, Danielle A.; Anderson, Stasia A.; Starost, Matthew F.; Patel, Vyomesh; Ten Hagen, Kelly G.; Tabak, Lawrence A.			Galnt1 Is Required for Normal Heart Valve Development and Cardiac Function	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; O-GLYCOSYLATION; PROTEOLYTIC CLEAVAGE; VERSICAN CLEAVAGE; TGF-BETA; MICE; DISEASE; ADAMTS5; FAMILY; DIFFERENTIATION	Congenital heart valve defects in humans occur in approximately 2% of live births and are a major source of compromised cardiac function. In this study we demonstrate that normal heart valve development and cardiac function are dependent upon Galnt1, the gene that encodes a member of the family of glycosyltransferases (GalNAc- Ts) responsible for the initiation of mucin-type O-glycosylation. In the adult mouse, compromised cardiac function that mimics human congenital heart disease, including aortic and pulmonary valve stenosis and regurgitation; altered ejection fraction; and cardiac dilation, was observed in Galnt1 null animals. The underlying phenotype is aberrant valve formation caused by increased cell proliferation within the outflow tract cushion of developing hearts, which is first detected at developmental stage E11.5. Developing valves from Galnt1 deficient animals displayed reduced levels of the proteases ADAMTS1 and ADAMTS5, decreased cleavage of the proteoglycan versican and increased levels of other extracellular matrix proteins. We also observed increased BMP and MAPK signaling. Taken together, the ablation of Galnt1 appears to disrupt the formation/ remodeling of the extracellular matrix and alters conserved signaling pathways that regulate cell proliferation. Our study provides insight into the role of this conserved protein modification in cardiac valve development and may represent a new model for idiopathic valve disease.	[Tian, E.; Ten Hagen, Kelly G.] Natl Inst Dent & Craniofacial Res, Dev Glycobiol Sect, Lab Cell & Dev Biol, NIH, Bethesda, MD USA; [Stevens, Sharon R.; Guan, Yu; Tabak, Lawrence A.] Natl Inst Dent & Craniofacial Res, Sect Biol Chem, NIH, Bethesda, MD 20892 USA; [Springer, Danielle A.; Anderson, Stasia A.] NHLBI, NIH, Bethesda, MD 20892 USA; [Starost, Matthew F.] NIH, Div Vet Resources, Bethesda, MD 20892 USA; [Patel, Vyomesh] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Tabak, LA (corresponding author), Natl Inst Dent & Craniofacial Res, Sect Biol Chem, NIH, Bethesda, MD 20892 USA.	Lawrence.Tabak@nih.gov		Anderson, Stasia/0000-0002-2566-6947; Stevens, Sharon/0000-0003-2238-8029	Intramural Research Programs of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005909, ZIGHL006190, ZIGHL006020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000739, ZIADE000713] Funding Source: NIH RePORTER	Intramural Research Programs of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Intramural Research Programs of the National Institutes of Health.	Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Barrick CJ, 2009, AM J PHYSIOL-HEART C, V297, pH65, DOI 10.1152/ajpheart.00866.2008; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566; DeLaughter DM, 2013, J MOL CELL CARDIOL, V59, P196, DOI 10.1016/j.yjmcc.2013.03.016; Dupuis LE, 2011, DEV BIOL, V357, P152, DOI 10.1016/j.ydbio.2011.06.041; Foulcer SJ, 2014, J BIOL CHEM, V289, P27859, DOI 10.1074/jbc.M114.573287; Freitas VM, 2013, MOL CANCER, V5, P12; Garbern JC, 2013, CELL STEM CELL, V12, P689, DOI 10.1016/j.stem.2013.05.008; Hatano S, 2012, GLYCOBIOLOGY, V22, P1268, DOI 10.1093/glycob/cws095; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Kern CB, 2006, DEV DYNAM, V235, P2238, DOI 10.1002/dvdy.20838; Kern CB, 2010, MATRIX BIOL, V29, P304, DOI 10.1016/j.matbio.2010.01.005; Krenz M, 2008, P NATL ACAD SCI USA, V105, P18930, DOI 10.1073/pnas.0806556105; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Kruithof BPT, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.04.003; Kumar S, 2012, AM J PATHOL, V181, P1056, DOI 10.1016/j.ajpath.2012.05.022; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Llamazares M, 2003, J BIOL CHEM, V278, P13382, DOI 10.1074/jbc.M211900200; Lockhart M, 2011, BIRTH DEFECTS RES A, V91, P535, DOI 10.1002/bdra.20810; Radisic M, 2013, MAYO CLIN PROC, V88, P884, DOI 10.1016/j.mayocp.2013.05.003; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Russell DL, 2003, J BIOL CHEM, V278, P42330, DOI 10.1074/jbc.M300519200; Savolainen SM, 2009, TOXICOL PATHOL, V37, P395, DOI 10.1177/0192623309335060; Schroeder JA, 2003, J MOL MED-JMM, V81, P392, DOI 10.1007/s00109-003-0456-5; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Tian E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1874; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Wirrig EE, 2007, DEV BIOL, V310, P291, DOI 10.1016/j.ydbio.2007.07.041	32	29	30	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115861	10.1371/journal.pone.0115861	http://dx.doi.org/10.1371/journal.pone.0115861			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615642	Green Submitted, Green Published, gold			2022-12-26	WOS:000349122100020
J	Taghavi, S; Wu, X; Ouyang, LM; Zhang, YB; Stadler, A; McCorkle, S; Zhu, W; Maslov, S; Van der Lelie, D				Taghavi, Safiyh; Wu, Xiao; Ouyang, Liming; Zhang, Yian Biao; Stadler, Andrea; McCorkle, Sean; Zhu, Wei; Maslov, Sergei; Van der Lelie, Daniel			Transcriptional Responses to Sucrose Mimic the Plant-Associated Life Style of the Plant Growth Promoting Endophyte Enterobacter sp 638	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; DIFFERENTIAL EXPRESSION ANALYSIS; QUORUM-SENSING SIGNAL; BINDING PROTEIN CSRA; GENE-EXPRESSION; BIOFILM FORMATION; RNA-SEQ; INDOLE-3-ACETIC-ACID BIOSYNTHESIS; PSEUDOMONAS-AERUGINOSA; SYSTEMIC RESISTANCE	Growth in sucrose medium was previously found to trigger the expression of functions involved in the plant associated life style of the endophytic bacterium Enterobacter sp. 638. Therefore, comparative transcriptome analysis between cultures grown in sucrose or lactate medium was used to gain insights in the expression levels of bacterial functions involved in the endophytic life style of strain 638. Growth on sucrose as a carbon source resulted in major changes in cell physiology, including a shift from a planktonic life style to the formation of bacterial aggregates. This shift was accompanied by a decrease in transcription of genes involved in motility (e.g. flagella biosynthesis) and an increase in the transcription of genes involved in colonization, adhesion and biofilm formation. The transcription levels of functions previously suggested as being involved in endophytic behavior and functions responsible for plant growth promoting properties, including the synthesis of indole-acetic acid, acetoin and 2,3-butanediol, also increased significantly for cultures grown in sucrose medium. Interestingly, despite an abundance of essential nutrients transcription levels of functions related to uptake and processing of nitrogen and iron became increased for cultures grown on sucrose as sole carbon source. Transcriptome data were also used to analyze putative regulatory relationships. In addition to the small RNA csrABCD regulon, which seems to play a role in the physiological adaptation and possibly the shift between free-living and plant-associated endophytic life style of Enterobacter sp. 638, our results also pointed to the involvement of rcsAB in controlling responses by Enterobacter sp. 638 to a plant-associated life style. Targeted mutagenesis was used to confirm this role and showed that compared to wild-type Enterobacter sp. 638 a Delta rcsB mutant was affected in its plant growth promoting ability.	[Taghavi, Safiyh; Ouyang, Liming; Van der Lelie, Daniel] Ctr Agr & Environm Biotechnol, RTI Int, Charlotte, NC USA; [Taghavi, Safiyh; Wu, Xiao; Zhang, Yian Biao; Stadler, Andrea; McCorkle, Sean; Maslov, Sergei; Van der Lelie, Daniel] Dept Biosci, Brookhaven Natl Lab, Upton, NY USA; [Wu, Xiao; Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Ouyang, Liming] E China Univ Sci & Technol, Sch Biotechnol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	Research Triangle Institute; United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; East China University of Science & Technology	Van der Lelie, D (corresponding author), FMC Corp, Ctr Excellence Agr Biotechnol, Res Triangle Pk, Charlotte, NC 28208 USA.	daniel.vanderlelie@FMC.com	Maslov, Sergei/C-2397-2009	Maslov, Sergei/0000-0002-3701-492X; McCorkle, Sean/0000-0003-1126-4071	U.S. Department of Energy, Office of Science, BER [KP1102010, DE-AC02-98CH10886]; Laboratory Directed Research and Development funds at the Brookhaven National Laboratory [LDRD09-005]	U.S. Department of Energy, Office of Science, BER(United States Department of Energy (DOE)); Laboratory Directed Research and Development funds at the Brookhaven National Laboratory	This research was funded by the U.S. Department of Energy, Office of Science, BER, Project KP1102010 under Contract DE-AC02-98CH10886, and by Laboratory Directed Research and Development funds (LDRD09-005) at the Brookhaven National Laboratory under contract with the U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2008, MOL MICROBIOL, V70, P323, DOI 10.1111/j.1365-2958.2008.06404.x; Barac T, 2004, NAT BIOTECHNOL, V22, P583, DOI 10.1038/nbt960; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLACK DS, 1994, J BACTERIOL, V176, P4081, DOI 10.1128/JB.176.13.4081-4091.1994; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Burse A, 2004, MOL PLANT MICROBE IN, V17, P43, DOI 10.1094/MPMI.2004.17.1.43; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Clarke MB, 2005, MOL MICROBIOL, V57, P1734, DOI 10.1111/j.1365-2958.2005.04792.x; COGAN TM, 1981, APPL ENVIRON MICROB, V41, P1; Dorr J, 1998, MOL MICROBIOL, V30, P7, DOI 10.1046/j.1365-2958.1998.01010.x; Dosanjh NS, 2007, BIOCHEMISTRY-US, V46, P2520, DOI 10.1021/bi062092w; Ferrieres L, 2007, MICROBIOL-SGM, V153, P1070, DOI 10.1099/mic.0.2006/002907-0; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Hofte Monica, 2007, V12, P121; Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002; JUNI E, 1952, J BIOL CHEM, V195, P727; Kasari V, 2010, J BACTERIOL, V192, P2908, DOI 10.1128/JB.01266-09; Kincaid R, 2008, BIOINFORMATICS, V24, P2112, DOI 10.1093/bioinformatics/btn368; KOGA J, 1994, BBA-PROTEIN STRUCT M, V1209, P241, DOI 10.1016/0167-4838(94)90191-0; KOGA J, 1995, BBA-PROTEIN STRUCT M, V1249, P1, DOI 10.1016/0167-4838(95)00011-I; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Lesic B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-20; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Majdalani N, 2005, CRIT REV BIOCHEM MOL, V40, P93, DOI 10.1080/10409230590918702; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MISAGHI IJ, 1990, PHYTOPATHOLOGY, V80, P808, DOI 10.1094/Phyto-80-808; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NEWMAN L, 2013, Patent No. 2011027842; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Prigent-Combaret C, 1999, J BACTERIOL, V181, P5993, DOI 10.1128/JB.181.19.5993-6002.1999; Reid SJ, 2005, APPL MICROBIOL BIOT, V67, P312, DOI 10.1007/s00253-004-1885-y; Reisner A, 2003, MOL MICROBIOL, V48, P933, DOI 10.1046/j.1365-2958.2003.03490.x; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rogers A, 2012, GCB BIOENERGY, V4, P364, DOI 10.1111/j.1757-1707.2011.01119.x; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; ROMEO T, 1993, J BACTERIOL, V175, P4744, DOI 10.1128/JB.175.15.4744-4755.1993; Rozhon W, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-56; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Ryu CM, 2004, PLANT PHYSIOL, V134, P1017, DOI 10.1104/pp.103.026583; SCHATZ A, 1952, J BACTERIOL, V63, P87, DOI 10.1128/JB.63.1.87-98.1952; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Schembri MA, 2003, MOL MICROBIOL, V48, P253, DOI 10.1046/j.1365-2958.2003.03432.x; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stanley NR, 2003, J BACTERIOL, V185, P1951, DOI 10.1128/JB.185.6.1951-1957.2003; Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606; Taghavi S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000943; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; Walsh UF, 2001, CURR OPIN BIOTECH, V12, P289, DOI 10.1016/S0958-1669(00)00212-3; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Wood TK, 2006, APPL MICROBIOL BIOT, V72, P361, DOI 10.1007/s00253-005-0263-8; Wood TK, 2009, ENVIRON MICROBIOL, V11, P1, DOI 10.1111/j.1462-2920.2008.01768.x; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zhang XS, 2008, ISME J, V2, P615, DOI 10.1038/ismej.2008.24	63	16	18	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115455	10.1371/journal.pone.0115455	http://dx.doi.org/10.1371/journal.pone.0115455			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607953	Green Submitted, Green Published, gold			2022-12-26	WOS:000348205300014
J	Chen, Z; Cao, SS; Wang, HR; Li, YQ; Kishen, A; Deng, XL; Yang, XP; Wang, YH; Cong, CH; Wang, HJ; Zhang, X				Chen, Zhen; Cao, Shansong; Wang, Haorong; Li, Yanqiu; Kishen, Anil; Deng, Xuliang; Yang, Xiaoping; Wang, Yinghui; Cong, Changhong; Wang, Huajun; Zhang, Xu			Biomimetic Remineralization of Demineralized Dentine Using Scaffold of CMC/ACP Nanocomplexes in an In Vitro Tooth Model of Deep Caries	PLOS ONE			English	Article							PHOSPHORYLATED CHITOSAN; CARBOXYMETHYL CHITOSAN; COLLAGENOUS MATRIX; MINERALIZATION; NUCLEATION; LESIONS; BONE; BIOACTIVITY; MECHANISMS; MICROSCOPY	Currently, it is still a tough task for dentists to remineralize dentine in deep caries. The aim of this study was to remineralize demineralized dentine in a tooth model of deep caries using nanocomplexes of carboxymethyl chitosan/amorphous calcium phosphate (CMC/ACP) based on mimicking the stabilizing effect of dentine matrix protein 1 (DMP1) on ACP in the biomineralization of dentine. The experimental results indicate that CMC can stabilize ACP to form nanocomplexes of CMC/ACP, which is able to be processed into scaffolds by lyophilization. In the single-layer collagen model, ACP nanoparticles are released from scaffolds of CMC/ACP nanocomplexes dissolved and then infiltrate into collagen fibrils via the gap zones (40 nm) to accomplish intrafibrillar mineralization of collagen. With this method, the completely demineralized dentine was partially remineralized in the tooth mode. This is a bottom-up remineralizing strategy based on non-classical crystallization theory. Since nanocomplexes of CMC/ACP show a promising effect of remineralization on demineralized dentine via biomimetic strategy, thereby preserving dentinal tissue to the maximum extent possible, it would be a potential indirect pulp capping (IPC) material for the management of deep caries during vital pulp therapy based on the concept of minimally invasive dentistry (MID).	[Chen, Zhen; Cao, Shansong; Wang, Haorong; Li, Yanqiu; Wang, Yinghui; Cong, Changhong; Zhang, Xu] Tianjin Med Univ, Hosp Stomatol, Sch Stomatol, Tianjin, Peoples R China; [Kishen, Anil] Univ Toronto, Fac Dent, Discipline Endodont, Toronto, ON, Canada; [Deng, Xuliang] Peking Univ Sch & Hosp Stomatol, Dept Geriatr Dent, Beijing, Peoples R China; [Yang, Xiaoping] Beijing Univ Chem Technol, Key Lab Beijing City Preparat & Proc Novel Polyme, Beijing 100029, Peoples R China; [Wang, Huajun] Hebei Univ Technol, Sch Energy & Environm Engn, Tianjin, Peoples R China	Tianjin Medical University; University of Toronto; Peking University; Beijing University of Chemical Technology; Hebei University of Technology	Zhang, X (corresponding author), Tianjin Med Univ, Hosp Stomatol, Sch Stomatol, Tianjin, Peoples R China.	zhxden@gmail.com		Kishen, Anil/0000-0002-6953-2633	National Natural Science Foundation of China [81200817]; Tianjin Research Program of Application Foundation and Advanced Technology (Youth Research Program) [12JCQNJC09200]; National Basic Research Program of China [2012CB933900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of Application Foundation and Advanced Technology (Youth Research Program); National Basic Research Program of China(National Basic Research Program of China)	This work was funded by 1) National Natural Science Foundation of China (Grant No: 81200817), http://www.nsfc.gov.cn/; 2) Tianjin Research Program of Application Foundation and Advanced Technology (Youth Research Program) (Grant No: 12JCQNJC09200), http://www.tstc.gov.cn/ 3) National Basic Research Program of China (2012CB933900), http://www.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold WH, 2003, ANN ANAT, V185, P419, DOI 10.1016/S0940-9602(03)80099-7; ARSENAULT AL, 1988, CALCIFIED TISSUE INT, V43, P202, DOI 10.1007/BF02555136; Bertassoni LE, 2009, CARIES RES, V43, P70, DOI 10.1159/000201593; Budiraharjo R, 2010, INT ENDOD J, V43, P930, DOI 10.1111/j.1365-2591.2010.01771.x; Burwell AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038852; BYSTROM A, 1985, Endodontics and Dental Traumatology, V1, P170; Chen XG, 2003, CARBOHYD POLYM, V53, P355, DOI 10.1016/S0144-8617(03)00051-1; Chesnick IE, 2008, BIOPHYS J, V95, P2017, DOI 10.1529/biophysj.107.120923; Christensen GJ, 2005, J AM DENT ASSOC, V136, P1563, DOI 10.14219/jada.archive.2005.0088; Combes C, 2010, ACTA BIOMATER, V6, P3362, DOI 10.1016/j.actbio.2010.02.017; Eidelman E, 1965, J Dent Child, V32, P218; Featherstone JDB, 2000, J AM DENT ASSOC, V131, P887, DOI 10.14219/jada.archive.2000.0307; Gebauer D, 2011, NANO TODAY, V6, P564, DOI 10.1016/j.nantod.2011.10.005; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Gower LB, 2008, CHEM REV, V108, P4551, DOI 10.1021/cr800443h; Gupta A, 2011, J Conserv Dent, V14, P113, DOI 10.4103/0972-0707.82603; He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200; Jayakumar R, 2008, INT J BIOL MACROMOL, V42, P335, DOI 10.1016/j.ijbiomac.2007.12.011; Kawasaki K, 1999, CARIES RES, V33, P275, DOI 10.1159/000016529; Kim J, 2010, ACTA BIOMATER, V6, P2740, DOI 10.1016/j.actbio.2009.12.052; Kinney JH, 2003, J DENT RES, V82, P957, DOI 10.1177/154405910308201204; KLONT B, 1991, CARIES RES, V25, P39, DOI 10.1159/000261340; KLONT B, 1991, CARIES RES, V25, P46, DOI 10.1159/000261341; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192; Lee JY, 2007, BIOMATERIALS, V28, P4257, DOI 10.1016/j.biomaterials.2007.05.040; Liang P, 2004, J CRYST GROWTH, V261, P571, DOI 10.1016/j.jcrysgro.2003.03.001; Liu Y, 2011, BIOMATERIALS, V32, P1291, DOI 10.1016/j.biomaterials.2010.10.018; Marchi Juliana J, 2006, J Clin Pediatr Dent, V31, P68; Mourya V.K., 2010, ADV MAT LETT, V1, P11; Nakornchai S, 2004, ARCH ORAL BIOL, V49, P267, DOI 10.1016/j.archoralbio.2003.11.003; Niederberger M, 2006, PHYS CHEM CHEM PHYS, V8, P3271, DOI 10.1039/b604589h; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Olszta MJ, 2003, CONNECT TISSUE RES, V44, P326, DOI 10.1080/03008200390181852; Preston KP, 2008, ARCH ORAL BIOL, V53, P20, DOI 10.1016/j.archoralbio.2007.08.001; Sakoolnamarka R, 2002, AUST DENT J, V47, P116, DOI 10.1111/j.1834-7819.2002.tb00314.x; Sangwan P, 2013, INT ENDOD J, V46, P3, DOI 10.1111/j.1365-2591.2012.02101.x; Tay FR, 2008, BIOMATERIALS, V29, P1127, DOI 10.1016/j.biomaterials.2007.11.001; ten Cate J M, 2008, Aust Dent J, V53, P281, DOI 10.1111/j.1834-7819.2008.00063.x; ten Cate JM, 2001, J DENT RES, V80, P1407, DOI 10.1177/00220345010800050401; TERMINE J. D., 1967, CALCIFIED TISSUE RES, V1, P8, DOI 10.1007/BF02008070; TRAUB W, 1989, P NATL ACAD SCI USA, V86, P9822, DOI 10.1073/pnas.86.24.9822; Wan ACA, 1998, BIOMATERIALS, V19, P1309; XU Z, 2012, J MATER SCI-MATER M, V23, P733, DOI DOI 10.1007/S10856-012-4550-5; Xu Z, 2011, J BIOMED MATER RES B, V98B, P150, DOI 10.1002/jbm.b.31844; Xu Z, 2010, MAT SCI ENG C-MATER, V30, P822, DOI 10.1016/j.msec.2010.03.014; Zhao J, 2011, CHEM CENT J, V5, DOI 10.1186/1752-153X-5-40; Zhou H, 2012, J BIOMED MATER RES B, V100B, P1142, DOI 10.1002/jbm.b.32681	48	81	85	12	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116553	10.1371/journal.pone.0116553	http://dx.doi.org/10.1371/journal.pone.0116553			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587986	Green Published, gold, Green Submitted			2022-12-26	WOS:000347928300016
J	Hamaoui, A; Hassaine, M; Zanone, PG				Hamaoui, Alain; Hassaine, Myriam; Zanone, Pier-Giorgio			Sitting on a Sloping Seat Does Not Reduce the Strain Sustained by the Postural Chain	PLOS ONE			English	Article							PAIN-FREE POPULATION; LOW-BACK-PAIN; INTRADISCAL PRESSURE; SCHOOL FURNITURE; MUSCLE-ACTIVITY; TRUNK	The objective of this study was to explore the effect of a forward sloping seat on posture and muscular activity of the trunk and lower limbs. To this aim, twelve asymptomatic participants were tested in six conditions varying seat slope (0 degrees, 15 degrees forward) and height (high, medium, low). Angular position of head, trunk and pelvis was assessed with an inertial orientation system, and muscular activity of 11 superficial postural muscles located in the trunk and lower limbs was estimated using normalized EMG. Results showed that a forward sloping seat, compared to a flat seat, induced a greater activity of the soleus (p < 0.01), vastus lateralis (p < 0.05) and vastus medialis (p < 0.05), as well a lower hip flexion (p < 0.01). In contrast, no significant variation of head, trunk and pelvis angular position was observed according to seat slope. It was concluded that forward sloping seats increase the load sustained by the lower limbs, without a systematic improvement of body posture.	[Hamaoui, Alain; Hassaine, Myriam] Univ Champoll, Lab Posture & Movement Physiol, Albi, France; [Hamaoui, Alain; Hassaine, Myriam; Zanone, Pier-Giorgio] Univ Toulouse 3, PRISSMH, F-31062 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Hamaoui, A (corresponding author), Univ Champoll, Lab Posture & Movement Physiol, Albi, France.	alain.hamaoui@univ-jfc.fr	Zanone, Pier-Giorgio/B-7165-2011; Hamaoui, Alain/H-4118-2019	Zanone, Pier-Giorgio/0000-0002-6744-9772; Hamaoui, Alain/0000-0001-7410-2710	University JF Champollion; Conseil Regional Midi-Pyrenees, France	University JF Champollion; Conseil Regional Midi-Pyrenees, France(Region Occitanie)	This work has been funded by University JF Champollion and Conseil Regional Midi-Pyrenees, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson EA, 1996, CLIN BIOMECH, V11, P392, DOI 10.1016/0268-0033(96)00033-2; BENDIX T, 1984, HUM FACTORS, V26, P695, DOI 10.1177/001872088402600609; BENDIX T, 1983, SCAND J REHABIL MED, V15, P197; BRIDGER RS, 1988, HUM FACTORS, V30, P237, DOI 10.1177/001872088803000210; Caneiro JP, 2010, MANUAL THER, V15, P54, DOI 10.1016/j.math.2009.06.002; Claus AP, 2009, SPINE, V34, pE208, DOI 10.1097/BRS.0b013e3181908ead; Eklund J., 1991, INT J IND ERGONOM, V8, P67, DOI [DOI 10.1016/0169-8141(91)90026-I, 10.1016/0169-8141(91)90026-I]; Gouvali MK, 2006, APPL ERGON, V37, P765, DOI 10.1016/j.apergo.2005.11.009; GURFINKEL VS, 1995, NEUROSCIENCE, V68, P229, DOI 10.1016/0306-4522(95)00136-7; Hoy D, 2010, BEST PRACT RES CL RH, V24, P155, DOI 10.1016/j.berh.2009.11.002; Jonsson B, 1970, Electromyography, V10, P5; KEEGAN JJ, 1953, J BONE JOINT SURG AM, V35-A, P589, DOI 10.2106/00004623-195335030-00007; LUNDERVOLD A J S, 1951, Acta Physiol Scand Suppl, V24, P1; MANDAL AC, 1981, APPL ERGON, V12, P19, DOI 10.1016/0003-6870(81)90089-2; MANDAL AC, 1982, HUM FACTORS, V24, P257, DOI 10.1177/001872088202400301; MANDAL AC, 1976, ERGONOMICS, V19, P157, DOI 10.1080/00140137608931528; Mandal AC, 1991, INT J IND ERGONOM, V8, P75, DOI [dx.doi.org/10.1016/0169-8141(91)90027-J, DOI 10.1016/0169-8141(91)90027-J]; NACHEMSON A, 1975, Rheumatology and Rehabilitation, V14, P129; NACHEMSON A, 1964, J BONE JOINT SURG AM, V46, P1077, DOI 10.2106/00004623-196446050-00012; Nairn BC, 2013, MANUAL THER, V18, P498, DOI 10.1016/j.math.2013.03.003; O'Sullivan PB, 2002, SPINE, V27, P1238, DOI 10.1097/00007632-200206010-00019; O'Sullivan PB, 2006, SPINE, V31, pE707, DOI 10.1097/01.brs.0000234735.98075.50; OKADA M, 1972, Journal of Human Ergology, V1, P75; PAPAGEORGIOU AC, 1995, SPINE, V20, P1889, DOI 10.1097/00007632-199509000-00009; Sato K, 1999, SPINE, V24, P2468, DOI 10.1097/00007632-199912010-00008; Schoberth H., 1962, SITZHALTUNG SITZSCHA; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005	27	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116353	10.1371/journal.pone.0116353	http://dx.doi.org/10.1371/journal.pone.0116353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587989	Green Submitted, Green Published, gold			2022-12-26	WOS:000347928300010
J	Schaarschmidt, BM; Buchbender, C; Nensa, F; Grueneien, J; Gomez, B; Kohler, J; Reis, H; Ruhlmann, V; Umutlu, L; Heusch, P				Schaarschmidt, Benedikt Michael; Buchbender, Christian; Nensa, Felix; Grueneien, Johannes; Gomez, Benedikt; Koehler, Jens; Reis, Henning; Ruhlmann, Verena; Umutlu, Lale; Heusch, Philipp			Correlation of the Apparent Diffusion Coefficient (ADC) with the Standardized Uptake Value (SUV) in Lymph Node Metastases of Non-Small Cell Lung Cancer (NSCLC) Patients Using Hybrid 18F-FDG PET/MRI	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PULMONARY NODULES; WEIGHTED MRI; PET/CT; LESIONS; CHEST; REPEATABILITY; BRAIN; FDG	Objective To compare the apparent diffusion coefficient (ADC) in lymph node metastases of non-small cell lung cancer (NSCLC) patients with standardized uptake values (SUV) derived from combined 18F-fluoro-deoxy-glucose-positron emission tomography/magnetic resonance imaging (18F-FDG PET/MRI). Material and Methods 38 patients with histopathologically proven NSCLC (mean age 60.1 +/- 9.5y) received wholebody PET/CT (Siemens mCT (TM)) 60min after injection of a mean dose of 280 +/- 50 MBq 18F-FDG and subsequent PET/MRI (mean time after tracer injection: 139 +/- 26 min, Siemens Biograph mMR). During PET acquisition, simultaneous diffusion-weighted imaging (DWI, b values: 0, 500, 1000 s/mm(2)) was performed. A maximum of 10 lymph nodes per patient suspicious for malignancy were analyzed. Regions of interest (ROI) were drawn covering the entire lymph node on the attenuation-corrected PET-image and the monoexponential ADC-map. According to histopathology or radiological follow-up, lymph nodes were classified as benign or malignant. Pearson's correlation coefficients were calculated for all lymph node metastases correlating SUVmax and SUVmean with ADC(mean). Results A total of 146 suspicious lymph nodes were found in 25 patients. One hundred lymph nodes were eligible for final analysis. Ninety-one lymph nodes were classified as malignant and 9 as benign according to the reference standard. In malignant lesions, mean SUVmax was 9.1 +/- 3.8 and mean SUVmean was 6.0 +/- 2.5 while mean ADC(mean) was 877.0 +/- 128.6 x 10(-5) mm(2)/s in PET/MRI. For all malignant lymph nodes, a weak, inverse correlation between SUVmax and ADCmean as well as SUVmean and ADCmean (r = -0.30, p<0.05 and r = -0.36, p<0.05) existed. Conclusion The present data show a weak inverse correlation between increased glucose-metabolism and cellularity in lymph node metastases of NSCLC patients. 18F-FDG-PET and DWI thus may offer complementary information for the evaluation of treatment response in lymph node metastases of NSCLC.	[Schaarschmidt, Benedikt Michael; Buchbender, Christian; Heusch, Philipp] Univ Dusseldorf, Fac Med, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany; [Schaarschmidt, Benedikt Michael; Nensa, Felix; Grueneien, Johannes; Umutlu, Lale] Univ Duisburg Essen, Fac Med, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Gomez, Benedikt; Ruhlmann, Verena] Univ Duisburg Essen, Fac Med, Dept Nucl Med, Essen, Germany; [Koehler, Jens] Univ Duisburg Essen, Fac Med, Dept Med Oncol, Essen, Germany; [Reis, Henning] Univ Duisburg Essen, Fac Med, Inst Pathol, Essen, Germany	Heinrich Heine University Dusseldorf; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Schaarschmidt, BM (corresponding author), Univ Dusseldorf, Fac Med, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany.	Benedikt.Schaarschmidt@med.uni-duesseldorf.de	Reis, Henning/AAX-9545-2020; Köhler, Jens/AAK-1541-2021	Reis, Henning/0000-0003-1373-5295; Schaarschmidt, Benedikt Michael/0000-0001-6331-7679; Nensa, Felix/0000-0002-5811-7100; Kohler (MD), Jens/0000-0002-9922-6469				Akbarzadeh A, 2013, ANN NUCL MED, V27, P152, DOI 10.1007/s12149-012-0667-3; Antoch G, 2003, RADIOLOGY, V229, P526, DOI 10.1148/radiol.2292021598; Antoch G, 2009, EUR J NUCL MED MOL I, V36, P113, DOI 10.1007/s00259-008-0951-6; Bernardin L, 2014, EUR RADIOL, V24, P502, DOI 10.1007/s00330-013-3048-y; Biederer J, 2003, RADIOLOGY, V227, P475, DOI 10.1148/radiol.2272020635; Buchbender C, 2012, J NUCL MED, V53, P928, DOI 10.2967/jnumed.112.105338; Bunyaviroch T, 2006, J NUCL MED, V47, P451; Chen W, 2010, MAGN RESON IMAGING, V28, P613, DOI 10.1016/j.mri.2010.02.009; Cheng G, 2013, MOL IMAGING BIOL, V15, P345, DOI 10.1007/s11307-012-0600-0; De Leyn P, 2007, EUR J CARDIO-THORAC, V32, P1, DOI 10.1016/j.ejcts.2007.01.075; Donati OF, 2014, RADIOLOGY, V270, P454, DOI 10.1148/radiol.13130819; Goeckenjan G, 2010, Pneumologie, V64 Suppl 2, pe1, DOI 10.1055/s-0029-1243837; Grueneisen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096751; Heusch P, 2013, ROFO-FORTSCHR RONTG, V185, P1059, DOI 10.1055/s-0033-1350110; Heusch P, 2014, J NUCL MED, V55, P373, DOI 10.2967/jnumed.113.129825; Heusch P, 2013, EUR J RADIOL, V82, P2055, DOI 10.1016/j.ejrad.2013.05.027; Heusch P, 2013, EUR J RADIOL, V82, P870, DOI 10.1016/j.ejrad.2013.01.008; Kosucu P, 2009, J MAGN RESON IMAGING, V30, P292, DOI 10.1002/jmri.21850; Landwehr P, 1999, EUR RADIOL, V9, P1737, DOI 10.1007/s003300050917; Lardinois D, 2003, NEW ENGL J MED, V348, P2500, DOI 10.1056/NEJMoa022136; Leslie H., 2011, TNM CLASSIFICATION M, V7th ed., P138; Mac Manus MP, 2001, INT J RADIAT ONCOL, V50, P287, DOI 10.1016/S0360-3016(01)01477-8; Malyarenko D, 2013, J MAGN RESON IMAGING, V37, P1238, DOI 10.1002/jmri.23825; Martinez-Moller A, 2009, J NUCL MED, V50, P520, DOI 10.2967/jnumed.108.054726; Matoba M, 2007, RADIOLOGY, V243, P570, DOI 10.1148/radiol.2432060131; Mori T, 2008, J THORAC ONCOL, V3, P358, DOI 10.1097/JTO.0b013e318168d9ed; Nomori H, 2008, J THORAC CARDIOV SUR, V135, P816, DOI 10.1016/j.jtcvs.2007.10.035; Ohba Y, 2009, J THORAC CARDIOV SUR, V138, P439, DOI 10.1016/j.jtcvs.2008.12.026; Ohno Y, 2012, AM J ROENTGENOL, V198, P75, DOI 10.2214/AJR.11.6525; Pieterman RM, 2000, NEW ENGL J MED, V343, P254, DOI 10.1056/NEJM200007273430404; Quick HH, 2014, J MAGN RESON IMAGING, V39, P243, DOI 10.1002/jmri.24523; Rakheja R, 2013, AM J ROENTGENOL, V201, P1115, DOI 10.2214/AJR.13.11304; Regier M, 2012, EUR J RADIOL, V81, P2913, DOI 10.1016/j.ejrad.2011.11.050; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Satoh S, 2008, AM J ROENTGENOL, V191, P464, DOI 10.2214/AJR.07.3133; Schmidt H, 2013, INVEST RADIOL, V48, P247, DOI 10.1097/RLI.0b013e31828d56a1; Schwenzer NF, 2012, RADIOLOGY, V264, P551, DOI 10.1148/radiol.12111942; Travis WD, 2004, TUMOURS LUNG PLEURA, P9; van Tinteren H, 2002, LANCET, V359, P1388, DOI 10.1016/S0140-6736(02)08352-6; Wu XC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084999; Yi CA, 2013, CANCER-AM CANCER SOC, V119, P1784, DOI 10.1002/cncr.28000	41	30	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0116277	10.1371/journal.pone.0116277	http://dx.doi.org/10.1371/journal.pone.0116277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25574968	Green Submitted, Green Published, gold			2022-12-26	WOS:000348168100004
J	Lecointre, C; Desrues, L; Joubert, JE; Perzo, N; Guichet, PO; Le Joncour, V; Brule, C; Chabbert, M; Leduc, R; Prezeau, L; Laquerriere, A; Proust, F; Gandolfo, P; Morin, F; Castel, H				Lecointre, C.; Desrues, L.; Joubert, J. E.; Perzo, N.; Guichet, P-O; Le Joncour, V.; Brule, C.; Chabbert, M.; Leduc, R.; Prezeau, L.; Laquerriere, A.; Proust, F.; Gandolfo, P.; Morin, F.; Castel, H.			Signaling switch of the urotensin II vasosactive peptide GPCR: prototypic chemotaxic mechanism in glioma	ONCOGENE			English	Article							PROTEIN-COUPLED RECEPTORS; CANCER CELL-MIGRATION; EXTRACELLULAR-MATRIX; CEREBROSPINAL-FLUID; ENDOTHELIAL-CELLS; MALIGNANT GLIOMAS; ORPHAN RECEPTOR; IN-VITRO; EXPRESSION; ACTIVATION	Multiform glioblastomas (GBM) are the most frequent and aggressive primary brain tumors in adults. The poor prognosis is due to neo-angiogenesis and cellular invasion, processes that require complex chemotaxic mechanisms involving motility, migration and adhesion. Understanding these different cellular events implies identifying receptors and transduction pathways that lead to and promote either migration or adhesion. Here we establish that glioma express the vasoactive peptide urotensin II (UII) and its receptor UT and that UT-mediated signaling cascades are involved in glioma cell migration and adhesion. Components of the urotensinergic systems, UII and UT, are widely expressed in patient-derived GBM tissue sections, glioma cell lines and fresh biopsy explants. Interestingly, gradient concentrations of UII produced chemoattracting migratory/motility effects in glioma as well as HEK293 cells expressing human UT. These effects mainly involved the G(13)/Rho/rho kinase pathway while partially requiring G(i/o)/PI3K components. In contrast, we observed that homogeneous concentrations of UII drastically blocked cell motility and stimulated cell-matrix adhesions through a UT/G(i/o) signaling cascade, partially involving phosphatidylinositol-3 kinase. Finally, we provide evidence that, in glioma cells, homogeneous concentration of UII allowed translocation of G(alpha 13) to the UT receptor at the plasma membrane and increased actin stress fibers, lamellipodia formation and vinculin-stained focal adhesions. UII also provoked a re-localization of UT precoupled to G(alpha i) in filipodia and initiated integrin-stained focal points. Altogether, these findings suggest that UT behaves as a chemotaxic receptor, relaying a signaling switch between directional migration and cell adhesion under gradient or homogeneous concentrations, thereby redefining sequential mechanisms affecting tumor cells during glioma invasion. Taken together, our results allow us to propose a model in order to improve the design of compounds that demonstrate signaling bias for therapies that target specifically the G(i/o) signaling pathway.	[Lecointre, C.; Desrues, L.; Joubert, J. E.; Perzo, N.; Guichet, P-O; Le Joncour, V.; Proust, F.; Gandolfo, P.; Morin, F.; Castel, H.] Univ Rouen, Lab Neuronal & Neuroendocrine Commun & Differenti, Biomed Res Inst IRIB, Inserm,U982,DC2N,Astrocyte & Vasc Niche,Network T, F-76821 Mont St Aignan, France; [Perzo, N.; Brule, C.; Leduc, R.] Univ Sherbrooke, Fac Med & Sci Sante, Inst Pharmacol, Dept Pharmacol, Sherbrooke, PQ J1K 2R1, Canada; [Brule, C.; Prezeau, L.] Univ Montpellier 1 & 2, Inst Funct Genom, IGF, CNRS,UMR 5203,Inserm,U661, Montpellier, France; [Chabbert, M.] Fac Med 3, UMR CNRS 6214, Inserm 1083, Angers, France; [Laquerriere, A.] CHU Rouen, Serv Anatomocytopathol, INSERM, ERI28, Rouen, France; [Proust, F.] CHU Rouen, Serv Neurosurg, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; University of Sherbrooke; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen	Castel, H (corresponding author), Univ Rouen, Lab Neuronal & Neuroendocrine Commun & Differenti, Biomed Res Inst IRIB, Inserm,U982,DC2N,Astrocyte & Vasc Niche,Network T, F-76821 Mont St Aignan, France.	helene.castel@univ-rouen.fr	castel, helene/B-8675-2009; Le Joncour, Vadim/X-6274-2019	castel, helene/0000-0002-8972-5555; Le Joncour, Vadim/0000-0001-8153-8563; Guichet, Pierre-Olivier/0000-0003-0115-2199; Morin, Fabrice/0000-0001-6785-1967	CIHR (Canadian Institutes of Health Research); Inserm; Gefluc; TC2N network; LARC Neuroscience; Institute on Innovative and Biomedical Research (IRIB), The University of Rouen; Haute-Normandy or French ministry	CIHR (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Gefluc; TC2N network; LARC Neuroscience; Institute on Innovative and Biomedical Research (IRIB), The University of Rouen; Haute-Normandy or French ministry	We thank Mme Marie-Therese Schouft for her expertise in cytometry, the PRIMACEN platform (University of Rouen, France) for imaging equipments and Mr Arnaud Arabo and Mrs Huguette Lemonnier for skillful technical assistance. This work was supported by a CIHR (Canadian Institutes of Health Research) grant to RL and by Inserm, Gefluc, TC2N network, LARC Neuroscience and Institute on Innovative and Biomedical Research (IRIB), The University of Rouen. CL, VL, J-EJ and P-OG were recipients of a fellowship from the Haute-Normandy or French ministry.	Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8; Bartolome RA, 2008, CANCER RES, V68, P8221, DOI 10.1158/0008-5472.CAN-08-0561; Bian D, 2006, ONCOGENE, V25, P2234, DOI 10.1038/sj.onc.1209261; BOCCHINI V, 1991, CELL TISSUE RES, V265, P73, DOI 10.1007/BF00318141; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Brule C, 2014, FASEB J, V28, P5148, DOI 10.1096/fj.14-249771; Castel H, 2006, J NEUROCHEM, V99, P582, DOI 10.1111/j.1471-4159.2006.04130.x; Cirillo P, 2008, J THROMB HAEMOST, V6, P726, DOI 10.1111/j.1538-7836.2008.02923.x; Coulouarn Y, 1998, P NATL ACAD SCI USA, V95, P15803, DOI 10.1073/pnas.95.26.15803; Cowley E, 2005, BRIT J ANAESTH, V95, P495, DOI 10.1093/bja/aei222; Daher Z, 2008, CELL SIGNAL, V20, P2256, DOI 10.1016/j.cellsig.2008.08.021; Desrues L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036319; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Federico A, 2014, EUR J CLIN INVEST, V44, P285, DOI 10.1111/eci.12231; Filipeanu CM, 2002, J NEUROCHEM, V83, P879, DOI 10.1046/j.1471-4159.2002.01196.x; Franco R, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-48; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Glodek AM, 2003, J EXP MED, V197, P461, DOI 10.1084/jem.20021477; Gould PS, 2010, HYPERTENSION, V56, P172, DOI 10.1161/HYPERTENSIONAHA.110.152074; Grieco P, 2011, J CELL BIOCHEM, V112, P341, DOI 10.1002/jcb.22933; Hotchin NA, 1995, J CELL BIOL, V131, P1857, DOI 10.1083/jcb.131.6.1857; Jarjour AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025408; Jarry M, 2010, BIOCHEM J, V428, P113, DOI 10.1042/BJ20090867; Johnston ALM, 2007, PLOS BIOL, V5, P1723, DOI 10.1371/journal.pbio.0050212; Kenakin T, 1997, TRENDS PHARMACOL SCI, V18, P456, DOI 10.1016/S0165-6147(97)90683-0; Kirui JK, 2010, J PHARMACOL EXP THER, V333, P393, DOI 10.1124/jpet.109.164814; Lachance M, 1999, CELL SIGNAL, V11, P523, DOI 10.1016/S0898-6568(99)00024-8; Lin YZ, 2003, HYPERTENS RES, V26, P839, DOI 10.1291/hypres.26.839; Lu DY, 2010, J CELL BIOCHEM, V110, P141, DOI 10.1002/jcb.22520; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; Matsusaka S, 2006, N-S ARCH PHARMACOL, V373, P381, DOI 10.1007/s00210-006-0086-x; Medeiros PJ, 2012, INT J CANCER, V131, P276, DOI 10.1002/ijc.26350; Mitra P, 2001, CELL SIGNAL, V13, P311, DOI 10.1016/S0898-6568(01)00156-5; Monterrubio M, 2009, BIOCHEM BIOPH RES CO, V388, P199, DOI 10.1016/j.bbrc.2009.07.153; Mori M, 1999, BIOCHEM BIOPH RES CO, V265, P123, DOI 10.1006/bbrc.1999.1640; Mugabe BE, 2010, J PHARMACOL EXP THER, V332, P116, DOI 10.1124/jpet.109.157552; MUNSHI R, 1991, J BIOL CHEM, V266, P22285; Nishikawa K, 2011, NEUROCHEM INT, V58, P261, DOI 10.1016/j.neuint.2010.11.013; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Nothacker HP, 1999, NAT CELL BIOL, V1, P383, DOI 10.1038/14081; Panetti TS, 2000, ARTERIOSCL THROM VAS, V20, P1013, DOI 10.1161/01.ATV.20.4.1013; Perzelova A, 1998, NEOPLASMA, V45, P25; Proulx CD, 2008, MOL PHARMACOL, V74, P552, DOI 10.1124/mol.108.045054; Rempel SA, 2000, CLIN CANCER RES, V6, P102; Rossowski WJ, 2002, EUR J PHARMACOL, V438, P159, DOI 10.1016/S0014-2999(02)01341-9; Sauzeau V, 2001, CIRC RES, V88, P1102, DOI 10.1161/hh1101.092034; Segain JP, 2007, J IMMUNOL, V179, P901, DOI 10.4049/jimmunol.179.2.901; Shyu KG, 2012, EUR J CLIN INVEST, V42, P17, DOI 10.1111/j.1365-2362.2011.02549.x; Song W, 2006, N-S ARCH PHARMACOL, V373, P148, DOI 10.1007/s00210-006-0057-2; Stupp R, 2005, ANN ONCOL, V16, P64, DOI 10.1093/annonc/mdi834; Sugo T, 2003, BIOCHEM BIOPH RES CO, V310, P860, DOI 10.1016/j.bbrc.2003.09.102; Takahashi K, 2003, PEPTIDES, V24, P301, DOI 10.1016/S0196-9781(03)00039-1; Takahashi K, 2001, PEPTIDES, V22, P1175, DOI 10.1016/S0196-9781(01)00441-7; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Thompson JP, 2003, ANESTH ANALG, V97, P1501, DOI 10.1213/01.ANE.0000086723.97421.BC; Totsune K, 2001, LANCET, V358, P810, DOI 10.1016/S0140-6736(01)06002-0; Tzanidis A, 2003, CIRC RES, V93, P246, DOI 10.1161/01.RES.0000084382.64418.BC; Wang SC, 2012, LAB INVEST, V92, P151, DOI 10.1038/labinvest.2011.128; Watson AMD, 2013, DIABETOLOGIA, V56, P1155, DOI 10.1007/s00125-013-2837-9; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu YQ, 2010, ONCOL REP, V24, P1179, DOI 10.3892/or_00000970; Xie Y, 2013, BIOCHEM PHARMACOL, V85, P1454, DOI 10.1016/j.bcp.2013.03.001; Xu SK, 2009, TOHOKU J EXP MED, V219, P283, DOI 10.1620/tjem.219.283; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221; Yamazaki F, 2005, BIOCHEM BIOPH RES CO, V332, P782, DOI 10.1016/j.bbrc.2005.05.023; Yi KH, 2012, PEPTIDES, V33, P87, DOI 10.1016/j.peptides.2011.11.016; Zagzag D, 2008, AM J PATHOL, V173, P545, DOI 10.2353/ajpath.2008.071197; Zagzag D, 2006, LAB INVEST, V86, P1221, DOI 10.1038/labinvest.3700482; Zhang YG, 2008, J HYPERTENS, V26, P1119, DOI 10.1097/HJH.0b013e3282fa1412; Zhang YG, 2011, PEPTIDES, V32, P2452, DOI 10.1016/j.peptides.2011.10.018; Zhou CH, 2012, ONCOL LETT, V4, P1259, DOI 10.3892/ol.2012.932; Ziltener P, 2002, J RECEPT SIGNAL TR R, V22, P155, DOI 10.1081/RRS-120014593	76	16	17	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 24	2015	34	39					5080	5094		10.1038/onc.2014.433	http://dx.doi.org/10.1038/onc.2014.433			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR9RC	25597409				2022-12-26	WOS:000361693300008
J	Lee, D; Kraus, A; Prins, D; Groenendyk, J; Aubry, I; Liu, WX; Li, HD; Julien, O; Touret, N; Sykes, BD; Tremblay, ML; Michalak, M				Lee, Dukgyu; Kraus, Allison; Prins, Daniel; Groenendyk, Jody; Aubry, Isabelle; Liu, Wen-Xin; Li, Hao-Dong; Julien, Olivier; Touret, Nicolas; Sykes, Brian D.; Tremblay, Michel L.; Michalak, Marek			UBC9-dependent Association between Calnexin and Protein Tyrosine Phosphatase 1B (PTP1B) at the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR; QUALITY-CONTROL; SARCOPLASMIC-RETICULUM; KEY COMPONENT; HEAT-SHOCK; SUMO; PHOSPHORYLATION; SUMOYLATION; SITES; CALRETICULIN	Calnexin is a type I integral endoplasmic reticulum (ER) membrane protein, molecular chaperone, and a component of the translocon. We discovered a novel interaction between the calnexin cytoplasmic domain and UBC9, a SUMOylation E2 ligase, which modified the calnexin cytoplasmic domain by the addition of SUMO. We demonstrated that calnexin interaction with the SUMOylation machinery modulates an interaction with protein tyrosine phosphatase 1B (PTP1B), an ER-associated protein tyrosine phosphatase involved in the negative regulation of insulin and leptin signaling. We showed that calnexin and PTP1B form UBC9-dependent complexes, revealing a previously unrecognized contribution of calnexin to the retention of PTP1B at the ER membrane. This work shows that the SUMOylation machinery links two ER proteins from divergent pathways to potentially affect cellular protein quality control and energy metabolism.	[Lee, Dukgyu; Kraus, Allison; Prins, Daniel; Groenendyk, Jody; Liu, Wen-Xin; Li, Hao-Dong; Julien, Olivier; Touret, Nicolas; Sykes, Brian D.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Aubry, Isabelle; Tremblay, Michel L.; Michalak, Marek] McGill Univ, Dept Biochem, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada	University of Alberta; McGill University	Michalak, M (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S7, Canada.	marek.michalak@ualberta.ca	Julien, Olivier/N-9198-2019; Julien, Olivier/A-1594-2013	Julien, Olivier/0000-0001-7068-7299; 	Canadian Institutes of Health Research (CIHR) [MOP15291, MOP62887, MOP37769, MOP93659]; Canadian Foundation for Innovation [CFI-17625]; Natural Sciences and Engineering Research Council (NSERC) Discovery Research grants; Alberta Innovates-Health Solutions (AI-HS); Multiple Sclerosis Society of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council (NSERC) Discovery Research grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates-Health Solutions (AI-HS); Multiple Sclerosis Society of Canada	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) (to M. M. MOP15291; to M. L. T. MOP62887; to B. D. S. MOP37769; to N. T. MOP93659), from the Canadian Foundation for Innovation (CFI-17625) and the Natural Sciences and Engineering Research Council (NSERC) Discovery Research grants (to N. T.). A. K. was supported by a fellowship from Alberta Innovates-Health Solutions (AI-HS) and from the Multiple Sclerosis Society of Canada.	Bass J, 1998, J CELL BIOL, V141, P637, DOI 10.1083/jcb.141.3.637; Benyair R, 2011, INT REV CEL MOL BIO, V292, P197, DOI 10.1016/B978-0-12-386033-0.00005-0; Boute N, 2003, EMBO REP, V4, P313, DOI 10.1038/sj.embor.embor767; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALA SE, 1993, J BIOL CHEM, V268, P2969; Cameron PH, 2009, J BIOL CHEM, V284, P34570, DOI 10.1074/jbc.M109.053165; Chevet E, 1999, EMBO J, V18, P3655, DOI 10.1093/emboj/18.13.3655; Chevet E, 2010, SEMIN CELL DEV BIOL, V21, P486, DOI 10.1016/j.semcdb.2009.12.005; Dadke S, 2007, NAT CELL BIOL, V9, P80, DOI 10.1038/ncb1522; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; Felberbaum R, 2012, MOL CELL BIOL, V32, P64, DOI 10.1128/MCB.05878-11; Feldhammer M, 2013, CRIT REV BIOCHEM MOL, V48, P430, DOI 10.3109/10409238.2013.819830; Ferrari E, 2011, J BIOL CHEM, V286, P4173, DOI 10.1074/jbc.M110.157420; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Ho SC, 1999, MOL IMMUNOL, V36, P1, DOI 10.1016/S0161-5890(99)00018-8; Jentsch S, 2013, ANNU REV GENET, V47, P167, DOI 10.1146/annurev-genet-111212-133453; Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407; Kraus A, 2010, J BIOL CHEM, V285, P18928, DOI 10.1074/jbc.M110.107201; Kushner JA, 2004, DIABETES, V53, P61, DOI 10.2337/diabetes.53.1.61; Lakkaraju AKK, 2013, MOL CELL, V51, P386, DOI 10.1016/j.molcel.2013.07.009; Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Li HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021678; Lynes EM, 2013, J CELL SCI, V126, P3893, DOI 10.1242/jcs.125856; Lynes EM, 2012, EMBO J, V31, P457, DOI 10.1038/emboj.2011.384; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; MILNER RE, 1991, J BIOL CHEM, V266, P7155; Myhill N, 2008, MOL BIOL CELL, V19, P2777, DOI 10.1091/mbc.E07-10-0995; Nakamura K, 2000, J CELL BIOL, V150, P731, DOI 10.1083/jcb.150.4.731; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Popov D, 2012, BIOCHEM BIOPH RES CO, V422, P535, DOI 10.1016/j.bbrc.2012.05.048; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Romsicki Y, 2004, J BIOL CHEM, V279, P12868, DOI 10.1074/jbc.M309600200; Rosenbaum EE, 2006, NEURON, V49, P229, DOI 10.1016/j.neuron.2005.12.011; Saitoh T, 2002, MOL PHARMACOL, V62, P847, DOI 10.1124/mol.62.4.847; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; SCHUE V, 1994, BIOCHEM BIOPH RES CO, V203, P22, DOI 10.1006/bbrc.1994.2143; St-Pierre J, 2012, CELL METAB, V15, P292, DOI 10.1016/j.cmet.2012.02.004; Stuible M, 2010, J BIOL CHEM, V285, P23899, DOI 10.1074/jbc.M110.115295; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; TJOELKER LW, 1994, BIOCHEMISTRY-US, V33, P3229, DOI 10.1021/bi00177a013; Wong HN, 1998, J BIOL CHEM, V273, P17227, DOI 10.1074/jbc.273.27.17227; Yang SH, 2006, E SCHERING RES FDN W, V57, P193; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; Yunus AA, 2005, METHOD ENZYMOL, V398, P74, DOI 10.1016/S0076-6879(05)98008-7	60	12	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5725	5738		10.1074/jbc.M114.635474	http://dx.doi.org/10.1074/jbc.M114.635474			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25586181	Green Published, hybrid			2022-12-26	WOS:000350044200040
J	Badisa, RB; Kumar, SS; Mazzio, E; Haughbrook, RD; Allen, JR; Davidson, MW; Fitch-Pye, CA; Goodman, CB				Badisa, Ramesh B.; Kumar, Sanjay S.; Mazzio, Elizabeth; Haughbrook, Rasheda D.; Allen, John R.; Davidson, Michael W.; Fitch-Pye, Cheryl A.; Goodman, Carl B.			N-Acetyl Cysteine Mitigates the Acute Effects of Cocaine-Induced Toxicity in Astroglia-Like Cells	PLOS ONE			English	Article							INDUCED APOPTOSIS; GLIAL-CELLS; RAT; BRAIN; GLUTATHIONE; ACTIVATION; EXPRESSION; NEURONS; PHOSPHORYLATION; ACETYLCYSTEINE	Cocaine has a short half-life of only about an hour but its effects, predominantly on the central nervous system (CNS), are fairly long-lasting. Of all cells within the CNS, astrocytes may be the first to display cocaine toxicity owing to their relative abundance in the brain. Cocaine entry could trigger several early response changes that adversely affect their survival, and inhibiting these changes could conversely increase their rate of survival. In order to identify these changes and the minimal concentrations of cocaine that can elicit them in vitro, rat C6 astroglia-like cells were treated with cocaine (2-4 mM for 1h) and assayed for alterations in gross cell morphology, cytoplasmic vacuolation, viability, reactive oxygen species (ROS) generation, glutathione (GSH) levels, cell membrane integrity, F-actin cytoskeleton, and histone methylation. We report here that all of the above identified features are significantly altered by cocaine, and may collectively represent the key pathology underlying acute toxicity-mediated death of astroglia-like cells. Pretreatment of the cells with the clinically available antioxidant N-acetyl cysteine (NAC, 5 mM for 30 min) inhibited these changes during subsequent application of cocaine and mitigated cocaine-induced toxicity. Despite repeated cocaine exposure, NAC pretreated cells remained highly viable and post NAC treatment also increased viability of cocaine treated cells to a smaller yet significant level. We show further that this alleviation by NAC is mediated through an increase in GSH levels in the cells. These findings, coupled with the fact that astrocytes maintain neuronal integrity, suggest that compounds which target and mitigate these early toxic changes in astrocytes could have a potentially broad therapeutic role in cocaine-induced CNS damage.	[Badisa, Ramesh B.; Mazzio, Elizabeth; Goodman, Carl B.] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA; [Kumar, Sanjay S.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Haughbrook, Rasheda D.] Florida A&M Univ, Dept Biol, Tallahassee, FL 32307 USA; [Allen, John R.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32307 USA; [Fitch-Pye, Cheryl A.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida A&M University; State University System of Florida; Florida State University; State University System of Florida; Florida A&M University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Badisa, RB (corresponding author), Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.	badisa66@gmail.com		Kumar, Sanjay/0000-0002-1952-3624	National Institute on Minority Health and Health Disparities of the National Institutes of Health of the USA [G12MD007582]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003020] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007582, P20MD006738] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities of the National Institutes of Health of the USA; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by the National Institute on Minority Health and Health Disparities of the National Institutes of Health under award number G12MD007582 of the USA.	Abbott NJ, 2013, J INHERIT METAB DIS, V36, P437, DOI 10.1007/s10545-013-9608-0; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Araque A, 2006, CURR OPIN INVEST DR, V7, P619; ATTWELL D, 1994, NATURE, V369, P707, DOI 10.1038/369707a0; Badisa RB, 2014, MOL MED REP, V10, P2287, DOI 10.3892/mmr.2014.2524; Badisa RB, 2013, INT J MOL MED, V32, P497, DOI 10.3892/ijmm.2013.1391; Badisa RB, 2012, INT J MOL MED, V30, P687, DOI 10.3892/ijmm.2012.1038; Badisa RB, 2010, NEUROCHEM RES, V35, P288, DOI 10.1007/s11064-009-0053-2; Badisa RB, 2003, PHYTOTHER RES, V17, P472, DOI 10.1002/ptr.1175; Bahar M, 1984, Eur J Anaesthesiol, V1, P293; BARNETT G, 1981, J ETHNOPHARMACOL, V3, P353, DOI 10.1016/0378-8741(81)90063-5; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; BISSELL MG, 1974, BRAIN RES, V82, P77, DOI 10.1016/0006-8993(74)90894-4; Bragin DE, 2010, J CEREBR BLOOD F MET, V30, P734, DOI 10.1038/jcbfm.2010.9; Buttner Andreas, 2006, Forensic Sci Med Pathol, V2, P115, DOI 10.1385/FSMP:2:2:115; Cechin SR, 2005, NEUROCHEM RES, V30, P603, DOI 10.1007/s11064-005-2747-4; Chen TJ, 2006, TOXICOLOGY, V223, P113, DOI 10.1016/j.tox.2006.03.007; Chen YC, 2006, TOXICOL APPL PHARM, V216, P263, DOI 10.1016/j.taap.2006.05.008; CHIU SY, 1994, GLIA, V11, P191, DOI 10.1002/glia.440110213; CHOW MJ, 1985, CLIN PHARMACOL THER, V38, P318, DOI 10.1038/clpt.1985.179; Covington HE, 2011, NEURON, V71, P656, DOI 10.1016/j.neuron.2011.06.007; CUBELLS JF, 1994, J NEUROSCI, V14, P2260, DOI 10.1523/jneurosci.14-04-02260.1994; Cunha-Oliveira T, 2006, TOXICOLOGY, V217, P54, DOI 10.1016/j.tox.2005.08.022; Cunha-Oliveira T, 2006, BRAIN RES, V1089, P44, DOI 10.1016/j.brainres.2006.03.061; Deigner HP, 2000, EXPERT OPIN INV DRUG, V9, P747, DOI 10.1517/13543784.9.4.747; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Fattore L, 2002, NEUROSCIENCE, V110, P1, DOI 10.1016/S0306-4522(01)00598-X; Feng Z, 2004, FREE RADICAL BIO MED, V37, P1790, DOI 10.1016/j.freeradbiomed.2004.08.023; Finol H. J., 2000, Journal of Submicroscopic Cytology and Pathology, V32, P111; FRAKER TD, 1990, CIRCULATION, V81, P1012, DOI 10.1161/01.CIR.81.3.1012; Fumagalli F, 2006, MOL PHARMACOL, V70, P1726, DOI 10.1124/mol.106.026302; Funchal C, 2005, METAB BRAIN DIS, V20, P205, DOI 10.1007/s11011-005-7208-x; GARG UC, 1993, NEUROSCIENCE, V57, P467, DOI 10.1016/0306-4522(93)90079-U; GU J, 1993, NEUROTOXICOLOGY, V14, P19; Ipsen J., 1970, BANCROFTS INTRO BIOS; Kramer Jamie M, 2013, Biomol Concepts, V4, P1, DOI 10.1515/bmc-2012-0026; KUGELMASS AD, 1993, CIRCULATION, V88, P876, DOI 10.1161/01.CIR.88.3.876; LaRowe SD, 2006, AM J ADDICTION, V15, P105, DOI 10.1080/10550490500419169; Little KY, 2009, PSYCHIAT RES, V168, P173, DOI 10.1016/j.psychres.2008.10.034; Lopez-Erauskin J, 2013, HUM MOL GENET, V22, P3296, DOI 10.1093/hmg/ddt186; Lotharius J, 1999, J NEUROSCI, V19, P1284; MANGOURA D, 1989, NEUROCHEM RES, V14, P941, DOI 10.1007/BF00965927; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; National Institute on Drug Abuse, 2010, NAT I DRUG AB RES RE; Odewumi CO, 2011, INT J MOL MED, V27, P243, DOI 10.3892/ijmm.2010.564; Oliveira MT, 2002, ANN NY ACAD SCI, V965, P487; Park SJ, 2012, J IMMUNOL, V188, P5132, DOI 10.4049/jimmunol.1101600; Pearson J, 1979, HDB CLIN NEUROLOGY 2, P365; Phillips K, 2009, AM J CARDIOVASC DRUG, V9, P177, DOI 10.2165/00129784-200909030-00005; PIXLEY SK, 1992, NEURON, V8, P1191, DOI 10.1016/0896-6273(92)90139-5; Quincozes-Santos A, 2007, NEUROTOXICOLOGY, V28, P886, DOI 10.1016/j.neuro.2007.03.008; Quincozes-Santos A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064372; Repetto G, 1997, TOXICOL IN VITRO, V11, P519, DOI 10.1016/S0887-2333(97)00066-0; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Shao ZJ, 2006, J PSYCHIATR NEUROSCI, V31, P32; Sibenaller Zita A, 2005, Neurosurg Focus, V19, pE1; SMART RG, 1987, J FORENSIC SCI, V32, P303; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; STEWART A, 1990, POSTGRAD MED J, V66, P659, DOI 10.1136/pgmj.66.778.659; Stichenwirth M, 2000, FORENSIC SCI INT, V108, P61, DOI 10.1016/S0379-0738(99)00142-5; Su TP, 2001, TRENDS PHARMACOL SCI, V22, P456, DOI 10.1016/S0165-6147(00)01740-5; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; VITULLO JC, 1989, AM J PATHOL, V135, P85; Yu CTR, 2008, J BIOMED SCI, V15, P215, DOI 10.1007/s11373-007-9213-z; Zheng F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002610; ZIMMER DB, 1989, J CELL BIOL, V108, P141, DOI 10.1083/jcb.108.1.141	68	23	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0114285	10.1371/journal.pone.0114285	http://dx.doi.org/10.1371/journal.pone.0114285			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617894	Green Submitted, Green Published, gold			2022-12-26	WOS:000350336000002
J	Chen, YC; Ho, HO; Liu, DZ; Siow, WS; Sheu, MT				Chen, Ying-Chen; Ho, Hsiu-O; Liu, Der-Zen; Siow, Wen-Shian; Sheu, Ming-Thau			Swelling/Floating Capability and Drug Release Characterizations of Gastroretentive Drug Delivery System Based on a Combination of Hydroxyethyl Cellulose and Sodium Carboxymethyl Cellulose	PLOS ONE			English	Article							FLOATING MATRIX TABLETS; SUSTAINED-RELEASE; DOSAGE FORMS; IN-VITRO; HELICOBACTER-PYLORI; GASTRIC RETENTION; BIOADHESIVE; FORMULATION; DESIGN; HYDROCHLORIDE	The aim of this study was to characterize the swelling and floating behaviors of gastroretentive drug delivery system (GRDDS) composed of hydroxyethyl cellulose (HEC) and sodium carboxymethyl cellulose (NaCMC) and to optimize HEC/NaCMC GRDDS to incorporate three model drugs with different solubilities (metformin, ciprofloxacin, and esomeprazole). Various ratios of NaCMC to HEC were formulated, and their swelling and floating behaviors were characterized. Influences of media containing various NaCl concentrations on the swelling and floating behaviors and drug solubility were also characterized. Finally, release profiles of the three model drugs from GRDDS formulation (F1-4) and formulation (F1-1) were examined. Results demonstrated when the GRDDS tablets were tested in simulated gastric solution, the degree of swelling at 6 h was decreased for each formulation that contained NaCMC in comparison to those in de-ionized water (DIW). Of note, floating duration was enhanced when in simulated gastric solution compared to DIW. Further, the hydration of tablets was found to be retarded as the NaCl concentration in the medium increased resulting in smaller gel layers and swelling sizes. Dissolution profiles of the three model drugs in media containing various concentrations of NaCl showed that the addition of NaCl to the media affected the solubility of the drugs, and also their gelling behaviors, resulting in different mechanisms for controlling a drug's release. The release mechanism of the freely water-soluble drug, metformin, was mainly diffusion-controlled, while those of the water-soluble drug, ciprofloxacin, and the slightly water-soluble drug, esomeprazole, were mainly anomalous diffusion. Overall results showed that the developed GRDDS composed of HEC 250HHX and NaCMC of 450 cps possessed proper swelling extents and desired floating periods with sustained-release characteristics.	[Chen, Ying-Chen; Ho, Hsiu-O; Siow, Wen-Shian; Sheu, Ming-Thau] Taipei Med Univ, Sch Pharm, Coll Pharm, Taipei, Taiwan; [Liu, Der-Zen] Taipei Med Univ, Grad Inst Biomed Mat & Engn, Taipei, Taiwan; [Liu, Der-Zen] Hsuan Chuang Univ, Ctr Gen Educ, Hsinchu, Taiwan; [Sheu, Ming-Thau] Taipei Med Univ Hosp, Canc & Chinese Herb Res Ctr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Hsuan Chuang University; Taipei Medical University; Taipei Medical University Hospital	Sheu, MT (corresponding author), Taipei Med Univ, Sch Pharm, Coll Pharm, Taipei, Taiwan.	mingsheu@tmu.edu.tw						ALFREY T, 1966, J POLYM SCI POL SYM, P249, DOI 10.1002/polc.5070120119; Arza RAK, 2009, AAPS PHARMSCITECH, V10, P220, DOI 10.1208/s12249-009-9200-y; Atyabi F, 1996, J CONTROL RELEASE, V42, P25, DOI 10.1016/0168-3659(96)01343-0; Atyabi F., 1994, P INT S CONTR REL BI, V21, P806; Bardonnet PL, 2006, J CONTROL RELEASE, V111, P1, DOI 10.1016/j.jconrel.2005.10.031; Basak SC, 2007, PHARMAZIE, V62, P145, DOI 10.1691/ph.2007.2.6108; Bermudez JM, 2008, AAPS PHARMSCITECH, V9, P924, DOI 10.1208/s12249-008-9098-9; Berner B., 2002, U.S. Patent, Patent No. [6,488,962, 6488962]; BOGENTOFT C, 1982, PHARM INT, V3, P366; Chavanpatil MD, 2006, INT J PHARMACEUT, V316, P86, DOI 10.1016/j.ijpharm.2006.02.038; Chen J, 2000, J CONTROL RELEASE, V64, P39, DOI 10.1016/S0168-3659(99)00139-X; Chen J, 1999, J BIOMED MATER RES, V44, P53, DOI 10.1002/(SICI)1097-4636(199901)44:1<53::AID-JBM6>3.0.CO;2-W; Chen RN, 2010, EUR J PHARM SCI, V39, P82, DOI 10.1016/j.ejps.2009.10.015; Chen YC, 2013, INT J PHARMACEUT, V441, P162, DOI 10.1016/j.ijpharm.2012.12.002; Conway BR, 2005, CURR PHARM DESIGN, V11, P775, DOI 10.2174/1381612053381819; de la Torre PM, 2003, BIOMATERIALS, V24, P1459, DOI 10.1016/S0142-9612(02)00541-0; Edgren DE, 2004, US Patent, Patent No. [6,797,283, 6797283]; Flashner-Barak M, 2005, US Patent, Patent No. [6,881,420, 6881420]; Gusler G., 2004, U.S. Patent, Patent No. 6723340; Iannuccelli V, 1998, INT J PHARM, V174, P47, DOI 10.1016/S0378-5173(98)00229-4; ICHIKAWA M, 1991, J PHARM SCI, V80, P1062, DOI 10.1002/jps.2600801113; Jimenez-Martinez I, 2008, INT J PHARMACEUT, V362, P37, DOI 10.1016/j.ijpharm.2008.05.040; JIMENEZCASTELLANOS MR, 1994, INT J PHARM, V105, P65, DOI 10.1016/0378-5173(94)90236-4; Klausner EA, 2002, PHARMACEUT RES, V19, P1516, DOI 10.1023/A:1020412817716; Nur AO, 2000, DRUG DEV IND PHARM, V26, P965, DOI 10.1081/DDC-100101323; Preda M, 2003, J MICROENCAPSUL, V20, P777, DOI 10.1080/02652040310001599742; SHELL JW, 2003, Patent No. 6635280; Sheth PR, 1979, US patent application US Patent, Patent No. 4167558; Streubel A, 2002, INT J PHARMACEUT, V241, P279, DOI 10.1016/S0378-5173(02)00241-7; Streubel Alexander, 2006, Expert Opin Drug Deliv, V3, P217, DOI 10.1517/17425247.3.2.217; Streubel A, 2006, CURR OPIN PHARMACOL, V6, P501, DOI 10.1016/j.coph.2006.04.007; Strubing S, 2008, EUR J PHARM BIOPHARM, V69, P708, DOI 10.1016/j.ejpb.2007.12.009; Strubing S, 2008, J CONTROL RELEASE, V126, P149, DOI 10.1016/j.jconrel.2007.11.013; Sujja-areevath J, 1998, EUR J PHARM SCI, V6, P207, DOI 10.1016/S0928-0987(97)00072-9; Torrado S, 2004, BIOMATERIALS, V25, P917, DOI 10.1016/S0142-9612(03)00579-9; Varshosaz J, 2006, DRUG DELIV, V13, P277, DOI 10.1080/10717540500395106; Zuleger S, 2001, INT J PHARMACEUT, V217, P139, DOI 10.1016/S0378-5173(01)00596-8; [No title captured], Patent No. 4126672	38	33	35	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116914	10.1371/journal.pone.0116914	http://dx.doi.org/10.1371/journal.pone.0116914			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617891	Green Published, Green Submitted, gold			2022-12-26	WOS:000350336000030
J	Tinholt, M; Stavik, B; Louch, W; Carlson, CR; Sletten, M; Ruf, W; Skretting, G; Sandset, PM; Iversen, N				Tinholt, Mari; Stavik, Benedicte; Louch, William; Carlson, Cathrine Rein; Sletten, Marit; Ruf, Wolfram; Skretting, Grethe; Sandset, Per Morten; Iversen, Nina			Syndecan-3 and TFPI Colocalize on the Surface of Endothelial-, Smooth Muscle-, and Cancer Cells	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR; HEPARAN-SULFATE PROTEOGLYCANS; TISSUE FACTOR; GROWTH-FACTOR; IN-VITRO; BINDING; EXPRESSION; TERMINUS; PROTEIN; ALPHA	Background Tissue factor (TF) pathway inhibitor (TFPI) exists in two isoforms; TFPI alpha and TFPI beta. Both isoforms are cell surface attached mainly through glycosylphosphatidylinositol (GPI) anchors. TFPI alpha has also been proposed to bind other surface molecules, like glycosaminoglycans (GAGs). Cell surface TFPI beta has been shown to exert higher anticoagulant activity than TFPI alpha, suggesting alternative functions for TFPI alpha. Further characterization and search for novel TFPI binding partners is crucial to completely understand the biological functions of cell associated TFPI. Methods and Results Potential association of TFPI to heparan sulphate (HS) proteoglycans in the syndecan family were evaluated by knock down studies and flow cytometry analysis. Cell surface colocallzation was assessed by confocal microscopy, and native PAGE or immunoprecipitation followed by Western blotting was used to test for protein interaction. Heparanase was used to enzymatically degrade cell surface HS GAGs. Anticoagulant potential was evaluated using a factor Xa (FXa) activity assay. Knock down of syndecan-3 in endothelial,- smooth muscle- and breast cancer cells reduced the TFPI surface levels by 20-50%, and an association of TFPI alpha to syndecan-3 on the cell surface was demonstrated. Western blotting indicated that TFPI alpha was found in complex with syndecan-3. The TFPI bound to syndecan-3 did not inhibit the FXa generation. Removal of HS GAGs did not release TFPI antigen from the cells. Conclusions We demonstrated an association between TFPI alpha and syndecan-3 in vascular cells and in cancer cells, which did not appear to depend on HS GAGs. No anticoagulant activity was detected for the TFPI associated with syndecan-3, which may indicate coagulation independent functions for this cell associated TFPI pool. This will, however, require further investigation.	[Tinholt, Mari; Sletten, Marit; Iversen, Nina] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Tinholt, Mari; Sletten, Marit; Iversen, Nina] Univ Oslo, Oslo, Norway; [Tinholt, Mari; Stavik, Benedicte; Skretting, Grethe; Sandset, Per Morten] Oslo Univ Hosp, Dept Haematol, Oslo, Norway; [Tinholt, Mari; Stavik, Benedicte; Skretting, Grethe; Sandset, Per Morten] Oslo Univ Hosp, Internal Med Res Inst, Oslo, Norway; [Tinholt, Mari; Sandset, Per Morten] Univ Oslo, Inst Clin Med, Oslo, Norway; [Louch, William; Carlson, Cathrine Rein] Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway; [Ruf, Wolfram] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Scripps Research Institute	Iversen, N (corresponding author), Oslo Univ Hosp, Dept Med Genet, Oslo, Norway.	nina.iversen@medisin.uio.no	Stavik, Benedicte/U-3406-2017; Sandset, Per Morten/J-8141-2019	Stavik, Benedicte/0000-0003-3341-9847; Sandset, Per Morten/0000-0001-5556-8099	South-Eastern Norway Regional Health Authority, Hamar, Norway; A. Jahre foundation; H. G. Andrine Berg son foundation	South-Eastern Norway Regional Health Authority, Hamar, Norway; A. Jahre foundation; H. G. Andrine Berg son foundation	This work was funded by research grants from the South-Eastern Norway Regional Health Authority, Hamar, Norway and A. Jahre and H. G. Andrine Berg & son foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Blackhall FH, 2001, BRIT J CANCER, V85, P1094, DOI 10.1054/bjoc.2001.2054; Caplice NM, 1998, CIRC RES, V83, P1264, DOI 10.1161/01.RES.83.12.1264; Chang JY, 1999, THROMB HAEMOSTASIS, V81, P45; CHERNOUSOV MA, 1993, J BIOL CHEM, V268, P16810; Dealy CN, 1997, DEV BIOL, V184, P343, DOI 10.1006/dbio.1997.8525; Dreyfuss JL, 2009, AN ACAD BRAS CIENC, V81, P409, DOI 10.1590/S0001-37652009000300007; Hansen JB, 2000, THROMB HAEMOSTASIS, V83, P937; Hienola A, 2006, J CELL BIOL, V174, P569, DOI 10.1083/jcb.200602043; Ho GY, 1997, J BIOL CHEM, V272, P16838, DOI 10.1074/jbc.272.27.16838; Iverson N, 1996, THROMB RES, V84, P267, DOI 10.1016/S0049-3848(96)00186-7; Kojima T, 1996, J BIOL CHEM, V271, P5914, DOI 10.1074/jbc.271.10.5914; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lupu C, 1997, ARTERIOSCL THROM VAS, V17, P2964, DOI 10.1161/01.ATV.17.11.2964; Lupu C, 1999, ARTERIOSCL THROM VAS, V19, P2251, DOI 10.1161/01.ATV.19.9.2251; Maroney SA, 2013, J THROMB HAEMOST, V11, P911, DOI 10.1111/jth.12188; Maroney SA, 2006, J THROMB HAEMOST, V4, P1114, DOI 10.1111/j.1538-7836.2006.01873.x; Mast AE, 2002, ARTERIOSCL THROM VAS, V22, P2099, DOI 10.1161/01.ATV.0000042456.84190.F0; Mast AE, 1997, BIOCHEM J, V327, P577; Nadir Y, 2008, THROMB HAEMOSTASIS, V99, P133, DOI 10.1055/s-0037-1608919; NOVOTNY WF, 1988, BLOOD, V72, P2020; Ott I, 2001, BLOOD, V97, P3721, DOI 10.1182/blood.V97.12.3721; Piro O, 2005, J THROMB HAEMOST, V3, P2677, DOI 10.1111/j.1538-7836.2005.01636.x; Piro O, 2004, CIRCULATION, V110, P3567, DOI 10.1161/01.CIR.0000148778.76917.89; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; Sharifpoor S, 2011, BIOMATERIALS, V32, P4816, DOI 10.1016/j.biomaterials.2011.03.034; Stavik B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-357; Stavik B, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-5; Tiemann C, 1997, EUR J CLIN CHEM CLIN, V35, P855; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; VALENTIN S, 1993, BLOOD COAGUL FIBRIN, V4, P713, DOI 10.1097/00001721-199304050-00007; VALENTIN S, 1994, THROMB RES, V75, P173, DOI 10.1016/0049-3848(94)90066-3; WARSHAWSKY I, 1995, J CLIN INVEST, V95, P1773, DOI 10.1172/JCI117855; WUN TC, 1988, J BIOL CHEM, V263, P6001; Zhang J, 2003, CIRCULATION, V108, P623, DOI 10.1161/01.CIR.0000078642.45127.7B	35	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117404	10.1371/journal.pone.0117404	http://dx.doi.org/10.1371/journal.pone.0117404			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617766	Green Published, Green Submitted, gold			2022-12-26	WOS:000350336000044
J	Beutel, ME; Fischbeck, S; Binder, H; Blettner, M; Brahler, E; Emrich, K; Friedrich-Mai, P; Imruck, BH; Weyer, V; Zeissig, SR				Beutel, Manfred E.; Fischbeck, Sabine; Binder, Harald; Blettner, Maria; Braehler, Elmar; Emrich, Katharina; Friedrich-Mai, Peter; Imruck, Barbara H.; Weyer, Veronika; Zeissig, Sylke R.			Depression, Anxiety and Quality of Life in Long-Term Survivors of Malignant Melanoma: A Register-Based Cohort Study	PLOS ONE			English	Article							PSYCHOLOGICAL ADJUSTMENT; FOLLOW-UP; CANCER; STANDARDIZATION; ASSOCIATION; QLQ-C30	Aim The purpose of the study was to determine anxiety and depression, quality of life, and their determinants in long-term survivors of malignant melanoma. Methods In a state cancer registry a cohort of survivors of malignant melanoma was contacted via the physician registered. Of 1302 contactable patients, 689 (52.2%) completed a questionnaire including the Patient Health Questionnaire with generalized anxiety (GAD-7) and depression (PHQ-9) and the EORTC Quality of Life Questionnaire (EORTC QLQ 30). Based on multiple regression analysis, predictors of quality of life and distress were identified. Comparison data were assessed in two waves of representative face-to-face household surveys of the adult German population. Results An average of 8.4 (5.7 to 12.2) years after diagnosis, distress was higher in women compared to men and in middle adulthood (vs. older patients). Symptoms were higher in women than in men, and there was a decline of functioning and increase of symptoms across the age range of both genders. Compared to the general population, there were slightly increased depression and anxiety (only women), but no impaired global quality of life. Yet, survivors evidenced functional decline and more physical symptoms. Distress and reduced quality of life were consistently predicted by lack of social support, fear of recurrence, pessimism and self-blame. Distress was increased by a family history of melanoma, and additional mental and somatic diseases. Conclusion Overall, long-term survivors have adjusted well achieving a global quality of life comparable to the general population. Yet, compromised functional dimensions, physical symptoms and distress indicate the need for integrating psychooncological screening into oncological follow-up, which might be guided by predictors such as family history or social support. Further prospective study is needed to determine the course of adaptation to the disease and corroborate the risk factors identified.	[Beutel, Manfred E.; Braehler, Elmar; Friedrich-Mai, Peter; Imruck, Barbara H.] Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Germany; [Binder, Harald; Blettner, Maria; Emrich, Katharina; Weyer, Veronika; Zeissig, Sylke R.] Univ Med Ctr Mainz, Inst Med Biostat Epidemiol & Informat, Mainz, Germany; [Fischbeck, Sabine] Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Beutel, ME (corresponding author), Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Germany.	Manfred.Beutel@unimedizin-mainz.de	Binder, Harald/C-7413-2009; Weyer-Elberich, Veronika/AAB-8993-2020; Braehler, Elmar/C-6535-2009	Binder, Harald/0000-0002-5666-8662; Braehler, Elmar/0000-0002-2648-2728	German Cancer Aid [109225]	German Cancer Aid(Deutsche Krebshilfe)	This work was supported by German Cancer Aid (grant number 109225). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Albrecht K, 2013, PSYCHO-ONCOLOGY, V22, P1972, DOI 10.1002/pon.3238; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Eakin EG, 2006, CANCER EPIDEM BIOMAR, V15, P1969, DOI 10.1158/1055-9965.EPI-06-0122; Francken AB, 2005, LANCET ONCOL, V6, P608, DOI 10.1016/S1470-2045(05)70283-7; Hamama-Raz Y, 2007, PSYCHO-ONCOLOGY, V16, P287, DOI 10.1002/pon.1055; Hamama-Raz Y, 2012, PSYCHO-ONCOLOGY, V21, P255, DOI 10.1002/pon.1889; Hinz A, 2014, ACTA ONCOL, V53, P958, DOI 10.3109/0284186X.2013.879998; Holterhues C, 2011, ARCH DERMATOL, V147, P177, DOI 10.1001/archdermatol.2010.433; Kasparian NA, 2013, CLIN DERMATOL, V31, P41, DOI 10.1016/j.clindermatol.2011.11.005; Kocalevent RD, 2013, GEN HOSP PSYCHIAT, V35, P551, DOI 10.1016/j.genhosppsych.2013.04.006; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Loquai C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066800; Lowe B, 2004, PSYCHOTHER PSYCHOSOM, V73, P386, DOI 10.1159/000080393; McLoone J, 2012, QUAL HEALTH RES, V22, P1102, DOI 10.1177/1049732312448542; Mehnert A, 2008, J PSYCHOSOM RES, V64, P383, DOI 10.1016/j.jpsychores.2007.12.005; Pflugfelder A, 2013, J DTSCH DERMATOL GES, V11, P1, DOI 10.1111/ddg.12113_suppl; Ramm GC, 2003, Z MED PSYCHOL, V12, P29; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Stava C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-95; Strittmatter G, 1998, PSYCHOTHER PSYCH MED, V48, P349; Thong MSY, 2013, CANCER-AM CANCER SOC, V119, P2109, DOI 10.1002/cncr.28056; Trotter Shannon C, 2013, J Clin Aesthet Dermatol, V6, P18	24	51	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116440	10.1371/journal.pone.0116440	http://dx.doi.org/10.1371/journal.pone.0116440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UF	25615573	gold, Green Published, Green Submitted			2022-12-26	WOS:000349122100027
J	Madhuprakash, J; El Gueddari, NE; Moerschbacher, BM; Podile, AR				Madhuprakash, Jogi; El Gueddari, Nour Eddine; Moerschbacher, Bruno M.; Podile, Appa Rao			Catalytic Efficiency of Chitinase-D on Insoluble Chitinous Substrates Was Improved by Fusing Auxiliary Domains	PLOS ONE			English	Article							SERRATIA-PROTEAMACULANS 568; BINDING DOMAIN; AROMATIC RESIDUES; DEGRADATION; MARCESCENS; CHITOOLIGOSACCHARIDES; TRANSGLYCOSYLATION; EXPRESSION; CELLULASE; SYNERGISM	Chitin is an abundant renewable polysaccharide, next only to cellulose. Chitinases are important for effective utilization of this biopolymer. Chitinase D from Serratia proteamaculans (SpChiD) is a single domain chitinase with both hydrolytic and transglycosylation (TG) activities. SpChiD had less of hydrolytic activity on insoluble polymeric chitin substrates due to the absence of auxiliary binding domains. We improved catalytic efficiency of SpChiD in degradation of insoluble chitin substrates by fusing with auxiliary domains like polycystic kidney disease (PKD) domain and chitin binding protein 21 (CBP21). Of the six different SpChiD fusion chimeras, two C-terminal fusions viz. ChiD+ PKD and ChiD+CBP resulted in improved hydrolytic activity on alpha-and beta-chitin, respectively. Time-course degradation of colloidal chitin also confirmed that these two C-terminal SpChiD fusion chimeras were more active than other chimeras. More TG products were produced for a longer duration by the fusion chimeras ChiD+ PKD and PKD+ChiD+CBP.	[Madhuprakash, Jogi; Podile, Appa Rao] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India; [El Gueddari, Nour Eddine; Moerschbacher, Bruno M.] Westphalian Wilhelms Univ Munster, Dept Plant Biol & Biotechnol, Munster, Germany	University of Hyderabad; University of Munster	Podile, AR (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India.	arpsl@uohyd.ernet.in	Moerschbacher, Bruno M/C-2012-2017; Jogi, Madhuprakash/AAU-9958-2021; Podile, Appa Rao/W-5077-2018	Podile, Appa Rao/0000-0003-3208-765X	Department of Biotechnology (DBT), Government of India [BT/PR5800/PID/6/681/2012]; Council of Scientific and Industrial Research (CSIR), Govt. of India; Deutsche Forschungsgemeinschaft (DFG) (Germany); UGC (India)	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); Deutsche Forschungsgemeinschaft (DFG) (Germany)(German Research Foundation (DFG)); UGC (India)(University Grants Commission, India)	This work was carried out under Deutsche Forschungsgemeinschaft (DFG) (Germany) and UGC (India)-supported International Research and Training Group on "Molecular and Cellular Glycosciences" between University of Munster and University of Hyderabad. The authors also thank Department of Biotechnology (DBT), Government of India for the research grant No: BT/PR5800/PID/6/681/2012 to ARP. JM thanks Council of Scientific and Industrial Research (CSIR), Govt. of India for Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aam BB, 2010, MAR DRUGS, V8, P1482, DOI 10.3390/md8051482; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Das SN, 2015, CRIT REV BIOTECHNOL, V35, P29, DOI 10.3109/07388551.2013.798255; DIN N, 1994, P NATL ACAD SCI USA, V91, P11383, DOI 10.1073/pnas.91.24.11383; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; GARDNER KH, 1975, BIOPOLYMERS, V14, P1581, DOI 10.1002/bip.1975.360140804; Hashimoto M, 2000, J BACTERIOL, V182, P3045, DOI 10.1128/JB.182.11.3045-3054.2000; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Madhuprakash J, 2012, J BIOL CHEM, V287, P44619, DOI 10.1074/jbc.M112.400879; MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3; Neeraja C, 2010, BIORESOURCE TECHNOL, V101, P3635, DOI 10.1016/j.biortech.2009.12.118; Orikoshi H, 2005, J APPL MICROBIOL, V99, P551, DOI 10.1111/j.1365-2672.2005.02630.x; Purushotham P, 2012, J BACTERIOL, V194, P4260, DOI 10.1128/JB.06473-11; Purushotham P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036714; Purushotham P, 2012, BIORESOURCE TECHNOL, V112, P261, DOI 10.1016/j.biortech.2012.02.062; Songsiriritthigul C, 2010, BIORESOURCE TECHNOL, V101, P4096, DOI 10.1016/j.biortech.2010.01.036; Suma K, 2013, BIORESOURCE TECHNOL, V133, P213, DOI 10.1016/j.biortech.2013.01.103; Suzuki K, 2002, BIOSCI BIOTECH BIOCH, V66, P1075, DOI 10.1271/bbb.66.1075; Tang CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064766; Thongekkaew J, 2013, ENZYME MICROB TECH, V52, P241, DOI 10.1016/j.enzmictec.2013.02.002; UCHIDA Y, 1989, CHITIN CHITOSAN SOUR, P373; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; Uni F, 2012, BIOSCI BIOTECH BIOCH, V76, P530, DOI 10.1271/bbb.110835; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Villa-Lerma G, 2013, BIORESOURCE TECHNOL, V146, P794, DOI 10.1016/j.biortech.2013.08.003; Zakariassen H, 2011, BIOCHEMISTRY-US, V50, P5693, DOI 10.1021/bi2002532; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200	30	19	22	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116823	10.1371/journal.pone.0116823	http://dx.doi.org/10.1371/journal.pone.0116823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615694	Green Submitted, Green Published, gold			2022-12-26	WOS:000349122100044
J	Waye, KP; Magnusson, L; Fredriksson, S; Croy, I				Waye, Kerstin Persson; Magnusson, Lennart; Fredriksson, Sofie; Croy, Ilona			A Screening Approach for Classroom Acoustics Using Web-Based Listening Tests and Subjective Ratings	PLOS ONE			English	Article							SPEECH-INTELLIGIBILITY; NOISE; PERFORMANCE; PERCEPTION; RECALL	Background Perception of speech is crucial in school where speech is the main mode of communication. The aim of the study was to evaluate whether a web based approach including listening tests and questionnaires could be used as a screening tool for poor classroom acoustics. The prime focus was the relation between pupils' comprehension of speech, the classroom acoustics and their description of the acoustic qualities of the classroom. Methodology/Principal Findings In total, 1106 pupils aged 13-19, from 59 classes and 38 schools in Sweden participated in a listening study using Hagerman's sentences administered via Internet. Four listening conditions were applied: high and low background noise level and positions close and far away from the loudspeaker. The pupils described the acoustic quality of the classroom and teachers provided information on the physical features of the classroom using questionnaires. Conclusions/Significance In 69% of the classes, at least three pupils described the sound environment as adverse and in 88% of the classes one or more pupil reported often having difficulties concentrating due to noise. The pupils' comprehension of speech was strongly influenced by the background noise level (p<0.001) and distance to the loudspeakers (p<0.001). Of the physical classroom features, presence of suspended acoustic panels (p<0.05) and length of the classroom (p<0.01) predicted speech comprehension. Of the pupils' descriptions of acoustic qualities, clattery significantly (p<0.05) predicted speech comprehension. Clattery was furthermore associated to difficulties understanding each other, while the description noisy was associated to concentration difficulties. The majority of classrooms do not seem to have an optimal sound environment. The pupil's descriptions of acoustic qualities and listening tests can be one way of predicting sound conditions in the classroom.	[Waye, Kerstin Persson; Fredriksson, Sofie; Croy, Ilona] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Magnusson, Lennart] Univ Gothenburg, Sect Audiol, Dept Clin Neurosci & Rehabil, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Waye, KP (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden.	kerstin.persson.waye@amm.gu.se	Persson Waye, Kerstin/J-7136-2012	Persson Waye, Kerstin/0000-0003-3789-4557; Fredriksson, Sofie/0000-0003-0698-527X; Croy, Ilona/0000-0002-0361-5559	Regional Hospital fundings	Regional Hospital fundings	Support was provided by Regional Hospital fundings; KPW received the funding (www.vgregion.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg F. S., 1993, ACOUSTICS SOUND SYST; Berg FS, 1996, LANG SPEECH HEAR SER, V27, P16, DOI 10.1044/0161-1461.2701.16; Bradley JS, 2011, APPL ACOUST, V72, P713, DOI 10.1016/j.apacoust.2011.04.004; Clark C, 2012, NOISE HEALTH, V14, P292, DOI 10.4103/1463-1741.104896; COX RM, 1991, J SPEECH HEAR RES, V34, P904, DOI 10.1044/jshr.3404.904; DAVIS R, 1989, SOUND REINFORCEMENT; EVEREST A, 1989, MASTER HDB ACOUSTICS; Fallon M, 2000, J ACOUST SOC AM, V108, P3023, DOI 10.1121/1.1323233; Finitzo T., 1988, AUDITORY DISORDERS S, V2, P221; FINITZOHIEBER T, 1978, J SPEECH HEAR RES, V21, P440, DOI 10.1044/jshr.2103.440; Hagerman B, 2002, INT J AUDIOL, V41, P321, DOI 10.3109/14992020209090406; HAGERMAN B, 1982, SCAND AUDIOL, V11, P79, DOI 10.3109/01050398209076203; Haines M M, 2003, Noise Health, V5, P19; Kjellberg A, 2008, APPL COGNITIVE PSYCH, V22, P1088, DOI 10.1002/acp.1422; Klatte M, 2010, ENVIRON BEHAV, V42, P659, DOI 10.1177/0013916509336813; KUTTRUFF H, 2002, ROOM ACOUSTICS; LANDSTROM U, 1999, ARBETE HALSA, V27; Ljung R, 2009, BUILD ACOUST, V16, P301, DOI 10.1260/135101009790291273; Ljung R, 2009, BUILD ACOUST, V16, P257, DOI 10.1260/135101009789877031; Lundquist Par, 2000, Noise Health, V2, P39; MARSHALL LG, 1995, J ACOUST SOC AM, V98, P2845, DOI 10.1121/1.413184; PEKKARINEN E, 1991, SCAND AUDIOL, V20, P257, DOI 10.3109/01050399109045973; Picard M, 2001, AUDIOLOGY, V40, P221; POPLAVSKA O. M., 2006, ERGONOMICS TXB; SALA E, 2013, ACTIVITY NOISE COMPR; Shield B. M., 2003, Building Acoustics, V10, P97, DOI 10.1260/135101003768965960; Shield BM, 2008, J ACOUST SOC AM, V123, P133, DOI 10.1121/1.2812596; STEENEKEN HJM, 1980, J ACOUST SOC AM, V67, P318, DOI 10.1121/1.384464; Talarico M, 2007, AUDIOL NEURO-OTOL, V12, P13, DOI 10.1159/000096153; Waye KP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002408; Werner LA, 2012, SPRINGER HANDB AUDIT, V42, P1, DOI 10.1007/978-1-4614-1421-6_1	31	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116572	10.1371/journal.pone.0116572	http://dx.doi.org/10.1371/journal.pone.0116572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UF	25615692	Green Published, gold, Green Submitted			2022-12-26	WOS:000349122100033
J	Sun, LL; Nguyen, AT; Spitsbergen, JM; Gong, ZY				Sun, Lili; Anh Tuan Nguyen; Spitsbergen, Jan M.; Gong, Zhiyuan			Myc-Induced Liver Tumors in Transgenic Zebrafish Can Regress in tp53 Null Mutation	PLOS ONE			English	Article							DIFFERENT DEVELOPMENTAL-STAGES; C-MYC; HEPATOCELLULAR-CARCINOMA; GENOME DUPLICATION; EXPOSURE ROUTES; GENE-EXPRESSION; CANCER; TUMORIGENESIS; NEOPLASIA; MODELS	Hepatocellular carcinoma (HCC) is currently one of the top lethal cancers with an increasing trend. Deregulation of MYC in HCC is frequently detected and always correlated with poor prognosis. As the zebrafish genome contains two differentially expressed zebrafish myc orthologs, myca and mycb, it remains unclear about the oncogenicity of the two zebrafish myc genes. In the present study, we developed two transgenic zebrafish lines to over-express myca and mycb respectively in the liver using a mifepristone-inducible system and found that both myc genes were oncogenic. Moreover, the transgenic expression of myca in hepatocytes caused robust liver tumors with several distinct phenotypes of variable severity. similar to 5% of myca transgenic fish developing multinodular HCC with cirrhosis after 8 months of induced myca expression. Apoptosis was also observed with myca expression; introduction of homozygous tp53(-/) -mutation into the myca transgenic fish reduced apoptosis and accelerated tumor progression. The malignant status of hepatocytes was dependent on continued expression of myca; withdrawal of the mifepristone inducer resulted in a rapid regression of liver tumors, and the tumor regression occurred even in the tp53(-/-) mutation background. Thus, our data demonstrated the robust oncogenicity of zebrafish myca and the requirement of sustained Myc overexpression for maintenance of the liver tumor phenotype in this transgenic model. Furthermore, tumor regression is independent of the function of Tp53.	[Sun, Lili; Anh Tuan Nguyen; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Spitsbergen, Jan M.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Spitsbergen, Jan M.] Oregon State Univ, Marine & Freshwater Biomed Sci Ctr, Corvallis, OR 97331 USA	National University of Singapore; Oregon State University; Oregon State University	Gong, ZY (corresponding author), Inst Cell & Mol Biol, Singapore 138673, Singapore.	dbsgzy@nus.edu.sg	Gong, Zhiyuan/H-8794-2012; Sun, lili/GQH-2057-2022	Gong, Zhiyuan/0000-0002-9660-5260; 	National Medical Research Council of Singapore	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was supported by a grant from National Medical Research Council of Singapore. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nguyen AT, 2012, DIS MODEL MECH, V5, P63, DOI 10.1242/dmm.008367; Berghmans S, 2005, BIOTECHNIQUES, V39, P227, DOI 10.2144/05392RV02; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Beverly LJ, 2009, ONCOGENE, V28, P1274, DOI 10.1038/onc.2008.466; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Emelyanov A, 2008, DEV BIOL, V320, P113, DOI 10.1016/j.ydbio.2008.04.042; Emelyanov A, 2006, GENETICS, V174, P1095, DOI 10.1534/genetics.106.061184; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Giuriato S, 2006, P NATL ACAD SCI USA, V103, P16266, DOI 10.1073/pnas.0608017103; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Huang XQ, 2012, FUTURE ONCOL, V8, P21, DOI [10.2217/FON.11.137, 10.2217/fon.11.137]; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Li Z, 2013, DIS MODEL MECH, V6, P414, DOI 10.1242/dmm.010462; Li Z, 2012, J HEPATOL, V56, P419, DOI 10.1016/j.jhep.2011.07.025; Loosveld M, 2014, GENE CHROMOSOME CANC, V53, P52, DOI 10.1002/gcc.22117; Marandel L, 2012, MOL REPROD DEV, V79, P85, DOI 10.1002/mrd.22004; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Menescal LA, 2012, DIS MODEL MECH, V5, P492, DOI 10.1242/dmm.008730; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Ruggeri BA, 2014, BIOCHEM PHARMACOL, V87, P150, DOI 10.1016/j.bcp.2013.06.020; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Spitsbergen JM, 2012, ILAR J, V53, P114, DOI 10.1093/ilar.53.2.114; Spitsbergen JM, 2000, TOXICOL PATHOL, V28, P705, DOI 10.1177/019262330002800511; Spitsbergen JM, 2000, TOXICOL PATHOL, V28, P716, DOI 10.1177/019262330002800512; Takahashi Y, 2007, PATHOL INT, V57, P437, DOI 10.1111/j.1440-1827.2007.02120.x; Thompson EB, 1998, ANNU REV PHYSIOL, V60, P575, DOI 10.1146/annurev.physiol.60.1.575; Wang Y, 2002, CANCER-AM CANCER SOC, V95, P2346, DOI 10.1002/cncr.10963; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; White R, 2013, NAT REV CANCER, V13, P624, DOI 10.1038/nrc3589; Xue XY, 2012, DEV NEUROBIOL, V72, P475, DOI 10.1002/dneu.20887	35	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0117249	10.1371/journal.pone.0117249	http://dx.doi.org/10.1371/journal.pone.0117249			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25612309	gold, Green Published, Green Submitted			2022-12-26	WOS:000348562900035
J	Bogaerts, K; Rayen, L; Lavrysen, A; Van Diest, I; Janssens, T; Schruers, K; Van den Bergh, O				Bogaerts, Katleen; Rayen, Liselotte; Lavrysen, Ann; Van Diest, Ilse; Janssens, Thomas; Schruers, Koen; Van den Bergh, Omer			Unraveling the Relationship between Trait Negative Affectivity and Habitual Symptom Reporting	PLOS ONE			English	Article							MEDICALLY UNEXPLAINED SYMPTOMS; SUBJECTIVE HEALTH COMPLAINTS; HYPNOTIC RESPONSIVENESS; PSYCHOSOMATIC SYMPTOMS; SOMATIC COMPLAINTS; ABSORPTION; FIBROMYALGIA; HYPNOTIZABILITY; SUSCEPTIBILITY; SOMATIZATION	Objective In two studies, we aimed at further elucidating the relationship between trait negative affectivity (NA) and habitual symptom reporting (HSR) by relating these variables to measures of executive function, trait questionnaires, and effects of emotion induction. Methods Healthy female participants (N = 75) were selected on their scores for trait NA and for the Checklist for Symptoms in Daily Life. Three groups were compared: (1) low NA-low HSR; (2) high NA-low HSR; and (3) high NA-high HSR (low NA-high HSR did not occur). In study 1, participants underwent a Parametric Go/No-go Task and a Stroop Color-Word test, and trait questionnaires measured alexithymia and absorption. Forty-five participants (N = 15 in each group) were further engaged in study 2 to induce state NA using an affective picture paradigm. Results Impaired inhibition on the Stroop and Go/No go Task characterized high trait NA, but not high HSR, whereas alexithymia and absorption were elevated in HSR, regardless of trait NA. Negative picture viewing induced elevated state NA in all groups, but only high HSR also reported more bodily symptoms. This effect was moderated, but not mediated by state NA. Conclusion High trait NA is a vulnerability factor but not a sufficient condition to develop HSR. Deficient inhibition is related to the broad trait of NA, whereas the moderating effect of state NA on symptom reporting is specific for high HSR. Understanding processes related to alexithymia and absorption may specifically help to explain elevated HSR.	[Bogaerts, Katleen; Rayen, Liselotte; Van Diest, Ilse; Janssens, Thomas; Van den Bergh, Omer] Univ Leuven, Leuven, Belgium; [Lavrysen, Ann] Univ Leuven, Movement Control & Neuroplast Res Grp, Leuven, Belgium; [Schruers, Koen] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands	KU Leuven; KU Leuven; Maastricht University	Van den Bergh, O (corresponding author), Univ Leuven, Leuven, Belgium.	omer.vandenbergh@ppw.kuleuven.be	Janssens, Thomas/D-2077-2011; Schruers, Koen/AAV-2922-2021	Janssens, Thomas/0000-0003-3140-9952; Schruers, Koen/0000-0003-0134-406X; Van den Bergh, Omer/0000-0001-6394-7363; Lavrysen, Ann/0000-0002-6852-2230; Bogaerts, Katleen/0000-0002-0247-0941; Van Diest, Ilse/0000-0002-0048-774X	Research Council of the University of Leuven	Research Council of the University of Leuven(KU Leuven)	The authors (OVDB, KD, and IVD) received funding from the Research Council of the University of Leuven (http://www.kuleuven.be/wieiswie/en/unit/50000079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachner-Melman R, 2005, PLOS GENET, V1, P394, DOI 10.1371/journal.pgen.0010042; Barsky AJ, 1998, PSYCHOSOM MED, V60, P604, DOI 10.1097/00006842-199809000-00016; Bogaerts K, 2005, J PSYCHOSOM RES, V58, P537, DOI 10.1016/j.jpsychores.2004.12.005; Bogaerts K, 2008, J PSYCHOSOM RES, V65, P417, DOI 10.1016/j.jpsychores.2008.03.019; Bogaerts K, 2010, PSYCHOL HEALTH, V25, P685, DOI 10.1080/08870440902814639; Bogaerts K, 2010, J ABNORM PSYCHOL, V119, P226, DOI 10.1037/a0017780; Brown R. J., 2004, HIGHLY HYPNOTIZABLE, P152; Brown RJ, 2004, PSYCHOL BULL, V130, P793, DOI 10.1037/0033-2909.130.5.793; Cohen S, 2003, PSYCHOSOM MED, V65, P652, DOI 10.1097/01.PSY.0000077508.57784.DA; COMBS AL, 1988, PERCEPT MOTOR SKILL, V67, P453, DOI 10.2466/pms.1988.67.2.453; Constantinou E, 2013, J PSYCHOSOM RES, V74, P191, DOI 10.1016/j.jpsychores.2012.12.015; Correa A, 2011, BRAIN COGNITION, V75, P211, DOI 10.1016/j.bandc.2010.11.005; COSTA PT, 1987, J PERS, V55, P299, DOI 10.1111/j.1467-6494.1987.tb00438.x; CRAWFORD HJ, 1982, J PERS SOC PSYCHOL, V42, P915, DOI 10.1037/0022-3514.42.5.915; De Gucht V, 2003, J PSYCHOSOM RES, V54, P425, DOI 10.1016/S0022-3999(02)00467-1; Everitt B. S., 2006, HDB STAT ANAL USING; Glass JM, 2011, J PAIN, V12, P1219, DOI 10.1016/j.jpain.2011.06.007; GLISKY ML, 1991, J PERS SOC PSYCHOL, V60, P263, DOI 10.1037/0022-3514.60.2.263; Green JP, 2011, INT J CLIN EXP HYP, V59, P103, DOI 10.1080/00207144.2011.522914; Han JN, 2000, J PSYCHOSOM RES, V49, P319, DOI 10.1016/S0022-3999(00)00165-3; HERMANS D, 2005, AFFECT VERSION 4 0 C; HILGARD ER, 1981, INT J CLIN EXP HYP, V29, P66, DOI 10.1080/00207148108409144; Ihlebaek C, 2002, SCAND J PUBLIC HEALT, V30, P20, DOI 10.1080/140349401753481547; Ito LM, 2001, BRIT J PSYCHIAT, V178, P331, DOI 10.1192/bjp.178.4.331; Kirmayer L. J., 1997, ADULT PSYCHOPATHOLOG, P333; Krull JL, 2001, MULTIVAR BEHAV RES, V36, P249, DOI 10.1207/S15327906MBR3602_06; Lang P. J., 1999, INT AFFECTIVE PICTUR; Langenecker SA, 2007, J CLIN EXP NEUROPSYC, V29, P842, DOI 10.1080/13803390601147611; Leavitt F, 2008, JCR-J CLIN RHEUMATOL, V14, P214, DOI 10.1097/RHU.0b013e31817a2472; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Mayer EA, 2006, GASTROENTEROLOGY, V131, P1925, DOI 10.1053/j.gastro.2006.10.026; Mikels JA, 2005, BEHAV RES METHODS, V37, P626, DOI 10.3758/BF03192732; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Montoya P, 2005, PSYCHOSOM MED, V67, P957, DOI 10.1097/01.psy.0000188401.55394.18; Mora PA, 2007, ANN BEHAV MED, V34, P77, DOI 10.1007/BF02879923; Nemiah JC, 1976, MODERN TRENDS PSYCHO, V3; Nimnuan C, 2001, J PSYCHOSOM RES, V51, P361, DOI 10.1016/S0022-3999(01)00223-9; Reid S, 2001, BRIT MED J, V322, P767, DOI 10.1136/bmj.322.7289.767; RHODES LA, 1988, PERCEPT MOTOR SKILL, V66, P737, DOI 10.2466/pms.1988.66.3.737; Rief W, 2007, CLIN PSYCHOL REV, V27, P821, DOI 10.1016/j.cpr.2007.07.005; SHIPKO S, 1982, PSYCHOTHER PSYCHOSOM, V37, P193, DOI 10.1159/000287573; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Taylor G.J., 1997, DISORDERS AFFECT REG; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; Tellegen A., 1982, CONTENT CATEGO UNPUB; Van den Bergh O, 2002, SCAND J PSYCHOL, V43, P147, DOI 10.1111/1467-9450.00280; Van den Bergh O, 1998, HEALTH PSYCHOL, V17, P241, DOI 10.1037/0278-6133.17.3.241; Van Den Bergh O., 2006, GEDRAG GEZONDHEID TI, V34, P89, DOI [10.1007/BF03087979, DOI 10.1007/BF03087979]; Van Diest I, 2005, SOC SCI MED, V61, P1835, DOI 10.1016/j.socscimed.2005.03.031; VandenBergh O, 1997, PSYCHOSOM MED, V59, P13, DOI 10.1097/00006842-199701000-00003; VASSEND O, 1989, SOC SCI MED, V28, P29, DOI 10.1016/0277-9536(89)90303-1; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465; Weissman-Fogel I, 2011, PAIN, V152, P384, DOI 10.1016/j.pain.2010.10.046; WIENTJES CJE, 1994, PSYCHOSOM MED, V56, P533, DOI 10.1097/00006842-199411000-00009; Witthoft M, 2008, J TOXICOL ENV HEAL A, V71, P795, DOI 10.1080/15287390801985687; WMA - Wold-Medical-Association. Declaration of Helsinki, 2008, ETH PRINC MED RES IN	58	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0115748	10.1371/journal.pone.0115748	http://dx.doi.org/10.1371/journal.pone.0115748			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4OZ	25603317	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000348203500016
J	Chen, YL; de Bernardis, F; Yu, SJ; Sandini, S; Kauffman, S; Tams, RN; Bethea, E; Reynolds, TB				Chen, Ying-Lien; de Bernardis, Flavia; Yu, Shang-Jie; Sandini, Silvia; Kauffman, Sarah; Tams, Robert N.; Bethea, Emily; Reynolds, Todd B.			Candida albicans OPI1 Regulates Filamentous Growth and Virulence in Vaginal Infections, but Not Inositol Biosynthesis	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; SECRETED ASPARTYL PROTEINASES; PHOSPHOLIPID BIOSYNTHESIS; TRANSCRIPTIONAL ACTIVATION; NEGATIVE REGULATOR; GENE FAMILY; EXPRESSION; SAP2; TRANSFORMATION; PATHOGENICITY	ScOpi1p is a well-characterized transcriptional repressor and master regulator of inositol and phospholipid biosynthetic genes in the baker's yeast Saccharomyces cerevisiae. An ortholog has been shown to perform a similar function in the pathogenic fungus Candida glabrata, but with the distinction that CgOpi1p is essential for growth in this organism. However, in the more distantly related yeast Yarrowia lipolytica, the OPI1 homolog was not found to regulate inositol biosynthesis, but alkane oxidation. In Candida albicans, the most common cause of human candidiasis, its Opi1p homolog, CaOpi1p, has been shown to complement a S. cerevisiae opi1. mutant for inositol biosynthesis regulation when heterologously expressed, suggesting it might serve a similar role in this pathogen. This was tested in the pathogen directly in this report by disrupting the OPI1 homolog and examining its phenotypes. It was discovered that the OPI1 homolog does not regulate INO1 expression in C. albicans, but it does control SAP2 expression in response to bovine serum albumin containing media. Meanwhile, we found that CaOpi1 represses filamentous growth at lower temperatures (30 degrees C) on agar, but not in liquid media. Although, the mutant does not affect virulence in a mouse model of systemic infection, it does affect virulence in a rat model of vaginitis. This may be because Opi1p regulates expression of the SAP2 protease, which is required for rat vaginal infections.	[Chen, Ying-Lien; Yu, Shang-Jie] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [de Bernardis, Flavia; Sandini, Silvia] Dept Infect Parasit & Immunomediated Dis, Rome, Italy; [Kauffman, Sarah; Tams, Robert N.; Bethea, Emily; Reynolds, Todd B.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA	National Taiwan University; University of Tennessee System; University of Tennessee Knoxville	Bethea, E (corresponding author), Brandon High Sch Hlth Sci, Brandon, MS 39042 USA.	ychen28@ntu.edu.tw; treynol6@utk.edu	DE BERNARDIS, FLAVIA/C-9589-2016; SANDINI, SILVIA/C-9593-2016; SANDINI, SILVIA/ABA-7711-2021	DE BERNARDIS, FLAVIA/0000-0001-9440-8629; SANDINI, SILVIA/0000-0002-1289-9098; SANDINI, SILVIA/0000-0002-1289-9098; Reynolds, Todd/0000-0002-2867-7182; Chen, Ying-Lien/0000-0002-1966-470X	NSC [102-2320-B-002-041-MY2]; AHA [0765366B, NIH-1R03AI071863, NIH-1 R01AL105690]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105690, R03AI071863] Funding Source: NIH RePORTER	NSC(Ministry of Science and Technology, Taiwan); AHA(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants NSC 102-2320-B-002-041-MY2 (YLC) and AHA 0765366B, NIH-1R03AI071863, NIH-1 R01AL105690 (TBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2006, J BIOL CHEM, V281, P688, DOI 10.1074/jbc.M509297200; Bethea EK, 2010, MICROBIOL-SGM, V156, P452, DOI 10.1099/mic.0.030072-0; Calderone R.A.C.C.J., 2012, CANDIDA CANDIDIASIS; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; Chen YC, 2002, MICROBIOL-SGM, V148, P3743, DOI 10.1099/00221287-148-11-3743; Chen YL, 2008, INFECT IMMUN, V76, P2793, DOI 10.1128/IAI.01514-07; Chen YL, 2010, MOL MICROBIOL, V75, P1112, DOI 10.1111/j.1365-2958.2009.07018.x; Csank C, 1997, MOL BIOL CELL, V8, P2539, DOI 10.1091/mbc.8.12.2539; Dabas N, 2008, MOL MICROBIOL, V69, P586, DOI 10.1111/j.1365-2958.2008.06297.x; De Backer MD, 1999, YEAST, V15, P1609, DOI 10.1002/(SICI)1097-0061(199911)15:15&lt;1609::AID-YEA485&gt;3.0.CO;2-Y; De Bernardis F, 1999, J INFECT DIS, V179, P201, DOI 10.1086/314546; De Bernardis F, 2001, MED MYCOL, V39, P303, DOI 10.1080/mmy.39.4.303.313; DEBERNARDIS F, 1995, INFECT IMMUN, V63, P1887, DOI 10.1128/IAI.63.5.1887-1892.1995; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; Felk A, 2002, INFECT IMMUN, V70, P3689, DOI 10.1128/IAI.70.7.3689-3700.2002; FISCHL AS, 1983, J BACTERIOL, V154, P304, DOI 10.1128/JB.154.1.304-311.1983; Guhad FA, 1998, APMIS, V106, P1049, DOI 10.1111/j.1699-0463.1998.tb00257.x; Heitman J, 2006, MOLECULAR PRINCIPLES OF FUNGAL PATHOGENESIS, P1; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Heyken WT, 2003, YEAST, V20, P1177, DOI 10.1002/yea.1031; Hirakawa K, 2009, J BIOL CHEM, V284, P7126, DOI 10.1074/jbc.M806864200; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hoppen J, 2007, MOL GENET GENOMICS, V278, P317, DOI 10.1007/s00438-007-0253-x; Hube B, 1997, INFECT IMMUN, V65, P3529, DOI 10.1128/IAI.65.9.3529-3538.1997; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; KLIG LS, 1988, CURR GENET, V13, P7, DOI 10.1007/BF00365749; Kohrer K., 1991, METHOD ENZYMOL, V194, P398, DOI DOI 10.1016/0076-6879(91)94030-G; Lermann U, 2008, MICROBIOL-SGM, V154, P3281, DOI 10.1099/mic.0.2008/022525-0; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Martchenko M, 2007, EUKARYOT CELL, V6, P291, DOI 10.1128/EC.00183-06; Martinez P, 2005, MOL CELL BIOL, V25, P9435, DOI 10.1128/MCB.25.21.9435-9446.2005; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Murray M, 2000, MOL MICROBIOL, V36, P651, DOI 10.1046/j.1365-2958.2000.01886.x; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Naglik JR, 2008, MICROBIOL-SGM, V154, P3266, DOI 10.1099/mic.0.2008/022293-0; Reynolds TB, 2006, EUKARYOT CELL, V5, P1266, DOI 10.1128/EC.00022-06; Schaller M, 2003, INFECT IMMUN, V71, P3227, DOI 10.1128/IAI.71.6.3227-3234.2003; Schroppel K, 2000, INFECT IMMUN, V68, P7159, DOI 10.1128/IAI.68.12.7159-7161.2000; Shen JQ, 2005, INFECT IMMUN, V73, P1239, DOI 10.1128/IAI.73.2.1239-1242.2005; SHEPHERD MG, 1985, INFECT IMMUN, V50, P541, DOI 10.1128/IAI.50.2.541-544.1985; Staib P, 2008, ANTIMICROB AGENTS CH, V52, P146, DOI 10.1128/AAC.01072-07; Styles C, 2002, METHOD ENZYMOL, V350, P42, DOI 10.1016/S0076-6879(02)50955-1; Uhl MA, 2001, MICROBIOL-SGM, V147, P1189, DOI 10.1099/00221287-147-5-1189; Wagner C, 1999, YEAST, V15, P843, DOI 10.1002/(SICI)1097-0061(199907)15:10A<843::AID-YEA424>3.0.CO;2-M; Wagner C, 2001, MOL MICROBIOL, V41, P155, DOI 10.1046/j.1365-2958.2001.02495.x; WHITE MJ, 1991, J BIOL CHEM, V266, P863	47	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116974	10.1371/journal.pone.0116974	http://dx.doi.org/10.1371/journal.pone.0116974			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602740	Green Submitted, gold, Green Published			2022-12-26	WOS:000348203500038
J	Tewawong, N; Suwannakarn, K; Prachayangprecha, S; Korkong, S; Vichiwattana, P; Vongpunsawad, S; Poovorawan, Y				Tewawong, Nipaporn; Suwannakarn, Kamol; Prachayangprecha, Slinporn; Korkong, Sumeth; Vichiwattana, Preeyaporn; Vongpunsawad, Sompong; Poovorawan, Yong			Molecular Epidemiology and Phylogenetic Analyses of Influenza B Virus in Thailand during 2010 to 2014	PLOS ONE			English	Article							COCIRCULATING LINEAGES; STRUCTURAL BASIS; HEMAGGLUTININ; EVOLUTION; REASSORTMENT; RESISTANCE; DELETION; GENES	Influenza B virus remains a major contributor to the seasonal influenza outbreak and its prevalence has increased worldwide. We investigated the epidemiology and analyzed the full genome sequences of influenza B virus strains in Thailand between 2010 and 2014. Samples from the upper respiratory tract were collected from patients diagnosed with influenza like-illness. All samples were screened for influenza A/B viruses by one-step multiplex real-time RT-PCR. The whole genome of 53 influenza B isolates were amplified, sequenced, and analyzed. From 14,418 respiratory samples collected during 2010 to 2014, a total of 3,050 tested positive for influenza virus. Approximately 3.27% (471/14,418) were influenza B virus samples. Fifty three isolates of influenza B virus were randomly chosen for detailed whole genome analysis. Phylogenetic analysis of the HA gene showed clusters in Victoria clades 1A, 1B, 3, 5 and Yamagata clades 2 and 3. Both B/Victoria and B/Yamagata lineages were found to co-circulate during this time. The NA sequences of all isolates belonged to lineage II and consisted of viruses from both HA Victoria and Yamagata lineages, reflecting possible reassortment of the HA and NA genes. No significant changes were seen in the NA protein. The phylogenetic trees generated through the analysis of the PB1 and PB2 genes closely resembled that of the HA gene, while trees generated from the analysis of the PA, NP, and M genes showed similar topology. The NS gene exhibited the pattern of genetic reassortment distinct from those of the PA, NP or M genes. Thus, antigenic drift and genetic reassortment among the influenza B virus strains were observed in the isolates examined. Our findings indicate that the co-circulation of two distinct lineages of influenza B viruses and the limitation of cross-protection of the current vaccine formulation provide support for quadrivalent influenza vaccine in this region.	[Tewawong, Nipaporn; Suwannakarn, Kamol; Prachayangprecha, Slinporn; Korkong, Sumeth; Vichiwattana, Preeyaporn; Vongpunsawad, Sompong; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand	Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand.	Yong.P@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Tewawong, Nipaporn/0000-0003-1098-3701; vongpunsawad, sompong/0000-0001-7520-8728; Poovorawan, Yong/0000-0002-2337-6807	National Research University Project, Office of Higher Education Commission [HA1155A]; Research Chair Grant from NSTDA; Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093]; Outstanding Professor of the Thailand Research Fund [DPG5480002]; MK Restaurant Company Limited [WCU007-HR-57, WCU001-HR-57]; 100th anniversary Chulalongkorn University Fund for doctoral scholarship; Rachadapisek Sompote Fund for postdoctoral fellowship; Chulalongkorn University	National Research University Project, Office of Higher Education Commission; Research Chair Grant from NSTDA; Chulalongkorn University Centenary Academic Development Project; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); Outstanding Professor of the Thailand Research Fund; MK Restaurant Company Limited; 100th anniversary Chulalongkorn University Fund for doctoral scholarship; Rachadapisek Sompote Fund for postdoctoral fellowship; Chulalongkorn University(Chulalongkorn University)	This work was supported by grant HA1155A from the National Research University Project, Office of Higher Education Commission, the Research Chair Grant from NSTDA, CU56-HR01 from Chulalongkorn University Centenary Academic Development Project, RES560530093 from the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University, DPG5480002 from the Outstanding Professor of the Thailand Research Fund, and WCU007-HR-57 and WCU001-HR-57 from MK Restaurant Company Limited. The authors thank the 100th anniversary Chulalongkorn University Fund for doctoral scholarship awarded to Nipaporn Tewawong. This research is also supported by Rachadapisek Sompote Fund for postdoctoral fellowship, Chulalongkorn University, to Sompong Vongpunsawad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received funding from a commercial source, MK Restaurant Company Limited. However, this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P245; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Beran J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-2; Burnham AJ, 2014, ANTIMICROB AGENTS CH, V58, P2718, DOI 10.1128/AAC.02628-13; Byarugaba DK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-11; Chan PKS, 2009, J MED VIROL, V81, P1797, DOI 10.1002/jmv.21551; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; CHIEOCHANSIN TMJ, 2009, ASIAN BIOMED, V3, P7; Chittaganpitch M, 2012, INFLUENZA OTHER RESP, V6, P276, DOI 10.1111/j.1750-2659.2011.00302.x; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; Cox NJ, 1995, SEMIN VIROL, V6, P359, DOI 10.1016/S1044-5773(05)80013-7; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Gutierrez-Pizarraya A, 2012, J INFECTION, V65, P423, DOI 10.1016/j.jinf.2012.07.004; Heikkinen T, 2014, CLIN INFECT DIS, V59, P1519, DOI 10.1093/cid/ciu664; HEMMES JH, 1960, NATURE, V188, P430, DOI 10.1038/188430a0; Hiromoto Y, 2000, J GEN VIROL, V81, P929, DOI 10.1099/0022-1317-81-4-929; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; KANEGAE Y, 1990, J VIROL, V64, P2860, DOI 10.1128/JVI.64.6.2860-2865.1990; Kimura Y, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-36; KRYSTAL M, 1982, P NATL ACAD SCI-BIOL, V79, P4800, DOI 10.1073/pnas.79.15.4800; KRYSTAL M, 1983, P NATL ACAD SCI-BIOL, V80, P4527, DOI 10.1073/pnas.80.14.4527; Lindstrom SE, 1999, J VIROL, V73, P4413, DOI 10.1128/JVI.73.5.4413-4426.1999; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; MANISAN V, 1995, TECHNICAL DOCUMENT O; McCullers JA, 1999, J VIROL, V73, P7343, DOI 10.1128/JVI.73.9.7343-7348.1999; McCullers JA, 2004, J VIROL, V78, P12817, DOI 10.1128/JVI.78.23.12817-12828.2004; Nerome R, 1998, ARCH VIROL, V143, P1569, DOI 10.1007/s007050050399; Ni FY, 2013, VIROLOGY, V446, P112, DOI 10.1016/j.virol.2013.07.035; Oakley AJ, 2010, J MED CHEM, V53, P6421, DOI 10.1021/jm100621s; Osterhaus ADME, 2000, SCIENCE, V288, P1051, DOI 10.1126/science.288.5468.1051; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; SULLIVAN KM, 1993, AM J PUBLIC HEALTH, V83, P1712, DOI 10.2105/AJPH.83.12.1712; Suwannakarn K, 2008, J VIROL METHODS, V152, P25, DOI 10.1016/j.jviromet.2008.06.002; Virk RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088345; Wang QH, 2008, J VIROL, V82, P3011, DOI 10.1128/JVI.02477-07; Wang QH, 2007, P NATL ACAD SCI USA, V104, P16874, DOI 10.1073/pnas.0708363104; Yang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047179; Yen HL, 2006, J VIROL, V80, P8787, DOI 10.1128/JVI.00477-06; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1	43	37	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116302	10.1371/journal.pone.0116302	http://dx.doi.org/10.1371/journal.pone.0116302			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602617	Green Published, gold, Green Submitted			2022-12-26	WOS:000348203500021
J	Nakazawa, H; Yamada, M; Tanaka, T; Kramer, J; Yu, YM; Fischman, AJ; Martyn, JAJ; Tompkins, RG; Kaneki, M				Nakazawa, Harumasa; Yamada, Marina; Tanaka, Tomokazu; Kramer, Joshua; Yu, Yong-Ming; Fischman, Alan J.; Martyn, J. A. Jeevendra; Tompkins, Ronald G.; Kaneki, Masao			Role of Protein Farnesylation in Burn-Induced Metabolic Derangements and Insulin Resistance in Mouse Skeletal Muscle	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOPLASMIC-RETICULUM STRESS; CRITICALLY-ILL PATIENTS; FARNESYLTRANSFERASE INHIBITOR; GLUCOSE-TOLERANCE; POTENTIAL ROLE; BASE DEFICIT; KINASE B; MICE; LACTATE	Objective Metabolic derangements, including insulin resistance and hyperlactatemia, are a major complication of major trauma (e.g., burn injury) and affect the prognosis of burn patients. Protein farnesylation, a posttranslational lipid modification of cysteine residues, has been emerging as a potential component of inflammatory response in sepsis. However, farnesylation has not yet been studied in major trauma. To study a role of farnesylation in burn-induced metabolic aberration, we examined the effects of farnesyltransferase (FTase) inhibitor, FTI-277, on burn-induced insulin resistance and metabolic alterations in mouse skeletal muscle. Methods A full thickness burn (30% total body surface area) was produced under anesthesia in male C57BL/6 mice at 8 weeks of age. After the mice were treated with FTI-277 (5 mg/kg/day, IP) or vehicle for 3 days, muscle insulin signaling, metabolic alterations and inflammatory gene expression were evaluated. Results Burn increased FTase expression and farnesylated proteins in mouse muscle compared with sham-burn at 3 days after burn. Simultaneously, insulin-stimulated phosphorylation of insulin receptor (IR), insulin receptor substrate (IRS)-1, Akt and GSK-3 beta was decreased. Protein expression of PTP-1B (a negative regulator of IR-IRS-1 signaling), PTEN (a negative regulator of Akt-mediated signaling), protein degradation and lactate release by muscle, and plasma lactate levels were increased by burn. Burn-induced impaired insulin signaling and metabolic dysfunction were associated with increased inflammatory gene expression. These burn-induced alterations were reversed or ameliorated by FTI-277. Conclusions Our data demonstrate that burn increased FTase expression and protein farnesylation along with insulin resistance, metabolic alterations and inflammatory response in mouse skeletal muscle, all of which were prevented by FTI-277 treatment. These results indicate that increased protein farnesylation plays a pivotal role in burn-induced metabolic dysfunction and inflammatory response. Our study identifies FTase as a novel potential molecular target to reverse or ameliorate metabolic derangements in burn patients.	[Nakazawa, Harumasa; Yamada, Marina; Tanaka, Tomokazu; Martyn, J. A. Jeevendra; Kaneki, Masao] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Charlestown, MA 02129 USA; [Yamada, Marina; Yu, Yong-Ming; Fischman, Alan J.; Martyn, J. A. Jeevendra; Kaneki, Masao] Shriners Hosp Children, Boston, MA USA; [Kramer, Joshua] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Yu, Yong-Ming; Tompkins, Ronald G.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Kaneki, M (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Charlestown, MA 02129 USA.	mkaneki@helix.mgh.harvard.edu		Nakazawa, Harumasa/0000-0002-3258-9310	Shriners Hospitals for Children [71000, 85800, 84203]; National Institutes of Health(NIGMS) [P50GM02700]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM021700] Funding Source: NIH RePORTER	Shriners Hospitals for Children; National Institutes of Health(NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a research grant to MK (71000, 85800) and a fellowship to MY (84203) from Shriners Hospitals for Children, and to RGT (P50GM02700) from National Institutes of Health(NIGMS). The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Andel D, 2007, BURNS, V33, P973, DOI 10.1016/j.burns.2007.06.016; Beffa DC, 2011, BURNS, V37, P222, DOI 10.1016/j.burns.2010.10.010; Birle D, 2002, J IMMUNOL, V169, P286, DOI 10.4049/jimmunol.169.1.286; Bonab AA, 2010, INT J MOL MED, V26, P311, DOI 10.3892/ijmm_00000467; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Calisto KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014232; Callahan Leigh Ann, 2009, Crit Care Med, V37, pS354, DOI 10.1097/CCM.0b013e3181b6e439; Cree MG, 2008, AM J PHYSIOL-ENDOC M, V294, pE1, DOI 10.1152/ajpendo.00562.2007; Crossland H, 2008, J PHYSIOL-LONDON, V586, P5589, DOI 10.1113/jphysiol.2008.160150; Dare AJ, 2009, FREE RADICAL BIO MED, V47, P1517, DOI 10.1016/j.freeradbiomed.2009.08.019; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fogerty MD, 2010, J TRAUMA, V69, P99, DOI 10.1097/TA.0b013e3181df61b1; Gore DC, 2000, J TRAUMA, V49, P673, DOI 10.1097/00005373-200010000-00015; Gunst J, 2010, SEMIN DIALYSIS, V23, P157, DOI 10.1111/j.1525-139X.2010.00702.x; Hojlund K, 2006, CURR DIABETES REV, V2, P375, DOI 10.2174/1573399810602040375; Jeng JC, 2002, BURNS, V28, P161, DOI 10.1016/S0305-4179(01)00098-5; Jeschke MG, 2014, ANN SURG, V259, P814, DOI 10.1097/SLA.0b013e31828dfbf1; Jeschke MG, 2012, ANN SURG, V255, P370, DOI 10.1097/SLA.0b013e31823e76e7; Kamolz LP, 2005, BURNS, V31, P986, DOI 10.1016/j.burns.2005.06.019; Kaneki M, 2007, ANTIOXID REDOX SIGN, V9, P319, DOI 10.1089/ars.2006.1464; Kaneki M, 2013, METABOLISM, V62, P341, DOI 10.1016/j.metabol.2012.08.010; Kaneki M, 2009, CRIT CARE MED, V37, P2856, DOI 10.1097/CCM.0b013e3181aff7bb; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; KREISBERG RA, 1972, NEW ENGL J MED, V287, P132, DOI 10.1056/NEJM197207202870307; Krinsley J, 2010, CRIT CARE, V14, DOI 10.1186/cc9275; Lantos J, 2010, SHOCK, V33, P562, DOI 10.1097/SHK.0b013e3181cd8c88; Lee HY, 2011, SHOCK, V36, P580, DOI 10.1097/SHK.0b013e3182366872; Li YQ, 2011, SURGERY, V150, P442, DOI 10.1016/j.surg.2011.07.003; Long YC, 2011, MOL CELL BIOL, V31, P430, DOI 10.1128/MCB.00983-10; LOVEJOY J, 1992, METABOLISM, V41, P22, DOI 10.1016/0026-0495(92)90185-D; Lu XM, 2013, INT J BURNS TRAUMA, V3, P37; Martyn JAJ, 2008, ANESTHESIOLOGY, V109, P137, DOI 10.1097/ALN.0b013e3181799d45; Nantais DE, 1996, J LEUKOCYTE BIOL, V60, P423, DOI 10.1002/jlb.60.3.423; PEDROSO FE, 2012, J CACHEXIA SARCOPENI; Riesenman PJ, 2007, J BURN CARE RES, V28, P342, DOI 10.1097/BCR.0B013E318031A1FE; Robinson K, 2011, BEST PRACT RES CL EN, V25, P835, DOI 10.1016/j.beem.2011.04.008; Schernthaner G, 2010, DIABETES OBES METAB, V12, P1023, DOI 10.1111/j.1463-1326.2010.01262.x; Sekiya M, 2009, CELL METAB, V10, P219, DOI 10.1016/j.cmet.2009.08.004; Shinozaki S, 2011, J BIOL CHEM, V286, P34959, DOI 10.1074/jbc.M110.187666; Shinozaki S, 2010, BIOCHEM BIOPH RES CO, V391, P1459, DOI 10.1016/j.bbrc.2009.12.094; Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022; Stein W, 2011, J HEART LUNG TRANSPL, V30, P761, DOI 10.1016/j.healun.2011.01.720; Sugita H, 2005, AM J PHYSIOL-ENDOC M, V288, pE585, DOI 10.1152/ajpendo.00321.2004; Sugita H, 2005, J BIOL CHEM, V280, P14203, DOI 10.1074/jbc.M411226200; Sugita M, 2007, ARTERIOSCL THROM VAS, V27, P1390, DOI 10.1161/ATVBAHA.107.140673; Sugita M, 2012, METABOLISM, V61, P127, DOI 10.1016/j.metabol.2011.06.001; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; VESTAL DJ, 1995, J LEUKOCYTE BIOL, V58, P607, DOI 10.1002/jlb.58.5.607; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wei W, 2005, AM J PHYSIOL-REG I, V288, pR580, DOI 10.1152/ajpregu.00341.2004; Xue XH, 2006, J PHARMACOL EXP THER, V317, P53, DOI 10.1124/jpet.105.095976; Yang W, 2011, J PHARMACOL EXP THER, V339, P832, DOI 10.1124/jpet.111.183558; Zhang LT, 2008, SHOCK, V30, P449, DOI 10.1097/SHK.0b013e3181672495	58	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2015	10	1							e0116633	10.1371/journal.pone.0116633	http://dx.doi.org/10.1371/journal.pone.0116633			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OS	25594415	Green Published, Green Submitted, gold			2022-12-26	WOS:000348202900004
J	Xu, D; Chen, ZM; Chen, HZ; Huang, RY; Zhao, SY; Liu, XY; Zhou, CJ; Peng, Y; Yuan, XY; Zou, JZ; Zhang, HL; Zhao, DY; Liu, EM; Zheng, YJ; Zhong, LL; Lu, M; Lu, JR; Nong, GM				Xu, Dan; Chen, Zhimin; Chen, Huizhong; Huang, Rongyan; Zhao, Shunying; Liu, Xiuyun; Zhou, Chunju; Peng, Yun; Yuan, Xinyu; Zou, Jizhen; Zhang, Hailing; Zhao, Deyu; Liu, Enmei; Zheng, Yuejie; Zhong, Lili; Lu, Min; Lu, Jirong; Nong, Guangmin			Application of Clinico-Radiologic-Pathologic Diagnosis of Diffuse Parenchymal Lung Diseases in Children in China	PLOS ONE			English	Article							INTERSTITIAL PNEUMONIA; CT; GENE	Diffuse parenchymal lung diseases in children (chDPLD) or interstitial lung diseases in children (chILD) represent a heterogeneous group of respiratory disorders that are mostly chronic and associated with high morbidity and mortality. However, the incidence of chDPLD is so low that most pediatricians lack sufficient knowledge of chDPLD, especially in China. Based on the clinico-radiologic-pathologic (CRP) diagnosis, we tried to describe (1) the characteristics of chDPLD and (2) the ratio of each constituent of chDPLD in China. Data were evaluated, including clinical, radiographic, and pathologic results from lung biopsies. We collected 25 cases of chDPLD, 18 boys and 7 girls with a median age of 6.0 years, from 16 hospitals in China. The most common manifestations included cough (n = 24), dyspnea (n = 21), and fever (n = 4). There were three cases of exposure-related interstitial lung disease (ILD), three cases of systemic disease-associated ILD, nineteen cases of alveolar structure disorder-associated ILD, and no cases of ILD specific to infancy. Non-specific interstitial pneumonia (n = 9) was the two largest groups. Conclusion: Non-specific interstitial pneumonia is the main categories of chDPLD in China. Lung biopsy is always a crucial step in the final diagnosis. However, clinical and imaging studies should be carefully evaluated for their value in indicating a specific chDPLD.	[Xu, Dan; Chen, Zhimin] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Pulmonol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Huizhong; Huang, Rongyan] Capital Inst Pediat, Childrens Hosp, Dept Resp Dis, Beijing, Peoples R China; [Zhao, Shunying; Liu, Xiuyun] Capital Med Univ, Beijing Childrens Hosp, Dept Pediat Internal Med, Beijing, Peoples R China; [Zhou, Chunju] Capital Med Univ, Beijing Childrens Hosp, Dept Pathol, Beijing, Peoples R China; [Peng, Yun] Capital Med Univ, Beijing Childrens Hosp, Dept Radiol, Beijing, Peoples R China; [Yuan, Xinyu] Capital Inst Pediat, Childrens Hosp, Dept Radiol, Beijing, Peoples R China; [Zou, Jizhen] Capital Inst Pediat, Childrens Hosp C, Dept Pathol, Beijing, Peoples R China; [Zhang, Hailing] Wenzhou Med Coll, Yuying Childrens Hosp, Dept Resp Dis, Wenzhou, Peoples R China; [Zhao, Deyu] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Resp Dis, Nanjing, Jiangsu, Peoples R China; [Liu, Enmei] Chongqing Med Univ, Childrens Hosp, Resp Ctr, Chongqing, Peoples R China; [Zheng, Yuejie] Shenzhen Childrens Hosp, Dept Resp Dis, Shenzhen, Peoples R China; [Zhong, Lili] Hunan Normal Univ, Affiliated Hosp 1, Dept Pediat, Changsha, Hunan, Peoples R China; [Lu, Min] Jiao Tong Univ, Shanghai Childrens Hosp, Dept Pulmonol, Shanghai 200030, Peoples R China; [Lu, Jirong] Jilin Univ, Hosp 1, Dept Pediat, Changchun 130023, Peoples R China; [Nong, Guangmin] Guangxi Med Univ, Affiliated Hosp 1, Dept Pediat, Nanning, Peoples R China	Zhejiang University; Capital Institute of Pediatrics (CIP); Capital Medical University; Capital Medical University; Capital Medical University; Capital Institute of Pediatrics (CIP); Capital Institute of Pediatrics (CIP); Wenzhou Medical University; Nanjing Medical University; Chongqing Medical University; Hunan Normal University; Shanghai Jiao Tong University; Jilin University; Guangxi Medical University	Chen, ZM (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Dept Pulmonol, Hangzhou 310003, Zhejiang, Peoples R China.	drchenzm@163.com; chenhzvip@126.com						Amenomori M, 2010, RESP MED, V104, P895, DOI 10.1016/j.rmed.2010.01.011; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Brasch F, 2004, EUR RESPIR J, V24, P30, DOI 10.1183/09031936.04.00000104; Gomes VCC, 2013, J BRAS PNEUMOL, V39, P569, DOI 10.1590/S1806-37132013000500007; Clement A, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-22; COULTAS DB, 1994, AM J RESP CRIT CARE, V150, P967, DOI 10.1164/ajrccm.150.4.7921471; Deterding R, 2007, SEMIN RESP CRIT CARE, V28, P333, DOI 10.1055/s-2007-981654; Dinwiddle R, 2002, PEDIATR PULM, V34, P23, DOI 10.1002/ppul.10125; Griese M, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-26; KIDO S, 1992, Nippon Acta Radiologica, V52, P382; KIDO S, 1992, Nippon Acta Radiologica, V52, P392; Kornum Jette B, 2008, BMC Pulm Med, V8, P24, DOI 10.1186/1471-2466-8-24; Lloyd CR, 2011, BRIT J RADIOL, V84, P581, DOI 10.1259/bjr/65090500; Martin SG, 2010, EUR RADIOL, V20, P1297, DOI 10.1007/s00330-009-1671-4; Park SC, 2011, PHYS MED BIOL, V56, P1139, DOI 10.1088/0031-9155/56/4/016; Venkatesh Purnima, 2005, Paediatr Drugs, V7, P235, DOI 10.2165/00148581-200507040-00003; Wagner M, 2011, REV MAL RESPIR, V28, P1207, DOI 10.1016/j.rmr.2011.04.016; Wang Ping, 2009, Chinese Medical Sciences Journal, V24, P202; Wuyts W, 2008, EUR J CARDIO-THORAC, V34, P1271, DOI 10.1016/j.ejcts.2008.09.018; Yang IV, 2007, AM J RESP CRIT CARE, V175, P45, DOI 10.1164/rccm.200601-062OC; Zacharisen MC, 2011, IMMUNOL ALLERGY CLIN, V31, P769, DOI 10.1016/j.iac.2011.07.004; Zar HJ, 2008, PEDIATR PULM, V43, P1, DOI 10.1002/ppul.20676	22	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e0116930	10.1371/journal.pone.0116930	http://dx.doi.org/10.1371/journal.pone.0116930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25569558	Green Published, Green Submitted, gold			2022-12-26	WOS:000348168000009
J	Amoroso, F; Capece, M; Rotondo, A; Cangelosi, D; Ferracin, M; Franceschini, A; Raffaghello, L; Pistoia, V; Varesio, L; Adinolfi, E				Amoroso, F.; Capece, M.; Rotondo, A.; Cangelosi, D.; Ferracin, M.; Franceschini, A.; Raffaghello, L.; Pistoia, V.; Varesio, L.; Adinolfi, E.			The P2X7 receptor is a key modulator of the PI3K/GSK3 beta/VEGF signaling network: evidence in experimental neuroblastoma	ONCOGENE			English	Article							INCREASES CELLULAR ATP; P2X(7) RECEPTOR; CANCER-CELLS; EXPRESSION; ACTIVATION; MYCN; DIFFERENTIATION; PROLIFERATION; METASTASIS; INHIBITION	Neuroblastoma (NB) is an aggressive pediatric tumor, responsible for 15% of cancer-related deaths in childhood, lacking an effective treatment in its advanced stages. The P2X7 receptor for extracellular ATP was associated to NB cell proliferation and recently emerged as a promoter of tumor engraftment, growth and vascularization. In an effort to identify new therapeutic options for neuroblastoma, we studied the role of P2X7 receptor in NB biology. We first analyzed the effect of P2X7 activation or down-modulation of the main biochemical ways involved in NB progression: the PI3K/Akt/GSK3 beta/MYCN and the HIF1 alpha/VEGF pathways. In ACN human NB cells, P2X7 stimulation enhanced PI3K/Akt, while decreasing GSK3 beta activity. In the same model, P2X7 silencing or antagonist administration reduced the activity of PI3K/Akt and increased that of GSK3 beta, leading to a decrease in cellular glycogen stores. Similarly, P2X7 downmodulation caused a reduction in HIF1 alpha levels and vascular endothelial growth factor (VEGF) secretion. Systemic administration of two different P2X7 antagonists (AZ10606120 or A740003) in nude/nude mice reduced ACN-derived tumor growth. An even stronger effect of P2X7 blockade was obtained in a syngeneic immune-competent neuroblastoma model: Neuro2A cells injected in AlbinoJ mice. Together with tumor regression, treatment with P2X7 antagonists caused downmodulation of the Akt/HIF1 alpha axis, leading to reduced VEGF content and decreased vessel formation. Interestingly, in both experimental models, P2X7 antagonists strongly reduced the expression of the probably best-accepted oncogene in NB: MYCN. Finally, we associated P2X7 overexpression with poor prognosis in advanced-stage NB patients. Taken together, our data suggest that P2X7 receptor is an upstream regulator of the main signaling pathways involved in NB growth, metabolic activity and angiogenesis, and a promising therapeutic target for neuroblastoma treatment.	[Amoroso, F.; Capece, M.; Rotondo, A.; Ferracin, M.; Franceschini, A.; Adinolfi, E.] Univ Ferrara, Sect Expt Pathol Oncol & Biol, Dept Morphol Surg & Expt Med, I-44121 Ferrara, Italy; [Cangelosi, D.; Varesio, L.] Ist Giannina Gaslini, Lab Mol Biol, I-16148 Genoa, Italy; [Raffaghello, L.; Pistoia, V.] Ist Giannina Gaslini, Lab Oncol, I-16148 Genoa, Italy	University of Ferrara; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini	Adinolfi, E (corresponding author), Univ Ferrara, Sect Expt Pathol Oncol & Biol, Dept Morphol Surg & Expt Med, Via Luigi Borsari 46, I-44121 Ferrara, Italy.	elena.adinolfi@unife.it	varesio, luigi/J-8261-2016; Ferracin, Manuela/K-2097-2016; Adinolfi, Elena/F-9169-2010; Franceschini, Alessia/H-4992-2017; Franceschini, Alessia/K-3426-2018; Cangelosi, Davide/K-2627-2016	varesio, luigi/0000-0001-5659-2218; Ferracin, Manuela/0000-0002-1595-6887; Adinolfi, Elena/0000-0001-8129-9929; Franceschini, Alessia/0000-0001-7122-6232; Franceschini, Alessia/0000-0001-7122-6232; Cangelosi, Davide/0000-0002-6010-5619; Raffaghello, Lizzia/0000-0003-2357-0607; Amoroso, Francesca Saveria/0000-0002-5946-2491	AIRC [MFAG11630]; Regione Emilia Romagna of Italy (bando Alessandro Liberati)	AIRC(Fondazione AIRC per la ricerca sul cancro); Regione Emilia Romagna of Italy (bando Alessandro Liberati)	This work was supported by AIRC grant MFAG11630 and young researchers' funds of the Regione Emilia Romagna of Italy (bando Alessandro Liberati) to EA.	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Adinolfi E, 2002, BLOOD, V99, P706, DOI 10.1182/blood.V99.2.706; Adinolfi E, 2015, CURR MED CHEM, V22, P878, DOI 10.2174/0929867321666141012172913; Adinolfi E, 2012, J OSTEOPOROS, V2012, DOI 10.1155/2012/637863; Adinolfi E, 2012, CANCER RES, V72, P2957, DOI 10.1158/0008-5472.CAN-11-1947; Adinolfi E, 2010, FASEB J, V24, P3393, DOI 10.1096/fj.09-153601; Adinolfi E, 2009, J BIOL CHEM, V284, P10120, DOI 10.1074/jbc.M805805200; Agani F, 2013, CURR CANCER DRUG TAR, V13, P245, DOI 10.2174/1568009611313030003; Amoroso F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.105; Aymeric L, 2010, CANCER RES, V70, P855, DOI 10.1158/0008-5472.CAN-09-3566; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Bianchi G, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.109; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Cheng KW, 2012, EMBO MOL MED, V4, P125, DOI 10.1002/emmm.201100193; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Chong JH, 2010, BIOCHEM BIOPH RES CO, V391, P498, DOI 10.1016/j.bbrc.2009.11.087; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Dent P, 2014, CANCER BIOL THER, V15, P481, DOI 10.4161/cbt.28465; Di Virgilio F, 2012, CANCER RES, V72, P5441, DOI 10.1158/0008-5472.CAN-12-1600; Di Virgilio F, 2009, PURINERG SIGNAL, V5, P251, DOI 10.1007/s11302-009-9145-3; Fardin P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-185; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; Fransson S, 2013, INT J ONCOL, V42, P609, DOI 10.3892/ijo.2012.1732; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Ghalali A, 2014, CARCINOGENESIS, V35, P1547, DOI 10.1093/carcin/bgu019; Giuliani AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107224; Gomez-Villafuertes R, 2009, FEBS J, V276, P5307, DOI 10.1111/j.1742-4658.2009.07228.x; Gu LQ, 2010, ENDOCRINE, V38, P276, DOI 10.1007/s12020-010-9384-7; Gutierrez-Martin Y, 2011, J BIOL CHEM, V286, P11370, DOI 10.1074/jbc.M110.139410; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heine VM, 2010, CANCER RES, V70, P5220, DOI 10.1158/0008-5472.CAN-10-0554; Hogarty MD, 2012, CANCER CELL, V21, P145, DOI 10.1016/j.ccr.2012.01.018; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Jelassi B, 2011, ONCOGENE, V30, P2108, DOI 10.1038/onc.2010.593; Kang J, 2008, ONCOGENE, V27, P3999, DOI 10.1038/onc.2008.15; Keystone EC, 2012, ANN RHEUM DIS, P71; Martins I, 2009, CELL CYCLE, V8, P3723, DOI 10.4161/cc.8.22.10026; Maurer U, 2014, J CELL SCI, V127, P1369, DOI 10.1242/jcs.138057; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Raffaghello L, 2006, CANCER RES, V66, P907, DOI 10.1158/0008-5472.CAN-05-3185; Schumacher D, 2013, CANCER CELL, V24, P130, DOI 10.1016/j.ccr.2013.05.008; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Stock TC, 2012, J RHEUMATOL, V39, P720, DOI 10.3899/jrheum.110874; Sun SH, 2010, MOL NEUROBIOL, V41, P351, DOI 10.1007/s12035-010-8120-x; Takai E, 2012, J CELL SCI, V125, P5051, DOI 10.1242/jcs.104976; Westhoff MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083128; Williams EL, 2013, CLIN CANCER RES, V19, P3545, DOI 10.1158/1078-0432.CCR-12-3226; Witney TH, 2014, CANCER RES, V74, P1319, DOI 10.1158/0008-5472.CAN-13-2768; Wu PY, 2009, CELL SIGNAL, V21, P881, DOI 10.1016/j.cellsig.2009.01.036	51	107	108	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2015	34	41					5240	5251		10.1038/onc.2014.444	http://dx.doi.org/10.1038/onc.2014.444			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CT1QL	25619831	Green Submitted			2022-12-26	WOS:000362575400004
J	Zhou, Y; Mohan, A; Moore, DC; Lin, LJ; Zhou, FL; Cao, J; Wu, Q; Qin, YX; Reginato, AM; Ehrlich, MG; Yang, WT				Zhou, Yi; Mohan, Aron; Moore, Douglas C.; Lin, Liangjun; Zhou, Frank Li; Cao, Jay; Wu, Qian; Qin, Yi-Xian; Reginato, Anthony M.; Ehrlich, Michael G.; Yang, Wentian			SHP2 regulates osteoclastogenesis by promoting preosteoclast fusion	FASEB JOURNAL			English	Article						M-CSF; RANKL; Nfatc1	COLONY-STIMULATING FACTOR; TYROSINE-PHOSPHATASE SHP-2; ACTIVATED T-CELLS; NOONAN-SYNDROME; SIGNALING PATHWAY; NUCLEAR FACTOR; RANK LIGAND; DC-STAMP; C-FOS; DIFFERENTIATION	Genes that regulate osteoclast (OC) development and function in both physiologic and disease conditions remain incompletely understood. Shp2 (the Src homology-2 domain containing protein tyrosine phosphatase 2), a ubiquitously expressed cytoplasmic protein tyrosine phosphatase, is implicated in regulating M-CSF and receptor activator of nuclear factor-B ligand (RANKL)-evoked signaling; its role in osteoclastogenesis and bone homeostasis, however, remains unknown. Using a tissue-specific gene knockout approach, we inactivated Shp2 expression in murine OCs. Shp2 mutant mice are phenotypically osteopetrotic, featuring a marked increase of bone volume (BV)/total volume (TV) (+42.8%), trabeculae number (Tb.N) (+84.1%), structure model index (+119%), and a decrease of trabecular thickness (Tb.Th) (-34.1%) and trabecular spacing (Tb.Sp) (-41.0%). Biochemical analyses demonstrate that Shp2 is required for RANKL-induced formation of giant multinucleated OCs by up-regulating the expression of nuclear factor of activated T cells, cytoplasmic 1 (Nfatc1), a master transcription factor that is indispensable for terminal OC differentiation. Shp2 deletion, however, has minimal effect on M-CSF-dependent survival and proliferation of OC precursors. Instead, its deficiency aborts the fusion of OC precursors and formation of multinucleated OCs and decreases bone matrix resorption. Moreover, pharmacological intervention of Shp2 is sufficient to prevent preosteoclast fusion in vitro. These findings uncover a novel mechanism through which Shp2 regulates osteoclastogenesis by promoting preosteoclast fusion. Shp2 or its signaling partners could potentially serve as pharmacological targets to regulate the population of OCs locally and/or systematically, and thus treat OC-related diseases, such as periprosthetic osteolysis and osteoporosis.	[Zhou, Yi] Boston Childrens Hosp, Stem Cell Program, Boston, MA USA; [Zhou, Yi] Harvard Univ, Sch Med, Boston, MA USA; [Mohan, Aron; Moore, Douglas C.; Ehrlich, Michael G.; Yang, Wentian] Brown Univ, Dept Orthopaed, Alpert Med Sch, Providence, RI 02912 USA; [Mohan, Aron; Moore, Douglas C.; Ehrlich, Michael G.; Yang, Wentian] Rhode Isl Hosp, Providence, RI USA; [Lin, Liangjun; Qin, Yi-Xian] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Zhou, Frank Li] CALTECH, Engn & Appl Sci, Pasadena, CA 91125 USA; [Cao, Jay] USDA, Grand Forks Human Nutr Res Ctr, Grand Forks, ND USA; [Wu, Qian] Univ Connecticut, Ctr Hlth, Dept Pathol & Lab Med, Farmington, CT USA; [Reginato, Anthony M.] Brown Univ, Alpert Med Sch, Div Rheumatol, Providence, RI 02912 USA; [Reginato, Anthony M.] Rhode Isl Hosp, Providence, RI USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; California Institute of Technology; United States Department of Agriculture (USDA); University of Connecticut; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Yang, WT (corresponding author), 1 Hoppin St,Coro 402E, Providence, RI 02903 USA.	wyang@lifespan.org			U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [R21AR57156]; NIH National Institute of General Medical Sciences [P20 GM103468]; Pediatric Orthopaedic Society of North America; Orthopaedic Research and Education Foundation; U.S. Department of Agriculture Research Service [5450-51000-046-00D]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR057156, R01AR061821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103468, P20GM104937] Funding Source: NIH RePORTER; ARS [ARS-0427566] Funding Source: Federal RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pediatric Orthopaedic Society of North America; Orthopaedic Research and Education Foundation; U.S. Department of Agriculture Research Service(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors thank Dr. Nhiem Tran for critical reading, Ms. Xiaohong Wang for histological section and staining, and Dr. T. Taniguchi for pMX-IRES-GFP and pMX-Nfatc1/IRES-GFP constructs. The authors are grateful to Mr. Howard Yang (Moses Brown High School) for assistance in performing experiments and data collection. This work was supported in part by the U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant R21AR57156 (to W.Y.) and NIH National Institute of General Medical Sciences Grant P20 GM103468. This study was also aided by a grant from the Pediatric Orthopaedic Society of North America and the Orthopaedic Research and Education Foundation (to W.Y.), and the U.S. Department of Agriculture Research Service program Grant #5450-51000-046-00D (to J.C.).	Aoki K, 1999, BONE, V25, P261, DOI 10.1016/S8756-3282(99)00174-X; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Balkan W, 2009, GENE, V446, P90, DOI 10.1016/j.gene.2009.06.013; Bauler TJ, 2011, DIS MODEL MECH, V4, P228, DOI 10.1242/dmm.006130; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chan G, 2011, BLOOD, V117, P4253, DOI 10.1182/blood-2010-11-319517; Chan G, 2009, BLOOD, V113, P4414, DOI 10.1182/blood-2008-10-182626; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Fornaro M, 2006, J CELL BIOL, V175, P87, DOI 10.1083/jcb.200602029; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Huang H, 2006, BIOCHEM BIOPH RES CO, V351, P99, DOI 10.1016/j.bbrc.2006.10.011; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Lee AWM, 2006, CELL DEATH DIFFER, V13, P1900, DOI 10.1038/sj.cdd.4401884; Lee AWM, 2000, MOL CELL BIOL, V20, P6779, DOI 10.1128/MCB.20.18.6779-6798.2000; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Neel B. G., 2009, HDB CELL SIGNALING, P771; Noonan JA, 2006, REV ENDOCR METAB DIS, V7, P251, DOI 10.1007/s11154-006-9021-1; Ozcivici Engin, 2008, V455, P323, DOI 10.1007/978-1-59745-104-8_22; Ross FP, 2006, ANN NY ACAD SCI, V1068, P110, DOI 10.1196/annals.1346.014; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; Sundaram K, 2007, EXP CELL RES, V313, P168, DOI 10.1016/j.yexcr.2006.10.001; Sweet MG, 2009, AM FAM PHYSICIAN, V79, P193; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tolar J, 2004, NEW ENGL J MED, V351, P2839, DOI 10.1056/NEJMra040952; Umeda S, 1999, AM J PATHOL, V155, P223, DOI 10.1016/S0002-9440(10)65116-4; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wada T, 2005, NAT MED, V11, P394, DOI 10.1038/nm1203; Watts NB, 2010, J CLIN ENDOCR METAB, V95, P1555, DOI 10.1210/jc.2009-1947; Xu DR, 2004, BIOCHEM J, V383, P219, DOI 10.1042/BJ20040961; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yang WT, 2013, NATURE, V499, P491, DOI 10.1038/nature12396; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; Yu MJ, 2009, J BIOL CHEM, V284, P32968, DOI 10.1074/jbc.M109.001016	42	19	20	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1635	1645		10.1096/fj.14-260844	http://dx.doi.org/10.1096/fj.14-260844			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25593124	Green Published, Bronze			2022-12-26	WOS:000354114600003
J	Wang, WL; Li, F; Sun, Y; Lei, L; Zhou, H; Lei, TL; Xia, Y; Verkman, AS; Yang, BX				Wang, Weiling; Li, Fei; Sun, Yi; Lei, Lei; Zhou, Hong; Lei, Tianluo; Xia, Yin; Verkman, A. S.; Yang, Baoxue			Aquaporin-1 retards renal cyst development in polycystic kidney disease by inhibition of Wnt signaling	FASEB JOURNAL			English	Article						water channel; MDCK; destruction complex; ADPKD	CATENIN DESTRUCTION COMPLEX; C-TERMINAL TAIL; BETA-CATENIN; CELL-MIGRATION; WATER CHANNEL; E-CADHERIN; PHOSPHORYLATION; EXPRESSION; ROLES; AQP1	Water channel aquaporin-1 (AQP1) is expressed at epithelial cell plasma membranes in renal proximal tubules and thin descending limb of Henle. Recently, AQP1 was reported to interact with beta-catenin. Here we investigated the relationship between AQP1 and Wnt signaling in in vitro and in vivo models of autosomal dominant polycystic kidney disease (PKD). AQP1 overexpression decreased beta-catenin and cyclinD1 expression, suggesting down-regulation of Wnt signaling, and coimmunoprecipitation showed AQP1 interaction with beta-catenin, glycogen synthase kinase 3 beta, LRP6, and Axin1. AQP1 inhibited cyst development and promoted branching in matrix-grown MDCK cells. In embryonic kidney cultures, AQP1 deletion increased cyst development by up to similar to 40%. Kidney size and cyst number were significantly greater in AQP1-null PKD mice than in AQP1-expressing PKD mice, with the difference mainly attributed to a greater number of proximal tubule cysts. Biochemical analysis revealed decreased beta-catenin phosphorylation and increased beta-catenin expression in AQP1-null PKD mice, suggesting enhanced Wnt signaling. These results implicate AQP1 as a novel determinant in renal cyst development that may involve inhibition of Wnt signaling by an AQP1-macromolecular signaling complex.	[Wang, Weiling; Li, Fei; Sun, Yi; Lei, Lei; Zhou, Hong; Lei, Tianluo; Yang, Baoxue] Peking Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing 100191, Peoples R China; [Wang, Weiling; Li, Fei; Sun, Yi; Lei, Lei; Zhou, Hong; Lei, Tianluo; Yang, Baoxue] Minist Educ, Key Lab Mol Cardiovasc Sci, State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China; [Xia, Yin] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Verkman, A. S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA	Peking University; Chinese University of Hong Kong; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yang, BX (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Pharmacol, 38 Xueyuan Lu, Beijing 100191, Peoples R China.	baoxue@bjmu.edu.cn	Xia, Yin/M-5440-2018	Xia, Yin/0000-0003-0315-7532; Li, Fei/0000-0003-2016-6422	National Natural Science Foundation of China [31200869, 81261160507, 81330074, 81170632]; Research Fund for the Doctoral Program of Higher Education [20100001110047]; 111 Project; International Science & Technology Cooperation Program of China [2012DFA11070]; U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases Grant [DK35124]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, R37DK035124] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); 111 Project(Ministry of Education, China - 111 Project); International Science & Technology Cooperation Program of China; U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Natural Science Foundation of China (Grants 31200869, 81261160507, 81330074 and 81170632); the Research Fund for the Doctoral Program of Higher Education (Grant 20100001110047); the 111 Project; and International Science & Technology Cooperation Program of China (Grant 2012DFA11070). This work was also supported by the U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases Grant DK35124. The authors thank Peter Igarashi and Stefan Somlo for the Ksp-Cre and Pkd1<SUP>flox/flox</SUP> mouse strains.	Anders C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057797; BACHINSKY DR, 1995, AM J PHYSIOL-RENAL, V268, pF398, DOI 10.1152/ajprenal.1995.268.3.F398; Baffert F, 2004, CIRC RES, V94, P984, DOI 10.1161/01.RES.0000125295.43813.1F; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Boca M, 2007, MOL BIOL CELL, V18, P4050, DOI 10.1091/mbc.E07-02-0142; Buchholz B, 2014, KIDNEY INT, V85, P1058, DOI 10.1038/ki.2013.418; CARONE FA, 1995, KIDNEY INT, V47, P861, DOI 10.1038/ki.1995.129; Chen D, 2004, AM J PHYSIOL-RENAL, V287, pF602, DOI 10.1152/ajprenal.00015.2004; Cho EAaD G. R., 2003, FORMATION DEV NEPHRO; Cornec-Le Gall E, 2013, J AM SOC NEPHROL, V24, P1006, DOI 10.1681/ASN.2012070650; Czyzewska J, 2010, FOLIA HISTOCHEM CYTO, V48, P37, DOI 10.2478/v10042-010-0017-z; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Devuyst O, 1998, NEPHRON, V78, P116, DOI 10.1159/000044893; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Fu YL, 2010, EUR J CELL BIOL, V89, P428, DOI 10.1016/j.ejcb.2010.01.002; Galli C, 2013, CLIN ORAL IMPLAN RES, V24, P921, DOI 10.1111/j.1600-0501.2012.02488.x; Hara-Chikuma M, 2006, J AM SOC NEPHROL, V17, P39, DOI 10.1681/ASN.2005080846; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Igarashi P, 2004, J AM SOC NEPHROL, V15, P2237, DOI 10.1097/01.ASN.0000136298.09488.D7; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jia LW, 2011, MOL BIOL CELL, V22, P2031, DOI 10.1091/mbc.E11-01-0038; Kawakami T, 2013, J PATHOL, V229, P221, DOI 10.1002/path.4121; Kim E, 1999, J BIOL CHEM, V274, P4947, DOI 10.1074/jbc.274.8.4947; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kriz V, 2014, J BIOL CHEM, V289, P1128, DOI 10.1074/jbc.M113.498444; La Porta C, 2010, CELL ADHES MIGR, V4, P204, DOI 10.4161/cam.4.2.10949; Lai N, 2014, AM J RESP CELL MOL, V50, P1010, DOI 10.1165/rcmb.2013-0374OC; Lal M, 2008, HUM MOL GENET, V17, P3105, DOI 10.1093/hmg/ddn208; Lancaster MA, 2010, TRENDS MOL MED, V16, P349, DOI 10.1016/j.molmed.2010.05.004; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu M, 2010, J AM SOC NEPHROL, V21, P1510, DOI 10.1681/ASN.2010030237; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Magenheimer BS, 2006, J AM SOC NEPHROL, V17, P3424, DOI 10.1681/ASN.2006030295; Meng FB, 2014, STEM CELLS DEV, V23, P66, DOI 10.1089/scd.2013.0185; Monzani E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006167; Nakamura E, 2005, J PATHOL, V205, P349, DOI 10.1002/path.1718; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P11663, DOI 10.1073/pnas.90.24.11663; Noda Y, 2010, NAT REV NEPHROL, V6, P168, DOI 10.1038/nrneph.2009.231; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Ohira T, 2003, P NATL ACAD SCI USA, V100, P10429, DOI 10.1073/pnas.1734137100; Orellana SA, 1998, SEMIN NEPHROL, V18, P233; Pallone TL, 1997, AM J PHYSIOL-RENAL, V272, pF587, DOI 10.1152/ajprenal.1997.272.5.F587; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Park CH, 2010, J INVEST DERMATOL, V130, P2049, DOI 10.1038/jid.2010.62; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Pathomthongtaweechai N, 2014, EUR J PHARMACOL, V724, P67, DOI 10.1016/j.ejphar.2013.12.013; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Pollack AL, 1998, DEV BIOL, V204, P64, DOI 10.1006/dbio.1998.9091; Qian CN, 2005, J BIOL CHEM, V280, P3938, DOI 10.1074/jbc.M410697200; Roberts DM, 2011, MOL BIOL CELL, V22, P1845, DOI 10.1091/mbc.E10-11-0871; Rowe I, 2014, BIOCHEM BIOPH RES CO, V444, P473, DOI 10.1016/j.bbrc.2014.01.068; Ruiz-Ederra J, 2007, INVEST OPHTH VIS SCI, V48, P4802, DOI 10.1167/iovs.07-0537; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Silva AK, 2010, MOL VIS, V16, P36; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Verkman AS, 2008, SEMIN NEPHROL, V28, P217, DOI 10.1016/j.semnephrol.2008.03.004; Verkman AS, 2014, NAT REV DRUG DISCOV, V13, P259, DOI 10.1038/nrd4226; Verkman AS, 2011, J CELL SCI, V124, P2107, DOI 10.1242/jcs.079467; Wallace DP, 2004, AM J PHYSIOL-RENAL, V287, pF639, DOI 10.1152/ajprenal.00448.2003; Wilson SJ, 2006, BBA-MOL BASIS DIS, V1762, P647, DOI 10.1016/j.bbadis.2006.04.006; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Wuebken A, 2011, KIDNEY INT, V80, P135, DOI 10.1038/ki.2011.87; Yao G, 2014, HUM MOL GENET, V23, P2769, DOI 10.1093/hmg/ddt672; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045976; Zhou H, 2012, AM J PHYSIOL-RENAL, V302, pF1234, DOI 10.1152/ajprenal.00356.2011	74	40	45	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1551	1563		10.1096/fj.14-260828	http://dx.doi.org/10.1096/fj.14-260828			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25573755	Green Published			2022-12-26	WOS:000354115000039
J	Kobayashi, S; Fukuhara, A; Otsuki, M; Suganami, T; Ogawa, Y; Morii, E; Shimomura, I				Kobayashi, Sachiko; Fukuhara, Atsunori; Otsuki, Michio; Suganami, Takayoshi; Ogawa, Yoshihiro; Morii, Eiichi; Shimomura, Iichiro			Fat/Vessel-derived Secretory Protein (Favine)/CCDC3 Is Involved in Lipid Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipogenesis; Adipose Tissue; Lipogenesis; Liver; Obesity; Coiled-coil Domain Containing 3 Gene; Favine Gene; Hepatic Steatosis	ACTIVATED RECEPTOR-GAMMA; ADIPOSE-TISSUE; INSULIN-RESISTANCE; INDUCED OBESITY; ADIPOGENESIS; LIPOGENESIS; ADIPOCYTES; BETA; FAT; DIFFERENTIATION	Background: Coiled-coil domain-containing 3 (Ccdc3) mRNA is highly expressed in adipose tissue and vessels, but its function remains unknown. Results: CCDC3 overexpression promoted adipogenesis of 3T3-L1 adipocytes, whereas CCDC3 deficiency reduced adiposity and inhibited age-related hepatic steatosis in mice. Conclusion: CCDC3 positively regulates lipid accumulation. Significance: CCDC3 is a possible therapeutic target to age-related obesity and diseases. We previously identified a novel gene encoding Favine/CCDC3 (NCBI protein entry NP_083080), a possible secretory factor, the mRNA of which is highly expressed in adipose tissue and the aorta. The Favine mRNA levels are increased in the course of differentiation of rat primary adipocytes and are more elevated in the adipose tissue of genetically obese and diet-induced obese mice than in lean mice. However, its biological function has not yet been elucidated until now. Here, we tested the hypothesis that Favine is involved in lipid metabolism in adipocytes. We found that overexpression of Favine promoted 3T3-L1 adipocyte differentiation. To further investigate the function of Favine in vivo, we generated Favine knock-out (KO) mice. Favine KO mice exhibited a lean phenotype as they aged. The weights of white adipose tissue and liver were less, and adipocyte size was smaller in Favine KO mice compared with wild-type littermates (WT). Expression levels of lipogenic genes, such as fatty-acid synthase (FAS), acetyl-CoA carboxylase (ACC1), and diacylglycerol O-acyltransferase-2 (Dgat2), were decreased in adipose tissue of Favine KO mice. In 1-year-old mice, Favine deficiency decreased the number of inflammatory cells in white adipose tissue and diminished hepatic steatosis. In vitro, deficiency of Favine attenuated differentiation of primary adipocytes. Taken together, these data demonstrate that Favine has adipogenic and lipogenic effects on adipocytes.	[Kobayashi, Sachiko; Fukuhara, Atsunori; Otsuki, Michio; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan; [Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka, Japan; [Suganami, Takayoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Organ Network & Metab, Bunkyo Ku, Tokyo, Japan; [Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Endocrinol & Metab, Bunkyo Ku, Tokyo, Japan	Osaka University; Osaka University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Fukuhara, A (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2 Yamadaoka, Suita, Osaka, Japan.	fukuhara@endmet.med.osaka-u.ac.jp	SUGANAMI, Takayoshi/A-9475-2016; Fukuhara, Atsunori/A-9601-2018	Fukuhara, Atsunori/0000-0002-6289-3778; Ogawa, Yoshihiro/0000-0002-0834-2836	Japan Society for the Promotion of Science [215490, 25860767, 24390238]; Japan Foundation for Applied Enzymology; Japan Health Foundation; Grants-in-Aid for Scientific Research [25860767] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Foundation for Applied Enzymology; Japan Health Foundation(Japan Health Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for JSPS Fellows 215490, Grant-in-aid for Young Scientists 25860767, and Grants-in-aid for Scientific Research 24390238 from the Japan Society for the Promotion of Science and a grant from Japan Foundation for Applied Enzymology and from the Japan Health Foundation.	Azad AK, 2014, CELL SIGNAL, V26, P2793, DOI 10.1016/j.cellsig.2014.08.025; BJORNTORP P, 1978, J LIPID RES, V19, P316; Boren J, 2013, J INTERN MED, V274, P25, DOI 10.1111/joim.12071; Eberlein A, 2010, COMP BIOCHEM PHYS B, V156, P19, DOI 10.1016/j.cbpb.2010.01.013; Filhoulaud G, 2013, TRENDS ENDOCRIN MET, V24, P257, DOI 10.1016/j.tem.2013.01.003; FOLCH J, 1957, J BIOL CHEM, V226, P497; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; IGNOTZ RA, 1985, P NATL ACAD SCI USA, V82, P8530, DOI 10.1073/pnas.82.24.8530; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Ito A, 2007, J BIOL CHEM, V282, P25445, DOI 10.1074/jbc.M701549200; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kobayashi S, 2010, BIOCHEM BIOPH RES CO, V392, P29, DOI 10.1016/j.bbrc.2009.12.142; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; RICHARDSON RL, 1989, J ANIM SCI, V67, P2171; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Tan JTM, 2008, AM J PHYSIOL-CELL PH, V295, pC740, DOI 10.1152/ajpcell.00333.2007; Tan JTM, 2013, AM J PHYSIOL-ENDOC M, V304, pE1291, DOI 10.1152/ajpendo.00654.2012; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Ugi S, 2014, OBESITY, V22, P1070, DOI 10.1002/oby.20645; WIESE RJ, 1995, J BIOL CHEM, V270, P3442, DOI 10.1074/jbc.270.7.3442; Zamani N, 2011, ENDOCR REV, V32, P387, DOI 10.1210/er.2010-0018; Zamboni M, 2014, MECH AGEING DEV, V136, P129, DOI 10.1016/j.mad.2013.11.008	32	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7443	7451		10.1074/jbc.M114.592493	http://dx.doi.org/10.1074/jbc.M114.592493			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25605713	hybrid, Green Published			2022-12-26	WOS:000351613600013
J	Zhao, H; Chiaro, CR; Zhang, LM; Smith, PB; Chan, CY; Pedley, AM; Pugh, RJ; French, JB; Patterson, AD; Benkovic, SJ				Zhao, Hong; Chiaro, Christopher R.; Zhang, Limin; Smith, Philip B.; Chan, Chung Yu; Pedley, Anthony M.; Pugh, Raymond J.; French, Jarrod B.; Patterson, Andrew D.; Benkovic, Stephen J.			Quantitative Analysis of Purine Nucleotides Indicates That Purinosomes Increase de Novo Purine Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLOSUCCINATE SYNTHETASE; MASS-SPECTROMETRY; CELL-GROWTH; ENZYME; COMPLEX; DNA; COMPARTMENTATION; PURIFICATION; VARIANTS; MODEL	Enzymes in the de novo purine biosynthesis pathway are recruited to form a dynamic metabolic complex referred to as the purinosome. Previous studies have demonstrated that purinosome assembly responds to purine levels in culture medium. Purine-depleted medium or 2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole (DMAT) treatment stimulates the purinosome assembly in HeLa cells. Here, several metabolomic technologies were applied to quantify the static cellular levels of purine nucleotides and measure the de novo biosynthesis rate of IMP, AMP, and GMP. Direct comparison of purinosome-rich cells (cultured in purine-depleted medium) and normal cells showed a 3-fold increase in IMP concentration in purinosomerich cells and similar levels of AMP, GMP, and ratios of AMP/GMP and ATP/ADP for both. In addition, a higher level of IMP was also observed in HeLa cells treated with DMAT. Furthermore, increases in the de novo IMP/AMP/GMP biosynthetic flux rate under purine-depleted condition were observed. The synthetic enzymes, adenylosuccinate synthase (ADSS) and inosine monophosphate dehydrogenase (IMPDH), downstream of IMP were also shown to be part of the purinosome. Collectively, these results provide further evidence that purinosome assembly is directly related to activated de novo purine biosynthesis, consistent with the functionality of the purinosome.	[Zhao, Hong; Pedley, Anthony M.; Pugh, Raymond J.; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Chiaro, Christopher R.; Zhang, Limin; Smith, Philip B.; Patterson, Andrew D.] Penn State Univ, Metabol Facil, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; [Chan, Chung Yu] Penn State Univ, Dept Engn Sci & Mech, University Pk, PA 16802 USA; [Zhang, Limin] Chinese Acad Sci, CAS Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Ctr Magnet Resonance,Wuhan Inst Phys & Math, Wuhan 430071, Peoples R China; [French, Jarrod B.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [French, Jarrod B.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Patterson, AD (corresponding author), Penn State Univ, Metabol Facil, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA.	adp117@psu.edu; sjb1@psu.edu	limin, zhang/O-8208-2016; Patterson, Andrew/G-3852-2012; French, Jarrod/K-6669-2014; Patterson, Andrew/ABF-1575-2020	limin, zhang/0000-0001-5689-948X; Patterson, Andrew/0000-0003-2073-0070; French, Jarrod/0000-0002-6762-1309; Patterson, Andrew/0000-0003-2073-0070; Pedley, Anthony/0000-0003-1034-5072	National Institutes of Health [GM024129, ES022186]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024129, R37GM024129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM024129 (to S. J. B.) and ES022186 (to A. D. P).	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; An S, 2010, J BIOL CHEM, V285, P11093, DOI 10.1074/jbc.M110.101139; Castellana M, 2014, NAT BIOTECHNOL, V32, P1011, DOI 10.1038/nbt.3018; Cordell RL, 2008, J CHROMATOGR B, V871, P115, DOI 10.1016/j.jchromb.2008.07.005; Danielsson APH, 2010, ANAL BIOCHEM, V404, P30, DOI 10.1016/j.ab.2010.04.013; DELUCA M, 1983, ARCH BIOCHEM BIOPHYS, V226, P285, DOI 10.1016/0003-9861(83)90295-3; Deng YJ, 2012, J BIOL CHEM, V287, P36201, DOI 10.1074/jbc.M112.407056; Dettmer K, 2011, ANAL BIOANAL CHEM, V399, P1127, DOI 10.1007/s00216-010-4425-x; French JB, 2013, P NATL ACAD SCI USA, V110, P2528, DOI 10.1073/pnas.1300173110; Gunter JH, 2008, INT J BIOCHEM CELL B, V40, P1716, DOI 10.1016/j.biocel.2007.12.018; Labesse G, 2013, STRUCTURE, V21, P975, DOI 10.1016/j.str.2013.03.011; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; MATHEWS CK, 1993, J BACTERIOL, V175, P6377, DOI 10.1128/jb.175.20.6377-6381.1993; Muddana HS, 2010, J AM CHEM SOC, V132, P2110, DOI 10.1021/ja908773a; OVADI J, 1991, J THEOR BIOL, V152, P1, DOI 10.1016/S0022-5193(05)80500-4; Pabst M, 2010, ANAL CHEM, V82, P9782, DOI 10.1021/ac101975k; ROWE PB, 1968, J BIOL CHEM, V243, P6373; ROWE PB, 1978, J BIOL CHEM, V253, P7711; Sengupta S, 2014, ACS NANO, V8, P2410, DOI 10.1021/nn405963x; Sengupta S, 2013, J AM CHEM SOC, V135, P1406, DOI 10.1021/ja3091615; SIDI Y, 1985, J CLIN INVEST, V76, P2416, DOI 10.1172/JCI112255; SMITH GK, 1980, BIOCHEMISTRY-US, V19, P4313, DOI 10.1021/bi00559a026; SRERE PA, 1973, P NATL ACAD SCI USA, V70, P2534, DOI 10.1073/pnas.70.9.2534; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Sun HY, 2005, MOL CELL BIOCHEM, V269, P85, DOI 10.1007/s11010-005-2539-9; Thomas EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051096; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; VANDERWE.MB, 1974, J BIOL CHEM, V249, P7282; Wang W, 2009, J BIOL CHEM, V284, P3521, DOI 10.1074/jbc.M806707200; WHITTAM R, 1960, J PHYSIOL-LONDON, V154, P614, DOI 10.1113/jphysiol.1960.sp006601; WOMBACHER H, 1983, MOL CELL BIOCHEM, V56, P155; Yamaoka T, 1997, J BIOL CHEM, V272, P17719, DOI 10.1074/jbc.272.28.17719; Yamaoka T, 2001, J BIOL CHEM, V276, P21285, DOI 10.1074/jbc.M011103200; Zamzami MA, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-24	35	65	65	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6705	6713		10.1074/jbc.M114.628701	http://dx.doi.org/10.1074/jbc.M114.628701			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605736	Green Published, hybrid			2022-12-26	WOS:000350991500005
J	Gournas, C; Evangelidis, T; Athanasopoulos, A; Mikros, E; Sophianopoulou, V				Gournas, Christos; Evangelidis, Thomas; Athanasopoulos, Alexandros; Mikros, Emmanuel; Sophianopoulou, Vicky			The Aspergillus nidulans Proline Permease as a Model for Understanding the Factors Determining Substrate Binding and Specificity of Fungal Amino Acid Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON CATABOLITE REPRESSION; UTILIZATION GENE-CLUSTER; MUTATIONAL ANALYSIS; METABOLITE REPRESSION; PROTEIN STRUCTURES; YEAST; MECHANISM; EXPRESSION; PREDICTION; RESIDUES	Amino acid uptake in fungi is mediated by general and specialized members of the yeast amino acid transporter (YAT) family, a branch of the amino acid polyamine organocation (APC) transporter superfamily. PrnB, a highly specific L-proline transporter, only weakly recognizes other Put4p substrates, its Saccharomyces cerevisiae orthologue. Taking advantage of the high sequence similarity between the two transporters, we combined molecular modeling, induced fit docking, genetic, and biochemical approaches to investigate the molecular basis of this difference and identify residues governing substrate binding and specificity. We demonstrate that L-proline is recognized by PrnB via interactions with residues within TMS1 (Gly(56), Thr(57)), TMS3(Glu(138)), and TMS6(Phe(248)), which are evolutionary conserved in YATs, whereas specificity is achieved by subtle amino acid substitutions in variable residues. Put4p-mimicking substitutions in TMS3 (S130C), TMS6 (F252L, S253G), TMS8 (W351F), and TMS10 (T414S) broadened the specificity of PrnB, enabling it to recognize more efficiently L-alanine, L-azetidine-2-carboxylic acid, and glycine without significantly affecting the apparent K-m for L-proline. S253G and W351F could transport L-alanine, whereas T414S, despite displaying reduced proline uptake, could transport L-alanine and glycine, a phenotype suppressed by the S130C mutation. A combination of all five Put4p-ressembling substitutions resulted in a functional allele that could also transport L-alanine and glycine, displaying a specificity profile impressively similar to that of Put4p. Our results support a model where residues in these positions determine specificity by interacting with the substrates, acting as gating elements, altering the flexibility of the substrate binding core, or affecting conformational changes of the transport cycle.	[Gournas, Christos; Athanasopoulos, Alexandros; Sophianopoulou, Vicky] NCSR Demokritos, Microbial Mol Genet Lab, Inst Biosci & Applicat, Athens 15310, Greece; [Evangelidis, Thomas; Mikros, Emmanuel] Univ Athens, Sch Pharm, GR-15771 Athens, Greece	National Centre of Scientific Research "Demokritos"; National & Kapodistrian University of Athens	Sophianopoulou, V (corresponding author), NCSR Demokritos, Microbial Mol Genet Lab, Inst Biosci & Applicat, Athens 15310, Greece.	vicky@bio.demokritos.gr	Mikros, Emmanuel/E-4223-2017; Gournas, Christos/ABD-6186-2021; Gournas, Christos/ADL-6622-2022	Mikros, Emmanuel/0000-0002-5984-5169; Gournas, Christos/0000-0003-4755-8602; Athanasopoulos, Alexandros/0000-0001-5551-4613	European Commission [262348]	European Commission(European CommissionEuropean Commission Joint Research Centre)	We are grateful to Prof. Claudio Scazzocchio and Dr. Sotiris Amillis for useful discussions and for critically reading the manuscript and Dr. Efstratios Stratikos for critically reading the manuscript. We also acknowledge financial support from the European Commission under the Seventh Framework Program by means of the grant agreement for the Integrated Infrastructure Initiative No. 262348 European Soft Matter Infrastructure (ESMI).	Amillis S, 2011, J MOL BIOL, V411, P567, DOI 10.1016/j.jmb.2011.06.024; Andre B, 1995, YEAST, V11, P1575, DOI 10.1002/yea.320111605; ANDRE B, 1993, MOL GEN GENET, V237, P17; Andreasson C, 2004, YEAST, V21, P193, DOI 10.1002/yea.1052; Apostolaki A, 2012, MOL MICROBIOL, V84, P530, DOI 10.1111/j.1365-2958.2012.08042.x; Apostolaki A, 2009, EUKARYOT CELL, V8, P339, DOI 10.1128/EC.00270-08; Athanasopoulos A, 2013, FUNGAL GENET BIOL, V53, P84, DOI 10.1016/j.fgb.2013.01.002; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Chang JM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S1; CUBERO B, 1994, EMBO J, V13, P407, DOI 10.1002/j.1460-2075.1994.tb06275.x; Cubero B, 2000, J BACTERIOL, V182, P233, DOI 10.1128/JB.182.1.233-235.2000; Dieterle MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010703; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Garcia I, 2004, EUKARYOT CELL, V3, P144, DOI 10.1128/EC.3.1.144-156.2004; Ghaddar K, 2014, J BIOL CHEM, V289, P7232, DOI 10.1074/jbc.M113.525915; Gomez D, 2003, MOL MICROBIOL, V50, P277, DOI 10.1046/j.1365-2958.2003.03682.x; Gonzalez R, 1997, EMBO J, V16, P2937, DOI 10.1093/emboj/16.10.2937; Gournas C, 2010, MOL MICROBIOL, V75, P246, DOI 10.1111/j.1365-2958.2009.06997.x; HORAK J, 1982, BIOCHIM BIOPHYS ACTA, V691, P144, DOI 10.1016/0005-2736(82)90223-1; Hutchings H, 1999, MOL MICROBIOL, V32, P557, DOI 10.1046/j.1365-2958.1999.01371.x; Jeschke G, 2013, EUR BIOPHYS J BIOPHY, V42, P181, DOI 10.1007/s00249-012-0802-z; Kafasla P, 2007, FUNGAL GENET BIOL, V44, P615, DOI 10.1016/j.fgb.2007.01.011; Kanda N, 2013, BIOCHEMISTRY-US, V52, P4296, DOI 10.1021/bi4004638; Karena E, 2011, J BIOL CHEM, V286, P39595, DOI 10.1074/jbc.M111.299164; Karplus K, 2009, NUCLEIC ACIDS RES, V37, pW492, DOI 10.1093/nar/gkp403; KINGHORN JR, 1975, J GEN MICROBIOL, V86, P174, DOI 10.1099/00221287-86-1-174; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Krypotou E, 2014, MOL MICROBIOL, V93, P129, DOI 10.1111/mmi.12646; Krypotou E, 2012, J BIOL CHEM, V287, P36792, DOI 10.1074/jbc.M112.400382; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Ma D, 2012, NATURE, V483, P632, DOI 10.1038/nature10917; Moretti MB, 1998, CELL MOL BIOL, V44, P585; Nasuno R, 2013, P NATL ACAD SCI USA, V110, P11821, DOI 10.1073/pnas.1300558110; Nomura M, 2003, J BIOCHEM, V133, P67, DOI 10.1093/jb/mvg003; Ogawa-Mitsuhashi K, 2009, YEAST, V26, P587, DOI 10.1002/yea.1708; Omura F, 2005, BIOSCI BIOTECH BIOCH, V69, P1162, DOI 10.1271/bbb.69.1162; Papageorgiou L, 2008, J MOL BIOL, V382, P1121, DOI 10.1016/j.jmb.2008.08.005; Papakostas K, 2013, J BIOL CHEM, V288, P36827, DOI 10.1074/jbc.M113.523340; Papakostas K, 2012, J BIOL CHEM, V287, P15684, DOI 10.1074/jbc.M112.355818; Piscitelli CL, 2012, EMBO J, V31, P228, DOI 10.1038/emboj.2011.353; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roumelioti K, 2010, FUNGAL GENET BIOL, V47, P254, DOI 10.1016/j.fgb.2009.12.004; Sanguinetti M, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140070; Schulze S, 2010, NATURE, V467, P233, DOI 10.1038/nature09310; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; SOPHIANOPOULOU V, 1995, FEMS MICROBIOL REV, V16, P53, DOI 10.1016/0168-6445(94)00091-C; SOPHIANOPOULOU V, 1989, MOL MICROBIOL, V3, P705, DOI 10.1111/j.1365-2958.1989.tb00219.x; SOPHIANOPOULOU V, 1993, MOL GEN GENET, V236, P209, DOI 10.1007/BF00277114; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tavoularis S, 2001, FUNGAL GENET BIOL, V33, P115, DOI 10.1006/fgbi.2001.1280; Tavoularis SN, 2003, MOL MEMBR BIOL, V20, P285, DOI 10.1080/0968768031000106339; Tazebay UH, 1997, MOL MICROBIOL, V24, P105, DOI 10.1046/j.1365-2958.1997.3201689.x; TAZEBAY UH, 1995, FEMS MICROBIOL LETT, V132, P27; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; Trip H, 2004, APPL ENVIRON MICROB, V70, P4775, DOI 10.1128/AEM.70.8.4775-4783.2004; Usami Y, 2014, BBA-BIOMEMBRANES, V1838, P1719, DOI 10.1016/j.bbamem.2014.03.018; Van Belle D, 2001, CURR OPIN CELL BIOL, V13, P389, DOI 10.1016/S0955-0674(00)00226-X; Vangelatos I, 2010, EUKARYOT CELL, V9, P1441, DOI 10.1128/EC.00087-10; Vangelatos I, 2009, MOL MEMBR BIOL, V26, P356, DOI 10.1080/09687680903170546; Vastermark A, 2014, PROTEINS, V82, P2797, DOI 10.1002/prot.24643; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wong FH, 2012, J MOL MICROB BIOTECH, V22, P105, DOI 10.1159/000338542; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Yadav AK, 2011, J BIOL CHEM, V286, P19714, DOI 10.1074/jbc.M111.240648; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	79	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6141	6155		10.1074/jbc.M114.612069	http://dx.doi.org/10.1074/jbc.M114.612069			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25572393	Green Published, hybrid			2022-12-26	WOS:000350732500023
J	Kaps, S; Kettner, K; Migotti, R; Kanashova, T; Krause, U; Rodel, G; Dittmar, G; Kriegel, TM				Kaps, Sonja; Kettner, Karina; Migotti, Rebekka; Kanashova, Tamara; Krause, Udo; Roedel, Gerhard; Dittmar, Gunnar; Kriegel, Thomas M.			Protein Kinase Ymr291w/Tda1 Is Essential for Glucose Signaling in Saccharomyces cerevisiae on the Level of Hexokinase Isoenzyme ScHxk2 Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO PHOSPHORYLATION; KLUYVEROMYCES-LACTIS; YEAST-HEXOKINASE; AUTOPHOSPHORYLATION-INACTIVATION; POSTTRANSLATIONAL MODIFICATIONS; GENE; PURIFICATION; PATHWAY; COMPLEX; CELLS	The enzyme ScHxk2 of Saccharomyces cerevisiae is a dual-function hexokinase that besides its catalytic role in glycolysis is involved in the transcriptional regulation of glucose-repressible genes. Relief from glucose repression is accompanied by the phosphorylation of the nuclear fraction of ScHxk2 at serine 15 and the translocation of the phosphoenzyme into the cytosol. Different studies suggest different serine/threonine protein kinases, Ymr291w/Tda1 or Snf1, to accomplish ScHxk2-S15 phosphorylation. The current paper provides evidence that Ymr291w/Tda1 is essential for that modification, whereas protein kinases Ydr477w/Snf1, Ynl307c/Mck1, Yfr014c/Cmk1, and Ykl126w/Ypk1, which are co-purified during Ymr291w/Tda1 tandem affinity purification, as well as protein kinase PKA and PKB homolog Sch9 are dispensable. Taking into account the detection of a significantly higher amount of the Ymr291w/Tda1 protein in cells grown in low-glucose media as compared with a high-glucose environment, Ymr291w/Tda1 is likely to contribute to glucose signaling in S. cerevisiae on the level of ScHxk2-S15 phosphorylation in a situation of limited external glucose availability. The evolutionary conservation of amino acid residue serine 15 in yeast hexokinases and its phosphorylation is illustrated by the finding that YMR291W/TDA1 of S. cerevisiae and the homologous KLLA0A09713 gene of Kluyveromyces lactis allow for cross-complementation of the respective protein kinase single-gene deletion strains.	[Kaps, Sonja; Kettner, Karina; Kriegel, Thomas M.] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Physiol Chem, D-01307 Dresden, Germany; [Migotti, Rebekka; Kanashova, Tamara; Dittmar, Gunnar] Max Delbruck Ctr Mol Med, Mass Spectrometry Platform, D-13125 Berlin, Germany; [Krause, Udo; Roedel, Gerhard] Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany	Technische Universitat Dresden; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Technische Universitat Dresden	Kettner, K (corresponding author), Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Physiol Chem, D-01307 Dresden, Germany.	Karina.Kettner@tu-dresden.de	Roedel, Gerhard/AFQ-8997-2022; Roedel, Gerhard/AAH-3762-2022; Dittmar, Gunnar/C-6333-2019; Krause, Udo/N-8167-2014; Dittmar, Gunnar/B-6383-2016	Dittmar, Gunnar/0000-0003-3647-8623; Krause, Udo/0000-0001-9493-4522; Dittmar, Gunnar/0000-0003-3647-8623				Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Ahuatzi D, 2004, J BIOL CHEM, V279, P14440, DOI 10.1074/jbc.M313431200; Ahuatzi D, 2007, J BIOL CHEM, V282, P4485, DOI 10.1074/jbc.M606854200; Bar D, 2003, J BIOL CHEM, V278, P39280, DOI 10.1074/jbc.M305706200; Behlke J, 1998, BIOCHEMISTRY-US, V37, P11989, DOI 10.1021/bi980914m; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; BREUNIG KD, 1987, MOL CELL BIOL, V7, P4400, DOI 10.1128/MCB.7.12.4400; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cyert MS, 2001, ANNU REV GENET, V35, P647, DOI 10.1146/annurev.genet.35.102401.091302; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Farriol-Mathis N, 2004, PROTEOMICS, V4, P1537, DOI 10.1002/pmic.200300764; Fernandez-Garcia P, 2012, J BIOL CHEM, V287, P42151, DOI 10.1074/jbc.M112.401679; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; Golbik R, 2001, BIOCHEMISTRY-US, V40, P1083, DOI 10.1021/bi001745k; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Granot D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00044; Heidrich K, 1997, BIOCHEMISTRY-US, V36, P1960, DOI 10.1021/bi9623643; Herrero P, 1998, FEBS LETT, V434, P71, DOI 10.1016/S0014-5793(98)00872-2; HERRERO P, 1995, YEAST, V11, P137, DOI 10.1002/yea.320110205; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kettner K, 2013, BIOCHEM BIOPH RES CO, V435, P313, DOI 10.1016/j.bbrc.2013.03.121; Kettner K, 2012, FEBS LETT, V586, P455, DOI 10.1016/j.febslet.2012.01.030; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; KRIEGEL TM, 1994, BIOCHEMISTRY-US, V33, P148, DOI 10.1021/bi00167a019; Kuettner EB, 2010, J BIOL CHEM, V285, P41019, DOI 10.1074/jbc.M110.185850; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; LAZARUS NR, 1966, BIOCHEMISTRY-US, V5, P4003, DOI 10.1021/bi00876a035; MAITRA PK, 1970, J BIOL CHEM, V245, P2423; Mates N, 2014, MOL CELL PROTEOMICS, V13, P860, DOI 10.1074/mcp.M113.032714; Moreno F, 2002, FEMS MICROBIOL REV, V26, P83, DOI 10.1111/j.1574-6976.2002.tb00600.x; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Oliveira AP, 2012, FEMS YEAST RES, V12, P104, DOI 10.1111/j.1567-1364.2011.00765.x; Pelaez R, 2012, J BIOL CHEM, V287, P3518, DOI 10.1074/jbc.M111.317230; Pelaez R, 2009, J BIOL CHEM, V284, P20548, DOI 10.1074/jbc.M109.013730; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Randez-Gil F, 1998, MOL CELL BIOL, V18, P2940, DOI 10.1128/MCB.18.5.2940; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHULZ WA, 1993, BIOL CHEM H-S, V374, P313, DOI 10.1515/bchm3.1993.374.1-6.313; Sherman F, 1986, LAB COURSE MANUAL ME; SHERO JH, 1991, GENE DEV, V5, P549, DOI 10.1101/gad.5.4.549; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; VOJTEK AB, 1990, EUR J BIOCHEM, V190, P371, DOI 10.1111/j.1432-1033.1990.tb15585.x; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Zaman S, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.2	61	13	13	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6243	6255		10.1074/jbc.M114.595074	http://dx.doi.org/10.1074/jbc.M114.595074			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25593311	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000350732500031
J	Villagomez, R; Hatti-Kaul, R; Sterner, O; Almanza, G; Linares-Pasten, JA				Villagomez, Rodrigo; Hatti-Kaul, Rajni; Sterner, Olov; Almanza, Giovanna; Linares-Pasten, Javier A.			Effect of Natural and Semisynthetic Pseudoguianolides on the Stability of NF-kappa B: DNA Complex Studied by Agarose Gel Electrophoresis	PLOS ONE			English	Article							SESQUITERPENE LACTONES; TRANSCRIPTION; INHIBITORS; CANCER; ALPHA; IKK; P65/NF-KAPPA-B; ACTIVATION; LUCIFERASE; EXPRESSION	The nuclear factor.B (NF-kappa B) is a promising target for drug discovery. NF-kappa B is a heterodimeric complex of RelA and p50 subunits that interact with the DNA, regulating the expression of several genes; its dysregulation can trigger diverse diseases including inflammation, immunodeficiency, and cancer. There is some experimental evidence, based on whole cells studies, that natural sesquiterpene lactones (Sls) can inhibit the interaction of NF-kappa B with DNA, by alkylating the RelA subunit via a Michael addition. In the present work, 28 natural and semisynthetic pseudoguianolides were screened as potential inhibitors of NF-kappa B in a biochemical assay that was designed using pure NF-kappa B heterodimer, pseudoguianolides and a similar to 1000 bp palindromic DNA fragment harboring two NF-kappa B recognition sequences. By comparing the relative amount of free DNA fragment to the NF-kappa B -DNA complex, in a routine agarose gel electrophoresis, the destabilizing effect of a compound on the complex is estimated. The results of the assay and the following structure-activity relationship study, allowed the identification of several relevant structural features in the pseudoguaianolide skeleton, which are necessary to enhance the dissociating capacity of NF-kappa B-DNA complex. The most active compounds are substituted at C-3 (alpha-carbonyl), in addition to having the alpha-methylene-gamma-lactone moiety which is essential for the alkylation of RelA.	[Villagomez, Rodrigo; Sterner, Olov] Lund Univ, Ctr Anal & Synth, S-22100 Lund, Sweden; [Villagomez, Rodrigo; Almanza, Giovanna] Univ Mayor San Andres, Fac Ciencias Puras & Nat, Inst Invest Quim, La Paz, Bolivia; [Hatti-Kaul, Rajni; Linares-Pasten, Javier A.] Lund Univ, Dept Chem, SE-22100 Lund, Sweden	Lund University; Universidad Mayor de San Andres; Lund University	Linares-Pasten, JA (corresponding author), Lund Univ, Dept Chem, POB 124, SE-22100 Lund, Sweden.	Javier.Linares_Pasten@biotek.lu.se	Linares-Pastén, Javier/N-8450-2018	Linares-Pastén, Javier/0000-0001-6999-6334; Almanza, Giovanna Rocio/0000-0002-5362-252X	Research Department of the Swedish International Development Cooperation Agency (SIDA-SAREC)	Research Department of the Swedish International Development Cooperation Agency (SIDA-SAREC)	This work was financially supported by the Research Department of the Swedish International Development Cooperation Agency (SIDA-SAREC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHOND A, 1968, J AM CHEM SOC, V90, P5622, DOI 10.1021/ja01022a063; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Bremner P, 2002, J PHARM PHARMACOL, V54, P453, DOI 10.1211/0022357021778637; Castro AC, 2003, BIOORG MED CHEM LETT, V13, P2419, DOI 10.1016/S0960-894X(03)00408-6; Chen FE, 1999, PROTEIN ENG, V12, P423, DOI 10.1093/protein/12.5.423; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Di L, 2006, DRUG DISCOV TODAY, V11, P446, DOI 10.1016/j.drudis.2006.03.004; Ding CY, 2014, ORG BIOMOL CHEM, V12, P8442, DOI 10.1039/c4ob01040j; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; DJALALIBEHZAD G, 1981, MUTAT RES, V84, P1, DOI 10.1016/0027-5107(81)90044-0; FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884; Garcia-Pineres AJ, 2004, LIFE SCI, V75, P841, DOI 10.1016/j.lfs.2004.01.024; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Gasparian AV, 2009, CELL CYCLE, V8, P1559, DOI 10.4161/cc.8.10.8415; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; ISRAEL N, 1992, J IMMUNOL, V149, P3386; Johansson MH, 2012, MINI-REV MED CHEM, V12, P1330; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Lai CF, 2006, ASSAY DRUG DEV TECHN, V4, P307, DOI 10.1089/adt.2006.4.307; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Lindenmeyer MT, 2004, ANAL BIOCHEM, V328, P147, DOI 10.1016/j.ab.2004.01.021; Ma DL, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr106; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Miller SC, 2010, BIOCHEM PHARMACOL, V79, P1272, DOI 10.1016/j.bcp.2009.12.021; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Olivier S, 2006, BIOCHEM PHARMACOL, V72, P1054, DOI 10.1016/j.bcp.2006.07.023; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Plummer SM, 1999, ONCOGENE, V18, P6013, DOI 10.1038/sj.onc.1202980; Riganti C, 2008, MOL PHARMACOL, V74, P476, DOI 10.1124/mol.108.045286; Rungeler P, 1999, BIOORGAN MED CHEM, V7, P2343, DOI 10.1016/S0968-0896(99)00195-9; Salminen A, 2008, CELL MOL LIFE SCI, V65, P2979, DOI 10.1007/s00018-008-8103-5; Sue SC, 2008, J MOL BIOL, V380, P917, DOI 10.1016/j.jmb.2008.05.048; SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346; Verma IM, 2004, ANN RHEUM DIS, V63, P57, DOI 10.1136/ard.2004.028266; Villagomez R., 2014, J BIOMEDICAL SCI ENG, DOI DOI 10.4236/JBISE.2014.710083; VILLAGOMEZ R, 2014, THESIS LUND U LUND; Villagomez R, 2013, ANTICANCER RES, V33, P3799; Zhao XN, 2003, ASSAY DRUG DEV TECHN, V1, P823, DOI 10.1089/154065803772613453	41	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115819	10.1371/journal.pone.0115819	http://dx.doi.org/10.1371/journal.pone.0115819			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615602	Green Published, Green Submitted, gold			2022-12-26	WOS:000349122100018
J	Bi, YD; Li, W; Xiao, JL; Lin, H; Liu, M; Liu, M; Luan, XY; Zhang, BX; Xie, XJ; Guo, DL; Lai, YC				Bi, Yingdong; Li, Wei; Xiao, Jialei; Lin, Hong; Liu, Ming; Liu, Miao; Luan, Xiaoyan; Zhang, Bixian; Xie, Xuejun; Guo, Donglin; Lai, Yongcai			Heterosis and Combining Ability Estimates in Isoflavone Content Using Different Parental Soybean Accessions: Wild Soybean, a Valuable Germplasm for Soybean Breeding	PLOS ONE			English	Article							GENETIC-RESOURCES; CROP IMPROVEMENT; RESISTANCE; QTL; SOY; IDENTIFICATION; ENVIRONMENT; TOLERANCE; CULTIVARS; DIVERSITY	Isoflavone, a group of secondary metabolites in soybean, is beneficial to human health. Improving isoflavone content in soybean seeds has become one of the most important breeding objectives. However, the narrow genetic base of soybean cultivars hampered crop improvement. Wild soybean is an extraordinarily important gene pool for soybean breeding. In order to select an optimal germplasm for breeding programs to increase isoflavone concentration, 36 F1 soybean progenies from different parental accessions (cultivars, wild, Semi-wild and Interspecific) with various total isoflavone (TIF) concentration (High, Middle, Low) were analyzed for their isoflavone content. Results showed that male parents, except for Cultivars, showed positive GCA effects. In particular, wild soybean had higher positive GCA effects for TIF concentration. Both MP and BP heterosis value declined in the hybrid in which male parents were wild soybean, semi-wild soybean, interspecific offspring and cultivar in turn. In general, combining ability and heterosis in hybrids which had relative higher TIF concentration level parents showed better performance than those which had lower TIF concentration level parents. These results indicated characteristics of isoflavone content were mainly governed by additive type of gene action, and wild relatives could be utilized for breeding of soybean cultivars with this trait. A promising combination was found as the best potential hybrid for isoflavone content improvement.	[Bi, Yingdong] Northeast Forestry Univ, Heilongjiang Acad Agr Sci, Postdoctoral Programme, Harbin 150086, Peoples R China; [Bi, Yingdong; Li, Wei; Xiao, Jialei; Liu, Ming; Liu, Miao; Zhang, Bixian; Lai, Yongcai] Heilongjiang Acad Agr Sci, Inst Crops Tillage & Cultivat, Harbin 150086, Peoples R China; [Lin, Hong] Heilongjiang Acad Agr Sci, Crops Breeding Inst, Harbin 150086, Peoples R China; [Luan, Xiaoyan] Heilongjiang Acad Agr Sci, Inst Soybean, Harbin 150086, Peoples R China; [Xie, Xuejun] Heilongjiang Acad Agr Sci, Inst Food Proc, Harbin 150086, Peoples R China; [Guo, Donglin] Harbin Normal Univ, Life Sci & Technol Coll, Harbin 150025, Peoples R China	Heilongjiang Academy of Agricultural Sciences; Northeast Forestry University - China; Heilongjiang Academy of Agricultural Sciences; Heilongjiang Academy of Agricultural Sciences; Heilongjiang Academy of Agricultural Sciences; Heilongjiang Academy of Agricultural Sciences; Harbin Normal University	Lai, YC (corresponding author), Heilongjiang Acad Agr Sci, Inst Crops Tillage & Cultivat, 368 Xuefu Rd, Harbin 150086, Peoples R China.	ydbi308@163.com			Special Financial Grant from China Postdoctoral Science Foundation [2014T70373]; China Postdoctoral Science Foundation [2013M541422]; Department of Science and Technology of Heilongjiang Province [LC2011C30]; Haerbin Science and Technology Bureau [2011RFLYN019]; Young Foundation major project of HAAS [2012ZD031]; Department of Human Resource of Heilongjiang Province [2012-134]; Conservation and utilization of wild plant resources in agriculture, China Ministry of Agriculture [201003021]; National Natural Science Foundation of China [31101171]	Special Financial Grant from China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Department of Science and Technology of Heilongjiang Province; Haerbin Science and Technology Bureau; Young Foundation major project of HAAS; Department of Human Resource of Heilongjiang Province; Conservation and utilization of wild plant resources in agriculture, China Ministry of Agriculture; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is a part of a project financed by Special Financial Grant from China Postdoctoral Science Foundation (2014T70373); 54-class General Financial Grant from China Postdoctoral Science Foundation (2013M541422); Department of Science and Technology of Heilongjiang Province (LC2011C30); Haerbin Science and Technology Bureau (2011RFLYN019); Young Foundation major project of HAAS (2012ZD031); Department of Human Resource of Heilongjiang Province (2012-134); Conservation and utilization of wild plant resources in agriculture, China Ministry of Agriculture (201003021); and National Natural Science Foundation of China (Grant No. 31101171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Gallegos JA, 2007, CROP SCI, V47, pS44, DOI 10.2135/cropsci2007.04.0008IPBS; Berger JD, 2012, FIELD CROP RES, V126, P119, DOI 10.1016/j.fcr.2011.09.020; Berger M, 2008, CROP SCI, V48, P700, DOI 10.2135/cropsci2007.08.0431; Burton JW, 2006, CROP SCI, V46, P2643, DOI 10.2135/cropsci2006.03.0156; Chiari L, 2004, EUPHYTICA, V138, P55, DOI 10.1023/B:EUPH.0000047060.03101.4a; Cvejic J, 2011, FOOD RES INT, V44, P2698, DOI 10.1016/j.foodres.2011.05.024; Damania AB, 2008, AGRON J, V100, P9, DOI 10.2134/agronj2005.0239c; Dixon RA, 2003, PLANT PHYSIOL, V131, P878, DOI 10.1104/pp.102.017319; Djuric Z, 2001, CANCER LETT, V172, P1, DOI 10.1016/S0304-3835(01)00627-9; DUDLEY JW, 1969, CROP SCI, V9, P257, DOI 10.2135/cropsci1969.0011183X000900030001x; ELDRIDGE AC, 1983, J AGR FOOD CHEM, V31, P394, DOI 10.1021/jf00116a052; Forkmann G, 2001, CURR OPIN BIOTECH, V12, P155, DOI 10.1016/S0958-1669(00)00192-0; Gutierrez-Gonzalez JJ, 2009, THEOR APPL GENET, V119, P1069, DOI 10.1007/s00122-009-1109-z; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; Heywood Vernon Hilton, 2008, Turkish Journal of Botany, V32, P421; Hill CB, 2004, J ECON ENTOMOL, V97, P1071, DOI 10.1603/0022-0493(2004)097[1071:ROGSAV]2.0.CO;2; Hill CB, 2006, CROP SCI, V46, P1601, DOI 10.2135/cropsci2005.11-0421; Hoeck JA, 2000, CROP SCI, V40, P48, DOI 10.2135/cropsci2000.40148x; Huizhen L, 2005, AGR SCI CHINA, V4, P555; Jin Y, 2003, NEW PHYTOL, V159, P513, DOI 10.1046/j.1469-8137.2003.00824.x; Jung W, 2000, NAT BIOTECHNOL, V18, P208, DOI 10.1038/72671; Kim KS, 2012, THEOR APPL GENET, V125, P1353, DOI 10.1007/s00122-012-1944-1; Kim M, 2011, CROP SCI, V51, P934, DOI 10.2135/cropsci2010.08.0459; Kim SH, 2005, EUR FOOD RES TECHNOL, V220, P207, DOI 10.1007/s00217-004-1048-5; KORNEGAY JL, 1986, CROP SCI, V26, P1153, DOI 10.2135/cropsci1986.0011183X002600060015x; Kuroda Y, 2013, ECOL EVOL, V3, P2150, DOI 10.1002/ece3.606; [来永才 LAI Yongcai], 2008, [大豆科学, Soybean Science], V27, P212; Lakew B, 2011, FIELD CROP RES, V120, P161, DOI 10.1016/j.fcr.2010.09.011; Lee SJ, 2003, FIELD CROP RES, V81, P181, DOI 10.1016/S0378-4290(02)00220-4; Li DD, 2008, CROP SCI, V48, P571, DOI 10.2135/cropsci2007.06.0361; Liang HuiZhen, 2005, Scientia Agricultura Sinica, V38, P2147; Lin H, 2005, J PLANT GENETIC RESO, V6, P53; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Luo XJ, 2011, PLANT SCI, V181, P14, DOI 10.1016/j.plantsci.2010.12.009; Makanda I, 2010, FIELD CROP RES, V116, P75, DOI 10.1016/j.fcr.2009.11.015; Messina M, 2004, CURR OPIN CLIN NUTR, V7, P649, DOI 10.1097/00075197-200411000-00010; Messina M, 2010, J NUTR, V140, p1350S, DOI 10.3945/jn.109.118315; Morrison MJ, 2010, FIELD CROP RES, V117, P113, DOI 10.1016/j.fcr.2010.02.005; Ohara Masashi, 2002, Plant Species Biology, V17, P51, DOI 10.1046/j.1442-1984.2002.00073.x; Primomo VS, 2005, CROP SCI, V45, P2454, DOI 10.2135/cropsci2004.0672; Primomo VS, 2005, CROP SCI, V45, P2203, DOI 10.2135/cropsci2004.0610; Riday H, 2005, CROP SCI, V45, P8; Schnable PS, 2013, ANNU REV PLANT BIOL, V64, P71, DOI 10.1146/annurev-arplant-042110-103827; Sebolt AM, 2000, CROP SCI, V40, P1438, DOI 10.2135/cropsci2000.4051438x; Seguin P, 2004, J SCI FOOD AGR, V84, P1327, DOI 10.1002/jsfa.1825; Setchell KDR, 1999, J NUTR, V129, p758S, DOI 10.1093/jn/129.3.758S; Singh RJ, 1999, GENOME, V42, P605, DOI 10.1139/gen-42-4-605; Singh SP, 2001, CROP SCI, V41, P1659, DOI 10.2135/cropsci2001.1659; Sneller CH, 2005, J CROP IMPROV, V14, P103, DOI 10.1300/J411v14n01_06; Sun JunMing, 2002, Agricultural Sciences in China, V1, P274; TAYYAB M A, 1990, PKV Research Journal, V14, P1; Tepavcevic V, 2010, J MED FOOD, V13, P657, DOI 10.1089/jmf.2009.0050; Ulukan H, 2007, J TEKIRDAG AGR FACUL, V4, P113; Ulukan H, 2011, ACTA AGR SCAND B-S P, V61, P97, DOI 10.1080/09064710903573390; Verpoorte R, 2002, CURR OPIN BIOTECH, V13, P181, DOI 10.1016/S0958-1669(02)00308-7; Wang CY, 2000, J AM OIL CHEM SOC, V77, P483, DOI 10.1007/s11746-000-0077-6; WANG HJ, 1994, J AGR FOOD CHEM, V42, P1674, DOI 10.1021/jf00044a017; Wang KJ, 2011, PLANT BREEDING, V130, P117, DOI 10.1111/j.1439-0523.2010.01815.x; Zamir D, 2001, NAT REV GENET, V2, P983, DOI 10.1038/35103590	59	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0114827	10.1371/journal.pone.0114827	http://dx.doi.org/10.1371/journal.pone.0114827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607952	gold, Green Published, Green Submitted			2022-12-26	WOS:000348205300005
J	Wessel, SW; van der Mei, HC; Morando, D; Slomp, AM; van de Belt-Gritter, B; Maitra, A; Busscher, HJ				Wessel, Stefan W.; van der Mei, Henny C.; Morando, David; Slomp, Anje M.; van de Belt-Gritter, Betsy; Maitra, Amarnath; Busscher, Henk J.			Quantification and Qualification of Bacteria Trapped in Chewed Gum	PLOS ONE			English	Article							FREE CHEWING GUM; REAL-TIME PCR; PORPHYROMONAS-GINGIVALIS; BIOFILM FORMATION; DENTAL BIOFILM; HUMAN SALIVA; ORAL-HEALTH; PLAQUE; XYLITOL; CARIES	Chewing of gum contributes to the maintenance of oral health. Many oral diseases, including caries and periodontal disease, are caused by bacteria. However, it is unknown whether chewing of gum can remove bacteria from the oral cavity. Here, we hypothesize that chewing of gum can trap bacteria and remove them from the oral cavity. To test this hypothesis, we developed two methods to quantify numbers of bacteria trapped in chewed gum. In the first method, known numbers of bacteria were finger-chewed into gum and chewed gums were molded to standard dimensions, sonicated and plated to determine numbers of colony- forming-units incorporated, yielding calibration curves of colony-forming-units retrieved versus finger-chewed in. In a second method, calibration curves were created by finger-chewing known numbers of bacteria into gum and subsequently dissolving the gum in a mixture of chloroform and tris-ethylenediaminetetraacetic-acid (TE)-buffer. The TE-buffer was analyzed using quantitative Polymerase-Chain-Reaction (qPCR), yielding calibration curves of total numbers of bacteria versus finger-chewed in. Next, five volunteers were requested to chew gum up to 10 min after which numbers of colony-forming-units and total numbers of bacteria trapped in chewed gum were determined using the above methods. The qPCR method, involving both dead and live bacteria yielded higher numbers of retrieved bacteria than plating, involving only viable bacteria. Numbers of trapped bacteria were maximal during initial chewing after which a slow decrease over time up to 10 min was observed. Around 108 bacteria were detected per gum piece depending on the method and gum considered. The number of species trapped in chewed gum increased with chewing time. Trapped bacteria were clearly visualized in chewed gum using scanning-electron-microscopy. Summarizing, using novel methods to quantify and qualify oral bacteria trapped in chewed gum, the hypothesis is confirmed that chewing of gum can trap and remove bacteria from the oral cavity.	[Wessel, Stefan W.; van der Mei, Henny C.; Slomp, Anje M.; van de Belt-Gritter, Betsy; Busscher, Henk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands; [Morando, David; Maitra, Amarnath] William Wrigley Jr Co, Chicago, IL USA	University of Groningen; Mars	van der Mei, HC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.	h.c.van.der.mei@umcg.nl	Busscher, Henk/AAU-2113-2020	Busscher, Henk/0000-0002-3644-5533	Wm. Wrigley Jr. Co, Chicago, USA; SASA BV, Thesinge, NL	Wm. Wrigley Jr. Co, Chicago, USA; SASA BV, Thesinge, NL	This work was funded by Wm. Wrigley Jr. Co, Chicago, USA and SASA BV, Thesinge, NL. Authors were employed by their own organizations. Wm. Wrigley Jr. Co, Chicago had a role in study design (qPCR experiments), decision to publish and preparation of manuscript. SASA BV had a role in study design, data analysis and preparation of manuscript.	Al-Ahmad A, 2008, ARCH ORAL BIOL, V53, P765, DOI 10.1016/j.archoralbio.2008.02.014; Balakrishnan M, 2000, AUST DENT J, V45, P235, DOI 10.1111/j.1834-7819.2000.tb00257.x; BIRKHED D, 1994, ACTA ODONTOL SCAND, V52, P116, DOI 10.3109/00016359409029065; Burt BA, 2006, J AM DENT ASSOC, V137, P190, DOI 10.14219/jada.archive.2006.0144; Chaudhari Lalit Kumar D, 2012, J Contemp Dent Pract, V13, P71; Dawes C, 2001, ARCH ORAL BIOL, V46, P625, DOI 10.1016/S0003-9969(01)00017-6; Diaz PI, 2012, MOL ORAL MICROBIOL, V27, P182, DOI 10.1111/j.2041-1014.2012.00642.x; Dige I, 2009, MICROBIOL-SGM, V155, P2116, DOI 10.1099/mic.0.027706-0; Drakopoulou S, 2009, ULTRASON SONOCHEM, V16, P629, DOI 10.1016/j.ultsonch.2008.11.011; Edgar M., 2004, SALIVA ORAL HLTH; Ferreira A.V.B., 1996, FUNGAL GENETICS NEWS, V43, P25; Fritz D., 2006, FORMULATION PRODUCTI; Greenberg M, 2007, J AGR FOOD CHEM, V55, P9465, DOI 10.1021/jf072122h; Hanham A, 2001, J CLIN PERIODONTOL, V28, P255, DOI 10.1034/j.1600-051x.2001.028003255.x; Hetherington MM, 2011, APPETITE, V57, P475, DOI 10.1016/j.appet.2011.06.008; Imfeld T, 1999, CRIT REV ORAL BIOL M, V10, P405, DOI 10.1177/10454411990100030901; Imfeld Thomas, 2006, Schweiz Monatsschr Zahnmed, V116, P476; Johnson AJ, 2011, APPETITE, V56, P408, DOI 10.1016/j.appet.2010.12.025; Kakodkar P, 2011, DENT RES J ISFAHAN, V7, P64; Keukenmeester RS, 2013, INT J DENT HYG, V11, P2, DOI 10.1111/j.1601-5037.2012.00562.x; Kreth J, 2009, DNA CELL BIOL, V28, P397, DOI 10.1089/dna.2009.0868; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Ly KA, 2008, J AM DENT ASSOC, V139, P553, DOI 10.14219/jada.archive.2008.0215; Lyons SR, 2000, J CLIN MICROBIOL, V38, P2362; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Mickenautsch S, 2007, J APPL ORAL SCI, V15, P83, DOI 10.1590/S1678-77572007000200002; Milgrom P, 2006, J DENT RES, V85, P177, DOI 10.1177/154405910608500212; MOUTON C, 1975, ACTA ODONTOL SCAND, V33, P33, DOI 10.3109/00016357509004624; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Pitt WG, 2003, BIOTECHNOL PROGR, V19, P1038, DOI 10.1021/bp0340685; Quirynen M, 2003, J PERIODONTOL, V74, P312, DOI 10.1902/jop.2003.74.3.312; Quirynen M, 2001, J CLIN PERIODONTOL, V28, P1106, DOI 10.1034/j.1600-051X.2001.281204.x; Rasooli I, 2009, INT J DENT HYG, V7, P196, DOI 10.1111/j.1601-5037.2009.00389.x; ROSENHEK M, 1993, ARCH ORAL BIOL, V38, P885, DOI 10.1016/0003-9969(93)90098-7; Scholey A, 2004, APPETITE, V43, P215, DOI 10.1016/j.appet.2004.07.004; Sjogren K, 2002, CARIES RES, V36, P64, DOI 10.1159/000057593; Smith A, 2010, NUTR NEUROSCI, V13, P7, DOI 10.1179/147683010X12611460763526; STINSON MW, 1993, CRIT REV ORAL BIOL M, V4, P309, DOI 10.1177/10454411930040030801; SYED SA, 1972, APPL MICROBIOL, V24, P638, DOI 10.1128/AEM.24.4.638-644.1972; van der Mei H C, 2003, J Clin Dent, V14, P14; Weiger R, 1997, J PERIODONTAL RES, V32, P233, DOI 10.1111/j.1600-0765.1997.tb00529.x; Yamanaka A, 2000, Bull Tokyo Dent Coll, V41, P123, DOI 10.2209/tdcpublication.41.123; Zarco MF, 2012, ORAL DIS, V18, P109, DOI 10.1111/j.1601-0825.2011.01851.x	43	11	12	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0117191	10.1371/journal.pone.0117191	http://dx.doi.org/10.1371/journal.pone.0117191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602256	Green Published, Green Submitted, gold			2022-12-26	WOS:000348203500044
J	Prentice, K; Pertry, I; Christiaens, O; Bauters, L; Bailey, A; Niblett, C; Ghislain, M; Gheysen, G; Smagghe, G				Prentice, Katterinne; Pertry, Ine; Christiaens, Olivier; Bauters, Lander; Bailey, Ana; Niblett, Chuck; Ghislain, Marc; Gheysen, Godelieve; Smagghe, Guy			Transcriptome Analysis and Systemic RNAi Response in the African Sweetpotato Weevil (Cylas puncticollis, Coleoptera, Brentidae)	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DISTINCT ROLES; INTERFERENCE; GENE; EXPRESSION; MICRORNAS; PROTEIN; BEETLE; IDENTIFICATION; PERSPECTIVE	The African sweetpotato weevil (SPW) Cylas puncticollis Boheman is one of the most important constraints of sweetpotato production in Sub-Saharan Africa and yet is largely an uncharacterized insect pest. Here, we report on the transcriptome analysis of SPW generated using an Illumina platform. More than 213 million sequencing reads were obtained and assembled into 89,599 contigs. This assembly was followed by a gene ontology annotation. Subsequently, a transcriptome search showed that the necessary RNAi components relevant to the three major RNAi pathways, were found to be expressed in SPW. To address the functionality of the RNAi mechanism in this species, dsRNA was injected into second instar larvae targeting laccase2, a gene which encodes an enzyme involved in the sclerotization of insect exoskeleton. The body of treated insects showed inhibition of sclerotization, leading eventually to death. Quantitative Real Time PCR (qPCR) confirmed this phenotype to be the result of gene silencing. Together, our results provide valuable sequence data on this important insect pest and demonstrate that a functional RNAi pathway with a strong and systemic effect is present in SPW and can further be explored as a new strategy for controlling this important pest.	[Prentice, Katterinne; Christiaens, Olivier; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium; [Prentice, Katterinne; Bauters, Lander; Gheysen, Godelieve] Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, B-9000 Ghent, Belgium; [Prentice, Katterinne; Ghislain, Marc] Int Potato Ctr CIP, Genom & Biotechnol Program, Nairobi 00603, Kenya; [Pertry, Ine] VIB, Inst Plant Biotechnol Outreach, B-9052 Ghent, Belgium; [Pertry, Ine] Univ Ghent, Dept Mol Biotechnol, Inst Plant Biotechnol Outreach, B-9052 Ghent, Belgium; [Bailey, Ana; Niblett, Chuck] Venganza Inc, St Augustine, FL 32080 USA	Ghent University; Ghent University; CGIAR; International Potato Center (CIP); Flanders Institute for Biotechnology (VIB); Ghent University	Smagghe, G (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium.	guy.smagghe@ugent.be	Smagghe, Guy/AAE-8914-2019; Christiaens, Olivier/AAB-3634-2019	Smagghe, Guy/0000-0001-8334-3313; Christiaens, Olivier/0000-0001-5850-340X; Prentice, Katterinne/0000-0001-6631-4318	Ghent University (BOF, Gent, Belgium); Bill and Melinda Gates Foundation through the Sweetpotato Action for Security and Health in Africa (SASHA) project; Grand Challenge Exploration 9 [OPP1068494]	Ghent University (BOF, Gent, Belgium); Bill and Melinda Gates Foundation through the Sweetpotato Action for Security and Health in Africa (SASHA) project; Grand Challenge Exploration 9	Authors are grateful to the support of the Special Research Fund of the Ghent University (BOF, Gent, Belgium), the Bill and Melinda Gates Foundation through the Sweetpotato Action for Security and Health in Africa (SASHA) project and the Grand Challenge Exploration 9 (grant number: OPP1068494). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade M., 2009, 20091 CIP; ANSARI A, 1995, EMBO J, V14, P4001, DOI 10.1002/j.1460-2075.1995.tb00071.x; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Bachman PM, 2013, TRANSGENIC RES, V22, P1207, DOI 10.1007/s11248-013-9716-5; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Billi AC, 2012, PLOS GENET, V8, P84, DOI 10.1371/journal.pgen.1002617; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Cauchi RJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000265; CHALFANT RB, 1990, ANNU REV ENTOMOL, V35, P157, DOI 10.1146/annurev.en.35.010190.001105; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; Fuglie KO, 2007, HORTSCIENCE, V42, P1200, DOI 10.21273/HORTSCI.42.5.1200; Gaynor JW, 2010, CHEM SOC REV, V39, P4169, DOI 10.1039/b920362c; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gourley BL, 2003, J BIOL CHEM, V278, P3227, DOI 10.1074/jbc.M210333200; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Hartig JV, 2007, GENE DEV, V21, P1707, DOI 10.1101/gad.1567007; Hunter CP, 2006, COLD SPRING HARB SYM, V71, P95, DOI 10.1101/sqb.2006.71.060; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Katoch R, 2013, APPL BIOCHEM BIOTECH, V171, P847, DOI 10.1007/s12010-013-0399-4; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Lee MH, 2001, GENE DEV, V15, P2408, DOI 10.1101/gad.915901; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065931; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Lipardi C, 2010, FLY, V4, P30, DOI 10.4161/fly.4.1.10777; Liu JH, 2012, J INSECT PHYSIOL, V58, P1166, DOI 10.1016/j.jinsphys.2012.05.016; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miller SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047431; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Mwanga R., 2011, PROC INT C AGRO BIOT, P25; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pek JW, 2011, P NATL ACAD SCI USA, V108, P12007, DOI 10.1073/pnas.1106245108; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sabin LR, 2009, CELL, V138, P340, DOI 10.1016/j.cell.2009.04.045; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712; Saleh MC, 2006, J INSECT PHYSL, V56, P227; Schneider MD, 2006, J CELL BIOL, V174, P349, DOI 10.1083/jcb.200512103; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Scully ED, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-850; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Skoglund L G, 1994, MAJOR DIS PEST SWEET; Smit NEJM, 2001, CROP PROT, V20, P643, DOI 10.1016/S0261-2194(01)00026-6; Smit NEJM, 1997, AGR ECOSYST ENVIRON, V64, P191, DOI 10.1016/S0167-8809(97)00022-4; Stathers TE, 2003, INT J PEST MANAGE, V49, P131, DOI 10.1080/0967087021000043085; Stevenson PC, 2009, PURE APPL CHEM, V81, P141, DOI 10.1351/PAC-CON-08-02-10; Swevers L, 2013, INSECT MOL BIOL, V22, P668, DOI 10.1111/imb.12054; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wolfe G.W., 1991, P13; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yamanaka S, 2013, NATURE, V493, P557, DOI 10.1038/nature11716; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Yu N, 2013, INSECT SCI, V20, P4, DOI 10.1111/j.1744-7917.2012.01534.x	69	26	29	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0115336	10.1371/journal.pone.0115336	http://dx.doi.org/10.1371/journal.pone.0115336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590333	Green Published, Green Submitted, gold			2022-12-26	WOS:000350679400005
J	Qian, Y; Lu, F; Dong, MH; Lin, YD; Li, HZ; Dai, JC; Jin, GF; Hu, ZB; Shen, HB				Qian, Yun; Lu, Feng; Dong, Meihua; Lin, Yudi; Li, Huizhang; Dai, Juncheng; Jin, Guangfu; Hu, Zhibin; Shen, Hongbing			Cumulative Effect and Predictive Value of Genetic Variants Associated with Type 2 Diabetes in Han Chinese: A Case-Control Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IMPAIRED FASTING GLUCOSE; SUSCEPTIBILITY LOCI; COMMON VARIANTS; RISK LOCI; JAPANESE POPULATION; CDKAL1; POLYMORPHISMS; IGF2BP2; SLC30A8	Background Genome-wide association studies (GWAS) have identified dozens of single nucleotide polymorphisms (SNPs) associated with type 2 diabetes risk. We have previously confirmed the associations of genetic variants in HHEX, CDKAL1, VEGFA and FTO with type 2 diabetes in Han Chinese. However, the cumulative effect and predictive value of these GWAS identified SNPs on the risk of type 2 diabetes in Han Chinese are largely unknown. Methodology/Principal Findings We conducted a two-stage case-control study consisting of 2,925 cases and 3,281controls to examine the association of 30 SNPs identified by GWAS with type 2 diabetes in Han Chinese. Significant associations were found for proxy SNPs at KCNQ1 [odds ratio (OR) = 1.41, P = 9.91 x 10-16 for rs2237897], CDKN2A/CDKN2B (OR = 1.30, P = 1.34 x 10-10 for rs10811661), CENTD2 (OR = 1.28, P = 9.88 x 10-4 for rs1552224) and SLC30A8 (OR = 1.19, P = 1.43 x 10-5 for rs13266634). We further evaluated the cumulative effect on type 2 diabetes of these 4 SNPs, in combination with 5 SNPs at HHEX, CDKAL1, VEGFA and FTO reported previously. Individuals carrying 12 or more risk alleles had a nearly 4-fold increased risk for developing type 2 diabetes compared with those carrying less than 6 risk alleles [adjusted OR = 3.68, 95% confidence interval (CI): 2.76 - 4.91]. Adding the genetic factors to clinical factors slightly improved the prediction of type 2 diabetes, with the area under the receiver operating characteristic curve increasing from 0.76 to 0.78. However, the difference was statistically significant (P < 0.0001). Conclusions/Significance We confirmed associations of SNPs in KCNQ1, CDKN2A/CDKN2B, CENTD2 and SLC30A8 with type 2 diabetes in Han Chinese. The utilization of genetic information may improve the accuracy of risk prediction in combination with clinical characteristics for type 2 diabetes.	[Qian, Yun; Dong, Meihua; Lin, Yudi] Wuxi Ctr Dis Control & Prevent, Dept Chron Noncommunicable Dis Control, Wuxi 214023, Peoples R China; [Lu, Feng; Li, Huizhang; Dai, Juncheng; Jin, Guangfu; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University	Qian, Y (corresponding author), Wuxi Ctr Dis Control & Prevent, Dept Chron Noncommunicable Dis Control, Wuxi 214023, Peoples R China.	wxqianyun111@sina.com; hbshen@njmu.edu.cn		Shen, Hongbing/0000-0002-2581-5906	Project of National Natural Science Foundation of China [81072379]; Ministry of Health Research Program [WKJ2010-2-032]; Wuxi Science & Technology Research Program [CSE01016]	Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health Research Program; Wuxi Science & Technology Research Program	This work was supported by grants from the Project of National Natural Science Foundation of China (81072379), Ministry of Health Research Program (WKJ2010-2-032) and Wuxi Science & Technology Research Program (CSE01016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao XY, 2012, MOL BIOL REP, V39, P2447, DOI 10.1007/s11033-011-0995-8; Been LF, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-18; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Han XY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-81; Hu C, 2009, DIABETOLOGIA, V52, P1322, DOI 10.1007/s00125-009-1335-6; Hu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007643; International Diabetes Federation, 2006, DIABETES ATLAS; Jonsson A, 2009, DIABETES, V58, P2409, DOI 10.2337/db09-0246; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Lee YH, 2008, J HUM GENET, V53, P991, DOI 10.1007/s10038-008-0341-8; LIN Y, 2010, BMC BIOINFORMATIC S1, V11, P10393, DOI DOI 10.1186/1471-; Liu Y, 2009, DIABETOLOGIA, V52, P1315, DOI 10.1007/s00125-009-1375-y; Lu F, 2012, J HUM GENET, V57, P320, DOI 10.1038/jhg.2012.25; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Nielsen T, 2011, DIABETOLOGIA, V54, P1052, DOI 10.1007/s00125-011-2054-3; Ohshige T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026911; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Qi QB, 2009, HUM MOL GENET, V18, P3508, DOI 10.1093/hmg/ddp294; Qian Y, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-86; Qian Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035060; Rees SD, 2011, DIABETOLOGIA, V54, P1368, DOI 10.1007/s00125-011-2063-2; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Tan JT, 2010, J CLIN ENDOCR METAB, V95, P390, DOI 10.1210/jc.2009-0688; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Xu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014022; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091790; Zhou DZ, 2010, J HUM GENET, V55, P810, DOI 10.1038/jhg.2010.117	47	15	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116537	10.1371/journal.pone.0116537	http://dx.doi.org/10.1371/journal.pone.0116537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587982	Green Submitted, Green Published, gold			2022-12-26	WOS:000347928300015
J	Chu, HS; Chang, SC; Shen, EP; Hu, FR				Chu, Hsiao-Sang; Chang, Shan-Chwen; Shen, Elizabeth P.; Hu, Fung-Rong			Nontuberculous Mycobacterial Ocular Infections-Comparing the Clinical and Microbiological Characteristics between Mycobacterium abscessus and Mycobacterium massiliense	PLOS ONE			English	Article							ANTIMICROBIAL SUSCEPTIBILITY; KERATITIS; IDENTIFICATION; PENETRATION; UPDATE; COHORT	Purpose To analyze the clinical characteristics of nontuberculous mycobacterial (NTM) ocular infections and the species-specific in vitro antimicrobial susceptibility. Material and Methods In 2000 to 2011 at the National Taiwan University Hospital, multilocus sequencing of rpoB, hsp65 and secA was used to identify NTM isolates from ocular infections. The clinical presentation and treatment outcomes were retrospectively compared between species. Broth microdilution method was used to determine the minimum inhibitory concentrations of amikacin (AMK), clarithromycin (CLA), ciprofloxacin (CPF), levofloxacin (LVF), moxifloxacin (MXF) and gatifloxacin (GAF) against all strains. The activities of antimicrobial combinations were assessed by the checkerboard titration method. Results A total of 24 NTM strains (13 Mycobacterium abscessus and 11 Mycobacterium massiliense) were isolated from 13 keratitis, 10 buckle infections, and 1 canaliculitis cases. Clinically, manifestations and outcomes caused by these two species were similar and surgical intervention was necessary for medically unresponsive NTM infection. Microbiologically, 100% of M. abscessus and 90.9% of M. massiliense ocular isolates were susceptible to amikacin but all were resistant to fluoroquinolones. Inducible clarithromycin resistance existed in 69.3% of M. abscessus but not in M. massiliense isolates. None of the AMK-CLA, AMK-MXF, AMK-GAF, CLA-MXF and CLA-GAF combinations showed synergistic or antagonistic effect against both species in vitro. Conclusions M. abscessus and M. massiliense are the most commonly identified species for NTM ocular infections in Taiwan. Both species were resistant to fluoroquinolones, susceptible to amikacin, and differ in clarithromycin resistance. Combined antimicrobial treatments showed no interaction in vitro but could be considered in combination with surgical interventions for eradication of this devastating ocular infection.	[Chu, Hsiao-Sang; Shen, Elizabeth P.; Hu, Fung-Rong] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei 10764, Taiwan; [Chang, Shan-Chwen] Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp,Div Infect Dis, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Hu, FR (corresponding author), Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei 10764, Taiwan.	fungronghu@ntu.edu.tw		HU, FUNG-RONG/0000-0002-2102-5317; CHANG, SHAN-CHWEN/0000-0001-6505-4139	National Taiwan University Hospital Research Grant [102-N2276]; National Center of Excellence for Clinical Trial and Research Grant [DOH 101-TD-B-111-001]	National Taiwan University Hospital Research Grant; National Center of Excellence for Clinical Trial and Research Grant	Funding: Funding provided by 1. National Taiwan University Hospital Research Grant 102-N2276, http://www.ntuh.gov.tw/ntuh_chinese.aspx.2. The National Center of Excellence for Clinical Trial and Research Grant DOH 101-TD-B-111-001, http://www.ntuh.gov.tw/en/nctrc/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown-Elliott BA, 2012, CORNEA, V31, P900, DOI 10.1097/ICO.0b013e31823f8bb9; Brown-Elliott BA, 2012, CLIN MICROBIOL REV, V25, P545, DOI 10.1128/CMR.05030-11; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Chu HS, 2013, CLIN MICROBIOL INFEC, V19, P221, DOI 10.1111/1469-0691.12094; EIFERMAN RA, 1982, ARCH OPHTHALMOL-CHIC, V100, P1817, DOI 10.1001/archopht.1982.01030040797018; Ford JG, 1998, OPHTHALMOLOGY, V105, P1652, DOI 10.1016/S0161-6420(98)99034-0; Girgis DO, 2012, CLIN EXP OPHTHALMOL, V40, P467, DOI 10.1111/j.1442-9071.2011.02679.x; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hu FR, 1998, OPHTHALMOLOGY, V105, P269; Hu FR, 1998, JPN J OPHTHALMOL, V42, P115, DOI 10.1016/S0021-5155(97)00117-2; Huang SCM, 1996, BRIT J OPHTHALMOL, V80, P962, DOI 10.1136/bjo.80.11.962; John T, 2005, CORNEA, V24, P245, DOI 10.1097/01.ico.0000151565.63107.64; Koh WJ, 2011, AM J RESP CRIT CARE, V183, P405, DOI 10.1164/rccm.201003-0395OC; Lai CC, 2010, EMERG INFECT DIS, V16, P294, DOI 10.3201/eid1602.090675; Macheras E, 2011, J CLIN MICROBIOL, V49, P491, DOI 10.1128/JCM.01274-10; Moorthy RS, 2012, SURV OPHTHALMOL, V57, P202, DOI 10.1016/j.survophthal.2011.10.006; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Sasaki H, 1999, CRIT REV THER DRUG, V16, P85; Springer B, 1996, J CLIN MICROBIOL, V34, P296, DOI 10.1128/JCM.34.2.296-303.1996; Tortoli E, 2003, CLIN MICROBIOL REV, V16, P319, DOI 10.1128/CMR.16.2.319-354.2003; Tortoli E, 2006, FEMS IMMUNOL MED MIC, V48, P159, DOI 10.1111/j.1574-695X.2006.00123.x; van Ingen J, 2009, CLIN MICROBIOL INFEC, V15, P888, DOI 10.1111/j.1469-0691.2009.03013.x; Wallace R.J.J., 2011, M24A2 CLIN LAB STAND, V2nd; Zelazny AM, 2009, J CLIN MICROBIOL, V47, P1985, DOI 10.1128/JCM.01688-08	24	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2015	10	1							e0116236	10.1371/journal.pone.0116236	http://dx.doi.org/10.1371/journal.pone.0116236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4CF	25581038	Green Published, Green Submitted, gold			2022-12-26	WOS:000348169100003
J	Gorski, PA; Trieber, CA; Ashrafi, G; Young, HS				Gorski, Przennek A.; Trieber, Catharine A.; Ashrafi, Ghazaleh; Young, Howard S.			Regulation of the Sarcoplasmic Reticulum Calcium Pump by Divergent Phospholamban Isoforms in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; CA2+ PUMP; DILATED CARDIOMYOPATHY; CYTOPLASMIC DOMAIN; PEPTIDE INHIBITORS; STRUCTURAL BASIS; HYBRID SOLUTION; LIPID-BILAYERS; PROTEIN-KINASE; HEART-FAILURE	The sarcoplasmic reticulum calcium pump (SERCA) is regulated by the small integral membrane proteins phospholamban (PLN) and sarcolipin (SLN). These regulators have homologous transmembrane regions, yet they differ in their cytoplasmic and luminal domains. Although the sequences of PLN and SLN are practically invariant among mammals, they vary in fish. Zebrafish (zf) appear to harbor multiple PLN isoforms, one of which contains 18 sequence variations and a unique luminal extension. Characterization of this isoform (zfPLN) revealed that SERCA inhibition and reversal by phosphorylation were comparable with human PLN. To understand the sequence variations in zfPLN, chimeras were created by transferring the N terminus, linker, and C terminus of zfPLN onto human PLN. A chimera containing the N-terminal domain resulted in a mild loss of function, whereas a chimera containing the linker domain resulted in a gain of function. This latter effect was due to changes in basic residues in the linker region of PLN. Removing the unique luminal domain of zfPLN ((53)SFHGM) resulted in loss of function, whereas adding this domain to human PLN had a minimal effect on SERCA inhibition. We conclude that the luminal extension contributes to SERCA inhibition but only in the context of zfPLN. Although this domain is distinct from the SLN luminal tail, zfPLN appears to use a hybrid PLN-SLN inhibitory mechanism. Importantly, the different zebrafish PLN isoforms raise the interesting possibility that sarcoplasmic reticulum calcium handling and cardiac contractility may be regulated by the differential expression of PLN functional variants.	[Gorski, Przennek A.; Trieber, Catharine A.; Ashrafi, Ghazaleh; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Trieber, Catharine A.; Young, Howard S.] Univ Alberta, Natl Inst Nanotechnol, Edmonton, AB T6G 2H7, Canada	University of Alberta; National Research Council Canada; University of Alberta	Young, HS (corresponding author), Univ Alberta, Med Sci Bldg,Rm 327, Edmonton, AB T6G 2H7, Canada.	hyoung@ualberta.ca		Young, Howard/0000-0002-5990-8422; Trieber, Catharine/0000-0002-1336-1126	Heart and Stroke Foundation of Canada	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported in part by a grant from Heart and Stroke Foundation of Canada.	Afara MR, 2008, BIOCHEMISTRY-US, V47, P9522, DOI 10.1021/bi800880q; Afara MR, 2006, BIOCHEMISTRY-US, V45, P8617, DOI 10.1021/bi0523761; Akin BL, 2013, J BIOL CHEM, V288, P30181, DOI 10.1074/jbc.M113.501585; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bhupathy P, 2009, J MOL CELL CARDIOL, V47, P723, DOI 10.1016/j.yjmcc.2009.07.014; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Ceholski DK, 2012, J BIOL CHEM, V287, P26596, DOI 10.1074/jbc.M112.382713; Ceholski DK, 2012, J BIOL CHEM, V287, P16521, DOI 10.1074/jbc.M112.360859; Douglas JL, 2005, PROTEIN EXPRES PURIF, V40, P118, DOI 10.1016/j.pep.2004.11.015; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; FUJII J, 1989, J BIOL CHEM, V264, P12950; Glaves JP, 2011, J MOL BIOL, V405, P707, DOI 10.1016/j.jmb.2010.11.014; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; Gorski PA, 2012, J BIOL CHEM, V287, P19876, DOI 10.1074/jbc.M111.335620; Gramolini AO, 2006, P NATL ACAD SCI USA, V103, P2446, DOI 10.1073/pnas.0510883103; Gramolini AO, 2004, P NATL ACAD SCI USA, V101, P16807, DOI 10.1073/pnas.0407815101; Gustavsson M, 2013, P NATL ACAD SCI USA, V110, P17338, DOI 10.1073/pnas.1303006110; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Hughes E, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M611668200; INESI G, 1988, METHOD ENZYMOL, V157, P154; Karim CB, 2001, J BIOL CHEM, V276, P38814, DOI 10.1074/jbc.M104006200; Katz A M, 1975, Adv Cyclic Nucleotide Res, V5, P453; Kimura Y, 1996, J BIOL CHEM, V271, P21726, DOI 10.1074/jbc.271.36.21726; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; Kirchberber M A, 1975, Recent Adv Stud Cardiac Struct Metab, V5, P103; Lamberth S, 2000, HELV CHIM ACTA, V83, P2141, DOI 10.1002/1522-2675(20000906)83:9<2141::AID-HLCA2141>3.0.CO;2-W; Medeiros A, 2011, AM HEART J, V162, P1088, DOI 10.1016/j.ahj.2011.07.028; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; MORTISHIRESMITH RJ, 1995, BIOCHEMISTRY-US, V34, P7603, DOI 10.1021/bi00023a006; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Reddy LG, 2003, BIOCHEMISTRY-US, V42, P4585, DOI 10.1021/bi026995a; Reddy LG, 1996, J BIOL CHEM, V271, P14964, DOI 10.1074/jbc.271.25.14964; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Seidel K, 2008, BIOCHEMISTRY-US, V47, P4369, DOI 10.1021/bi7024194; Sharma P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011496; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Traaseth NJ, 2009, P NATL ACAD SCI USA, V106, P10165, DOI 10.1073/pnas.0904290106; Trieber CA, 2005, BIOCHEMISTRY-US, V44, P3289, DOI 10.1021/bi047878d; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; Vandecaetsbeek I, 2009, P NATL ACAD SCI USA, V106, P18533, DOI 10.1073/pnas.0906797106; Verardi R, 2011, P NATL ACAD SCI USA, V108, P9101, DOI 10.1073/pnas.1016535108; WARREN GB, 1974, P NATL ACAD SCI USA, V71, P622, DOI 10.1073/pnas.71.3.622; WAWRZYNOW A, 1992, ARCH BIOCHEM BIOPHYS, V298, P620, DOI 10.1016/0003-9861(92)90457-8; WILL H, 1985, EXPERIENTIA, V41, P1052, DOI 10.1007/BF01952139; WILL H, 1983, FEBS LETT, V155, P326, DOI 10.1016/0014-5793(82)80630-3; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Young HS, 2001, BIOPHYS J, V81, P884, DOI 10.1016/S0006-3495(01)75748-7	56	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6777	6788		10.1074/jbc.M114.585604	http://dx.doi.org/10.1074/jbc.M114.585604			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25593315	Green Published, hybrid			2022-12-26	WOS:000350991500014
J	Verma, R; Marchese, A				Verma, Rita; Marchese, Adriano			The Endosomal Sorting Complex Required for Transport Pathway Mediates Chemokine Receptor CXCR4-promoted Lysosomal Degradation of the Mammalian Target of Rapamycin Antagonist DEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; RICTOR-MTOR COMPLEX; E3 UBIQUITIN LIGASE; ENDOCYTIC TRAFFICKING; ESCRT MACHINERY; BETA-TRCP; PHOSPHATIDYLINOSITOL 3-KINASE; MULTIVESICULAR ENDOSOMES; SUBSTRATE-SPECIFICITY; DEPENDENT DEGRADATION	G protein-coupled receptor (GPCR) signaling mediates many cellular functions, including cell survival, proliferation, and cell motility. Many of these processes are mediated by GPCR-promoted activation of Akt signaling by mammalian target of rapamycin complex 2 (mTORC2) and the phosphatidylinositol 3-kinase (PI3K)/phosphoinositide-dependent kinase 1 (PDK1) pathway. However, the molecular mechanisms by which GPCRs govern Akt activation by these kinases remain poorly understood. Here, we show that the endosomal sorting complex required for transport (ESCRT) pathway mediates Akt signaling promoted by the chemokine receptor CXCR4. Pharmacological inhibition of heterotrimeric G protein G alpha(i) or PI3K signaling and siRNA targeting ESCRTs blocks CXCR4-promoted degradation of DEPTOR, an endogenous antagonist of mTORC2 activity. Depletion of ESCRTs by siRNA leads to increased levels of DEPTOR and attenuated CXCR4-promoted Akt activation and signaling, consistent with decreased mTORC2 activity. In addition, ESCRTs likely have a broad role in Akt signaling because ESCRT depletion also attenuates receptor tyrosine kinase-promoted Akt activation and signaling. Our data reveal a novel role for the ESCRT pathway in promoting intracellular signaling, which may begin to identify the signal transduction pathways that are important in the physiological roles of ESCRTs and Akt.	[Verma, Rita; Marchese, Adriano] Loyola Univ Chicago, Biochem & Mol Biol Program, Maywood, IL 60153 USA; [Marchese, Adriano] Loyola Univ Chicago, Div Hlth Sci, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA	Loyola University Chicago; Loyola University Chicago	Marchese, A (corresponding author), Loyola Univ Chicago, Div Hlth Sci, Dept Mol Pharmacol & Therapeut, 2160 S First Ave, Maywood, IL 60153 USA.	amarchese@luc.edu			National Institutes of Health [R01 GM106727]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM106727 (to A. M.).	Agarwal U, 2010, CIRC RES, V107, P667, DOI 10.1161/CIRCRESAHA.110.223289; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Ciechanover A, 2013, BIOORGAN MED CHEM, V21, P3400, DOI 10.1016/j.bmc.2013.01.056; Clague MJ, 2012, DEV CELL, V23, P457, DOI 10.1016/j.devcel.2012.08.011; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Delgado-Martin C, 2011, J BIOL CHEM, V286, P37222, DOI 10.1074/jbc.M111.294116; Dobrowolski R, 2012, CELL REP, V2, P1316, DOI 10.1016/j.celrep.2012.09.026; Dobrowolski R, 2012, NAT REV MOL CELL BIO, V13, P53, DOI 10.1038/nrm3244; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Greer EL, 2008, ACTA PHYSIOL, V192, P19, DOI 10.1111/j.1748-1716.2007.01780.x; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Henne WM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016766; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hislop JN, 2011, TRAFFIC, V12, P137, DOI 10.1111/j.1600-0854.2010.01121.x; Holleman J, 2014, MOL BIOL CELL, V25, P1892, DOI 10.1091/mbc.E13-10-0612; Hurley JH, 2011, ANNU REV BIOPHYS, V40, P119, DOI 10.1146/annurev-biophys-042910-155404; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Katada T, 2012, BIOL PHARM BULL, V35, P2103, DOI 10.1248/bpb.b212024; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leopoldt D, 1998, J BIOL CHEM, V273, P7024, DOI 10.1074/jbc.273.12.7024; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Lobert VH, 2012, J CELL SCI, V125, P29, DOI 10.1242/jcs.088310; Luzio JP, 2009, BIOCHEM SOC T, V37, P1019, DOI 10.1042/BST0371019; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mageswaran SK, 2014, TRAFFIC, V15, P212, DOI 10.1111/tra.12135; Malerod L, 2011, TRAFFIC, V12, P1211, DOI 10.1111/j.1600-0854.2011.01220.x; Malik R, 2012, J BIOL CHEM, V287, P9013, DOI 10.1074/jbc.M111.336792; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2014, CURR OPIN CELL BIOL, V27, P72, DOI 10.1016/j.ceb.2013.11.011; Marchese A, 2013, CELL SIGNAL, V25, P707, DOI 10.1016/j.cellsig.2012.11.024; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nazarewicz Rafal Robert, 2011, J Biol Chem, V286, P2886, DOI 10.1074/jbc.M110.141499; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Peng SB, 2005, MOL CANCER RES, V3, P227; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; Raiborg C, 2001, J CELL SCI, V114, P2255; Raiborg C, 2013, FEBS J, V280, P2730, DOI 10.1111/febs.12116; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Robles-Molina E, 2014, BIOCHEM BIOPH RES CO, V444, P218, DOI 10.1016/j.bbrc.2014.01.044; Rodahl LM, 2009, BIOCHEM SOC T, V37, P137, DOI 10.1042/BST0370137; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; SEGLEN PO, 1983, METHOD ENZYMOL, V96, P737; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shields SB, 2011, TRAFFIC, V12, P1306, DOI 10.1111/j.1600-0854.2011.01242.x; Shpetner H, 1996, J CELL BIOL, V132, P595, DOI 10.1083/jcb.132.4.595; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Stefani F, 2011, CURR BIOL, V21, P1245, DOI 10.1016/j.cub.2011.06.028; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tu C, 2010, P NATL ACAD SCI USA, V107, P16107, DOI 10.1073/pnas.1009471107; Valiathan RR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-23; VOLINIA S, 1995, EMBO J, V14, P3339, DOI 10.1002/j.1460-2075.1995.tb07340.x; Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	82	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6810	6824		10.1074/jbc.M114.606699	http://dx.doi.org/10.1074/jbc.M114.606699			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605718	hybrid, Green Published			2022-12-26	WOS:000350991500017
J	You, LY; Zou, JF; Zhao, H; Bertos, NR; Park, M; Wang, E; Yang, XJ				You, Linya; Zou, Jinfeng; Zhao, Hong; Bertos, Nicholas R.; Park, Morag; Wang, Edwin; Yang, Xiang-Jiao			Deficiency of the Chromatin Regulator Brpf1 Causes Abnormal Brain Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RUBINSTEIN-TAYBI-SYNDROME; HOX GENE-EXPRESSION; DE-NOVO MUTATIONS; HISTONE ACETYLTRANSFERASE; EPIGENETIC MECHANISMS; TRANSCRIPTION FACTOR; RADIAL GLIA; CEREBRAL-CORTEX; MOZ; ACETYLATION	Epigenetic mechanisms are important in different neurological disorders, and one such mechanism is histone acetylation. The multivalent chromatin regulator BRPF1 (bromodomain- and plant homeodomain-linked (PHD) zinc finger-containing protein 1) recognizes different epigenetic marks and activates three histone acetyltransferases, so it is both a reader and a co-writer of the epigenetic language. The three histone acetyltransferases are MOZ, MORF, and HBO1, which are also known as lysine acetyltransferase 6A (KAT6A), KAT6B, and KAT7, respectively. The MORF gene is mutated in four neurodevelopmental disorders sharing the characteristic of intellectual disability and frequently displaying callosal agenesis. Here, we report that forebrain-specific inactivation of the mouse Brpf1 gene caused early postnatal lethality, neocortical abnormalities, and partial callosal agenesis. With respect to the control, the mutant forebrain contained fewer Tbr2-positive intermediate neuronal progenitors and displayed aberrant neurogenesis. Molecularly, Brpf1 loss led to decreased transcription of multiple genes, such as Robo3 and Otx1, important for neocortical development. Surprisingly, elevated expression of different Hox genes and various other transcription factors, such as Lhx4, Foxa1, Tbx5, and Twist1, was also observed. These results thus identify an important role of Brpf1 in regulating forebrain development and suggest that it acts as both an activator and a silencer of gene expression in vivo.	[You, Linya; Zhao, Hong; Bertos, Nicholas R.; Park, Morag; Yang, Xiang-Jiao] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [You, Linya; Park, Morag; Yang, Xiang-Jiao] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Zou, Jinfeng; Wang, Edwin] Natl Res Council Canada, Montreal, PQ H4P 2R2, Canada; [Park, Morag; Yang, Xiang-Jiao] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Park, Morag; Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; National Research Council Canada; McGill University; McGill University	Yang, XJ (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.	xiang-jiao.yang@mcgill.ca	Wang, Edwin/Y-1553-2019	You, Linya/0000-0002-2569-0269	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Canadian Cancer Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by grants from Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, and the Canadian Cancer Society (to X. J. Y.).	Armentano M, 2006, DEVELOPMENT, V133, P4151, DOI 10.1242/dev.02600; Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Baala L, 2007, NAT GENET, V39, P454, DOI 10.1038/ng1993; Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Butler JS, 2013, BLOOD, V121, P3076, DOI 10.1182/blood-2012-10-451237; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Campeau PM, 2012, HUM MUTAT, V33, P1520, DOI 10.1002/humu.22141; Campeau PM, 2012, AM J HUM GENET, V90, P282, DOI 10.1016/j.ajhg.2011.11.023; Champagne N, 1999, J BIOL CHEM, V274, P28528, DOI 10.1074/jbc.274.40.28528; Chesi A, 2013, NAT NEUROSCI, V16, P851, DOI 10.1038/nn.3412; Choe Y, 2012, NEURON, V73, P698, DOI 10.1016/j.neuron.2011.11.036; Clayton-Smith J, 2011, AM J HUM GENET, V89, P675, DOI 10.1016/j.ajhg.2011.10.008; Crump JG, 2006, DEVELOPMENT, V133, P2661, DOI 10.1242/dev.02435; Cubelos B, 2008, CEREB CORTEX, V18, P1758, DOI 10.1093/cercor/bhm199; Das Gitanjali, 2013, Methods Mol Biol, V1018, P313, DOI 10.1007/978-1-62703-444-9_29; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Deacon R, 2012, JOVE-J VIS EXP, DOI 10.3791/2607; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Donahoo ALS, 2009, SEMIN PEDIATR NEUROL, V16, P127, DOI 10.1016/j.spen.2009.07.003; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Grienenberger A, 2002, CURR BIOL, V12, P762, DOI 10.1016/S0960-9822(02)00814-X; Hibiya K, 2009, DEV BIOL, V329, P176, DOI 10.1016/j.ydbio.2009.02.021; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kim GW, 2013, J BIOL CHEM, V288, P20334, DOI 10.1074/jbc.M113.464792; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kraft M, 2011, J CLIN INVEST, V121, P3479, DOI 10.1172/JCI43428; Lalonde ME, 2013, GENE DEV, V27, P2009, DOI 10.1101/gad.223396.113; Laue K, 2008, DEVELOPMENT, V135, P1935, DOI 10.1242/dev.017160; Li JA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1043; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Lubula MY, 2014, FEBS LETT, V588, P3844, DOI 10.1016/j.febslet.2014.09.028; Maden M, 1998, CURR BIOL, V8, pR846, DOI 10.1016/S0960-9822(07)00528-3; Mairet-Coello G, 2012, DEVELOPMENT, V139, P475, DOI 10.1242/dev.067314; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marszall MP, 2015, EUR J CANCER PREV, V24, P51, DOI 10.1097/CEJ.0000000000000046; Miller CT, 2004, DEVELOPMENT, V131, P2443, DOI 10.1242/dev.01134; Mishima Y, 2011, BLOOD, V118, P2443, DOI 10.1182/blood-2011-01-331892; Moffatt P, 2009, CELL MOL LIFE SCI, V66, P1135, DOI 10.1007/s00018-009-8716-3; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Munroe RJ, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-27; Nepveu A, 2001, GENE, V270, P1, DOI 10.1016/S0378-1119(01)00485-1; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Perez-Campo FM, 2014, STEM CELLS, V32, P1591, DOI 10.1002/stem.1606; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; Roelfsema JH, 2005, AM J HUM GENET, V76, P572, DOI 10.1086/429130; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Sansregret L, 2011, P NATL ACAD SCI USA, V108, P1949, DOI 10.1073/pnas.1008403108; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Simpson MA, 2012, AM J HUM GENET, V90, P290, DOI 10.1016/j.ajhg.2011.11.024; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Thomas T, 2000, DEVELOPMENT, V127, P2537; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Voss AK, 2012, DEV CELL, V23, P652, DOI 10.1016/j.devcel.2012.07.010; Voss AK, 2009, DEV CELL, V17, P674, DOI 10.1016/j.devcel.2009.10.006; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Williams S, 2010, BRIT DENT J, V208, P4, DOI 10.1038/sj.bdj.2010.7; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; You LY, 2014, EPIGENETICS-US, V9, P860, DOI 10.4161/epi.28530; Yu HC, 2014, AM J MED GENET A, V164, P950, DOI 10.1002/ajmg.a.36379	81	34	34	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7114	7129		10.1074/jbc.M114.635250	http://dx.doi.org/10.1074/jbc.M114.635250			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25568313	Green Published, hybrid			2022-12-26	WOS:000350991500042
J	Benton, DJ; Martin, SR; Wharton, SA; McCauley, JW				Benton, Donald J.; Martin, Stephen R.; Wharton, Stephen A.; McCauley, John W.			Biophysical Measurement of the Balance of Influenza A Hemagglutinin and Neuraminidase Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING; SUBSTRATE-SPECIFICITY; VIRUS NEURAMINIDASE; HUMAN AIRWAY; IN-VITRO; GENERATION; 4-GUANIDINO-NEU5AC2EN; VARIANTS; MUCUS	The interaction of influenza A viruses with the cell surface is controlled by the surface glycoproteins hemagglutinin (HA) and neuraminidase (NA). These two glycoproteins have opposing activities: HA is responsible for binding the host receptor (sialic acid) to allow infection, and NA is responsible for cleaving the receptor to facilitate virus release. Several studies have demonstrated that compatible levels of HA and NA activity are required for a virus to replicate efficiently. This is consequently of great interest for determining virus transmissibility. The concurrent role of these two proteins in receptor binding has never been directly measured. We demonstrate a novel biophysical approach based on bio-layer interferornetry to measure the balance of the activities of these two proteins in real time. This technique measures virus binding to and release from a surface coated with either the human-like receptor analog alpha 2,6-linked sialic acid or the avian-like receptor analog alpha 2,3-linked sialic acid in both the presence and absence of NA inhibitors. Biolayer interferometry measurements were also carried out to determine the effect of altering HA receptor affinity and NA stalk length on receptor binding.	[Benton, Donald J.; Wharton, Stephen A.; McCauley, John W.] Natl Inst Med Res, MRC, Div Virol, London NW7 1AA, England; [Martin, Stephen R.] Natl Inst Med Res, MRC, Div Phys Biochem, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	McCauley, JW (corresponding author), Natl Inst Med Res, MRC, Div Virol, Mill Hill, London NW7 1AA, England.	john.mccauley@nimr.mrc.ac.uk			Medical Research Council Programs [U117585868, U117512723, U117570592]; Medical Research Council [1112246] Funding Source: researchfish	Medical Research Council Programs(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council Programs U117585868, U117512723, and U117570592.	Baigent SJ, 1999, VIROLOGY, V263, P323, DOI 10.1006/viro.1999.9931; Bantia S, 1998, ANTIMICROB AGENTS CH, V42, P801, DOI 10.1128/AAC.42.4.801; BAUM LG, 1991, VIROLOGY, V180, P10, DOI 10.1016/0042-6822(91)90003-T; Blick TJ, 1998, VIROLOGY, V246, P95, DOI 10.1006/viro.1998.9194; BREG J, 1987, EUR J BIOCHEM, V168, P57, DOI 10.1111/j.1432-1033.1987.tb13387.x; CABEZAS JA, 1980, BIOCHIM BIOPHYS ACTA, V616, P228, DOI 10.1016/0005-2744(80)90141-2; Cohen M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-321; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Kaverin NV, 1998, VIROLOGY, V244, P315, DOI 10.1006/viro.1998.9119; Kobasa D, 1999, J VIROL, V73, P6743, DOI 10.1128/JVI.73.8.6743-6751.1999; Li JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014722; Li YH, 2011, VIROLOGY, V415, P12, DOI 10.1016/j.virol.2011.03.024; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; McKimmBreschkin JL, 1996, ANTIMICROB AGENTS CH, V40, P40, DOI 10.1128/AAC.40.1.40; PALESE P, 1976, J GEN VIROL, V33, P159, DOI 10.1099/0022-1317-33-1-159; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; SAUTER NK, 1989, BIOCHEMISTRY-US, V28, P8388, DOI 10.1021/bi00447a018; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; van der Vries E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002914; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144	24	35	35	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6516	6521		10.1074/jbc.M114.622308	http://dx.doi.org/10.1074/jbc.M114.622308			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25586179	hybrid, Green Published			2022-12-26	WOS:000350732500054
J	Buchner, DA; Charrier, A; Srinivasan, E; Wang, L; Paulsen, MT; Ljungman, M; Bridges, D; Saltiel, AR				Buchner, David A.; Charrier, Alyssa; Srinivasan, Ethan; Wang, Li; Paulsen, Michelle T.; Ljungman, Mats; Bridges, Dave; Saltiel, Alan R.			Zinc Finger Protein 407 (ZFP407) Regulates Insulin-stimulated Glucose Uptake and Glucose Transporter 4 (Glut4) mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; TRANSPORTER GLUT4; TRANSCRIPTIONAL REGULATION; PLASMA-MEMBRANE; TRANSGENIC MICE; GENE; COMPLEX; ADIPOCYTES; EXPRESSION; PROMOTER	The glucose transporter GLUT4 facilitates insulin-stimulated glucose uptake in peripheral tissues including adipose, muscle, and heart. GLUT4 function is impaired in obesity and type 2 diabetes leading to hyperglycemia and an increased risk of cardiovascular disease and neuropathy. To better understand the regulation of GTUT4 function, a targeted siRNA screen was performed and led to the discovery that ZFP407 regulates insulin-stimulated glucose uptake in adipocytes. The decrease in insulin-stimulated glucose uptake due to ZFP407 deficiency was attributed to a reduction in GLUT4 mRNA and protein levels. The decrease in GLUT4 was due to both decreased transcription of Glut4 mRNA and decreased efficiency of Glut4 pre-mRNA splicing. Interestingly, ZFP407 coordinately regulated this decrease in transcription with an increase in the stability of Glut4 mRNA, resulting in opposing effects on steady-state Glut4 mRNA levels. More broadly, transcriptome analysis revealed that ZFP407 regulates many peroxisome proliferator-activated receptor (PPAR) gamma target genes beyond Glut4. ZFP407 was required for the PPAR gamma agonist rosiglitazone to increase Glut4 expression, but was not sufficient to increase expression of a PPAR gamma target gene reporter construct. However, ZFP407 and PPAR gamma co-overexpression synergistically activated a PPAR gamma reporter construct beyond the level of PPAR gamma alone. Thus, ZTP407 may represent a new modulator of the PPAR gamma signaling pathway.	[Buchner, David A.; Charrier, Alyssa; Wang, Li] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Buchner, David A.] Case Western Reserve Univ, Dept Biol Chem, Cleveland, OH 44106 USA; [Srinivasan, Ethan; Saltiel, Alan R.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Paulsen, Michelle T.; Ljungman, Mats] Univ Michigan, Dept Oncol, Div Radiat & Canc Biol, Ctr Canc, Ann Arbor, MI 48109 USA; [Bridges, Dave] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Bridges, Dave] Univ Tennessee, Ctr Hlth Sci, Childrens Fdn Res Inst, Le Bonheur Childrens Hosp,Dept Pediat, Memphis, TN 38103 USA	Case Western Reserve University; Case Western Reserve University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Buchner, DA (corresponding author), Case Western Reserve Univ, 10900 Euclid Ave, Cleveland, OH 44106 USA.	dab22@case.edu; saltiel@lsi.umich.edu	Bridges, Dave/A-8825-2010; Saltiel, Alan/L-3632-2019	Bridges, Dave/0000-0002-5334-972X; Buchner, David/0000-0003-3920-4871; Saltiel, Alan/0000-0002-9726-9828; Srinivasan, Ethan/0000-0002-9892-5866	National Institutes of Health [DK084079, DK61618]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK084079, R01DK061618, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in wholeor in part, by National Institutes of Health Grants DK084079 and DK61618.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Armoni M, 2003, J BIOL CHEM, V278, P30614, DOI 10.1074/jbc.M304654200; Armoni M, 2007, TRENDS ENDOCRIN MET, V18, P100, DOI 10.1016/j.tem.2007.02.001; Atkinson BJ, 2013, DIABETES, V62, P2249, DOI 10.2337/db12-1146; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Bridges D, 2012, J BIOL CHEM, V287, P20913, DOI 10.1074/jbc.M111.334060; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chen XW, 2011, MOL BIOL CELL, V22, P141, DOI 10.1091/mbc.E10-08-0665; Chiang SH, 2006, METHOD ENZYMOL, V406, P701, DOI 10.1016/S0076-6879(06)06055-1; Dalen KT, 2003, J BIOL CHEM, V278, P48283, DOI 10.1074/jbc.M302287200; Deng T, 2011, J BIOL CHEM, V286, P30723, DOI 10.1074/jbc.M111.251926; Dybkov O, 2006, MOL CELL BIOL, V26, P2803, DOI 10.1128/MCB.26.7.2803-2816.2006; FLORESRIVEROS JR, 1993, P NATL ACAD SCI USA, V90, P512, DOI 10.1073/pnas.90.2.512; Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356; Frische EW, 2010, DEV BIOL, V340, P1, DOI 10.1016/j.ydbio.2009.12.043; Frische EW, 2007, EMBO J, V26, P5083, DOI 10.1038/sj.emboj.7601922; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J, 2001, P NATL ACAD SCI USA, V98, P13084, DOI 10.1073/pnas.241368698; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Karnieli E, 2008, AM J PHYSIOL-ENDOC M, V295, pE38, DOI 10.1152/ajpendo.90306.2008; Karunanithi S, 2014, MOL BIOL CELL, V25, P3059, DOI 10.1091/mbc.E14-06-1060; Knight JB, 2003, P NATL ACAD SCI USA, V100, P14725, DOI 10.1073/pnas.2432756100; Kusminski CM, 2012, TRENDS ENDOCRIN MET, V23, P435, DOI 10.1016/j.tem.2012.06.004; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Liao W, 2006, ENDOCRINOLOGY, V147, P2245, DOI 10.1210/en.2005-1638; Marin-Juez R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080628; Morgan BJ, 2011, RECENT PATENTS ENDOC, V5, P25, DOI 10.2174/187221411794351914; Paulsen MT, 2013, P NATL ACAD SCI USA, V110, P2240, DOI 10.1073/pnas.1219192110; Sanduja S, 2011, WIRES RNA, V2, P42, DOI 10.1002/wrna.28; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shewan AM, 2013, J CELL SCI, V126, P1576, DOI 10.1242/jcs.114371; Spitali P, 2012, CELL, V148, P1085, DOI 10.1016/j.cell.2012.02.014; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200	44	26	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6376	6386		10.1074/jbc.M114.623736	http://dx.doi.org/10.1074/jbc.M114.623736			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25596527	hybrid, Green Published			2022-12-26	WOS:000350732500042
J	Pignataro, MF; Dodes-Traian, MM; Gonzalez-Flecha, FL; Sica, M; Mangialavori, IC; Rossi, JPFC				Florencia Pignataro, Mara; Dodes-Traian, Martin M.; Luis Gonzalez-Flecha, F.; Sica, Mauricio; Mangialavori, Irene C.; Rossi, Juan Pablo F. C.			Modulation of Plasma Membrane Ca2+-ATPase by Neutral Phospholipids EFFECT OF THE MICELLE-VESICLE TRANSITION AND THE BILAYER THICKNESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CALCIUM-PUMP ISOFORMS; ACYL-CHAIN-LENGTH; BIOLOGICAL-MEMBRANES; OCTYL GLUCOSIDE; LIPID-BILAYERS; TRITON X-100; ATP BINDING; PROTEIN; MECHANISM	The effects of lipids on membrane proteins are likely to be complex and unique for each membrane protein. Here we studied different detergent/phosphatidylcholine reconstitution media and tested their effects on plasma membrane Ca2+ pump (PMCA). We found that Ca2+-ATPase activity shows a biphasic behavior with respect to the detergent/phosphatidylcholine ratio. Moreover, the maximal Ca2+-ATPase activity largely depends on the length and the unsaturation degree of the hydrocarbon chain. Using static light scattering and fluorescence correlation spectroscopy, we monitored the changes in hydrodynamic radius of detergent/phosphatidylcholine particles during the micelle-vesicle transition. We found that, when PMCA is reconstituted in mixed micelles, neutral phospholipids increase the enzyme turnover. The biophysical changes associated with the transition from mixed micelles to bicelles increase the time of residence of the phosphorylated intermediate (EP), decreasing the enzyme turnover. Molecular dynamics simulations analysis of the interactions between PMCA and the phospholipid bilayer in which it is embedded show that in the 1,2-dioleoyl-sn-glycero-3-phosphocholine bilayer, charged residues of the protein are trapped in the hydrophobic core. Conversely, in the 1,2-dimyristoyl-sn-glycero-3-phosphocholine bilayer, the overall hydrophobic-hydrophilic requirements of the protein surface are fulfilled the best, reducing the thermodynamic cost of exposing charged residues to the hydrophobic core. The apparent mismatch produced by a 1,2-dioleoyl-sn-glycero-3-phosphocholine thicker bilayer could be a structural foundation to explain its functional effect on PMCA.	[Mangialavori, Irene C.; Rossi, Juan Pablo F. C.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, CONICET, RA-1113 Buenos Aires, DF, Argentina; [Sica, Mauricio] CONICET Ctr Atom Bariloche, IEDS, Lab Bioenergias, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Mangialavori, IC (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, CONICET, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	irenem@qb.ffyb.uba.ar	Mangialavori, Irene/GLU-8182-2022; González Flecha, F Luis/J-7060-2014	González Flecha, F Luis/0000-0003-2828-7907; Mangialavori, Irene/0000-0003-3187-3130	Agencia Nacional de Promocion Cientifica y Tecnologica; CONICET; Universidad de Buenos Aires, Ciencia y Tecnica	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires, Ciencia y Tecnica	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica, CONICET, and Universidad de Buenos Aires, Ciencia y Tecnica.	Adamian L, 2011, BBA-BIOMEMBRANES, V1808, P1092, DOI 10.1016/j.bbamem.2010.12.008; ALMOG S, 1990, BIOCHEMISTRY-US, V29, P4582, DOI 10.1021/bi00471a012; Booth PJ, 1997, BIOCHEMISTRY-US, V36, P197, DOI 10.1021/bi962200m; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Cornelius F, 2001, BIOCHEMISTRY-US, V40, P8842, DOI 10.1021/bi010541g; Culbertson CT, 2002, TALANTA, V56, P365, DOI 10.1016/S0039-9140(01)00602-6; Curran AR, 1999, BIOCHEMISTRY-US, V38, P9328, DOI 10.1021/bi982322+; Traian MMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039255; Durr UHN, 2013, PROG NUCL MAG RES SP, V69, P1, DOI 10.1016/j.pnmrs.2013.01.001; Echarte MM, 2007, BIOCHEMISTRY-US, V46, P1034, DOI 10.1021/bi061857x; Echarte MM, 2001, ANAL BIOCHEM, V289, P267, DOI 10.1006/abio.2000.4950; EDWARDS K, 1989, LANGMUIR, V5, P473, DOI 10.1021/la00086a032; ERDAHL WL, 1994, BIOPHYS J, V66, P1678, DOI 10.1016/S0006-3495(94)80959-2; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Filomatori CV, 2003, J BIOL CHEM, V278, P22265, DOI 10.1074/jbc.M302657200; Fiske CH, 1925, J BIOL CHEM, V66, P375; Haustein E, 2003, METHODS, V29, P153, DOI 10.1016/S1046-2023(02)00306-7; Herscher CJ, 1996, BIOCHEMISTRY-US, V35, P14917, DOI 10.1021/bi961879r; JACKSON ML, 1982, BIOCHEMISTRY-US, V21, P4576, DOI 10.1021/bi00262a010; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Kandasamy SK, 2006, BIOPHYS J, V90, P2326, DOI 10.1529/biophysj.105.073395; KOSKKOSICKA D, 1990, MOL CELL BIOCHEM, V99, P75; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lee AG, 2011, TRENDS BIOCHEM SCI, V36, P493, DOI 10.1016/j.tibs.2011.06.007; Lee AG, 2011, BIOCHEM SOC T, V39, P761, DOI 10.1042/BST0390761; Levi V, 2000, J MEMBRANE BIOL, V173, P215, DOI 10.1007/s002320001021; LEVY D, 1990, BIOCHEMISTRY-US, V29, P9480, DOI 10.1021/bi00492a022; LICHTENBERG D, 1985, BIOCHIM BIOPHYS ACTA, V821, P470, DOI 10.1016/0005-2736(85)90052-5; Lind J, 2008, BBA-BIOMEMBRANES, V1778, P2526, DOI 10.1016/j.bbamem.2008.07.010; LUTERBACHER S, 1983, EXPERIENTIA, V39, P311, DOI 10.1007/BF01955322; Mangialavori I, 2011, J BIOL CHEM, V286, P18397, DOI 10.1074/jbc.M110.210088; Mangialavori I, 2011, FEBS LETT, V585, P1153, DOI 10.1016/j.febslet.2011.03.024; Mangialavori I, 2009, J BIOL CHEM, V284, P4823, DOI 10.1074/jbc.M806912200; Mangialavori IC, 2013, J BIOL CHEM, V288, P31030, DOI 10.1074/jbc.M113.494633; Mangialavori IC, 2012, BIOCHEM J, V443, P125, DOI 10.1042/BJ20111035; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; MULLER K, 1981, BIOCHEMISTRY-US, V20, P404, DOI 10.1021/bi00505a028; NIGGLI V, 1979, J BIOL CHEM, V254, P9955; NIGGLI V, 1981, J BIOL CHEM, V256, P8588; PATERNOSTRE MT, 1988, BIOCHEMISTRY-US, V27, P2668, DOI 10.1021/bi00408a006; Penniston JT, 2014, J CELL SCI, V127, P72, DOI 10.1242/jcs.132548; Pinto FD, 2002, J BIOL CHEM, V277, P12784, DOI 10.1074/jbc.M111055200; PRESSMAN BC, 1976, ANNU REV BIOCHEM, V45, P501, DOI 10.1146/annurev.bi.45.070176.002441; REED PW, 1972, J BIOL CHEM, V247, P6970; Rega A., 1986, CA2 PUMP PLASMA MEMB, P115; RICHARDS DE, 1978, BIOCHIM BIOPHYS ACTA, V511, P194, DOI 10.1016/0005-2736(78)90313-9; Roman EA, 2014, BIOMOLECULES, V4, P354, DOI 10.3390/biom4010354; RONNER P, 1977, ARCH BIOCHEM BIOPHYS, V179, P578, DOI 10.1016/0003-9861(77)90146-1; SARKADI B, 1986, J BIOL CHEM, V261, P9552; Schmidt TH, 2012, J CHEM INF MODEL, V52, P2657, DOI [10.1021/ci3000453, 10.1021/ci30006531]; SEIGNEURET M, 1985, FEBS LETT, V188, P101, DOI 10.1016/0014-5793(85)80883-8; SILVIUS JR, 1992, BIOCHEMISTRY-US, V31, P3398, DOI 10.1021/bi00128a014; SINES JJ, 1987, BIOCHEM J, V243, P159, DOI 10.1042/bj2430159; Sonntag Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1307; STARLING AP, 1993, BIOCHEMISTRY-US, V32, P1593, DOI 10.1021/bi00057a025; STARLING AP, 1995, BIOCHEM J, V310, P875, DOI 10.1042/bj3100875; STREHLER EE, 1990, J BIOL CHEM, V265, P2835; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VINSON PK, 1989, BIOPHYS J, V56, P669, DOI 10.1016/S0006-3495(89)82714-6; Warisnoicharoen W, 2000, AAPS PHARMSCI, V2	63	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6179	6190		10.1074/jbc.M114.585828	http://dx.doi.org/10.1074/jbc.M114.585828			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605721	hybrid, Green Published			2022-12-26	WOS:000350732500026
J	Stadler, T; O'Reilly, AO; Lampert, A				Stadler, Theresa; O'Reilly, Andrias O.; Lampert, Angelika			Erythromelalgia Mutation Q875E Stabilizes the Activated State of Sodium Channel Nav1.7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VOLTAGE SENSOR; CRYSTAL-STRUCTURE; NA(V)1.7 CHANNEL; PRIMARY ERYTHERMALGIA; PORE DOMAIN; K+ CHANNEL; PAIN; SCN9A; DISORDER; FAMILY	The human voltage-gated sodium channel Nav1.7 plays a crucial role in transmission of noxious stimuli. The inherited pain disorder erythromelalgia (IEM) has been linked to Nav1.7 gain-of-function mutations. Here we show that the IEM-associated Q875E mutation located on the pore module of Nav1.7 produces a large hyperpolarizing shift (-18 mV) in the voltage dependence of activation. Three-dimensional homology modeling indicates that the side chains of Gln-875 and the gating charge Arg-214 of the domain I voltage sensor are spatially close in the activated conformation of the channel. We verified this proximity by using an engineered disulfide bridge approach. The Q875E mutation introduces a negative charge that may modify the local electrical field experienced by the voltage sensor and, upon activation, interact directly via a salt bridge with the Arg-214 gating charge residue. Together these processes could promote transition to, and stabilization of, the domain I voltage sensor in the activated conformation and thus produce the observed gain of function. In support of this hypothesis, an increase in the extracellular concentration of Ca2+ or Mg2+ reverted the voltage dependence of activation of the IEM mutant to near WT values, suggesting a cation-mediated electrostatic screening of the proposed interaction between Q875E and Arg-214.	[Stadler, Theresa; O'Reilly, Andrias O.; Lampert, Angelika] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany; [O'Reilly, Andrias O.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 3AF, Merseyside, England; [Lampert, Angelika] RWTH Aachen Univ Hosp, Inst Physiol, D-52074 Aachen, Germany	University of Erlangen Nuremberg; Liverpool John Moores University; RWTH Aachen University; RWTH Aachen University Hospital	Lampert, A (corresponding author), RWTH Aachen Univ Hosp, Inst Physiol, Pauwelsstr 30, D-52074 Aachen, Germany.	alampert@ukaachen.de	Lampert, Angelika/F-7198-2010; O'Reilly, Andrias/AAC-7628-2022	Lampert, Angelika/0000-0001-6319-6272; O'Reilly, Andrias/0000-0003-3449-2368	Deutsche Forschungsgemeinschaft (DFG) [LA2740/2-1]; German Israeli Foundation (GIF) [1091-27.1/2010]; Marie-Curie Fellowship FP7-PEOPLE-IEF [275768]; Studienstiftung des deutschen Volkes	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); Marie-Curie Fellowship FP7-PEOPLE-IEF; Studienstiftung des deutschen Volkes	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant LA2740/2-1 (to A. L.), German Israeli Foundation (GIF) Grant 1091-27.1/2010 (to A. L.), Marie-Curie Fellowship FP7-PEOPLE-2010-IEF, Number 275768 (to A. O. R.), and a fellowship from the Studienstiftung des deutschen Volkes (to T. S.).	Bennett E, 1997, J GEN PHYSIOL, V109, P327, DOI 10.1085/jgp.109.3.327; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cheng XY, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-1; Choi JS, 2006, NEUROLOGY, V67, P1563, DOI 10.1212/01.wnl.0000231514.33603.1e; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cregg R, 2013, NEUROMOL MED, V15, P265, DOI 10.1007/s12017-012-8216-8; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; Drenth JPH, 2005, J INVEST DERMATOL, V124, P1333, DOI 10.1111/j.0022-202X.2005.23737.x; Eberhardt M, 2014, J BIOL CHEM, V289, P1971, DOI 10.1074/jbc.M113.502211; Estacion M, 2008, J NEUROSCI, V28, P11079, DOI 10.1523/JNEUROSCI.3443-08.2008; Fertleman CR, 2007, NEUROLOGY, V69, P586, DOI 10.1212/01.wnl.0000268065.16865.5f; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Han CY, 2009, BRAIN, V132, P1711, DOI 10.1093/brain/awp078; He BJ, 2010, NEUROSCI LETT, V469, P268, DOI 10.1016/j.neulet.2009.12.012; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; Kontis KJ, 1997, J GEN PHYSIOL, V110, P391, DOI 10.1085/jgp.110.4.391; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Lampert A, 2008, J BIOL CHEM, V283, P24118, DOI 10.1074/jbc.M802900200; Lampert Angelika, 2014, Handb Exp Pharmacol, V221, P91, DOI 10.1007/978-3-642-41588-3_5; Lampert A, 2010, PFLUG ARCH EUR J PHY, V460, P249, DOI 10.1007/s00424-009-0779-3; Lampert A, 2009, BIOCHEM BIOPH RES CO, V390, P319, DOI 10.1016/j.bbrc.2009.09.121; Lewis A, 2008, J GEN PHYSIOL, V131, P549, DOI 10.1085/jgp.200809962; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MILLER JA, 1983, BIOCHEMISTRY-US, V22, P462, DOI 10.1021/bi00271a032; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Phillips LR, 2010, J GEN PHYSIOL, V136, P629, DOI 10.1085/jgp.201010517; Sheets PL, 2007, J PHYSIOL-LONDON, V581, P1019, DOI 10.1113/jphysiol.2006.127027; Skeik N, 2012, VASC MED, V17, P44, DOI 10.1177/1358863X11422584; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Takeshita K, 2014, NAT STRUCT MOL BIOL, V21, P352, DOI 10.1038/nsmb.2783; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Vargas E, 2011, NEURON, V72, P713, DOI 10.1016/j.neuron.2011.09.024; Waxman SG, 2013, TRENDS MOL MED, V19, P406, DOI 10.1016/j.molmed.2013.04.003; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153	39	16	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6316	6325		10.1074/jbc.M114.605899	http://dx.doi.org/10.1074/jbc.M114.605899			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25575597	Green Published, hybrid			2022-12-26	WOS:000350732500037
J	Sun, YM; Ren, WY; Cote, JF; Hinds, PW; Hu, XX; Du, KY				Sun, Yingmin; Ren, Wenying; Cote, Jean-Franoiscois; Hinds, Philip W.; Hu, Xiaoxiang; Du, Keyong			ClipR-59 Interacts with Elmo2 and Modulates Myoblast Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; RAC ACTIVATION; EXCHANGE FACTORS; APOPTOTIC CELLS; CLIP-170 FAMILY; PROTEIN; DOMAIN; ASSOCIATION; ENGULFMENT; MEMBRANE	Recent studies using ClipR-59 knock-out mice implicated this protein in the regulation of muscle function. In this report, we have examined the role of ClipR-59 in muscle differentiation and found that ClipR-59 knockdown in C2C12 cells suppressed myoblast fusion. To elucidate the molecular mechanism whereby ClipR-59 regulates myoblast fusion, we carried out a yeast two-hybrid screen using ClipR-59 as the bait and identified Elmo2, a member of the Engulfment and cell motility protein family, as a novel ClipR-59-associated protein. We showed that the interaction between ClipR-59 and Elmo2 was mediated by the atypical PH domain of Elmo2 and the Glu-Pro-rich domain of ClipR-59 and regulated by Rho-GTPase. We have examined the impact of ClipR-59 on Elmo2 downstream signaling and found that interaction of ClipR-59 with Elmo2 enhanced Rac1 activation. Collectively, our studies demonstrate that formation of an Elmo2.ClipR-59 complex plays an important role in myoblast fusion.	[Sun, Yingmin; Hu, Xiaoxiang] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 10083, Peoples R China; [Sun, Yingmin; Ren, Wenying; Hinds, Philip W.; Du, Keyong] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Cote, Jean-Franoiscois] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada	China Agricultural University; Tufts Medical Center; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Du, KY (corresponding author), 800 Washington St, Boston, MA 02111 USA.	kdu@tuftsmedicalcenter.org			National Institutes of Health [RO1 DK084319]; Major Transgenic project [2011ZX08009-003-006]; Fonds de recherche du Quebec-Sante senior investigator salary award; Canadian Institutes of Health Research [77591]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Major Transgenic project; Fonds de recherche du Quebec-Sante senior investigator salary award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK084319 (to K. D.).; Supported in part by Major Transgenic project 2011ZX08009-003-006 (to X. H.).; Recipient of a Fonds de recherche du Quebec-Sante senior investigator salary award and supported by Canadian Institutes of Health Research Grant 77591.	Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Burks DJ, 1998, J BIOL CHEM, V273, P31061, DOI 10.1074/jbc.273.47.31061; Couesnon A, 2013, DEVELOPMENT, V140, P1583, DOI 10.1242/dev.087106; Ding JX, 2009, MOL CELL BIOL, V29, P1459, DOI 10.1128/MCB.00754-08; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Duquette P. M., 2014, SMALL GTPASES, V5, P1; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Fujikura D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.3; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Grimsley CM, 2006, J BIOL CHEM, V281, P5928, DOI 10.1074/jbc.M510647200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; Hanawa-Suetsugu K, 2012, P NATL ACAD SCI USA, V109, P3305, DOI 10.1073/pnas.1113512109; Hiramoto K, 2006, EXP CELL RES, V312, P4205, DOI 10.1016/j.yexcr.2006.09.006; Hiramoto-Yamaki N, 2010, J CELL BIOL, V190, P461, DOI 10.1083/jcb.201005141; Ho E, 2012, CELL ADHES MIGR, V6, P168, DOI 10.4161/cam.20399; Kato S, 2007, BIOCHEM BIOPH RES CO, V353, P933, DOI 10.1016/j.bbrc.2006.12.161; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Lallemand-Breitenbach V, 2004, J BIOL CHEM, V279, P41168, DOI 10.1074/jbc.M406482200; Laurin M, 2014, GENE DEV, V28, P533, DOI 10.1101/gad.236349.113; Li HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2680; Linseman DA, 2008, FRONT BIOSCI-LANDMRK, V13, P657, DOI 10.2741/2710; Lu MJ, 2004, NAT STRUCT MOL BIOL, V11, P756, DOI 10.1038/nsmb800; Maekawa H, 2004, DEV CELL, V6, P746, DOI 10.1016/j.devcel.2004.05.017; Margaron Y, 2013, J BIOL CHEM, V288, P1184, DOI 10.1074/jbc.M112.431825; MILLER JB, 1990, J CELL BIOL, V111, P1149, DOI 10.1083/jcb.111.3.1149; Mohammadi S, 2009, INFECT IMMUN, V77, P4771, DOI 10.1128/IAI.00850-09; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Patel Manishha, 2011, Small GTPases, V2, P268; Patel M, 2010, CURR BIOL, V20, P2021, DOI 10.1016/j.cub.2010.10.028; Perez F, 2002, J CELL BIOL, V156, P631, DOI 10.1083/jcb.200111003; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ren WY, 2013, MOL CELL BIOL, V33, P4255, DOI 10.1128/MCB.00527-13; Ren WY, 2012, J BIOL CHEM, V287, P26890, DOI 10.1074/jbc.M112.357699; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Zhang G, 2014, J BIOL CHEM, V289, P23112, DOI 10.1074/jbc.M114.549550	39	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6130	6140		10.1074/jbc.M114.616680	http://dx.doi.org/10.1074/jbc.M114.616680			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25572395	Green Published, hybrid			2022-12-26	WOS:000350732500022
J	Xu, GL; Liu, GL; Xiong, SD; Liu, HY; Chen, X; Zheng, B				Xu, Guiliang; Liu, Guilin; Xiong, Sidong; Liu, Haiyan; Chen, Xi; Zheng, Biao			The Histone Methyltransferase Smyd2 Is a Negative Regulator of Macrophage Activation by Suppressing Interleukin 6 (IL-6) and Tumor Necrosis Factor alpha (TNF-alpha) Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNITY; ALTERNATIVE ACTIVATION; EPIGENETIC REGULATION; POLARIZATION; P53	SET and MYND domain-containing 2 (Smyd2), a histone 3 lysine 4- and histone 3 lysine 36 (H3K36)-specific methyltransferase, plays critical roles in cardiac development and tumorigenesis. However, the role of Smyd2 in immunity and inflammation remains poorly understood. In this study, we report that Smyd2 is a novel negative regulator for macrophage activation and M1 polarization. Elevated Smyd2 expression suppresses the production of proinflammatory cytokines, including IL-6 and TNF, and inhibits the expression of important cell surface molecules, including major MHC-II and costimulatory molecules. Furthermore, macrophages with high Smyd2 expression inhibit Th-17 cell differentiation but promote regulatory T cell differentiation as a result of increased TGF-beta production and decreased IL-6 secretion. In macrophages, Smyd2 specifically facilitates H3K36 dimethylation at Tnf and Il6 promoters to suppress their transcription and inhibits NF-kappa B and ERK signaling. Therefore, our data demonstrate that epigenetic modification by Smyd2-mediated H3K36 dimethylation at Tnf and Il6 promoters plays an important role in the regulation of macrophage activation during inflammation.	[Xu, Guiliang; Liu, Guilin; Xiong, Sidong; Liu, Haiyan] Soochow Univ, Inst Biol & Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Peoples R China; [Chen, Xi; Zheng, Biao] E China Normal Univ, Sch Biol Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Chen, Xi; Zheng, Biao] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Soochow University - China; East China Normal University; Baylor College of Medicine	Chen, X (corresponding author), E China Normal Univ, Sch Biol Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China.	xichen0919@gmail.com; bzheng@bcm.edu	Liu, Haiyan/ABD-8689-2021	Liu, Haiyan/0000-0002-4652-469X				Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Abu-Farha M, 2011, J MOL CELL BIOL, V3, P301, DOI 10.1093/jmcb/mjr025; An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Bordon Y, 2013, NAT REV IMMUNOL, V13, P706, DOI 10.1038/nri3533; Bordon Y, 2012, NAT REV IMMUNOL, V12, DOI 10.1038/nri3332; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Cho HS, 2012, NEOPLASIA, V14, P476, DOI 10.1593/neo.12656; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Koch MW, 2013, NAT REV NEUROL, V9, P35, DOI 10.1038/nrneurol.2012.226; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Kugelberg E, 2014, NAT REV IMMUNOL, V14, P359, DOI 10.1038/nri3688; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lin L, 2013, J IMMUNOL, V191, P3896, DOI 10.4049/jimmunol.1203450; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Papatriantafyllou M, 2012, NAT REV IMMUNOL, V12, DOI 10.1038/nri3324; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuch O, 2011, EUR J IMMUNOL, V41, P2490, DOI 10.1002/eji.201141792; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Xia M, 2013, IMMUNITY, V39, P470, DOI 10.1016/j.immuni.2013.08.016; Yang XS, 2014, MOL ENDOCRINOL, V28, P565, DOI 10.1210/me.2013-1293	40	67	73	5	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5414	5423		10.1074/jbc.M114.610345	http://dx.doi.org/10.1074/jbc.M114.610345			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25583990	Green Published, hybrid			2022-12-26	WOS:000350044200015
J	Catarsi, P; Rosti, V; Morreale, G; Poletto, V; Villani, L; Bertorelli, R; Pedrazzini, M; Zorzetto, M; Barosi, G				Catarsi, Paolo; Rosti, Vittorio; Morreale, Giacomo; Poletto, Valentina; Villani, Laura; Bertorelli, Roberto; Pedrazzini, Matteo; Zorzetto, Michele; Barosi, Giovanni		AGIMM Investigators	JAK2 Exon 14 Skipping in Patients with Primary Myelofibrosis: A Minor Splice Variant Modulated by the JAK2-V617F Allele Burden	PLOS ONE			English	Article							NONSENSE-MEDIATED DECAY; QUANTITATIVE FLUORESCENT PCR; TYROSINE KINASE JAK2; MYELOPROLIFERATIVE NEOPLASMS; POLYCYTHEMIA-VERA; MUTATION; DIAGNOSIS; ANEUPLOIDIES; DISORDERS; DEFINITION	Background Primary myelofibrosis (PMF) is an acquired clonal disease of the hematopoietic stem cell compartment, characterized by bone marrow fibrosis, anemia, splenomegaly and extramedullary hematopoiesis. About 60% of patients with PMF harbor a somatic mutation of the JAK2 gene (JAK2-V617F) in their hematopoietic lineage. Recently, a splicing isoform of JAK2, lacking exon 14 (JAK2 Delta 14) was described in patients affected by myeloproliferative diseases. Materials and Methods By using a specific RT-qPCR method, we measured the ratio between the splicing isoform and the JAK2 full-length transcript (JAK2+14) in granulocytes, isolated from peripheral blood, of forty-four patients with PMF and nine healthy donors. Results We found that JAK2.14 was only slightly increased in patients and, at variance with published data, the splicing isoform was also detectable in healthy controls. We also found that, in patients bearing the JAK2-V617F mutation, the percentage of mutated alleles correlated with the observed increase in JAK2 Delta 14. Homozygosity for the mutation was also associated with a higher level of JAK2+14. Bioinformatic analysis indicates the possibility that the G> T transversion may interfere with the correct splicing of exon 14 by modifying a splicing regulatory sequence. Conclusions Increased levels of JAK2 full-length transcript and a small but significant increase in JAK2 exon 14 skipping, are associated with the JAK2-V617F allele burden in PMF granulocytes. Our data do not confirm a previous claim that the production of the JAK2 Delta 14 isoform is related to the pathogenesis of PMF.	[Catarsi, Paolo; Rosti, Vittorio; Poletto, Valentina; Villani, Laura; Barosi, Giovanni] Fdn IRCCS Policlin San Matteo, Biotechnol Res Labs, Ctr Study & Treatment Myelofibrosis, Pavia, PV, Italy; [Morreale, Giacomo] Consiglio Ric & Sperimentaz Agr, Viticulture Res Ctr, Conegliano, TV, Italy; [Bertorelli, Roberto] Fdn Bruno Kessler, Lab Biomol Sequence & Struct Anal Hlth, Trento, TN, Italy; [Pedrazzini, Matteo] Ist Auxol Italiano, Biomed & Technol Res Ctr, Cardiovasc Genet Lab, Cusano Milanino, MI, Italy; [Zorzetto, Michele] Fdn IRCCS Policlin San Matteo, Dept Mol Med, Div Pneumol, Lab Biochem & Genet, Pavia, PV, Italy	IRCCS Fondazione San Matteo; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Fondazione Bruno Kessler; IRCCS Istituto Auxologico Italiano; IRCCS Fondazione San Matteo; University of Pavia	Catarsi, P (corresponding author), Fdn IRCCS Policlin San Matteo, Biotechnol Res Labs, Ctr Study & Treatment Myelofibrosis, Pavia, PV, Italy.	p.catarsi@smatteo.pv.it	Zorzetto, Michele/K-2281-2015; Rosti, Vittorio/K-1743-2018; Barosi, Giovanni/AAI-1714-2019; Catarsi, Paolo/J-4463-2016; Villani, Laura/K-1794-2018	Zorzetto, Michele/0000-0002-7826-3666; Rosti, Vittorio/0000-0003-4195-2289; Catarsi, Paolo/0000-0002-1862-8168; Villani, Laura/0000-0003-4199-5633; Morreale, Giacomo/0000-0003-3833-7103	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano), Special Program Molecular Clinical Oncology [1005]	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano), Special Program Molecular Clinical Oncology(Fondazione AIRC per la ricerca sul cancro)	This work was supported by a grant from Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano), Special Program Molecular Clinical Oncology "5x1000" to the AGIMM (AIRC-Gruppo Italiano Malattie Mieloproliferative) project number # 1005. A detailed description of the AGIMM project is available at http://www.progettoagimm.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bench AJ, 2013, BRIT J HAEMATOL, V160, P25, DOI 10.1111/bjh.12075; Bonomi S, 2013, NUCLEIC ACIDS RES, V41, P8665, DOI 10.1093/nar/gkt579; Campbell PJ, 2009, NAT GENET, V41, P385, DOI 10.1038/ng0409-385; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chern T-M, 2006, PLOS GENET, V2, pe45, DOI [10.1371/journal.pgen.0020045, DOI 10.1371/JOURNAL.PGEN.0020045]; Cirigliano V, 2002, MOL HUM REPROD, V8, P1042, DOI 10.1093/molehr/8.11.1042; Cross NCP, 2011, HEMATOL-AM SOC HEMAT, P208, DOI 10.1182/asheducation-2011.1.208; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Fiedler W, 2000, CANCER-AM CANCER SOC, V88, P344, DOI 10.1002/(SICI)1097-0142(20000115)88:2<344::AID-CNCR14>3.0.CO;2-6; Filippov V, 2008, GENE, V420, P34, DOI 10.1016/j.gene.2008.05.008; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jensen MA, 2014, NAT STRUCT MOL BIOL, V21, P189, DOI 10.1038/nsmb.2756; Jones AV, 2009, NAT GENET, V41, P446, DOI 10.1038/ng.334; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Kralovics R, 2008, LEUKEMIA, V22, P1841, DOI 10.1038/leu.2008.233; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lippert E, 2006, BLOOD, V108, P1865, DOI 10.1182/blood-2006-01-013540; Ma WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012165; MANSFIELD ES, 1993, HUM MOL GENET, V2, P43, DOI 10.1093/hmg/2.1.43; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Pickrell JK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001236; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Rahil H, 2002, EUR J HUM GENET, V10, P462, DOI 10.1038/sj.ejhg.5200833; Spasovski V, 2013, J APPL GENET, V54, P21, DOI 10.1007/s13353-012-0125-x; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; Tefferi A, 2011, LEUKEMIA, V25, P1059, DOI 10.1038/leu.2011.92; Vandenbroucke I I, 2001, Nucleic Acids Res, V29, pE68, DOI 10.1093/nar/29.13.e68; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Zhang CL, 2008, P NATL ACAD SCI USA, V105, P5797, DOI 10.1073/pnas.0801692105; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; ZHUANG HM, 1995, J BIOL CHEM, V270, P14500, DOI 10.1074/jbc.270.24.14500	40	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116636	10.1371/journal.pone.0116636	http://dx.doi.org/10.1371/journal.pone.0116636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617626	Green Submitted, gold, Green Published			2022-12-26	WOS:000350336000019
J	Rouet, F; Deleplancque, L; Mboumba, BB; Sica, J; Mouinga-Ondeme, A; Liegeois, F; Goudeau, A; Dubois, F; Gaudy-Graffin, C				Rouet, Francois; Deleplancque, Luc; Mboumba, Berthold Bivigou; Sica, Jeanne; Mouinga-Ondeme, Augustin; Liegeois, Florian; Goudeau, Alain; Dubois, Frederic; Gaudy-Graffin, Catherine			Usefulness of a Fourth Generation ELISA Assay for the Reliable Identification of HCV Infection in HIV-Positive Adults from Gabon (Central Africa)	PLOS ONE			English	Article							C VIRUS-INFECTION; CORE ANTIGEN-ASSAY; TO-CUTOFF RATIOS; LIMITED RESOURCES; PREGNANT-WOMEN; SCREENING-TEST; BLOOD-DONORS; HEPATITIS; RNA; VIREMIA	Background/Objectives Guidelines for optimized HCV screening are urgently required in Africa, especially for patients infected with HIV, who sometimes show false positive or false negative reactivity in anti-HCV antibody assays. Here, we assessed the usefulness of a fourth-generation HCV Ag-Ab ELISA for the identification of active HCV infection in HIV-positive patients. Methods This cross-sectional study was conducted between 03/2010 and 01/2013 and included 762 Gabonese HIV-positive adult patients. The results of ELISA (Monolisa HCV Ag-Ab ULTRA, Bio-Rad) were compared with those obtained by RT-PCR (gold standard). The optimal ELISA signal-to-cutoff (S/CO) ratio to identify patients with active hepatitis C (positive HCV RNA) was determined. Specimens were further tested by the INNO-LIA HCV core assay (Innogenetics) and the Architect HCV Ag kit (Abbott) to define the best diagnostic strategy. Results Sixty-seven patients tested positive for HCV (S/CO ratio >= 1) by ELISA. Of these, 47 (70.1%) tested positive for HCV RNA. The optimal S/CO associated with active HCV infection was 1.7. At this threshold, the sensitivity of ELISA was 97.9%(95% confidence interval (CI) 90.0-99.9%), its specificity was 91.3% (95% CI 85.0-95.5%), and HCV seroprevalence rate was 7.3% (56/762) (95% CI 5.6-9.4%). Among 57 HCV-seropositive patients with available INNO-LIA results, false reactivity was identified in 14 (24.6%), resolved HCV infection in two (3.5%), possible acute HCV infections in nine (15.8%) and likely chronic HCV infections in 32 (56.1%) patients. HCV core Ag was undetectable in 14/15 (93.3%) specimens that tested negative for HCV RNA whereas it was quantified in 34 (out of 39, 87.2%) samples that tested positive for HCV RNA. Conclusions Our study provides comprehensive guidance for HCV testing in Gabon, and will help greatly clinicians to improve case definitions for both the notification and surveillance of HCV in patients co-infected with HIV.	[Rouet, Francois; Deleplancque, Luc; Mboumba, Berthold Bivigou; Mouinga-Ondeme, Augustin; Liegeois, Florian] CIRMF, Lab Retrovirol, Franceville, Gabon; [Sica, Jeanne] CTA, Franceville, Gabon; [Liegeois, Florian] IRD, UMI Trans VIH MI Transit Epidemiol Rech Translat, Montpellier, France; [Liegeois, Florian] Univ Montpellier I, Montpellier, France; [Goudeau, Alain; Dubois, Frederic; Gaudy-Graffin, Catherine] CHRU Tours, Hop Bretonneau, Serv Bacteriol Virol, Tours, France; [Goudeau, Alain; Gaudy-Graffin, Catherine] Univ Tours, PRES Ctr Val de Loire Univ, INSERM, U966, Tours, France; [Dubois, Frederic] Inst Inter Reg Sante IRSA, La Riche, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Rouet, F (corresponding author), Pasteur Inst Cambodia, HIV Hepatitis Unit, Phnom Penh, Cambodia.	frouet@pasteur-kh.org	Florian, Liegeois/D-3798-2013	Florian, Liegeois/0000-0003-1048-0661				Acar A, 2010, TRANSFUSION MED, V20, P152, DOI 10.1111/j.1365-3148.2009.00987.x; Agha S, 2004, J MED VIROL, V73, P216, DOI 10.1002/jmv.20078; Alipour A, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.13593; Alter Miriam J, 2003, MMWR Recomm Rep, V52, P1; Berger A, 2008, J CLIN VIROL, V43, P158, DOI 10.1016/j.jcv.2008.05.009; BUKH J, 1992, P NATL ACAD SCI USA, V89, P187, DOI 10.1073/pnas.89.1.187; Castelain S, 2008, J INFECT DIS, V198, P332, DOI 10.1086/589777; Caudai C, 1998, INFECTION, V26, P151, DOI 10.1007/BF02771840; Chasela CS, 2012, J CLIN VIROL, V54, P318, DOI 10.1016/j.jcv.2012.05.003; Dawson GJ, 2012, ANTIVIR THER, V17, P1431, DOI 10.3851/IMP2463; Descamps V, 2012, J CLIN MICROBIOL, V50, P465, DOI 10.1128/JCM.06503-11; Dubois F, 1998, ANN BIOL CLIN-PARIS, V56, P417; Easterbrook P, 2012, SEMIN LIVER DIS, V32, P147, DOI 10.1055/s-0032-1316476; El Sharkawi FZ, 2008, J MED VIROL, V80, P2086, DOI 10.1002/jmv.21325; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Firdaus R, 2013, J VIRAL HEPATITIS, V20, P290, DOI 10.1111/jvh.12002; Gaudy C, 2005, J CLIN MICROBIOL, V43, P1722, DOI 10.1128/JCM.43.4.1722-1726.2005; Gaudy-Graffin C, 2010, J CLIN MICROBIOL, V48, P3281, DOI 10.1128/JCM.00303-10; Getchell JP, 2013, MMWR-MORBID MORTAL W, V62, P362; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hanley JA, 1996, STAT MED, V15, P1575, DOI 10.1002/(SICI)1097-0258(19960730)15:14<1575::AID-SIM283>3.0.CO;2-2; Kamili S., 2012, Clinical Infectious Diseases, V55, P43, DOI 10.1093/cid/cis368; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Kiely P, 2010, TRANSFUSION, V50, P1344, DOI 10.1111/j.1537-2995.2009.02572.x; Liegeois F, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17985; Lin S, 2005, J CLIN MICROBIOL, V43, P3917, DOI 10.1128/JCM.43.8.3917-3924.2005; Maniez-Montreuil M, 2000, TRANSFUS CLIN BIOL, V7, p25S, DOI 10.1016/S1246-7820(00)80012-9; Martel-Laferriere V, 2014, J CLIN GASTROENTEROL, V48, P106, DOI 10.1097/MCG.0000000000000010; McGovern BH, 2009, CLIN INFECT DIS, V49, P1051, DOI 10.1086/605561; Medici MC, 2011, J CLIN VIROL, V51, P260, DOI 10.1016/j.jcv.2011.05.003; Messick K, 2001, HAEMOPHILIA, V7, P568, DOI 10.1046/j.1365-2516.2001.00559.x; Moretti M, 2012, CLIN VACCINE IMMUNOL, V19, P1329, DOI 10.1128/CVI.00175-12; Mullis CE, 2013, CLIN INFECT DIS, V57, P1747, DOI 10.1093/cid/cit602; Njouom R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042002; Obach D, 2014, CLIN INFECT DIS, V58, P1064, DOI 10.1093/cid/ciu066; Ottiger C, 2013, J CLIN VIROL, V58, P535, DOI 10.1016/j.jcv.2013.08.028; Perz JF, 2013, HEPATOLOGY, V57, P917, DOI 10.1002/hep.25688; Proust B, 2000, J CLIN MICROBIOL, V38, P3125, DOI 10.1128/JCM.38.8.3125-3127.2000; Rouet F, 2004, J MED VIROL, V74, P34, DOI 10.1002/jmv.20143; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Scheiblauer H, 2006, TRANSFUSION, V46, P708, DOI 10.1111/j.1537-2995.2006.00789.x; Schnuriger A, 2006, J CLIN MICROBIOL, V44, P1561, DOI 10.1128/JCM.44.4.1561-1563.2006; Tagny CT, 2014, J VIROL METHODS, V199, P119, DOI 10.1016/j.jviromet.2014.01.002; VECCHIO TJ, 1966, NEW ENGL J MED, V274, P1171, DOI 10.1056/NEJM196605262742104; Wu SJ, 2011, J MED VIROL, V83, P1930, DOI 10.1002/jmv.22168; zur Wiesch JS, 2012, J EXP MED, V209, P61, DOI 10.1084/jem.20100388	46	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116975	10.1371/journal.pone.0116975	http://dx.doi.org/10.1371/journal.pone.0116975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617896	gold, Green Submitted, Green Published			2022-12-26	WOS:000350336000034
J	Choi, JR; Pingguan-Murphy, B; Abas, WAW; Yong, KW; Poon, CT; Azmi, MAN; Omar, SZ; Chua, KH; Xu, F; Safwani, WKZW				Choi, Jane Ru; Pingguan-Murphy, Belinda; Abas, Wan Abu Bakar Wan; Yong, Kar Wey; Poon, Chi Tat; Azmi, Mat Adenan Noor; Omar, Siti Zawiah; Chua, Kien Hui; Xu, Feng; Safwani, Wan Kamarul Zaman Wan			In Situ Normoxia Enhances Survival and Proliferation Rate of Human Adipose Tissue-Derived Stromal Cells without Increasing the Risk of Tumourigenesis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; LOW-OXYGEN TENSION; BONE-MARROW; HYPOXIA INCREASES; VITRO EXPANSION; DNA-REPAIR; TELOMERASE; CANCER; DIFFERENTIATION; P53	Adipose tissue-derived stromal cells (ASCs) natively reside in a relatively low-oxygen tension (i.e., hypoxic) microenvironment in human body. Low oxygen tension (i.e., in situ normoxia), has been known to enhance the growth and survival rate of ASCs, which, however, may lead to the risk of tumourigenesis. Here, we investigated the tumourigenic potential of ASCs under their physiological condition to ensure their safe use in regenerative therapy. Human ASCs isolated from subcutaneous fat were cultured in atmospheric O-2 concentration (21% O-2) or in situ normoxia (2% O-2). We found that ASCs retained their surface markers, tri-lineage differentiation potential, and self-renewal properties under in situ normoxia without altering their morphology. In situ normoxia displayed a higher proliferation and viability of ASCs with less DNA damage as compared to atmospheric O-2 concentration. Moreover, low oxygen tension significantly up-regulated VEGF and bFGF mRNA expression and protein secretion while reducing the expression level of tumour suppressor genes p16, p21, p53, and pRb. However, there were no significant differences in ASCs telomere length and their relative telomerase activity when cultured at different oxygen concentrations. Collectively, even with high proliferation and survival rate, ASCs have a low tendency of developing tumour under in situ normoxia. These results suggest 2% O-2 as an ideal culture condition for expanding ASCs efficiently while maintaining their characteristics.	[Choi, Jane Ru; Pingguan-Murphy, Belinda; Abas, Wan Abu Bakar Wan; Yong, Kar Wey; Poon, Chi Tat; Safwani, Wan Kamarul Zaman Wan] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia; [Azmi, Mat Adenan Noor; Omar, Siti Zawiah] Univ Malaya, Fac Med, Dept Obstet & Gynaecol, Kuala Lumpur 50603, Malaysia; [Chua, Kien Hui] Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur 50300, Malaysia; [Xu, Feng] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lib Biomed Informat Engn, Xian 710049, Peoples R China; [Xu, Feng] Xi An Jiao Tong Univ, Bioinspired Engn & Biomech Ctr, Xian 710049, Peoples R China	Universiti Malaya; Universiti Malaya; Universiti Kebangsaan Malaysia; Xi'an Jiaotong University; Xi'an Jiaotong University	Safwani, WKZW (corresponding author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.	wansafwani@um.edu.my	Xu, Feng/H-4468-2011; Zaman, Wan Safwani Wan Kamarul/L-1321-2015; OMAR, SITI ZAWIAH BINTI/B-9817-2010; Xu, Feng/C-7430-2011; chua, kienhui kh/M-7245-2017; Pingguan-Murphy, Belinda/B-8332-2010; Choi, Jane Ru/A-1245-2015; Yong, Kar Wey/Q-4248-2017	Xu, Feng/0000-0003-4351-0222; Zaman, Wan Safwani Wan Kamarul/0000-0002-8113-0370; Pingguan-Murphy, Belinda/0000-0001-5567-1141; Choi, Jane Ru/0000-0002-1537-6989; Yong, Kar Wey/0000-0002-9761-9402; Kien Hui, Chua/0000-0002-2595-5087	University of Malaya, High Impact Research Grant from the Ministry of Higher Education Malaysia [UM.C/HIR/MOHE/ENG/44]; Major International Joint Research Program of China [11120101002]; National Natural Science Foundation of China [11372243]; National 111 Project of China [B06024]	University of Malaya, High Impact Research Grant from the Ministry of Higher Education Malaysia; Major International Joint Research Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 111 Project of China(Ministry of Education, China - 111 Project)	This work was financially supported by the University of Malaya, High Impact Research Grant (UM.C/HIR/MOHE/ENG/44) from the Ministry of Higher Education Malaysia. FX was partially supported by the Major International Joint Research Program of China (11120101002), the National Natural Science Foundation of China (11372243), and the National 111 Project of China (B06024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2009, FEBS LETT, V583, P2922, DOI 10.1016/j.febslet.2009.07.056; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Barkholt L, 2013, CYTOTHERAPY, V15, P753, DOI 10.1016/j.jcyt.2013.03.005; Ben-David U, 2011, CELL STEM CELL, V9, P97, DOI 10.1016/j.stem.2011.06.013; Berniakovich I, 2013, INT J MOL SCI, V14, P2119, DOI 10.3390/ijms14012119; Blasco MA, 2003, CURR OPIN GENET DEV, V13, P70, DOI 10.1016/S0959-437X(02)00011-4; Buchheiser A, 2012, CYTOTHERAPY, V14, P967, DOI 10.3109/14653249.2012.671518; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Charbord P, 2011, M S-MED SCI, V27, P261, DOI 10.1051/medsci/2011273261; Chen GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073673; Choi JR, 2014, BIOCHEM BIOPH RES CO, V448, P218, DOI 10.1016/j.bbrc.2014.04.096; Chung HM, 2009, EXPERT OPIN BIOL TH, V9, P1499, DOI 10.1517/14712590903307362; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Crisan M, 2008, STEM CELLS, V26, P2425, DOI 10.1634/stemcells.2008-0325; Crisostomo PR, 2008, AM J PHYSIOL-CELL PH, V294, pC675, DOI 10.1152/ajpcell.00437.2007; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dos Santos F, 2010, J CELL PHYSIOL, V223, P27, DOI 10.1002/jcp.21987; Doulatov S, 2013, SCIENCE, V342, P700, DOI 10.1126/science.1238363; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Estrada JC, 2012, CELL DEATH DIFFER, V19, P743, DOI 10.1038/cdd.2011.172; Gomez DE, 2012, INT J ONCOL, V41, P1561, DOI 10.3892/ijo.2012.1611; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsiao ST, 2013, STEM CELLS DEV, V22, P1614, DOI 10.1089/scd.2012.0602; Hung SP, 2013, CELL TRANSPLANT, V22, P1869, DOI 10.3727/096368912X657954; Inoue K, 2012, MED MOL MORPHOL, V45, P115, DOI 10.1007/s00795-012-0575-6; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Jin YH, 2010, BIOCHEM BIOPH RES CO, V391, P1471, DOI 10.1016/j.bbrc.2009.12.096; Kikuchi S, 2013, ANTICANCER RES, V33, P3891; Kim JH, 2011, STEM CELLS DEV, V20, P1753, DOI 10.1089/scd.2010.0469; Kim S, 2013, STEM CELLS DEV, V20, P20; Kolle SFT, 2013, LANCET, V382, P1113, DOI 10.1016/S0140-6736(13)61410-5; Lee EY, 2009, WOUND REPAIR REGEN, V17, P540, DOI 10.1111/j.1524-475X.2009.00499.x; Lilian C-N, 2010, DUAL ROLE SENESCENCE, P28; Malladi P, 2006, AM J PHYSIOL-CELL PH, V290, pC1139, DOI 10.1152/ajpcell.00415.2005; Matsumoto A, 2005, MAGN RESON MED, V54, P1530, DOI 10.1002/mrm.20714; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Murofushi Y, 2006, INT J ONCOL, V29, P681; Offer H, 2002, CARCINOGENESIS, V23, P1025, DOI 10.1093/carcin/23.6.1025; Pan Q, 2013, EXPT BIOL MED; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Pelicci PG, 2004, J CLIN INVEST, V113, P4, DOI 10.1172/JCI200420750; Pilgaard L, 2009, EXP CELL RES, V315, P1937, DOI 10.1016/j.yexcr.2009.01.020; Plotkin JB, 2002, J THEOR BIOL, V214, P453, DOI 10.1006/jtbi.2001.2471; Prockop DJ, 2012, STEM CELLS, V30, P1051, DOI 10.1002/stem.1103; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Rubin JP, 2013, LANCET, V382, P1077, DOI 10.1016/S0140-6736(13)61744-4; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Sheehy EJ, 2012, BIOCHEM BIOPH RES CO, V417, P305, DOI 10.1016/j.bbrc.2011.11.105; Shih-Chieh H, 2007, PLOS ONE, V2; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; Smith A, 2006, NATURE, V441, P1060, DOI 10.1038/nature04954; Solozobova V, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-46; Stampfer MR, 2003, ONCOGENE, V22, P5238, DOI 10.1038/sj.onc.1206667; Stewart SA, 2002, ONCOGENE, V21, P627, DOI 10.1038/sj.onc.1205062; Stoeltzing O, 2004, JNCI-J NATL CANCER I, V96, P946, DOI 10.1093/jnci/djh168; Stubbs SL, 2012, STEM CELLS DEV, V21, P1887, DOI 10.1089/scd.2011.0289; Tamama K, 2011, J CELL BIOCHEM, V112, P804, DOI 10.1002/jcb.22961; Thangarajah H, 2009, STEM CELLS, V27, P266, DOI 10.1634/stemcells.2008-0276; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Tsai CC, 2011, BLOOD, V117, P459, DOI 10.1182/blood-2010-05-287508; Valorani MG, 2012, CELL PROLIFERAT, V45, P225, DOI 10.1111/j.1365-2184.2012.00817.x; Valorani MG, 2010, CELL TISSUE RES, V341, P111, DOI 10.1007/s00441-010-0982-8; Wagegg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046483; Wagers AJ, 2012, CELL STEM CELL, V10, P362, DOI 10.1016/j.stem.2012.02.018; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Xu Y, 2007, TISSUE ENG, V13, P2981, DOI 10.1089/ten.2007.0050; Yanada S, 2006, CELL PROLIFERAT, V39, P575, DOI 10.1111/j.1365-2184.2006.00397.x; Yang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023965; Zaman WSWK, 2014, J TISSUE ENG REGEN M, V8, P67, DOI 10.1002/term.1501	76	61	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115034	10.1371/journal.pone.0115034	http://dx.doi.org/10.1371/journal.pone.0115034			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615717	Green Published, Green Submitted, gold			2022-12-26	WOS:000349122100008
J	Lilja, A; Weeden, CE; McArthur, K; Nguyen, T; Donald, A; Wong, ZX; Dousha, L; Bozinovski, S; Vlahos, R; Burns, CJ; Asselin-Labat, ML; Anderson, GP				Lilja, Andrew; Weeden, Clare E.; McArthur, Kate; Thao Nguyen; Donald, Alastair; Wong, Zi Xin; Dousha, Lovisa; Bozinovski, Steve; Vlahos, Ross; Burns, Christopher J.; Asselin-Labat, Marie-Liesse; Anderson, Gary P.			HSP90 Inhibition Suppresses Lipopolysaccharide-Induced Lung Inflammation In Vivo	PLOS ONE			English	Article							POTENT ANTITUMOR-ACTIVITY; PROTEIN 90 INHIBITORS; NF-KAPPA-B; BACTERIAL LIPOPOLYSACCHARIDE; INNATE IMMUNITY; PHASE-II; GM-CSF; CANCER; GANETESPIB; ACTIVATION	Inflammation is an important component of cancer diathesis and treatment-refractory inflammation is a feature of many chronic degenerative lung diseases. HSP90 is a 90kDa protein which functions as an ATP-dependent molecular chaperone that regulates the signalling conformation and expression of multiple protein client proteins especially oncogenic mediators. HSP90 inhibitors are in clinical development as cancer therapies but the myeleosuppressive and neutropenic effect of first generation geldanamycin-class inhibitors has confounded studies on the effects on HSP90 inhibitors on inflammation. To address this we assessed the ability of Ganetespib, a non-geldanamycin HSP90 blocker, to suppress lipopolysaccharide (LPS)-induced cellular infiltrates, proteases and inflammatory mediator and transcriptional profiles. Ganetespib (10-100mg/kg, i.v.) did not directly cause myelosuppression, as assessed by video micrography and basal blood cell count, but it strongly and dosedependently suppressed LPS-induced neutrophil mobilization into blood and neutrophil-and mononuclear cell-rich steroid-refractory lung inflammation. Ganetespib also suppressed B cell and NK cell accumulation, inflammatory cytokine and chemokine induction and MMP9 levels. These data identify non-myelosuppresssive HSP90 inhibitors as potential therapies for inflammatory diseases refractory to conventional therapy, in particular those of the lung.	[Lilja, Andrew; Wong, Zi Xin; Dousha, Lovisa; Bozinovski, Steve; Vlahos, Ross; Anderson, Gary P.] Univ Melbourne, Dept Pharmacol & Therapeut, Lung Hlth Res Ctr, Parkville, Vic 3010, Australia; [Weeden, Clare E.; Asselin-Labat, Marie-Liesse] Walter & Eliza Hall Inst Med Res, Div ACRF Stem Cells & Canc, Parkville, Vic 3052, Australia; [McArthur, Kate; Thao Nguyen; Donald, Alastair; Burns, Christopher J.] Walter & Eliza Hall Inst Med Res, Div Chem Biol, Parkville, Vic 3052, Australia; [McArthur, Kate; Thao Nguyen; Donald, Alastair; Burns, Christopher J.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	University of Melbourne; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of Melbourne	Asselin-Labat, ML (corresponding author), Walter & Eliza Hall Inst Med Res, Div ACRF Stem Cells & Canc, Parkville, Vic 3052, Australia.	labat@wehi.edu.au; gpa@unimelb.edu.au	Nguyen, Thao/GWN-0419-2022; Vlahos, Ross/AAM-3837-2020	Vlahos, Ross/0000-0001-8443-7071; Burns, Christopher/0000-0002-4463-4916; Weeden, Clare/0000-0002-1561-1416; Anderson, Gary/0000-0001-6580-3398; Bozinovski, Steven/0000-0001-6533-8641; McArthur, Kate/0000-0002-8838-4146	Australian National Health and Medical Research Council [1038895]; Victorian State Government Operational Infrastructure Support (OIS) Grant; Australian Cancer Research Foundation; Australian Research Council Queen Elizabeth II Fellowship; Dyson Bequest funding	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support (OIS) Grant; Australian Cancer Research Foundation; Australian Research Council Queen Elizabeth II Fellowship(Australian Research Council); Dyson Bequest funding	This work is supported by scholarships, fellowships and grants from the Australian National Health and Medical Research Council (Development Grant 1038895); Victorian State Government Operational Infrastructure Support (OIS) Grant; Australian Cancer Research Foundation; Australian Research Council Queen Elizabeth II Fellowship (MLAL); and, Dyson Bequest funding (Dunn Fellowship to CJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva J, 2012, MOL CANCER THER, V11, P2633, DOI 10.1158/1535-7163.MCT-12-0615; Anthony D, 2014, FASEB J, V28, P3867, DOI 10.1096/fj.14-250332; BARTH MW, 1995, J LEUKOCYTE BIOL, V57, P361, DOI 10.1002/jlb.57.3.361; BOZIC CR, 1995, J IMMUNOL, V154, P6048; Bozinovski S, 2004, AM J PHYSIOL-LUNG C, V286, pL877, DOI 10.1152/ajplung.00275.2003; Bozinovski S, 2002, J BIOL CHEM, V277, P42808, DOI 10.1074/jbc.M207840200; Bucci M, 2000, BRIT J PHARMACOL, V131, P13, DOI 10.1038/sj.bjp.0703549; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; Cauwe B, 2009, INTEGR BIOL-UK, V1, P404, DOI 10.1039/b904701h; Croker BA, 2011, P NATL ACAD SCI USA, V108, P13135, DOI 10.1073/pnas.1110358108; Croker BA, 2011, J IMMUNOL, V186, P1131, DOI 10.4049/jimmunol.1002702; Fuchs CS, 2003, J CLIN ONCOL, V21, P807, DOI 10.1200/JCO.2003.08.058; Hacker S, 2009, CLIN LAB, V55, P31; Hance MW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.389015; He WG, 2007, MOL IMMUNOL, V44, P2850, DOI 10.1016/j.molimm.2007.01.022; Hendrickson AEW, 2012, GYNECOL ONCOL, V124, P210, DOI 10.1016/j.ygyno.2011.10.002; Iyer G, 2012, CANCER CHEMOTH PHARM, V69, P1089, DOI 10.1007/s00280-011-1789-3; Jhaveri K, 2014, EXPERT OPIN INV DRUG, V23, P611, DOI 10.1517/13543784.2014.902442; Laederich MB, 2011, J BIOL CHEM, V286, P19597, DOI 10.1074/jbc.M110.206151; Lai CH, 2014, ONCOGENE, V33, P4867, DOI 10.1038/onc.2013.439; Liu K, 2008, J BIOL CHEM, V283, P9977, DOI 10.1074/jbc.M710257200; Madrigal-Matute J, 2010, CARDIOVASC RES, V86, P330, DOI 10.1093/cvr/cvq046; Malhotra V, 2001, AM J RESP CELL MOL, V25, P92, DOI 10.1165/ajrcmb.25.1.4384; Maus U, 2002, AM J RESP CRIT CARE, V165, P95, DOI 10.1164/ajrccm.165.1.2106148; Miyajima N, 2013, CANCER RES, V73, P7022, DOI 10.1158/0008-5472.CAN-13-1156; Porter JR, 2010, CURR OPIN CHEM BIOL, V14, P412, DOI 10.1016/j.cbpa.2010.03.019; Poulaki V, 2007, FASEB J, V21, P2113, DOI 10.1096/fj.06-7637com; Proia DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018552; Rice JW, 2008, ARTHRITIS RHEUM-US, V58, P3765, DOI 10.1002/art.24047; Salminen A, 2008, IMMUNOL LETT, V117, P9, DOI 10.1016/j.imlet.2007.12.017; Schleimer Robert P, 2004, Proc Am Thorac Soc, V1, P222, DOI 10.1513/pats.200402-018MS; Shimamura T, 2012, CLIN CANCER RES, V18, P4973, DOI 10.1158/1078-0432.CCR-11-2967; Socinski MA, 2013, CLIN CANCER RES, V19, P3068, DOI 10.1158/1078-0432.CCR-12-3381; Stellas D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-51; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tartour E, 2013, LANCET RESP MED, V1, P551, DOI 10.1016/S2213-2600(13)70159-0; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Thangjam GS, 2014, AM J RESP CELL MOL, V50, P942, DOI 10.1165/rcmb.2013-0214OC; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Triantafilou K, 2001, J CELL SCI, V114, P2535; Triantafilou M, 2005, J ENDOTOXIN RES, V11, P5, DOI 10.1179/096805105225006641; Triantafilou M, 2004, BIOCHEM SOC T, V32, P636, DOI 10.1042/BST0320636; Vega VL, 2003, MOL BIOL CELL, V14, P764, DOI 10.1091/mbc.E02-08-0498; Vlahos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033277; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755; Yun TJ, 2011, J IMMUNOL, V186, P563, DOI 10.4049/jimmunol.1000222	46	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0114975	10.1371/journal.pone.0114975	http://dx.doi.org/10.1371/journal.pone.0114975			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615645	Green Published, gold			2022-12-26	WOS:000349122100007
J	Scharton, D; Van Wettere, AJ; Bailey, KW; Vest, Z; Westover, JB; Siddharthan, V; Gowen, BB				Scharton, Dionna; Van Wettere, Amaud J.; Bailey, Kevin W.; Vest, Zachary; Westover, Jonna B.; Siddharthan, Venkatraman; Gowen, Brian B.			Rift Valley Fever Virus Infection in Golden Syrian Hamsters	PLOS ONE			English	Article							PUNTA-TORO VIRUS; MESOCRICETUS-AURATUS; LETHAL DISEASE; ANIMAL-MODELS; PATHOGENESIS; PHLEBOVIRUS; ENCEPHALITIS; BUNYAVIRIDAE; EPIDEMIC; PROTECTS	Rift Valley fever virus (RVFV) is a formidable pathogen that causes severe disease and abortion in a variety of livestock species and a range of disease in humans that includes hemorrhagic fever, fulminant hepatitis, encephalitis and blindness. The natural transmission cycle involves mosquito vectors, but exposure can also occur through contact with infected fluids and tissues. The lack of approved antiviral therapies and vaccines for human use underlies the importance of small animal models for proof-of-concept efficacy studies. Several mouse and rat models of RVFV infection have been well characterized and provide useful systems for the study of certain aspects of pathogenesis, as well as antiviral drug and vaccine development. However, certain host-directed therapeutics may not act on mouse or rat pathways. Here, we describe the natural history of disease in golden Syrian hamsters challenged subcutaneously with the pathogenic ZH501 strain of RVFV. Peracute disease resulted in rapid lethality within 2 to 3 days of RVFV challenge. High titer viremia and substantial viral loads were observed in most tissues examined; however, histopathology and immunostaining for RVFV antigen were largely restricted to the liver. Acute hepatocellular necrosis associated with a strong presence of viral antigen in the hepatocytes indicates that fulminant hepatitis is the likely cause of mortality. Further studies to assess the susceptibility and disease progression following respiratory route exposure are warranted. The use of the hamsters to model RVFV infection is suitable for early stage antiviral drug and vaccine development studies.	[Scharton, Dionna; Van Wettere, Amaud J.; Bailey, Kevin W.; Vest, Zachary; Westover, Jonna B.; Siddharthan, Venkatraman; Gowen, Brian B.] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Scharton, Dionna; Bailey, Kevin W.; Vest, Zachary; Westover, Jonna B.; Siddharthan, Venkatraman; Gowen, Brian B.] Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA; [Van Wettere, Amaud J.; Gowen, Brian B.] Utah State Univ, Sch Vet Med, Logan, UT 84322 USA; [Van Wettere, Amaud J.] Utah Vet Diagnost Lab, Logan, UT USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Gowen, BB (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA.	brian.gowen@usu.edu		Van Wettere, Arnaud/0000-0002-9611-1316	National Institute of Health [HSN272201000039I]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by the National Institute of Health contract HSN272201000039I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON GW, 1990, ARCH VIROL, V114, P203, DOI 10.1007/BF01310749; ANDERSON GW, 1988, ARCH VIROL, V102, P187, DOI 10.1007/BF01310824; Bales JM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00105; Bird BH, 2007, J VIROL, V81, P2805, DOI 10.1128/JVI.02095-06; Chevalier V, 2004, REV SCI TECH OIE, V23, P535, DOI 10.20506/rst.23.2.1505; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; Easterday B C, 1965, Adv Vet Sci, V10, P65; Findlay GM, 1931, LANCET, V2, P1350; Fisher AF, 2003, AM J TROP MED HYG, V69, P269, DOI 10.4269/ajtmh.2003.69.269; Flick R, 2005, CURR MOL MED, V5, P827, DOI 10.2174/156652405774962263; GARGAN TP, 1988, AM J TROP MED HYG, V38, P440, DOI 10.4269/ajtmh.1988.38.440; Gerdes GH, 2004, REV SCI TECH OIE, V23, P613, DOI 10.20506/rst.23.2.1500; Gowen BB, 2008, ANTIVIR RES, V78, P79, DOI 10.1016/j.antiviral.2007.10.002; Gowen BB, 2008, ANTIVIR RES, V77, P215, DOI 10.1016/j.antiviral.2007.12.002; Gowen BB, 2014, VIRUSES-BASEL, V6, P1410, DOI 10.3390/v6031410; Gowen BB, 2013, ANTIVIR RES, V98, P135, DOI 10.1016/j.antiviral.2013.03.009; Gowen BB, 2012, ANTIMICROB AGENTS CH, V56, P4168, DOI 10.1128/AAC.00376-12; Gowen BB, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-240; Gray KK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001529; Hartley David M, 2011, Emerg Infect Dis, V17, pe1, DOI 10.3201/eid1708.101088; Hartman AL, 2014, J VIROL, V88, P2235, DOI 10.1128/JVI.02341-13; Hooper JW, 2001, VIROLOGY, V289, P6, DOI 10.1006/viro.2001.1133; Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493; LAUGHLIN LW, 1979, T ROY SOC TROP MED H, V73, P630, DOI 10.1016/0035-9203(79)90006-3; Madani TA, 2003, CLIN INFECT DIS, V37, P1084, DOI 10.1086/378747; Morrey JD, 2004, ANTIVIR RES, V63, P41, DOI 10.1016/j.antiviral.2004.02.005; MORRILL JC, 1990, ARCH VIROL, V110, P195, DOI 10.1007/BF01311288; Nguku PM, 2010, AM J TROP MED HYG, V83, P5, DOI 10.4269/ajtmh.2010.09-0288; NIKLASSON BS, 1984, ACTA PATH MICRO IM C, V92, P197; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; PETERS CJ, 1986, ANTIVIR RES, V6, P285, DOI 10.1016/0166-3542(86)90024-0; PETERS CJ, 1988, ARCH VIROL, V99, P31, DOI 10.1007/BF01311021; PIFAT DY, 1987, MICROB PATHOGENESIS, V3, P409, DOI 10.1016/0882-4010(87)90011-8; Reed C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002156; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROSSI CA, 1988, J GEN VIROL, V69, P817, DOI 10.1099/0022-1317-69-4-817; SALUZZO JF, 1989, RES VIROLOGY, V140, P155, DOI 10.1016/S0923-2516(89)80093-7; Scharton D, 2014, ANTIVIR RES, V104, P84, DOI 10.1016/j.antiviral.2014.01.016; Schmaljohn C.S., 2007, FIELDS VIROLOGY, P1741; Smith DR, 2014, ANTIVIR RES, V112, P59, DOI 10.1016/j.antiviral.2014.10.001; Smith DR, 2012, J VIROL, V86, P2109, DOI 10.1128/JVI.06190-11; Smith DR, 2010, VIROLOGY, V407, P256, DOI 10.1016/j.virol.2010.08.016; Wahl-Jensen V, 2012, VIRUSES-BASEL, V4, P3754, DOI 10.3390/v4123754; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; *WHO, 2007, OCHR A EV CERT FOOD, P169; Xiao SY, 2001, AM J TROP MED HYG, V64, P111, DOI 10.4269/ajtmh.2001.64.111; Xiao SY, 2001, EMERG INFECT DIS, V7, P714	47	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116722	10.1371/journal.pone.0116722	http://dx.doi.org/10.1371/journal.pone.0116722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607955	gold, Green Published, Green Submitted			2022-12-26	WOS:000348205300032
J	Khaldun, ABM; Huang, WJ; Liao, SH; Lv, HY; Wang, Y				Khaldun, A. B. M.; Huang, Wenjun; Liao, Sihong; Lv, Haiyan; Wang, Ying			Identification of MicroRNAs and Target Genes in the Fruit and Shoot Tip of Lycium chinense: A Traditional Chinese Medicinal Plant	PLOS ONE			English	Article							F-BOX PROTEINS; SMALL RNAS; EXPRESSION; TRANSCRIPTION; BIOGENESIS; ETHYLENE; ANNOTATION; EXTRACTS; BARBARUM; REVEALS	Although Lycium chinense (goji berry) is an important traditional Chinese medicinal plant, little genome information is available for this plant, particularly at the small-RNA level. Recent findings indicate that the evolutionary role of miRNAs is very important for a better understanding of gene regulation in different plant species. To elucidate small RNAs and their potential target genes in fruit and shoot tissues, high-throughput RNA sequencing technology was used followed by qRT-PCR and RLM 5'-RACE experiments. A total of 60 conserved miRNAs belonging to 31 families and 30 putative novel miRNAs were identified. A total of 62 significantly differentially expressed miRNAs were identified, of which 15 (14 known and 1 novel) were shoot-specific, and 12 (7 known and 5 novel) were fruit-specific. Additionally, 28 differentially expressed miRNAs were recorded as up-regulated in fruit tissues. The predicted potential targets were involved in a wide range of metabolic and regulatory pathways. GO (Gene Ontology) enrichment analysis and the KEGG (Kyoto Encyclopedia of Genes and Genomes) database revealed that "metabolic pathways" is the most significant pathway with respect to the rich factor and gene numbers. Moreover, five miRNAs were related to fruit maturation, lycopene biosynthesis and signaling pathways, which might be important for the further study of fruit molecular biology. This study is the first, to detect known and novel miRNAs, and their potential targets, of L. chinense. The data and findings that are presented here might be a good source for the functional genomic study of medicinal plants and for understanding the links among diversified biological pathways.	[Khaldun, A. B. M.; Huang, Wenjun; Liao, Sihong; Lv, Haiyan; Wang, Ying] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan 430074, Hubei, Peoples R China; [Khaldun, A. B. M.; Liao, Sihong] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Wang, Ying] Chinese Acad Sci, Northwest Ctr Agrobiotechnol Ningxia, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Wang, Y (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan 430074, Hubei, Peoples R China.	yingwang@wbgcas.cn	Khaldun, A B M/ABE-4597-2020; HUANG, WENJUN/GXM-9167-2022		National Natural Science Foundation of China [31200242, 31470391]; Scientific Research Equipment Project of Chinese Academy of Sciences [YZ201227]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Equipment Project of Chinese Academy of Sciences	This work was supported by National Natural Science Foundation of China (Grant no. 31200242 and 31470391) and Scientific Research Equipment Project of Chinese Academy of Sciences (YZ201227) (YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bapat VA, 2010, BIOTECHNOL ADV, V28, P94, DOI 10.1016/j.biotechadv.2009.10.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; *CAMS, 1980, DAT BOOK FOOD INGR; Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021; Carra A, 2009, PLANT J, V59, P750, DOI 10.1111/j.1365-313X.2009.03906.x; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chang RCC, 2008, CELL MOL NEUROBIOL, V28, P643, DOI 10.1007/s10571-007-9181-x; Elitzur T, 2010, J EXP BOT, V61, P1523, DOI 10.1093/jxb/erq017; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gan L, 2004, INT IMMUNOPHARMACOL, V4, P563, DOI 10.1016/j.intimp.2004.01.023; Gao ZH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-371; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guilfoyle TJ, 1998, CELL MOL LIFE SCI, V54, P619, DOI 10.1007/s000180050190; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; HOU K, 1984, DICT FAMILIES GENERA; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Karlova R, 2013, J EXP BOT, V64, P1863, DOI 10.1093/jxb/ert049; Kolotilin I, 2007, PLANT PHYSIOL, V145, P389, DOI 10.1104/pp.107.102962; KOZOMARA SGJ, 2013, NUCLEIC ACIDS RES, V42, P68, DOI DOI 10.1093/NAR/GKT1181; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu Q, 2009, FEBS LETT, V583, P723, DOI 10.1016/j.febslet.2009.01.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Luo Q, 2004, LIFE SCI, V76, P137, DOI 10.1016/j.lfs.2004.04.056; Luo XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079090; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mao F, 2011, MED ONCOL, V28, P121, DOI 10.1007/s12032-009-9415-5; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Meijer AH, 1997, PLANT J, V11, P263, DOI 10.1046/j.1365-313X.1997.11020263.x; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Mosher Rebecca A, 2010, Silence, V1, P13, DOI 10.1186/1758-907X-1-13; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Oh YC, 2012, INT IMMUNOPHARMACOL, V13, P181, DOI 10.1016/j.intimp.2012.03.020; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Qian JY, 2004, FOOD CHEM, V87, P283, DOI 10.1016/j.foodchem.2003.11.008; Qiao H, 2009, GENE DEV, V23, P512, DOI 10.1101/gad.1765709; Qiu DY, 2009, GENE, V436, P37, DOI 10.1016/j.gene.2009.01.006; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Song CN, 2009, PLANTA, V230, P671, DOI 10.1007/s00425-009-0971-x; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang XW, 2010, MOL BIOTECHNOL, V44, P61, DOI 10.1007/s12033-009-9204-6; Wang XL, 2009, GENE DEV, V23, P391, DOI 10.1101/gad.1781609; Welsch R, 2007, PLANT PHYSIOL, V145, P1073, DOI 10.1104/pp.107.104828; Wen M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-140; Wu HJ, 2012, NUCLEIC ACIDS RES, V40, pW22, DOI 10.1093/nar/gks554; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Xu MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-521; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295; Zuo JH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-7	71	27	31	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116334	10.1371/journal.pone.0116334	http://dx.doi.org/10.1371/journal.pone.0116334			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587984	Green Published, Green Submitted, gold			2022-12-26	WOS:000347928300009
J	Steinke, JW; Liu, LX; Turner, RB; Braciale, TJ; Borish, L				Steinke, John W.; Liu, Lixia; Turner, Ronald B.; Braciale, Thomas J.; Borish, Larry			Immune Surveillance by Rhinovirus-Specific Circulating CD4(+) and CD8(+) T Lymphocytes	PLOS ONE			English	Article							ASTHMA EXACERBATIONS; LUNG INFLAMMATION; VIRAL-INFECTIONS; GENE-EXPRESSION; DENDRITIC CELLS; VIRUS-INFECTION; IN-VIVO; CHILDREN; RISK; HYPERRESPONSIVENESS	Background It is difficult to experimentally infect volunteers with RV strains to which the subject demonstrates serological immunity. However, in RV challenges, viral clearance begins before de novo adaptive immune responses would develop. We speculated that adaptive immunity to RV reflects heterologous immunity by effector memory cells. Methods DCs were generated from monocytes using GM-CSF and IL-4 and RV39 loading accomplished with a dose of similar to 350 TCID50/10(5) cells. RV-induced maturation was established as modulation of MHC class II, CD80, CD83, and CD86. Circulating RV targeting CD4 and CD8 T cells were investigated as induction of RV-specific proliferation (CFSE-dilution). Results Maturation of DC by RV was confirmed as upregulation of MHC Class II (83.3 +/- 5.0% to 87.8 +/- 4.1%), CD80 (39.4 +/- 7.2% to 47.6 +/- 7.7%) and CD86 (78.4 +/- 4.7% to 84.1 +/- 3.4%). Both CD4 and CD8 memory T cells were recognized in the circulation of healthy subjects. Conclusions RV drives DC maturation and results in their ability to present RV antigens to both T helper and cytotoxic lymphocytes. Both CD4 and CD8 cells capable of recognizing RV-associated antigens are present in the circulation of healthy subjects where they are presumably involved in immune surveillance and explain the rapid recruitment of an adaptive immune response during RV infection.	[Steinke, John W.; Liu, Lixia] Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA 22908 USA; [Steinke, John W.; Braciale, Thomas J.; Borish, Larry] Univ Virginia, Carter Immunol Ctr, Charlottesville, VA USA; [Turner, Ronald B.] Univ Virginia Hlth Syst, Dept Pediat, Charlottesville, VA USA; [Braciale, Thomas J.] Univ Virginia Hlth Syst, Dept Pathol, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Steinke, JW (corresponding author), Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA 22908 USA.	js3ch@virginia.edu			National Institutes of Health [R21 AI1090413, UO1: AI057438, RO1: AI057438]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015608, U19AI083024, R01AI057438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health: Grant numbers: R21 AI1090413 LB, UO1: AI057438 LB to TJB, RO1: AI057438 LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Cerwenka A, 1999, J EXP MED, V189, P423, DOI 10.1084/jem.189.2.423; Chen Y, 2006, AM J RESP CELL MOL, V34, P192, DOI 10.1165/rcmb.2004-0417OC; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Denlinger LC, 2011, AM J RESP CRIT CARE, V184, P1007, DOI 10.1164/rccm.201103-0585OC; Early SB, 2007, AM J RESP CELL MOL, V36, P715, DOI 10.1165/rcmb.2006-0252OC; Fleming HE, 1999, AM J RESP CRIT CARE, V160, P100, DOI 10.1164/ajrccm.160.1.9808074; HALPERIN SA, 1985, AM REV RESPIR DIS, V132, P976; Heymann PW, 2004, J ALLERGY CLIN IMMUN, V114, P239, DOI 10.1016/j.jaci.2004.04.006; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jartti T, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-85; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kennedy JL, 2014, AM J RESP CRIT CARE, V189, P532, DOI 10.1164/rccm.201310-1767OC; Kirchberger S, 2005, J IMMUNOL, V175, P1145, DOI 10.4049/jimmunol.175.2.1145; Laza-Stanca V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002114; Li L, 1997, J IMMUNOL, V158, P4152; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Miyahara N, 2004, NAT MED, V10, P865, DOI 10.1038/nm1081; Nascimento CR, 2011, BLOOD, V117, P489, DOI 10.1182/blood-2010-03-272690; Papadopoulos NG, 2002, THORAX, V57, P328, DOI 10.1136/thorax.57.4.328; Peltola V, 2008, J CLIN VIROL, V43, P411, DOI 10.1016/j.jcv.2008.08.014; PRICE WH, 1956, P NATL ACAD SCI USA, V42, P892, DOI 10.1073/pnas.42.12.892; Proud D, 2008, AM J RESP CRIT CARE, V178, P962, DOI 10.1164/rccm.200805-670OC; Rakes CP, 1999, AM J RESP CRIT CARE, V159, P785, DOI 10.1164/ajrccm.159.3.9801052; Sawicka E, 2004, EUR J IMMUNOL, V34, P2599, DOI 10.1002/eji.200425018; Schempp S, 2011, VIRUS RES, V155, P446, DOI 10.1016/j.virusres.2010.11.014; Schrauf C, 2009, J IMMUNOL, V183, P4440, DOI 10.4049/jimmunol.0804147; Soto-Quiros M, 2012, J ALLERGY CLIN IMMUN, V129, P1499, DOI 10.1016/j.jaci.2012.03.040; Spencer LA, 2009, J LEUKOCYTE BIOL, V85, P117, DOI 10.1189/jlb.0108058; Steinke JW, 2007, CELL IMMUNOL, V249, P101, DOI 10.1016/j.cellimm.2007.12.001; Steinke JW, 2004, AM J RESP CELL MOL, V30, P212, DOI 10.1165/rcmb.2003-0071OC; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Turner RB, 2005, NEW ENGL J MED, V353, P341, DOI 10.1056/NEJMoa044441; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Williams JV, 2005, J ALLERGY CLIN IMMUN, V115, P1311, DOI 10.1016/j.jaci.2005.02.001; Zambrano JC, 2003, J ALLERGY CLIN IMMUN, V111, P1008, DOI 10.1067/mai.2003.1396	38	42	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0115271	10.1371/journal.pone.0115271	http://dx.doi.org/10.1371/journal.pone.0115271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OG	25584821	Green Published, gold, Green Submitted			2022-12-26	WOS:000348201300002
J	Oner, J; Sengoz, B				Oner, Julide; Sengoz, Burak			Utilization of Recycled Asphalt Concrete with Warm Mix Asphalt and Cost-Benefit Analysis	PLOS ONE			English	Article							BINDERS; ADDITIVES	The asphalt paving industries are faced with two major problems. These two important challenges are generated with an increase in demand for environmentally friendly paving mixtures and the problem of rapidly rising raw materials. Recycling of reclaimed asphalt pavement (RAP) is a critical necessity to save precious aggregates and reduce the use of costly bitumen. Warm Mix Asphalt (WMA) technology provides not only the option of recycling asphalt pavement at a lower temperature than the temperature maintained in hot mixtures but also encourages the utilization of RAP and therefore saves energy and money. This paper describes the feasibility of utilizing three different WMA additives (organic, chemical and water containing) at recommended contents with different percentages of RAP. The mechanical properties and cost-benefit analysis of WMA containing RAP have been performed and compared with WMA without RAP. The results indicated that, 30%, 10% and 20% can be accepted as an optimum RAP addition related to organic, chemical and water containing additives respectively and organic additive with 30% RAP content has an appreciable increase in tensile strength over the control mix. It was also concluded that the RAP with WMA technology is the ability to reduce final cost compared to HMA and WMA mixtures.	[Oner, Julide] Dokuz Eylul Univ, Dept Civil Engn, Div Transportat, Grad Sch Nat & Appl Sci, Izmir, Turkey; [Sengoz, Burak] Dokuz Eylul Univ, Dept Civil Engn, Div Transportat, Izmir, Turkey	Dokuz Eylul University; Dokuz Eylul University	Sengoz, B (corresponding author), Dokuz Eylul Univ, Dept Civil Engn, Div Transportat, Izmir, Turkey.	burak.sengoz@deu.edu.tr	Sengoz, Burak/O-9005-2019; Sengoz, Burak/AAR-7612-2020	Sengoz, Burak/0000-0003-0684-4880; Sengoz, Burak/0000-0003-0684-4880				[Anonymous], 2012, D693112 ASTM INT; [Anonymous], D175497 ASTM, DOI [10.1520/D1754-97R02, DOI 10.1520/D1754-97R02]; [Anonymous], 2006, C13106 ASTM; [Anonymous], 1998, C1252 ASTM; [Anonymous], 2005, C88 ASTM; [Anonymous], 2010, D4791 ASTM; [Anonymous], 2000, D36 ASTM; [Anonymous], 2006, D506 ASTM; [Anonymous], 2008, C136 ASTM; ASTM, 2012, C128 ASTM; ASTM, 2002, D440206 ASTM; ASTM, 2012, C127 ASTM; ASTM International, 2011, D3549D3549M11 ASTM I; Austerman AJ, 2009, TRANSP RES BOARD 88; Button J. W., 2007, SYNTHESIS WARM MIX A; Chang CJ, 2012, INDIAN J ENG MATER S, V19, P31; CHOWDHURY A., 2008, REV WARM MIX ASPHALT; d'Angelo J, 2008, WARM MIX ASPHALT EUR; Estakhri C, 2010, FIELD LAB INVESTIGAT; Feih S, 2011, COMPOS PART B-ENG, V42, P350, DOI 10.1016/j.compositesb.2010.12.020; Iskender E, 2013, COMPOS PART B-ENG, V54, P255, DOI 10.1016/j.compositesb.2013.05.019; Jamshidi A, 2012, MATER RES-IBERO-AM J, V15, P628, DOI [10.1590/S1516-14392012005000083, 10.1590/S1516-14392012000400022]; Jones D., 2010, WARM MIX ASPHALT STU; Kanitpong K, 2008, PROC INST CIV ENG-CO, V161, P1, DOI 10.1680/coma.2008.161.1.1; Mallick R, 2007, EVALUATION HEATED RE; Mallick RB, 2008, TRANSPORT RES REC, P71, DOI 10.3141/2051-09; Newcomb D., 2007, INTRO WARM MIX ASPHA; O'Sullivan K, 2009, EFFECT WARM MIX ASPH; Prowell, 2005, EVALUATION SASOBIT U; Sengoz B, 2008, J HAZARD MATER, V150, P424, DOI 10.1016/j.jhazmat.2007.04.122; Sengupta S, 2011, COMPOS PART B-ENG, V42, P1834, DOI 10.1016/j.compositesb.2011.06.021; Shahadan Z, 2013, INDIAN J ENG MATER S, V20, P376; Specht Luciano Pivoto, 2007, Mat. Res., V10, P69, DOI 10.1590/S1516-14392007000100015; Tao M, 2009, 88 ANN M TRANSP RES; Wasiuddin NM, 2007, TRANSPORT RES REC, P82, DOI 10.3141/1998-10; Whiteoak D., 2003, SHELL BITUMEN HDB, VFifth; Wu SP, 2006, FUEL, V85, P1298, DOI 10.1016/j.fuel.2005.10.014; Xiao FP, 2012, FUEL, V94, P144, DOI 10.1016/j.fuel.2011.09.017; Zaumanis M., 2010, THESIS TU DENMARK KO; Zaumanis M, 2014, GREEN ENERGY TECHNOL, P309, DOI 10.1007/978-3-662-44719-2_10	40	21	22	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e116180	10.1371/journal.pone.0116180	http://dx.doi.org/10.1371/journal.pone.0116180			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25574851	Green Published, Green Submitted, gold			2022-12-26	WOS:000348168100003
J	Kato, S; Hayashi, S; Kitahara, Y; Nagasawa, K; Aono, H; Shibata, J; Utsumi, D; Amagase, K; Kadowaki, M				Kato, Shinichi; Hayashi, Shusaku; Kitahara, Yumeno; Nagasawa, Koyo; Aono, Hitomi; Shibata, Junichiro; Utsumi, Daichi; Amagase, Kikuko; Kadowaki, Makoto			Saireito (TJ-114), a Japanese Traditional Herbal Medicine, Reduces 5-Fluorouracil-Induced Intestinal Mucositis in Mice by Inhibiting Cytokine-Mediated Apoptosis in Intestinal Crypt Cells	PLOS ONE			English	Article							DAI-KENCHU-TO; RECOMMENDED GUIDELINES; POSTOPERATIVE ILEUS; DAIKENCHUTO TU-100; EPITHELIAL-CELLS; INDUCED DIARRHEA; CHEMOTHERAPY; CANCER; HUMANS; COLON	Clinical chemotherapy frequently causes intestinal mucositis as a side effect, which is accompanied by severe diarrhea. We recently showed that the cytokine-mediated apoptotic pathway might be important for the development of intestinal mucositis induced by 5-fluorouracil (5-FU). Saireito, the traditional Japanese herbal (Kampo) medicine, is widely used to treat diarrhea and various inflammatory diseases in Japan. In the present study, we investigated the effect of saireito on 5-FU-induced intestinal mucositis in mice, especially in relation to apoptosis in the intestinal crypt. Male C57BL/6 mice were given 5-FU (50 mg/kg), i.p. once daily for 6 days. Intestinal mucositis was evaluated histochemically. Saireito (1001000 mg/kg) was administered p.o. twice daily for 6 days. Repeated 5-FU treatment caused severe intestinal mucositis including morphological damage, which was accompanied by body weight loss and diarrhea. Daily administration of saireito reduced the severity of intestinal mucositis in a dose-dependent manner. Body weight loss and diarrhea during 5-FU treatment were also significantly attenuated by saireito administration. The number of apoptotic and caspase-3-activated cells in the intestinal crypt was increased, and was accompanied by up-regulated tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta mRNA within 24 h of the first 5-FU injection. However, all of these measures were significantly lower after saireito administration. These results suggest that saireito attenuates 5-FU-induced intestinal mucositis. This action may come from the reduction of apoptosis in the intestinal crypt via suppression of the up-regulation of inflammatory cytokines. Therefore, saireito may be clinically useful for the prevention of intestinal mucositis during cancer chemotherapy.	[Kato, Shinichi; Kitahara, Yumeno; Nagasawa, Koyo; Aono, Hitomi; Shibata, Junichiro; Utsumi, Daichi; Amagase, Kikuko] Kyoto Pharmaceut Univ, Div Pathol Sci, Dept Pharmacol & Expt Therapeut, Yamashina Ku, Kyoto 6078414, Japan; [Hayashi, Shusaku; Kadowaki, Makoto] Toyama Univ, Div Gastrointestinal Pathophysiol, Dept Biosci, Inst Nat Med, Toyama 9300194, Japan	Kyoto Pharmaceutical University; University of Toyama	Kato, S (corresponding author), Kyoto Pharmaceut Univ, Div Pathol Sci, Dept Pharmacol & Expt Therapeut, Yamashina Ku, Kyoto 6078414, Japan.	skato@mb.kyoto-phu.ac.jp	UTSUMI, DAICHI/ABB-8650-2021; UTSUMI, DAICHI/W-6307-2019; Hayashi, Shusaku/AAP-1185-2020	UTSUMI, DAICHI/0000-0001-6602-8426; Hayashi, Shusaku/0000-0002-8304-7255	Institute of Natural Medicine, University of Toyama	Institute of Natural Medicine, University of Toyama	This study was supported by a Grant-in-Aid for the Cooperative Research Project from Institute of Natural Medicine, University of Toyama in 2012 and 2013.	ANILKUMAR TV, 1992, BRIT J CANCER, V65, P552, DOI 10.1038/bjc.1992.113; BEARD DV, 1993, INVEST RADIOL, V28, P732, DOI 10.1097/00004424-199308000-00015; Benson AB, 2004, J CLIN ONCOL, V22, P2918, DOI 10.1200/jco.2004.04.132; Bowen JM, 2005, PATHOLOGY, V37, P56, DOI 10.1080/00313020400023461; Bowen JM, 2006, SUPPORT CARE CANCER, V14, P713, DOI 10.1007/s00520-005-0004-7; Chikakiyo M, 2012, SURG TODAY, V42, P60, DOI 10.1007/s00595-011-0014-7; Daniele B, 2001, J CLIN GASTROENTEROL, V32, P228, DOI 10.1097/00004836-200103000-00010; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Duncan M, 2003, ALIMENT PHARM THER, V18, P853, DOI 10.1046/j.1365-2036.2003.01784.x; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Huang TY, 2009, BIOCHEM BIOPH RES CO, V389, P634, DOI 10.1016/j.bbrc.2009.09.041; Inomata A, 2002, TOXICOL LETT, V133, P231, DOI 10.1016/S0378-4274(02)00204-7; Ito T, 2002, J DERMATOL SCI, V28, P198, DOI 10.1016/S0923-1811(01)00161-X; Itoh T, 2002, J INT MED RES, V30, P428, DOI 10.1177/147323000203000410; Iwasa T, 2012, DIGEST DIS SCI, V57, P2571, DOI 10.1007/s10620-012-2218-0; Kaburaki T, 2013, GRAEF ARCH CLIN EXP, V251, P2733, DOI 10.1007/s00417-013-2473-6; Kaneko A, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/384057; Keefe DMK, 2000, GUT, V47, P632, DOI 10.1136/gut.47.5.632; Kono T, 2011, J GASTROENTEROL, V46, P1187, DOI 10.1007/s00535-011-0438-2; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Li TS, 2009, CANCER CHEMOTH PHARM, V63, P873, DOI 10.1007/s00280-008-0809-4; Lu CN, 2012, INT IMMUNOPHARMACOL, V14, P121, DOI 10.1016/j.intimp.2012.06.010; Manabe N, 2010, AM J PHYSIOL-GASTR L, V298, pG970, DOI 10.1152/ajpgi.00043.2010; Matsuike T, 1999, PROG MED, V19, P879; Ohno S, 2007, J TRAD MED, V16, P73; Ono T, 2005, NEPHRON EXP NEPHROL, V100, pE132, DOI 10.1159/000085059; Perner A, 2003, GUT, V52, P231, DOI 10.1136/gut.52.2.231; Pritchard DM, 1998, CANCER RES, V58, P5453; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Symonds RP, 1998, BRIT J CANCER, V77, P1689, DOI 10.1038/bjc.1998.279; Tokita Y., 2007, Inflammopharmacology, V15, P65, DOI 10.1007/s10787-006-1552-2; Tokita Y, 2007, J PHARMACOL SCI, V104, P303, DOI 10.1254/jphs.FP0070831; Tomita K, 2003, J PHARMACOL SCI, V93, P321, DOI 10.1254/jphs.93.321; Wadler S, 1998, J CLIN ONCOL, V16, P3169, DOI 10.1200/JCO.1998.16.9.3169; Watanabe T, 2010, INT ARCH ALLERGY IMM, V151, P98, DOI 10.1159/000235999; Wu ZQ, 2011, CANCER CHEMOTH PHARM, V68, P87, DOI 10.1007/s00280-010-1451-5; Yasuda M, 2013, BRIT J PHARMACOL, V168, P1388, DOI 10.1111/bph.12019; Yasuda M, 2012, AM J PHYSIOL-GASTR L, V302, pG1133, DOI 10.1152/ajpgi.00535.2011; Yoon SB, 2009, J ETHNOPHARMACOL, V125, P286, DOI 10.1016/j.jep.2009.06.027; Zhu J, 2013, EXP THER MED, V5, P1345, DOI 10.3892/etm.2013.988	40	35	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2015	10	1							e0116213	10.1371/journal.pone.0116213	http://dx.doi.org/10.1371/journal.pone.0116213			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BS	25565296	Green Published, Green Submitted, gold			2022-12-26	WOS:000348167900004
J	Kong, LY; Shaw, N; Yan, LM; Lou, ZY; Rao, ZH				Kong, Lingying; Shaw, Neil; Yan, Lingming; Lou, Zhiyong; Rao, Zihe			Structural View and Substrate Specificity of Papain-like Protease from Avian Infectious Bronchitis Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-SYNDROME-CORONAVIRUS; INHIBITOR DESIGN IMPLICATIONS; TERMINAL CLEAVAGE SITE; DEUBIQUITINATING ACTIVITY; CRYSTAL-STRUCTURE; SARS; REPLICATION; PROTEINS; BINDING; DOMAIN	Papain-like protease (PLpro) of coronaviruses (CoVs) carries out proteolytic maturation of non-structural proteins that play a role in replication of the virus and performs deubiquitination of host cell factors to scuttle antiviral responses. Avian infectious bronchitis virus (IBV), the causative agent of bronchitis in chicken that results in huge economic losses every year in the poultry industry globally, encodes a PLpro. The substrate specificities of this PLpro are not clearly understood. Here, we show that IBV PLpro can degrade Lys(48)- and Lys(63)-linked polyubiquitin chains to monoubiquitin but not linear polyubiquitin. To explain the substrate specificities, we have solved the crystal structure of PLpro from IBV at 2.15-angstrom resolution. The overall structure is reminiscent of the structure of severe acute respiratory syndrome CoV PLpro. However, unlike the severe acute respiratory syndrome CoV PLpro that lacks blocking loop (BL) 1 of deubiquitinating enzymes, the IBV PLpro has a short BL1-like loop. Access to a conserved catalytic triad consisting of Cys(101), His(264), and Asp(275) is regulated by the flexible BL2. A model of ubiquitin-bound IBV CoV PLpro brings out key differences in substrate binding sites of PLpros. In particular, P3 and P4 subsites as well as residues interacting with the beta-barrel of ubiquitin are different, suggesting different catalytic efficiencies and substrate specificities. We show that IBV PLpro cleaves peptide substrates KKAG-7-amino-4-methylcoumarin and LRGG-7-amino-4-methylcoumarin with different catalytic efficiencies. These results demonstrate that substrate specificities of IBV PLpro are different from other PLpros and that IBV PLpro might target different ubiquitinated host factors to aid the propagation of the virus.	[Kong, Lingying; Yan, Lingming; Lou, Zhiyong; Rao, Zihe] Tsinghua Univ, Sch Med, Struct Biol Lab, Beijing 100084, Peoples R China; [Shaw, Neil; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Shaw, Neil; Rao, Zihe] Chinese Acad Sci, Natl Lab Macromol, Inst Biophys, Beijing 100101, Peoples R China	Tsinghua University; Nankai University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Rao, ZH (corresponding author), Tsinghua Univ, Sch Med, Struct Biol Lab, Beijing 100084, Peoples R China.	raozh@xtal.tsinghua.edu.cn	Rao, Zihe/HCH-6944-2022	Shaw, Neil/0000-0003-2722-9967	National Major Project (973 Program) [2014CB542800, 2013CB911100]; National Natural Science Foundation of China [81330036, 81322023]; Tsinghua University Initiative Scientific Research Program [20141080146]	National Major Project (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative Scientific Research Program	This work is supported by National Major Project (973 Program) Grants 2014CB542800 and 2013CB911100, National Natural Science Foundation of China Grants 81330036 and 81322023, and Tsinghua University Initiative Scientific Research Program Grant 20141080146.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baez-Santos YM, 2014, J VIROL, V88, P12511, DOI 10.1128/JVI.01294-14; Bailey-Elkin BA, 2014, J BIOL CHEM, V289, P34667, DOI 10.1074/jbc.M114.609644; Barretto N, 2005, J VIROL, V79, P15189, DOI 10.1128/JVI.79.24.15189-15198.2005; Casais R, 2005, J VIROL, V79, P8065, DOI 10.1128/JVI.79.13.8065-8078.2005; Cavanagh D, 2007, VACCINE, V25, P5558, DOI 10.1016/j.vaccine.2007.02.046; Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055; Chaudhuri R, 2011, J MOL BIOL, V414, P272, DOI 10.1016/j.jmb.2011.09.030; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XJ, 2014, PROTEIN CELL, V5, P369, DOI 10.1007/s13238-014-0026-3; Chou CY, 2014, ACTA CRYSTALLOGR D, V70, P572, DOI 10.1107/S1399004713031040; Clementz MA, 2010, J VIROL, V84, P4619, DOI 10.1128/JVI.02406-09; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghosh AK, 2010, J MED CHEM, V53, P4968, DOI 10.1021/jm1004489; Ghosh AK, 2009, J MED CHEM, V52, P5228, DOI 10.1021/jm900611t; Han YS, 2005, BIOCHEMISTRY-US, V44, P10349, DOI 10.1021/bi0504761; Hodgson T, 2006, J VIROL, V80, P296, DOI 10.1128/JVI.80.1.296-305.2006; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lee H, 2013, CHEMMEDCHEM, V8, P1361, DOI 10.1002/cmdc.201300134; Lei J, 2014, ANTIVIR RES, V109, P72, DOI 10.1016/j.antiviral.2014.06.011; Lim KP, 1998, ADV EXP MED BIOL, V440, P173; Lim KP, 1998, VIROLOGY, V245, P303, DOI 10.1006/viro.1998.9164; Lim KP, 2000, J VIROL, V74, P1674, DOI 10.1128/JVI.74.4.1674-1685.2000; Mielech AM, 2014, VIROLOGY, V450, P64, DOI 10.1016/j.virol.2013.11.040; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Ng LFP, 2002, J VIROL, V76, P6257, DOI 10.1128/JVI.76.12.6257-6267.2002; Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103; Ratia K, 2008, P NATL ACAD SCI USA, V105, P16119, DOI 10.1073/pnas.0805240105; Ratia K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004113; Shaw N, 2013, PROTEIN CELL, V4, P117, DOI 10.1007/s13238-012-2071-0; Stern D F, 1984, Adv Exp Med Biol, V173, P11; STERN DF, 1984, J VIROL, V50, P22, DOI 10.1128/JVI.50.1.22-29.1984; van Ginkel FW, 2008, AVIAN DIS, V52, P608, DOI 10.1637/8349-050908-Reg.1; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Ziebuhr J, 2001, J BIOL CHEM, V276, P33220, DOI 10.1074/jbc.M104097200	36	23	24	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7160	7168		10.1074/jbc.M114.628636	http://dx.doi.org/10.1074/jbc.M114.628636			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25609249	Green Published, hybrid			2022-12-26	WOS:000350991500046
J	Wujak, L; Didiasova, M; Zakrzewicz, D; Frey, H; Schaefer, L; Wygrecka, M				Wujak, Lukasz; Didiasova, Miroslava; Zakrzewicz, Dariusz; Frey, Helena; Schaefer, Liliana; Wygrecka, Malgorzata			Heparan Sulfate Proteoglycans Mediate Factor XIIa Binding to the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR-XII; PLASMINOGEN-ACTIVATOR RECEPTOR; VEIN ENDOTHELIAL-CELLS; BRADYKININ FORMATION; PULMONARY-FIBROSIS; SIGNALING PATHWAYS; IN-VIVO; GLYCOSAMINOGLYCANS; INHIBITOR; KININOGEN	Hageman factor (FXIIa) initiates the intrinsic coagulation pathway and triggers the kallikrein-kinin and the complement systems. In addition, it functions as a growth factor by expressing promitogenic activities toward several cell types. FXIIa binds to the cell surface via a number of structurally unrelated surface receptors; however, the underlying mechanisms are not yet fully understood. Here, we demonstrate that FXIIa utilizes cell membrane-bound glycosaminoglycans to interact with the cell surface of human lung fibroblasts (HLF). The combination of enzymatic, inhibitory, and overexpression approaches identified a heparan sulfate (HS) component of proteoglycans as an important determinant of the FXIIa binding capacity of HLF. Moreover, cell-free assays and competition experiments revealed preferential binding of FXIIa to HS and heparin over dextran sulfate, dermatan sulfate, and chondroitin sulfate A and C. Finally, we demonstrate that fibroblasts isolated from the lungs of the patients suffering from idiopathic pulmonary fibrosis (IPF) exhibit enhanced FXIIa binding capacity. Increased sulfation of HS resulting from elevated HS 6-O-sulfotransferase-1 expression in IPF HLF accounted, in part, for this phenomenon. Application of RNA interference technology and inhibitors of intracellular sulfation revealed the cooperative action of cell surface-associated HS and urokinase-type plasminogen activator receptor in the accumulation of FXIIa on the cell surface of IPF HLF. Moreover, FXIIa stimulated IPF HIS migration, which was abrogated by pretreatment of cells with heparinase I. Collectively, our study uncovers a novel role of HS-type glycosaminoglycans in a local accumulation of FXIIa on the cell membrane. The enhanced association of FXIIa with IPF HLF suggests its contribution to fibrogenesis.	[Wujak, Lukasz; Didiasova, Miroslava; Zakrzewicz, Dariusz; Wygrecka, Malgorzata] Univ Giessen, Dept Biochem, Lung Ctr, D-35392 Giessen, Germany; [Frey, Helena; Schaefer, Liliana] Goethe Univ Frankfurt, Univ Hosp, Inst Pharmacol & Toxicol, Sch Med, D-60590 Frankfurt, Germany	Justus Liebig University Giessen; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Wygrecka, M (corresponding author), Univ Giessen, Dept Biochem, Lung Ctr, Friedrichstr 24, D-35392 Giessen, Germany.	malgorzata.wygrecka@innere.med.uni-giessen.de	Wygrecka, Malgorzata/AAZ-3679-2020	Wygrecka, Malgorzata/0000-0002-3656-2932; Zakrzewicz, Dariusz/0000-0003-3292-9706; Schaefer, Liliana/0000-0002-3318-3005	Deutsche Forschungsgemeinschaft [WY119/1-1, SFB 815]; Excellence Cluster "Cardiopulmonary System"; University Medical Center Giessen and Marburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster "Cardiopulmonary System"(German Research Foundation (DFG)); University Medical Center Giessen and Marburg	This study was supported by Deutsche Forschungsgemeinschaft Grant WY119/1-1 (to M. W.) and SFB 815, Project A5 (to L. S.), the Excellence Cluster "Cardiopulmonary System" (to M. W. and L S.), and the University Medical Center Giessen and Marburg (to M. W.).	Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Badellino KO, 2001, BIOCHEMISTRY-US, V40, P7569, DOI 10.1021/bi0027433; Ben-Zaken O, 2003, J BIOL CHEM, V278, P40041, DOI 10.1074/jbc.M301152200; Beringer DX, 2013, ACTA CRYSTALLOGR F, V69, P94, DOI 10.1107/S1744309113000286; Bradford HN, 2000, J BIOL CHEM, V275, P22756, DOI 10.1074/jbc.M002591200; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; DEAGOSTINI AI, 1990, J CELL BIOL, V111, P1293, DOI 10.1083/jcb.111.3.1293; Friedrich U, 2001, J BIOL CHEM, V276, P24122, DOI 10.1074/jbc.M011567200; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; Gordon EM, 1996, P NATL ACAD SCI USA, V93, P2174, DOI 10.1073/pnas.93.5.2174; HENDERSON LM, 1994, BLOOD, V84, P474; Ho GY, 1997, J BIOL CHEM, V272, P16838, DOI 10.1074/jbc.272.27.16838; HOJIMA Y, 1984, BLOOD, V63, P1453; Jablonska E, 2010, J BIOL CHEM, V285, P11638, DOI 10.1074/jbc.M109.045963; Johnson DJD, 2010, P NATL ACAD SCI USA, V107, P645, DOI 10.1073/pnas.0910144107; KOJIMA T, 1992, J BIOL CHEM, V267, P4859; LaRusch GA, 2010, BLOOD, V115, P5111, DOI 10.1182/blood-2009-08-236430; Lu JN, 2014, AM J RESP CELL MOL, V50, P106, DOI 10.1165/rcmb.2013-0204OC; Mahdi F, 2002, BLOOD, V99, P3585, DOI 10.1182/blood.V99.10.3585; Malavaki CJ, 2013, FEBS J, V280, P2477, DOI 10.1111/febs.12163; MALI M, 1993, J BIOL CHEM, V268, P24215; Moreth K, 2014, MATRIX BIOL, V35, P143, DOI 10.1016/j.matbio.2014.01.010; Oschatz C, 2011, IMMUNITY, V34, P258, DOI 10.1016/j.immuni.2011.02.008; PIXLEY RA, 1987, ARCH BIOCHEM BIOPHYS, V256, P490, DOI 10.1016/0003-9861(87)90606-0; Ploug M, 1998, J BIOL CHEM, V273, P13933, DOI 10.1074/jbc.273.22.13933; Pol-Fachin L, 2014, GLYCOBIOLOGY, V24, P97, DOI 10.1093/glycob/cwt095; Pucci M, 2001, J BIOL CHEM, V276, P4756, DOI 10.1074/jbc.M005993200; REDDIGARI SR, 1993, J BIOL CHEM, V268, P11982; Renne T, 2000, J BIOL CHEM, V275, P33688, DOI 10.1074/jbc.M000313200; Renne T, 2005, J IMMUNOL, V175, P3377, DOI 10.4049/jimmunol.175.5.3377; Renne T, 2001, FEBS LETT, V500, P36, DOI 10.1016/S0014-5793(01)02570-4; Renne T, 2012, BLOOD, V120, P4296, DOI 10.1182/blood-2012-07-292094; Rostand KS, 1997, INFECT IMMUN, V65, P1; Sakai N, 2013, BBA-MOL BASIS DIS, V1832, P911, DOI 10.1016/j.bbadis.2013.03.001; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; SCHMEIDLERSAPIRO KT, 1991, P NATL ACAD SCI USA, V88, P4382, DOI 10.1073/pnas.88.10.4382; Schousboe I, 2003, EUR J BIOCHEM, V270, P111, DOI 10.1046/j.1432-1033.2003.03367.x; Schousboe I, 2001, EUR J BIOCHEM, V268, P3958, DOI 10.1046/j.1432-1327.2001.02305.x; SHIMADA K, 1985, J CLIN INVEST, V75, P1308, DOI 10.1172/JCI111831; Skandalis SS, 2014, MATRIX BIOL, V35, P182, DOI 10.1016/j.matbio.2013.09.002; Stavrou E, 2010, THROMB RES, V125, P210, DOI 10.1016/j.thromres.2009.11.028; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Thacker BE, 2014, MATRIX BIOL, V35, P60, DOI 10.1016/j.matbio.2013.12.001; Wei Z, 2005, J BIOL CHEM, V280, P15742, DOI 10.1074/jbc.M501102200; Wygrecka M, 2009, BLOOD, V113, P5588, DOI 10.1182/blood-2008-08-170837; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314	48	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7027	7039		10.1074/jbc.M114.606343	http://dx.doi.org/10.1074/jbc.M114.606343			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25589788	Green Published, hybrid			2022-12-26	WOS:000350991500036
J	Du, JT; Aleff, RA; Soragni, E; Kalari, K; Nie, JF; Tang, XJ; Davila, J; Kocher, JP; Patel, SV; Gottesfeld, JM; Baratz, KH; Wieben, ED				Du, Jintang; Aleff, Ross A.; Soragni, Elisabetta; Kalari, Krishna; Nie, Jinfu; Tang, Xiaojia; Davila, Jaime; Kocher, Jean-Pierre; Patel, Sanjay V.; Gottesfeld, Joel M.; Baratz, Keith H.; Wieben, Eric D.			RNA Toxicity and Missplicing in the Common Eye Disease Fuchs Endothelial Corneal Dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; MYOTONIC-DYSTROPHY; SKELETAL-MUSCLE; REPEAT EXPANSION; OXIDATIVE STRESS; BHLH FACTORS; MOUSE MODEL; STEM-CELLS; PROTEIN; EXPRESSION	Fuchs endothelial corneal dystrophy (FECD) is an inherited degenerative disease that affects the internal endothelial cell monolayer of the cornea and can result in corneal edema and vision loss in severe cases. FECD affects similar to 5% of middle-aged Caucasians in the United States and accounts for >14,000 corneal transplantations annually. Among the several genes and loci associated with FECD, the strongest association is with an intronic (CTG.CAG)(n) trinucleotide repeat expansion in the TCF4 gene, which is found in the majority of affected patients. Corneal endothelial cells from FECD patients harbor a poly(CUG)(n) RNA that can be visualized as RNA foci containing this condensed RNA and associated proteins. Similar to myotonic dystrophy type 1, the poly(CUG)(n) RNA co-localizes with and sequesters the mRNA-splicing factor MBNL1, leading to missplicing of essential MBNL1-regulated mRNAs. Such foci and missplicing are not observed in similar cells from FECD patients who lack the repeat expansion. RNA-Seq splicing data from the corneal endothelia of FECD patients and controls reveal hundreds of differential alternative splicing events. These include events previously characterized in the context of myotonic dystrophy type 1 and epithelial-to-mesenchymal transition, as well as splicing changes in genes related to proposed mechanisms of FECD pathogenesis. We report the first instance of RNA toxicity and missplicing in a common non-neurological/neuromuscular disease associated with a repeat expansion. The FECD patient population with this (CTG.CAG)(n) trinucleotide repeat expansion exceeds that of the combined number of patients in all other microsatellite expansion disorders.	[Du, Jintang; Soragni, Elisabetta; Gottesfeld, Joel M.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Aleff, Ross A.; Wieben, Eric D.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Kalari, Krishna; Nie, Jinfu; Tang, Xiaojia; Davila, Jaime; Kocher, Jean-Pierre] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Patel, Sanjay V.; Baratz, Keith H.] Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA	Scripps Research Institute; Mayo Clinic; Mayo Clinic; Mayo Clinic	Wieben, ED (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	wieben.eric@mayo.edu	Davila, Jaime/AAI-2023-2019	Davila, Jaime/0000-0002-8163-6267; Kalari, Krishna/0000-0001-8944-8378; Tang, Xiaojia/0000-0003-2457-9953; Gottesfeld, Joel/0000-0002-4643-5777; Patel, Sanjay/0000-0001-6694-1530	California Institute for Regenerative Medicine (CIRM) Grant [RB3-05022]; Research to Prevent Blindness grants; Myotonic Dystrophy Foundation; Scripps Research Institute Stem Cell Fellowship; Biomarker Discovery Program of the Mayo Clinic Center for Individualized Medicine	California Institute for Regenerative Medicine (CIRM) Grant; Research to Prevent Blindness grants(Research to Prevent Blindness (RPB)); Myotonic Dystrophy Foundation; Scripps Research Institute Stem Cell Fellowship; Biomarker Discovery Program of the Mayo Clinic Center for Individualized Medicine	This work was supported by California Institute for Regenerative Medicine (CIRM) Grant RB3-05022 (to J. D., E. S., and J. M. G.), Research to Prevent Blindness grants (to S. V. P. and K. H. B.), a postdoctoral fellowship from the Myotonic Dystrophy Foundation (to J. D.), a Scripps Research Institute Stem Cell Fellowship (to J. D.), and a grant from the Biomarker Discovery Program of the Mayo Clinic Center for Individualized Medicine (to R. A. A., S. V. P., K. H. B., and E. D. W.).	Aldave AJ, 2013, CLIN GENET, V84, P109, DOI 10.1111/cge.12191; ASHIZAWA T, 1993, NEUROLOGY, V43, P2674, DOI 10.1212/WNL.43.12.2674; Baratz KH, 2010, NEW ENGL J MED, V363, P1016, DOI 10.1056/NEJMoa1007064; Batra R, 2014, MOL CELL, V56, P311, DOI 10.1016/j.molcel.2014.08.027; Chamberlain CM, 2012, HUM MOL GENET, V21, P4645, DOI 10.1093/hmg/dds306; Childs-Disney JL, 2012, ACS CHEM BIOL, V7, P1984, DOI 10.1021/cb3001606; Cleary JD, 2014, CURR OPIN GENET DEV, V26, P6, DOI 10.1016/j.gde.2014.03.002; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Doors M, 2013, JAMA OPHTHALMOL, V131, P1443, DOI 10.1001/jamaophthalmol.2013.5009; Du JT, 2013, HUM MOL GENET, V22, P5276, DOI 10.1093/hmg/ddt386; Eye Bank Association of America, 2014, 2013 EY BANK STAT RE; Gates DP, 2011, J BIOL CHEM, V286, P34224, DOI 10.1074/jbc.M111.236547; Hagerman R, 2013, LANCET NEUROL, V12, P786, DOI 10.1016/S1474-4422(13)70125-X; Iliff BW, 2012, EXPERT REV OPHTHALMO, V7, P363, DOI 10.1586/EOP.12.39; Jonson I, 2013, STEM CELL RES, V11, P1264, DOI 10.1016/j.scr.2013.08.010; Jurkunas UV, 2010, AM J PATHOL, V177, P2278, DOI 10.2353/ajpath.2010.100279; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kazerounian S, 2003, J BIOL CHEM, V278, P36707, DOI 10.1074/jbc.M303896200; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klinck R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107324; Koizumi N, 2013, CORNEA, V32, P1167, DOI 10.1097/ICO.0b013e318285475d; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; LeMasters KE, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-22; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; Mankodi A, 2003, ANN NEUROL, V54, P760, DOI 10.1002/ana.10763; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Mohan A, 2014, BRAIN RES, V1584, P3, DOI 10.1016/j.brainres.2014.03.039; Mootha VV, 2014, INVEST OPHTH VIS SCI, V55, P33, DOI 10.1167/iovs.13-12611; Nakamori M, 2013, ANN NEUROL, V74, P862, DOI 10.1002/ana.23992; Norrmen C, 2010, BLOOD, V115, P906, DOI 10.1182/blood-2009-03-212274; Orengo JP, 2008, P NATL ACAD SCI USA, V105, P2646, DOI 10.1073/pnas.0708519105; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Rao PV, 2009, INVEST OPHTH VIS SCI, V50, P1769, DOI 10.1167/iovs.08-2909; Repp DJ, 2013, OPHTHALMOLOGY, V120, P687, DOI 10.1016/j.ophtha.2012.09.022; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; Rossell D, 2014, ANN APPL STAT, V8, P309, DOI 10.1214/13-AOAS687; Samarelli AV, 2014, J BIOL CHEM, V289, P19466, DOI 10.1074/jbc.M113.530972; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sepp M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022138; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Sobrado VR, 2009, J CELL SCI, V122, P1014, DOI 10.1242/jcs.028241; Suenaga K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033218; Tse SW, 2005, GENE, V359, P63, DOI 10.1016/j.gene.2005.06.025; Venables JP, 2013, MOL CELL BIOL, V33, P396, DOI 10.1128/MCB.01174-12; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Warzecha CC, 2012, SEMIN CANCER BIOL, V22, P417, DOI 10.1016/j.semcancer.2012.04.003; Wheeler TM, 2007, J CLIN INVEST, V117, P3952, DOI 10.1172/JCI33355; Wieben ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049083; Yamashita Y, 2012, J HUM GENET, V57, P368, DOI 10.1038/jhg.2012.37; Yamazoe K, 2011, J CATARACT REFR SURG, V37, P2130, DOI 10.1016/j.jcrs.2011.05.039; Zhu AY, 2014, JAMA OPHTHALMOL, V132, P377, DOI 10.1001/jamaophthalmol.2013.7993	53	84	94	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					5979	5990		10.1074/jbc.M114.621607	http://dx.doi.org/10.1074/jbc.M114.621607			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25593321	hybrid, Green Published			2022-12-26	WOS:000350732500004
J	Kuo, IY; Hu, J; Ha, Y; Ehrlich, BE				Kuo, Ivana Y.; Hu, Jian; Ha, Ya; Ehrlich, Barbara E.			Presenilin-like GxGD Membrane Proteases Have Dual Roles as Proteolytic Enzymes and Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; GAMMA-SECRETASE ACTIVITY; CA2+ LEAK CHANNELS; CALCIUM LEAK; LINKED MUTATIONS; MOUSE MODELS; IN-VIVO; CELLS; HOMEOSTASIS; DIMERIZATION	The GxCiD proteases function to cleave protein substrates within the membrane. As these proteases contain multiple transmembrane domains typical of ion channels, we examined if GxGD proteases also function as ion channels. We tested the putative dual function by examining two archeobacterial GxGD proteases (PSH and FlaK), with known three-dimensional structures. Both are in the same GxGD family as presenilin, a protein mutated in Alzheimer Disease. Here, we demonstrate that PSH and FlaK form cation channels in lipid bilayers. A limitation that affected the enzymatic activity of FlaK rendered the channel catalytically inactive and altered the ion selectivity, indicating that the ion channel and the catalytic activities are linked. We report that the GxGD proteases, PSH and FlaK, are true "chanzymes" with interdependent ion channel and protease activity conferred by a single structural domain embedded in the membrane, supporting the proposal that higher-order proteases, including presenilin, have channel function.	[Kuo, Ivana Y.; Hu, Jian; Ha, Ya; Ehrlich, Barbara E.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; [Ehrlich, Barbara E.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University; Yale University	Ehrlich, BE (corresponding author), Yale Univ, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	Barbara.ehrlich@yale.edu	/AAX-8408-2021	/0000-0001-9657-9704; Kuo, Ivana/0000-0002-9867-2408	National Institutes of Health [DK087844, DK090744]; AHA Postdoctoral Fellowship [R10682]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090744, R01DK087844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Postdoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK087844 and DK090744 (to B.E.E.).; Supported by AHA Postdoctoral Fellowship R10682.	Anyatonwu GI, 2005, J BIOL CHEM, V280, P29488, DOI 10.1074/jbc.M504359200; Bandara S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003649; Bezprozvanny I, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004296; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brunello L, 2009, J CELL MOL MED, V13, P3358, DOI 10.1111/j.1582-4934.2009.00755.x; Bruno A. M., 2012, NEUROBIOL AGING, V33; Cai CX, 2006, J BIOL CHEM, V281, P16649, DOI 10.1074/jbc.M512026200; Castellani RJ, 2011, J PATHOL, V224, P147, DOI 10.1002/path.2885; Cervantes S, 2004, J BIOL CHEM, V279, P36519, DOI 10.1074/jbc.M404832200; Cervantes S, 2001, FEBS LETT, V505, P81, DOI 10.1016/S0014-5793(01)02785-5; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Cheung KH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000818; Das HK, 2012, J NEUROCHEM, V122, P487, DOI 10.1111/j.1471-4159.2012.07794.x; Giacomello M, 2005, NEUROBIOL DIS, V18, P638, DOI 10.1016/j.nbd.2004.10.016; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Hebert SS, 2003, BIOCHEM BIOPH RES CO, V301, P119, DOI 10.1016/S0006-291X(02)02984-4; Herl L, 2006, BIOCHEM BIOPH RES CO, V340, P668, DOI 10.1016/j.bbrc.2005.12.063; Hu J, 2011, NATURE, V475, P528, DOI 10.1038/nature10218; Leissring MA, 2000, P NATL ACAD SCI USA, V97, P8590, DOI 10.1073/pnas.97.15.8590; Leissring MA, 1999, J NEUROCHEM, V72, P1061, DOI 10.1046/j.1471-4159.1999.0721061.x; Leissring MA, 1999, J BIOL CHEM, V274, P32535, DOI 10.1074/jbc.274.46.32535; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Mattson M. P., 2010, SCI SIGNAL, V3, ppe10; Montell C, 2003, CURR BIOL, V13, pR799, DOI 10.1016/j.cub.2003.09.048; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Nelson O, 2011, J BIOL CHEM, V286, P22339, DOI 10.1074/jbc.M111.243063; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Shan J, 2012, CIRC RES, V111, P708, DOI 10.1161/CIRCRESAHA.112.273342; Shilling D, 2012, J BIOL CHEM, V287, P10933, DOI 10.1074/jbc.M111.300491; Stutzmann GE, 2005, NEUROSCIENTIST, V11, P110, DOI 10.1177/1073858404270899; Stutzmann GE, 2007, ANN NY ACAD SCI, V1097, P265, DOI 10.1196/annals.1379.025; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Supnet C, 2011, CELL CALCIUM, V50, P303, DOI 10.1016/j.ceca.2011.05.013; Torres-Arancivia C., 2010, PLOS ONE, V5; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Wolfe MS, 2013, NATURE, V493, P34, DOI 10.1038/nature11768; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	40	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6419	6427		10.1074/jbc.M114.629584	http://dx.doi.org/10.1074/jbc.M114.629584			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25609250	Green Published, hybrid			2022-12-26	WOS:000350732500046
J	Weber, S; Salabei, JK; Moller, G; Kremmer, E; Bhatnagar, A; Adamski, J; Barski, OA				Weber, Susanne; Salabei, Joshua K.; Moeller, Gabriele; Kremmer, Elisabeth; Bhatnagar, Aruni; Adamski, Jerzy; Barski, Oleg A.			Aldo-keto Reductase 1B15 (AKR1B15) A MITOCHONDRIAL HUMAN ALDO-KETO REDUCTASE WITH ACTIVITY TOWARD STEROIDS AND 3-KETO-ACYL-CoA CONJUGATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN L-3-HYDROXYACYL-COA DEHYDROGENASE; GAMMA-HYDROXYBUTYRATE; DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE; 3-HYDROXYACYL-COA DEHYDROGENASE; SUBCELLULAR-LOCALIZATION; DIABETIC COMPLICATIONS; ALDEHYDE REDUCTASE; POTASSIUM CHANNELS; INSULIN-SECRETION; ACTIVE-SITE	Aldo-keto reductases (AKRs) comprise a superfamily of proteins involved in the reduction and oxidation of biogenic and xenobiotic carbonyls. In humans, at least 15 AKR superfamily members have been identified so far. One of these is a newly identified gene locus, AKR1B15, which clusters on chromosome 7 with the other human AKR1B subfamily members (i.e. AKR1B1 and AKR1B10). We show that alternative splicing of the AKR1B15 gene transcript gives rise to two protein isoforms with different N termini: AKR1B15.1 is a 316-amino acid protein with 91% amino acid identity to AKR1B10; AKR1B15.2 has a prolonged N terminus and consists of 344 amino acid residues. The two gene products differ in their expression level, subcellutar localization, and activity. In contrast with other AKR enzymes, which are mostly cytosolic, AKR1B15.1 co-localizes with the mitochondria. Kinetic studies show that AKR1B15.1 is predominantly a reductive enzyme that catalyzes the reduction of androgens and estrogens with high positional selectivity (17 beta-hydroxysteroid dehydrogenase activity) as well as 3-ketoacyl-CoA conjugates and exhibits strong cofactor selectivity toward NADP(H). In accordance with its substrate spectrum, the enzyme is expressed at the highest levels in steroid-sensitive tissues, namely placenta, testis, and adipose tissue. Placental and adipose expression could be reproduced in the Be Wo and SCiBS cell lines, respectively. In contrast, AKR1 B15.2 localizes to the cytosol and displays no enzymatic activity with the substrates tested. Collectively, these results demonstrate the exis- tence of a novel catalytically active AKR, which is associated with mitochondria and expressed mainly in steroid-sensitive tissues.	[Weber, Susanne; Moeller, Gabriele; Adamski, Jerzy] Helmholtz Zentrum Muenchen, German Res Ctr Environm Hlth, Genome Anal Ctr, Inst Expt Genet, D-85764 Neuherberg, Germany; [Salabei, Joshua K.; Bhatnagar, Aruni; Barski, Oleg A.] Univ Louisville, Sch Med, Diabet & Obes Ctr, Louisville, KY 40202 USA; [Kremmer, Elisabeth] Helmholtz Zentrum Muenchen, Inst Mol Immunol, German Res Ctr Environm Hlth, D-81377 Munich, Germany; [Adamski, Jerzy] Tech Univ Munich, Lehrstuhl Expt Genet, D-85356 Freising Weihenstephan, Germany; [Adamski, Jerzy] German Ctr Diabet Res, D-85764 Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Louisville; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Adamski, J (corresponding author), Helmholtz Zentrum Muenchen, German Res Ctr Environm Hlth, Genome Anal Ctr, Inst Expt Genet, Ingolstaedter Landstr 1, D-85764 Neuherberg, Germany.	Adamski@helmholtz-muenchen.de; olegbarski@gmail.com		Moller, Gabriele/0000-0002-2730-1351; Adamski, Jerzy/0000-0001-9259-0199	National Institutes of Health [HL55477, HL59378, GM103492]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055477, R01HL059378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL55477, HL59378, and GM103492.	Alexiou P, 2009, CURR MED CHEM, V16, P734, DOI 10.2174/092986709787458362; Alias M, 2010, ORG BIOMOL CHEM, V8, P788, DOI 10.1039/b919671d; Baba SP, 2009, DIABETES, V58, P2486, DOI 10.2337/db09-0375; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Barski OA, 2005, AM J PHYSIOL-RENAL, V289, pF200, DOI 10.1152/ajprenal.00411.2004; BARSKI OA, 1995, BIOCHEMISTRY-US, V34, P11264, DOI 10.1021/bi00035a036; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Barski OA, 2013, CHEM-BIOL INTERACT, V202, P153, DOI 10.1016/j.cbi.2012.12.012; Bril V, 2006, DIABETES CARE, V29, P68, DOI 10.2337/diacare.29.1.68; Byrns MC, 2011, J STEROID BIOCHEM, V125, P95, DOI 10.1016/j.jsbmb.2010.11.004; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Cao DL, 1998, J BIOL CHEM, V273, P11429, DOI 10.1074/jbc.273.19.11429; Clayton PT, 2001, J CLIN INVEST, V108, P457; DEMONACOS C, 1995, J STEROID BIOCHEM, V55, P43, DOI 10.1016/0960-0760(95)00159-W; Demonacos CV, 1996, STEROIDS, V61, P226, DOI 10.1016/0039-128X(96)00019-0; DVORNIK D, 1973, SCIENCE, V182, P1146, DOI 10.1126/science.182.4117.1146; Endo S, 2009, ARCH BIOCHEM BIOPHYS, V487, P1, DOI 10.1016/j.abb.2009.05.009; FUJII Y, 1990, J BIOL CHEM, V265, P9914; Gabbay Kenneth H, 2004, Curr Diab Rep, V4, P405, DOI 10.1007/s11892-004-0047-z; Gallego O, 2007, P NATL ACAD SCI USA, V104, P20764, DOI 10.1073/pnas.0705659105; Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P727, DOI 10.1021/tx010005p; Heslegrave AJ, 2013, J CLIN ENDOCR METAB, V98, P496, DOI 10.1210/jc.2012-3134; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; Hyndman DJ, 1998, BBA-GENE STRUCT EXPR, V1399, P198, DOI 10.1016/S0167-4781(98)00109-2; Kabututu Z, 2009, J BIOCHEM, V145, P161, DOI 10.1093/jb/mvn152; Keenan C, 2006, ENZYMOL MOL BIOL CAR, V12, P388; Keller B, 2009, MOL CELL ENDOCRINOL, V301, P43, DOI 10.1016/j.mce.2008.07.022; Kelly VP, 2002, BIOCHEM J, V366, P847, DOI 10.1042/BJ20020342; KINOSHITA JH, 1990, EXP EYE RES, V50, P567, DOI 10.1016/0014-4835(90)90096-D; KONDO KH, 1994, EUR J BIOCHEM, V219, P357, DOI 10.1111/j.1432-1033.1994.tb19947.x; Lam CW, 2006, CLIN CHIM ACTA, V364, P256, DOI 10.1016/j.cca.2005.07.025; Lemonde HA, 2003, GUT, V52, P1494, DOI 10.1136/gut.52.10.1494; Liu SQ, 2001, CHEM-BIOL INTERACT, V130, P955, DOI 10.1016/S0009-2797(00)00248-9; Luu-The V, 2006, MOL ENDOCRINOL, V20, P437, DOI 10.1210/me.2005-0058; Lyon RC, 2007, J BIOL CHEM, V282, P25986, DOI 10.1074/jbc.M702465200; Malup T. K., 2000, Molekulyarnaya Biologiya (Moscow), V34, P366; Martin HJO, 2006, DRUG METAB DISPOS, V34, P464, DOI 10.1124/dmd; Maser E, 2004, TRENDS PHARMACOL SCI, V25, P235, DOI 10.1016/j.tips.2004.03.001; MCCORMACK K, 1995, FEBS LETT, V370, P32, DOI 10.1016/0014-5793(95)00785-8; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Mindnich R, 2004, MOL CELL ENDOCRINOL, V218, P7, DOI 10.1016/j.mce.2003.12.006; Mindnich R, 2005, J MOL ENDOCRINOL, V35, P305, DOI 10.1677/jme.1.01853; Pan A, 2013, BIOCHEM BIOPH RES CO, V441, P418, DOI 10.1016/j.bbrc.2013.10.072; Pedram A, 2006, MOL BIOL CELL, V17, P2125, DOI 10.1091/mbc.E05-11-1013; Peltoketo H, 1999, J MOL ENDOCRINOL, V23, P1, DOI 10.1677/jme.0.0230001; Penning TM, 2007, ARCH BIOCHEM BIOPHYS, V464, P241, DOI 10.1016/j.abb.2007.04.024; Penning TM, 2011, J STEROID BIOCHEM, V125, P46, DOI 10.1016/j.jsbmb.2011.01.009; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; PURANEN TJ, 1994, BIOCHEM J, V304, P289, DOI 10.1042/bj3040289; Ramana Kota V, 2011, Biomol Concepts, V2, P103; Ramana KV, 2002, J BIOL CHEM, V277, P32063, DOI 10.1074/jbc.M202126200; Salabei JK, 2011, CHEM-BIOL INTERACT, V191, P177, DOI 10.1016/j.cbi.2011.01.020; Schmitt S, 2013, ANAL BIOCHEM, V443, P66, DOI 10.1016/j.ab.2013.08.007; Schulte U, 2001, J BIOENERG BIOMEMBR, V33, P205, DOI 10.1023/A:1010730919074; Schulz N, 2011, ENDOCRINOLOGY, V152, P4641, DOI 10.1210/en.2011-1547; Shafqat N, 2003, BIOCHEM J, V376, P49, DOI 10.1042/BJ20030877; Shinmura K, 2002, CIRC RES, V91, P240, DOI 10.1161/01.RES.0000029970.97247.57; Srivastava S, 2004, J BIOL CHEM, V279, P53395, DOI 10.1074/jbc.M403416200; Srivastava S, 1998, BIOCHEM J, V329, P469, DOI 10.1042/bj3290469; Srivastava S, 2009, CIRC RES, V105, P793, DOI 10.1161/CIRCRESAHA.109.200568; VANDERJAGT DL, 1992, J BIOL CHEM, V267, P4364; Vasconsuelo A, 2013, AGEING RES REV, V12, P907, DOI 10.1016/j.arr.2013.09.001; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Weng J, 2006, J BIOL CHEM, V281, P15194, DOI 10.1074/jbc.M513809200; WILSON DK, 1992, SCIENCE, V257, P81, DOI 10.1126/science.1621098; Witkowski A, 2007, J BIOL CHEM, V282, P14178, DOI 10.1074/jbc.M701486200; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Yang SY, 2005, FEBS J, V272, P4874, DOI 10.1111/j.1742-4658.2005.04911.x; Yashin AI, 2010, AGING-US, V2, P612, DOI 10.18632/aging.100191; Yoshitake H, 2007, INT J GYNECOL CANCER, V17, P1300, DOI 10.1111/j.1525-1438.2007.00932.x; Zhong LL, 2011, TOXICOL APPL PHARM, V255, P40, DOI 10.1016/j.taap.2011.05.014	72	13	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6531	6545		10.1074/jbc.M114.610121	http://dx.doi.org/10.1074/jbc.M114.610121			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25577493	Green Published, hybrid			2022-12-26	WOS:000350732500056
J	van Giessen, A; Moons, KGM; de Wit, GA; Verschuren, WMM; Boer, JMA; Koffijberg, H				van Giessen, A.; Moons, K. G. M.; de Wit, G. A.; Verschuren, W. M. M.; Boer, J. M. A.; Koffijberg, H.			Tailoring the Implementation of New Biomarkers Based on Their Added Predictive Value in Subgroups of Individuals	PLOS ONE			English	Article							NET RECLASSIFICATION IMPROVEMENT; CARDIOVASCULAR RISK-ASSESSMENT; CLINICAL-PRACTICE; INCREMENTAL VALUE; VALIDATION; DISEASE; MODELS; IMPACT; MARKERS; SCORE	Background The value of new biomarkers or imaging tests, when added to a prediction model, is currently evaluated using reclassification measures, such as the net reclassification improvement (NRI). However, these measures only provide an estimate of improved reclassification at population level. We present a straightforward approach to characterize subgroups of reclassified individuals in order to tailor implementation of a new prediction model to individuals expected to benefit from it. Methods In a large Dutch population cohort (n = 21,992) we classified individuals to low (< 5%) and high (>= 5%) fatal cardiovascular disease risk by the Framingham risk score (FRS) and reclassified them based on the systematic coronary risk evaluation (SCORE). Subsequently, we characterized the reclassified individuals and, in case of heterogeneity, applied cluster analysis to identify and characterize subgroups. These characterizations were used to select individuals expected to benefit from implementation of SCORE. Results Reclassification after applying SCORE in all individuals resulted in an NRI of 5.00% (95% CI [-0.53%; 11.50%]) within the events, 0.06% (95% CI [-0.08%; 0.22%]) within the nonevents, and a total NRI of 0.051 (95% CI [-0.004; 0.116]). Among the correctly downward reclassified individuals cluster analysis identified three subgroups. Using the characterizations of the typically correctly reclassified individuals, implementing SCORE only in individuals expected to benefit (n = 2,707,12.3%) improved the NRI to 5.32% (95% CI [-0.13%; 12.06%]) within the events, 0.24% (95% CI [0.10%; 0.36%]) within the nonevents, and a total NRI of 0.055 (95% CI [0.001; 0.123]). Overall, the risk levels for individuals reclassified by tailored implementation of SCORE were more accurate. Discussion In our empirical example the presented approach successfully characterized subgroups of reclassified individuals that could be used to improve reclassification and reduce implementation burden. In particular when newly added biomarkers or imaging tests are costly or burdensome such a tailored implementation strategy may save resources and improve (cost-) effectiveness.	[van Giessen, A.; Moons, K. G. M.; de Wit, G. A.; Verschuren, W. M. M.; Koffijberg, H.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Wit, G. A.; Verschuren, W. M. M.; Boer, J. M. A.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment	van Giessen, A (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	a.vangiessen@umcutrecht.nl		Koffijberg, Hendrik/0000-0002-1753-0652; de Wit, G. Ardine/0000-0002-1375-7657	NWO, the Netherlands Organization for Scientific Research [916.11.126, 912.08.004, 918.10.615]	NWO, the Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by NWO, the Netherlands Organization for Scientific Research (916.11.126 to HK and 912.08.004 and 918.10.615 to KGMM).	ALDENDERFER MS, 1984, CLUSTER ANALYSIS; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Ankerst DP, 2012, BIOMETRICAL J, V54, P127, DOI 10.1002/bimj.201100062; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; BACHER J, 2004, PROCEEDINGS OF THE R; BLOKSTRA A, 2005, MONITORING VAN RISIC; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cook NR, 2012, AM J EPIDEMIOL, V176, P488, DOI 10.1093/aje/kws208; den Ruijter HM, 2013, J HYPERTENS, V31, P782, DOI 10.1097/HJH.0b013e32835e8ee5; Dolnicar S, 2010, MARKET LETT, V21, P83, DOI 10.1007/s11002-009-9083-4; Efron B., 1993, INTRO BOOTSTRAP; EVERITT B, 2011, CLUSTER ANALYSIS; EVERITT BS, 1979, BIOMETRICS, V35, P169, DOI 10.2307/2529943; Formann A.K, 1984, DIE LATENT CLASS ANA; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; GAMBERGER G, 2002, J ARTIF INT RES, V17, P501; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Herrera F, 2011, KNOWL INF SYST, V29, P495, DOI 10.1007/s10115-010-0356-2; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Hung CL, 2013, INT J CARDIOVAS IMAG, V29, P765, DOI 10.1007/s10554-012-0146-x; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; JAIN AK, 1987, PATTERN RECOGN, V20, P547, DOI 10.1016/0031-3203(87)90081-1; KAUFMAN L, 1990, FINDING GROUPS IN DA; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Koller MT, 2012, ANN INTERN MED, V157, P389, DOI 10.7326/0003-4819-157-6-201209180-00002; Leening MJG, 2014, STAT MED, V33, P3415, DOI 10.1002/sim.6133; Leening MJG, 2014, ANN INTERN MED, V160, P122, DOI 10.7326/M13-1522; LEVY D, 1990, CIRCULATION, V81, P815, DOI 10.1161/01.CIR.81.3.815; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; NORUSIS MJ, 2012, IBM SPSS STATISTICS, P361; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Perk J, 2012, INT J BEHAV MED, V19, P403, DOI 10.1007/s12529-012-9242-5; R Core Team, 2012, R LANG ENV STAT COMP; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; SPSS, 2011, IBM SPSS STATISTICS; Steyerberg EW, 2012, EUR J CLIN INVEST, V42, P216, DOI 10.1111/j.1365-2362.2011.02562.x; Tian L, 2009, BIOMETRICS, V65, P894, DOI 10.1111/j.1541-0420.2008.01125.x; van Dis I, 2010, EUR J CARDIOV PREV R, V17, P244, DOI 10.1097/HJR.0b013e328337cca2; van Houwelingen HC, 2000, STAT MED, V19, P3401, DOI 10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2; Vickers AJ, 2014, ANN INTERN MED, V160, P136, DOI 10.7326/M13-2841; Wallace E, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-62; Wierzbicki AS, 2012, INT J CLIN PRACT, V66, P622, DOI 10.1111/j.1742-1241.2012.02956.x; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	50	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0114020	10.1371/journal.pone.0114020	http://dx.doi.org/10.1371/journal.pone.0114020			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25622035	Green Published, gold, Green Submitted			2022-12-26	WOS:000348470400001
J	Zhong, X; Shi, CZ; Gong, J; Guo, B; Li, MZ; Xu, H				Zhong, Xing; Shi, Changzheng; Gong, Jian; Guo, Bin; Li, Mingzhu; Xu, Hao			Experimental Study of Nasopharyngeal Carcinoma Radionuclide Imaging and Therapy Using Transferred Human Sodium/Iodide Symporter Gene	PLOS ONE			English	Article							SODIUM-IODIDE SYMPORTER; APPARENT DIFFUSION-COEFFICIENT; PROSTATE-CANCER; RADIOIODINE THERAPY; RADIATION-THERAPY; TUMOR XENOGRAFTS; WEIGHTED MRI; CELL-DEATH; APOPTOSIS; RADIOTHERAPY	Purpose The aim of this study was to design a method of radionuclide for imaging and therapy of nasopharyngeal carcinoma (NPC) using the transferred human sodium/iodide symporter (hNIS) gene. Methods A stable NPC cell line expressing hNIS was established (CNE-2-hNIS). After I-131 treatment, we detected proliferation and apoptosis of NPC cells, both in vitro and vivo. In vivo, the radioactivity of different organs of nude mice was counted and Tc-99m imaging using SPECT was performed. The apparent diffusion coefficient (ADC) value changes of tumor xenografts were observed by diffusion-weighted magnetic resonance imaging (DW-MRI) within 6-24 days of I-131 treatment. The correlation of ADC changes with apoptosis and proliferation was investigated. Post-treatment expression levels of P53, Bax, Bcl-2, Caspase-3, and Survivin proteins were detected by western blotting. Results I-131 uptake was higher in CNE-2-hNIS than in CNE-2 cells. The proliferation and apoptosis rate decreased and increased respectively both in vitro and vivo in the experimental group after I-131 treatment. The experimental group tumors accumulated 99mTc in vivo, leading to a good visualization by SPECT. DW-MRI showed that ADC values increased in the experimental group 6 days after treatment, while ADC values were positively and negatively correlated with the apoptotic and Ki-67 proliferation indices, respectively. After treatment, CNE-2-hNIS cells up-regulated the expression of P53 and Survivin proteins and activated Caspase-3, and down-regulated the expression of Bcl-2 proteins. Conclusions The radionuclide imaging and therapy technique for NPC hNIS-transfected cell lines can provide a new therapy strategy for monitoring and treatment of NPC.	[Zhong, Xing; Shi, Changzheng; Li, Mingzhu] Jinan Univ, Affiliated Hosp 1, Dept Med Imaging Ctr, Guangzhou 510630, Guangdong, Peoples R China; [Gong, Jian; Guo, Bin; Xu, Hao] Jinan Univ, Affiliated Hosp 1, Dept Nucl Med, Guangzhou 510630, Guangdong, Peoples R China	Jinan University; Jinan University	Xu, H (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Nucl Med, Guangzhou 510630, Guangdong, Peoples R China.	txh@jnu.edu.cn			Guangdong Provincial Science and Technology Project [2011B061200028]; major science and technology projects of Guangdong Province [2003 A3080501]	Guangdong Provincial Science and Technology Project; major science and technology projects of Guangdong Province	This work was supported by Guangdong Provincial Science and Technology Project - Project Government's commitment to a particular task (2011B061200028), and the major science and technology projects of Guangdong Province (2003 A3080501). Guangdong Province Medical Research Foundation (A2012342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braren R, 2011, J HEPATOL, V55, P1034, DOI 10.1016/j.jhep.2011.01.049; Buchsbaum DJ, 2005, J NUCL MED, V46, p179S; Chang JTC, 2000, RADIOTHER ONCOL, V54, P135, DOI 10.1016/S0167-8140(99)00177-2; Chen L, 2006, J NUCL MED, V47, P854; Chow SM, 2002, INT J RADIAT ONCOL, V52, P784, DOI 10.1016/S0360-3016(01)02686-4; Dadachova E, 2004, SEMIN NUCL MED, V34, P23, DOI 10.1053/j.semnuclmed.2003.09.004; Dingli D, 2004, BLOOD, V103, P1641, DOI 10.1182/blood-2003-07-2233; Dutta P, 2012, PITUITARY, V15, P166, DOI 10.1007/s11102-011-0300-9; Dwyer RM, 2006, GENE THER, V13, P60, DOI 10.1038/sj.gt.3302599; Dwyer RM, 2005, MOL THER, V12, P835, DOI 10.1016/j.ymthe.2005.05.013; Geschwind JFH, 2000, J VASC INTERV RADIOL, V11, P1245, DOI 10.1016/S1051-0443(07)61299-8; Goldman M, 2006, J NEUROSURG, V105, P175, DOI 10.3171/sup.2006.105.7.175; Humphries PD, 2007, RADIOLOGY, V245, P848, DOI 10.1148/radiol.2452061535; Kauppinen RA, 2002, NMR BIOMED, V15, P6, DOI 10.1002/nbm.742; Kim H, 2008, RADIOLOGY, V248, P844, DOI 10.1148/radiol.2483071740; Kim S, 2009, CLIN CANCER RES, V15, P986, DOI 10.1158/1078-0432.CCR-08-1287; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Larson SM, 2005, J NUCL MED, V46, p1S; Lin JC, 2003, J CLIN ONCOL, V21, P631, DOI 10.1200/JCO.2003.06.158; Liu Z, 2010, CLIN CANCER RES, V16, P6009, DOI 10.1158/1078-0432.CCR-10-1627; Mairs RJ, 2003, J BIOMED BIOTECHNOL, P102; Mardor Y, 2004, NEOPLASIA, V6, P136, DOI 10.1593/neo.03349; Mardor Y, 2003, J CLIN ONCOL, V21, P1094, DOI 10.1200/JCO.2003.05.069; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Riesco-Eizaguirre G, 2006, EUR J ENDOCRINOL, V155, P495, DOI 10.1530/eje.1.02257; Spitzweg C, 2000, CANCER RES, V60, P6526; Spitzweg C, 2001, GENE THER, V8, P1524, DOI 10.1038/sj.gt.3301558; Taatjes DJ, 2008, HISTOCHEM CELL BIOL, V129, P33, DOI 10.1007/s00418-007-0356-9; van Meerten ELV, 2010, EUR RADIOL, V20, P1456, DOI 10.1007/s00330-009-1685-y; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1090, DOI 10.1210/endo-114-4-1090	30	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117053	10.1371/journal.pone.0117053	http://dx.doi.org/10.1371/journal.pone.0117053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615643	Green Published, Green Submitted, gold			2022-12-26	WOS:000349122100054
J	Zhang, ZY; Jiang, WW; Jian, Q; Song, WC; Zheng, ZT; Wang, DL; Liu, XJ				Zhang, Zhiyong; Jiang, Wayne W.; Jian, Qiu; Song, Wencheng; Zheng, Zuntao; Wang, Donglan; Liu, Xianjin			Changes of Field Incurred Chlorpyrifos and Its Toxic Metabolite Residues in Rice during Food Processing from-RAC-to-Consumption	PLOS ONE			English	Article							ORGANOPHOSPHORUS PESTICIDE-RESIDUES; HOME PREPARATION; RISK-ASSESSMENT; DISSIPATION; PRODUCTS; TOMATOES; STORAGE; MARKET; HEALTH; CHINA	The objectives of this study were to determine the effects of food processing on field incurred residues levels of chlorpyrifos and its metabolite 3,5,6-Trichloro-2-pyridinol (TCP) in rice. The chlorpyrifos and TCP were found to be 1.27 and 0.093 mg kg-1 in straw and 0.41 and 0.073 mg kg-1 in grain, respectively. It is observed that the sunlight for 2 hours does not decrease the chlorpyrifos and TCP residues in grain significantly. Their residues in rice were reduced by up to 50% by hulling. The cooking reduced the chlorpyrifos and TCP in rice to undetectable level (below 0.01 mg kg-1). Processing factors (PFs) of chlorpyrifos and TCP residues in rice during food processing were similar. Various factors have impacts on the fates of chlorpyrifos and TCP residues and the important steps to reduce their residues in rice were hulling and cooking. The results can contribute to assure the consumer of a safe wholesome food supply.	[Zhang, Zhiyong; Wang, Donglan; Liu, Xianjin] Minist Agr PR China, Key Lab Control Technol & Standard Agroprod Safet, State Key Lab Breeding Base, Key Lab Food Qual & Safety Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Jiang, Wayne W.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Jian, Qiu; Song, Wencheng; Zheng, Zuntao] Minist Agr PR China, Inst Control Agrochem, Beijing, Peoples R China	Ministry of Agriculture & Rural Affairs; Michigan State University; Ministry of Agriculture & Rural Affairs	Zhang, ZY (corresponding author), Minist Agr PR China, Key Lab Control Technol & Standard Agroprod Safet, State Key Lab Breeding Base, Key Lab Food Qual & Safety Jiangsu Prov, Nanjing, Jiangsu, Peoples R China.	yzuzzy@163.com			Natural Science Foundation of China [31471797]; Independent Innovation of Agricultural Sciences in Jiangsu Province [CX (14) 2060]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation of Agricultural Sciences in Jiangsu Province	This work was financially supported by the Natural Science Foundation of China (Grant No. 31471797) and Independent Innovation of Agricultural Sciences in Jiangsu Province [Grant No. CX (14) 2060]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Arab AAK, 1999, FOOD CHEM, V65, P509, DOI 10.1016/S0308-8146(98)00231-3; Akoto O, 2013, CHEMOSPHERE, V92, P67, DOI 10.1016/j.chemosphere.2013.02.057; Andreia NOJ, 2012, FOOD CONTROL, V25, P607; [Anonymous], 2013, JAPANESE POSITVE LIS; [Anonymous], 2009, KOREA MRLS PESTICIDE; [Anonymous], 2014, GB 2763 2014; [Anonymous], 2004, 7882004 NYT; Bonnechere A., 2012, J FOOD RES, V3, P68; Bonnechere A, 2012, FOOD CONTROL, V25, P397, DOI 10.1016/j.foodcont.2011.11.010; Burchat CS, 1998, FOOD ADDIT CONTAM, V15, P61, DOI 10.1080/02652039809374599; Cabras P, 2000, J AGR FOOD CHEM, V48, P6128, DOI 10.1021/jf0007176; Chen C, 2011, FOOD CONTROL, V22, P1114, DOI 10.1016/j.foodcont.2011.01.007; Chen C, 2009, FOOD ADDIT CONTAM A, V26, P340, DOI 10.1080/02652030802524516; Codex Pesticide Residues Limits in Food, 2005, COD PEST RES LIM FOO; John PJ, 2001, ENVIRON INT, V26, P231, DOI 10.1016/S0160-4120(00)00111-2; Kaushik G, 2009, FOOD RES INT, V42, P26, DOI 10.1016/j.foodres.2008.09.009; Keikotlhaile BM, 2010, FOOD CHEM TOXICOL, V48, P1, DOI 10.1016/j.fct.2009.10.031; Lee WJ, 2004, JNCI-J NATL CANCER I, V96, P1781, DOI 10.1093/jnci/djh324; Lehotay SJ, 2005, J AOAC INT, V88, P595; Liang Y, 2012, FOOD CHEM, V133, P636, DOI 10.1016/j.foodchem.2012.01.016; Ling Y, 2011, FOOD CONTROL, V22, P54, DOI 10.1016/j.foodcont.2010.06.009; Lu HY, 2013, J SCI FOOD AGR, V93, P2917, DOI 10.1002/jsfa.6080; Lu MX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100556; Lucia P, 2011, TRENDS ANAL CHEM, V30, P270; Meeker JD, 2006, EPIDEMIOLOGY, V17, P61, DOI 10.1097/01.ede.0000190602.14691.70; Ministero per le Politiche Agricole e Forestali, 2004, 738F01006 EPA; NAKAMURA Y, 1993, J AGR FOOD CHEM, V41, P1910, DOI 10.1021/jf00035a019; Nguyen D, 2007, RAPID COMMUN MASS SP, V21, P3115, DOI [10.1002/rcm.3199, DOI 10.1002/RCM.3199]; OECD, 2008, TEST NO 407 REP DOS; Osman KA, 2011, FOOD CONTROL, V22, P947, DOI 10.1016/j.foodcont.2010.11.031; Pazzirota T, 2013, FOOD ADDIT CONTAM A, V30, P1752, DOI 10.1080/19440049.2013.815806; Shen Yan, 2011, Jiangsu Journal of Agricultural Sciences, V27, P1376; Soliman KM, 2001, FOOD CHEM TOXICOL, V39, P887, DOI 10.1016/S0278-6915(00)00177-0; The Institute for the Control of Agrochemicals Ministry of Agriculture (ICAMA), 2009, GUID SAF APPL PEST; Ticha J, 2008, FOOD CONTROL, V19, P247, DOI 10.1016/j.foodcont.2007.03.011; Uddin R, 2011, B ENVIRON CONTAM TOX, V86, P83, DOI 10.1007/s00128-010-0178-7; Wang RH, 2013, THESIS ZHEJIANG U; Wang SM, 2013, FOOD CHEM, V138, P2016, DOI 10.1016/j.foodchem.2012.11.116; Zhang CunZheng, 2010, Scientia Agricultura Sinica, V43, P151; Zhang JL, 2007, PETROL SCI, V4, P1, DOI 10.1007/s12182-007-0001-1; Zhang X, 2012, ECOTOX ENVIRON SAFE, V78, P276, DOI 10.1016/j.ecoenv.2011.11.036; Zhang ZY, 2007, FOOD CONTROL, V18, P1484, DOI 10.1016/j.foodcont.2006.11.002	42	5	7	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116467	10.1371/journal.pone.0116467	http://dx.doi.org/10.1371/journal.pone.0116467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25608031	Green Submitted, Green Published, gold			2022-12-26	WOS:000348205300026
J	Wielders, CCH; Boerman, AW; Schimmer, B; van den Brom, R; Notermans, DW; van der Hoek, W; Schneeberger, PM				Wielders, Cornelia C. H.; Boerman, Anneroos W.; Schimmer, Barbara; van den Brom, Rene; Notermans, Daan W.; van der Hoek, Wim; Schneeberger, Peter M.			Persistent High IgG Phase I Antibody Levels against Coxiella burnetii among Veterinarians Compared to Patients Previously Diagnosed with Acute Q Fever after Three Years of Follow-Up	PLOS ONE			English	Article							EPIDEMIC; HISTORY	Background Little is known about the development of chronic Q fever in occupational risk groups. The aim of this study was to perform long-term follow-up of Coxiella burnetii seropositive veterinarians and investigate the course of IgG phase I and phase II antibodies against C. burnetii antigens and to compare this course with that in patients previously diagnosed with acute Q fever. Methods Veterinarians with IgG phase I >= 1: 256 (immunofluorescence assay) that participated in a previous seroprevalence study were asked to provide a second blood sample three years later. IgG antibody profiles were compared to a group of acute Q fever patients who had IgG phase I >= 1: 256 twelve months after diagnosis. Results IgG phase I was detected in all veterinarians (n = 76) and in 85% of Q fever patients (n = 98) after three years (p<0.001). IgG phase I >= 1: 1,024, indicating possible chronic Q fever, was found in 36% of veterinarians and 12% of patients (OR 3.95, 95% CI: 1.84-8.49). Conclusions IgG phase I persists among veterinarians presumably because of continuous exposure to C. burnetii during their work. Serological and clinical follow-up of occupationally exposed risk groups should be considered.	[Wielders, Cornelia C. H.; Boerman, Anneroos W.; Schneeberger, Peter M.] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands; [Wielders, Cornelia C. H.; Boerman, Anneroos W.; Schimmer, Barbara; Notermans, Daan W.; van der Hoek, Wim; Schneeberger, Peter M.] Ctr Infect Dis Control, Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [van den Brom, Rene] GD Anim Hlth, Dept Small Ruminant Hlth, Deventer, Netherlands	Jeroen Bosch Ziekenhuis; Netherlands National Institute for Public Health & the Environment	Wielders, CCH (corresponding author), Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands.	wielders@jbz.nl	Wielders, Cornelia CH/I-1970-2019	Wielders, Cornelia CH/0000-0002-2413-9088	Netherlands Organisation for Health Research and Development [205520006]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	The follow-up study of acute Q fever patients four years after diagnosis was financially supported by The Netherlands Organisation for Health Research and Development (ZonMw; grant number 205520006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Bernard H, 2012, VECTOR-BORNE ZOONOT, V12, P552, DOI 10.1089/vbz.2011.0879; Bosnjak E, 2010, CLIN MICROBIOL INFEC, V16, P1285, DOI 10.1111/j.1469-0691.2009.03062.x; De Lange MMA, 2014, EPIDEMIOL INFECT, V142, P1231, DOI 10.1017/S0950268813001726; European Centre for Disease Prevention and Control (ECDC), 2010, RISK ASS Q FEV, DOI [10.2900/28860, DOI 10.2900/28860]; Fenollar F, 2001, CLIN INFECT DIS, V33, P312, DOI 10.1086/321889; Kampschreur LM, 2012, J INFECTION, V65, P362, DOI 10.1016/j.jinf.2012.08.002; Kampschreur LM, 2014, J CLIN MICROBIOL, V52, P1637, DOI 10.1128/JCM.03221-13; Kampschreur LM, 2012, EMERG INFECT DIS, V18, P563, DOI 10.3201/eid1804.111478; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; Peters JB, 2009, QUAL LIFE RES, V18, P901, DOI 10.1007/s11136-009-9502-2; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Raoult D, 2012, J INFECTION, V65, P102, DOI 10.1016/j.jinf.2012.04.006; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Schimmer B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042364; Schneeberger Peter M, 2010, Clin Vaccine Immunol, V17, P286, DOI 10.1128/CVI.00454-09; Swart AN, 2012, EPIDEMICS-NETH, V4, P43, DOI 10.1016/j.epidem.2011.12.002; Teunis P, 2005, EPIDEMIOL INFECT, V133, P583, DOI 10.1017/S0950268805003912; Teunis PFM, 2013, EPIDEMIOL INFECT, V141, P2051, DOI 10.1017/S0950268812002774; Teunis PFM, 2013, EPIDEMIOL INFECT, V141, P62, DOI 10.1017/S0950268812000404; Van den Brom R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054021; Van Den Wijngaard CC, 2011, EPIDEMIOL INFECT, V139, P19, DOI 10.1017/S0950268810001032; van der Hoek W, 2012, EURO SURVEILL, V17; van der Hoek W, 2010, EURO SURVEILL, V15; Wattiau P, 2011, EMERG INFECT DIS, V17, P2368, DOI 10.3201/eid1712.101786; Wegdam-Blans MCA, 2012, J INFECTION, V64, P247, DOI 10.1016/j.jinf.2011.12.014; Whitney EAS, 2009, CLIN INFECT DIS, V48, P550, DOI 10.1086/596705; Wielders CCH, 2013, J CLIN MICROBIOL, V51, P3192, DOI 10.1128/JCM.00993-13; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	30	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116937	10.1371/journal.pone.0116937	http://dx.doi.org/10.1371/journal.pone.0116937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602602	Green Published, gold, Green Submitted			2022-12-26	WOS:000348203500037
J	Kawamoto, A; Kato, T; Shioi, T; Okuda, J; Kawashima, T; Tamaki, Y; Niizuma, S; Tanada, Y; Takemura, G; Narazaki, M; Matsuda, T; Kimura, T				Kawamoto, Akira; Kato, Takao; Shioi, Tetsuo; Okuda, Junji; Kawashima, Tsuneaki; Tamaki, Yodo; Niizuma, Shinichiro; Tanada, Yohei; Takemura, Genzou; Narazaki, Michiko; Matsuda, Tetsuya; Kimura, Takeshi			Measurement of Technetium-99m Sestamibi Signals in Rats Administered a Mitochondrial Uncoupler and in a Rat Model of Heart Failure	PLOS ONE			English	Article							HEXAKIS 2-METHOXYISOBUTYL ISONITRILE; LEFT-VENTRICULAR HYPERTROPHY; CHICK MYOCARDIAL-CELLS; FATTY-ACID-METABOLISM; MEMBRANE-POTENTIALS; CARDIAC-HYPERTROPHY; DISEASE; PLASMA; EXERCISE; LIVER	Background Many methods have been used to assess mitochondrial function. Technetium-99m sestamibi ( Tc-99m-MIBI), a lipophilic cation, is rapidly incorporated into myocardial cells by diffusion and mainly localizes to the mitochondria. The purpose of this study was to investigate whether measurement of Tc-99m-MIBI signals in animal models could be used as a tool to quantify mitochondrial membrane potential at the organ level. Methods and Results We analyzed Tc-99m-MIBI signals in Sprague-Dawley (SD) rat hearts perfused with carbonyl cyanide m-chlorophenylhydrazone (CCCP), a mitochondrial uncoupler known to reduce the mitochondrial membrane potential. Tc-99m-MIBI signals could be used to detect changes in the mitochondrial membrane potential with sensitivity comparable to that obtained by two-photon laser microscopy with the cationic probe tetramethylrhodamine ethyl ester (TMRE). We also measured Tc-99m-MIBI signals in the hearts of SD rats administered CCCP (4 mg/kg intraperitoneally) or vehicle. Tc-99m-MIBI signals decreased in rat hearts administered CCCP, and the ATP content, as measured by P-31 magnetic resonance spectroscopy, decreased simultaneously. Next, we administered Tc-99m-MIBI to Dahl salt-sensitive rats fed a high-salt diet, which leads to hypertension and heart failure. The Tc-99m-MIBI signal per heart tissue weight was inversely correlated with heart weight, cardiac function, and the expression of atrial natriuretic factor, a marker of heart failure, and positively correlated with the accumulation of labeled fatty acid analog. The Tc-99m-MIBI signal per liver tissue weight was lower than that per heart tissue weight. Conclusion Measurement of Tc-99m-MIBI signals can be an effective tool for semiquantitative investigation of cardiac mitochondrial membrane potential in the SD rat model by using a chemical to decrease the mitochondrial membrane potential. The Tc-99m-MIBI signal per heart tissue weight was inversely correlated with the severity of heart failure in the Dahl rat model.	[Kawamoto, Akira; Kato, Takao; Shioi, Tetsuo; Okuda, Junji; Kawashima, Tsuneaki; Tamaki, Yodo; Niizuma, Shinichiro; Tanada, Yohei; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Kato, Takao] Kitano Hosp, Ctr Cardiovasc, Tazuke Kofukai Med Res Inst, Osaka, Japan; [Takemura, Genzou] Gifu Univ, Grad Sch Med, Div Cardiol, Gifu, Japan; [Narazaki, Michiko; Matsuda, Tetsuya] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Kyoto, Japan	Kyoto University; Kitano Hospital; Gifu University; Kyoto University	Shioi, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan.	tshioi@kuhp.kyoto-u.ac.jp	Tamaki, Yodo/AAF-8026-2020	Tamaki, Yodo/0000-0003-0217-6598; Kato, Takao/0000-0001-8213-7999	Japan Society for the Promotion of Science; Suzuken Memorial Foundation; Uehara Memorial Foundation; Tazuke Kofukai Medical Research Institutes	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Suzuken Memorial Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Tazuke Kofukai Medical Research Institutes	This work was supported by grants from the Japan Society for the Promotion of Science, the Suzuken Memorial Foundation, the Uehara Memorial Foundation, and the Tazuke Kofukai Medical Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2011, CARDIOVASC RES, V90, P234, DOI 10.1093/cvr/cvr015; BACHE RJ, 1979, AM J CARDIOL, V44, P1029, DOI 10.1016/0002-9149(79)90240-6; BACKUS M, 1993, AM J PHYSIOL, V265, pC178, DOI 10.1152/ajpcell.1993.265.1.C178; Bay J, 2013, J MOL CELL CARDIOL, V61, P20, DOI 10.1016/j.yjmcc.2013.05.010; BOTTOMLEY PA, 1985, SCIENCE, V229, P769, DOI 10.1126/science.4023711; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BUELL U, 1990, NUCL MED COMMUN, V11, P77, DOI 10.1097/00006231-199002000-00002; CARVALHO PA, 1992, J NUCL MED, V33, P1516; CHIU ML, 1990, J NUCL MED, V31, P1646; Cortese JD, 1999, AM J PHYSIOL-CELL PH, V276, pC611, DOI 10.1152/ajpcell.1999.276.3.C611; Cossarizza A, 1996, EXP CELL RES, V222, P84, DOI 10.1006/excr.1996.0011; COSTA LE, 1988, AM J PHYSIOL, V255, pC123, DOI 10.1152/ajpcell.1988.255.1.C123; CRANE P, 1993, EUR J NUCL MED, V20, P20, DOI 10.1007/BF02261241; da Silva EM, 1998, CHEMOSPHERE, V36, P2375, DOI 10.1016/S0045-6535(97)10206-5; DILLS RL, 1986, DRUG METAB DISPOS, V14, P190; DUNCKER DJ, 1995, AM J PHYSIOL-HEART C, V269, pH271, DOI 10.1152/ajpheart.1995.269.1.H271; ELSE PL, 1985, AM J PHYSIOL, V248, pR415, DOI 10.1152/ajpregu.1985.248.4.R415; FLYNN TG, 1985, BIOCHEM J, V232, P313, DOI 10.1042/bj2320313; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; HOEK JB, 1980, J BIOL CHEM, V255, P1458; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; INOKO M, 1994, AM J PHYSIOL-HEART C, V267, pH2471, DOI 10.1152/ajpheart.1994.267.6.H2471; JONES AG, 1984, INT J NUCL MED BIOL, V11, P225, DOI 10.1016/0047-0740(84)90004-4; KAHN JK, 1989, CIRCULATION, V79, P1282, DOI 10.1161/01.CIR.79.6.1282; Kapur A, 2002, EUR J NUCL MED MOL I, V29, P1608, DOI 10.1007/s00259-002-0998-8; Karamanlidis G, 2011, CIRC-HEART FAIL, V4, P707, DOI 10.1161/CIRCHEARTFAILURE.111.961474; Kato M, 2009, CARDIOVASC RES, V83, P335, DOI 10.1093/cvr/cvp094; Kato T, 2010, CIRC-HEART FAIL, V3, P420, DOI 10.1161/CIRCHEARTFAILURE.109.888479; Kawashima T, 2011, J MOL CELL CARDIOL, V51, P1026, DOI 10.1016/j.yjmcc.2011.09.013; KNAPP FF, 1995, EUR J NUCL MED, V22, P361, DOI 10.1007/BF00941855; Kyparos D, 2006, PHYSIOL RES, V55, P653, DOI 10.33549/physiolres.930890; Labajova A, 2006, ANAL BIOCHEM, V353, P37, DOI 10.1016/j.ab.2006.03.032; Langenickel T, 2000, AM J PHYSIOL-HEART C, V278, pH1500, DOI 10.1152/ajpheart.2000.278.5.H1500; Laskowski Karl R, 2008, Curr Heart Fail Rep, V5, P75, DOI 10.1007/s11897-008-0013-1; Matsumoto-Ida M, 2006, CIRCULATION, V114, P1497, DOI 10.1161/CIRCULATIONAHA.106.628834; Miyamoto T, 2004, EUR J CLIN INVEST, V34, P176, DOI 10.1111/j.1365-2362.2004.01312.x; Moreira PI, 2001, BIOSCIENCE REP, V21, P789, DOI 10.1023/A:1015536808304; Nakagawa M, 2008, CIRC RES, V103, P98, DOI 10.1161/CIRCRESAHA.108.177568; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; NOBES CD, 1990, J BIOL CHEM, V265, P12903; O'Neill BT, 2007, CELL METAB, V6, P294, DOI 10.1016/j.cmet.2007.09.001; Okuda J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072173; OLSON MS, 1967, J BIOL CHEM, V242, P333; Padmaraj D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101793; Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712; PIWNICAWORMS D, 1990, J NUCL MED, V31, P464; PIWNICAWORMS D, 1990, CIRCULATION, V82, P1826, DOI 10.1161/01.CIR.82.5.1826; POOL PE, 1966, CIRC RES, V19, P221, DOI 10.1161/01.RES.19.2.221; Rimbaud S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026391; Tang Y, 2014, CARDIOVASC PATHOL, V23, P101, DOI 10.1016/j.carpath.2013.11.002; TATE EL, 1976, J GERONTOL, V31, P129, DOI 10.1093/geronj/31.2.129; Veech RL, 2002, IUBMB LIFE, V54, P241, DOI 10.1080/15216540215678; WACKERS FJT, 1989, J NUCL MED, V30, P301; Wallbridge DR, 1996, HEART, V75, P369, DOI 10.1136/hrt.75.4.369; WAN B, 1993, AM J PHYSIOL, V265, pH453, DOI 10.1152/ajpheart.1993.265.2.H453; Ward MW, 2007, J NEUROSCI, V27, P8238, DOI 10.1523/JNEUROSCI.1984-07.2007; Watanabe K, 2000, J BIOL CHEM, V275, P22293, DOI 10.1074/jbc.M000248200; Zhang H, 2001, ANAL BIOCHEM, V298, P170, DOI 10.1006/abio.2001.5348	59	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2015	10	1							e0117091	10.1371/journal.pone.0117091	http://dx.doi.org/10.1371/journal.pone.0117091			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OS	25594546	Green Published, Green Submitted, gold			2022-12-26	WOS:000348202900007
J	Blackmore, KM; Knight, JA; Walter, J; Lilge, L				Blackmore, Kristina M.; Knight, Julia A.; Walter, Jane; Lilge, Lothar			The Association between Breast Tissue Optical Content and Mammographic Density in Pre- and Post-Menopausal Women	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; X-RAY MAMMOGRAPHY; CANCER-RISK; TRANSILLUMINATION SPECTROSCOPY; PARENCHYMAL PATTERNS; DIFFUSE-REFLECTANCE; OXYGEN-SATURATION; IN-VIVO; TOMOGRAPHY; HEMOGLOBIN	Mammographic density (MD), associated with higher water and lower fat content in the breast, is strongly related to breast cancer risk. Optical attenuation spectroscopy (OS) is a non-imaging method of evaluating breast tissue composition by red and near-infrared light transmitted through the breast that, unlike mammography, does not involve radiation. OS provides information on wavelength dependent light scattering of tissue and on absorption by water, lipid, oxy-, deoxy-hemoglobin. We propose that OS could be an alternative marker of breast cancer risk and that OS breast tissue measures will be associated with MD. In the present analysis, we developed an algorithm to estimate breast tissue composition and light scattering parameters using a spectrally constrained global fitting procedure employing a diffuse light transport model. OS measurements were obtained from 202 pre-and postmenopausal women with normal mammograms. Percent density (PD) and dense area (DA) were measured using Cumulus. The association between OS tissue composition and PD and DA was analyzed using linear regression adjusted for body mass index. Among premenopausal women, lipid content was significantly inversely associated with square root transformed PD (beta = -0.05, p = 0.0002) and DA (beta = -0.05, p = 0.019); water content was significantly positively associated with PD (beta = 0.06, p = 0.008). Tissue oxygen saturation was marginally inversely associated with PD (beta = -0.03, p = 0.057) but significantly inversely associated with DA (beta = -0.10, p = 0.002). Among post-menopausal women lipid and water content were significantly associated (negatively and positively, respectively) with PD (beta(lipid) = -0.08, beta(water) = 0.14, both p< 0.0001) and DA (beta(lipid) = -0.10, p< 0.0001; beta(water) = 0.11, p = 0.001). The association between OS breast content and PD and DA is consistent with more proliferation in dense tissue of younger women, greater lipid content in low density tissue and higher water content in high density tissue. OS may be useful for assessing physiologic tissue differences related to breast cancer risk, particularly when mammography is not feasible or easily accessible.	[Blackmore, Kristina M.; Knight, Julia A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Blackmore, Kristina M.; Walter, Jane; Lilge, Lothar] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5S 1A1, Canada; [Blackmore, Kristina M.; Walter, Jane; Lilge, Lothar] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Blackmore, KM (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.	blackmore@lunenfeld.ca	Knight, Julia/R-5617-2019; Knight, Julia/A-6843-2012	Knight, Julia/0000-0002-7610-7635; Blackmore, Kristina/0000-0001-6662-6741; lilge, lothar/0000-0001-5533-0005	CDMRP (Congress Directed Medical Research Plan) [DAMD 17-00-1-0393]; CIPI (Canadian Institute of Photonics Innovation); CBCRA (Canadian Breast Cancer Research Alliance)	CDMRP (Congress Directed Medical Research Plan); CIPI (Canadian Institute of Photonics Innovation); CBCRA (Canadian Breast Cancer Research Alliance)	This work was supported by CDMRP (Congress Directed Medical Research Plan) under DAMD 17-00-1-0393, CIPI (Canadian Institute of Photonics Innovation) and CBCRA (Canadian Breast Cancer Research Alliance). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, 6082511993 IEC, P54; Blackmore KM, 2007, BRIT J RADIOL, V80, P545, DOI 10.1259/bjr/26858614; Blackmore KM, 2008, CANCER EPIDEM BIOMAR, V17, P1043, DOI 10.1158/1055-9965.EPI-07-2658; Blyschak K, 2004, MED PHYS, V31, P1398, DOI 10.1118/1.1738191; Boyd N, 2002, CANCER EPIDEM BIOMAR, V11, P1048; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; BOYD NF, 1982, BRIT J CANCER, V45, P185, DOI 10.1038/bjc.1982.32; Bryson J, 1982, AM J EPIDERNIOL, V115, P428; Byng JW, 1997, CANCER, V80, P66, DOI 10.1002/(SICI)1097-0142(19970701)80:1<66::AID-CNCR9>3.0.CO;2-D; Cerussi AE, 2001, ACAD RADIOL, V8, P211, DOI 10.1016/S1076-6332(03)80529-9; Durduran T, 2002, PHYS MED BIOL, V47, P2847, DOI 10.1088/0031-9155/47/16/302; FARRELL TJ, 1992, MED PHYS, V19, P879, DOI 10.1118/1.596777; Graham SJ, 1996, BRIT J CANCER, V73, P162, DOI 10.1038/bjc.1996.30; Harvey JA, 2004, RADIOLOGY, V230, P29, DOI 10.1148/radiol.2301020870; KATO I, 1995, CANCER CAUSE CONTROL, V6, P431, DOI 10.1007/BF00052183; Lee NA, 1997, AM J ROENTGENOL, V168, P501, DOI 10.2214/ajr.168.2.9016235; Maskarinec G, 2005, AM J EPIDEMIOL, V162, P743, DOI 10.1093/aje/kwi270; MATCHER SJ, 1994, PHYS MED BIOL, V39, P177, DOI 10.1088/0031-9155/39/1/011; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; O'Sullivan TD, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3389; OZA AM, 1993, EPIDEMIOL REV, V15, P196, DOI 10.1093/oxfordjournals.epirev.a036105; Pogue BW, 2001, RADIOLOGY, V218, P261, DOI 10.1148/radiology.218.1.r01ja51261; Quaresima V, 1998, PHOTOCHEM PHOTOBIOL, V67, P4, DOI 10.1111/j.1751-1097.1998.tb05159.x; SAFTLAS AF, 1991, CANCER, V67, P2833, DOI 10.1002/1097-0142(19910601)67:11<2833::AID-CNCR2820671121>3.0.CO;2-U; Shah N, 2001, P NATL ACAD SCI USA, V98, P4420, DOI 10.1073/pnas.071511098; Simick MK, 2005, BRIT J RADIOL, V78, P1009, DOI 10.1259/bjr/14696165; Simick MK, 2004, J BIOMED OPT, V9, P794, DOI 10.1117/1.1758269; Sliney DH, 1990, P SPIE, V1207; Srinivasan S, 2006, ACAD RADIOL, V13, P195, DOI 10.1016/j.acra.2005.10.002; Srinivasan S, 2003, P NATL ACAD SCI USA, V100, P12349, DOI 10.1073/pnas.2032822100; Suzuki K, 1996, J Biomed Opt, V1, P330, DOI 10.1117/12.239902; Taroni P, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2699170; Taroni P, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3506043; Torres-Mejia G, 2005, CANCER EPIDEM BIOMAR, V14, P1052, DOI 10.1158/1055-9965.EPI-04-0717; Tromberg BJ, 1997, PHILOS T R SOC B, V352, P661, DOI 10.1098/rstb.1997.0047; Vacek PM, 2004, CANCER EPIDEM BIOMAR, V13, P715; van Veen RLP, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2085149; Wang X, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2342747; WOLFE JN, 1987, AM J ROENTGENOL, V148, P1087, DOI 10.2214/ajr.148.6.1087; Yaffe MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2102; Yaffe MJ, 1998, EUR J CANCER PREV, V7, pS47, DOI 10.1097/00008469-199802001-00010	42	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0115851	10.1371/journal.pone.0115851	http://dx.doi.org/10.1371/journal.pone.0115851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590139	Green Published, Green Submitted, gold			2022-12-26	WOS:000350679400011
J	Ruiz, JA; Bernar, EM; Jung, K				Ruiz, Jimena A.; Bernar, Evangelina M.; Jung, Kirsten			Production of Siderophores Increases Resistance to Fusaric Acid in Pseudomonas protegens Pf-5	PLOS ONE			English	Article							CHLAMYDOSPORE GERMINATION; SPECTROPHOTOMETRIC DETERMINATION; CHLORORAPHIS PCL1391; RADICIS-LYCOPERSICI; GENE-EXPRESSION; 1ST REPORT; FLUORESCENS; OXYSPORUM; AERUGINOSA; GROWTH	Fusaric acid is produced by pathogenic fungi of the genus Fusarium, and is toxic to plants and rhizobacteria. Many fluorescent pseudomonads can prevent wilt diseases caused by these fungi. This study was undertaken to evaluate the effect of fusaric acid on P. protegens Pf-5 and elucidate the mechanisms that enable the bacterium to survive in the presence of the mycotoxin. The results confirm that fusaric acid negatively affects growth and motility of P. protegens. Moreover, a notable increase in secretion of the siderophore pyoverdine was observed when P. protegens was grown in the presence of fusaric acid. Concomitantly, levels of enzymes involved in the biosynthesis of pyoverdine and enantio-pyochelin, the second siderophore encoded by P. protegens, increased markedly. Moreover, while similar levels of resistance to fusaric acid were observed for P. protegens mutants unable to synthesize either pyoverdine or enanto-pyochelin and the wild type strain, a double mutant unable to synthesize both kinds of siderophores showed a dramatically reduced resistance to this compound. This reduced resistance was not observed when this mutant was grown under conditions of iron excess. Spectrophotometric titrations revealed that fusaric acid binds not only Fe2+ and Fe3+, but also Zn2+, Mn2+ and Cu2+, with high affinity. Our results demonstrate that iron sequestration accounts at least in part for the deleterious effect of the mycotoxin on P. protegens.	[Ruiz, Jimena A.] Univ Buenos Aires, Fac Agron, Consejo Nacl Invest Cient & Tecn, Inst Invest Biociencias Agr & Ambientales, Buenos Aires, DF, Argentina; [Ruiz, Jimena A.; Jung, Kirsten] Univ Munich, Munich Ctr Integrated Prot Sci CiPSM, Dept Biol 1, Martinsried, Germany; [Ruiz, Jimena A.; Bernar, Evangelina M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Munich; University of Buenos Aires	Ruiz, JA (corresponding author), Univ Buenos Aires, Fac Agron, Consejo Nacl Invest Cient & Tecn, Inst Invest Biociencias Agr & Ambientales, Buenos Aires, DF, Argentina.	jruiz@agro.uba.ar; jung@lmu.de			Deutsche Forschungsgemeinschaft [Exc114/2]; Humboldt Foundation; Argentinean National Research Council (CONICET)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Humboldt Foundation(Alexander von Humboldt Foundation); Argentinean National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the Deutsche Forschungsgemeinschaft (Exc114/2) (KJ), the Humboldt Foundation (fellowship to JR) and the Argentinean National Research Council (CONICET). JR is a career researcher from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almario J, 2013, MOL PLANT MICROBE IN, V26, P566, DOI 10.1094/MPMI-11-12-0274-R; BACHMANN BJ, 1996, ESCHERICHIA COLI SAL, P2460; Bacon CW, 2006, J APPL MICROBIOL, V100, P185, DOI 10.1111/j.1365-2672.2005.02770.x; Bacon CW, 1996, APPL ENVIRON MICROB, V62, P4039, DOI 10.1128/AEM.62.11.4039-4043.1996; Capasso R, 1996, PHYTOCHEMISTRY, V41, P1035, DOI 10.1016/0031-9422(95)00716-4; Chin-A-Woeng TFC, 1998, MOL PLANT MICROBE IN, V11, P1069, DOI 10.1094/MPMI.1998.11.11.1069; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; COX CD, 1981, P NATL ACAD SCI-BIOL, V78, P4256, DOI 10.1073/pnas.78.7.4256; de Weert S, 2004, MOL PLANT MICROBE IN, V17, P1185, DOI 10.1094/MPMI.2004.17.11.1185; DEWEGER LA, 1987, J BACTERIOL, V169, P2769, DOI 10.1128/jb.169.6.2769-2773.1987; Di Pietro A, 2003, MOL PLANT PATHOL, V4, P315, DOI [10.1046/j.1364-3703.2003.00180.x, 10.1046/J.1364-3703.2003.00180.X]; Duffy B, 2004, APPL ENVIRON MICROB, V70, P1836, DOI 10.1128/AEM.70.3.1836-1842.2004; Duffy BK, 1999, APPL ENVIRON MICROB, V65, P2429; ELAD Y, 1985, PHYTOPATHOLOGY, V75, P1053, DOI 10.1094/Phyto-75-1053; ELAD Y, 1985, PHYTOPATHOLOGY, V75, P1047, DOI 10.1094/Phyto-75-1047; FERNANDEZPOL JA, 1977, P NATL ACAD SCI USA, V74, P2889, DOI 10.1073/pnas.74.7.2889; FERNANDEZPOL JA, 1993, ANTICANCER RES, V13, P57; Gapillout I, 1996, EUR J PLANT PATHOL, V102, P127, DOI 10.1007/BF01877099; GAUMANN E, 1958, PHYTOPATHOLOGY, V48, P670; Gross H, 2007, CHEM BIOL, V14, P53, DOI 10.1016/j.chembiol.2006.11.007; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; HENZEL WJ, 1993, P NATL ACAD SCI USA, V90, P5011, DOI 10.1073/pnas.90.11.5011; HILL-COTTINGHAM D. G., 1957, SOIL SCI, V84, P43, DOI 10.1097/00010694-195707000-00005; HILLCOTTINGHAM DG, 1957, ANALYST, V82, P524; HILLCOTTINGHAM DG, 1955, ANALYST, V80, P906; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOWELL CR, 1979, PHYTOPATHOLOGY, V69, P480, DOI 10.1094/Phyto-69-480; KING EO, 1954, J LAB CLIN MED, V44, P301; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGEVEEN RG, 1988, APPL ENVIRON MICROB, V54, P2924, DOI 10.1128/AEM.54.12.2924-2932.1988; Landa BB, 2002, CAN J MICROBIOL, V48, P971, DOI 10.1139/W02-094; Lassak J, 2010, APPL ENVIRON MICROB, V76, P3263, DOI 10.1128/AEM.00512-10; Lim CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039139; LIU PV, 1978, INFECT IMMUN, V22, P878, DOI 10.1128/IAI.22.3.878-890.1978; Lori GA, 2003, MICROBIOL RES, V158, P29, DOI 10.1078/0944-5013-00173; Lugtenberg BJJ, 2001, ANNU REV PHYTOPATHOL, V39, P461, DOI 10.1146/annurev.phyto.39.1.461; MALINI S., 1966, Phytopathologische Zeitschrift, V57, P221, DOI 10.1111/j.1439-0434.1966.tb02277.x; MEGNEGNEAU B, 1988, PLANT PHYSIOL BIOCH, V26, P585; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; MEYER JM, 1978, J GEN MICROBIOL, V107, P319, DOI 10.1099/00221287-107-2-319; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Notz R, 2002, APPL ENVIRON MICROB, V68, P2229, DOI 10.1128/AEM.68.5.2229-2235.2002; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pioli RN, 2004, PLANT DIS, V88, P220, DOI 10.1094/PDIS.2004.88.2.220A; Ramautar A, 2003, THESIS U NATAL DURBA; Reynoso M, 2009, EUR J PLANT PATHOL, V123, P207, DOI 10.1007/s10658-008-9359-1; RINEHART KL, 1995, J ORG CHEM, V60, P2786, DOI 10.1021/jo00114a029; Rudrappa T, 2008, FEMS MICROBIOL ECOL, V64, P153, DOI 10.1111/j.1574-6941.2008.00465.x; Saikia R, 2009, MICROBIOL RES, V164, P365, DOI 10.1016/j.micres.2007.05.001; Schweizer Herbert P, 2003, Genet Mol Res, V2, P48; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SNEH B, 1984, PHYTOPATHOLOGY, V74, P1115, DOI 10.1094/Phyto-74-1115; Stenglein S, 2009, PLANT PATHOL, V58, P401, DOI 10.1111/j.1365-3059.2008.01973.x; Stenglein SA, 2009, J PLANT PATHOL, V91, P25; TOYODA H, 1991, J PHYTOPATHOL, V133, P265, DOI 10.1111/j.1439-0434.1991.tb00162.x; UTSUMI R, 1991, AGR BIOL CHEM TOKYO, V55, P1913, DOI 10.1080/00021369.1991.10870864; van Rij ET, 2005, MICROBIOL-SGM, V151, P2805, DOI 10.1099/mic.0.28063-0; van Rij ET, 2004, MOL PLANT MICROBE IN, V17, P557, DOI 10.1094/MPMI.2004.17.5.557; VISCA P, 1992, APPL ENVIRON MICROB, V58, P2886, DOI 10.1128/AEM.58.9.2886-2893.1992; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; WEBER K, 1969, J BIOL CHEM, V244, P4406; WENDENBAUM S, 1983, TETRAHEDRON LETT, V24, P4877, DOI 10.1016/S0040-4039(00)94031-0; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Youard ZA, 2007, J BIOL CHEM, V282, P35546, DOI 10.1074/jbc.M707039200	64	28	28	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e0117040	10.1371/journal.pone.0117040	http://dx.doi.org/10.1371/journal.pone.0117040			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25569682	Green Published, Green Submitted, gold			2022-12-26	WOS:000348168000010
J	Abrol, N; de Tombe, PP; Robia, SL				Abrol, Neha; de Tombe, Pieter P.; Robia, Seth L.			Acute Inotropic and Lusitropic Effects of Cardiomyopathic R9C Mutation of Phospholamban	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DILATED CARDIOMYOPATHY; CYTOPLASMIC DOMAIN; PROTEIN-STRUCTURE; ENERGY-TRANSFER; HEART-FAILURE; CALCIUM-PUMP; PHOSPHORYLATION; LETHAL; SERCA; REVEALS	A naturally occurring R9C mutation of phospholamban (PLB) triggers cardiomyopathy and premature death by altering regulation of sarco/endoplasmic reticulurn calcitun-ATPase (SERCA). The goal of this study was to investigate the acute physiological consequences of the R9C-PLB mutation on cardioniyocyte calcium kinetics and contractility. We measured the physiological consequences of R9C-PLB mutation on calcium transients and sarcomere shortening in adult cardiomyocytes. In contrast to studies of chronic R9C-PLB expression in transgenic mice, we found that acute expression of R9C-PLB exerts a positively inotropic and lusitropic effect in cardiomyocytes. Importantly, R9C-PLB exhibited blunted sensitivity to frequency potentiation and p-adrenergic stimulation, two major physiological mechanisms for the regulation of cardiac performance. To identify the molecular mechanism of R9C pathology, we quantified the effect of R9C on PLB oligomerization and PLB-SERCA binding. FRET measurements in live cells revealed that R9C-PLB exhibited an increased propensity for oligomerization, and this was further increased by oxidative stress. The R9C also decreased PLB binding to SERCA and altered the structure of the PLB-SERCA regulatory complex. The structural change after oxidative modification of R9C-PLB was similar to that observed after PLB phosphorylation. We conclude that R9C mutation of PLB decreases SERCA inhibition by decreasing the amount of the regulatory complex and altering its conformation. This has an acute inotropic/lusitropic effect but yields negative consequences of impaired frequency potentiation and blunted p-adrenergic responsiveness. We envision a self-reinforcing mechanism beginning with phosphomimetic R9C-PLB oxidation and loss of SERCA inhibition, leading to impaired calcium regulation and heart failure.	[Abrol, Neha; de Tombe, Pieter P.; Robia, Seth L.] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60163 USA	Loyola University Chicago	Robia, SL (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, 2160 South First Ave, Maywood, IL 60153 USA.	srobia@luc.edu			National Institutes of Health [HL-092321, HL-62426, HL-75494]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092321, P01HL062426, R01HL075494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-092321 (to S. L. R.) and HL-62426 and HL-75494 (to P. dT.).	Abrol N, 2014, J BIOL CHEM, V289, P25855, DOI 10.1074/jbc.M114.562579; Autry JM, 1998, ANN NY ACAD SCI, V853, P92, DOI 10.1111/j.1749-6632.1998.tb08259.x; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; Ceholski DK, 2012, J BIOL CHEM, V287, P26596, DOI 10.1074/jbc.M112.382713; Ceholski DK, 2012, J BIOL CHEM, V287, P16521, DOI 10.1074/jbc.M112.360859; Choudhary Gaurav, 2002, Congest Heart Fail, V8, P148, DOI 10.1111/j.1527-5299.2002.00716.x; Dellefave L, 2010, CURR OPIN CARDIOL, V25, P198, DOI 10.1097/HCO.0b013e328337ba52; DeWitt MM, 2006, J AM COLL CARDIOL, V48, P1396, DOI 10.1016/j.jacc.2006.07.016; Domeier TL, 2009, J PHYSIOL-LONDON, V587, P5197, DOI 10.1113/jphysiol.2009.177576; Dong XQ, 2014, BIOCHEM BIOPH RES CO, V449, P196, DOI 10.1016/j.bbrc.2014.04.166; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; FUJII J, 1989, J BIOL CHEM, V264, P12950; Gadella T. W., 2009, FRET FLIM TECHNIQUES, P193; Gramolini AO, 2008, MOL CELL PROTEOMICS, V7, P519, DOI 10.1074/mcp.M700245-MCP200; Gustavsson M, 2013, P NATL ACAD SCI USA, V110, P17338, DOI 10.1073/pnas.1303006110; Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108; Hagemann D, 2002, TRENDS CARDIOVAS MED, V12, P51, DOI 10.1016/S1050-1738(01)00145-1; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Hasenfuss G, 1998, CARDIOVASC RES, V39, P60, DOI 10.1016/S0008-6363(98)00110-2; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hou ZJ, 2010, J MOL BIOL, V402, P210, DOI 10.1016/j.jmb.2010.07.023; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; King C, 2014, BIOPHYS J, V106, P1309, DOI 10.1016/j.bpj.2014.01.039; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Landstrom AP, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.08.001; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; Lipskaia L, 2009, PFLUG ARCH EUR J PHY, V457, P673, DOI 10.1007/s00424-007-0428-7; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Medeiros A, 2011, AM HEART J, V162, P1088, DOI 10.1016/j.ahj.2011.07.028; Pallikkuth S, 2013, BIOPHYS J, V105, P1812, DOI 10.1016/j.bpj.2013.08.045; Parvari R, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/639250; Paterlini MG, 2005, BIOPHYS J, V88, P3243, DOI 10.1529/biophysj.104.054460; Pattison JS, 2008, TRANSGENIC RES, V17, P157, DOI 10.1007/s11248-007-9139-2; Periasamy M, 2001, J MOL CELL CARDIOL, V33, P1053, DOI 10.1006/jmcc.2001.1366; Posch MG, 2009, HEART RHYTHM, V6, P480, DOI 10.1016/j.hrthm.2009.01.016; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; Robia SL, 2005, BIOCHEMISTRY-US, V44, P4302, DOI 10.1021/bi0478446; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; Schmitt JP, 2009, CIRCULATION, V119, P436, DOI 10.1161/CIRCULATIONAHA.108.783506; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Schroder E, 2008, CURR OPIN PHARMACOL, V8, P153, DOI 10.1016/j.coph.2007.12.012; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Smeazzetto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052744; van Rijsingen IAW, 2014, CIRC-CARDIOVASC GENE, V7, P455, DOI 10.1161/CIRCGENETICS.113.000374; WEGENER AD, 1984, J BIOL CHEM, V259, P1834; WEGENER AD, 1989, J BIOL CHEM, V264, P11468; Yu XT, 2014, J PHYS CHEM B, V118, P2124, DOI 10.1021/jp500316s; Yu XT, 2013, BBA-BIOMEMBRANES, V1828, P2444, DOI 10.1016/j.bbamem.2013.07.003; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	52	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7130	7140		10.1074/jbc.M114.630319	http://dx.doi.org/10.1074/jbc.M114.630319			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25593317	hybrid, Green Published			2022-12-26	WOS:000350991500043
J	Keembiyehetty, C; Love, DC; Harwood, KR; Gavrilova, O; Comly, ME; Hanover, JA				Keembiyehetty, Chithra; Love, Dona C.; Harwood, Katryn R.; Gavrilova, Oksana; Comly, Marcella E.; Hanover, John A.			Conditional Knock-out Reveals a Requirement for O-Linked N-Acetylglucosaminase (O-GlcNAcase) in Metabolic Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCE INSULIN-RESISTANCE; TYPE-2 DIABETES-MELLITUS; CAENORHABDITIS-ELEGANS; GLYCOGEN-SYNTHASE; 3T3-L1 ADIPOCYTES; TRANSGENIC MICE; ADIPOSE-TISSUE; NUCLEOCYTOPLASMIC GLYCOSYLATION; PROTEIN GLYCOSYLATION; DYNAMIC INTERPLAY	O-GlcNAc cycling is maintained by the reciprocal activities of the O-GlcNAc transferase and the O-GlcNAcase (OGA) enzymes. O-GlcNAc transferase is responsible forO-GlcNAc addition to serine and threonine (Ser/Thr) residues and OGA for its removal. Although the Oga gene (MGEA5) is a documented human diabetes susceptibility locus, its role in maintaining insulin-glucose homeostasis is unclear. Here, we report a conditional disruption of the Oga gene in the mouse. The resulting homozygous Oga null (KO) animals lack OGA enzymatic activity and exhibit elevated levels of the O-GlcNAc modification. The Oga KO animals showed nearly complete perinatal lethality associated with low circulating glucose and low liver glycogen stores. Defective insulin-responsive GSK3 beta phosphorylation was observed in both heterozygous (HET) and KO Oga animals. Although Oga HET animals were viable, they exhibited alterations in both transcription and metabolism. Transcriptome analysis using mouse embryonic fibroblasts revealed deregulation in the transcripts of both HET and KO animals specifically in genes associated with metabolism and growth. Additionally, metabolic profiling showed increased fat accumulation in HET and KO animals compared with WT, which was increased by a high fat diet. Reduced insulin sensitivity, glucose tolerance, and hyperleptinemia were also observed in HET and KO female mice. Notably, the respiratory exchange ratio of the HET animals was higher than that observed in WT animals, indicating the preferential utilization of glucose as an energy source. These results suggest that the loss of mouse OGA leads to defects in metabolic homeostasis culminating in obesity and insulin resistance.	[Keembiyehetty, Chithra; Love, Dona C.; Harwood, Katryn R.; Comly, Marcella E.; Hanover, John A.] NIDDK, LCBB, NIH, Bethesda, MD 20892 USA; [Gavrilova, Oksana] NIDDK, Mouse Metab Core Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hanover, JA (corresponding author), NIDDK, LCBB, NIH, 8 Ctr Dr, Bethesda, MD 20892 USA.	jah@helix.nih.gov			National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK070002, ZIADK060102, ZIADK060101, ZIADK060103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by a National Institutes of Health Intramural Grant.	Abramowitz Lara K, 2014, J Genomics, V2, P77, DOI 10.7150/jgen.8123; Akimoto Y, 2007, GLYCOBIOLOGY, V17, P127, DOI 10.1093/glycob/cwl067; Babinet C, 2001, AN ACAD BRAS CIENC, V73, P365, DOI 10.1590/S0001-37652001000300007; Benz V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037794; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Chen M, 2012, ENDOCRINOLOGY, V153, P4256, DOI 10.1210/en.2012-1113; Comtesse N, 2001, BIOCHEM BIOPH RES CO, V283, P634, DOI 10.1006/bbrc.2001.4815; Cooksey RC, 2002, ANN NY ACAD SCI, V967, P102; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; Farook VS, 2002, MOL GENET METAB, V77, P189, DOI 10.1016/S1096-7192(02)00127-0; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Fuentes L, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/219583; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Hanover John A, 2013, Worm, V2, pe27043, DOI 10.4161/worm.27043; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Harwood KR, 2014, J CELL SCI, V127, P1857, DOI 10.1242/jcs.113233; Hazel M, 2004, ENDOCRINOLOGY, V145, P2118, DOI 10.1210/en.2003-0812; Heckel D, 1998, HUM MOL GENET, V7, P1859, DOI 10.1093/hmg/7.12.1859; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; INGHAM PW, 1984, CELL, V37, P815, DOI 10.1016/0092-8674(84)90416-1; Issad T, 2008, TRENDS ENDOCRIN MET, V19, P380, DOI 10.1016/j.tem.2008.09.001; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; Keembiyehetty CN, 2011, J CELL SCI, V124, P2851, DOI 10.1242/jcs.083287; Kim EJ, 2006, J AM CHEM SOC, V128, P4234, DOI 10.1021/ja0582915; Kim EJ, 2007, J AM CHEM SOC, V129, P14854, DOI 10.1021/ja076038u; Kim EJ, 2014, CRIT REV BIOCHEM MOL, V49, P327, DOI 10.3109/10409238.2014.931338; Kim EJ, 2006, CARBOHYD RES, V341, P971, DOI 10.1016/j.carres.2006.03.004; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kudlow JE, 2002, MOL GENET METAB, V77, P1, DOI 10.1016/S1096-7192(02)00128-2; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Ma JF, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-8; Macauley MS, 2010, CHEM BIOL, V17, P937, DOI 10.1016/j.chembiol.2010.07.006; Macauley MS, 2010, CHEM BIOL, V17, P949, DOI 10.1016/j.chembiol.2010.07.005; Macauley MS, 2008, J BIOL CHEM, V283, P34687, DOI 10.1074/jbc.M804525200; Marshall Stephen, 2006, Sci STKE, V2006, pre7; McClain DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE973, DOI 10.1152/ajpendo.00549.2004; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; McClain DA, 2002, J DIABETES COMPLICAT, V16, P72, DOI 10.1016/S1056-8727(01)00188-X; McClain DA, 2000, ENDOCRINOLOGY, V141, P1999, DOI 10.1210/en.141.6.1999; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mondoux MA, 2011, GENETICS, V188, P369, DOI 10.1534/genetics.111.126490; Muller G, 1997, J BIOL CHEM, V272, P10585, DOI 10.1074/jbc.272.16.10585; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Orena SJ, 2000, J BIOL CHEM, V275, P15765, DOI 10.1074/jbc.M910002199; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; Qiao LP, 2011, DIABETES, V60, P1519, DOI 10.2337/db10-1017; Radermacher PT, 2014, P NATL ACAD SCI USA, V111, P5592, DOI 10.1073/pnas.1322396111; Rahman MM, 2010, AGING-US, V2, P678, DOI 10.18632/aging.100208; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Schultz J, 2002, FEBS LETT, V529, P179, DOI 10.1016/S0014-5793(02)03322-7; Sekine O, 2010, J BIOL CHEM, V285, P38684, DOI 10.1074/jbc.M110.155192; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Slawson C, 2003, CURR OPIN STRUC BIOL, V13, P631, DOI 10.1016/j.sbi.2003.08.003; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Soesanto YA, 2008, AM J PHYSIOL-ENDOC M, V295, pE974, DOI 10.1152/ajpendo.90366.2008; Stichelen SOV, 2014, BIOCHEM BIOPH RES CO, V453, P201, DOI 10.1016/j.bbrc.2014.06.068; Summers SA, 1999, J BIOL CHEM, V274, P17934, DOI 10.1074/jbc.274.25.17934; Teo CF, 2010, MOL CELL ENDOCRINOL, V318, P44, DOI 10.1016/j.mce.2009.09.022; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wan M, 2012, MOL CELL BIOL, V32, P96, DOI 10.1128/MCB.05806-11; Wang P, 2013, AUTOPHAGY, V9, P604, DOI 10.4161/auto.23459; Wang P, 2012, P NATL ACAD SCI USA, V109, P17669, DOI 10.1073/pnas.1205748109; Wang Z, 2007, MOL CELL PROTEOMICS, V6, P1365, DOI 10.1074/mcp.M600453-MCP200; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang YR, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.24; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016	84	82	82	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7097	7113		10.1074/jbc.M114.617779	http://dx.doi.org/10.1074/jbc.M114.617779			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25596529	hybrid, Green Published			2022-12-26	WOS:000350991500041
J	Mayer, F; Lim, JK; Langer, JD; Kang, SG; Muller, V				Mayer, Florian; Lim, Jae Kyu; Langer, Julian D.; Kang, Sung Gyun; Mueller, Volker			Na+ Transport by the A(1)A(O)-ATP Synthase Purified from Thermococcus onnurineus and Reconstituted into Liposomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A(1)A(0) ATP SYNTHASE; METHANOSARCINA-MAZEI GO1; PROPIONIGENIUM-MODESTUM; H+-ATPASE; ION; ARCHAEON; EVOLUTION; PROTEINS; FORMATE; SUBUNIT	The ATP synthase of many archaea has the conserved sodium ion binding motif in its rotor subunit, implying that these A(1)A(O)-ATP synthases use Na+ as coupling ion. However, this has never been experimentally verified with a purified system. To experimentally address the nature of the coupling ion, we have purified the A(1)A(O)-ATP synthase from T. onnurineus. It contains nine subunits that are functionally coupled. The enzyme hydrolyzed ATP, CTP, GTP, UTP, and ITP with nearly identical activities of around 40 units/mg of protein and was active over a wide pH range with maximal activity at pH 7. Noteworthy was the temperature profile. ATP hydrolysis was maximal at 80 degrees C and still retained an activity of 2.5 units/mg of protein at 45 degrees C. The high activity of the enzyme at 45 degrees C opened, for the first time, a way to directly measure ion transport in an A(1)A(O)-ATP synthase. Therefore, the enzyme was reconstituted into liposomes generated from Escherichia coli lipids. These proteoliposomes were still active at 45 degrees C. and coupled ATP hydrolysis to primary and electrogenic Na+ transport. This is the first proof of Na+ transport by an A(1)A(O)-ATP synthase and these findings are discussed in light of the distribution of the sodium ion binding motif in archaea and the role of Na+ in the bioenergetics of archaea.	[Mayer, Florian; Mueller, Volker] Goethe Univ Frankfurt, Inst Mol Biosci, Mol Microbiol & Bioenerget, D-60438 Frankfurt, Germany; [Lim, Jae Kyu; Kang, Sung Gyun] Korea Inst Ocean Sci & Technol, Anson 426744, South Korea; [Lim, Jae Kyu; Kang, Sung Gyun] Univ Sci & Technol, Dept Marine Biotechnol, Taejon 350333, South Korea; [Langer, Julian D.] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Korea Institute of Ocean Science & Technology (KIOST); Max Planck Society	Muller, V (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Mol Microbiol & Bioenerget, Max von Laue Str 9, D-60438 Frankfurt, Germany.	vmueller@bio.uni-frankfurt.de	Mueller, Volker/ABE-4305-2021	Mueller, Volker/0000-0001-7955-5508; LIM, JAE KYU/0000-0002-9696-9830; Langer, Julian David/0000-0002-5190-577X	Deutsche Forschungsgemeinschaft [SFB807]; ESFRI-Instruct initiative of the European Union; Korea Institute of Ocean Science and Technology [PE99212, PE99263]; Ministry of Oceans and Fisheries	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ESFRI-Instruct initiative of the European Union; Korea Institute of Ocean Science and Technology; Ministry of Oceans and Fisheries	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB807 (to V. M.), a grant from the ESFRI-Instruct initiative of the European Union (to J. D. L.), Korea Institute of Ocean Science and Technology in-house program Grants PE99212 and PE99263 (to S. G. K.), and the program "Development of Biohydrogen Production Technology Using the Hyper-thermophilic Archaea" of the Ministry of Oceans and Fisheries (to S. G. K.).	Bae SS, 2006, J MICROBIOL BIOTECHN, V16, P1826; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braley R, 1997, FEBS LETT, V418, P123, DOI 10.1016/S0014-5793(97)01359-8; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Coskun U, 2004, J BIOENERG BIOMEMBR, V36, P249, DOI 10.1023/B:JOBB.0000031976.44466.6e; Coskun U, 2002, J BIOL CHEM, V277, P17327, DOI 10.1074/jbc.M110407200; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; Deppenmeier Uwe, 2008, V45, P123, DOI 10.1007/400_2006_026; DIMROTH P, 1992, ACTA PHYSIOL SCAND, V146, P97; FENG Y, 1994, J BIOL CHEM, V269, P13224; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gruber G, 2001, BIOCHEMISTRY-US, V40, P1890, DOI 10.1021/bi002195t; Gruber G, 2014, BBA-BIOENERGETICS, V1837, P940, DOI 10.1016/j.bbabio.2014.03.004; HEINONEN JK, 1981, ANAL BIOCHEM, V113, P313, DOI 10.1016/0003-2697(81)90082-8; HEISE R, 1992, EUR J BIOCHEM, V206, P553, DOI 10.1111/j.1432-1033.1992.tb16959.x; Kaim G, 1998, BIOCHEMISTRY-US, V37, P4626, DOI 10.1021/bi973022f; Kim YJ, 2010, NATURE, V467, P352, DOI 10.1038/nature09375; Knol J, 1998, BIOCHEMISTRY-US, V37, P16410, DOI 10.1021/bi981596u; Knol J, 1996, J BIOL CHEM, V271, P15358, DOI 10.1074/jbc.271.26.15358; Koga Y, 2012, ARCHAEA, V2012, DOI 10.1155/2012/789652; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lane N, 2012, CELL, V151, P1406, DOI 10.1016/j.cell.2012.11.050; LAUBINGER W, 1988, BIOCHEMISTRY-US, V27, P7531, DOI 10.1021/bi00419a053; Lemker T, 2003, FEBS LETT, V544, P206, DOI 10.1016/S0014-5793(03)00496-4; Lim JK, 2014, P NATL ACAD SCI USA, V111, P11497, DOI 10.1073/pnas.1407056111; Lim JK, 2012, APPL ENVIRON MICROB, V78, P7393, DOI 10.1128/AEM.01316-12; Lingl A, 2003, EXTREMOPHILES, V7, P249, DOI 10.1007/s00792-003-0318-7; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; Mayer F, 2014, FEMS MICROBIOL REV, V38, P449, DOI 10.1111/1574-6976.12043; Mayer F, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.411223; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; McMillan DGG, 2011, J BIOL CHEM, V286, P39882, DOI 10.1074/jbc.M111.281675; Meier T, 2009, J MOL BIOL, V391, P498, DOI 10.1016/j.jmb.2009.05.082; Muller V, 2005, J MOL MICROB BIOTECH, V10, P167, DOI 10.1159/000091563; Muller V, 2004, J BIOENERG BIOMEMBR, V36, P115, DOI 10.1023/B:JOBB.0000019603.68282.04; Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Pisa KY, 2007, FEMS MICROBIOL LETT, V277, P56, DOI 10.1111/j.1574-6968.2007.00939.x; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Schlegel K, 2012, P NATL ACAD SCI USA, V109, P947, DOI 10.1073/pnas.1115796109; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SPRUTH M, 1995, BBA-BIOENERGETICS, V1229, P96, DOI 10.1016/0005-2728(94)00192-8; vandeVossenberg JLCM, 1995, MOL MICROBIOL, V18, P925, DOI 10.1111/j.1365-2958.1995.18050925.x; Vonck J, 2009, J BIOL CHEM, V284, P10110, DOI 10.1074/jbc.M808498200; WEBER K, 1969, J BIOL CHEM, V244, P4406; Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576	50	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6994	7002		10.1074/jbc.M114.616862	http://dx.doi.org/10.1074/jbc.M114.616862			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25593316	hybrid, Green Published			2022-12-26	WOS:000350991500033
J	Williams, AS; Kang, L; Zheng, J; Grueter, C; Bracy, DP; James, FD; Pozzi, A; Wasserman, DH				Williams, Ashley S.; Kang, Li; Zheng, Jenny; Grueter, Carrie; Bracy, Deanna P.; James, Freyja D.; Pozzi, Ambra; Wasserman, David H.			Integrin alpha 1-null Mice Exhibit Improved Fatty Liver When Fed a High Fat Diet Despite Severe Hepatic Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; ENDOGENOUS GLUCOSE-PRODUCTION; TYROSINE-PHOSPHATASE; GENE-EXPRESSION; NONALCOHOLIC STEATOHEPATITIS; EXTRACELLULAR-MATRIX; RECEPTOR SUBSTRATE-1; DIABETES-MELLITUS; CROSS-TALK; DISEASE	Hepatic insulin resistance is associated with increased collagen. Integrin alpha 1 beta 1 is a collagen-binding receptor expressed on hepatocytes. Here, we show that expression of the alpha 1 subunit is increased in hepatocytes isolated from high fat (HF)-fed mice. To determine whether the integrin al subunit protects against impairments in hepatic glucose metabolism, we analyzed glucose tolerance and insulin sensitivity in Ft-F.-fed integrin alpha 1-null (itgal(-/-)) and wild-type (itga1(+/+)) littermates. Using the insulin clamp, we found that insulin-stimulated hepatic glucose production was suppressed by similar to 50% in HF-fed itgal(+/+) mice. In contrast, it was not suppressed in HF-fed itga1(-/-) mice, indicating severe hepatic insulin resistance. This was associated with decreased hepatic insulin signaling in FIF-fed itgal(-/-) mice. Interestingly, hepatic triglyceride and diglyceride contents were normalized to chow-fed levels in FIF-fed itgal(-/-) mice. This indicates that hepatic steatosis is dissociated from insulin resistance in FIF-fed itgal(-/-) mice. The decrease in hepatic lipid accumulation in HF-fed itgal-1- mice was associated with altered free fatty acid metabolism. These studies establish a role for integrin signaling in facilitating hepatic insulin action while promoting lipid accumulation in mice challenged with a HF diet.	[Williams, Ashley S.; Kang, Li; Zheng, Jenny; Bracy, Deanna P.; James, Freyja D.; Pozzi, Ambra; Wasserman, David H.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Grueter, Carrie] Vanderbilt Univ, Dept Anesthesiol, Nashville, TN 37232 USA; [Pozzi, Ambra] Vanderbilt Univ, Div Nephrol, Dept Med, Nashville, TN 37232 USA; [Wasserman, David H.] Vanderbilt Univ, Mouse Metab Phenotyping Ctr, Nashville, TN 37232 USA; [Pozzi, Ambra] Dept Vet Affairs, Dept Med, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University	Williams, AS (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, 823 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	ashley.s.williams@vanderbilt.edu		Kang, Li/0000-0002-6990-1996; Grueter, Carrie/0000-0002-1913-2527	National Institutes of Health [R37 DK050277, R01 DK054902, U24 DK059637, R01 DK095761, DK20593]; Veterans Affairs Merit Review [1I01BX002025-01]; Vanderbilt Molecular Endocrinology Training Program; NATIONAL CANCER INSTITUTE [R01CA162433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095761, P60DK020593, R37DK050277, P30DK020593, U24DK059637, R01DK054902] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); Vanderbilt Molecular Endocrinology Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants R37 DK050277, R01 DK054902, and U24 DK059637 (to D. H. W.); Grant R01 DK095761 (to A. P.); and Grant DK20593 (to the Vanderbilt Diabetes Research and Training Center). This work was also supported by Veterans Affairs Merit Review 1I01BX002025-01 (to A. P.) and the Vanderbilt Molecular Endocrinology Training Program.	Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Best JD, 1996, DIABETES CARE, V19, P1018, DOI 10.2337/diacare.19.9.1018; Bisht B, 2008, J PHYSIOL-LONDON, V586, P3825, DOI 10.1113/jphysiol.2008.157107; Buque X, 2012, AM J PHYSIOL-ENDOC M, V303, pE504, DOI 10.1152/ajpendo.00653.2011; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Chen XW, 2007, MOL CELL BIOL, V27, P3313, DOI 10.1128/MCB.01476-06; Cheung AT, 2000, DIABETES, V49, P810, DOI 10.2337/diabetes.49.5.810; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; DeFronzo RA, 1996, J DIABETES COMPLICAT, V10, P243, DOI 10.1016/1056-8727(96)00046-3; Dixon LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056100; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; FINEGOOD DT, 1988, DIABETES, V37, P1025, DOI 10.2337/diabetes.37.8.1025; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujita M, 2012, J BIOL CHEM, V287, P12491, DOI 10.1074/jbc.M111.304170; Gardner H, 1996, DEV BIOL, V175, P301, DOI 10.1006/dbio.1996.0116; Guilherme A, 1998, J BIOL CHEM, V273, P22899, DOI 10.1074/jbc.273.36.22899; Guilherme A, 1998, J BIOL CHEM, V273, P33119, DOI 10.1074/jbc.273.50.33119; He JH, 2011, EXP BIOL MED, V236, P1116, DOI 10.1258/ebm.2011.011128; Hepple RT, 2005, FASEB J, V19, P1320, DOI 10.1096/fj.04-3535fje; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jaskiewicz K, 2008, DIGEST DIS SCI, V53, P785, DOI 10.1007/s10620-007-9942-x; Kang L, 2011, DIABETES, V60, P416, DOI 10.2337/db10-1116; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Kuznetsov AV, 2002, ANAL BIOCHEM, V305, P186, DOI 10.1006/abio.2002.5658; Lebrun P, 1998, J BIOL CHEM, V273, P32244, DOI 10.1074/jbc.273.48.32244; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loster K, 2001, BIOCHEM J, V356, P233, DOI 10.1042/0264-6021:3560233; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; MORRISON WR, 1964, J LIPID RES, V5, P600; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; MURTHY VK, 1979, DIABETES, V28, P472, DOI 10.2337/diab.28.5.472; Nejjari M, 2001, J PATHOL, V195, P473, DOI 10.1002/path.964; PEHLING G, 1984, J CLIN INVEST, V74, P985, DOI 10.1172/JCI111519; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Pozzi A, 2000, P NATL ACAD SCI USA, V97, P2202, DOI 10.1073/pnas.040378497; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382; Shi M, 2012, J BIOL CHEM, V287, P35139, DOI 10.1074/jbc.M112.358648; STEELE R, 1956, AM J PHYSIOL, V187, P15, DOI 10.1152/ajplegacy.1956.187.1.15; Stefan N, 2011, DIABETES, V60, P2011, DOI 10.2337/db11-0231; Summers S. A., 2000, INT J OBES RELAT MET, V24; Tonelli J, 2005, CURR OPIN CLIN NUTR, V8, P450, DOI 10.1097/01.mco.0000172588.47811.63; VOLPES R, 1991, GASTROENTEROLOGY, V101, P200, DOI 10.1016/0016-5085(91)90478-4; Vulin AI, 2005, ENDOCRINOLOGY, V146, P3535, DOI 10.1210/en.2004-1386; VUORI K, 1994, SCIENCE, V266, P1576, DOI 10.1126/science.7527156; Wada T, 2013, AM J PHYSIOL-ENDOC M, V305, pE1415, DOI 10.1152/ajpendo.00419.2013; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Zong HH, 2009, J BIOL CHEM, V284, P4679, DOI 10.1074/jbc.M807408200	55	24	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6546	6557		10.1074/jbc.M114.615716	http://dx.doi.org/10.1074/jbc.M114.615716			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25593319	Green Published, hybrid			2022-12-26	WOS:000350732500057
J	Wang, HM; Yan, Q; Yang, T; Cheng, H; Du, J; Yoshioka, K; Kung, SKP; Ding, GH				Wang, Hui-ming; Yan, Qi; Yang, Tao; Cheng, Hui; Du, Juan; Yoshioka, Katsuji; Kung, Sam K. P.; Ding, Guo-hua			Scaffold Protein JLP Is Critical for CD40 Signaling in B Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; AXONAL-TRANSPORT; CYTOPLASMIC DYNEIN; ENDOTHELIAL-CELLS; RAB PROTEINS; ACTIVATION; KINESIN; RECEPTOR; KINASE; JNK	CD40 expression on the surface of B lymphocytes is essential for their biological function and fate decision. The engagement of CD40 with its cognate ligand, CD154, leads to a sequence of cellular events in B lymphocytes, including CD40 cytoplasmic translocation, a temporal and spatial organization of effector molecules, and a cascade of CD40-induced signal transduction. The JLP scaffold protein was expressed in murine B lymphocytes. Using B lymphocytes from jlp-deficient mice, we observed that JLP deficiency resulted in defective CD40 internalization upon CD154/CD40 engagement. Examination of interactions and co-localization among CD40, JLP, dynein, and Rab5 in B lymphocytes suggested that CD40 internalization is a process of JLP-mediated vesicle transportation that depends on Rab5 and dynein. JLP deficiency also diminished CD40-dependent activation of MAPK and JNK, but not NF-kappa B. Inhibiting vesicle transportation from the direction of cell periphery to the cell center by a dynein inhibitor (ciliobrevin D) impaired both CD154-induced CD40 internalization and CD40-dependent MAPK activities in B lymphocytes. Collectively, our data demonstrate a novel role of the JLP scaffold protein in the bridging of CD154-triggered CD40 internalization and CD40-dependent signaling in splenic B lymphocytes.	[Wang, Hui-ming; Yan, Qi; Yang, Tao; Cheng, Hui; Du, Juan; Ding, Guo-hua] Wuhan Univ, Renmin Hosp, Dept Nephrol, Wuhan 430060, Peoples R China; [Kung, Sam K. P.] Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB R3T 2N2, Canada; [Yoshioka, Katsuji] Kanazawa Univ, Canc Res Inst, Dept Mol & Cellular Biol, Div Mol Cell Signaling, Kanazawa, Ishikawa 9200934, Japan	Wuhan University; University of Manitoba; Kanazawa University	Wang, HM (corresponding author), Wuhan Univ, Renmin Hosp, Dept Nephrol, Wuhan 430060, Peoples R China.	wanghuimingwhm@yahoo.com; ghxding@gmail.com	Wang, Huiming/AAU-8981-2021	Wang, Huiming/0000-0002-1706-2342; Wang, Huiming/0000-0002-9344-4609	National Natural Science Foundation of China [81172793, 81370800]; Chongqing Science and Technology Community of Chongqing City [2011BB5028]; Independent Research Project of Wuhan University; National Key Technology R&D Program of China [2011BA110B04]; Canadian Institutes of Health Research/Manitoba Health Research Council Regional Partnership Program Operating Grant [109761]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Community of Chongqing City; Independent Research Project of Wuhan University; National Key Technology R&D Program of China(National Key Technology R&D Program); Canadian Institutes of Health Research/Manitoba Health Research Council Regional Partnership Program Operating Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by National Natural Science Foundation of China Grants 81172793 and 81370800, Chongqing Science and Technology Community of Chongqing City Grant 2011BB5028, the Independent Research Project of Wuhan University, and National Key Technology R&D Program of China Grant 2011BA110B04 (to H. W.) and by Canadian Institutes of Health Research/Manitoba Health Research Council Regional Partnership Program Operating Grant 109761 (to S. K. P. K.).	Anolik J, 2003, EUR J IMMUNOL, V33, P2398, DOI 10.1002/eji.200323515; Arimoto M, 2011, J NEUROSCI, V31, P2216, DOI 10.1523/JNEUROSCI.2653-10.2011; Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Chen JJ, 2007, ARTERIOSCL THROM VAS, V27, P2005, DOI 10.1161/ATVBAHA.107.145961; Chen YL, 2006, BIOCHEM BIOPH RES CO, V345, P106, DOI 10.1016/j.bbrc.2006.04.034; Clippinger AJ, 2012, GENE DEV, V26, P2015, DOI 10.1101/gad.196147.112; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Graham JP, 2010, IMMUNOL REV, V237, P226, DOI 10.1111/j.1600-065X.2010.00932.x; Grassme H, 2002, J IMMUNOL, V168, P298, DOI 10.4049/jimmunol.168.1.298; Grassme H, 2002, J BIOL CHEM, V277, P30289, DOI 10.1074/jbc.M200494200; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; Ikonomov OC, 2009, J BIOL CHEM, V284, P3750, DOI 10.1074/jbc.M806539200; Iwanaga A, 2008, TRANSGENIC RES, V17, P1045, DOI 10.1007/s11248-008-9191-6; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Kashef K, 2005, BIOCHEMISTRY-US, V44, P14090, DOI 10.1021/bi050604l; Kashef K, 2006, J CELL BIOCHEM, V98, P715, DOI 10.1002/jcb.20930; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Kikkawa M, 2013, J CELL BIOL, V202, P15, DOI 10.1083/jcb.201304099; Lee CM, 2002, P NATL ACAD SCI USA, V99, P14189, DOI 10.1073/pnas.232310199; Li YY, 1996, J IMMUNOL, V157, P1440; Manning E, 2002, EUR J IMMUNOL, V32, P39, DOI 10.1002/1521-4141(200201)32:1<39::AID-IMMU39>3.0.CO;2-Y; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Muresan Z, 2005, J NEUROSCI, V25, P3741, DOI 10.1523/JNEUROSCI.0152-05.2005; Nadiri A, 2011, EUR J IMMUNOL, V41, P2358, DOI 10.1002/eji.201041143; Nguyen Q, 2005, J BIOL CHEM, V280, P30185, DOI 10.1074/jbc.M505499200; Pham LV, 2002, IMMUNITY, V16, P37, DOI 10.1016/S1074-7613(01)00258-8; Reyes-Moreno C, 2007, J BIOL CHEM, V282, P19473, DOI 10.1074/jbc.M701076200; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Sakata N, 1995, J BIOL CHEM, V270, P30823, DOI 10.1074/jbc.270.51.30823; Schnyder T, 2011, IMMUNITY, V34, P905, DOI 10.1016/j.immuni.2011.06.001; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Sutherland CL, 1996, J IMMUNOL, V157, P3381; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Wang HM, 2013, IMMUNOBIOLOGY, V218, P835, DOI 10.1016/j.imbio.2012.10.002; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	44	11	16	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5256	5266		10.1074/jbc.M114.618496	http://dx.doi.org/10.1074/jbc.M114.618496			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25586186	Green Published, hybrid			2022-12-26	WOS:000350044200003
J	Patrut, A; Woodborne, S; von Reden, KF; Hall, G; Hofmeyr, M; Lowy, DA; Patrut, RT				Patrut, Adrian; Woodborne, Stephan; von Reden, Karl F.; Hall, Grant; Hofmeyr, Michele; Lowy, Daniel A.; Patrut, Roxana T.			African Baobabs with False Inner Cavities: The Radiocarbon Investigation of the Lebombo Eco Trail Baobab	PLOS ONE			English	Article							PERFORMANCE; CARBON; AGE	The article reports the radiocarbon investigation results of the Lebombo Eco Trail tree, a representative African baobab from Mozambique. Several wood samples collected from the large inner cavity and from the outer part of the tree were investigated by AMS radiocarbon dating. According to dating results, the age values of all samples increase from the sampling point with the distance into the wood. For samples collected from the cavity walls, the increase of age values with the distance into the wood (up to a point of maximum age) represents a major anomaly. The only realistic explanation for this anomaly is that such inner cavities are, in fact, natural empty spaces between several fused stems disposed in a ring-shaped structure. We named them false cavities. Several important differences between normal cavities and false cavities are presented. Eventually, we dated other African baobabs with false inner cavities. We found that this new architecture enables baobabs to reach large sizes and old ages. The radiocarbon date of the oldest sample was 1425 +/- 24 BP, which corresponds to a calibrated age of 1355 +/- 15 yr. The dating results also show that the Lebombo baobab consists of five fused stems, with ages between 900 and 1400 years; these five stems build the complete ring. The ring and the false cavity closed 800-900 years ago. The results also indicate that the stems stopped growing toward the false cavity over the past 500 years.	[Patrut, Adrian] Univ Babes Bolyai, Dept Chem, Fac Chem, R-3400 Cluj Napoca, Romania; [Woodborne, Stephan] iThemba Labs, Somerset West, South Africa; [von Reden, Karl F.] Woods Hole Oceanog Inst, Dept Geol & Geophys, NOSAMS Facil, Woods Hole, MA 02543 USA; [Hall, Grant] Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Hofmeyr, Michele] SANPk Sci Serv, Skukuza, South Africa; [Lowy, Daniel A.] Nova Univ, Alexandria, VA USA; [Patrut, Roxana T.] Univ Babes Bolyai, Fac Biol & Geol, R-3400 Cluj Napoca, Romania	Babes Bolyai University from Cluj; National Research Foundation - South Africa; iThemba LABS; Woods Hole Oceanographic Institution; University of Pretoria; Babes Bolyai University from Cluj	Patrut, A (corresponding author), Univ Babes Bolyai, Dept Chem, Fac Chem, Arany Janos 11, R-3400 Cluj Napoca, Romania.	apatrut@gmail.com	Hall, Grant/J-9886-2016; Patrut, Adrian/C-3566-2012; Lowy, Daniel A/C-3265-2016	Hall, Grant/0000-0002-2164-4900; Patrut, Adrian/0000-0002-9862-6735; Patrut, Roxana/0000-0002-8691-2160; von Reden, Karl/0000-0001-6413-9018	Romanian Ministry of National Education CNCS-UEFISCDI [PN-II-ID-PCE-2013-76]; Directorate For Geosciences [1239667] Funding Source: National Science Foundation	Romanian Ministry of National Education CNCS-UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The research was fully funded by the Romanian Ministry of National Education CNCS-UEFISCDI under grant PN-II-ID-PCE-2013-76. URL:http://uefiscdi.gov.ro/. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adam JG, 1962, NOTES AFRICAINES, V94, P33; BAUM DA, 1995, ANN MO BOT GARD, V82, P440, DOI 10.2307/2399893; Breitenbach F, 1985, J DENDROLOGY, V5, P1; Coates Palgrave K., 2002, TREES SO AFRICA; Esterhuyse N., 2001, REMARKABLE TREES S A; FISHER JB, 1981, IAWA BULL, V2, P193, DOI 10.1163/22941932-90000732; Guy G. L., 1970, Proceedings & Transactions, Rhodesia Scientific Association, Salisbury, V54, P68; Guy GL, 1967, RHODESIANA, V16, P17; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Olsson I.U., 1986, P273; Pakenham T., 2004, REMARKABLE BAOBAB; Patrut A, 2007, TREE PHYSIOL, V27, P1569, DOI 10.1093/treephys/27.11.1569; Patrut A, 2013, NUCL INSTRUM METH B, V294, P622, DOI 10.1016/j.nimb.2012.04.025; Patrut A, 2011, ANN FOREST SCI, V68, P993, DOI 10.1007/s13595-011-0107-x; Patrut A, 2010, RADIOCARBON, V52, P727; Patrut A, 2010, NUCL INSTRUM METH B, V268, P910, DOI 10.1016/j.nimb.2009.10.062; Pettigrew JD, 2012, TAXON, V61, P1240, DOI 10.1002/tax.616006; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Roberts ML, 2010, RADIOCARBON, V52, P228, DOI 10.1017/S0033822200045252; Robertson I, 2006, APPL GEOCHEM, V21, P1674, DOI 10.1016/j.apgeochem.2006.07.005; SOFER Z, 1980, ANAL CHEM, V52, P1389, DOI 10.1021/ac50058a063; Stutchbury R, 2013, THE BAOBAB, DOI [10.1002/jobm.201300390, DOI 10.1002/JOBM.201300390]; SWART ER, 1963, NATURE, V198, P708, DOI 10.1038/198708b0; VOGEL JS, 1984, NUCL INSTRUM METH B, V5, P289, DOI 10.1016/0168-583X(84)90529-9; VONREDEN KF, 1994, NUCL INSTRUM METH B, V92, P7, DOI 10.1016/0168-583X(94)95964-1; Watson R, 2007, THE AFRICAN BAOBAB; WICKENS G E, 1982, Kew Bulletin, V37, P173, DOI 10.2307/4109961; Wickens G.E., 2008, BAOBABS PACHYCAULS A, DOI DOI 10.1007/978-1-4020-6431-9	28	35	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117193	10.1371/journal.pone.0117193	http://dx.doi.org/10.1371/journal.pone.0117193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25621989	Green Published, gold, Green Submitted			2022-12-26	WOS:000348470400021
J	Savage, SR; Bretz, CA; Penn, JS				Savage, Sara R.; Bretz, Colin A.; Penn, John S.			RNA-Seq Reveals a Role for NFAT-Signaling in Human Retinal Microvascular Endothelial Cells Treated with TNF alpha	PLOS ONE			English	Article							PROLIFERATIVE DIABETIC-RETINOPATHY; SMALL ORGANIC-MOLECULES; LARGE GENE LISTS; NUCLEAR FACTOR; T-CELLS; EXPRESSION; ADHESION; DISEASE; INFLAMMATION; INHIBITION	TNF alpha has been identified as playing an important role in pathologic complications associated with diabetic retinopathy and retinal inflammation, such as retinal leukostasis. However, the transcriptional effects of TNF alpha on retinal microvascular endothelial cells and the different signaling pathways involved are not yet fully understood. In the present study, RNA-seq was used to profile the transcriptome of human retinal microvascular endothelial cells (HRMEC) treated for 4 hours with TNF alpha in the presence or absence of the NFAT-specific inhibitor INCA-6, in order to gain insight into the specific effects of TNF alpha on RMEC and identify any involvement of NFAT signaling. Differential expression analysis revealed that TNF alpha treatment significantly upregulated the expression of 579 genes when compared to vehicle-treated controls, and subsequent pathway analysis revealed a TNF alpha-induced enrichment of transcripts associated with cytokine-cytokine receptor interactions, cell adhesion molecules, and leukocyte transendothelial migration. Differential expression analysis comparing TNF alpha-treated cells to those co-treated with INCA-6 revealed 10 genes whose expression was significantly reduced by the NFAT inhibitor, including those encoding the proteins VCAM1 and CX3CL1 and cytokines CXCL10 and CXCL11. This study identifies the transcriptional effects of TNF alpha on HRMEC, highlighting its involvement in multiple pathways that contribute to retinal leukostasis, and identifying a previously unknown role for NFAT-signaling downstream of TNF alpha.	[Savage, Sara R.; Penn, John S.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Bretz, Colin A.; Penn, John S.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Penn, John S.] Vanderbilt Univ, Sch Med, Dept Ophthalmol & Visual Sci, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Penn, JS (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA.	john.penn@vanderbilt.edu		Bretz, Colin/0000-0001-5296-9399	National Eye institute [R01-EY07533, R01-EY023639, P30-EY08126]; National Institute of General Medical Sciences [T32-GM007628]; National Center for Advancing Translational Sciences [UL1-TR000445]; Research to Prevent Blindness, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126, R01EY023639, R01EY007533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007628] Funding Source: NIH RePORTER	National Eye institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from the National Eye institute: R01-EY07533 (JSP) and R01-EY023639 (JSP), the National Institute of General Medical Sciences: T32-GM007628, the National Center for Advancing Translational Sciences: UL1-TR000445, and an unrestricted grant from Research to Prevent Blindness, Inc. The sequencing was performed by the Vanderbilt VANTAGE core which is funded by a grant from the National Eye Institute: P30-EY08126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis AP, 2002, BRIT J OPHTHALMOL, V86, P363, DOI 10.1136/bjo.86.4.363; Alvarez S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016100; Arndt H, 1996, GUT, V38, P911, DOI 10.1136/gut.38.6.911; Bittner S, 2013, NAT MED, V19, P1161, DOI 10.1038/nm.3303; Boss V, 1998, MOL PHARMACOL, V54, P264, DOI 10.1124/mol.54.2.264; Centers for Disease Control and Prevention, 1996, JAMA-J AM MED ASSOC, V276, P1865; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Demircan N, 2006, EYE, V20, P1366, DOI 10.1038/sj.eye.6702138; Funatsu H, 2005, GRAEF ARCH CLIN EXP, V243, P3, DOI 10.1007/s00417-004-0950-7; Graef IA, 2001, P NATL ACAD SCI USA, V98, P5740, DOI 10.1073/pnas.101602398; Guo Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/248090; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang H, 2011, INVEST OPHTH VIS SCI, V52, P1336, DOI 10.1167/iovs.10-5768; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Joussen AM, 2009, MOL VIS, V15, P1418; Kaminuma O, 2008, J IMMUNOL, V180, P319, DOI 10.4049/jimmunol.180.1.319; Kang SH, 2005, J BIOL CHEM, V280, P37698, DOI 10.1074/jbc.M502247200; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lawrence MC, 2011, J BIOL CHEM, V286, P1025, DOI 10.1074/jbc.M110.158675; Li JH, 2003, J IMMUNOL, V171, P1526, DOI 10.4049/jimmunol.171.3.1526; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Murugeswari P, 2008, RETINA-J RET VIT DIS, V28, P817, DOI 10.1097/IAE.0b013e31816576d5; Nilsson LM, 2007, AM J PHYSIOL-CELL PH, V292, pC1167, DOI 10.1152/ajpcell.00590.2005; Patel KD, 1999, J IMMUNOL, V162, P6209; Porter JC, 2008, J IMMUNOL, V180, P1866, DOI 10.4049/jimmunol.180.3.1866; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Roehrl MHA, 2004, P NATL ACAD SCI USA, V101, P7554, DOI 10.1073/pnas.0401835101; Saaddine JB, 2008, ARCH OPHTHALMOL-CHIC, V126, P1740, DOI 10.1001/archopht.126.12.1740; SCHRODER S, 1991, AM J PATHOL, V139, P81; Schweighofer B, 2009, THROMB HAEMOSTASIS, V102, P544, DOI 10.1160/TH08-12-0830; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Xue JP, 2009, PHYSIOL GENOMICS, V38, P42, DOI 10.1152/physiolgenomics.00012.2009; Yarilina A, 2011, P NATL ACAD SCI USA, V108, P1573, DOI 10.1073/pnas.1010030108; Zhang JL, 2010, INT J CLIN EXP MED, V3, P233; Zhang QH, 2013, MOL VIS, V19, P796	39	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116941	10.1371/journal.pone.0116941	http://dx.doi.org/10.1371/journal.pone.0116941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617622	Green Published, gold, Green Submitted			2022-12-26	WOS:000350336000031
J	Tang, Y; Wu, S; Liu, Q; Xie, JY; Zhang, JX; Han, D; Lu, QX; Lu, QJ				Tang, Yong; Wu, Shen; Liu, Qian; Xie, Jiayi; Zhang, Jingxue; Han, Dong; Lu, Qingxian; Lu, Qingjun			Mertk Deficiency Affects Macrophage Directional Migration via Disruption of Cytoskeletal Organization	PLOS ONE			English	Article							FOCAL ADHESION KINASE; RECEPTOR TYROSINE KINASE; RETINAL-PIGMENT EPITHELIUM; ALPHA-V-BETA-5 INTEGRIN; APOPTOTIC CELLS; TYRO-3 FAMILY; LEADING-EDGE; PHAGOCYTOSIS; MOTILITY; ACTIVATION	Mertk belongs to the Tyro3, Axl and Mertk (TAM) family of receptor tyrosine kinases, and plays a pivotal role in regulation of cytoskeletal rearrangement during phagocytosis. Phagocytosis by either professional or non-professional phagocytes is impaired in the Mertk deficient individual. In the present study, we further investigated the effects of Mertk mutation on peritoneal macrophage morphology, attachment, spreading and movement. Mertk-mutated macrophages exhibited decreased attachment, weak spreading, loss of spindle-like body shape and lack of clear leading and trailing edges within the first few hours of culture, as observed by environmental scanning electron microscopy. Time-lapse video photography recording showed that macrophage without Mertk conducted mainly random movement with oscillating swing around the cell body, and lost the directional migration action seen on the WT cells. Western blotting showed a decreased phosphorylation of focal adhesion kinase (FAK). Immunocytochemistry revealed that actin filaments and dynamic protein myosin II failed to concentrate in the leading edge of migrating cells. Microtubules were localized mainly in one side of mutant cell body, with no clear MTOC and associated radial-ly- distributed microtubule bundles, which were clearly evident in the WT cells. Our results suggest that Mertk deficiency affects not only phagocytosis but also cell shape and migration, likely through a common regulatory mechanism on cytoskeletons.	[Tang, Yong; Lu, Qingxian; Lu, Qingjun] Capital Med Univ, Beijing Tong Ren Hosp, Beijing Inst Ophthalmol, Beijing 100069, Peoples R China; [Wu, Shen; Liu, Qian; Zhang, Jingxue; Lu, Qingjun] Capital Med Univ, Beijing Tong Ren Hosp, Beijing Tong Ren Eye Ctr, Beijing 100069, Peoples R China; [Wu, Shen; Liu, Qian; Zhang, Jingxue; Lu, Qingjun] Beijing Ophthalmol & Visual Sci Key Lab, Beijing 100069, Peoples R China; [Xie, Jiayi; Han, Dong] Natl Ctr Nanosci & Technol, Beijing 100190, Peoples R China; [Lu, Qingxian] Univ Louisville, Sch Med, Dept Ophthalmol & Visual Sci, Louisville, KY 40202 USA	Capital Medical University; Capital Medical University; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; University of Louisville	Lu, QX (corresponding author), Capital Med Univ, Beijing Tong Ren Hosp, Beijing Inst Ophthalmol, Beijing 100069, Peoples R China.	q.lu@louisville.edu; biocmu@163.com			National Institutes of Health [R01-EY018830]; National Natural Science Foundation of China [30400229]; Beijing Natural Science Foundation [7093116]; NATIONAL EYE INSTITUTE [R01EY018830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health grant R01-EY018830 (to Qingxian Lu), by National Natural Science Foundation of China 30400229, and Beijing Natural Science Foundation 7093116 (to Qingjun Lu). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akakura S, 2004, EXP CELL RES, V292, P403, DOI 10.1016/j.yexcr.2003.09.011; Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; BHISEY AN, 1971, EXP CELL RES, V64, P419, DOI 10.1016/0014-4827(71)90096-6; CHEUNG HT, 1978, EXP CELL RES, V111, P95, DOI 10.1016/0014-4827(78)90240-9; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Deramaudt TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092059; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Finnemann SC, 2003, ADV EXP MED BIOL, V533, P337; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Ganguly A, 2012, J BIOL CHEM, V287, P43359, DOI 10.1074/jbc.M112.423905; Georgescu MM, 1999, MOL CELL BIOL, V19, P1171; GOLDMAN RD, 1971, J CELL BIOL, V51, P752, DOI 10.1083/jcb.51.3.752; Hall MO, 2003, ADV EXP MED BIOL, V533, P331; Hoshino D, 2013, J CELL SCI, V126, P2979, DOI 10.1242/jcs.079475; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Mahajan NP, 2003, J BIOL CHEM, V278, P42596, DOI 10.1074/jbc.M305817200; MALECH HL, 1977, J CELL BIOL, V75, P666, DOI 10.1083/jcb.75.3.666; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; OSBORN M, 1976, P NATL ACAD SCI USA, V73, P867, DOI 10.1073/pnas.73.3.867; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rogers AEJ, 2012, ONCOGENE, V31, P4171, DOI 10.1038/onc.2011.588; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sieg DJ, 1999, J CELL SCI, V112, P2677; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Strick DJ, 2009, INVEST OPHTH VIS SCI, V50, P2427, DOI 10.1167/iovs.08-3058; Tilghman RW, 2005, J CELL SCI, V118, P2613, DOI 10.1242/jcs.02380; Todt JC, 2004, J LEUKOCYTE BIOL, V75, P705, DOI 10.1189/jlb.0903439; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Wu YM, 2004, CANCER RES, V64, P7311, DOI 10.1158/0008-5472.CAN-04-0972	44	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117787	10.1371/journal.pone.0117787	http://dx.doi.org/10.1371/journal.pone.0117787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617898	gold, Green Submitted, Green Published			2022-12-26	WOS:000350336000046
J	Adolfsson, L; Solymosi, K; Andersson, MX; Keresztes, A; Uddling, J; Schoefs, B; Spetea, C				Adolfsson, Lisa; Solymosi, Katalin; Andersson, Mats X.; Keresztes, Aron; Uddling, Johan; Schoefs, Benoit; Spetea, Cornelia			Mycorrhiza Symbiosis Increases the Surface for Sunlight Capture in Medicago truncatula for Better Photosynthetic Production	PLOS ONE			English	Article							CADMIUM STRESS ALLEVIATION; ARBUSCULAR MYCORRHIZAE; TEMPERATURE RESPONSE; FUNGI; PLANT; GROWTH; PHOSPHORUS; ROOTS; NITROGEN; CARBON	Arbuscular mycorrhizal (AM) fungi play a prominent role in plant nutrition by supplying mineral nutrients, particularly inorganic phosphate (P-i), and also constitute an important carbon sink. AM stimulates plant growth and development, but the underlying mechanisms are not well understood. In this study, Medicago truncatula plants were grown with Rhizophagus irregularis BEG141 inoculum (AM), mock inoculum (control) or with P-i fertilization. We hypothesized that AM stimulates plant growth through either modifications of leaf anatomy or photosynthetic activity per leaf area. We investigated whether these effects are shared with Pi fertilization, and also assessed the relationship between levels of AM colonization and these effects. We found that increased P-i supply by either mycorrhization or fertilization led to improved shoot growth associated with increased nitrogen uptake and carbon assimilation. Both mycorrhized and P-i-fertilized plants had more and longer branches with larger and thicker leaves than the control plants, resulting in an increased photosynthetically active area. AM-specific effects were earlier appearance of the first growth axes and increased number of chloroplasts per cell section, since they were not induced by P-i fertilization. Photosynthetic activity per leaf area remained the same regardless of type of treatment. In conclusion, the increase in growth of mycorrhized and P-i-fertilized Medicago truncatula plants is linked to an increase in the surface for sunlight capture, hence increasing their photosynthetic production, rather than to an increase in the photosynthetic activity per leaf area.	[Adolfsson, Lisa; Andersson, Mats X.; Uddling, Johan; Spetea, Cornelia] Univ Gothenburg, Dept Biol & Environm Sci, S-40530 Gothenburg, Sweden; [Solymosi, Katalin; Keresztes, Aron] Eotvos Lorand Univ, Dept Plant Anat, H-1117 Budapest, Hungary; [Schoefs, Benoit] Univ Le Mans, IUML CNRS FR 3473, LUNAM Univ, Mer Mol Sante MicroMar EA2160, F-72085 Le Mans, France	University of Gothenburg; Eotvos Lorand University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Le Mans Universite	Schoefs, B (corresponding author), Univ Le Mans, IUML CNRS FR 3473, LUNAM Univ, Mer Mol Sante MicroMar EA2160, F-72085 Le Mans, France.	benoit.schoefs@univ-lemans.fr; cornelia.spetea.wiklund@bioenv.gu.se	Schoefs, Benoit/AAE-4010-2019; Andersson, Mats/E-7958-2010; Wiklund, Cornelia Spetea/S-3635-2019	Schoefs, Benoit/0000-0002-7804-8130; Andersson, Mats/0000-0003-4279-6572; Solymosi, Katalin/0000-0001-5246-2547; Uddling, Johan/0000-0003-4893-1915	Swedish Research Council; Carl Tryggers Foundation; Engkvists Stiftelser; Adlebertska Forskningsstiftelser; University of Gothenburg; Ministry of Research and Education of the Republic of France; University of Le Mans; Helge Ax:Son Johnsons Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Tryggers Foundation; Engkvists Stiftelser; Adlebertska Forskningsstiftelser; University of Gothenburg; Ministry of Research and Education of the Republic of France; University of Le Mans; Helge Ax:Son Johnsons Foundation	Research in the C.S. laboratory has been supported by grants from the Swedish Research Council, Carl Tryggers Foundation, Engkvists Stiftelser, Adlebertska Forskningsstiftelser and University of Gothenburg. B.S. acknowledges funding from the Ministry of Research and Education of the Republic of France and the University of Le Mans. C.S. and B.S. also thank the University of Le Mans and the Region "Pays de la Loire" for guest professor and 'chercheur haut niveau' positions. L.A. acknowledges a travel grant from Helge Ax:Son Johnsons Foundation.	Aloui A, 2009, PROTEOMICS, V9, P420, DOI 10.1002/pmic.200800336; Aloui A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-75; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Andersson MX, 2006, PLANT J, V47, P947, DOI 10.1111/j.1365-313X.2006.02844.x; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; Bernacchi CJ, 2001, PLANT CELL ENVIRON, V24, P253, DOI 10.1111/j.1365-3040.2001.00668.x; Bestel-Corre G, 2002, ELECTROPHORESIS, V23, P122, DOI 10.1002/1522-2683(200201)23:1&lt;122::AID-ELPS122&gt;3.0.CO;2-4; Boldt K, 2011, J PLANT PHYSIOL, V168, P1256, DOI 10.1016/j.jplph.2011.01.026; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Brundrett MC, 2002, NEW PHYTOL, V154, P275, DOI 10.1046/j.1469-8137.2002.00397.x; Bucciarelli B, 2006, PLANT PHYSIOL, V142, P207, DOI 10.1104/pp.106.082594; Bucher M, 2007, NEW PHYTOL, V173, P11, DOI 10.1111/j.1469-8137.2006.01935.x; Doidy J, 2012, MOL PLANT, V5, P1346, DOI 10.1093/mp/sss079; DUMASGAUDOT E, 1994, MYCORRHIZA, V4, P215, DOI 10.1007/BF00206783; Dutt S, 2013, SCI HORTIC-AMSTERDAM, V155, P97, DOI 10.1016/j.scienta.2013.03.012; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Fester T., 2008, Plant cell compartments: selected topics, P335; Fusconi A, 2014, ANN BOT-LONDON, V113, P19, DOI 10.1093/aob/mct258; Gong MG, 2013, NEW FOREST, V44, P399, DOI 10.1007/s11056-012-9349-1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harrison MJ, 1999, J EXP BOT, V50, P1013, DOI 10.1093/jexbot/50.suppl_1.1013; Hartwig UA, 2002, J EXP BOT, V53, P1207, DOI 10.1093/jexbot/53.371.1207; Hata S, 2010, INT REV CEL MOL BIO, V281, P1, DOI 10.1016/S1937-6448(10)81001-9; Hewitt E. J., 1966, Technical Communications. Commonwealth Bureau of Horticulture and Plantation Crops, P547; Kaschuk G, 2009, SOIL BIOL BIOCHEM, V41, P1233, DOI 10.1016/j.soilbio.2009.03.005; KRISHNA KR, 1981, NEW PHYTOL, V87, P717, DOI 10.1111/j.1469-8137.1981.tb01706.x; Leigh J, 2009, NEW PHYTOL, V181, P199, DOI 10.1111/j.1469-8137.2008.02630.x; Lendenmann M, 2011, MYCORRHIZA, V21, P689, DOI 10.1007/s00572-011-0371-5; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Lohse S, 2005, PLANT PHYSIOL, V139, P329, DOI 10.1104/pp.105.061457; Louche-Tessandier D, 1999, NEW PHYTOL, V142, P539, DOI 10.1046/j.1469-8137.1999.00408.x; Meddad-Hamza A, 2010, AFR J BIOTECHNOL, V9, P1159; Medlyn BE, 2002, PLANT CELL ENVIRON, V25, P1167, DOI 10.1046/j.1365-3040.2002.00891.x; Moreau D, 2006, PLANT CELL ENVIRON, V29, P1087, DOI 10.1111/j.1365-3040.2005.01483.x; Muller A, 2013, PLANT SOIL, V364, P341, DOI 10.1007/s11104-012-1372-7; Paradi I, 2003, BIOL PLANTARUM, V46, P563, DOI 10.1023/A:1024819729317; Pfeffer PE, 1999, PLANT PHYSIOL, V120, P587, DOI 10.1104/pp.120.2.587; Rai MK, 2008, PLANT BIOSYST, V142, P191, DOI 10.1080/11263500802150225; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; Redecker D, 2013, MYCORRHIZA, V23, P515, DOI 10.1007/s00572-013-0486-y; Rohacek K., 2008, Plant cell compartments: selected topics, P41; Sheng M, 2008, MYCORRHIZA, V18, P287, DOI 10.1007/s00572-008-0180-7; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smith SE, 2011, PLANT PHYSIOL, V156, P1050, DOI 10.1104/pp.111.174581; Solymosi K, 2006, TREE PHYSIOL, V26, P1087, DOI 10.1093/treephys/26.8.1087; STREETER J, 1988, CRIT REV PLANT SCI, V7, P1, DOI 10.1080/07352688809382257; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; Tsimilli-Michael M, 2000, APPL SOIL ECOL, V15, P169, DOI 10.1016/S0929-1393(00)00093-7; VALDERRAMA JC, 1981, MAR CHEM, V10, P109, DOI 10.1016/0304-4203(81)90027-X; Valentine AJ, 2001, SCI HORTIC-AMSTERDAM, V88, P177, DOI 10.1016/S0304-4238(00)00205-3; Verbruggen E, 2013, NEW PHYTOL, V197, P1104, DOI 10.1111/j.1469-8137.2012.04348.x; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Yin L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046206; Zhang QA, 2011, ANN BOT-LONDON, V107, P407, DOI 10.1093/aob/mcq249	55	21	23	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115314	10.1371/journal.pone.0115314	http://dx.doi.org/10.1371/journal.pone.0115314			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615871	gold, Green Published, Green Submitted			2022-12-26	WOS:000349122100009
J	Zhang, JL; Upadhya, D; Lu, L; Reneker, LW				Zhang, Jinglin; Upadhya, Dinesh; Lu, Lin; Reneker, Lixing W.			Fibroblast Growth Factor Receptor 2 (FGFR2) Is Required for Corneal Epithelial Cell Proliferation and Differentiation during Embryonic Development	PLOS ONE			English	Article							LENS-SPECIFIC EXPRESSION; ECTOPIC GLAND INDUCTION; EYE DEVELOPMENT; FACTOR-ALPHA; MOUSE; MORPHOGENESIS; PAX6; EGF; KERATOCAN; CYTOKINE	Fibroblast growth factors (FGFs) play important roles in many aspects of embryonic development. During eye development, the lens and corneal epithelium are derived from the same surface ectodermal tissue. FGF receptor (FGFR)-signaling is essential for lens cell differentiation and survival, but its role in corneal development has not been fully investigated. In this study, we examined the corneal defects in Fgfr2 conditional knockout mice in which Cre expression is activated at lens induction stage by Pax6 P0 promoter. The cornea in LeCre, Fgfr2(loxP/loxP) mice (referred as Fgfr2(CKO)) was analyzed to assess changes in cell proliferation, differentiation and survival. We found that Fgfr2(CKO) cornea was much thinner in epithelial and stromal layer when compared to WT cornea. At embryonic day 12.5-13.5 (E12.5-13.5) shortly after the lens vesicle detaches from the overlying surface ectoderm, cell proliferation (judged by labeling indices of Ki-67, BrdU and phospho-histone H3) was significantly reduced in corneal epithelium in Fgfr2(CKO) mice. At later stage, cell differentiation markers for corneal epithelium and underlying stromal mesenchyme, keratin-12 and keratocan respectively, were not expressed in Fgfr2(CKO) cornea. Furthermore, Pax6, a transcription factor essential for eye development, was not present in the Fgfr2(CKO) mutant corneal epithelial at E16.5 but was expressed normally at E12.5, suggesting that FGFR2-signaling is required for maintaining Pax6 expression in this tissue. Interestingly, the role of FGFR2 in corneal epithelial development is independent of ERK1/2-signaling. In contrast to the lens, FGFR2 is not required for cell survival in cornea. This study demonstrates for the first time that FGFR2 plays an essential role in controlling cell proliferation and differentiation, and maintaining Pax6 levels in corneal epithelium via ERK-independent pathways during embryonic development.	[Zhang, Jinglin; Lu, Lin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Upadhya, Dinesh; Reneker, Lixing W.] Univ Missouri, Mason Eye Inst, Dept Ophthalmol, Columbia, MO 65211 USA	Sun Yat Sen University; University of Missouri System; University of Missouri Columbia	Reneker, LW (corresponding author), Univ Missouri, Mason Eye Inst, Dept Ophthalmol, Columbia, MO 65211 USA.	renekerl@health.missouri.edu	Upadhya, Dinesh/I-1224-2019; Upadhya, Dinesh/GOV-6410-2022	Upadhya, Dinesh/0000-0003-0673-9765; Upadhya, Dinesh/0000-0003-0673-9765	International Program of Project 985 (Sun Yat-Sen University, China); NIH [EY13146, EY14795]; Research to Prevent Blindness (RPB); NATIONAL EYE INSTITUTE [R24EY014795, R01EY013146] Funding Source: NIH RePORTER	International Program of Project 985 (Sun Yat-Sen University, China); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	JZ was supported by International Program of Project 985 (Sun Yat-Sen University, China). LWR was supported by NIH EY13146. This work was also supported by NIH minicore grant EY14795 and unrestricted funding from Research to Prevent Blindness (RPB) to the Department of Ophthalmology at University of Missouri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen JL, 1998, CURR EYE RES, V17, P79; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Burgess D, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-13; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Carrington LM, 2005, J CATARACT REFR SURG, V31, P412, DOI 10.1016/j.jcrs.2004.04.072; Chandrasekher G, 2001, EXP EYE RES, V73, P191, DOI 10.1006/exer.2001.1026; Chikama T, 2008, AM J PATHOL, V172, P638, DOI 10.2353/ajpath.2008.070897; Collinson JM, 2003, DEV BIOL, V255, P303, DOI 10.1016/S0012-1606(02)00095-7; Cvekl A, 2004, BIOESSAYS, V26, P374, DOI 10.1002/bies.20009; Davis J, 2003, J CELL SCI, V116, P2157, DOI 10.1242/jcs.00441; deIongh RU, 1997, INVEST OPHTH VIS SCI, V38, P1688; Dora NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109193; Faber SC, 2001, DEVELOPMENT, V128, P4425; FINCH PW, 1995, DEV DYNAM, V203, P223, DOI 10.1002/aja.1002030210; FROMM L, 1994, MOL CELL BIOL, V14, P6743, DOI 10.1128/MCB.14.10.6743; Garcia CM, 2005, DEV DYNAM, V233, P516, DOI 10.1002/dvdy.20356; Govindarajan V, 2000, DEV BIOL, V225, P188, DOI 10.1006/dbio.2000.9812; Graw J, 2010, CURR TOP DEV BIOL, V90, P343, DOI 10.1016/S0070-2153(10)90010-0; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Hay E D, 1979, Curr Top Eye Res, V1, P1; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Huang J, 2009, DEVELOPMENT, V136, P1741, DOI 10.1242/dev.034082; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Kao WWY, 2008, OCUL SURF, V6, P9; Koroma BM, 1997, INVEST OPHTH VIS SCI, V38, P108; Li CL, 2001, DEV DYNAM, V222, P471, DOI 10.1002/dvdy.1205; Li DQ, 1997, J CELL PHYSIOL, V172, P361, DOI 10.1002/(SICI)1097-4652(199709)172:3<361::AID-JCP10>3.0.CO;2-9; LI DQ, 1995, J CELL PHYSIOL, V163, P61, DOI 10.1002/jcp.1041630108; Li DQ, 1996, INVEST OPHTH VIS SCI, V37, P2068; Li SX, 2007, INVEST OPHTH VIS SCI, V48, P3292, DOI 10.1167/iovs.06-1482; Liu CY, 1998, J BIOL CHEM, V273, P22584, DOI 10.1074/jbc.273.35.22584; Liu JJ, 1999, EXP EYE RES, V68, P295, DOI 10.1006/exer.1998.0593; Lovicu FJ, 1999, MECH DEVELOP, V88, P43, DOI 10.1016/S0925-4773(99)00169-0; Makarenkova HP, 2000, DEVELOPMENT, V127, P2563; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Mort RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028895; OGUIN WM, 1987, CURR TOP DEV BIOL, V22, P97; Ornitz DM, 2001, GENOME BIOL, V2; Ou JX, 2010, INVEST OPHTH VIS SCI, V51, P1415, DOI 10.1167/iovs.09-4023; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Ramaesh T, 2003, INVEST OPHTH VIS SCI, V44, P1871, DOI 10.1167/iovs.02-0576; Reneker LW, 2000, DEVELOPMENT, V127, P533; Robinson ML, 2006, SEMIN CELL DEV BIOL, V17, P726, DOI 10.1016/j.semcdb.2006.10.002; Robinson ML, 1998, DEV BIOL, V198, P13, DOI 10.1016/S0012-1606(98)80026-2; Saika S, 2001, DEV BIOL, V240, P419, DOI 10.1006/dbio.2001.0480; SOTOZONO C, 1995, INVEST OPHTH VIS SCI, V36, P1524; Tanifuji-Terai N, 2006, INVEST OPHTH VIS SCI, V47, P545, DOI 10.1167/iovs.05-1182; Upadhya D, 2013, DEVELOPMENT, V140, P1573, DOI 10.1242/dev.081042; WATANABE K, 1987, INVEST OPHTH VIS SCI, V28, P205; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; WILSON SE, 1994, EXP EYE RES, V59, P665, DOI 10.1006/exer.1994.1152; WILSON SE, 1993, INVEST OPHTH VIS SCI, V34, P2544; Xie LK, 2006, DEV BIOL, V298, P403, DOI 10.1016/j.ydbio.2006.06.045; Yanai R, 2006, EXP EYE RES, V83, P76, DOI 10.1016/j.exer.2005.10.033; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhang Y, 2007, MOL VIS, V13, P2289; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz; ZIESKE JD, 1993, J CELL SCI, V106, P145	59	28	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117089	10.1371/journal.pone.0117089	http://dx.doi.org/10.1371/journal.pone.0117089			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615698	Green Published, Green Submitted, gold			2022-12-26	WOS:000349122100055
J	Kainz, P; Mayrhofer-Reinhartshuber, M; Ahammer, H				Kainz, Philipp; Mayrhofer-Reinhartshuber, Michael; Ahammer, Helmut			IQM: An Extensible and Portable Open Source Application for Image and Signal Analysis in Java	PLOS ONE			English	Article							OPEN-SOURCE SOFTWARE; PHYSIOLOGICAL TIME-SERIES; FRACTAL CHARACTERIZATION; FREQUENCY-ANALYSIS; CLASSIFICATION; PLATFORM; ENTROPY; REGISTRATION; DIMENSIONS; ALGORITHM	Image and signal analysis applications are substantial in scientific research. Both open source and commercial packages provide a wide range of functions for image and signal analysis, which are sometimes supported very well by the communities in the corresponding fields. Commercial software packages have the major drawback of being expensive and having undisclosed source code, which hampers extending the functionality if there is no plugin interface or similar option available. However, both variants cannot cover all possible use cases and sometimes custom developments are unavoidable, requiring open source applications. In this paper we describe IQM, a completely free, portable and open source (GNU GPLv3) image and signal analysis application written in pure Java. IQM does not depend on any natively installed libraries and is therefore runnable out-of-the-box. Currently, a continuously growing repertoire of 50 image and 16 signal analysis algorithms is provided. The modular functional architecture based on the three-tier model is described along the most important functionality. Extensibility is achieved using operator plugins, and the development of more complex workflows is provided by a Groovy script interface to the JVM. We demonstrate IQM's image and signal processing capabilities in a proof-of-principle analysis and provide example implementations to illustrate the plugin framework and the scripting interface. IQM integrates with the popular ImageJ image processing software and is aiming at complementing functionality rather than competing with existing open source software. Machine learning can be integrated into more complex algorithms via the WEKA software package as well, enabling the development of transparent and robust methods for image and signal analysis.	[Kainz, Philipp; Mayrhofer-Reinhartshuber, Michael; Ahammer, Helmut] Med Univ Graz, Ctr Physiol Med, Inst Biophys, Graz, Austria	Medical University of Graz	Ahammer, H (corresponding author), Med Univ Graz, Ctr Physiol Med, Inst Biophys, Graz, Austria.	helmut.ahammer@medunigraz.at		Ahammer, Helmut/0000-0001-5400-294X				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; AGUILAR M, 1993, J MICROSC-OXFORD, V172, P233, DOI 10.1111/j.1365-2818.1993.tb03417.x; Ahammer H, 2008, PHYSICA D, V237, P446, DOI 10.1016/j.physd.2007.09.016; Ahammer H, 2005, CHAOS SOLITON FRACT, V26, P707, DOI 10.1016/j.chaos.2005.01.050; Ahammer H, 2004, CHAOS, V14, P183, DOI 10.1063/1.1638947; Ahammer H, 2012, FRACTALS, V20, P281, DOI 10.1142/S0218348X12500260; Ahammer H, 2011, CHAOS SOLITON FRACT, V44, P86, DOI 10.1016/j.chaos.2010.12.004; AHAMMER H, 2010, IMAGEJ US DEV C 2010; AHAMMER H, 2011, HIGUCHI DIMENSION DI; Ahonen T, 2004, LECT NOTES COMPUT SC, V3021, P469; ANGUIANO E, 1993, J MICROSC-OXFORD, V172, P223, DOI 10.1111/j.1365-2818.1993.tb03416.x; Arganda-Carreras I, 2006, LECT NOTES COMPUT SC, V4241, P85; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Barboriak DP, 2005, J DIGIT IMAGING, V18, P91, DOI 10.1007/s10278-004-1879-4; Barnsley M, 1993, FRACTALS EVERYWHERE; Bishop Christopher M., 2006, PATTERN RECOGNITION; Bonaccorsi A, 2003, RES POLICY, V32, P1243, DOI 10.1016/S0048-7333(03)00051-9; Bradski G., 2000, DOBBS J SOFTWARE TOO; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Carpenter AE, 2012, NAT METHODS, V9, P666, DOI 10.1038/nmeth.2073; DANIELSSON PE, 1980, COMPUT VISION GRAPH, V14, P227, DOI 10.1016/0146-664X(80)90054-4; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Eckerson W, 1995, OPEN INFORM SYST, V3, P46; Eliceiri KW, 2012, NAT METHODS, V9, P697, DOI [10.1038/nmeth.2084, 10.1038/NMETH.2084]; Eliceiri KW, 2005, PHOTOCHEM PHOTOBIOL, V81, P1116, DOI 10.1562/2004-11-22-IR-377; FUCHS TJ, 2010, THESIS SWISS FEDERAL; Gallego MD, 2008, COMPUT HUM BEHAV, V24, P2199, DOI 10.1016/j.chb.2007.10.006; Gamma E., 1994, DESIGN PATTERNS ELEM; Gering E, 2004, J PARASITOL, V90, P879, DOI 10.1645/GE-222R; Gonzalez R.C., 2008, DIGITAL IMAGE PROCES; Hajnal JV, 2001, MED IMAGE REGISTRATI; Hall M., 2009, ACM SIGKDD EXPLOR NE, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; HENON M, 1976, COMMUN MATH PHYS, V50, P69, DOI 10.1007/BF01608556; Henriksson J, 2013, NAT METHODS, V10, P454, DOI 10.1038/nmeth.2478; Hibbard B, 2003, COMPUT GRAPHICS-US, V37, P5, DOI 10.1145/941552.941556; Janamanchi B, 2009, INT J MED INFORM, V78, P457, DOI 10.1016/j.ijmedinf.2009.02.006; JIN XC, 1995, PATTERN RECOGN LETT, V16, P457, DOI 10.1016/0167-8655(94)00119-N; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; KARPERIEN A, 1999, FRACLAC FOR IMAGEJ; KOENIG D, 2007, GROOVY IN ACTION; KOVACS G, 2010, P INT C MULT MM 10 A, P1489, DOI DOI 10.1145/1873951.1874255; Kumar N, 2005, SIAM PROC S, P531; Lake DE, 2006, IEEE T BIO-MED ENG, V53, P21, DOI 10.1109/TBME.2005.859782; Lake DE, 2011, AM J PHYSIOL-HEART C, V300, pH319, DOI 10.1152/ajpheart.00561.2010; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; LIEBOVITCH LS, 1989, PHYS LETT A, V141, P386, DOI 10.1016/0375-9601(89)90854-2; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Lu W, 2006, MED PHYS, V33, P3634, DOI 10.1118/1.2348764; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; Mandelbrot BB, 1983, FRACTAL GEOMETRY NAT; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Rasband W.S., 1997, IMAGEJ; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rueden C, 2004, TRAFFIC, V5, P411, DOI 10.1111/j.1600-0854.2004.00189.x; SARKAR N, 1995, SIGNAL PROCESS, V42, P181, DOI 10.1016/0165-1684(94)00126-K; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuffler Peter J, 2013, J Pathol Inform, V4, pS2, DOI 10.4103/2153-3539.109804; Shelhamer M, 2007, NONLINEAR DYNAMICS IN PHYSIOLOGY: A STATE-SPACE APPROACH, P1; Sprott JC, 2003, CHAOS TIME SERIES AN; Subramaniam C, 2009, DECIS SUPPORT SYST, V46, P576, DOI 10.1016/j.dss.2008.10.005; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; VOKES MS, 2008, CURRENT PROTOCOLS MO, P1; Yoo TS, 2002, STUD HEALTH TECHNOL, V85, P586; Zenil H, 2012, COMPLEXITY, V17, P26, DOI 10.1002/cplx.20388	72	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116329	10.1371/journal.pone.0116329	http://dx.doi.org/10.1371/journal.pone.0116329			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25612319	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000348562900012
J	Oliveira, U; Brescovit, AD; Santos, AJ				Oliveira, Ubirajara; Brescovit, Antonio D.; Santos, Adalberto J.			Delimiting Areas of Endemism through Kernel Interpolation	PLOS ONE			English	Article							BRAZILIAN ATLANTIC FOREST; PARSIMONY ANALYSIS; BIOGEOGRAPHY; DIVERSITY; PHYLOGEOGRAPHY; BIODIVERSITY; PATTERNS; AMAZON; DIVERSIFICATION; DISTRIBUTIONS	We propose a new approach for identification of areas of endemism, the Geographical Interpolation of Endemism (GIE), based on kernel spatial interpolation. This method differs from others in being independent of grid cells. This new approach is based on estimating the overlap between the distribution of species through a kernel interpolation of centroids of species distribution and areas of influence defined from the distance between the centroid and the farthest point of occurrence of each species. We used this method to delimit areas of endemism of spiders from Brazil. To assess the effectiveness of GIE, we analyzed the same data using Parsimony Analysis of Endemism and NDM and compared the areas identified through each method. The analyses using GIE identified 101 areas of endemism of spiders in Brazil GIE demonstrated to be effective in identifying areas of endemism in multiple scales, with fuzzy edges and supported by more synendemic species than in the other methods. The areas of endemism identified with GIE were generally congruent with those identified for other taxonomic groups, suggesting that common processes can be responsible for the origin and maintenance of these biogeographic units.	[Oliveira, Ubirajara; Santos, Adalberto J.] Univ Fed Minas Gerais, Dept Zool, Belo Horizonte, MG, Brazil; [Brescovit, Antonio D.] Inst Butantan, Lab Especial Colecoes Zool, Sao Paulo, Brazil	Universidade Federal de Minas Gerais; Instituto Butantan	Oliveira, U (corresponding author), Univ Fed Minas Gerais, Dept Zool, Belo Horizonte, MG, Brazil.	ubiologia@yahoo.com.br	Brescovit, Antonio/B-5215-2016; Santos, Adalberto J/H-8349-2012; BRESCOVIT, ANTONIO/Y-1169-2019	Brescovit, Antonio/0000-0002-1511-5324; Santos, Adalberto J/0000-0002-0010-346X; 	FAPEMIG [PPM-00335-13]; CAPES; CNPq [301776/2004-0, 475179/2012-9, 308072/2012-0]; FAPESP [2011/50689-0]; Instituto Nacional de Ciencia e Tecnologia dos Hymenoptera Parasitoides da Regiao Sudeste Brasileira	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Ciencia e Tecnologia dos Hymenoptera Parasitoides da Regiao Sudeste Brasileira	This study was sponsored by a FAPEMIG and CAPES graduate fellowships to UO and by research grants from CNPq (301776/2004-0) and FAPESP (2011/50689-0) to ADB; and CNPq (475179/2012-9, 308072/2012-0), FAPEMIG (PPM-00335-13) and Instituto Nacional de Ciencia e Tecnologia dos Hymenoptera Parasitoides da Regiao Sudeste Brasileira (http://www.hympar.ufscar.br/) to AJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagesen L, 2013, J BIOGEOGR, V40, P2011, DOI 10.1111/jbi.12172; AXELIUS B, 1991, CLADISTICS, V7, P197, DOI 10.1111/j.1096-0031.1991.tb00032.x; Bailey T, 1995, INTERACTIVE SPATIAL; Bell JR, 2005, B ENTOMOL RES, V95, P69, DOI 10.1079/BER2004350; Bridgewater S, 2004, BIODIVERS CONSERV, V13, P2295, DOI 10.1023/B:BIOC.0000047903.37608.4c; Brunes TO, 2010, MOL PHYLOGENET EVOL, V57, P1120, DOI 10.1016/j.ympev.2010.08.026; Cabanne GS, 2011, BIOL J LINN SOC, V103, P801, DOI 10.1111/j.1095-8312.2011.01678.x; Cabanne GS, 2008, MOL PHYLOGENET EVOL, V49, P760, DOI 10.1016/j.ympev.2008.09.013; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Costa LP, 2000, BIOTROPICA, V32, P872; Cracraft J, 1985, ORNITHOLOGICAL MONOG, V36, P49, DOI DOI 10.2307/40168278; Crisci J. V., 2003, HIST BIOGEOGRAPHY IN; Crother BI, 2011, J BIOGEOGR, V38, P1009, DOI 10.1111/j.1365-2699.2011.02483.x; da Silva JMC, 2004, GLOBAL ECOL BIOGEOGR, V13, P85, DOI 10.1111/j.1466-882X.2004.00077.x; de Moraes-Barros N, 2006, GENETICA, V126, P189, DOI 10.1007/s10709-005-1448-x; Deo AJ, 2006, J BIOGEOGR, V33, P1511, DOI 10.1111/j.1365-2699.2006.01559.x; Duffey E., 1997, P 17 EUR C AR ED; Ferretti N, 2014, J INSECT CONSERV, V18, P1087, DOI 10.1007/s10841-014-9718-5; Fouquet A, 2012, MOL PHYLOGENET EVOL, V65, P547, DOI 10.1016/j.ympev.2012.07.012; Gamble T, 2012, MOL PHYLOGENET EVOL, V62, P943, DOI 10.1016/j.ympev.2011.11.033; Garcia-Barros E, 2002, J BIOGEOGR, V29, P109, DOI 10.1046/j.1365-2699.2002.00653.x; Gillespie RG, 2013, SPIDER RES 21 CENTUR, P154; Goldani A., 2006, Braz. J. Biol., V66, P61, DOI 10.1590/S1519-69842006000100009; Goloboff P. A., 2005, NDM VNDM VER 2 5 PRO; Goloboff P, 2008, CLADISTICS, V24, P91; Guo DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072352; Haffer J., 2002, Estud. av., V16, P175, DOI 10.1590/S0103-40142002000300014; Haffer J., 1985, Ornithological Monographs, P113; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HAROLD AS, 1994, SYST BIOL, V43, P261, DOI 10.2307/2413466; Harris MB, 2005, CONSERV BIOL, V19, P714, DOI 10.1111/j.1523-1739.2005.00708.x; HOORN C, 1993, PALAEOGEOGR PALAEOCL, V105, P267, DOI 10.1016/0031-0182(93)90087-Y; Hopkins MJG, 2007, J BIOGEOGR, V34, P1400, DOI 10.1111/j.1365-2699.2007.01737.x; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Linder HP, 2001, SYST BIOL, V50, P892, DOI 10.1080/106351501753462867; Lowenberg-Neto P, 2009, J BIOGEOGR, V36, P1750, DOI 10.1111/j.1365-2699.2009.02112.x; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; Moline PM, 2006, J BIOGEOGR, V33, P47, DOI 10.1111/j.1365-2699.2005.01369.x; MORRONE JJ, 1994, SYST BIOL, V43, P438, DOI 10.2307/2413679; NELSON BW, 1990, NATURE, V345, P714, DOI 10.1038/345714a0; Nelson G., 1981, SYSTEMATICS BIOGEORA; OLIVEIRA U., 2011, DIVERSIDADE BIOGEOGR; Pellegrino KCM, 2005, BIOL J LINN SOC, V85, P13, DOI 10.1111/j.1095-8312.2005.00472.x; Platnick N. I., 2013, WORLD SPIDER CATALOG; Platnick NI, 1991, AUSTR SYSTEMATIC BOT; Porto TJ, 2013, DIVERS DISTRIB, V19, P330, DOI 10.1111/j.1472-4642.2012.00944.x; Porzecanski AL, 2005, J BIOGEOGR, V32, P261, DOI 10.1111/j.1365-2699.2004.01138.x; Posadas P, 2001, CONSERV BIOL, V15, P1325, DOI 10.1046/j.1523-1739.2001.99404.x; Rasanen ME, 1990, TERRA NOVA, V2, P320, DOI 10.1111/j.1365-3121.1990.tb00084.x; Rasanen ME, 1996, SCIENCE, V273, P124, DOI 10.1126/science.273.5271.124; Rosen B.R., 1988, P437; SAADI A, 1993, GEONOMOS, V1, P1, DOI DOI 10.18285/GEONOMOS.V1I1E2.233; Santos JC, 2011, TROP CONSERV SCI, V4, P276, DOI 10.1177/194008291100400306; Nihei SS, 2006, J BIOGEOGR, V33, P2099, DOI 10.1111/j.1365-2699.2006.01619.x; Sigrist Mário Sérgio, 2008, Biota Neotrop., V8, P0, DOI 10.1590/S1676-06032008000400002; Silva SM, 2012, BIOL J LINN SOC, V107, P39, DOI 10.1111/j.1095-8312.2012.01919.x; Soderstrom T. R, 1988, P WORKSH NEOTR DISTR, P121; Szumik CA, 2002, SYST BIOL, V51, P806, DOI 10.1080/10635150290102483; Szumik CA, 2004, SYST BIOL, V53, P968, DOI 10.1080/10635150490888859; Thome MTC, 2010, MOL PHYLOGENET EVOL, V55, P1018, DOI 10.1016/j.ympev.2010.02.003; Townsend Peterson A., 1998, Diversity & Distributions, V4, P189, DOI 10.1046/j.1472-4642.1998.00021.x; TYLER HA, 1994, SWALLOWTAIL BUTTERFL	64	46	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116673	10.1371/journal.pone.0116673	http://dx.doi.org/10.1371/journal.pone.0116673			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611971	Green Submitted, gold, Green Published			2022-12-26	WOS:000348562900019
J	Guenard, F; Lamontagne, M; Bosse, Y; Deshaies, Y; Cianflone, K; Kral, JG; Marceau, P; Vohl, MC				Guenard, Frederic; Lamontagne, Maxime; Bosse, Yohan; Deshaies, Yves; Cianflone, Katherine; Kral, John G.; Marceau, Picard; Vohl, Marie-Claude			Influences of Gestational Obesity on Associations between Genotypes and Gene Expression Levels in Offspring following Maternal Gastrointestinal Bypass Surgery for Obesity	PLOS ONE			English	Article							WHITE ADIPOSE-TISSUE; BODY-MASS INDEX; WEIGHT-LOSS; METABOLIC SYNDROME; PRENATAL EXPOSURE; ENZYME EXPRESSION; RISK-FACTORS; METHYLATION; COMPONENTS; VARIANTS	Maternal obesity and excess gestational weight gain with compromised metabolic fitness predispose offspring to lifelong obesity and its comorbidities. We demonstrated that compared to offspring born before maternal gastrointestinal bypass surgery (BMS) those born after (AMS) were less obese, with less cardiometabolic risk reflected in the expression and methylation of diabetes, immune and inflammatory pathway genes. Here we examine relationships between gestational obesity and offspring gene variations on expression levels. Methods Whole-genome genotyping and gene expression analyses in blood of 22 BMS and 23 AMS offspring from 19 mothers were conducted using Illumina HumanOmni-5-Quad and HumanHT-12 v4 Expression BeadChips, respectively. Using PLINK we analyzed interactions between offspring gene variations and maternal surgical status on offspring gene expression levels. Altered biological functions and pathways were identified and visualized using DAVID and Ingenuity Pathway Analysis. Results Significant interactions (p <= 1.22x10(-12)) were found for 525 among the 16,060 expressed transcripts: 1.9% of tested SNPs were involved. Gene function and pathway analysis demonstrated enrichment of transcription and of cellular metabolism functions and overrepresentation of cellular stress and signaling, immune response, inflammation, growth, proliferation and development pathways. Conclusion We suggest that impaired maternal gestational metabolic fitness interacts with offspring gene variations modulating gene expression levels, providing potential mechanisms explaining improved cardiometabolic risk profiles of AMS offspring related to ameliorated maternal lipid and carbohydrate metabolism.	[Guenard, Frederic; Vohl, Marie-Claude] Univ Laval, Inst Nutr & Funct Foods INAF, Quebec City, PQ G1K 7P4, Canada; [Guenard, Frederic; Vohl, Marie-Claude] Univ Laval, Dept Food Sci & Nutr, Quebec City, PQ G1K 7P4, Canada; [Guenard, Frederic; Vohl, Marie-Claude] CHU, Quebec Res Ctr, Quebec City, PQ, Canada; [Lamontagne, Maxime; Bosse, Yohan; Deshaies, Yves; Cianflone, Katherine; Marceau, Picard] Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Bosse, Yohan] Univ Laval, Dept Mol Med, Quebec City, PQ G1K 7P4, Canada; [Deshaies, Yves; Cianflone, Katherine] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Kral, John G.] Suny Downstate Med Ctr, Dept Surg, Brooklyn, NY 11203 USA; [Marceau, Picard] Univ Laval, Dept Surg, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University; Quebec Heart & Lung Institute; Laval University; Laval University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Laval University	Vohl, MC (corresponding author), Univ Laval, Inst Nutr & Funct Foods INAF, Quebec City, PQ G1K 7P4, Canada.	marie-claude.vohl@fsaa.ulaval.ca	Vohl, Marie-Claude/AAQ-1378-2021	Vohl, Marie-Claude/0000-0002-7017-5848; Lamontagne, Maxime/0000-0001-6674-4983	Canadian Institutes of Health Research [CIHR MOP-209380]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Canadian Institutes of Health Research (CIHR MOP-209380; http://www.cihr-irsc.gc.ca). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaradhi Maria Z., 2011, Frontiers in Genetics, V2, P27, DOI 10.3389/fgene.2011.00027; Arim RG, 2007, CAN J PUBLIC HEALTH, V98, P91, DOI 10.1007/BF03404316; Baik JH, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00152; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berisha SZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016729; Blazejczyk M., 2007, FLEXARRAY STAT DATA; Borengasser SJ, 2013, ENDOCRINOLOGY, V154, P4113, DOI 10.1210/en.2012-2255; Botden IPG, 2012, DIABETES CARE, V35, P424, DOI 10.2337/dc11-1203; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cannon MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090335; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Clement K, 2004, FASEB J, V18, P1657, DOI 10.1096/fj.04-2204com; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Dabelea D, 2008, DIABETES CARE, V31, P1422, DOI 10.2337/dc07-2417; De Rooij SR, 2006, DIABETES CARE, V29, P1052, DOI 10.2337/dc05-1993; DELLORM, 2013, INT J OBES LOND, V37, P914, DOI DOI 10.1038/IJO.2013.35; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Edlow AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088661; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Gerrits A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000692; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Guenard F, 2013, P NATL ACAD SCI USA, V110, P11439, DOI 10.1073/pnas.1216959110; Guenard F, 2013, J OBES, V2013, DOI 10.1155/2013/492170; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; Hochner H, 2012, CIRCULATION, V125, P1381, DOI 10.1161/CIRCULATIONAHA.111.070060; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kitamoto A, 2013, ENDOCR J, V60, P991, DOI 10.1507/endocrj.EJ13-0100; Kotlarz D, 2012, GASTROENTEROLOGY, V143, P347, DOI 10.1053/j.gastro.2012.04.045; Kral JG, 2004, SURGERY, V135, P48, DOI 10.1016/j.surg.2003.10.003; Kral JG, 2006, PEDIATRICS, V118, pE1644, DOI 10.1542/peds.2006-1379; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Ledue TB, 1998, ANN CLIN BIOCHEM, V35, P745, DOI 10.1177/000456329803500607; Lee W, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-40; Ma J, 2007, ATHEROSCLEROSIS, V191, P63, DOI 10.1016/j.atherosclerosis.2006.05.032; Moran CJ, 2013, INFLAMM BOWEL DIS, V19, P115, DOI 10.1002/ibd.22974; Moschen AR, 2010, GUT, V59, P1259, DOI 10.1136/gut.2010.214577; Murabayashi N, 2013, EUR J OBSTET GYN R B, V169, P39, DOI 10.1016/j.ejogrb.2013.02.003; *NAT CTR HLTH STAT, 2007, NHANES 3 CLIN GROWTH; Nicholas LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084594; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; O'Shaughnessy PJ, 2013, MOL HUM REPROD, V19, P177, DOI 10.1093/molehr/gas059; O'Shaughnessy PJ, 2011, J CLIN ENDOCR METAB, V96, P2851, DOI 10.1210/jc.2011-1437; Palmer ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029202; Park HK, 2013, MOL BIOL REP, V40, P1785, DOI 10.1007/s11033-012-2232-5; Park JJ, 2006, PHYSIOL GENOMICS, V27, P114, DOI 10.1152/physiolgenomics.00045.2006; Paus T, 2012, CEREB CORTEX, V22, P2634, DOI 10.1093/cercor/bhr350; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rudkowska I, 2011, OMICS, V15, P1, DOI 10.1089/omi.2010.0073; Scopinaro N, 2005, DIABETES CARE, V28, P2406, DOI 10.2337/diacare.28.10.2406; Shankar K, 2011, ENDOCRINOLOGY, V152, P4158, DOI 10.1210/en.2010-1078; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; Smith J, 2009, J CLIN ENDOCR METAB, V94, P4275, DOI 10.1210/jc.2009-0709; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Steck AK, 2011, CLIN CHEM, V57, P176, DOI 10.1373/clinchem.2010.148221; VAN HM, 2009, DIABETES, P58, DOI DOI 10.2337/DB08-1173; Vassy JL, 2012, BEST PRACT RES CL EN, V26, P189, DOI 10.1016/j.beem.2011.09.002; Vohl MC, 2004, OBES RES, V12, P1217, DOI 10.1038/oby.2004.153; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018939; Whitaker KL, 2010, AM J CLIN NUTR, V91, P1560, DOI 10.3945/ajcn.2009.28838; Xia QH, 2013, ANN NY ACAD SCI, V1281, P178, DOI 10.1111/nyas.12020; Zarkesh M, 2012, GENET RES, V94, P331, DOI 10.1017/S001667231200050X	69	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0117011	10.1371/journal.pone.0117011	http://dx.doi.org/10.1371/journal.pone.0117011			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603303	Green Published, gold, Green Submitted			2022-12-26	WOS:000348203500041
J	Wang, Q; Fu, AZ; Brenner, S; Kalmus, O; Banda, HT; De Allegri, M				Wang, Qun; Fu, Alex Z.; Brenner, Stephan; Kalmus, Olivier; Banda, Hastings Thomas; De Allegri, Manuela			Out-of-Pocket Expenditure on Chronic Non-Communicable Diseases in Sub-Saharan Africa: The Case of Rural Malawi	PLOS ONE			English	Article							HEALTH-CARE EXPENDITURE; DEVELOPING-COUNTRY; DIABETIC SUBJECTS; ECONOMIC BURDEN; COSTS; INDIA; STRATEGIES; HOUSEHOLDS; MODELS; CANCER	In Sub-Saharan Africa (SSA) the disease burden of chronic non-communicable diseases (CNCDs) is rising considerably. Given weaknesses in existing financial arrangements across SSA, expenditure on CNCDs is often borne directly by patients through out-of-pocket (OOP) payments. This study explored patterns and determinants of OOP expenditure on CNCDs in Malawi. We used data from the first round of a longitudinal household health survey conducted in 2012 on a sample of 1199 households in three rural districts in Malawi. We used a two-part model to analyze determinants of OOP expenditure on CNCDs. 475 respondents reported at least one CNCD. More than 60% of the 298 individuals who reported seeking care incurred OOP expenditure. The amount of OOP expenditure on CNCDs comprised 22% of their monthly per capita household expenditure. The poorer the household, the higher proportion of their monthly per capita household expenditure was spent on CNCDs. Higher severity of disease was significantly associated with an increased likelihood of incurring OOP expenditure. Use of formal care was negatively associated with the possibility of incurring OOP expenditure. The following factors were positively associated with the amount of OOP expenditure: being female, Alomwe and household head, longer duration of disease, CNCDs targeted through active screening programs, higher socio-economic status, household head being literate, using formal care, and fewer household members living with a CNCD within a household. Our study showed that, in spite of a context where care for CNCDs should in principle be available free of charge at point of use, OOP payments impose a considerable financial burden on rural households, especially among the poorest. This suggests the existence of important gaps in financial protection in the current coverage policy.	[Wang, Qun; Brenner, Stephan; Kalmus, Olivier; De Allegri, Manuela] Heidelberg Univ, Fac Med, Inst Publ Hlth, Heidelberg, Germany; [Fu, Alex Z.] Georgetown Univ, Med Ctr, Canc Prevent & Control Program, Washington, DC 20007 USA; [Banda, Hastings Thomas] Res Equ & Community Hlth Trust REACH Trust, Lilongwe, Malawi	Ruprecht Karls University Heidelberg; Georgetown University	Wang, Q (corresponding author), Heidelberg Univ, Fac Med, Inst Publ Hlth, Heidelberg, Germany.	qun.wang@uni-heidelberg.de			German Research Society (Deutsche Forschungsgemeinschaft); DFG-AL [1361/2-1]	German Research Society (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); DFG-AL	This study was supported by a research grant of the German Research Society (Deutsche Forschungsgemeinschaft). The grant number is DFG-AL 1361/2-1. MDA received the funding. The URLs is http://www.dfg.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2008, SOC SCI MED, V66, P2296, DOI 10.1016/j.socscimed.2008.01.041; Abiiro GA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-234; Acock AC, 2008, MULTIPLE REGRESSION, P243; [Anonymous], 2005, PREV CHRON DIS VIT I; Basu A, 2006, HEALTH ECON, V15, P1091, DOI 10.1002/hec.1099; Basu A, 2009, MED CARE, V47, pS109, DOI 10.1097/MLR.0b013e31819c94a1; Belotti F, 2015, STATA J, V15, P3, DOI 10.1177/1536867X1501500102; Bowie C, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-4; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Campbell D. T., 1986, NEW DIR PROGRAM EVAL, V31, P67, DOI DOI 10.1002/EV.1434; Chadza E., 2012, Health, V4, P1015, DOI 10.4236/health.2012.411155; Chuma J, 2007, TROP MED INT HEALTH, V12, P673, DOI 10.1111/j.1365-3156.2007.01825.x; Cohen S, 1994, J OFF STAT, V10, P3; Costa-i-Font J, 2008, REVISITING HLTH CARE; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Deb P, 2006, J APPL ECONOMET, V21, P1081, DOI 10.1002/jae.891; Dror DM, 2008, INDIAN J MED RES, V127, P347; Elrayah H, 2005, DIABETES RES CLIN PR, V70, P159, DOI 10.1016/j.diabres.2005.03.034; Elrayah-Eliadarous H, 2010, EXP CLIN ENDOCR DIAB, V118, P220, DOI 10.1055/s-0029-1246216; Finkelstein EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099572; Fu AZ, 2011, BREAST CANCER RES TR, V130, P235, DOI 10.1007/s10549-011-1541-z; Getzen TE, 2000, J HEALTH ECON, V19, P259, DOI 10.1016/S0167-6296(99)00032-6; Gottret P. E., 2006, HLTH FINANCING REVIS; Goudge J, 2009, TROP MED INT HEALTH, V14, P458, DOI 10.1111/j.1365-3156.2009.02256.x; GROSSMAN M, 1972, J POLIT ECON, V80, P223, DOI 10.1086/259880; Hardin JW., 2007, GEN LINEAR MODELS EX, V2, DOI DOI 10.1016/j.marpol.2012.12.026; Huffman MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020821; Ibanez-Gonzalez DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078800; Kankeu HT, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-31; Kirigia JM, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-6; Maher D, 2010, B WORLD HEALTH ORGAN, V88, P943, DOI 10.2471/BLT.10.077891; Malik AM, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-51; Manning WG, 1998, J HEALTH ECON, V17, P283, DOI 10.1016/S0167-6296(98)00025-3; Matsaganis M, 2009, EUR J HEALTH ECON, V10, P329, DOI 10.1007/s10198-008-0137-y; Ministry of Health Malawi, 2011, MAL HLTH SECT STRAT; Miszkurka M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-24; Msyamboza KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020316; Mueller DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020741; Mwandira RH., 2011, EXAMINING EQUITY OUT; National Statistical Office-NSO/Malawi ICF Macro, 2011, MAL DEM HLTH SURV 20; National Statistics Office of Malawi, 2008, 2008 POP HOUS CENS P; Obi SN, 2008, J OBSTET GYNAECOL, V28, P526, DOI 10.1080/01443610802273507; Okunade AA, 2010, HEALTH ECON, V19, P365, DOI 10.1002/hec.1471; Onwujekwe OE, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-67; Orem JN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-175; OSBORN CE, 2000, STAT APPL HLTH INFOR; PARK RE, 1966, ECONOMETRICA, V34, P888, DOI 10.2307/1910108; Phillips PP, 2013, SURVEY BASICS GUIDE; Rahman MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056873; Ramachandran A, 2007, DIABETES CARE, V30, P252, DOI 10.2337/dc06-0144; Sauerborn R, 1996, Health Transit Rev, V6, P131; Schwarz J, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-103; Schwarzkopf L, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-165; Shobhana R, 2000, DIABETES RES CLIN PR, V48, P37, DOI 10.1016/S0168-8227(99)00130-8; Su Tin Tin, 2006, Eur J Health Econ, V7, P199; Suhrcke M., 2006, CHRONIC DIS EC PERSP; Tagoe HA, 2013, GHANA MED J, V46, P54; Trogdon JG, 2008, DIABETES CARE, V31, P2307, DOI 10.2337/dc08-1375; Wang Q, 2015, HEALTH POLICY PLANN, V30, P242, DOI 10.1093/heapol/czu004; WEDDERBURN RWM, 1974, BIOMETRIKA, V61, P439, DOI 10.2307/2334725; WHO, 2011, GLOBAL STATUS REPORT; World Health Organization, 2008, 2008 2013 ACT PLAN G; World Health Organization, 2011, NONCOMMUNICABLE DIS; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 1980, INT CLASS IMP DIS HA; World Health Organization Regional Office for Africa, 2011, UN NCDS TIM ACT IS N; Xu K, 2006, EMPIRICAL MODEL ACCE; YAFFE R, 1978, MED CARE, V16, P641, DOI 10.1097/00005650-197808000-00003; Yardim MS, 2014, HEALTH POLICY PLANN, V29, P177, DOI 10.1093/heapol/czt002; Zere E, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-27	70	64	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0116897	10.1371/journal.pone.0116897	http://dx.doi.org/10.1371/journal.pone.0116897			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4OG	25584960	Green Published, Green Submitted, gold			2022-12-26	WOS:000348201300010
J	Bernitt, E; Koh, CG; Gov, N; Dobereiner, HG				Bernitt, Erik; Koh, Cheng Gee; Gov, Nir; Doebereiner, Hans-Guenther			Dynamics of Actin Waves on Patterned Substrates: A Quantitative Analysis of Circular Dorsal Ruffles	PLOS ONE			English	Article							TRAVELING-WAVES; GROWTH-FACTOR; CELLS; MOTILITY; MACROPINOCYTOSIS; OSCILLATIONS; ORGANIZATION; BEHAVIOR; STATES; MODEL	Circular Dorsal Ruffles (CDRs) have been known for decades, but the mechanism that organizes these actin waves remains unclear. In this article we systematically analyze the dynamics of CDRs on fibroblasts with respect to characteristics of current models of actin waves. We studied CDRs on heterogeneously shaped cells and on cells that we forced into disk-like morphology. We show that CDRs exhibit phenomena such as periodic cycles of formation, spiral patterns, and mutual wave annihilations that are in accord with an active medium description of CDRs. On cells of controlled morphologies, CDRs exhibit extremely regular patterns of repeated wave formation and propagation, whereas on random-shaped cells the dynamics seem to be dominated by the limited availability of a reactive species. We show that theoretical models of reaction-diffusion type incorporating conserved species capture partially the behavior we observe in our data.	[Bernitt, Erik; Doebereiner, Hans-Guenther] Univ Bremen, Inst Biophys, D-28359 Bremen, Germany; [Koh, Cheng Gee] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Gov, Nir] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel	University of Bremen; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Weizmann Institute of Science	Bernitt, E (corresponding author), Univ Bremen, Inst Biophys, D-28359 Bremen, Germany.	ebernitt@uni-bremen.de	Koh, Cheng Gee/A-2215-2011; Döbereiner, Hans-Günther/F-7302-2012; GOV, NIR/K-1415-2012	Koh, Cheng Gee/0000-0003-1905-8010; Döbereiner, Hans-Günther/0000-0003-1691-634X; GOV, NIR/0000-0001-7774-1139	German Research Foundation [DO 699/4-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by grant DO 699/4-1 of the German Research Foundation (http://www. dfg.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard J, 2013, CURR OPIN CELL BIOL, V25, P107, DOI 10.1016/j.ceb.2012.08.012; Argentina M, 2000, J THEOR BIOL, V205, P47, DOI 10.1006/jtbi.2000.2044; Bretschneider T, 2009, BIOPHYS J, V96, P2888, DOI 10.1016/j.bpj.2008.12.3942; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; Doubrovinski K, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.258103; Doubrovinski K, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/18003; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; Dreher A, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/5/055007; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Edgar AJ, 1997, EUR J CELL BIOL, V73, P132; Gerisch G, 2004, BIOPHYS J, V87, P3493, DOI 10.1529/biophysj.104.047589; Gerisch G, 2012, BIOPHYS J, V103, P1170, DOI [10.1016/j.bpj.2012.08.004, 10.1016/j.bpj.2012.05.00.4]; Gholami A, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/115002; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Hoon JL, 2012, MOL CELL BIOL, V32, P4246, DOI 10.1128/MCB.00551-12; Itoh T, 2013, J BIOCHEM, V153, P21, DOI 10.1093/jb/mvs138; Julicher F, 2007, PHYS REP, V449, P3, DOI 10.1016/j.physrep.2007.02.018; KEENER JP, 1986, SIAM J APPL MATH, V46, P1039, DOI 10.1137/0146062; Kruse K, 2005, CURR OPIN CELL BIOL, V17, P20, DOI 10.1016/j.ceb.2004.12.007; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Mata MA, 2013, J THEOR BIOL, V334, P149, DOI 10.1016/j.jtbi.2013.06.020; MELLSTROM K, 1983, J MUSCLE RES CELL M, V4, P589, DOI 10.1007/BF00712117; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Orth JD, 2006, CANCER RES, V66, P11094, DOI 10.1158/0008-5472.CAN-06-3397; Payne LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108257; Peleg B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018635; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ryan GL, 2012, BIOPHYS J, V102, P1493, DOI 10.1016/j.bpj.2012.03.005; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schroth-Diez B, 2009, HFSP J, V3, P412, DOI 10.2976/1.3239407; Singh P, 2011, PROTEOMICS, V11, P2891, DOI 10.1002/pmic.201100044; Taniguchi D, 2013, P NATL ACAD SCI USA, V110, P5016, DOI 10.1073/pnas.1218025110; Thery M, 2009, COLD SPRING HARB PRO, V4, DOI 10.1101/pdb.prot5255; Vasiev BN, 2004, PHYS LETT A, V323, P194, DOI 10.1016/j.physleta.2004.01.068; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Whitelam S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.198103; Wrholmes WR, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/046005; Wu M, 2013, P NATL ACAD SCI USA, V110, P1339, DOI 10.1073/pnas.1221538110; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Zeng YK, 2011, BIOPHYS J, V101, P2122, DOI 10.1016/j.bpj.2011.09.047	42	26	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0115857	10.1371/journal.pone.0115857	http://dx.doi.org/10.1371/journal.pone.0115857			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25574668	Green Published, gold			2022-12-26	WOS:000348168100002
J	Schuster, A; Erpenbeck, D; Pisera, A; Hooper, J; Bryce, M; Fromont, J; Worheide, G				Schuster, Astrid; Erpenbeck, Dirk; Pisera, Andrzej; Hooper, John; Bryce, Monika; Fromont, Jane; Woerheide, Gert			Deceptive Desmas: Molecular Phylogenetics Suggests a New Classification and Uncovers Convergent Evolution of Lithistid Demosponges	PLOS ONE			English	Article							PORIFERA DEMOSPONGIAE; MORPHOLOGICAL CHARACTERS; PETROMICA TOPSENT; SPONGES PORIFERA; GENUS; DNA; TETRACTINELLIDA; HALICHONDRIDA; SYSTEMATICS; SEQUENCES	Reconciling the fossil record with molecular phylogenies to enhance the understanding of animal evolution is a challenging task, especially for taxa with a mostly poor fossil record, such as sponges (Porifera). 'Lithistida', a polyphyletic group of recent and fossil sponges, are an exception as they provide the richest fossil record among demosponges. Lithistids, currently encompassing 13 families, 41 genera and >300 recent species, are defined by the common possession of peculiar siliceous spicules (desmas) that characteristically form rigid articulated skeletons. Their phylogenetic relationships are to a large extent unresolved and there has been no (taxonomically) comprehensive analysis to formally reallocate lithistid taxa to their closest relatives. This study, based on the most comprehensive molecular and morphological investigation of 'lithistid' demosponges to date, corroborates some previous weakly-supported hypotheses, and provides novel insights into the evolutionary relationships of the previous 'order Lithistida'. Based on molecular data (partial mtDNA CO1 and 28S rDNA sequences), we show that 8 out of 13 'Lithistida' families belong to the order Astrophorida, whereas Scleritodermidae and Siphonidiidae form a separate monophyletic clade within Tetractinellida. Most lithistid astrophorids are dispersed between different clades of the Astrophorida and we propose to formally reallocate them, respectively. Corallistidae, Theonellidae and Phymatellidae are monophyletic, whereas the families Pleromidae and Scleritodermidae are polyphyletic. Family Desmanthidae is polyphyletic and groups within Halichondriidae - we formally propose a reallocation. The sister group relationship of the family Vetulinidae to Spongillida is confirmed and we propose here for the first time to include Vetulina into a new Order Sphaerocladina. Megascleres and microscleres possibly evolved and/or were lost several times independently in different 'lithistid' taxa, and microscleres might at least be four times more likely lost than megascleres. Desma spicules occasionally may have undergone secondary losses too. Our study provides a framework for further detailed investigations of this important demosponge group.	[Schuster, Astrid; Erpenbeck, Dirk; Woerheide, Gert] Univ Munich, Dept Earth & Environm Sci, D-80333 Munich, Germany; [Schuster, Astrid; Woerheide, Gert] SNSB Bavarian State Collect Palaeontol & Geol, D-80333 Munich, Germany; [Erpenbeck, Dirk; Woerheide, Gert] Univ Munich, GeoBio Ctr LMU, D-80333 Munich, Germany; [Pisera, Andrzej] Polish Acad Sci, Inst Paleobiol, PL-00818 Warsaw, Poland; [Hooper, John; Bryce, Monika] Queensland Museum, South Brisbane, Qld 4101, Australia; [Hooper, John] Griffith Univ, Eskitis Inst Drug Discovery, Nathan, Qld 4111, Australia; [Bryce, Monika; Fromont, Jane] Western Australian Museum, Dept Aquat Zool, Welshpool Dc, WA 6986, Australia	University of Munich; University of Munich; Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences; Queensland Museum; Griffith University; Western Australian Museum	Worheide, G (corresponding author), Univ Munich, Dept Earth & Environm Sci, Richard Wagner Str 10, D-80333 Munich, Germany.	woerheide@lmu.de	Pisera, Andrzej/AAX-7259-2020; Pisera, Andrzej/F-4429-2011; Wörheide, Gert/C-1080-2008	Pisera, Andrzej/0000-0001-7112-6063; Wörheide, Gert/0000-0002-6380-7421; Erpenbeck, Dirk/0000-0003-2716-1085; Hooper, John/0000-0003-1722-5954; Schuster, Astrid/0000-0001-8978-3256	PROSALMU; LMUMentoring GeoSciences program	PROSALMU; LMUMentoring GeoSciences program	AS wants to thank PROSALMU for financing the research visit to the Institute of Palaeobiology in Poland, the LMUMentoring GeoSciences program for funding her attendance to the 9th World Sponge Conference and the Sponge Training Workshop in Fremantle and Perth, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis JS, 2005, ZOOL SCR, V34, P549, DOI 10.1111/j.1463-6409.2005.00211.x; [Anonymous], 9 WORLD SPONG C FREM, P109; [Anonymous], 1998, P 5 INT SPONG S BRIS, P343; Bergquist P.R., 1978, SPONGES; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Bowerbank JS, 1869, P ZOOL SOC LOND, V1869, p[66, 323]; Burton M, 1929, FISHERIES B FISHERIE, V2, P1; Cardenas P, 2012, ADV MAR BIOL, V61, P79, DOI 10.1016/B978-0-12-387787-1.00010-6; Cardenas P, 2012, ZOOTAXA, P1; Cardenas P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018318; Cardenas P, 2009, ZOOTAXA, P1; Carvalho FC, 2014, J MAR BIOL ASSOC UK, P1; Chombard C, 1998, SYST BIOL, V47, P351, DOI 10.1080/106351598260761; de Laubenfels M. W., 1936, Papers from the Tortugas Laboratory of the Carnegie Institution of Washington, V30, P1; Dendy A., 1905, REPORT GOVT CEYL S18, V3, P57; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erpenbeck D, 2007, ZOOTAXA, P107, DOI 10.11646/zootaxa.1668.1.10; Erpenbeck D, 2007, CONTRIB ZOOL, V76, P95, DOI 10.1163/18759866-07602003; Erpenbeck D, 2012, MOL PHYLOGENET EVOL, V63, P809, DOI 10.1016/j.ympev.2012.02.024; Galtier N, 1997, J MOL EVOL, V44, P632, DOI 10.1007/PL00006186; Grant RE, 1861, ZOOLOGY, P1; Gruber Gabriele, 1993, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V10, P1; Hill MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050437; HOOPER J N A, 1989, Memoirs of the Queensland Museum, V27, P437; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jenner RA, 2004, EVOL DEV, V6, P372, DOI 10.1111/j.1525-142X.2004.04045.x; Kelly Borges M, 1994, MOL MARINE BIOL BIOT, V3, P87; Kelly Michelle, 2000, Zoosystema, V22, P265; Kelly-Borges Michelle, 1994, Molecular Marine Biology and Biotechnology, V3, P87; Le Hoc Lanh Van, 1993, Molecular Phylogenetics and Evolution, V2, P31, DOI 10.1006/mpev.1993.1005; Levi C., 1991, P72; Levi C., 1973, TRAITE ZOOLOGIE P GR, V3, P577; List-Armitage SE, 2002, INVERTEBR SYST, V16, P813, DOI 10.1071/IT00036; Maddison WP, 2011, MESQUITE MODULAR SYS; Maldonado M, 1999, NATURE, V401, P785, DOI 10.1038/44560; Manconi R, 2008, ZOOKEYS, P71, DOI 10.3897/zookeys.4.39; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Morrow CC, 2012, MOL PHYLOGENET EVOL, V62, P174, DOI 10.1016/j.ympev.2011.09.016; Morrow CC, 2013, INTEGR COMP BIOL, V53, P428, DOI 10.1093/icb/ict065; Muricy G, 2001, HYDROBIOLOGIA, V443, P103, DOI 10.1023/A:1017504422239; Nichols SA, 2005, MOL PHYLOGENET EVOL, V34, P81, DOI 10.1016/j.ympev.2004.08.019; Ozdikmen Huseyin, 2009, Munis Entomology & Zoology, V4, P212; Pisera, 2002, SYSTEMA PORIFERA GUI, P380, DOI DOI 10.1007/978-1-4615-0747-5_46; Pisera A., 2002, SYSTEMA PORIFERA GUI, P356; Pisera A., 2002, SYSTEMA PORIFERA GUI, P302; Pisera A, 2002, SYSTEMA PORIFERA GUI, P363; Pisera A., 2002, SYSTEMA PORIFERA GUI, P299, DOI DOI 10.1007/978-1-4615-0747-5_33; Pisera A., 2002, SYSTEMA PORIFERA GUI, V1, P388; Pisera A, 2002, SYSTEMA PORIFERA GUI, P377; Pisera A, 2011, SCI MAR, V75, P17, DOI 10.3989/scsimar.2011.75n1017; Pisera Andrzej, 1999, Memoirs of the Queensland Museum, V44, P463; Redmond NE, 2013, INTEGR COMP BIOL, V53, P388, DOI 10.1093/icb/ict078; Reid R. B. H., 1963, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V4, P196; Reid REH, 1970, BIOL PORIFERA, P415; Rigby JK, 2004, TREATISE INVERTEBR E; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrook E., 1989, MOL CLONING; Schlacher-Hoenlinger MA, 2005, ZOOSYSTEMA, V27, P649; Schmidt EO, 1870, GRUNDZUGE SPONGIEN F, P1; Schrammen, 1924, MONOGRAPHIEN GEOLOGI, V1, P1; Schrammen A., 1910, PALAEONTOGRAPHICA S, V5, P1; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; Sollas D, 1885, ANN MAGAZINE NATURAL, V5, P395; Sollas WJ, 1888, REPORT SCI RESULTS V, P1; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Szitenberg A, 2013, MOL PHYLOGENET EVOL, V67, P509, DOI 10.1016/j.ympev.2013.02.018; Thacker RW, 2013, INTEGR COMP BIOL, V53, P373, DOI 10.1093/icb/ict071; TOPSENT E, 1894, ARCH ZOOLOGIE EXPT G, V3, P259; URIZ MJ, 1995, BIOL J LINN SOC, V55, P1; Vacelet J., 1969, Memoires du Museum Nationale d'Histoire Naturelle Paris (Ser A), V59, P145; Van Soest, 2002, SYSTEMA PORIFERA GUI, V1, P921, DOI DOI 10.1007/978-1-4615-0747-5_97; Van Soest R. W, 2014, WORLD PORIFERA DATAB; van Soest R.W.M., 1986, Bulletin Zoologisch Museum Universiteit van Amsterdam, V10, P201; Van Soest Rob W. M., 2000, Zoosystema, V22, P299; VANSOEST RWM, 1988, STUD FAUNA CURACAO, V70, P1; Vargas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039345; von Lendenfeld R, 1903, TIERREICH, V19, P1; Wilson H. V., 1925, Bulletin United States National Museum, V100, P273; Winder PL, 2011, MAR DRUGS, V9, P2643, DOI 10.3390/md9122643; Worheide G, 2012, ADV MAR BIOL, V61, P1, DOI 10.1016/B978-0-12-387787-1.00007-6; Wright AE, 2010, CURR OPIN BIOTECH, V21, P801, DOI 10.1016/j.copbio.2010.09.012; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3	84	44	47	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2015	10	1							e116038	10.1371/journal.pone.0116038	http://dx.doi.org/10.1371/journal.pone.0116038			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BS	25565279	Green Published, Green Submitted, gold			2022-12-26	WOS:000348167900003
J	Fentz, J; Kjobsted, R; Birk, JB; Jordy, AB; Jeppesen, J; Thorsen, K; Schjerling, P; Kiens, B; Jessen, N; Viollet, B; Wojtaszewski, JFP				Fentz, Joachim; Kjobsted, Rasmus; Birk, Jesper B.; Jordy, Andreas B.; Jeppesen, Jacob; Thorsen, Kasper; Schjerling, Peter; Kiens, Bente; Jessen, Niels; Viollet, Benoit; Wojtaszewski, Jorgen F. P.			AMPK alpha is critical for enhancing skeletal muscle fatty acid utilization during in vivo exercise in mice	FASEB JOURNAL			English	Article						CD36; fat oxidation; glucose uptake; physical activity; TBC1D1	ACTIVATED PROTEIN-KINASE; GLUCOSE-UPTAKE; PALMITATE UPTAKE; MALONYL-COA; INSULIN; TBC1D1; TRANSPORT; CONTRACTION; BINDING; PHOSPHORYLATION	The importance of AMPK in regulation of fatty acid (FA) oxidation in skeletal muscle with contraction/exercise is unresolved. Using a mouse model lacking both AMPK1 and -2 in skeletal muscle specifically (mdKO), we hypothesized that FA utilization would be impaired in skeletal muscle. AMPK mdKO mice displayed normal respiratory exchange ratio (RER) when fed chow or a high-fat diet, or with prolonged fasting. However, in vivo treadmill exercise at the same relative intensity induced a higher RER in AMPK mdKO mice compared to wild-type (WT = 0.81 +/- 0.01 (sem); mdKO = 0.87 +/- 0.02 (sem); P < 0.01), indicating a decreased utilization of FA. Further, ex vivo contraction-induced FA oxidation was impaired in AMPK mdKO muscle, suggesting that the increased RER during exercise originated from decreased skeletal muscle FA oxidation. A decreased muscle protein expression of CD36 (cluster of differentiation 36) and FABPpm (plasma membrane fatty acid binding protein) (by approximate to 17-40%), together with fully abolished TBC1D1 (tre-2/USP6, BUB2, cdc16 domain family member 1) Ser(237) phosphorylation during contraction/exercise in AMPK mdKO mice, may impair FA transport capacity and FA transport protein translocation to sarcolemma, respectively. AMPK is thus required for normal FA metabolism during exercise and muscle contraction.Fentz, J., KjObsted, R., Birk, J. B., Jordy, A. B., Jeppesen, J., Thorsen, K., Schjerling, P., Kiens, B., Jessen, N., Viollet, B., Wojtaszewski, J. F. P. AMPK is critical for enhancing skeletal muscle fatty acid utilization during in vivo exercise in mice.	[Fentz, Joachim; Kjobsted, Rasmus; Birk, Jesper B.; Jordy, Andreas B.; Jeppesen, Jacob; Kiens, Bente; Wojtaszewski, Jorgen F. P.] Univ Copenhagen, August Krogh Ctr, Dept Nutr Exercise & Sports, Sect Mol Physiol, DK-2100 Copenhagen, Denmark; [Thorsen, Kasper; Jessen, Niels] Aarhus Univ Hosp, Dept Mol Med, DK-8000 Aarhus, Denmark; [Schjerling, Peter] Univ Copenhagen, Bispebjerg Hosp, Inst Sports Med, Dept Orthoped Surg, DK-2100 Copenhagen, Denmark; [Schjerling, Peter] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Hlth Aging, DK-2100 Copenhagen, Denmark; [Viollet, Benoit] INSERM, Inst Cochin, U1016, Paris, France; [Viollet, Benoit] CNRS, Unites Mixtes Rech 8104, Paris, France; [Viollet, Benoit] Univ Descartes, Sorbonne Paris Cite, Paris, France	University of Copenhagen; Aarhus University; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Wojtaszewski, JFP (corresponding author), Univ Copenhagen, August Krogh Ctr, Dept Nutr Exercise & Sports, Sect Mol Physiol, Univ Pk 13, DK-2100 Copenhagen, Denmark.	jwojtaszewski@nexs.ku.dk	Jessen, Niels/E-1731-2011; Schjerling, Peter/F-6194-2011; Birk, Jesper B/D-3523-2015; Viollet, Benoit/O-6927-2017; Kjøbsted, Rasmus/AAY-8228-2020; Viollet, Benoit/N-2397-2019; Kiens, Bente/B-1375-2015	Schjerling, Peter/0000-0001-7138-3211; Birk, Jesper B/0000-0001-9775-4789; Viollet, Benoit/0000-0002-0121-0224; Kjøbsted, Rasmus/0000-0002-0628-4994; Viollet, Benoit/0000-0002-0121-0224; Jessen, Niels/0000-0001-5613-7274; wojtaszewski, jorgen/0000-0001-8185-3408; Kiens, Bente/0000-0001-5705-5625	Danish Ministry of Science, Technology and Innovation; Danish Council for Independent Research Medical Sciences (FSS); Novo Nordisk Foundation; Danish Diabetes Academy; Novo Nordisk Fonden [NNF14OC0012009] Funding Source: researchfish	Danish Ministry of Science, Technology and Innovation; Danish Council for Independent Research Medical Sciences (FSS)(Det Frie Forskningsrad (DFF)Danish Medical Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Diabetes Academy; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was carried out as a part of the research programs "Physical activity and nutrition for improvement of health" funded by the University of Copenhagen Excellence Program for Interdisciplinary Research; and the UNIK project: Food, Fitness & Pharma for Health and Disease (http://www.foodfitnesspharma.ku.dk) supported by the Danish Ministry of Science, Technology and Innovation. The study was funded by the Danish Council for Independent Research Medical Sciences (FSS) and the Novo Nordisk Foundation. J.F. was the recipient of a Ph.D. fellowship from the Danish Diabetes Academy funded by the Novo Nordisk Foundation. The authors acknowledge the assistance of Betina Bolmgren, Nicoline Resen Andersen, and Irene Bech Nielsen, Section of Molecular Physiology, August Krogh Centre, Department of Nutrition, Exercise and Sports, University of Copenhagen, and Anja Jokipii and Ida Trondhjem Haakansson, Institute of Sports Medicine Copenhagen, Bispebjerg Hospital (Copenhagen, Denmark). The authors also appreciate the kind donation of antibodies by D. G. Hardie (Division of Molecular Physiology, College of Life Sciences, University of Dundee, Scotland, United Kingdom), M. Mahlapuu (Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden), and J. Calles-Escandon (Wake Forest University, Winston-Salem, NC, USA).	Bonen A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1740, DOI 10.1152/ajpendo.00579.2006; BROOKS GA, 1994, J APPL PHYSIOL, V76, P2253, DOI 10.1152/jappl.1994.76.6.2253; Chabowski A, 2005, FEBS LETT, V579, P2428, DOI 10.1016/j.febslet.2004.11.118; Chabowski A, 2007, PROSTAG LEUKOTR ESS, V77, P345, DOI 10.1016/j.plefa.2007.10.017; Chadt A., 2014, DIABETES IN PRESS; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chao LC, 2012, J LIPID RES, V53, P2610, DOI 10.1194/jlr.M029355; Clarke DC, 2004, PHYSIOL GENOMICS, V17, P31, DOI 10.1152/physiolgenomics.00190.2003; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Dokas J, 2013, ENDOCRINOLOGY, V154, P3502, DOI 10.1210/en.2012-2147; Dzamko N, 2008, J PHYSIOL-LONDON, V586, P5819, DOI 10.1113/jphysiol.2008.159814; Fueger PT, 2007, J PHYSIOL-LONDON, V582, P801, DOI 10.1113/jphysiol.2007.132902; Fueger PT, 2005, J PHYSIOL-LONDON, V566, P533, DOI 10.1113/jphysiol.2005.085043; Fueger PT, 2004, AM J PHYSIOL-ENDOC M, V286, pE77, DOI 10.1152/ajpendo.00309.2003; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Holloway GP, 2007, J PHYSIOL-LONDON, V582, P393, DOI 10.1113/jphysiol.2007.135301; Jeppesen J, 2011, J LIPID RES, V52, P699, DOI 10.1194/jlr.M007138; Jeppesen J, 2013, DIABETES, V62, P1490, DOI 10.2337/db12-1160; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; KRAEGEN EW, 1985, AM J PHYSIOL, V248, pE353; Lantier L, 2014, FASEB J, V28, P3211, DOI 10.1096/fj.14-250449; Lee-Young RS, 2009, J BIOL CHEM, V284, P23925, DOI 10.1074/jbc.M109.021048; Luiken JJFP, 2003, DIABETES, V52, P1627, DOI 10.2337/diabetes.52.7.1627; Luiken JJFP, 1999, J LIPID RES, V40, P1007; Maarbjerg SJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE924, DOI 10.1152/ajpendo.90653.2008; McFarlan JT, 2012, J BIOL CHEM, V287, P23502, DOI 10.1074/jbc.M111.315358; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; Miura S, 2013, AM J PHYSIOL-ENDOC M, V305, pE213, DOI 10.1152/ajpendo.00114.2013; Miura S, 2009, AM J PHYSIOL-ENDOC M, V296, pE47, DOI 10.1152/ajpendo.90690.2008; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; PASSONNEAU JV, 1967, ANAL BIOCHEM, V19, P315, DOI 10.1016/0003-2697(67)90167-4; Pehmoller C, 2009, AM J PHYSIOL-ENDOC M, V297, pE665, DOI 10.1152/ajpendo.00115.2009; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Samovski D, 2012, J LIPID RES, V53, P709, DOI 10.1194/jlr.M023424; SOMOGYI M, 1945, J BIOL CHEM, V160, P69; Stephenson EJ, 2014, BBA-GEN SUBJECTS, V1840, P1285, DOI 10.1016/j.bbagen.2013.12.004; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; Szekeres F, 2012, AM J PHYSIOL-ENDOC M, V303, pE524, DOI 10.1152/ajpendo.00605.2011; Treebak JT, 2014, J PHYSIOL-LONDON, V592, P351, DOI 10.1113/jphysiol.2013.266338; Treebak JT, 2009, AM J PHYSIOL-CELL PH, V297, pC1041, DOI 10.1152/ajpcell.00051.2009; Turcotte LP, 2000, MOL CELL BIOCHEM, V210, P53, DOI 10.1023/A:1007046929776; Vichaiwong K, 2010, BIOCHEM J, V431, P311, DOI 10.1042/BJ20101100; Wang SB, 2010, J BIOL CHEM, V285, P19976, DOI 10.1074/jbc.M110.102467; WINDER WW, 1990, AM J PHYSIOL, V259, pE266, DOI 10.1152/ajpendo.1990.259.2.E266; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299	49	57	61	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1725	1738		10.1096/fj.14-266650	http://dx.doi.org/10.1096/fj.14-266650			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25609422				2022-12-26	WOS:000354114600011
J	Jiang, Y; Wang, S; Zhao, YY; Lin, CZ; Zhong, F; Jin, L; He, FC; Wang, HJ				Jiang, Yan; Wang, Sheng; Zhao, Yuanyuan; Lin, Chengzhao; Zhong, Fan; Jin, Li; He, Fuchu; Wang, Haijian			Histone H3K9 demethylase JMJD1A modulates hepatic stellate cells activation and liver fibrosis by epigenetically regulating peroxisome proliferator-activated receptor gamma	FASEB JOURNAL			English	Article						liver fibrogenesis; adipogenic transcription factor; PPAR gamma; HSC biology	MYOFIBROBLAST TRANSDIFFERENTIATION; MOLECULAR-MECHANISMS; LYSINE METHYLATION; DNA METHYLATION; GROWTH-FACTOR; STEM-CELLS; JHDM2A; DIFFERENTIATION; TRANSCRIPTION; FIBROGENESIS	As a central event in liver fibrogenesis, hepatic stellate cell (HSC) transdifferentiation involves loss of regulation by adipogenic transcription factors such as peroxisome proliferator-activated receptor gamma; (PPAR gamma), which is epigenetically silenced during HSC activation. We hypothesized that JMJD1A, an H3K9 demethylase involved in adipogenic metabolism, could regulate PPAR gamma. In human HSC cell line, rat primary HSCs, and carbontetrachloride-induced mouse liver fibrogenesis model, we down-regulated the expression of JMJD1A using small interfering or short hairpin RNAs, and overexpressed its wild-type and mutant. We analyzed the effects of JMJD1A manipulation on the histone di-methyl-H3K9 (H3k9me2) status of PPAR gamma gene and the expression of PPAR gamma and fibrosis markers using chromatin immunoprecipitation, real-time quantitative RT-PCR and Western blot, and also investigated the in vitro and in vivo consequences on liver fibrosis and necrosis by Masson or hematoxylin-eosin staining, respectively. JMJD1A knockdown in HSCs correlated with reinforced H3K9me2 in the PPAR gamma gene promoter, and its down-regulation in both mRNA and protein led to increased expression of fibrosis markers, which could be consistently rescued by JMJD1A overexpression. Jmjd1a knockdown in situ resulted in significantly increased expression of alpha-smooth muscle actin (P = 0.005) and Col1a (P = 0.036), strengthened production of collagens (P = 0.028), and remarkably enhanced necrosis (P = 0.007) 4 weeks after treatment. This study suggests JMJD1A as a novel epigenetic regulator that modulates HSC activation and liver fibrosis through targeting PPAR gamma gene expression.	[Jiang, Yan; Wang, Sheng; Zhao, Yuanyuan; Lin, Chengzhao; Zhong, Fan; Jin, Li; He, Fuchu; Wang, Haijian] Fudan Univ, Shanghai Med Coll, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci,Inst Biomed Sci,State Key Lab Genet, Shanghai 200032, Peoples R China; [Jiang, Yan; Wang, Sheng; Zhao, Yuanyuan; Lin, Chengzhao; Zhong, Fan; Jin, Li; He, Fuchu; Wang, Haijian] Fudan Univ, Shanghai Med Coll, Collaborat Innovat Ctr Genet & Dev,Minist Educ, Sch Life Sci,Inst Biomed Sci,Key Lab Contemporary, Shanghai 200032, Peoples R China; [Jiang, Yan; He, Fuchu] Fudan Univ, Dept Chem, Shanghai 200032, Peoples R China; [He, Fuchu] Beijing Proteome Res Ctr, Beijing Inst Radiat Med, State Key Lab Prote, Beijing, Peoples R China	Fudan University; Fudan University; Fudan University; Academy of Military Medical Sciences - China	He, FC (corresponding author), Fudan Univ, Sch Life Sci, Yixueyuan Rd 138, Shanghai 200032, Peoples R China.	hefc@nic.bmi.ac.cn; haijianwang@fudan.edu.cn	Jin, Li/M-5063-2019; ZHAO, YUAN/HCI-5831-2022; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415	National Science and Technology Major [2012ZX10002]; National Natural Science Foundation of China [81172093, 81372526, 31301050]; Shanghai Rising-Star Program Grant [12QH1400200]; Shanghai Pujiang Program Grant [11PJD005]	National Science and Technology Major; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program Grant; Shanghai Pujiang Program Grant	This study was supported by National Science and Technology Major Project 2012ZX10002, National Natural Science Foundation of China Grants 81172093, 81372526, and 31301050, Shanghai Rising-Star Program Grant 12QH1400200, and Shanghai Pujiang Program Grant 11PJD005. The authors declare no conflicts of interest.	Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200; Hu B, 2010, AM J PATHOL, V177, P21, DOI 10.2353/ajpath.2010.090999; Inagaki T, 2009, GENES CELLS, V14, P991, DOI 10.1111/j.1365-2443.2009.01326.x; Jenuwein T, 2006, FEBS J, V273, P3121, DOI 10.1111/j.1742-4658.2006.05343.x; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Lee MJ, 2013, J CELL MOL MED, V17, P1188, DOI 10.1111/jcmm.12098; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Mann J, 2007, CELL DEATH DIFFER, V14, P275, DOI 10.1038/sj.cdd.4401979; Mann J, 2013, CURR OPIN RHEUMATOL, V25, P101, DOI 10.1097/BOR.0b013e32835b13e1; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Miyahara T, 2000, J BIOL CHEM, V275, P35715, DOI 10.1074/jbc.M006577200; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; PINZANI M, 1994, HEPATOLOGY, V19, P701, DOI 10.1002/hep.1840190323; Saile B, 1999, HEPATOLOGY, V30, P196, DOI 10.1002/hep.510300144; Senoo H, 2010, CELL BIOL INT, V34, P1247, DOI 10.1042/CBI20100321; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Shu Jian-chang, 2004, Zhonghua Gan Zang Bing Za Zhi, V12, P353; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Tsukamoto H, 2006, J GASTROEN HEPATOL, V21, pS102, DOI 10.1111/j.1440-1746.2006.04573.x; Tsukamoto H, 2011, HEPATOL RES, V41, P675, DOI 10.1111/j.1872-034X.2011.00804.x; Wang YX, 2010, CELL RES, V20, P124, DOI 10.1038/cr.2010.13; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zeybel M, 2012, NAT MED, V18, P1369, DOI 10.1038/nm.2893; Zhang F, 2012, CELL SIGNAL, V24, P596, DOI 10.1016/j.cellsig.2011.11.008; Zhu NL, 2010, J BIOL CHEM, V285, P30463, DOI 10.1074/jbc.M110.156703	35	29	33	6	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1830	1841		10.1096/fj.14-251751	http://dx.doi.org/10.1096/fj.14-251751			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25609425				2022-12-26	WOS:000354114600019
J	Aki, S; Yoshioka, K; Okamoto, Y; Takuwa, N; Takuwa, Y				Aki, Sho; Yoshioka, Kazuaki; Okamoto, Yasuo; Takuwa, Noriko; Takuwa, Yoh			Phosphatidylinositol 3-Kinase Class II alpha-Isoform PI3K-C2 alpha Is Required for Transforming Growth Factor beta-induced Smad Signaling in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR ACTIVATION SARA; YOLK-SAC VASCULATURE; TGF-BETA; PHOSPHOINOSITIDE 3-KINASE; C2 DOMAIN; TUMOR ANGIOGENESIS; COATED VESICLES; EARLY ENDOSOMES; FYVE DOMAIN; MICE	We have recently demonstrated that the PI3K class II-alpha isoform (PI3K-C2 alpha), which generates phosphatidylinositol 3-phosphate and phosphatidylinositol 3,4-bisphosphates, plays crucial roles in angiogenesis, by analyzing PI3K-C2 alpha knock-out mice. The PI3K-C2 alpha actions are mediated at least in part through its participation in the internalization of VEGF receptor-2 and sphingosine-1-phosphate receptor S1P(1) and thereby their signaling on endosomes. TGF beta, which is also an essential angiogenic factor, signals via the serine/threonine kinase receptor complex to induce phosphorylation of Smad2 and Smad3 (Smad2/3). SARA (Smad anchor for receptor activation) protein, which is localized in early endosomes through its FYVE domain, is required for Smad2/3 signaling. In the present study, we showed that PI3K-C2 alpha knockdown nearly completely abolished TGF beta 1-induced phosphorylation and nuclear translocation of Smad2/3 in vascular endothelial cells (ECs). PI3K-C2 alpha was necessary for TGF beta-induced increase in phosphatidylinositol 3,4-bisphosphates in the plasma membrane and TGF beta receptor internalization into the SARA-containing early endosomes, but not for phosphatidylinositol 3-phosphate enrichment or localization of SARA in the early endosomes. PI3K-C2 alpha was also required for TGF beta receptor-mediated formation of SARA-Smad2/3 complex. Inhibition of dynamin, which is required for the clathrin-dependent receptor endocytosis, suppressed both TGF beta receptor internalization and Smad2/3 phosphorylation. TGF beta 1 stimulated Smad-dependent VEGF-A expression, VEGF receptor-mediated EC migration, and capillary-like tube formation, which were all abolished by either PI3K-C2 alpha knockdown or a dynamin inhibitor. Finally, TGF beta 1-induced microvessel formation in Matrigel plugs was greatly attenuated in EC-specific PI3K-C2 alpha-deleted mice. These observations indicate that PI3K-C2 alpha plays the pivotal role in TGF beta receptor endocytosis and thereby Smad2/3 signaling, participating in angiogenic actions of TGF beta.	[Aki, Sho; Yoshioka, Kazuaki; Okamoto, Yasuo; Takuwa, Noriko; Takuwa, Yoh] Kanazawa Univ, Dept Physiol, Sch Med, Kanazawa, Ishikawa 9208640, Japan; [Takuwa, Noriko] Ishikawa Prefectural Nursing Univ, Dept Hlth & Med Sci, Kahoku, Ishikawa 9291210, Japan	Kanazawa University	Takuwa, Y (corresponding author), Kanazawa Univ, Dept Physiol, Sch Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	ytakuwa@med.kanazawa-u.ac.jp	Yoshioka, Kazuaki/G-1038-2013; OKAMOTO, Yasuo/J-8438-2015	Yoshioka, Kazuaki/0000-0002-8631-3846; TAKUWA, Noriko/0000-0002-4278-2704	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japanese Society for the Promotion of Science; Ube foundation; Japan Foundation for Applied Enzymology; Life Science Foundation of Japan; Grants-in-Aid for Scientific Research [15K10970] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ube foundation(UBE Foundation); Japan Foundation for Applied Enzymology; Life Science Foundation of Japan(Life Science Foundation of Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, the Japanese Society for the Promotion of Science, the Ube foundation, the Japan Foundation for Applied Enzymology, and the Life Science Foundation of Japan.	Bakkebo M, 2012, FEBS LETT, V586, P3367, DOI 10.1016/j.febslet.2012.07.027; Biswas K, 2013, J PHYSIOL SCI, V63, pS136; Biswas K, 2013, J BIOL CHEM, V288, P2325, DOI 10.1074/jbc.M112.409656; Borner GHH, 2012, J CELL BIOL, V197, P141, DOI 10.1083/jcb.201111049; Bostrom K, 2004, J BIOL CHEM, V279, P52904, DOI 10.1074/jbc.M406868200; Breier G, 2002, INT J CANCER, V97, P142, DOI 10.1002/ijc.1599; Carvalho RLC, 2007, J CELL SCI, V120, P4269, DOI 10.1242/jcs.013169; Carvalho RLC, 2004, DEVELOPMENT, V131, P6237, DOI 10.1242/dev.01529; Clifford RL, 2008, J BIOL CHEM, V283, P35337, DOI 10.1074/jbc.M803342200; Cui H, 2013, J ALLERGY CLIN IMMUN, V132, P1205, DOI 10.1016/j.jaci.2013.07.026; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Domin J, 2000, J BIOL CHEM, V275, P11943, DOI 10.1074/jbc.275.16.11943; Du W, 2010, CANCER RES, V70, P772, DOI 10.1158/0008-5472.CAN-09-2722; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Falasca M, 2012, BIOCHEM J, V443, P587, DOI 10.1042/BJ20120008; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Harada K, 2005, MOL CELL BIOL, V25, P11122, DOI 10.1128/MCB.25.24.11122-11130.2005; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Inoki I, 2006, BIOCHEM BIOPH RES CO, V346, P293, DOI 10.1016/j.bbrc.2006.05.119; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; Itoh F, 2012, BLOOD, V119, P5320, DOI 10.1182/blood-2011-12-395772; Lamouille S, 2002, BLOOD, V100, P4495, DOI 10.1182/blood.V100.13.4495; Lan Y, 2007, MOL CELL BIOL, V27, P7683, DOI 10.1128/MCB.00577-07; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Leibiger B, 2010, FASEB J, V24, P1824, DOI 10.1096/fj.09-148072; Lu ZX, 2002, J BIOL CHEM, V277, P29363, DOI 10.1074/jbc.M203495200; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Maffucci T, 2003, EMBO J, V22, P4178, DOI 10.1093/emboj/cdg402; Mizuide M, 2003, J BIOL CHEM, V278, P531, DOI 10.1074/jbc.C200596200; Molz L, 1996, J BIOL CHEM, V271, P13892, DOI 10.1074/jbc.271.23.13892; Okamoto H, 2000, MOL CELL BIOL, V20, P9247, DOI 10.1128/MCB.20.24.9247-9261.2000; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Pardali E, 2012, INT J BIOL SCI, V8, P195, DOI [10.7150/ijbs.8.195, 10.7150/ijbs.3805]; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Shao ES, 2009, BLOOD, V114, P2197, DOI 10.1182/blood-2009-01-199166; Simons M., 2012, PHYSL BETHESDA, V27, P213; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Traer Colin J, 2006, Bull Cancer, V93, pE53; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Virbasius JV, 1996, J BIOL CHEM, V271, P13304, DOI 10.1074/jbc.271.23.13304; Wang Y, 2006, BIOCHEM J, V394, P581, DOI 10.1042/BJ20051471; Yoshioka K, 2012, NAT MED, V18, P1560, DOI 10.1038/nm.2928	53	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6086	6105		10.1074/jbc.M114.601484	http://dx.doi.org/10.1074/jbc.M114.601484			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25614622	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000350732500019
J	Sasazawa, Y; Sato, N; Umezawa, K; Simizu, S				Sasazawa, Yukiko; Sato, Natsumi; Umezawa, Kazuo; Simizu, Siro			Conophylline Protects Cells in Cellular Models of Neurodegenerative Diseases by Inducing Mammalian Target of Rapamycin (mTOR)-independent Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUNTINGTONS-DISEASE; ALPHA-SYNUCLEIN; MUTANT HUNTINGTIN; SUBSTANTIA-NIGRA; INHIBITION; APOPTOSIS; TOXICITY; POLYGLUTAMINE; AGGREGATION; INVOLVEMENT	Macroautophagy is a cellular response that leads to the bulk, nonspecific degradation of cytosolic components, including-organelles. In recent years, it has been recognized that autophagy is essential for prevention of neurodegenerative diseases, including Parkinson disease (PD) and Huntington disease (HD). Here, we show that conophylline (CNP), a vinca alkaloid, induces autophagy in an mammalian target of rapamycin-independent manner. Using a cellular model of PD, CNP suppressed protein aggregation and protected cells from cell death caused by treatment with 1-methyl-4-phenylpyridinium, a neurotoxin, by inducing autophagy. Moreover, in the HD model, CNP also eliminated mutant huntingtin aggregates. Our findings demonstrate the possible use of CNP as a therapeutic drug for neurodegenerative disorders, including PD and HD.	[Sasazawa, Yukiko; Sato, Natsumi; Simizu, Siro] Keio Univ, Dept Appl Chem, Fac Sci & Technol, Yokohama, Kanagawa 2238522, Japan; [Umezawa, Kazuo] Aichi Med, Dept Mol Target Med Screening, Sch Med, Aichi 4801195, Japan	Keio University; Aichi Medical University	Simizu, S (corresponding author), Keio Univ, Dept Appl Chem, Fac Sci & Technol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	simizu@applc.keio.ac.jp		Simizu, Siro/0000-0003-2949-2427	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23310163, 24310167, 26750373]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (B) 23310163 and 24310167 and Grant-in-Aid for Young Scientists (B) 26750373 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Cheng YF, 2009, NEUROSCI RES, V63, P52, DOI 10.1016/j.neures.2008.10.009; Fleming A, 2011, NAT CHEM BIOL, V7, P9, DOI 10.1038/NCHEMBIO.500; Fujii M, 2009, BIOMED PHARMACOTHER, V63, P710, DOI 10.1016/j.biopha.2009.01.006; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Hyrskyluoto A, 2014, HUM MOL GENET, V23, P5928, DOI 10.1093/hmg/ddu317; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kalivendi SV, 2004, J BIOL CHEM, V279, P15240, DOI 10.1074/jbc.M312497200; KAM TS, 1993, J NAT PROD, V56, P1865, DOI 10.1021/np50101a001; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kowall NW, 2000, NEUROREPORT, V11, P211, DOI 10.1097/00001756-200001170-00041; LANGSTON JW, 1984, NEUROSCI LETT, V48, P87, DOI 10.1016/0304-3940(84)90293-3; Nara A, 2002, CELL STRUCT FUNCT, V27, P29, DOI 10.1247/csf.27.29; Narain Y, 1999, J MED GENET, V36, P739, DOI 10.1136/jmg.36.10.739; Ogata T, 2004, DIABETES, V53, P2596, DOI 10.2337/diabetes.53.10.2596; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Saiki S, 2011, AUTOPHAGY, V7, P176, DOI 10.4161/auto.7.2.14074; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sasazawa Y, 2012, ACS CHEM BIOL, V7, P892, DOI 10.1021/cb200492h; Suzuki E, 2009, BIOORGAN MED CHEM, V17, P6188, DOI 10.1016/j.bmc.2009.07.062; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Umezawa K, 2003, BIOMED PHARMACOTHER, V57, P341, DOI 10.1016/S0753-3322(03)00096-9; UMEZAWA K, 1994, ANTICANCER RES, V14, P2413; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	33	40	46	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6168	6178		10.1074/jbc.M114.606293	http://dx.doi.org/10.1074/jbc.M114.606293			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25596530	Green Published, hybrid			2022-12-26	WOS:000350732500025
J	Schaker, K; Bartsch, S; Patry, C; Stoll, SJ; Hillebrands, JL; Wieland, T; Kroll, J				Schaeker, Kathrin; Bartsch, Susanne; Patry, Christian; Stoll, Sandra J.; Hillebrands, Jan-Luuk; Wieland, Thomas; Kroll, Jens			The Bipartite Rac1 Guanine Nucleotide Exchange Factor Engulfment and Cell Motility 1/Dedicator of Cytokinesis 180 (Elmo1/Dock180) Protects Endothelial Cells from Apoptosis in Blood Vessel Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR MORPHOGENESIS; SIGNAL-TRANSDUCTION; MYOBLAST FUSION; DOCK180; ACTIVATION; RECEPTOR; ANGIOGENESIS; INHIBITION; SURVIVAL; REGRESSION	Engulfment and cell motility 1/dedicator of cytokinesis 180 (Elmol/Dock180) is a bipartite guanine nucleotide exchange factor for the monomeric GTPase Ras-related C3 botulinum toxin substrate 1 (Racl). Elmol/Dock180 regulates Racl activity in a specific spatiotemporal manner in endothelial cells (ECs) during zebrafish development and acts downstream of the Netrin-1/Unc5-homolog B (Unc5B) signaling cascade. However, mechanistic details on the pathways by which Elmol/ Dock 180 regulates endothelial function and vascular development remained elusive. In this study, we aimed to analyze the vascular function of Elmol and Dock180 in human ECs and during vascular development in zebrafish embryos. In vitro overexpression of Elmol and Dock180 in ECs reduced caspase-3/7 activity and annexin V-positive cell number upon induction of apoptosis. This protective effect of Elmol and Dock180 is mediated by activation of Racl, p21-activated kinase (PAK) and AKT/protein kinase B (AKT) signaling. In zebrafish, Elmol and Dock 180 overexpression reduced the total apoptotic cell and apoptotic EC number and promoted the formation of blood vessels during embryogenesis. In conclusion, Elmol and Dock 180 protect ECs from apoptosis by the activation of the Rac 1/ PAK/AKT signaling cascade in vitro and in vivo. Thus, Elmol and Dock180 facilitate blood vessel formation by stabilization of the endothelium during angiogenesis.	[Schaeker, Kathrin; Bartsch, Susanne; Patry, Christian; Kroll, Jens] Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Dept Vasc Biol & Tumor Angiogenesis, D-68167 Mannheim, Germany; [Wieland, Thomas] Heidelberg Univ, Med Fac Mannheim, Inst Expt & Clin Pharmacol & Toxicol, D-68167 Mannheim, Germany; [Schaeker, Kathrin; Kroll, Jens] German Canc Res Ctr DKFZ ZMBH Alliance, Div Vasc Oncol & Metastasis, D-69120 Heidelberg, Germany; [Hillebrands, Jan-Luuk] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Pathol, NL-9700 RB Groningen, Netherlands	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Groningen	Kroll, J (corresponding author), Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Dept Vasc Biol & Tumor Angiogenesis, D-68167 Mannheim, Germany.	jens.kroll@medma.uni-heidelberg.de	Wieland, Thomas/G-1772-2012; Wieland, Thomas/Q-1506-2019	Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261; Hillebrands, Jan-Luuk/0000-0003-3135-3274	Core Facility Live Cell Imaging [DFG INST 91027/10-1 FUGG]	Core Facility Live Cell Imaging	We thank Stefanie Uhlig, operating the Mannheim Cell Sorting Core Facility and we acknowledge the support of the Core Facility Live Cell Imaging (DFG INST 91027/10-1 FUGG). We thank Dr. Mauro Cozzolino (Rome, Italy) for kindly providing adenoviral constructs for the overexpression of RacN17 and RacV12. We are grateful to Sabine Zapf, Jana Braun and Marlene Hausner for technical assistance with FACS and Western blot experiments.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005; Bouvree K, 2008, DEV BIOL, V318, P172, DOI 10.1016/j.ydbio.2008.03.023; Bryan BA, 2007, CELL MOL LIFE SCI, V64, P2053, DOI 10.1007/s00018-007-7008-z; Castets M, 2009, DEV CELL, V16, P614, DOI 10.1016/j.devcel.2009.02.006; Chen Q, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001374; Claxton S, 2003, EXP EYE RES, V77, P305, DOI 10.1016/S0014-4835(03)00153-2; Cozzolino M, 2003, MOL BIOL CELL, V14, P1964, DOI 10.1091/mbc.E02-08-0469; Das S, 2011, P NATL ACAD SCI USA, V108, P2136, DOI 10.1073/pnas.1014775108; Del Galdo S, 2013, CELL SIGNAL, V25, P2478, DOI 10.1016/j.cellsig.2013.08.017; Deshpande SS, 2000, FASEB J, V14, P1705, DOI 10.1096/fj.99-0910com; Dormond O, 2001, NAT MED, V7, P1041, DOI 10.1038/nm0901-1041; Elliott MR, 2010, ANN NY ACAD SCI, V1209, P30, DOI 10.1111/j.1749-6632.2010.05764.x; Embade N, 2000, MOL BIOL CELL, V11, P4347, DOI 10.1091/mbc.11.12.4347; Epting D, 2010, CIRC RES, V107, P45, DOI 10.1161/CIRCRESAHA.109.213983; Eriksson A, 2003, CIRCULATION, V107, P1532, DOI 10.1161/01.CIR.0000055324.34758.32; Feng HZ, 2012, P NATL ACAD SCI USA, V109, P3018, DOI 10.1073/pnas.1121457109; Franke K, 2012, EMBO J, V31, P2908, DOI 10.1038/emboj.2012.130; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Genot EM, 2000, MOL CELL BIOL, V20, P5469, DOI 10.1128/MCB.20.15.5469-5478.2000; Goldschneider D, 2010, ONCOGENE, V29, P1865, DOI 10.1038/onc.2010.13; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; He XW, 2010, MOL CELL BIOL, V30, P3569, DOI 10.1128/MCB.01366-09; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Im E, 2006, CELL CYCLE, V5, P2057, DOI 10.4161/cc.5.18.3210; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; Jarzynka NJ, 2007, CANCER RES, V67, P7203, DOI 10.1158/0008-5472.CAN-07-0473; Jin S, 2006, AM J PHYSIOL-GASTR L, V291, pG1137, DOI 10.1152/ajpgi.00031.2006; Kanekura K, 2005, J BIOL CHEM, V280, P4532, DOI 10.1074/jbc.M410508200; Kather JN, 2013, EXP CELL RES, V319, P1289, DOI 10.1016/j.yexcr.2012.12.015; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kim JY, 2011, J BIOL CHEM, V286, P37615, DOI 10.1074/jbc.M111.268029; Kim MJ, 2008, BIOTECHNIQUES, V45, P331, DOI 10.2144/000112909; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kochhan E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075060; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; Lobov IB, 2011, BLOOD, V117, P6728, DOI 10.1182/blood-2010-08-302067; Lu MJ, 2006, METHOD ENZYMOL, V406, P388, DOI 10.1016/S0076-6879(06)06028-9; Lu MJ, 2004, NAT STRUCT MOL BIOL, V11, P756, DOI 10.1038/nsmb800; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Mack NA, 2011, CELL CYCLE, V10, P1571, DOI 10.4161/cc.10.10.15612; Makino Y, 2006, J CELL SCI, V119, P923, DOI 10.1242/jcs.02797; Murakami M, 2008, J CLIN INVEST, V118, P3355, DOI 10.1172/JCI35298; Murga C, 2002, ONCOGENE, V21, P207, DOI 10.1038/sj.onc.1205036; Nacak TG, 2007, CIRC RES, V100, P1155, DOI 10.1161/01.RES.0000265844.56493.ac; Nishida K, 1999, ONCOGENE, V18, P407, DOI 10.1038/sj.onc.1202301; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rao GK, 2008, CIRC RES, V103, P328, DOI 10.1161/CIRCRESAHA.108.182238; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Sanematsu F, 2010, CIRC RES, V107, P1102, DOI 10.1161/CIRCRESAHA.110.223388; Shen E, 2009, DIABETES, V58, P2386, DOI 10.2337/db08-0617; Soga N, 2001, CELL COMMUN ADHES, V8, P1, DOI 10.3109/15419060109080703; Stoll SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058311; Stoll SJ, 2011, CIRC RES, V108, P1367, DOI 10.1161/CIRCRESAHA.111.244095; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Taniguchi H, 1999, ANN ANAT, V181, P555, DOI 10.1016/S0940-9602(99)80061-2; van Ham TJ, 2012, CURR BIOL, V22, P830, DOI 10.1016/j.cub.2012.03.027; Velaithan R, 2011, BLOOD, V117, P6214, DOI 10.1182/blood-2010-08-301283; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wacker A, 2011, CURR OPIN CELL BIOL, V23, P676, DOI 10.1016/j.ceb.2011.10.002; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Yan A, 2013, MED SCI MONIT BASIC, V19, P12, DOI 10.12659/MSMBR.883738; Yoshida T, 2010, MOL CANCER THER, V9, P1657, DOI 10.1158/1535-7163.MCT-09-0906; Zhang BL, 2004, MOL CELL BIOL, V24, P6205, DOI 10.1128/MCB.24.14.6205-6214.2004; Zhang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044590	76	23	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6408	6418		10.1074/jbc.M114.633701	http://dx.doi.org/10.1074/jbc.M114.633701			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25586182	Green Published, hybrid			2022-12-26	WOS:000350732500045
J	Singh, RK; Cho, K; Padi, SKR; Yu, JR; Haldar, M; Mandal, T; Yan, CH; Cook, G; Guo, B; Mallik, S; Srivastava, DK				Singh, Raushan K.; Cho, Kyongshin; Padi, Satish K. R.; Yu, Junru; Haldar, Manas; Mandal, Tanmay; Yan, Changhui; Cook, Gregory; Guo, Bin; Mallik, Sanku; Srivastava, D. K.			Mechanism of N-Acylthiourea-mediated Activation of Human Histone Deacetylase 8 (HDAC8) at Molecular and Cellular Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I; BINDING; INHIBITORS; FAMILY; PROTEIN; SIRT1; P53; RESVERATROL; COMPLEXES; CHEMISTRY	We reported previously that an N-acylthiourea derivative (TM-2-51) serves as a potent and isozyme-selective activator for human histone deacetylase 8 (HDAC8). To probe the molecular mechanism of the enzyme activation, we performed a detailed account of the steady-state kinetics, thermodynamics, molecular modeling, and cell biology studies. The steady-state kinetic data revealed that TM-2-51 binds to HDAC8 at two sites in a positive cooperative manner. Isothermal titration calorimetric and molecular modeling data conformed to the two-site binding model of the enzyme-activator complex. We evaluated the efficacy of TM-2-51 on SH-SY5Y and BE(2)-C neuroblastoma cells, wherein the HDAC8 expression has been correlated with cellular malignancy. Whereas TM-2-51 selectively induced cell growth inhibition and apoptosis in SH-SY5Y cells, it showed no such effects in BE(2)-C cells, and this discriminatory feature appears to be encoded in the p53 genotype of the above cells. Our mechanistic and cellular studies on HDAC8 activation have the potential to provide insight into the development of novel anticancer drugs.	[Singh, Raushan K.; Yu, Junru; Mandal, Tanmay; Cook, Gregory; Srivastava, D. K.] N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA; [Cho, Kyongshin] N Dakota State Univ, Dept Anim Sci, Fargo, ND 58108 USA; [Padi, Satish K. R.; Haldar, Manas; Guo, Bin; Mallik, Sanku] N Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58108 USA; [Yan, Changhui] N Dakota State Univ, Dept Comp Sci, Fargo, ND 58108 USA	North Dakota State University Fargo; North Dakota State University Fargo; North Dakota State University Fargo; North Dakota State University Fargo	Srivastava, DK (corresponding author), N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA.	dk.srivastava@ndsu.edu	Srivastava, Deo Kumar/P-2435-2017; Guo, Bin/AAA-2445-2019; Padi, Sathish Kumar Reddy/ABG-9521-2021	Srivastava, Deo Kumar/0000-0001-6693-8120; Guo, Bin/0000-0003-3296-9177; Padi, Sathish Kumar Reddy/0000-0002-5526-4287; Singh, Raushan/0000-0002-3636-9112; Mallik, Sanku/0000-0003-4236-2512	National Institutes of Health [CA113746, CA132034, NCRR-P20-RR15566]; NATIONAL CANCER INSTITUTE [R01CA132034, R01CA113746] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015566] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1306154] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA113746 and CA132034 (to D. K. S. and S. M.) and NCRR-P20-RR15566 (to G. C.).	Adair GS, 1925, J BIOL CHEM, V63, P529; Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Byerly DW, 2002, PROTEIN SCI, V11, P1850, DOI 10.1110/ps.0203402; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dahlquist F W, 1978, Methods Enzymol, V48, P270; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Decroos C, 2014, ACS CHEM BIOL, V9, P2157, DOI 10.1021/cb5003762; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; FRANK HS, 1968, J CHEM PHYS, V48, P4746, DOI 10.1063/1.1668057; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Gurard-Levin ZA, 2009, CHEMBIOCHEM, V10, P2159, DOI 10.1002/cbic.200900417; Haberland M, 2009, GENE DEV, V23, P1625, DOI 10.1101/gad.1809209; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Kasahara K, 2010, BIOINFORMATICS, V26, P1493, DOI 10.1093/bioinformatics/btq232; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KrennHrubec K, 2007, BIOORG MED CHEM LETT, V17, P2874, DOI 10.1016/j.bmcl.2007.02.064; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Laptenko O, 2011, P NATL ACAD SCI USA, V108, P10385, DOI 10.1073/pnas.1105680108; Lee H, 2006, MOL CELL BIOL, V26, P5259, DOI 10.1128/MCB.01971-05; Lombardi PM, 2011, CURR OPIN STRUC BIOL, V21, P735, DOI 10.1016/j.sbi.2011.08.004; Marmorstein R, 2004, BIOCHEM SOC T, V32, P904, DOI 10.1042/BST0320904; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Oehme I, 2009, CLIN CANCER RES, V15, P91, DOI 10.1158/1078-0432.CCR-08-0684; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Reichert N, 2012, CELL MOL LIFE SCI, V69, P2173, DOI 10.1007/s00018-012-0921-9; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Rothbart SB, 2014, BBA-GENE REGUL MECH, V1839, P627, DOI 10.1016/j.bbagrm.2014.03.001; Schultz BE, 2004, BIOCHEMISTRY-US, V43, P11083, DOI 10.1021/bi0494471; Singh RK, 2014, BIOCHEMISTRY-US, V53, P7445, DOI 10.1021/bi500711x; Singh RK, 2011, BIOORG MED CHEM LETT, V21, P5920, DOI 10.1016/j.bmcl.2011.07.080; Singh RK, 2011, ANAL BIOCHEM, V408, P309, DOI 10.1016/j.ab.2010.08.040; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Tsuzuki S, 2002, J AM CHEM SOC, V124, P104, DOI 10.1021/ja0105212; Van Maerken T, 2011, MOL CANCER THER, V10, P983, DOI 10.1158/1535-7163.MCT-10-1090; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Wilson BJ, 2010, MOL ENDOCRINOL, V24, P1349, DOI 10.1210/me.2009-0441; Wolfson NA, 2013, BIOPOLYMERS, V99, P112, DOI 10.1002/bip.22135; Yan W, 2013, ONCOGENE, V32, P599, DOI 10.1038/onc.2012.81; Ziarek JJ, 2011, METHOD ENZYMOL, V493, P241, DOI 10.1016/B978-0-12-381274-2.00010-8	46	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6607	6619		10.1074/jbc.M114.600627	http://dx.doi.org/10.1074/jbc.M114.600627			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605725	Green Published, hybrid			2022-12-26	WOS:000350732500062
J	Wong, KKL; Li, WY; An, YR; Duan, YY; Li, ZH; Kang, YB; Yan, Y				Wong, Kenneth Kin Lam; Li, Wenyang; An, Yanru; Duan, Yangyang; Li, Zhuoheng; Kang, Yibin; Yan, Yan			beta-Spectrin Regulates the Hippo Signaling Pathway and Modulates the Basal Actin Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOMATIC FOLLICLE CELLS; ALPHA-SPECTRIN; F-ACTIN; ERYTHROCYTE-MEMBRANE; DROSOPHILA HOMOLOGS; ANTERIOR-POSTERIOR; DISTINCT FUNCTIONS; TUMOR-SUPPRESSOR; PROLIFERATION; PROTEIN	Emerging evidence suggests functional regulation of the Hippo pathway by the actin cytoskeleton, although the detailed molecular mechanism remains incomplete. In a genetic screen, we identified a requirement for beta-Spectrin in the posterior follicle cells for the oocyte repolarization process during Drosophila mid-oogenesis. beta-spectrin mutations lead to loss of Hippo signaling activity in the follicle cells. A similar reduction of Hippo signaling activity was observed after beta-Spectrin knockdown in mammalian cells. We further demonstrated that beta-spectrin mutations disrupt the basal actin network in follicle cells. The abnormal stress fiber-like actin structure on the basal side of follicle cells provides a likely link between the beta-spectrin mutations and the loss of the Hippo signaling activity phenotype.	[Wong, Kenneth Kin Lam; An, Yanru; Duan, Yangyang; Li, Zhuoheng; Yan, Yan] Hong Kong Univ Sci & Technol, Sch Sci, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Wong, Kenneth Kin Lam; An, Yanru; Yan, Yan] Hong Kong Univ Sci & Technol, Sch Sci, Ctr Syst Biol & Human Hlth, Kowloon, Hong Kong, Peoples R China; [Wong, Kenneth Kin Lam; An, Yanru; Yan, Yan] Hong Kong Univ Sci & Technol, Inst Adv Study, Kowloon, Hong Kong, Peoples R China; [Li, Wenyang; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Princeton University	Yan, Y (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Ctr Syst Biol & Human Hlth, Hong Kong, Hong Kong, Peoples R China.	yany@ust.hk		, Kin Lam/0000-0002-5597-4051; Kang, Yibin/0000-0002-1626-6730	Research Grants Council of the Hong Kong Special Administrative Region [16103314, AoE/M-09/12, IGN125C01]	Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council)	This work was supported by Research Grants Council of the Hong Kong Special Administrative Region Grants 16103314, AoE/M-09/12, and IGN125C01.	AGRE P, 1982, NEW ENGL J MED, V306, P1155, DOI 10.1056/NEJM198205133061906; AGRE P, 1985, NATURE, V314, P380, DOI 10.1038/314380a0; [Anonymous], DEV CELL, V14, P354; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1982, NATURE, V299, P126, DOI 10.1038/299126a0; BOEDIGHEIMER M, 1993, DEVELOPMENT, V118, P1291; BURRIDGE K, 1982, J CELL BIOL, V95, P478, DOI 10.1083/jcb.95.2.478; BYERS TJ, 1989, J CELL BIOL, V109, P1633, DOI 10.1083/jcb.109.4.1633; BYERS TJ, 1985, P NATL ACAD SCI USA, V82, P6153, DOI 10.1073/pnas.82.18.6153; BYERS TJ, 1987, J CELL BIOL, V105, P2103, DOI 10.1083/jcb.105.5.2103; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; COHEN CM, 1980, CELL, V21, P875, DOI 10.1016/0092-8674(80)90451-1; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Delaunay J, 2007, BLOOD REV, V21, P1, DOI 10.1016/j.blre.2006.03.005; Deng WM, 2001, DEVELOPMENT, V128, P4737; DUBREUIL RR, 1990, J CELL BIOL, V111, P1849, DOI 10.1083/jcb.111.5.1849; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Featherstone DE, 2001, J NEUROSCI, V21, P4215, DOI 10.1523/JNEUROSCI.21-12-04215.2001; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Gao YZ, 2011, J NEUROSCI, V31, P16581, DOI 10.1523/JNEUROSCI.3332-11.2011; GLENNEY JR, 1982, CELL, V28, P843, DOI 10.1016/0092-8674(82)90063-0; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; GUTZEIT HO, 1990, EUR J CELL BIOL, V53, P349; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hammarlund M, 2000, J CELL BIOL, V149, P931, DOI 10.1083/jcb.149.4.931; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; He L, 2010, NAT CELL BIOL, V12, P1133, DOI 10.1038/ncb2124; Hulsmeier J, 2007, DEVELOPMENT, V134, P713, DOI 10.1242/dev.02758; Krieg M, 2014, NAT CELL BIOL, V16, P224, DOI 10.1038/ncb2915; Kwon Y, 2013, SCIENCE, V342, P737, DOI 10.1126/science.1243971; Lee JK, 1997, DEVELOPMENT, V124, P353; LEE JK, 1993, J CELL BIOL, V123, P1797, DOI 10.1083/jcb.123.6.1797; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; Lucas EP, 2013, J CELL BIOL, V201, P875, DOI 10.1083/jcb.201210073; Machnicka B, 2012, CELL MOL LIFE SCI, V69, P191, DOI 10.1007/s00018-011-0804-5; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; MANGEAT PH, 1984, J CELL BIOL, V98, P1363, DOI 10.1083/jcb.98.4.1363; MARCHESI V. T., 1968, SCIENCE, V159, P203, DOI 10.1126/science.159.3811.203; McCartney BM, 1996, J CELL BIOL, V133, P843, DOI 10.1083/jcb.133.4.843; McKeown C, 1998, DEVELOPMENT, V125, P2087; Meignin C, 2007, CURR BIOL, V17, P1871, DOI 10.1016/j.cub.2007.09.062; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Moorthy S, 2000, J CELL BIOL, V149, P915, DOI 10.1083/jcb.149.4.915; NELSON WJ, 1990, J CELL BIOL, V110, P349, DOI 10.1083/jcb.110.2.349; Oda H, 2001, J CELL SCI, V114, P493; Pai LM, 2000, CELL, V103, P51, DOI 10.1016/S0092-8674(00)00104-5; PALEK J, 1983, SEMIN HEMATOL, V20, P189; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; PESACRETA TC, 1989, J CELL BIOL, V108, P1697, DOI 10.1083/jcb.108.5.1697; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; PINDER JC, 1975, NATURE, V258, P765, DOI 10.1038/258765a0; Polesello C, 2007, CURR BIOL, V17, P1864, DOI 10.1016/j.cub.2007.09.049; Prasad M, 2007, NAT PROTOC, V2, P2467, DOI 10.1038/nprot.2007.363; Rauskolb C, 2014, CELL, V158, P143, DOI 10.1016/j.cell.2014.05.035; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Roth S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001891; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Sun JJ, 2005, DEVELOPMENT, V132, P4299, DOI 10.1242/dev.02015; TILNEY LG, 1975, J CELL BIOL, V66, P508, DOI 10.1083/jcb.66.3.508; TSUKITA S, 1980, J CELL BIOL, V85, P567, DOI 10.1083/jcb.85.3.567; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Xi RW, 2003, DEV CELL, V4, P167, DOI 10.1016/S1534-5807(02)00412-4; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yan Y, 2011, DEVELOPMENT, V138, P1697, DOI 10.1242/dev.059279; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001761; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111	75	50	51	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6397	6407		10.1074/jbc.M114.629493	http://dx.doi.org/10.1074/jbc.M114.629493			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25589787	hybrid, Green Published			2022-12-26	WOS:000350732500044
J	Munns, CH; Chung, MK; Sanchez, YE; Arnzel, LM; Caterina, MJ				Munns, Clare H.; Chung, Man-Kyo; Sanchez, Yuly E.; Arnzel, L. Mario; Caterina, Michael J.			Role of the Outer Pore Domain in Transient Receptor Potential Vanilloid 1 Dynamic Permeability to Large Cations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2X(2) CHANNEL PERMEABILITY; ION-PERMEATION PATHWAY; CAPSAICIN RECEPTOR; POTASSIUM CHANNEL; TRP CHANNEL; MOLECULAR-BASIS; PAIN PATHWAY; ACTIVATION; SELECTIVITY; DILATION	Transient receptor potential vanilloid 1 (TRPV1) has been shown to alter its ionic selectivity profile in a time- and agonist-dependent manner. One hallmark of this dynamic process is an increased permeability to large cations such as N-methyl-D-glucamine (NMDG). In this study, we mutated residues throughout the TRPV1 pore domain to identify loci that contribute to dynamic large cation permeability. Using resiniferatoxin (RTX) as the agonist, we identified multiple gain-of-function substitutions within the TRPV1 pore turret (N628P and S629A), pore helix (F638A), and selectivity filter (M644A) domains. In all of these mutants, maximum NMDG permeability was substantially greater than that recorded in wild type TRPV1, despite similar or even reduced sodium current density. Two additional mutants, located in the pore turret (G618W) and selectivity filter (M644I), resulted in significantly reduced maximum NMDG permeability. M644A and M644I also showed increased and decreased minimum NMDG permeability, respectively. The phenotypes of this panel of mutants were confirmed by imaging the RTX-evoked uptake of the large cationic fluorescent dye YO-PROL Whereas none of the mutations selectively altered capsaicin-induced changes in NMDG permeability, the loss-of-function phenotypes seen with RTX stimulation of G618W and M644I were recapitulated in the capsaicin-evoked YO-PRO1 uptake assay. Curiously, the M644A substitution resulted in a loss, rather than a gain, in capsaicin-evoked YO-PRO1 uptake. Modeling of our mutations onto the recently determined TRPV1 structure revealed several plausible mechanisms for the phenotypes observed. We conclude that side chain interactions at a few specific loci within the TRPV1 pore contribute to the dynamic process of ionic selectivity.	[Munns, Clare H.; Caterina, Michael J.] Johns Hopkins Sch Med, Neurosurg Pain Res Inst, Dept Neurosurg, Baltimore, MD 21205 USA; [Munns, Clare H.; Caterina, Michael J.] Johns Hopkins Sch Med, Neurosurg Pain Res Inst, Dept Biol Chem, Baltimore, MD 21205 USA; [Munns, Clare H.; Caterina, Michael J.] Johns Hopkins Sch Med, Neurosurg Pain Res Inst, Dept Neurosci, Baltimore, MD 21205 USA; [Munns, Clare H.; Caterina, Michael J.] Johns Hopkins Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Sanchez, Yuly E.; Arnzel, L. Mario] Johns Hopkins Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Chung, Man-Kyo] Univ Maryland, Sch Dent, Dept Neural & Pain Sci, Baltimore, MD 21201 USA; [Sanchez, Yuly E.] Univ Nacl Colombia, Fac Ciencias, Dept Fis, Bogota 111321, Colombia; [Sanchez, Yuly E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota 110231, Colombia	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore; Universidad Nacional de Colombia; Pontificia Universidad Javeriana	Caterina, MJ (corresponding author), Johns Hopkins Sch Med, Neurosurg Pain Res Inst, Dept Neurosurg, 725 N Wolfe St, Baltimore, MD 21205 USA.	caterina@jhmi.edu	Chung, Man-Kyo/S-7433-2019	Chung, Man-Kyo/0000-0001-7637-1148; Amzel, L. Mario/0000-0002-0129-9572	National Institutes of Health from NINDS [NS054902]; National Institutes of Health from NIDCR [DE023846]; Neurosurgery Pain Research Institute; Blaustein Pain Research Fund at Johns Hopkins School of Medicine; John J. Bonica Fellowship from the International Association for the Study of Pain; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054902] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; National Institutes of Health from NIDCR; Neurosurgery Pain Research Institute; Blaustein Pain Research Fund at Johns Hopkins School of Medicine; John J. Bonica Fellowship from the International Association for the Study of Pain; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS054902 from NINDS (to M. J. C.), Grant DE023846 from NIDCR (to M. K. C.) by funding from the Neurosurgery Pain Research Institute and Blaustein Pain Research Fund at Johns Hopkins School of Medicine (to M. J. C.), and a John J. Bonica Fellowship from the International Association for the Study of Pain (to C. H. M.). Dr. Caterina is an inventor on a patent on the use of products related to TRPV1, which is licensed through UCSF and Merck. This conflict is being managed by the Johns Hopkins Office on Policy Coordination.	Ahern GP, 2006, J BIOL CHEM, V281, P8991, DOI 10.1074/jbc.M513429200; Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Aneiros E, 2011, EMBO J, V30, P994, DOI 10.1038/emboj.2011.19; Banke TG, 2010, AM J PHYSIOL-CELL PH, V298, pC1457, DOI 10.1152/ajpcell.00489.2009; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chao CC, 2010, J PHYSIOL SCI, V60, P441, DOI 10.1007/s12576-010-0111-1; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Chung MK, 2005, J BIOL CHEM, V280, P15928, DOI 10.1074/jbc.M500596200; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cui YY, 2012, J GEN PHYSIOL, V139, P273, DOI 10.1085/jgp.201110724; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eickhorst AN, 2002, J GEN PHYSIOL, V120, P119, DOI 10.1085/jgp.20028535; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Fisher JA, 2004, J NEUROSCI, V24, P10475, DOI 10.1523/JNEUROSCI.3250-04.2004; Fujiwara Y, 2004, J PHYSIOL-LONDON, V558, P31, DOI 10.1113/jphysiol.2004.064568; Garcia-Martinez C, 2000, J BIOL CHEM, V275, P32552, DOI 10.1074/jbc.M002391200; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; Hellwig N, 2004, J BIOL CHEM, V279, P34553, DOI 10.1074/jbc.M402966200; Jansson ET, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-1; Jiang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC1295, DOI 10.1152/ajpcell.00253.2005; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Karashima Y, 2010, BIOPHYS J, V98, P773, DOI 10.1016/j.bpj.2009.11.007; Khakh BS, 2005, J BIOL CHEM, V280, P6118, DOI 10.1074/jbc.M411324200; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kim SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059593; Lees-Miller JP, 2009, BIOPHYS J, V96, P3600, DOI 10.1016/j.bpj.2009.01.028; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Meyers JR, 2003, J NEUROSCI, V23, P4054; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Myrdal SE, 2005, HEARING RES, V204, P170, DOI 10.1016/j.heares.2005.02.005; Puopolo M, 2013, J NEUROPHYSIOL, V109, P1704, DOI 10.1152/jn.00012.2013; Raisinghani M, 2005, J PHYSIOL-LONDON, V567, P771, DOI 10.1113/jphysiol.2005.087874; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Veldhuis NA, 2012, J BIOL CHEM, V287, P21765, DOI 10.1074/jbc.M112.342022; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Vriens J, 2014, NAT CHEM BIOL, V10, P188, DOI [10.1038/nchembio.1428, 10.1038/NCHEMBIO.1428]; Wang ZR, 2009, J GEN PHYSIOL, V133, P361, DOI 10.1085/jgp.200810139; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yeh BI, 2005, EMBO J, V24, P3224, DOI 10.1038/sj.emboj.7600795	49	34	36	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5707	5724		10.1074/jbc.M114.597435	http://dx.doi.org/10.1074/jbc.M114.597435			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568328	Green Published, hybrid			2022-12-26	WOS:000350044200039
J	Gueler, F; Shushakova, N; Mengel, M; Hueper, K; Chen, R; Liu, XK; Park, JK; Haller, H; Wensvoort, G; Rong, S				Gueler, Faikah; Shushakova, Nelli; Mengel, Michael; Hueper, Katja; Chen, Rongjun; Liu, Xiaokun; Park, Joon-Keun; Haller, Hermann; Wensvoort, Gert; Rong, Song			A Novel Therapy to Attenuate Acute Kidney Injury and Ischemic Allograft Damage after Allogenic Kidney Transplantation in Mice	PLOS ONE			English	Article							LONG-TERM OUTCOMES; PERITUBULAR CAPILLARIES; DELAYED GRAFT; INHIBITION; REPERFUSION; RECEPTOR; HYPOXIA; MODEL; AKI	Ischemia followed by reperfusion contributes to the initial damage to allografts after kidney transplantation (ktx). In this study we tested the hypothesis that a tetrapeptide EA-230 (AQGV), might improve survival and attenuate loss of kidney function in a mouse model of renal ischemia/reperfusion injury (IRI) and ischemia-induced delayed graft function after allogenic kidney transplantation. IRI was induced in male C57Bl/6N mice by transient bilateral renal pedicle clamping for 35 min. Treatment with EA-230 (20-50mg/kg twice daily i.p. for four consecutive days) was initiated 24 hours after IRI when acute kidney injury (AKI) was already established. The treatment resulted in markedly improved survival in a dose dependent manner. Acute tubular injury two days after IRI was diminished and tubular epithelial cell proliferation was significantly enhanced by EA-230 treatment. Furthermore, CTGF up-regulation, a marker of post-ischemic fibrosis, at four weeks after IRI was significantly less in EA-230 treated renal tissue. To learn more about these effects, we measured renal blood flow (RBF) and glomerular filtration rate (GFR) at 28 hours after IRI. EA-230 improved both GFR and RBF significantly. Next, EA-230 treatment was tested in a model of ischemia-induced delayed graft function after allogenic kidney transplantation. The recipients were treated with EA-230 (50 mg/kg) twice daily i.p. which improved renal function and allograft survival by attenuating ischemic allograft damage. In conclusion, EA-230 is a novel and promising therapeutic agent for treating acute kidney injury and preventing IRI-induced post-transplant ischemic allograft injury. Its beneficial effect is associated with improved renal perfusion after IRI and enhanced regeneration of tubular epithelial cells.	[Gueler, Faikah; Shushakova, Nelli; Chen, Rongjun; Liu, Xiaokun; Park, Joon-Keun; Haller, Hermann; Rong, Song] Hannover Med Sch, Dept Nephrol, Hannover, Germany; [Shushakova, Nelli; Rong, Song] Phenos GmbH, Hannover, Germany; [Mengel, Michael] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Hueper, Katja] Hannover Med Sch, Hannover, Germany; [Chen, Rongjun] Zhejiang Univ, Affiliated Hosp 1, Kidney Dis Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Xiaokun] Zhejiang Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Wensvoort, Gert] Exponential Biotherapies Inc, The Hague, Netherlands; [Rong, Song] Zunyi Med Coll, Affiliated Hosp, Transplantat Ctr, Zunyi, Peoples R China	Hannover Medical School; University of Alberta; Hannover Medical School; Zhejiang University; Zhejiang University; Zunyi Medical University	Wensvoort, G (corresponding author), Exponential Biotherapies Inc, The Hague, Netherlands.	hetwittehuis@planet.nl	Hueper, Katja/J-9566-2016	Hueper, Katja/0000-0002-3195-4400; /0000-0001-9985-1515	Exponential Biotherapies Inc.	Exponential Biotherapies Inc.	Studies were outsourced by, funded by, and designed in guidance with Exponential Biotherapies Inc. The funders, through GW, had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bonventre JV, 2010, CONTRIB NEPHROL, V165, P9, DOI 10.1159/000313738; Chapal M, 2013, TRANSPLANTATION, V96, P739, DOI 10.1097/TP.0b013e31829f4772; Chatterjee PK, 2002, KIDNEY INT, V61, P862, DOI 10.1046/j.1523-1755.2002.00234.x; Cooper JE, 2013, CURR OPIN NEPHROL HY, V22, P698, DOI 10.1097/MNH.0b013e328365b388; Feng MG, 2012, AM J PHYSIOL-RENAL, V303, pF775, DOI 10.1152/ajprenal.00233.2012; Gentle ME, 2013, J AM SOC NEPHROL, V24, P787, DOI 10.1681/ASN.2012101024; Grossini E, 2013, J APPL PHYSIOL, V115, P422, DOI 10.1152/japplphysiol.00425.2013; Gueler F, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000026609.45827.3D; Gueler F, 2008, J AM SOC NEPHROL, V19, P2302, DOI 10.1681/ASN.2007111267; Hueper K, 2013, RADIOLOGY; Hueper K, 2013, INVEST RADIOL, V48, P834, DOI 10.1097/RLI.0b013e31829d0414; Hueper K, 2012, INVEST RADIOL, V47, P430, DOI 10.1097/RLI.0b013e31824f272d; Ishii Y, 2005, TRANSPL P, V37, P981, DOI 10.1016/j.transproceed.2004.12.284; Khan NA, 2002, HUM IMMUNOL, V63, P1, DOI 10.1016/S0198-8859(01)00372-X; Khan NA, 2009, NEPHROL DIAL TRANSPL, V24, P2701, DOI 10.1093/ndt/gfp369; Le Dorze M, 2009, CURR OPIN CRIT CARE, V15, P503, DOI 10.1097/MCC.0b013e328332f6cf; Legrand M, 2009, AM J PHYSIOL-RENAL, V296, pF1109, DOI 10.1152/ajprenal.90371.2008; Matsumoto M, 2004, J AM SOC NEPHROL, V15, P1574, DOI 10.1097/01.ASN.0000128047.13396.48; Nakagawa T, 2003, CURR OPIN NEPHROL HY, V12, P233, DOI 10.1097/00041552-200305000-00003; Parikh CR, 2008, BIOL BLOOD MARROW TR, V14, P309, DOI 10.1016/j.bbmt.2007.12.492; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Rong S, 2014, AM J PHYSL RENAL PHY; Rong S, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/127215; Snoeijs MGJ, 2011, ANN SURG, V253, P598, DOI 10.1097/SLA.0b013e31820d9ae9; van den Berg JW, 2011, CRIT CARE MED, V39, P126, DOI 10.1097/CCM.0b013e3181fa3a93; Wehbe E, 2013, CLIN J AM SOC NEPHRO, V8, P19, DOI 10.2215/CJN.04800512; Wehbe E, 2012, J HEART LUNG TRANSPL, V31, P244, DOI 10.1016/j.healun.2011.08.016; Wong MG, 2008, J AM SOC NEPHROL, V19, P290, DOI 10.1681/ASN.2007020226	28	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0115709	10.1371/journal.pone.0115709	http://dx.doi.org/10.1371/journal.pone.0115709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617900	Green Published, gold, Green Submitted			2022-12-26	WOS:000350336000006
J	Zhu, XM; Bai, YJ; Yu, WZ; Pan, CT; Jin, EZ; Song, D; Xu, Q; Yao, YO; Huang, LZ; Tao, Y; Li, XX; Zhao, MW				Zhu, Xuemei; Bai, Yujing; Yu, Wenzhen; Pan, Chungting; Jin, Enzhong; Song, Dan; Xu, Qiong; Yao, Yuou; Huang, Lvzhen; Tao, Yong; Li, Xiaoxin; Zhao, Mingwei			The Effects of Pleiotrophin in Proliferative Diabetic Retinopathy	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; GLYCATION END-PRODUCTS; SIGNALING PATHWAYS; PANCREATIC-CANCER; ENDOTHELIAL-CELLS; NEURAL APOPTOSIS; VEGF EXPRESSION; SEMAPHORIN 3A; GROWTH; RAT	Pleiotrophin (PTN), a secreted, multifunctional cytokine, is involved in angiogenic, fibrotic and neurodegenerative diseases. However, little is known about its effects on diabetic retinopathy, a neurovascular disease. To investigate the role of PTN in proliferative diabetic retinopathy (PDR), PTN concentration in the vitreous was evaluated in PDR patients and non-diabetic controls. PTN expression was observed in epiretinal membranes from patients. PTN knockdown was performed using small interfering (si) RNA, and the effects on retinal pigment epithelium (RPE) cells and human umbilical vascular endothelia cells (HUVECs) were observed in vitro under hyperglycemic and hypoxic conditions. Cell attachment, proliferation, migration, tube formation, cell cycle, apoptosis, extracellular signal-regulated kinase 1/2 (ERK 1/2) phosphorylation, and VEGF levels were studied. The vitreous PTN concentration in PDR patients was higher than that in non-diabetic controls, and PTN was highly expressed in the fibrovascular membranes of PDR patients. Under hyperglycemic and hypoxic conditions, PTN knockdown reduced cell attachment, proliferation, migration, and tube formation and induced cell cycle arrest and apoptosis in vitro. Mechanically, PTN depletion decreased ERK 1/2 phosphorylation. Recombinant PTN up regulated the concentration of VEGF in vitro, which can be attenuated by the ERK 1/2 inhibitor. Taken together, our results implied that elevated PTN in PDR patients might participate in the critical processes of the development of PDR, most likely playing roles in angiogenesis and proliferation, possibly by activating the ERK 1/2 pathway and regulating VEGF secretion. These findings provide new insight into the roles of PTN in PDR and suggest that PTN may become a new target for therapeutic intervention in PDR. .	[Zhu, Xuemei; Bai, Yujing; Yu, Wenzhen; Pan, Chungting; Jin, Enzhong; Song, Dan; Xu, Qiong; Yao, Yuou; Huang, Lvzhen; Tao, Yong; Li, Xiaoxin; Zhao, Mingwei] Peking Univ, Peoples Hosp, Dept Ophthalmol,Minist Educ, Key Lab Vis Loss & Restorat,Beijing Key Lab Diago, Beijing 100044, Peoples R China	Peking University	Zhao, MW (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol,Minist Educ, Key Lab Vis Loss & Restorat,Beijing Key Lab Diago, Beijing 100044, Peoples R China.	zhaomingwei@medmail.com.cn		Jin, Enzhong/0000-0003-1450-5846	Specialized Research Fund for the Doctoral Program of Higher Education [20130001110086]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the Specialized Research Fund for the Doctoral Program of Higher Education for ZMW (20130001110086) http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/2013/10/1382602963718681.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YJ, 2013, INVEST OPHTH VIS SCI, V54, P6628, DOI 10.1167/iovs.13-12625; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; BLOCH B, 1992, DEV BRAIN RES, V70, P267, DOI 10.1016/0165-3806(92)90206-C; Bowden ET, 2002, J BIOL CHEM, V277, P35862, DOI 10.1074/jbc.M203963200; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; Chang YC, 2007, P NATL ACAD SCI USA, V104, P10888, DOI 10.1073/pnas.0704366104; Chen M, 2013, CURR MED CHEM, V20, P3234, DOI 10.2174/09298673113209990025; Cheung N, 2014, DIABETES CARE, V37, P900, DOI 10.2337/dc13-1990; Christman KL, 2005, BIOMATERIALS, V26, P1139, DOI 10.1016/j.biomaterials.2004.04.025; CZUBAYKO F, 1994, J BIOL CHEM, V269, P21358; D'Amico AG, 2014, J MOL NEUROSCI, V54, P405, DOI 10.1007/s12031-014-0335-2; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; Deuel TF, 2013, BBA-PROTEINS PROTEOM, V1834, P2219, DOI 10.1016/j.bbapap.2013.06.004; Early Treatment Diabetic Retinopathy Study Research Group, 1991, OPHTHALMOLOGY, V98, P766; Fan JB, 2014, BIOCHEM BIOPH RES CO, V447, P425, DOI 10.1016/j.bbrc.2014.04.002; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; FERRIS FL, 1991, JAMA-J AM MED ASSOC, V266, P1263, DOI 10.1001/jama.266.9.1263; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Heng LZ, 2013, DIABETIC MED, V30, P640, DOI 10.1111/dme.12089; Herradon G, 2014, BRIT J PHARMACOL, V171, P837, DOI 10.1111/bph.12312; Herradon G, 2009, CURR MED CHEM, V16, P3322, DOI 10.2174/092986709788803240; Hida H, 2003, EUR J NEUROSCI, V17, P2127, DOI 10.1046/j.1460-9568.2003.02661.x; Isenovic ER, 2010, ANGIOLOGY, V61, P357, DOI 10.1177/0003319709358693; Jindal V., 2014, MOL NEUROBIOL; Jung KI, 2013, J PHARMACOL EXP THER, V345, P457, DOI 10.1124/jpet.113.203067; Kohashi T, 2002, GROWTH FACTORS, V20, P53, DOI 10.1080/08977190290023913; Kong Y, 2012, INT J COLORECTAL DIS, V27, P287, DOI 10.1007/s00384-011-1344-z; Koutsioumpa M, 2013, J BIOL CHEM, V288, P343, DOI 10.1074/jbc.M112.387076; Li JL, 2007, J BIOL CHEM, V282, P34984, DOI 10.1074/jbc.M703513200; Li PY, 2011, CURR EYE RES, V36, P673, DOI 10.3109/02713683.2011.572220; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Liu J, 2013, INT J MOL MED, V32, P1150, DOI 10.3892/ijmm.2013.1491; Mentlein R, 2002, J NEUROCHEM, V83, P747, DOI 10.1046/j.1471-4159.2002.01179.x; Miao JY, 2012, NEUROSCI RES, V74, P269, DOI 10.1016/j.neures.2012.09.001; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Osaadon P, 2014, EYE, V28, P510, DOI 10.1038/eye.2014.13; Perez-Pinera P, 2006, P NATL ACAD SCI USA, V103, P17795, DOI 10.1073/pnas.0607299103; Pufe T, 2003, ARTHRITIS RHEUM, V48, P660, DOI 10.1002/art.10839; Rumsby M, 1999, GLIA, V26, P361, DOI 10.1002/(SICI)1098-1136(199906)26:4<361::AID-GLIA10>3.0.CO;2-Q; Saker S, 2014, EXP EYE RES, V121, P161, DOI 10.1016/j.exer.2014.02.016; Simo R, 2009, DIABETES CARE, V32, P1556, DOI 10.2337/dc09-0565; Tsai TT, 2014, J ORTHOP RES, V32, P238, DOI 10.1002/jor.22508; Weber D, 2000, CANCER RES, V60, P5284; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Yao J, 2013, WORLD J GASTROENTERO, V19, P6555, DOI 10.3748/wjg.v19.i39.6555; Ye XF, 2010, INVEST OPHTH VIS SCI, V51, P5226, DOI 10.1167/iovs.09-4899; Yokoi H, 2012, KIDNEY INT, V81, P160, DOI 10.1038/ki.2011.305; Yu WZ, 2013, MOL VIS, V19, P1397; Zhang N, 1997, J BIOL CHEM, V272, P16733, DOI 10.1074/jbc.272.27.16733; Zhang Q, 2013, J MOL HISTOL, V44, P91, DOI 10.1007/s10735-012-9453-8; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111	52	16	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0115523	10.1371/journal.pone.0115523	http://dx.doi.org/10.1371/journal.pone.0115523			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617851	gold, Green Published, Green Submitted			2022-12-26	WOS:000350336000005
J	Kaulfers, AM; Deka, R; Dolan, L; Martin, LJ				Kaulfers, Anne-Marie; Deka, Ranjan; Dolan, Lawrence; Martin, Lisa J.			Association of INSIG2 Polymorphism with Overweight and LDL in Children	PLOS ONE			English	Article							COMMON GENETIC VARIANT; BODY-MASS INDEX; RS7566605 POLYMORPHISM; NO ASSOCIATION; OBESITY; UPSTREAM; REPLICATION; CHOLESTEROL; METABOLISM; PHENOTYPES	Background Dyslipidemia and overweight are common issues in children. Identifying genetic markers of risk could lead to targeted interventions. A polymorphism of SNP rs7566605 near insulin-induced gene 2 (INSIG2) has been identified as a strong candidate gene for obesity, through its feedback control of lipid synthesis. Objective To identify polymorphisms in INSIG2 which are associated with overweight (BMI >= 85% for age) and dyslipidemia in children. Hypothesis: The C allele of rs7566605 would be significantly associated with BMI and LDL. Design/Methods We genotyped 15 SNPs in/near INSIG2 in 1,058 healthy children (53% non-Hispanic white (NHW), 37% overweight) participating in a school based study. Genotype was compared with BMI and lipid markers, adjusting for age, gender, and puberty. Results We found a significant association between the SNP rs12464355 and LDL in NHW children, p < 0.001. The G allele is protective (lower LDL). A different SNP was associated with overweight in NHW: rs17047757. SNP rs7566605 was not associated with overweight or lipid levels. Conclusions We identified novel genetic associations between INSIG2 and both overweight and LDL in NHW children. Polymorphisms in INSIG2 may be important in the development of obesity through its effects on lipid regulation.	[Kaulfers, Anne-Marie] Univ S Alabama, Div Pediat Endocrinol, Mobile, AL 36688 USA; [Deka, Ranjan] Univ Cincinnati, Sch Med, Dept Environm Hlth, Cincinnati, OH USA; [Dolan, Lawrence] Cincinnati Childrens Hosp Med Ctr, Div Endocrinol, Cincinnati, OH 45229 USA; [Dolan, Lawrence; Martin, Lisa J.] Univ Cincinnati, Sch Med, Cincinnati, OH USA; [Martin, Lisa J.] Cincinnati Childrens Hosp Med Ctr, Div Biostat, Cincinnati, OH 45229 USA; [Martin, Lisa J.] Cincinnati Childrens Hosp Med Ctr, Div Epidemiol, Div Human Genet, Cincinnati, OH 45229 USA	University of South Alabama; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Kaulfers, AM (corresponding author), Univ S Alabama, Div Pediat Endocrinol, Mobile, AL 36688 USA.	akaulfers@health.southalabama.edu	Martin, Lisa/E-2425-2016	Martin, Lisa/0000-0001-8702-9946	National Institute of Health (NIH) [DK59183]; Institutional Clinical and Translational Science Award; NIH/NCRR [1UL1RR026314-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR026314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059183, P30DK078392] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Clinical and Translational Science Award; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by National Institute of Health (NIH) Grant DK59183 and by an Institutional Clinical and Translational Science Award, NIH/NCRR Grant Number 1UL1RR026314-01; www.nih.gov. LD received the funding. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002872; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Boes E, 2008, OBESITY, V16, P827, DOI 10.1038/oby.2007.132; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Ciullo M, 2008, DIABETES, V57, P783, DOI 10.2337/db07-0970; Dahlman I, 2007, INT J OBESITY, V31, P1629, DOI 10.1038/sj.ijo.0803657; Dina C, 2007, SCIENCE, V315, DOI [10.1126/science.1129402, 10.1126/science.1130571, 10.1126/science.1130012]; Do R, 2010, CIRC-CARDIOVASC GENE, V3, P454, DOI 10.1161/CIRCGENETICS.109.917039; Dolan LM, 2005, J PEDIATR-US, V146, P751, DOI 10.1016/j.jpeds.2005.01.045; Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Feng Y, 2007, HUM GENET, V120, P743, DOI 10.1007/s00439-006-0258-2; Freedman DS, 2009, AM J CLIN NUTR, V90, P210, DOI 10.3945/ajcn.2009.27525; Hall DH, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-83; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hotta K, 2008, J HUM GENET, V53, P857, DOI 10.1007/s10038-008-0317-8; Krapivner S, 2008, J CLIN ENDOCR METAB, V93, P1995, DOI 10.1210/jc.2007-1850; Kumar J, 2007, CLIN GENET, V71, P415, DOI 10.1111/j.1399-0004.2007.00795.x; Kuzuya M, 2007, OBESITY, V15, P2531, DOI 10.1038/oby.2007.301; Le Hellard S, 2009, MOL PSYCHIATR, V14, P308, DOI 10.1038/sj.mp.4002133; Lyon HN, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030061; Oki K, 2009, BRIT J NUTR, V101, P322, DOI 10.1017/S0007114508006557; Pal P, 2007, HUM GENET, V122, P251, DOI 10.1007/s00439-007-0394-3; Skelly T, 2007, MOL PSYCHIATR, V12, P321, DOI 10.1038/sj.mp.4001956; Smith AJP, 2007, INT J OBESITY, V31, P1753, DOI 10.1038/sj.ijo.0803645; Tabara Y, 2008, OBESITY, V16, P211, DOI 10.1038/oby.2007.25; Vimaleswaran KS, 2009, OBESITY, V17, P1453, DOI 10.1038/oby.2008.650; Wang HJ, 2008, BIOMED ENVIRON SCI, V21, P528, DOI 10.1016/S0895-3988(09)60013-1; Wiedmann S, 2009, OBESITY, V17, P1390, DOI 10.1038/oby.2008.669; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang L, 2008, EUR J HUM GENET, V16, P759, DOI 10.1038/ejhg.2008.8; Zhang Jun, 2008, Diabetes Res Clin Pract, V81, pe11, DOI 10.1016/j.diabres.2008.03.022	32	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116340	10.1371/journal.pone.0116340	http://dx.doi.org/10.1371/journal.pone.0116340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607990	Green Published, gold, Green Submitted			2022-12-26	WOS:000348205300024
J	Kim, SH; Park, J; Joo, C; Kim, D; Ha, T				Kim, Sung Hyun; Park, Jeehae; Joo, Chirlmin; Kim, Doseok; Ha, Taekjip			Dynamic Growth and Shrinkage Govern the pH Dependence of RecA Filament Stability	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; C-TERMINUS; PROTEIN; MOLECULES; EXCHANGE; REPLICATION; MECHANISM; MONOMER	RecA proteins form a long stable filament on a single-stranded DNA and catalyze strand exchange reaction. The stability of RecA filament changes dramatically with pH, yet its detailed mechanism is not known. Here, using a single molecule assay, we determined the binding and dissociation rates of RecA monomers at the filament ends at various pH. The pH-induced rate changes were moderate but occurred in opposite directions for binding and dissociation, resulting in a substantial increase in filament stability in lower pH. The highly charged residues in C-terminal domain do not contribute to the pH dependent stability. The stability enhancement of RecA filament in low pH may help the cell to cope with acidic stress by fine-tuning of the binding and dissociation rates without losing the highly dynamic nature of the filament required for strand exchange.	[Kim, Sung Hyun; Kim, Doseok] Sogang Univ, Dept Phys, Seoul 100611, South Korea; [Kim, Sung Hyun; Kim, Doseok] Sogang Univ, Interdisciplinary Program Integrated Biotechnol, Seoul 100611, South Korea; [Park, Jeehae; Ha, Taekjip] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL USA; [Joo, Chirlmin] Delft Univ Technol, Kavli Inst NanoSci, Dept BioNanoSci, Delft, Netherlands; [Ha, Taekjip] Univ Illinois, Howard Hughes Med Inst, Dept Phys, Urbana, IL USA	Sogang University; Sogang University; University of Illinois System; University of Illinois Urbana-Champaign; Delft University of Technology; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	Kim, D (corresponding author), Sogang Univ, Dept Phys, Seoul 100611, South Korea.	doseok@sogang.ac.kr; tjha@illinois.edu	Ha, Taekjip/B-9506-2009; Kim, Doseok/N-9521-2019; Joo, Chirlmin/B-9294-2008	Ha, Taekjip/0000-0003-2195-6258; Joo, Chirlmin/0000-0003-2803-0335; Kim, Sung Hyun/0000-0001-9272-7036	US National Science Foundation [PHY-0646550, PHY-1430124]; US National Institutes of Health [GM065367]; Korean Government (MEST) [2011-0017435]; European Research Council under the European Union's Seventh Framework Programme/ERC grant [309509]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); European Research Council under the European Union's Seventh Framework Programme/ERC grant(European Research Council (ERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by a grant from the US National Science Foundation [PHY-0646550, PHY-1430124 to TH]; US National Institutes of Health [GM065367 to TH]. DK acknowledges support from the Korean Government (MEST) grant No. 2011-0017435. CJ has received funding from the European Research Council under the European Union's Seventh Framework Programme [FP7/2007-2013]/ERC grant agreement no [309509]. RecA mutant was a kind gift from M. M. Cox (University of Wisconsin, Madison, USA).	Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; Bell JC, 2012, NATURE, V491, P274, DOI 10.1038/nature11598; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; EGELMAN EH, 1993, MICRON, V24, P309, DOI 10.1016/0968-4328(93)90056-7; Eggler AL, 2003, J BIOL CHEM, V278, P16389, DOI 10.1074/jbc.M212920200; Fu HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066712; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2012, ANNU REV BIOPHYS, V41, P295, DOI 10.1146/annurev-biophys-042910-155351; Jeong KC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-181; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kim SH, 2013, NUCLEIC ACIDS RES, V41, P7738, DOI 10.1093/nar/gkt570; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Len ACL, 2004, MICROBIOL-SGM, V150, P1339, DOI 10.1099/mic.0.27008-0; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2003, J BIOL CHEM, V278, P16381, DOI 10.1074/jbc.M212916200; MCENTEE K, 1981, J BIOL CHEM, V256, P8835; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; MIKAWA T, 1995, J MOL BIOL, V250, P471, DOI 10.1006/jmbi.1995.0391; MUENCH KA, 1990, J BIOL CHEM, V265, P11560; PINSINCE JM, 1993, J MOL BIOL, V233, P59, DOI 10.1006/jmbi.1993.1484; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Vaze MB, 1999, BIOCHEMISTRY-US, V38, P3175, DOI 10.1021/bi9819125; WEINSTOCK GM, 1981, J BIOL CHEM, V256, P8829	25	36	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0115611	10.1371/journal.pone.0115611	http://dx.doi.org/10.1371/journal.pone.0115611			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25608006	Green Published, gold			2022-12-26	WOS:000348205300017
J	Dasgupta, MG; Dharanishanthi, V; Agarwal, I; Krutovsky, KV				Dasgupta, Modhumita Ghosh; Dharanishanthi, Veeramuthu; Agarwal, Ishangi; Krutovsky, Konstantin V.			Development of Genetic Markers in Eucalyptus Species by Target Enrichment and Exome Sequencing	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PINUS-TAEDA L.; COTTONWOOD POPULUS-TRICHOCARPA; DOMAIN TRANSCRIPTION FACTOR; THROUGHPUT SNP DISCOVERY; WOOD-FORMING TISSUES; CELL-WALL FORMATION; RAPD MARKERS; LIGNIN BIOSYNTHESIS; LINKAGE DISEQUILIBRIUM	The advent of next-generation sequencing has facilitated large-scale discovery, validation and assessment of genetic markers for high density genotyping. The present study was undertaken to identify markers in genes supposedly related to wood property traits in three Eucalyptus species. Ninety four genes involved in xylogenesis were selected for hybridization probe based nuclear genomic DNA target enrichment and exome sequencing. Genomic DNA was isolated from the leaf tissues and used for on-array probe hybridization followed by Illumina sequencing. The raw sequence reads were trimmed and high-quality reads were mapped to the E. grandis reference sequence and the presence of single nucleotide variants (SNVs) and insertions/deletions (InDels) were identified across the three species. The average read coverage was 216X and a total of 2294 SNVs and 479 InDels were discovered in E. camaldulensis, 2383 SNVs and 518 InDels in E. tereticornis, and 1228 SNVs and 409 InDels in E. grandis. Additionally, SNV calling and InDel detection were conducted in pair-wise comparisons of E. tereticornis vs. E. grandis, E. camaldulensis vs. E. tereticornis and E. camaldulensis vs. E. grandis. This study presents an efficient and high throughput method on development of genetic markers for family-based QTL and association analysis in Eucalyptus.	[Dasgupta, Modhumita Ghosh; Dharanishanthi, Veeramuthu] Inst Forest Genet & Tree Breeding, Div Plant Biotechnol, Coimbatore 641002, Tamil Nadu, India; [Agarwal, Ishangi] Genotyp Technol Private Ltd, Bangalore 560094, India; [Krutovsky, Konstantin V.] Univ Gottingen, Dept Forest Genet, D-37077 Gottingen, Germany; [Krutovsky, Konstantin V.] Univ Gottingen, Busgen Inst, D-37077 Gottingen, Germany; [Krutovsky, Konstantin V.] Texas A&M Univ, Dept Ecosystem Sci & Management, College Stn, TX 77843 USA; [Krutovsky, Konstantin V.] Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow 119333, Russia; [Krutovsky, Konstantin V.] Siberian Fed Univ, Genome Res & Educ Ctr, Krasnoyarsk 660036, Russia	Indian Council of Forestry Research & Education (ICFRE); Institute of Forest Genetics & Tree Breeding (IFGTB); University of Gottingen; University of Gottingen; Texas A&M University System; Texas A&M University College Station; Russian Academy of Sciences; Vavilov Institute of General Genetics; Siberian Federal University	Dasgupta, MG (corresponding author), Inst Forest Genet & Tree Breeding, Div Plant Biotechnol, PB 1061,R S Puram, Coimbatore 641002, Tamil Nadu, India.	modhumitaghosh@hotmail.com	Dasgupta, Modhumita Ghosh/AAX-9028-2020; Krutovsky, Konstantin V./A-5419-2012	Dasgupta, Modhumita Ghosh/0000-0001-8878-5911; Krutovsky, Konstantin V./0000-0002-8819-7084; , Dharanishanthi/0000-0001-6910-3524	Department of Biotechnology, Government of India under the DBT-CREST Awardship [BT/IN/CREST-Awards/15/MDG/2010-11]; Department of Biotechnology, Government of India [BT/PR10055/PBD/16/772/2007]	Department of Biotechnology, Government of India under the DBT-CREST Awardship; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The funding for the research work was provided to MDG by Department of Biotechnology, Government of India under the DBT-CREST Awardship with grant number BT/IN/CREST-Awards/15/MDG/2010-11 and under the research project with grant number BT/PR10055/PBD/16/772/2007. The funding support as research fellowship was provided to VD by Department of Biotechnology, Government of India under the research project with grant number BT/PR10055/PBD/16/772/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Andersson-Gunneras S, 2003, PLANT J, V34, P339, DOI 10.1046/j.1365-313X.2003.01727.x; Arumugasundaram S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028252; Balasaravanan T, 2005, TREE PHYSIOL, V25, P1295, DOI 10.1093/treephys/25.10.1295; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Brandstrom M, 2007, GENETICS, V176, P1691, DOI 10.1534/genetics.107.070805; Britten RJ, 2003, P NATL ACAD SCI USA, V100, P4661, DOI 10.1073/pnas.0330964100; Brooker MIH, 2000, AUST SYST BOT, V13, P79, DOI 10.1071/SB98008; Byers RL, 2012, THEOR APPL GENET, V124, P1201, DOI 10.1007/s00122-011-1780-8; Byrne M, 1998, HEREDITY, V81, P225, DOI 10.1038/sj.hdy.6883860; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Chezhian P, 2010, NEW FOREST, V40, P85, DOI 10.1007/s11056-009-9184-1; Ching A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-19; Chu YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098334; Cseke LJ, 2003, GENE, V318, P55, DOI 10.1016/S0378-1119(03)00765-0; Doughty RW, 2000, EUCALYPTUS NATURAL C; Eckert AJ, 2009, TREE GENET GENOMES, V5, P225, DOI 10.1007/s11295-008-0183-8; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Gaiotto FA, 1997, P IUFRO C SILV IMPR, V2, P46; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Grattapaglia D., 1992, RESOLVING TROPICAL F, P436; Grattapaglia D, 2012, TREE GENET GENOMES, V8, P463, DOI 10.1007/s11295-012-0491-x; Grattapaglia D, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-65; Hamilton JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-302; Harakava R, 2005, GENET MOL BIOL, V28, P601, DOI 10.1590/S1415-47572005000400015; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hayashi K, 2006, THEOR APPL GENET, V113, P251, DOI 10.1007/s00122-006-0290-6; Hefer C., 2011, BMC P, V5, pO49, DOI [10.1186/1753-6561-5-S7-O49, DOI 10.1186/1753-6561-5-S7-O49]; Hendre PS, 2012, PLANT BIOTECHNOL J, V10, P646, DOI 10.1111/j.1467-7652.2012.00699.x; Hertzberg M, 2001, P NATL ACAD SCI USA, V98, P14732, DOI 10.1073/pnas.261293398; Hirakawa H, 2011, PLANT BIOTECHNOL-NAR, V28, P471, DOI 10.5511/plantbiotechnology.11.1027b; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; Howe GT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-137; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Iglesias I., 2009, EUCALYPTOLOGICS INFO; Jensen JK, 2011, PLANT J, V66, P387, DOI 10.1111/j.1365-313X.2010.04475.x; Jones E, 2009, MOL BREEDING, V24, P165, DOI 10.1007/s11032-009-9281-z; Junghans DT, 2003, THEOR APPL GENET, V108, P175, DOI 10.1007/s00122-003-1415-9; Jupe F, 2013, PLANT J, V76, P530, DOI 10.1111/tpj.12307; Kallarackal J, 1997, FOREST ECOL MANAG, V95, P53, DOI 10.1016/S0378-1127(97)00004-2; Kallarackal J., 2002, RECENT EUCALYPT RES, P94; Kalluri UC, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-59; Kaya HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073674; Keller G, 2009, TREE GENET GENOMES, V5, P317, DOI 10.1007/s11295-008-0184-7; Kenny EM, 2011, DNA RES, V18, P31, DOI 10.1093/dnares/dsq029; Kirst M, 2003, P NATL ACAD SCI USA, V100, P7383, DOI 10.1073/pnas.1132171100; Kirst M, 2004, PLANT PHYSIOL, V135, P2368, DOI 10.1104/pp.103.037960; KLOCKO AL, 2013, P PLANT AN GEN 22 HE; KONG F, 2013, J PLANT BIOCH PHYSL, V1, P2; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Kulheim C, 2011, NEW PHYTOL, V191, P1041, DOI 10.1111/j.1469-8137.2011.03769.x; Kulheim C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-452; Kumar S., 2012, INT J COMP APP IRAFI, V5, P1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Dantec L, 2004, PLANT MOL BIOL, V54, P461, DOI 10.1023/B:PLAN.0000036376.11710.6f; Lenhard M, 2002, DEVELOPMENT, V129, P3195; Li EY, 2012, NEW PHYTOL, V194, P102, DOI 10.1111/j.1469-8137.2011.04016.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-6; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; LIMA BM, 2011, BMC PROC SUPPL 7, V5, pP31, DOI DOI 10.1186/1753-6561-5-S7-P31; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Marques CM, 1999, THEOR APPL GENET, V99, P936, DOI 10.1007/s001220051400; Marques CM, 1998, THEOR APPL GENET, V96, P727, DOI 10.1007/s001220050795; Mauriat M, 2009, PLANT J, V58, P989, DOI 10.1111/j.1365-313X.2009.03836.x; Meirmans PG, 2007, CAN J BOT, V85, P1082, DOI 10.1139/B07-069; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Moghaddam SM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00185; Mokry M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq072; Muchero W, 2009, P NATL ACAD SCI USA, V106, P18159, DOI 10.1073/pnas.0905886106; Muro-Abad J. I., 2005, Scientia Forestalis, P53; Myburg AA, 2003, THEOR APPL GENET, V107, P1028, DOI 10.1007/s00122-003-1347-4; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Neves LG, 2014, G3-GENES GENOM GENET, V4, P29, DOI 10.1534/g3.113.008714; Nieminen K, 2008, P NATL ACAD SCI USA, V105, P20032, DOI 10.1073/pnas.0805617106; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ohashi-Ito K, 2010, CURR OPIN PLANT BIOL, V13, P670, DOI 10.1016/j.pbi.2010.08.011; Ollitrault F, 2012, AM J BOT, V99, pE268, DOI 10.3732/ajb.1100569; Ometto L, 2005, GENETICS, V169, P1521, DOI 10.1534/genetics.104.037689; Paiva JAP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-137; Park S, 2004, MOL BREEDING, V14, P429, DOI 10.1007/s11032-004-0603-x; Paszkiewicz K, 2012, BIOINFORMATICS FOR HIGH THROUGHPUT SEQUENCING, P231, DOI 10.1007/978-1-4614-0782-9_14; Paux E, 2005, NEW PHYTOL, V167, P89, DOI 10.1111/j.1469-8137.2005.01396.x; Pavy N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-21; Perdereau AC, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-114; Poltri SNM, 2003, TREE PHYSIOL, V23, P625, DOI 10.1093/treephys/23.9.625; Potts BM., 2004, ENCY FOREST SCI, P1480, DOI [10.1016/B0-12-145160-7/00084-3, DOI 10.1016/B0-12-145160-7/00084-3]; RASMUSSENPOBLET.S, 2008, ELECTRON J BIOTECHN, V11, pP1; Rengel D, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-36; Resende MDV, 2012, NEW PHYTOL, V194, P116, DOI 10.1111/j.1469-8137.2011.04038.x; Ruprecht C, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00023; Saintenac C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r88; Salathia N, 2007, PLANT J, V51, P727, DOI 10.1111/j.1365-313X.2007.03194.x; Sansaloni CP, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-16; Schneeberger K, 2011, TRENDS PLANT SCI, V16, P282, DOI 10.1016/j.tplants.2011.02.006; Schroeder H., 2011, BMC P, V5, P1, DOI [10.1186/1753-6561-5-S7-P56, DOI 10.1186/1753-6561-5-S7-P56]; SEXTON T, 2011, THESIS SO CROSS U LI; Shao HJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1143; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shepherd M, 1999, THEOR APPL GENET, V99, P1207, DOI 10.1007/s001220051326; Shi R, 2010, PLANT CELL PHYSIOL, V51, P144, DOI 10.1093/pcp/pcp175; SINGH P, 2014, P PLANT AN GEN 22 HE; Singh TR, 2011, J GENET, V90, pE34; Southerton SG, 2010, AUST FORESTRY, V73, P259, DOI 10.1080/00049158.2010.10676337; Sterky F, 1998, P NATL ACAD SCI USA, V95, P13330, DOI 10.1073/pnas.95.22.13330; Teixeira J, 2011, BMC P S7, V5, pP40, DOI DOI 10.1186/1753-6561-5-S7-P40; Tennessen JA, 2013, G3-GENES GENOM GENET, V3, P1341, DOI 10.1534/g3.113.006288; Thamarus KA, 2002, THEOR APPL GENET, V104, P379, DOI 10.1007/s001220100717; Thavamanikumar S, 2011, AUST FORESTRY, V74, P23, DOI 10.1080/00049158.2011.10676342; Thumma BR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-364; Thumma BR, 2005, GENETICS, V171, P1257, DOI 10.1534/genetics.105.042028; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Verhaegen D, 1997, THEOR APPL GENET, V95, P597, DOI 10.1007/s001220050601; Verhaegen D, 1996, GENOME, V39, P1051, DOI 10.1139/g96-132; Villar E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-538; Waugh R, 2009, CURR OPIN PLANT BIOL, V12, P218, DOI 10.1016/j.pbi.2008.12.007; Wegrzyn JL, 2010, NEW PHYTOL, V188, P515, DOI 10.1111/j.1469-8137.2010.03415.x; Winfield MO, 2012, PLANT BIOTECHNOL J, V10, P733, DOI 10.1111/j.1467-7652.2012.00713.x; Wong MML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-342; Wu XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-469; Yang XH, 2011, PLANT SCI, V181, P675, DOI 10.1016/j.plantsci.2011.01.020; Zhang X, 2009, GENETICS, V182, P943, DOI 10.1534/genetics.109.103499; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhou LC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-703	130	28	30	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116528	10.1371/journal.pone.0116528	http://dx.doi.org/10.1371/journal.pone.0116528			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602379	gold, Green Published, Green Submitted			2022-12-26	WOS:000348203500028
J	Calve, S; Ready, A; Huppenbauer, C; Main, R; Neu, CP				Calve, Sarah; Ready, Andrew; Huppenbauer, Christopher; Main, Russell; Neu, Corey P.			Optical Clearing in Dense Connective Tissues to Visualize Cellular Connectivity In Situ	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; BETA-CATENIN; MORPHOLOGY; CELLS; CHONDROCYTE; EXPRESSION; MOUSE; RECONSTRUCTION; CYTOSKELETON; MICROSCOPY	Visualizing the three-dimensional morphology and spatial patterning of cells embedded deep within dense connective tissues of the musculoskeletal system has been possible only by utilizing destructive techniques. Here we utilize fructose-based clearing solutions to image cell connectivity and deep tissue-scale patterning in situ by standard confocal microscopy. Optical clearing takes advantage of refractive index matching of tissue and the embedding medium to visualize light transmission through a broad range of bovine and whole mount murine tissues, including cartilage, bone, and ligament, of the head and hindlimb. Using non-destructive methods, we show for the first time intercellular chondrocyte connections throughout the bulk of cartilage, and we reveal in situ patterns of osteocyte processes and the lacunar-canalicular system deep within mineralized cortical bone. Optical clearing of connective tissues is expected to find broad application for the study of cell responses in normal physiology and disease pathology.	[Calve, Sarah; Ready, Andrew; Main, Russell; Neu, Corey P.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Huppenbauer, Christopher] W Nuhsbaum Inc, Mchenry, IL USA; [Main, Russell] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Calve, S (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	scalve@purdue.edu; cpneu@purdue.edu			National Institutes of Health (NIH) [R01 AR063712, R21 AR064178, R21 AR066230, R21 AR065659, R03 AR065201]; NSF [1349735]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR065659, R21AR064178, R01AR063712, R21AR066230, R03AR065201] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding: This research was supported in part by National Institutes of Health (NIH) grants R01 AR063712, R21 AR064178, R21 AR066230, R21 AR065659, and R03 AR065201, and NSF CAREER 1349735. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush PG, 2003, OSTEOARTHR CARTILAGE, V11, P242, DOI 10.1016/S1063-4584(02)00369-2; Calle E. A., 2014, TISSUE ENG C; Chen JQ, 2013, J BONE MINER RES, V28, P1160, DOI 10.1002/jbmr.1834; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; DENT JA, 1989, DEVELOPMENT, V105, P61; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Fu YY, 2013, AM J PHYSIOL-GASTR L, V304, pG1, DOI 10.1152/ajpgi.00209.2012; Genina EA, 2010, EXPERT REV MED DEVIC, V7, P825, DOI 10.1586/ERD.10.50; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hambach L, 1998, ARTHRITIS RHEUM, V41, P986, DOI 10.1002/1529-0131(199806)41:6<986::AID-ART5>3.0.CO;2-N; Himeno-Ando A, 2012, BIOCHEM BIOPH RES CO, V417, P765, DOI 10.1016/j.bbrc.2011.12.031; Holloway I, 2004, OSTEOARTHR CARTILAGE, V12, P17, DOI 10.1016/j.joca.2003.09.001; Hutcheson DA, 2009, GENE DEV, V23, P997, DOI 10.1101/gad.1769009; Jung Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094054; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kerschnitzki M, 2011, J STRUCT BIOL, V173, P303, DOI 10.1016/j.jsb.2010.11.014; Kostrominova TY, 2011, MICROSC RES TECHNIQ, V74, P18, DOI 10.1002/jemt.20865; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Langelier E, 2000, J HISTOCHEM CYTOCHEM, V48, P1307, DOI 10.1177/002215540004801002; Le Graverand MPH, 2001, J ANAT, V198, P525, DOI 10.1046/j.1469-7580.2000.19850525.x; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McNeilly CM, 1996, J ANAT, V189, P593; Moy AJ, 2014, BIOMED OPT EXPRESS, V5, P69, DOI 10.1364/BOE.5.000069; Murray DH, 2010, J ORTHOP RES, V28, P1507, DOI 10.1002/jor.21155; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Neu CP, 2007, ARTHRITIS RHEUM-US, V56, P3706, DOI 10.1002/art.23024; Ralphs JR, 2002, MATRIX BIOL, V21, P67, DOI 10.1016/S0945-053X(01)00179-2; Rosenzweig DH, 2012, OSTEOARTHR CARTILAGE, V20, P1591, DOI 10.1016/j.joca.2012.08.012; Rylander CG, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2343208; Sasazaki Y, 2008, RHEUMATOLOGY, V47, P1641, DOI 10.1093/rheumatology/ken341; Scott GD, 2014, AM J RESP CELL MOL B, DOI [10.1165/rcmb.2013-0284OC, DOI 10.1165/RCMB.2013-02840C]; Sharma D, 2012, BONE, V51, P488, DOI 10.1016/j.bone.2012.05.014; van Hove RP, 2009, BONE, V45, P321, DOI 10.1016/j.bone.2009.04.238; Wang J, 2012, LASER PHYS LETT, V9, P469, DOI 10.7452/lapl.201210017; Webster DJ, 2013, BONE, V54, P285, DOI 10.1016/j.bone.2013.01.004; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Yang XQ, 2014, OPT EXPRESS, V22, P1094, DOI 10.1364/OE.22.001094; Yao W, 2008, ARTHRITIS RHEUM, V58, P1674, DOI 10.1002/art.23454; Youn I, 2006, OSTEOARTHR CARTILAGE, V14, P889, DOI 10.1016/j.joca.2006.02.017; Zhong ZD, 2012, P NATL ACAD SCI USA, V109, pE2197, DOI 10.1073/pnas.1120407109; Zhu D, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3369739	42	31	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2015	10	1							e0116662	10.1371/journal.pone.0116662	http://dx.doi.org/10.1371/journal.pone.0116662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4CF	25581165	Green Submitted, Green Published, gold			2022-12-26	WOS:000348169100005
J	Barbato, S; Sgarbi, G; Gorini, G; Baracca, A; Solaini, G				Barbato, Simona; Sgarbi, Gianluca; Gorini, Giulia; Baracca, Alessandra; Solaini, Giancarlo			The Inhibitor Protein (IF1) of the F1F0-ATPase Modulates Human Osteosarcoma Cell Bioenergetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE-PHOSPHORYLATION ENZYMES; ATP SYNTHASE; ADENOSINE-TRIPHOSPHATASE; MITOCHONDRIAL ATPASE; RAT-LIVER; COMPLEX; DYSFUNCTION; MUSCLE; HEART; DIMERIZATION	The bioenergetics of IF1 transiently silenced cancer cells has been extensively investigated, but the role of IF1 (the natural inhibitor protein of F1F0-ATPase) in cancer cell metabolism is still uncertain. To shed light on this issue, we established a method to prepare stably IF1-silenced human osteosarcoma clones and explored the bioenergetics of IF1 null cancer cells. We showed that IF1-silenced cells proliferate normally, consume glucose, and release lactate as controls do, and contain a normal steady-state ATP level. However, IF1-silenced cells displayed an enhanced steady-state mitochondrial membrane potential and consistently showed a reduced ADP-stimulated respiration rate. In the parental cells (i.e. control cells containing IF1) the inhibitor protein was found to be associated with the dimeric form of the ATP synthase complex, therefore we propose that the interaction of IF1 with the complex either directly, by increasing the catalytic activity of the enzyme, or indirectly, by improving the structure of mitochondrial cristae, can increase the oxidative phosphorylation rate in osteosarcoma cells grown under normoxic conditions.	[Barbato, Simona; Sgarbi, Gianluca; Gorini, Giulia; Baracca, Alessandra; Solaini, Giancarlo] Univ Bologna, Dept Biomed & NeuroMotor Sci DIBINEM, I-40126 Bologna, Italy	University of Bologna	Baracca, A (corresponding author), Univ Bologna, Dept Biomed & NeuroMotor Sci DIBINEM, Via Irnerio 48, I-40126 Bologna, Italy.	alessandra.baracca@unibo.it; giancarlo.solaini@unibo.it	Sgarbi, Gianluca/AAG-9727-2021; Sgarbi, Gianluca/AAD-8061-2021	Barbato, Simona/0000-0002-7828-8230; SOLAINI, GIANCARLO/0000-0001-7825-0446; Gorini, Giulia/0000-0002-5127-0049	Ministero dell'Istruzione, dell'Universita e della Ricerca, MIUR, Italy [PRIN2010-11 20107Z8XBW]	Ministero dell'Istruzione, dell'Universita e della Ricerca, MIUR, Italy(Ministry of Education, Universities and Research (MIUR))	This work was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca, MIUR, Italy Grant PRIN2010-11 20107Z8XBW.	BARACCA A, 1992, COMP BIOCHEM PHYS B, V101, P421, DOI 10.1016/0305-0491(92)90022-J; Baracca A, 2013, INT J BIOCHEM CELL B, V45, P1356, DOI 10.1016/j.biocel.2013.03.013; Baracca A, 2010, BBA-BIOENERGETICS, V1797, P314, DOI 10.1016/j.bbabio.2009.11.006; Barogi S, 1995, MECH AGEING DEV, V84, P139, DOI 10.1016/0047-6374(95)01640-6; Bason JV, 2014, P NATL ACAD SCI USA, V111, P11305, DOI 10.1073/pnas.1411560111; Bisetto E, 2013, BBA-BIOENERGETICS, V1827, P807, DOI 10.1016/j.bbabio.2013.04.002; Borsi E, 2014, ONCOTARGET, V5, P1779, DOI 10.18632/oncotarget.1736; Bosetti F, 2000, MOL CELL BIOCHEM, V215, P31, DOI 10.1023/A:1026558922596; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Bravo C, 2004, J BIOENERG BIOMEMBR, V36, P257, DOI 10.1023/B:JOBB.0000031977.99479.ea; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Campanella M, 2009, BBA-BIOENERGETICS, V1787, P393, DOI 10.1016/j.bbabio.2009.02.023; Capuano F, 1997, J BIOENERG BIOMEMBR, V29, P379, DOI 10.1023/A:1022402915431; Chaban Y, 2014, BBA-BIOENERGETICS, V1837, P418, DOI 10.1016/j.bbabio.2013.10.004; Di Lisa F, 1998, MOL CELL BIOCHEM, V184, P379, DOI 10.1023/A:1006810523586; Faccenda D, 2013, CELL CYCLE, V12, P2530, DOI 10.4161/cc.25840; Formentini L, 2014, EMBO J, V33, P762, DOI 10.1002/embj.201386392; Frezza C, 2009, SEMIN CANCER BIOL, V19, P4, DOI 10.1016/j.semcancer.2008.11.008; Fujikawa M, 2012, J BIOL CHEM, V287, P18781, DOI 10.1074/jbc.M112.345793; Garcia JJ, 2006, BIOCHEMISTRY-US, V45, P12695, DOI 10.1021/bi060339j; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARRIS DA, 1991, BIOCHEM J, V280, P561, DOI 10.1042/bj2800561; HORSTMAN LL, 1970, J BIOL CHEM, V245, P1336; HUSAIN I, 1985, BIOCHIM BIOPHYS ACTA, V806, P64, DOI 10.1016/0005-2728(85)90082-9; Ichikawa N, 1999, BIOSCI BIOTECH BIOCH, V63, P2225, DOI 10.1271/bbb.63.2225; JENNINGS RB, 1991, J MOL CELL CARDIOL, V23, P1383, DOI 10.1016/0022-2828(91)90185-O; Kun E, 1979, Methods Enzymol, V55, P115; LIPPE G, 1988, BIOCHIM BIOPHYS ACTA, V933, P1, DOI 10.1016/0005-2728(88)90050-3; LOPEZMEDIAVILLA C, 1993, EUR J BIOCHEM, V215, P487, DOI 10.1111/j.1432-1033.1993.tb18058.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUCIAKOVA K, 1984, FEBS LETT, V177, P85, DOI 10.1016/0014-5793(84)80986-2; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Porcelli AM, 2009, J BIOL CHEM, V284, P2045, DOI 10.1074/jbc.M807321200; ROUSLIN W, 1991, J BIOENERG BIOMEMBR, V23, P873, DOI 10.1007/BF00786006; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; SCHWERZMANN K, 1981, BIOCHEMISTRY-US, V20, P6305, DOI 10.1021/bi00525a004; Sgarbi G, 2011, J BIOENERG BIOMEMBR, V43, P673, DOI 10.1007/s10863-011-9390-3; Sgarbi G, 2014, AGING-US, V6, P296, DOI 10.18632/aging.100654; Solaini G, 2005, BIOCHEM J, V390, P377, DOI 10.1042/BJ20042006; Solaini G, 1997, BIOCHEM J, V327, P443, DOI 10.1042/bj3270443; SOLAINI G, 1993, EUR J BIOCHEM, V214, P729, DOI 10.1111/j.1432-1033.1993.tb17974.x; Solaini G, 2008, BBA-BIOENERGETICS, V1777, P941, DOI 10.1016/j.bbabio.2008.04.034; Solaini G, 2011, BBA-BIOENERGETICS, V1807, P534, DOI 10.1016/j.bbabio.2010.09.003; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Tomasetig L, 2002, BBA-BIOENERGETICS, V1556, P133, DOI 10.1016/S0005-2728(02)00344-4; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	49	30	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6338	6348		10.1074/jbc.M114.631788	http://dx.doi.org/10.1074/jbc.M114.631788			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605724	hybrid, Green Published			2022-12-26	WOS:000350732500039
J	Ruiz-Perez, MV; Medina, MA; Urdiales, JL; Keinanen, TA; Sanchez-Jimenez, F				Victoria Ruiz-Perez, M.; Angel Medina, Miguel; Luis Urdiales, Jose; Keinanen, Tuomo A.; Sanchez-Jimenez, Francisca			Polyamine Metabolism Is Sensitive to Glycolysis Inhibition in Human Neuroblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-DECARBOXYLASE; N-MYC; C-MYC; CANCER; CHEMOPREVENTION; EXPRESSION; TARGET; GROWTH; GENE; 2-DEOXYGLUCOSE	Polyamines are essential for cell proliferation, and their levels are elevated in many human tumors. The oncogene n-myc is known to potentiate polyamine metabolism. Neuroblastoma, the most frequent extracranial solid tumor in children, harbors the amplification of n-myc oncogene in 25% of the cases, and it is associated with treatment failure and poor prognosis. We evaluated several metabolic features of the human neuroblastoma cell lines Kelly, IMR-32, and SK-N-SH. We further investigated the effects of glycolysis impairment in polyamine metabolism in these cell lines. A previously unknown linkage between glycolysis impairment and polyamine reduction is unveiled. We show that glycolysis inhibition is able to trigger signaling events leading to the reduction of N-Myc protein levels and a subsequent decrease of both ornithine decarboxylase expression and polyamine levels, accompanied by cell cycle blockade preceding cell death. New anti-tumor strategies could take advantage of the direct relationship between glucose deprivation and polyamine metabolism impairment, leading to cell death, and its apparent dependence on n-myc. Combined therapies targeting glucose metabolism and polyamine synthesis could be effective in the treatment of n-myc-expressing tumors.	[Victoria Ruiz-Perez, M.; Angel Medina, Miguel; Luis Urdiales, Jose; Sanchez-Jimenez, Francisca] Univ Malaga, Andalucia Tech, Dept Biol Mol & Bioquim, Fac Ciencias, E-29071 Malaga, Spain; [Victoria Ruiz-Perez, M.; Angel Medina, Miguel; Luis Urdiales, Jose; Sanchez-Jimenez, Francisca] Univ Malaga, IBIMA Biomed Res Inst Malaga, E-29071 Malaga, Spain; [Angel Medina, Miguel; Luis Urdiales, Jose; Sanchez-Jimenez, Francisca] CIBER Enfermedades Raras CIBERER, Unidad 741, Malaga, Spain; [Keinanen, Tuomo A.] Univ Eastern Finland, Sch Pharm, FIN-70211 Kuopio, Finland	Universidad de Malaga; Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Eastern Finland	Ruiz-Perez, MV (corresponding author), Univ Malaga, Fac Sci, Dept Mol Biol & Biochem, Campus Teatinos, E-29071 Malaga, Spain.	mariaviruiz@uma.es	Medina, Miguel Ángel/K-1763-2014; Ruiz-Pérez, María Victoria/F-8639-2014; Urdiales, José Luis/K-1125-2014; Keinänen, Tuomo/AAC-5630-2019; Jiménez, Francisca María Sánchez/H-2513-2015	Medina, Miguel Ángel/0000-0001-7275-6462; Urdiales, José Luis/0000-0002-2519-9293; Jiménez, Francisca María Sánchez/0000-0002-4958-6060; Keinanen, Tuomo/0000-0002-0659-5573	Ministerio de Economia y Competitividad, Spain [SAF2011-26518]; Junta de Andalucia, Spain [CTS-1507, CVI-06585]; fondos PAIDI, Junta de Andalucia, Spain [BIO-267]; University of Eastern Finland	Ministerio de Economia y Competitividad, Spain; Junta de Andalucia, Spain(Junta de Andalucia); fondos PAIDI, Junta de Andalucia, Spain; University of Eastern Finland	Supported by Grants SAF2011-26518 (Ministerio de Economia y Competitividad, Spain), Excellence Grants CTS-1507 and CVI-06585 (Junta de Andalucia, Spain), and BIO-267 (fondos PAIDI, Junta de Andalucia, Spain).; Supported by strategic funding of the University of Eastern Finland.	Agostinelli E, 2010, AMINO ACIDS, V38, P393, DOI 10.1007/s00726-009-0396-7; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Bailey HH, 2010, CANCER PREV RES, V3, P35, DOI 10.1158/1940-6207.CAPR-09-0096; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Cascante M, 2010, BIOCHEM SOC T, V38, P1302, DOI 10.1042/BST0381302; CELANO P, 1989, J BIOL CHEM, V264, P8922; Coleman CS, 2004, BIOCHEM J, V379, P849, DOI 10.1042/BJ20040035; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Dasso M., 2004, SHORT PROTOCOLS CELL; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Fajardo I, 2001, EUR J BIOCHEM, V268, P768, DOI 10.1046/j.1432-1327.2001.01930.x; FELL D, 1996, UNDERSTANDING CONTRO; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Forshell TP, 2010, CANCER PREV RES, V3, P140, DOI 10.1158/1940-6207.CAPR-09-0166; Geerts D, 2010, INT J CANCER, V126, P2012, DOI 10.1002/ijc.25074; Gerner EW, 2010, CANCER PREV RES, V3, P125, DOI 10.1158/1940-6207.CAPR-09-0252; Gerner EW, 2003, RECENT RES CANCER, V163, P58; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Gnaiger E., 2012, MITOCHONDRIAL PATHWA, P44; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Koomoa DLT, 2009, MOL CANCER THER, V8, P2067, DOI 10.1158/1535-7163.MCT-08-1217; Kunst A., 1984, METHOD ENZYMAT AN, P178; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Ledford H, 2014, NATURE, V508, P158, DOI 10.1038/508158a; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lutz W, 1996, ONCOGENE, V13, P803; Mandal S, 2013, P NATL ACAD SCI USA, V110, P2169, DOI 10.1073/pnas.1219002110; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Mazzio E, 2003, NEUROTOXICOLOGY, V24, P137, DOI 10.1016/S0161-813X(02)00110-9; MEDINA MA, 1992, FEBS LETT, V311, P99, DOI 10.1016/0014-5793(92)81376-W; Meyskens Frank L Jr, 2014, Recent Results Cancer Res, V202, P115, DOI 10.1007/978-3-642-45195-9_14; Noll F., 1984, METHOD ENZYMAT AN, VIV, P582; Nowotarski SL, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.3; PASSONNEAU JV, 1976, J BIOL CHEM, V251, P2015; Pegg AE, 2014, IUBMB LIFE, V66, P8, DOI 10.1002/iub.1237; Perez-Leal O, 2012, AMINO ACIDS, V42, P611, DOI 10.1007/s00726-011-1036-6; Qing GL, 2010, CANCER RES, V70, P10351, DOI 10.1158/0008-5472.CAN-10-0740; Ray RM, 2012, J BIOL CHEM, V287, P3674, DOI 10.1074/jbc.M111.232561; Rodriguez-Caso C, 2006, J BIOL CHEM, V281, P21799, DOI 10.1074/jbc.M602756200; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; SCHULZELOHOFF E, 1994, BIOCHEM J, V298, P647, DOI 10.1042/bj2980647; Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172; Sun Y, 2014, ONCOGENE, V33, P2987, DOI 10.1038/onc.2013.253; Tabib A, 1999, INT J BIOCHEM CELL B, V31, P1289, DOI 10.1016/S1357-2725(99)00098-9; URDIALES JL, 1992, FEBS LETT, V305, P260, DOI 10.1016/0014-5793(92)80682-7; Wallick CJ, 2005, ONCOGENE, V24, P5606, DOI 10.1038/sj.onc.1208808; Wang QL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017234; Wolff EC, 1999, YEAST, V15, P43; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60; Zhong DS, 2009, J BIOL CHEM, V284, P23225, DOI 10.1074/jbc.M109.005280	55	25	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6106	6119		10.1074/jbc.M114.619197	http://dx.doi.org/10.1074/jbc.M114.619197			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25593318	Green Published, hybrid			2022-12-26	WOS:000350732500020
J	Zhong, YM; Dong, S; Strattan, E; Ren, L; Butchar, JP; Thornton, K; Mishra, A; Porcu, P; Bradshaw, JM; Bisconte, A; Owens, TD; Verner, E; Brameld, KA; Funk, JO; Hill, RJ; Johnson, AJ; Dubovsky, JA				Zhong, Yiming; Dong, Shuai; Strattan, Ethan; Ren, Li; Butchar, Jonathan P.; Thornton, Kelsey; Mishra, Anjali; Porcu, Pierluigi; Bradshaw, J. Michael; Bisconte, Angelina; Owens, Timothy D.; Verner, Erik; Brameld, Ken A.; Funk, Jens Oliver; Hill, Ronald J.; Johnson, Amy J.; Dubovsky, Jason A.			Targeting Interleukin-2-inducible T-cell Kinase (ITK) and Resting Lymphocyte Kinase (RLK) Using a Novel Covalent Inhibitor PRN694	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELL; TEC FAMILY KINASES; TYROSINE KINASE; TH17 CELLS; MICE LACKING; IRREVERSIBLE INHIBITORS; ALLERGIC-ASTHMA; DISCOVERY; RECEPTOR; EXPRESSION	Interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK or TXK) are essential mediators of intracellular signaling in both normal and neoplastic T-cells and natural killer (NK) cells. Thus, ITK and RLK inhibitors have therapeutic potential in a number of human autoimmune, inflammatory, and malignant diseases. Here we describe a novel ITK/RLK inhibitor, PRN694, which covalently binds to cysteine residues 442 of ITK and 350 of RLK and blocks kinase activity. Molecular modeling was utilized to design molecules that interact with cysteine while binding to the ATP binding site in the kinase domain. PRN694 exhibits extended target residence time on ITK and RLK and is highly selective for a subset of the TEC kinase family. In vitro cellular assays confirm that PRN694 prevents T-cell receptor-and Fc receptor-induced cellular and molecular activation, inhibits T-cell receptor-induced T-cell proliferation, and blocks proinflammatory cytokine release as well as activation of Th17 cells. Ex vivo assays demonstrate inhibitory activity against T-cell prolymphocytic leukemia cells, and in vivo assays demonstrate durable pharmacodynamic effects on ITK, which reduces an oxazolone-induced delayed type hypersensitivity reaction. These data indicate that PRN694 is a highly selective and potent covalent inhibitor of ITK and RLK, and its extended target residence time enables durable attenuation of effector cells in vitro and in vivo. The results from this study highlight potential applications of this dual inhibitor for the treatment of T-cell-or NK cell-mediated inflammatory, autoimmune, and malignant diseases.	[Zhong, Yiming; Strattan, Ethan; Ren, Li; Butchar, Jonathan P.; Thornton, Kelsey; Mishra, Anjali; Porcu, Pierluigi; Johnson, Amy J.; Dubovsky, Jason A.] Ohio State Univ, Coll Med, Div Hematol, Columbus, OH 43210 USA; [Dong, Shuai] Ohio State Univ, Div Pharmaceut & Pharmaceut Chem, Coll Pharm, Columbus, OH 43210 USA; [Bradshaw, J. Michael; Bisconte, Angelina; Owens, Timothy D.; Verner, Erik; Brameld, Ken A.; Funk, Jens Oliver; Hill, Ronald J.] Principia Biopharma, San Francisco, CA 94080 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hill, RJ (corresponding author), Principia Biopharma, 400 E Jamie Ct,Suite 302, San Francisco, CA 94080 USA.	ron.hill@principiabio.com; jason.dubovsky@nationwidechildrens.org	Strattan, Ethan/AAK-3373-2021; Butchar, Jonathan/E-2825-2011	Strattan, Ethan/0000-0001-6905-0813; Brameld, Ken/0000-0001-8643-3218; Dong, Shuai/0000-0002-2434-2430	NATIONAL CANCER INSTITUTE [P01CA095426, P30CA016058] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA095426, P30 CA016058] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alder CM, 2013, ACS MED CHEM LETT, V4, P948, DOI 10.1021/ml400206q; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Andreotti AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002287; Bedoya SK, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/986789; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Bergamini G, 2012, NAT CHEM BIOL, V8, P576, DOI [10.1038/NCHEMBIO.957, 10.1038/nchembio.957]; Brameld K. A., 2014, International Patent, Patent No. [WO 2014/036016 A1, 2014036016]; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Carpenter RL, 2012, J THORAC DIS, V4, P639, DOI 10.3978/j.issn.2072-1439.2012.10.09; Charrier JD, 2011, J MED CHEM, V54, P2341, DOI 10.1021/jm101499u; Cohnen A, 2013, BLOOD, V122, P1411, DOI 10.1182/blood-2012-07-441832; Das J, 2006, BIOORG MED CHEM LETT, V16, P3706, DOI 10.1016/j.bmcl.2006.04.060; Dubovsky JA, 2013, BLOOD, V122, P2539, DOI 10.1182/blood-2013-06-507947; Dubovsky JA, 2009, CLIN CANCER RES, V15, P3406, DOI 10.1158/1078-0432.CCR-08-2099; Felices M, 2008, J IMMUNOL, V180, P3007, DOI 10.4049/jimmunol.180.5.3007; Ferrara TJ, 2006, J ALLERGY CLIN IMMUN, V117, P780, DOI 10.1016/j.jaci.2005.12.1330; Finkelstein LD, 2005, J IMMUNOL, V175, P5923, DOI 10.4049/jimmunol.175.9.5923; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; GALLI SJ, 1984, SCIENCE, V226, P710, DOI 10.1126/science.6494907; Gomez-Rodriguez J, 2014, J EXP MED, V211, P529, DOI 10.1084/jem.20131459; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Guo WC, 2012, MOL PHARMACOL, V82, P938, DOI 10.1124/mol.112.079889; Han S, 2014, BIOCHEM J, V460, P211, DOI 10.1042/BJ20131139; Harling JD, 2013, J BIOL CHEM, V288, P28195, DOI 10.1074/jbc.M113.474114; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Horwood NJ, 2012, INT REV IMMUNOL, V31, P87, DOI 10.3109/08830185.2012.670334; Hundorfean G, 2012, INFLAMM BOWEL DIS, V18, P180, DOI 10.1002/ibd.21677; Iyer AS, 2011, J BIOL CHEM, V286, P9503, DOI 10.1074/jbc.M110.165613; Kannan Yashaswini, 2012, J Clin Cell Immunol, VSuppl 12, P11; Kaukonen J, 1999, LEUKEMIA LYMPHOMA, V32, P513, DOI 10.3109/10428199909058409; KAWAKAMI Y, 1995, J IMMUNOL, V155, P3556; Khurana D, 2007, J IMMUNOL, V178, P3575, DOI 10.4049/jimmunol.178.6.3575; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Koprulu AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060476; Kosaka Y, 2006, TRENDS IMMUNOL, V27, P453, DOI 10.1016/j.it.2006.08.006; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Lin TA, 2004, BIOCHEMISTRY-US, V43, P11056, DOI 10.1021/bi049428r; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; McLean LR, 2012, BIOORG MED CHEM LETT, V22, P3296, DOI 10.1016/j.bmcl.2012.03.016; Melton AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058966; Moriarty KJ, 2008, BIOORG MED CHEM LETT, V18, P5545, DOI 10.1016/j.bmcl.2008.09.015; Mueller C, 2003, J IMMUNOL, V170, P5056, DOI 10.4049/jimmunol.170.10.5056; Pan ZY, 2007, CHEMMEDCHEM, V2, P58, DOI 10.1002/cmdc.200600221; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Pastor RM, 2014, BIOORG MED CHEM LETT, V24, P2448, DOI 10.1016/j.bmcl.2014.04.023; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Readinger JA, 2009, IMMUNOL REV, V228, P93, DOI 10.1111/j.1600-065X.2008.00757.x; Sahu N, 2009, CURR TOP MED CHEM, V9, P690, DOI 10.2174/156802609789044443; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Serafimova IM, 2012, NAT CHEM BIOL, V8, P471, DOI [10.1038/NCHEMBIO.925, 10.1038/nchembio.925]; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Shin J, 2007, BLOOD, V110, P3015, DOI 10.1182/blood-2006-12-061507; Snow RJ, 2007, BIOORG MED CHEM LETT, V17, P3660, DOI 10.1016/j.bmcl.2007.04.045; Susaki K, 2010, IMMUNOL LETT, V127, P135, DOI 10.1016/j.imlet.2009.10.009; UYEMURA K, 1993, J INVEST DERMATOL, V101, P701, DOI 10.1111/1523-1747.ep12371679; Vargas L, 2013, SCAND J IMMUNOL, V78, P130, DOI 10.1111/sji.12069; Velankar AD, 2010, BIOORGAN MED CHEM, V18, P4547, DOI 10.1016/j.bmc.2010.04.056; Waite JC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/819467; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Warner K, 2013, CRIT REV ONCOL HEMAT, V88, P680, DOI 10.1016/j.critrevonc.2013.07.014; Warner K, 2013, CURR HEMATOL MALIG R, V8, P163, DOI 10.1007/s11899-013-0165-2; Wu L, 2008, CLIN CANCER RES, V14, P4650, DOI 10.1158/1078-0432.CCR-07-4405; Xu DG, 2012, J PHARMACOL EXP THER, V341, P90, DOI 10.1124/jpet.111.187740; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194; Zhao WL, 2010, LEUKEMIA, V24, P13, DOI 10.1038/leu.2009.223; Zhong YM, 2010, BIOCHEM BIOPH RES CO, V398, P377, DOI 10.1016/j.bbrc.2010.06.075	68	28	33	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					5960	5978		10.1074/jbc.M114.614891	http://dx.doi.org/10.1074/jbc.M114.614891			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25593320	hybrid, Green Published			2022-12-26	WOS:000350732500003
J	Simard, JC; Vallieres, F; de Liz, R; Lavastre, V; Girard, D				Simard, Jean-Christophe; Vallieres, Francis; de Liz, Rafael; Lavastre, Valerie; Girard, Denis			Silver Nanoparticles Induce Degradation of the Endoplasmic Reticulum Stress Sensor Activating Transcription Factor-6 Leading to Activation of the NLRP-3 Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL-DEATH; ER STRESS; IL-1-BETA RELEASE; CASPASE-4; PYROPTOSIS; IRE1; NANOSILVER; INHIBITION; RECEPTORS	In the past decade, the increasing amount of nanoparticles (NP) and nanomaterials used in multiple applications led the scientific community to investigate the potential toxicity of NP. Many studies highlighted the cytotoxic effects of various NP, including titanium dioxide, zinc oxide, and silver nanoparticles (AgNP). In a few studies, endoplasmic reticulum (ER) stress was found to be associated with NP cytotoxicity leading to apoptosis in different cell types. In this study, we report for the first time that silver nanoparticles of 15 nm (AgNP15), depending on the concentration, induced different signature ER stress markers in human THP-1 monocytes leading to a rapid ER stress response with degradation of the ATF-6 sensor. Also, AgNP15 induced pyroptosis and activation of the NLRP-3 inflammasome as demonstrated by the processing and increased activity of caspase-1 and secretion of IL-1 beta and ASC (apoptosis-associated speck-like protein containing a CARD domain) pyroptosome formation. Transfection of THP-1 cells with siRNA targeting NLRP-3 decreased the AgNP15-induced IL-1 beta production. The absence of caspase-4 expression resulted in a significant reduction of pro-IL-1 beta. However, caspase-1 activity was significantly higher in caspase-4-deficient cells when compared with WT cells. Inhibition of AgNP15-induced ATF-6 degradation with Site-2 protease inhibitors completely blocked the effect of AgNP15 on pyroptosis and secretion of IL-1 beta, indicating that ATF-6 is crucial for the induction of this type of cell death. We conclude that AgNP15 induce degradation of the ER stress sensor ATF-6, leading to activation of the NLRP-3 inflammasome regulated by caspase-4 in human monocytes.	[Simard, Jean-Christophe; Vallieres, Francis; de Liz, Rafael; Lavastre, Valerie; Girard, Denis] Univ Quebec, Inst Armand Frappier, Inst Natl Rech Sci, Lab Rech Inflammat & Physiol Granulocytes, Laval, PQ H7V 1B7, Canada	University of Quebec; Institut national de la recherche scientifique (INRS)	Simard, JC (corresponding author), Univ Quebec, Inst Armand Frappier, Inst Natl Rech Sci, 531 Blvd Prairies, Laval, PQ H7V 1B7, Canada.	J-Christophe.Simard@iaf.inrs.ca; Denis.girard@iaf.inrs.ca		Girard, Denis/0000-0002-3342-5027				Akhtar MJ, 2014, CLIN CHIM ACTA, V436, P78, DOI 10.1016/j.cca.2014.05.004; Bartlomiejczyk T, 2013, ANN AGR ENV MED, V20, P48; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Binet F, 2010, INT IMMUNOPHARMACOL, V10, P508, DOI 10.1016/j.intimp.2010.01.013; Binet F, 2010, BIOCHEM BIOPH RES CO, V391, P18, DOI 10.1016/j.bbrc.2009.10.141; Chen R, 2014, ACS NANO, V8, P2562, DOI 10.1021/nn406184r; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; Christen V, 2013, TOXICOL APPL PHARM, V272, P519, DOI 10.1016/j.taap.2013.06.011; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Edamatsu T, 1997, BRIT J PHARMACOL, V121, P1651, DOI 10.1038/sj.bjp.0701322; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Guan M, 2012, FEBS J, V279, P2399, DOI 10.1111/j.1742-4658.2012.08619.x; Guan M, 2011, CLIN CANCER RES, V17, P1796, DOI 10.1158/1078-0432.CCR-10-3216; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Ivask A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102108; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kajiwara Y, 2014, J IMMUNOL, V193, P335, DOI 10.4049/jimmunol.1303424; Kanapathipillai M, 2014, ADV DRUG DELIVER REV, V79-80, P107, DOI 10.1016/j.addr.2014.05.005; Kim HJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01142; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kim S, 2014, INNATE IMMUN-LONDON, V20, P799, DOI 10.1177/1753425913508593; Kulthong K, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-8; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Labbe K, 2011, PROG INFLAMM RES SER, P17, DOI 10.1007/978-3-0348-0148-5_2; Lakshmanan U, 2007, J IMMUNOL, V179, P8480, DOI 10.4049/jimmunol.179.12.8480; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Lohcharoenkal W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/180549; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Meunier E, 2012, NANOMED-NANOTECHNOL, V8, P987, DOI 10.1016/j.nano.2011.11.004; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Nowack B, 2011, ENVIRON SCI TECHNOL, V45, P1177, DOI 10.1021/es103316q; Obeng EA, 2005, J BIOL CHEM, V280, P29578, DOI 10.1074/jbc.M502685200; Poirier M, 2014, J APPL TOXICOL, V34, P404, DOI 10.1002/jat.2956; Reisetter AC, 2011, J BIOL CHEM, V286, P21844, DOI 10.1074/jbc.M111.238519; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Simard JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072138; SLAWSON RM, 1992, ARCH MICROBIOL, V158, P398; Sollberger G, 2012, J IMMUNOL, V188, P1992, DOI 10.4049/jimmunol.1101620; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Stebounova LV, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-5; Vallieres F, 2013, J IMMUNOL, V190, P2904, DOI 10.4049/jimmunol.1201941; Yallapu MM, 2010, J COLLOID INTERF SCI, V351, P19, DOI 10.1016/j.jcis.2010.05.022; Yang EJ, 2012, BIOMATERIALS, V33, P6858, DOI 10.1016/j.biomaterials.2012.06.016; Yang M, 2013, SMALL, V9, P4194, DOI 10.1002/smll.201300481; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang R, 2012, INT J BIOCHEM CELL B, V44, P224, DOI 10.1016/j.biocel.2011.10.019	55	76	81	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5926	5939		10.1074/jbc.M114.610899	http://dx.doi.org/10.1074/jbc.M114.610899			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25593314	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000350044200055
J	Nie, C; Hu, HX; Shen, CL; Ye, B; Wu, H; Xiang, ML				Nie, Chen; Hu, Haixia; Shen, Chenling; Ye, Bin; Wu, Hao; Xiang, Mingliang			Expression of EFR3A in the Mouse Cochlea during Degeneration of Spiral Ganglion following Hair Cell Loss	PLOS ONE			English	Article							WALLERIAN DEGENERATION; ROLLING BLACKOUT; AUDITORY-NERVE; TIME-COURSE; IN-VIVO; KANAMYCIN; FUROSEMIDE; NEURONS; MICE	Retrograde degeneration of spiral ganglion cells in the cochlea following hair cell loss is similar to dying back in pathology. The EFR3A gene has recently been discovered to be involved in the pathogenesis of dying back. The relationship of EFR3A and spiral ganglion degeneration, however, was rarely investigated. In this study, we destroyed the hair cells of the mouse cochlea by co-administration of kanamycin and furosemide and then investigated the EFR3A expression during the induced spiral ganglion cell degeneration. Our results revealed that co-administration of kanamycin and furosemide quickly induced hair cell loss in the C57BL/6J mice and then resulted in progressive degeneration of the spiral ganglion beginning at day 5 following drug administration. The number of the spiral ganglion cells began to decrease at day 15. The expression of EFR3A increased remarkably in the spiral ganglion at day 5 and then decreased to near normal level within the next 10 days. Our study suggested that the change of EFR3A expression in the spiral ganglion was coincident with the time of the spiral ganglion degeneration, which implied that high expression of EFR3A may be important to prompt initiation of spiral ganglion degeneration following hair cell loss.	[Nie, Chen; Hu, Haixia; Shen, Chenling; Ye, Bin; Wu, Hao; Xiang, Mingliang] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Otolaryngol & Head & Neck Surg, Sch Med, Shanghai 200030, Peoples R China; [Nie, Chen; Hu, Haixia; Shen, Chenling; Ye, Bin; Wu, Hao; Xiang, Mingliang] Shanghai Jiao Tong Univ, Ear Inst, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wu, H (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Otolaryngol & Head & Neck Surg, Sch Med, Shanghai 200030, Peoples R China.	wuhao622@sina.cn; mingliangxiang@163.com			National Natural Science Foundation [81271088]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation (No. 81271088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agterberg MJH, 2009, JARO-J ASSOC RES OTO, V10, P355, DOI 10.1007/s10162-009-0170-2; Alam SA, 2007, J COMP NEUROL, V503, P832, DOI 10.1002/cne.21430; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Edge ASB, 2008, CURR OPIN NEUROBIOL, V18, P377, DOI 10.1016/j.conb.2008.10.001; Hirose K, 2011, HEARING RES, V272, P108, DOI 10.1016/j.heares.2010.10.011; Huang FD, 2006, J NEUROSCI, V26, P2369, DOI 10.1523/JNEUROSCI.3770-05.2006; Huang FD, 2004, NAT NEUROSCI, V7, P1070, DOI 10.1038/nn1313; Imamura S, 2003, JARO-J ASSOC RES OTO, V4, P196, DOI 10.1007/s10162-002-2037-7; Iseki E, 2001, J NEUROL SCI, V185, P129, DOI 10.1016/S0022-510X(01)00481-6; Kong WJ, 2010, BRAIN RES, V1331, P28, DOI 10.1016/j.brainres.2010.02.058; McFadden SL, 2004, BRAIN RES, V997, P40, DOI 10.1016/j.brainres.2003.10.031; Munemoto Y, 2004, MOL BRAIN RES, V128, P131, DOI 10.1016/j.molbrainres.2004.06.022; Murray LM, 2008, J ANAT, V213, P633, DOI 10.1111/j.1469-7580.2008.01007.x; Nourski KV, 2004, HEARING RES, V187, P131, DOI 10.1016/S0378-5955(03)00336-8; Parker MA, 2011, J SPEECH LANG HEAR R, V54, P1709, DOI 10.1044/1092-4388(2011/10-0149); Sugawara M, 2005, JARO-J ASSOC RES OTO, V6, P136, DOI 10.1007/s10162-004-5050-1; Tang WX, 2006, J NEUROSCI, V26, P1991, DOI 10.1523/JNEUROSCI.5055-05.2006; Versnel H, 2007, HEARING RES, V231, P1, DOI 10.1016/j.heares.2007.03.003; Vijayakrishnan N, 2009, J CELL SCI, V122, P114, DOI 10.1242/jcs.036673; Xiong H, 2011, LAB ANIM-UK, V45, P95, DOI 10.1258/la.2010.009142	21	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117345	10.1371/journal.pone.0117345	http://dx.doi.org/10.1371/journal.pone.0117345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25622037	Green Published, Green Submitted, gold			2022-12-26	WOS:000348470400023
J	Meirelles, LA; Montoya, QV; Solomon, SE; Rodrigues, A				Meirelles, Lucas A.; Montoya, Quimi V.; Solomon, Scott E.; Rodrigues, Andre			New Light on the Systematics of Fungi Associated with Attine Ant Gardens and the Description of Escovopsis kreiselii sp nov.	PLOS ONE			English	Article							LEAF-CUTTING ANTS; ANAMORPHIC BASIDIOMYCETOUS YEAST; FORMICIDAE MYRMICINAE ATTINI; MICROBE SYMBIOSIS; GROWING ANTS; HYMENOPTERA-FORMICIDAE; ENDOPHYTIC FUNGI; ATTA-SEXDENS; NESTS; COEVOLUTION	Since the formal description of fungi in the genus Escovopsis in 1990, only a few studies have focused on the systematics of this group. For more than two decades, only two Escovopsis species were described; however, in 2013, three additional Escovopsis species were formally described along with the genus Escovopsioides, both found exclusively in attine ant gardens. During a survey for Escovopsis species in gardens of the lower attine ant Mycetophylax morschi in Brazil, we found four strains belonging to the pink-colored Escovopsis clade. Careful examination of these strains revealed significant morphological differences when compared to previously described species of Escovopsis and Escovopsioides. Based on the type of conidiogenesis (sympodial), as well as morphology of conidiogenous cells (percurrent), non-vesiculated conidiophores, and DNA sequences, we describe the four new strains as a new species, Escovopsis kreiselii sp. nov. Phylogenetic analyses using three nuclear markers (Large subunit RNA; translation elongation factor 1-alpha; and internal transcribed spacer) from the new strains as well as available sequences in public databases confirmed that all known fungi infecting attine ant gardens comprise a monophyletic group within the Hypocreaceae family, with very diverse morphological characteristics. Specifically, Escovopsis kreiselii is likely associated with gardens of lower-attine ants and its pathogenicity remains uncertain.	[Meirelles, Lucas A.; Montoya, Quimi V.; Rodrigues, Andre] UNESP, Dept Biochem & Microbiol, Rio Claro, SP, Brazil; [Solomon, Scott E.] Rice Univ, Dept Biosci, Houston, TX USA	Universidade Estadual Paulista; Rice University	Rodrigues, A (corresponding author), UNESP, Dept Biochem & Microbiol, Rio Claro, SP, Brazil.	andrer@rc.unesp.br	Rodrigues, Andre/B-8148-2012; Montoya, Quimi Vidaurre/I-1479-2018; Montoya, Quimi Vidaurre/L-3569-2019	Rodrigues, Andre/0000-0002-4164-9362; Montoya, Quimi Vidaurre/0000-0002-3285-5981; Montoya, Quimi Vidaurre/0000-0002-3285-5981; Meirelles, Lucas/0000-0003-3194-7136; Solomon, Scott/0000-0002-6376-5671	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2011/16765-0]; NSF IRFP (United States National Science Foundation International Research Fellowship Program) [07012333]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NSF IRFP (United States National Science Foundation International Research Fellowship Program)	The authors thank FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) for providing financial support (grant # 2011/16765-0) and a scholarship to LAM and NSF IRFP (United States National Science Foundation International Research Fellowship Program no. 07012333) for supporting SES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attili-Angelis D, 2014, FUNGAL DIVERS, V65, P65, DOI 10.1007/s13225-013-0275-0; Augustin JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082265; Belt T., 1874, NATURALIST NICARAGUA; Bollazzi M, 2002, INSECT SOC, V49, P153, DOI 10.1007/s00040-002-8295-x; Carreiro SC, 2004, INT J SYST EVOL MICR, V54, P1891, DOI 10.1099/ijs.0.63200-0; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Currie C, 2001, OECOLOGIA, V128, P99106; Currie CR, 2003, SCIENCE, V299, P386, DOI 10.1126/science.1078155; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Folgarait PJ, 2011, ENVIRON ENTOMOL, V40, P342, DOI 10.1603/EN10111; Folgarait P, 2011, CURR MICROBIOL, V63, P250, DOI 10.1007/s00284-011-9944-y; Gerardo NM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-88; Gerardo NM, 2004, P ROY SOC B-BIOL SCI, V271, P1791, DOI 10.1098/rspb.2004.2792; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Klingenberg C, 2007, STUD NEOTROP FAUNA E, V42, P121, DOI 10.1080/01650520601065509; Klingenberg C, 2009, ZOOTAXA, P1; KREISEL H, 1972, Z ALLG MIKROBIOL, V12, P643, DOI 10.1002/jobm.3630120805; Little AEF, 2008, ECOLOGY, V89, P1216, DOI 10.1890/07-0815.1; Mehdiabadi NJ, 2010, MYRMECOL NEWS, V13, P37; Meirelles LA, 2014, ENV MICROBIOL REP, V6, P339, DOI 10.1111/1758-2229.12132; Melo WGP, 2014, INT J SYST EVOL MICR, V64, P1428, DOI 10.1099/ijs.0.058818-0; Mendes Thais D., 2012, Insects, V3, P228, DOI 10.3390/insects3010228; Middelhoven WJ, 2003, ANTON LEEUW INT J G, V83, P167, DOI 10.1023/A:1023384830802; Mikheyev AS, 2007, MOL ECOL, V16, P209, DOI 10.1111/j.1365-294X.2006.03134.x; Mikheyev AS, 2008, MOL ECOL, V17, P4480, DOI 10.1111/j.1365-294X.2008.03940.x; Mikheyev AS, 2006, P NATL ACAD SCI USA, V103, P10702, DOI 10.1073/pnas.0601441103; Mikheyev AS, 2010, AM NAT, V175, pE126, DOI 10.1086/652472; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; MUCHOVEJ JJ, 1990, MYCOTAXON, V37, P191; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012668; Muller A, 1893, BOT MITTHEILUNGEN TR; Nixon KC., 2002, WINCLADA VER 1 0000; Pagnocca FC, 2010, INT J SYST EVOL MICR, V60, P1454, DOI 10.1099/ijs.0.015727-0; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; Reynolds HT, 2004, MYCOLOGIA, V96, P955, DOI 10.2307/3762079; Rodrigues A, 2008, MICROB ECOL, V56, P604, DOI 10.1007/s00248-008-9380-0; Rodrigues A, 2014, J BASIC MICROB, V54, P1186, DOI 10.1002/jobm.201200458; Rodrigues A, 2011, FEMS MICROBIOL ECOL, V78, P244, DOI 10.1111/j.1574-6941.2011.01152.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; SEIFERT KA, 1995, MYCOLOGIA, V87, P407, DOI 10.2307/3760838; Silva-Pinhati ACO, 2004, BRAZ J MED BIOL RES, V37, P1463, DOI 10.1590/S0100-879X2004001000004; Sosa-Calvo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080498; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Taerum SJ, 2010, ENVIRON ENTOMOL, V39, P105, DOI 10.1603/EN09137; Taerum SJ, 2007, P ROY SOC B-BIOL SCI, V274, P1971, DOI 10.1098/rspb.2007.0431; Van Bael SA, 2012, ECOL ENTOMOL, V37, P318, DOI 10.1111/j.1365-2311.2012.01364.x; Van Bael SA, 2009, P ROY SOC B-BIOL SCI, V276, P2419, DOI 10.1098/rspb.2009.0196; Weber N. A., 1972, GARDENING ANTS ATTIN; WEBER NA, 1966, SCIENCE, V153, P587, DOI 10.1126/science.153.3736.587; White T. J, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	54	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0112067	10.1371/journal.pone.0112067	http://dx.doi.org/10.1371/journal.pone.0112067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617836	Green Published, gold, Green Submitted			2022-12-26	WOS:000350336000001
J	Rusu, MC; Poalelungi, CV; Vrapciu, AD; Nicolescu, MI; Hostiuc, S; Mogoanta, L; Taranu, T				Rusu, Mugurel C.; Poalelungi, Cristian V.; Vrapciu, Alexandra D.; Nicolescu, Mihnea I.; Hostiuc, Sorin; Mogoanta, Laurentiu; Taranu, Traian			Endocardial Tip Cells in the Human Embryo - Facts and Hypotheses	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; SPROUTING ANGIOGENESIS; CORONARY-ARTERIES; AVIAN HEART; PROGENITORS; EPICARDIUM; FILOPODIA; LINEAGE; MUCOSA	Experimental studies regarding coronary embryogenesis suggest that the endocardium is a source of endothelial cells for the myocardial networks. As this was not previously documented in human embryos, we aimed to study whether or not endothelial tip cells could be correlated with endocardial-dependent mechanisms of sprouting angiogenesis. Six human embryos (43-56 days) were obtained and processed in accordance with ethical regulations; immunohistochemistry was performed for CD105 (endoglin), CD31, CD34, alpha-smooth muscle actin, desmin and vimentin antibodies. Primitive main vessels were found deriving from both the sinus venosus and aorta, and were sought to be the primordia of the venous and arterial ends of cardiac microcirculation. Subepicardial vessels were found branching into the outer ventricular myocardium, with a pattern of recruiting alpha-SMA+/desmin+ vascular smooth muscle cells and pericytes. Endothelial sprouts were guided by CD31+/CD34+/CD105+/vimentin+ endothelial tip cells. Within the inner myocardium, we found endothelial networks rooted from endocardium, guided by filopodia-projecting CD31+/CD34+/CD105+/vimentin+ endocardial tip cells. The myocardial microcirculatory bed in the atria was mostly originated from endocardium, as well. Nevertheless, endocardial tip cells were also found in cardiac cushions, but they were not related to cushion endothelial networks. A general anatomical pattern of cardiac microvascular embryogenesis was thus hypothesized; the arterial and venous ends being linked, respectively, to the aorta and sinus venosus. Further elongation of the vessels may be related to the epicardium and subepicardial stroma and the intramyocardial network, depending on either endothelial and endocardial filopodia-guided tip cells in ventricles, or mostly on endocardium, in atria.	[Rusu, Mugurel C.; Vrapciu, Alexandra D.] Carol Davila Univ Med & Pharm, Fac Med Dent, Div Anat, Bucharest, Romania; [Rusu, Mugurel C.] MEDCTR Ctr Excellence Lab Med & Pathol, Bucharest, Romania; [Poalelungi, Cristian V.] Carol Davila Univ Med & Pharm, Dr I Cantacuzino Hosp, Dept Obstet & Gynaecol, Bucharest, Romania; [Nicolescu, Mihnea I.] Carol Davila Univ Med & Pharm, Fac Med Dent, Div Histol & Cytol, Bucharest, Romania; [Nicolescu, Mihnea I.] Victor Babes Natl Inst Pathol, Mol Med Lab, Bucharest, Romania; [Hostiuc, Sorin] Carol Davila Univ Med & Pharm, Fac Med, Dept Morphol Sci 2, Div Legal Med & Bioeth, Bucharest, Romania; [Mogoanta, Laurentiu] Univ Med & Pharm Craiova, Dept Morphol, Res Ctr Microscop Morphol & Immunol, Craiova, Romania; [Taranu, Traian] Gr T Popa Univ Med & Pharm, Fac Med, Div Anat, Iasi, Romania	Carol Davila University of Medicine & Pharmacy; Carol Davila University of Medicine & Pharmacy; Carol Davila University of Medicine & Pharmacy; Victor Babes National Institute of Pathology; Carol Davila University of Medicine & Pharmacy; University of Medicine & Pharmacy of Craiova; Grigore T Popa University of Medicine & Pharmacy	Nicolescu, MI (corresponding author), Carol Davila Univ Med & Pharm, Fac Med Dent, Div Histol & Cytol, Bucharest, Romania.	mihnea.nicolescu@gmail.com	Poalelungi, Cristian/A-3965-2017; Mogoanta, Laurentiu/M-5856-2017; Rusu, Mugurel Constantin/C-7565-2009; Hostiuc, Sorin/I-2017-2019; Jalali, Amir/V-2562-2018; Nicolescu, Mihnea Ioan/C-6033-2011; Hostiuc, Sorin I/A-2292-2009	Mogoanta, Laurentiu/0000-0002-0350-834X; Rusu, Mugurel Constantin/0000-0002-8723-0540; Hostiuc, Sorin/0000-0003-4130-9402; Jalali, Amir/0000-0002-0307-879X; Nicolescu, Mihnea Ioan/0000-0001-8051-1166; Hostiuc, Sorin I/0000-0003-4130-9402				Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Carmona R, 2010, J CELL MOL MED, V14, P2066, DOI 10.1111/j.1582-4934.2010.01088.x; Crawford MH, 2010, CARDIOLOGY; del Monte G, 2012, CELL, V151, P932, DOI 10.1016/j.cell.2012.11.004; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Diaz-Flores L, 2011, HISTOL HISTOPATHOL, V26, P623, DOI 10.14670/HH-26.623; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Fantin A, 2013, BLOOD, V121, P2352, DOI 10.1182/blood-2012-05-424713; Gerhardt H, 2005, EXP SUPPL, V94, P3; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gerhardt H., 2008, ORGANOGENESIS, V4, P241, DOI [DOI 10.4161/0RG.4.4.7414, DOI 10.4161/org.4.4.7414]; Gittenberger-de Groot AC, 2003, CARDIOL YOUNG, V13, P175, DOI 10.1017/S1047951103000337; Gutierrez R, 2014, HISTOL HISTOPATHOL; Hagedorn M, 2004, DEV DYNAM, V230, P23, DOI 10.1002/dvdy.20020; Hoffman J. I. E., 2012, PEDIAT CARDIOVASCULA; Ishii Y, 2009, CELL TISSUE RES, V335, P67, DOI 10.1007/s00441-008-0663-z; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Kattan J, 2004, DEV DYNAM, V230, P34, DOI 10.1002/dvdy.20022; Magara J, 2012, J ANAT, V220, P612, DOI 10.1111/j.1469-7580.2012.01501.x; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Milgrom-Hoffman M, 2011, DEVELOPMENT, V138, P4777, DOI 10.1242/dev.061192; Morabito CJ, 2002, CURR OPIN CARDIOL, V17, P235, DOI 10.1097/00001573-200205000-00005; Ott Harald C, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS27, DOI 10.1038/ncpcardio0771; Perez-Pomares JM, 2003, DEV DYNAM, V227, P56, DOI 10.1002/dvdy.10284; Perez-Pomares JM, 1998, DEV BIOL, V200, P57, DOI 10.1006/dbio.1998.8949; Perez-Pomares JM, 2006, ANAT REC PART A, V288A, P700, DOI 10.1002/ar.a.20338; Phng LK, 2013, DEVELOPMENT, V140, P4031, DOI 10.1242/dev.097352; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Reese DE, 2002, CIRC RES, V91, P761, DOI 10.1161/01.RES.0000038961.53759.3C; RHODIN JAG, 1989, J SUBMICR CYTOL PATH, V21, P1; Rusu MC, 2013, ANAT SCI INT, V88, P25, DOI 10.1007/s12565-012-0154-x; Rusu MC, 2014, ANAT REC, V297, P301, DOI 10.1002/ar.22837; Rusu MC, 2013, ANAT REC, V296, P350, DOI 10.1002/ar.22630; Sadler TW, 2009, LANGMANS MED EMBRYOL; Siemerink MJ, 2013, J HISTOCHEM CYTOCHEM, V61, P101, DOI 10.1369/0022155412467635; Siemerink MJ, 2012, ANGIOGENESIS, V15, P151, DOI 10.1007/s10456-011-9251-z; Stanescu R, 2012, ROM J MORPHOL EMBRYO, V53, P375; Vrapciu AD, 2014, MED HYPOTHESES, V83, P497, DOI 10.1016/j.mehy.2014.08.014; Weinstein BM, 1999, DEV DYNAM, V215, P2, DOI 10.1002/(SICI)1097-0177(199905)215:1<2::AID-DVDY2>3.0.CO;2-U; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Wu BR, 2012, CELL, V151, P1083, DOI 10.1016/j.cell.2012.10.023; Zhang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070570; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	48	13	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0115853	10.1371/journal.pone.0115853	http://dx.doi.org/10.1371/journal.pone.0115853			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617624	Green Published, Green Submitted, gold			2022-12-26	WOS:000350336000007
J	Dagleish, MP; Martin, S; Steele, P; Finlayson, J; Eaton, SL; Siso, S; Stewart, P; Fernandez-Borges, N; Hamilton, S; Pang, Y; Chianini, F; Reid, HW; Goldmann, W; Gonzalez, L; Castilla, J; Jeffrey, M				Dagleish, Mark P.; Martin, Stuart; Steele, Philip; Finlayson, Jeanie; Eaton, Samantha L.; Siso, Silvia; Stewart, Paula; Fernandez-Borges, Natalia; Hamilton, Scott; Pang, Yvonne; Chianini, Francesca; Reid, Hugh W.; Goldmann, Wilfred; Gonzalez, Lorenzo; Castilla, Joaquin; Jeffrey, Martin			Susceptibility of European Red Deer (Cervus elaphus elaphus) to Alimentary Challenge with Bovine Spongiform Encephalopathy	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; PRION PROTEIN; TRANSGENIC MICE; ODOCOILEUS-HEMIONUS; PRP ACCUMULATION; SHEEP; SCRAPIE; BSE; INFECTION; ANIMALS	European red deer (Cervus elaphus elaphus) are susceptible to the agent of bovine spongiform encephalopathy, one of the transmissible spongiform encephalopathies, when challenged intracerebrally but their susceptibility to alimentary challenge, the presumed natural route of transmission, is unknown. To determine this, eighteen deer were challenged via stomach tube with a large dose of the bovine spongiform encephalopathy agent and clinical signs, gross and histological lesions, presence and distribution of abnormal prion protein and the attack rate recorded. Only a single animal developed clinical disease, and this was acute with both neurological and respiratory signs, at 1726 days post challenge although there was significant (27.6%) weight loss in the preceding 141 days. The clinically affected animal had histological lesions of vacuolation in the neuronal perikaryon and neuropil, typical of transmissible spongiform encephalopathies. Abnormal prion protein, the diagnostic marker of transmissible encephalopathies, was primarily restricted to the central and peripheral nervous systems although a very small amount was present in tingible body macrophages in the lymphoid patches of the caecum and colon. Serial protein misfolding cyclical amplification, an in vitro ultra-sensitive diagnostic technique, was positive for neurological tissue from the single clinically diseased deer. All other alimentary challenged deer failed to develop clinical disease and were negative for all other investigations. These findings show that transmission of bovine spongiform encephalopathy to European red deer via the alimentary route is possible but the transmission rate is low. Additionally, when deer carcases are subjected to the same regulations that ruminants in Europe with respect to the removal of specified offal from the human food chain, the zoonotic risk of bovine spongiform encephalopathy, the cause of variant Creutzfeldt-Jakob disease, from consumption of venison is probably very low.	[Dagleish, Mark P.; Steele, Philip; Finlayson, Jeanie; Hamilton, Scott; Pang, Yvonne; Chianini, Francesca; Reid, Hugh W.] Pentlands Sci Pk, Moredun Res Inst, Edinburgh EH26 0PZ, Midlothian, Scotland; [Martin, Stuart; Siso, Silvia; Gonzalez, Lorenzo; Jeffrey, Martin] Pentlands Sci Pk, Anim Hlth & Vet Labs Agcy Lasswade, Edinburgh EH26 0PZ, Midlothian, Scotland; [Eaton, Samantha L.; Stewart, Paula; Goldmann, Wilfred] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Div Neurobiol, Edinburgh EH25 9RG, Midlothian, Scotland; [Fernandez-Borges, Natalia; Castilla, Joaquin] CIC bioGUNE, Derio 48160, Spain; [Castilla, Joaquin] Ikerbasque, Basque Fdn Sci, Bilbao 48013, Bizkaia, Spain	Moredun Research Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; CIC bioGUNE; Basque Foundation for Science	Dagleish, MP (corresponding author), Pentlands Sci Pk, Moredun Res Inst, Edinburgh EH26 0PZ, Midlothian, Scotland.	mark.dagleish@moredun.ac.uk	SISO, SILVIA/D-4240-2009; Castilla, Joaquin/D-5261-2011; Chianini, Francesca/K-1451-2013; Castilla, Joaquín/J-8414-2019; Fernández-Borges, Natalia/H-1875-2012; Siso, Silvia/X-7690-2019; González, Lorenzo/A-5325-2010	Castilla, Joaquin/0000-0002-2216-1361; Chianini, Francesca/0000-0001-9962-446X; Castilla, Joaquín/0000-0002-2216-1361; González, Lorenzo/0000-0003-4199-4526; Siso, Silvia/0000-0002-3642-2956; Fernandez-Borges, Natalia/0000-0001-6274-0096	UK Food Standards Agency [M03024];  [AGL2012-37988-C04-01];  [CTP2013-P05];  [EFA282/11]; BBSRC [BBS/E/D/20251968, BBS/E/D/20251967] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251967, BBS/E/D/20251968] Funding Source: researchfish	UK Food Standards Agency; ; ; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	These studies were funded by the UK Food Standards Agency grant M03024 and three Spanish grants (AGL2012-37988-C04-01, CTP2013-P05 and EFA282/11).	[Anonymous], 1990, SPECIFIED BOVINE OFF; Brayton KA, 2004, GENE, V326, P167, DOI 10.1016/j.gene.2003.10.022; Brun A, 2004, NEUROSCI RES, V48, P75, DOI 10.1016/j.neures.2003.09.004; Brun A, 2007, J GEN VIROL, V88, P1842, DOI 10.1099/vir.0.82568-0; Carlson NR, 2007, PHYSIOL BEHAV, P69; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2004, J NEUROSCI, V24, P2156, DOI 10.1523/JNEUROSCI.3811-03.2004; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collins SJ, 2004, LANCET, V363, P51, DOI 10.1016/S0140-6736(03)15171-9; Dagleish MP, 2010, J GEN VIROL, V91, P3116, DOI 10.1099/vir.0.025049-0; Dagleish MP, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-17; Espinosa JC, 2007, J GEN VIROL, V88, P1379, DOI 10.1099/vir.0.82647-0; Ferguson NM, 1997, PHILOS T R SOC B, V352, P803, DOI 10.1098/rstb.1997.0063; Foster JD, 2004, J GEN VIROL, V85, P3159, DOI 10.1099/vir.0.80099-0; FOSTER JD, 1993, VET REC, V133, P339, DOI 10.1136/vr.133.14.339; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; Gavier-Widen D, 2005, J VET DIAGN INVEST, V17, P509, DOI 10.1177/104063870501700601; Goldmann W, 2008, VET RES, V39, DOI [10.1051/vetres:2008038, DOI 10.1051/VETRES:2008038]; Goldmann W, 2006, J GEN VIROL, V87, P3741, DOI 10.1099/vir.0.82083-0; Gonzalez L, 2008, VET REC, V162, P397, DOI 10.1136/vr.162.13.397; Gonzalez L, 2002, J COMP PATHOL, V126, P17, DOI 10.1053/jcpa.2001.0516; Gonzalez L, 2007, J GEN VIROL, V88, P714, DOI 10.1099/vir.0.82426-0; Gonzalez L, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-55; Haase B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-15; Happ GM, 2007, J WILDLIFE DIS, V43, P224, DOI 10.7589/0090-3558-43.2.224; Houston F, 2003, NATURE, V423, P498, DOI 10.1038/423498a; Hunter N, 2012, J VIROL, V86, P11856, DOI 10.1128/JVI.01573-12; Jeffrey M, 2006, J PATHOL, V209, P4, DOI 10.1002/path.1962; Jeffrey M, 2007, NEUROPATH APPL NEURO, V33, P373, DOI 10.1111/j.1365-2990.2007.00868.x; Jeffrey M, 2006, J COMP PATHOL, V134, P17, DOI 10.1016/j.jcpa.2005.06.005; Jeffrey M, 2000, ARCH VIROL, P23; Jeffrey M, 2001, J COMP PATHOL, V124, P280, DOI 10.1053/jcpa.2001.0465; Jewell JE, 2005, J GEN VIROL, V86, P2127, DOI 10.1099/vir.0.81077-0; Johnson C, 2006, J GEN VIROL, V87, P2109, DOI 10.1099/vir.0.81615-0; KIRKWOOD JK, 1994, VET REC, V135, P296, DOI 10.1136/vr.135.13.296; Konold T, 2004, VET REC, V155, P659, DOI 10.1136/vr.155.21.659; McBride SD, 2015, BEHAV BRAIN RES, V276, P45, DOI 10.1016/j.bbr.2014.05.057; Mitchell GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039055; O'Rourke KI, 1999, J GEN VIROL, V80, P2765, DOI 10.1099/0022-1317-80-10-2765; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Peletto S, 2009, J VET SCI, V10, P115, DOI 10.4142/jvs.2009.10.2.115; Perucchini M, 2008, J GEN VIROL, V89, P1324, DOI 10.1099/vir.0.83424-0; Robinson SJ, 2012, PRION, V6, P153, DOI 10.4161/pri.19640; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Siso S, 2009, NEUROPATH APPL NEURO, V35, P232, DOI 10.1111/j.1365-2990.2008.00978.x; Tan BC, 2012, J GEN VIROL, V93, P2749, DOI 10.1099/vir.0.039008-0; Terry LA, 2003, VET REC, V152, P387, DOI 10.1136/vr.152.13.387; Vickery CM, 2014, J VIROL, V88, P1830, DOI 10.1128/JVI.02762-13; Watson P, 2009, DEER CULLING EXMOOR; WELLS GAH, 1992, RES VET SCI, V53, P1, DOI 10.1016/0034-5288(92)90076-E; WELLS GAH, 1995, BRAIN PATHOL, V5, P91, DOI 10.1111/j.1750-3639.1995.tb00580.x; WILLIAMS ES, 1993, VET PATHOL, V30, P36, DOI 10.1177/030098589303000105; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; Williams ES, 2004, P AM ASS VET LAB DIA; Windl O, 1996, HUM GENET, V98, P259, DOI 10.1007/s004390050204; WYATT JM, 1991, VET REC, V129, P233, DOI 10.1136/vr.129.11.233	56	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116094	10.1371/journal.pone.0116094	http://dx.doi.org/10.1371/journal.pone.0116094			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615837	Green Published, Green Submitted, gold			2022-12-26	WOS:000349122100022
J	Mostafa, A; Kanrai, P; Petersen, H; Ibrahim, S; Rautenschlein, S; Pleschka, S				Mostafa, Ahmed; Kanrai, Pumaree; Petersen, Henning; Ibrahim, Sherif; Rautenschlein, Silke; Pleschka, Stephan			Efficient Generation of Recombinant Influenza A Viruses Employing a New Approach to Overcome the Genetic Instability of HA Segments	PLOS ONE			English	Article							CANDIDATE VACCINE VIRUSES; ESCHERICHIA-COLI; REVERSE GENETICS; VERO CELLS; DNA-REPAIR; TRANSCRIPTION; REPLICATION; SYSTEM; MAINTENANCE; RESTRICTION	Influenza A viruses (IAVs) are the most relevant and continual source of severe infectious respiratory complications in humans and different animal species, especially poultry. Therefore, an efficient vaccination that elicits protective and neutralizing antibodies against the viral hemagglutinin (HA) and neuraminidase (NA) is an important strategy to counter annual epidemics or occasional pandemics. With the help of plasmid-based reverse genetics technology, it is possible that IAV vaccine strains (IVVS) are rapidly generated. However, the genetic instability of some cloned HA-cDNAs after transformation into competent bacteria represents a major obstacle. Herein, we report efficient cloning strategies of different genetically volatile HA segments (H5- and H9-subtypes) employing either a newly constructed vector for reverse genetics (pMKPccdB) or by the use of the Escherichia coli strain HB101. Both approaches represent improved and generalizable strategies to establish functional reverse genetics systems preventing genetic changes to the cloned (HA) segments of IAV facilitating more efficient rescue of recombinant IAV for basic research and vaccine development.	[Mostafa, Ahmed] Natl Res Ctr, Ctr Sci Excellence Influenza Viruses, Cairo, Egypt; [Kanrai, Pumaree; Pleschka, Stephan] Univ Giessen, Inst Med Virol, D-35390 Giessen, Germany; [Petersen, Henning; Rautenschlein, Silke] Univ Vet Med Hannover, Clin Poultry, Hannover, Germany; [Ibrahim, Sherif] Agr Res Ctr, VSVRI, Dept Genet Engn, Cairo, Egypt	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Justus Liebig University Giessen; University of Veterinary Medicine Hannover, Foundation; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt	Pleschka, S (corresponding author), Univ Giessen, Inst Med Virol, D-35390 Giessen, Germany.	stephan.pleschka@viro.med.uni-giessen.de	Mostafa, Ahmed/S-7462-2016; Pleschka, Stephan/HGU-9354-2022	Mostafa, Ahmed/0000-0002-2878-5714; Pleschka, Stephan/0000-0002-7372-7089; Ibrahim, Sherif/0000-0002-1503-8701	FluResearchNet, "Molecular Signatures Determining Pathogenicity and Species Transmission of Influenza A Viruses" - German Federal Ministry of Education and Research (BMBF) [01 KI 1006E, 01 KI 1006D]; German-Egyptian Research Long-Term Scholarship "GERLS" program - Egyptian government; German Academic Exchange Service (DAAD); Egyptian Science and Technology Development Fund (STDF)	FluResearchNet, "Molecular Signatures Determining Pathogenicity and Species Transmission of Influenza A Viruses" - German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German-Egyptian Research Long-Term Scholarship "GERLS" program - Egyptian government; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Egyptian Science and Technology Development Fund (STDF)(Science and Technology Development Fund (STDF))	This work was supported in part by the FluResearchNet, "Molecular Signatures Determining Pathogenicity and Species Transmission of Influenza A Viruses", funded by the German Federal Ministry of Education and Research (BMBF, grant 01 KI 1006E, to S. P. and grant, 01 KI 1006D to S. R.) and by a fellowship of the German-Egyptian Research Long-Term Scholarship "GERLS" program co-funded by the Egyptian government and the German Academic Exchange Service (DAAD, to A. M.). This work was also supported by a fellowship of the Egyptian Science and Technology Development Fund (STDF, to S. I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHYA S, 1982, CELL, V29, P939, DOI 10.1016/0092-8674(82)90456-1; Al-Allaf FA, 2013, 3 BIOTECH, V3, P61, DOI 10.1007/s13205-012-0070-8; BERNARD P, 1994, GENE, V148, P71, DOI 10.1016/0378-1119(94)90235-6; Bowater RP, 2001, PROG NUCLEIC ACID RE, V66, P159; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; CESARENI G, 1982, P NATL ACAD SCI-BIOL, V79, P6313, DOI 10.1073/pnas.79.20.6313; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Corchero JL, 1998, BIOTECHNOL BIOENG, V58, P625, DOI 10.1002/(SICI)1097-0290(19980620)58:6<625::AID-BIT8>3.3.CO;2-1; CUNNINGHAM TP, 1993, GENE, V124, P93, DOI 10.1016/0378-1119(93)90766-V; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Feng T, 2002, BIOTECHNIQUES, V32, P992, DOI 10.2144/02325bm03; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Harvey R, 2011, J VIROL, V85, P6086, DOI 10.1128/JVI.00096-11; Harvey R, 2010, VACCINE, V28, P8008, DOI 10.1016/j.vaccine.2010.09.006; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Hirst GK, 1942, J EXP MED, V75, P49, DOI 10.1084/jem.75.1.49; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2000, VIROLOGY, V267, P310, DOI 10.1006/viro.1999.0140; Hoffmann E, 2002, P NATL ACAD SCI USA, V99, P11411, DOI 10.1073/pnas.172393399; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; HOWARDFLANDERS P, 1966, GENETICS, V53, P1137; Kang HY, 1996, GENOMICS, V35, P189, DOI 10.1006/geno.1996.0338; KIYAMA R, 1994, GENE, V150, P57; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Lewin A, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-19; Liao H H, 1991, Protein Expr Purif, V2, P43, DOI 10.1016/1046-5928(91)90008-7; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; LUYTJES W, 1989, CELL, V59, P1107, DOI 10.1016/0092-8674(89)90766-6; Ma WJ, 2010, J VIROL, V84, P2122, DOI 10.1128/JVI.01668-09; Malagon F, 1998, MOL GEN GENET, V259, P639, DOI 10.1007/s004380050858; Mostafa A, 2013, J VIROL METHODS, V193, P603, DOI 10.1016/j.jviromet.2013.07.021; Neumann G, 2000, J VIROL, V74, P547, DOI 10.1128/JVI.74.1.547-551.2000; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Nicolson C, 2005, VACCINE, V23, P2943, DOI 10.1016/j.vaccine.2004.08.054; Okamatsu M, 2008, ARCH VIROL, V153, P2189, DOI 10.1007/s00705-008-0243-2; Ozaki H, 2004, J VIROL, V78, P1851, DOI 10.1128/JVI.78.4.1851-1857.2004; Parry J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2151; PEREIRA HG, 1967, B WORLD HEALTH ORGAN, V37, P553; Pleschka S, 1996, J VIROL, V70, P4188, DOI 10.1128/JVI.70.6.4188-4192.1996; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Schambach A, 2006, GENE THER, V13, P1524, DOI 10.1038/sj.gt.3302807; Sorrell EM, 2011, CURR OPIN VIROL, V1, P635, DOI 10.1016/j.coviro.2011.07.003; Stech J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn646; STUEBER D, 1982, EMBO J, V1, P1399, DOI 10.1002/j.1460-2075.1982.tb01329.x; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; SUGAWARA K, 1991, J GEN VIROL, V72, P103, DOI 10.1099/0022-1317-72-1-103; To KKW, 2014, J INFECTION, V68, P205, DOI 10.1016/j.jinf.2013.12.014; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WU Y, 2014, TRENDS MICROBIOL; Yoon SW, 2013, J VIROL, V87, P4786, DOI 10.1128/JVI.03551-12; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhou B, 2011, J VIROL METHODS, V173, P378, DOI 10.1016/j.jviromet.2011.01.021	64	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116917	10.1371/journal.pone.0116917	http://dx.doi.org/10.1371/journal.pone.0116917			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615576	Green Published, Green Submitted, gold			2022-12-26	WOS:000349122100049
J	Pua, YH; Clark, RA; Ong, PH				Pua, Yong-Hao; Clark, Ross A.; Ong, Peck-Hoon			Evaluation of the Wii Balance Board for Walking Aids Prediction: Proof-of-Concept Study in Total Knee Arthroplasty	PLOS ONE			English	Article							STANDING BALANCE; OSTEOARTHRITIS; REPLACEMENT; RELIABILITY; INJURIES; MODELS; PAIN; HIP	Background and Objectives To provide proof-of-concept for the validity of the Wii Balance Board (WBB) measures to predict the type of walking aids required by inpatients with a recent (<= 4days) total knee arthroplasty (TKA). Methods A cross-sectional sample of 89 inpatients (mean age, 67.0 +/- 8years) with TKA was analyzed. A multivariable proportional odds prediction model was constructed using 8 pre-specified predictors - namely, age, sex, body mass index, knee pain, knee range-of-motion, active knee lag, and WBB-derived standing balance. The type of walking aids prescribed on day 4 post-surgery was the outcome of interest - an ordinal variable with 4 categories (walking stick, narrow-and broad-base quadstick, and walking frame). Results Women, increasing body mass index, and poorer standing balance were independently associated with greater odds for requiring walking aids with a larger base-of-support. The concordance-index of the prediction model was 0.74. The model comprising only WBB-derived standing balance had nearly half (44%) the explanatory power of the full model. Adding WBB-derived standing balance to conventional demographic and knee variables resulted in a continuous net reclassification index of 0.60 (95% CI, 0.19-1.01), predominantly due to better identification of patients who required walking aids with a large base-of-support (sensitivity gain). Conclusions The WBB was able to provide quantitative measures of standing balance which could assist healthcare professionals in prescribing the appropriate type of walking aids for patients. Further investigation is needed to assess whether using the WBB could lead to meaningful changes in clinical outcomes such as falls.	[Pua, Yong-Hao; Ong, Peck-Hoon] Singapore Gen Hosp, Dept Physiotherapy, Singapore, Singapore; [Clark, Ross A.] Australian Catholic Univ, Sch Exercise Sci, Melbourne, Vic, Australia	Singapore General Hospital; Australian Catholic University	Clark, RA (corresponding author), Australian Catholic Univ, Sch Exercise Sci, Melbourne, Vic, Australia.	ross.clark@acu.edu.au	Clark, Ross A/R-5664-2018; Clark, Ross/K-7613-2019	Clark, Ross A/0000-0002-7291-8553; Clark, Ross/0000-0002-7291-8553; Pua, Yong-Hao/0000-0003-2313-9665	Singhealth Foundation Grant [SHF/FG444S/2009]	Singhealth Foundation Grant(SingHealth)	This study was supported by Singhealth Foundation Grant (SHF/FG444S/2009). The study sponsors had no involvement in study design, collection, analysis and interpretation of the data, writing of the manuscript and in the decision to submit the manuscript for publication.	Bateni H, 2005, ARCH PHYS MED REHAB, V86, P134, DOI 10.1016/j.apmr.2004.04.023; Bradley SM, 2011, AM FAM PHYSICIAN, V84, P405; Brooks L L, 1994, Wis Med J, V93, P16; CHARRON PM, 1995, AM J PHYS MED REHAB, V74, P237, DOI 10.1097/00002060-199505000-00011; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; Cibere J, 2004, ARTHRITIS RHEUM, V50, P458, DOI 10.1002/art.20025; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Fitz Gerald JD, 2004, ARTHRIT RHEUM-ARTHR, V51, P100, DOI 10.1002/art.20090; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrell FE, 2013, RMS REGRESSION MODEL; Harrell FE, 2001, REGRESSION MODELING; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Holmes JD, 2013, CLIN REHABIL, V27, P361, DOI 10.1177/0269215512458684; Kaye H. S., 2000, MOBILITY DEVICE USE; Kearns Richard J, 2008, Orthopedics, V31, P225, DOI 10.3928/01477447-20080301-20; Leening MJG, 2014, ANN INTERN MED, V160, P122, DOI 10.7326/M13-1522; Moons KGM, 2004, J CLIN EPIDEMIOL, V57, P1262, DOI 10.1016/j.jclinepi.2004.01.020; O'Hare MP, 2013, PHYS THER REV, V18, P11, DOI 10.1179/1743288X12Y.0000000036; Oliver D, 2008, AGE AGEING, V37, P248, DOI 10.1093/ageing/afn088; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Prieto-Alhambra D, 2011, ANN RHEUM DIS, V70, P134, DOI 10.1136/ard.2010.131110; Pua YH, 2013, J ARTHROPLASTY, V28, P1521, DOI 10.1016/j.arth.2012.10.020; Ritter PL, 2006, J RHEUMATOL, V33, P574; Simpson C, 1991, PHYSIOTHERAPY, V77, P231; Stevens JA, 2009, J AM GERIATR SOC, V57, P1464, DOI 10.1111/j.1532-5415.2009.02365.x; Takacs J, 2014, GAIT POSTURE, V40, P270, DOI 10.1016/j.gaitpost.2014.03.016; Tung JY, 2011, J BIOMECH, V44, P1466, DOI 10.1016/j.jbiomech.2011.03.015; Van der Esch M, 2003, ARTHRIT RHEUM-ARTHR, V49, P838, DOI 10.1002/art.11463; Watson SC, 2004, AUSTRALAS J AGEING, V23, P77, DOI 10.1111/j.1741-6612.2004.00021.x	30	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117124	10.1371/journal.pone.0117124	http://dx.doi.org/10.1371/journal.pone.0117124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615952	Green Published, gold, Green Submitted			2022-12-26	WOS:000349122100057
J	Boldrin, E; Rumiato, E; Fassan, M; Cappellesso, R; Rugge, M; Chiarion-Sileni, V; Ruol, A; Alfieri, R; Cagol, M; Castoro, C; Amadori, A; Saggioro, D				Boldrin, Elisa; Rumiato, Enrica; Fassan, Matteo; Cappellesso, Rocco; Rugge, Massimo; Chiarion-Sileni, Vanna; Ruol, Alberto; Alfieri, Rita; Cagol, Matteo; Castoro, Carlo; Amadori, Alberto; Saggioro, Daniela			Genetic Features of Metachronous Esophageal Cancer Developed in Hodgkin's Lymphoma or Breast Cancer Long-Term Survivors: An Exploratory Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; FREQUENT LOSS; MICROSATELLITE INSTABILITY; HETEROZYGOSITY; ADENOCARCINOMA; RISK; PATTERNS; ETIOLOGY; THERAPY; REGIONS	Background Development of novel therapeutic drugs and regimens for cancer treatment has led to improvements in patient long-term survival. This success has, however, been accompanied by the increased occurrence of second primary cancers. Indeed, patients who received regional radiotherapy for Hodgkin's Lymphoma (HL) or breast cancer may develop, many years later, a solid metachronous tumor in the irradiated field. Despite extensive epidemiological studies, little information is available on the genetic changes involved in the pathogenesis of these solid therapy-related neoplasms. Methods Using microsatellite markers located in 7 chromosomal regions frequently deleted in sporadic esophageal cancer, we investigated loss of heterozygosity (LOH) and microsatellite instability (MSI) in 46 paired (normal and tumor) samples. Twenty samples were of esophageal carcinoma developed in HL or breast cancer long-term survivors: 14 squamous cell carcinomas (ESCC) and 6 adenocarcinomas (EADC), while 26 samples, used as control, were of sporadic esophageal cancer (15 ESCC and 11 EADC). Results We found that, though the overall LOH frequency at the studied chromosomal regions was similar among metachronous and sporadic tumors, the latter exhibited a statistically different higher LOH frequency at 17q21.31 (p = 0.018). By stratifying for tumor histotype we observed that LOH at 3p24.1, 5q11.2 and 9p21.3 were more frequent in ESCC than in EADC suggesting a different role of the genetic determinants located nearby these regions in the development of the two esophageal cancer histotypes. Conclusions Altogether, our results strengthen the genetic diversity among ESCC and EADC whether they occurred spontaneously or after therapeutic treatments. The presence of histotype-specific alterations in esophageal carcinoma arisen in HL or breast cancer long-term survivors suggests that their transformation process, though the putative different etiological origin, may retrace sporadic ESCC and EADC carcinogenesis.	[Boldrin, Elisa; Rumiato, Enrica; Chiarion-Sileni, Vanna; Alfieri, Rita; Cagol, Matteo; Castoro, Carlo; Amadori, Alberto; Saggioro, Daniela] IOV IRCCS, Veneto Inst Oncol, Padua, Italy; [Fassan, Matteo; Cappellesso, Rocco; Rugge, Massimo] Univ Padua, Dept Med Surg Pathol & Cytopathol, Padua, Italy; [Ruol, Alberto; Amadori, Alberto] Univ Padua, Dept Surg Sci Oncol & Gastroenterol, Padua, Italy	IRCCS Istituto Oncologico Veneto (IOV); University of Padua; University of Padua	Saggioro, D (corresponding author), IOV IRCCS, Veneto Inst Oncol, Padua, Italy.	d.saggioro@unipd.it	Rugge, Massimo/K-7525-2016; Castoro, Carlo/AAO-6927-2020; Alfieri, Rita/HCH-3044-2022; Cappellesso, Rocco/L-5463-2016; sileni, vanna chiarion/B-9042-2018; Alfieri, Rita/F-1676-2018; Boldrin, Elisa/V-9766-2018; Fassan, Matteo/F-5152-2012; Saggioro, Daniela/W-1443-2018; Castoro, Carlo/GNM-8249-2022	Cappellesso, Rocco/0000-0002-0480-3412; sileni, vanna chiarion/0000-0001-9191-9124; Alfieri, Rita/0000-0002-4993-2197; Boldrin, Elisa/0000-0002-7898-5845; Rumiato, Enrica/0000-0002-1142-0006; Fassan, Matteo/0000-0001-6515-5482; Saggioro, Daniela/0000-0002-7136-2821; Castoro, Carlo/0000-0001-9601-9336	Associazione Italiana per la Ricerca sul Cancro (AIRC) [10430]; Ministero della Istruzione, della Universita e della Ricerca (MIUR) [2010MCLPLB-003]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero della Istruzione, della Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by the following grants: Associazione Italiana per la Ricerca sul Cancro (AIRC, Ref. 10430), Ministero della Istruzione, della Universita e della Ricerca (MIUR, Prot. 2010MCLPLB-003); AA received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; Araki K, 2004, ONCOLOGY-BASEL, V67, P151, DOI 10.1159/000081002; Bandla S, 2012, ANN THORAC SURG, V93, P1101, DOI 10.1016/j.athoracsur.2012.01.064; Behrens C, 2000, CANCER EPIDEM BIOMAR, V9, P1027; Brat DJ, 1999, AM J PATHOL, V154, P1431, DOI 10.1016/S0002-9440(10)65397-7; Cai YYC, 2007, INT J ONCOL, V30, P1059; Chai JY, 2012, WORLD J GASTROENTERO, V18, P6521, DOI 10.3748/wjg.v18.i45.6521; Chattopadhyay I, 2010, MUTAT RES-GEN TOX EN, V696, P130, DOI 10.1016/j.mrgentox.2010.01.001; DeBenedetti VMG, 1996, CANCER EPIDEM BIOMAR, V5, P93; Dolan K, 1998, BRIT J CANCER, V78, P950, DOI 10.1038/bjc.1998.607; Dores GM, 2002, J CLIN ONCOL, V20, P3484, DOI 10.1200/JCO.2002.09.038; Dubrova YE, 1996, NATURE, V380, P683, DOI 10.1038/380683a0; Dulak AM, 2012, CANCER RES, V72, P4383, DOI 10.1158/0008-5472.CAN-11-3893; Evans SC, 2004, CANCER LETT, V212, P241, DOI 10.1016/j.canlet.2004.03.011; Fekete F, 1994, Dysphagia, V9, P289; Foulkes WD, 2013, J PATHOL, V230, P347, DOI 10.1002/path.4205; Gleeson CM, 1996, CANCER RES, V56, P259; Hu N, 2000, GENE CHROMOSOME CANC, V27, P217, DOI 10.1002/(SICI)1098-2264(200003)27:3<217::AID-GCC1>3.0.CO;2-A; Ko JMY, 2001, CANCER LETT, V170, P131, DOI 10.1016/S0304-3835(01)00577-8; Little JB, 2000, CARCINOGENESIS, V21, P397, DOI 10.1093/carcin/21.3.397; Liu M, 2011, INT J MOL SCI, V12, P7401, DOI 10.3390/ijms12117401; Mertens F, 2000, CANCER GENET CYTOGEN, V116, P89, DOI 10.1016/S0165-4608(99)00105-3; Micke O, 1999, JPN J CLIN ONCOL, V29, P164, DOI 10.1093/jjco/29.3.164; Montesano R, 1996, INT J CANCER, V69, P225, DOI 10.1002/(SICI)1097-0215(19960621)69:3<225::AID-IJC13>3.0.CO;2-6; Morgan WF, 1996, RADIAT RES, V146, P247, DOI 10.2307/3579454; MORI T, 1994, CANCER RES, V54, P1638; Morton LM, 2012, ANN ONCOL, V23, P3081, DOI 10.1093/annonc/mds144; Muzeau F, 1997, BRIT J CANCER, V75, P1336, DOI 10.1038/bjc.1997.226; Nancarrow DJ, 2008, CANCER RES, V68, P4163, DOI 10.1158/0008-5472.CAN-07-6710; Ng AK, 2008, HEMATOL ONCOL CLIN N, V22, P271, DOI 10.1016/j.hoc.2008.01.007; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Peralta RC, 1998, INT J CANCER, V78, P600, DOI 10.1002/(SICI)1097-0215(19981123)78:5<600::AID-IJC12>3.0.CO;2-1; Rumiato E, 2011, CANCER LETT, V310, P84, DOI 10.1016/j.canlet.2011.06.017; Ruol A, 2009, ARCH SURG-CHICAGO, V144, P247, DOI 10.1001/archsurg.2008.574; Shoshan Y, 2000, J NEUROPATH EXP NEUR, V59, P614, DOI 10.1093/jnen/59.7.614; Stoner GD, 2001, CARCINOGENESIS, V22, P1737, DOI 10.1093/carcin/22.11.1737; TARMIN L, 1994, CANCER RES, V54, P6094; Yang LC, 2004, CANCER LETT, V203, P71, DOI 10.1016/j.canlet.2003.09.027	38	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0117070	10.1371/journal.pone.0117070	http://dx.doi.org/10.1371/journal.pone.0117070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611972	Green Submitted, Green Published, gold			2022-12-26	WOS:000348562900031
J	Anckar, J; Bonni, A				Anckar, Julius; Bonni, Azad			Regulation of Neuronal Morphogenesis and Positioning by Ubiquitin-Specific Proteases in the Cerebellum	PLOS ONE			English	Article							SIGNALING PATHWAY; CELL-CYCLE; CENTROSOME; UBIQUITYLATION; DOMAINS; USP33	Ubiquitin signaling mechanisms play fundamental roles in the cell-intrinsic control of neuronal morphogenesis and connectivity in the brain. However, whereas specific ubiquitin ligases have been implicated in key steps of neural circuit assembly, the roles of ubiquitin-specific proteases (USPs) in the establishment of neuronal connectivity have remained unexplored. Here, we report a comprehensive analysis of USP family members in granule neuron morphogenesis and positioning in the rodent cerebellum. We identify a set of 32 USPs that are expressed in granule neurons. We also characterize the subcellular localization of the 32 USPs in granule neurons using a library of expression plasmids encoding GFP-USPs. In RNAi screens of the 32 neuronally expressed USPs, we uncover novel functions for USP1, USP4, and USP20 in the morphogenesis of granule neuron dendrites and axons and we identify a requirement for USP30 and USP33 in granule neuron migration in the rodent cerebellar cortex in vivo. These studies reveal that specific USPs with distinct spatial localizations harbor key functions in the control of neuronal morphogenesis and positioning in the mammalian cerebellum, with important implications for our understanding of the cell-intrinsic mechanisms that govern neural circuit assembly in the brain.	[Anckar, Julius; Bonni, Azad] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Bonni, Azad] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Harvard University; Harvard Medical School; Washington University (WUSTL)	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	bonni@wustl.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051255] Funding Source: NIH RePORTER; NINDS NIH HHS [NS051255] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1997, DEVELOPMENT OF THE C, P89023; Anckar J, 2006, MOL CELL BIOL, V26, P955, DOI 10.1128/MCB.26.3.955-964.2006; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Chedotal A, 2010, TRENDS NEUROSCI, V33, P163, DOI 10.1016/j.tins.2010.01.004; Courchet J, 2013, CELL, V153, P1510, DOI 10.1016/j.cell.2013.05.021; de la Torre-Ubieta L, 2011, NEURON, V72, P22, DOI 10.1016/j.neuron.2011.09.018; de la Torre-Ubieta L, 2010, GENE DEV, V24, P799, DOI 10.1101/gad.1880510; Endo A, 2009, J CELL SCI, V122, P678, DOI 10.1242/jcs.044461; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Famulski JK, 2010, SCIENCE, V330, P1834, DOI 10.1126/science.1198480; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Gaudilliere B, 2002, J BIOL CHEM, V277, P46442, DOI 10.1074/jbc.M206653200; HAMORI J, 1983, J COMP NEUROL, V220, P365, DOI 10.1002/cne.902200402; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Huynh MA, 2011, NEURON, V69, P930, DOI 10.1016/j.neuron.2011.02.008; Kawabe H, 2011, NAT REV NEUROSCI, V12, P251, DOI 10.1038/nrn3009; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Komuro H, 1998, J NEUROSCI, V18, P1478; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Li J, 2013, NATURE, V495, P255, DOI 10.1038/nature11941; Litterman N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001060; Palay S. L., 1974, CEREBELLAR CORTEX CY; Puram SV, 2011, NAT NEUROSCI, V14, P973, DOI 10.1038/nn.2857; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Urbe S, 2012, MOL BIOL CELL, V23, P1095, DOI 10.1091/mbc.E11-08-0668; Yamada T, 2014, NEURON, V83, P122, DOI 10.1016/j.neuron.2014.05.039; Yamada T, 2013, TRENDS NEUROSCI, V36, P218, DOI 10.1016/j.tins.2012.12.004; Yang Y, 2009, SCIENCE, V326, P575, DOI 10.1126/science.1177087	38	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0117076	10.1371/journal.pone.0117076	http://dx.doi.org/10.1371/journal.pone.0117076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607801	gold, Green Published, Green Submitted			2022-12-26	WOS:000348205300048
J	Niu, Y; Zhang, ZQ; Liu, CQ; Li, ZM; Sun, H				Niu, Yang; Zhang, Zhi-Qiang; Liu, Chang-Qiu; Li, Zhi-Min; Sun, Hang			A Sexually Dimorphic Corolla Appendage Affects Pollen Removal and Floral Longevity in Gynodioecious Cyananthus delavayi (Campanulaceae)	PLOS ONE			English	Article							MALE REPRODUCTIVE SUCCESS; EVOLUTION; SELECTION; PLANTS; POLLINATION; FITNESS; INTERFERENCE; DISPERSAL; STIGMAS; FLOWERS	The floral traits of bisexual flowers may evolve in response to selection on both male and female functions, but the relative importance of selection associated with each of these two aspects is poorly resolved. Sexually dimorphic traits in plants with unisexual flowers may reflect gender-specific selection, providing opportunities for gaining an increased understanding of the evolution of specific floral traits. We examined sexually dimorphic patterns of floral traits in perfect and female flowers of the gynodioecious species Cyananthus delavayi. A special corolla appendage, the throat hair, was investigated experimentally to examine its influences on male and female function. We found that perfect flowers have larger corollas and much longer throat hairs than female flowers, while female ones have much exerted stigmas. The presence of throat hairs prolonged the duration of pollen presentation by restricting the amount of pollen removed by pollen-collecting bees during each visit. Floral longevity was negatively related to the rate of pollen removal. When pollen removal rate was limited in perfect flowers, the duration of the female phases diminished with the increased male phase duration. There was a weak negative correlation between throat hair length and seed number per fruit in female flowers, but this correlation was not significant in perfect flowers. These results suggest that throat hairs may enhance male function in terms of prolonged pollen presentation. However, throat hairs have no obvious effect on female function in terms of seed number per fruit. The marked sexual dimorphism of this corolla appendage in C. delavayi is likely to have evolved and been maintained by gender-specific selection.	[Niu, Yang; Zhang, Zhi-Qiang; Liu, Chang-Qiu; Sun, Hang] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Li, Zhi-Min] Yunnan Normal Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Yunnan Normal University	Sun, H (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China.	hsun@mail.kib.ac.cn	Zhi-Qiang, Zhang/GWZ-6955-2022; Niu, Yang/GPX-1099-2022	Zhi-Qiang, Zhang/0000-0002-6907-3481; 	Natural Science Foundation of China [31200183, 30625004, 40930209]; NSFC-Yunnan Natural Science Foundation Unite Project [U1136601]; "Strategic Priority Research Program (B)" of the Chinese Academy of Sciences [XDB03030112]; Hundred Talents Program of the Chinese Academy of Sciences [2011312D11022]; Science Foundation of the Key Laboratory for Plant Diversity and Biogeography of East Asia [KLBB201209]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-Yunnan Natural Science Foundation Unite Project; "Strategic Priority Research Program (B)" of the Chinese Academy of Sciences(Chinese Academy of Sciences); Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Science Foundation of the Key Laboratory for Plant Diversity and Biogeography of East Asia	This work was supported by the Natural Science Foundation of China (http://www. nsfc.gov.cn/publish/portal1/) (grants 31200183 to YN and 30625004 and 40930209 to HS), the NSFC-Yunnan Natural Science Foundation Unite Project (U1136601 to HS), the "Strategic Priority Research Program (B)" of the Chinese Academy of Sciences, Grant No. XDB03030112, the Hundred Talents Program of the Chinese Academy of Sciences (2011312D11022 to HS), and the Science Foundation of the Key Laboratory for Plant Diversity and Biogeography of East Asia (KLBB201209 to YN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 1998, AM J BOT, V85, P245, DOI 10.2307/2446312; Armbruster WS, 2014, ANN BOT-LONDON, V113, P97, DOI 10.1093/aob/mct261; Armbruster WS, 2009, ANN BOT-LONDON, V103, P1529, DOI 10.1093/aob/mcp095; Ashman TL, 1997, EVOL ECOL, V11, P289, DOI 10.1023/A:1018416403530; Barrett SCH, 2002, HEREDITY, V88, P154, DOI 10.1038/sj/hdy/6800020; Barrett SCH, 2008, INT J PLANT SCI, V169, P1, DOI 10.1086/522511; Barrett SCH, 2013, J EXP BOT, V64, P67, DOI 10.1093/jxb/ers308; Castellanos MC, 2006, AM NAT, V167, P288, DOI 10.1086/498854; Cox RM, 2003, EVOLUTION, V57, P1653, DOI 10.1554/02-227; Cox RM, 2009, AM NAT, V173, P176, DOI 10.1086/595841; Delph LF, 2006, INTEGR COMP BIOL, V46, P465, DOI 10.1093/icb/icj038; Duffy KJ, 2011, PLANT BIOLOGY, V13, P556, DOI 10.1111/j.1438-8677.2011.00445.x; Eckhart V.M., 1999, GENDER SEXUAL DIMORP, P123, DOI [DOI 10.1007/978-3-662-03908-3_5, 10.1007/978-3-662-03908-3_5]; Evanhoe L, 2002, AM J BOT, V89, P587, DOI 10.3732/ajb.89.4.587; Giblin DE, 2005, AM J BOT, V92, P1714, DOI 10.3732/ajb.92.10.1714; HARDER LD, 1994, EVOL ECOL, V8, P542, DOI 10.1007/BF01238257; HARDER LD, 1989, AM NAT, V133, P323, DOI 10.1086/284922; Hargreaves AL, 2009, BIOL REV, V84, P259, DOI 10.1111/j.1469-185X.2008.00074.x; Hong D-Y, 2012, FLORA CHINA, V19; Ishii HS, 2000, FUNCT ECOL, V14, P122, DOI 10.1046/j.1365-2435.2000.00401.x; Lau JA, 2004, OECOLOGIA, V141, P577, DOI 10.1007/s00442-004-1677-1; LLOYD DG, 1982, EVOLUTION, V36, P903, DOI 10.1111/j.1558-5646.1982.tb05462.x; LLOYD DG, 1986, NEW ZEAL J BOT, V24, P135, DOI 10.1080/0028825X.1986.10409725; LLOYD DG, 1977, BOT REV, V43, P177, DOI 10.1007/BF02860717; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Marshall M, 2001, AM J BOT, V88, P1437, DOI 10.2307/3558451; MORGAN MT, 1994, AM NAT, V144, pS100, DOI 10.1086/285655; Niu Y, 2011, THESIS U CHINESE ACA; Niu Y, 2011, ANN BOT-LONDON, V108, P1257, DOI 10.1093/aob/mcr224; PERCIVAL M. S., 1955, NEW PHYTOL, V54, P353, DOI 10.1111/j.1469-8137.1955.tb06192.x; PLACK A, 1957, NATURE, V180, P1218, DOI 10.1038/1801218a0; PRIMACK RB, 1985, ANNU REV ECOL SYST, V16, P15, DOI 10.1146/annurev.es.16.110185.000311; Ramsey M, 2001, INT J PLANT SCI, V162, P589, DOI 10.1086/320142; Richards A.J, 1997, PLANT BREEDING SYSTE; Shykoff JA, 2003, OECOLOGIA, V135, P1, DOI 10.1007/s00442-002-1133-z; STANTON M, 1994, J EVOLUTION BIOL, V7, P271, DOI 10.1046/j.1420-9101.1994.7030271.x; Thomson JD, 2006, INTEGR COMP BIOL, V46, P390, DOI 10.1093/icb/icj046; THOMSON JD, 1992, ECOLOGY AND EVOLUTION OF PLANT REPRODUCTION, P1; vanDoorn WG, 1997, J EXP BOT, V48, P1615, DOI 10.1093/jexbot/48.314.1615; WEBB CJ, 1987, ANN MO BOT GARD, V74, P51, DOI 10.2307/2399261; WILSON P, 1995, BIOL J LINN SOC, V55, P355, DOI 10.1111/j.1095-8312.1995.tb01071.x; Zhou Z, 2013, MOL PHYLOGENET EVOL, V68, P482, DOI 10.1016/j.ympev.2013.04.027	42	4	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0117149	10.1371/journal.pone.0117149	http://dx.doi.org/10.1371/journal.pone.0117149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603479	gold, Green Published, Green Submitted			2022-12-26	WOS:000348203500043
J	Altena, R; Fehrmann, RSN; Boer, H; de Vries, EGE; Meijer, C; Gietema, JA				Altena, Renske; Fehrmann, Rudolf S. N.; Boer, Hink; de Vries, Elisabeth G. E.; Meijer, Coby; Gietema, Jourik A.			Growth Differentiation Factor 15 (GDF-15) Plasma Levels Increase during Bleomycin- and Cisplatin-Based Treatment of Testicular Cancer Patients and Relate to Endothelial Damage	PLOS ONE			English	Article							LONG-TERM SURVIVORS; MACROPHAGE INHIBITORY CYTOKINE-1; CARDIOVASCULAR-DISEASE; ACTIVATING TRANSCRIPTION; INDUCED APOPTOSIS; 5-YEAR SURVIVORS; CELL; CHEMOTHERAPY; EXPRESSION; PLATINUM	Introduction Chemotherapy-related endothelial damage contributes to the early development of cardiovascular morbidity in testicular cancer patients. We aimed to identify relevant mechanisms of and search for candidate biomarkers for this endothelial damage. Methods Human micro-vascular endothelial cells (HMEC-1) were exposed to bleomycin or cisplatin with untreated samples as control. 18k cDNA microarrays were used. Gene expression differences were analysed at single gene level and in gene sets clustered in biological pathways and validated by qRT-PCR. Protein levels of a candidate biomarker were measured in testicular cancer patient plasma before, during and after bleomycin-etoposide-cisplatin chemotherapy, and related to endothelial damage biomarkers (von Willebrand Factor (vWF), high-sensitivity C-Reactive Protein (hsCRP)). Results Microarray data identified several genes with highly differential expression; e.g. Growth Differentiation Factor 15 (GDF-15), Activating Transcription Factor 3 (ATF3) and Amphiregulin (AREG). Pathway analysis revealed strong associations with 'p53' and 'Diabetes Mellitus' gene sets. Based on known function, we measured GDF-15 protein levels in 41 testicular patients during clinical follow-up. Pre-chemotherapy GDF-15 levels equalled controls. Throughout chemotherapy GDF-15, vWF and hsCRP levels increased, and were correlated at different time-points. Conclusion An unbiased approach in a preclinical model revealed genes related to chemotherapy-induced endothelial damage, like GDF-15. The increases in plasma GDF-15 levels in testicular cancer patients during chemotherapy and its association with vWF and hsCRP suggest that GDF-15 is a potentially useful biomarker related to endothelial damage.	[Altena, Renske; Fehrmann, Rudolf S. N.; Boer, Hink; de Vries, Elisabeth G. E.; Meijer, Coby; Gietema, Jourik A.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [Fehrmann, Rudolf S. N.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	University of Groningen; University of Groningen	Gietema, JA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands.	j.a.gietema@umcg.nl	Fehrmann, Rudolf/E-2551-2011	Fehrmann, Rudolf/0000-0002-7516-315X; Gietema, Jourik/0000-0003-0629-7354; Altena-Kornalijnslijper, Renske/0000-0001-6944-5209; de Vries, Elisabeth/0000-0002-8949-7425	Dutch Cancer Society [RUG 2009-4365]	Dutch Cancer Society(KWF Kankerbestrijding)	Support was provided by RUG 2009-4365 from the Dutch Cancer Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Ago T, 2006, CIRC RES, V98, P294, DOI 10.1161/01.RES.0000207919.83894.9d; ALBERTS DS, 1978, CANCER CHEMOTH PHARM, V1, P177; Breit SN, 2011, GROWTH FACTORS, V29, P187, DOI 10.3109/08977194.2011.607137; Brouwer CAJ, 2013, J CLIN ONCOL, V31, P3906, DOI 10.1200/JCO.2012.46.6086; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Chen SC, 2008, ATHEROSCLEROSIS, V201, P281, DOI 10.1016/j.atherosclerosis.2008.02.014; Dirix LY, 1997, ANTI-CANCER DRUG, V8, P859, DOI 10.1097/00001813-199710000-00007; Eckstein N, 2008, J BIOL CHEM, V283, P739, DOI 10.1074/jbc.M706287200; Eggers KM, 2012, SCAND J CLIN LAB INV, V72, P45, DOI 10.3109/00365513.2011.626072; Feldman DR, 2008, JAMA-J AM MED ASSOC, V299, P672, DOI 10.1001/jama.299.6.672; Fossa SD, 2004, BRIT J CANCER, V90, P607, DOI 10.1038/sj.bjc.6601558; Fu MG, 2003, GENE, V315, P33, DOI 10.1016/S0378-1119(03)00730-3; Gietema JA, 2000, LANCET, V355, P1075, DOI 10.1016/S0140-6736(00)02044-4; Hamdi M, 2008, DNA REPAIR, V7, P487, DOI 10.1016/j.dnarep.2007.12.004; Haugnes HS, 2010, J CLIN ONCOL, V28, P4649, DOI 10.1200/JCO.2010.29.9362; Hellemons ME, 2012, DIABETES CARE, V35, P2340, DOI 10.2337/dc12-0180; Herder M, 2013, OBESITY METABOLIS S3, V15, P39; Huang CY, 2007, CLIN CANCER RES, V13, P5825, DOI 10.1158/1078-0432.CCR-07-1037; Huddart RA, 2003, J CLIN ONCOL, V21, P1513, DOI 10.1200/JCO.2003.04.173; Ishii H, 2002, TOXICOL APPL PHARM, V184, P88, DOI 10.1006/taap.2002.9499; Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Kempf T, 2012, EUR J ENDOCRINOL, V167, P671, DOI 10.1530/EJE-12-0466; Kool J, 2005, ONCOGENE, V22, P4235, DOI [10.1038/sj.onc.1206611, DOI 10.1038/SJ.0NC.1206611]; L'Azou B, 2005, CELL BIOL TOXICOL, V21, P127, DOI 10.1007/s10565-005-0172-8; Lechner D, 2007, J THROMB HAEMOST, V5, P2445, DOI 10.1111/j.1538-7836.2007.02788.x; Lok DJ, 2013, AM J CARDIOL, V112, P831, DOI 10.1016/j.amjcard.2013.05.013; Mehta RS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju016; Meinardi MT, 2000, J CLIN ONCOL, V18, P1725, DOI 10.1200/JCO.2000.18.8.1725; Montiel M, 2009, CELL PHYSIOL BIOCHEM, V23, P441, DOI 10.1159/000218191; Nawa T, 2002, ATHEROSCLEROSIS, V161, P281, DOI 10.1016/S0021-9150(01)00639-6; Nobori K, 2002, J MOL CELL CARDIOL, V34, P1387, DOI 10.1006/jmcc.2002.2091; Nuver J, 2005, J CLIN ONCOL, V23, P9130, DOI 10.1200/JCO.2005.01.4092; Nuver J, 2005, EUR J CLIN INVEST, V35, P99, DOI 10.1111/j.1365-2362.2005.01460.x; Nuver J, 2004, EUR J CANCER, V40, P701, DOI 10.1016/j.ejca.2003.12.012; Nuver J, 2010, ONCOL REP, V23, P247, DOI 10.3892/or_00000630; Shi YC, 1998, JPN J CANCER RES, V89, P757, DOI 10.1111/j.1349-7006.1998.tb03281.x; Song HJ, 2012, MOL BIOL REP, V39, P4017, DOI 10.1007/s11033-011-1182-7; Sprauten M, 2012, J CLIN ONCOL, V30, P300, DOI 10.1200/JCO.2011.37.4025; STEFENELLI T, 1988, EUR HEART J, V9, P552, DOI 10.1093/oxfordjournals.eurheartj.a062542; Strumberg D, 2002, ANN ONCOL, V13, P229, DOI 10.1093/annonc/mdf058; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Unsicker K, 2013, CYTOKINE GROWTH F R, V24, P373, DOI 10.1016/j.cytogfr.2013.05.003; Urien S, 2005, CANCER CHEMOTH PHARM, V55, P55, DOI 10.1007/s00280-004-0852-8; van den Belt-Dusebout AW, 2007, J CLIN ONCOL, V25, P4370, DOI 10.1200/JCO.2006.10.5296; van den Belt-Dusebout AW, 2006, J CLIN ONCOL, V24, P467, DOI 10.1200/JCO.2005.02.7193; Vaughn DJ, 2008, CANCER-AM CANCER SOC, V112, P1949, DOI 10.1002/cncr.23389; Weijl NI, 2000, J CLIN ONCOL, V18, P2169, DOI 10.1200/JCO.2000.18.10.2169; Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x; Yu MH, 2008, CANCER SCI, V99, P391, DOI 10.1111/j.1349-7006.2008.00696.x	52	30	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0115372	10.1371/journal.pone.0115372	http://dx.doi.org/10.1371/journal.pone.0115372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590623	Green Published, Green Submitted, gold			2022-12-26	WOS:000350679400008
J	Mellou, K; Sideroglou, T; Papaevangelou, V; Katsiaflaka, A; Bitsolas, N; Verykouki, E; Triantafillou, E; Baka, A; Georgakopoulou, T; Hadjichristodoulou, C				Mellou, Kassiani; Sideroglou, Theologia; Papaevangelou, Vassiliki; Katsiaflaka, Anna; Bitsolas, Nikolaos; Verykouki, Eleni; Triantafillou, Eleni; Baka, Agoritsa; Georgakopoulou, Theano; Hadjichristodoulou, Christos			Considerations on the Current Universal Vaccination Policy against Hepatitis A in Greece after Recent Outbreaks	PLOS ONE			English	Article							COST-EFFECTIVENESS; UNITED-STATES; CHILDREN; VIRUS; SEROPREVALENCE; RISK; AREA; EPIDEMIOLOGY; ADOLESCENTS; INFECTION	Greece is the only European Union member state that in 2008 included hepatitis A (HAV) vaccine in the routine national childhood immunization program (NCIP). Given that the resources allocated to public health have dramatically decreased since 2008 and that Greece is a low endemicity country for the disease, the benefit from universal vaccination has been questioned. The aim of this paper is to summarize the available epidemiological data of the disease for 1982-2013, and discuss the effects of universal vaccination on disease morbidity. Descriptive analysis, ARIMA modeling and time series intervention analysis were conducted using surveillance data of acute HAV. A decreasing trend of HAV notification rate over the years was identified (p<0.001). However, universal vaccination (similar to 80% vaccine coverage of children) had no significant effect on the annual number of reported cases (p = 0.261) and has resulted to a progressive increase of the average age of infection in the general population. The mean age of cases before the inclusion of the vaccine to NCIP (24.1 years, SD = 1.5) was significantly lower than the mean age of cases after 2008 (31.7 years, SD = 2.1) (p<0.001). In the last decade, one third of all reported cases were Roma (a population accounting for 1.5% of the country's total population) and in 2013 three outbreaks with 16, 9 and 25 Roma cases respectively, were recorded, indicating the decreased effectiveness of the current immunization strategy in this group. Data suggest that universal vaccination may need to be re-considered. Probably a more cost effective approach would be to implement a program that will include: a) vaccination of high risk groups, b) universal vaccination of Roma children and improving conditions at Roma camps, c) education of the population and travel advice, and d) enhancement of the control measures to increase safety of shellfish and other foods.	[Mellou, Kassiani; Sideroglou, Theologia; Triantafillou, Eleni; Baka, Agoritsa; Georgakopoulou, Theano; Hadjichristodoulou, Christos] Hellen Ctr Dis Control & Prevent, Athens, Greece; [Papaevangelou, Vassiliki] Univ Athens, Gen Univ Hosp ATTIKON, Dept Pediat 3, Athens, Greece; [Katsiaflaka, Anna; Bitsolas, Nikolaos; Verykouki, Eleni; Hadjichristodoulou, Christos] Univ Thessaly, Fac Med, Dept Hyg & Epidemiol, Larisa, Greece	National & Kapodistrian University of Athens; University Hospital Attikon; University of Thessaly	Mellou, K (corresponding author), Hellen Ctr Dis Control & Prevent, Athens, Greece.	mellou@keelpno.gr	MELLOU, KASSIANI/AAD-5108-2020; SIderoglou, Theologia/ABG-5856-2021	MELLOU, KASSIANI/0000-0002-0065-5766; Hadjichristodoulou, Christos/0000-0002-4769-8376; Bitsolas, Nikolaos/0000-0001-6207-4441				Alexopoulou Z, 2013, ESPID 2013; Andre FE, 2006, CURR TOP MICROBIOL, V304, P95; Anonychuk AM, 2008, PHARMACOECONOMICS, V26, P17, DOI 10.2165/00019053-200826010-00003; Barkai G, 2009, PEDIATR INFECT DIS J, V28, P391, DOI 10.1097/INF.0b013e318190655c; Bell BP, 2002, VIRAL HEPATITIS LIVE, P359; Centers for Diseases Control and Prevention, 2012, PINK BOOK EP PREV VA; Drositis I, 2013, EUR J INTERN MED, V24, P839, DOI 10.1016/j.ejim.2013.08.003; Elam-Evans LD, 2014, MMWR-MORBID MORTAL W, V63, P741; Hanafiah KM, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-57; Hellenic Centre for Diseases Control and Prevention, 2014, NAT VACC COV STUDY 3; Jacobs RJ, 2003, PEDIATR INFECT DIS J, V22, P904, DOI 10.1097/01.inf.0000091295.53969.6a; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Jacobsen KH, 2009, GLOBAL PREVALENCE HE; KREMASTINOU J, 1984, AM J EPIDEMIOL, V120, P703, DOI 10.1093/oxfordjournals.aje.a113937; Kyrka A, 2009, J MED VIROL, V81, P582, DOI 10.1002/jmv.21434; Lim TA, 2013, EUR J PUBLIC HEALTH, V23, P663, DOI 10.1093/eurpub/cks182; Lopalco PL, 2000, VACCINE, V19, P470, DOI 10.1016/S0264-410X(00)00193-6; Martinelli D, 2010, VACCINE, V28, P6783, DOI 10.1016/j.vaccine.2010.07.069; Martinez A, 2011, HUM VACCINES, V7, P205, DOI 10.4161/hv.7.0.14598; Mayoral CJ, 2012, EUROSURVEILLANCE, V18, P17; Mazokopakis E, 2000, EUR J EPIDEMIOL, V16, P1069, DOI 10.1023/A:1010857128629; Michos A, 2008, J MED VIROL, V80, P791, DOI 10.1002/jmv.21134; Ott JJ, 2012, VACCINE, V31, P3, DOI 10.1016/j.vaccine.2012.04.104; Panagiotopoulos T, 2007, NATL STUDY VACCINATI; Panagiotopoulos T, 2013, NATL STUDY VACCINATI; PAPAEVANGELOU GJ, 1987, INFECTION, V15, P221, DOI 10.1007/BF01644116; Pervanidou D, 2010, EUROSURVEILLANCE, P15; Quezada A, 2008, REV PANAM SALUD PUBL, V23, P303, DOI 10.1590/S1020-49892008000500002; Rachiotis G, 2012, INT J ENV RES PUB HE, V9, P4498, DOI 10.3390/ijerph9124498; Rein DB, 2007, PEDIATRICS, V119, pE12, DOI 10.1542/peds.2006-1573; Sartori AMC, 2012, VACCINE, V30, P7489, DOI 10.1016/j.vaccine.2012.10.056; Scheifele DW, 2005, EXPERT OPIN PHARMACO, V6, P157, DOI 10.1517/14656566.6.2.157; Valenzuela MT, 2005, VACCINE, V23, P4110, DOI 10.1016/j.vaccine.2005.03.021; Van Herck K, 2011, J MED VIROL, V83, P1885, DOI 10.1002/jmv.22200; Vantarakis A, 2010, EPIDEMIOL INFECT, V138, P1025, DOI 10.1017/S0950268809991257; Vogt TM, 2008, J INFECT DIS, V197, P1282, DOI 10.1086/586899; Wei WWS, 1990, TIME SERIES ANAL UNI, P184; World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P176; World Health Organization, INT TRAV HLTH INT	39	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116939	10.1371/journal.pone.0116939	http://dx.doi.org/10.1371/journal.pone.0116939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590132	Green Submitted, gold, Green Published			2022-12-26	WOS:000350679400025
J	Shieh, BS; Liang, SH; Chiu, YW				Shieh, Bao-Sen; Liang, Shih-Hsiung; Chiu, Yuh-Wen			Acoustic and Temporal Partitioning of Cicada Assemblages in City and Mountain Environments	PLOS ONE			English	Article							INTERFERENCE COMPETITION; DETERMINISTIC CHAOS; COMMUNITY; COMMUNICATION; COMPLEX; NOISE; FROGS; BIOACOUSTICS; CONSERVATION; HOMOPTERA	Comparing adaptations to noisy city environments with those to natural mountain environments on the community level can provide significant insights that allow an understanding of the impact of anthropogenic noise on invertebrates that employ loud calling songs for mate attraction, especially when each species has its distinct song, as in the case of cicadas. In this study, we investigated the partitioning strategy of cicada assemblages in city and mountain environments by comparing the acoustic features and calling activity patterns of each species, recorded using automated digital recording systems. Our comparison of activity patterns of seasonal and diel calling revealed that there was no significant temporal partitioning of cicada assemblages in either environment. In addition, there was no correlation between the acoustic distance based on spectral features and temporal segregation. Heterospecific spectral overlap was low in both city and mountain environments, although city and mountain cicada assemblages were subject to significantly different levels of anthropogenic or interspecific noise. Furthermore, for the common species found in both environments, the calling activity patterns at both seasonal and diel time scales were significantly consistent across sites and across environments. We suggest that the temporal calling activity is constrained by endogenous factors for each species and is less flexible in response to external factors, such as anthropogenic noise. As a result, cicada assemblages in city environments with low species diversity do not demonstrate a more significant temporal partitioning than those in mountain environments with high species diversity.	[Shieh, Bao-Sen] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Liang, Shih-Hsiung] Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Chiu, Yuh-Wen] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan	Kaohsiung Medical University; National Kaohsiung Normal University; National Museum of Marine Biology & Aquarium	Shieh, BS (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan.	bsshieh@kmu.edu.tw		Shieh, Bao-Sen/0000-0002-5438-3735	National Science Council of Taiwan [NSC 98-2313-B-037-002-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of Taiwan (grant no. NSC 98-2313-B-037-002-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2001, OECOLOGIA, V126, P134, DOI 10.1007/s004420000494; Amezquita A, 2011, P NATL ACAD SCI USA, V108, P17058, DOI 10.1073/pnas.1104773108; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Benko TP, 2006, J BIOL SYST, V14, P555, DOI 10.1142/S0218339006002008; Benko TP, 2007, J BIOSCIENCES, V32, P797, DOI 10.1007/s12038-007-0081-5; CAROTHERS JH, 1984, OIKOS, V42, P403, DOI 10.2307/3544413; CASE TJ, 1974, P NATL ACAD SCI USA, V71, P3073, DOI 10.1073/pnas.71.8.3073; Chek AA, 2003, ECOL LETT, V6, P235, DOI 10.1046/j.1461-0248.2003.00420.x; Chen C.S., 2004, CICADAS TAIWAN; CLARIDGE MF, 1985, ANNU REV ENTOMOL, V30, P297, DOI 10.1146/annurev.en.30.010185.001501; Diwakar S, 2007, BIOACOUSTICS, V16, P113, DOI 10.1080/09524622.2007.9753571; DREWRY GE, 1983, COPEIA, P941, DOI 10.2307/1445095; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; Gogala Matija, 1995, Malayan Nature Journal, V48, P297; Gottsberger B, 2004, J TROP ECOL, V20, P271, DOI 10.1017/S0266467403001172; Jain M, 2014, EVOL ECOL, V28, P1, DOI 10.1007/s10682-013-9658-7; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Laiolo P, 2010, BIOL CONSERV, V143, P1635, DOI 10.1016/j.biocon.2010.03.025; Lampe U, 2012, FUNCT ECOL, V26, P1348, DOI 10.1111/1365-2435.12000; Luddecke H, 2000, STUD NEOTROP FAUNA E, V35, P185, DOI 10.1076/snfe.35.3.185.8855; Luther D, 2009, BEHAV ECOL, V20, P864, DOI 10.1093/beheco/arp074; Marshall DC, 2000, EVOLUTION, V54, P1313, DOI 10.1111/j.0014-3820.2000.tb00564.x; Morley EL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2683; Pianka ER, 1973, ANNU REV ECOL SYST, V4, P53, DOI [DOI 10.1146/ANNUREV.ES.04.110173.000413, 10.1146/annurev.es.04.110173.000413]; Planque R, 2008, ETHOLOGY, V114, P262, DOI 10.1111/j.1439-0310.2007.01461.x; Romer H, 1998, SPR HDB AUD, V10, P63; Sanborn AF, 2001, ANN ENTOMOL SOC AM, V94, P159, DOI 10.1603/0013-8746(2001)094[0159:REOTDD]2.0.CO;2; Schmidt AKD, 2013, BEHAV ECOL, V24, P470, DOI 10.1093/beheco/ars187; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Shieh BS, 2012, ACTA ETHOL, V15, P33, DOI 10.1007/s10211-011-0105-x; Shochat E, 2006, TRENDS ECOL EVOL, V21, P661, DOI 10.1016/j.tree.2006.09.007; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Sol D, 2013, ANIM BEHAV, V85, P1101, DOI 10.1016/j.anbehav.2013.01.023; Sueur J, 2002, BIOL J LINN SOC, V75, P379, DOI 10.1111/j.1095-8312.2002.tb02079.x; Tobias JA, 2014, P NATL ACAD SCI USA, V111, P1020, DOI 10.1073/pnas.1314337111; Warren PS, 2006, ANIM BEHAV, V71, P491, DOI 10.1016/j.anbehav.2005.07.014	36	9	9	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116794	10.1371/journal.pone.0116794	http://dx.doi.org/10.1371/journal.pone.0116794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590620	Green Submitted, Green Published, gold			2022-12-26	WOS:000350679400023
J	Tarzemany, R; Jiang, GQ; Larjava, H; Hakkinen, L				Tarzemany, Rana; Jiang, Guoqiao; Larjava, Hannu; Haekkinen, Lari			Expression and Function of Connexin 43 in Human Gingival Wound Healing and Fibroblasts	PLOS ONE			English	Article							HEMICHANNEL-INDEPENDENT ACTIONS; GAP JUNCTIONAL COMMUNICATION; TGF-BETA; MIMETIC PEPTIDE; INTERCELLULAR COMMUNICATION; GROWTH-FACTOR; CELL; CX43; SKIN; MATRIX	Connexins (Cxs) are a family of transmembrane proteins that form hemichannels and gap junctions (GJs) on the cell membranes, and transfer small signaling molecules between the cytoplasm and extracellular space and between connecting cells, respectively. Among Cxs, suppressing Cx43 expression or function promotes skin wound closure and granulation tissue formation, and may alleviate scarring, but the mechanisms are not well understood. Oral mucosal gingiva is characterized by faster wound closure and scarless wound healing outcome as compared to skin wounds. Therefore, we hypothesized that Cx43 function is down regulated during human gingival wound healing, which in fibroblasts promotes expression of genes conducive for fast and scarless wound healing. Cultured gingival fibroblasts expressed Cx43 as their major connexin. Immunostaining of unwounded human gingiva showed that Cx43 was abundantly present in the epithelium, and in connective tissue formed large Cx43 plaques in fibroblasts. At the early stages of wound healing, Cx43 was strongly down regulated in wound epithelial cells and fibroblasts, returning to the level of normal tissue by day 60 post-wounding. Blocking of Cx43 function by Cx43 mimetic peptide Gap27 suppressed GJ-mediated dye transfer, promoted migration, and caused significant changes in the expression of wound healing-associated genes in gingival fibroblasts. In particular, out of 54 genes analyzed, several MMPs and TGF-beta 1, involved in regulation of inflammation and extracellular matrix (ECM) turnover, and VEGF-A, involved in angiogenesis, were significantly upregulated while pro-fibrotic ECM molecules, including Collagen type I, and cell contractility-related molecules were significantly down regulated. These responses involved MAPK, GSK3 alpha/beta and TGF-beta signaling pathways, and AP1 and SP1 transcription factors. Thus, suppressed function of Cx43 in fibroblasts promotes their migration, and regulates expression of wound healing-associated genes via AP1, SP1, MAPK, GSK3 alpha/beta and TGF-beta signaling pathways, and may promote fast and scarless wound healing in human gingiva.	[Tarzemany, Rana; Jiang, Guoqiao; Larjava, Hannu; Haekkinen, Lari] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Hakkinen, L (corresponding author), Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada.	lhakkine@dentistry.ubc.ca	Hakkinen, Lari/B-2228-2016; Larjava, Hannu/GRO-4325-2022		Canadian Institutes of Health Research; University of British Columbia CIHR Skin Research Training Centre (SRTC) Award; CIHR IMHA Institute Community Support Travel Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of British Columbia CIHR Skin Research Training Centre (SRTC) Award; CIHR IMHA Institute Community Support Travel Award(Canadian Institutes of Health Research (CIHR))	Supported by Canadian Institutes of Health Research (LH), University of British Columbia CIHR Skin Research Training Centre (SRTC) Award (RT), and CIHR IMHA Institute Community Support Travel Award (RT).	Akita S, 2013, ADV WOUND CARE, V2, P44, DOI 10.1089/wound.2011.0324; Asazuma-Nakamura Y, 2009, EXP CELL RES, V315, P1190, DOI 10.1016/j.yexcr.2008.12.021; Becker DL, 2012, BBA-BIOMEMBRANES, V1818, P2068, DOI 10.1016/j.bbamem.2011.11.017; Brandner JM, 2004, J INVEST DERMATOL, V122, P1310, DOI 10.1111/j.0022-202X.2004.22529.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caillou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022567; Chaytor AT, 1997, J PHYSIOL-LONDON, V503, P99, DOI 10.1111/j.1469-7793.1997.099bi.x; Cheon SS, 2006, FASEB J, V20, P692, DOI 10.1096/fj.05-4759com; Churko JM, 2013, PHYSIOLOGY, V28, P190, DOI 10.1152/physiol.00058.2012; Churko JM, 2011, HUM MUTAT, V32, P456, DOI 10.1002/humu.21472; Coutinho P, 2005, BRIT J PLAST SURG, V58, P658, DOI 10.1016/j.bjps.2004.12.022; Coutinho P, 2003, CELL BIOL INT, V27, P525, DOI 10.1016/S1065-6995(03)00077-5; Dai P, 2007, MOL BIOL CELL, V18, P2264, DOI 10.1091/mbc.E06-12-1064; Davis NG, 2013, WOUND REPAIR REGEN, V21, P571, DOI 10.1111/wrr.12054; Degen KE, 2012, BIRTH DEFECTS RES C, V96, P258, DOI 10.1002/bdrc.21019; Desplantez T, 2012, PHARMACOL RES, V65, P546, DOI 10.1016/j.phrs.2012.02.002; Dufour A, 2013, TRENDS PHARMACOL SCI, V34, P233, DOI 10.1016/j.tips.2013.02.004; Ehrlich HP, 2013, ADV WOUND CARE, V2, P113, DOI 10.1089/wound.2012.0414; Ehrlich HP, 2000, J CELL PHYSIOL, V184, P86, DOI 10.1002/(SICI)1097-4652(200007)184:1<86::AID-JCP9>3.0.CO;2-5; Eslami A, 2009, J HISTOCHEM CYTOCHEM, V57, P543, DOI 10.1369/jhc.2009.952572; Evans WH, 2012, J MEMBRANE BIOL, V245, P437, DOI 10.1007/s00232-012-9488-5; Fournier BPJ, 2013, STEM CELLS DEV, V22, P3157, DOI 10.1089/scd.2013.0015; Fujita T, 2008, J PERIODONTAL RES, V43, P96, DOI 10.1111/j.1600-0765.2007.01000.x; GABBIANI G, 1978, J CELL BIOL, V76, P561, DOI 10.1083/jcb.76.3.561; Garcia-Dorado D, 2002, CARDIOVASC RES, V55, P456, DOI 10.1016/S0008-6363(02)00441-8; Ghatnekar GS, 2009, REGEN MED, V4, P205, DOI 10.2217/17460751.4.2.205; Ghersi G, 2002, J BIOL CHEM, V277, P29231, DOI 10.1074/jbc.M202770200; Glim JE, 2013, WOUND REPAIR REGEN, V21, P648, DOI 10.1111/wrr.12072; GOLIGER JA, 1995, MOL BIOL CELL, V6, P1491, DOI 10.1091/mbc.6.11.1491; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Gopalakrishnan A, 2006, ARCH PHARM RES, V29, P633, DOI 10.1007/BF02968247; Gourdie RG, 2006, ANN NY ACAD SCI, V1080, P49, DOI 10.1196/annals.1380.005; Hakkinen L, 2014, CYTOTHERAPY, V16, P1171, DOI 10.1016/j.jcyt.2014.04.004; Hakkinen L, 2000, PERIODONTOL 2000, V24, P127, DOI 10.1034/j.1600-0757.2000.2240107.x; HAKKINEN L, 1994, BBA-MOL CELL RES, V1224, P33, DOI 10.1016/0167-4889(94)90110-4; Hakkinen L, 2014, STEM CELL B IN PRESS; Hakkinen L., 2012, ORAL WOUND HEALING C, P125; Harks EGA, 2001, J PHARMACOL EXP THER, V298, P1033; Hatakeyama S, 2006, J PERIODONTAL RES, V41, P322, DOI 10.1111/j.1600-0765.2006.00875.x; Hawat G, 2012, J MOL CELL CARDIOL, V53, P559, DOI 10.1016/j.yjmcc.2012.07.008; Hawat G, 2010, PFLUG ARCH EUR J PHY, V460, P583, DOI 10.1007/s00424-010-0849-6; Hebert C, 2013, J CELL BIOCHEM, V114, P2542, DOI 10.1002/jcb.24603; Hematti P, 2012, CYTOTHERAPY, V14, P516, DOI 10.3109/14653249.2012.677822; Herve JC, 2012, BBA-BIOMEMBRANES, V1818, P1844, DOI 10.1016/j.bbamem.2011.12.009; Honardoust D, 2008, WOUND REPAIR REGEN, V16, P814, DOI 10.1111/j.1524-475X.2008.00435.x; Honardoust HA, 2006, HISTOPATHOLOGY, V49, P634, DOI 10.1111/j.1365-2559.2006.02559.x; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Ishikawa S, 2012, AM J PHYSIOL-HEART C, V302, pH2536, DOI 10.1152/ajpheart.00940.2011; Jiang JX, 2005, BBA-BIOMEMBRANES, V1711, P208, DOI 10.1016/j.bbamem.2004.10.001; Kandyba EE, 2008, J INVEST DERMATOL, V128, P1039, DOI 10.1038/sj.jid.5701125; King SJ, 2011, METHODS MOL BIOL, V769, P53, DOI 10.1007/978-1-61779-207-6_5; Ko K, 2000, AM J PHYSIOL-CELL PH, V279, pC147, DOI 10.1152/ajpcell.2000.279.1.C147; Komatsu I, 2010, J HAND SURG-AM, V35A, P1580, DOI 10.1016/j.jhsa.2010.07.009; Kretz M, 2004, EUR J CELL BIOL, V83, P647, DOI 10.1078/0171-9335-00422; Kretz M, 2003, J CELL SCI, V116, P3443, DOI 10.1242/jcs.00638; LAL R, 1995, AM J PHYSIOL-CELL PH, V268, pC968, DOI 10.1152/ajpcell.1995.268.4.C968; Langevin HM, 2004, HISTOCHEM CELL BIOL, V122, P7, DOI 10.1007/s00418-004-0667-z; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Mah W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090715; Mak K, 2009, J DERMATOL SCI, V56, P168, DOI 10.1016/j.jdermsci.2009.09.005; McCubrey JA, 2014, LEUKEMIA, V28, P15, DOI 10.1038/leu.2013.184; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Mori R, 2006, J CELL SCI, V119, P5193, DOI 10.1242/jcs.03320; Moyer KE, 2002, EXP MOL PATHOL, V72, P10, DOI 10.1006/exmp.2001.2406; NAGASE H, 1991, BIOMED BIOCHIM ACTA, V50, P749; Nakano Y, 2008, INVEST OPHTH VIS SCI, V49, P93, DOI 10.1167/iovs.07-0255; Negoro H, 2013, FEBS LETT, V587, P98, DOI 10.1016/j.febslet.2012.11.021; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Niger C, 2011, BONE, V49, P683, DOI 10.1016/j.bone.2011.07.027; Ongstad EL, 2013, ADV WOUND CARE, V2, P55, DOI 10.1089/wound.2011.0341; Penn JW, 2012, INT J BURNS TRAUMA, V2, P18; Pollok S, 2011, J CELL MOL MED, V15, P861, DOI 10.1111/j.1582-4934.2010.01057.x; Principi Mariabeatrice, 2013, World J Gastrointest Pathophysiol, V4, P100, DOI 10.4291/wjgp.v4.i4.100; Profyris C, 2012, J AM ACAD DERMATOL, V66, P1, DOI 10.1016/j.jaad.2011.05.055; Qiu C, 2003, CURR BIOL, V13, P1697, DOI 10.1016/j.cub.2003.09.007; Rhett JM, 2008, TRENDS BIOTECHNOL, V26, P173, DOI 10.1016/j.tibtech.2007.12.007; Richards TS, 2004, J CELL BIOL, V167, P555, DOI 10.1083/jcb.200404142; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Salameh A, 2008, J PHARMACOL EXP THER, V326, P315, DOI 10.1124/jpet.108.136663; SALOMON D, 1988, J CLIN INVEST, V82, P248, DOI 10.1172/JCI113578; Schalper KA, 2012, MOL BIOSYST, V8, P685, DOI 10.1039/c1mb05294b; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Sosinsky GE, 2007, BIOCHEM J, V408, P375, DOI 10.1042/BJ20070550; Stains JP, 2014, CALCIFIED TISSUE INT, V94, P55, DOI 10.1007/s00223-013-9742-6; Steffensen B, 2001, CRIT REV ORAL BIOL M, V12, P373, DOI 10.1177/10454411010120050201; SULLIVAN R, 1993, GENE, V130, P191, DOI 10.1016/0378-1119(93)90419-4; Vinken M, 2012, BBA-BIOMEMBRANES, V1818, P2002, DOI 10.1016/j.bbamem.2011.06.011; Wang CM, 2007, DIABETES, V56, P2809, DOI 10.2337/db07-0613; Wang N, 2013, NEUROPHARMACOLOGY, V75, P506, DOI 10.1016/j.neuropharm.2013.08.021; Wong JW, 2009, WOUND REPAIR REGEN, V17, P717, DOI 10.1111/j.1524-475X.2009.00531.x; Wong VW, 2012, SEMIN CELL DEV BIOL, V23, P981, DOI 10.1016/j.semcdb.2012.09.010; Wright CS, 2012, J CELL PHYSIOL, V227, P77, DOI 10.1002/jcp.22705; Wright CS, 2009, WOUND REPAIR REGEN, V17, P240, DOI 10.1111/j.1524-475X.2009.00471.x; Yamaoka Y, 2002, TISSUE CELL, V34, P375, DOI 10.1016/S0040816602000381; Ye P, 2000, J PATHOL, V192, P58; Zhou JZ, 2014, FEBS LETT, V588, P1186, DOI 10.1016/j.febslet.2014.01.001	99	36	40	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0115524	10.1371/journal.pone.0115524	http://dx.doi.org/10.1371/journal.pone.0115524			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OG	25584940	Green Published, Green Submitted, gold			2022-12-26	WOS:000348201300003
J	Gazzolo, D; Pluchinotta, F; Bashir, M; Aboulgar, H; Said, HM; Iman, I; Ivani, G; Conio, A; Tina, LG; Nigro, F; Li Volti, G; Galvano, F; Michetti, F; Di Iorio, R; Marinoni, E; Zimmermann, LJ; Gavilanes, ADW; Vles, HJS; Kornacka, M; Gruszfeld, D; Frulio, R; Sacchi, R; Ciotti, S; Risso, FM; Sannia, A; Florio, P				Gazzolo, Diego; Pluchinotta, Francesca; Bashir, Moataza; Aboulgar, Hanna; Said, Hala Mufeed; Iman, Iskander; Ivani, Giorgio; Conio, Alessandra; Tina, Lucia Gabriella; Nigro, Francesco; Li Volti, Giovanni; Galvano, Fabio; Michetti, Fabrizio; Di Iorio, Romolo; Marinoni, Emanuela; Zimmermann, Luc J.; Gavilanes, Antonio D. W.; Vles, Hans J. S.; Kornacka, Maria; Gruszfeld, Darek; Frulio, Rosanna; Sacchi, Renata; Ciotti, Sabina; Risso, Francesco M.; Sannia, Andrea; Florio, Pasquale			Neurological Abnormalities in Full-Term Asphyxiated Newborns and Salivary S100B Testing: The "Cooperative Multitask against Brain Injury of Neonates" (CoMBINe) International Study	PLOS ONE			English	Article							NEURON-SPECIFIC ENOLASE; PROTEIN CONCENTRATIONS; EARLY IDENTIFICATION; GESTATIONAL-AGE; INTRAVENTRICULAR HEMORRHAGE; CEREBROSPINAL-FLUID; PRETERM INFANTS; EARLY INDICATOR; BLOOD; ENCEPHALOPATHY	Background Perinatal asphyxia (PA) is a leading cause of mortality and morbidity in newborns: its prognosis depends both on the severity of the asphyxia and on the immediate resuscitation to restore oxygen supply and blood circulation. Therefore, we investigated whether measurement of S100B, a consolidated marker of brain injury, in salivary fluid of PA newborns may constitute a useful tool for the early detection of asphyxia-related brain injury. Methods We conducted a cross-sectional study in 292 full-term newborns admitted to our NICUs, of whom 48 suffered PA and 244 healthy controls admitted at our NICUs. Saliva S100B levels measurement longitudinally after birth; routine laboratory variables, neurological patterns, cerebral ultrasound and, magnetic resonance imaging were performed. The primary end-point was the presence of neurological abnormalities at 12-months after birth. Results S100B salivary levels were significantly (P<0.001) higher in newborns with PA than in normal infants. When asphyxiated infants were subdivided according to a good (Group A; n = 15) or poor (Group B; n = 33) neurological outcome at 12-months, S100B was significantly higher at all monitoring time-points in Group B than in Group A or controls (P<0.001, for all). A cut-off >3.25 MoM S100B achieved a sensitivity of 100% (CI5-95%: 89.3%-100%) and a specificity of 100% (CI5-95%: 98.6%-100%) as a single marker for predicting the occurrence of abnormal neurological outcome (area under the ROC curve: 1.000; CI5-95%: 0.987-1.0). Conclusions S100B protein measurement in saliva, soon after birth, is a useful tool to identify which asphyxiated infants are at risk of neurological sequelae.	[Gazzolo, Diego] C Arrigo Childrens Hosp Alessandria, Dept Maternal Fetal & Neonatal Med, Alessandria, Italy; [Pluchinotta, Francesca] S Donato Milanese Univ Hosp, Dept Cardiol & Lab Reasearch, Milan, Italy; [Bashir, Moataza; Aboulgar, Hanna; Said, Hala Mufeed; Iman, Iskander] Cairo Univ, Dept Neonatol, Cairo, Egypt; [Ivani, Giorgio; Conio, Alessandra] Regina Margherita Childrens Hosp Turin, Pediat Intens Care Unit, Turin, Italy; [Tina, Lucia Gabriella; Nigro, Francesco] G Garibaldi Hosp, Dept Maternal Fetal & Neonatal Hlth, Catania, Italy; [Li Volti, Giovanni; Galvano, Fabio] Catania Univ, Dept Biochem, Catania, Italy; [Michetti, Fabrizio] Catholic Univ, Inst Anat & Cell Biol, Rome, Italy; [Di Iorio, Romolo; Marinoni, Emanuela] Univ Roma La Sapienza, Dept Obstet & Gynecol, Lab Perinatal Med, I-00185 Rome, Italy; [Zimmermann, Luc J.; Gavilanes, Antonio D. W.] Maastricht Univ, Dept Pediat & Neonatol, Maastricht, Netherlands; [Vles, Hans J. S.] Maastricht Univ, Dept Child Neurol, Maastricht, Netherlands; [Kornacka, Maria; Gruszfeld, Darek] Warsaw Univ, Dept Neonatol & Intens Care Neonate, Warsaw, Poland; [Frulio, Rosanna; Sacchi, Renata; Ciotti, Sabina; Risso, Francesco M.; Sannia, Andrea] G Gaslini Childrens Univ Hosp, Dept Pediat, Genoa, Italy; [Florio, Pasquale] S Iacopo Hosp, UOC Obstet & Gynecol, Pistoia, Italy	Egyptian Knowledge Bank (EKB); Cairo University; A.O.U. Citta della Salute e della Scienza di Torino; University of Catania; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; Maastricht University; Maastricht University; University of Warsaw; University of Genoa; IRCCS AOU San Martino IST; IRCCS Istituto Giannina Gaslini	Gazzolo, D (corresponding author), C Arrigo Childrens Hosp Alessandria, Dept Maternal Fetal & Neonatal Med, Alessandria, Italy.	dgazzolo@hotmail.com	Gavilanes, Antonio W. Danilo/J-3656-2014; Pluchinotta, Francesca Romana/J-7680-2016; Volti, Giovanni Li/A-2435-2008; Galvano, Fabio/F-8122-2010	Gavilanes, Antonio W. Danilo/0000-0002-6670-3927; Pluchinotta, Francesca Romana/0000-0001-7185-7157; Volti, Giovanni Li/0000-0002-8678-2183; Galvano, Fabio/0000-0003-0644-0755; Gruszfeld, Dariusz/0000-0002-2414-4928; risso, francesco maria/0000-0002-5799-0522	Italian Society of Neonatology; Stella Cometa Foundation, Italy; I Colori della Vita Foundation, Italy	Italian Society of Neonatology; Stella Cometa Foundation, Italy; I Colori della Vita Foundation, Italy	This work is part of the I.O. PhD International Program under the auspices of the Italian Society of Neonatology and was partially supported by grants to DG from Stella Cometa, I Colori della Vita Foundations, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists, 2005, OBSTET GYNECOL, V106, P1469, DOI DOI 10.1097/00006250-200512000-00056; AMIELTISON C, 1968, ARCH DIS CHILD, V43, P89, DOI 10.1136/adc.43.227.89; Barkovich AJ, 2006, AM J NEURORADIOL, V27, P533; Barkovich AJ, 1998, AM J NEURORADIOL, V19, P143; Blennow M, 2001, ACTA PAEDIATR, V90, P1171, DOI 10.1080/080352501317061594; Cowan F, 2003, LANCET, V361, P736, DOI 10.1016/S0140-6736(03)12658-X; Florio P, 2004, LANCET, V364, P270, DOI 10.1016/S0140-6736(04)16677-4; Garnier Y, 2009, REPROD SCI, V16, P758, DOI 10.1177/1933719109335801; Gazzolo D, 2005, PEDIATR RES, V58, P1170, DOI 10.1203/01.pdr.0000185131.22985.30; Gazzolo D, 2005, CLIN BIOCHEM, V38, P229, DOI 10.1016/j.clinbiochem.2004.12.006; Gazzolo D, 2004, CRIT CARE MED, V32, P131, DOI 10.1097/01.CCM.0000104116.91462.CD; Gazzolo D, 2003, ARCH PEDIAT ADOL MED, V157, P1163, DOI 10.1001/archpedi.157.12.1163; Gazzolo D, 2002, CRIT CARE MED, V30, P1356, DOI 10.1097/00003246-200206000-00037; Gazzolo D, 2001, CLIN CHEM, V47, P1132; Gazzolo D, 2001, CLIN CHEM, V47, P1836; Gazzolo D, 1999, J NEUROL SCI, V170, P32, DOI 10.1016/S0022-510X(99)00194-X; Gazzolo D, 2000, CLIN CHEM, V46, P998; Gazzolo D, 2010, J MATERN-FETAL NEO M, V23, P66, DOI 10.3109/14767058.2010.507960; Gazzolo D, 2009, J MATERN-FETAL NEO M, V22, P57, DOI 10.1080/14767050903181468; Gazzolo D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004298; Giussani DA, 2005, PEDIATR RES, V58, P179, DOI 10.1203/01.PDR.0000169999.66157.C0; Higgins RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c397; Huang CC, 1999, NEW ENGL J MED, V341, P328, DOI 10.1056/NEJM199907293410504; Jaranyi Z, 2003, CLIN CHEM LAB MED, V41, P1320, DOI 10.1515/CCLM.2003.201; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; JURGENSVANDERZEE AD, 1979, EARLY HUM DEV, V3, P141, DOI 10.1016/0378-3782(79)90003-3; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawrence R, 2009, J PEDIATR-US, V154, P835, DOI 10.1016/j.jpeds.2009.01.002; LEE SK, 1993, PATHOL RES PRACT, V189, P1036; Maas YGH, 2000, J PEDIATR-US, V137, P100, DOI 10.1067/mpd.2000.106901; MICHETTI F, 1980, J NEUROL SCI, V44, P259, DOI 10.1016/0022-510X(80)90133-1; Michetti F, 2012, J NEUROCHEM, V120, P644, DOI 10.1111/j.1471-4159.2011.07612.x; Prechtl H. F. R., 1977, NEUROLOGICAL EXAMINA, V2nd; Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608; Richardson WS, 1999, JAMA-J AM MED ASSOC, V281, P1214, DOI 10.1001/jama.281.13.1214; Roka A, 2012, ACTA PAEDIATR, V101, P319, DOI 10.1111/j.1651-2227.2011.02480.x; Sanders RD, 2010, ANESTHESIOLOGY, V113, P233, DOI 10.1097/ALN.0b013e3181dc1b84; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; van Wezel-Meijler G, 2010, SEMIN PERINATOL, V34, P28, DOI 10.1053/j.semperi.2009.10.002; ZWEIG MH, 1993, CLIN CHEM, V39, P561	41	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e0115194	10.1371/journal.pone.0115194	http://dx.doi.org/10.1371/journal.pone.0115194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25569796	gold, Green Published, Green Submitted			2022-12-26	WOS:000348168000001
J	Mizokami, D; Araki, K; Tanaka, N; Suzuki, H; Tomifuji, M; Yamashita, T; Ueda, Y; Shimada, H; Matsushita, K; Shiotani, A				Mizokami, Daisuke; Araki, Koji; Tanaka, Nobuaki; Suzuki, Hiroshi; Tomifuji, Masayuki; Yamashita, Taku; Ueda, Yasuji; Shimada, Hideaki; Matsushita, Kazuyuki; Shiotani, Akihiro			Gene Therapy of c-myc Suppressor FUSE-Binding Protein-Interacting Repressor by Sendai Virus Delivery Prevents Tracheal Stenosis	PLOS ONE			English	Article							FAR-UPSTREAM ELEMENT; SUBGLOTTIC STENOSIS; LARYNGOTRACHEAL STENOSIS; IN-VIVO; EXPRESSION; VECTOR; DISEASE; DEATH; ADULTS	Acquired tracheal stenosis remains a challenging problem for otolaryngologists. The objective of this study was to determine whether the Sendai virus (SeV)-mediated c-myc suppressor, a far upstream element (FUSE)-binding protein (FBP)-interacting repressor (FIR), modulates wound healing of the airway mucosa, and whether it prevents tracheal stenosis in an animal model of induced mucosal injury. A fusion gene-deleted, non-transmissible SeV vector encoding FIR (FIR-SeV/Delta F) was prepared. Rats with scraped airway mucosae were administered FIR-SeV/Delta F through the tracheostoma. The pathological changes in the airway mucosa and in the tracheal lumen were assessed five days after scraping. Untreated animals showed hyperplasia of the airway epithelium and a thickened submucosal layer with extensive fibrosis, angiogenesis, and collagen deposition causing lumen stenosis. By contrast, the administration of FIR-SeV/Delta F decreased the degree of tracheal stenosis (P < 0.05) and improved the survival rate (P < 0.05). Immunohistochemical staining showed that c-Myc expression was downregulated in the tracheal basal cells of the FIRSeV/Delta F-treated animals, suggesting that c-myc was suppressed by FIR-SeV/Delta F in the regenerating airway epithelium of the injured tracheal mucosa. The airway-targeted gene therapy of the c-myc suppressor FIR, using a recombinant SeV vector, prevented tracheal stenosis in a rat model of airway mucosal injury.	[Mizokami, Daisuke; Araki, Koji; Tanaka, Nobuaki; Suzuki, Hiroshi; Tomifuji, Masayuki; Yamashita, Taku; Shiotani, Akihiro] Natl Def Med Coll, Dept Otolaryngol Head & Neck Surg, Tokorozawa, Saitama 359, Japan; [Ueda, Yasuji] DNAVEC Corp, Tsukuba, Ibaraki, Japan; [Shimada, Hideaki] Toho Univ, Sch Med, Dept Surg, Ota Ku, Tokyo, Japan; [Matsushita, Kazuyuki] Chiba Univ, Grad Sch Med, Dept Mol Diag F8, Chiba, Japan	National Defense Medical College - Japan; DNAVEC Corporation; Chiba University	Araki, K (corresponding author), Natl Def Med Coll, Dept Otolaryngol Head & Neck Surg, Tokorozawa, Saitama 359, Japan.	kojaraki@ndmc.ac.jp	Matsushita, Kazuyuki/AAJ-5380-2020	Matsushita, Kazuyuki/0000-0001-6742-0761	National Defense Medical College Special Research Grant; Research Promotion-Grant on Defense Medicine; DNAVEC Corporation;  [23592545];  [23592544];  [25462699];  [25670723]; Grants-in-Aid for Scientific Research [25670723] Funding Source: KAKEN	National Defense Medical College Special Research Grant; Research Promotion-Grant on Defense Medicine; DNAVEC Corporation; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the National Defense Medical College Special Research Grant, Research Promotion-Grant on Defense Medicine, and Grant-in-Aid for Scientific Research (C) (JSPS KAKENHI No. 23592545, 23592544 & 25462699), and Grant-in-Aid for Challenging Exploratory Research (JSPS KAKENHI No. 25670723). Co-author Yasuji Ueda is employed by DNAVEC Corporation. DNAVEC Corporation provided support in the form of salary for author YU, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ban H, 2007, GENE THER, V14, P1688, DOI 10.1038/sj.gt.3303032; Bent JP, 2010, ANN OTO RHINOL LARYN, V119, P619, DOI 10.1177/000348941011900909; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Chan KH, 2007, BIOMATERIALS, V28, P1218, DOI 10.1016/j.biomaterials.2006.11.009; CHEN JC, 1995, ARCH OTOLARYNGOL, V121, P537; Cole BB, 2010, AM J PATHOL, V177, P362, DOI 10.2353/ajpath.2010.090870; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Ferrari S, 2004, GENE THER, V11, P1659, DOI 10.1038/sj.gt.3302334; Gallo A, 2012, ACTA OTORHINOLARYNGO, V32, P182; George M, 2005, EUR ARCH OTO-RHINO-L, V262, P609, DOI 10.1007/s00405-004-0887-9; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hartnick CJ, 2001, ANN OTO RHINOL LARYN, V110, P1109; Kajiwara T, 2013, CANCER SCI, V104, P149, DOI 10.1111/cas.12058; KIRSNER RS, 1993, DERMATOL CLIN, V11, P629, DOI 10.1016/S0733-8635(18)30216-X; Kitamura A, 2011, CANCER SCI, V102, P1366, DOI 10.1111/j.1349-7006.2011.01931.x; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; Liu JH, 2006, EMBO J, V25, P2119, DOI 10.1038/sj.emboj.7601101; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marshall E, 1999, SCIENCE, V286, P2244, DOI 10.1126/science.286.5448.2244; Matsushita K, 2006, CANCER RES, V66, P1409, DOI 10.1158/0008-5472.CAN-04-4459; Matsushita K, 2014, WORLD J GASTROENTERO, V20, P4316, DOI 10.3748/wjg.v20.i15.4316; Matsushita K, 2013, MOL CANCER RES, V11, P689, DOI 10.1158/1541-7786.MCR-12-0673; Matsushita K, 2012, MOL CANCER RES, V10, P787, DOI 10.1158/1541-7786.MCR-11-0462; Matsushita K, 2009, FRONT BIOSCI-LANDMRK, V14, P3401, DOI 10.2741/3461; Mizokami D, 2013, LARYNGOSCOPE, V123, P1717, DOI 10.1002/lary.23917; Morita Y, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-14; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Rahmutulla B, 2014, ONCOTARGET, V5, P2404, DOI 10.18632/oncotarget.1650; Shirakura M, 2004, GENE THER, V11, P784, DOI 10.1038/sj.gt.3302224; Shoji F, 2003, GENE THER, V10, P213, DOI 10.1038/sj.gt.3301847; Singh T, 2010, ARCH OTOLARYNGOL, V136, P163, DOI 10.1001/archoto.2009.175; Slobod KS, 2004, VACCINE, V22, P3182, DOI 10.1016/j.vaccine.2004.01.053; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Takeda A, 2003, J VIROL, V77, P9710, DOI 10.1128/JVI.77.17.9710-9715.2003; Tan A, 1999, AM J RESP CRIT CARE, V159, P220, DOI 10.1164/ajrccm.159.1.9802104; Walner DL, 2001, LARYNGOSCOPE, V111, P48, DOI 10.1097/00005537-200101000-00009; Yonemitsu Y, 2000, NAT BIOTECHNOL, V18, P970, DOI 10.1038/79463; Yonemitsu Y, 2013, MOL THER, V21, P707, DOI 10.1038/mt.2012.279	38	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e0116279	10.1371/journal.pone.0116279	http://dx.doi.org/10.1371/journal.pone.0116279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25569246	gold, Green Published, Green Submitted			2022-12-26	WOS:000348168000006
J	Klein, SR; Piya, S; Lu, Z; Xia, Y; Alonso, MM; White, EJ; Wei, J; Gomez-Manzano, C; Jiang, H; Fueyo, J				Klein, S. R.; Piya, S.; Lu, Z.; Xia, Y.; Alonso, M. M.; White, E. J.; Wei, J.; Gomez-Manzano, C.; Jiang, H.; Fueyo, J.			C-Jun N-terminal kinases are required for oncolytic adenovirus-mediated autophagy	ONCOGENE			English	Article							PATHWAY; PHOSPHORYLATION; VIRUS; ACTIVATION; INHIBITOR; APOPTOSIS; BECLIN-1; STRESS; CELLS; TSC2	Oncolytic adenoviruses, such as Delta-24-RGD (Delta 24RGD), are replication-competent viruses that are genetically engineered to induce selective cancer cell lysis. In cancer cells,Delta 24RGD induces massive autophagy, which is required for efficient cell lysis and adenoviral spread. Understanding the cellular mechanisms underlying the regulation of autophagy in cells treated with oncolytic adenoviruses may provide new avenues to improve the therapeutic effect. In this work, we showed that cancer cells infected with Delta 24RGDundergo autophagy despite the concurrent activation of the AKT/mTOR pathway. Moreover, adenovirus replication induced sustained activation of JNK proteins in vitro. ERK1/2 phosphorylation remained unchanged during adenoviral infection, suggesting specificity of JNK activation. Using genetic ablation and pharmacological inactivation of JNK, we unequivocally demonstrated that cells infected with Delta 24RGD required JNK activation. Thus, genetic co-ablation of JNK1 and JNK2 genes or inhibition of JNK kinase function rendered Delta 24RGD-treated cells resistant to autophagy. Accordingly, JNK activation induced phosphorylation of Bcl-2 and prevented the formation of Bcl-2/Beclin 1 autophagy suppressor complexes. Using an orthotopic model of human glioma xenograft, we showed that treatment with.24RGD induced phosphorylation and nuclear translocation of JNK, as well as phosphorylation of Bcl-2. Collectively, our data identified JNK proteins as an essential mechanistic link between Delta 24RGD infection and autophagy in cancer cells. Activation of JNK without inactivation of the AKT/mTOR pathway constitutes a distinct molecular signature of autophagy regulation that differentiates Delta 24RGD adenovirus from the mechanism used by other oncolytic viruses to induce autophagy and provides a new rationale for the combination of oncolytic viruses and chemotherapy.	[Klein, S. R.; Piya, S.; Lu, Z.; Xia, Y.; White, E. J.; Gomez-Manzano, C.; Jiang, H.; Fueyo, J.] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Klein, S. R.; Piya, S.; Gomez-Manzano, C.] Univ Texas Houston, Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX USA; [Alonso, M. M.] Univ Hosp Navarra, Dept Med Oncol, Pamplona, Spain; [Wei, J.; Fueyo, J.] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Dept Neurosurg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Servicio Navarro de Salud - Osasunbidea; University of Navarra; University of Texas System; UTMD Anderson Cancer Center	Fueyo, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Dept Neurooncol, S5-8316,Unit 1002,1515 Holcombe Blvd, Houston, TX 77030 USA.	jfueyo@mdanderson.org	Alonso, Marta M/AAI-9457-2020	Alonso, Marta M/0000-0002-7520-7351; Gomez-Manzano, Candelaria/0000-0002-1259-2133; Fueyo, Juan/0000-0001-6941-2335	NHI/NCI [P50CA127001, P30CA016672]; Marnie Rose Foundation; Will Power Foundation; Schissler Foundation; American Legion Auxiliary; NATIONAL CANCER INSTITUTE [P50CA127001, P30CA016672] Funding Source: NIH RePORTER	NHI/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Marnie Rose Foundation; Will Power Foundation; Schissler Foundation; American Legion Auxiliary; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Tamara Locke (Department of Scientific Publications, The University of Texas MD Anderson Cancer Center) for editorial assistance. This work was supported by grants from the NHI/NCI (P50CA127001; Cancer Center Support Grant P30CA016672-High Resolution Electron Microscopy and Research Animal Support Facilities), the Marnie Rose Foundation, the Will Power Foundation, the Schissler Foundation and the American Legion Auxiliary.	Alonso MM, 2008, MOL THER, V16, P487, DOI 10.1038/sj.mt.6300400; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Chen L, 2009, CANCER LETT, V284, P141, DOI 10.1016/j.canlet.2009.04.026; Dong XN, 2013, J INNATE IMMUN, V5, P480, DOI 10.1159/000346388; Eyre TA, 2014, BRIT J HAEMATOL, V166, P336, DOI 10.1111/bjh.12945; Fueyo J, 2000, ONCOGENE, V19, P2, DOI 10.1038/sj.onc.1203251; Fueyo J, 2003, J NATL CANCER I, V95, P652, DOI 10.1093/jnci/95.9.652; Gibson S, 1999, J BIOL CHEM, V274, P10916, DOI 10.1074/jbc.274.16.10916; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Hung CH, 2014, J VIROL, V88, P12133, DOI 10.1128/JVI.02033-14; Ingemarsdotter CK, 2010, ONCOGENE, V29, P6051, DOI 10.1038/onc.2010.335; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ito H, 2006, JNCI-J NATL CANCER I, V98, P625, DOI 10.1093/jnci/djj161; Jiang H, 2011, J VIROL, V85, P4720, DOI 10.1128/JVI.02032-10; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kudchodkar SB, 2004, J VIROL, V78, P11030, DOI 10.1128/JVI.78.20.11030-11039.2004; Kumar SH, 2009, J VIROL, V83, P8565, DOI 10.1128/JVI.00603-09; Li XD, 2005, VIROLOGY, V333, P180, DOI 10.1016/j.virol.2005.01.002; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liu TC, 2007, NAT CLIN PRACT ONCOL, V4, P101, DOI 10.1038/ncponc0736; Martin JH, 1996, MOL BRAIN RES, V35, P47, DOI 10.1016/0169-328X(95)00181-Q; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Orvedahl A, 2008, AUTOPHAGY, V4, P280, DOI 10.4161/auto.5289; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Piya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029467; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Shertz CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002269; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Wang W, 2014, MOL CANCER THER, V13, P1480, DOI 10.1158/1535-7163.MCT-13-0629; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Xu P, 2011, GENE DEV, V25, P310, DOI 10.1101/gad.1984311	42	36	37	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2015	34	41					5295	5301		10.1038/onc.2014.452	http://dx.doi.org/10.1038/onc.2014.452			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CT1QL	25619840	Green Accepted			2022-12-26	WOS:000362575400009
J	Yan, J; Almilaji, A; Schmid, E; Elvira, B; Shimshek, DR; van der Putten, H; Wagner, CA; Shumilina, E; Lang, F				Yan, Jing; Almilaji, Ahmad; Schmid, Evi; Elvira, Bernat; Shimshek, Derya R.; van der Putten, Herman; Wagner, Carsten A.; Shumilina, Ekaterina; Lang, Florian			Leucine-rich repeat kinase 2-sensitive Na+/Ca2+ exchanger activity in dendritic cells	FASEB JOURNAL			English	Article						Ca2+ signaling; Crohn's disease; Parkinson's disease; CD86; LPS	NA/CA EXCHANGE; PARKINSONS-DISEASE; CA2+ TRANSPORT; CALCIUM-ENTRY; MAST-CELLS; T-CELLS; LRRK2; MACROPHAGES; EXPRESSION; ASSOCIATION	Gene variants of the leucine-rich repeat kinase 2 (LRRK2) are associated with susceptibility to Parkinson's disease (PD). Besides brain and periphery, LRRK2 is expressed in various immune cells including dendritic cells (DCs), antigen-presenting cells linking innate and adaptive immunity. However, the function of LRRK2 in the immune system is still incompletely understood. Here, Ca2+-signaling was analyzed in DCs isolated from gene-targeted mice lacking lrrk2 (Lrrk2(-/-)) and their wild-type littermates (Lrrk2(+/+)). According to Western blotting, Lrrk2 was expressed in Lrrk2(+/+) DCs but not in Lrrk2(-/-)DCs. Cytosolic Ca2+ levels ([Ca2+](i)) were determined utilizing Fura-2 fluorescence and whole cell currents to decipher electrogenic transport. The increase of [Ca2+](i) following inhibition of sarcoendoplasmatic Ca2+-ATPase with thapsigargin (1 mu M) in the absence of extracellular Ca2+ (Ca2+-release) and the increase of [Ca2+](i) following subsequent readdition of extracellular Ca2+ (SOCE) were both significantly larger in Lrrk2(-/-) than in Lrrk2(+/+) DCs. The augmented increase of [Ca2+](i) could have been due to impaired Ca2+ extrusion by K+-independent (NCX) and/or K+-dependent (NCKX) Na+/Ca2+-exchanger activity, which was thus determined from the increase of [Ca2+](i), ([Ca2+](i)), and current following abrupt replacement of Na+ containing (130 mM) and Ca2+ free (0 mM) extracellular perfusate by Na+ free (0 mM) and Ca2+ containing (2 mM) extracellular perfusate. As a result, both slope and peak of [Ca2+](i) as well as Na+/Ca2+ exchanger-induced current were significantly lower in Lrrk2(-/-) than in Lrrk2(+/+) DCs. A 6 or 24 hour treatment with the LRRK2 inhibitor GSK2578215A (1 mu M) significantly decreased NCX1 and NCKX1 transcript levels, significantly blunted Na+/Ca2+-exchanger activity, and significantly augmented the increase of [Ca2+](i) following Ca2+-release and SOCE. In conclusion, the present observations disclose a completely novel functional significance of LRRK2, i.e., the up-regulation of Na+/Ca2+ exchanger transcription and activity leading to attenuation of Ca2+-signals in DCs.Yan, J., Almilaji, A., Schmid, E., Elvira, B., Shimshek, D. R., van der Putten, H., Wagner, C. A., Shumilina, E., Lang, F. Leucine-rich repeat kinase 2-sensitive Na+/Ca2(+) exchanger activity in dendritic cells.	[Yan, Jing; Almilaji, Ahmad; Schmid, Evi; Elvira, Bernat; Shumilina, Ekaterina; Lang, Florian] Univ Tubingen, Dept Physiol, D-72076 Tubingen, Germany; [Shimshek, Derya R.; van der Putten, Herman] Novartis Inst BioMed Res, Dept Neurosci, Basel, Switzerland; [Wagner, Carsten A.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [van der Putten, Herman] Natl Contest Life Fdn, Hamburg, Germany; [Schmid, Evi] Univ Childrens Hosp Tubingen, Dept Pediat Surg & Pediat Urol, Tubingen, Germany	Eberhard Karls University of Tubingen; Novartis; University of Zurich; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL	Lang, F (corresponding author), Univ Tubingen, Dept Physiol, Gmelinstr 5, D-72076 Tubingen, Germany.	florian.lang@uni-tuebingen.de	; Elvira, Bernat/A-2404-2017	Yan, Jing/0000-0002-0307-1635; Elvira, Bernat/0000-0003-0434-2238; Shimshek, Derya/0000-0001-8602-7850	Deutsche Forschungsgemeinschaft DFG [SFB 766, GRK 1302/1]; Michael J. Fox Foundation for Parkinson Research	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Michael J. Fox Foundation for Parkinson Research	The authors gratefully acknowledge the technical assistance of E. Faber and Melanie Hauth and the meticulous preparation of the manuscript by Tanja Loch and Sari Rube. J.Y. and A.A. are first authors of this work. This work was supported by the Deutsche Forschungsgemeinschaft DFG (SFB 766; GRK 1302/1) to F.L. and by the Michael J. Fox Foundation for Parkinson Research to C.A.W. The authors declare no conflicts of interest.	Aki D, 2008, GENES CELLS, V13, P199, DOI 10.1111/j.1365-2443.2007.01159.x; Aneiros E, 2005, J IMMUNOL, V174, P119, DOI 10.4049/jimmunol.174.1.119; BALASUBRAMANYAM M, 1994, J CLIN INVEST, V94, P2002, DOI 10.1172/JCI117553; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Canitano A, 2002, ANN NY ACAD SCI, V976, P394; Cherra SJ, 2013, AM J PATHOL, V182, P474, DOI 10.1016/j.ajpath.2012.10.027; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Connolly SF, 2007, IMMUNOL RES, V39, P115, DOI 10.1007/s12026-007-0076-1; den Haan JMM, 2000, P NATL ACAD SCI USA, V97, P12950, DOI 10.1073/pnas.97.24.12950; Dzamko N, 2012, BIOCHEM SOC T, V40, P1134, DOI 10.1042/BST20120119; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Hakimi M, 2011, J NEURAL TRANSM, V118, P795, DOI 10.1007/s00702-011-0653-2; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hassin-Baer S, 2009, J NEUROL, V256, P483, DOI 10.1007/s00415-009-0117-x; Herchuelz A, 2007, ANN NY ACAD SCI, V1099, P456, DOI 10.1196/annals.1387.048; Herrmann TL, 2007, J LEUKOCYTE BIOL, V82, P686, DOI 10.1189/jlb.0107045; Herzig MC, 2011, HUM MOL GENET, V20, P4209, DOI 10.1093/hmg/ddr348; Hsu SF, 2001, J IMMUNOL, V166, P6126, DOI 10.4049/jimmunol.166.10.6126; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; Khananshvili D, 2014, PFLUG ARCH EUR J PHY, V466, P43, DOI 10.1007/s00424-013-1405-y; Kimura M, 1999, AM J PHYSIOL-HEART C, V277, pH911, DOI 10.1152/ajpheart.1999.277.3.H911; Koski GK, 1999, J IMMUNOL, V163, P82; Kuss M, 2014, J NEUROCHEM, V129, P980, DOI 10.1111/jnc.12668; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Mamais A, 2014, J NEUROCHEM, V129, P895, DOI 10.1111/jnc.12691; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; Miklavc P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084926; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Nurbaeva MK, 2012, FASEB J, V26, P3049, DOI 10.1096/fj.12-204024; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reppel M, 2007, ANN NY ACAD SCI, V1099, P361, DOI 10.1196/annals.1387.065; Roberts DE, 2012, BRIT J PHARMACOL, V165, P922, DOI 10.1111/j.1476-5381.2011.01600.x; Rumpel E, 2000, BIOPHYS J, V79, P2975, DOI 10.1016/S0006-3495(00)76534-9; Russo I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-52; Schmitt R, 1999, AM J PHYSIOL-RENAL, V276, pF367, DOI 10.1152/ajprenal.1999.276.3.F367; Sipido KR, 2007, ANN NY ACAD SCI, V1099, P339, DOI 10.1196/annals.1387.066; Staiano RL, 2009, EUR J IMMUNOL, V39, P1405, DOI 10.1002/eji.200838792; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Thevenet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021519; Tintinger GR, 2004, BIOCHEM PHARMACOL, V67, P2263, DOI 10.1016/j.bcp.2004.02.029; Venetucci LA, 2007, ANN NY ACAD SCI, V1099, P315, DOI 10.1196/annals.1387.033; Visser F, 2007, PHYSIOLOGY, V22, P185, DOI 10.1152/physiol.00001.2007; Visser F, 2007, J BIOL CHEM, V282, P4453, DOI 10.1074/jbc.M610582200; Vukcevic M, 2008, J BIOL CHEM, V283, P34913, DOI 10.1074/jbc.M804472200; Yamazaki S, 2009, J DERMATOL SCI, V54, P69, DOI 10.1016/j.jdermsci.2009.02.001; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	54	14	15	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1701	1710		10.1096/fj.14-264028	http://dx.doi.org/10.1096/fj.14-264028			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25609428				2022-12-26	WOS:000354114600009
J	Zhang, JY; Sadowska, GB; Chen, XD; Park, SY; Kim, JE; Bodge, CA; Cummings, E; Lim, YP; Makeyev, O; Besio, WG; Gaitanis, J; Banks, WA; Stonestreet, BS				Zhang, Jiyong; Sadowska, Grazyna B.; Chen, Xiaodi; Park, Seon Yeong; Kim, Jeong-Eun; Bodge, Courtney A.; Cummings, Erin; Lim, Yow-Pin; Makeyev, Oleksandr; Besio, Walter G.; Gaitanis, John; Banks, William A.; Stonestreet, Barbara S.			Anti-IL-6 neutralizing antibody modulates blood-brain barrier function in the ovine fetus	FASEB JOURNAL			English	Article						development; ischemia; monoclonal; permeability; tight junction proteins	NECROSIS-FACTOR-ALPHA; JUNCTION PROTEIN EXPRESSION; WHITE-MATTER LESIONS; MICROVESSEL ENDOTHELIAL-CELLS; FOCAL CEREBRAL-ISCHEMIA; FETAL SHEEP; MATRIX METALLOPROTEINASES; HYPOXIA-ISCHEMIA; MONOCLONAL-ANTIBODIES; ACUTE HYPEROSMOLALITY	Impaired blood-brain barrier function represents an important component of hypoxic-ischemic brain injury in the perinatal period. Proinflammatory cytokines could contribute to ischemia-related blood-brain barrier dysfunction. IL-6 increases vascular endothelial cell monolayer permeability in vitro. However, contributions of IL-6 to blood-brain barrier abnormalities have not been examined in the immature brain in vivo. We generated pharmacologic quantities of ovine-specific neutralizing anti-IL-6 mAbs and systemically infused mAbs into fetal sheep at 126 days of gestation after exposure to brain ischemia. Anti-IL-6 mAbs were measured by ELISA in fetal plasma, cerebral cortex, and cerebrospinal fluid, blood-brain barrier permeability was quantified using the blood-to-brain transfer constant in brain regions, and IL-6, tight junction proteins, and plasmalemma vesicle protein (PLVAP) were detected by Western immunoblot. Anti-IL-6 mAb infusions resulted in increases in mAb (P < 0.05) in plasma, brain parenchyma, and cerebrospinal fluid and decreases in brain IL-6 protein. Twenty-four hours after ischemia, anti-IL-6 mAb infusions attenuated ischemia-related increases in blood-brain barrier permeability and modulated tight junction and PLVAP protein expression in fetal brain. We conclude that inhibiting the effects of IL-6 protein with systemic infusions of neutralizing antibodies attenuates ischemia-related increases in blood-brain barrier permeability by inhibiting IL-6 and modulates tight junction proteins after ischemia.Zhang, J., Sadowska, G. B., Chen, X., Park, S. Y., Kim, J.-E., Bodge, C. A., Cummings, E., Lim, Y.-P., Makeyev, O., Besio, W. G., Gaitanis, J., Banks, W. A., Stonestreet, B. S. Anti-IL-6 neutralizing antibody modulates blood-brain barrier function in the ovine fetus.	[Zhang, Jiyong; Sadowska, Grazyna B.; Chen, Xiaodi; Park, Seon Yeong; Kim, Jeong-Eun; Bodge, Courtney A.; Cummings, Erin; Stonestreet, Barbara S.] Brown Univ, Women & Infants Hosp Rhode Isl, Alpert Med Sch, Dept Pediat, Providence, RI 02905 USA; [Lim, Yow-Pin] ProThera Biol Inc, Providence, RI USA; [Makeyev, Oleksandr; Besio, Walter G.] Univ Rhode Isl, Dept Elect Comp & Biomed Engn, Kingston, RI 02881 USA; [Gaitanis, John] Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Dept Neurol, Providence, RI 02905 USA; [Banks, William A.] Univ Washington, Geriatr Res Educ & Clin Ctr, Dept Med, Div Gerontol & Geriatr Med,Vet Affairs Puget Soun, Seattle, WA 98195 USA	Brown University; Women & Infants Hospital Rhode Island; University of Rhode Island; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Geriatric Research Education & Clinical Center; University of Washington; University of Washington Seattle	Stonestreet, BS (corresponding author), Brown Univ, Women & Infants Hosp Rhode Isl, Alpert Med Sch, Dept Pediat, 101 Dudley St, Providence, RI 02905 USA.	bstonestreet@wihri.org	Banks, William A/K-1330-2017	Banks, William A/0000-0002-0496-3619; Makeyev, Oleksandr/0000-0003-2648-0500; Chen, Xiaodi/0000-0002-1860-2814	U.S. National Institutes of Health, National Institute of General Medical Sciences (NIH NIGMS) [1R01-HD-057100, RI-INBRE P20RR016457-11]; Institutional Development Award from the NIH NIGMS [P20 RR018728, P20GM103537]; American Heart Association [13POST16860015]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016457, P20RR018728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103537] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences (NIH NIGMS); Institutional Development Award from the NIH NIGMS; American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge the gift of the ovine IL-6 pQE30 vector and mouse monoclonal cell lines from Commonwealth Scientific and Industrial Research Organization, Livestock Industries (Victoria, Australia), that enabled the production of IL-6 protein and anti-IL-6 mAb, respectively. This work was supported by The U.S. National Institutes of Health, National Institute of General Medical Sciences (NIH NIGMS) Awards 1R01-HD-057100 and RI-INBRE P20RR016457-11; an Institutional Development Award from the NIH NIGMS Grants P20 RR018728 and P20GM103537; and a postdoctoral fellowship award from American Heart Association Grant 13POST16860015. The authors declare no conflicts of interest.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abbruscato TJ, 1999, J PHARMACOL EXP THER, V289, P668; Abraham CS, 1996, NEUROSCI LETT, V208, P85; Ali C, 2000, J CEREBR BLOOD F MET, V20, P956, DOI 10.1097/00004647-200006000-00008; Atwal JK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002254; Back SA, 2006, J CHILD NEUROL, V21, P582, DOI 10.1177/08830738060210070101; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Banks WA, 2002, PEPTIDES, V23, P2223, DOI 10.1016/S0196-9781(02)00261-9; Banks WA, 2007, EXP NEUROL, V206, P248, DOI 10.1016/j.expneurol.2007.05.005; BARLOW RM, 1969, J COMP NEUROL, V135, P249, DOI 10.1002/cne.901350302; Bauman MD, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.47; Benjelloun N, 1999, STROKE, V30, P1916, DOI 10.1161/01.STR.30.9.1916; Bernhard C G, 1967, Prog Brain Res, V26, P60; BRALET AM, 1979, STROKE, V10, P34, DOI 10.1161/01.STR.10.1.34; Brimberg L, 2013, MOL PSYCHIATR, V18, P1171, DOI 10.1038/mp.2013.101; Brown RC, 2002, STROKE, V33, P1706, DOI 10.1161/01.STR.0000016405.06729.83; Brunssen SH, 2013, BRAIN BEHAV IMMUN, V27, P42, DOI 10.1016/j.bbi.2012.08.017; Cai ZW, 1998, DEV BRAIN RES, V109, P265, DOI 10.1016/S0165-3806(98)00080-7; Carson-Walter EB, 2005, CLIN CANCER RES, V11, P7643, DOI 10.1158/1078-0432.CCR-05-1099; Chai Z, 1996, J EXP MED, V183, P311, DOI 10.1084/jem.183.1.311; Chen X, 2013, J COMP PATHOL, V148, P252, DOI 10.1016/j.jcpa.2012.06.001; Chen X, 2012, NEUROSCIENCE, V226, P89, DOI 10.1016/j.neuroscience.2012.08.043; Chen X., 2015, NEUROBIOL DIS; Chiesa C, 2003, EUR J CLIN INVEST, V33, P352, DOI 10.1046/j.1365-2362.2003.01136.x; Chiesa C, 2003, CLIN CHEM, V49, P60, DOI 10.1373/49.1.60; Cohen SS, 2013, NEUROIMMUNOMODULAT, V20, P264, DOI 10.1159/000350470; COOK CJ, 1987, J DEV PHYSIOL, V9, P429; COOK CJ, 1987, J DEV PHYSIOL, V9, P441; CSERR HF, 1987, AM J PHYSIOL, V253, pF522, DOI 10.1152/ajprenal.1987.253.3.F522; Dammann O, 2000, J PEDIATR-US, V136, P433, DOI 10.1016/S0022-3476(00)90004-0; Dammann O, 1997, PEDIATR RES, V42, P1, DOI 10.1203/00006450-199707000-00001; del Zoppo GJ, 2009, NEUROSCIENCE, V158, P972, DOI 10.1016/j.neuroscience.2008.08.028; Desai TR, 2002, J SURG RES, V104, P118, DOI 10.1006/jsre.2002.6415; Dickey EJ, 2011, J VET INTERN MED, V25, P1231, DOI 10.1111/j.1939-1676.2011.00818.x; Ellison VJ, 2005, PEDIATR RES, V57, P282, DOI 10.1203/01.PDR.0000148286.53572.95; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Fischer S, 1999, AM J PHYSIOL-CELL PH, V276, pC812; Fujimoto M, 2008, J CEREBR BLOOD F MET, V28, P1674, DOI 10.1038/jcbfm.2008.59; GIBSON KJ, 1995, J PHYSIOL-LONDON, V485, P835, DOI 10.1113/jphysiol.1995.sp020773; Goussev S, 2003, J NEUROSURG, V99, P188, DOI 10.3171/spi.2003.99.2.0188; Gu Y, 2012, J NEUROCHEM, V120, P147, DOI 10.1111/j.1471-4159.2011.07542.x; Gu Yong, 2011, Front Biosci (Schol Ed), V3, P1216; Gunn AJ, 1997, J CLIN INVEST, V99, P248, DOI 10.1172/JCI119153; Hagberg H, 1996, PEDIATR RES, V40, P603, DOI 10.1203/00006450-199610000-00015; Hans VHJ, 1999, NEUROREPORT, V10, P409; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hnasko R, 2006, CELL CYCLE, V5, P2012, DOI 10.4161/cc.5.17.3216; Huber JD, 2001, AM J PHYSIOL-HEART C, V280, pH1241, DOI 10.1152/ajpheart.2001.280.3.H1241; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; ITO U, 1979, STROKE, V10, P542, DOI 10.1161/01.STR.10.5.542; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; Kim CR, 2006, REPROD FERT DEVELOP, V18, P413, DOI 10.1071/RD05114; Kumar A, 2008, PEDIATRICS, V122, pE722, DOI 10.1542/peds.2008-0269; Lai MC, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/609813; Lakhan SE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00032; Lavine SD, 1998, J CEREBR BLOOD F MET, V18, P52, DOI 10.1097/00004647-199801000-00005; Leviton A, 2011, J PEDIATR-US, V158, P897, DOI 10.1016/j.jpeds.2010.11.059; Loddick SA, 1998, J CEREBR BLOOD F MET, V18, P176, DOI 10.1097/00004647-199802000-00008; Longo M, 2009, Minerva Ginecol, V61, P421; LOTZ M, 1988, J EXP MED, V167, P1253, DOI 10.1084/jem.167.3.1253; Malaeb S, 2009, J CHILD NEUROL, V24, P1119, DOI 10.1177/0883073809338066; Malaeb SN, 2007, BRAIN RES, V1160, P11, DOI 10.1016/j.brainres.2007.05.043; MALLARD EC, 1993, PEDIATR RES, V33, P61, DOI 10.1203/00006450-199301000-00013; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; MartinAncel A, 1997, PEDIATRICS, V100, P789, DOI 10.1542/peds.100.5.789; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; McCarthy KM, 2000, J CELL SCI, V113, P1277; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; McWaters P, 2000, VET IMMUNOL IMMUNOP, V73, P155, DOI 10.1016/S0165-2427(99)00158-0; MEGYERI P, 1992, NEUROSCI LETT, V148, P137, DOI 10.1016/0304-3940(92)90823-P; Nedelcu J, 1999, PEDIATR RES, V46, P297, DOI 10.1203/00006450-199909000-00008; OHNO K, 1978, AM J PHYSIOL, V235, pH299, DOI 10.1152/ajpheart.1978.235.3.H299; Pantoni L, 1998, ARTERIOSCL THROM VAS, V18, P503, DOI 10.1161/01.ATV.18.4.503; Petersson KH, 2002, PEDIATR RES, V51, P768, DOI 10.1203/01.PDR.0000017486.64723.D1; POUSSET F, 1994, DEV BRAIN RES, V81, P143, DOI 10.1016/0165-3806(94)90078-7; Prout AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039043; Prout AP, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.020; QUAGLIARELLO VJ, 1991, J CLIN INVEST, V87, P1360, DOI 10.1172/JCI115140; Rezaie P, 2002, NEUROPATHOLOGY, V22, P106, DOI 10.1046/j.1440-1789.2002.00438.x; Roelfsema V, 2004, J CEREBR BLOOD F MET, V24, P877, DOI 10.1097/01.WCB.0000123904.17746.92; Ron NP, 2005, REPROD FERT DEVELOP, V17, P535, DOI 10.1071/RD03044; Sadowska GB, 2006, J SOC GYNECOL INVEST, V13, P248, DOI 10.1016/j.jsgi.2006.02.012; Sadowska GB, 2012, INT J DEV NEUROSCI, V30, P457, DOI 10.1016/j.ijdevneu.2012.06.001; Sadowska GB, 2010, AM J PHYSIOL-HEART C, V298, pH179, DOI 10.1152/ajpheart.00828.2009; Saito K, 1996, NEUROSCI LETT, V206, P149, DOI 10.1016/S0304-3940(96)12460-5; Samland H, 2003, J NEUROSCI RES, V73, P176, DOI 10.1002/jnr.10635; Sas A, 2008, NEUROCHEM RES, V33, P2281, DOI 10.1007/s11064-008-9715-8; Schlachetzki F, 2002, J NEUROCHEM, V81, P203, DOI 10.1046/j.1471-4159.2002.00840.x; SEOW HF, 1994, VET IMMUNOL IMMUNOP, V41, P229, DOI 10.1016/0165-2427(94)90099-X; Shankaran S, 2010, NEW ENGL J MED, V362, P1051, DOI 10.1056/NEJMc0912848; Shrivastava K, 2013, DEV NEUROSCI-BASEL, V35, P212, DOI 10.1159/000348432; Shue EH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-29; Stanimirovic D, 2000, BRAIN PATHOL, V10, P113; Stonestreet BS, 2006, AM J PHYSIOL-REG I, V291, pR1031, DOI 10.1152/ajpregu.00883.2005; Stonestreet BS, 2012, J CEREBR BLOOD F MET, V32, P115, DOI 10.1038/jcbfm.2011.114; STONESTREET BS, 1989, AM J PHYSIOL, V257, pR1199, DOI 10.1152/ajpregu.1989.257.5.R1199; STONESTREET BS, 1993, AM J PHYSIOL, V265, pH1098, DOI 10.1152/ajpheart.1993.265.4.H1098; Stonestreet BS, 1996, AM J PHYSIOL-REG I, V271, pR1594, DOI 10.1152/ajpregu.1996.271.6.R1594; Stonestreet BS, 2000, AM J PHYSIOL-REG I, V279, pR468, DOI 10.1152/ajpregu.2000.279.2.R468; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/neu.2004.21.1706; Suzuki S, 2009, J CEREBR BLOOD F MET, V29, P464, DOI 10.1038/jcbfm.2008.141; SZAFLARSKI J, 1995, STROKE, V26, P1093, DOI 10.1161/01.STR.26.6.1093; Thorns V, 2002, J NEUROIMMUNOL, V127, P22, DOI 10.1016/S0165-5728(02)00072-3; Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003; TOULMOND S, 1992, NEUROSCI LETT, V144, P49, DOI 10.1016/0304-3940(92)90713-H; Van Wagoner NJ, 1999, J NEUROSCI, V19, P5236; Virgintino D, 2002, NEUROSCIENCE, V115, P145, DOI 10.1016/S0306-4522(02)00374-3; Virgintino D, 2014, J NEUROPATH EXP NEUR, V73, P495, DOI 10.1097/NEN.0000000000000071; WILLIAMS CE, 1992, ANN NEUROL, V31, P14, DOI 10.1002/ana.410310104; WOOD PR, 1990, VET IMMUNOL IMMUNOP, V25, P37, DOI 10.1016/0165-2427(90)90108-5; YAMADA M, 1994, BRAIN RES, V643, P173, DOI 10.1016/0006-8993(94)90023-X; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P19, DOI 10.1016/S0002-9378(97)70432-0; Yoon BH, 1996, AM J OBSTET GYNECOL, V174, P1433, DOI 10.1016/S0002-9378(96)70585-9; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P406, DOI 10.1016/S0002-9378(97)70206-0; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334; Zhang Y, 2001, J NEUROIMMUNOL, V114, P168, DOI 10.1016/S0165-5728(01)00242-9	117	48	51	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1739	1753		10.1096/fj.14-258822	http://dx.doi.org/10.1096/fj.14-258822			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25609424	Green Published			2022-12-26	WOS:000354114600012
J	Muter, J; Lucas, ES; Chan, YW; Brighton, PJ; Moore, JD; Lacey, L; Quenby, S; Lam, EWF; Brosens, JJ				Muter, Joanne; Lucas, Emma S.; Chan, Yi-Wah; Brighton, Paul J.; Moore, Jonathan D.; Lacey, Lauren; Quenby, Siobhan; Lam, Eric W. -F.; Brosens, Jan J.			The clock protein period 2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells	FASEB JOURNAL			English	Article						endometrium; circadian rhythm; cell cycle; miscarriage	DIFFERENTIAL EXPRESSION ANALYSIS; CIRCADIAN CLOCK; GENE-EXPRESSION; DOWN-REGULATION; PER2; RECEPTOR; MOUSE; TRANSCRIPTION; ACTIVATION; TISSUES	Implantation requires coordinated interactions between the conceptus and surrounding decidual cells, but the involvement of clock genes in this process is incompletely understood. Circadian oscillations are predicated on transcriptional-translational feedback loops, which balance the activities of the transcriptional activators CLOCK (circadian locomotor output cycles kaput) and brain muscle arnt-like 1 and repressors encoded by PER (Period) and Cryptochrome genes. We show that loss of PER2 expression silences circadian oscillations in decidualizing human endometrial stromal cells (HESCs). Downregulation occurred between 12 and 24 hours following differentiation and coincided with reduced CLOCK binding to a noncanonical E-box enhancer in the PER2 promoter. RNA sequencing revealed that premature inhibition of PER2 by small interfering RNA knockdown leads to a grossly disorganized decidual response. Gene ontology analysis highlighted a preponderance of cell cycle regulators among the 1121 genes perturbed upon PER2 knockdown. Congruently, PER2 inhibition abrogated mitotic expansion of differentiating HESCs by inducing cell cycle block at G2/M. Analysis of 70 midluteal endometrial biopsies revealed an inverse correlation between PER2 transcript levels and the number of miscarriages in women suffering reproductive failure (Spearman rank test, rho = -0.3260; P = 0.0046). Thus, PER2 synchronizes endometrial proliferation with initiation of aperiodic decidual gene expression; uncoupling of these events may cause recurrent pregnancy loss.	[Muter, Joanne; Lucas, Emma S.; Brighton, Paul J.; Lacey, Lauren; Quenby, Siobhan; Brosens, Jan J.] Univ Warwick, Warwick Med Sch, Div Translat & Syst Med, Coventry CV4 7AL, W Midlands, England; [Chan, Yi-Wah; Moore, Jonathan D.] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Lam, Eric W. -F.] Univ London Imperial Coll Sci Technol & Med, Imperial Ctr Translat & Expt Med, Dept Surg & Canc, London, England	University of Warwick; University of Warwick; Imperial College London	Brosens, JJ (corresponding author), Univ Hosp, Warwick Med Sch, Clin Sci Res Inst, Dept Reprod Hlth, Coventry CV2 2DX, W Midlands, England.	j.j.brosens@warwick.ac.uk	Lam, Eric W-F/AAW-8566-2020; Lucas, Emma S/I-2719-2013; Moore, Jonathan D/D-1796-2013	Lam, Eric W-F/0000-0003-1274-3576; Lucas, Emma S/0000-0002-8571-8921; Moore, Jonathan D/0000-0002-5486-0407; Brosens, Jan/0000-0003-0116-9329; Quenby, Siobhan/0000-0003-3221-5471	Biomedical Research Unit in Reproductive Health; University Hospitals Coventry; Warwickshire National Health Service Trust; Warwick Medical School; Warwick Chancellor's studentship; Biotechnology and Biological Sciences Research Council [BBS/B/03785] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1234732] Funding Source: researchfish	Biomedical Research Unit in Reproductive Health; University Hospitals Coventry; Warwickshire National Health Service Trust; Warwick Medical School; Warwick Chancellor's studentship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Biomedical Research Unit in Reproductive Health, a joint initiative between the University Hospitals Coventry and Warwickshire National Health Service Trust and Warwick Medical School. J.M. is the recipient of a Warwick Chancellor's studentship. The authors declare no conflicts of interest.	Al-Sabbagh M, 2012, MOL CELL ENDOCRINOL, V358, P208, DOI 10.1016/j.mce.2011.10.035; Al-Sabbagh M, 2011, ENDOCRINOLOGY, V152, P730, DOI 10.1210/en.2010-0899; Albrecht U, 2007, COLD SPRING HARB SYM, V72, P95, DOI 10.1101/sqb.2007.72.001; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Boden MJ, 2013, PROG BIOPHYS MOL BIO, V113, P387, DOI 10.1016/j.pbiomolbio.2013.01.003; Brosens JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03894; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Chappell PE, 2003, J NEUROSCI, V23, P11202; Chu A, 2013, ENDOCRINOLOGY, V154, P2924, DOI 10.1210/en.2013-1080; Dolatshad H, 2009, REPROD FERT DEVELOP, V21, P1, DOI 10.1071/RD08223; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Gery S, 2007, ONCOGENE, V26, P7916, DOI 10.1038/sj.onc.1210585; Grimaldi B, 2009, INT J BIOCHEM CELL B, V41, P81, DOI 10.1016/j.biocel.2008.08.035; Grimaldi G, 2011, MOL ENDOCRINOL, V25, P1892, DOI 10.1210/me.2011-1139; Hwang-Verslues WW, 2013, P NATL ACAD SCI USA, V110, P12331, DOI 10.1073/pnas.1222684110; Jones MC, 2006, P NATL ACAD SCI USA, V103, P16272, DOI 10.1073/pnas.0603002103; Karman BN, 2006, BIOL REPROD, V75, P624, DOI 10.1095/biolreprod.106.050732; Kennaway DJ, 2003, MOL HUM REPROD, V9, P503, DOI 10.1093/molehr/gag067; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Koyanagi S, 2011, J BIOL CHEM, V286, P32416, DOI 10.1074/jbc.M111.258970; Lal S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003926; Lamas M, 1996, PHILOS T R SOC B, V351, P561, DOI 10.1098/rstb.1996.0055; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2008, MOL CELL BIOL, V28, P6056, DOI 10.1128/MCB.00583-08; Leitao B, 2010, FASEB J, V24, P1541, DOI 10.1096/fj.09-149153; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; Markson JS, 2009, FEBS LETT, V583, P3938, DOI 10.1016/j.febslet.2009.11.021; Miki T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3444; Morin LP, 2013, EXP NEUROL, V243, P4, DOI 10.1016/j.expneurol.2012.06.026; Nakamura TJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE1025, DOI 10.1152/ajpendo.90392.2008; Nakamura TJ, 2005, J NEUROSCI RES, V82, P622, DOI 10.1002/jnr.20677; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; O'Neill John S, 2013, Handb Exp Pharmacol, P67, DOI 10.1007/978-3-642-25950-0_4; Ogasawara M, 2000, FERTIL STERIL, V73, P300, DOI 10.1016/S0015-0282(99)00495-1; Pilorz V, 2008, REPRODUCTION, V135, P559, DOI 10.1530/REP-07-0434; Pohnke Y, 2004, J CLIN ENDOCR METAB, V89, P5233, DOI 10.1210/jc.2004-0012; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Ratajczak CK, 2012, REPROD FERT DEVELOP, V24, P759, DOI 10.1071/RD11164; Ratajczak CK, 2009, ENDOCRINOLOGY, V150, P1879, DOI 10.1210/en.2008-1021; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JA, 2010, PROTEIN REV, V12, P37, DOI 10.1007/978-1-4419-1262-6_2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Salker MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052252; Salker MS, 2011, NAT MED, V17, P1509, DOI 10.1038/nm.2498; Stocker LJ, 2014, OBSTET GYNECOL, V124, P99, DOI 10.1097/AOG.0000000000000321; Stojkovic K, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00069; Sun CM, 2010, PATHOL ONCOL RES, V16, P403, DOI 10.1007/s12253-009-9227-0; Talbi S, 2006, ENDOCRINOLOGY, V147, P1097, DOI 10.1210/en.2005-1076; Telgmann R, 1998, HUM REPROD UPDATE, V4, P472, DOI 10.1093/humupd/4.5.472; Thoennissen NH, 2012, LEUKEMIA LYMPHOMA, V53, P1577, DOI 10.3109/10428194.2012.658792; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uchikawa M, 2011, CHRONOBIOL INT, V28, P1, DOI 10.3109/07420528.2010.522289; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wang W, 2010, ENDOCRINOLOGY, V151, P3929, DOI 10.1210/en.2009-1437; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102	59	26	27	1	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1603	1614		10.1096/fj.14-267195	http://dx.doi.org/10.1096/fj.14-267195			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25573754	Green Published, hybrid			2022-12-26	WOS:000354115000043
J	Gudi, R; Haycraft, CJ; Bell, PD; Li, ZH; Vasu, C				Gudi, Radhika; Haycraft, Courtney J.; Bell, P. Darwin; Li, Zihai; Vasu, Chenthamarakshan			Centrobin-mediated Regulation of the Centrosomal Protein 4.1-associated Protein (CPAP) Level Limits Centriole Length during Elongation Stage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO KINASE; DUPLICATION; CYCLE; BIOGENESIS; TUBULIN; CILIA; REQUIREMENT; COOPERATE; SUBSTRATE; INTERACTS	Microtubule-based centrioles in the centrosome mediate accurate bipolar cell division, spindle orientation, and primary cilia formation. Cellular checkpoints ensure that the centrioles duplicate only once in every cell cycle and achieve precise dimensions, dysregulation of which results in genetic instability and neuro- and ciliopathies. The normal cellular level of centrosomal protein 4.1-associated protein (CPAP), achieved by its degradation at mitosis, is considered as one of the major mechanisms that limits centriole growth at a predetermined length. Here we show that CPAP levels and centriole elongation are regulated by centrobin. Exogenous expression of centrobin causes abnormal elongation of centrioles due to massive accumulation of CPAP in the cell. Conversely, CPAP was undetectable in centrobin-depleted cells, suggesting that it undergoes degradation in the absence of centrobin. Only the reintroduction of full-length centrobin, but not its mutant form that lacks the CPAP binding site, could restore cellular CPAP levels in centrobin-depleted cells, indicating that persistence of CPAP requires its interaction with centrobin. Interestingly, inhibition of the proteasome in centrobin-depleted cells restored the cellular and centriolar CPAP expression, suggesting its ubiquitination and proteasome-mediated degradation when centrobin is absent. Intriguingly, however, centrobin-overexpressing cells also showed proteasome-independent accumulation of ubiquitinated CPAP and abnormal, ubiquitin-positive, elongated centrioles. Overall, our results show that centrobin interacts with ubiquitinated CPAP and prevents its degradation for normal centriole elongation function. Therefore, it appears that loss of centrobin expression destabilizes CPAP and triggers its degradation to restrict the centriole length during biogenesis.	[Gudi, Radhika; Li, Zihai; Vasu, Chenthamarakshan] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Haycraft, Courtney J.] Med Univ S Carolina, Dept Oral Hlth Sci, Charleston, SC 29425 USA; [Bell, P. Darwin] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Vasu, Chenthamarakshan] Med Univ S Carolina, Dept Surg, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Gudi, R (corresponding author), Med Univ S Carolina, HO602,86 Jonathan Lucas St, Charleston, SC 29425 USA.	gudi@musc.edu		vasu, chenthamarakshan/0000-0002-1772-6508	Department of Surgery, MUSC; Department of Microbiology, MUSC; Department of Immunology, MUSC; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK074038] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002007] Funding Source: NIH RePORTER	Department of Surgery, MUSC; Department of Microbiology, MUSC; Department of Immunology, MUSC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by internal funds from the Departments of Surgery and Microbiology and Immunology, MUSC (to C. V.).	Al-Dosari MS, 2010, J MED GENET, V47, P411, DOI 10.1136/jmg.2009.076646; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Balestra FR, 2013, DEV CELL, V25, P555, DOI 10.1016/j.devcel.2013.05.016; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Chretien D, 1997, J STRUCT BIOL, V120, P117, DOI 10.1006/jsbi.1997.3928; Comartin D, 2013, CURR BIOL, V23, P1360, DOI 10.1016/j.cub.2013.06.002; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Godinho SA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0467; Gudi R, 2014, J BIOL CHEM, V289, P15166, DOI 10.1074/jbc.M113.531152; Gudi R, 2011, J CELL BIOL, V193, P711, DOI 10.1083/jcb.201006135; Gul A, 2006, J HUM GENET, V51, P760, DOI 10.1007/s10038-006-0017-1; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hung LY, 2004, MOL BIOL CELL, V15, P2697, DOI 10.1091/mbc.E04-02-0121; Iwai K, 2012, TRENDS CELL BIOL, V22, P355, DOI 10.1016/j.tcb.2012.04.001; Januschke J, 2013, NAT CELL BIOL, V15, P241, DOI 10.1038/ncb2671; Jeffery JM, 2010, ONCOGENE, V29, P2649, DOI 10.1038/onc.2010.37; Jeong Y, 2007, J CELL SCI, V120, P2106, DOI 10.1242/jcs.03458; Kim MK, 2012, EMBO REP, V13, P724, DOI 10.1038/embor.2012.86; Kitagawa D, 2011, J CELL SCI, V124, P3884, DOI 10.1242/jcs.089888; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; KOCHANSKI RS, 1990, J CELL BIOL, V110, P1599, DOI 10.1083/jcb.110.5.1599; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Korzeniewski N, 2010, MOL BIOL CELL, V21, P3942, DOI 10.1091/mbc.E09-12-1049; Lee J, 2010, J BIOL CHEM, V285, P25476, DOI 10.1074/jbc.M109.099127; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Li J, 2013, NATURE, V495, P255, DOI 10.1038/nature11941; Lin YN, 2013, J CELL BIOL, V202, P211, DOI 10.1083/jcb.201212060; Lin YC, 2013, EMBO J, V32, P1141, DOI 10.1038/emboj.2013.56; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; McIntyre RE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003022; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; Middendorp S, 2000, J CELL BIOL, V148, P405, DOI 10.1083/jcb.148.3.405; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Pihan GA, 2001, CANCER RES, V61, P2212; Pihan GA, 1998, CANCER RES, V58, P3974; ROBBINS E, 1968, J CELL BIOL, V36, P329, DOI 10.1083/jcb.36.2.329; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Schmukle AC, 2012, J CELL SCI, V125, P549, DOI 10.1242/jcs.091793; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; STEARNS T, 1991, CELL, V65, P825, DOI 10.1016/0092-8674(91)90390-K; Stinchcombe JC, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-45; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Tang CJC, 2011, EMBO J, V30, P4790, DOI 10.1038/emboj.2011.378; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; VOROBJEV IA, 1980, CELL BIOL INT REP, V4, P1037, DOI 10.1016/0309-1651(80)90177-0; Vulprecht J, 2012, J CELL SCI, V125, P1353, DOI 10.1242/jcs.104109; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Wu KS, 2012, BIOL OPEN, V1, P559, DOI 10.1242/bio.20121388; Zou CZ, 2005, J CELL BIOL, V171, P437, DOI 10.1083/jcb.200506185	64	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6890	6902		10.1074/jbc.M114.603423	http://dx.doi.org/10.1074/jbc.M114.603423			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25616662	Green Published, hybrid			2022-12-26	WOS:000350991500024
J	Lorenz, M; Vollmer, B; Unsay, JD; Klupp, BG; Garcia-Saez, AJ; Mettenleiter, TC; Antonin, W				Lorenz, Michael; Vollmer, Benjamin; Unsay, Joseph D.; Klupp, Barbara G.; Garcia-Saez, Ana J.; Mettenleiter, Thomas C.; Antonin, Wolfram			A Single Herpesvirus Protein Can Mediate Vesicle Formation in the Nuclear Envelope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGRESS COMPLEX; PORE COMPLEX; PSEUDORABIES VIRUS; CELLULAR MEMBRANES; LIPID-COMPOSITION; ESCRT MACHINERY; INFECTED-CELLS; GENE-PRODUCTS; CURVATURE; COEXPRESSION	Herpesviruses assemble capsids in the nucleus and egress by unconventional vesicle-mediated trafficking through the nuclear envelope. Capsids bud at the inner nuclear membrane into the nuclear envelope lumen. The resulting intralumenal vesicles fuse with the outer nuclear membrane, delivering the capsids to the cytoplasm. Two viral proteins are required for vesicle formation, the tail-anchored pUL34 and its soluble interactor, pUL31. Whether cellular proteins are involved is unclear. Using giant unilamellar vesicles, we show that pUL31 and pUL34 are sufficient for membrane budding and scission. pUL34 function can be bypassed by membrane tethering of pUL31, demonstrating that pUL34 is required for pUL31 membrane recruitment but not for membrane remodeling. pUL31 can inwardly deform membranes by oligomerizing on their inner surface to form buds that constrict to vesicles. Therefore, a single viral protein can mediate all events necessary for membrane budding and abscission.	[Lorenz, Michael; Vollmer, Benjamin; Antonin, Wolfram] Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany; [Unsay, Joseph D.; Garcia-Saez, Ana J.] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Klupp, Barbara G.; Mettenleiter, Thomas C.] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, D-17493 Greifswald, Germany	Eberhard Karls University of Tubingen; Max Planck Society; Eberhard Karls University of Tubingen; Friedrich Loeffler Institute	Antonin, W (corresponding author), Max Planck Gesell, Friedrich Miescher Lab, Spemannstr 79, D-72076 Tubingen, Germany.	wolfram.antonin@tuebingen.mpg.de	Mettenleiter, h. c. Thomas C./U-1016-2019; Saez, Ana J. Garcia/U-1611-2019; Unsay, Joseph/H-7739-2019; Antonin, Wolfram/A-8656-2014; Vollmer, Benjamin/AAJ-7327-2021; Antonin, Wolfram/P-3648-2019	Unsay, Joseph/0000-0003-0569-7962; Antonin, Wolfram/0000-0003-4669-379X; Vollmer, Benjamin/0000-0002-7526-0582; Antonin, Wolfram/0000-0003-4669-379X	Max Planck Society; German Research Foundation [DFG Me 854/12-1]	Max Planck Society(Max Planck Society); German Research Foundation(German Research Foundation (DFG))	This work was supported by funding from the Max Planck Society (to W. A.) and by German Research Foundation Grant DFG Me 854/12-1.	Adams RL, 2013, CELL, V152, P1218, DOI 10.1016/j.cell.2013.02.042; ALOIA RC, 1988, P NATL ACAD SCI USA, V85, P900, DOI 10.1073/pnas.85.3.900; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Bigalke JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5131; Bjerke SL, 2006, VIROLOGY, V347, P261, DOI 10.1016/j.virol.2005.11.053; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Chang YE, 1997, J VIROL, V71, P8307, DOI 10.1128/JVI.71.11.8307-8315.1997; Cohen S, 2011, BBA-MOL CELL RES, V1813, P1634, DOI 10.1016/j.bbamcr.2010.12.009; Desai PJ, 2012, J VIROL, V86, P594, DOI 10.1128/JVI.05988-11; Eisenhardt N, 2014, J CELL SCI, V127, P908, DOI 10.1242/jcs.141739; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fuchs W, 2002, J VIROL, V76, P364, DOI 10.1128/JVI.76.1.364-378.2002; GAROFF H, 1974, P NATL ACAD SCI USA, V71, P3988, DOI 10.1073/pnas.71.10.3988; Granato M, 2008, J VIROL, V82, P4042, DOI 10.1128/JVI.02436-07; Haugo AC, 2011, J VIROL, V85, P7203, DOI 10.1128/JVI.00262-11; Hetzer MW, 2009, DEV CELL, V17, P606, DOI 10.1016/j.devcel.2009.10.007; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Jokhi V, 2013, CELL REP, V3, P988, DOI 10.1016/j.celrep.2013.03.015; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; KLEINIG H, 1970, J CELL BIOL, V46, P396, DOI 10.1083/jcb.46.2.396; Klupp BG, 2007, P NATL ACAD SCI USA, V104, P7241, DOI 10.1073/pnas.0701757104; Klupp BG, 2011, J VIROL, V85, P8285, DOI 10.1128/JVI.00741-11; Kobiler O, 2012, NUCLEUS-PHILA, V3, P526, DOI 10.4161/nucl.21979; Lake CM, 2004, VIROLOGY, V320, P99, DOI 10.1016/j.virol.2003.11.018; Ledesma MD, 2003, INT REV CYTOL, V227, P183, DOI 10.1016/S0074-7696(03)01010-6; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Luitweiler EM, 2013, J VIROL, V87, P3915, DOI 10.1128/JVI.03418-12; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Merrifield CJ, 2004, TRENDS CELL BIOL, V14, P352, DOI 10.1016/j.tcb.2004.05.008; Mettenleiter TC, 2002, J VIROL, V76, P1537, DOI 10.1128/JVI.76.4.1537-1547.2002; Mettenleiter TC, 2013, CELL MICROBIOL, V15, P170, DOI 10.1111/cmi.12044; Mettenleiter TC, 2009, VIRUS RES, V143, P222, DOI 10.1016/j.virusres.2009.03.018; Milbradt J, 2009, J GEN VIROL, V90, P579, DOI 10.1099/vir.0.005231-0; Mou F, 2007, J VIROL, V81, P6459, DOI 10.1128/JVI.00380-07; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Ono A, 2005, ADV VIRUS RES, V64, P311, DOI 10.1016/S0065-3527(05)64010-9; Reynolds AE, 2004, J VIROL, V78, P5564, DOI 10.1128/JVI.78.11.5564-5575.2004; Reynolds AE, 2001, J VIROL, V75, P8803, DOI 10.1128/JVI.75.18.8803-8817.2001; Roller RJ, 2011, J VIROL, V85, P11615, DOI 10.1128/JVI.05730-11; Roller RJ, 2010, J VIROL, V84, P3921, DOI 10.1128/JVI.01638-09; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Sam MD, 2009, J VIROL, V83, P2996, DOI 10.1128/JVI.02441-08; Schnee M, 2006, J VIROL, V80, P11658, DOI 10.1128/JVI.01662-06; Schooley A, 2012, CHROMOSOMA, V121, P539, DOI 10.1007/s00412-012-0388-3; Schuster F, 2012, J VIROL, V86, P2079, DOI 10.1128/JVI.05484-11; Shnyrova AV, 2007, J CELL BIOL, V179, P627, DOI 10.1083/jcb.200705062; Skepper JN, 2001, J VIROL, V75, P5697, DOI 10.1128/JVI.75.12.5697-5702.2001; Solon J, 2005, J GEN VIROL, V86, P3357, DOI 10.1099/vir.0.81129-0; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Theerthagiri G, 2010, J CELL BIOL, V189, P1129, DOI 10.1083/jcb.200912045; Ulbert S, 2006, J CELL BIOL, V173, P469, DOI 10.1083/jcb.200512078; Unsay JD, 2013, LANGMUIR, V29, P15878, DOI 10.1021/la402669z; Van Engelenburg SB, 2014, SCIENCE, V343, P653, DOI 10.1126/science.1247786; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vennema H, 1996, EMBO J, V15, P2020, DOI 10.1002/j.1460-2075.1996.tb00553.x; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Vollmer B, 2012, EMBO J, V31, P4072, DOI 10.1038/emboj.2012.256; Walser PJ, 2012, CELL, V150, P752, DOI 10.1016/j.cell.2012.06.042; Welsch S, 2007, FEBS LETT, V581, P2089, DOI 10.1016/j.febslet.2007.03.060; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836	71	57	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6962	6974		10.1074/jbc.M114.627521	http://dx.doi.org/10.1074/jbc.M114.627521			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605719	Green Published, hybrid			2022-12-26	WOS:000350991500030
J	Izumikawa, T; Sato, B; Mikami, T; Tamura, J; Igarashi, M; Kitagawa, H				Izumikawa, Tomomi; Sato, Ban; Mikami, Tadahisa; Tamura, Jun-ichi; Igarashi, Michihiro; Kitagawa, Hiroshi			GlcUA beta 1-3Gal beta 1-3Gal beta 1-4Xyl(2-O-phosphate) Is the Preferred Substrate for Chondroitin N-Acetylgalactosaminyltransferase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-LINKAGE REGION; SWARM MOUSE-TUMOR; MOLECULAR-CLONING; SULFATE N-ACETYLGALACTOSAMINYLTRANSFERASE-1; N-ACETYLGALACTOSAMINYLTRANSFERASE; GLYCOSAMINOGLYCAN BIOSYNTHESIS; POLYMERIZING FACTOR; EXPRESSION; PROTEOGLYCANS; FAMILY	A deficiency in chondroitin N-acetylgalactosaminyltransferase- 1 (ChGn-1) was previously shown to reduce the number of chondroitin sulfate (CS) chains, leading to skeletal dysplasias in mice, suggesting that ChGn-1 regulates the number of CS chains for normal cartilage development. Recently, we demonstrated that 2-phosphoxylose phosphatase (XYLP) regulates the number of CS chains by dephosphorylating the Xyl residue in the glycosaminoglycan-protein linkage region of proteoglycans. However, the relationship between ChGn-1 and XYLP in controlling the number of CS chains is not clear. In this study, we for the first time detected a phosphorylated tetrasaccharide linkage structure, GlcUA beta 1-3Gal beta 1-3Gal beta 1-4Xyl(2-O-phosphate), in ChGn-1(-/-) growth plate cartilage but not in ChGn-2(-/-) or wild-type growth plate cartilage. In contrast, the truncated linkage tetrasaccharide GlcUA beta 1-3Gal beta 1-3Gal beta 1-4Xyl was detected in wild-type, ChGn-1(-/-), and ChGn-2(-/-) growth plate cartilage. Consistent with the findings, ChGn-1 preferentially transferred N-acetylgalactosamine to the phosphorylated tetrasaccharide linkage in vitro. Moreover, ChGn-1 and XYLP interacted with each other, and ChGn-1-mediated addition of N-acetylgalactosamine was accompanied by rapid XYLP-dependent dephosphorylation during formation of the CS linkage region. Taken together, we conclude that the phosphorylated tetrasaccharide linkage is the preferred substrate for ChGn-1 and that ChGn-1 and XYLP cooperatively regulate the number of CS chains in growth plate cartilage.	[Izumikawa, Tomomi; Sato, Ban; Mikami, Tadahisa; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Tamura, Jun-ichi] Tottori Univ, Dept Reg Environm, Tottori 6808557, Japan; [Igarashi, Michihiro] Niigata Univ, Grad Sch Med & Dent Sci, Dept Neurochem & Mol Cell Biol, Chuo Ku, Niigata 9518510, Japan; [Igarashi, Michihiro] Niigata Univ, Trans Disciplinary Program, Chuo Ku, Niigata 9518510, Japan	Kobe Pharmaceutical University; Tottori University; Niigata University; Niigata University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Ministry of Education, Culture, Sports, Science and Technology, Japan [25293014, 24590132, 23110003]; Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [15K01823, 24590132] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research (B) 25293014 (to H. K.), for Scientific Research (C) 24590132 (to T. M.), and for Scientific Research on Innovative Areas 23110003 (to H. K.) and by the Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016 (to H. K.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Evers MR, 2001, J BIOL CHEM, V276, P36344, DOI 10.1074/jbc.M105848200; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Izumikawa T, 2012, BIOCHEM J, V441, P697, DOI 10.1042/BJ20111472; Izumikawa T, 2011, BIOCHEM J, V434, P321, DOI 10.1042/BJ20101456; Kang HG, 2002, J BIOL CHEM, V277, P34766, DOI 10.1074/jbc.M204907200; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Kitagawa H, 2014, BIOL PHARM BULL, V37, P1705, DOI 10.1248/bpb.b14-00613; Koike T, 2014, J BIOL CHEM, V289, P6695, DOI 10.1074/jbc.M113.520536; Koike T, 2009, BIOCHEM J, V421, P157, DOI 10.1042/BJ20090474; Mikami T, 2003, J BIOL CHEM, V278, P36115, DOI 10.1074/jbc.M306044200; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Miyata S, 2015, J BIOCHEM, V157, P13, DOI 10.1093/jb/mvu067; Nadanaka S, 1998, J BIOL CHEM, V273, P33728, DOI 10.1074/jbc.273.50.33728; Nadanaka S, 2014, MATRIX BIOL, V35, P18, DOI 10.1016/j.matbio.2013.10.010; Nadanaka S, 2013, J BIOL CHEM, V288, P9321, DOI 10.1074/jbc.M112.416909; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Saigoh K, 2011, J HUM GENET, V56, P143, DOI 10.1038/jhg.2010.148; Sakaguchi H, 2001, J BIOCHEM-TOKYO, V129, P107, DOI 10.1093/oxfordjournals.jbchem.a002820; Sakai K, 2007, J BIOL CHEM, V282, P4152, DOI 10.1074/jbc.M606870200; Sato T, 2011, J BIOL CHEM, V286, P5803, DOI 10.1074/jbc.M110.159244; SHIBATA S, 1992, J BIOL CHEM, V267, P6548; SUGAHARA K, 1992, EUR J BIOCHEM, V204, P401, DOI 10.1111/j.1432-1033.1992.tb16649.x; SUGAHARA K, 1989, BIOCHEM BIOPH RES CO, V162, P189, DOI 10.1016/0006-291X(89)91980-3; Takeuchi K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3740; Tamura J, 2002, BIOORG MED CHEM LETT, V12, P1901, DOI 10.1016/S0960-894X(02)00327-X; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; WATANABE H, 1995, BIOCHEM J, V308, P433, DOI 10.1042/bj3080433; Watanabe Y, 2010, BIOCHEM J, V432, P47, DOI 10.1042/BJ20100847; Yamauchi S, 2000, J BIOL CHEM, V275, P8975, DOI 10.1074/jbc.275.12.8975; Zeng-Brouwers J, 2014, MATRIX BIOL, V35, P132, DOI 10.1016/j.matbio.2013.12.003	36	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5438	5448		10.1074/jbc.M114.603266	http://dx.doi.org/10.1074/jbc.M114.603266			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568321	Green Published, hybrid			2022-12-26	WOS:000350044200017
J	Zhu, QS; Kao, LY; Azimov, R; Abuladze, N; Newman, D; Kurtz, I				Zhu, Quansheng; Kao, Liyo; Azimov, Rustam; Abuladze, Natalia; Newman, Debra; Kurtz, Ira			Interplay between Disulfide Bonding and N-Glycosylation Defines SLC4 Na+-coupled Transporter Extracellular Topography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-HCO3-COTRANSPORTER NBC1; ANION-EXCHANGER; PLASMA-MEMBRANE; IDENTIFICATION; TOPOLOGY; NBCE1-A; MUTAGENESIS; VARIANTS; MUTATION; ROLES	The extracellular loop 3 (EL-3) of SLC4 Na+-coupled transporters contains 4 highly conserved cysteines and multiple N-glycosylation consensus sites. In the electrogenic Na+-HCO3- cotransporter NBCe1-A, EL-3 is the largest extracellular loop and is predicted to consist of 82 amino acids. To determine the structural-functional importance of the conserved cysteines and the N-glycosylation sites in NBCe1-A EL-3, we analyzed the potential interplay between EL-3 disulfide bonding and N-glycosylation and their roles in EL-3 topological folding. Our results demonstrate that the 4 highly conserved cysteines form two intramolecular disulfide bonds, Cys(583)-Cys(585) and Cys(617)-Cys(642), respectively, that constrain EL-3 in a folded conformation. The formation of the second disulfide bond is spontaneous and unaffected by the N-glycosylation state of EL-3 or the first disulfide bond, whereas formation of the first disulfide bond relies on the presence of the second disulfide bond and is affected by N-glycosylation. Importantly, EL-3 from each monomer is adjacently located at the NBCe1-A dimeric interface. When the two disulfide bonds are missing, EL-3 adopts an extended conformation highly accessible to protease digestion. This unique adjacent parallel location of two symmetrically folded EL-3 loops from each monomer resembles a domain-like structure that is potentially important for NBCe1-A function in vivo. Moreover, the formation of this unique structure is critically dependent on the finely tuned interplay between disulfide bonding and N-glycosylation in the membrane processed NBCe1-A dimer.	[Zhu, Quansheng; Kao, Liyo; Azimov, Rustam; Abuladze, Natalia; Newman, Debra; Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zhu, QS (corresponding author), Univ Calif Los Angeles, Dept Med, 7-155 Factor Bldg,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	quzhu@mednet.ucla.edu			National Institutes of Health [DK077162]; Norman S. Coplon Grant from Satellite Healthcare; Factor Family Foundation; Allan Smidt Charitable Fund; Arvey Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norman S. Coplon Grant from Satellite Healthcare; Factor Family Foundation; Allan Smidt Charitable Fund; Arvey Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK077162 (to I. K.). This work was also supported by a Norman S. Coplon Grant from Satellite Healthcare (to Q. Z.) and by the Factor Family Foundation, the Allan Smidt Charitable Fund, and the Arvey Foundation (to I. K.).	Abuladze N, 2000, GENE, V251, P109, DOI 10.1016/S0378-1119(00)00204-3; Blum AP, 2011, J BIOL CHEM, V286, P32251, DOI 10.1074/jbc.M111.254235; Bok D, 2001, AM J PHYSIOL-RENAL, V281, pF920, DOI 10.1152/ajprenal.2001.281.5.F920; Brast S, 2012, FASEB J, V26, P976, DOI 10.1096/fj.11-180679; Choi I, 2003, AM J PHYSIOL-RENAL, V284, pF1199, DOI 10.1152/ajprenal.00131.2002; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Kao LY, 2008, J BIOL CHEM, V283, P26782, DOI 10.1074/jbc.M804006200; Kurtz I, 2013, SELDIN GIEBISCHS KID, P1837, DOI DOI 10.1016/B978-0-12-381462-3.00053-7; Kurtz I, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00350; Li HC, 2004, J BIOL CHEM, V279, P43190, DOI 10.1074/jbc.M405780200; Li HC, 2007, AM J PHYSIOL-RENAL, V292, pF1245, DOI 10.1152/ajprenal.00410.2006; Liu Y, 2011, GENOMICS, V98, P112, DOI 10.1016/j.ygeno.2011.04.010; Lu J, 2007, AM J PHYSIOL-CELL PH, V292, pC1787, DOI 10.1152/ajpcell.00267.2006; McAlear SD, 2006, J BIOL CHEM, V281, P32417, DOI 10.1074/jbc.M607253200; McAlear SD, 2006, J GEN PHYSIOL, V127, P639, DOI 10.1085/jgp.200609520; Parker MD, 2013, PHYSIOL REV, V93, P803, DOI 10.1152/physrev.00023.2012; Patterson ST, 2010, J BIOL CHEM, V285, P33423, DOI 10.1074/jbc.M110.144261; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Seki G, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00270; Suzuki M, 2010, P NATL ACAD SCI USA, V107, P15963, DOI 10.1073/pnas.1008705107; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Yang HS, 2009, J BIOL CHEM, V284, P15970, DOI 10.1074/jbc.M109.001438; Zhu Q., 2010, J AM SOC NEPHROL, V21, p251A; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004; Zhu QS, 2013, AM J PHYSIOL-CELL PH, V305, pC392, DOI 10.1152/ajpcell.00044.2013; Zhu QS, 2013, J BIOL CHEM, V288, P7894, DOI 10.1074/jbc.M112.404533; Zhu QS, 2010, J BIOL CHEM, V285, P37178, DOI 10.1074/jbc.M110.169201; Zhu QS, 2010, J BIOL CHEM, V285, P13416, DOI 10.1074/jbc.M109.093286; Zhu QS, 2009, J BIOL CHEM, V284, P8909, DOI 10.1074/jbc.M806674200	30	7	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5391	5404		10.1074/jbc.M114.619320	http://dx.doi.org/10.1074/jbc.M114.619320			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568315	Green Published, hybrid			2022-12-26	WOS:000350044200013
J	Liu, TY; Gong, W; Tan, ZJ; Lu, W; Wu, XS; Weng, H; Ding, Q; Shu, YJ; Bao, RF; Cao, Y; Wang, XA; Zhang, F; Li, HF; Xiang, SS; Jiang, L; Hu, YP; Mu, JS; Li, ML; Wu, WG; Shen, BY; Jiang, LX; Liu, YB				Liu, Tian-Yu; Gong, Wei; Tan, Zhu-Jun; Lu, Wei; Wu, Xiang-Song; Weng, Hao; Ding, Qian; Shu, Yi-Jun; Bao, Run-Fa; Cao, Yang; Wang, Xu-An; Zhang, Fei; Li, Huai-Feng; Xiang, Shan-Shan; Jiang, Lin; Hu, Yun-ping; Mu, Jia-Sheng; Li, Mao-Lan; Wu, Wen-Guang; Shen, Bai-Yong; Jiang, Li-Xin; Liu, Ying-Bin			Baicalein Inhibits Progression of Gallbladder Cancer Cells by Downregulating ZFX	PLOS ONE			English	Article							SELF-RENEWAL; CARCINOMA METASTASIS; PROTEOMIC ANALYSIS; IN-VIVO; PROLIFERATION; GROWTH; SCUTELLARIA; EXPRESSION; KNOCKDOWN; APOPTOSIS	Baicalein, a widely used Chinese herbal medicine, has multiple pharmacological activities. However, the precise mechanisms of the anti-proliferation and anti-metastatic effects of baicalein on gallbladder cancer (GBC) remain poorly understood. Therefore, the aim of this study was to assess the anti-proliferation and anti-metastatic effects of baicalein and the related mechanism(s) on GBC. In the present study, we found that treatment with baicalein induced a significant inhibitory effect on proliferation and promoted apoptosis in GBC-SD and SGC996 cells, two widely used gallbladder cancer cell lines. Additionally, treatment with baicalein inhibited the metastasis of GBC cells. Moreover, we demonstrated for the first time that baicalein inhibited GBC cell growth and metastasis via down-regulation of the expression level of Zinc finger protein X-linked (ZFX). In conclusion, our studies suggest that baicalein may be a potential phytochemical flavonoid for therapeutics of GBC and ZFX may serve as a molecular marker or predictive target for GBC.	[Liu, Tian-Yu; Gong, Wei; Tan, Zhu-Jun; Lu, Wei; Jiang, Lin; Hu, Yun-ping; Liu, Ying-Bin] Shanghai Jiao Tong Univ, Sch Med, Inst Biliary Tract Dis, Shanghai 200030, Peoples R China; [Liu, Tian-Yu; Gong, Wei; Tan, Zhu-Jun; Lu, Wei; Jiang, Lin; Hu, Yun-ping; Liu, Ying-Bin] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Lab Gen Surg, Shanghai 200030, Peoples R China; [Liu, Tian-Yu; Gong, Wei; Tan, Zhu-Jun; Lu, Wei; Wu, Xiang-Song; Weng, Hao; Ding, Qian; Shu, Yi-Jun; Bao, Run-Fa; Cao, Yang; Wang, Xu-An; Zhang, Fei; Li, Huai-Feng; Xiang, Shan-Shan; Jiang, Lin; Hu, Yun-ping; Mu, Jia-Sheng; Li, Mao-Lan; Wu, Wen-Guang; Liu, Ying-Bin] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Gen Surg, Shanghai 200092, Peoples R China; [Shen, Bai-Yong] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Gen Surg, Shanghai 200025, Peoples R China; [Jiang, Li-Xin] Jiangyin Hosp Tradit Chinese Med, Dept Gen Surg, Jiangyin, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Jiang, LX (corresponding author), Jiangyin Hosp Tradit Chinese Med, Dept Gen Surg, Jiangyin, Peoples R China.	15961665000@163.com; liuybphd@126.com	Liu, Yingbin/AAI-1919-2020; wang, xuan/GXF-3679-2022; LIU, YING/GZL-7252-2022	Liu, Yingbin/0000-0001-6110-0185; 	National Natural Science Foundation of China [81172026, 81272402, 81301816, 81172029]; National High Technology Research and Development Program (863 Program) [2012AA022606]; Foundation for Interdisciplinary research of Shanghai Jiao Tong University [YG2011ZD07]; Shanghai science and technology commission inter-governmental international cooperation project [12410705900]; Shanghai science and technology commission medical-guiding project [12401905800]; Natural Science Research Foundation of Shanghai Jiao Tong University School of Medicine [13XJ10037]; Sailing program of Shanghai science and technology commission [14YF1403000]; Specialized Research Foundation for Ph.D Program of Higher Education-Priority Development Field [20130073130014]; Program for Changjiang Scholars; Leading Talent program of Shanghai	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); Foundation for Interdisciplinary research of Shanghai Jiao Tong University; Shanghai science and technology commission inter-governmental international cooperation project; Shanghai science and technology commission medical-guiding project; Natural Science Research Foundation of Shanghai Jiao Tong University School of Medicine; Sailing program of Shanghai science and technology commission; Specialized Research Foundation for Ph.D Program of Higher Education-Priority Development Field; Program for Changjiang Scholars(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Leading Talent program of Shanghai	This study was supported by National Natural Science Foundation of China (No. 81172026, 81272402, 81301816 and 81172029), National High Technology Research and Development Program (863 Program) (No. 2012AA022606), Foundation for Interdisciplinary research of Shanghai Jiao Tong University (No. YG2011ZD07), Shanghai science and technology commission inter-governmental international cooperation project (No. 12410705900), Shanghai science and technology commission medical-guiding project (No. 12401905800), Program for Changjiang Scholars, Natural Science Research Foundation of Shanghai Jiao Tong University School of Medicine (No. 13XJ10037), Leading Talent program of Shanghai, Sailing program of Shanghai science and technology commission (14YF1403000) and Specialized Research Foundation for Ph.D Program of Higher Education-Priority Development Field (No. 20130073130014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 1999, ONCOGENE, V18, P6477, DOI 10.1038/sj.onc.1203067; Akiyoshi S, 2012, BRIT J CANCER, V107, P1345, DOI 10.1038/bjc.2012.326; Buttar NS, 2006, CURR OPIN GASTROEN, V22, P505, DOI 10.1097/01.mog.0000239864.73962.db; Cellot S, 2007, CELL, V129, P239, DOI 10.1016/j.cell.2007.04.002; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Chen JC, 2013, INT J MOL SCI, V14, P6012, DOI 10.3390/ijms14036012; Cheng YH, 2012, TOXICOL APPL PHARM, V263, P360, DOI 10.1016/j.taap.2012.07.010; Dong P, 2011, CHINESE MED J-PEKING, V124, P4236, DOI 10.3760/cma.j.issn.0366-6999.2011.24.021; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Harel S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042302; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Huang WS, 2012, PROTEOMICS, V12, P810, DOI 10.1002/pmic.201100270; KIMURA Y, 1981, CHEM PHARM BULL, V29, P2308; Li K, 2013, INT J CLIN EXP PATHO, V6, P2460; Li ML, 2013, TUMOR BIOL, V34, P3995, DOI 10.1007/s13277-013-0988-4; Li ML, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0587-7; Li-Weber M, 2009, CANCER TREAT REV, V35, P57, DOI 10.1016/j.ctrv.2008.09.005; Lin CC, 1996, AM J CHINESE MED, V24, P31, DOI 10.1142/S0192415X96000050; Liu TY, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-64; Ma GZ, 2013, INFLAMMATION, V36, P457, DOI 10.1007/s10753-012-9566-y; Miller G, 2008, EJSO-EUR J SURG ONC, V34, P306, DOI 10.1016/j.ejso.2007.07.206; Naveenkumar C, 2013, BASIC CLIN PHARMACOL, V112, P270, DOI 10.1111/bcpt.12025; Ohashi K, 2000, CANCER-AM CANCER SOC, V88, P2201, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2201::AID-CNCR2>3.3.CO;2-E; Orrenius S, 2004, TOXICOL LETT, V149, P19, DOI 10.1016/j.toxlet.2003.12.017; Quan ZW, 2010, CANCER LETT, V295, P252, DOI 10.1016/j.canlet.2010.03.008; SHIMA I, 1992, CANCER, V70, P2747, DOI 10.1002/1097-0142(19921215)70:12<2747::AID-CNCR2820701204>3.0.CO;2-5; Shimada K, 2011, BRIT J SURG, V98, P117, DOI 10.1002/bjs.7262; Tan ZJ, 2013, GENE, V528, P261, DOI 10.1016/j.gene.2013.06.064; Tan ZJ, 2012, MOL CELL BIOCHEM, V369, P27, DOI 10.1007/s11010-012-1365-0; Wang JD, 2011, MED ONCOL, V28, pS295, DOI 10.1007/s12032-010-9758-y; Wang JW, 2009, CANCER LETT, V281, P71, DOI 10.1016/j.canlet.2009.02.020; Wu S, 2013, CANCER LETT, V337, P293, DOI 10.1016/j.canlet.2013.04.003; Yu SY, 2011, BLOOD, V117, P2166, DOI 10.1182/blood-2010-09-306563; Zha WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074175; Zhang ZP, 2012, PHYTOTHER RES, V26, P932, DOI 10.1002/ptr.3657	35	140	147	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0114851	10.1371/journal.pone.0114851	http://dx.doi.org/10.1371/journal.pone.0114851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617627	Green Published, Green Submitted, gold			2022-12-26	WOS:000350336000003
J	Kobayashi, S; Susa, T; Ishiguchi, H; Myoren, T; Murakami, W; Kato, T; Fukuda, M; Hino, A; Suetomi, T; Ono, M; Uchinoumi, H; Tateishi, H; Mochizuki, M; Oda, T; Okuda, S; Doi, M; Yamamoto, T; Yano, M				Kobayashi, Shigeki; Susa, Takehisa; Ishiguchi, Hironori; Myoren, Takeki; Murakami, Wakako; Kato, Takayoshi; Fukuda, Masakazu; Hino, Akihiro; Suetomi, Takeshi; Ono, Makoto; Uchinoumi, Hitoshi; Tateishi, Hiroki; Mochizuki, Mamoru; Oda, Tetsuro; Okuda, Shinichi; Doi, Masahiro; Yamamoto, Takeshi; Yano, Masafumi			A Low-Dose beta 1-Blocker in Combination with Milrinone Improves Intracellular Ca2+ Handling in Failing Cardiomyocytes by Inhibition of Milrinone-Induced Diastolic Ca2+ Leakage from the Sarcoplasmic Reticulum	PLOS ONE			English	Article							CHANNEL RYANODINE RECEPTOR; CALCIUM CYCLING PROTEINS; ACUTE HEART-FAILURE; FKBP12.6-MEDIATED STABILIZATION; INTERDOMAIN INTERACTIONS; DILATED CARDIOMYOPATHY; MECHANICAL ALTERNANS; THERAPEUTIC STRATEGY; DEFECTIVE REGULATION; PULSUS ALTERNANS	Objectives The purpose of this study was to investigate whether adding a low-dose beta 1-blocker to milrinone improves cardiac function in failing cardiomyocytes and the underlying cardioprotective mechanism. Background The molecular mechanism underlying how the combination of low-dose beta 1-blocker and milrinone affects intracellular Ca2+ handling in heart failure remains unclear. Methods We investigated the effect of milrinone plus landiolol on intracellular Ca2+ transient (CaT), cell shortening (CS), the frequency of diastolic Ca2+ sparks (CaSF), and sarcoplasmic reticulum Ca2+ concentration ({Ca2+}(SR)) in normal and failing canine cardiomyocytes and used immunoblotting to determine the phosphorylation level of ryanodine receptor (RyR2) and phospholamban (PLB). Results In failing cardiomyocytes, CaSF significantly increased, and peak CaT and CS markedly decreased compared with normal myocytes. Administration of milrinone alone slightly increased peak CaT and CS, while CaSF greatly increased with a slight increase in {Ca2+}(SR). Co-administration of beta 1-blocker landiolol to failing cardiomyocytes at a dose that does not inhibit cardiomyocyte function significantly decreased CaSF with a further increase in {Ca2+}(SR), and peak CaT and CS improved compared with milrinone alone. Landiolol suppressed the hyperphosphorylation of RyR2 (Ser2808) in failing cardiomyocytes but had no effect on levels of phosphorylated PLB (Ser16 and Thr17). Low-dose landiolol significantly inhibited the alternans of CaT and CS under a fixed pacing rate (0.5 Hz) in failing cardiomyocytes. Conclusion A low-dose beta 1-blocker in combination with milrinone improved cardiac function in failing cardiomyocytes, apparently by inhibiting the phosphorylation of RyR2, not PLB, and subsequent diastolic Ca2+ leak.	[Kobayashi, Shigeki; Susa, Takehisa; Ishiguchi, Hironori; Myoren, Takeki; Murakami, Wakako; Kato, Takayoshi; Fukuda, Masakazu; Hino, Akihiro; Suetomi, Takeshi; Ono, Makoto; Uchinoumi, Hitoshi; Tateishi, Hiroki; Mochizuki, Mamoru; Oda, Tetsuro; Okuda, Shinichi; Doi, Masahiro; Yamamoto, Takeshi; Yano, Masafumi] Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, Div Cardiol, Ube, Yamaguchi 755, Japan	Yamaguchi University	Kobayashi, S (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, Div Cardiol, Ube, Yamaguchi 755, Japan.	skoba@yamaguchi-u.ac.jp	Okuda, Shinichi/AAG-8968-2020; ishiguchi, hironori/AAK-9793-2020	Okuda, Shinichi/0000-0003-2639-5373; Suetomi, Takeshi/0000-0002-5257-9865; Kato, Takayoshi/0000-0001-9723-242X	Ministry of Education in Japan [23592256, 23390215]; Takeda Science Foundation in Japan; SENSHIN Medical Research Foundation; Grants-in-Aid for Scientific Research [26293189] Funding Source: KAKEN	Ministry of Education in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation in Japan(Takeda Science Foundation (TSF)); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by grants-in-aid for scientific research from the Ministry of Education in Japan (Grant No. 23592256 to SK and Grant No. 23390215 to MY), grant from Takeda Science Foundation in Japan to SK, and grant from SENSHIN Medical Research Foundation to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG PW, 1986, CIRCULATION, V74, P1075, DOI 10.1161/01.CIR.74.5.1075; Baartscheer A, 2003, CARDIOVASC RES, V58, P99, DOI 10.1016/S0008-6363(02)00854-4; Dobrev D, 2014, CIRC RES, V114, P1311, DOI 10.1161/CIRCRESAHA.114.300568; Dodge-Kafka KL, 2006, CIRC RES, V98, P993, DOI 10.1161/01.RES.0000218273.91741.30; Doi M, 2002, CIRCULATION, V105, P1374, DOI 10.1161/hc1102.105270; ENDOH M, 1986, CIRCULATION, V73, P117; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; GWATHMEY JK, 1985, BRIT J PHARMACOL, V85, P97, DOI 10.1111/j.1476-5381.1985.tb08835.x; Gyorke S, 2008, PHARMACOL THERAPEUT, V119, P340, DOI 10.1016/j.pharmthera.2008.06.002; Hasenfuss G, 1996, BASIC RES CARDIOL, V91, P17, DOI 10.1007/BF00795357; Hirashiki A, 2006, J AM COLL CARDIOL, V47, P1382, DOI 10.1016/j.jacc.2005.10.069; Ikeshita K, 2008, J ANESTH, V22, P361, DOI 10.1007/s00540-008-0640-4; INOUE H, GUIDELINE PHARM ATRI; Kapiloff MS, 2002, MOL PHARMACOL, V62, P193, DOI 10.1124/mol.62.2.193; KIHARA Y, 1991, AM J PHYSIOL, V261, pH1746, DOI 10.1152/ajpheart.1991.261.6.H1746; Kobayashi S, 2014, CARDIOLOGY, V127, P105, DOI 10.1159/000355312; Kobayashi S, 2012, CIRC J, V76, P1646, DOI 10.1253/circj.CJ-12-0033; Kobayashi S, 2009, J AM COLL CARDIOL, V53, P1993, DOI 10.1016/j.jacc.2009.01.065; Lowes BD, 2001, INT J CARDIOL, V81, P141, DOI 10.1016/S0167-5273(01)00520-4; Maack K, 2001, BRIT J PHARMACOL, V132, P1817, DOI 10.1038/sj.bjp.0703992; Maier LS, 2003, CIRC RES, V92, P904, DOI 10.1161/01.RES.0000069685.20258.F1; Majure DT, 2011, CURR TREAT OPT CARD, V13, P570, DOI DOI 10.1007/S11936-011-0149-2; MANN DL, 1992, CIRCULATION, V85, P790, DOI 10.1161/01.CIR.85.2.790; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Maytin M, 2005, AM J CARDIOL, V96, p26G, DOI 10.1016/j.amjcard.2005.07.018; McCauley MD, 2011, ACTA PHARMACOL SIN, V32, P749, DOI 10.1038/aps.2011.44; Mochizuki M, 2007, J AM COLL CARDIOL, V49, P1722, DOI 10.1016/j.jacc.2007.01.064; MULIERI LA, 1992, CIRCULATION, V85, P1743, DOI 10.1161/01.CIR.85.5.1743; Nagai R, 2013, CIRC J, V77, P908, DOI 10.1253/circj.CJ-12-1618; Oda T, 2005, CIRCULATION, V111, P3400, DOI 10.1161/CIRCULATIONAHA.104.507921; RYAN JM, 1956, CIRCULATION, V14, P1099, DOI 10.1161/01.CIR.14.6.1099; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Thomas SS, 2012, CIRC J, V76, P278, DOI 10.1253/circj.CJ-11-1441; Uchinoumi H, 2010, CIRC RES, V106, DOI 10.1161/CIRCRESAHA.109.209312; Xiao BL, 2006, BIOCHEM J, V396, P7, DOI 10.1042/BJ20060116; Yamada M, 2006, FASEB J, V20, P1197, DOI 10.1096/fj.05-5299fje; Yamamoto T, 2008, CIRCULATION, V117, P762, DOI 10.1161/CIRCULATIONAHA.107.718957; Yano M, 2005, J CLIN INVEST, V115, P556, DOI 10.1172/JCI200524159; Yano M, 2005, CIRCULATION, V112, P3633, DOI 10.1161/CIRCULATIONAHA.105.555623; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE; Yoshida Y, 2005, ANESTH ANALG, V100, P294, DOI 10.1213/01.ANE.0000140814.28118.6F; Yoshida Y, 2008, J ANESTH, V22, P64, DOI 10.1007/s00540-007-0573-3; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5	45	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0114314	10.1371/journal.pone.0114314	http://dx.doi.org/10.1371/journal.pone.0114314			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25614983	Green Published, gold, Green Submitted			2022-12-26	WOS:000349122100003
J	Noman, N; Monjo, T; Moscato, P; Iba, H				Noman, Nasimul; Monjo, Taku; Moscato, Pablo; Iba, Hitoshi			Evolving Robust Gene Regulatory Networks	PLOS ONE			English	Article							TOGGLE SWITCH; EVOLUTION; OSCILLATIONS; GENERATION; DYNAMICS; BEHAVIOR; DESIGN	Design and implementation of robust network modules is essential for construction of complex biological systems through hierarchical assembly of 'parts' and 'devices'. The robustness of gene regulatory networks (GRNs) is ascribed chiefly to the underlying topology. The automatic designing capability of GRN topology that can exhibit robust behavior can dramatically change the current practice in synthetic biology. A recent study shows that Darwinian evolution can gradually develop higher topological robustness. Subsequently, this work presents an evolutionary algorithm that simulates natural evolution in silico, for identifying network topologies that are robust to perturbations. We present a Monte Carlo based method for quantifying topological robustness and designed a fitness approximation approach for efficient calculation of topological robustness which is computationally very intensive. The proposed framework was verified using two classic GRN behaviors: oscillation and bistability, although the framework is generalized for evolving other types of responses. The algorithm identified robust GRN architectures which were verified using different analysis and comparison. Analysis of the results also shed light on the relationship among robustness, cooperativity and complexity. This study also shows that nature has already evolved very robust architectures for its crucial systems; hence simulation of this natural process can be very valuable for designing robust biological systems.	[Noman, Nasimul; Moscato, Pablo] Univ Newcastle, Prior Res Ctr Bioinformat Biomarker Discovery & I, Newcastle, NSW 2300, Australia; [Noman, Nasimul; Moscato, Pablo] Univ Newcastle, Fac Engn & Built Environm, Sch Elect Engn & Comp Sci, Newcastle, NSW 2300, Australia; [Monjo, Taku] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba, Japan; [Iba, Hitoshi] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Informat & Commun Engn, Bunkyo Ku, Tokyo, Japan	University of Newcastle; University of Newcastle; University of Tokyo; University of Tokyo	Noman, N (corresponding author), Univ Newcastle, Prior Res Ctr Bioinformat Biomarker Discovery & I, Newcastle, NSW 2300, Australia.	nasimul.noman@newcastle.edu.au	MOSCATO, PABLO ALBERTO/G-7668-2013	Moscato, Pablo/0000-0003-2570-5966; Noman, Nasimul/0000-0002-8566-0870	 [23119009]		This work was supported by Research Project Number: 23119009 (http://kaken.nii.ac.jp/d/p/23119009.en.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Benitez M, 2010, BIOSYSTEMS, V102, P11, DOI 10.1016/j.biosystems.2010.07.007; Cao Hongqing, 2010, Syst Synth Biol, V4, P55, DOI 10.1007/s11693-009-9050-7; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Conrad E, 2008, J R SOC INTERFACE, V5, pS9, DOI 10.1098/rsif.2008.0046.focus; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Donze A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024246; DRENNAN B, 2006, ARTIF LIFE, P22; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Evans DM, 2013, ECOL LETT, V16, P844, DOI 10.1111/ele.12117; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Francois P, 2004, P NATL ACAD SCI USA, V101, P580, DOI 10.1073/pnas.0304532101; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Graudenzi A, 2011, J COMPUT BIOL, V18, P559, DOI 10.1089/cmb.2010.0224; Gunawan R, 2006, BIOPHYS J, V91, P2131, DOI 10.1529/biophysj.105.078006; Hache H, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/617281; Hilgers V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000396; Holme P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016605; Hsiao TL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000014; Jostins L, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-17; Karlsson M, 2012, CURR OPIN BIOTECH, V23, P703, DOI 10.1016/j.copbio.2012.01.003; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kitano H, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100039; Kwok R, 2010, NATURE, V463, P288, DOI 10.1038/463288a; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; MacNeil LT, 2011, GENOME RES, V21, P645, DOI 10.1101/gr.097378.109; Masuda M, 2013, MOL ONCOL, V7, P14, DOI 10.1016/j.molonc.2012.10.009; Mendes P, 2003, BIOINFORMATICS, V19, pII122, DOI 10.1093/bioinformatics/btg1069; Montagne K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.120; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Noman N, 2013, NEW GENERAT COMPUT, V31, P71, DOI 10.1007/s00354-013-0201-8; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Paladugu SR, 2006, IEE P SYST BIOL, V153, P223, DOI 10.1049/ip-syb:20050096; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Plata G, 2014, NUCLEIC ACIDS RES, V42, P2405, DOI 10.1093/nar/gkt1200; Qiu YF, 2012, J IMMUNOL, V188, P3940, DOI 10.4049/jimmunol.1103053; Rizk A, 2009, BIOINFORMATICS, V25, pI169, DOI 10.1093/bioinformatics/btp200; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Staniczenko PPA, 2010, ECOL LETT, V13, P891, DOI 10.1111/j.1461-0248.2010.01485.x; Tenne Y, 2010, ADAPT LEARN OPTIM, V2, P1, DOI 10.1007/978-3-642-10701-6; Tian TH, 2011, INTEGR BIOL-UK, V3, P17, DOI 10.1039/c0ib00046a; van Dijk ADJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030591; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Wagner GP., 2005, ROBUSTNESS EVOLVABIL; Wilkins AK, 2009, SIAM J SCI COMPUT, V31, P2706, DOI 10.1137/070707129; Zheng LL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003901; Zhu XY, 1996, IEEE DECIS CONTR P, P3412, DOI 10.1109/CDC.1996.573688	53	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116258	10.1371/journal.pone.0116258	http://dx.doi.org/10.1371/journal.pone.0116258			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25616055	Green Submitted, Green Published, gold			2022-12-26	WOS:000349122100024
J	Chen, YT; Tang, HJ; Chao, CM; Lai, CC				Chen, Yen-Ting; Tang, Hung-Jen; Chao, Chien-Ming; Lai, Chih-Cheng			Clinical Manifestations of Non-01 Vibrio cholerae Infections	PLOS ONE			English	Article							UNITED-STATES; SEPTICEMIA; CHOLECYSTITIS; PATIENT; ABSCESS	Background Infections caused by non-01 Vibrio cholera are uncommon. The aim of our study was to investigate the clinical and microbiological characteristics of patients with non-01 V. cholera infections. Methods The clinical charts of all patients with non-01 V. cholera infections and who were treated in two hospitals in Taiwan were retrospectively reviewed. Results From July 2009 to June 2014, a total of 83 patients with non-01 V. cholera infections were identified based on the databank of the bacteriology laboratories of two hospitals. The overall mean age was 53.3 years, and men comprised 53 (63.9%) of the patients. Liver cirrhosis and diabetes mellitus were the two most common underlying diseases, followed by malignancy. The most common type of infection was acute gastroenteritis (n = 45, 54.2%), followed by biliary tract infection (n = 12, 14.5%) and primary bacteremia (n = 11, 13.3%). Other types of infection, such as peritonitis (n = 5, 6.0%), skin and soft tissue infection (SSTI) (n = 5, 6.0%), urinary tract infection (n = 3, 3.6%) and pneumonia (2, 2.4%), were rare. July and June were the most common months of occurrence of V. cholera infections. The overall in-hospital mortality of 83 patients with V. cholera infections was 7.2%, but it was significantly higher for patients with primary bacteremia, hemorrhage bullae, acute kidney injury, acute respiratory failure, or admission to an ICU. Furthermore, multivariate analysis showed that in-hospital mortality was significantly associated with acute respiratory failure (odds ratio, 60.47; 95% CI, 4.79-763.90, P = 0.002). Conclusions Non-01 V. cholera infections can cause protean disease, especially in patients with risk factors and during warm-weather months. The overall mortality of 83 patients with non-01 V. cholera infections was only 7.2%; however, this value varied among different types of infection.	[Chen, Yen-Ting] Chi Mei Med Ctr, Dept Emergency Med, Tainan, Taiwan; [Tang, Hung-Jen] Chi Mei Med Ctr, Dept Med, Tainan, Taiwan; [Tang, Hung-Jen] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan; [Lai, Chih-Cheng] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan	Chi Mei Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital	Lai, CC (corresponding author), Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan.	dtmed141@gmail.com		Chen, Yen Ting/0000-0001-8251-263X				Aguinaga A, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-17; BLAKE PA, 1979, NEW ENGL J MED, V300, P1, DOI 10.1056/NEJM197901043000101; Cavuoti D, 2002, DIAGN MICR INFEC DIS, V43, P311, DOI 10.1016/S0732-8893(02)00412-1; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Dechet AM, 2008, CLIN INFECT DIS, V46, P970, DOI 10.1086/529148; JANDA J M, 1988, Clinical Microbiology Reviews, V1, P245; Kerketta Joshi Anand, 2002, Indian Journal of Pediatrics, V69, P909, DOI 10.1007/BF02723720; Ko WC, 1998, CLIN INFECT DIS, V27, P774, DOI 10.1086/514947; Lai CC, 2012, DIAGN MICR INFEC DIS, V73, P84, DOI 10.1016/j.diagmicrobio.2012.01.011; Lai CC, 2011, J INFECTION, V62, P235, DOI 10.1016/j.jinf.2011.01.011; Lin CJ, 1996, AM J GASTROENTEROL, V91, P336; Liou CW, 2001, EUR J CLIN MICROBIOL, V20, P678, DOI 10.1007/s100960100569; Nishikawa M, 1989, Nihon Geka Hokan, V58, P155; PETSARIS O, 2010, J MED MICROBIOL; Sangare L, 2006, Med Trop (Mars), V66, P513; Shannon JD, 2006, J CLIN MICROBIOL, V44, P3459, DOI 10.1128/JCM.02343-05; TACKET CO, 1984, J INFECT DIS, V149, P558, DOI 10.1093/infdis/149.4.558; Vogt AP, 2010, J CLIN MICROBIOL, V48, P1002, DOI 10.1128/JCM.02198-09; West BC, 1998, DIAGN MICR INFEC DIS, V30, P187, DOI 10.1016/S0732-8893(97)00235-6; Wiwatworapan Weerapan, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P1098; Yang CC, 2008, JPN J INFECT DIS, V61, P475	21	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116904	10.1371/journal.pone.0116904	http://dx.doi.org/10.1371/journal.pone.0116904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602257	Green Published, gold, Green Submitted			2022-12-26	WOS:000348203500035
J	Greaves, NS; Morris, J; Benatar, B; Alonso-Rasgado, T; Baguneid, M; Bayat, A				Greaves, Nicholas S.; Morris, Julie; Benatar, Brian; Alonso-Rasgado, Teresa; Baguneid, Mohamed; Bayat, Ardeshir			Acute Cutaneous Wounds Treated with Human Decellularised Dermis Show Enhanced Angiogenesis during Healing	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXTRACELLULAR-MATRIX; PROMOTES ANGIOGENESIS; GENE-EXPRESSION; LUMEN FORMATION; MECHANISMS; ULCERS; CELLS; MORPHOGENESIS; RECEPTORS	Background The influence of skin substitutes upon angiogenesis during wound healing is unclear. Objectives To compare the angiogenic response in acute cutaneous human wounds treated with autogenic, allogenic and xenogenic skin substitutes to those left to heal by secondary intention. Methods On day 0, four 5mm full-thickness punch biopsies were harvested from fifty healthy volunteers (sites 1-4). In all cases, site 1 healed by secondary intention (control), site 2 was treated with collagen-GAG scaffold (CG), cadaveric decellularised dermis (DCD) was applied to site 3, whilst excised tissue was re-inserted into site 4 (autograft). Depending on study group allocation, healing tissue from sites 1-4 was excised on day 7, 14, 21 or 28. All specimens were bisected, with half used in histological and immunohistochemical evaluation whilst extracted RNA from the remainder enabled whole genome microarrays and qRT-PCR of highlighted angiogenesis-related genes. All wounds were serially imaged over 6 weeks using laser-doppler imaging and spectrophotometric intracutaneous analysis. Results Inherent structural differences between skin substitutes influenced the distribution and organisation of capillary networks within regenerating dermis. Haemoglobin flux (p = 0.0035), oxyhaemoglobin concentration (p = 0.0005), and vessel number derived from CD31-based immunohistochemistry (p = 0.046) were significantly greater in DCD wounds at later time points. This correlated with time-matched increases in mRNA expression of membrane-type 6 matrix metalloproteinase (MT6-MMP) (p = 0.021) and prokineticin 2 (PROK2) (p = 0.004). Conclusion Corroborating evidence from invasive and non-invasive modalities demonstrated that treatment with DCD resulted in increased angiogenesis after wounding. Significantly elevated mRNA expression of pro-angiogenic PROK2 and extracellular matrix protease MT6-MMP seen only in the DCD group may contribute to observed responses.	[Greaves, Nicholas S.; Bayat, Ardeshir] Univ Manchester, MIB, Manchester, Lancs, England; [Greaves, Nicholas S.; Morris, Julie; Baguneid, Mohamed] Wythenshawe Hosp, Univ Hosp, South Manchester NHS Fdn Trust, Manchester M23 9LT, Lancs, England; [Benatar, Brian] Royal Oldham Hosp, Pennine Acute Hosp NHS Trust, Dept Histopathol, Oldham, Lancs, England; [Alonso-Rasgado, Teresa] Univ Manchester, Sch Mat, Manchester, Lancs, England; [Bayat, Ardeshir] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Ctr Dermatol,Inst Inflammat & Repair, Manchester, Lancs, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; University of Manchester	Greaves, NS (corresponding author), Univ Manchester, MIB, Manchester, Lancs, England.	nickgreaves@doctors.org.uk; ardeshir.bayat@manchester.ac.uk		Baguneid, Mohamed/0000-0002-3819-4993; BAYAT, ARDESHIR/0000-0002-4116-6491	Tissue Regenix Group plc (York, UK)	Tissue Regenix Group plc (York, UK)	This study was in part funded by the Tissue Regenix Group plc (York, UK) to AB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remainder of the funds for this study were sourced from existing internal budgets.	ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J; Brigido Stephen A, 2006, Int Wound J, V3, P181, DOI 10.1111/j.1742-481X.2006.00209.x; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Davis GE, 2003, MICROCIRCULATION, V10, P27, DOI 10.1038/sj.mn.7800175; Davis George E., 2007, Birth Defects Research, V81, P270, DOI 10.1002/bdrc.20107; Dengler VL, 2013, CRITICAL REV BIOCH M, P1; Di Peppe SR, 2002, GENE THER, V9, P1271, DOI 10.1038/sj.gt.3301798; Drinkwater SL, 2003, J VASC SURG, V38, P1106, DOI 10.1016/S0741-5214(03)01053-X; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Greaves NS, 2013, WOUND REPAIR REGEN, V21, P813, DOI 10.1111/wrr.12113; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Guilini C, 2010, AM J PHYSIOL-HEART C, V298, pH844, DOI 10.1152/ajpheart.00898.2009; Hogg P, 2012, CELL TISSUE BANK, P1; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Jones JE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001737.pub4; Kisliouk T, 2005, ENDOCRINOLOGY, V146, P3950, DOI 10.1210/en.2005-0297; Ko J, 2005, J SURG RES, V129, P251, DOI 10.1016/j.jss.2005.05.006; La Ferla K, 2002, FASEB J, V16, P1811, DOI 10.1096/fj.02-0168fje; Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093; LeCouter J, 2003, P NATL ACAD SCI USA, V100, P2685, DOI 10.1073/pnas.0337667100; Liechty KW, 1998, J SURG RES, V77, P80, DOI 10.1006/jsre.1998.5345; Lindenblatt N, 2008, PLAST RECONSTR SURG, V122, P1669, DOI 10.1097/PRS.0b013e31818cbeb1; Liu W, 2004, CURR GENE THER, V4, P123, DOI 10.2174/1566523044578004; Mace KA, 2007, WOUND REPAIR REGEN, V15, P636, DOI 10.1111/j.1524-475X.2007.00278.x; Macri L, 2009, SKIN PHARMACOL PHYS, V22, P83, DOI 10.1159/000178867; Makino Y, 2007, J BIOL CHEM, V282, P14073, DOI 10.1074/jbc.M700732200; Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042; O'Ceallaigh S, 2006, PLAST RECONSTR SURG, V117, P140, DOI 10.1097/01.prs.0000185611.87601.b8; Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007; Reiffel AJ, 2011, PLASTIC RECONSTRUCTI, V128, P37, DOI [10.1097/01.prs.0000406253.95834.01, DOI 10.1097/01.PRS.0000406253.95834.01]; Reyzelman A, 2009, INT WOUND J, V6, P196, DOI 10.1111/j.1742-481X.2009.00585.x; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Shaterian A, 2009, BURNS, V35, P811, DOI 10.1016/j.burns.2008.12.012; Shih B, 2012, WOUND REPAIR REGEN, V20, P757, DOI 10.1111/j.1524-475X.2012.00832.x; Soga T, 2002, BBA-GENE STRUCT EXPR, V1579, P173, DOI 10.1016/S0167-4781(02)00546-8; Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002; Supp DM, 2002, FASEB J, V16, DOI 10.1096/fj.01-0868com; Syeda MM, 2012, AM J PATHOL, V181, P334, DOI 10.1016/j.ajpath.2012.03.012; Tanaka T, 2009, BIOCHEM J, V424, P143, DOI 10.1042/BJ20090120; Tonnesen MG, 2000, J INVESTIGATIVE DERM; Truong ATN, 2005, J BURNS WOUNDS, V4; VERNON RB, 1995, AM J PATHOL, V147, P873; Winters Christopher L, 2008, Adv Skin Wound Care, V21, P375, DOI 10.1097/01.ASW.0000323532.98003.26	46	40	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0113209	10.1371/journal.pone.0113209	http://dx.doi.org/10.1371/journal.pone.0113209			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602294	Green Published, gold, Green Submitted			2022-12-26	WOS:000348203500001
J	Pan, SH; Chen, WJ; Liu, X; Xiao, JJ; Wang, YQ; Liu, J; Du, Y; Wang, YS; Zhang, Y				Pan, Shaohui; Chen, Wuju; Liu, Xu; Xiao, Jiajia; Wang, Yanqin; Liu, Jun; Du, Yue; Wang, Yongsheng; Zhang, Yong			Application of a Novel Population of Multipotent Stem Cells Derived from Skin Fibroblasts as Donor Cells in Bovine SCNT	PLOS ONE			English	Article							BONE-MARROW; NUCLEAR TRANSFER; IN-VITRO; CLONING EFFICIENCY; CORD BLOOD; PLURIPOTENT; EMBRYOS; GENERATION; DIFFERENTIATION; SUBPOPULATION	Undifferentiated stem cells are better donor cells for somatic cell nuclear transfer (SCNT), resulting in more offspring than more differentiated cells. While various stem cell populations have been confirmed to exist in the skin, progress has been restricted due to the lack of a suitable marker for their prospective isolation. To address this fundamental issue, a marker is required that could unambiguously prove the differentiation state of the donor cells. We therefore utilized magnetic activated cell sorting (MACS) to separate a homogeneous population of small SSEA-4(+) cells from a heterogeneous population of bovine embryonic skin fibroblasts (BEF). SSEA-4(+) cells were 8-10 mu m in diameter and positive for alkaline phosphatase (AP). The percentage of SSEA-4(+) cells within the cultured BEF population was low (2-3%). Immunocytochemistry and PCR analyses revealed that SSEA-4(+) cells expressed pluripotency-related markers, and could differentiate into cells comprising all three germ layers in vitro. They remained undifferentiated over 20 passages in suspension culture. In addition, cloned embryos derived from SSEA-4 cells showed significant differences in cleavage rate and blastocyst development when compared with those from BEF and SSEA-4(-) cells. Moreover, blastocysts derived from SSEA-4(+) cells showed a higher total cell number and lower apoptotic index as compared to BEF and SSEA-4(-) derived cells. It is well known that nuclei from pluripotent stem cells yield a higher cloning efficiency than those from adult somatic cells, however, pluripotent stem cells are relatively difficult to obtain from bovine. The SSEA-4(+) cells described in the current study provide an attractive candidate for SCNT and a promising platform for the generation of transgenic cattle.	[Pan, Shaohui; Chen, Wuju; Liu, Xu; Xiao, Jiajia; Wang, Yanqin; Liu, Jun; Du, Yue; Wang, Yongsheng; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Pan, Shaohui; Chen, Wuju; Liu, Xu; Xiao, Jiajia; Wang, Yanqin; Liu, Jun; Du, Yue; Wang, Yongsheng; Zhang, Yong] Northwest A&F Univ, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Zhang, Y (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	wangyongsheng01@nwsuaf.edu.cn; zhy1956@263.net			Northwest A&F University PhD Research Start-up Funds [Z1110213030]; National Major Project for Production of Transgenic Breeding [2013ZX08007-004]; National High Technology Research and Development Program of China (863 Program) [2011AA100303]	Northwest A&F University PhD Research Start-up Funds; National Major Project for Production of Transgenic Breeding; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the Northwest A&F University PhD Research Start-up Funds (No. Z1110213030), the National Major Project for Production of Transgenic Breeding (No. 2013ZX08007-004) and the National High Technology Research and Development Program of China (863 Program) (No. 2011AA100303).	Afrikanova I, 2012, BIORESEARCH OPEN ACC, V1, P184, DOI 10.1089/biores.2012.0235; Barraud P, 2007, J NEUROSCI RES, V85, P250, DOI 10.1002/jnr.21116; Beltrami AR, 2007, BLOOD, V110, P3438, DOI 10.1182/blood-2006-11-055566; Bhartiya D, 2012, STEM CELLS DEV, V21, P2563, DOI 10.1089/scd.2012.0158; Byrne JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007118; Cao H., 2012, SPACECR RECOVER REMO, V3, P7, DOI DOI 10.1371/J0URNAL.P0NE.0031502; Cao HG, 2011, REPROD FERT DEVELOP, V23, P243, DOI 10.1071/RDv23n1Ab290; CHINNICI CM, 2013, CELL TRANSPLANTATION; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; Dyce PW, 2006, NAT CELL BIOL, V8, P384, DOI 10.1038/ncb1388; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; Fahrudin M, 2002, REPRODUCTION, V124, P813, DOI 10.1530/rep.0.1240813; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Galli R, 2000, NAT NEUROSCI, V3, P986, DOI 10.1038/79924; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Han XP, 2011, CELL RES, V21, P1509, DOI 10.1038/cr.2011.125; Hardy K, 1997, MOL HUM REPROD, V3, P919, DOI 10.1093/molehr/3.10.919; He YL, 2009, THERIOGENOLOGY, V71, P1417, DOI 10.1016/j.theriogenology.2009.01.012; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Inoue K, 2007, STEM CELLS, V25, P1279, DOI 10.1634/stemcells.2006-0747; Jaenisch Rudolf, 2002, Cloning and Stem Cells, V4, P389, DOI 10.1089/153623002321025069; Kassmer SH, 2013, STEM CELLS, V31, P2759, DOI 10.1002/stem.1413; Kato Y, 2004, BIOL REPROD, V70, P415, DOI 10.1095/biolreprod.103.020271; Kawanabe N, 2012, EXP CELL RES, V318, P453, DOI 10.1016/j.yexcr.2012.01.008; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Kucia M, 2007, DEV DYNAM, V236, P3309, DOI 10.1002/dvdy.21180; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Liu J, 2013, CELL REPROGRAM, V15, P159, DOI 10.1089/cell.2012.0073; Oback B, 2007, MOL REPROD DEV, V74, P646, DOI 10.1002/mrd.20654; Oback Bjorn, 2002, Cloning and Stem Cells, V4, P147, DOI 10.1089/153623002320253328; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Ratajczak MZ, 2008, J AUTOIMMUN, V30, P151, DOI 10.1016/j.jaut.2007.12.003; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Saito S, 2003, BIOCHEM BIOPH RES CO, V309, P104, DOI 10.1016/S0006-291X(03)01536-5; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Vaculik C, 2012, J INVEST DERMATOL, V132, P563, DOI 10.1038/jid.2011.355; VanSoom A, 1996, MOL REPROD DEV, V45, P171, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;171::AID-MRD10&gt;3.0.CO;2-4; Virant-Klun I, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/690415; Wakao S, 2011, P NATL ACAD SCI USA, V108, P9875, DOI 10.1073/pnas.1100816108; Wojakowski W, 2008, EUR HEART J, V29, P398; Wojakowski W, 2009, J AM COLL CARDIOL, V53, P1, DOI 10.1016/j.jacc.2008.09.029; Yang ZC, 2013, CELL REPROGRAM, V15, P195, DOI 10.1089/cell.2012.0080; Yu Y, 2007, REPRODUCTION, V133, P947, DOI 10.1530/REP-06-0358; Zuba-Surma EK, 2009, MECH AGEING DEV, V130, P58, DOI 10.1016/j.mad.2008.02.003	46	18	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0114423	10.1371/journal.pone.0114423	http://dx.doi.org/10.1371/journal.pone.0114423			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602959	Green Published, Green Submitted, gold			2022-12-26	WOS:000348203500005
J	Shan, XY; Zhou, HJ; Zhang, J; Zhu, BQ; Xu, L; Hu, GC; Bai, AY; Shao, ZJ; Jiang, BF				Shan, Xiaoying; Zhou, Haijian; Zhang, Ji; Zhu, Bingqing; Xu, Li; Hu, Guangchun; Bai, Aiying; Shao, Zhujun; Jiang, Baofa			Application of Multiple-Locus Variable Number Tandem Repeat Analysis to Identify Outbreak-Associated Neisseria meningitidis Serogroup C Sequence Type 4821 in China	PLOS ONE			English	Article							IDENTIFICATION; EPIDEMIOLOGY; CLONE	Neisseria meningitidis (N. meningitidis) serogroup C sequence type (ST)-4821 caused an outbreak in 2010 in Shandong province of China. Twenty-one non-outbreak-associated strains were isolated, along with twenty-eight N. meningitides serogroup C ST-4821 isolates. Therefore, it's essential to identify and clarify characterization of the real outbreak-associated strains with a rapid method during an outbreak investigation. In this study, multiple-locus variable number tandem repeat analysis (MLVA) was applied to analyze 84 N. meningitidis strains, among which 58 were recovered from two outbreaks and 26 were sporadic isolates. Three MLVA schemes with different combination of VNTR loci were tested, and two of them were suitable for isolates from China: scheme 2 with six loci was found to separate ST into finer resolution, and scheme 3 with five loci can be used to identify outbreak-associated isolates from the same outbreak that caused by N. meningitidis serogroup C ST-4821.	[Shan, Xiaoying; Jiang, Baofa] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan, Shandong, Peoples R China; [Shan, Xiaoying; Zhou, Haijian; Zhu, Bingqing; Xu, Li; Shao, Zhujun] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Shan, Xiaoying; Zhang, Ji; Hu, Guangchun; Bai, Aiying] Jinan Municipal Ctr Dis Control & Prevent, Jinan, Shandong, Peoples R China; [Shan, Xiaoying; Zhou, Haijian; Zhu, Bingqing; Xu, Li; Shao, Zhujun] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Shandong University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Shao, ZJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	shaozhujun@icdc.cn; bjiang@sdu.edu.cn			National Key Program for Infectious Disease of China [2013ZX10004221]; National Basic Research Program of China (973 Program) [2011CB504904]	National Key Program for Infectious Disease of China; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by The National Key Program for Infectious Disease of China (Contract No. 2013ZX10004221) and the National Basic Research Program of China (973 Program, 2011CB504904) to SZJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P107, DOI 10.1016/S0924-8579(02)00356-4; Caugant DA, 2008, INFECT GENET EVOL, V8, P558, DOI 10.1016/j.meegid.2008.04.002; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Liao JC, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-44; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Nicolas P, 2005, J CLIN MICROBIOL, V43, P5129, DOI 10.1128/JCM.43.10.5129-5135.2005; Schouls LM, 2006, J CLIN MICROBIOL, V44, P1509, DOI 10.1128/JCM.44.4.1509-1518.2006; Shao ZJ, 2006, LANCET, V367, P419, DOI 10.1016/S0140-6736(06)68141-5; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Wang YingTong, 2013, Disease Surveillance, V28, P443; Zhang XB, 2007, J MED MICROBIOL, V56, P1224, DOI 10.1099/jmm.0.47263-0; Yazdankhah SP, 2005, J CLIN MICROBIOL, V43, P1699, DOI 10.1128/JCM.43.4.1699-1705.2005; Zhang J, 2013, BIOMED ENVIRON SCI, V26, P331, DOI 10.3967/0895-3988.2013.05.002	15	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116422	10.1371/journal.pone.0116422	http://dx.doi.org/10.1371/journal.pone.0116422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603352	Green Published, gold, Green Submitted			2022-12-26	WOS:000348203500025
J	Averna, M; De Tullio, R; Pedrazzi, M; Bavestrello, M; Pellegrini, M; Salamino, F; Pontremoli, S; Melloni, E				Averna, Monica; De Tullio, Roberta; Pedrazzi, Marco; Bavestrello, Margherita; Pellegrini, Matteo; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon			Interaction between Calpain-1 and HSP90: New Insights into the Regulation of Localization and Activity of the Protease	PLOS ONE			English	Article							D-ASPARTATE RECEPTORS; NMDA RECEPTORS; RAT-BRAIN; CALPASTATIN; COMPLEX; EXPRESSION; CLEAVAGE; PROTEOLYSIS; ACTIVATION; PROTEINS	Here we demonstrate that heat shock protein 90 (HSP90) interacts with calpain-1, but not with calpain-2, and forms a discrete complex in which the protease maintains its catalytic activity, although with a lower affinity for Ca2+. Equilibrium gel distribution experiments show that this complex is composed by an equal number of molecules of each protein partner. Moreover, in resting cells, cytosolic calpain-1 is completely associated with HSP90. Since calpain-1, in association with HSP90, retains its proteolytic activity, and the chaperone is displaced by calpastatin also in the absence of Ca2+, the catalytic cleft of the protease is not involved in this association. Thus, calpain-1 can form two distinct complexes depending on the availability of calpastatin in the cytosol. The occurrence of a complex between HSP90 and calpain-1, in which the protease is still activable, can prevent the complete inhibition of the protease even in the presence of high calpastatin levels. We also demonstrate that in basal cell conditions HSP90 and calpain-1, but not calpain-2, are inserted in the multi-protein N-Methyl-D-Aspartate receptor (NMDAR) complex. The amount of calpain-1 at the NMDAR cluster is not modified in conditions of increased [Ca2+] (i), and this resident protease is involved in the processing of NMDAR components. Finally, the amount of calpain-1 associated with NMDAR cluster is independent from Ca2+ -mediated translocation. Our findings show that HSP90 plays an important role in maintaining a given and proper amount of calpain-1 at the functional sites.	[Averna, Monica] Univ Genoa, Dept Expt Med DIMES, Biochem Sect, I-16132 Genoa, Italy; Univ Genoa, CEBR, I-16132 Genoa, Italy	University of Genoa; University of Genoa	Averna, M (corresponding author), Univ Genoa, Dept Expt Med DIMES, Biochem Sect, Viale Benedetto 15,1, I-16132 Genoa, Italy.	monica.averna@unige.it	AVERNA, MONICA/R-5719-2019	AVERNA, MONICA/0000-0002-9463-7533; DE TULLIO, ROBERTA/0000-0001-6925-3207	University of Genoa	University of Genoa	This work was supported by grants from the University of Genoa to MA (PRA Averna 2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERS GK, 1964, BIOCHEMISTRY-US, V3, P723, DOI 10.1021/bi00893a021; Averna M, 2001, BIOCHEM J, V354, P25, DOI 10.1042/0264-6021:3540025; Averna M, 2008, J BIOL CHEM, V283, P29069, DOI 10.1074/jbc.M803638200; Averna M, 2007, FEBS J, V274, P6116, DOI 10.1111/j.1742-4658.2007.06133.x; Averna M, 2007, J BIOL CHEM, V282, P2656, DOI 10.1074/jbc.M606919200; Averna M, 2011, BBA-MOL CELL RES, V1813, P50, DOI 10.1016/j.bbamcr.2010.11.008; Averna M, 2010, BIOCHEM J, V430, P255, DOI 10.1042/BJ20100344; Averna M, 2009, J NEUROCHEM, V110, P412, DOI 10.1111/j.1471-4159.2009.06149.x; Bellocq A, 1999, J BIOL CHEM, V274, P36891, DOI 10.1074/jbc.274.52.36891; Bi X, 1996, NEUROSCIENCE, V73, P903, DOI 10.1016/0306-4522(96)00157-1; Campbell RL, 2012, BIOCHEM J, V447, P335, DOI 10.1042/BJ20120921; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; De Tullio R, 2003, BIOCHEM J, V375, P689, DOI 10.1042/BJ20030706; De Tullio R, 1999, BIOCHEM J, V343, P467; De Tullio R, 2009, BBA-GEN SUBJECTS, V1790, P182, DOI 10.1016/j.bbagen.2008.11.002; Edwards MA, 2007, NEUROTOXICOLOGY, V28, P876, DOI 10.1016/j.neuro.2007.04.006; FAHIEN LA, 1974, J BIOL CHEM, V249, P2696; Fan XL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00160; Garcia M, 2005, BIOCHEM BIOPH RES CO, V338, P1241, DOI 10.1016/j.bbrc.2005.10.081; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Grant SGN, 2001, CURR OPIN NEUROBIOL, V11, P363, DOI 10.1016/S0959-4388(00)00220-8; Guttmann RP, 2002, J PHARMACOL EXP THER, V302, P1023, DOI 10.1124/jpet.102.036962; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Hood JL, 2006, BIOESSAYS, V28, P850, DOI 10.1002/bies.20440; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kambe Y, 2010, J NEUROSCI RES, V88, P2177, DOI 10.1002/jnr.22388; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Lombardi G, 2001, BRIT J PHARMACOL, V133, P936, DOI 10.1038/sj.bjp.0704134; Ma H, 2001, J BIOL CHEM, V276, P28525, DOI 10.1074/jbc.M100603200; MACGREGOR JS, 1980, P NATL ACAD SCI-BIOL, V77, P3889, DOI 10.1073/pnas.77.7.3889; Makhnevych T, 2012, BBA-MOL CELL RES, V1823, P674, DOI 10.1016/j.bbamcr.2011.09.001; MELLONI E, 1982, BIOCHEM BIOPH RES CO, V106, P731, DOI 10.1016/0006-291X(82)91772-7; Melloni E, 2006, J BIOL CHEM, V281, P24945, DOI 10.1074/jbc.M601449200; Miglio G, 2005, BIOCHEM BIOPH RES CO, V338, P1875, DOI 10.1016/j.bbrc.2005.10.164; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; North WG, 1997, MOL CHEM NEUROPATHOL, V30, P77, DOI 10.1007/BF02815151; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Pedrazzi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044518; Raynaud F, 2008, INT J DEV BIOL, V52, P383, DOI 10.1387/ijdb.072448fr; Salamino F, 1997, FEBS LETT, V412, P433, DOI 10.1016/S0014-5793(97)00819-3; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vazhappilly R, 2002, NEUROSCI LETT, V318, P153, DOI 10.1016/S0304-3940(01)02482-X; von Reyn CR, 2012, J NEUROCHEM, V121, P793, DOI 10.1111/j.1471-4159.2012.07735.x; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wang YB, 2013, J NEUROSCI, V33, P18880, DOI 10.1523/JNEUROSCI.3293-13.2013; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Yorikawa C, 2008, J BIOCHEM, V143, P731, DOI 10.1093/jb/mvn030; Yuen EY, 2007, J PHYSIOL-LONDON, V580, P241, DOI 10.1113/jphysiol.2006.122754	52	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2015	10	1							e0116738	10.1371/journal.pone.0116738	http://dx.doi.org/10.1371/journal.pone.0116738			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BU	25575026	gold, Green Published, Green Submitted			2022-12-26	WOS:000348168100007
J	Oelschlegel, AM; Geissen, M; Lenk, M; Riebe, R; Angermann, M; Schaetzl, H; Groschup, MH				Oelschlegel, Anja M.; Geissen, Markus; Lenk, Matthias; Riebe, Roland; Angermann, Marlies; Schaetzl, Hermann; Groschup, Martin H.			A Bovine Cell Line That Can Be Infected by Natural Sheep Scrapie Prions	PLOS ONE			English	Article							NEUROBLASTOMA-CELLS; IN-VITRO; TRANSGENIC MICE; MOUSE MODELS; PROTEIN; AGENT; PROPAGATION; STRAINS; REPLICATION; INHIBITION	Cell culture systems represent a crucial part in basic prion research; yet, cell lines that are susceptible to prions, especially to field isolated prions that were not adapted to rodents, are very rare. The purpose of this study was to identify and characterize a cell line that was susceptible to ruminant-derived prions and to establish a stable prion infection within it. Based on species and tissue of origin as well as PrP expression rate, we pre-selected a total of 33 cell lines that were then challenged with natural and with mouse propagated BSE or scrapie inocula. Here, we report the successful infection of a non-transgenic bovine cell line, a sub-line of the bovine kidney cell line MDBK, with natural sheep scrapie prions. This cell line retained the scrapie infection for more than 200 passages. Selective cloning resulted in cell populations with increased accumulation of PrPres, although this treatment was not mandatory for retaining the infection. The infection remained stable, even under suboptimal culture conditions. The resulting infectivity of the cells was confirmed by mouse bioassay ( Tgbov mice, Tgshp mice). We believe that PES cells used together with other prion permissive cell lines will prove a valuable tool for ongoing efforts to understand and defeat prions and prion diseases.	[Oelschlegel, Anja M.; Geissen, Markus; Angermann, Marlies; Groschup, Martin H.] Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Greifswald, Germany; [Oelschlegel, Anja M.] Leibniz Inst Neurobiol, Project Grp Neuropharmacol, Magdeburg, Germany; [Geissen, Markus] UKE, Univ Heart Ctr Hamburg, Dept Vasc Med, Hamburg, Germany; [Lenk, Matthias; Riebe, Roland] Friedrich Loeffler Inst, Dept Expt Anim Facil & Biorisk Management, Greifswald, Germany; [Angermann, Marlies] Adm Dist Off Goerlitz, Goerlitz, Germany; [Schaetzl, Hermann] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB, Canada	Friedrich Loeffler Institute; Leibniz Institut fur Neurobiologie (LIN); University of Hamburg; University Medical Center Hamburg-Eppendorf; Friedrich Loeffler Institute; University of Calgary	Groschup, MH (corresponding author), Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Greifswald, Germany.	Martin.Groschup@fli.bund.de						Archer F, 2004, J VIROL, V78, P482, DOI 10.1128/JVI.78.1.482-490.2004; Arellano-Anaya ZE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020563; Baron T, 2002, TRENDS MOL MED, V8, P495, DOI 10.1016/S1471-4914(02)02416-4; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; Bosque PJ, 2000, J VIROL, V74, P4377, DOI 10.1128/JVI.74.9.4377-4386.2000; Buschmann A, 2000, ARCH VIROL, P75; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; CLARKE MC, 1970, NATURE, V225, P100, DOI 10.1038/225100a0; CLARKE MC, 1976, NATURE, V261, P144, DOI 10.1038/261144a0; CLARKE MC, 1970, RES VET SCI, V11, P500; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Dlakic WM, 2007, J VIROL, V81, P4615, DOI 10.1128/JVI.02628-06; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Follet J, 2002, J VIROL, V76, P2434, DOI 10.1128/JVI.76.5.2434-2439.2002; Geissen M, 2011, CHEMMEDCHEM, V6, P1928, DOI 10.1002/cmdc.201100119; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Giri RK, 2006, P NATL ACAD SCI USA, V103, P3875, DOI 10.1073/pnas.0510902103; Gretzschel A, 2005, J VET MED B, V52, P55, DOI 10.1111/j.1439-0450.2005.00827.x; Gustafson DP, 1965, SLOW LATENT TEMPERAT, P221; Harmeyer S, 1998, J GEN VIROL, V79, P937, DOI 10.1099/0022-1317-79-4-937; Holscher C, 1998, J VIROL, V72, P1153; Hope J, 2000, J GEN VIROL, V81, P851, DOI 10.1099/0022-1317-81-3-851; Hope J, 1999, J GEN VIROL, V80, P1, DOI 10.1099/0022-1317-80-1-1; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kupfer L, 2007, BBA-MOL BASIS DIS, V1772, P704, DOI 10.1016/j.bbadis.2006.10.009; Li JL, 2011, EMBO REP, V12, P1243, DOI 10.1038/embor.2011.191; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Mahal SP, 2010, P NATL ACAD SCI USA, V107, P22653, DOI 10.1073/pnas.1013014108; MARKOVITS P, 1983, ACTA NEUROPATHOL, V60, P75, DOI 10.1007/BF00685350; Milhavet O, 2006, STEM CELLS, V24, P2284, DOI 10.1634/stemcells.2006-0088; Neale MH, 2010, J VIROL, V84, P2444, DOI 10.1128/JVI.01855-09; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Oelschlegel AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003158; Oelschlegel AM, 2012, J VIROL, V86, P5297, DOI 10.1128/JVI.00181-12; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; RACE RE, 1988, J VIROL, V62, P2845, DOI 10.1128/JVI.62.8.2845-2849.1988; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; Raymond GJ, 2006, J VIROL, V80, P596, DOI 10.1128/JVI.80.2.596-604.2006; RUBENSTEIN R, 1984, J GEN VIROL, V65, P2191, DOI 10.1099/0022-1317-65-12-2191; RUBENSTEIN R, 1991, J GEN VIROL, V72, P1279, DOI 10.1099/0022-1317-72-6-1279; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Schatzl HM, 1997, J VIROL, V71, P8821; Solassol J, 2003, BRIT MED BULL, V66, P87, DOI 10.1093/bmb/66.1.87; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; Telling Glenn C., 2008, V459, P249, DOI 10.1007/978-1-59745-234-2_17; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vorberg I, 2004, J BIOL CHEM, V279, P29218, DOI 10.1074/jbc.M402576200; Vorberg I, 1999, VIROLOGY, V255, P26, DOI 10.1006/viro.1998.9561; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Weissmann C, 2011, EMBO REP, V12, P1109, DOI 10.1038/embor.2011.192	59	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2015	10	1							e0117154	10.1371/journal.pone.0117154	http://dx.doi.org/10.1371/journal.pone.0117154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BS	25565633	gold, Green Published, Green Submitted			2022-12-26	WOS:000348167900007
J	Warnier, M; Roudbaraki, M; Derouiche, S; Delcourt, P; Bokhobza, A; Prevarskaya, N; Mariot, P				Warnier, M.; Roudbaraki, M.; Derouiche, S.; Delcourt, P.; Bokhobza, A.; Prevarskaya, N.; Mariot, P.			CACNA2D2 promotes tumorigenesis by stimulating cell proliferation and angiogenesis	ONCOGENE			English	Article							PROSTATE-CANCER CELLS; GATED CALCIUM-CHANNELS; TUMOR-SUPPRESSOR; ION CHANNELS; GENE; ALPHA(2)DELTA; SUBUNITS; METHYLATION; PROGRESSION; TRAFFICKING	In the present study, we have assessed whether a putative calcium channel alpha 2 delta 2 auxiliary subunit (CACNA2D2 gene) could be involved in prostate cancer (PCA) progression. We therefore carried out experiments to determine whether this protein is expressed in PCA LNCaP cells and in PCA tissues, and whether its expression may be altered during cancer development. In addition, we evaluated the influence on cell proliferation of overexpressing or downregulating this subunit. In vitro experiments show that alpha 2 delta 2 subunit overexpression is associated with increased cell proliferation, alterations of calcium homeostasis and the recruitment of a nuclear factor of activated T-cells pathway. Furthermore, we carried out in vivo experiments on immuno-deficient nude mice in order to evaluate the tumorigenic potency of the alpha 2 delta 2 subunit. We show that alpha 2 delta 2-overexpressing PCA LNCaP cells are more tumorigenic than control LNCaP cells when injected into nude mice. In addition, gabapentin, a ligand of alpha 2 delta 2, reduces tumor development in LNCaP xenografts. Finally, we show that the action of alpha 2 delta 2 on tumor development occurs not only through a stimulation of proliferation, but also through a stimulation of angiogenesis, via an increased secretion of vascular endothelial growth factor in cells overexpressing alpha 2 delta 2.	[Warnier, M.; Roudbaraki, M.; Derouiche, S.; Delcourt, P.; Bokhobza, A.; Prevarskaya, N.; Mariot, P.] INSERM, Lab Phys Cellulaire, U1003, Villeneuve Dascq, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Mariot, P (corresponding author), Univ Lille 1, Lab Physiol Cellulaire, INSERM, U1003, Batiment SN3, F-59655 Villeneuve Dascq, France.	Pascal.Mariot@univ-lille1.fr		Morad, Roudbaraki/0000-0001-5751-3323; bokhobza, Alexandre/0000-0001-7953-4328; Mariot, Pascal/0000-0001-7226-9162; Prevarskaya, natacha/0000-0003-0316-197X	INSERM; University of Lille1; Region Nord-Pas de Calais	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Lille1; Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission)	We thank the members of the imaging platform BICEL, E Richard and C Slommiany for their helpful contribution. This work was supported by INSERM, the University of Lille1 and the Region Nord-Pas de Calais. This work was supported by INSERM, the University of Lille1 and the Region Nord-Pas de Calais.	Bennett ES, 2004, PFLUG ARCH EUR J PHY, V447, P908, DOI 10.1007/s00424-003-1205-x; Bidaud I, 2006, BBA-MOL CELL RES, V1763, P1169, DOI 10.1016/j.bbamcr.2006.08.049; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Dolphin AC, 1999, J PHYSIOL-LONDON, V519, P35, DOI 10.1111/j.1469-7793.1999.0035o.x; Dolphin AC, 2012, NAT REV NEUROSCI, V13, P542, DOI 10.1038/nrn3311; Dooley DJ, 2007, TRENDS PHARMACOL SCI, V28, P75, DOI 10.1016/j.tips.2006.12.006; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Fiske JL, 2006, CANCER METAST REV, V25, P493, DOI 10.1007/s10555-006-9017-z; Gackiere F, 2006, CELL CALCIUM, V39, P357, DOI 10.1016/j.ceca.2005.12.003; Gackiere F, 2008, J BIOL CHEM, V283, P10162, DOI 10.1074/jbc.M707159200; Gackiere F, 2013, BIOL OPEN, V2, P941, DOI 10.1242/bio.20135215; Garcia K, 2008, J PHYSIOL-LONDON, V586, P727, DOI 10.1113/jphysiol.2007.147959; Ghosh S, 2008, INT J CANCER, V123, P2594, DOI 10.1002/ijc.23834; Halatsch ME, 2009, J NEUROSURG, V111, P211, DOI 10.3171/2008.9.JNS08551; Hobom M, 2000, EUR J NEUROSCI, V12, P1217, DOI 10.1046/j.1460-9568.2000.01009.x; Katsogiannou M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007068; Kondratska K., 2014, ONCOGENE, V1843, P2263; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Lee JM, 2011, AM J PHYSIOL-CELL PH, V301, pC969, DOI 10.1152/ajpcell.00136.2011; Li Z, 2011, EUR J PHARMACOL, V667, P80, DOI 10.1016/j.ejphar.2011.05.054; LIM DJ, 1993, PROSTATE, V22, P109, DOI 10.1002/pros.2990220203; LIU CM, 1978, J BIOL CHEM, V253, P5892; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Mariot P, 2002, J BIOL CHEM, V277, P10824, DOI 10.1074/jbc.M108754200; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; Negrini S, 2013, TRENDS CELL BIOL, V23, P289, DOI 10.1016/j.tcb.2013.01.006; Oh C, 2013, SCI REP-UK, V3, DOI 10.1038/srep02623; Pelosi G, 2010, ANTICANCER RES, V30, P4269; Prando ED, 2011, EPIGENETICS-US, V6, P1413, DOI 10.4161/epi.6.12.18271; Spitzner M, 2007, FASEB J, V21, P35, DOI 10.1096/fj.06-6200com; Starborg M, 1996, J CELL SCI, V109, P143; Toyota M, 1999, CANCER RES, V59, P4535; Wanajo A, 2008, GASTROENTEROLOGY, V135, P580, DOI 10.1053/j.gastro.2008.05.041; Wang XT, 2000, AM J PATHOL, V157, P1549, DOI 10.1016/S0002-9440(10)64792-X; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Zhao W, 2013, CANCER CELL, V23, P541, DOI 10.1016/j.ccr.2013.02.025; ZOUR E, 1992, PHARMACEUT RES, V9, P595, DOI 10.1023/A:1015833622943	41	30	32	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 16	2015	34	42					5383	5394		10.1038/onc.2014.467	http://dx.doi.org/10.1038/onc.2014.467			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU4EI	25619833				2022-12-26	WOS:000363479200008
J	Hung, HA; Sun, GN; Keles, S; Svaren, J				Hung, Holly A.; Sun, Guannan; Keles, Sunduz; Svaren, John			Dynamic Regulation of Schwann Cell Enhancers after Peripheral Nerve Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN PROTEIN ZERO; ERK-SIGNALING PATHWAY; MARIE-TOOTH-DISEASE; LARGE GENE LISTS; TRANSCRIPTION FACTORS; C-JUN; HUMAN-GENOME; CHIP-SEQ; IN-VIVO; AXONAL REGENERATION	Myelination of the peripheral nervous system is required for axonal function and long term stability. After peripheral nerve injury, Schwann cells transition from axon myelination to a demyelinated state that supports neuronal survival and ultimately remyelination of axons. Reprogramming of gene expression patterns during development and injury responses is shaped by the actions of distal regulatory elements that integrate the actions of multiple transcription factors. We used ChIP-seq to measure changes in histone H3K27 acetylation, a mark of active enhancers, to identify enhancers in myelinating rat peripheral nerve and their dynamics after demyelinating nerve injury. Analysis of injury-induced enhancers identified enriched motifs for c-Jun, a transcription factor required for Schwann cells to support nerve regeneration. We identify a c-Jun-bound enhancer in the gene for Runx2, a transcription factor induced after nerve injury, and we show that Runx2 is required for activation of other induced genes. In contrast, enhancers that lose H3K27ac after nerve injury are enriched for binding sites of the Sox10 and early growth response 2 (Egr2/Krox20) transcription factors, which are critical determinants of Schwann cell differentiation. Egr2 expression is lost after nerve injury, and many Egr2-binding sites lose H3K27ac after nerve injury. However, the majority of Egr2-bound enhancers retain H3K27ac, indicating that other transcription factors maintain active enhancer status after nerve injury. The global epigenomic changes in H3K27ac deposition pinpoint dynamic changes in enhancers that mediate the effects of transcription factors that control Schwann cell myelination and peripheral nervous system responses to nerve injury.	[Hung, Holly A.; Svaren, John] Univ Wisconsin, Waisman Ctr, 1500 Highland Ave, Madison, WI 53705 USA; [Hung, Holly A.] Univ Wisconsin, Cellular & Mol Pathol Grad Program, Madison, WI 53705 USA; [Sun, Guannan; Keles, Sunduz] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53705 USA; [Svaren, John] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Svaren, J (corresponding author), Univ Wisconsin, Waisman Ctr, 1500 Highland Ave, Madison, WI 53705 USA.	jpsvaren@wisc.edu	Svaren, John/A-1605-2010	Svaren, John/0000-0003-2963-7921	National Institutes of Health [NS075269, HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS075269 (to J. S.) and Core Grant HD03352.	[Anonymous], CELL STEM CELL; Arthur-Farraj P, 2011, GLIA, V59, P720, DOI 10.1002/glia.21144; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Barrette B, 2010, BRAIN BEHAV IMMUN, V24, P1254, DOI 10.1016/j.bbi.2010.07.249; Barutcu AR, 2014, NUCLEIC ACIDS RES, V42, P10360, DOI 10.1093/nar/gku712; Berti C, 2011, DEVELOPMENT, V138, P4025, DOI 10.1242/dev.065490; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Bondurand N, 2001, HUM MOL GENET, V10, P2783, DOI 10.1093/hmg/10.24.2783; Brewer MH, 2014, HUM MOL GENET, V23, P5171, DOI 10.1093/hmg/ddu240; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chen LM, 2010, PROTEIN CELL, V1, P1073, DOI 10.1007/s13238-010-0138-3; Chen Y, 2011, NAT NEUROSCI, V14, P437, DOI 10.1038/nn.2780; Cotney J, 2012, GENOME RES, V22, P1069, DOI 10.1101/gr.129817.111; Court FA, 2009, J NEUROSCI, V29, P3908, DOI 10.1523/JNEUROSCI.5672-08.2009; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; D'Alonzo RC, 2002, J BIOL CHEM, V277, P816, DOI 10.1074/jbc.M107082200; Decker L, 2006, J NEUROSCI, V26, P9771, DOI 10.1523/JNEUROSCI.0716-06.2006; Denarier E, 2005, J NEUROSCI, V25, P11210, DOI 10.1523/JNEUROSCI.2596-05.2005; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Fischer S, 2008, GLIA, V56, P836, DOI 10.1002/glia.20657; Fontana X, 2012, J CELL BIOL, V198, P127, DOI 10.1083/jcb.201205025; Fulton DL, 2011, NUCLEIC ACIDS RES, V39, P7974, DOI 10.1093/nar/gkr326; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Ghislain J, 2002, DEVELOPMENT, V129, P155; Ghislain J, 2006, EMBO REP, V7, P52, DOI 10.1038/sj.embor.7400573; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heller BA, 2014, J CELL BIOL, V204, P1219, DOI 10.1083/jcb.201307057; Houlden H, 2004, ANN NEUROL, V56, P730, DOI 10.1002/ana.20267; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jacob C, 2011, NAT NEUROSCI, V14, P429, DOI 10.1038/nn.2762; Jagalur NB, 2011, J NEUROSCI, V31, P8585, DOI 10.1523/JNEUROSCI.0659-11.2011; Jang SW, 2006, J NEUROCHEM, V98, P1678, DOI 10.1111/j.1471-4159.2006.04069.x; Jang SW, 2009, J BIOL CHEM, V284, P20111, DOI 10.1074/jbc.M109.022426; Jiang N, 2014, NEURAL REGEN RES, V9, P1186, DOI 10.4103/1673-5374.135325; Jones EA, 2007, NEURON GLIA BIOL, V3, P377, DOI 10.1017/S1740925X08000173; Jones EA, 2012, HUM MOL GENET, V21, P1581, DOI 10.1093/hmg/ddr595; Jones EA, 2011, J NEUROSCI, V31, P4242, DOI 10.1523/JNEUROSCI.5893-10.2011; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Kim HA, 2013, STEM CELL TRANSL MED, V2, P553, DOI 10.5966/sctm.2013-0011; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; LeBlanc SE, 2007, MOL CELL BIOL, V27, P3521, DOI 10.1128/MCB.01689-06; LeBlanc SE, 2006, J BIOL CHEM, V281, P5453, DOI 10.1074/jbc.M512159200; Liang K, 2012, BIOINFORMATICS, V28, P121, DOI 10.1093/bioinformatics/btr605; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luciano RL, 2003, J BIOL CHEM, V278, P51116, DOI 10.1074/jbc.M303470200; Lutz AB, 2014, DEV CELL, V28, P7, DOI 10.1016/j.devcel.2013.12.002; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mckee KK, 2012, J CELL SCI, V125, P4609, DOI 10.1242/jcs.107995; Meijer D., 2013, PATTERNING CELL TYPE, P759; Mogha A, 2013, J NEUROSCI, V33, P17976, DOI 10.1523/JNEUROSCI.1809-13.2013; Nagarajan R, 2002, P NATL ACAD SCI USA, V99, P8998, DOI 10.1073/pnas.132080999; Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031; Nodari A, 2008, J NEUROSCI, V28, P6714, DOI 10.1523/JNEUROSCI.0326-08.2008; Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033; Painter MW, 2014, NEURON, V83, P331, DOI 10.1016/j.neuron.2014.06.016; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Parkinson DB, 2002, MOL CELL NEUROSCI, V20, P154, DOI 10.1006/mcne.2002.1109; Parkinson DB, 2004, J CELL BIOL, V164, P385, DOI 10.1083/jcb.200307132; Patodia S, 2012, CELL TISSUE RES, V349, P15, DOI 10.1007/s00441-012-1416-6; Patodia S, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00008; Pellegatta M, 2013, J NEUROSCI, V33, P17995, DOI 10.1523/JNEUROSCI.3179-13.2013; Pereira JA, 2012, TRENDS NEUROSCI, V35, P123, DOI 10.1016/j.tins.2011.11.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Ramesh V, 2004, NAT REV NEUROSCI, V5, P462, DOI 10.1038/nrn1407; Reiprich S, 2010, J NEUROCHEM, V112, P744, DOI 10.1111/j.1471-4159.2009.06498.x; Salzer James L, 2012, J Peripher Nerv Syst, V17 Suppl 3, P14, DOI 10.1111/j.1529-8027.2012.00425.x; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Serrano I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3976; Sherman DL, 2012, J NEUROSCI, V32, P9419, DOI 10.1523/JNEUROSCI.1220-12.2012; Shin YK, 2013, GLIA, V61, P892, DOI 10.1002/glia.22482; Srinivasan R, 2012, NUCLEIC ACIDS RES, V40, P6449, DOI 10.1093/nar/gks313; STEWART HJS, 1995, EUR J NEUROSCI, V7, P1366, DOI 10.1111/j.1460-9568.1995.tb01128.x; Sun GN, 2013, METHODS MOL BIOL, V1038, P193, DOI 10.1007/978-1-62703-514-9_12; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P4094, DOI 10.1073/pnas.83.11.4094; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Timmerman V, 2014, GENES-BASEL, V5, P13, DOI 10.3390/genes5010013; Topilko P, 1997, J NEUROSCI RES, V50, P702, DOI 10.1002/(SICI)1097-4547(19971201)50:5<702::AID-JNR7>3.0.CO;2-L; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Verheijen MHG, 2003, GENE DEV, V17, P2450, DOI 10.1101/gad.1116203; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Werner T, 2007, NUCLEIC ACIDS RES, V35, P6526, DOI 10.1093/nar/gkm727; Yang DP, 2012, J NEUROSCI, V32, P7158, DOI 10.1523/JNEUROSCI.5812-11.2012; Yang DR, 2005, J CELL BIOL, V168, P655, DOI 10.1083/jcb.200411158; Yu WM, 2009, J CELL SCI, V122, P929, DOI 10.1242/jcs.033928; Yu WM, 2005, J NEUROSCI, V25, P4463, DOI 10.1523/JNEUROSCI.5032-04.2005; Zorick TS, 1996, MOL CELL NEUROSCI, V8, P129, DOI 10.1006/mcne.1996.0052	94	78	81	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6937	6950		10.1074/jbc.M114.622878	http://dx.doi.org/10.1074/jbc.M114.622878			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25614629	Green Published, hybrid			2022-12-26	WOS:000350991500028
J	Chen, CJ; Shih, CH; Chang, YJ; Hong, SJ; Li, TN; Wang, LHC; Chen, LY				Chen, Chien-Jen; Shih, Chien-Hung; Chang, Yu-Jung; Hong, Shao-Jing; Li, Tian-Neng; Wang, Lily Hui-Ching; Chen, Linyi			SH2B1 and IRSp53 Proteins Promote the Formation of Dendrites and Dendritic Branches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL DIFFERENTIATION; ACTIN CYTOSKELETON; SH2-B-BETA; MEMBRANE; IDENTIFICATION; EXPRESSION; FILOPODIA; DYNAMICS; RECEPTOR; DOMAIN	SH2B1 is an adaptor protein known to enhance neurite outgrowth. In this study, we provide evidence suggesting that the SH2B1 level is increased during in vitro culture of hippocampal neurons, and the beta isoform (SH2B1 beta) is the predominant isoform. The fact that formation of filopodia is prerequisite for neurite initiation suggests that SH2B1 may regulate filopodium formation and thus neurite initiation. To investigate whether SH2B1 may regulate filopodium formation, the effect of SH2B1 and a membrane and actin regulator, IRSp53 (insulin receptor tyrosine kinase substrate p53), is investigated. Overexpressing both SH2B1 beta and IRSp53 significantly enhances filopodium formation, neurite outgrowth, and branching. Both in vivo and in vitro data show that SH2B1 interacts with IRSp53 in hippocampal neurons. This interaction depends on the N-terminal proline-rich domains of SH2B1. In addition, SH2B1 and IRSp53 co-localize at the plasma membrane, and their levels increase in the Triton X-100-insoluble fraction of developing neurons. These findings suggest that SH2B1-IRSp53 complexes promote the formation of filopodia, neurite initiation, and neuronal branching.	[Chen, Chien-Jen; Shih, Chien-Hung; Chang, Yu-Jung; Hong, Shao-Jing; Chen, Linyi] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu 30013, Taiwan; [Li, Tian-Neng; Wang, Lily Hui-Ching] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu 30013, Taiwan; [Wang, Lily Hui-Ching; Chen, Linyi] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu 30013, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University	Chen, LY (corresponding author), Natl Tsing Hua Univ, Inst Mol Med, 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan.	lchen@life.nthu.edu.tw	Chen, Linyi/AAV-2632-2020; Wang, Lily Hui-Ching/D-1967-2011	Chen, Linyi/0000-0001-7258-8817; Wang, Lily Hui-Ching/0000-0003-0659-0139; Chang, Yu-Jung/0000-0002-4781-0946	National Science Council of Taiwan [NSC101-2311-B-007-012-MY3]; National Health Research Institutes [NHRI-EX104-10206NI]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan)	This work was supported by National Science Council of Taiwan Grant NSC101-2311-B-007-012-MY3 and National Health Research Institutes Grant NHRI-EX104-10206NI.	Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; Bisi S, 2013, CURR OPIN CELL BIOL, V25, P565, DOI 10.1016/j.ceb.2013.04.001; Chang YJ, 2014, MOL CELL BIOL, V34, P1003, DOI 10.1128/MCB.00940-13; Chen L, 2008, MOL ENDOCRINOL, V22, P454, DOI 10.1210/me.2007-0384; Chen LY, 2004, MOL CELL BIOL, V24, P3633, DOI 10.1128/MCB.24.9.3633-3647.2004; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Diakonova M, 2007, INFECT IMMUN, V75, P3581, DOI 10.1128/IAI.00214-07; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Doche ME, 2012, J CLIN INVEST, V122, P4732, DOI 10.1172/JCI62696; Funato Y, 2004, CANCER RES, V64, P5237, DOI 10.1158/0008-5472.CAN-04-0327; Futo K, 2013, BBA-MOL CELL BIOL L, V1831, P1651, DOI 10.1016/j.bbalip.2013.07.006; Ho SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-230; HUANG XM, 1995, P NATL ACAD SCI USA, V92, P11618, DOI 10.1073/pnas.92.25.11618; Iseki M, 2000, BIOCHEM BIOPH RES CO, V272, P45, DOI 10.1006/bbrc.2000.2736; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lin WF, 2009, CELL SIGNAL, V21, P1060, DOI 10.1016/j.cellsig.2009.02.009; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Maures TJ, 2011, J CELL SCI, V124, P1542, DOI 10.1242/jcs.078949; Maures TJ, 2009, MOL ENDOCRINOL, V23, P1077, DOI 10.1210/me.2009-0011; Nelms K, 1999, MAMM GENOME, V10, P1160, DOI 10.1007/s003359901183; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Rider L, 2009, MOL ENDOCRINOL, V23, P1065, DOI 10.1210/me.2008-0428; Rui LY, 1999, P NATL ACAD SCI USA, V96, P7172, DOI 10.1073/pnas.96.13.7172; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; Sandholt CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023531; Schirenbeck A, 2005, BIOCHEM SOC T, V33, P1256, DOI 10.1042/BST0331256; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Shih CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079619; Vaggi F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002088; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Volckmar AL, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-65; Wang TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026433; Yang CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005678; Yousaf N, 2001, J BIOL CHEM, V276, P40940, DOI 10.1074/jbc.M104191200; Zhao HX, 2011, CURR OPIN CELL BIOL, V23, P14, DOI 10.1016/j.ceb.2010.10.005	35	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6010	6021		10.1074/jbc.M114.603795	http://dx.doi.org/10.1074/jbc.M114.603795			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25586189	hybrid, Green Published			2022-12-26	WOS:000350732500013
J	Choi, DH; Park, KT; An, SM; Lee, K; Cho, JC; Lee, JH; Kim, D; Jeon, D; Noh, JH				Choi, Dong Han; Park, Ki-Tae; An, Sung Min; Lee, Kitack; Cho, Jang-Cheon; Lee, Jung-Hyun; Kim, Dongseon; Jeon, Dongchull; Noh, Jae Hoon			Pyrosequencing Revealed SAR116 Clade as Dominant dddP-Containing Bacteria in Oligotrophic NW Pacific Ocean	PLOS ONE			English	Article							DIMETHYL SULFIDE; DIMETHYLSULFONIOPROPIONATE LYASE; MAXIMUM-LIKELIHOOD; ATMOSPHERIC SULFUR; CHEMICAL DEFENSE; DISSOLVED DMSP; MARINE; PHYTOPLANKTON; GENE; DEGRADATION	Dimethyl sulfide (DMS) is a climatically active gas released into the atmosphere from oceans. It is produced mainly by bacterial enzymatic cleavage of dimethylsulfoniopropionate (DMSP), and six DMSP lyases have been identified to date. To determine the biogeographical distribution of bacteria relevant to DMS production, we investigated the diversity of dddP-the most abundant DMS-producing gene-in the northwestern Pacific Ocean using newly developed primers and the pyrosequencing method. Consistent with previous studies, the major dddP-containing bacteria in coastal areas were those belonging to the Roseobacter clade. However, genotypes closely related to the SAR116 group were found to represent a large portion of dddP-containing bacteria in the surface waters of the oligotrophic ocean. The addition of DMSP to a culture of the SAR116 strain Candidatus Puniceispirillum marinum IMCC1322 resulted in the production of DMS and upregulated expression of the dddP gene. Considering the large area of oligotrophic water and the wide distribution of the SAR116 group in oceans worldwide, we propose that these bacteria may play an important role in oceanic DMS production and biogeochemical sulfur cycles, especially via bacteriamediated DMSP degradation.	[Choi, Dong Han; Lee, Jung-Hyun] Korea Inst Ocean Sci & Technol, Marine Biotechnol Res Div, Ansan, South Korea; [Choi, Dong Han; Lee, Jung-Hyun] Korea Univ Sci & Technol, Dept Marine Biotechnol, Taejon, South Korea; [Park, Ki-Tae; Lee, Kitack] Pohang Univ Sci & Technol, Sch Environm Sci & Engn, Pohang, South Korea; [An, Sung Min; Noh, Jae Hoon] Korea Inst Ocean Sci & Technol, Marine Ecosyst Res Div, Ansan, South Korea; [Cho, Jang-Cheon] Inha Univ, Div Biol & Ocean Sci, Inchon, South Korea; [Kim, Dongseon; Jeon, Dongchull] Korea Inst Ocean Sci & Technol, Ocean Circulat & Climate Res Div, Ansan, South Korea; [Noh, Jae Hoon] Korea Univ Sci & Technol, Dept Marine Biol, Taejon, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Pohang University of Science & Technology (POSTECH); Korea Institute of Ocean Science & Technology (KIOST); Inha University; Korea Institute of Ocean Science & Technology (KIOST)	Noh, JH (corresponding author), Korea Inst Ocean Sci & Technol, Marine Ecosyst Res Div, Ansan, South Korea.	jhnoh@kiost.ac	Park, Ki-Tae/CAF-2480-2022; Lee, Kitack/G-7184-2015	Park, Ki-Tae/0000-0003-4874-6189; Cho, Jang-Cheon/0000-0002-0666-3791; Lee, Kitack/0000-0002-4226-2303	Korea Institute of Ocean and Science Technology (KIOST) [PE98704, PE99231, PE99212]	Korea Institute of Ocean and Science Technology (KIOST)	This study was supported by in-house research programs (PE98704, PE99231, PE99212) of the Korea Institute of Ocean and Science Technology (KIOST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Ahn JH, 2012, J MICROBIOL, V50, P735, DOI 10.1007/s12275-012-2188-0; Boyce R, 2009, NUCLEIC ACIDS RES, V37, pW222, DOI 10.1093/nar/gkp379; BURGERMEISTER S, 1990, J GEOPHYS RES-ATMOS, V95, P20607, DOI 10.1029/JD095iD12p20607; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Choi DH, 2013, AQUAT MICROB ECOL, V71, P75, DOI 10.3354/ame01669; Curson ARJ, 2008, ENVIRON MICROBIOL, V10, P757, DOI 10.1111/j.1462-2920.2007.01499.x; Curson ARJ, 2011, NAT REV MICROBIOL, V9, P849, DOI 10.1038/nrmicro2653; Curson ARJ, 2011, ISME J, V5, P1191, DOI 10.1038/ismej.2010.203; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hill RW, 1998, AQUAT MICROB ECOL, V14, P1, DOI 10.3354/ame014001; Ichikawa H, 2002, J OCEANOGR, V58, P77, DOI 10.1023/A:1015876701363; KARSTEN U, 1992, POLAR BIOL, V12, P603; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kiene RP, 1999, APPL ENVIRON MICROB, V65, P4549; Kiene RP, 2000, LIMNOL OCEANOGR, V45, P849, DOI 10.4319/lo.2000.45.4.0849; Kirkwood M, 2010, ISME J, V4, P147, DOI 10.1038/ismej.2009.102; KIRST GO, 1990, ANNU REV PLANT PHYS, V41, P21, DOI 10.1146/annurev.pp.41.060190.000321; Levine NM, 2012, ENVIRON MICROBIOL, V14, P1210, DOI 10.1111/j.1462-2920.2012.02700.x; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Oh HM, 2010, J BACTERIOL, V192, P3240, DOI 10.1128/JB.00347-10; Park KT, 2008, LIMNOL OCEANOGR-METH, V6, P548, DOI 10.4319/lom.2008.6.548; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Peng MJ, 2012, CAN J MICROBIOL, V58, P523, DOI [10.1139/w2012-019, 10.1139/W2012-019]; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Reisch CR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00172; Reisch CR, 2008, J BACTERIOL, V190, P8018, DOI 10.1128/JB.00770-08; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Slezak D, 2007, AQUAT SCI, V69, P377, DOI 10.1007/s00027-007-0896-z; SOMERVILLE CC, 1989, APPL ENVIRON MICROB, V55, P548, DOI 10.1128/AEM.55.3.548-554.1989; Steinke M, 2000, J SEA RES, V43, P233, DOI 10.1016/S1385-1101(00)00024-1; Strom S, 2003, LIMNOL OCEANOGR, V48, P230, DOI 10.4319/lo.2003.48.1.0230; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Todd JD, 2009, ENVIRON MICROBIOL, V11, P1376, DOI 10.1111/j.1462-2920.2009.01864.x; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Todd JD, 2012, ISME J, V6, P223, DOI 10.1038/ismej.2011.79; Todd JD, 2011, ENVIRON MICROBIOL, V13, P427, DOI 10.1111/j.1462-2920.2010.02348.x; Varaljay VA, 2012, APPL ENVIRON MICROB, V78, P2775, DOI 10.1128/AEM.07559-11; Wolfe GV, 1997, NATURE, V387, P894, DOI 10.1038/43168; Zhang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-198	45	23	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116271	10.1371/journal.pone.0116271	http://dx.doi.org/10.1371/journal.pone.0116271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615446	Green Published, Green Submitted, gold			2022-12-26	WOS:000349122100026
J	Rogoz, K; Stjarne, L; Kullander, K; Lagerstrom, MC				Rogoz, Katarzyna; Stjarne, Ludvig; Kullander, Klas; Lagerstrom, Malin C.			VGLUT2 controls heat and punctuate hyperalgesia associated with nerve injury via TRPV1-Cre primary afferents	PLOS ONE			English	Article							VESICULAR GLUTAMATE TRANSPORTER-2; NMDA RECEPTOR ANTAGONISTS; GENE-RELATED PEPTIDE; NEUROPATHIC PAIN; SENSORY NEURONS; SUBSTANCE-P; VANILLOID RECEPTOR-1; EXPRESSION; MODEL; RAT	Nerve injury induces a state of prolonged thermal and mechanical hypersensitivity in the innervated area, causing distress in affected individuals. Nerve injury-induced hypersensitivity is partially due to increased activity and thereby sustained release of neurotransmitters from the injured fibers. Glutamate, a prominent neurotransmitter in primary afferents, plays a major role in development of hypersensitivity. Glutamate is packed in vesicles by vesicular glutamate transporters (VGLUTs) to enable controlled release upon depolarization. While a role for peripheral VGLUTs in nerve injury-induced pain is established, their contribution in specific peripheral neuronal populations is unresolved. We investigated the role of VGLUT2, expressed by transient receptor potential vanilloid (TRPV1) fibers, in nerve injury-induced hypersensitivity. Our data shows that removal of Vglut2 from Trpv1-Cre neurons using transgenic mice abolished both heat and punctuate hyperalgesia associated with nerve injury. In contrast, the development of cold hypersensitivity after nerve injury was unaltered. Here, we show that, VGLUT2-mediated glutamatergic transmission from Trpv1-Cre neurons selectively mediates heat and mechanical hypersensitivity associated with nerve injury. Our data clarifies the role of the Trpv1-Cre population and the dependence of VGLUT2-mediated glutamatergic transmission in nerve injury-induced hyperalgesia.	[Rogoz, Katarzyna; Stjarne, Ludvig; Kullander, Klas; Lagerstrom, Malin C.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University	Lagerstrom, MC (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	malin.lagerstrom@neuro.uu.se		Kullander, Klas/0000-0001-6418-5460				Binns BC, 2005, BRAIN RES, V1041, P38, DOI 10.1016/j.brainres.2005.01.088; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Christoph T, 2008, MOL CELL NEUROSCI, V37, P579, DOI 10.1016/j.mcn.2007.12.006; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dickenson AH, 1997, ACTA ANAESTH SCAND, V41, P112, DOI 10.1111/j.1399-6576.1997.tb04624.x; DICKENSON AH, 1990, TRENDS PHARMACOL SCI, V11, P307, DOI 10.1016/0165-6147(90)90228-Z; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Fundytus ME, 2001, CNS DRUGS, V15, P29, DOI 10.2165/00023210-200115010-00004; Gezelius H, 2006, J PHYSIOL-PARIS, V100, P297, DOI 10.1016/j.jphysparis.2007.05.001; Hudson LJ, 2001, EUR J NEUROSCI, V13, P2105, DOI 10.1046/j.0953-816x.2001.01591.x; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Jang JH, 2004, NEUROSCIENCE, V128, P169, DOI 10.1016/j.neuroscience.2004.06.040; Knowlton WM, 2013, J NEUROSCI, V33, P2837, DOI 10.1523/JNEUROSCI.1943-12.2013; Lagerstrom MC, 2011, P NATL ACAD SCI USA, V108, P5789, DOI 10.1073/pnas.1013602108; Lagerstrom MC, 2010, NEURON, V68, P529, DOI 10.1016/j.neuron.2010.09.016; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; Malmberg AB, 1998, PAIN, V76, P215, DOI 10.1016/S0304-3959(98)00045-1; MAO JR, 1993, BRAIN RES, V605, P164, DOI 10.1016/0006-8993(93)91368-3; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Mogil JS, 2005, P NATL ACAD SCI USA, V102, P12938, DOI 10.1073/pnas.0503264102; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pomonis JD, 2003, J PHARMACOL EXP THER, V306, P387, DOI 10.1124/jpet.102.046268; Rogoz K, 2014, J NEUROSCI, V34, P14055, DOI 10.1523/JNEUROSCI.1722-14.2014; Rogoz K, 2014, MOL PHARMACOL, V85, P322, DOI 10.1124/mol.113.089532; Rogoz K, 2012, PAIN, V153, P1525, DOI 10.1016/j.pain.2012.04.017; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Scherrer G, 2010, P NATL ACAD SCI USA, V107, P22296, DOI 10.1073/pnas.1013413108; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Shen J, 2012, ANESTHESIOLOGY, V117, P365, DOI 10.1097/ALN.0b013e318260de41; Sung BK, 2003, J NEUROSCI, V23, P2899; Urano H, 2012, INT J MED SCI, V9, P690, DOI 10.7150/ijms.4706; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Watabiki T, 2011, BIOL PHARM BULL, V34, P1105, DOI 10.1248/bpb.34.1105; Wu ZZ, 2013, PAIN, V154, P2130, DOI 10.1016/j.pain.2013.06.040; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	41	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116568	10.1371/journal.pone.0116568	http://dx.doi.org/10.1371/journal.pone.0116568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615623	Green Published, Green Submitted, gold			2022-12-26	WOS:000349122100031
J	Xiao, P; Yang, HX; Di, DD; Piao, DR; Zhang, QX; Hao, R; Yao, SX; Zhao, R; Zhang, FF; Tian, GZ; Zhao, HY; Fan, WX; Cui, BY; Jiang, H				Xiao, Pei; Yang, Hongxia; Di, Dongdong; Piao, Dongri; Zhang, Qiuxiang; Hao, Ruie; Yao, Suxia; Zhao, Rong; Zhang, Fanfei; Tian, Guozhong; Zhao, Hongyan; Fan, Weixing; Cui, Buyun; Jiang, Hai			Genotyping of Human Brucella melitensis Biovar 3 Isolated from Shanxi Province in China by MLVA16 and HOOF	PLOS ONE			English	Article							GENETIC DIVERSITY; STRAINS; ABORTUS	Background Brucellosis presents a significant economic burden for China because it causes reproductive failure in host species and chronic health problems in humans. These problems can involve multiple organs. Brucellosis is highly endemic in Shanxi Province China. Molecular typing would be very useful to epidemiological surveillance. The purpose of this study was to assess the diversity of Brucella melitensis strains for epidemiological surveillance. Historical monitoring data suggest that Brucella melitensis biovar 3 is the predominant strain associated with the epidemic of brucellosis in Shanxi Province. Methods/Principal Findings Multiple-locus variable-number repeat analysis (MLVA-16) and hypervariable octameric oligonucleotide fingerprinting (HOOF-print) were used to type a human-hosted Brucella melitensis population (81 strains). Sixty-two MLVA genotypes (discriminatory index: 0.99) were detected, and they had a genetic similarity coefficient ranging from 84.9% to 100%. Eighty strains of the population belonged to the eastern Mediterranean group with panel 1 genotypes 42 (79 strains) and 43 (1 strain). A new panel 1 genotype was found in this study. It was named 114 MLVAorsay genotype and it showed similarity to the two isolates from Guangdong in a previous study. Brucella melitensis is distributed throughout Shanxi Province, and like samples from Inner Mongolia, the eastern Mediterranean genotype 42 was the main epidemic strain (97%). The HOOF-printing showed a higher diversity than MLVA-16 with a genetic similarity coefficient ranging from 56.8% to 100%. Conclusions According to the MLVA-16 and HOOF-printing results, both methods could be used for the epidemiological surveillance of brucellosis. A new genotype was found in both Shanxi and Guangdong Provinces. In areas with brucellosis, the MLVA-16 scheme is very important for tracing cases back to their origins during outbreak investigations. It may facilitate the expansion and eradication of the disease.	[Xiao, Pei; Piao, Dongri; Tian, Guozhong; Zhao, Hongyan; Cui, Buyun; Jiang, Hai] Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Yang, Hongxia; Zhang, Qiuxiang; Hao, Ruie; Yao, Suxia; Zhao, Rong; Zhang, Fanfei] Shanxi Ctr Dis Control & Prevent, Dis Inspect Lab, Taiyuan, Peoples R China; [Di, Dongdong; Fan, Weixing] China Anim Hlth & Epidemiol Ctr, MOA, Lab Zoonoses, Qingdao, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; China Animal Health & Epidemiology Center	Fan, WX (corresponding author), China Anim Hlth & Epidemiol Ctr, MOA, Lab Zoonoses, Qingdao, Peoples R China.	fwxsjl@126.com; cuibuyun@icdc.cn; jianghai@icdc.cn		Xiao, Pei/0000-0001-9976-7655	National Nature Science Foundation [81271900]; National Key Program for Infectious Diseases of China [2013ZX10004221, 2013ZX10004805, 2014ZX10004003]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Program for Infectious Diseases of China	This study was funded by the National Nature Science Foundation (81271900), National Key Program for Infectious Diseases of China (2013ZX10004221, 2013ZX10004805 and 2014ZX10004003). The funders contributed to the study design and data collection.	Al Dahouk S, 2007, J MICROBIOL METH, V69, P137, DOI 10.1016/j.mimet.2006.12.015; Alton G G, 1975, Monogr Ser World Health Organ, P1; BANAI M, 1990, J CLIN MICROBIOL, V28, P1057, DOI 10.1128/JCM.28.5.1057-1059.1990; Bodur H, 2003, SCAND J INFECT DIS, V35, P337, DOI 10.1080/00365540310008348; BRICKER BJ, 1994, J CLIN MICROBIOL, V32, P2660, DOI 10.1128/JCM.32.11.2660-2666.1994; Bricker BJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-37; Bricker BJ, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-15; Buyun C, 2007, ENDEMIC SURVEILLANCE, P649; Chen SY, 2014, EMERG INFECT DIS, V20, P126, DOI 10.3201/eid2001.130324; Garofolo G, 2013, INFECT GENET EVOL, V19, P59, DOI 10.1016/j.meegid.2013.06.021; Godfroid J, 2011, PREV VET MED, V102, P118, DOI 10.1016/j.prevetmed.2011.04.007; Gorvel JP, 2008, MICROBES INFECT, V10, P1010, DOI 10.1016/j.micinf.2008.07.007; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jiang H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-256; Kasymbekov J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002047; Kattar MM, 2008, J CLIN MICROBIOL, V46, P3935, DOI 10.1128/JCM.00464-08; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Menshawy AMS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/353876; Mick E, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087257, 10.1371/journal.pone.0094168]; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Qiu JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034246; Ragan VE, 2002, VET MICROBIOL, V90, P11, DOI 10.1016/S0378-1135(02)00240-7; Rubach MP, 2013, CURR OPIN INFECT DIS, V26, P404, DOI 10.1097/QCO.0b013e3283638104; Shang DQ, 2002, VET MICROBIOL, V90, P165, DOI 10.1016/S0378-1135(02)00252-3; Valdezate S, 2010, J CLIN MICROBIOL, V48, P2734, DOI 10.1128/JCM.00533-10; Zhang WY, 2010, EMERG INFECT DIS, V16, P2001, DOI 10.3201/eid1612.091081	28	14	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115932	10.1371/journal.pone.0115932	http://dx.doi.org/10.1371/journal.pone.0115932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615697	Green Submitted, gold, Green Published			2022-12-26	WOS:000349122100021
J	Boakye, MK; Pietersen, DW; Kotze, A; Dalton, DL; Jansen, R				Boakye, Maxwell Kwame; Pietersen, Darren William; Kotze, Antoinette; Dalton, Desire-Lee; Jansen, Raymond			Knowledge and Uses of African Pangolins as a Source of Traditional Medicine in Ghana	PLOS ONE			English	Article							PLANTS; CONSENSUS; REMEDIES; HEALERS; STATE	Traditional medicine has been practised in Ghana for centuries with the majority of Ghanaians still patronising the services of traditional healers. Throughout Africa a large number of people use pangolins as a source of traditional medicine, however, there is a dearth of information on the use of animals in folk medicine in Ghana, in particular the use of pangolins. The aim of this study was to determine the prevalent use of pangolins and the level of knowledge of pangolin use among traditional healers in Ghana for the treatment of human ailments. Data was gathered from 48 traditional healers using semi-structured interviews on the traditional medicinal use of pangolin body parts in the Kumasi metropolis of Ghana. The cultural importance index, relative frequency of citation, informant agreement ratio and use agreement values were calculated to ascertain the most culturally important pangolin body part as well as the level of knowledge dissemination among traditional healers with regards pangolin body parts. Our study revealed that 13 body parts of pangolins are used to treat various medicinal ailments. Pangolin scales and bones were the most prevalent prescribed body parts and indicated the highest cultural significance among traditional healing practices primarily for the treatment of spiritual protection, rheumatism, financial rituals and convulsions. Despite being classified under Schedule 1 of Ghana's Wildlife Conservation Act of 1971 (LI 685), that prohibits anyone from hunting or being in possession of a pangolin, our results indicated that the use of pangolins for traditional medicinal purposes is widespread among traditional healers in Ghana. A study on the population status and ecology of the three species of African pangolins occurring in Ghana is urgently required in order to determine the impact this harvest for traditional medical purposes has on their respective populations as current levels appear to be unmonitored and unsustainable.	[Boakye, Maxwell Kwame; Jansen, Raymond] Tshwane Univ Technol, Dept Environm Water & Earth Sci, Pretoria, South Africa; [Kotze, Antoinette; Dalton, Desire-Lee] Natl Zool Gardens South Africa, Pretoria, South Africa; [Kotze, Antoinette] Univ Free State, Dept Genet, Bloemfontein, South Africa; [Pietersen, Darren William; Kotze, Antoinette; Jansen, Raymond] African Pangolin Working Grp, Pretoria, South Africa	Tshwane University of Technology; National Research Foundation - South Africa; National Zoological Gardens of South Africa; University of the Free State	Boakye, MK (corresponding author), Tshwane Univ Technol, Dept Environm Water & Earth Sci, Pretoria, South Africa.	maxwell_boakye@yahoo.com	Boakye, Maxwell Kwame/Q-9301-2019	Boakye, Maxwell Kwame/0000-0002-5796-4121; Jansen, Raymond/0000-0003-4741-3307; Dalton, Desire Lee/0000-0001-5975-6425	Tshwane University of Technology; National Zoological Gardens of South Africa; Rufford Foundation [13600-1]	Tshwane University of Technology; National Zoological Gardens of South Africa(National Research Foundation - South Africa); Rufford Foundation	The authors are grateful to the Tshwane University of Technology (www.tut.ac.za), National Zoological Gardens of South Africa (www.nzg.ac.za) and the Rufford Foundation (www.rufford.org) (RSG reference: 13600-1) for funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel C, 2005, ALTERN MED REV, V10, P112; Akpona HA, 2008, MAMMALIA, V72, P198, DOI 10.1515/MAMM.2008.046; Almeida CDCBR, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-15; Alves RRN, 2007, BIOSCIENCE, V57, P949, DOI 10.1641/B571107; Alves RRN, 2006, J ETHNOPHARMACOL, V107, P259, DOI 10.1016/j.jep.2006.03.007; Alves RRN, 2008, J ETHNOBIOL ETHNOMED, V4, DOI 10.1186/1746-4269-4-3; Alves RRN, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-44; Alves RRN, 2005, J ETHNOBIOL ETHNOMED, V1, DOI [10.1186/1746-4269-1-10, 10.1186/1746-4269-1-5]; Asante E., 2013, J SOCIOL RES, V4, P256, DOI DOI 10.5296/JSR.V4I2.4224; Ayodele, 2012, GLOBAL J MED RES, V12, P6; Babbie E., 2010, PRACTICE SOCIAL RES, V10th; Boakye MK, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-76; Brautigam Amie, 1994, Traffic Bulletin, V15, P15; Chakkaravarthy QA, 2012, P 3 SEM SMALL MAMM I, P50; Challender D, 2014, ASIAN GEOGRAPHIC, V103, P86; CHALLENDER D. W. S., 2012, TRAFFIC B, V24, P53; Challender DWS, 2014, SCALING PANGOLIN CON; Costa-Neto EM, 2004, SUSTAIN DEV, V12, P161, DOI 10.1002/sd.234; de Graft Aikins A, 2012, Ghana Med J, V46, P59; Department for International Development (DFID), 2011, MAL COUNTR PROF VERS; Dove N, 2010, J BLACK STUD, V40, P823, DOI 10.1177/0021934708320001; Gaski AL, 1994, PRESCRIPTION EXTINCT; Gaudin TJ, 2009, J MAMM EVOL, V16, P235, DOI 10.1007/s10914-009-9119-9; Ghana Districts, 2006, REP ALL DISTR REP GH; Ghana Health Service, 2010, ANN REPORT; Ghana Statistical Service, 2012, POP REG DISTR AG GRO; Heinrich M, 1998, SOC SCI MED, V47, P1859, DOI 10.1016/S0277-9536(98)00181-6; Heinrich M, 2009, J ETHNOPHARMACOL, V124, P1, DOI 10.1016/j.jep.2009.03.043; Insoll Timothy, 2011, Anthropol Med, V18, P181, DOI 10.1080/13648470.2011.591196; Kang S, 2003, QUESTION ATTITUDE S; Kaspal P, 2012, P 3 SEM SMALL MAMM I, P37; Kumasi Metropolitan Assembly, 2006, THIS METR; Marshall NT, 1998, SEARCHING CURE CONSE; Ministry of Health, 2005, POL GUID TRAD MED DE; Moerman DE, 2007, J ETHNOPHARMACOL, V112, P451, DOI 10.1016/j.jep.2007.04.001; Ntiamoa-Baidu Y., 1997, WILDLIFE FOOD SECURI; Omolewa M, 2007, INT REV EDUC, V53, P593, DOI 10.1007/s11159-007-9060-1; Pietersen DW, 2014, S AFR J WILDL RES, V44, P167, DOI 10.3957/056.044.0209; President's Malaria Initiative, 2012, MAL OP PLAN FY2012 Y; Gazzaneo LRS, 2005, J ETHNOBIOL ETHNOMED, V1, DOI 10.1186/1746-4269-1-9; Sato A, 2012, THESIS LONDON SCH EC; Sodeinde O.A., 1999, Traffic Bulletin, V18, P35; Sodeinde Olufemi A., 1994, Oryx, V28, P43; Soewu DA, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-25; Soewu DA, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-39; Tabi MM, 2006, INT NURS REV, V53, P52, DOI 10.1111/j.1466-7657.2006.00444.x; Tabong PTN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054429; Tardio J, 2008, ECON BOT, V62, P24, DOI 10.1007/s12231-007-9004-5; Thomas E, 2009, J ETHNOPHARMACOL, V122, P60, DOI 10.1016/j.jep.2008.11.021; Trotter R.T., 1986, PLANTS INDIGENOUS ME, P91, DOI DOI 10.4324/9781315060385-6; Twumasi PA, 1979, J OPINION, V9, P29, DOI [10.2307/1166260, DOI 10.2307/1166260]; World Health Organization, 2002, WHO TRADITIONAL MED, P1	52	44	48	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0117199	10.1371/journal.pone.0117199	http://dx.doi.org/10.1371/journal.pone.0117199			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602281	Green Submitted, gold, Green Published			2022-12-26	WOS:000348203500045
J	Li, XT; Hu, XM; Li, XQ; Hao, XR				Li, Xiantao; Hu, Ximu; Li, Xiaoqing; Hao, Xuran			Overexpression of Tau Downregulated the mRNA Levels of Kv Channels and Improved Proliferation in N2A Cells	PLOS ONE			English	Article							GATED POTASSIUM CHANNELS; PROTEIN-TAU; K+ CHANNELS; NEUROBLASTOMA-CELLS; NEURITE GROWTH; EXPRESSION; PHOSPHORYLATION; IDENTIFICATION; LOCALIZATION; ESTRADIOL	Microtubule binding protein tau has a crucial function in promoting the assembly and stabilization of microtubule. Besides tuning the action potentials, voltage-gated K+ channels (Kv) are important for cell proliferation and appear to play a role in the development of cancer. However, little is known about the possible interaction of tau with Kv channels in various tissues. In the present study, tau plasmids were transiently transfected into mouse neuroblastoma N2A cells to explore the possible linkages between tau and Kv channels. This treatment led to a downregulation of mRNA levels of several Kv channels, including Kv2.1, Kv3.1, Kv4.1, Kv9.2, and KCNH4, but no significant alteration was observed for Kv5.1 and KCNQ4. Furthermore, the macroscopic currents through Kv channels were reduced by 36.5% at +60 mV in tau-tranfected N2A cells. The proliferation rates of N2A cells were also improved by the induction of tau expression and the incubation of TEA (tetraethylammonium) for 48 h by 120.9% and 149.3%, respectively. Following the cotransfection with tau in HEK293 cells, the mRNA levels and corresponding currents of Kv2.1 were significantly declined compared with single Kv2.1 transfection. Our data indicated that overexpression of tau declined the mRNA levels of Kv channels and related currents. The effects of tau overexpression on Kv channels provided an alternative explanation for low sensitivity to anticancer chemicals in some specific cancer tissues.	[Li, Xiantao; Li, Xiaoqing; Hao, Xuran] South Cent Univ Nationalities, Coll Life Sci, Dept Neurosci, Wuhan 430074, Peoples R China; [Hu, Ximu] South Cent Univ Nationalities, Wuhan 430074, Peoples R China	South Central Minzu University; South Central Minzu University	Li, XT (corresponding author), South Cent Univ Nationalities, Coll Life Sci, Dept Neurosci, Wuhan 430074, Peoples R China.	lixiantao@yahoo.com			Basic research project of South-Central University for Nationalities [YCZY12019]	Basic research project of South-Central University for Nationalities	This work was supported by the grants from the Basic research project of South-Central University for Nationalities. [YCZY12019]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcangeli A, 1995, J PHYSIOL-LONDON, V489, P455, DOI 10.1113/jphysiol.1995.sp021065; Atlas R, 2004, J NEUROCHEM, V89, P613, DOI 10.1111/j.1471-4159.2004.02371.x; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Brocchieri A, 1996, INVAS METAST, V16, P56; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; DIAZNIDO J, 1991, J CELL SCI, P51; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; FERREIRA A, 1991, J NEUROSCI, V11, P392; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Gu YJ, 1996, J NEUROCHEM, V67, P1235; Ikeda H, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2598; Jan LY, 1997, J PHYSIOL-LONDON, V505, P267, DOI 10.1111/j.1469-7793.1997.267bb.x; Kim JA, 1998, ARCH PHARM RES, V21, P664, DOI 10.1007/BF02976754; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Lang F, 2005, J MEMBRANE BIOL, V205, P147, DOI 10.1007/s00232-005-0780-5; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LeppleWienhues A, 1996, J MEMBRANE BIOL, V151, P149, DOI 10.1007/s002329900066; Leung YM, 2011, J CELL PHYSIOL, V226, P1090, DOI 10.1002/jcp.22430; Li HL, 2007, P NATL ACAD SCI USA, V104, P3591, DOI 10.1073/pnas.0609303104; Li XQ, 2014, NEUROREPORT, V25, P574, DOI 10.1097/WNR.0000000000000137; Mandelkow EM, 1996, ANN NY ACAD SCI, V777, P96, DOI 10.1111/j.1749-6632.1996.tb34407.x; Moschner K, 2014, J BIOL CHEM, V289, P16814, DOI 10.1074/jbc.M113.541425; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; Ouadid-Ahidouch H, 2000, BIOCHEM BIOPH RES CO, V278, P272, DOI 10.1006/bbrc.2000.3790; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; Pollock NS, 2005, EUR J NEUROSCI, V22, P569, DOI 10.1111/j.1460-9568.2005.04242.x; Prediger ME, 2004, NEUROCHEM RES, V29, P1923; Rouzier R, 2005, P NATL ACAD SCI USA, V102, P8315, DOI 10.1073/pnas.0408974102; Sergeant N, 2005, BBA-MOL BASIS DIS, V1739, P179, DOI 10.1016/j.bbadis.2004.06.020; Tsevi I, 2005, J CELL PHYSIOL, V202, P400, DOI 10.1002/jcp.20132; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; Yi BA, 2001, P NATL ACAD SCI USA, V98, P11016, DOI 10.1073/pnas.191351798	36	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116628	10.1371/journal.pone.0116628	http://dx.doi.org/10.1371/journal.pone.0116628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590133	Green Published, Green Submitted, gold			2022-12-26	WOS:000350679400018
J	Curtright, A; Rosser, M; Goh, S; Keown, B; Wagner, E; Sharifi, J; Raible, DW; Dhaka, A				Curtright, Andrew; Rosser, Micaela; Goh, Shamii; Keown, Bailey; Wagner, Erinn; Sharifi, Jasmine; Raible, David W.; Dhaka, Ajay			Modeling Nociception in Zebrafish: A Way Forward for Unbiased Analgesic Discovery	PLOS ONE			English	Article							SODIUM-CHANNEL BLOCKER; INFLAMMATORY PAIN; MICE LACKING; IMPAIRED NOCICEPTION; ANIMAL-MODELS; TELEOST FISH; BUPRENORPHINE; HYPERALGESIA; ANTIDEPRESSANTS; AMITRIPTYLINE	Acute and chronic pain conditions are often debilitating, inflicting severe physiological, emotional and economic costs and affect a large percentage of the global population. However, the development of therapeutic analgesic agents based primarily on targeted drug development has been largely ineffective. An alternative approach to analgesic development would be to develop low cost, high throughput, untargeted animal based behavioral screens that model complex nociceptive behaviors in which to screen for analgesic compounds. Here we describe the development of a behavioral based assay in zebrafish larvae that is effective in identifying small molecule compounds with analgesic properties. In a place aversion assay, which likely utilizes supraspinal neuronal circuitry, individually arrayed zebrafish larvae show temperature-dependent aversion to increasing and decreasing temperatures deviating from rearing temperature. Modeling thermal hyperalgesia, the addition of the noxious inflammatory compound and TRPA1 agonist allyl isothiocyanate sensitized heat aversion and reversed cool aversion leading larvae to avoid rearing temperature in favor of otherwise acutely aversive cooler temperatures. We show that small molecules with known analgesic properties are able to inhibit acute and/or sensitized temperature aversion.	[Curtright, Andrew; Rosser, Micaela; Goh, Shamii; Keown, Bailey; Wagner, Erinn; Sharifi, Jasmine; Raible, David W.; Dhaka, Ajay] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Raible, David W.; Dhaka, Ajay] Univ Washington, Neurobiol & Behav Grad Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dhaka, A (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	dhaka@uw.edu		Raible, David/0000-0002-5342-5841	Scan Design Foundation Innovative Pain Research Grant; National Institutes of Health (National Institute of Dental and Craniofacial Research) [DE023730]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023730] Funding Source: NIH RePORTER	Scan Design Foundation Innovative Pain Research Grant; National Institutes of Health (National Institute of Dental and Craniofacial Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Scan Design Foundation Innovative Pain Research Grant (AD), and National Institutes of Health (National Institute of Dental and Craniofacial Research) DE023730 (AD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Balayssac D, 2014, BEHAV PHARMACOL, V25, P99, DOI 10.1097/FBP.0000000000000026; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bingham S, 2006, SEMIN CELL DEV BIOL, V17, P544, DOI 10.1016/j.semcdb.2006.09.001; Bomholt SF, 2005, NEUROPHARMACOLOGY, V48, P252, DOI 10.1016/j.neuropharm.2004.09.012; Braithwaite VA, 2007, DIS AQUAT ORGAN, V75, P131, DOI 10.3354/dao075131; Bregman H, 2011, J MED CHEM, V54, P4427, DOI 10.1021/jm200018k; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; BRYANT RM, 1983, BRIT J PHARMACOL, V78, P659, DOI 10.1111/j.1476-5381.1983.tb09417.x; Caron SJC, 2008, DEVELOPMENT, V135, P3259, DOI 10.1242/dev.023200; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chan AKM, 2010, EXPERT OPIN PHARMACO, V11, P2849, DOI 10.1517/14656566.2010.511613; CHAPMAN CR, 1985, PAIN, V22, P1, DOI 10.1016/0304-3959(85)90145-9; Christoph T, 2005, EUR J PHARMACOL, V507, P87, DOI 10.1016/j.ejphar.2004.11.052; Clare JJ, 2010, EXPERT OPIN INV DRUG, V19, P45, DOI 10.1517/13543780903435340; Clark DT, 1981, VISUAL RESPONSES DEV; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Drew LJ, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-8; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; EISENACH JC, 1995, ANESTHESIOLOGY, V83, P1046, DOI 10.1097/00000542-199511000-00018; Evans HC, 2003, DRUGS, V63, P1999, DOI 10.2165/00003495-200363190-00003; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Field MJ, 1997, BRIT J PHARMACOL, V121, P1513, DOI 10.1038/sj.bjp.0701320; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Gau P, 2013, J NEUROSCI, V33, P5249, DOI 10.1523/JNEUROSCI.5403-12.2013; Granato M, 1996, DEVELOPMENT, V123, P399; Gregory NS, 2013, J PAIN, V14, P1255, DOI 10.1016/j.jpain.2013.06.008; HEEL RC, 1979, DRUGS, V17, P81, DOI 10.2165/00003495-197917020-00001; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; KIMMEL CB, 1974, DEV PSYCHOBIOL, V7, P47, DOI 10.1002/dev.420070109; KOLTZENBURG M, 2013, WALL MELZACKS TXB PA, V6; Le Bars D, 2001, PHARMACOL REV, V53, P597; Lee HS, 2005, J NEUROSCI, V25, P1304, DOI 10.1523/JNEUROSCI.4745.04.2005; Lee JH, 2014, CELL, V157, P1393, DOI 10.1016/j.cell.2014.03.064; McGowan E, 2009, ANESTH ANALG, V109, P951, DOI 10.1213/ane.0b013e3181b01b02; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mika J, 2013, PHARMACOL REP, V65, P1611, DOI 10.1016/S1734-1140(13)71522-6; Minett MS, 2014, CELL REP, V6, P301, DOI 10.1016/j.celrep.2013.12.033; Moilanen LJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00380; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Neely GG, 2010, CELL, V143, P628, DOI 10.1016/j.cell.2010.09.047; Negri L, 2006, J NEUROSCI, V26, P6716, DOI 10.1523/JNEUROSCI.5403-05.2006; Novak AE, 2006, DEV DYNAM, V235, P1962, DOI 10.1002/dvdy.20811; Okun A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-4; Pan YA, 2012, DEVELOPMENT, V139, P591, DOI 10.1242/dev.076588; Priest BT, 2009, CURR OPIN DRUG DISC, V12, P682; Prober DA, 2008, J NEUROSCI, V28, P10102, DOI 10.1523/JNEUROSCI.2740-08.2008; Ren Ke, 1999, ILAR J, V40, P111; Sneddon LU, 2003, BRAIN RES, V972, P44, DOI 10.1016/S0006-8993(03)02483-1; Sneddon LU, 2002, NEUROSCI LETT, V319, P167, DOI 10.1016/S0304-3940(01)02584-8; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Vierck CJ, 2008, PAIN, V135, P7, DOI 10.1016/j.pain.2007.12.008; Wallace MS, 2008, CLIN J PAIN, V24, P544, DOI 10.1097/AJP.0b013e3181673b93; Woolf CJ, 2010, NAT MED, V16, P1241, DOI 10.1038/nm.2230; Yaksh TL, 2001, J NEUROSCI, V21, P5847, DOI 10.1523/JNEUROSCI.21-16-05847.2001; 2011, CURR CLIN PHARM, V6, P280, DOI DOI 10.2174/157488411798375886	58	47	47	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116766	10.1371/journal.pone.0116766	http://dx.doi.org/10.1371/journal.pone.0116766			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587718	gold, Green Published, Green Submitted			2022-12-26	WOS:000347928300019
J	Rousseau, M; Belleannee, C; Duchez, AC; Cloutier, N; Levesque, T; Jacques, F; Perron, J; Nigrovic, PA; Dieude, M; Hebert, MJ; Gelb, MH; Boilard, E				Rousseau, Matthieu; Belleannee, Clemence; Duchez, Anne-Claire; Cloutier, Nathalie; Levesque, Tania; Jacques, Frederic; Perron, Jean; Nigrovic, Peter A.; Dieude, Melanie; Hebert, Marie-Josee; Gelb, Michael H.; Boilard, Eric			Detection and Quantification of Microparticles from Different Cellular Lineages Using Flow Cytometry. Evaluation of the Impact of Secreted Phospholipase A(2) on Microparticle Assessment	PLOS ONE			English	Article							CALIBRATED POLYSTYRENE BEADS; GROUP-II PHOSPHOLIPASE-A2; HUMAN SEMINAL PLASMA; HUMAN T-CELLS; CIRCULATING MICROPARTICLES; EXTRACELLULAR VESICLES; ENDOTHELIAL-CELLS; GROUP-X; PROCOAGULANT MICROPARTICLES; BIOLOGICAL MICROPARTICLES	Microparticles, also called microvesicles, are submicron extracellular vesicles produced by plasma membrane budding and shedding recognized as key actors in numerous physio (patho) logical processes. Since they can be released by virtually any cell lineages and are retrieved in biological fluids, microparticles appear as potent biomarkers. However, the small dimensions of microparticles and soluble factors present in body fluids can considerably impede their quantification. Here, flow cytometry with improved methodology for microparticle resolution was used to detect microparticles of human and mouse species generated from platelets, red blood cells, endothelial cells, apoptotic thymocytes and cells from the male reproductive tract. A family of soluble proteins, the secreted phospholipases A(2) (sPLA(2)), comprises enzymes concomitantly expressed with microparticles in biological fluids and that catalyze the hydrolysis of membrane phospholipids. As sPLA(2) can hydrolyze phosphatidylserine, a phospholipid frequently used to assess microparticles, and might even clear microparticles, we further considered the impact of relevant sPLA(2) enzymes, sPLA(2) group IIA, V and X, on microparticle quantification. We observed that if enriched in fluids, certain sPLA(2) enzymes impair the quantification of microparticles depending on the species studied, the source of microparticles and the means of detection employed (surface phosphatidylserine or protein antigen detection). This study provides analytical considerations for appropriate interpretation of microparticle cytofluorometric measurements in biological samples containing sPLA2 enzymes.	[Rousseau, Matthieu; Duchez, Anne-Claire; Cloutier, Nathalie; Levesque, Tania; Boilard, Eric] Univ Laval, Ctr Rech Rhumatol & Immunol, Ctr Hosp Univ Quebec, Fac Med,Ctr Rech, Quebec City, PQ, Canada; [Belleannee, Clemence] Univ Laval, Ctr Rech, CHUQ, Quebec City, PQ, Canada; [Belleannee, Clemence] Univ Laval, Dept Obstet & Gynecol, Fac Med, Quebec City, PQ, Canada; [Jacques, Frederic; Perron, Jean] Ctr Hosp Univ Quebec, Quebec City, PQ, Canada; [Nigrovic, Peter A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Nigrovic, Peter A.] Harvard Univ, Sch Med, Div Immunol, Boston Childrens Hosp, Boston, MA USA; [Dieude, Melanie; Hebert, Marie-Josee] Ctr Hosp Univ Montreal CRCHUM, Montreal, PQ, Canada; [Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA	Laval University; Laval University; Laval University; Laval University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Universite de Montreal; University of Washington; University of Washington Seattle	Boilard, E (corresponding author), Univ Laval, Ctr Rech Rhumatol & Immunol, Ctr Hosp Univ Quebec, Fac Med,Ctr Rech, Quebec City, PQ, Canada.	eric.boilard@crchuq.ulaval.ca	Rousseau, Matthieu/AAA-5385-2022; Duchez, anne-claire/AAK-5041-2020	Rousseau, Matthieu/0000-0002-2895-2957; gelb, michael/0000-0001-7000-5219; Dieude, Melanie/0000-0002-9300-4232; Duchez, Anne-Claire/0000-0001-5654-4320; Belleannee, Clemence/0000-0001-9284-9420	National Sciences and Engineering Research Council; National Institutes of Health [R37 HL36235]; Fonds Quebecois de Recherche en Sante (FQRS); Canadian Arthritis Network; Arthritis Society; Faculte de Medecine (Universite Laval); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036235, R37HL036235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065538] Funding Source: NIH RePORTER	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds Quebecois de Recherche en Sante (FQRS); Canadian Arthritis Network; Arthritis Society; Faculte de Medecine (Universite Laval); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by an operating discovery grant from the National Sciences and Engineering Research Council awarded to EB and by National Institutes of Health grant R37 HL36235 awarded to MHG. EB is recipient of awards from the Fonds Quebecois de Recherche en Sante (FQRS) and the Canadian Arthritis Network and is a Canadian Institutes of Health Research New Investigator. ACD and MR are recipients of a fellowship from The Arthritis Society and the Faculte de Medecine (Universite Laval), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberts M, 2014, REPRODUCTION, V147, pR1, DOI 10.1530/REP-13-0358; Aatonen MT, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24692; Aho VV, 2002, GRAEF ARCH CLIN EXP, V240, P521, DOI 10.1007/s00417-002-0477-8; Arienti G, 1997, BBA-GEN SUBJECTS, V1336, P533, DOI 10.1016/S0304-4165(97)00071-8; Arraud N, 2014, J THROMB HAEMOST, V12, P614, DOI 10.1111/jth.12554; Augustine D, 2014, CIRC RES, V114, P109, DOI 10.1161/CIRCRESAHA.114.301904; Belleannee C, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110486; Bernatchez PN, 2001, BRIT J PHARMACOL, V134, P197, DOI 10.1038/sj.bjp.0704215; Bezzine S, 2002, J BIOL CHEM, V277, P48523, DOI 10.1074/jbc.M203137200; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Biro E, 2007, ANN RHEUM DIS, V66, P1085, DOI 10.1136/ard.2006.061309; Boilard E, 2003, FASEB J, V17, P1068, DOI 10.1096/fj.02-0938com; Boilard E, 2003, BLOOD, V102, P2901, DOI 10.1182/blood-2002-12-3702; Boilard E, 2014, BLOOD, V123, P2854, DOI 10.1182/blood-2013-07-515536; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Boing AN, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23430; Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543; Bowton DL, 1997, AM J RESP CRIT CARE, V155, P421, DOI 10.1164/ajrccm.155.2.9032172; Burnier L, 2009, THROMB HAEMOSTASIS, V101, P439, DOI 10.1160/TH08-08-0521; Buzas EI, 2014, NAT REV RHEUMATOL, V10, P356, DOI 10.1038/nrrheum.2014.19; Chalbot S, 2009, CLIN CHEM, V55, P2171, DOI 10.1373/clinchem.2009.130286; Chamouard P, 2005, DIGEST DIS SCI, V50, P574, DOI 10.1007/s10620-005-2477-0; Chandler WL, 2011, J THROMB HAEMOST, V9, P1216, DOI 10.1111/j.1538-7836.2011.04283.x; Cloutier N, 2013, EMBO MOL MED, V5, P235, DOI 10.1002/emmm.201201846; Connor DE, 2010, THROMB HAEMOSTASIS, V103, P1044, DOI 10.1160/TH09-09-0644; Crookston KP, 2013, INT J RHEUM DIS, V16, P72, DOI 10.1111/1756-185x.12026; Cunningham TJ, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-26; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Dasgupta SK, 2009, BLOOD, V113, P1332, DOI 10.1182/blood-2008-07-167148; Dasgupta SK, 2012, CIRCULATION, V125, P1664, DOI 10.1161/CIRCULATIONAHA.111.068833; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Eerola LI, 2006, BBA-MOL CELL BIOL L, V1761, P745, DOI 10.1016/j.bbalip.2006.04.002; Escoffier J, 2010, J CLIN INVEST, V120, P1415, DOI 10.1172/JCI40494; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; Franz C, 2013, J REPROD IMMUNOL, V98, P45, DOI 10.1016/j.jri.2013.02.002; Gidlof O, 2013, BLOOD, V121, P3908, DOI 10.1182/blood-2012-10-461798; Grass DS, 1996, J CLIN INVEST, V97, P2233, DOI 10.1172/JCI118664; Guervilly C, 2011, CRIT CARE, V15, DOI 10.1186/cc9978; Gyorgy B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049726; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Gyorgy B, 2011, BLOOD, V117, pE39, DOI 10.1182/blood-2010-09-307595; Harrison P, 2012, J THROMB HAEMOST, V10, P916, DOI 10.1111/j.1538-7836.2012.04711.x; Headland SE, 2014, SCI REP-UK, V4, DOI 10.1038/srep05237; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Issman L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083680; Janssen MJW, 1999, PROTEIN ENG, V12, P497, DOI 10.1093/protein/12.6.497; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; Komiyama K, 2009, ORAL MEDICINE PATHOL, V13, P99, DOI DOI 10.3353/OMP.13.99; Lacroix R, 2012, J THROMB HAEMOST, V10, P437, DOI 10.1111/j.1538-7836.2011.04610.x; Lacroix R, 2010, SEMIN THROMB HEMOST, V36, P807, DOI 10.1055/s-0030-1267034; Laffont B, 2013, BLOOD, V122, P253, DOI 10.1182/blood-2013-03-492801; Laine VJO, 1999, J IMMUNOL, V162, P7402; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; LEMOINNE S, 2014, NAT REV GASTRO HEPAT, DOI DOI 10.1038/NRGASTRO.2014; Leroyer AS, 2007, J AM COLL CARDIOL, V49, P772, DOI 10.1016/j.jacc.2006.10.053; Masuda S, 2004, BBA-MOL CELL BIOL L, V1686, P61, DOI 10.1016/j.bbalip.2004.08.017; Montoro-Garcia S, 2013, ATHEROSCLEROSIS, V227, P313, DOI 10.1016/j.atherosclerosis.2013.01.028; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Morel O, 2004, CURR OPIN HEMATOL, V11, P156, DOI 10.1097/01.moh.0000131441.10020.87; Morel O, 2006, ARTERIOSCL THROM VAS, V26, P2594, DOI 10.1161/01.ATV.0000246775.14471.26; Morel O, 2011, ARTERIOSCL THROM VAS, V31, P15, DOI 10.1161/ATVBAHA.109.200956; Mullier F, 2011, J THROMB HAEMOST, V9, P1679, DOI 10.1111/j.1538-7836.2011.04386.x; Murakami M, 2011, J BIOCHEM, V150, P233, DOI 10.1093/jb/mvr088; Murakami M, 2010, BIOCHIMIE, V92, P561, DOI 10.1016/j.biochi.2010.03.015; NAKAE H, 1995, BURNS, V21, P422, DOI 10.1016/0305-4179(95)00022-4; NEVALAINEN TJ, 1993, ANDROLOGIA, V25, P355; Nevalainen TJ, 2005, BBA-MOL CELL BIOL L, V1733, P210, DOI 10.1016/j.bbalip.2004.12.012; NEVALAINEN TJ, 1994, INVEST OPHTH VIS SCI, V35, P417; Nolte-'t Hoen ENM, 2012, NANOMED-NANOTECHNOL, V8, P712, DOI 10.1016/j.nano.2011.09.006; Olson ED, 2010, J BIOL CHEM, V285, P10993, DOI 10.1074/jbc.M109.070797; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Perez-Pujol S, 2007, CYTOM PART A, V71A, P38, DOI 10.1002/cyto.a.20354; Rand ML, 2006, J THROMB HAEMOST, V4, P1621, DOI 10.1111/j.1538-7836.2006.02011.x; Rank A, 2011, PLATELETS, V22, P111, DOI 10.3109/09537104.2010.520373; Robert S, 2011, J THROMB HAEMOST, V9, P1676, DOI 10.1111/j.1538-7836.2011.04387.x; Robert S, 2009, J THROMB HAEMOST, V7, P190, DOI 10.1111/j.1538-7836.2008.03200.x; Robert S, 2012, ARTERIOSCL THROM VAS, V32, P1054, DOI 10.1161/ATVBAHA.111.244616; Rouault M, 2007, BIOCHEMISTRY-US, V46, P1647, DOI 10.1021/bi062119b; Sellam J, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2833; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Sossdorf M, 2011, MED SCI SPORT EXER, V43, P1169, DOI 10.1249/MSS.0b013e3182068645; Styles LA, 2000, BLOOD, V96, P3276; Sullivan R, 2013, REPRODUCTION, V146, pR21, DOI 10.1530/REP-13-0058; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; TAKAYAMA K, 1991, BIOCHEM BIOPH RES CO, V178, P1505, DOI 10.1016/0006-291X(91)91064-J; Turiak L, 2011, J PROTEOMICS, V74, P2025, DOI 10.1016/j.jprot.2011.05.023; Van der Pol E, 2012, J THROMB HAEMOST, V10, P919, DOI 10.1111/j.1538-7836.2012.04683.x; van der Vlist EJ, 2012, NAT PROTOC, V7, P1311, DOI 10.1038/nprot.2012.065; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Willekens FLA, 2008, BRIT J HAEMATOL, V141, P549, DOI 10.1111/j.1365-2141.2008.07055.x; Zhang JH, 2007, EXP HEMATOL, V35, P490, DOI 10.1016/j.exphem.2006.11.011; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	93	56	57	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116812	10.1371/journal.pone.0116812	http://dx.doi.org/10.1371/journal.pone.0116812			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587983	Green Submitted, gold, Green Published			2022-12-26	WOS:000347928300021
J	Larabee, JL; Krumholz, A; Hunt, JJ; Lanis, JM; Ballard, JD				Larabee, Jason L.; Krumholz, Aleze; Hunt, Jonathan J.; Lanis, Jordi M.; Ballard, Jimmy D.			Exposure of Neutralizing Epitopes in the Carboxyl-terminal Domain of TcdB Is Altered by a Proximal Hypervariable Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIDIUM-DIFFICILE TOXIN; TRANSLOCATION; INFECTION; CELLS; ANTIBODIES; FRAGMENTS; MECHANISM; CLEAVAGE; DISEASE; CYTOSOL	The sequence, activity, and antigenicity of TcdB varies between different strains of Clostridium difficile. As a result, ribotype-specific forms of TcdB exhibit different toxicities and are not strongly cross-neutralized. Using a combination of biochemical and immunological approaches, we compared two important variants of TcdB (TcdB(012) and TcdB(027)) to identify the mechanisms through which sequence differences alter epitopes and activity of the toxin. These analyses led to the discovery of a critical variation in the 1753-1851 (B2') region of Taal, which affects the exposure of neutralizing epitopes in the toxin, Sequence comparisons found that the B2' region exhibits only 77% identity and is the most variable sequence between the two forms of TcdB. A combination of biochemical, analytical, and rnutagenesis experiments revealed that the B2' region promotes protein-protein interactions. These interactions appear to shield neutralizing epitopes that would otherwise be exposed in the toxin, an event found to be less prominent in TcdB012 due to sequence differences in the 1773-1780 and 1791-1798 regions of the B2' domain. When the carboxyl-terminal domains of TcdB(027) and TcdB, are swapped, neutralization experiments suggest that the amino terminus of TcdB interacts with the B2' region and impacts the exposure of neutralizing epitopes in the carboxyl terminus. Collectively, these data suggest that variations in the B2' region affect protein-protein interactions within TcdB and that these interactions influence the exposure of neutralizing epitopes.	[Larabee, Jason L.; Krumholz, Aleze; Hunt, Jonathan J.; Lanis, Jordi M.; Ballard, Jimmy D.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Ballard, JD (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, BMSB 1053,940 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	jimmy-ballard@ouhsc.edu		Larabee, Jason/0000-0001-5757-7247	National Institutes of Health [R01HL084489]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI119048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL084489 (to J. D. B.).	Barth H, 2001, J BIOL CHEM, V276, P10670, DOI 10.1074/jbc.M009445200; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Chumbler NM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003072; Farrow MA, 2013, P NATL ACAD SCI USA, V110, P18674, DOI 10.1073/pnas.1313658110; Genisyuerek S, 2011, MOL MICROBIOL, V79, P1643, DOI 10.1111/j.1365-2958.2011.07549.x; Hernandez L. D., 2014, ANTIMICROB AGENTS CH, DOI [101128/AAC.04433-04414, DOI 10.1128/AAC.04433-04414]; Humphreys DP, 2014, CLIN VACCINE IMMUNOL, V21, P913, DOI 10.1128/CVI.00116-14; Lanis JM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003523; Lanis JM, 2012, MOL MICROBIOL, V84, P66, DOI 10.1111/j.1365-2958.2012.08009.x; Lanis JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001061; Leuzzi R, 2013, INFECT IMMUN, V81, P2851, DOI 10.1128/IAI.01341-12; Li S, 2013, PATHOG DIS, V67, P11, DOI 10.1111/2049-632X.12016; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Marozsan AJ, 2012, J INFECT DIS, V206, P706, DOI 10.1093/infdis/jis416; Marsh JW, 2012, J CLIN MICROBIOL, V50, P4078, DOI 10.1128/JCM.02291-12; Musher DM, 2006, NEW ENGL J MED, V354, P1199; Orth P, 2014, J BIOL CHEM, V289, P18008, DOI 10.1074/jbc.M114.560748; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Rupnik M, 1997, FEMS MICROBIOL LETT, V148, P197, DOI 10.1016/S0378-1097(97)00033-5; Savidge TC, 2003, GASTROENTEROLOGY, V125, P413, DOI 10.1016/S0016-5085(03)00902-8; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Sun XM, 2010, TOXINS, V2, P1848, DOI 10.3390/toxins2071848; Valiente E, 2014, CLIN MICROBIOL INFEC, V20, P396, DOI 10.1111/1469-0691.12619; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wilcox MH, 2012, CLIN INFECT DIS, V55, P1056, DOI 10.1093/cid/cis614; Wohlan K, 2014, CELL MICROBIOL, V16, P1678, DOI 10.1111/cmi.12317; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; Zhang YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058634; Zhang ZF, 2014, P NATL ACAD SCI USA, V111, P3721, DOI 10.1073/pnas.1400680111	34	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6975	6985		10.1074/jbc.M114.612184	http://dx.doi.org/10.1074/jbc.M114.612184			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25614625	Green Published, hybrid			2022-12-26	WOS:000350991500031
J	Comeaux, EQ; Cuya, SM; Kojima, K; Jafari, N; Wanzeck, KC; Mobley, JA; Bjornsti, MA; van Waardenburg, RCAM				Comeaux, Evan Q.; Cuya, Selma M.; Kojima, Kyoko; Jafari, Nauzanene; Wanzeck, Keith C.; Mobley, James A.; Bjornsti, Mary-Ann; van Waardenburg, Robert C. A. M.			Tyrosyl-DNA Phosphodiesterase I Catalytic Mutants Reveal an Alternative Nucleophile That Can Catalyze Substrate Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; PHOSPHOLIPASE-D SUPERFAMILY; TOPOISOMERASE-I; ACTIVE-SITE; SPINOCEREBELLAR ATAXIA; SACCHAROMYCES-CEREVISIAE; COVALENT COMPLEXES; CRYSTAL-STRUCTURE; VERTEBRATE CELLS; TDP1	Tyrosyl-DNA phosphodiesterase I (Tdp1) catalyzes the repair of 3'-DNA adducts, such as the 3'-phosphotyrosyl linkage of DNA topoisomerase I to DNA. Tdp1 contains two conserved catalytic histidines: a nucleophilic His (His(nuc)) that attacks DNA adducts to form a covalent 3'-phosphohistidyl intermediate and a general acid/base His (His(gab)), which resolves the Tdp1-DNA linkage. A His(nuc) to Ala mutant protein is reportedly inactive, whereas the autosomal recessive neurodegenerative disease SCAN1 has been attributed to the enhanced stability of the Tdp1-DNA intermediate induced by mutation of His(gab) to Arg. However, here we report that expression of the yeast His(nuc)Ala (H182A) mutant actually induced topoisomerase I-dependent cytotoxicity and further enhanced the cytotoxicity of Tdp1 His(gab) mutants, including H432N and the SCAN1-related H432R. Moreover, the His(nuc)Ala mutant was catalytically active in vitro, albeit at levels 85-fold less than that observed with wild type Tdp1. In contrast, the His(nuc)Phe mutant was catalytically inactive and suppressed His(gab) mutant-induced toxicity. These data suggest that the activity of another nucleophile when His(nuc) is replaced with residues containing a small side chain (Ala, Asn, and Gln), but not with a bulky side chain. Indeed, genetic, biochemical, and mass spectrometry analyses show that a highly conserved His, immediately N-terminal to His(nuc), can act as a nucleophile to catalyze the formation of a covalent Tdp1-DNA intermediate. These findings suggest that the flexibility of Tdp1 active site residues may impair the resolution of mutant Tdp1 covalent phosphohistidyl intermediates and provide the ration-ale for developing chemotherapeutics that stabilize the covalent Tdp1-DNA intermediate.	[Comeaux, Evan Q.; Cuya, Selma M.; Wanzeck, Keith C.; Bjornsti, Mary-Ann; van Waardenburg, Robert C. A. M.] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA; [Kojima, Kyoko] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Jafari, Nauzanene] St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA; [Mobley, James A.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; St Jude Children's Research Hospital; University of Alabama System; University of Alabama Birmingham	van Waardenburg, RCAM (corresponding author), Univ Alabama Birmingham, Dept Pharmacol & Toxicol, VH 155,1720 2nd Ave S, Birmingham, AL 35294 USA.	rvanwaar@uab.edu		Cuya, Selma/0000-0002-5842-0679; mobley, james/0000-0002-3229-7975	National Institutes of Health [CA58755]; NCI [5P30CA013148]; Alabama Drug Discovery Alliance; Comprehensive Cancer Center Core Support Grant; NATIONAL CANCER INSTITUTE [P30CA013148, R01CA058755] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alabama Drug Discovery Alliance; Comprehensive Cancer Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA58755 (to M. A. B.) and NCI Grant 5P30CA013148. This work was also supported in part by funds from the Alabama Drug Discovery Alliance (to R. C. A. M. v. W.) and a Comprehensive Cancer Center Core Support Grant (to A. M. and K. K.).	Akada R, 2006, YEAST, V23, P399, DOI 10.1002/yea.1365; Caldecott KW, 2003, CELL, V112, P7, DOI 10.1016/S0092-8674(02)01247-3; CHEN GL, 1984, J BIOL CHEM, V259, P3560; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Colley WC, 2004, J BIOL CHEM, V279, P54069, DOI 10.1074/jbc.M409764200; Das BB, 2009, EMBO J, V28, P3667, DOI 10.1038/emboj.2009.302; Davies DR, 2003, CHEM BIOL, V10, P139, DOI 10.1016/S1074-5521(03)00021-8; Davies DR, 2002, J MOL BIOL, V324, P917, DOI 10.1016/S0022-2836(02)01154-3; Davies DR, 2002, STRUCTURE, V10, P237, DOI 10.1016/S0969-2126(02)00707-4; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Fertala J, 2000, J BIOL CHEM, V275, P15246, DOI 10.1074/jbc.275.20.15246; Gajewski S, 2012, J MOL BIOL, V415, P741, DOI 10.1016/j.jmb.2011.11.044; He XP, 2007, J MOL BIOL, V372, P1070, DOI 10.1016/j.jmb.2007.07.055; HSIANG YH, 1989, CANCER RES, V49, P5077; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Huang SYN, 2013, NUCLEIC ACIDS RES, V41, P7793, DOI 10.1093/nar/gkt483; Inamdar KV, 2002, J BIOL CHEM, V277, P27162, DOI 10.1074/jbc.M204688200; Interthal H, 2005, J BIOL CHEM, V280, P36518, DOI 10.1074/jbc.M508898200; Interthal H, 2005, EMBO J, V24, P2224, DOI 10.1038/sj.emboj.7600694; Interthal H, 2001, P NATL ACAD SCI USA, V98, P12009, DOI 10.1073/pnas.211429198; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; KAUH EA, 1995, P NATL ACAD SCI USA, V92, P6299, DOI 10.1073/pnas.92.14.6299; Lebedeva NA, 2011, FEBS LETT, V585, P683, DOI 10.1016/j.febslet.2011.01.032; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Liu CY, 2004, DNA REPAIR, V3, P593, DOI 10.1016/j.dnarep.2004.03.030; LYNN RM, 1989, P NATL ACAD SCI USA, V86, P3559, DOI 10.1073/pnas.86.10.3559; Megonigal MD, 1997, J BIOL CHEM, V272, P12801, DOI 10.1074/jbc.272.19.12801; Murai J, 2012, J BIOL CHEM, V287, P12848, DOI 10.1074/jbc.M111.333963; Nitiss KC, 2006, P NATL ACAD SCI USA, V103, P8953, DOI 10.1073/pnas.0603455103; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pouliot JJ, 2001, GENES CELLS, V6, P677, DOI 10.1046/j.1365-2443.2001.00452.x; Raymond AC, 2004, J MOL BIOL, V338, P895, DOI 10.1016/j.jmb.2004.03.013; SAUER B, 1990, New Biologist, V2, P441; Schellenberg MJ, 2012, NAT STRUCT MOL BIOL, V19, P1363, DOI 10.1038/nsmb.2418; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Shi K, 2012, NAT STRUCT MOL BIOL, V19, P1372, DOI 10.1038/nsmb.2423; SIOUD M, 1989, BIOCHEMISTRY-US, V28, P3638, DOI 10.1021/bi00435a002; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Tumbale P, 2011, NAT STRUCT MOL BIOL, V18, P1189, DOI 10.1038/nsmb.2146; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534; Yang W, 2010, CRIT REV BIOCHEM MOL, V45, P520, DOI 10.3109/10409238.2010.513375; Zeng ZH, 2011, J BIOL CHEM, V286, P403, DOI 10.1074/jbc.M110.181016; Zhou T, 2005, NUCLEIC ACIDS RES, V33, P289, DOI 10.1093/nar/gki170	47	10	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6203	6214		10.1074/jbc.M114.635284	http://dx.doi.org/10.1074/jbc.M114.635284			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25609251	hybrid, Green Published			2022-12-26	WOS:000350732500028
J	Kondo, N; Marin, M; Kim, JH; Desai, TM; Melikyan, GB				Kondo, Naoyuki; Marin, Mariana; Kim, Jeong Hwa; Desai, Tanay M.; Melikyan, Gregory B.			Distinct Requirements for HIV-Cell Fusion and HIV-mediated Cell-Cell Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIN CYTOSKELETON; MEMBRANE-FUSION; T-CELLS; CONFORMATIONAL-CHANGES; ENDOCYTIC PATHWAY; CYTOPLASMIC TAIL; PLASMA-MEMBRANE; DENDRITIC CELLS; PORE EXPANSION	Whether HIV-1 enters cells by fusing with the plasma membrane or with endosomes is a subject of active debate. The ability of HIV-1 to mediate fusion between adjacent cells, a process referred to as "fusion-from-without" (FFNX10), shows that this virus can fuse with the plasma membrane. To compare FTWO occurring at the cell surface with HIV-cell fusion through a conventional entry route, we designed an experimental approach that enabled the measurements of both processes in the same sample. The following key differences were observed. First, a very small fraction of viruses fusing with target cells participated in MVO. Second, whereas HIV-1 fusion with adherent cells was insensitive to actin inhibitors, post-C1)4/coreceptor binding steps during FTWO were abrogated. A partial dependence of HINT-cell fusion on actin remodeling was observed in CD4(+) T cells, but this effect appeared to be due to the actin dependence of virus uptake. Third, deletion of the cytoplasmic tail of HIV-1 gp41 dramatically enhanced the ability of the virus to promote FFWO, while having a modest effect on virus-cell fusion. Distinct efficiencies and actin dependences of ITWO versus HIVcell fusion are consistent with the notion that, except for a minor fraction of particles that mediate fusion between the plasma membranes of adjacent cells, HIV-1 enters through an endocytic pathway. We surmise, however, that cell-cell contacts enabling HIV-1 fusion with the plasma membrane could be favored at the sites of high density of target cells, such as lymph nodes.	[Kondo, Naoyuki; Marin, Mariana; Kim, Jeong Hwa; Desai, Tanay M.; Melikyan, Gregory B.] Emory Univ, Childrens Ctr, Div Pediat Infect Dis, Atlanta, GA 30322 USA; [Melikyan, Gregory B.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA	Emory University; Children's Healthcare of Atlanta (CHOA)	Melikyan, GB (corresponding author), Emory Univ, Dept Pediat Infect Dis, Sch Med, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	gmeliki@emory.edu	Kondo, Naoyuki/W-5845-2019	Kondo, Naoyuki/0000-0002-6624-5989	National Institutes of Health [R01 GM054787]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM054787 (to G. B. M.).	Abrahamyan LG, 2005, J VIROL, V79, P106, DOI 10.1128/JVI.79.1.106-115.2005; Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; Anand AR, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-2; Barrero-Villar M, 2009, J CELL SCI, V122, P103, DOI 10.1242/jcs.035873; BEDINGER P, 1988, NATURE, V334, P162, DOI 10.1038/334162a0; Binley JM, 2003, J VIROL, V77, P5678, DOI 10.1128/JVI.77.10.5678-5684.2003; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; Cameron PU, 2010, P NATL ACAD SCI USA, V107, P16934, DOI 10.1073/pnas.1002894107; Campbell EM, 2004, J VIROL, V78, P5745, DOI 10.1128/JVI.78.11.5745-5755.2004; Carter GC, 2011, VIROLOGY, V409, P234, DOI 10.1016/j.virol.2010.10.018; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chen A, 2008, J CELL SCI, V121, P3619, DOI 10.1242/jcs.032169; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chojnacki J, 2012, SCIENCE, V338, P524, DOI 10.1126/science.1226359; CLAVEL F, 1994, J VIROL, V68, P1179, DOI 10.1128/JVI.68.2.1179-1185.1994; Clotet-Codina I, 2009, ANTIVIR RES, V83, P94, DOI 10.1016/j.antiviral.2009.03.009; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Cureton DK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001127; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Dale BM, 2011, CELL HOST MICROBE, V10, P551, DOI 10.1016/j.chom.2011.10.015; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Deng YQ, 2007, BIOCHEMISTRY-US, V46, P4360, DOI 10.1021/bi7001289; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Earl LA, 2013, TRENDS MICROBIOL, V21, P397, DOI 10.1016/j.tim.2013.06.004; Fackler OT, 2006, CURR OPIN MICROBIOL, V9, P409, DOI 10.1016/j.mib.2006.06.010; Felts RL, 2010, P NATL ACAD SCI USA, V107, P13336, DOI 10.1073/pnas.1003040107; Forster MJ, 2000, J MOL BIOL, V298, P841, DOI 10.1006/jmbi.2000.3715; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gallo SA, 2001, BIOCHEMISTRY-US, V40, P12231, DOI 10.1021/bi0155596; Gobeil LA, 2013, J VIROL, V87, P735, DOI 10.1128/JVI.01802-12; Guo J, 2011, J VIROL, V85, P9824, DOI 10.1128/JVI.05170-11; Hammonds J, 2007, VACCINE, V25, P8036, DOI 10.1016/j.vaccine.2007.09.016; Harmon B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000956; Herold N, 2014, J VIROL, V88, P13956, DOI 10.1128/JVI.01543-14; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Iyengar S, 1998, J VIROL, V72, P5251, DOI 10.1128/JVI.72.6.5251-5255.1998; Janas AM, 2008, VIROLOGY, V375, P442, DOI 10.1016/j.virol.2008.01.044; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kondo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044827; Kondo N, 2010, J BIOL CHEM, V285, P14681, DOI 10.1074/jbc.M109.067090; Lehmann MJ, 2005, J CELL BIOL, V170, P317, DOI 10.1083/jcb.200503059; Lin PF, 2003, P NATL ACAD SCI USA, V100, P11013, DOI 10.1073/pnas.1832214100; MADDON PJ, 1988, CELL, V54, P865, DOI 10.1016/S0092-8674(88)91241-X; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; Marechal V, 2001, J VIROL, V75, P11166, DOI 10.1128/JVI.75.22.11166-11177.2001; Markosyan RM, 2005, MOL BIOL CELL, V16, P5502, DOI 10.1091/mbc.E05-06-0496; Massarwa R, 2007, DEV CELL, V12, P557, DOI 10.1016/j.devcel.2007.01.016; Matsuda Z., 2011, CURR PROTOC CELL BIO, V50, DOI [10.1002/0471143030.cb2609s50, DOI 10.1002/0471143030.CB2609S50]; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2014, CURR OPIN VIROL, V4, P1, DOI 10.1016/j.coviro.2013.09.004; Melikyan GB, 2011, CURR TOP MEMBR, V68, P81, DOI 10.1016/B978-0-12-385891-7.00004-0; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mkrtchyan SR, 2005, J VIROL, V79, P11161, DOI 10.1128/JVI.79.17.11161-11169.2005; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Naghavi MH, 2007, CURR OPIN IMMUNOL, V19, P402, DOI 10.1016/j.coi.2007.07.003; Nguyen DH, 2005, EXP CELL RES, V304, P559, DOI 10.1016/j.yexcr.2004.11.022; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; PELCHENMATTHEWS A, 1995, J VIROL, V69, P8164, DOI 10.1128/JVI.69.12.8164-8168.1995; Permanyer M, 2010, TRENDS MICROBIOL, V18, P543, DOI 10.1016/j.tim.2010.09.003; Platt EJ, 2014, J VIROL, V88, P4304, DOI 10.1128/JVI.03447-13; Pontow SE, 2004, J VIROL, V78, P7138, DOI 10.1128/JVI.78.13.7138-7147.2004; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Qi ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003278; Richard JP, 2009, BBA-BIOMEMBRANES, V1788, P450, DOI 10.1016/j.bbamem.2008.09.014; Si ZH, 2004, P NATL ACAD SCI USA, V101, P5036, DOI 10.1073/pnas.0307953101; Sloan RD, 2013, J VIROL, V87, P8110, DOI 10.1128/JVI.00815-13; Soda Y, 1999, BIOCHEM BIOPH RES CO, V258, P313, DOI 10.1006/bbrc.1999.0633; Spear M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-45; Steffens CM, 2003, J VIROL, V77, P4985, DOI 10.1128/JVI.77.8.4985-4991.2003; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; Tardif MR, 2005, J IMMUNOL, V175, P926, DOI 10.4049/jimmunol.175.2.926; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Teeranaipong P, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18723; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; van Wilgenburg B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086071; Vidricaire G, 2007, J MOL BIOL, V368, P1267, DOI 10.1016/j.jmb.2007.03.003; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; WEISS CD, 1993, J VIROL, V67, P7060, DOI 10.1128/JVI.67.12.7060-7066.1993; Weng J, 2009, J VIROL, V83, P7467, DOI 10.1128/JVI.00163-09; WHITE J, 1981, J CELL BIOL, V89, P674, DOI 10.1083/jcb.89.3.674; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Wurth MA, 2010, VIROLOGY, V404, P117, DOI 10.1016/j.virol.2010.04.024; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Yoder A, 2011, J VIROL, V85, P3020, DOI 10.1128/JVI.02462-10; Yonezawa A, 2005, J VIROL, V79, P918, DOI 10.1128/JVI.79.2.918-926.2005; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	94	24	24	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6558	6573		10.1074/jbc.M114.623181	http://dx.doi.org/10.1074/jbc.M114.623181			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25589785	Green Published, hybrid			2022-12-26	WOS:000350732500058
J	Yang, CH; Pfeffer, SR; Sims, M; Yue, JM; Wang, YN; Linga, VG; Paulus, E; Davidoff, AM; Pfeffer, LM				Yang, Chuan He; Pfeffer, Susan R.; Sims, Michelle; Yue, Junming; Wang, Yinan; Linga, Vijay G.; Paulus, Elena; Davidoff, Andrew M.; Pfeffer, Lawrence M.			The Oncogenic MicroRNA-21 Inhibits the Tumor Suppressive Activity of FBXO11 to Promote Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLS; TARGETS; MIR-21; CANCER; MECHANISMS; EXPRESSION; LYMPHOMA; SURVIVAL; ONCOMIR; GROWTH	The microRNA miR-21 is overexpressed in most human cancers and accumulating evidence indicates that it functions as an oncogene. Since miRNAs suppress the expression of their target genes, we hypothesized that some miR-21 targets may act as tumor suppressors, and thus their expression would be anticipated to be reduced by the high miR-21 levels observed in various human cancers. By microarray analysis and quantitative PCR we identified and validated FBXO11 (a member of the F-box subfamily lacking a distinct unifying domain) as a miR-21 target gene. FBXO11 is a component of the SKP1-CUL1-F-box ubiquitin ligase complex that targets proteins for ubiquitination and proteosomal degradation. By loss of function and gain of function studies, we show that FBXO11 acts as a tumor suppressor, promotes apoptosis and mediates the degradation of the oncogenic protein BCL6. The critical role that FBXO11 plays in miR-21-mediated tumorigenesis was demonstrated by a rescue experiment, in which silencing FBXO11 in miR-21KD cancer cells restored their high tumorigenicity. Expression of miR-21 and FBXO11 are inversely correlated in tumor tissue, and their expression correlates with patient survival and tumor grade. High FBXO11 expression correlates with better patient survival and lower tumor grade consistent with its tumor suppressor activity. In contrast high miR-21 expression, which correlates with poor patient survival and higher tumor grade, is consistent with its oncogenic activity. Our results identify FBXO11 as a novel miR-21 target gene, and demonstrate that the oncogenic miRNA miR-21 decreases the expression of FBXO11, which normally acts as a tumor suppressor, and thereby promotes tumorigenesis.	[Yang, Chuan He; Pfeffer, Susan R.; Sims, Michelle; Yue, Junming; Wang, Yinan; Linga, Vijay G.; Davidoff, Andrew M.; Pfeffer, Lawrence M.] Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Paulus, Elena] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA; [Yang, Chuan He; Pfeffer, Susan R.; Sims, Michelle; Yue, Junming; Wang, Yinan; Linga, Vijay G.; Pfeffer, Lawrence M.] Univ Tennessee, Ctr Hlth Sci, Ctr Canc Res, Memphis, TN 38163 USA; [Davidoff, Andrew M.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Pfeffer, LM (corresponding author), Canc Res Bldg,19 South Manassas St Rm 154, Memphis, TN 38163 USA.	lpfeffer@uthsc.edu	Linga, Vijay G/M-5487-2015; Linga, Vijay Gandhi/AAC-6947-2019	Linga, Vijay G/0000-0001-8540-7296; Linga, Vijay Gandhi/0000-0001-8540-7296; Pfeffer, Lawrence/0000-0003-2809-1234	National Institutes of Health [CA133322]; Department of Defense [W81XWH-11-1-0533]; Cancer Center Support Grant from the National Cancer Institute [21766]; Assisi Foundation of Memphis; Muirhead Chair Endowment of the UTHSC; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA133322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Cancer Center Support Grant from the National Cancer Institute; Assisi Foundation of Memphis; Muirhead Chair Endowment of the UTHSC; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Institutes of Health CA133322 (to L. M. P. and A. M. D.), the Department of Defense W81XWH-11-1-0533 (to L. M. P.), the Cancer Center Support Grant 21766 from the National Cancer Institute and the Assisi Foundation of Memphis (to A. M. D.), by the Muirhead Chair Endowment (to L. M. P.) of the UTHSC and by the American Lebanese Syrian Associated Charities (to A. M. D.).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Folini M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-12; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Hideshima T, 2010, BLOOD, V115, P3772, DOI 10.1182/blood-2010-02-270082; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Parekh S, 2007, BLOOD, V110, P2067, DOI 10.1182/blood-2007-01-069575; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; Yang CH, 2014, J BIOL CHEM, V289, P25079, DOI 10.1074/jbc.M114.593863; Yang CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071130; Yang CH, 2011, J BIOL CHEM, V286, P39172, DOI 10.1074/jbc.M111.285098; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	27	81	84	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6037	6046		10.1074/jbc.M114.632125	http://dx.doi.org/10.1074/jbc.M114.632125			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25589783	Green Published, hybrid			2022-12-26	WOS:000350732500015
J	Bai, XT; Nicot, C				Bai, Xue Tao; Nicot, Christophe			miR-28-3p Is a Cellular Restriction Factor That Inhibits Human T Cell Leukemia Virus, Type 1 (HTLV-1) Replication and Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JAK-STAT PATHWAY; HIV-1 LATENCY; MICRORNAS; TAX; PROTEIN; DNA; PROLIFERATION; TRANSMISSION; LYMPHOCYTES; MECHANISMS	Human T cell leukemia virus, type 1 (HTLV-1) replication and spread are controlled by different viral and cellular factors. Although several anti-HIV cellular microRNAs have been described, such a regulation for HTLV-1 has not been reported. In this study, we found that miR-28-3p inhibits HTLV-1 virus expression and its replication by targeting a specific site within the genomic gag/pol viral mRNA. Because miR-28-3p is highly expressed in resting T cells, which are resistant to HTLV-1 infection, we investigated a potential protective role of miR-28-3p against de novo HTLV-1 infection. To this end, we developed a new sensitive and quantitative assay on the basis of the detection of products of reverse transcription. We demonstrate that miR-28-3p does not prevent virus receptor interaction or virus entry but, instead, induces a post-entry block at the reverse transcription level. In addition, we found that HTLV-1, subtype 1A isolates corresponding to the Japanese strain ATK-1 present a natural, single-nucleotide polymorphism within the miR-28-3p target site. As a result of this polymorphism, the ATK-1 virus sequence was not inhibited by miR-28. Interestingly, genetic studies on the transmission of the virus has shown that the ATK-1 strain, which carries a Thr-to-Cys transition mutation, is transmitted efficiently between spouses, suggesting that miR-28 may play an important role in HTLV-1 transmission.	[Nicot, Christophe] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; Ctr Viral Oncol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Nicot, C (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA.	cnicot@kumc.edu			NIAID/National Institutes of Health [AI058944]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103326] Funding Source: NIH RePORTER	NIAID/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIAID/National Institutes of Health Grant AI058944 (to C. N.).	Andresen V, 2011, BLOOD, V118, P1549, DOI 10.1182/blood-2010-06-293340; Arad U, 1998, BIOTECHNIQUES, V24, P760, DOI 10.2144/98245bm14; ASTIERGIN T, 1995, J VIROL METHODS, V51, P19, DOI 10.1016/0166-0934(94)00097-Z; Bangham CRM, 2009, FRONT BIOSCI-LANDMRK, V14, P2889, DOI 10.2741/3420; Baydoun HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042226; Baydoun HH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-302; Bazarbachi A, 2011, BLOOD, V118, P1736, DOI 10.1182/blood-2011-03-345702; Chaib-Mezrag H, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-205; Chiang KR, 2012, VIRUSES-BASEL, V4, P1390, DOI 10.3390/v4091390; Clarke C. J. P., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P117, DOI 10.2174/1568008013341361; Detsika MG, 2012, AIDS REV, V14, P188; Gaudray G, 2002, J VIROL, V76, P12813, DOI 10.1128/JVI.76.24.12813-12822.2002; GESSAIN A, 1985, LANCET, V2, P407; Girardot M., 2014, ONCOGENE, DOI [10.1038/onc.2014.60, DOI 10.1038/0NC.2014.60]; Girardot M, 2010, BLOOD, V116, P437, DOI 10.1182/blood-2008-06-165985; Gottwein E, 2013, CURR TOP MICROBIOL, V371, P201, DOI 10.1007/978-3-642-37765-5_8; Haller O, 2007, CURR TOP MICROBIOL, V316, P315; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Hussenet T, 2006, CANCER GENET CYTOGEN, V169, P102, DOI 10.1016/j.cancergencyto.2006.03.009; Iga M, 2002, J INFECT DIS, V185, P691, DOI 10.1086/339002; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jimenez VC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00763; Jones KS, 2008, NAT MED, V14, P429, DOI 10.1038/nm1745; Jopling CL, 2006, COLD SPRING HARB SYM, V71, P369, DOI 10.1101/sqb.2006.71.022; Kirken RA, 2000, J IMMUNOL, V165, P5097, DOI 10.4049/jimmunol.165.9.5097; KITAMURA K, 1993, AIDS RES HUM RETROV, V9, P1167, DOI 10.1089/aid.1993.9.1167; Ko NL, 2013, BLOOD, V121, P791, DOI 10.1182/blood-2012-03-420414; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lei XF, 2010, CELL CYCLE, V9, P1225, DOI 10.4161/cc.9.7.11387; Malbec M, 2011, VIRUSES-BASEL, V3, P254, DOI 10.3390/v3030254; Matsuoka M, 2013, CURR OPIN VIROL, V3, P684, DOI 10.1016/j.coviro.2013.08.010; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; Nicot C, 2000, MOL CELL BIOL, V20, P8580, DOI 10.1128/MCB.20.22.8580-8589.2000; Nicot C, 2004, NAT MED, V10, P197, DOI 10.1038/nm984; Pancewicz J, 2010, P NATL ACAD SCI USA, V107, P16619, DOI 10.1073/pnas.1010722107; Pessoa R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093374; PIQUE C, 1992, J VIROL, V66, P906, DOI 10.1128/JVI.66.2.906-913.1992; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Rowan Aileen G, 2012, Leuk Res Treatment, V2012, P391953, DOI 10.1155/2012/391953; Russo A, 2011, FEBS LETT, V585, P2551, DOI 10.1016/j.febslet.2011.07.015; Sampey Gavin C., 2012, Frontiers in Genetics, V3, P295, DOI 10.3389/fgene.2012.00295; Satou Y, 2010, J CLIN EXP HEMATOP, V50, P1, DOI 10.3960/jslrt.50.1; Sedger LM, 2013, MOL IMMUNOL, V56, P781, DOI 10.1016/j.molimm.2013.07.009; Sun Le, 2012, Virologica Sinica, V27, P333, DOI 10.1007/s12250-012-3266-5; Swaminathan S, 2008, J CELL PHYSIOL, V216, P321, DOI 10.1002/jcp.21480; Tabakin-Fix Y, 2006, CARCINOGENESIS, V27, P673, DOI 10.1093/carcin/bgi274; Takemoto S, 2000, BLOOD, V95, P3939; Tomita M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-22; Watanabe T, 1997, INT J HEMATOL, V66, P257; Zhang H, 2009, INT J BIOCHEM CELL B, V41, P451, DOI 10.1016/j.biocel.2008.07.016	51	41	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5381	5390		10.1074/jbc.M114.626325	http://dx.doi.org/10.1074/jbc.M114.626325			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568327	Green Published, hybrid			2022-12-26	WOS:000350044200012
J	Garenaux, E; Kanagawa, M; Tsuchiyama, T; Hori, K; Kanazawa, T; Goshima, A; Chiba, M; Yasue, H; Ikeda, A; Yamaguchi, Y; Sato, C; Kitajima, K				Garenaux, Estelle; Kanagawa, Mayumi; Tsuchiyama, Tomoyuki; Hori, Kazuki; Kanazawa, Takeru; Goshima, Ami; Chiba, Mitsuru; Yasue, Hiroshi; Ikeda, Akemi; Yamaguchi, Yoshiki; Sato, Chihiro; Kitajima, Ken			Discovery, Primary, and Crystal Structures and Capacitation-related Properties of a Prostate-derived Heparin-binding Protein WGA16 from Boar Sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZONA-PELLUCIDA; MEMBRANE MICRODOMAINS; LIPID RAFTS; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; ACROSOME REACTION; MAMMALIAN SPERM; LECTIN REVEALS; CELL-ADHESION; X-RAY	Mammalian sperm acquire fertility through a functional maturation process called capacitation, where sperm membrane molecules are drastically remodeled. In this study, we found that a wheat germ agglutinin (WGA)-reactive protein on lipid rafts, named WGA16, is removed from the sperm surface on capacitation. WGA16 is a prostate-derived seminal plasma protein that has never been reported and is deposited on the sperm surface in the male reproductive tract. Based on protein and cDNA sequences for purified WGA16, it is a homologue of human zymogen granule protein 16(ZG16) belonging to the Jacalin-relatedlectin(JRL) family in crystal and primary structures. A glycan array shows that WGA16 binds heparin through a basic patch containing Lys-53/Lys-73 residues but not the conventional lectin domain of the JRL family. WGA16 is glycosylated, contrary to other ZG16 members, and comparative mass spectrometry clearly shows its unique N-glycosylation profile among seminal plasma proteins. It has exposed GlcNAc and GalNAc residues without additional Gal residues. The GlcNAc/GalNAc residues can work as binding ligands for a sperm surface galactosyltransferase, which actuallygalactosylates WGA16 in situ in the presence of UDP-Gal. Interestingly, surface removal of WGA16 is experimentally induced by either UDP-Gal or heparin. In the crystal structure, N-glycosylated sites and a potential heparin-binding site face opposite sides. This geography of two functional sites suggest that WGA16 is deposited on the sperm surface through interaction between its N-glycans and the surface galactosyltransferase, whereas its heparin-binding domain may be involved in binding to sulfated glycosaminoglycans in the female tract, enabling removal of WGA16 from the sperm surface.	[Garenaux, Estelle; Tsuchiyama, Tomoyuki; Hori, Kazuki; Kanazawa, Takeru; Goshima, Ami; Sato, Chihiro; Kitajima, Ken] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Kanagawa, Mayumi; Ikeda, Akemi; Yamaguchi, Yoshiki] RIKEN Struct Glycobiol Team, Wako, Saitama 3510198, Japan; [Tsuchiyama, Tomoyuki; Hori, Kazuki; Kanazawa, Takeru; Goshima, Ami; Sato, Chihiro; Kitajima, Ken] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Chiba, Mitsuru] Hirosaki Univ, Grad Sch Hlth Sci, Hirosaki, Aomori 0368564, Japan; [Yasue, Hiroshi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan	Nagoya University; RIKEN; Nagoya University; Hirosaki University; National Institute of Agrobiological Sciences - Japan	Kitajima, K (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	kitajima@agr.nagoya-u.ac.jp	SATO, Chihiro/B-7396-2014; Naganawa, Shinji/I-1572-2012; Chiba, Mitsuru/F-4882-2013; Yamaguchi, Yoshiki/N-5246-2015	Naganawa, Shinji/0000-0002-0214-613X; Chiba, Mitsuru/0000-0002-4514-7124; Yamaguchi, Yoshiki/0000-0003-0100-5439	Ministry of Education, Science, and Sports [22380187, 25292216, 21-09722, 23570133]; JSPS Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation Ministry of Education, Science, and Sports; CNRS; Japan Science and Technology Agency (JST) Strategic Japanese-French Cooperative Program on Marine Genome and Marine Biotechnology; Naito Foundation Subsidy for Promotion of Specific Research Projects; Grants-in-Aid for Scientific Research [25292216] Funding Source: KAKEN	Ministry of Education, Science, and Sports; JSPS Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation Ministry of Education, Science, and Sports; CNRS(Centre National de la Recherche Scientifique (CNRS)); Japan Science and Technology Agency (JST) Strategic Japanese-French Cooperative Program on Marine Genome and Marine Biotechnology; Naito Foundation Subsidy for Promotion of Specific Research Projects; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by Grants-in-Aid for Scientific Research (B) 22380187 and 25292216; Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) fellows relating to JSPS Postdoctoral Fellowship for Foreign Researchers 21-09722 (to K. K. and E. G.); Grant-in-Aid for Scientific Research (C) 23570133 (to C. S.); the JSPS Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation (to K. K.) from the Ministry of Education, Science, and Sports; the CNRS and Japan Science and Technology Agency (JST) Strategic Japanese-French Cooperative Program on Marine Genome and Marine Biotechnology (to K. K.); and a grant from the Naito Foundation Subsidy for Promotion of Specific Research Projects in 2012 (to E. G. and K. K.).	Adachi T, 2007, BIOCHEM BIOPH RES CO, V358, P848, DOI 10.1016/j.bbrc.2007.04.197; Adachi T, 2009, GLYCOCONJUGATE J, V26, P285, DOI 10.1007/s10719-008-9184-y; Ambatipudi KS, 2010, J PROTEOME RES, V9, P6605, DOI 10.1021/pr100786y; AUSTIN CR, 1952, NATURE, V170, P326, DOI 10.1038/170326a0; Bourne Y, 1999, STRUCTURE, V7, P1473, DOI 10.1016/S0969-2126(00)88338-0; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Caballero I, 2009, INT J ANDROL, V32, P505, DOI 10.1111/j.1365-2605.2008.00887.x; CALVETE JJ, 1993, EUR J BIOCHEM, V218, P719, DOI 10.1111/j.1432-1033.1993.tb18426.x; Calvete JJ, 1996, FEBS LETT, V379, P207, DOI 10.1016/0014-5793(95)01513-2; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Dacheux JL, 2003, MICROSC RES TECHNIQ, V61, P7, DOI 10.1002/jemt.10312; Dapino DG, 2006, BIOL RES, V39, P631, DOI 10.4067/S0716-97602006000500006; De Jonge C, 2005, HUM REPROD UPDATE, V11, P205, DOI 10.1093/humupd/dmi010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flesch FM, 1999, BIOCHEM BIOPH RES CO, V262, P787, DOI 10.1006/bbrc.1999.1300; Flesch FM, 2001, J CELL SCI, V114, P3543; GADELLA BM, 1995, J CELL SCI, V108, P935; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P143, DOI 10.1023/A:1026524820177; HARA S, 1987, ANAL BIOCHEM, V164, P138, DOI 10.1016/0003-2697(87)90377-0; HARRIS JD, 1994, DNA SEQUENCE, V4, P361, DOI 10.3109/10425179409010186; HARRISON RAP, 1993, MOL REPROD DEV, V35, P197, DOI 10.1002/mrd.1080350214; Horejsi V, 2003, IMMUNOL REV, V191, P148, DOI 10.1034/j.1600-065X.2003.00001.x; Inoko E, 2010, GLYCOBIOLOGY, V20, P916, DOI 10.1093/glycob/cwq049; Kanagawa M, 2011, BIOCHEM BIOPH RES CO, V404, P201, DOI 10.1016/j.bbrc.2010.11.093; Kasekarn W, 2012, BIOCHEM BIOPH RES CO, V426, P356, DOI 10.1016/j.bbrc.2012.08.090; Khalil MB, 2006, DEV BIOL, V290, P220, DOI 10.1016/j.ydbio.2005.11.030; Kim SA, 2009, CANCER SCI, V100, P828, DOI 10.1111/j.1349-7006.2009.01106.x; Kleene R, 1999, EUR J CELL BIOL, V78, P79, DOI 10.1016/S0171-9335(99)80009-0; Kumazawa-Inoue K, 2012, GLYCOBIOLOGY, V22, P258, DOI 10.1093/glycob/cwr145; Larson JL, 1997, BIOL REPROD, V57, P442, DOI 10.1095/biolreprod57.2.442; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee Y, 2011, EXP MOL MED, V43, P291, DOI 10.3858/emm.2011.43.5.030; Lu QX, 1997, DEVELOPMENT, V124, P4121; Maehashi E, 2003, J BIOL CHEM, V278, P42050, DOI 10.1074/jbc.M307493200; Meagher JL, 2005, GLYCOBIOLOGY, V15, P1033, DOI 10.1093/glycob/cwi088; MELENDREZ CS, 1994, MOL REPROD DEV, V39, P433, DOI 10.1002/mrd.1080390412; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakata D, 2000, BIOCHEM BIOPH RES CO, V273, P642, DOI 10.1006/bbrc.2000.2983; Nimtz M, 1999, EUR J BIOCHEM, V265, P703, DOI 10.1046/j.1432-1327.1999.00766.x; NOMOTO H, 1982, ARCH BIOCHEM BIOPHYS, V218, P335, DOI 10.1016/0003-9861(82)90352-6; Ohta K, 2000, ZYGOTE, V8, pS63; Ohta K, 1999, BIOCHEM BIOPH RES CO, V258, P616, DOI 10.1006/bbrc.1999.0686; Ohtsuki T, 1998, CALCIFIED TISSUE INT, V63, P167, DOI 10.1007/s002239900509; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park KH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001595; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; Primakoff P, 2002, SCIENCE, V296, P2183, DOI 10.1126/science.1072029; Rebeiz M, 1999, MOL REPROD DEV, V54, P379, DOI 10.1002/(SICI)1098-2795(199912)54:4&lt;379::AID-MRD8&gt;3.0.CO;2-8; Rodriguez-Martinez H, 2011, AM J REPROD IMMUNOL, V66, P11, DOI 10.1111/j.1600-0897.2011.01033.x; Sharma A, 2011, GLYCOBIOLOGY, V21, P23, DOI 10.1093/glycob/cwq128; Shur BD, 1993, CURR OPIN CELL BIOL, V5, P854, DOI 10.1016/0955-0674(93)90035-O; SHUR BD, 1982, J CELL BIOL, V95, P567, DOI 10.1083/jcb.95.2.567; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Snell WJ, 1996, CELL, V85, P629, DOI 10.1016/S0092-8674(00)81230-1; Suarez SS, 1996, J ANDROL, V17, P331; Subedi GP, 2012, PROTEIN EXPRES PURIF, V82, P197, DOI 10.1016/j.pep.2011.12.010; Tateno H, 2012, GLYCOBIOLOGY, V22, P210, DOI 10.1093/glycob/cwr130; THERIEN I, 1995, BIOL REPROD, V52, P1372, DOI 10.1095/biolreprod52.6.1372; Tienthai P, 2000, REPROD FERT DEVELOP, V12, P173, DOI 10.1071/RD00034; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Visconti PE, 1999, J BIOL CHEM, V274, P3235, DOI 10.1074/jbc.274.5.3235; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; Visconti PE, 1998, BIOL REPROD, V59, P1, DOI 10.1095/biolreprod59.1.1; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Yamamura S, 1997, BIOCHEM BIOPH RES CO, V236, P218, DOI 10.1006/bbrc.1997.6933; Yanagimachi R., 1994, Zygote, V2, P371; Zhou YB, 2007, BIOCHEM BIOPH RES CO, V355, P679, DOI 10.1016/j.bbrc.2007.02.020	68	14	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5484	5501		10.1074/jbc.M114.635268	http://dx.doi.org/10.1074/jbc.M114.635268			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568322	Green Published, hybrid			2022-12-26	WOS:000350044200021
J	Bauer, C; Gobel, K; Nagaraj, N; Colantuoni, C; Wang, MX; Muller, U; Kremmer, E; Rottach, A; Leonhardt, H				Bauer, Christina; Goebel, Klaus; Nagaraj, Nagarjuna; Colantuoni, Christian; Wang, Mengxi; Mueller, Udo; Kremmer, Elisabeth; Rottach, Andrea; Leonhardt, Heinrich			Phosphorylation of TET Proteins Is Regulated via O-GlcNAcylation by the O-Linked N-Acetylglucosamine Transferase (OGT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; GLCNAC TRANSFERASE; GENE-EXPRESSION; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; COMPLEX; DIFFERENTIATION; DIOXYGENASE; 5-FORMYLCYTOSINE; HYDROXYLATION	TET proteins oxidize 5-methylcytosine to 5-hydroxymethyl-cytosine, 5-formylcytosine, and 5-carboxylcytosine and thus provide a possible means for active DNA demethylation in mammals. Although their catalytic mechanism is well characterized and the catalytic dioxygenase domain is highly conserved, the function of the regulatory regions (the N terminus and the low-complexity insert between the two parts of the dioxygenase domains) is only poorly understood. Here, we demonstrate that TET proteins are subject to a variety of post-translational modifications that mostly occur at these regulatory regions. We mapped TET modification sites at amino acid resolution and show for the first time that TET1, TET2, and TET3 are highly phosphorylated. The O-linked GlcNAc transferase, which we identified as a strong interactor with all three TET proteins, catalyzes the addition of a GlcNAc group to serine and threonine residues of TET proteins and thereby decreases both the number of phosphorylation sites and site occupancy. Interestingly, the different TET proteins display unique post-translational modification patterns, and some modifications occur in distinct combinations. In summary, our results provide a novel potential mechanism for TET protein regulation based on a dynamic interplay of phosphorylation and O-GlcNAcylation at the N terminus and the low-complexity insert region. Our data suggest strong cross-talk between the modification sites that could allow rapid adaption of TET protein localization, activity, or targeting due to changing environmental conditions as well as in response to external stimuli.	[Bauer, Christina; Goebel, Klaus; Colantuoni, Christian; Wang, Mengxi; Mueller, Udo; Rottach, Andrea; Leonhardt, Heinrich] Univ Munich, Bioctr, D-82152 Planegg Martinsried, Germany; [Nagaraj, Nagarjuna] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Kremmer, Elisabeth] Helmholtz Ctr Munich, Inst Mol Immunol, D-81377 Munich, Germany; [Leonhardt, Heinrich] CIPSM, D-81377 Munich, Germany	University of Munich; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Rottach, A (corresponding author), Univ Munich, Bioctr, D-82152 Planegg Martinsried, Germany.	a.rottach@lmu.de	Leonhardt, Heinrich/B-2791-2014	Bauer, Christina/0000-0001-9511-2491	Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Center [SFB 646/B10, SFB 1064/A17]; International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS)	Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Center(German Research Foundation (DFG)); International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS)	This work was supported in part by Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Center Grants SFB 646/B10 and SFB 1064/A17.; Supported by the International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS).	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Andres-Bergos J, 2012, J BIOL CHEM, V287, P33615, DOI 10.1074/jbc.M112.354241; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Cartron Pierre-Francois, 2013, Genes Cancer, V4, P235, DOI 10.1177/1947601913489020; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016627; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Harwood KR, 2014, J CELL SCI, V127, P1857, DOI 10.1242/jcs.113233; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; Huang Y, 2014, P NATL ACAD SCI USA, V111, P1361, DOI 10.1073/pnas.1322921111; Ito R, 2014, GENES CELLS, V19, P52, DOI 10.1111/gtc.12107; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Jost KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026499; Kim M, 2014, HUM MOL GENET, V23, P657, DOI 10.1093/hmg/ddt453; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Konstandin N, 2011, LEUKEMIA, V25, P1649, DOI 10.1038/leu.2011.134; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Langlois T, 2014, STEM CELLS, V32, P2084, DOI 10.1002/stem.1718; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Liu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062755; Loenarz C, 2009, CHEM BIOL, V16, P580, DOI 10.1016/j.chembiol.2009.06.002; Minor EA, 2013, J BIOL CHEM, V288, P13669, DOI 10.1074/jbc.C113.464800; Muller U, 2014, NUCLEIC ACIDS RES, V42, P8592, DOI 10.1093/nar/gku552; Myers SA, 2011, P NATL ACAD SCI USA, V108, P9490, DOI 10.1073/pnas.1019289108; Olivier-Van Stichelen S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00256; Pfaffeneder T, 2014, NAT CHEM BIOL, V10, P574, DOI [10.1038/NCHEMBIO.1532, 10.1038/nchembio.1532]; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rottach A, 2008, HYBRIDOMA, V27, P337, DOI 10.1089/hyb.2008.0031; Rudenko A, 2013, NEURON, V79, P1109, DOI 10.1016/j.neuron.2013.08.003; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Shi FT, 2013, J BIOL CHEM, V288, P20776, DOI 10.1074/jbc.M113.460386; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Zhang HK, 2010, CELL RES, V20, P1390, DOI 10.1038/cr.2010.156; Zhang Q, 2014, J BIOL CHEM, V289, P5986, DOI 10.1074/jbc.M113.524140	59	83	85	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4801	4812		10.1074/jbc.M114.605881	http://dx.doi.org/10.1074/jbc.M114.605881			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25568311	Green Published, hybrid			2022-12-26	WOS:000350042000022
J	Flachsbarth, I; Willaarts, B; Xie, H; Pitois, G; Mueller, ND; Ringler, C; Garrido, A				Flachsbarth, Insa; Willaarts, Barbara; Xie, Hua; Pitois, Gauthier; Mueller, Nathaniel D.; Ringler, Claudia; Garrido, Alberto			The Role of Latin America's Land and Water Resources for Global Food Security: Environmental Trade-Offs of Future Food Production Pathways	PLOS ONE			English	Article							SUSTAINABLE INTENSIFICATION; LIVESTOCK PRODUCTION; DEFORESTATION; NITROGEN; FOOTPRINT; POLLUTION; DYNAMICS; CLIMATE; IMPACT; MODEL	One of humanity's major challenges of the 21st century will be meeting future food demands on an increasingly resource constrained-planet. Global food production will have to rise by 70 percent between 2000 and 2050 to meet effective demand which poses major challenges to food production systems. Doing so without compromising environmental integrity is an even greater challenge. This study looks at the interdependencies between land and water resources, agricultural production and environmental outcomes in Latin America and the Caribbean (LAC), an area of growing importance in international agricultural markets. Special emphasis is given to the role of LAC's agriculture for (a) global food security and (b) environmental sustainability. We use the International Model for Policy Analysis of Agricultural Commodities and Trade (IMPACT)-a global dynamic partial equilibrium model of the agricultural sector-to run different future production scenarios, and agricultural trade regimes out to 2050, and assess changes in related environmental indicators. Results indicate that further trade liberalization is crucial for improving food security globally, but that it would also lead to more environmental pressures in some regions across Latin America. Contrasting land expansion versus more intensified agriculture shows that productivity improvements are generally superior to agricultural land expansion, from an economic and environmental point of view. Finally, our analysis shows that there are trade-offs between environmental and food security goals for all agricultural development paths.	[Flachsbarth, Insa; Willaarts, Barbara; Garrido, Alberto] Univ Politecn Madrid, Res Ctr Management Agr & Environm Risks CEIGRAM, Dept Agr Econ & Social Sci, Madrid, Spain; [Flachsbarth, Insa; Willaarts, Barbara; Garrido, Alberto] Botin Fdn, Water Observ, Madrid, Spain; [Xie, Hua; Pitois, Gauthier; Ringler, Claudia] Int Food Policy Res Inst, Environm & Prod Technol Div, Washington, DC 20036 USA; [Mueller, Nathaniel D.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA	Universidad Politecnica de Madrid; CGIAR; International Food Policy Research Institute (IFPRI); Harvard University	Flachsbarth, I (corresponding author), Univ Politecn Madrid, Res Ctr Management Agr & Environm Risks CEIGRAM, Dept Agr Econ & Social Sci, Madrid, Spain.	flachsbarth.insa@gmail.com	Garrido, Alberto/B-9524-2008; Mueller, Nathan D/E-5864-2010	Mueller, Nathan D/0000-0003-1857-5104; Flachsbarth, Insa/0000-0003-2642-9211; Willaarts, Barbara Anna/0000-0001-6589-1543	Fundacion Botin-CEIGRAM, Universidad Politecnica de Madrid [P12 0220c-003, P13 0220c-008]	Fundacion Botin-CEIGRAM, Universidad Politecnica de Madrid	Funding provided by Fundacion Botin-CEIGRAM, Universidad Politecnica de Madrid (grant numbers: P12 0220c-003 and P13 0220c-008; URLs: www.ceigram.upm.es and www.fundacionbotin.org): IF BW AG, CGIAR Research Program on Water, Land and Ecosystems: HX GP CR and NDM received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aide TM, 2013, BIOTROPICA, V45, P262, DOI 10.1111/j.1744-7429.2012.00908.x; ANDERSON K, 1992, WORLD ECON, V15, P153, DOI 10.1111/j.1467-9701.1992.tb00801.x; [Anonymous], TECHNICAL REPORT; Antweiler W, 2001, AM ECON REV, V91, P877, DOI 10.1257/aer.91.4.877; Arima EY, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024010; Arnold JG, 1998, J AM WATER RESOUR AS, V34, P73, DOI 10.1111/j.1752-1688.1998.tb05961.x; Bouwman L, 2013, P NATL ACAD SCI USA, V110, P20882, DOI 10.1073/pnas.1012878108; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; CHICHILNISKY G, 1994, AM ECON REV, V84, P851; Cole MA, 2004, ECOL ECON, V48, P71, DOI 10.1016/j.ecolecon.2003.09.007; Conforti P, 2004, TECHNICAL REPORT; de Fraiture C, 2010, AGR WATER MANAGE, V97, P502, DOI 10.1016/j.agwat.2009.08.008; Dingemans A, 2012, 108 CEPAL; Driscoll CT, 2003, BIOSCIENCE, V53, P357, DOI 10.1641/0006-3568(2003)053[0357:NPITNU]2.0.CO;2; Elobeld A, 2006, J AGR ECON, V57, P23, DOI 10.1111/j.1477-9552.2006.00030.x; Ercin AE, 2014, ENVIRON INT, V64, P71, DOI 10.1016/j.envint.2013.11.019; FAO, 2009, STAT FOOD AGR LIF BA, V2; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Fargione JE, 2010, ANNU REV ECOL EVOL S, V41, P351, DOI 10.1146/annurev-ecolsys-102209-144720; Finger R, 2011, NATURE, V480, P39, DOI 10.1038/480039e; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Frankel JA, 2005, REV ECON STAT, V87, P85, DOI 10.1162/0034653053327577; Garnett T, 2013, SCIENCE, V341, P33, DOI 10.1126/science.1234485; Garrido A, 2010, WATER FOOTPRINT VIRT; Gasparri NI, 2013, GLOBAL ENVIRON CHANG, V23, P1605, DOI 10.1016/j.gloenvcha.2013.09.007; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Healy S, 1998, IMPLICATIONS URUGUAY; Hoekstra A.Y., 2011, WATER FOOTPRINT ASSE, DOI DOI 10.1080/0969160X.2011.593864; Hoekstra AY, 2012, P NATL ACAD SCI USA, V109, P3232, DOI 10.1073/pnas.1109936109; IPCC Intergovernmental Panel on Climate Change (IPCC), 2013, 5 ASSESSMENT REPORT; Koneswaran G, 2008, ENVIRON HEALTH PERSP, V116, P578, DOI 10.1289/ehp.11034; Lapola DM, 2010, P NATL ACAD SCI USA, V107, P3388, DOI 10.1073/pnas.0907318107; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; Licker R, 2010, GLOBAL ECOL BIOGEOGR, V19, P769, DOI 10.1111/j.1466-8238.2010.00563.x; Liu JG, 2010, P NATL ACAD SCI USA, V107, P8035, DOI 10.1073/pnas.0913658107; Macedo MN, 2012, P NATL ACAD SCI USA, V109, P1341, DOI 10.1073/pnas.1111374109; Managi S, 2009, J ENVIRON ECON MANAG, V58, P346, DOI 10.1016/j.jeem.2009.04.008; McIntyre B. D, 2009, AGR CROSSROADS SYNTH; Mejia A, 2014, WATER AM CHALLENGES; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Nations United, 2005, TECHNICAL REPORT; Nelson GC, 2010, INT FOOD POL RES I, DOI DOI 10.2499/9780896291867; OECD (Organisation for Economic Co-operation and Development), 2013, GLOB FOOD SEC CHALL; Pereira HM, 2006, ECOLOGY, V87, P1877, DOI 10.1890/0012-9658(2006)87[1877:MBDICL]2.0.CO;2; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Pradhan P, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044044; Pradhan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062228; Ramankutty N, 2010, GLOBAL AGR LANDS PAS, DOI DOI 10.1111/J.1758-8111.2010.00001.X; Grau HR, 2008, ECOL SOC, V13; Ringler C, 2010, WATER RESOUR DEV MAN, P1, DOI 10.1007/978-3-642-04615-5; Rosegrant MW, 2012, TECHNICAL REPORT; Santhi C, 2001, J AM WATER RESOUR AS, V37, P1169, DOI 10.1111/j.1752-1688.2001.tb03630.x; Schmitz C, 2012, GLOBAL ENVIRON CHANG, V22, P189, DOI 10.1016/j.gloenvcha.2011.09.013; Smith LC, 2000, EXPLAINING CHILD MAL, V39; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Thornton PK, 2010, PHILOS T R SOC B, V365, P2853, DOI 10.1098/rstb.2010.0134; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Ullrich A, 2009, AGR WATER MANAGE, V96, P1207, DOI 10.1016/j.agwat.2009.03.010; UNEP, 2010, GEO LAC, P380; Valin H, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035019; van Ittersum MK, 2013, FIELD CROP RES, V143, P4, DOI 10.1016/j.fcr.2012.09.009; Wassenaar T, 2007, GLOBAL ENVIRON CHANG, V17, P86, DOI 10.1016/j.gloenvcha.2006.03.007; Willaarts B.A., 2014, WATER FOOD SECURITY; Willaarts BA., 2014, WATER FOOD SECUR HUM, P55; Witcover J., 2001, GLOBAL FOOD PROJECTI	66	37	37	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116733	10.1371/journal.pone.0116733	http://dx.doi.org/10.1371/journal.pone.0116733			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4PT	25617621	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000350336000023
J	Horridge, A				Horridge, Adrian			How Bees Discriminate a Pattern of Two Colours from Its Mirror Image	PLOS ONE			English	Article							HONEYBEE APIS-MELLIFERA; VISION	A century ago, in his study of colour vision in the honeybee (Apis mellifera), Karl von Frisch showed that bees distinguish between a disc that is half yellow, half blue, and a mirror image of the same. Although his inference of colour vision in this example has been accepted, some discrepancies have prompted a new investigation of the detection of polarity in coloured patterns. In new experiments, bees restricted to their blue and green receptors by exclusion of ultraviolet could learn patterns of this type if they displayed a difference in green contrast between the two colours. Patterns with no green contrast required an additional vertical black line as a landmark. Tests of the trained bees revealed that they had learned two inputs; a measure and the retinotopic position of blue with large field tonic detectors, and the measure and position of a vertical edge or line with small-field phasic green detectors. The angle between these two was measured. This simple combination was detected wherever it occurred in many patterns, fitting the definition of an algorithm, which is defined as a method of processing data. As long as they excited blue receptors, colours could be any colour to human eyes, even white. The blue area cue could be separated from the green receptor modulation by as much as 50 degrees. When some blue content was not available, the bees learned two measures of the modulation of the green receptors at widely separated vertical edges, and the angle between them. There was no evidence that the bees reconstructed the lay-out of the pattern or detected a tonic input to the green receptors.	Australian Natl Univ, Canberra, ACT, Australia	Australian National University	Horridge, A (corresponding author), Australian Natl Univ, Canberra, ACT, Australia.	horridge@netspeed.com.au						AUTRUM H, 1964, Z VERGL PHYSIOL, V48, P357, DOI 10.1007/BF00299270; Forel A, 1886, SENSES INSECTS; FRIEDLAENDER M, 1931, Z VERGL PHYSIOL, V15, P193, DOI DOI 10.1007/BF00339109; Frisch K.v, 1914, ZOOLOGISCHE JB, V37, P1, DOI DOI 10.5962/BHL.TITLE.11736; Giger AD, 1996, J COMP PHYSIOL A, V178, P763; Hertz M, 1939, J EXP BIOL, V16, P1; HERTZ MATHILDE, 1933, BIOL ZENTRALBL, V53, P10; Horridge A, 2003, J INSECT PHYSIOL, V49, P1145, DOI 10.1016/j.jinsphys.2003.08.008; Horridge A., 2012, ACTA BIOL HUNGARI S2, V63, P146; Horridge A, 2014, EYE BRAIN, V6, P9, DOI 10.2147/EB.S70522; Horridge A, 2009, J INSECT PHYSIOL, V55, P499, DOI 10.1016/j.jinsphys.2009.03.006; Horridge G. A., 2009, WHAT DOES HONEYBEE S; Horridge GA, 1996, J INSECT PHYSIOL, V42, P373, DOI 10.1016/0022-1910(95)00118-2; Horridge GA, 1999, J COMP PHYSIOL A, V185, P105, DOI 10.1007/s003590050370; Horridge GA, 2003, J EXP BIOL, V206, P2105, DOI 10.1242/jeb.00379; Horridge GA, 1997, J COMP PHYSIOL A, V181, P267, DOI 10.1007/s003590050113; Horridge GA, 1998, J INSECT PHYSIOL, V44, P343, DOI 10.1016/S0022-1910(97)00116-9; Lubbock J, 1881, ANTS BEES WASPS; Plateau F, 1885, B ACAD ROY SOC BELG, P30; Sanchez D., 1915, TRAB LAB INVEST BIOL, V13, P1, DOI DOI 10.5962/BHL.TITLE.37839; SRINIVASAN MV, 1988, J COMP PHYSIOL A, V162, P159, DOI 10.1007/BF00606081; von Hess C., 1918, ARCH GESAMPTE PHYSL, V170, P337, DOI DOI 10.1007/BF01700270; Wakakuwa M, 2005, NATURWISSENSCHAFTEN, V92, P464, DOI 10.1007/s00114-005-0018-5; Yang EC, 2004, J INSECT PHYSIOL, V50, P913, DOI 10.1016/j.jinsphys.2004.06.010	24	7	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116224	10.1371/journal.pone.0116224	http://dx.doi.org/10.1371/journal.pone.0116224			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617892	Green Published, Green Submitted, gold			2022-12-26	WOS:000350336000010
J	Ling, C; Wang, L; Wang, Z; Xu, LM; Sun, LF; Yang, H; Li, WD; Wang, K				Ling, Chao; Wang, Lin; Wang, Zheng; Xu, Luming; Sun, Lifang; Yang, Hui; Li, Wei-Dong; Wang, Kai			A Pathway-Centric Survey of Somatic Mutations in Chinese Patients with Colorectal Carcinomas	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COLON-CANCER; APC MUTATIONS; MICROSATELLITE INSTABILITY; MOLECULAR CHARACTERIZATION; SUSCEPTIBILITY LOCI; HUMAN BREAST; COPY NUMBER; GENE; IDENTIFICATION	Previous genetic studies on colorectal carcinomas (CRC) have identified multiple somatic mutations in four candidate pathways (TGF-beta, Wnt, P53 and RTK-RAS pathways) on populations of European ancestry. However, it is under-studied whether other populations harbor different sets of hot-spot somatic mutations in these pathways and other oncogenes. In this study, to evaluate the mutational spectrum of novel somatic mutations, we assessed 41 pairs of tumor-stroma tissues from Chinese patients with CRC, including 29 colon carcinomas and 12 rectal carcinomas. We designed Illumina Custom Amplicon panel to target 43 genes, including genes in the four candidate pathways, as well as several known oncogenes for other cancers. Candidate mutations were validated by Sanger sequencing, and we further used SIFT and PolyPhen-2 to assess potentially functional mutations. We discovered 3 new somatic mutations in gene APC, TCF7L2, and PIK3CA that had never been reported in the COSMIC or NCI-60 databases. Additionally, we confirmed 6 known somatic mutations in gene SMAD4, APC, FBXW7, BRAF and PTEN in Chinese CRC patients. While most were previously reported in CRC, one mutation in PTEN was reported only in malignant endometrium cancer. Our study confirmed the existence of known somatic mutations in the four candidate pathways for CRC in Chinese patients. We also discovered a number of novel somatic mutations in these pathways, which may have implications for the pathogenesis of CRC.	[Ling, Chao; Yang, Hui; Wang, Kai] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Ling, Chao] Peking Union Med Coll Hosp, Lab Clin Genet, Beijing 100730, Peoples R China; [Ling, Chao; Li, Wei-Dong] Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin 300070, Peoples R China; [Wang, Lin; Wang, Zheng; Xu, Luming; Sun, Lifang] Huazhong Univ Sci & Technol, Ctr Tissue Engn & Regenerat Med, Union Hosp, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China; [Wang, Kai] Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Wang, Kai] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90089 USA	University of Southern California; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Tianjin Medical University; Huazhong University of Science & Technology; University of Southern California; University of Southern California	Wang, K (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA.	kaiwang@usc.edu	LING, CHAO/W-3528-2019	Li, Wei-Dong/0000-0003-0521-7412; LING, CHAO/0000-0001-5328-4906	Zilkha Neurogenetic Institute at the University of Southern California	Zilkha Neurogenetic Institute at the University of Southern California	This project was supported by start-up funds from the Zilkha Neurogenetic Institute at the University of Southern California. KW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHTONRICKARDT PG, 1989, ONCOGENE, V4, P1169; BABA S, 1994, ANTICANCER RES, V14, P2189; Berg M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013978; Boman BM, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00244; Casey G, 2013, GUT, V62, P920, DOI 10.1136/gutjnl-2011-301935; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Ewing I, 2014, FRONTLINE GASTROENTE, V5, P26, DOI 10.1136/flgastro-2013-100329; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fleming NI, 2013, CANCER RES, V73, P725, DOI 10.1158/0008-5472.CAN-12-2706; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gay LJ, 2012, J PATHOL, V228, P405, DOI 10.1002/path.4085; HAN SM, 2013, PLOS GENET, V9, DOI DOI 10.1371/JOURNAL.PONE.0064271; Hanna MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074950; Hou P, 2007, CLIN CANCER RES, V13, P1161, DOI 10.1158/1078-0432.CCR-06-1125; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Hu FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060233; Hutter CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-670; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Kapitanovic S, 2004, EXP MOL PATHOL, V77, P193, DOI 10.1016/j.yexmp.2004.06.001; Kimura ET, 2003, CANCER RES, V63, P1454; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Matsumura G, 1990, NIHON HIFUKA GAKKAI, V100, P57; MIYAKI M, 1994, CANCER RES, V54, P3011; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Naguib A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-99; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Ogino S, 2013, ONCOGENE; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Peterson LM, 2012, INT J GYNECOL PATHOL, V31, P195, DOI 10.1097/PGP.0b013e318231fc51; Planck M, 2002, CANCER GENET CYTOGEN, V134, P46, DOI 10.1016/S0165-4608(01)00587-8; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIDRANSKY D, 1992, SCIENCE, V256, P102, DOI 10.1126/science.1566048; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smith G, 2002, P NATL ACAD SCI USA, V99, P9433, DOI 10.1073/pnas.122612899; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Vasovcak P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024114; Wahlberg SS, 2002, CANCER RES, V62, P3485; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu GJ, 2005, BREAST CANCER RES, V7, pR609, DOI 10.1186/bcr1262; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; Yu C, 2014, CELL RES, V24, P701, DOI 10.1038/cr.2014.43; Zhang R, 2012, COLORECTAL DIS, V14, pe80, DOI 10.1111/j.1463-1318.2011.02858.x; Zhou XP, 2002, HUM MOL GENET, V11, P445, DOI 10.1093/hmg/11.4.445	57	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116753	10.1371/journal.pone.0116753	http://dx.doi.org/10.1371/journal.pone.0116753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617745	Green Published, gold, Green Submitted			2022-12-26	WOS:000350336000024
J	Sun, YF; Yang, ZY; Zhang, YP; Xue, J; Wang, MW; Shi, W; Zhu, BL; Hu, SL; Yao, ZF; Pan, HR; Zhang, YJ				Sun, Yifei; Yang, Zhongyi; Zhang, Yongping; Xue, Jing; Wang, Mingwei; Shi, Wei; Zhu, Beiling; Hu, Silong; Yao, Zhifeng; Pan, Herong; Zhang, Yingjian			The Preliminary Study of 16 alpha-[18F] fluoroestradiol PET/CT in Assisting the Individualized Treatment Decisions of Breast Cancer Patients	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ESTROGEN-RECEPTORS; IN-VIVO; F-18-FLUOROESTRADIOL; HETEROGENEITY; EXPRESSION; CARCINOMA	Objective To evaluate the clinical value of 16 alpha-[18F] fluoroestradiol (18F-FES) PET/CT in assisting the individualized treatment decisions of breast cancer patients. Methods Thirty-three breast cancer patients, who underwent both 18F-FES and 18F-FDG PET/CT from July 2010 to March 2013 in our center, were enrolled in this preliminary study. All the patients used 18F-FES PET/CT as a diagnostic tool with a clinical dilemma. We used the maximum Standardized Uptake Value (SUVmax) to quantify ER expression and a cutoff value of 1.5 to dichotomize results into ER positive and negative lesions. All patients were clinically followed up at least 6 months. Results In evaluating equivocal lesions on conventional work-up group (n = 4), three lung lesions and another iliac lesion were enrolled. As for three lung lesions, 18F-FES PET/CT showed one lesion with high uptake, which suggested it was an ER positive metastasis. The other two lesions were 18F-FES negative, which meant an ER negative metastasis or secondary primary tumor. Additionally, one iliac lesion was detected by MRI. 18F-FDG uptake was high at the suspected lesion, whereas 18F-FES uptake was absent; In predicting origin of metastasis group (n = 2), two breast cancer patients had secondary primary tumors were collected. They were 18F-FES negative, which showed low possibility of metastasis from breast cancer and they were all confirmed by biopsy. In detecting ER status in metastasis group (n = 27), 18F-FES PET/CT showed increased 18F-FES uptake in all metastatic lesions in 11 patients; absent in all lesions in 13 patients; and the remaining 3 patients had both 18F-FES positive and negative lesions. Totally, on the basis of the 18F-FES PET/CT results, we found changes in the treatment plans in 16 patients (48.5%,16/33). Conclusions 18F-FES PET/CT could assess the entire tumor volume receptor status; therefore, it may be used to assist the individualized treatment decisions of breast cancer patients.	[Sun, Yifei; Yang, Zhongyi; Zhang, Yongping; Xue, Jing; Wang, Mingwei; Shi, Wei; Zhu, Beiling; Hu, Silong; Yao, Zhifeng; Pan, Herong; Zhang, Yingjian] Fudan Univ, Shanghai Canc Ctr, Dept Nucl Med, Shanghai 200433, Peoples R China; [Sun, Yifei; Yang, Zhongyi; Zhang, Yongping; Xue, Jing; Wang, Mingwei; Shi, Wei; Zhu, Beiling; Hu, Silong; Yao, Zhifeng; Pan, Herong; Zhang, Yingjian] Fudan Univ, Ctr Biomed Imaging, Shanghai 200433, Peoples R China; [Sun, Yifei; Yang, Zhongyi; Zhang, Yongping; Xue, Jing; Wang, Mingwei; Shi, Wei; Zhu, Beiling; Hu, Silong; Yao, Zhifeng; Pan, Herong; Zhang, Yingjian] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Sun, Yifei; Yang, Zhongyi; Zhang, Yongping; Xue, Jing; Wang, Mingwei; Shi, Wei; Zhu, Beiling; Hu, Silong; Yao, Zhifeng; Pan, Herong; Zhang, Yingjian] Shanghai Engn Res Ctr Mol Imaging Probes, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Zhang, YJ (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Nucl Med, Shanghai 200433, Peoples R China.	profzhangyj@163.com		Wang, Ming-Wei/0000-0003-0020-4700	Science and Technology Commission of Shanghai Municipality [12431900208, 15ZR1407600]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This research was supported by Science and Technology Commission of Shanghai Municipality (No. 12431900208 and 15ZR1407600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir E, 2012, CANCER TREAT REV, V38, P708, DOI 10.1016/j.ctrv.2011.11.006; Buzdar A, 1996, J CLIN ONCOL, V14, P2000, DOI 10.1200/JCO.1996.14.7.2000; Fisher B, 2008, J CLIN ONCOL, V26, P2068, DOI 10.1200/JCO.2007.14.1804; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Kurland BF, 2011, J NUCL MED, V52, P1541, DOI 10.2967/jnumed.111.091439; Linden HM, 2006, J CLIN ONCOL, V24, P2793, DOI 10.1200/JCO.2005.04.3810; Liu WS, 2014, EUR J CANCER CARE, V23, P36, DOI 10.1111/ecc.12084; MCGUIRE AH, 1991, J NUCL MED, V32, P1526; MINTUN MA, 1988, RADIOLOGY, V169, P45, DOI 10.1148/radiology.169.1.3262228; Mori T, 2006, NUCL MED BIOL, V33, P281, DOI 10.1016/j.nucmedbio.2005.11.002; Mortimer JE, 1996, CLIN CANCER RES, V2, P933; Peterson LM, 2008, J NUCL MED, V49, P367, DOI 10.2967/jnumed.107.047506; Peterson LM, 2014, MOL IMAGING BIOL, V16, P431, DOI 10.1007/s11307-013-0699-7; Pusztai L, 2006, ONCOLOGIST, V11, P868, DOI 10.1634/theoncologist.11-8-868; Sharangpani GM, 2007, J MICROSC-OXFORD, V226, P244, DOI 10.1111/j.1365-2818.2007.01772.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simmons C, 2009, ANN ONCOL, V20, P1499, DOI 10.1093/annonc/mdp028; Sundararajan L, 2007, SEMIN NUCL MED, V37, P470, DOI 10.1053/j.semnuclmed.2007.08.003; van Kruchten M, 2013, LANCET ONCOL, V14, pE465, DOI 10.1016/S1470-2045(13)70292-4; van Kruchten M, 2012, J NUCL MED, V53, P182, DOI 10.2967/jnumed.111.092734; Yang ZY, 2013, CLIN BREAST CANCER, V13, P359, DOI 10.1016/j.clbc.2013.02.012; Yoshida T, 2000, CARCINOGENESIS, V21, P2193, DOI 10.1093/carcin/21.12.2193; Zhang Yu, 2011, Chinese Journal of Applied and Environmental Biology, V17, P196, DOI 10.3724/SP.J.1145.2011.00196	23	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116341	10.1371/journal.pone.0116341	http://dx.doi.org/10.1371/journal.pone.0116341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617853	Green Published, Green Submitted, gold			2022-12-26	WOS:000350336000013
J	Vargas-Alarcon, G; Angeles-Martiinez, J; Villarreal-Molina, T; Alvarez-Leon, E; Posadas-Sanchez, R; Cardoso-Saldana, G; Ramirez-Bello, J; Perez-Hernandez, N; Juarez-Rojas, JG; Rodriguez-Perez, JM; Fragoso, JM; Posadas-Romero, C				Vargas-Alarcon, Gilberto; Angeles-Martinez, Javier; Villarreal-Molina, Teresa; Alvarez-Leon, Edith; Posadas-Sanchez, Rosalinda; Cardoso-Saldana, Guillermo; Ramirez-Bello, Julian; Perez-Hernandez, Nonanzit; Gabriel Juarez-Rojas, Juan; Manuel Rodriguez-Perez, Jose; Manuel Fragoso, Jose; Posadas-Romero, Carlos			Interleukin-17A Gene Haplotypes Are Associated with Risk of Premature Coronary Artery Disease in Mexican Patients from the Genetics of Atherosclerotic Disease (GEA) Study	PLOS ONE			English	Article							FAMILY CYTOKINES; ADMIXTURE; FREQUENCIES; POLYMORPHISMS; MECHANISMS; IL-17A; CELLS	Aim The role of interleukin 17A (IL-17A) in the inflammatory process has caused interest in the potential significance of IL-17A as a biomarker for coronary artery disease (CAD). The aim of the present study was to evaluate the role of IL-17A gene polymorphisms as susceptibility markers for CAD in the Mexican population. Methods Four IL-17A gene polymorphisms (rs8193036, rs3819024, rs2275913 and rs8193037) were genotyped by 5' exonuclease TaqMan assays in a group of 900 patients with premature CAD and 667 healthy controls (with negative calcium score by computed tomography), seeking associations with CAD and other metabolic and cardiovascular risk factors using logistic regression analyses. Results No single IL-17A polymorphism was associated with premature CAD, however two haplotypes (CAGG and TAGA) were significantly associated with increased risk of premature CAD (OR = 1.35, 95% CI: 1.00-1.84, P = 0.018 and OR = 2.09, 95% CI: 1.16-3.76, P = 0.003, respectively). Moreover, rs3819024 was associated with increased levels of visceral abdominal fat (P = 0.002) and rs8193036 was significantly associated with risk of central obesity (P = 0.020), hypertriglyceridemia (P = 0.027), and metabolic syndrome (P = 0.027) in the premature CAD group, under dominant models adjusted by age, gender, BMI, smoking history, alcohol consumption, and treatment. Conclusion The results suggest that IL-17A haplotypes are involved in the risk of developing premature CAD and some IL-17A polymorphisms are associated with cardiovascular risk factors in Mexican individuals with premature CAD.	[Vargas-Alarcon, Gilberto; Angeles-Martinez, Javier; Alvarez-Leon, Edith; Perez-Hernandez, Nonanzit; Manuel Rodriguez-Perez, Jose; Manuel Fragoso, Jose] Inst Nacl Cardiol Ignacio Chavez, Dept Mol Biol, Mexico City, DF, Mexico; [Villarreal-Molina, Teresa] Inst Nacl Med Genom INMEGEN, Cardiovasc Genom Lab, Mexico City, DF, Mexico; [Posadas-Sanchez, Rosalinda; Cardoso-Saldana, Guillermo; Gabriel Juarez-Rojas, Juan; Posadas-Romero, Carlos] Inst Nacl Cardiol Ignacio Chavez, Dept Endocrinol, Mexico City, DF, Mexico; [Ramirez-Bello, Julian] Hosp Juarez Mexico, Unit Res, Lab Genom Med, Mexico City, DF, Mexico	National Institute of Cardiology - Mexico; Instituto Nacional de Medicina Genomica; National Institute of Cardiology - Mexico	Vargas-Alarcon, G (corresponding author), Inst Nacl Cardiol Ignacio Chavez, Dept Mol Biol, Mexico City, DF, Mexico.	gvargas63@yahoo.com	Ramírez-Bello, Julian/AAR-1308-2020; Juárez-Rojas, Juan Gabriel/AAM-9486-2020	Ramírez-Bello, Julian/0000-0002-4153-9315; Juárez-Rojas, Juan Gabriel/0000-0001-8864-2304; Angeles Martinez, Javier/0000-0001-5405-0482; Vargas-Alarcon, Gilberto/0000-0001-7916-5163; Cardoso, Guillermo/0000-0001-9525-1731; VILLARREAL MOLINA, TERESA/0000-0003-4450-7690	Consejo Nacional de Ciencia y Tecnologia [156911]; Fundacion Gonzalo Rio Arronte, Mexico City, Mexico	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion Gonzalo Rio Arronte, Mexico City, Mexico	This work was supported by grants from the Consejo Nacional de Ciencia y Tecnologia (projects 156911) and Fundacion Gonzalo Rio Arronte, Mexico City, Mexico. All of the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Chang SH, 2011, CELL SIGNAL, V23, P1069, DOI 10.1016/j.cellsig.2010.11.022; Chen SA, 2010, J IMMUNOL, V185, P5619, DOI 10.4049/jimmunol.1001879; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; D'Acquisto F, 2010, BIOCHEM PHARMACOL, V79, P525, DOI 10.1016/j.bcp.2009.09.015; de Boer OJ, 2010, J PATHOL, V220, P499, DOI 10.1002/path.2667; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Garcia-Moll X, 2005, REV ESP CARDIOL, V58, P615, DOI 10.1157/13076412; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hayashi R, 2012, J GASTROINTEST LIVER, V21, P243; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Juarez-Cedillo T, 2008, FORENSIC SCI INT-GEN, V2, pE37, DOI 10.1016/j.fsigen.2007.08.017; Kadkhodazadeh M, 2013, IMMUNOL INVEST, V42, P156, DOI 10.3109/08820139.2012.746697; KVIST H, 1988, AM J CLIN NUTR, V48, P1351, DOI 10.1093/ajcn/48.6.1351; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; LISKER R, 1988, AM J PHYS ANTHROPOL, V76, P331, DOI 10.1002/ajpa.1330760307; LISKER R, 1986, AM J PHYS ANTHROPOL, V71, P203, DOI 10.1002/ajpa.1330710207; LISKER R, 1990, HUM BIOL, V62, P791; LONGO R, 1993, INVEST RADIOL, V28, P297, DOI 10.1097/00004424-199304000-00006; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Maione F, 2009, BIOCHEM PHARMACOL, V77, P878, DOI 10.1016/j.bcp.2008.11.011; MAUTNER GC, 1994, RADIOLOGY, V192, P619, DOI 10.1148/radiology.192.3.8058924; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Villarreal-Molina T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049285; Xie JJ, 2010, CYTOKINE, V49, P185, DOI 10.1016/j.cyto.2009.09.007; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhang XF, 2013, INFLAMM RES, V62, P743, DOI 10.1007/s00011-013-0629-9; Zhang XL, 2011, CLIN CHIM ACTA, V412, P327, DOI 10.1016/j.cca.2010.10.027; Zhao XF, 2010, MOL BIOL REP, V37, P81, DOI 10.1007/s11033-009-9533-3; Zhu QH, 2014, GENE, V537, P328, DOI 10.1016/j.gene.2013.11.007	34	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0114943	10.1371/journal.pone.0114943	http://dx.doi.org/10.1371/journal.pone.0114943			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615631	Green Submitted, Green Published, gold			2022-12-26	WOS:000349122100006
J	Watanabe, Y; Nakayama, K; Taniuchi, N; Horai, Y; Kuriyama, C; Ueta, K; Arakawa, K; Senbonmatsu, T; Shiotani, M				Watanabe, Yoshinori; Nakayama, Keiko; Taniuchi, Nobuhiko; Horai, Yasushi; Kuriyama, Chiaki; Ueta, Kiichiro; Arakawa, Kenji; Senbonmatsu, Takaaki; Shiotani, Masaharu			Beneficial Effects of Canagliflozin in Combination with Pioglitazone on Insulin Sensitivity in Rodent Models of Obese Type 2 Diabetes	PLOS ONE			English	Article							GLUCOSE COTRANSPORTER INHIBITOR; SGLT2 INHIBITORS; FATTY RATS; RESISTANCE; HYPERGLYCEMIA; PREVALENCE; STRATEGIES; MANAGEMENT; TOLERANCE; MELLITUS	Background Despite its insulin sensitizing effects, pioglitazone may induce weight gain leading to an increased risk of development of insulin resistance. A novel sodium glucose co-transporter 2 (SGLT2) inhibitor, canagliflozin, provides not only glycemic control but also body weight reduction through an insulin-independent mechanism. The aim of this study was to investigate the combined effects of these agents on body weight control and insulin sensitivity. Methods Effects of combination therapy with canagliflozin and pioglitazone were evaluated in established diabetic KK-Ay mice and prediabetic Zucker diabetic fatty (ZDF) rats. Results In the KK-Ay mice, the combination therapy further improved glycemic control compared with canagliflozin or pioglitazone monotherapy. Furthermore, the combination significantly attenuated body weight and fat gain induced by pioglitazone and improved hyperinsulinemia. In the ZDF rats, early intervention with pioglitazone monotherapy almost completely prevented the progressive development of hyperglycemia, and no further improvement was observed by add-on treatment with canagliflozin. However, the combination significantly reduced pioglitazone-induced weight gain and adiposity and improved the Matsuda index, suggesting improved whole-body insulin sensitivity. Conclusions Our study indicates that combination therapy with canagliflozin and pioglitazone improves insulin sensitivity partly by preventing glucotoxicity and, at least partly, by attenuating pioglitazone-induced body weight gain in two different obese diabetic animal models. This combination therapy may prove to be a valuable option for the treatment and prevention of obese type 2 diabetes.	[Watanabe, Yoshinori; Nakayama, Keiko; Taniuchi, Nobuhiko; Kuriyama, Chiaki; Ueta, Kiichiro; Arakawa, Kenji; Shiotani, Masaharu] Mitsubishi Tanabe Pharma Corp, Div Res, Pharmacol Res Labs 2, Saitama, Japan; [Horai, Yasushi] Mitsubishi Tanabe Pharma Corp, Div Res, Safety Res Lab, Saitama, Japan; [Watanabe, Yoshinori; Senbonmatsu, Takaaki] Saitama Med Univ, Dept Pharmacol, Saitama, Japan	Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma Corporation; Saitama Medical University	Watanabe, Y (corresponding author), Mitsubishi Tanabe Pharma Corp, Div Res, Pharmacol Res Labs 2, Saitama, Japan.	watanabe.yoshinori@mr.mt-pharma.co.jp			Mitsubishi Tanabe Pharma Corporation	Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation)	Mitsubishi Tanabe Pharma Corporation sponsored this study. Editorial assistance was provided by Tanabe R&D service CO., Ltd. The authors who are employees of Mitsubishi Tanabe Pharma Corporation designed the studies, participated in data collection and analysis, made the decision to publish, and prepared the manuscript.	Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Arakawa K, 2001, BRIT J PHARMACOL, V132, P578, DOI 10.1038/sj.bjp.0703829; Bergenstal RM, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.07.017; BLONDEL O, 1990, METABOLISM, V39, P787, DOI 10.1016/0026-0495(90)90120-2; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; DeFronzo RA, 2011, DIABETES CARE, V34, pS202, DOI 10.2337/dc11-s221; Del Prato S, 2009, DIABETIC MED, V26, P1185, DOI 10.1111/j.1464-5491.2009.02847.x; Devenny JJ, 2012, OBESITY, V20, P1645, DOI 10.1038/oby.2012.59; Devineni D, 2012, DIABETES OBES METAB, V14, P539, DOI 10.1111/j.1463-1326.2012.01558.x; Etgen GJ, 2000, METABOLISM, V49, P684, DOI 10.1016/S0026-0495(00)80049-9; Everson SA, 1998, DIABETES CARE, V21, P1637, DOI 10.2337/diacare.21.10.1637; Forst T, 2014, DIABETES OBES METAB, V16, P467, DOI 10.1111/dom.12273; Fujimori Y, 2008, J PHARMACOL EXP THER, V327, P268, DOI 10.1124/jpet.108.140210; Fujimoto Y, 2006, DIABETES, V55, P2479, DOI 10.2337/db05-1511; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Jia L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078284; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kuriyama C, 2014, J PHARM EXP THER; Kurosaki E, 2013, PHARMACOL THERAPEUT, V139, P51, DOI 10.1016/j.pharmthera.2013.04.003; Liang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030555; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MITRAKOU A, 1992, NEW ENGL J MED, V326, P22, DOI 10.1056/NEJM199201023260104; Nawano M, 2000, AM J PHYSIOL-ENDOC M, V278, pE535, DOI 10.1152/ajpendo.2000.278.3.E535; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Nyenwe EA, 2011, METABOLISM, V60, P1, DOI 10.1016/j.metabol.2010.09.010; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rosenstock J, 2012, DIABETES CARE, V35, P1232, DOI 10.2337/dc11-1926; ROSSETTI L, 1987, J CLIN INVEST, V79, P1510, DOI 10.1172/JCI112981; Sha S, 2011, DIABETES OBES METAB, V13, P669, DOI 10.1111/j.1463-1326.2011.01406.x; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x	35	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116851	10.1371/journal.pone.0116851	http://dx.doi.org/10.1371/journal.pone.0116851			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615826	Green Published, Green Submitted, gold			2022-12-26	WOS:000349122100045
J	Sepsa, A; Levidou, G; Gargalionis, A; Adamopoulos, C; Spyropoulou, A; Dalagiorgou, G; Thymara, I; Boviatsis, E; Themistocleous, MS; Petraki, K; Vrettakos, G; Samaras, V; Zisakis, A; Patsouris, E; Piperi, C; Korkolopoulou, P				Sepsa, Athanasia; Levidou, Georgia; Gargalionis, Antonis; Adamopoulos, Christos; Spyropoulou, Anastasia; Dalagiorgou, Georgia; Thymara, Irene; Boviatsis, Efstathios; Themistocleous, Marios S.; Petraki, Kalliopi; Vrettakos, George; Samaras, Vassilis; Zisakis, Athanassios; Patsouris, Efstratios; Piperi, Christina; Korkolopoulou, Penelope			Emerging Role of Linker Histone Variant H1x as a Biomarker with Prognostic Value in Astrocytic Gliomas. A Multivariate Analysis including Trimethylation of H3K9 and H4K20	PLOS ONE			English	Article							ONCOMETABOLITE 2-HYDROXYGLUTARATE; EPIGENETIC CONTROL; BREAST-CANCER; IN-VITRO; METHYLATION; DNA; CELLS; DIFFERENTIATION; EXPRESSION; SURVIVAL	Although epigenetic alterations play an essential role in gliomagenesis, the relevance of aberrant histone modifications and the respective enzymes has not been clarified. Experimental data implicates histone H3 lysine (K) methyltransferases SETDB1 and SUV39H1 into glioma pathobiology, whereas linker histone variant H1.0 and H4K20me3 reportedly affect prognosis. We investigated the expression of H3K9me3 and its methyltransferases along with H4K20me3 and H1x in 101 astrocytic tumors with regard to clinicopathological characteristics and survival. The effect of SUV39H1 inhibition by chaetocin on the proliferation, colony formation and migration of T98G cells was also examined. SETDB1 and cytoplasmic SUV39H1 levels increased from normal brain through low-grade to high-grade tumors, nuclear SUV39H1 correlating inversely with grade. H3K9me3 immunoreactivity was higher in normal brain showing no association with grade, whereas H1x and H4K20me3 expression was higher in grade 2 than in normal brain or high grades. These expression patterns of H1x, H4K20me3 and H3K9me3 were verified by Western immunoblotting. Chaetocin treatment significantly reduced proliferation, clonogenic potential and migratory ability of T98G cells. H1x was an independent favorable prognosticator in glioblastomas, this effect being validated in an independent set of 66 patients. Diminished nuclear SUV39H1 expression adversely affected survival in univariate analysis. In conclusion, H4K20me3 and H3K9 methyltransferases are differentially implicated in astroglial tumor progression. Deregulation of H1x emerges as a prognostic biomarker.	[Sepsa, Athanasia; Levidou, Georgia; Thymara, Irene; Patsouris, Efstratios; Korkolopoulou, Penelope] Univ Athens, Laikon Gen Hosp, Sch Med, Dept Pathol 1, Athens 11527, Greece; [Gargalionis, Antonis; Adamopoulos, Christos; Spyropoulou, Anastasia; Dalagiorgou, Georgia; Piperi, Christina] Univ Athens, Sch Med, Dept Biol Chem, Athens 11527, Greece; [Boviatsis, Efstathios; Themistocleous, Marios S.] Univ Athens, Evangelismos Hosp, Sch Med, Dept Neurosurg, Athens 10676, Greece; [Petraki, Kalliopi] Metropolitan Hosp, Dept Pathol, Athens 18547, Greece; [Vrettakos, George] Metropolitan Hosp, Dept Neurosurg, Athens 18547, Greece; [Samaras, Vassilis] Red Cross Hosp, Dept Pathol, Athens 11526, Greece; [Zisakis, Athanassios] Red Cross Hosp, Dept Neurosurg, Athens 11526, Greece	Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; Evangelismos Hospital; National & Kapodistrian University of Athens	Levidou, G (corresponding author), Univ Athens, Laikon Gen Hosp, Sch Med, Dept Pathol 1, Athens 11527, Greece.	glevidou@yahoo.gr	Piperi, Christina/AAF-2009-2020	Piperi, Christina/0000-0002-2701-0618; Spyropoulou, Anastasia/0000-0001-8599-7740				Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Chen JH, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0513-z; Chernov AV, 2009, J BIOL CHEM, V284, P12727, DOI 10.1074/jbc.M900273200; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; Ellinger J, 2014, UROL INT, V93, P113, DOI 10.1159/000355467; Elsheikh SE, 2009, CANCER RES, V69, P3802, DOI 10.1158/0008-5472.CAN-08-3907; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fanelli M, 2008, ONCOGENE, V27, P358, DOI 10.1038/sj.onc.1210642; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gabrovsky N, 2013, ACTA NEUROCHIR, V155, P1437, DOI 10.1007/s00701-013-1802-1; Gerlitz G, 2010, J CELL SCI, V123, P2207, DOI 10.1242/jcs.058271; Han XS, 2014, J NEURO-ONCOL, V118, P61, DOI 10.1007/s11060-014-1419-0; Harshman SW, 2013, NUCLEIC ACIDS RES, V41, P9593, DOI 10.1093/nar/gkt700; Harvey AC, 2004, MOL MICROBIOL, V53, P771, DOI 10.1111/j.1365-2958.2004.04195.x; He YL, 2012, ACTA BIOCH BIOPH SIN, V44, P70, DOI 10.1093/abbs/gmr109; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; Isham CR, 2007, BLOOD, V109, P2579, DOI 10.1182/blood-2006-07-027326; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kreth S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017156; LACHIN JM, 1986, BIOMETRICS, V42, P507, DOI 10.2307/2531201; Li FQ, 2011, APPL IMMUNOHISTO M M, V19, P389, DOI 10.1097/PAI.0b013e3182108e2e; Liu BL, 2010, CANCER EPIDEM BIOMAR, V19, P2888, DOI 10.1158/1055-9965.EPI-10-0454; Lohmann F, 2010, STEM CELLS, V28, P201, DOI 10.1002/stem.278; Louis D. N, 2007, 2007 WHO CLASSIFICAT; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin C, 2006, J BIOL CHEM, V281, P8365, DOI 10.1074/jbc.M513425200; Martinez R, 2010, NEUROBIOL DIS, V39, P40, DOI 10.1016/j.nbd.2009.12.030; McBryant SJ, 2010, CELL RES, V20, P519, DOI 10.1038/cr.2010.35; Medrzycki M, 2012, FRONT BIOSCI-LANDMRK, V17, P396, DOI 10.2741/3934; Metellus P, 2010, ACTA NEUROPATHOL, V120, P719, DOI 10.1007/s00401-010-0777-8; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Myung JK, 2012, ONCOL REP, V28, P1639, DOI 10.3892/or.2012.1994; Patani N, 2011, ANTICANCER RES, V31, P4115; Rai K, 2006, MOL CELL BIOL, V26, P7077, DOI 10.1128/MCB.00312-06; Rai K, 2010, J BIOL CHEM, V285, P4110, DOI 10.1074/jbc.M109.073676; Rajendran G, 2011, J NEURO-ONCOL, V104, P483, DOI 10.1007/s11060-010-0520-2; Saratsis AM, 2014, ACTA NEUROPATHOL, V127, P881, DOI 10.1007/s00401-013-1218-2; Sarg B, 2002, J BIOL CHEM, V277, P39195, DOI 10.1074/jbc.M205166200; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schneider AC, 2011, BJU INT, V108, pE290, DOI 10.1111/j.1464-410X.2011.10203.x; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Spyropoulou A, 2014, NEUROMOL MED, V16, P70, DOI 10.1007/s12017-013-8254-x; Spyropoulou A, 2013, NEUROMOL MED, V15, P1, DOI 10.1007/s12017-012-8205-y; Tan SL, 2012, DEVELOPMENT, V139, P3806, DOI 10.1242/dev.082198; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Venneti S, 2013, J NEUROPATH EXP NEUR, V72, P298, DOI 10.1097/NEN.0b013e3182898113; Wang HJ, 2013, ONCOL REP, V30, P2089, DOI 10.3892/or.2013.2706; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Watanabe H, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-15; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan FT, 2014, CANCER RES, V74, P1752, DOI 10.1158/0008-5472.CAN-13-0884	59	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0115101	10.1371/journal.pone.0115101	http://dx.doi.org/10.1371/journal.pone.0115101			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602259	Green Published, gold, Green Submitted			2022-12-26	WOS:000348203500008
J	Jiang, DQ; Ma, SZ; Jing, F; Xu, C; Yan, F; Wang, AH; Zhao, JJ				Jiang, Dongqing; Ma, Shizhan; Jing, Fei; Xu, Chao; Yan, Fang; Wang, Aihong; Zhao, Jiajun			Thyroid-Stimulating Hormone Inhibits Adipose Triglyceride Lipase in 3T3-L1 Adipocytes through the PKA Pathway	PLOS ONE			English	Article							TRIACYLGLYCEROL LIPASE; ENERGY-METABOLISM; LIPOLYSIS; PHOSPHORYLATION; PROTEIN; IDENTIFICATION; EXERCISE; TISSUE	Thyroid-stimulating hormone (TSH) has been shown to play an important role in the regulation of triglyceride (TG) metabolism in adipose tissue. Adipose triglyceride lipase (ATGL) is a rate-limiting enzyme controlling the hydrolysis of TG. Thus far, it is unclear whether TSH has a direct effect on the expression of ATGL. Because TSH function is mediated through the TSH receptor (TSHR), TSHR knockout mice (Tshr-/-mice) (supplemented with thyroxine) were used in this study to determine the effects of TSHR deletion on ATGL expression. These effects were verified in 3T3-L1 adipocytes and potential underlying mechanisms were explored. In the Tshr-/-mice, ATGL expression in epididymal adipose tissue was significantly increased compared with that in Tshr+/+ mice. ATGL expression was observed to increase with the differentiation process of 3T3-L1 preadipocytes. In mature 3T3-L1 adipocytes, TSH significantly suppressed ATGL expression at both the protein and mRNA levels in a dose-dependent manner. Forskolin, which is an activator of adenylate cyclase, suppressed the expression of ATGL in 3T3-L1 adipocytes. The inhibitory effects of TSH on ATGL expression were abolished by H89, which is a protein kinase A (PKA) inhibitor. These results indicate that TSH has an inhibitory effect on ATGL expression in mature adipocytes. The associated mechanism is related to PKA activation.	[Jiang, Dongqing; Ma, Shizhan; Jing, Fei; Xu, Chao; Yan, Fang; Zhao, Jiajun] Shandong Univ, Shandong Prov Hosp, Dept Endocrinol & Metab, Jinan 250100, Shandong, Peoples R China; [Ma, Shizhan; Jing, Fei; Xu, Chao; Yan, Fang; Zhao, Jiajun] Shandong Acad Clin Med, Inst Endocrinol, Jinan, Shandong, Peoples R China; [Jiang, Dongqing] Shandong Univ, Hosp 2, Dept Endocrinol & Metab, Jinan 250100, Shandong, Peoples R China; [Wang, Aihong] Shandong Univ, Shandong Prov Hosp, Dept Cardiol, Jinan 250100, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Wang, AH (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Cardiol, Jinan 250100, Shandong, Peoples R China.	wah2905@sina.com; jjzhao@medmail.com.cn	Zhao, Jiajun/W-2963-2018	Zhao, Jiajun/0000-0003-3267-9292; Ma, Shizhan/0000-0002-0506-6557	National Basic Research Program [2012CB524900]; National Natural Science Foundation [81230018, 81170794, 81370891, 81300644]; Chinese Society of Endocrinology [13050830468]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Society of Endocrinology	This work was funded by The National Basic Research Program (2012CB524900; http://www.nsfc.gov.cn/); the National Natural Science Foundation (81230018, 81170794, 81370891, 81300644; http://www.nsfc.gov.cn/); the Chinese Society of Endocrinology (13050830468; http://www.china-endo.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Dumont J E, 1971, Vitam Horm, V29, P287; Elgadi A, 2010, BIOCHEM BIOPH RES CO, V393, P526, DOI 10.1016/j.bbrc.2010.02.042; Gagnon A, 2010, METABOLISM, V59, P547, DOI 10.1016/j.metabol.2009.08.018; Garg A, 2013, BRIT MED BULL, V107, P101, DOI 10.1093/bmb/ldt024; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; JANSON A, 1995, J CLIN ENDOCR METAB, V80, P1712, DOI 10.1210/jc.80.5.1712; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Lu SM, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-17; MARCUS C, 1988, J CLIN INVEST, V82, P1793, DOI 10.1172/JCI113793; Marians RC, 2002, P NATL ACAD SCI USA, V99, P15776, DOI 10.1073/pnas.242322099; Martinez-Gonzalez C, 2012, EUR J NEUROSCI, V35, P723, DOI 10.1111/j.1460-9568.2012.08002.x; Mason RR, 2012, AM J PHYSIOL-ENDOC M, V303, pE534, DOI 10.1152/ajpendo.00082.2012; Pagnon J, 2012, ENDOCRINOLOGY, V153, P4278, DOI 10.1210/en.2012-1127; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang TT, 2013, ENDOCR J, V60, P941; Xing WJ, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-44; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zimmermann R, 2003, J LIPID RES, V44, P2089, DOI 10.1194/jlr.M300190-JLR200	24	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116439	10.1371/journal.pone.0116439	http://dx.doi.org/10.1371/journal.pone.0116439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590597	Green Published, Green Submitted, gold			2022-12-26	WOS:000350679400014
J	Lameira, AR; Hardus, ME; Bartlett, AM; Shumaker, RW; Wich, SA; Menken, SBJ				Lameira, Adriano R.; Hardus, Madeleine E.; Bartlett, Adrian M.; Shumaker, Robert W.; Wich, Serge A.; Menken, Steph B. J.			Speech-Like Rhythm in a Voiced and Voiceless Orangutan Call	PLOS ONE			English	Article							VOCALIZATIONS; EVOLUTION; SUMATRAN; MONKEYS	The evolutionary origins of speech remain obscure. Recently, it was proposed that speech derived from monkey facial signals which exhibit a speech-like rhythm of similar to 5 open-close lip cycles per second. In monkeys, these signals may also be vocalized, offering a plausible evolutionary stepping stone towards speech. Three essential predictions remain, however, to be tested to assess this hypothesis' validity; (i) Great apes, our closest relatives, should likewise produce 5Hz-rhythm signals, (ii) speech-like rhythm should involve calls articulatorily similar to consonants and vowels given that speech rhythm is the direct product of stringing together these two basic elements, and (iii) speech-like rhythm should be experience-based. Via cinematic analyses we demonstrate that an ex-entertainment orangutan produces two calls at a speech-like rhythm, coined "clicks'' and "faux-speech'' Like voiceless consonants, clicks required no vocal fold action, but did involve independent manoeuvring over lips and tongue. In parallel to vowels, faux-speech showed harmonic and formant modulations, implying vocal fold and supralaryngeal action. This rhythm was several times faster than orangutan chewing rates, as observed in monkeys and humans. Critically, this rhythm was seven-fold faster, and contextually distinct, than any other known rhythmic calls described to date in the largest database of the orangutan repertoire ever assembled. The first two predictions advanced by this study are validated and, based on parsimony and exclusion of potential alternative explanations, initial support is given to the third prediction. Irrespectively of the putative origins of these calls and underlying mechanisms, our findings demonstrate irrevocably that great apes are not respiratorily, articulatorilly, or neurologically constrained for the production of consonant- and vowel-like calls at speech rhythm. Orangutan clicks and faux-speech confirm the importance of rhythmic speech antecedents within the primate lineage, and highlight potential articulatory homologies between great ape calls and human consonants and vowels.	[Lameira, Adriano R.; Hardus, Madeleine E.; Wich, Serge A.; Menken, Steph B. J.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Lameira, Adriano R.; Hardus, Madeleine E.] Pongo Fdn, Oudewater, Netherlands; [Bartlett, Adrian M.] Princeton Univ, Dept Psychol, Inst Neurosci, Princeton, NJ 08544 USA; [Shumaker, Robert W.] Indianapolis Zoo, Indianapolis, IN USA; [Shumaker, Robert W.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Wich, Serge A.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Res Ctr Evolutionary Anthropol & Palaeoecol, Liverpool L3 5UX, Merseyside, England	University of Amsterdam; Princeton University; Indiana University System; Indiana University Bloomington; Liverpool John Moores University	Lameira, AR (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	adriano@orangutan.nl		Lameira, Adriano/0000-0003-3071-4824; Wich, Serge/0000-0003-3954-5174	Menken Funds of the University of Amsterdam	Menken Funds of the University of Amsterdam	A.R.L. thanks the Menken Funds of the University of Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2008, CURR BIOL, V18, pR202, DOI 10.1016/j.cub.2008.01.040; Bergman TJ, 2013, CURR BIOL, V23, pR268, DOI 10.1016/j.cub.2013.02.038; Boersma Paul, 2002, GLOT INT, V5, P341; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Chandrasekaran C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000436; Delgado Roberto A., 2009, P215; Dunkel LP, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-12; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Furness W.H., 1916, P AM PHILOS SOC, V55, P281; GARNER RL, 1892, SPEECH MONKEYS; Ghazanfar AA, 2014, J COGNITIVE NEUROSCI, V26, P1196, DOI 10.1162/jocn_a_00575; Green JR, 1997, J NEUROPHYSIOL, V77, P2704, DOI 10.1152/jn.1997.77.5.2704; Gustison ML, 2012, PHILOS T R SOC B, V367, P1847, DOI 10.1098/rstb.2011.0218; Hardus ME, 2012, INT J PRIMATOL, V33, P287, DOI 10.1007/s10764-011-9574-z; Hardus ME, 2009, P ROY SOC B-BIOL SCI, V276, P3689, DOI 10.1098/rspb.2009.1027; Hardus Madeleine E., 2009, P49; Hopkins WD, 2007, ANIM BEHAV, V73, P281, DOI 10.1016/j.anbehav.2006.08.004; Krutzen M, 2011, CURR BIOL, V21, P1808, DOI 10.1016/j.cub.2011.09.017; Lameira AR, 2014, TRENDS COGN SCI, V18, P60, DOI 10.1016/j.tics.2013.10.013; Lameira AR, 2013, J ACOUST SOC AM, V134, P2326, DOI 10.1121/1.4817929; Lameira AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069749; Lameira AR, 2013, BEHAV ECOL SOCIOBIOL, V67, P519, DOI 10.1007/s00265-012-1471-8; Maddieson Ian., 2011, WORLD ATLAS LANGUAGE; Maddieson Ian, 1984, PATTERNS SOUNDS; Ouattara K, 2009, P NATL ACAD SCI USA, V106, P22026, DOI 10.1073/pnas.0908118106; Ross MD, 2007, AM J PRIMATOL, V69, P305, DOI 10.1002/ajp.20356; Spillmann B, 2010, ETHOLOGY, V116, P385, DOI 10.1111/j.1439-0310.2010.01744.x; Stevens NJ, 2013, NATURE, V497, P611, DOI 10.1038/nature12161; Wich SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036180	29	46	46	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e116136	10.1371/journal.pone.0116136	http://dx.doi.org/10.1371/journal.pone.0116136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25569211	Green Published, gold			2022-12-26	WOS:000348168000005
J	Chen, HY; Hu, JY; Chen, TH; Lin, YC; Liu, X; Lin, MY; Lang, YD; Yen, Y; Chen, RH				Chen, H. Y.; Hu, J. Y.; Chen, T. H.; Lin, Y. C.; Liu, X.; Lin, M. Y.; Lang, Y. D.; Yen, Y.; Chen, R. H.			KLHL39 suppresses colon cancer metastasis by blocking KLHL20-mediated PML and DAPK ubiquitination	ONCOGENE			English	Article							KELCH FAMILY PROTEIN; TUMOR-SUPPRESSOR; COLORECTAL CANCERS; LIGASES; KINASE; KEAP1; NRF2; CELLS; DEGRADATION; INTERACTS	Cullin 3 (Cul3)-family ubiquitin ligases use the BTB-domain-containing proteins for the recruitment of substrates, but the regulation of this family of ubiquitin ligases has not been completely understood. KLHL20 is a BTB-family protein and targets tumor suppressor promyelocytic leukemia protein (PML) and death-associated protein kinase (DAPK) to its kelch-repeat domain for ubiquitination and degradation. Here, we show that another BTB-kelch protein KLHL39 is recruited to the substrate-binding domain of KLHL20 but is not a substrate of Cul3-KLHL20 complex. Interestingly, KLHL39 does not bind Cul3 because of the absence of certain conserved residues in the BTB domain. Instead, KLHL39 blocks KLHL20-mediated ubiquitination of PML and DAPK by disrupting the binding of these substrates to KLHL20 as well as the binding of KLHL20 to Cul3. Through the two mechanisms, KLHL39 increases the stability of PML and DAPK. In human colon cancers, downregulations of KLHL39, PML and DAPK are associated with metastatic progression. Furthermore, preclinical data indicate that KLHL39 promotes colon cancer migration, invasion and survival in vitro and metastasis in vivo through a PML- and DAPK-dependent mechanism. Our study identifies KLHL39 as a negative regulator of Cul3-KLHL20 ubiquitin ligase and reveals a role of KLHL39-mediated PML and DAPK stabilization in colon cancer metastasis.	[Chen, H. Y.; Liu, X.; Yen, Y.] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Coll Med Sci & Technol, Taipei, Taiwan; [Chen, H. Y.; Hu, J. Y.; Chen, T. H.; Lin, Y. C.; Lin, M. Y.; Chen, R. H.] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Hu, J. Y.; Chen, T. H.; Chen, R. H.] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10764, Taiwan; [Lang, Y. D.] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Chen, R. H.] Natl Taiwan Univ, Coll Life Sci, Inst Biochem Sci, Taipei, Taiwan	Taipei Medical University; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University	Chen, RH (corresponding author), Acad Sinica, Inst Biol Chem, 128 Acad Rd,Sect 2, Taipei 115, Taiwan.	rhchen@gate.sinica.edu.tw	Yen, Yun/H-9591-2016; Chen, Ruey-Hwa/G-6121-2019	Chen, Ruey-Hwa/0000-0001-8124-5832	Academia Sinica Investigator Award; Taipei Medical University	Academia Sinica Investigator Award(Academia Sinica - Taiwan); Taipei Medical University	We thank National RNAi Core Facility for RNAi. This work was supported by Academia Sinica Investigator Award (RHC) and Aim for the Top University Project from Taipei Medical University (HYC).	Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bialik S, 2004, SEMIN CANCER BIOL, V14, P283, DOI 10.1016/j.semcancer.2004.04.008; Camp ND, 2012, J BIOL CHEM, V287, P6539, DOI 10.1074/jbc.M111.316471; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Chen HY, 2014, APOPTOSIS, V19, P364, DOI 10.1007/s10495-013-0923-6; Chen HY, 2012, CANCER RES, V72, P3631, DOI 10.1158/0008-5472.CAN-12-0667; Ebert MPA, 2005, NEOPLASIA, V7, P771, DOI 10.1593/neo.05235; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Genschik P, 2013, EMBO J, V32, P2307, DOI 10.1038/emboj.2013.173; Gozuacik D, 2006, AUTOPHAGY, V2, P74, DOI 10.4161/auto.2.2.2459; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hast BE, 2013, CANCER RES, V73, P2199, DOI 10.1158/0008-5472.CAN-12-4400; Ji AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060445; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lee YR, 2010, EMBO J, V29, P1748, DOI 10.1038/emboj.2010.62; Liu XY, 2013, CLIN SCI, V124, P567, DOI 10.1042/CS20120240; Ma JL, 2012, MOL CELL BIOL, V32, P1506, DOI 10.1128/MCB.06271-11; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ohta Y, 2010, INT J ONCOL, V36, P427, DOI 10.3892/ijo_00000516; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Rabellino A, 2012, CANCER RES, V72, P2275, DOI 10.1158/0008-5472.CAN-11-3159; Reineke EL, 2010, J BIOL CHEM, V285, P9485, DOI 10.1074/jbc.M109.063362; Salomoni P, 2008, CELL RES, V18, P620, DOI 10.1038/cr.2008.58; Sasagawa K, 2002, J BIOL CHEM, V277, P44140, DOI 10.1074/jbc.M202596200; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Schneider-Stock R, 2006, J PATHOL, V209, P95, DOI 10.1002/path.1951; Tsai PL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003460; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wang WJ, 2002, J CELL BIOL, V159, P169, DOI 10.1083/jcb.200204050; Wang WJ, 2007, MOL CELL, V27, P701, DOI 10.1016/j.molcel.2007.06.037; Wolff T, 1998, J VIROL, V72, P7170, DOI 10.1128/JVI.72.9.7170-7180.1998; Wolyniec K, 2012, BLOOD, V120, P822, DOI 10.1182/blood-2011-10-387647; Wu HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4214; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Xu XL, 2004, WORLD J GASTROENTERO, V10, P3441; Yen CC, 2011, J SURG ONCOL, V103, P761, DOI 10.1002/jso.21855; Yuan WC, 2011, CANCER CELL, V20, P214, DOI 10.1016/j.ccr.2011.07.008; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	40	19	21	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 1	2015	34	40					5141	5151		10.1038/onc.2014.435	http://dx.doi.org/10.1038/onc.2014.435			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CS6ZP	25619834				2022-12-26	WOS:000362233400004
J	Liu, Z; Leng, EC; Gunasekaran, K; Pentony, M; Shen, M; Howard, M; Stoops, J; Manchulenko, K; Razinkov, V; Liu, H; Fanslow, W; Hu, ZH; Sun, N; Hasegawa, H; Clark, R; Foltz, IN; Yan, W				Liu, Zhi; Leng, Esther C.; Gunasekaran, Kannan; Pentony, Martin; Shen, Min; Howard, Monique; Stoops, Janelle; Manchulenko, Kathy; Razinkov, Vladimir; Liu, Hua; Fanslow, William; Hu, Zhonghua; Sun, Nancy; Hasegawa, Haruki; Clark, Rutilio; Foltz, Ian N.; Yan, Wei			A Novel Antibody Engineering Strategy for Making Monovalent Bispecific Heterodimeric IgG Antibodies by Electrostatic Steering Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody; Antibody Engineering; Cancer Therapy; Fc- Receptor; Pancreatic Cancer	GROWTH-FACTOR RECEPTOR; CELLULAR CYTOTOXICITY ADCC; MONOCLONAL-ANTIBODY; DOMAIN; CANCER; EXPRESSION; GENERATION; THERAPY; HUMANIZATION; HERCEPTIN	Background: Bispecific heterodimeric antibody consisting of two different heavy chains and two different light chains requires heterodimerization of heavy chains and cognate light-heavy chain pairings. Results: Cognate light-heavy chain pairing can be achieved by an antibody engineering approach. Conclusion: Bispecific hetero-IgG antibodies can be made in mammalian cells. Significance: The technology could be used in the production of bispecific antibodies for many biotechnological applications. Producing pure and well behaved bispecific antibodies (bsAbs) on a large scale for preclinical and clinical testing is a challenging task. Here, we describe a new strategy for making monovalent bispecific heterodimeric IgG antibodies in mammalian cells. We applied an electrostatic steering mechanism to engineer antibody light chain-heavy chain (LC-HC) interface residues in such a way that each LC strongly favors its cognate HC when two different HCs and two different LCs are co-expressed in the same cell to assemble a functional bispecific antibody. We produced heterodimeric IgGs from transiently and stably transfected mammalian cells. The engineered heterodimeric IgG molecules maintain the overall IgG structure with correct LC-HC pairings, bind to two different antigens with comparable affinity when compared with their parental antibodies, and retain the functionality of parental antibodies in biological assays. In addition, the bispecific heterodimeric IgG derived from anti-HER2 and anti-EGF receptor (EGFR) antibody was shown to induce a higher level of receptor internalization than the combination of two parental antibodies. Mouse xenograft BxPC-3, Panc-1, and Calu-3 human tumor models showed that the heterodimeric IgGs strongly inhibited tumor growth. The described approach can be used to generate tools from two pre-existent antibodies and explore the potential of bispecific antibodies. The asymmetrically engineered Fc variants for antibody-dependent cellular cytotoxicity enhancement could be embedded in monovalent bispecific heterodimeric IgG to make best-in-class therapeutic antibodies.	[Liu, Zhi; Leng, Esther C.; Gunasekaran, Kannan; Pentony, Martin; Shen, Min; Howard, Monique; Stoops, Janelle; Manchulenko, Kathy; Hu, Zhonghua; Sun, Nancy; Hasegawa, Haruki; Clark, Rutilio; Foltz, Ian N.; Yan, Wei] Amgen Inc, Dept Therapeut Discovery, Seattle, WA 98119 USA; [Razinkov, Vladimir] Amgen Inc, Dept Proc & Prod Dev, Seattle, WA 98119 USA; [Liu, Hua; Fanslow, William] Amgen Inc, Therapeut Innovat Unit, Seattle, WA 98119 USA; [Liu, Zhi; Pentony, Martin; Shen, Min; Howard, Monique; Stoops, Janelle; Razinkov, Vladimir; Liu, Hua; Fanslow, William; Hu, Zhonghua; Sun, Nancy; Hasegawa, Haruki; Clark, Rutilio; Yan, Wei] Amgen Inc, Seattle, WA 98119 USA; [Gunasekaran, Kannan] Amgen Inc, Thousand Oaks, CA 91320 USA; [Leng, Esther C.; Manchulenko, Kathy; Foltz, Ian N.] Amgen Inc, Burnaby, BC V5A 1V7, Canada	Amgen; Amgen; Amgen; Amgen; Amgen	Liu, Z (corresponding author), Amgen Inc, Dept Therapeut Discovery, 1201 Amgen Court West, Seattle, WA 98119 USA.	phillipzhiliu@hotmail.com; fondofgo@yahoo.com		Hasegawa, Haruki/0000-0002-3464-4715				Adams CW, 2006, CANCER IMMUNOL IMMUN, V55, P717, DOI 10.1007/s00262-005-0058-x; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Carter P, 2001, J IMMUNOL METHODS, V248, P7, DOI 10.1016/S0022-1759(00)00339-2; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Chames P, 2009, MABS-AUSTIN, V1, P539, DOI 10.4161/mabs.1.6.10015; Davis JH, 2010, PROTEIN ENG DES SEL, V23, P195, DOI 10.1093/protein/gzp094; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Gijsen M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000563; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Igawa T, 2010, PROTEIN ENG DES SEL, V23, P667, DOI 10.1093/protein/gzq034; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; Klein C, 2012, MABS-AUSTIN, V4, P653, DOI 10.4161/mabs.21379; KNARR G, 1995, J BIOL CHEM, V270, P27589, DOI 10.1074/jbc.270.46.27589; Kontermann RE, 2012, MABS-AUSTIN, V4, P182, DOI 10.4161/mabs.4.2.19000; Kufer P, 2004, TRENDS BIOTECHNOL, V22, P238, DOI 10.1016/j.tibtech.2004.03.006; Labrijn AF, 2013, P NATL ACAD SCI USA, V110, P5145, DOI 10.1073/pnas.1220145110; Larbouret C, 2007, CLIN CANCER RES, V13, P3356, DOI 10.1158/1078-0432.CCR-06-2302; Lewis SM, 2014, NAT BIOTECHNOL, V32, P191, DOI 10.1038/nbt.2797; Liu Z, 2014, J BIOL CHEM, V289, P3571, DOI 10.1074/jbc.M113.513366; MACK M, 1995, P NATL ACAD SCI USA, V92, P7021, DOI 10.1073/pnas.92.15.7021; Maron R, 2013, P NATL ACAD SCI USA, V110, P15389, DOI 10.1073/pnas.1313857110; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; MILSTEIN C, 1983, NATURE, V305, P537, DOI 10.1038/305537a0; Olayioye MA, 1998, MOL CELL BIOL, V18, P5042, DOI 10.1128/MCB.18.9.5042; Potapov V, 2004, J MOL BIOL, V342, P665, DOI 10.1016/j.jmb.2004.06.072; Reiter Y, 1996, NAT BIOTECHNOL, V14, P1239, DOI 10.1038/nbt1096-1239; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; Rusnak DW, 2007, CELL PROLIFERAT, V40, P580, DOI 10.1111/j.1365-2184.2007.00455.x; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Scheuer W, 2009, CANCER RES, V69, P9330, DOI 10.1158/0008-5472.CAN-08-4597; Schlaeth M, 2010, CANCER SCI, V101, P1080, DOI 10.1111/j.1349-7006.2010.01505.x; Seimetz D, 2010, CANCER TREAT REV, V36, P458, DOI 10.1016/j.ctrv.2010.03.001; Spiess C, 2013, NAT BIOTECHNOL, V31, P753, DOI 10.1038/nbt.2621; Strop P, 2012, J MOL BIOL, V420, P204, DOI 10.1016/j.jmb.2012.04.020; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tanner M, 2004, MOL CANCER THER, V3, P1585; van Schouwenburg PA, 2014, J BIOL CHEM, V289, P34482, DOI 10.1074/jbc.M114.615500; Vlacich G, 2011, CANCER CELL, V20, P423, DOI 10.1016/j.ccr.2011.10.006; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345; YAMANAKA Y, 1993, ANTICANCER RES, V13, P565; Yamashita-Kashima Y, 2011, CLIN CANCER RES, V17, P5060, DOI 10.1158/1078-0432.CCR-10-2927; Yang XD, 1999, CANCER RES, V59, P1236; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Zhang JB, 2009, PROTEIN EXPRES PURIF, V65, P77, DOI 10.1016/j.pep.2008.10.011	48	50	75	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7535	7562		10.1074/jbc.M114.620260	http://dx.doi.org/10.1074/jbc.M114.620260			28	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25583986	Green Published, hybrid			2022-12-26	WOS:000351613600020
J	Nighot, PK; Hu, CAA; Ma, TY				Nighot, Prashant K.; Hu, Chien-An Andy; Ma, Thomas Y.			Autophagy Enhances Intestinal Epithelial Tight Junction Barrier Function by Targeting Claudin-2 Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROHNS-DISEASE; PERMEABILITY; EXPRESSION; CELLS; CONTRIBUTE; COLITIS; RELAPSE; FUSION; FLUX	Autophagy is an intracellular degradation pathway and is considered to be an essential cell survival mechanism. Defects in autophagy are implicated in many pathological processes, including inflammatory bowel disease. Among the innate defense mechanisms of intestinal mucosa, a defective tight junction (TJ) barrier has been postulated as a key pathogenic factor in the causation and progression of inflammatory bowel disease by allowing increased antigenic permeation. The cross-talk between autophagy and the TJ barrier has not yet been described. In this study, we present the novel finding that autophagy enhances TJ barrier function in Caco-2 intestinal epithelial cells. Nutrient starvation-induced autophagy significantly increased transepithelial electrical resistance and reduced the ratio of sodium/chloride paracellular permeability. Nutrient starvation reduced the paracellular permeability of small-sized urea but not larger molecules. The role of autophagy in the modulation of paracellular permeability was confirmed by pharmacological induction as well as pharmacological and genetic inhibition of autophagy. Consistent with the autophagy-induced reduction in paracellular permeability, a marked decrease in the level of the cation-selective, pore-forming TJ protein claudin-2 was observed after cell starvation. Starvation reduced the membrane presence of claudin-2 and increased its cytoplasmic, lysosomal localization. Therefore, our data show that autophagy selectively reduces epithelial TJ permeability of ions and small molecules by lysosomal degradation of the TJ protein claudin-2.	[Nighot, Prashant K.; Ma, Thomas Y.] Univ New Mexico, Sch Med, Dept Internal Med, Albuquerque, NM 87131 USA; [Hu, Chien-An Andy] Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; [Ma, Thomas Y.] Vet Affairs Med Ctr, Albuquerque, NM 87108 USA	University of New Mexico; University of New Mexico; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ma, TY (corresponding author), 1 Univ New Mexico, Div Gastroenterol & Hepatol, Hlth Sci Ctr, Univ New Mexico, MSC10-5550, Albuquerque, NM 87131 USA.	TMa@salud.unm.edu			NIDDK/National Institutes of Health [R01-DK-64165-01, KO1DK100562-01]; Veterans Affairs merit review grant from VA Research Service; University of New Mexico School of Medicine Research Allocation Committee; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064165, K01DK100562] Funding Source: NIH RePORTER	NIDDK/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs merit review grant from VA Research Service(US Department of Veterans Affairs); University of New Mexico School of Medicine Research Allocation Committee; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by NIDDK/National Institutes of Health Grants R01-DK-64165-01 (to T. M.) and KO1DK100562-01 (to P. N.). This work was also supported by a Veterans Affairs merit review grant from the VA Research Service (to T. M.) and by the University of New Mexico School of Medicine Research Allocation Committee (to P.N.).	Al-Sadi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085345; Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Arnott IDR, 2000, SCAND J GASTROENTERO, V35, P1163; Arrieta MC, 2009, GUT, V58, P41, DOI 10.1136/gut.2008.150888; BARKER G, 1981, Q J EXP PHYSIOL CMS, V66, P61, DOI 10.1113/expphysiol.1981.sp002529; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Buhner S, 2006, GUT, V55, P342, DOI 10.1136/gut.2005.065557; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Dhawan P, 2011, ONCOGENE, V30, P3234, DOI 10.1038/onc.2011.43; Dukes JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028659; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Groulx JF, 2012, AUTOPHAGY, V8, P893, DOI 10.4161/auto.19738; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Hou JH, 2005, J CELL SCI, V118, P5109, DOI 10.1242/jcs.02631; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lu RF, 2014, MOL BIOL CELL, V25, P1744, DOI 10.1091/mbc.E13-12-0724; Ma TY, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P1559; Mankertz J, 2009, CELL TISSUE RES, V336, P67, DOI 10.1007/s00441-009-0751-8; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sakiyama T, 2009, GASTROENTEROLOGY, V136, P924, DOI 10.1053/j.gastro.2008.12.002; Scherz-Shouval R, 2010, P NATL ACAD SCI USA, V107, P18511, DOI 10.1073/pnas.1006124107; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Strisciuglio C, 2013, J CROHNS COLITIS, V7, P534, DOI 10.1016/j.crohns.2012.08.009; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Van Itallie CM, 2011, J BIOL CHEM, V286, P3442, DOI 10.1074/jbc.M110.195578; Van Itallie CM, 2009, ANN NY ACAD SCI, V1165, P82, DOI 10.1111/j.1749-6632.2009.04052.x; Walczak M, 2013, AUTOPHAGY, V9, P424, DOI 10.4161/auto.22931; Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78; Wildenberg ME, 2012, GASTROENTEROLOGY, V142, P1493, DOI 10.1053/j.gastro.2012.02.034; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	47	121	125	4	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7234	7246		10.1074/jbc.M114.597492	http://dx.doi.org/10.1074/jbc.M114.597492			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25616664	Green Published, hybrid			2022-12-26	WOS:000350991500052
J	Zehrmann, A; Hartel, B; Glass, F; Bayer-Csaszar, E; Obata, T; Meyer, E; Brennicke, A; Takenaka, M				Zehrmann, Anja; Haertel, Barbara; Glass, Franziska; Bayer-Csaszar, Eszter; Obata, Toshihiro; Meyer, Etienne; Brennicke, Axel; Takenaka, Mizuki			Selective Homo- and Heteromer Interactions between the Multiple Organellar RNA Editing Factor (MORF) Proteins in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; PLANT ORGANELLES; STRUCTURAL BASIS; MESSENGER-RNAS; PPR PROTEINS; MITOCHONDRIA; RECOGNITION; COMPLEX; COMPLEMENTATION; EXPRESSION	RNA editing in plastids and mitochondria of flowering plants requires pentatricopeptide repeat proteins (PPR proteins) for site recognition and proteins of the multiple organellar RNA editing factor (MORE) family as cofactors. Two MORE proteins, MORES and MOM, are dual-targeted to plastids and mitochondria; two are targeted to plastids, and five are targeted to mitochondria. Pulldown assays from Arabidopsis thaliana tissue culture extracts with the mitochondrial MORE1 and the plastid M()RE2 proteins, respectively, both identify the dualtargeted MORE8 protein, showing that these complexes can assemble in the organelles. We have now determined the scope of potential interactions between the various MORE proteins by yeast two-hybrid, in vitro pulldown, and bimolecular fluorescence complementation assays. The resulting MORE-MORE interactorne identifies specific heterorneric MORE protein interactions in plastids and in mitochondria. Heteromers are observed for MORE protein combinations affecting a common site, suggesting their functional relevance. Most MORE proteins also undergo homomeric interactions. Submolecular analysis of the MOM protein reveals that the MORE-MORE protein connections require the C-terminal region of the central conserved MORE box. This domain has no similarity to known protein modules and may form a novel surface for protein-protein interactions.	[Zehrmann, Anja; Haertel, Barbara; Glass, Franziska; Bayer-Csaszar, Eszter; Brennicke, Axel; Takenaka, Mizuki] Univ Ulm, Mol Bot, D-89069 Ulm, Germany; [Obata, Toshihiro; Meyer, Etienne] Max Planck Inst Pflanzenphysiol, D-14476 Potsdam, Germany	Ulm University; Max Planck Society	Takenaka, M (corresponding author), Univ Ulm, Mol Bot, D-89069 Ulm, Germany.	mizuki.takenaka@uni-ulm.de	Takenaka, Mizuki/AAK-9884-2020; Obata, Toshihiro/AAX-4353-2020; Meyer, Etienne H/C-1952-2008	Takenaka, Mizuki/0000-0002-3242-5092; Obata, Toshihiro/0000-0001-8931-7722; Meyer, Etienne H/0000-0003-4712-9824	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (to M.T. and A.B.).	Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bentolila S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003584; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Bisanz C, 2003, PLANT MOL BIOL, V51, P651, DOI 10.1023/A:1022557825768; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Braun P, 2013, ANNU REV PLANT BIOL, V64, P161, DOI 10.1146/annurev-arplant-050312-120140; Braun P, 2012, PROTEOMICS, V12, P1499, DOI 10.1002/pmic.201100598; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chateigner-Boutin AL, 2010, RNA BIOL, V7, P213, DOI 10.4161/rna.7.2.11343; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Grewe F, 2011, NUCLEIC ACIDS RES, V39, P2890, DOI 10.1093/nar/gkq1227; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Horstman A, 2014, INT J MOL SCI, V15, P9628, DOI 10.3390/ijms15069628; James P, 1996, GENETICS, V144, P1425; Ke JY, 2013, NAT STRUCT MOL BIOL, V20, P1377, DOI 10.1038/nsmb.2710; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Obata T, 2011, PHYTOCHEMISTRY, V72, P1081, DOI 10.1016/j.phytochem.2010.11.003; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schutze K., 2009, BIMOLECULAR FLUORESC; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Takenaka M, 2007, METHOD ENZYMOL, V424, P439, DOI 10.1016/S0076-6879(07)24020-0; Takenaka M, 2014, MOL PLANT, V7, P582, DOI 10.1093/mp/sst170; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Takenaka M, 2011, METHODS MOL BIOL, V718, P163, DOI 10.1007/978-1-61779-018-8_10; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; Tanz SK, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00214; Tillich M, 2009, P NATL ACAD SCI USA, V106, P6002, DOI 10.1073/pnas.0808529106; Van Leene J, 2011, METHODS MOL BIOL, V754, P195, DOI 10.1007/978-1-61779-154-3_11; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651; Zehrmann A, 2009, PLANT CELL, V21, P558, DOI 10.1105/tpc.108.064535; Zhang F, 2014, P NATL ACAD SCI USA, V111, P2023, DOI 10.1073/pnas.1316183111; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	40	42	47	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6445	6456		10.1074/jbc.M114.602086	http://dx.doi.org/10.1074/jbc.M114.602086			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25583991	hybrid, Green Published			2022-12-26	WOS:000350732500048
J	Kuster, DWD; Govindan, S; Springer, TI; Martin, JL; Finley, NL; Sadayappan, S				Kuster, Diederik W. D.; Govindan, Suresh; Springer, Tzvia I.; Martin, Jody L.; Finley, Natosha L.; Sadayappan, Sakthivel			A Hypertrophic Cardiomyopathy-associated MYBPC3 Mutation Common in Populations of South Asian Descent Causes Contractile Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-C; PROTEASOME SYSTEM; CROSS-LINKING; SITE MUTATION; CMYBP-C; MYOSIN; PHOSPHORYLATION; GENE; ACTIVATION; DOMAIN	Hypertrophic cardiomyopathy (HCM) results from mutations in genes encoding sarcomeric proteins, most often MYBPC3, which encodes cardiac myosin binding protein-C (cMyBP-C). A recently discovered HCM-associated 25-base pair deletion in MYBPC3 is inherited in millions worldwide. Although this mutation causes changes in the C10 domain of cMyBP-C (cMyBP-C-C10mut), which binds to the light meromyosin (LMM) region of the myosin heavy chain, the underlying molecular mechanism causing HCM is unknown. In this study, adenoviral expression of cMyBP-C-C10mut in cultured adult rat cardiomyocytes was used to investigate protein localization and evaluate contractile function and Ca2+ transients, compared with wildtype cMyBP-C expression (cMyBP-C-WT) and controls. Forty-eight hours after infection, 44% of cMyBP-C-WT and 36% of cMyBP-C-C10mut protein levels were determined in total lysates, confirming equal expression. Immunofluorescence experiments showed little or no localization of cMyBP-C-C10mut to the C-zone, whereas cMyBP-C-WT mostly showed C-zone staining, suggesting that cMyBP-C-C10mut could not properly integrate in the C-zone of the sarcomere. Subcellular fractionation confirmed that most cMyBP-C-C10mut resided in the soluble fraction, with reduced presence in the myofilament fraction. Also, cMyBP-C-C10mut displayed significantly reduced fractional shortening, sarcomere shortening, and relaxation velocities, apparently caused by defects in sarcomere function, because Ca2+ transients were unaffected. Co-sedimentation and protein cross-linking assays confirmed that C10(mut) causes the loss of C10 domain interaction with myosin LMM. Protein homology modeling studies showed significant structural perturbation in cMyBP-C-C10mut, providing a potential structural basis for the alteration in its mode of interaction with myosin LMM. Therefore, expression of cMyBP-C-C10mut protein is sufficient to cause contractile dysfunction in vitro.	[Kuster, Diederik W. D.; Govindan, Suresh; Martin, Jody L.; Sadayappan, Sakthivel] Loyola Univ Chicago, Dept Cell & Mol Physiol, Div Hlth Sci, Maywood, IL 60153 USA; [Springer, Tzvia I.; Finley, Natosha L.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA; [Finley, Natosha L.] Miami Univ, Cell Mol & Struct Biol Program, Oxford, OH 45056 USA	Loyola University Chicago; University System of Ohio; Miami University; University System of Ohio; Miami University	Sadayappan, S (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, Div Hlth Sci, 2160 S First Ave, Maywood, IL 60153 USA.	ssadayappan@luc.edu	Kuster, Diederik/AAD-9272-2019	Kuster, Diederik/0000-0003-1498-6862; Springer, Tzvia/0000-0002-2811-5147; Sadayappan, Sakthivel/0000-0003-2006-7678	National Institutes of Health [R01HL105826, K02HL114749]; American Heart Association [14GRNT20490025, 13POST17220009, 13POST14720024]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL114749, R01HL105826] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL105826 and K02HL114749 (to S. S.). This work was also supported by American Heart Association Midwest Affiliate Research Programs Grant-in-Aid 14GRNT20490025 and Postdoctoral Fellowships 13POST17220009 (to D. W. D. K.) and 13POST14720024 (to S. G.),	Adalsteinsdottir B, 2014, CIRCULATION, V130, P1158, DOI 10.1161/CIRCULATIONAHA.114.011207; Alcalai R, 2007, ARCH INTERN MED, V167, P276, DOI 10.1001/archinte.167.3.276; Alders M, 2003, EUR HEART J, V24, P1848, DOI 10.1016/S0195-668X(03)00466-4; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bahrudin U, 2008, J MOL BIOL, V384, P896, DOI 10.1016/j.jmb.2008.09.070; Bardswell SC, 2012, J MUSCLE RES CELL M, V33, P53, DOI 10.1007/s10974-011-9276-3; Barefield D, 2014, AM J PHYSIOL-HEART C, V306, pH807, DOI 10.1152/ajpheart.00913.2013; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BONNE G, 1995, NAT GENET, V11, P438, DOI 10.1038/ng1295-438; Bulteau AL, 2002, ARCH BIOCHEM BIOPHYS, V397, P298, DOI 10.1006/abbi.2001.2663; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Dihazi GH, 2003, RAPID COMMUN MASS SP, V17, P2005, DOI 10.1002/rcm.1144; Flashman E, 2007, BIOCHEM J, V401, P97, DOI 10.1042/BJ20060500; Freiburg A, 1996, EUR J BIOCHEM, V235, P317, DOI 10.1111/j.1432-1033.1996.00317.x; FURST DO, 1992, J CELL SCI, V102, P769; Gilbert R, 1996, J CELL SCI, V109, P101; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Govindan S, 2012, J MUSCLE RES CELL M, V33, P17, DOI 10.1007/s10974-012-9292-y; Harris SP, 2011, CIRC RES, V108, P751, DOI 10.1161/CIRCRESAHA.110.231670; Harris SP, 2004, CIRC RES, V95, P930, DOI 10.1161/01.RES.0000147312.02673.56; Herron TJ, 2006, CIRC RES, V98, P1290, DOI 10.1161/01.RES.0000222059.54917.ef; Korte FS, 2003, CIRC RES, V93, P752, DOI 10.1161/01.RES.0000096363.85588.9A; Kuster DWD, 2014, PFLUG ARCH EUR J PHY, V466, P207, DOI 10.1007/s00424-013-1417-7; Kuster DWD, 2013, CIRC RES, V112, P633, DOI 10.1161/CIRCRESAHA.112.275602; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Miyamoto CA, 1999, J MUSCLE RES CELL M, V20, P703, DOI 10.1023/A:1005513312939; OKAGAKI T, 1993, J CELL BIOL, V123, P619, DOI 10.1083/jcb.123.3.619; Predmore JM, 2010, CIRCULATION, V121, P997, DOI 10.1161/CIRCULATIONAHA.109.904557; Razzaque MA, 2013, CIRC RES, V113, P553, DOI 10.1161/CIRCRESAHA.113.301225; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Rottbauer W, 1997, J CLIN INVEST, V100, P475, DOI 10.1172/JCI119555; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; Sarikas A, 2005, CARDIOVASC RES, V66, P33, DOI 10.1016/j.cardiores.2005.01.004; Sarkey JP, 2011, J MOL CELL CARDIOL, V50, P1044, DOI 10.1016/j.yjmcc.2011.03.004; Schlossarek S, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0235-3; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Simonson TS, 2010, ANN HUM GENET, V74, P184, DOI 10.1111/j.1469-1809.2010.00561.x; STARR R, 1978, BIOCHEM J, V171, P813, DOI 10.1042/bj1710813; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; Stelzer JE, 2006, CIRC RES, V98, P1212, DOI 10.1161/01.RES.0000219863.94390.ce; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; van Dijk SJ, 2009, CIRCULATION, V119, P1473, DOI 10.1161/CIRCULATIONAHA.108.838672; Waldmuller S, 2003, J MOL CELL CARDIOL, V35, P623, DOI 10.1016/S0022-2828(03)00050-6; WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434; Welikson RE, 2002, J CELL SCI, V115, P3517; Wilkins MR, 1999, METH MOL B, V112, P531; Witayavanitkul N, 2014, J BIOL CHEM, V289, P8818, DOI 10.1074/jbc.M113.541128; Zahka K, 2008, HEART, V94, P1326, DOI 10.1136/hrt.2007.127241	51	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5855	5867		10.1074/jbc.M114.607911	http://dx.doi.org/10.1074/jbc.M114.607911			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25583989	hybrid, Green Published			2022-12-26	WOS:000350044200050
J	Fu, TF; Cao, ML; Liu, F; Zhu, JA; Ye, DM; Feng, XX; Xu, YM; Wang, G; Bai, YH				Fu, Tengfei; Cao, Manlin; Liu, Fang; Zhu, Jiaan; Ye, Dongmei; Feng, Xianxuan; Xu, Yiming; Wang, Gang; Bai, Yuehong			Carpal Tunnel Syndrome Assessment with Ultrasonography: Value of Inlet-to-Outlet Median Nerve Area Ratio in Patients versus Healthy Volunteers	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; HIGH-RESOLUTION SONOGRAPHY; ULTRASOUND; DIAGNOSIS; ADULTS	Objective To evaluate the diagnostic value of the Inlet-to-outlet median nerve area ratio (IOR) in patients with clinically and electrophysiologically confirmed carpal tunnel syndrome (CTS). Methods Forty-six wrists in 46 consecutive patients with clinical and electrodiagnostic evidence of CTS and forty-four wrists in 44 healthy volunteers were examined with ultrasonography. The cross-sectional area (CSA) of the median nerve was measured at the carpal tunnel inlet (the level of scaphoid-pisiform) and outlet (the level of the hook of the hamate), and the IOR was calculated for each wrist. Ultrasonography and electrodiagnostic tests were performed under blinded conditions. Electrodiagnostic testing combined with clinical symptoms were considered to be the gold standard test. Receiver operating characteristic (ROC) curves were used to evaluate the diagnostic value between the inlet CSA and IOR. Results study population included 16 men and 30 women (mean age, 45.3 years; range, 18-83 years). The control population included 18 men and 26 women (mean age, 50.4 years; range, 18-79 years). The mean inlet CSA was 8.7 mm(2) in healthy controls and 14.6mm(2) in CTS group (P < 0.001). The mean IOR in healthy volunteers (1.0) was smaller than that in patients (1.6, P < 0.001). Receiver operating characteristic analysis revealed a diagnostic advantage to using the IOR rather than the inlet CSA (P < 0.01). An IOR cutoff value of >= 1.3 would yield 93% specificity and 91% sensitivity in the diagnosis of CTS. Conclusion The IOR of median nerve area promises to be an effective means in the diagnosis of CTS. A large-scale, randomized controlled trial is required to determine how and when this parameter will be used.	[Fu, Tengfei; Cao, Manlin; Ye, Dongmei; Feng, Xianxuan; Xu, Yiming; Wang, Gang; Bai, Yuehong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Rehabil Med, Shanghai 200030, Peoples R China; [Liu, Fang; Zhu, Jiaan] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Ultrasound, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Bai, YH (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Rehabil Med, Shanghai 200030, Peoples R China.	aibyhw@126.com	Xu, yiming/E-5687-2012	Xu, yiming/0000-0002-7123-5793				[Anonymous], 1993, NEUROLOGY, V43, P2406, DOI DOI 10.1212/WNL.43.11.2406; Bathala L, 2013, MUSCLE NERVE, V47, P673, DOI 10.1002/mus.23639; Beekman R, 2003, MUSCLE NERVE, V27, P26, DOI 10.1002/mus.10227; BUCHBERGER W, 1991, J ULTRAS MED, V10, P531, DOI 10.7863/jum.1991.10.10.531; BUCHBERGER W, 1992, AM J ROENTGENOL, V159, P793, DOI 10.2214/ajr.159.4.1529845; Cartwright MS, 2008, MUSCLE NERVE, V37, P566, DOI 10.1002/mus.21009; Cartwright MS, 2012, MUSCLE NERVE, V46, P287, DOI 10.1002/mus.23389; Cartwright MS, 2009, J NEUROIMAGING, V19, P47, DOI 10.1111/j.1552-6569.2008.00256.x; Cullen Karen A, 2009, Natl Health Stat Report, P1; Fleiss J. L., 1986, THE DESIGN AND ANALY; Hobson-Webb LD, 2008, CLIN NEUROPHYSIOL, V119, P1353, DOI 10.1016/j.clinph.2008.01.101; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Jayaraman S, 2004, NEUROIMAG CLIN N AM, V14, P103, DOI 10.1016/j.nic.2003.12.001; Kaymak B, 2008, ARCH PHYS MED REHAB, V89, P743, DOI 10.1016/j.apmr.2007.09.041; Keberle M, 2000, EUR RADIOL, V10, P1043, DOI 10.1007/s003300000386; Kele H, 2003, NEUROLOGY, V61, P389, DOI 10.1212/01.WNL.0000073101.04845.22; Keles I, 2005, AM J PHYS MED REHAB, V84, P443, DOI 10.1097/01.phm.0000163715.11645.96; Kim HS, 2013, ARCH PHYS MED REHAB, V94, P2151, DOI 10.1016/j.apmr.2013.05.008; Klauser AS, 2011, RADIOLOGY, V259, P808, DOI 10.1148/radiol.11101644; Martinoli C, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781553; MESGARZADEH M, 1989, RADIOLOGY, V171, P749, DOI 10.1148/radiology.171.3.2541464; Nakamichi KI, 2000, MUSCLE NERVE, V23, P1713, DOI 10.1002/1097-4598(200011)23:11<1713::AID-MUS7>3.3.CO;2-7; Nakamichi KI, 2002, MUSCLE NERVE, V26, P798, DOI 10.1002/mus.10276; Schappert Susan M, 2008, Natl Health Stat Report, P1; Sernik RA, 2008, SKELETAL RADIOL, V37, P49, DOI 10.1007/s00256-007-0372-9; Sugimoto T, 2013, ULTRASOUND MED BIOL, V39, P1560, DOI 10.1016/j.ultrasmedbio.2013.03.031; Therimadasamy A, 2012, MUSCLE NERVE, V46, P455, DOI 10.1002/mus.23401; Ulasli AM, 2013, MUSCLE NERVE, V47, P396, DOI 10.1002/mus.23528; Visser LH, 2008, J NEUROL NEUROSUR PS, V79, P63, DOI 10.1136/jnnp.2007.115337; Wang Lin-Yi, 2008, Chang Gung Med J, V31, P469; Werner RA, 2011, MUSCLE NERVE, V44, P597, DOI 10.1002/mus.22208; Won SJ, 2013, MUSCLE NERVE, V47, P864, DOI 10.1002/mus.23691; Wong SM, 2004, RADIOLOGY, V232, P93, DOI 10.1148/radiol.2321030071; Zaidman CM, 2009, MUSCLE NERVE, V40, P960, DOI 10.1002/mus.21431; Ziswiler HR, 2005, ARTHRITIS RHEUM-US, V52, P304, DOI 10.1002/art.20723	35	33	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116777	10.1371/journal.pone.0116777	http://dx.doi.org/10.1371/journal.pone.0116777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617835	Green Published, Green Submitted, gold			2022-12-26	WOS:000350336000025
J	Merkes, C; Turkalo, TK; Wilder, N; Park, H; Wenger, LW; Lewin, SJ; Azuma, M				Merkes, Chris; Turkalo, Timothy K.; Wilder, Nicole; Park, Hyewon; Wenger, Luke W.; Lewin, Seth J.; Azuma, Mizuki			Ewing Sarcoma Ewsa Protein Regulates Chondrogenesis of Meckel's Cartilage through Modulation of Sox9 in Zebrafish	PLOS ONE			English	Article							DIRECT TRANSCRIPTIONAL TARGET; CREB-BINDING PROTEIN; NEURAL CREST; RNA HELICASE; GENE; EXPRESSION; EWS-FLI1; FUSION; SKELETAL; ACTIVATOR	Ewing sarcoma is the second most common skeletal (bone and cartilage) cancer in adolescents, and it is characterized by the expression of the aberrant chimeric fusion gene EWS/FLI1. Wild-type EWS has been proposed to play a role in mitosis, splicing and transcription. We have previously shown that EWS/FLI1 interacts with EWS, and it inhibits EWS activity in a dominant manner. Ewing sarcoma is a cancer that specifically develops in skeletal tissues, and although the above data suggests the significance of EWS, its role in chondrogenesis/ skeletogenesis is not understood. To elucidate the function of EWS in skeletal development, we generated and analyzed a maternal zygotic (MZ) ewsa/ewsa line because the ewsa/wt and ewsa/ewsa zebrafish appeared to be normal and fertile. Compared with wt/wt, the Meckel's cartilage of MZ ewsa/ewsa mutants had a higher number of craniofacial prehypertrophic chondrocytes that failed to mature into hypertrophic chondrocytes at 4 days post-fertilization (dpf). Ewsa interacted with Sox9, which is the master transcription factor for chondrogenesis. Sox9 target genes were either upregulated (ctgfa, ctgfb, col2a1a, and col2a1b) or downregulated (sox5, nog1, nog2, and bmp4) inMZ ewsa/ewsa embryos compared with the wt/wt zebrafish embryos. Among these Sox9 target genes, the chromatin immunoprecipitation (ChIP) experiment demonstrated that Ewsa directly binds to ctgfa and ctgfb loci. Consistently, immunohistochemistry showed that the Ctgf protein is upregulated in the Meckel's cartilage of MZ ewsa/ewsa mutants. Together, we propose that Ewsa promotes the differentiation from prehypertrophic chondrocytes to hypertrophic chondrocytes of Meckel's cartilage through inhibiting Sox9 binding site of the ctgf gene promoter. Because Ewing sarcoma specifically develops in skeletal tissue that is originating from chondrocytes, this new role of EWS may provide a potential molecular basis of its pathogenesis.	[Merkes, Chris; Turkalo, Timothy K.; Wilder, Nicole; Park, Hyewon; Wenger, Luke W.; Lewin, Seth J.; Azuma, Mizuki] Univ Kansas, Lawrence, KS 66045 USA	University of Kansas	Azuma, M (corresponding author), Univ Kansas, 7031 Haworth,1200 Sunnyside Ave, Lawrence, KS 66045 USA.	azumam@ku.edu		Merkes, Christopher/0000-0001-8191-627X	Massman Family Ewing Sarcoma Research Fund; Sarcoma Foundation of America [P20RR016475 / P20GM103418, P20 RR032682-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103638, P20GM103418] Funding Source: NIH RePORTER	Massman Family Ewing Sarcoma Research Fund; Sarcoma Foundation of America; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This manuscript was supported by the Massman Family Ewing Sarcoma Research Fund, the Sarcoma Foundation of America, P20RR016475 / P20GM103418 and P20 RR032682-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaan OD, 2005, ONCOGENE, V24, P2715, DOI 10.1038/sj.onc.1208247; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Anumanthan G, 2006, CANCER RES, V66, P10824, DOI 10.1158/0008-5472.CAN-06-1599; Araya N, 2003, J BIOL CHEM, V278, P5427, DOI 10.1074/jbc.M210234200; Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Azuma M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000979; Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Bhatt S, 2013, COLD SPRING HARB PER, P5, DOI [10.1101/cshperspect.a019836, DOI 10.1101/CSHPERSPECT.A019836]; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Dale RM, 2011, DEV BIOL, V357, P518, DOI 10.1016/j.ydbio.2011.06.020; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246; Embree LJ, 2009, CANCER RES, V69, P4363, DOI 10.1158/0008-5472.CAN-08-3229; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Furumatsu T, 2005, J BIOL CHEM, V280, P35203, DOI 10.1074/jbc.M502409200; Hattori T, 2013, J BIOL CHEM, V288, P35138, DOI 10.1074/jbc.M113.486795; Hayashi MT, 2013, ONCOGENE, V32, P4593, DOI 10.1038/onc.2012.615; Henry SP, 2012, J BONE MINER RES, V27, P2511, DOI 10.1002/jbmr.1696; Javidan Y, 2004, METHOD CELL BIOL, V76, P415; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinsey M, 2009, CANCER RES, V69, P9047, DOI 10.1158/0008-5472.CAN-09-1540; Lakiza O, 2011, DEV BIOL, V359, P149, DOI 10.1016/j.ydbio.2011.08.012; Lee YH, 2004, DEV BIOL, V275, P93, DOI 10.1016/j.ydbio.2004.07.036; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Li HJ, 2007, J CLIN INVEST, V117, P1314, DOI 10.1172/JCI31222; Lindeman LC, 2009, METHODS MOL BIOL, V567, P75, DOI 10.1007/978-1-60327-414-2_5; Liu F, 2008, CURR BIOL, V18, P1234, DOI 10.1016/j.cub.2008.07.048; McKinsey EL, 2011, ONCOGENE, V30, P4910, DOI 10.1038/onc.2011.197; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; Oh CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010113; Paronetto MP, 2011, MOL CELL, V43, P353, DOI 10.1016/j.molcel.2011.05.035; Park H, 2014, CELL CYCLE, P13, DOI [10.4161/15384101.2014.949550, DOI 10.4161/15384101.2014.949550]; Piotrowski T, 1996, DEVELOPMENT, V123, P345; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rossow KL, 2001, CANCER RES, V61, P2690; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Sohn EJ, 2010, CANCER RES, V70, P1154, DOI 10.1158/0008-5472.CAN-09-1993; Spahn L, 2003, ONCOGENE, V22, P6819, DOI 10.1038/sj.onc.1206810; Strahle U, 1996, INT J DEV BIOL, V40, P929; Talbot JC, 2010, DEVELOPMENT, V137, P2506, DOI 10.1242/dev.049700; Tomita N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059226; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Toretsky JA, 2006, CANCER RES, V66, P5574, DOI 10.1158/0008-5472.CAN-05-3293; Tsuda M, 2003, J BIOL CHEM, V278, P27224, DOI 10.1074/jbc.M303471200; Yan YL, 2002, DEVELOPMENT, V129, P5065; Yang L, 2000, J BIOL CHEM, V275, P37612, DOI 10.1074/jbc.M005739200; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F; Zwerner JP, 2008, ONCOGENE, V27, P3282, DOI 10.1038/sj.onc.1210991	55	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116627	10.1371/journal.pone.0116627	http://dx.doi.org/10.1371/journal.pone.0116627			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617839	gold, Green Published, Green Submitted			2022-12-26	WOS:000350336000017
J	Ceacero, F; Landete-Castillejos, T; Olguin, A; Miranda, M; Garcia, A; Martinez, A; Cassinello, J; Miguel, V; Gallego, L				Ceacero, Francisco; Landete-Castillejos, Tomas; Olguin, Augusto; Miranda, Maria; Garcia, Andres; Martinez, Alberto; Cassinello, Jorge; Miguel, Valentin; Gallego, Laureano			Avoiding Toxic Levels of Essential Minerals: A Forgotten Factor in Deer Diet Preferences	PLOS ONE			English	Article							CERVUS-ELAPHUS-HISPANICUS; RED DEER; MEDITERRANEAN ENVIRONMENT; GROWTH-PERFORMANCE; CRUDE PROTEIN; ANTLER GROWTH; HIGH-SULFUR; SELECTION; NUTRITION; FORAGE	Ungulates select diets with high energy, protein, and sodium contents. However, it is scarcely known the influence of essential minerals other than Na in diet preferences. Moreover, almost no information is available about the possible influence of toxic levels of essential minerals on avoidance of certain plant species. The aim of this research was to test the relative importance of mineral content of plants in diet selection by red deer (Cervus elaphus) in an annual basis. We determined mineral, protein and ash content in 35 common Mediterranean plant species (the most common ones in the study area). These plant species were previously classified as preferred and non-preferred. We found that deer preferred plants with low contents of Ca, Mg, K, P, S, Cu, Sr and Zn. The model obtained was greatly accurate identifying the preferred plant species (91.3% of correct assignments). After a detailed analysis of these minerals (considering deficiencies and toxicity levels both in preferred and non-preferred plants) we suggest that the avoidance of excessive sulphur in diet (i.e., selection for plants with low sulphur content) seems to override the maximization for other nutrients. Low sulphur content seems to be a forgotten factor with certain relevance for explaining diet selection in deer. Recent studies in livestock support this conclusion, which is highlighted here for the first time in diet selection by a wild large herbivore. Our results suggest that future studies should also take into account the toxicity levels of minerals as potential drivers of preferences.	[Ceacero, Francisco] Czech Univ Life Sci, Dept Anim Sci & Food Proc, Prague, Czech Republic; [Ceacero, Francisco] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Landete-Castillejos, Tomas; Garcia, Andres] Inst Desarrollo Reg, Secc Recursos Cineget & Ganaderos, Albacete, Spain; [Landete-Castillejos, Tomas; Garcia, Andres; Cassinello, Jorge] CSIC UCLM JCCM, Inst Invest Recursos Cineget, Ciudad Real, Spain; [Landete-Castillejos, Tomas; Garcia, Andres; Gallego, Laureano] Univ Castilla La Mancha, Dept Ciencia Tecnol Agroforestal & Genet, Albacete, Spain; [Miranda, Maria] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Ctr African Ecol, Johannesburg, South Africa; [Martinez, Alberto; Miguel, Valentin] Inst Desarrollo Reg, Lab Ciencia Ingn Mat, Albacete, Spain	Czech University of Life Sciences Prague; Czech Research Institute of Animal Science; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; University of Witwatersrand	Ceacero, F (corresponding author), Czech Univ Life Sci, Dept Anim Sci & Food Proc, Prague, Czech Republic.	ceacero@ftz.czu.cz	Ceacero, Francisco/C-1088-2009; Cassinello, Jorge/A-4324-2009; Garcia Diaz, Andres Jose/A-9162-2012; Gallego, Laureano/G-9715-2015	Ceacero, Francisco/0000-0001-9014-147X; Cassinello, Jorge/0000-0001-8781-2009; Landete Castillejos, Tomas/0000-0001-9753-5295; Garcia Diaz, Andres Jose/0000-0002-4662-2185; miguel, valentin/0000-0003-4770-8180; Miranda, Maria/0000-0002-4236-7455; Gallego, Laureano/0000-0001-8219-087X	Ministry of Economy and Competitiveness, Spain [AGL2012-38898]; Ministry of Agriculture, Czech Republic [MZERO0714]; Czech University of Life Sciences, Czech Republic [CIGA-20145001]; Faculty of Tropical AgriSciences, Czech Republic [IGA-20145026]; Claude Leon postdoctoral fellowship	Ministry of Economy and Competitiveness, Spain; Ministry of Agriculture, Czech Republic(Ministry of Agriculture, Czech Republic); Czech University of Life Sciences, Czech Republic; Faculty of Tropical AgriSciences, Czech Republic; Claude Leon postdoctoral fellowship	This paper has been funded by the projects AGL2012-38898 (Ministry of Economy and Competitiveness, Spain), MZERO0714 (Ministry of Agriculture, Czech Republic), CIGA-20145001 (Czech University of Life Sciences, Czech Republic) and IGA-20145026 (Faculty of Tropical AgriSciences, Czech Republic). MM was supported by a Claude Leon postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agricultural Research Council (ARC), 1980, NUTR REQ RUM LIV; Alonso-Diaz MA, 2008, ANIM FEED SCI TECH, V141, P36, DOI 10.1016/j.anifeedsci.2007.04.009; ALVAREZ G, 1991, FOLIA ZOOL, V40, P117; [Anonymous], 2003, MINERALS ANIMAL HUMA, DOI DOI 10.1016/B978-0-444-51367-0.50006-4; Asher GW, 2011, LIVEST SCI, V140, P8, DOI 10.1016/j.livsci.2011.02.002; Asleson MA, 1996, J WILDLIFE MANAGE, V60, P744, DOI 10.2307/3802373; AUSTIN PJ, 1989, J CHEM ECOL, V15, P1335, DOI 10.1007/BF01014834; Barroso FG, 2001, J ARID ENVIRON, V49, P301, DOI 10.1006/jare.2000.0770; BELOVSKY GE, 1978, THEOR POPUL BIOL, V14, P105, DOI 10.1016/0040-5809(78)90007-2; Berteaux D, 1998, OECOLOGIA, V115, P84, DOI 10.1007/s004420050494; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Bugalho MN, 2003, FOREST ECOL MANAG, V181, P23, DOI 10.1016/S0378-1127(03)00125-7; Cammack KM, 2010, J ANIM SCI, V88, P1777, DOI 10.2527/jas.2009-2343; Ceacero F, 2014, BEHAV PROCESS, V103, P28, DOI 10.1016/j.beproc.2013.10.008; Ceacero F, 2010, BRIT J NUTR, V103, P617, DOI 10.1017/S0007114509992091; Ceacero F, 2009, LIVEST SCI, V122, P345, DOI 10.1016/j.livsci.2008.08.002; COOPER SM, 1988, OECOLOGIA, V75, P336, DOI 10.1007/BF00376934; Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7; Dias RS, 2013, J ANIM SCI, V91, P5714, DOI 10.2527/jas.2013-6195; Drewnoski ME, 2014, J ANIM SCI, V92, P3763, DOI 10.2527/jas.2013-7242; Dryden GM, 2011, ANIM PROD SCI, V51, P292, DOI 10.1071/AN10176; Dumont B, 2005, ANIM RES, V54, P369, DOI 10.1051/animres:2005030; Dytham C, 2003, CHOOSING USING STAT; Estell RE, 2010, SMALL RUMINANT RES, V94, P1, DOI 10.1016/j.smallrumres.2010.09.012; Estevez JA, 2009, ACTA THERIOL, V54, P235, DOI 10.4098/j.at.0001-7051.070.2008; Fernandez-Olalla M., 2006, Investigacion Agraria, Sistemas y Recursos Forestales, V15, P329; FREELAND WJ, 1985, BIOCHEM SYST ECOL, V13, P195, DOI 10.1016/0305-1978(85)90079-1; Gonzalez-Hernandez MP, 2000, J CHEM ECOL, V26, P293, DOI 10.1023/A:1005462100010; Hanley TA, 1997, OIKOS, V79, P209, DOI 10.2307/3546006; HARBORNE, 1982, INTRO ECOLOGICAL BIO; Iason GR, 2006, J CHEM ECOL, V32, P1115, DOI 10.1007/s10886-006-9075-2; Ivancic J, 2001, J DAIRY SCI, V84, P225, DOI 10.3168/jds.S0022-0302(01)74472-4; Jeon BT, 2006, ASIAN AUSTRAL J ANIM, V19, P1298, DOI 10.5713/ajas.2006.1298; KYRIAZAKIS I, 1993, BRIT J NUTR, V69, P617, DOI 10.1079/BJN19930064; Landete-Castillejos T, 2013, EUR J WILDLIFE RES, V59, P519, DOI 10.1007/s10344-013-0699-6; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; McArthur C, 2000, FOREST ECOL MANAG, V139, P157, DOI 10.1016/S0378-1127(99)00342-4; McBride MB, 2007, ENVIRON CHEM, V4, P134, DOI 10.1071/EN06066; MCNAUGHTON SJ, 1988, NATURE, V334, P343, DOI 10.1038/334343a0; MCNAUGHTON SJ, 1990, NATURE, V345, P613, DOI 10.1038/345613a0; Miranda M, 2012, J ARID ENVIRON, V85, P97, DOI 10.1016/j.jaridenv.2012.05.011; Miranda M, 2011, PLANT BIOLOGY, V13, P160, DOI 10.1111/j.1438-8677.2009.00316.x; Miranda M, 2012, WILDLIFE RES, V39, P171, DOI 10.1071/WR11146; MUIR PD, 1987, NEW ZEAL J AGR RES, V30, P305; MURRAY MG, 1991, J ANIM ECOL, V60, P1029, DOI 10.2307/5429; Nelson AC, 1999, CHEMOECOLOGY, V9, P81, DOI 10.1007/s000490050037; NRC-National Research Council Committee on the Nutrient Requirements of Small Ruminants Board on Agriculture Division on Earth & Life Studies, 2007, NUTR REQ SMALL RUM; Plumlee K., 2003, CLIN VET TOXICOLOGY; PROVENZA FD, 1995, J RANGE MANAGE, V48, P2, DOI 10.2307/4002498; Quinn JC, 2014, INT J MOL SCI, V15, P1441, DOI 10.3390/ijms15011441; Robbins C. T., 1993, WILDLIFE FEEDING NUT; RODRIGUEZBERROCAL J, 1978, ARCH ZOOTEC, V27, P73; Rogosic J, 2006, SMALL RUMINANT RES, V64, P169, DOI 10.1016/j.smallrumres.2005.04.017; SCHROENER TW, 1971, ANNU REV ECOL SYST, V2, P369; Spears JW, 2011, J ANIM SCI, V89, P2502, DOI 10.2527/jas.2010-3265; Stephens D.W., 1986, pi; Suttle N, 2010, MINERAL NUTRITION OF LIVESTOCK, 4TH EDITION, P306, DOI 10.1079/9781845934729.0306; Verheyden-Tixier H, 2008, OECOLOGIA, V156, P715, DOI 10.1007/s00442-008-1020-3; Yang FH, 2012, ANIM PROD SCI, V52, P728, DOI 10.1071/AN12010; Zhou LY, 2009, CAN VET J, V50, P1269; Zinn RA, 1997, J ANIM SCI, V75, P1723; Zuur AF, 2007, STAT BIOL HEALTH, P163	62	4	4	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115814	10.1371/journal.pone.0115814	http://dx.doi.org/10.1371/journal.pone.0115814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615596	Green Published, gold			2022-12-26	WOS:000349122100017
J	Chiew, YS; Pretty, C; Docherty, PD; Lambermont, B; Shaw, GM; Desaive, T; Chase, JG				Chiew, Yeong Shiong; Pretty, Christopher; Docherty, Paul D.; Lambermont, Bernard; Shaw, Geoffrey M.; Desaive, Thomas; Chase, J. Geoffrey			Time-Varying Respiratory System Elastance: A Physiological Model for Patients Who Are Spontaneously Breathing	PLOS ONE			English	Article							MECHANICAL VENTILATION; ESOPHAGEAL PRESSURE; LUNG-MECHANICS; PARAMETERS; SUPPORT; STRESS	Background Respiratory mechanics models can aid in optimising patient-specific mechanical ventilation (MV), but the applications are limited to fully sedated MV patients who have little or no spontaneously breathing efforts. This research presents a time-varying elastance (E-drs) model that can be used in spontaneously breathing patients to determine their respiratory mechanics. Methods A time-varying respiratory elastance model is developed with a negative elastic component (E-demand), to describe the driving pressure generated during a patient initiated breathing cycle. Data from 22 patients who are partially mechanically ventilated using Pressure Support (PS) and Neurally Adjusted Ventilatory Assist (NAVA) are used to investigate the physiology relevance of the time-varying elastance model and its clinical potential. E-drs of every breathing cycle for each patient at different ventilation modes are presented for comparison. Results At the start of every breathing cycle initiated by patient, E-drs is < 0. This negativity is attributed from the E-demand due to a positive lung volume intake at through negative pressure in the lung compartment. The mapping of E-drs trajectories was able to give unique information to patients' breathing variability under different ventilation modes. The area under the curve of E-drs (AUCE(drs)) for most patients is > 25 cmH(2)Os/ and thus can be used as an acute respiratory distress syndrome (ARDS) severity indicator. Conclusion The Edrs model captures unique dynamic respiratory mechanics for spontaneously breathing patients with respiratory failure. The model is fully general and is applicable to both fully controlled and partially assisted MV modes.	[Chiew, Yeong Shiong; Pretty, Christopher; Docherty, Paul D.; Chase, J. Geoffrey] Univ Canterbury, Dept Mech Engn, Christchurch 1, New Zealand; [Shaw, Geoffrey M.] Christchurch Hosp, Dept Intens Care, Christchurch, New Zealand; [Lambermont, Bernard; Desaive, Thomas] Univ Liege, GIGA Cardiovasc Sci, Liege, Belgium	University of Canterbury; Christchurch Hospital New Zealand; University of Liege	Chiew, YS (corresponding author), Univ Canterbury, Dept Mech Engn, Christchurch 1, New Zealand.	yeongshiong.chiew@canterbury.ac.nz	Chiew, Yeong Shiong/M-7028-2016; Pretty, Christopher G/B-6300-2014; Chiew, Yeong Shiong/AAL-8505-2021	Chiew, Yeong Shiong/0000-0003-3222-2006; Pretty, Christopher G/0000-0002-2265-6065; Chiew, Yeong Shiong/0000-0003-3222-2006; Docherty, Paul/0000-0003-1661-2573	FNRS (Belgium); FRST (New Zealand); University of Liege; Belgian French Community (ARC-Academie Wallonie Europe)	FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS); FRST (New Zealand)(New Zealand Foundation for Research, Science and Technology); University of Liege(University of Liege); Belgian French Community (ARC-Academie Wallonie Europe)	This work was supported in part by the FNRS 474 (Belgium), the FRST (New Zealand), the University of Liege, the 475, Belgian French Community (ARC-Academie Wallonie Europe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoumianaki E, 2013, CHEST, V143, P927, DOI 10.1378/chest.12-1817; Alencar AM, 2002, NATURE, V417, P809, DOI 10.1038/417809b; Avanzolini G, 1997, ANN BIOMED ENG, V25, P154, DOI 10.1007/BF02738546; Bates JHT, 2009, LUNG MECHANICS: AN INVERSE MODELING APPROACH, P1, DOI 10.1017/CBO9780511627156; Bauer K, 2009, J BIOMECH, V42, P1108, DOI 10.1016/j.jbiomech.2009.02.018; Benditt Joshua O, 2005, Respir Care, V50, P68; Brander L, 2006, CRIT CARE, V10, DOI 10.1186/cc3953; Brochard L, 2012, CRIT CARE, V16, DOI 10.1186/cc11146; Burchardi H, 2004, Minerva Anestesiol, V70, P137; Carvalho ARS, 2007, CRIT CARE, V11, DOI 10.1186/cc6093; Chiew YS, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-111; Chiumello D, 2008, AM J RESP CRIT CARE, V178, P346, DOI 10.1164/rccm.200710-1589OC; Docherty PD, 2014, BIOMED SIGNAL PROCES, V12, P47, DOI 10.1016/j.bspc.2013.12.001; Gilstrap D, 2013, AM J RESP CRIT CARE, V188, P1058, DOI 10.1164/rccm.201212-2214CI; Guerin C, 2012, RESP CARE, V57, P2045, DOI 10.4187/respcare.01883; IOTTI GA, 1995, INTENS CARE MED, V21, P406, DOI 10.1007/BF01707409; Khirani S, 2010, RESP MED, V104, P463, DOI 10.1016/j.rmed.2009.09.014; Kogler VM, 2009, SIGNA VITAE, V4, P10, DOI 10.22514/SV41.042009.2; Kuhlen R, 1999, INTENS CARE MED, V25, P1203, DOI 10.1007/s001340050087; LAUZON AM, 1991, J APPL PHYSIOL, V71, P1159, DOI 10.1152/jappl.1991.71.3.1159; Lucangelo U, 2007, CURR OPIN CRIT CARE, V13, P64, DOI 10.1097/MCC.0b013e32801162df; MOORHEAD K, 2012, JOURNAL OF CLINICAL, P1; Muramatsu K, 2001, EUR RESPIR J, V17, P1158, DOI 10.1183/09031936.01.00017801; Piquilloud L, 2011, INTENS CARE MED, V37, P263, DOI 10.1007/s00134-010-2052-9; Putensen C, 2001, AM J RESP CRIT CARE, V164, P43, DOI 10.1164/ajrccm.164.1.2001078; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Schranz C, 2012, IEEE T BIO-MED ENG, V59, P3396, DOI 10.1109/TBME.2012.2216526; SLUTSKY AS, 2005, MECH VENTILATION, P353; Steimle KL, 2011, COMPUT METH PROG BIO, V101, P144, DOI 10.1016/j.cmpb.2010.06.017; Talmor D, 2008, NEW ENGL J MED, V359, P2095, DOI 10.1056/NEJMoa0708638; Tawhai MH, 2011, J APPL PHYSIOL, V110, P1466, DOI 10.1152/japplphysiol.01289.2010; van Drunen EJ, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-33; Wrigge H, 2005, CRIT CARE, V9, pR780, DOI 10.1186/cc3908; Zhao ZQ, 2012, PHYSIOL MEAS, V33, P51, DOI 10.1088/0967-3334/33/1/51	34	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0114847	10.1371/journal.pone.0114847	http://dx.doi.org/10.1371/journal.pone.0114847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611069	Green Published, gold, Green Submitted			2022-12-26	WOS:000348562900001
J	Kaihola, H; Olivier, J; Poromaa, IS; Akerud, H				Kaihola, Helena; Olivier, Jocelien; Poromaa, Inger Sundstrom; Akerud, Helena			The Effect of Antenatal Depression and Selective Serotonin Reuptake Inhibitor Treatment on Nerve Growth Factor Signaling in Human Placenta	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SMOOTH-MUSCLE-CELLS; MATERNAL DEPRESSION; PROTEIN-KINASE; PULMONARY-HYPERTENSION; ANTIDEPRESSANT USE; FETAL-GROWTH; FACTOR NGF; IN-VITRO; PREGNANCY	Depressive symptoms during pregnancy are common and may have impact on the developing child. Selective serotonin reuptake inhibitors (SSRIs) are the most prescribed antidepressant treatment, but unfortunately, these treatments can also negatively affect the behavioral development and health of a child during pregnancy. In addition, serotonin (5-HT) exerts neurotrophic actions with thus far not fully known effects in the offspring. The neurotrophic growth factor (NGF) is involved in neuronal cell survival and differentiation, and altered placenta levels have been found to increase the risk for pregnancy complications, similar to those found in women treated with SSRIs. We therefore investigated whether the NGF signaling pathway was altered in the placenta from women treated with SSRIs (n = 12) and compared them with placenta from depressed (n = 12) and healthy mothers (n = 12). Results from immunohistochemical stainings revealed that placental NGF protein levels of SSRI-treated women were increased in both trophoblasts and endothelial cells compared with depressed and control women. In addition, downstream of the NGF receptor TrkA, increased levels of the signaling proteins ROCK2 and phosphorylated Raf-1 were found in stromal cells and a tendency towards increased levels of ROCK2 in trophoblasts and endothelial cells in SSRI-treated women when compared to healthy controls. SSRI-treated women also displayed increased levels of phosphorylated ROCK2 in all placental cell types studied in comparison with depressed and control women. Interestingly, in placental endothelial cells from depressed women, NGF levels were significantly lower compared to control women, but ROCK2 levels were increased compared with control and SSRI-treated women. Taken together, these results show that the NGF signaling and downstream pathways in the placenta are affected by SSRI treatment and/or antenatal depression. This might lead to an altered placental function, although the clinical relevance of our findings still needs to be investigated.	[Kaihola, Helena; Olivier, Jocelien; Poromaa, Inger Sundstrom; Akerud, Helena] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Olivier, Jocelien] Univ Groningen, Dept Behav Physiol, Groningen, Netherlands	Uppsala University; University of Groningen	Kaihola, H (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	helena.kaihola@kbh.uu.se		Sundstrom Poromaa, Inger/0000-0002-2491-2042; Olivier, Jocelien/0000-0003-4654-9763	Swedish Research Council [K2014-54X-20642-07-4]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding provided by Swedish Research Council K2014-54X-20642-07-4, http://www.vr.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2003, AM J OBSTET GYNECOL, V189, P148, DOI 10.1067/mob.2003.336; Ansorge MS, 2007, CURR OPIN PHARMACOL, V7, P8, DOI 10.1016/j.coph.2006.11.006; Ark M, 2005, PLACENTA, V26, P81, DOI 10.1016/j.placenta.2004.03.012; Barbey JT, 1998, J CLIN PSYCHIAT, V59, P42; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Bellissima V, 2011, J MATERN-FETAL NEO M, V24, P32, DOI 10.3109/14767058.2011.604931; Bhuiyan M, 2012, REPROD SCI, V19, P407, DOI 10.1177/1933719111424438; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Bottalico B, 2004, PLACENTA, V25, P518, DOI 10.1016/j.placenta.2003.10.017; Brummelte S, 2013, DEV PSYCHOBIOL, V55, P518, DOI 10.1002/dev.21056; Cantarella G, 2002, FASEB J, V16, P1307, DOI 10.1096/fj.01-1000fje; Charnock-Jones DS, 2000, BEST PRACT RES CL OB, V14, P953, DOI 10.1053/beog.2000.0137; Chaves RN, 2013, ZYGOTE, V21, P187, DOI 10.1017/S0967199412000111; Cikos S, 2011, HUM REPROD, V26, P2296, DOI 10.1093/humrep/der233; Dhobale MV, 2013, INT J DEV NEUROSCI, V31, P719, DOI 10.1016/j.ijdevneu.2013.09.006; Dissen GA, 2009, ENDOCRINOLOGY, V150, P2906, DOI 10.1210/en.2008-1575; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; El Marroun H, 2014, EUR CHILD ADOLES PSY, V23, P973, DOI 10.1007/s00787-014-0558-3; Fatemi S, 2002, MOL PSYCHIATR, V7, P919, DOI 10.1038/sj.mp.4001248; Fatemi SH, 2001, NEUROREPORT, V12, P3209, DOI 10.1097/00001756-200110290-00014; Florio P, 2007, ADV CLIN CHEM, V43, P117, DOI 10.1016/S0065-2423(06)43004-3; Forsen T, 2004, HEART, V90, P20, DOI 10.1136/heart.90.1.20; Forsen TJ, 2004, ANN MED, V36, P389, DOI 10.1080/07853890410028438; Frank P, 2014, REPRODUCTION, V148, P179, DOI 10.1530/REP-14-0112; Fujisawa K, 1996, J BIOL CHEM, V271, P23022, DOI 10.1074/jbc.271.38.23022; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gentile S, 2005, CNS DRUGS, V19, P623, DOI 10.2165/00023210-200519070-00004; Gibson J, 2009, ACTA PSYCHIAT SCAND, V119, P350, DOI 10.1111/j.1600-0447.2009.01363.x; GOLDSTEIN LD, 1978, NEUROCHEM RES, V3, P175, DOI 10.1007/BF00964058; Gorman LL, 2004, BRIT J PSYCHIAT, V184, pS17, DOI 10.1192/bjp.184.46.s17; GREENE LA, 1995, CURR OPIN NEUROBIOL, V5, P579, DOI 10.1016/0959-4388(95)80062-X; Heikkinen T, 2003, CLIN PHARMACOL THER, V73, P330, DOI 10.1016/S0009-9236(02)17634-X; HEINRICH G, 1988, BIOCHEM BIOPH RES CO, V155, P482, DOI 10.1016/S0006-291X(88)81112-4; Hendrick V, 2003, AM J PSYCHIAT, V160, P993, DOI 10.1176/appi.ajp.160.5.993; KanaiAzuma M, 1997, BIOCHEM BIOPH RES CO, V231, P309, DOI 10.1006/bbrc.1996.6032; Kieler H, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8012; Knaepen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057608; Larios JA, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-108; Leon DA, 1998, EUR J CLIN NUTR, V52, pS72; Loughhead AM, 2006, AM J PSYCHIAT, V163, P145, DOI 10.1176/appi.ajp.163.1.145; Masumoto A, 2001, HYPERTENSION, V38, P1307, DOI 10.1161/hy1201.096541; MATSUI K, 1990, FEBS LETT, V276, P78, DOI 10.1016/0014-5793(90)80511-G; Melville JL, 2010, OBSTET GYNECOL, V116, P1064, DOI 10.1097/AOG.0b013e3181f60b0a; Moriki N, 2004, HYPERTENS RES, V27, P263, DOI 10.1291/hypres.27.263; Mukai Yasushi, 2001, FASEB Journal, V15, P1062; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; Noorlander CW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002782; Oberlander TF, 2006, ARCH GEN PSYCHIAT, V63, P898, DOI 10.1001/archpsyc.63.8.898; Olivier JDA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00073; Olivier JDA, 2011, PROG NEURO-PSYCHOPH, V35, P1400, DOI 10.1016/j.pnpbp.2010.09.013; Olivier JDA, 2015, EUR J PHARMACOL, V753, P257, DOI 10.1016/j.ejphar.2014.07.049; Oufkir T, 2010, PLACENTA, V31, P439, DOI 10.1016/j.placenta.2010.02.019; Patkar Ashwin A, 2004, Ann Clin Psychiatry, V16, P87; Pawluski JL, 2012, NEUROENDOCRINOLOGY, V95, P39, DOI 10.1159/000329293; Ponder KL, 2011, DEV PSYCHOBIOL, V53, P711, DOI 10.1002/dev.20549; Qiu CF, 2009, AM J HYPERTENS, V22, P397, DOI 10.1038/ajh.2008.366; Rayen I, 2013, PSYCHONEUROENDOCRINO, V38, P1618, DOI 10.1016/j.psyneuen.2013.01.007; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Ross LE, 2013, JAMA PSYCHIAT, V70, P436, DOI 10.1001/jamapsychiatry.2013.684; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sahai E, 1999, CURR BIOL, V9, P136, DOI 10.1016/S0960-9822(99)80067-0; Shimizu T, 2013, ARTERIOSCL THROM VAS, V33, P2780, DOI 10.1161/ATVBAHA.113.301357; Stein CE, 1996, LANCET, V348, P1269, DOI 10.1016/S0140-6736(96)04547-3; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Toh S, 2009, AM J PSYCHIAT, V166, P320, DOI 10.1176/appi.ajp.2008.08060817; Tometten M, 2005, CHEM IMMUNOL ALLERGY, V89, P135, DOI 10.1159/000087962; Tometten M, 2004, AM J REPROD IMMUNOL, V51, P86, DOI 10.1046/j.8755-8920.2003.00123.x; Toti P, 2006, J ENDOCRINOL INVEST, V29, P337, DOI 10.1007/BF03344105; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Viau M, 2009, REPROD BIOMED ONLINE, V19, P207, DOI 10.1016/S1472-6483(10)60074-0; Waters CS, 2014, EUR CHILD ADOLES PSY, V23, P957, DOI 10.1007/s00787-014-0582-3	72	17	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0116459	10.1371/journal.pone.0116459	http://dx.doi.org/10.1371/journal.pone.0116459			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611484	Green Published, Green Submitted, gold			2022-12-26	WOS:000348562900015
J	Linhares, RD; Gigante, DP; Lopes, FC; de Barros, F; Horta, BL				Linhares, Rogerio da Silva; Gigante, Denise Petrucci; Lopes, Fernando Celso; de Barros, Fernandes; Horta, Bernardo Lessa			Carotid Intima-Media Thickness at Age 30, Birth Weight, Accelerated Growth during Infancy and Breastfeeding: A Birth Cohort Study in Southern Brazil	PLOS ONE			English	Article							BLOOD-PRESSURE; GAIN; ATHEROSCLEROSIS; RISK; ULTRASOUND; CHILDHOOD; ORIGINS; STROKE; HEALTH; FETAL	Objective To examine the relationship between carotid intima-media thickness (IMT) at age 30 and birth characteristics, growth during infancy, and breastfeeding duration, among subjects who have been prospectively followed since birth. Methods and Results In 1982, all births in the city of Pelotas, southern Brazil, were identified and those children (n = 5,914) whose families lived in the urban area of the city have been followed and evaluated at several time points. The cohort participants were evaluated in 2012-13, and IMT was measured at the posterior wall of the right and left common carotid arteries in longitudinal planes using ultrasound imaging. We obtained valid IMT measurements for 3,188 individuals. Weight-for-age z-score (WAZ) at age 2 years, weight-for-height z-score (WHZ) at age 4, height-for-age z-score (HAZ) at 4 years, WAZ at age 4 and relative conditional weight at 4 years were positively associated with IMT, even after controlling for confounding variables. The beta-coefficient associated with >= 1 s.d. WAZ at age 2 (compared to those with a <-1 s.d.) was 3.62 mu m (95% CI 0.86 to 6.38). The beta-coefficient associated with >= 1 s.d. WHZ at 4 (in relation to <-1 s.d) was 3.83 mu m (95% CI 0.24 to 7.42). For HAZ at 4, the beta-coefficient for >= 1 s.d. in relation to <-1 s.d. was 4.19 mu m (95% CI 1.14 to 7.25). For WAZ at 4, the beta-coefficient associated with >= 1 s.d. in relation to <-1 s.d. was 4.28 mu m (95% CI 1.59 to 6.97). The beta-coefficient associated with conditional weight gain at age 2-4 was 1.26 mu m (95% CI 0.49 to 2.02). Conclusion IMT at age 30 was positively associated with WAZ at age 2 years, WHZ at age 4, HAZ at age 4, WAZ at age 4 and conditional weight gain at age 4 years.	[Linhares, Rogerio da Silva; Gigante, Denise Petrucci; Lopes, Fernando Celso; de Barros, Fernandes; Horta, Bernardo Lessa] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, RS, Brazil	Universidade Federal de Pelotas	Linhares, RD (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, RS, Brazil.	rogerio.linhares@gmail.com	Horta, Bernardo/A-7604-2008; da Silva Linhares, Rogério/E-9172-2014; Gigante, Denise/G-9285-2015	Horta, Bernardo/0000-0001-9843-412X; da Silva Linhares, Rogério/0000-0002-9740-3548; Gigante, Denise/0000-0001-7309-5838; Barros, Fernando/0000-0001-5973-1746	Wellcome Trust; Brazilian Research Council (CNPq); International Development Research Center; World Health Organization; Overseas Development Administration; European Union; National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq); Brazilian Ministry of Health	Wellcome Trust(Wellcome TrustEuropean Commission); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); International Development Research Center; World Health Organization(World Health Organization); Overseas Development Administration; European Union(European Commission); National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Health	This article is based on data from the study "Pelotas Birth Cohort, 1982" conducted by the Postgraduate Program in Epidemiology at Universidade Federal de Pelotas with the collaboration of the Brazilian Public Health Association (ABRASCO). This study was supported by the Wellcome Trust and the Brazilian Research Council (CNPq). Previous phases of the study were supported by the International Development Research Center, the World Health Organization, Overseas Development Administration, European Union, National Support Program for Centers of Excellence (PRONEX), the Brazilian National Research Council (CNPq) and Brazilian Ministry of Health.	Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Amato M, 2007, EUR HEART J, V28, P2094, DOI 10.1093/eurheartj/ehm244; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Barros FC, 2008, REV SAUDE PUBL, V42, P7, DOI 10.1590/S0034-89102008000900003; Borghi E, 2006, STAT MED, V25, P247, DOI 10.1002/sim.2227; Dratva J, 2012, J PEDIATR-US, V162, P906, DOI [10.1016/j.jpeds.2012.10.060, DOI 10.1016/j.jpeds.2012.10.060]; Evelein AMV, 2013, J CLIN ENDOCR METAB, V98, P794, DOI 10.1210/jc.2012-3208; Evelein AMV, 2011, AM J CLIN NUTR, V93, P712, DOI 10.3945/ajcn.110.002980; Gale CR, 2002, ATHEROSCLEROSIS, V163, P141, DOI 10.1016/S0021-9150(01)00760-2; Horta BL, 2009, INT J EPIDEMIOL, V38, P724, DOI 10.1093/ije/dyp168; Horta BL, 2009, ACTA PAEDIATR, V98, P1024, DOI 10.1111/j.1651-2227.2009.01247.x; Hovi P, 2011, PEDIATRICS, V127, pE304, DOI 10.1542/peds.2010-2199; Jarvisalo MJ, 2009, EUR J CLIN NUTR, V63, P640, DOI 10.1038/ejcn.2008.17; Keijzer-Veen MG, 2005, J CLIN EPIDEMIOL, V58, P1320, DOI 10.1016/j.jclinepi.2005.04.004; Leunissen RWJ, 2012, HORM RES PAEDIAT, V77, P394, DOI 10.1159/000338791; Martin RM, 2005, ARTERIOSCL THROM VAS, V25, P1482, DOI 10.1161/01.ATV.0000170129.20609.49; Martorell R, 2010, J NUTR, V140, P348, DOI 10.3945/jn.109.112300; Mendis S., 2011, GLOBAL ATLAS CARDIOV; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Oren A, 2004, ANN EPIDEMIOL, V14, P8, DOI 10.1016/S1047-2797(03)00068-1; PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399; Regnault N, 2014, INT J EPIDEMIOL, V43, P149, DOI 10.1093/ije/dyt248; Skilton MR, 2014, ATHEROSCLEROSIS, V233, P370, DOI 10.1016/j.atherosclerosis.2014.01.020; Skilton MR, 2013, PEDIATRICS, V131, pE1821, DOI 10.1542/peds.2012-2789; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Victora Cesar G., 2003, Cad. Saúde Pública, V19, P1241, DOI 10.1590/S0102-311X2003000500003; Victora CG, 2006, INT J EPIDEMIOL, V35, P237, DOI 10.1093/ije/dyi290; WILLIAMS RL, 1982, OBSTET GYNECOL, V59, P624	28	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0115166	10.1371/journal.pone.0115166	http://dx.doi.org/10.1371/journal.pone.0115166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611747	Green Published, Green Submitted, gold			2022-12-26	WOS:000348562900005
J	Vollmers, C; Penland, L; Kanbar, JN; Quake, SR				Vollmers, Christopher; Penland, Lolita; Kanbar, Jad N.; Quake, Stephen R.			Novel Exons and Splice Variants in the Human Antibody Heavy Chain Identified by Single Cell and Single Molecule Sequencing	PLOS ONE			English	Article							CONSTANT-REGION GENES; ANALYSIS TOOL; GAMMA-GENES; IMMUNOGLOBULIN; MEMBRANE; HUMAN-CHROMOSOME-14; REPERTOIRE; ALIGNMENT; SEGMENTS; DIFFER	Antibody heavy chains contain a variable and a constant region. The constant region of the antibody heavy chain is encoded by multiple groups of exons which define the isotype and therefore many functional characteristics of the antibody. We performed both single B cell RNAseq and long read single molecule sequencing of antibody heavy chain transcripts and were able to identify novel exons for IGHA1 and IGHA2 as well as novel isoforms for IGHM antibody heavy chain.	[Vollmers, Christopher; Penland, Lolita; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Kanbar, Jad N.; Quake, Stephen R.] Howard Hughes Med Inst, Chevy Chase, MD USA	Stanford University; Stanford University; Howard Hughes Medical Institute	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	quake@stanford.edu			Howard Hughes Medical Institute; National Institutes of Health Grant [U19 AI057229]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Howard Hughes Medical Institute (http://www.hhmi.org/) and by National Institutes of Health (http://www.nih.gov/) Grant U19 AI057229 (to SRQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALT FW, 1980, CELL, V20, P293, DOI 10.1016/0092-8674(80)90615-7; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BENSMANA M, 1990, IMMUNOGENETICS, V32, P321; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Bruls T, 2001, NATURE, V409, P947, DOI 10.1038/35057177; COOK GP, 1994, NAT GENET, V7, P162, DOI 10.1038/ng0694-162; COX DW, 1982, NATURE, V297, P428, DOI 10.1038/297428a0; CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416; CUSHLEY W, 1982, NATURE, V298, P77, DOI 10.1038/298077a0; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; ELLISON J, 1982, P NATL ACAD SCI-BIOL, V79, P1984, DOI 10.1073/pnas.79.6.1984; ELLISON JW, 1982, NUCLEIC ACIDS RES, V10, P4071, DOI 10.1093/nar/10.13.4071; FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0; Heilig R, 2003, NATURE, V421, P601, DOI 10.1038/nature01348; KEHRY M, 1980, CELL, V21, P393, DOI 10.1016/0092-8674(80)90476-6; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lefranc M-P., 2001, IMMUNOGLOBULIN FACTS; RABBITTS TH, 1981, NUCLEIC ACIDS RES, V9, P4509, DOI 10.1093/nar/9.18.4509; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Treutlein B, 2014, P NATL ACAD SCI USA, V111, pE1291, DOI 10.1073/pnas.1403244111; Vollmers C, 2013, P NATL ACAD SCI USA, V110, P13463, DOI 10.1073/pnas.1312146110; Watson CT, 2013, AM J HUM GENET, V92, P530, DOI 10.1016/j.ajhg.2013.03.004; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382	25	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0117050	10.1371/journal.pone.0117050	http://dx.doi.org/10.1371/journal.pone.0117050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25611855	gold, Green Submitted, Green Published			2022-12-26	WOS:000348562900030
J	Barcus, CE; Holt, EC; Keely, PJ; Eliceiri, KW; Schuler, LA				Barcus, Craig E.; Holt, Elizabeth C.; Keely, Patricia J.; Eliceiri, Kevin W.; Schuler, Linda A.			Dense Collagen-I Matrices Enhance Pro-Tumorigenic Estrogen-Prolactin Crosstalk in MCF-7 and T47D Breast Cancer Cells	PLOS ONE			English	Article							ENDOCRINE RESISTANCE; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; MAMMOGRAPHIC DENSITY; RECEPTOR EXPRESSION; ER-ALPHA; ACTIVATION; SURVIVAL; THERAPY; SRC	Breast cancers that express estrogen receptor alpha (ER alpha+) constitute the majority of breast tumors. Estrogen is a major driver of their growth, and targeting ER-mediated signals is a largely successful primary therapeutic strategy. Nonetheless, ER alpha+ tumors also result in the most breast cancer mortalities. Other factors, including altered characteristics of the extracellular matrix such as density and orientation and consequences for estrogen crosstalk with other hormones such as prolactin (PRL), may contribute to these poor outcomes. Here we employed defined three dimensional low density/compliant and high density/stiff collagen-I matrices to investigate the effects on 17 beta-estradiol (E2) activity and PRL/E2 interactions in two well-characterized ER alpha+/PRLR+ luminal breast cancer cell lines in vitro. We demonstrate that matrix density modulated E2-induced transcripts, but did not alter the growth response. However, matrix density was a potent determinant of the behavioral outcomes of PRL/E2 crosstalk. High density/stiff matrices enhanced PRL/E2-induced growth mediated by increased activation of Src family kinases and insensitivity to the estrogen antagonist, 4-hydroxytamoxifen. It also permitted these hormones in combination to drive invasion and modify the alignment of collagen fibers. In contrast, low density/compliant matrices allowed modest if any cooperation between E2 and PRL to growth and did not permit hormone-induced invasion or collagen reorientation. Our studies demonstrate the power of matrix density to determine the outcomes of hormone actions and suggest that stiff matrices are potent collaborators of estrogen and PRL in progression of ER alpha+ breast cancer. Our evidence for bidirectional interactions between these hormones and the extracellular matrix provides novel insights into the regulation of the microenvironment of ER alpha+ breast cancer and suggests new therapeutic approaches.	[Barcus, Craig E.; Holt, Elizabeth C.; Schuler, Linda A.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA; [Barcus, Craig E.; Keely, Patricia J.; Eliceiri, Kevin W.; Schuler, Linda A.] Univ Wisconsin, Cellular & Mol Biol Program, Madison, WI 53706 USA; [Keely, Patricia J.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Keely, Patricia J.; Eliceiri, Kevin W.] Univ Wisconsin, Lab Cellular & Mol Biol, Madison, WI 53706 USA; [Keely, Patricia J.; Eliceiri, Kevin W.] Univ Wisconsin, Lab Opt & Computat Instrumentat, Madison, WI 53706 USA; [Keely, Patricia J.; Eliceiri, Kevin W.; Schuler, Linda A.] Univ Wisconsin, Paul P Carbone Comprehens Canc Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Schuler, LA (corresponding author), Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA.	schulerl@svm.vetmed.wisc.edu	Eliceiri, Kevin/ABD-4516-2020	Eliceiri, Kevin/0000-0001-8678-670X; Barcus, Craig/0000-0001-9887-0503	 [F31 CA177047];  [T35 OD011078];  [R01 CA157675];  [R01 CA179556];  [R01 CA142833];  [R01 CA114462];  [R01 CA136590]; NATIONAL CANCER INSTITUTE [R01CA157675, R01CA179556, R01CA114462, R01CA136590, F31CA177047, R01CA142833] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD011078] Funding Source: NIH RePORTER	; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by F31 CA177047 (C.E.B.), T35 OD011078 (E.C.H.), R01 CA157675 (L.A.S.), R01 CA179556 (L.A.S. and P.J.K.), R01 CA142833 and R01 CA114462 (P.J.K.), R01 CA136590 (P.J.K. and K.W.E.), www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JJ, 2003, MOL ENDOCRINOL, V17, P2268, DOI 10.1210/me.2002-0422; Aksamitiene E, 2011, CELL SIGNAL, V23, P1794, DOI 10.1016/j.cellsig.2011.06.014; Alowami S, 2003, BREAST CANCER RES, V5, pR129, DOI 10.1186/bcr622; Anderson WF, 2011, J NATL CANCER I, V103, P1397, DOI 10.1093/jnci/djr257; Arendt LM, 2010, SEMIN CELL DEV BIOL, V21, P11, DOI 10.1016/j.semcdb.2009.10.003; Arendt LM, 2009, AM J PATHOL, V174, P1065, DOI 10.2353/ajpath.2009.080719; Balaguer P, 1999, SCI TOTAL ENVIRON, V233, P47, DOI 10.1016/S0048-9697(99)00178-3; Barcus CE, 2013, J BIOL CHEM, V288, P12722, DOI 10.1074/jbc.M112.447631; Barni S, 1998, TUMORI, V84, P45, DOI 10.1177/030089169808400109; Bhatavdekar J M, 1994, Eur J Surg Oncol, V20, P118; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Bredfeldt JS, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016007; Brockman JL, 2002, MOL ENDOCRINOL, V16, P774, DOI 10.1210/me.16.4.774; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chan SR, 2014, CELL DEATH DIFFER, V21, P234, DOI 10.1038/cdd.2013.116; Charn TH, 2010, MOL ENDOCRINOL, V24, P47, DOI 10.1210/me.2009-0252; Chen YH, 2010, BREAST CANCER RES TR, V120, P369, DOI 10.1007/s10549-009-0400-7; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; Conklin MW, 2012, CELL ADHES MIGR, V6, P249, DOI 10.4161/cam.20567; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Cotarla I, 2004, INT J CANCER, V108, P665, DOI 10.1002/ijc.11619; Dong J, 2006, J BIOL CHEM, V281, P18825, DOI 10.1074/jbc.M512826200; DOWSETT M, 1983, BRIT J CANCER, V47, P763, DOI 10.1038/bjc.1983.129; Elsberger B, 2009, AM J PATHOL, V175, P1389, DOI 10.2353/ajpath.2009.090273; Fiorillo AA, 2013, AM J PATHOL, V182, P217, DOI 10.1016/j.ajpath.2012.09.021; Galbaugh T, 2010, MOL CANCER RES, V8, P1413, DOI 10.1158/1541-7786.MCR-10-0130; Gehler S, 2009, MOL BIOL CELL, V20, P3224, DOI 10.1091/mbc.E08-12-1186; Gilkes DM, 2013, CANCER RES, V73, P3285, DOI 10.1158/0008-5472.CAN-12-3963; Glass AG, 2007, JNCI-J NATL CANCER I, V99, P1152, DOI 10.1093/jnci/djm059; Gonzalez L, 2009, ONCOGENE, V28, P1298, DOI 10.1038/onc.2008.473; Greendale GA, 2007, BREAST CANCER RES TR, V105, P337, DOI 10.1007/s10549-006-9454-y; Gutzman JH, 2007, ONCOGENE, V26, P6341, DOI 10.1038/sj.onc.1210454; Gutzman JH, 2005, MOL ENDOCRINOL, V19, P1765, DOI 10.1210/me.2004-0339; Gutzman JH, 2004, J STEROID BIOCHEM, V88, P69, DOI 10.1016/j.jsbmb.2003.10.008; Hakak Y, 1999, CURR BIOL, V9, P1039, DOI 10.1016/S0960-9822(99)80453-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris KF, 1999, P NATL ACAD SCI USA, V96, P13738, DOI 10.1073/pnas.96.24.13738; Howell SJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2129; Ignatov A, 2010, BREAST CANCER RES TR, V123, P87, DOI 10.1007/s10549-009-0624-6; Kalyuga M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001461; Kanomata N, 2011, J CLIN PATHOL, V64, P578, DOI 10.1136/jclinpath-2011-200042; KAREY KP, 1988, CANCER RES, V48, P4083; Keely PJ, 2011, J MAMMARY GLAND BIOL, V16, P205, DOI 10.1007/s10911-011-9226-0; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; LaPensee EW, 2010, ENDOCR-RELAT CANCER, V17, pR91, DOI 10.1677/ERC-09-0253; LaPensee EW, 2009, CARCINOGENESIS, V30, P1298, DOI 10.1093/carcin/bgp120; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Lu JC, 2005, J BIOL CHEM, V280, P33909, DOI 10.1074/jbc.M508118200; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lundstrom E, 1999, AM J OBSTET GYNECOL, V181, P348, DOI 10.1016/S0002-9378(99)70560-0; Miller SL, 2007, ONCOGENE, V26, P4668, DOI 10.1038/sj.onc.1210264; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nitze LM, 2013, BREAST CANCER RES TR, V142, P31, DOI 10.1007/s10549-013-2731-7; Ormandy CJ, 1997, J CLIN ENDOCR METAB, V82, P3692, DOI 10.1210/jc.82.11.3692; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Peck AR, 2011, J CLIN ONCOL, V29, P2448, DOI 10.1200/JCO.2010.30.3552; Perks CC, 2004, BRIT J CANCER, V91, P305, DOI 10.1038/sj.bjc.6601947; Piazza TM, 2009, MOL ENDOCRINOL, V23, P202, DOI 10.1210/me.2008-0341; Planas-Silva MD, 2006, BIOCHEM BIOPH RES CO, V341, P73, DOI 10.1016/j.bbrc.2005.12.164; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2008, MICROSC MICROANAL, V14, P532, DOI 10.1017/S1431927608080884; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rasmussen LM, 2010, ENDOCR-RELAT CANCER, V17, P809, DOI 10.1677/ERC-09-0326; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Roop RP, 2012, FUTURE ONCOL, V8, P273, DOI [10.2217/fon.12.8, 10.2217/FON.12.8]; Sato T, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-59; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroeder MD, 2002, MOL ENDOCRINOL, V16, P45, DOI 10.1210/me.16.1.45; Song RXD, 2005, TRENDS ENDOCRIN MET, V16, P347, DOI 10.1016/j.tem.2005.06.010; Speroni L, 2014, TISSUE ENG PART C-ME, V20, P42, DOI [10.1089/ten.tec.2013.0054, 10.1089/ten.TEC.2013.0054]; Swaminathan G, 2008, J MAMMARY GLAND BIOL, V13, P81, DOI 10.1007/s10911-008-9068-6; Touraine P, 1998, J CLIN ENDOCR METAB, V83, P667, DOI 10.1210/jc.83.2.667; Tworoger SS, 2008, J MAMMARY GLAND BIOL, V13, P41, DOI 10.1007/s10911-008-9063-y; Tworoger SS, 2013, CANCER RES, V73, P4810, DOI 10.1158/0008-5472.CAN-13-0665; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Wagner KU, 2004, MOL CELL BIOL, V24, P5510, DOI 10.1128/MCB.24.12.5510-5520.2004; Walker RA, 2001, BREAST CANCER RES, V3, P143, DOI 10.1186/bcr287; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180; Wozniak MA, 2005, BIOL PROCED ONLINE, V7, P144, DOI 10.1251/bpo112; Yamashita H, 2006, ENDOCR-RELAT CANCER, V13, P885, DOI 10.1677/erc.1.01095	82	44	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116891	10.1371/journal.pone.0116891	http://dx.doi.org/10.1371/journal.pone.0116891			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607819	gold, Green Published, Green Submitted			2022-12-26	WOS:000348205300039
J	Gnedeva, K; Vorotelyak, E; Cimadamore, F; Cattarossi, G; Giusto, E; Terskikh, VV; Terskikh, AV				Gnedeva, Ksenia; Vorotelyak, Ekaterina; Cimadamore, Flavio; Cattarossi, Giulio; Giusto, Elena; Terskikh, Vasiliy V.; Terskikh, Alexey V.			Derivation of Hair-Inducing Cell from Human Pluripotent Stem Cells	PLOS ONE			English	Article							DERMAL PAPILLA CELLS; EPIGENETIC MEMORY; FOLLICLE DEVELOPMENT; BONE-MARROW; IN-VIVO; GROWTH; INDUCTION; MOUSE; SKIN; DIFFERENTIATION	Dermal Papillae (DP) is a unique population of mesenchymal cells that was shown to regulate hair follicle formation and growth cycle. During development most DP cells are derived from mesoderm, however, functionally equivalent DP cells of cephalic hairs originate from Neural Crest (NC). Here we directed human embryonic stem cells (hESCs) to generate first NC cells and then hair-inducing DP-like cells in culture. We showed that hESC-derived DP-like cells (hESC-DPs) express markers typically found in adult human DP cells (e.g. p-75, nestin, versican, SMA, alkaline phosphatase) and are able to induce hair follicle formation when transplanted under the skin of immunodeficient NUDE mice. Engineered to express GFP, hESC-derived DP-like cells incorporate into DP of newly formed hair follicles and express appropriate markers. We demonstrated that BMP signaling is critical for hESC-DP derivation since BMP inhibitor dorsomorphin completely eliminated hair-inducing activity from hESC-DP cultures. DP cells were proposed as the cell-based treatment for hair loss diseases. Unfortunately human DP cells are not suitable for this purpose because they cannot be obtained in necessary amounts and rapidly loose their ability to induce hair follicle formation when cultured. In this context derivation of functional hESC-DP cells capable of inducing a robust hair growth for the first time shown here can become an important finding for the biomedical science.	[Gnedeva, Ksenia; Cimadamore, Flavio; Cattarossi, Giulio; Giusto, Elena; Terskikh, Alexey V.] Sanford Burnham Med Res Inst, Dept Dev & Stem Cell Biol, La Jolla, CA 92037 USA; [Gnedeva, Ksenia; Vorotelyak, Ekaterina; Terskikh, Vasiliy V.] Koltsov Inst Dev Biol, Lab Cell Proliferat, Moscow, Russia	Sanford Burnham Prebys Medical Discovery Institute; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences	Terskikh, AV (corresponding author), Sanford Burnham Med Res Inst, Dept Dev & Stem Cell Biol, La Jolla, CA 92037 USA.	terskikh@sanfordburnham.org	Vorotelyak, Ekaterina A/I-2029-2014; Terskikh, Alexey/U-8407-2019; Terskikh, Vasiliy/ABE-6153-2020; Giusto, Elena/AAY-9554-2021	Giusto, Elena/0000-0003-0562-1466; Cimadamore, Flavio/0000-0002-3649-0545	Sanford Burnham Medical Research Institute	Sanford Burnham Medical Research Institute	This work was supported by funds from Sanford Burnham Medical Research Institute to AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Biernaskie J, 2009, CELL STEM CELL, V5, P610, DOI 10.1016/j.stem.2009.10.019; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Botchkarev VA, 2003, J EXP ZOOL PART B, V298B, P164, DOI 10.1002/jez.b.00033; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; BRONNERFRASER M, 1994, FASEB J, V8, P699, DOI 10.1096/fasebj.8.10.8050668; Chermnykh ES, 2010, HISTOCHEM CELL BIOL, V133, P567, DOI 10.1007/s00418-010-0691-0; Cimadamore F, 2011, CELL STEM CELL, V8, P538, DOI 10.1016/j.stem.2011.03.011; Curchoe CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013890; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Hoogduijn MJ, 2006, STEM CELLS DEV, V15, P49, DOI 10.1089/scd.2006.15.49; Inamatsu M, 2006, DEV GROWTH DIFFER, V48, P73, DOI 10.1111/j.1440-169x.2006.00848.x; Jahoda CAB, 1996, DERMATOL CLIN, V14, P573, DOI 10.1016/S0733-8635(05)70385-5; Jahoda CAB, 2001, EXP DERMATOL, V10, P229, DOI 10.1034/j.1600-0625.2001.100402.x; JAHODA CAB, 1984, NATURE, V311, P560, DOI 10.1038/311560a0; Jandial R, 2011, WORLD NEUROSURG, V75, P5, DOI 10.1016/j.wneu.2011.01.013; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kishimoto J, 2000, GENE DEV, V14, P1181; Kodaira K, 2006, BIOCHEM BIOPH RES CO, V345, P1224, DOI 10.1016/j.bbrc.2006.05.045; LICHTI U, 1993, J INVEST DERMATOL, V101, pS124, DOI 10.1111/1523-1747.ep12363165; LIU GH, 2011, NATURE; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; MOULD AP, 1994, J BIOL CHEM, V269, P27224; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Sieber-Blum Maya, 2004, Birth Defects Res C Embryo Today, V72, P162, DOI 10.1002/bdrc.20008; WEINBERG WC, 1993, J INVEST DERMATOL, V100, P229, DOI 10.1111/1523-1747.ep12468971; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wu JJ, 2006, ARCH DERMATOL RES, V298, P183, DOI 10.1007/s00403-006-0686-9; Yang CC, 2010, J DERMATOL SCI, V57, P2, DOI 10.1016/j.jdermsci.2009.11.005; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120; Zouboulis CC, 2008, EXP GERONTOL, V43, P986, DOI 10.1016/j.exger.2008.09.001	43	35	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116892	10.1371/journal.pone.0116892	http://dx.doi.org/10.1371/journal.pone.0116892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607935	gold, Green Submitted, Green Published			2022-12-26	WOS:000348205300040
J	Henriksen, RE; Torsheim, T; Thuen, F				Henriksen, Roger Ekeberg; Torsheim, Torbjorn; Thuen, Frode			Relationship Satisfaction Reduces the Risk of Maternal Infectious Diseases in Pregnancy: The Norwegian Mother and Child Cohort Study	PLOS ONE			English	Article							SOCIAL SUPPORT; MARITAL-STATUS; ANTIBODY-RESPONSE; CHRONIC STRESS; INFLUENZA VACCINATION; PSYCHOLOGICAL STRESS; PRENATAL INFECTION; PHYSICAL HEALTH; QUALITY; MORTALITY	Objectives The aims of this study were to explore the degree to which relationship satisfaction predicts the risk of infectious diseases during pregnancy and to examine whether relationship satisfaction moderates the association between stressful life events and the risk of infections. Methods This was a prospective study based on data from the Norwegian Mother and Child Cohort Study (MoBa) conducted by the Norwegian Institute of Public Health. Pregnant women (n = 67,244) completed questionnaires concerning relationship satisfaction and nine different categories of infectious diseases as well as socioeconomic characteristics and stressful life events. Associations between the predictor variables and the infectious diseases were assessed by logistic regression analyses. A multiple regression analysis was performed to assess a possible interaction of relationship satisfaction with stressful life events on the risk for infectious diseases. Results After controlling for marital status, age, education, income, and stressful life events, high levels of relationship satisfaction at week 15 of gestation were found to predict a significantly lower risk for eight categories of infectious diseases at gestational weeks 17-30. No significant interaction effect was found between relationship satisfaction and stressful life events on the risk for infections.	[Henriksen, Roger Ekeberg; Thuen, Frode] Bergen Univ Coll, Ctr Evidence Based Practice, Bergen, Norway; [Torsheim, Torbjorn] Univ Bergen, Fac Psychol, Dept Psychosocial Sci, Bergen, Norway	Western Norway University of Applied Sciences; University of Bergen	Henriksen, RE (corresponding author), Bergen Univ Coll, Ctr Evidence Based Practice, Bergen, Norway.	roger.ekeberg.henriksen@hib.no		Torsheim, Torbjorn/0000-0001-7825-4463	Norwegian Ministry of Health; Ministry of Education and Research (NIH/NIEHS) [NO1-ES-75558]; Ministry of Education and Research (NIH/NINDS) [1 UO1 NS 047537-01, 2 UO1 NS047537-06A1]; Norwegian Research Council/FUGE [151918/S10]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	Norwegian Ministry of Health; Ministry of Education and Research (NIH/NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Ministry of Education and Research (NIH/NINDS); Norwegian Research Council/FUGE(Research Council of Norway); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and the Ministry of Education and Research (NIH/NIEHS contract no. NO1-ES-75558, NIH/NINDS grant no. 1 UO1 NS 047537-01 and grant no. 2 UO1 NS047537-06A1) and the Norwegian Research Council/FUGE (grant no. 151918/S10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, and the authors received no specific funding for this work.	BENSHLOMO Y, 1993, J EPIDEMIOL COMMUN H, V47, P200, DOI 10.1136/jech.47.3.200; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Biondi M, 1997, PSYCHOTHER PSYCHOSOM, V66, P3, DOI 10.1159/000289101; Blum JS, 1999, J PERS, V67, P93, DOI 10.1111/1467-6494.00049; Bookwala J, 2005, J AGING HEALTH, V17, P85, DOI 10.1177/0898264304272794; Bradbury TN, 2000, J MARRIAGE FAM, V62, P964, DOI 10.1111/j.1741-3737.2000.00964.x; Brown AS, 2012, DEV NEUROBIOL, V72, P1272, DOI 10.1002/dneu.22024; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; BURMAN B, 1992, PSYCHOL BULL, V112, P39, DOI 10.1037/0033-2909.112.1.39; Burns VE, 2003, J PSYCHOSOM RES, V55, P569, DOI 10.1016/S0022-3999(03)00073-4; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; Cohen J., 2003, APPL MULTIPLE REGRES; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Conde-Agudelo A, 2008, AM J OBSTET GYNECOL, V198, P7, DOI 10.1016/j.ajog.2007.07.040; Creasey G, 2004, J RES ADOLESCENCE, V14, P235, DOI 10.1111/j.1532-7795.2004.01402005.x; Feldman PJ, 2000, PSYCHOSOM MED, V62, P715, DOI 10.1097/00006842-200009000-00016; Fiorillo D, 2011, SOC SCI MED, V73, P1644, DOI 10.1016/j.socscimed.2011.09.007; Gallo LC, 2003, HEALTH PSYCHOL, V22, P453, DOI 10.1037/0278-6133.22.5.453; Giesbrecht GF, 2013, PSYCHOSOM MED, V75, P856, DOI 10.1097/PSY.0000000000000004; Gouin JP, 2008, NEUROIMMUNOMODULAT, V15, P251, DOI 10.1159/000156468; Graham JE, 2006, J BEHAV MED, V29, P389, DOI 10.1007/s10865-006-9057-4; Graham JE, 2009, HEALTH PSYCHOL, V28, P621, DOI 10.1037/a0015208; Gupta K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3140; HENDRICK SS, 1988, J MARRIAGE FAM, V50, P93, DOI 10.2307/352430; Hennessy MB, 2009, FRONT NEUROENDOCRIN, V30, P470, DOI 10.1016/j.yfrne.2009.06.001; Hohmann-Marriott B, 2009, MATERN CHILD HLTH J, V13, P745, DOI 10.1007/s10995-009-0467-0; Holt-Lunstad J, 2008, ANN BEHAV MED, V35, P239, DOI 10.1007/s12160-008-9018-y; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Johnson NJ, 2000, ANN EPIDEMIOL, V10, P224, DOI 10.1016/S1047-2797(99)00052-6; Kiecolt-Glaser JK, 2010, NEUROSCI BIOBEHAV R, V35, P33, DOI 10.1016/j.neubiorev.2009.09.003; Kiecolt-Glaser JK, 2005, ARCH GEN PSYCHIAT, V62, P1377, DOI 10.1001/archpsyc.62.12.1377; Kiecolt-Glaser JK, 1998, ANN NY ACAD SCI, V840, P656, DOI 10.1111/j.1749-6632.1998.tb09604.x; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Lindstrom M, 2012, PUBLIC HEALTH, V126, P790, DOI 10.1016/j.puhe.2012.06.001; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Matthews SG, 2012, EXP NEUROL, V233, P95, DOI 10.1016/j.expneurol.2011.01.009; Mortensen O, 2012, FAM PROCESS, V51, P122, DOI 10.1111/j.1545-5300.2012.01384.x; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Phillips AC, 2006, BRAIN BEHAV IMMUN, V20, P279, DOI 10.1016/j.bbi.2005.08.003; Rasmussen SA, 2012, AM J OBSTET GYNECOL, V207, pS3, DOI 10.1016/j.ajog.2012.06.068; Robles TF, 2014, PSYCHOL BULL, V140, P140, DOI 10.1037/a0031859; Rosand GMB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-161; Saxbe DE, 2008, HEALTH PSYCHOL, V27, P15, DOI 10.1037/0278-6133.27.1.15; Snyder D. K, 1997, MARITAL SATISFACTION; Stadler G, 2012, PSYCHOSOM MED, V74, P398, DOI 10.1097/PSY.0b013e31825473b8; Stapleton LRT, 2012, J FAM PSYCHOL, V26, P453, DOI 10.1037/a0028332; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; Vedhara K, 1999, LANCET, V353, P627, DOI 10.1016/S0140-6736(98)06098-X; Wickrama KAS, 2001, J MARRIAGE FAM, V63, P527, DOI 10.1111/j.1741-3737.2001.00527.x	52	4	4	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116796	10.1371/journal.pone.0116796	http://dx.doi.org/10.1371/journal.pone.0116796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4PR	25608018	Green Published, gold, Green Submitted			2022-12-26	WOS:000348205300035
J	Johnston, SB; Raines, RT				Johnston, Sean B.; Raines, Ronald T.			Catalysis by the Tumor-Suppressor Enzymes PTEN and PTEN-L	PLOS ONE			English	Article							PHOSPHOINOSITIDE PHOSPHATASES; ALLOSTERIC ACTIVATION; ANIONIC PHOSPHOLIPIDS; ASSAY; MYOTUBULARIN; MOLECULES; SURVIVAL; BINDING; ENTERS	Phosphatase and tensin homologue deleted from chromosome ten (PTEN) is a lipid phosphatase tumor suppressor that is lost or inactivated in most human tumors. The enzyme catalyzes the hydrolysis of phosphatidylinositol-(3,4,5)-trisphosphate (PIP3) to form phosphatidylinositol-(4,5)-bisphosphate (PIP2) and inorganic phosphate. Here, we report on the first continuous assay for the catalytic activity of PTEN. Using this assay, we demonstrate that human PTEN is activated by the reaction product PIP2, as well as in solutions of low salt concentration. This activation is abrogated in the K13A variant, which has a disruption in a putative binding site for PIP2. We also demonstrate that PTEN-L, which derives from alternative translation of the PTEN mRNA, is activated constitutively. These findings have implications for catalysis by PTEN in physiological environments and could expedite the development of PTEN-based chemotherapeutic agents.	[Johnston, Sean B.; Raines, Ronald T.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Raines, Ronald T.] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Raines, RT (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	rtraines@wisc.edu	Raines, Ronald T./A-5009-2013	Raines, Ronald T./0000-0001-7164-1719	Dennis Weatherstone Predoctoral Fellowship from Autism Speaks and Molecular Biosciences Training Grant [T32 GM007215, R01 GM044783]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, R01GM044783] Funding Source: NIH RePORTER	Dennis Weatherstone Predoctoral Fellowship from Autism Speaks and Molecular Biosciences Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Dennis Weatherstone Predoctoral Fellowship from Autism Speaks and Molecular Biosciences Training Grant T32 GM007215 (National Institutes of Health) to SBJ, and Grant R01 GM044783 (NIH) to RTR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Andersen JF, 2006, BIOCHEMISTRY-US, V45, P5450, DOI 10.1021/bi052444j; Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Cornish-Bowden A, 2014, FEBS J, V281, P621, DOI 10.1111/febs.12469; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HESS HH, 1975, ANAL BIOCHEM, V63, P607, DOI 10.1016/0003-2697(75)90388-7; Hopkins BD, 2013, SCIENCE, V341, P399, DOI 10.1126/science.1234907; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Liang H, 2014, CELL METAB, V19, P836, DOI 10.1016/j.cmet.2014.03.023; Lukesh JC, 2012, J AM CHEM SOC, V134, P4057, DOI 10.1021/ja211931f; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; McConnachie G, 2003, BIOCHEM J, V371, P947, DOI 10.1042/BJ20021848; MELANDER W, 1977, ARCH BIOCHEM BIOPHYS, V183, P200, DOI 10.1016/0003-9861(77)90434-9; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; Park C, 2001, J AM CHEM SOC, V123, P11472, DOI 10.1021/ja0164834; Porter CM, 2012, BIOORG CHEM, V43, P44, DOI 10.1016/j.bioorg.2011.11.001; Pulido R, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005560; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Schaletzky J, 2003, CURR BIOL, V13, P504, DOI 10.1016/S0960-9822(03)00132-5; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Tamura M, 1999, J BIOL CHEM, V274, P20693, DOI 10.1074/jbc.274.29.20693; Taylor GS, 2003, METHOD ENZYMOL, V366, P43; Tipton Keith F., 2002, P1; Turner T, 1997, CLIN CANCER RES, V3, P2275; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Zhong SR, 2012, BIOCHEMISTRY-US, V51, P3170, DOI 10.1021/bi300086c	37	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116898	10.1371/journal.pone.0116898	http://dx.doi.org/10.1371/journal.pone.0116898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607987	Green Published, gold, Green Submitted			2022-12-26	WOS:000348205300041
J	Wang, LY; Lee, WC				Wang, Ling-Yi; Lee, Wen-Chung			A Permutation Method to Assess Heterogeneity in External Validation for Risk Prediction Models	PLOS ONE			English	Article							BREAST-CANCER; IMPACT	The value of a developed prediction model depends on its performance outside the development sample. The key is therefore to externally validate the model on a different but related independent data. In this study, we propose a permutation method to assess heterogeneity in external validation for risk prediction models. The permutation p value measures the extent of homology between development and validation datasets. If p < 0.05, the model may not be directly transported to the external validation population without further revision or updating. Monte-Carlo simulations are conducted to evaluate the statistical properties of the proposed method, and two microarray breast cancer datasets are analyzed for demonstration. The permutation method is easy to implement and is recommended for routine use in external validation for risk prediction models.	[Lee, Wen-Chung] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan; [Lee, Wen-Chung] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Wang, Ling-Yi] Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan	National Taiwan University; National Taiwan University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Lee, WC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan.	wenchung@ntu.edu.tw		Lee, Wen-Chung/0000-0003-3171-7672	Ministry of Science and Technology, Taiwan [NSC 102-2628-B-002-036-MY3]; National Taiwan University, Taiwan [NTU-CESRP-102R7622-8]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University, Taiwan(National Taiwan University)	This paper is partly supported by grants from Ministry of Science and Technology, Taiwan (NSC 102-2628-B-002-036-MY3) and National Taiwan University, Taiwan (NTU-CESRP-102R7622-8). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow WE, 2006, JNCI-J NATL CANCER I, V98, P1204, DOI 10.1093/jnci/djj331; DEBRAY TP, 2014, J CLIN EPID IN PRESS, P89023; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Efron B., 1994, INTRO BOOTSTRAP; Karatzoglou A., 2005, SUPPORT VECTOR MACHI; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Refaeilzadeh Payam, 2009, ENCY DATABASE SYSTEM, P532, DOI DOI 10.1007/978-0-387-39940-9_565; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1	13	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116957	10.1371/journal.pone.0116957	http://dx.doi.org/10.1371/journal.pone.0116957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25606854	Green Published, Green Submitted, gold			2022-12-26	WOS:000348205300045
J	Vieira, EP; Barbosa, MS; Quintao, CCA; Normando, D				Vieira, Elma Pinto; Barbosa, Mayara Silva; Abdo Quintao, Catia Cardoso; Normando, David			Relationship of Tooth Wear to Chronological Age among Indigenous Amazon Populations	PLOS ONE			English	Article							SKELETAL AGE; ADOLESCENTS; PREVALENCE; ADULTS; TEETH; ATTRITION; ACCURACY	In indigenous populations, age can be estimated based on family structure and physical examination. However, the accuracy of such methods is questionable. The aim of this cross-sectional study was to evaluate occlusal tooth wear related to estimated age in the remote indigenous populations of the Xingu River, Amazon. Two hundred and twenty three semiisolated indigenous subjects with permanent dentition from the Arara (n = 117), Xicrin- Kayapo (n = 60) and Assurini (n = 46) villages were examined. The control group consisted of 40 non-indigenous individuals living in an urban area in the Amazon basin (Belem). A modified tooth wear index was applied and then associated with chronological age by linear regression analysis. A strong association was found between tooth wear and chronological age in the indigenous populations (p < 0.001). Tooth wear measurements were able to explain 86% of the variation in the ages of the Arara sample, 70% of the Xicrin- Kaiapo sample and 65% of the Assurini sample. In the urban control sample, only 12% of ages could be determined by tooth wear. These findings suggest that tooth wear is a poor estimator of chronological age in the urban population; however, it has a strong association with age for the more remote indigenous populations. Consequently, these findings suggest that a simple tooth wear evaluation method, as described and applied in this study, can be used to provide a straightforward and efficient means to assist in age determination of newly contacted indigenous groups.	[Vieira, Elma Pinto] UFPA, Fac Dent, Sch Dent, Dept Orthodont, Belem, Para, Brazil; [Barbosa, Mayara Silva] State Univ Rio de Janeiro UERJ, Sch Dent, Dept Orthodont, Rio De Janeiro, Brazil; [Abdo Quintao, Catia Cardoso] State Univ Rio de Janeiro UERJ, Dept Orthodont, Rio De Janeiro, Brazil; [Normando, David] UFPA, Fac Dent, Dept Orthodont, Belem, Para, Brazil	Universidade Federal do Para; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Federal do Para	Normando, D (corresponding author), UFPA, Fac Dent, Dept Orthodont, Belem, Para, Brazil.	davidnormando@hotmail.com	Quintão, Cátia/ABB-3221-2020; Normando, David/C-5324-2018; Normando, David/AAG-7443-2020; Quintão, Cátia/AAY-8872-2020	Quintão, Cátia/0000-0003-4627-8190; Normando, David/0000-0002-1335-1040; Normando, David/0000-0002-1335-1040; Quintão, Cátia/0000-0003-4627-8190				Bartlett DW, 2011, J DENT, V39, P811, DOI 10.1016/j.jdent.2011.08.014; Bassed RB, 2012, FORENSIC SCI MED PAT, V8, P194, DOI 10.1007/s12024-011-9280-3; Bernhardt O, 2004, INT J PROSTHODONT, V17, P333; Bhat VJ, 2007, AM J FOREN MED PATH, V28, P238, DOI 10.1097/PAF.0b013e31805f67c0; Boldsen JL, 2005, AM J PHYS ANTHROPOL, V126, P169, DOI 10.1002/ajpa.20057; Brkic H, 2006, FORENSIC SCI INT, V162, P13, DOI 10.1016/j.forsciint.2006.06.022; Clement AF, 2012, J HUM EVOL, V62, P367, DOI 10.1016/j.jhevol.2011.11.014; d'Incau E, 2012, ARCH ORAL BIOL, V57, P214, DOI 10.1016/j.archoralbio.2011.08.021; DONACHIE MA, 1995, J DENT, V23, P157, DOI 10.1016/0300-5712(95)93573-K; El Aidi H, 2008, J DENT RES, V87, P731, DOI 10.1177/154405910808700813; Esclassan R, 2009, ARCH ORAL BIOL, V54, P287, DOI 10.1016/j.archoralbio.2008.11.004; Grimoud AM, 2012, ARCH ORAL BIOL, V57, P841, DOI 10.1016/j.archoralbio.2011.11.006; Regalo SCH, 2008, ARCH ORAL BIOL, V53, P282, DOI 10.1016/j.archoralbio.2007.10.003; Kim YK, 2000, J FORENSIC SCI, V45, P303; Kreulen CM, 2010, CARIES RES, V44, P151, DOI 10.1159/000308567; Kullman L, 1995, FORENSIC SCI INT, V75, P225, DOI 10.1016/0379-0738(95)01792-5; LOPEZNICOLAS M, 1990, FORENSIC SCI INT, V45, P143, DOI 10.1016/0379-0738(90)90231-M; Meng Y, 2011, ARCH ORAL BIOL, V56, P1424, DOI 10.1016/j.archoralbio.2011.04.003; Mockers O, 2004, EUR J ORTHODONT, V26, P151, DOI 10.1093/ejo/26.2.151; Normando D, 2013, ANGLE ORTHOD, V83, P10, DOI 10.2319/020112-91.1; Normando D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028387; PILLAI PS, 1974, FORENSIC SCI, V3, P135, DOI 10.1016/0300-9432(74)90022-3; SANTINI A, 1990, FORENSIC SCI INT, V48, P175, DOI 10.1016/0379-0738(90)90110-K; Smith BGN, 1997, J PROSTHET DENT, V78, P367, DOI 10.1016/S0022-3913(97)70043-X; SOLHEIM T, 1993, FORENSIC SCI INT, V59, P137, DOI 10.1016/0379-0738(93)90152-Z; XU XH, 1992, FORENSIC SCI INT, V54, P23; Yun JI, 2007, J FORENSIC SCI, V52, P678, DOI 10.1111/j.1556-4029.2007.00414.x	27	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							0116138	10.1371/journal.pone.0116138	http://dx.doi.org/10.1371/journal.pone.0116138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602501	gold, Green Submitted, Green Published			2022-12-26	WOS:000348203500020
J	Chen, G; Bai, Y; Ren, L; Zhu, D; Li, YH; Fang, MY; Al-Kateb, H; Doran, O				Chen, Gang; Bai, Ying; Ren, Li; Zhu, Dan; Li, Yanhua; Fang, Meiying; Al-Kateb, Huda; Doran, Olena			Metabolism of Androstenone, 17 beta-Estradiol and Dihydrotestosterone in Primary Cultured Pig Hepatocytes and the Role of 3 beta-Hydroxysteroid Dehydrogenase in This Process	PLOS ONE			English	Article							STEROID-HORMONE-METABOLISM; BOAR TAINT; 16-ANDROSTENE STEROIDS; PORCINE HEPATOCYTES; GENE-EXPRESSION; SPLICE VARIANTS; RECEPTOR; PATHWAYS	Steroids metabolism plays an important role in mammals and contributes to quality of pig meat. The main objective of this study was to identify metabolites of androstenone, 17 beta-estradiol and dihydrotestosterone using primary cultured pig hepatocytes as a model system. The role of 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) in regulation of steroid metabolism was also validated using trilostane, a specific 3 beta HSD inhibitor. Steroid glucuronide conjugated metabolites were detected by liquid chromatography time of flight mass spectrometry (LC-TOF-MS). 3 beta HSD enzyme was essential for metabolism of androstenone to 5 alpha-androst-16-en-3 beta-ol, which then formed androstenone glucuronide conjugate. Metabolism of 17 beta-estradiol was accompanied by formation of glucuronide-conjugated estrone and glucuronide-conjugated estradiol. The ratio of the two metabolites was around 5:1. 3 beta HSD enzyme was not involved in 17 beta-estradiol metabolism. 5 alpha-Dihydrotestosterone- 17 beta-glucuronide was identified as a dihydrotestosterone metabolite, and this metabolism was related to 3 beta HSD enzyme activity as demonstrated by inhibition study.	[Chen, Gang; Zhu, Dan; Li, Yanhua] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Key Lab Agroprod Qual & Safety, Beijing 100193, Peoples R China; [Bai, Ying; Fang, Meiying] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Ren, Li] Air Force Gen Hosp, Dept Pathol, Beijing, Peoples R China; [Al-Kateb, Huda; Doran, Olena] Univ W England, Fac Hlth & Appl Sci, Ctr Res Biosci, Bristol BS16 1QY, Avon, England	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS; China Agricultural University; Air Force General Hospital PLA; University of West England	Fang, MY (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	meiying@cau.edu.cn		ALKATEB, HUDA/0000-0002-8194-8906	Natural Science Foundation of China [31171691, 31371779]; International Science & Technology Cooperation Program of China [2012DFA31140]; Biotechnology and Biological Sciences Research Council (BBSRC) UK-China Partnering Award [BB/H531435/1]; EU Marie Curie International Research Staff Exchange Scheme [246760]; BBSRC [BB/H531435/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C506072/1, BB/H531435/1, BB/L024268/1] Funding Source: researchfish	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Biotechnology and Biological Sciences Research Council (BBSRC) UK-China Partnering Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU Marie Curie International Research Staff Exchange Scheme; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Natural Science Foundation of China (31171691, 31371779), International Science & Technology Cooperation Program of China (2012DFA31140), Biotechnology and Biological Sciences Research Council (BBSRC) UK-China Partnering Award (BB/H531435/1), and EU Marie Curie International Research Staff Exchange Scheme (FP7-PEOPLE-2009-IRSES, 246760). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKS RI, 1986, J ANIM SCI, V62, P632, DOI 10.2527/jas1986.623632x; Chen G, 2007, J ANIM SCI, V85, P2457, DOI 10.2527/jas.2007-0087; Chen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052255; De Brabander HF, 2007, J MASS SPECTROM, V42, P983, DOI 10.1002/jms.1272; Doran E, 2004, CHEM-BIOL INTERACT, V147, P141, DOI 10.1016/j.cbi.2003.12.002; GOWER DB, 1972, J STEROID BIOCHEMIST, V3, P45, DOI 10.1016/0022-4731(72)90011-8; Gray MA, 2009, XENOBIOTICA, V39, P915, DOI 10.3109/00498250903330348; Gray MA, 2013, J STEROID BIOCHEM, V133, P110, DOI 10.1016/j.jsbmb.2012.09.025; Gray MA, 2010, EXP BIOL MED, V235, P718, DOI 10.1258/ebm.2010.009339; Hansen LL, 2006, ANIM SCI, V82, P359, DOI 10.1079/ASC200648; Jin Y, 2009, J BIOL CHEM, V284, P10013, DOI 10.1074/jbc.M809465200; Lundstrom K, 2009, ANIMAL, V3, P1497, DOI 10.1017/S1751731109990693; Mareck U, 2008, J MASS SPECTROM, V43, P877, DOI 10.1002/jms.1457; Nicolau-Solano SI, 2006, J ANIM SCI, V84, P2809, DOI 10.2527/jas.2005-595; PATTERSON RL, 1968, J SCI FOOD AGR, V19, P31, DOI 10.1002/jsfa.2740190107; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Penning TM, 2010, J STEROID BIOCHEM, V121, P546, DOI 10.1016/j.jsbmb.2010.01.005; Robic A, 2014, J STEROID BIOCHEM, V140, P44, DOI 10.1016/j.jsbmb.2013.11.001; Sinclair PA, 2005, J STEROID BIOCHEM, V96, P79, DOI 10.1016/j.jsbmb.2005.01.030; Sinclair PA, 2005, J STEROID BIOCHEM, V96, P217, DOI 10.1016/j.jsbmb.2005.02.017; Steckelbroeck S, 2004, J BIOL CHEM, V279, P10784, DOI 10.1074/jbc.M313308200; Van LT, 2013, J STEROID BIOCHEM, V137, P176, DOI 10.1016/j.jsbmb.2013.05.017; YOKOYAMA MT, 1979, AM J CLIN NUTR, V32, P173; Zamaratskaia G, 2009, ANIMAL, V3, P1508, DOI 10.1017/S1751731108003674; Zhou J, 2010, DRUG METAB DISPOS, V38, P431, DOI 10.1124/dmd.109.028712	25	4	4	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e113194	10.1371/journal.pone.0113194	http://dx.doi.org/10.1371/journal.pone.0113194			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590624	Green Submitted, Green Published, gold			2022-12-26	WOS:000350679400002
J	van der Meer, MG; Backus, BE; van der Graaf, Y; Cramer, MJ; Appelman, Y; Doevendans, PA; Six, AJ; Nathoe, HM				van der Meer, Manon G.; Backus, Barbra E.; van der Graaf, Yolanda; Cramer, Maarten J.; Appelman, Yolande; Doevendans, Pieter A.; Six, A. Jacob; Nathoe, Hendrik M.			The Diagnostic Value of Clinical Symptoms in Women and Men Presenting with Chest Pain at the Emergency Department, a Prospective Cohort Study	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; ACUTE MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; GENDER-DIFFERENCES; AMERICAN-COLLEGE; SEX-DIFFERENCES; GUIDELINES; MANAGEMENT; AGE; ANGIOGRAPHY	Background Previous studies suggested that diagnosing coronary artery disease (CAD) is more difficult in women than in men. Studies investigating the predictive value of clinical signs and symptoms and compare its combined diagnostic value between women and men are lacking. Methodology Data from a large multicenter prospective study was used. Patients admitted to the emergency department (ED) with chest pain but without ST-elevation were eligible. The endpoint was proven CAD, defined as a significant stenosis at angiography or the diagnosis of a non-ST-elevation myocardial infarction or cardiovascular death within six weeks after presentation at the ED. Twelve clinical symptoms and seven cardiovascular risk factors were collected. Potential predictors of CAD with a p-value <0.15 in the univariable analysis were included in a multivariable model. The diagnostic value of clinical symptoms and cardiovascular risk factors was quantified in women and men separately and areas under the curve (AUC) were compared between sexes. Results A total of 2433 patients were included. We excluded 102 patients (4%) with either an incomplete follow up or ST-elevation. Of the remaining 2331 patients 43% (1003) were women. CAD was present in 111 (11%) women and 278 (21%) men. In women 11 out of 12 and in men 10 out of 12 clinical symptoms were univariably associated with CAD. The AUC of symptoms alone was 0.74 (95% CI: 0.69-0.79) in women and 0.71 (95% CI: 0.68-0.75) in men and increased to respectively 0.79 (95% CI: 0.74-0.83) in women versus 0.75 (95% CI: 0.72-0.78) in men after adding cardiovascular risk factors. The AUCs of women and men were not significantly different (p-value symptoms alone: 0.45, after adding cardiovascular risk factors: 0.11). Conclusion The diagnostic value of clinical symptoms and cardiovascular risk factors for the diagnosis of CAD in chest pain patients presenting on the ED was high in women and men. No significant differences were found between sexes.	[van der Meer, Manon G.; Backus, Barbra E.; Cramer, Maarten J.; Appelman, Yolande; Doevendans, Pieter A.; Nathoe, Hendrik M.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [van der Graaf, Yolanda] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Six, A. Jacob] Zuwe Hofpoort Hosp, Dept Cardiol, Woerden, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Nathoe, HM (corresponding author), Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands.	h.m.nathoe@umcutrecht.nl	Backus, Barbra/AAP-9802-2021					Anderson JL, 2011, J AM COLL CARDIOL, V57, pE215, DOI 10.1016/j.jacc.2011.02.011; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Assiri AS, 2011, J SAUDI HEART ASSOC, V23, P135, DOI 10.1016/j.jsha.2011.01.007; Backus BE, 2013, INT J CARDIOL, V168, P2153, DOI 10.1016/j.ijcard.2013.01.255; Bosner S, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-79; Canto JG, 2007, ARCH INTERN MED, V167, P2405, DOI 10.1001/archinte.167.22.2405; Canto JG, 2012, JAMA-J AM MED ASSOC, V307, P813, DOI 10.1001/jama.2012.199; Culic V, 2002, AM HEART J, V144, P1012, DOI 10.1067/mhj.2002.125625; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; DeVon HA, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000586; Dey S, 2009, HEART, V95, P20, DOI 10.1136/hrt.2007.138537; Forest RS, 2004, ANN EMERG MED, V44, P206, DOI 10.1016/j.annemergmed.2004.02.031; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Gimenez MR, 2014, JAMA INTERN MED, V174, P241, DOI 10.1001/jamainternmed.2013.12199; Halpern EJ, 2013, AM J EMERG MED, V31, P1479, DOI 10.1016/j.ajem.2013.08.001; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Johnston N, 2011, EUR HEART J, V32, P1331, DOI 10.1093/eurheartj/ehr009; Khan NA, 2013, JAMA INTERN MED, V173, P1863, DOI 10.1001/jamainternmed.2013.10149; Milner KA, 2004, AM J CARDIOL, V93, P606, DOI 10.1016/j.amjcard.2003.11.028; Milner KA, 2002, AM HEART J, V143, P283, DOI 10.1067/mhj.2002.119759; Milner KA, 2001, NURS RES, V50, P233, DOI 10.1097/00006199-200107000-00007; Milner KA, 1999, AM J CARDIOL, V84, P396, DOI 10.1016/S0002-9149(99)00322-7; Naaktgeboren CA, 2013, ANN INTERN MED, V159, P195, DOI 10.7326/0003-4819-159-3-201308060-00009; Nawar Eric W, 2007, Adv Data, P1; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Panju AA, 1998, JAMA-J AM MED ASSOC, V280, P1256, DOI 10.1001/jama.280.14.1256; Patel H, 2004, AM HEART J, V148, P27, DOI 10.1016/j.ahj.2004.03.005; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Roger VL, 2000, JAMA-J AM MED ASSOC, V283, P646, DOI 10.1001/jama.283.5.646; Rutherford J, 1992, ANONYMOUS HEART DIS, P1293; Sanchis J, 2005, HEART, V91, P1013, DOI 10.1136/hrt.2004.041673; Searle J, 2013, EUR HEART J-ACUTE CA, V2, P203, DOI 10.1177/2048872613484688; Shaw LJ, 2008, CIRCULATION, V117, P1787, DOI 10.1161/CIRCULATIONAHA.107.726562; Slot MHEB, 2012, FAM PRACT, V29, P332, DOI 10.1093/fampra/cmr089; Steyerberg E.W., 2019, CLIN PREDICTION MODE, DOI [10.1007/978-3-030-16399-0, DOI 10.1007/978-3-030-16399-0]; Swap CJ, 2005, JAMA-J AM MED ASSOC, V294, P2623, DOI 10.1001/jama.294.20.2623; Thygesen K, 2007, EUR HEART J, V28, P2525	37	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116431	10.1371/journal.pone.0116431	http://dx.doi.org/10.1371/journal.pone.0116431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590466	Green Published, gold, Green Submitted			2022-12-26	WOS:000350679400013
J	Parikh, BA; Beckman, DL; Patel, SJ; White, JM; Yokoyama, WM				Parikh, Bijal A.; Beckman, Diana L.; Patel, Swapneel J.; White, J. Michael; Yokoyama, Wayne M.			Detailed Phenotypic and Molecular Analyses of Genetically Modified Mice Generated by CRISPR-Cas9-Mediated Editing	PLOS ONE			English	Article							ONE-STEP GENERATION; CRISPR-CAS SYSTEM; GENOME MODIFICATION; TYROSINASE GENE; HUMAN-CELLS; RNA; DNA; MOUSE; SPECIFICITY; NUCLEASES	The bacterial CRISPR-Cas9 system has been adapted for use as a genome editing tool. While several recent reports have indicated that successful genome editing of mice can be achieved, detailed phenotypic and molecular analyses of the mutant animals are limited. Following pronuclear micro-injection of fertilized eggs with either wild-type Cas9 or the nickase mutant (D10A) and single or paired guide RNA (sgRNA) for targeting of the tyrosinase (Tyr) gene, we assessed genome editing in mice using rapid phenotypic readouts (eye and coat color). Mutant mice with insertions or deletions (indels) in Tyr were efficiently generated without detectable off-target cleavage events. Gene correction of a single nucleotide by homologous recombination (HR) could only occur when the sgRNA recognition sites in the donor DNA were modified. Gene repair did not occur if the donor DNA was not modified because Cas9 catalytic activity was completely inhibited. Our results indicate that allelic mosaicism can occur following -Cas9-mediated editing in mice and appears to correlate with sgRNA cleavage efficiency at the single-cell stage. We also show that larger than expected deletions may be overlooked based on the screening strategy employed. An unbiased analysis of all the deleted nucleotides in our experiments revealed that the highest frequencies of nucleotide deletions were clustered around the predicted Cas9 cleavage sites, with slightly broader distributions than expected. Finally, additional analysis of founder mice and their offspring indicate that their general health, fertility, and the transmission of genetic changes were not compromised. These results provide the foundation to interpret and predict the diverse outcomes following CRISPR-Cas9-mediated genome editing experiments in mice.	[Parikh, Bijal A.; White, J. Michael] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Beckman, Diana L.; Patel, Swapneel J.; Yokoyama, Wayne M.] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; [Yokoyama, Wayne M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Yokoyama, WM (corresponding author), Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA.	yokoyama@dom.wustl.edu	Parikh, Bijal/AAA-5839-2019	Parikh, Bijal/0000-0003-2490-8294; Patel, Swapneel/0000-0001-6088-4029	Rheumatic Diseases Core Center grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases [P30-AR048335]; Howard Hughes Medical Institute; NIH Career Development Award from the National Institute of Allergy and Infectious Diseases [K08-AI104991]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI104991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER	Rheumatic Diseases Core Center grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH Career Development Award from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The Washington University Department of Pathology Microinjection Core is partially supported by the Rheumatic Diseases Core Center grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30-AR048335). The authors also acknowledge the assistance of the Protein and Nucleic Acid Chemistry Labs (PNACL) at Washington University for their assistance with DNA sequencing. These studies were supported by the Howard Hughes Medical Institute. BAP was supported by an NIH Career Development Award from the National Institute of Allergy and Infectious Diseases (K08-AI104991). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Cho SW, 2013, GENOME RES, DOI [10.1128/genomeA.00897-13, DOI 10.1128/GENOMEA.00897-13]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Decottignies Anabelle, 2013, Frontiers in Genetics, V4, P48, DOI 10.3389/fgene.2013.00048; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Hall Bradford, 2009, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1912s44; HAMADA T, 1993, GENE, V128, P197, DOI 10.1016/0378-1119(93)90563-I; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Honma M, 2007, DNA REPAIR, V6, P781, DOI 10.1016/j.dnarep.2007.01.004; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; LeFur N, 1996, GENOMICS, V37, P245; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05290; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Ma YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089413; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Mizuno S, 2014, MAMM GENOME, V25, P327, DOI 10.1007/s00335-014-9524-0; Nagy A., 2003, MANIPULATING MOUSE E; O'Brien A, 2014, BIOINFORMATICS, V30, P2673, DOI 10.1093/bioinformatics/btu354; Pardo B, 2009, CELL MOL LIFE SCI, V66, P1039, DOI 10.1007/s00018-009-8740-3; Pennisi E, 2013, SCIENCE, V341, P833, DOI 10.1126/science.341.6148.833; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Sung YH, 2012, BMB REP, V45, P686, DOI 10.5483/BMBRep.2012.45.12.242; Vasquez KM, 2001, P NATL ACAD SCI USA, V98, P8403, DOI 10.1073/pnas.111009698; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yasue A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05705; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735; Zhou JK, 2014, INT J BIOCHEM CELL B, V46, P49, DOI 10.1016/j.biocel.2013.10.010	53	34	44	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116484	10.1371/journal.pone.0116484	http://dx.doi.org/10.1371/journal.pone.0116484			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587897	gold, Green Published, Green Submitted			2022-12-26	WOS:000347928300014
J	Qin, YJ; Paini, DR; Wang, C; Fang, Y; Li, ZH				Qin, Yujia; Paini, Dean R.; Wang, Cong; Fang, Yan; Li, Zhihong			Global Establishment Risk of Economically Important Fruit Fly Species (Tephritidae)	PLOS ONE			English	Article							GEOGRAPHICAL-DISTRIBUTION; DIPTERA; INVASIONS; INSECTS; THREAT; TOOL	The global invasion of Tephritidae (fruit flies) attracts a great deal of attention in the field of plant quarantine and invasion biology because of their economic importance. Predicting which one in hundreds of potential invasive fruit fly species is most likely to establish in a region presents a significant challenge, but can be facilitated using a self organising map (SOM), which is able to analyse species associations to rank large numbers of species simultaneously with an index of establishment. A global presence/absence dataset including 180 economically significant fruit fly species in 118 countries was analysed using a SOM. We compare and contrast ranked lists from six countries selected from each continent, and also show that those countries geographically close were clustered together by the SOM analysis because they have similar fruit fly assemblages. These closely clustered countries therefore represent greater threats to each other as sources of invasive fruit fly species. Finally, we indicate how this SOM method could be utilized as an initial screen to support prioritizing fruit fly species for further research into their potential to invade a region.	[Qin, Yujia; Wang, Cong; Fang, Yan; Li, Zhihong] China Agr Univ, Dept Entomol, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Paini, Dean R.] CSIRO Biosecur Flagship, Canberra, ACT, Australia	China Agricultural University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Paini, DR (corresponding author), CSIRO Biosecur Flagship, Canberra, ACT, Australia.	Dean.Paini@csiro.au; lizh@cau.edu.cn	Paini, Dean R/C-2341-2009		Introduction of International Advanced Agricultural Science and Technology Program of Ministry of Agriculture [2012-Z15]; Special Fund for Agro-scientific Research in the Public Interest [201003079]; Science and Technology Program of General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China [2012IK291]	Introduction of International Advanced Agricultural Science and Technology Program of Ministry of Agriculture; Special Fund for Agro-scientific Research in the Public Interest; Science and Technology Program of General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China	This study received financial support from the Chinese programs ("Introduction of International Advanced Agricultural Science and Technology Program of Ministry of Agriculture (No. 2012-Z15)", "Special Fund for Agro-scientific Research in the Public Interest (No. 201003079)" and "Science and Technology Program of General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China (No. 2012IK291)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, FRUIT FLIES EC SIGNI; CABI, 2012, CROP PROT COMP; Cereghino R, 2003, J N AM BENTHOL SOC, V22, P442, DOI 10.2307/1468273; Davis MA, 2009, INVASION BIOL, V74-75, P101; Ercsey-Ravasz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037810; Geng J, 2011, INSECT SCI, V18, P575, DOI 10.1111/j.1744-7917.2010.01402.x; Gevrey M, 2006, ECOL MODEL, V197, P361, DOI 10.1016/j.ecolmodel.2006.03.032; Grove T, 2014, ACTA HORTIC, V1029, P425, DOI 10.17660/ActaHortic.2014.1029.54; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kohonen T., 2001, SELF ORG MAPS; Koop AL, 2012, BIOL INVASIONS, V14, P273, DOI 10.1007/s10530-011-0061-4; Kriticos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064479; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Li ZhiHong, 2013, Plant Quarantine (Shanghai), V27, P1; Liang G.Q., 2011, FRUIT FLIES DIPTERA, DOI [10.1603/EN10198, DOI 10.1603/EN10198]; LIQUIDO NJ, 1990, J ECON ENTOMOL, V83, P1863, DOI 10.1093/jee/83.5.1863; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mathworks, 2007, MATLAB VERS 7 4; Morin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055547; Ni WL, 2012, B ENTOMOL RES, V102, P173, DOI 10.1017/S0007485311000538; Oliveira CM, 2013, J APPL ENTOMOL, V137, P1, DOI 10.1111/jen.12018; Paini DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025695; Paini DR, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1118; Paini DR, 2010, J APPL ECOL, V47, P290, DOI 10.1111/j.1365-2664.2010.01782.x; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Plant Health Australia, 2010, REG PLANT BIOS STRAT; Singh SK, 2014, BIOL INVASIONS, V16, P1515, DOI 10.1007/s10530-013-0588-7; Stanaway MA, 2001, AUST J ENTOMOL, V40, P180, DOI 10.1046/j.1440-6055.2001.00215.x; Steck GJ, 2001, FLA ENTOMOL, V84, P320, DOI 10.2307/3496193; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Vesanto J., 2000, SOM TOOLBOX MATLAB 5, V57, P60; Worner SP, 2006, J APPL ECOL, V43, P858, DOI 10.1111/j.1365-2664.2006.01202.x; WORNER SP, 1988, J ECON ENTOMOL, V81, P973, DOI 10.1093/jee/81.4.973; Wu J., 2009, ATLAS EC FRUIT FLIES; Yonow T, 1998, AUST J AGR RES, V49, P935, DOI 10.1071/A97152	36	61	65	7	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116424	10.1371/journal.pone.0116424	http://dx.doi.org/10.1371/journal.pone.0116424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25588025	gold, Green Published, Green Submitted			2022-12-26	WOS:000347928300012
J	Nishijo, M; Tai, PT; Anh, NTN; Nghi, TN; Nakagawa, H; Luong, HV; Anh, TH; Morikawa, Y; Waseda, T; Kido, T; Nishijo, H				Nishijo, Muneko; Pham The Tai; Nguyen Thi Nguyet Anh; Tran Ngoc Nghi; Nakagawa, Hideaki; Hoang Van Luong; Tran Hai Anh; Morikawa, Yuko; Waseda, Tomoo; Kido, Teruhiko; Nishijo, Hisao			Urinary Amino Acid Alterations in 3-Year-Old Children with Neurodevelopmental Effects due to Perinatal Dioxin Exposure in Vietnam: A Nested Case-Control Study for Neurobiomarker Discovery	PLOS ONE			English	Article							2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; BRAIN-DEVELOPMENT; BREAST-MILK; AUTISM; TAURINE; METABOLISM; HISTAMINE; DISORDER; GENE; MICE	In our previous study of 3-year-old children in a dioxin contamination hot spot in Vietnam, the high total dioxin toxic equivalent (TEQ-PCDDs/Fs)-exposed group during the perinatal period displayed lower Bayley III neurodevelopmental scores, whereas the high 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-exposed group displayed increased autistic traits. In autistic children, urinary amino acid profiles have revealed metabolic alterations in the amino acids that serve as neurotransmitters in the developing brain. Therefore, our present study aimed to investigate the use of alterations in urinary amino acid excretion as biomarkers of dioxin exposure-induced neurodevelopmental deficits in highly exposed 3-year-old children in Vietnam. A nested case-control study of urinary analyses was performed for 26 children who were selected from 111 3-year-old children whose perinatal dioxin exposure levels and neurodevelopmental status were examined in follow-up surveys conducted in a dioxin contaminated hot spot. We compared urinary amino acid levels between the following 4 groups: (1) a high TEQ-PCDDs/Fs and high TCDD-exposed group; (2) a high TEQ-PCDDs/Fs but low TCDD-exposed group; (3) a low TEQ-PCDDs/Fs exposed and poorly developed group; and (4) a low TEQ-PCDDs/Fs exposed and well-developed group. Urinary levels of histidine and tryptophan were significantly decreased in the high TEQ-PCDDs/Fs and high TCDD group, as well as in the high TEQ-PCDDs/Fs but low TCDD group, compared with the low TEQ-PCDDs/Fs and well-developed group. However, the ratio of histidine to glycine was significantly lower only in the high TEQ-PCDDs/Fs and high TCDD group. Furthermore, urinary histidine levels and the ratio of histidine to glycine were significantly correlated with neurodevelopmental scores, particularly for language and fine motor skills. These results indicate that urinary histidine is specifically associated with dioxin exposure-induced neurodevelopmental deficits, suggesting that urinary histidine may be a useful marker of dioxin-induced neurodevelopmental deficits and that histaminergic neuro-transmission may be an important pathological contributor to dioxin-mediated neurotoxicity.	[Nishijo, Muneko; Nguyen Thi Nguyet Anh; Tran Ngoc Nghi; Nakagawa, Hideaki] Kanazawa Med Univ, Dept Publ Hlth, Uchinada, Ishikawa 9200293, Japan; [Pham The Tai; Hoang Van Luong; Tran Hai Anh] Vietnam Mil Med Univ, Biomed & Pharmaceut Res Ctr, Hanoi, Vietnam; [Morikawa, Yuko] Kanazawa Med Univ, Sch Nursing, Uchinada, Ishikawa 9200293, Japan; [Waseda, Tomoo] Kanazawa Med Univ, Dept Obstet & Gynecol, Uchinada, Ishikawa 9200293, Japan; [Kido, Teruhiko] Kanazawa Univ, Fac Hlth Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9200942, Japan; [Nishijo, Hisao] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Sugitani, Toyama 9300194, Japan	Kanazawa Medical University; Kanazawa Medical University; Kanazawa Medical University; Kanazawa University; University of Toyama	Nishijo, M (corresponding author), Kanazawa Med Univ, Dept Publ Hlth, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	ni-koei@kanazawa-med.ac.jp			Japan Society for the Promotion of Science Asian Core Program; Ministry of Education, Science, Sports and Culture [25305024, 24659306];  [C-2013-4]	Japan Society for the Promotion of Science Asian Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported partly by the Japan Society for the Promotion of Science Asian Core Program and the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (B) (25305024) and Challenging Exploratory Research (24659306), (www.jsps.go.jp) and Grant for collaboration research from Kanazawa Medical University (C-2013-4)(www.kanazawa-med.ac.jp). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn WH, 2001, J AUTISM DEV DISORD, V31, P505, DOI 10.1023/A:1012221026124; AL-Ayadhi L, 2013, JCPSP-J COLL PHYSICI, V23, P137, DOI 02.2013/JCPSP.137143; Baldan LC, 2014, NEURON, V81, P77, DOI 10.1016/j.neuron.2013.10.052; Barnes-Ellerbe S, 2004, MOL PHARMACOL, V66, P502, DOI 10.1124/mol.104.000356; Boccuto L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-16; Boverhof DR, 2006, TOXICOL SCI, V94, P398, DOI 10.1093/toxsci/kfl100; Callaway E., 2012, NATURE NEWS, P11375, DOI [10.1038/nature.2012.11375, DOI 10.1038/NATURE.2012.11375]; CHAPMAN GE, 1988, NUTR RES, V8, P955, DOI 10.1016/S0271-5317(88)80135-0; CHRISTIAN BJ, 1986, TOXICOL APPL PHARM, V83, P360, DOI 10.1016/0041-008X(86)90313-3; Cohly HHP, 2005, INT REV NEUROBIOL, V71, P317, DOI 10.1016/S0074-7742(05)71013-8; Croonenberghs J, 2000, NEUROPSYCHOPHARMACOL, V22, P275, DOI 10.1016/S0893-133X(99)00131-1; Dwernychuk LW, 2005, CHEMOSPHERE, V60, P998, DOI 10.1016/j.chemosphere.2005.01.052; Eaton KK, 1991, J NUTR BIOCH, V9, P586; Ercan-Sencicek AG, 2010, NEW ENGL J MED, V362, P1901, DOI 10.1056/NEJMoa0907006; Evans C, 2008, NUTR NEUROSCI, V11, P9, DOI 10.1179/147683008X301360; Fernandez TV, 2012, BIOL PSYCHIAT, V71, P392, DOI 10.1016/j.biopsych.2011.09.034; Ghanizadeh A, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/536521; Hatfield Consultants Office of National Committee 33, 2009, ASS DIOX CONT ENV HU; Ito C, 2004, DRUG NEWS PERSPECT, V17, P383, DOI 10.1358/dnp.2004.17.6.829029; Kuhara T., 2005, METABOLOMICS FRONTIE, P53; Li Bin, 2014, Cerebellum Ataxias, V1, P5, DOI 10.1186/2053-8871-1-5; Minh N. H., 2009, INTERDISCIPLINARY ST, P21; Miyashita C, 2011, ENVIRON RES, V111, P551, DOI 10.1016/j.envres.2011.01.021; Molina-Hernandez A, 2012, J NEUROCHEM, V122, P872, DOI 10.1111/j.1471-4159.2012.07863.x; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Nishijo M, 2014, MOL PSYCHIATR, V19, P1220, DOI 10.1038/mp.2014.18; Nishijo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040273; PALACKAL T, 1986, J NEUROSCI RES, V15, P223, DOI 10.1002/jnr.490150212; Tai PT, 2013, OCCUP ENVIRON MED, V70, P656, DOI 10.1136/oemed-2012-101021; Tai PT, 2011, ENVIRON SCI TECHNOL, V45, P6625, DOI 10.1021/es201666d; Ragini M, 2011, INT J PHARM TECH RES, V3, P1281; Rasinger JD, 2014, TOXICOLOGY, V321, P1, DOI 10.1016/j.tox.2014.03.006; Shimmura C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025340; Steinman G, 2013, MED HYPOTHESES, V81, P21, DOI 10.1016/j.mehy.2013.03.034; STURMAN JA, 1985, J NEUROSCI RES, V13, P405, DOI 10.1002/jnr.490130307; Tai PT, 2012, ORGANOHALOGEN COMPOU, V74, P1369; Tawara K., 2003, J KANAZAWA MED U, V28, P17; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; TUOMISTO JT, 1991, AGENTS ACTIONS, V33, P154, DOI 10.1007/BF01993153; UNKILA M, 1994, TOXICOL APPL PHARM, V128, P280, DOI 10.1006/taap.1994.1208; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Viluksela M, 1999, ARCH TOXICOL, V73, P323, DOI 10.1007/s002040050626; Wang L, 2009, BIOMARKERS, V14, P596, DOI 10.3109/13547500903183962; Warren RP, 1996, NEUROPSYCHOBIOLOGY, V34, P72, DOI 10.1159/000119295; Yap IKS, 2010, J PROTEOME RES, V9, P2996, DOI 10.1021/pr901188e	45	3	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0116778	10.1371/journal.pone.0116778	http://dx.doi.org/10.1371/journal.pone.0116778			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OG	25584822	gold, Green Published, Green Submitted			2022-12-26	WOS:000348201300009
J	Paula, FMM; Leite, NC; Vanzela, EC; Kurauti, MA; Freitas-Dias, R; Carneiro, EM; Boschero, AC; Zoppi, CC				Paula, Flavia M. M.; Leite, Nayara C.; Vanzela, Emerielle C.; Kurauti, Mirian A.; Freitas-Dias, Ricardo; Carneiro, Everardo M.; Boschero, Antonio C.; Zoppi, Claudio C.			Exercise increases pancreatic beta-cell viability in a model of type 1 diabetes through IL-6 signaling	FASEB JOURNAL			English	Article						apoptosis; cytokine signaling myokines; pancreatic islets	STIMULATED INSULIN-SECRETION; ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; IN-VITRO; NITRIC-OXIDE; INTERLEUKIN-6; CYTOKINES; SURVIVAL; INFLAMMATION; NEUTROPHIL	Type 1 diabetes (T1D) is provoked by an autoimmune assault against pancreatic cells. Exercise training enhances beta cell mass in T1D. Here, we investigated how exercise signals beta cells in T1D condition. For this, we used several approaches. Wild-type and IL-6 knockout (KO) C57BL/6 mice were exercised. Afterward, islets from control and trained mice were exposed to inflammatory cytokines (IL-1 beta plus IFN-gamma). Islets from control mice and beta-cell lines (INS-1E and MIN6) were incubated with serum from control or trained mice or medium obtained from 5-aminoimidazole-4 carboxamide1-beta-D-ribofuranoside (AICAR)-treated C2C12 skeletal muscle cells. Subsequently, islets and beta cells were exposed to IL-1 beta plus IFN-gamma. Proteins were assessed by immunoblotting, apoptosis was determined by DNA-binding dye propidium iodide fluorescence, and NO center dot was estimated by nitrite. Exercise reduced 25, 75, and 50% of the IL-1 beta plus IFN-gamma-induced iNOS, nitrite, and cleaved caspase-3 content, respectively, in pancreatic islets. Serum from trained mice and medium from AICAR-treated C2C12 cells reduced beta-cell death, induced by IL-1 beta plus IFN-gamma treatment, in 15 and 38%, respectively. This effect was lost in samples treated with IL-6 inhibitor or with serum from exercised IL-6 KO mice. In conclusion, muscle contraction signals beta-cell survival in T1D through IL-6.	[Paula, Flavia M. M.; Leite, Nayara C.; Vanzela, Emerielle C.; Kurauti, Mirian A.; Freitas-Dias, Ricardo; Carneiro, Everardo M.; Boschero, Antonio C.; Zoppi, Claudio C.] Univ Estadual Campinas, Inst Biol, Dept Struct & Funct Biol, BR-13083865 Campinas, SP, Brazil; [Freitas-Dias, Ricardo] Univ Pernambuco, Dept Phys Therapy, Lab Exercise Physiol & Genet, Petrolina, Brazil	Universidade Estadual de Campinas; Universidade de Pernambuco (UPE)	Zoppi, CC (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Struct & Funct Biol, POB 6109, BR-13083865 Campinas, SP, Brazil.	czoppi@unicamp.br	Carneiro, Everardo/D-4758-2012; Kurauti, Mirian Ayumi/K-3309-2012; Boschero, Antonio/O-7525-2014; Vanzela, Emerielle/AAJ-1679-2021; Dias, Ricardo Freitas/E-1657-2013	Kurauti, Mirian Ayumi/0000-0003-2431-8120; Boschero, Antonio/0000-0003-3829-8570; Vanzela, Emerielle C/0000-0001-8487-9320; Leite, Nayara/0000-0003-4436-6947	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by research grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Brazil) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil).	Al-Jarrah M, 2013, NEUROREHABILITATION, V32, P141, DOI 10.3233/NRE-130831; Andersen JI, 2014, BIOCHEM BIOPH RES CO, V450, P1083, DOI 10.1016/j.bbrc.2014.06.124; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; BORDIN S, 1995, J MEMBRANE BIOL, V148, P177; Bouzakri K, 2011, DIABETES, V60, P1111, DOI 10.2337/db10-1178; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calegari VC, 2012, J APPL PHYSIOL, V112, P711, DOI 10.1152/japplphysiol.00318.2011; Calegari VC, 2011, J BIOL CHEM, V286, P12870, DOI 10.1074/jbc.M110.173021; Calegari VC, 2011, J ENDOCRINOL, V208, P257, DOI 10.1530/JOE-10-0450; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Chavoshan B, 2012, RESP MED, V106, P269, DOI 10.1016/j.rmed.2011.07.018; Choi SE, 2004, TRANSPL IMMUNOL, V13, P43, DOI 10.1016/j.trim.2004.04.001; Choi SB, 2006, J ENDOCRINOL, V190, P471, DOI 10.1677/joe.1.06400; Coskun O, 2004, TOHOKU J EXP MED, V203, P145, DOI 10.1620/tjem.203.145; DICOSMO BF, 1994, INT IMMUNOL, V6, P1829, DOI 10.1093/intimm/6.12.1829; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Ellingsgaard H, 2008, P NATL ACAD SCI USA, V105, P13163, DOI 10.1073/pnas.0801059105; Finucane OM, 2012, P NUTR SOC, V71, P622, DOI 10.1017/S0029665112000730; Fuqua JS, 2013, METABOLISM, V62, P911, DOI 10.1016/j.metabol.2013.01.016; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Haxhi J, 2013, ANN NUTR METAB, V62, P14, DOI 10.1159/000343788; Huang HH, 2011, EXP DIABETES RES, DOI 10.1155/2011/481427; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3; Kelly M, 2009, DIABETES, V58, P1953, DOI 10.2337/db08-1293; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; McGown C, 2014, CLIN LIVER DIS, V18, P41, DOI 10.1016/j.cld.2013.09.012; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Nogueira TC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003532; Osundiji MA, 2013, ENDOCRIN METAB CLIN, V42, P1, DOI 10.1016/j.ecl.2012.11.006; Park H, 2003, ANN NY ACAD SCI, V1005, P242, DOI 10.1196/annals.1288.036; Paula FMM, 2013, MOL CELL ENDOCRINOL, V374, P56, DOI 10.1016/j.mce.2013.04.009; Pedersen BK, 2013, COMPR PHYSIOL, V3, P1337, DOI 10.1002/cphy.c120033; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2006, ESSAYS BIOCHEM, V42, P105, DOI 10.1042/bse0420105; Rabinovitch A, 1998, BIOCHEM PHARMACOL, V55, P1139, DOI 10.1016/S0006-2952(97)00492-9; Radtke S, 2010, J CELL SCI, V123, P947, DOI 10.1242/jcs.065326; Rezende EL, 2006, J EXP BIOL, V209, P115, DOI 10.1242/jeb.01883; Ropelle ER, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000465; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; SCOTT AM, 1981, DIABETOLOGIA, V21, P470; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; Su SH, 2011, BIOCHEM BIOPH RES CO, V405, P58, DOI 10.1016/j.bbrc.2010.12.123; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Suzuki T, 2011, DIABETES, V60, P537, DOI 10.2337/db10-0796; Szalai Z, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/925981; Tonoli C, 2012, SPORTS MED, V42, P1059, DOI 10.2165/11635380-000000000-00000; Trautwein C, 1996, GASTROENTEROLOGY, V110, P1854, DOI 10.1053/gast.1996.v110.pm8964411; White PJ, 2014, NAT MED, V20, P664, DOI 10.1038/nm.3549; Wright HL, 2014, RHEUMATOLOGY, V53, P1321, DOI 10.1093/rheumatology/keu035	55	43	44	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1805	1816		10.1096/fj.14-264820	http://dx.doi.org/10.1096/fj.14-264820			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25609426				2022-12-26	WOS:000354114600017
J	Sanyal, A; Chen, AJ; Nakayasu, ES; Lazar, CS; Zbornik, EA; Worby, CA; Koller, A; Mattoo, S				Sanyal, Anwesha; Chen, Andy J.; Nakayasu, Ernesto S.; Lazar, Cheri S.; Zbornik, Erica A.; Worby, Carolyn A.; Koller, Antonius; Mattoo, Seema			A Novel Link between Fic (Filamentation Induced by cAMP)-mediated Adenylylation/AMPylation and the Unfolded Protein Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING; KINASE; TRANSFERASE; AMPYLATION; SUBSTRATE; TOPOLOGY; ENZYMES; FAMILY; IBPA; TU	The maintenance of endoplasmic reticulum (ER) homeostasis is a critical aspect of determining cell fate and requires a properly functioning unfolded protein response (UPR). Wehave discovered a previously unknown role of a post-translational modification termed adenylylation/AMPylation in regulating signal transduction events during UPR induction. A family of enzymes, defined by the presence of a Fic (filamentation induced by cAMP) domain, catalyzesthisadenylylationreaction. Thehumangenome encodes a single Fic protein, called HYPE (Huntingtin yeast interacting protein E), with adenylyltransferase activity but unknown physiological target(s). Here, we demonstrate that HYPE localizes to the lumen of the endoplasmic reticulum via its hydrophobic N terminus and adenylylates the ER molecular chaperone, BiP, at Ser-365 and Thr-366. BiP functions as a sentinel for protein misfolding and maintains ER homeostasis. We found that adenylylation enhances BiP's ATPase activity, which is required for refolding misfolded proteins while coping with ER stress. Accordingly, HYPE expression levels increase upon stress. Furthermore, siRNA-mediated knockdown of HYPE prevents the induction of an unfolded protein response. Thus, we identify HYPE as a new UPR regulator and provide the first functional data for Fic-mediated adenylylation in mammalian signaling.	[Sanyal, Anwesha; Chen, Andy J.; Zbornik, Erica A.; Mattoo, Seema] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Nakayasu, Ernesto S.] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Lazar, Cheri S.; Worby, Carolyn A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Koller, Antonius] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California San Diego; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Mattoo, S (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St,LILY G-227, W Lafayette, IN 47907 USA.	smattoo@purdue.edu	Nakayasu, Ernesto S./AAJ-8374-2020; Mattoo, Seema/ABD-5624-2021	Nakayasu, Ernesto S./0000-0002-4056-2695; Mattoo, Seema/0000-0003-3260-0046	American Cancer Society [ACS IRG 58-006-53]; Indiana Clinical and Translational Research Grant [CTSI 106564]; Purdue Research Foundation; Showalter Research Trust [207655]; Yeunkyung Woo Achieve Excellence Travel Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100092] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Indiana Clinical and Translational Research Grant; Purdue Research Foundation; Showalter Research Trust; Yeunkyung Woo Achieve Excellence Travel Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by American Cancer Society Institutional Research Grant ACS IRG 58-006-53, Indiana Clinical and Translational Research Grant CTSI 106564, a Purdue Research Foundation Summer Faculty Grant, Showalter Research Trust Award 207655 (to S. M.), and a Yeunkyung Woo Achieve Excellence Travel Grant (to A. S.).	Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Castro-Roa D, 2013, NAT CHEM BIOL, V9, P811, DOI [10.1038/NCHEMBIO.1364, 10.1038/nchembio.1364]; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cruz JW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004349; Cruz JW, 2014, J BIOL CHEM, V289, P7788, DOI 10.1074/jbc.M113.544429; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Garcia-Pino A, 2014, TRENDS BIOCHEM SCI, V39, P121, DOI 10.1016/j.tibs.2014.01.001; Ham H, 2014, J BIOL CHEM, V289, P36059, DOI 10.1074/jbc.M114.612515; Hohfeld J., 1995, CELL, V83, P589; Jwa M, 2012, NAT CELL BIOL, V14, P1223, DOI 10.1038/ncb2593; Lewallen DM, 2014, ACS CHEM BIOL, V9, P433, DOI 10.1021/cb4006886; Lorenz Holger, 2008, V440, P227, DOI 10.1007/978-1-59745-178-9_17; Mattoo S, 2011, J BIOL CHEM, V286, P32834, DOI 10.1074/jbc.M111.227603; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Palanivelu DV, 2011, PROTEIN SCI, V20, P492, DOI 10.1002/pro.581; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Tan YH, 2011, P NATL ACAD SCI USA, V108, P21212, DOI 10.1073/pnas.1114023109; Tavaria M, 1996, CELL STRESS CHAPERON, V1, P23, DOI 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2; Wiley SE, 2013, EMBO MOL MED, V5, P904, DOI 10.1002/emmm.201201429; Wiley SE, 2009, METHOD ENZYMOL, V456, P233, DOI 10.1016/S0076-6879(08)04413-3; Wiseman RL, 2010, CELL, V140, P590, DOI 10.1016/j.cell.2010.02.006; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Zekarias B, 2010, INFECT IMMUN, V78, P1850, DOI 10.1128/IAI.01277-09; Zelenski NG, 1999, J BIOL CHEM, V274, P21973, DOI 10.1074/jbc.274.31.21973	33	67	70	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8482	8499		10.1074/jbc.M114.618348	http://dx.doi.org/10.1074/jbc.M114.618348			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25601083	Green Published, hybrid			2022-12-26	WOS:000351662600040
J	Maretzky, T; Evers, A; Le Gall, S; Alabi, RO; Speck, N; Reiss, K; Blobel, CP				Maretzky, Thorsten; Evers, Astrid; Le Gall, Sylvain; Alabi, Rolake O.; Speck, Nancy; Reiss, Karina; Blobel, Carl P.			The Cytoplasmic Domain of A Disintegrin and Metalloproteinase 10 (ADAM10) Regulates Its Constitutive Activity but Is Dispensable for Stimulated ADAM10-dependent Shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM; Cell Surface Enzyme; Metalloprotease; Proprotein Convertase Subtilisin; Kexin Type 9 (PCSK9); Shedding; Cytoplasmic Domain; Protein Ectodomain Shedding	NECROSIS-FACTOR-ALPHA; AMYLOID PRECURSOR PROTEIN; GROWTH-FACTOR-RECEPTOR; SUBSTRATE SELECTIVITY; CONVERTING-ENZYME; SECRETASE ADAM10; NOTCH ACTIVATION; CALCIUM INFLUX; MOUSE MODEL; TACE	Background: Release of membrane proteins from the cell surface by the metalloproteinase ADAM10 is post-translationally regulated. Results: The cytoplasmic domain of ADAM10 negatively controls its constitutive activity but is dispensable for its stimulation. Conclusion: Post-translational stimulation of ADAM10 requires its transmembrane and/or extracellular domain. Significance: Elucidating the regulation of ADAM10 is crucial for understanding the control of ADAM10-dependent cell surface proteolysis. The membrane-anchored metalloproteinase a disintegrin and metalloprotease 10 (ADAM10) is required for shedding of membrane proteins such as EGF, betacellulin, the amyloid precursor protein, and CD23 from cells. ADAM10 is constitutively active and can be rapidly and post-translationally enhanced by several stimuli, yet little is known about the underlying mechanism. Here, we use ADAM10-deficient cells transfected with wild type or mutant ADAM10 to address the role of its cytoplasmic and transmembrane domain in regulating ADAM10-dependent protein ectodomain shedding. We report that the cytoplasmic domain of ADAM10 negatively regulates its constitutive activity through an ER retention motif but is dispensable for its stimulated activity. However, chimeras with the extracellular domain of ADAM10 and the transmembrane domain of ADAM17 with or without the cytoplasmic domain of ADAM17 show reduced stimulated shedding of the ADAM10 substrate betacellulin, whereas the ionomycin-stimulated shedding of the ADAM17 substrates CD62-L and TGF is not affected. Moreover, we show that influx of extracellular calcium activates ADAM10 but is not essential for its activation by APMA and BzATP. Finally, the rapid stimulation of ADAM10 is not significantly affected by incubation with proprotein convertase inhibitors for up to 8 h, arguing against a major role of increased prodomain removal in the rapid stimulation of ADAM10. Thus, the cytoplasmic domain of ADAM10 negatively influences constitutive shedding through an ER retention motif, whereas the cytoplasmic domain and prodomain processing are not required for the rapid activation of ADAM10-dependent shedding events.	[Maretzky, Thorsten; Evers, Astrid; Le Gall, Sylvain; Alabi, Rolake O.; Blobel, Carl P.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Blobel, Carl P.] Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA; [Blobel, Carl P.] Weill Cornell Med Coll, Dept Physiol Biophys & Syst Biol, New York, NY 10021 USA; [Evers, Astrid; Speck, Nancy; Reiss, Karina] Univ Hosp Schleswig Holstein, Dept Dermatol Venerol & Allergol, D-24105 Kiel, Germany; [Alabi, Rolake O.] Rockefeller Univ, Mem Sloan Kettering Canc Ctr, Weill Cornell Med Coll, Triinst MD PhD Program, New York, NY 10021 USA	Cornell University; Cornell University; University of Kiel; Schleswig Holstein University Hospital; Cornell University; Memorial Sloan Kettering Cancer Center; Rockefeller University	Blobel, CP (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, Caspary Res Bldg,Rm 426,535 East 70th St, New York, NY 10021 USA.	blobelc@hss.edu	Maretzky, Thorsten/AEN-1915-2022; Maretzky, Thorsten/GSN-2981-2022	Maretzky, Thorsten/0000-0003-1282-6080; ALABI, ROLAKE/0000-0001-7650-297X; Le Gall, Sylvie/0000-0003-0385-926X	National Institutes of Health [R01-GM64750, T32-GM007739, T32-EY713820]; Deutsche Forschungsgemeinschaft [DFG-CRC877, A4, DFG-EV 206/1-1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, R01GM064750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM64750 (to C. P. B.), T32-GM007739 (to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional M.D.-Ph.D. Program), and T32-EY713820 (to R. O. A. and the Tri-Institutional Training Program in Vision Research). This work was also supported by Deutsche Forschungsgemeinschaft Grants DFG-CRC877, A4 (to K. R.) and DFG-EV 206/1-1 (to A. E.).	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; BEELER TJ, 1979, J BIOL CHEM, V254, P6229; BLOBEL CP, 1990, J CELL BIOL, V111, P69, DOI 10.1083/jcb.111.1.69; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Dornier E, 2012, J CELL BIOL, V199, P481, DOI 10.1083/jcb.201201133; ElEtri M, 1996, AM J PHYSIOL-LUNG C, V270, pL386, DOI 10.1152/ajplung.1996.270.3.L386; Endres K, 2014, NEUROLOGY, V83, P1930, DOI 10.1212/WNL.0000000000001017; Endres K, 2010, FEBS J, V277, P1585, DOI 10.1111/j.1742-4658.2010.07566.x; Haining EJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416503; Hall KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031600; Hall RJ, 2003, DEV BIOL, V256, P146, DOI 10.1016/S0012-1606(02)00133-1; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Issuree PDA, 2013, J CLIN INVEST, V123, P928, DOI 10.1172/JCI66168; Kojro E, 2006, FASEB J, V20, P512, DOI 10.1096/fj.05-4812fje; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Marcello E, 2010, J BIOL CHEM, V285, P10376, DOI 10.1074/jbc.M109.055947; Maretzky T, 2013, P NATL ACAD SCI USA, V110, P11433, DOI 10.1073/pnas.1302553110; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Moss ML, 1997, J NEUROIMMUNOL, V72, P127, DOI 10.1016/S0165-5728(96)00180-4; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Prox J, 2012, CELL MOL LIFE SCI, V69, P2919, DOI 10.1007/s00018-012-0960-2; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Rooke J, 1996, SCIENCE, V273, P1227, DOI 10.1126/science.273.5279.1227; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin Umut, 2006, V327, P99; Sanderson MP, 2005, J BIOL CHEM, V280, P1826, DOI 10.1074/jbc.M408804200; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schmitt U, 2006, BEHAV BRAIN RES, V175, P278, DOI 10.1016/j.bbr.2006.08.030; Schroeder A, 2009, J ALZHEIMERS DIS, V16, P309, DOI 10.3233/JAD-2009-0952; Sotillos S, 1997, DEVELOPMENT, V124, P4769; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Wild-Bode C, 2006, J BIOL CHEM, V281, P23824, DOI 10.1074/jbc.M601542200; Xu DS, 2009, FASEB J, V23, P3674, DOI 10.1096/fj.09-133462; Yan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084617; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200	40	25	25	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7416	7425		10.1074/jbc.M114.603753	http://dx.doi.org/10.1074/jbc.M114.603753			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25605720	Green Published, hybrid			2022-12-26	WOS:000351613600010
J	Yang, YK; Mishra, V; Crasto, CJ; Chen, M; Dimmitt, R; Harmon, CM				Yang, Yingkui; Mishra, Vinod; Crasto, Chiquito J.; Chen, Min; Dimmitt, Reed; Harmon, Carroll M.			Third Transmembrane Domain of the Adrenocorticotropic Receptor Is Critical for Ligand Selectivity and Potency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-Helix Receptor; Cyclic AMP (cAMP); G Protein-coupled Receptor (GPCR); Membrane Protein; Peptide Hormone	FAMILIAL GLUCOCORTICOID DEFICIENCY; MOUSE MELANOCORTIN RECEPTORS; ALPHA-MELANOTROPIN; TETRAPEPTIDE AC-HIS-DPHE-ARG-TRP-NH2; MOLECULAR DETERMINANTS; STIMULATING HORMONE; BIOLOGICAL-ACTIVITY; GENE; ACTH; MUTATIONS	Background: The ACTH receptor regulates adrenocortical function. Results: Substitution of Phe(7) in ACTH with d-Phe or d-Nal(2) and mutation of MC2R TM3 resulted in decreased ACTH binding and signaling. Conclusion: Phe(7) in the ligand ACTH and TM3 of the ACTH receptor are crucial for ligand binding and signaling. Significance: Elucidating the ACTH receptor is crucial for development of MC2R drugs. The ACTH receptor, known as the melanocortin-2 receptor (MC2R), plays an important role in regulating and maintaining adrenocortical function. MC2R is a subtype of the melanocortin receptor (MCR) family and has unique characteristics among MCRs. Endogenous ACTH is the only endogenous agonist for MC2R, whereas the melanocortin peptides -, -, and -melanocyte-stimulating hormone and ACTH are full agonists for all other MCRs. In this study, we examined the molecular basis of MC2R responsible for ligand selectivity using ACTH analogs and MC2R mutagenesis. Our results indicate that substitution of Phe(7) with d-Phe or d-naphthylalanine (d-Nal(2)) in ACTH(1-24) caused a significant decrease in ligand binding affinity and potency. Substitution of Phe(7) with d-Nal(2) in ACTH(1-24) did not switch the ligand from agonist to antagonist at MC2R, which was observed in MC3R and MC4R. Substitution of Phe(7) with d-Phe(7) in ACTH(1-17) resulted in the loss of ligand binding and activity. Molecular analysis of MC2R indicated that only mutation of the third transmembrane domain of MC2R resulted in a decrease in d-Phe ACTH binding affinity and potency. Our results suggest that Phe(7) in ACTH plays an important role in ligand selectivity and that the third transmembrane domain of MC2R is crucial for ACTH selectivity and potency.	[Yang, Yingkui; Chen, Min; Harmon, Carroll M.] SUNY Buffalo, Dept Surg, Buffalo, NY 14203 USA; [Mishra, Vinod] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35233 USA; [Crasto, Chiquito J.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35233 USA; [Dimmitt, Reed] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35233 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Yang, YK (corresponding author), SUNY Buffalo, Div Pediat Surg, 875 Ellicott St,Rm 8030C, Buffalo, NY 14260 USA.	yingkuiy@buffalo.edu	Mishra, Vinod/S-1151-2019	Mishra, Vinod/0000-0002-4527-1512				BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Chen M, 2007, BIOCHEMISTRY-US, V46, P11389, DOI 10.1021/bi700125e; Clark AJL, 2005, TRENDS ENDOCRIN MET, V16, P451, DOI 10.1016/j.tem.2005.10.006; Clark AJL, 1998, ENDOCR REV, V19, P828, DOI 10.1210/er.19.6.828; CLARK AJL, 1993, LANCET, V341, P461, DOI 10.1016/0140-6736(93)90208-X; Conrad DM, 2004, J CELL BIOCHEM, V92, P387, DOI 10.1002/jcb.20064; Fluck CE, 2002, J CLIN ENDOCR METAB, V87, P4318, DOI 10.1210/jc.2002-020501; GOLDMAN JM, 1970, BRIT J PHARMACOL, V39, P160, DOI 10.1111/j.1476-5381.1970.tb09565.x; HaskellLuevano C, 1997, J MED CHEM, V40, P2133, DOI 10.1021/jm960840h; Holder JR, 2003, PEPTIDES, V24, P73, DOI 10.1016/S0196-9781(02)00278-4; Holder JR, 2003, EUR J PHARMACOL, V462, P41, DOI 10.1016/S0014-2999(03)01322-0; Holder JR, 2002, J MED CHEM, V45, P2801, DOI 10.1021/jm0104872; Holder JR, 2002, J MED CHEM, V45, P3073, DOI 10.1021/jm010524p; HRUBY VJ, 1995, J MED CHEM, V38, P3454, DOI 10.1021/jm00018a005; Imamine H, 2005, TOHOKU J EXP MED, V205, P123, DOI 10.1620/tjem.205.123; Matsuura H, 2006, J PEDIATR ENDOCR MET, V19, P1167; MIGEON CJ, 1968, PEDIATR RES, V2, P501, DOI 10.1203/00006450-196811000-00008; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Naville D, 1996, J CLIN ENDOCR METAB, V81, P1442, DOI 10.1210/jc.81.4.1442; SAWYER TK, 1982, P NATL ACAD SCI-BIOL, V79, P1751, DOI 10.1073/pnas.79.6.1751; SAWYER TK, 1980, P NATL ACAD SCI-BIOL, V77, P5754, DOI 10.1073/pnas.77.10.5754; SAWYER TK, 1982, J MED CHEM, V25, P1022, DOI 10.1021/jm00351a004; Schioth HB, 1999, NEUROPEPTIDES, V33, P191, DOI 10.1054/npep.1999.0760; Selva KA, 2004, J PEDIATR ENDOCR MET, V17, P85; SHEPARD TH, 1959, AMA J DIS CHILD, V97, P154, DOI 10.1001/archpedi.1959.02070010156002; SHIZUME K, 1954, ENDOCRINOLOGY, V54, P553, DOI 10.1210/endo-54-5-553; Slavotinek AM, 1998, CLIN GENET, V53, P57, DOI 10.1034/j.1399-0004.1998.531530112.x; Todorovic A, 2005, J MED CHEM, V48, P3328, DOI 10.1021/jm0490843; TSIGOS C, 1993, J CLIN INVEST, V92, P2458, DOI 10.1172/JCI116853; WEBER A, 1994, HUM MOL GENET, V3, P585, DOI 10.1093/hmg/3.4.585; WEBER A, 1995, J CLIN ENDOCR METAB, V80, P65, DOI 10.1210/jc.80.1.65; Yang Y, 2000, BIOCHEMISTRY-US, V39, P14900, DOI 10.1021/bi001684q; Yang YK, 1997, J BIOL CHEM, V272, P23000, DOI 10.1074/jbc.272.37.23000; Yang YK, 1999, J BIOL CHEM, V274, P14100, DOI 10.1074/jbc.274.20.14100; Yang YK, 2002, J BIOL CHEM, V277, P20328, DOI 10.1074/jbc.M201343200	35	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7685	7692		10.1074/jbc.M114.596122	http://dx.doi.org/10.1074/jbc.M114.596122			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25605722	hybrid, Green Published			2022-12-26	WOS:000351613600030
J	Bakhrebah, M; Zhang, T; Mann, JR; Kalitsis, P; Hudson, DF				Bakhrebah, Muhammed; Zhang, Tao; Mann, Jeff R.; Kalitsis, Paul; Hudson, Damien F.			Disruption of a Conserved CAP-D3 Threonine Alters Condensin Loading on Mitotic Chromosomes Leading to Chromosome Hypercondensation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL MAINTENANCE; VERTEBRATE CELLS; TOPOISOMERASE-II; EGG EXTRACTS; AURORA-B; CENP-C; MITOSIS; ARCHITECTURE; CHROMATIN; PROTEIN	The condensin complex plays a key role in organizing mitotic chromosomes. In vertebrates, there are two condensin complexes that have independent and cooperative roles in folding mitotic chromosomes. In this study, we dissect the role of a putative Cdk1 site on the condensin II subunit CAP-D3 in chicken DT40 cells. This conserved site has been shown to activate condensin II during prophase in human cells, and facilitate further phosphorylation by polo-like kinase I. We examined the functional significance of this phosphorylation mark by mutating the orthologous site of CAP-D3 (CAP-D3T1403A) in chicken DT40 cells. We show that this mutation is a gain of function mutant in chicken cells; it disrupts prophase, results in a dramatic shortening of the mitotic chromosome axis, and leads to abnormal INCENP localization. Our results imply phosphorylation of CAP-D3 acts to limit condensin II binding onto mitotic chromosomes. We present the first in vivo example that alters the ratio of condensin I: II on mitotic chromosomes. Our results demonstrate this ratio is a critical determinant in shaping mitotic chromosomes.	[Bakhrebah, Muhammed; Zhang, Tao; Mann, Jeff R.; Kalitsis, Paul; Hudson, Damien F.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Bakhrebah, Muhammed; Zhang, Tao; Mann, Jeff R.; Kalitsis, Paul; Hudson, Damien F.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne	Hudson, DF (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia.	damien.hudson@mcri.edu.au	Zhang, Tao/ABA-8667-2020; Kalitsis, Paul/C-1916-2015; Bakhrbh, Mohamed/O-2382-2019	Kalitsis, Paul/0000-0001-5569-0609; Zhang, Tao/0000-0003-1155-1492; Mann, Jeff/0000-0003-0028-8692	National Health and Medical Research Council (NHMRC) [GNT1030358, GNT1047009]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This work was supported by National Health and Medical Research Council (NHMRC) Project Grants GNT1030358 and GNT1047009 and the Victorian Government's Operational Infrastructure Support Program.	Abe S, 2011, GENE DEV, V25, P863, DOI 10.1101/gad.2016411; Aragon L, 2013, CURR OPIN GENET DEV, V23, P204, DOI 10.1016/j.gde.2012.11.004; Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; BAKSA K, 1993, GENETICS, V135, P117; Belmont AS, 2006, CURR OPIN CELL BIOL, V18, P632, DOI 10.1016/j.ceb.2006.09.007; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Chen H, 1996, J STRUCT BIOL, V116, P56, DOI 10.1006/jsbi.1996.0010; Dej KJ, 2004, GENETICS, V168, P895, DOI 10.1534/genetics.104.030908; Dowen JM, 2013, STEM CELL REP, V1, P371, DOI 10.1016/j.stemcr.2013.09.002; EARNSHAW WC, 1989, CHROMOSOMA, V98, P1, DOI 10.1007/BF00293329; Farr CJ, 2014, NUCLEIC ACIDS RES, V42, P4414, DOI 10.1093/nar/gku076; Flemming W, 1878, SCHRIFTEN NATURWISSE, V3, P23; Gerlich D, 2006, CURR BIOL, V16, P333, DOI 10.1016/j.cub.2005.12.040; Green LC, 2012, J CELL SCI, V125, P1591, DOI 10.1242/jcs.097790; GURDON JB, 1968, J EMBRYOL EXP MORPH, V20, P401; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Hudson DF, 2008, MOL BIOL CELL, V19, P3070, DOI 10.1091/mbc.E08-01-0057; Hudson DF, 2009, CHROMOSOME RES, V17, P131, DOI 10.1007/s10577-008-9009-7; Hudson DF, 2003, DEV CELL, V5, P323, DOI 10.1016/S1534-5807(03)00199-0; Hudson DF, 2002, TRENDS CELL BIOL, V12, P281, DOI 10.1016/S0962-8924(02)02281-X; Kim JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3537; Kim JH, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-50; Kimura K, 2001, J BIOL CHEM, V276, P5417, DOI 10.1074/jbc.C000873200; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kranz AL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r112; Kwon MS, 2007, MOL BIOL CELL, V18, P2155, DOI 10.1091/mbc.E07-01-0045; Lavoie BD, 2004, GENE DEV, V18, P76, DOI 10.1101/gad.1150404; Lipp JJ, 2007, J CELL SCI, V120, P1245, DOI 10.1242/jcs.03425; Maeshima K, 2014, CHROMOSOMA, V123, P225, DOI 10.1007/s00412-014-0460-2; Maresca TJ, 2005, J CELL BIOL, V169, P859, DOI 10.1083/jcb.200503031; Moser SC, 2011, CHROMOSOME RES, V19, P307, DOI 10.1007/s10577-011-9198-3; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Oliveira RA, 2007, CHROMOSOMA, V116, P259, DOI 10.1007/s00412-007-0097-5; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Piazza I, 2013, CHROMOSOMA, V122, P175, DOI 10.1007/s00412-013-0405-1; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; SAITOH N, 1994, J CELL BIOL, V127, P303, DOI 10.1083/jcb.127.2.303; Samejima K, 2008, P NATL ACAD SCI USA, V105, P2457, DOI 10.1073/pnas.0712083105; Samejima K, 2012, J CELL BIOL, V199, P755, DOI 10.1083/jcb.201202155; Shintomi K, 2011, GENE DEV, V25, P1464, DOI 10.1101/gad.2060311; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; Takemoto A, 2007, NUCLEIC ACIDS RES, V35, P2403, DOI 10.1093/nar/gkm157; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Vagnarelli P, 2012, EXP CELL RES, V318, P1435, DOI 10.1016/j.yexcr.2012.03.017; Warburton PE, 1997, CURR BIOL, V7, P901, DOI 10.1016/S0960-9822(06)00382-4; Wilkins BJ, 2014, SCIENCE, V343, P77, DOI 10.1126/science.1244508	54	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6156	6167		10.1074/jbc.M114.627109	http://dx.doi.org/10.1074/jbc.M114.627109			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605712	Green Published, hybrid			2022-12-26	WOS:000350732500024
J	Piejko, M; Dec, R; Babenko, V; Hoang, A; Szewczyk, M; Mak, P; Dzwolak, W				Piejko, Marcin; Dec, Robert; Babenko, Viktoria; Hoang, Agnieszka; Szewczyk, Monika; Mak, Pawel; Dzwolak, Wojciech			Highly Amyloidogenic Two-chain Peptide Fragments Are Released upon Partial Digestion of Insulin with Pepsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEIN; FIBRIL FORMATION; LIMITED PROTEOLYSIS; ALPHA-LACTALBUMIN; DEGRADING ENZYME; CORE STRUCTURE; AGGREGATION; MICROSCOPY; LYSOZYME; FEATURES	Proteases play a well recognized role in the emergence of highly aggregation-prone protein fragments in vivo, whereas in vitro limited proteolysis is often employed to probe different phases of amyloidogenic pathways. Here, we show that addition of moderate amounts of pepsin to acidified bovine insulin at close to physiological temperature results in an abrupt self-assembly of amyloid-like fibrils from partially digested insulin fragments. Biochemical analysis of the pepsin-induced fibrils implicates peptide fragments (named H) consisting of the 13 or 15 N-terminal residues of the A-chain and 11 or 13 N-terminal residues of the B-chain linked by the disulfide bond between Cys-7A-Cys-7B as the main constituents. There are up to eight pepsin-cleavage sites remaining within the double chain peptide, which become protected upon fast fibrillation unless concentration of the enzyme is increased resulting in complete digestion of insulin. Controlled re-association of H-peptides leads to "explosive" fibrillation only under nonreducing conditions implying the key role of the disulfide bond in their amyloidogenicity. Such re-assembled amyloid is similar in terms of morphology and infrared features to typical bovine insulin fibrils, although it lacks the ability to seed the intact protein.	[Piejko, Marcin; Babenko, Viktoria; Hoang, Agnieszka; Dzwolak, Wojciech] Polish Acad Sci, Inst High Pressure Phys, Prot Biophys Grp, PL-01142 Warsaw, Poland; [Piejko, Marcin; Mak, Pawel] Jagiellonian Univ, Dept Analyt Biochem, PL-30387 Krakow, Poland; [Hoang, Agnieszka] Jagiellonian Univ, Div Cell Biophys, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Mak, Pawel] Jagiellonian Univ, Malopolska Ctr Biotechnol, PL-30387 Krakow, Poland; [Dec, Robert; Babenko, Viktoria; Szewczyk, Monika; Dzwolak, Wojciech] Univ Warsaw, Dept Chem, Biol & Chem Res Ctr, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Institute of High Pressure Physics of the Polish Academy of Sciences; Jagiellonian University; Jagiellonian University; Jagiellonian University; University of Warsaw	Dzwolak, W (corresponding author), Univ Warsaw, Dept Chem, Biol & Chem Res Ctr, Pasteura 1, PL-02093 Warsaw, Poland.	wdzwolak@chem.uw.edu.pl	Piejko, Marcin/U-4183-2018	Piejko, Marcin/0000-0003-3251-5984; Dzwolak, Wojciech/0000-0002-1407-1497; Mak, Pawel/0000-0002-5222-3922	National Science Centre of Poland [DEC-2012/07/B/NZ1/02642]; European Union [POIG.02.01.00-12-064/08, POIG.02.01.00-12-167/08]	National Science Centre of Poland(National Science Centre, Poland); European Union(European Commission)	This work was supported by National Science Centre of Poland Grant DEC-2012/07/B/NZ1/02642 (to W. D.). Biochemical analysis of products of insulin degradation products was partially carried out using equipment obtained with the support of European Union structural funds (grants POIG.02.01.00-12-064/08 and POIG.02.01.00-12-167/08).	Anson ML, 1938, J GEN PHYSIOL, V22, P79, DOI 10.1085/jgp.22.1.79; Babenko V, 2013, LANGMUIR, V29, P5271, DOI 10.1021/la400612w; Babenko V, 2011, CHEM COMMUN, V47, P10686, DOI 10.1039/c1cc14230e; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; de Laureto PP, 2003, J MOL BIOL, V334, P129, DOI 10.1016/j.jmb.2003.09.024; de Laureto PP, 2005, FEBS J, V272, P2176, DOI 10.1111/j.1742-4658.2005.04638.x; DISCHE FE, 1988, DIABETOLOGIA, V31, P158, DOI 10.1007/BF00276849; Dzwolak W, 2004, PROTEIN SCI, V13, P1927, DOI 10.1110/ps.03607204; Dzwolak W, 2003, BIOCHEMISTRY-US, V42, P11347, DOI 10.1021/bi034879h; EMESON EE, 1966, J CELL BIOL, V28, P570, DOI 10.1083/jcb.28.3.570; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fodera V, 2010, SOFT MATTER, V6, P4413, DOI 10.1039/c0sm00169d; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frare E, 2004, J MOL BIOL, V340, P1153, DOI 10.1016/j.jmb.2004.05.056; Frare E, 2006, J MOL BIOL, V361, P551, DOI 10.1016/j.jmb.2006.06.055; Graveland-Bikker JF, 2006, NANO LETT, V6, P616, DOI 10.1021/nl052205h; Harel M, 2008, J AM CHEM SOC, V130, P7856, DOI 10.1021/ja7109822; Hartman K, 2013, PEERJ, V1, DOI 10.7717/peerj.5; Hooper NM, 2005, BIOCHEM SOC T, V33, P335, DOI 10.1042/BST0330335; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; Ipsen R, 2007, BIOTECHNOL ADV, V25, P602, DOI 10.1016/j.biotechadv.2007.07.006; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Krebs MRH, 2004, PROTEIN SCI, V13, P1933, DOI 10.1110/ps.04707004; Kubler E, 2003, BRIT MED BULL, V66, P267, DOI 10.1093/bmb/66.1.267; Kurochkin IV, 1998, FEBS LETT, V427, P153, DOI 10.1016/S0014-5793(98)00422-0; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Loksztejn A, 2008, J MOL BIOL, V379, P9, DOI 10.1016/j.jmb.2008.03.057; Malisauskas M, 2010, J MOL BIOL, V396, P60, DOI 10.1016/j.jmb.2009.11.012; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Picotti P, 2007, J MOL BIOL, V367, P1237, DOI 10.1016/j.jmb.2007.01.072; Podesta A, 2006, BIOPHYS J, V90, P589, DOI 10.1529/biophysj.105.068833; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Steiner DF, 2009, DIABETES OBES METAB, V11, P189, DOI 10.1111/j.1463-1326.2009.01106.x; STEINER DF, 1967, P NATL ACAD SCI USA, V57, P473, DOI 10.1073/pnas.57.2.473; Stix B, 2001, AM J PATHOL, V159, P561, DOI 10.1016/S0002-9440(10)61727-0; Surmacz-Chwedoruk W, 2012, BIOCHEMISTRY-US, V51, P9460, DOI 10.1021/bi301144d; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Weksler ME, 2005, IMMUNOL REV, V205, P244, DOI 10.1111/j.0105-2896.2005.00264.x; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; Wilson LM, 2007, J MOL BIOL, V366, P1639, DOI 10.1016/j.jmb.2006.12.040; Wolfe MS, 2007, J CELL SCI, V120, P3157, DOI 10.1242/jcs.03481; YAMADA T, 1995, SCAND J IMMUNOL, V41, P94, DOI 10.1111/j.1365-3083.1995.tb03538.x; Zurdo J, 2001, J AM CHEM SOC, V123, P8141, DOI 10.1021/ja016229b	52	22	23	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					5947	5958		10.1074/jbc.M114.608844	http://dx.doi.org/10.1074/jbc.M114.608844			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25586185	Green Published, hybrid			2022-12-26	WOS:000350732500002
J	Klix, S; Els, A; Paul, K; Graessl, A; Oezerdem, C; Weinberger, O; Winter, L; Thalhammer, C; Huelnhagen, T; Rieger, J; Mehling, H; Schulz-Menger, J; Niendorf, T				Klix, Sabrina; Els, Antje; Paul, Katharina; Graessl, Andreas; Oezerdem, Celal; Weinberger, Oliver; Winter, Lukas; Thalhammer, Christof; Huelnhagen, Till; Rieger, Jan; Mehling, Heidrun; Schulz-Menger, Jeanette; Niendorf, Thoralf			On the Subjective Acceptance during Cardiovascular Magnetic Resonance Imaging at 7.0 Tesla	PLOS ONE			English	Article							CORONARY MR-ANGIOGRAPHY; 7 T; STRAY FIELDS; CARDIAC MRI; CMR PROTOCOLS; VITAL SIGNS; COIL ARRAY; EXPOSURE; SYNCHRONIZATION; STIMULATION	Purpose This study examines the subjective acceptance during UHF-CMR in a cohort of healthy volunteers who underwent a cardiac MR examination at 7.0T. Methods Within a period of two-and-a-half years (January 2012 to June 2014) a total of 165 healthy volunteers (41 female, 124 male) without any known history of cardiac disease underwent UHF-CMR. For the assessment of the subjective acceptance a questionnaire was used to examine the participants experience prior, during and after the UHF-CMR examination. For this purpose, subjects were asked to respond to the questionnaire in an exit interview held immediately after the completion of the UHF-CMR examination under supervision of a study nurse to ensure accurate understanding of the questions. All questions were answered with "yes" or "no" including space for additional comments. Results Transient muscular contraction was documented in 12.7% of the questionnaires. Muscular contraction was reported to occur only during periods of scanning with the magnetic field gradients being rapidly switched. Dizziness during the study was reported by 12.7% of the subjects. Taste of metal was reported by 10.1% of the study population. Light flashes were reported by 3.6% of the entire cohort. 13% of the subjects reported side effects/observations which were not explicitly listed in the questionnaire but covered by the question about other side effects. No severe side effects as vomiting or syncope after scanning occurred. No increase in heart rate was observed during the UHF-CMR exam versus the baseline clinical examination. Conclusions This study adds to the literature by detailing the subjective acceptance of cardiovascular magnetic resonance imaging examinations at a magnetic field strength of 7.0T. Cardiac MR examinations at 7.0T are well tolerated by healthy subjects. Broader observational and multi-center studies including patient cohorts with cardiac diseases are required to gain further insights into the subjective acceptance of UHF-CMR examinations.	[Klix, Sabrina; Els, Antje; Paul, Katharina; Graessl, Andreas; Oezerdem, Celal; Weinberger, Oliver; Winter, Lukas; Thalhammer, Christof; Huelnhagen, Till; Rieger, Jan; Niendorf, Thoralf] Max Delbruck Ctr Mol Med, BUFF, Berlin, Germany; [Mehling, Heidrun; Schulz-Menger, Jeanette; Niendorf, Thoralf] ECRC, Berlin, Germany; [Schulz-Menger, Jeanette] HELIOS Klinikum Berlin Buch, Dept Cardiol & Nephrol, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helios Kliniken	Niendorf, T (corresponding author), Max Delbruck Ctr Mol Med, BUFF, Berlin, Germany.	Thoralf.Niendorf@mdc-berlin.de	Niendorf, Thoralf/H-7738-2013	Niendorf, Thoralf/0000-0001-7584-6527; Winter, Lukas/0000-0002-4381-275X; Huelnhagen, Till/0000-0002-6755-2171; Schulz-Menger, Jeanette/0000-0003-3100-1092	DZHK (German Centre for Cardiovascular Research); BMBF (Federal Ministry of Education and Research); Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association (ICEMED-Project) [1210251]; BMBF (Federal Ministry of Education and Research, "KMU-innovativ": Medizintechnik) [MED-373-046]	DZHK (German Centre for Cardiovascular Research); BMBF (Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association (ICEMED-Project); BMBF (Federal Ministry of Education and Research, "KMU-innovativ": Medizintechnik)(Federal Ministry of Education & Research (BMBF))	This work was supported (in part, C.O.) by the DZHK (German Centre for Cardiovascular Research) and by the BMBF (Federal Ministry of Education and Research). This work was funded (in part, A.G.) by the Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association (ICEMED-Project 1210251). L.W. received support by the BMBF (Federal Ministry of Education and Research, "KMU-innovativ": Medizintechnik MED-373-046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, HEALTH PHYSICS, V14, P8; Atkinson IC, 2007, J MAGN RESON IMAGING, V26, P1222, DOI 10.1002/jmri.21150; Atkinson IC, 2010, J MAGN RESON IMAGING, V32, P82, DOI 10.1002/jmri.22221; Becker M, 2010, EUR RADIOL, V20, P1344, DOI 10.1007/s00330-009-1676-z; Bizino MB, 2014, INVEST RADIOL, V49, P326, DOI 10.1097/RLI.0000000000000047; Brandts A, 2010, MAGN RESON MED, V64, P1472, DOI 10.1002/mrm.22529; Chakeres DW, 2005, PROG BIOPHYS MOL BIO, V87, P255, DOI 10.1016/j.pbiomolbio.2004.08.012; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; COREA J, 2012, BESPOKE COILS SCREEN, P434; Cosottini M, 2014, EUR RADIOL, V24, P1923, DOI 10.1007/s00330-014-3177-y; Crozier S, 2007, J MAGN RESON IMAGING, V26, P1236, DOI 10.1002/jmri.21162; Dieringer MA, 2011, J MAGN RESON IMAGING, V33, P736, DOI 10.1002/jmri.22451; Faber SC, 2003, MAGN RESON IMAGING, V21, P715, DOI 10.1016/S0730-725X(03)00106-1; Frauenrath T, 2008, ACTA ACUST UNITED AC, V94, P148, DOI 10.3813/AAA.918017; Frauenrath T, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-67; Frauenrath T, 2009, INVEST RADIOL, V44, P539, DOI 10.1097/RLI.0b013e3181b4c15e; Gilles M, 2013, STRESS, V16, P172, DOI 10.3109/10253890.2012.708949; Glover PM, 2007, BIOELECTROMAGNETICS, V28, P349, DOI 10.1002/bem.20316; GRAESSL A, 2013, 2 DIMENSIONAL 16 CHA, P136; Graessl A, 2014, MAGN RESON MED, V72, P276, DOI 10.1002/mrm.24903; Grassl A, 2013, EUR J RADIOL, V82, P752, DOI 10.1016/j.ejrad.2011.08.002; HEILMAIER C, 2011, BIOELECTROMAGNETICS, DOI DOI 10.1002/BEM.20695; Heinrich A, 2014, NEUROREPORT, V25, P1081, DOI 10.1097/WNR.0000000000000225; Heinrich A, 2013, RADIOLOGY, V266, P236, DOI 10.1148/radiol.12112172; Hezel F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052324; *IEC, 2010, 60601 2 33 MEDICAL E; Kraff O, 2015, J MAGN RESON IMAGING, V41, P13, DOI 10.1002/jmri.24573; Kramer CM, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-91; Kramer CM, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-35; Lattanzi R, 2012, MAGN RESON MED, V68, P286, DOI 10.1002/mrm.23198; Meloni A, 2014, MAGN RESON MED, V71, P2224, DOI 10.1002/mrm.24856; Mian OS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078748; Niendorf T, 2013, RADIOLOGE, V53, P422, DOI 10.1007/s00117-012-2348-6; Niendorf T, 2013, J MAGN RESON, V229, P208, DOI 10.1016/j.jmr.2012.11.015; Niendorf T, 2010, EUR RADIOL, V20, P2806, DOI 10.1007/s00330-010-1902-8; Rauschenberg J, 2014, INVEST RADIOL, V49, P249, DOI 10.1097/RLI.0000000000000035; RESETAR A, 2014, RETROSPECTIVELY GATE, P436; Roberts DC, 2011, CURR BIOL, V21, P1635, DOI 10.1016/j.cub.2011.08.029; Rodgers CT, 2014, MAGN RESON MED, V72, P304, DOI 10.1002/mrm.24922; Rodgers CT, 2013, MAGN RESON MED, V70, P1038, DOI 10.1002/mrm.24548; RUEHLE A, 2012, SODIUM IMAGING OF TH, P82; Schaap K, 2014, OCCUP ENVIRON MED, V71, P423, DOI 10.1136/oemed-2013-101890; Schlamann M, 2010, J MAGN RESON IMAGING, V31, P1061, DOI 10.1002/jmri.22065; Schlamann M, 2010, ACAD RADIOL, V17, P277, DOI 10.1016/j.acra.2009.10.004; Suttie JJ, 2012, NMR BIOMED, V25, P27, DOI 10.1002/nbm.1708; TAO Y, 2014, MAGN RESON MED, DOI DOI 10.1002/MRM.25522; Thalhammer C, 2012, J MAGN RESON IMAGING, V36, P847, DOI 10.1002/jmri.23724; Theysohn JM, 2008, MAGN RESON MATER PHY, V21, P63, DOI 10.1007/s10334-007-0095-x; Theysohn JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092104; Thormann M, 2013, EUR J RADIOL, V82, P768, DOI 10.1016/j.ejrad.2011.08.001; UWANO I, 2014, MAGN RESON MED SCI; van Elderen SGC, 2009, MAGN RESON MED, V62, P1379, DOI 10.1002/mrm.22168; van Elderen SGC, 2010, RADIOLOGY, V257, P254, DOI 10.1148/radiol.100615; van Nierop LE, 2013, MAGN RESON MED, V70, P232, DOI 10.1002/mrm.24454; van Nierop LE, 2012, OCCUP ENVIRON MED, V69, P759, DOI 10.1136/oemed-2011-100468; Vaughan TT, 2009, MAGN RESON MED, V61, P244, DOI 10.1002/mrm.21751; Versluis MJ, 2013, J MAGN RESON IMAGING, V38, P722, DOI 10.1002/jmri.23904; von Knobelsdorff-Brenkenhoff F, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-23; von Knobelsdorff-Brenkenhoff F, 2010, EUR RADIOL, V20, P2844, DOI 10.1007/s00330-010-1888-2; Ward BK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00028; WINTER L, 2014, MAGN RESON MED; Winter L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061661; Winter L, 2012, EUR RADIOL, V22, P2211, DOI 10.1007/s00330-012-2487-1; Ziegelberger G, 2009, HEALTH PHYS, V97, P259, DOI 10.1097/HP.0b013e3181aff9eb	65	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117095	10.1371/journal.pone.0117095	http://dx.doi.org/10.1371/journal.pone.0117095			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25621491	Green Published, gold, Green Accepted			2022-12-26	WOS:000348470400018
J	Toyono, T; Usui, T; Yokoo, S; Taketani, Y; Nakagawa, S; Kuroda, M; Yamagami, S; Amano, S				Toyono, Tetsuya; Usui, Tomohiko; Yokoo, Seiichi; Taketani, Yukako; Nakagawa, Suguru; Kuroda, Masahiko; Yamagami, Satoru; Amano, Shiro			Angiopoietin-Like 7 Is an Anti-Angiogenic Protein Required to Prevent Vascularization of the Cornea	PLOS ONE			English	Article							TRABECULAR MESHWORK CELLS; KERATOCYTE PHENOTYPE; INFLAMMATION; SUPPRESSION; GLAUCOMA; GENE; BETA	Purpose We sought to identify the anti-angiogenic molecule expressed in corneal keratocytes that is responsible for maintaining the avascularity of the cornea. Methods Human umbilical vein endothelial cells (HUVECs) were cultured with either human dermal fibroblasts or with human corneal keratocytes under serum-free conditions. The areas that exhibited blood vessel formation were estimated by immunostaining the cultures with an antitibody against CD31, a blood vessel marker. We also performed microarray geneexpression analysis and selected one molecule, angiopoietin-like 7 (ANGPTL7) for further functional studies conducted with the keratocytes and in vivo in mice. Results Areas showing blood vessel formation in normal serum-free medium were conditions were markedly smaller when HUVECs were co-cultured with corneal keratocytes than when they were co-cultured with the dermal fibroblasts under the same conditions. Microarray analysis revealed that ANGPTL7 expression was higher in keratocytes than in dermal fibroblasts. In vitro, inhibiting ANGPTL7 expression by using a specific siRNA led to greater tube formation than did the transfection of cells with a control siRNA, and this increase in tube formation was abolished when recombinant ANGPTL7 protein was added to the cultures. In vivo, intrastromal injections of an ANGPTL7 PshRNA into the avascular corneal stroma of mice resulted in the growth of blood vessels. Conclusions ANGPTL7, which is abundantly expressed in keratocytes, plays a major role in maintaining corneal avascularity and transparency.	[Toyono, Tetsuya; Usui, Tomohiko; Yokoo, Seiichi; Taketani, Yukako; Nakagawa, Suguru; Yamagami, Satoru; Amano, Shiro] Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan; [Kuroda, Masahiko] Tokyo Med Univ, Dept Pathol, Tokyo 1608402, Japan	University of Tokyo; Tokyo Medical University	Usui, T (corresponding author), Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan.	tomohiko-tky@umin.ac.jp		taketani, yukako/0000-0001-6424-3579	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	A grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Azar D, 2008, CURR EYE RES, V33, P954, DOI 10.1080/02713680802461106; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Bouis D, 2006, PHARMACOL RES, V53, P89, DOI 10.1016/j.phrs.2005.10.006; Bouis DRMH, 2007, ANTICANCER RES, V27, P2325; Choudhary A, 2005, MOL VIS, V11, P163; Comes N, 2011, GENES CELLS, V16, P243, DOI 10.1111/j.1365-2443.2010.01483.x; Funderburgh JL, 2003, J BIOL CHEM, V278, P45629, DOI 10.1074/jbc.M303292200; Guo L, 2014, INFLAMM RES, V63, P13, DOI 10.1007/s00011-013-0678-0; Hamasaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042655; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Hos D, 2011, ARCH OPHTHALMOL-CHIC, V129, P445, DOI 10.1001/archophthalmol.2011.42; Kawakita T, 2006, INVEST OPHTH VIS SCI, V47, P1918, DOI 10.1167/iovs.05-1040; Kroon Marielle E., 2002, Angiogenesis, V5, P257, DOI 10.1023/A:1024540701634; Kuchtey J, 2008, INVEST OPHTH VIS SCI, V49, P3438, DOI 10.1167/iovs.07-1347; Lo WR, 2003, INVEST OPHTH VIS SCI, V44, P473, DOI 10.1167/iovs.02-0444; Nakao S, 2012, INVEST OPHTH VIS SCI, V53, P4323, DOI 10.1167/iovs.11-9119; Peek R, 2002, J BIOL CHEM, V277, P686, DOI 10.1074/jbc.M105746200; Peek R, 1998, INVEST OPHTH VIS SCI, V39, P1782; Rozsa FW, 2006, MOL VIS, V12, P125; Sakai R, 2002, INVEST OPHTH VIS SCI, V43, P1749; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Toyono T, 2013, INVEST OPHTH VIS SCI, V54, P4278, DOI 10.1167/iovs.12-11497; Yamagami S, 2007, OPHTHALMOLOGY, V114, P433, DOI 10.1016/j.ophtha.2006.07.042; Zhao XJ, 2004, INVEST OPHTH VIS SCI, V45, P4023, DOI 10.1167/iovs.04-0535	25	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0116838	10.1371/journal.pone.0116838	http://dx.doi.org/10.1371/journal.pone.0116838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25622036	Green Published, gold, Green Submitted			2022-12-26	WOS:000348470400008
J	Manzo, G; Scorciapino, MA; Wadhwani, P; Buck, J; Montaldo, NP; Pintus, M; Sanna, R; Casu, M; Giuliani, A; Pirri, G; Luca, V; Ulrich, AS; Rinaldi, AC				Manzo, Giorgia; Scorciapino, Mariano A.; Wadhwani, Parvesh; Buerck, Jochen; Montaldo, Nicola Pietro; Pintus, Manuela; Sanna, Roberta; Casu, Mariano; Giuliani, Andrea; Pirri, Giovanna; Luca, Vincenzo; Ulrich, Anne S.; Rinaldi, Andrea C.			Enhanced Amphiphilic Profile of a Short beta-Stranded Peptide Improves Its Antimicrobial Activity	PLOS ONE			English	Article							F-19 NMR LABEL; CIRCULAR-DICHROISM; DENDRIMERIC PEPTIDE; MEMBRANES; PGLA; SPECTROSCOPY; AGGREGATION	SB056 is a novel semi-synthetic antimicrobial peptide with a dimeric dendrimer scaffold. Active against both Gram-negative and -positive bacteria, its mechanism has been attributed to a disruption of bacterial membranes. The branched peptide was shown to assume a beta-stranded conformation in a lipidic environment. Here, we report on a rational modification of the original, empirically derived linear peptide sequence [WKKIRVRLSA-NH2, SB056-lin]. We interchanged the first two residues [KWKIRVRLSA-NH2, beta-SB056-lin] to enhance the amphipathic profile, in the hope that a more regular beta-strand would lead to a better antimicrobial performance. MIC values confirmed that an enhanced amphiphilic profile indeed significantly increases activity against both Gram-positive and -negative strains. The membrane binding affinity of both peptides, measured by tryptophan fluorescence, increased with an increasing ratio of negatively charged/zwitterionic lipids. Remarkably, beta-SB056- lin showed considerable binding even to purely zwitterionic membranes, unlike the original sequence, indicating that besides electrostatic attraction also the amphipathicity of the peptide structure plays a fundamental role in binding, by stabilizing the bound state. Synchrotron radiation circular dichroism and solid-state F-19-NMR were used to characterize and compare the conformation and mobility of the membrane bound peptides. Both SB056-lin and beta-SB056- lin adopt a beta-stranded conformation upon binding POPC vesicles, but the former maintains an intrinsic structural disorder that also affects its aggregation tendency. Upon introducing some anionic POPG into the POPC matrix, the sequence-optimized beta-SB056- lin forms well-ordered beta-strands once electro-neutrality is approached, and it aggregates into more extended beta-sheets as the concentration of anionic lipids in the bilayer is raised. The enhanced antimicrobial activity of the analogue correlates with the formation of these extended beta-sheets, which also leads to a dramatic alteration of membrane integrity as shown by P-31-NMR. These findings are generally relevant for the design and optimization of other membrane-active antimicrobial peptides that can fold into amphipathic beta-strands.	[Manzo, Giorgia; Scorciapino, Mariano A.; Sanna, Roberta; Casu, Mariano] Univ Cagliari, Dept Chem & Geol Sci, I-09042 Monserrato, CA, Italy; [Wadhwani, Parvesh; Buerck, Jochen; Ulrich, Anne S.] Karlsruhe Inst Technol, Inst Biol Interfaces IBG 2, D-76021 Karlsruhe, Germany; [Montaldo, Nicola Pietro; Pintus, Manuela; Rinaldi, Andrea C.] Univ Cagliari, Dept Biomed Sci, I-09042 Monserrato, CA, Italy; [Giuliani, Andrea; Pirri, Giovanna] Spider Biotech Srl, Res & Dev Unit, I-10010 Colleretto Giacosa, TO, Italy; [Luca, Vincenzo] Univ Roma La Sapienza, Fdn Cenci Bolognetti, Ist Pasteur, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy; [Ulrich, Anne S.] Karlsruhe Inst Technol, Inst Organ Chem, D-76131 Karlsruhe, Germany	University of Cagliari; Helmholtz Association; Karlsruhe Institute of Technology; University of Cagliari; Fondazione Cenci Bolognetti; Sapienza University Rome; Helmholtz Association; Karlsruhe Institute of Technology	Rinaldi, AC (corresponding author), Univ Cagliari, Dept Biomed Sci, I-09042 Monserrato, CA, Italy.	rinaldi@unica.it	LUCA, Vincenzo/AAV-7385-2020; Scorciapino, Mariano Andrea/AAD-1256-2020; Montaldo, Nicola Pietro/GXV-6132-2022; Rinaldi, Andrea/N-1007-2019; Ulrich, Anne S./H-5519-2013	LUCA, Vincenzo/0000-0002-7834-0334; Montaldo, Nicola Pietro/0000-0003-3434-615X; Rinaldi, Andrea/0000-0002-9352-1037; Wadhwani, Parvesh/0000-0002-7290-5154; SCORCIAPINO, MARIANO ANDREA/0000-0001-7502-7265; Ulrich, Anne S./0000-0001-5571-9483	Sardinia Regional Government [CRP-17385]; Italian Ministry of Education, University and Research (MIUR); Sardinia Regional Government; Operational Programme of the Autonomous Region of Sardinia, European Social Fund	Sardinia Regional Government(Regione Sardegna); Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Sardinia Regional Government(Regione Sardegna); Operational Programme of the Autonomous Region of Sardinia, European Social Fund	ACR is the recipient of a grant from the Sardinia Regional Government (www.regione.sardegna. it/), L.R. 7/2007, bando 2009, grant number: CRP-17385. The Italian Ministry of Education, University and Research (MIUR) is acknowledged for a fellowship to MAS. The Sardinia Regional Government is acknowledged for the Ph.D. scholarship provided to GM (P.O.R. Sardegna F.S.E. Operational Programme of the Autonomous Region of Sardinia, European Social Fund 2007-2013). The Ordine Nazionale dei Biologi is acknowledged for the fellowship provided to VL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonin S, 2003, CHEMBIOCHEM, V4, P1151, DOI 10.1002/cbic.200300568; Afonin S, 2008, J AM CHEM SOC, V130, P16512, DOI 10.1021/ja803156d; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Blazyk J, 2001, J BIOL CHEM, V276, P27899, DOI 10.1074/jbc.M102865200; Borges A. Rosa, 2005, Current Drug Targets - Infectious Disorders, V5, P247, DOI 10.2174/1568005054880127; Breukink E, 1997, BIOCHEMISTRY-US, V36, P6968, DOI 10.1021/bi970008u; Bruschi M, 2010, PEPTIDES, V31, P1459, DOI 10.1016/j.peptides.2010.04.022; Burck J, 2014, JOURNAL OF SYNCHROTR; BUSTAMANTE C, 1983, P NATL ACAD SCI-BIOL, V80, P3568, DOI 10.1073/pnas.80.12.3568; Christiaens B, 2002, EUR J BIOCHEM, V269, P2918, DOI 10.1046/j.1432-1033.2002.02963.x; Clarke DT, 2004, J SYNCHROTRON RADIAT, V11, P142, DOI 10.1107/S0909049503024142; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; Diamond G, 2009, CURR PHARM DESIGN, V15, P2377, DOI 10.2174/138161209788682325; Epand RF, 2006, PROTEIN PEPTIDE LETT, V13, P1, DOI 10.2174/092986606774502063; Epand RM, 2009, MOL BIOSYST, V5, P580, DOI 10.1039/b900278m; Giuliani A, 2008, CELL MOL LIFE SCI, V65, P2450, DOI 10.1007/s00018-008-8188-x; Giuliani A, 2011, CELL MOL LIFE SCI, V68, P2255, DOI 10.1007/s00018-011-0717-3; Glaser RW, 2004, J MAGN RESON, V168, P153, DOI 10.1016/j.jmr.2004.02.008; Grage S, 2005, NMR SPECTROSCOPY BIO, P215; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; Maisch D, 2009, J AM CHEM SOC, V131, P15596, DOI 10.1021/ja9067595; Meier M, 2008, J AM CHEM SOC, V130, P1017, DOI 10.1021/ja077231r; Melo MN, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00236; Mikhailiuk PK, 2006, ANGEW CHEM INT EDIT, V45, P5659, DOI 10.1002/anie.200600346; Miles AJ, 2006, CHEM SOC REV, V35, P39, DOI 10.1039/b316168b; Mintzer MA, 2012, MOL PHARMACEUT, V9, P342, DOI 10.1021/mp2005033; Mykhailiuk PK, 2010, J FLUORINE CHEM, V131, P217, DOI 10.1016/j.jfluchem.2009.10.004; Opar A, 2007, NAT REV DRUG DISCOV, V6, P943, DOI 10.1038/nrd2477; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Pini A, 2005, ANTIMICROB AGENTS CH, V49, P2665, DOI 10.1128/AAC.49.7.2665-2672.2005; Rotem S, 2009, BBA-BIOMEMBRANES, V1788, P1582, DOI 10.1016/j.bbamem.2008.10.020; Sadler Kristen, 2002, J Biotechnol, V90, P195; Salwiczek M, 2010, AMINO ACIDS, V39, P1589, DOI 10.1007/s00726-010-0581-8; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Scorciapino MA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00171; Scorciapino MA, 2012, BIOPHYS J, V102, P1039, DOI 10.1016/j.bpj.2012.01.048; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Shaw N, 1974, Adv Appl Microbiol, V17, P63, DOI 10.1016/S0065-2164(08)70555-0; Strandberg E, 2004, CONCEPT MAGN RESON A, V23A, P89, DOI 10.1002/cmr.a.20024; Strandberg E, 2008, BIOCHEMISTRY-US, V47, P2601, DOI 10.1021/bi701944r; Tam JP, 2002, EUR J BIOCHEM, V269, P923, DOI 10.1046/j.0014-2956.2001.02728.x; Tew GN, 2010, ACCOUNTS CHEM RES, V43, P30, DOI 10.1021/ar900036b; Tkachenko AN, 2013, ANGEW CHEM INT EDIT, V52, P1486, DOI 10.1002/anie.201208069; Ulrich AS, 2005, PROG NUCL MAG RES SP, V46, P1, DOI 10.1016/j.pnmrs.2004.11.001; Wadhwani P, 2012, BIOPHYS J, V103, P265, DOI 10.1016/j.bpj.2012.06.004; Wadhwani P, 2013, PHYS CHEM CHEM PHYS, V15, P8962, DOI 10.1039/c3cp50896j; Wadhwani P, 2012, J AM CHEM SOC, V134, P6512, DOI 10.1021/ja301328f; Wadhwani P, 2012, EUR BIOPHYS J BIOPHY, V41, P177, DOI 10.1007/s00249-011-0771-7; Wadhwani P, 2008, J AM CHEM SOC, V130, P16515, DOI 10.1021/ja804928q; Wallace BA, 2010, BIOCHEM SOC T, V38, P861, DOI 10.1042/BST0380861; Wallace BA, 2009, Q REV BIOPHYS, V42, P317, DOI 10.1017/S003358351000003X; WALLACE BA, 1987, BIOCHEMISTRY-US, V26, P65, DOI 10.1021/bi00375a010; Wallace BA, 2009, MODERN TECHNIQUES FO; Wien F, 2005, APPL SPECTROSC, V59, P1109, DOI 10.1366/0003702055012546; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao HX, 2002, J BIOL CHEM, V277, P25170, DOI 10.1074/jbc.M203186200; [No title captured]	57	44	44	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116379	10.1371/journal.pone.0116379	http://dx.doi.org/10.1371/journal.pone.0116379			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617899	Green Published, Green Submitted, gold			2022-12-26	WOS:000350336000014
J	Wang, F; Ouyang, G; Zhou, CS; Wang, SP				Wang, Fang; Ouyang, Guang; Zhou, Changsong; Wang, Suiping			Re-Examination of Chinese Semantic Processing and Syntactic Processing: Evidence from Conventional ERPs and Reconstructed ERPs by Residue Iteration Decomposition (RIDE)	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SENTENCE COMPREHENSION; EYE-MOVEMENTS; TIME-COURSE; THEMATIC RELATIONSHIPS; BRAIN RESPONSES; INTEGRATION; VIOLATIONS; FORM; INDEPENDENCE	A number of studies have explored the time course of Chinese semantic and syntactic processing. However, whether syntactic processing occurs earlier than semantics during Chinese sentence reading is still under debate. To further explore this issue, an event-related potentials (ERPs) experiment was conducted on 21 native Chinese speakers who read individually-presented Chinese simple sentences (NP1+VP+NP2) word-by-word for comprehension and made semantic plausibility judgments. The transitivity of the verbs was manipulated to form three types of stimuli: congruent sentences (CON), sentences with a semantically violated NP2 following a transitive verb (semantic violation, SEM), and sentences with a semantically violated NP2 following an intransitive verb (combined semantic and syntactic violation, SEM+SYN). The ERPs evoked from the target NP2 were analyzed by using the Residue Iteration Decomposition (RIDE) method to reconstruct the ERP waveform blurred by trial-to-trial variability, as well as by using the conventional ERP method based on stimulus-locked averaging. The conventional ERP analysis showed that, compared with the critical words in CON, those in SEM and SEM+SYN elicited an N400-P600 biphasic pattern. The N400 effects in both violation conditions were of similar size and distribution, but the P600 in SEM+SYN was bigger than that in SEM. Compared with the conventional ERP analysis, RIDE analysis revealed a larger N400 effect and an earlier P600 effect (in the time window of 500-800 ms instead of 570-810ms). Overall, the combination of conventional ERP analysis and the RIDE method for compensating for trial-to-trial variability confirmed the non-significant difference between SEM and SEM+SYN in the earlier N400 time window. Converging with previous findings on other Chinese structures, the current study provides further precise evidence that syntactic processing in Chinese does not occur earlier than semantic processing.	[Wang, Fang; Wang, Suiping] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Wang, Fang; Wang, Suiping] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Wang, Fang; Wang, Suiping] S China Normal Univ, Key Lab Mental Hlth & Cognit Sci Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Ouyang, Guang; Zhou, Changsong] Hong Kong Baptist Univ, Dept Phys, Kowloon Tong, Hong Kong, Peoples R China; [Ouyang, Guang; Zhou, Changsong] Hong Kong Baptist Univ, Ctr Nonlinear Studies, Kowloon Tong, Hong Kong, Peoples R China; [Ouyang, Guang; Zhou, Changsong] Hong Kong Baptist Univ, Beijing Hong Kong Singapore Joint Ctr Nonlinear &, Inst Computat & Theoret Studies, Kowloon Tong, Hong Kong, Peoples R China	South China Normal University; South China Normal University; South China Normal University; Hong Kong Baptist University; Hong Kong Baptist University; Hong Kong Baptist University	Wang, SP (corresponding author), S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	suiping@scnu.edu.cn	wang, fang/GYD-4295-2022	Zhou, Changsong/0000-0002-4130-0216; Wang, Suiping/0000-0001-8726-169X; Ouyang, Guang/0000-0001-8939-7443	Natural Science Foundation of China [NSF 31271086]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS)	This work was funded by grants from the Natural Science Foundation of China (NSF 31271086) and Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS 2011) to Suiping Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornkessel-Schlesewsky I, 2011, BRAIN LANG, V117, P133, DOI 10.1016/j.bandl.2010.09.010; Braze D, 2002, J PSYCHOLINGUIST RES, V31, P25, DOI 10.1023/A:1014324220455; Chen HC, 1999, LANG COGNITIVE PROC, V14, P425, DOI 10.1080/016909699386130; Chen S, 1998, APHASIOLOGY, V12, P5, DOI 10.1080/02687039808249441; Chow WY, 2013, BRAIN RES, V1506, P76, DOI 10.1016/j.brainres.2013.02.016; Dapretto M, 1999, NEURON, V24, P427, DOI 10.1016/S0896-6273(00)80855-7; FERREIRA F, 1986, J MEM LANG, V25, P348, DOI 10.1016/0749-596X(86)90006-9; Fiebach CJ, 2002, J MEM LANG, V47, P250, DOI 10.1016/S0749-596X(02)00004-9; Friederici AD, 2004, NEUROREPORT, V15, P165, DOI 10.1097/00001756-200401190-00032; FRIEDERICI AD, 1995, BRAIN LANG, V50, P259, DOI 10.1006/brln.1995.1048; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Friederici AD, 2000, J MEM LANG, V43, P476, DOI 10.1006/jmla.2000.2709; Friederici AD, 2007, BRAIN RES, V1146, P50, DOI 10.1016/j.brainres.2006.08.038; Frisch S, 2004, COGNITION, V91, P191, DOI 10.1016/j.cognition.2003.09.009; Gunter TC, 1997, PSYCHOPHYSIOLOGY, V34, P660, DOI 10.1111/j.1469-8986.1997.tb02142.x; Hagoort P, 2003, J COGNITIVE NEUROSCI, V15, P883, DOI 10.1162/089892903322370807; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hahne A, 2002, COGNITIVE BRAIN RES, V13, P339, DOI 10.1016/S0926-6410(01)00127-6; Kaan E, 2003, J COGNITIVE NEUROSCI, V15, P98, DOI 10.1162/089892903321107855; Kolk HHJ, 2003, BRAIN LANG, V85, P1, DOI 10.1016/S0093-934X(02)00548-5; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Kuperberg GR, 2007, BRAIN LANG, V100, P223, DOI 10.1016/j.bandl.2005.12.006; Kuperberg GR, 2006, LANG COGNITIVE PROC, V21, P489, DOI 10.1080/01690960500094279; Kuperberg GR, 2003, COGNITIVE BRAIN RES, V17, P117, DOI 10.1016/S0926-6410(03)00086-7; Liu Y, 2007, BRAIN LANG, V103, P75, DOI 10.1016/j.bandl.2007.07.052; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Osterhout L, 1999, LANG COGNITIVE PROC, V14, P283, DOI 10.1080/016909699386310; Ouyang G., 2011, PSYCHOPHYSIOLOGY, V48, P1631, DOI [10.1111/j.1469-8986.2011.01269.x, DOI 10.1111/J.1469-8986.2011.01269.X]; Ouyang G, 2013, PSYCHOPHYSIOLOGY, V50, P253, DOI 10.1111/psyp.12004; Proverbio AM, 2009, NEUROSCI LETT, V459, P142, DOI 10.1016/j.neulet.2009.05.012; RAYNER K, 1983, J VERB LEARN VERB BE, V22, P358, DOI 10.1016/S0022-5371(83)90236-0; Rosler F, 1993, COGNITIVE NEUROSCIEN, V5, P345, DOI [10.1162/jocn.1993.5.3.345, DOI 10.1162/JOCN.1993.5.3.345]; Sitnikova T, 2008, J COGNITIVE NEUROSCI, V20, P2037, DOI 10.1162/jocn.2008.20143; Steinhauer K, 2012, BRAIN LANG, V120, P135, DOI 10.1016/j.bandl.2011.07.001; Sturmer B, 2013, PSYCHOPHYSIOLOGY, V50, P70, DOI 10.1111/j.1469-8986.2012.01479.x; TANENHAUS MK, 1989, J PSYCHOLINGUIST RES, V18, P37, DOI 10.1007/BF01069045; Verleger R, 2014, NEUROIMAGE, V100, P271, DOI 10.1016/j.neuroimage.2014.06.036; Wang S, 2013, LANG COGNITIVE PROC, P1; Wang SP, 2008, NEUROPSYCHOLOGIA, V46, P1371, DOI 10.1016/j.neuropsychologia.2007.12.020; Yang JM, 2009, MEM COGNITION, V37, P1164, DOI 10.3758/MC.37.8.1164; Ye Z, 2006, BRAIN RES, V1071, P186, DOI 10.1016/j.brainres.2005.11.085; Ye Z, 2007, BRAIN RES, V1142, P135, DOI 10.1016/j.brainres.2007.01.030; Yu J, 2008, NEUROREPORT, V19, P745, DOI 10.1097/WNR.0b013e3282fda21d; Zhang YX, 2008, NEUROREPORT, V19, P1039, DOI 10.1097/WNR.0b013e328302f14f; Zhang YX, 2013, BRAIN LANG, V126, P8, DOI 10.1016/j.bandl.2013.04.001; Zhang YX, 2010, J EXP PSYCHOL LEARN, V36, P765, DOI 10.1037/a0019254; Zhou DX, 2009, LANG COGNITIVE PROC, V24, P929; Zhou XL, 2010, NEUROPSYCHOLOGIA, V48, P1551, DOI 10.1016/j.neuropsychologia.2010.02.001	48	19	20	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117324	10.1371/journal.pone.0117324	http://dx.doi.org/10.1371/journal.pone.0117324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7UF	25615600	Green Published, Green Submitted, gold			2022-12-26	WOS:000349122100061
J	Fernandez, EM; Diaz-Ceso, MD; Vilar, M				Fernandez, Eva M.; Diaz-Ceso, Maria D.; Vilar, Marcal			Brain Expressed and X-Linked (Bex) Proteins Are Intrinsically Disordered Proteins (IDPs) and Form New Signaling Hubs	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; P75 NEUROTROPHIN RECEPTOR; GENOME-WIDE ANALYSIS; CELL-DEATH EXECUTOR; COILED-COIL DOMAINS; IDENTIFIES BEX1; PREDICTION; REGIONS; FAMILY; NADE	Intrinsically disordered proteins (IDPs) are abundant in complex organisms. Due to their promiscuous nature and their ability to adopt several conformations IDPs constitute important points of network regulation. The family of Brain Expressed and X-linked (Bex) proteins consists of 5 members in humans (Bex1-5). Recent reports have implicated Bex proteins in transcriptional regulation and signaling pathways involved in neurodegeneration, cancer, cell cycle and tumor growth. However, structural and biophysical data for this protein family is almost non-existent. We used bioinformatics analyses to show that Bex proteins contain long regions of intrinsic disorder which are conserved across all members. Moreover, we confirmed the intrinsic disorder by circular dichroism spectroscopy of Bex1 after expression and purification in E. coli. These observations strongly suggest that Bex proteins constitute a new group of IDPs. Based on these findings, together with the demonstrated promiscuity of Bex proteins and their involvement in different signaling pathways, we propose that Bex family members play important roles in the formation of protein network hubs.	[Fernandez, Eva M.; Diaz-Ceso, Maria D.; Vilar, Marcal] Spanish Inst Hlth Carlos III ISCIII, Lab Neurodegenerat, Chron Dis Program UFIEC, Madrid, Spain	Instituto de Salud Carlos III; Unidad Funcional de Investigacion de Enfermedades Cronicas (UFIEC)	Vilar, M (corresponding author), Spanish Inst Hlth Carlos III ISCIII, Lab Neurodegenerat, Chron Dis Program UFIEC, Madrid, Spain.	mvilar@isciii.es	Vilar, Marçal/B-4581-2016	Vilar, Marçal/0000-0002-9376-6544	Ministry of Economy and Competitiveness (MINECO) from the Government of Spain [BFU2010-15276, BFU2013-42746-P]	Ministry of Economy and Competitiveness (MINECO) from the Government of Spain	Ministry of Economy and Competitiveness (MINECO) from the Government of Spain. Projects: BFU2010-15276 and BFU2013-42746-P to MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 2005, GENE, V357, P18, DOI 10.1016/j.gene.2005.05.012; Baldisseri DM, 2002, J MOL BIOL, V319, P823, DOI 10.1016/S0022-2836(02)00282-6; Behrens M, 2003, J NEUROCHEM, V86, P1289, DOI 10.1046/j.1471-4159.2003.01940.x; Brown AL, 1999, HUM MOL GENET, V8, P611, DOI 10.1093/hmg/8.4.611; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Chen JH, 2012, ARCH BIOCHEM BIOPHYS, V524, P123, DOI 10.1016/j.abb.2012.04.024; Chien J, 2008, ONCOGENE, V27, P7223, DOI 10.1038/onc.2008.360; Cumberworth A, 2013, BIOCHEM J, V454, P361, DOI 10.1042/BJ20130545; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Ding KF, 2009, CARCINOGENESIS, V30, P35, DOI 10.1093/carcin/bgn251; Dosztanyi Z, 2010, BRIEF BIOINFORM, V11, P225, DOI 10.1093/bib/bbp061; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Foltz G, 2006, CANCER RES, V66, P6665, DOI 10.1158/0008-5472.CAN-05-4453; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Han CY, 2005, NUCLEIC ACIDS RES, V33, P6555, DOI 10.1093/nar/gki964; Han Qiu-Yue, 2012, Yichuan, V34, P711, DOI 10.3724/SP.J.1005.2012.00711; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Hite KC, 2012, PROTEIN SCI, V21, P531, DOI 10.1002/pro.2037; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones DT, 2014, BIOINFORMATICS; Kaczka P, 2014, EUR BIOPHYS J BIOPHY, V43, P581, DOI 10.1007/s00249-014-0987-4; Karakoula K, 2014, CANCER LETT, V346, P34, DOI 10.1016/j.canlet.2013.12.005; Khazaei MR, 2010, J NEUROCHEM, V115, P910, DOI 10.1111/j.1471-4159.2010.06960.x; Kim AJ, 2004, GENE, V343, P79, DOI 10.1016/j.gene.2004.08.031; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Kimura MT, 2001, J BIOL CHEM, V276, P17291, DOI 10.1074/jbc.M005453200; Koo JH, 2007, BIOCHEM BIOPH RES CO, V363, P405, DOI 10.1016/j.bbrc.2007.08.186; Latham KE, 2002, BIOL REPROD, V67, P386, DOI 10.1095/biolreprod67.2.386; Lee CH, 2013, J PATHOL, V230, P298, DOI 10.1002/path.4173; Livernois AM, 2009, ANAL BIOCHEM, V392, P70, DOI 10.1016/j.ab.2009.05.023; Longhi S, 2010, METHODS MOL BIOL, V609, P307, DOI 10.1007/978-1-60327-241-4_18; Louis-Jeune C, 2011, PROTEINS; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Meng QM, 2014, J MOL NEUROSCI, V53, P262, DOI 10.1007/s12031-013-0215-1; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mukai J, 2002, J BIOL CHEM, V277, P13973, DOI 10.1074/jbc.M106342200; Mukai J, 2000, J BIOL CHEM, V275, P17566, DOI 10.1074/jbc.C000140200; Naderi A, 2007, CANCER RES, V67, P6725, DOI 10.1158/0008-5472.CAN-06-4394; Naderi A, 2012, INT J CANCER, V130, P71, DOI 10.1002/ijc.25977; Naderi A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-111; Naderi A, 2010, INT J CANCER, V126, P1596, DOI 10.1002/ijc.24866; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Pancsa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034687; Patil A, 2010, INT J MOL SCI, V11, P1930, DOI 10.3390/ijms11041930; Peedicayil A, 2009, GYNECOL ONCOL, V114, P260, DOI 10.1016/j.ygyno.2009.03.038; Quentmeier H, 2005, LEUKEMIA, V19, P1488, DOI 10.1038/sj.leu.2403820; Rattan R, 2010, ONCOGENE, V29, P1362, DOI 10.1038/onc.2009.431; Rohrs S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-86; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Sano H, 2001, LARYNGOSCOPE, V111, P535, DOI 10.1097/00005537-200103000-00027; Singh GP, 2007, PROTEINS, V66, P761, DOI 10.1002/prot.21281; Su CT, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-319; Tantos A, 2013, BBA-PROTEINS PROTEOM, V1834, P342, DOI 10.1016/j.bbapap.2012.08.005; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Uversky VN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/568068; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Vilar M, 2006, EMBO J, V25, P1219, DOI 10.1038/sj.emboj.7601017; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Winter EE, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-54; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Xiao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091782; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yasui S, 2007, MOL CELL NEUROSCI, V35, P100, DOI 10.1016/j.mcn.2007.02.007; Yoon K, 2004, BIOCHEM BIOPH RES CO, V319, P649, DOI 10.1016/j.bbrc.2004.05.043; Yu Y, 2006, BRAIN RES, V1100, P13, DOI 10.1016/j.brainres.2006.05.010; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhang LQ, 2008, BIOCHEM GENET, V46, P293, DOI 10.1007/s10528-008-9148-8; Zhou X, 2012, J MOL NEUROSCI; Zhou XP, 2013, J MOL NEUROSCI, V50, P78, DOI 10.1007/s12031-012-9864-8	81	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0117206	10.1371/journal.pone.0117206	http://dx.doi.org/10.1371/journal.pone.0117206			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25612294	Green Published, Green Submitted, gold			2022-12-26	WOS:000348562900034
J	Papadimitriou, K; Anastasiou, R; Maistrou, E; Plakas, T; Papandreou, NC; Hamodrakas, SJ; Ferreira, S; Supply, P; Renault, P; Pot, B; Tsakalidou, E				Papadimitriou, Konstantinos; Anastasiou, Rania; Maistrou, Eleni; Plakas, Thomas; Papandreou, Nikos C.; Hamodrakas, Stavros J.; Ferreira, Stephanie; Supply, Philip; Renault, Pierre; Pot, Bruno; Tsakalidou, Effie			Acquisition through Horizontal Gene Transfer of Plasmid pSMA198 by Streptococcus macedonicus ACA-DC 198 Points towards the Dairy Origin of the Species	PLOS ONE			English	Article							INFANTARIUS SUBSP INFANTARIUS; COMPLETE GENOME SEQUENCE; LACTIC-ACID BACTERIA; LACTOCOCCUS-LACTIS; MOLECULAR CHARACTERIZATION; BOVIS ENDOCARDITIS; MINIMAL REPLICON; HOST-RANGE; GALLOLYTICUS; IDENTIFICATION	Background Streptococcus macedonicus is an intriguing streptococcal species whose most frequent source of isolation is fermented foods similarly to Streptococcus thermophilus. However, S. macedonicus is closely related to commensal opportunistic pathogens of the Streptococcus bovis/Streptococcus equinus complex. Methodology/Principal Findings We analyzed the pSMA198 plasmid isolated from the dairy strain Streptococcus macedonicus ACA-DC 198 in order to provide novel clues about the main ecological niche of this bacterium. pSMA198 belongs to the narrow host range pCI305/pWV02 family found primarily in lactococci and to the best of our knowledge it is the first such plasmid to be reported in streptococci. Comparative analysis of the pSMA198 sequence revealed a high degree of similarity with plasmids isolated from Lactococcus lactis strains deriving from milk or its products. Phylogenetic analysis of the pSMA198 Rep showed that the vast majority of closely related proteins derive from lactococcal dairy isolates. Additionally, cloning of the pSMA198 ori in L. lactis revealed a 100% stability of replication over 100 generations. Both pSMA198 and the chromosome of S. macedonicus exhibit a high percentage of potential pseudogenes, indicating that they have co-evolved under the same gene decay processes. We identified chromosomal regions in S. macedonicus that may have originated from pSMA198, also supporting a long co-existence of the two replicons. pSMA198 was also found in divergent biotypes of S. macedonicus and in strains isolated from dispersed geographic locations (e.g. Greece and Switzerland) showing that pSMA198's acquisition is not a recent event. Conclusions/Significance Here we propose that S. macedonicus acquired plasmid pSMA198 from L. lactis via an ancestral genetic exchange event that took place most probably in milk or dairy products. We provide important evidence that point towards the dairy origin of this species.	[Papadimitriou, Konstantinos; Anastasiou, Rania; Maistrou, Eleni; Plakas, Thomas; Tsakalidou, Effie] Agr Univ Athens, Dept Food Sci & Human Nutr, Dairy Res Lab, GR-11855 Athens, Greece; [Plakas, Thomas; Papandreou, Nikos C.; Hamodrakas, Stavros J.] Univ Athens, Fac Biol, Dept Cell Biol & Biophys, Athens 15701, Greece; [Ferreira, Stephanie; Supply, Philip] Genoscreen, Serv Res Dev & Innovat Hlth & Environm, F-59000 Lille, France; [Supply, Philip; Pot, Bruno] Inst Pasteur, Ctr Infect & Immun Lille CIIL, F-59019 Lille, France; [Supply, Philip; Pot, Bruno] INSERM, U1019, F-59019 Lille, France; [Supply, Philip; Pot, Bruno] CNRS, UMR8204, F-59019 Lille, France; [Supply, Philip; Pot, Bruno] Univ Lille Nord France, F-59019 Lille, France; [Renault, Pierre] INRA, Micalis UMR1319, F-78352 Jouy En Josas, France; [Renault, Pierre] AgroParisTech, UMR Micalis, F-78352 Jouy En Josas, France	Agricultural University of Athens; National & Kapodistrian University of Athens; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Papadimitriou, K (corresponding author), Agr Univ Athens, Dept Food Sci & Human Nutr, Dairy Res Lab, Iera Odos 75, GR-11855 Athens, Greece.	kpapadimitriou@aua.gr	Papandreou, Nikos/AAM-9403-2021; Supply, Philip/A-9580-2019	Papandreou, Nikos/0000-0002-3533-2182; Supply, Philip/0000-0003-3690-3853; Anastasiou, Rania/0000-0002-3341-6956	European Social Fund; National resource EPEAEK through the Thales project; National resource YPEPTH through the Thales project	European Social Fund(European Social Fund (ESF)); National resource EPEAEK through the Thales project(Thales Group); National resource YPEPTH through the Thales project(Thales Group)	The present work was cofinanced by the European Social Fund and the National resources EPEAEK and YPEPTH through the Thales project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgadir W, 2008, INT J FOOD MICROBIOL, V127, P215, DOI 10.1016/j.ijfoodmicro.2008.07.008; Ainsworth S, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00119-12; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Asteri IA, 2010, INT J FOOD MICROBIOL, V141, P222, DOI 10.1016/j.ijfoodmicro.2010.05.018; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Boleij A, 2011, J INFECT DIS, V203, P1101, DOI 10.1093/infdis/jiq169; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Danne C, 2011, J INFECT DIS, V204, P1960, DOI 10.1093/infdis/jir666; Darzentas N, 2010, BIOINFORMATICS, V26, P2620, DOI 10.1093/bioinformatics/btq484; Das D, 2009, PROTEINS, V75, P264, DOI 10.1002/prot.22338; Vuyst L, 2008, INT DAIRY J, V18, P476, DOI 10.1016/j.idairyj.2007.10.006; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Delorme C, 2008, INT J FOOD MICROBIOL, V126, P274, DOI 10.1016/j.ijfoodmicro.2007.08.014; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Gorecki RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022238; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta A, 2010, COLORECTAL DIS, V12, P164, DOI 10.1111/j.1463-1318.2009.01814.x; HAYES F, 1990, APPL ENVIRON MICROB, V56, P202, DOI 10.1128/AEM.56.1.202-209.1990; HAYES F, 1991, PLASMID, V25, P16, DOI 10.1016/0147-619X(91)90003-F; Heng NCK, 2011, J BACTERIOL, V193, P6402, DOI 10.1128/JB.06001-11; Herrero IA, 2002, J CLIN MICROBIOL, V40, P3848, DOI 10.1128/JCM.40.10.3848-3850.2002; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; Jans C, 2013, INT J FOOD MICROBIOL, V167, P186, DOI 10.1016/j.ijfoodmicro.2013.09.008; Jans C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-200; Jans C, 2012, J BACTERIOL, V194, P2105, DOI 10.1128/JB.00160-12; KIEWIET R, 1993, MOL MICROBIOL, V10, P319, DOI 10.1111/j.1365-2958.1993.tb01958.x; LAZAROVITCH T, 2012, RELATIONSHIP NEW TAX; LEENHOUTS KJ, 1991, PLASMID, V26, P55, DOI 10.1016/0147-619X(91)90036-V; Liu MJ, 2009, APPL ENVIRON MICROB, V75, P4120, DOI 10.1128/AEM.02898-08; Ljungh Asa, 2006, Current Issues in Intestinal Microbiology, V7, P73; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Malkin J, 2008, J HEART VALVE DIS, V17, P589; Maragkoudakis PA, 2009, INT J FOOD MICROBIOL, V133, P141, DOI 10.1016/j.ijfoodmicro.2009.05.012; Mills S, 2006, FEMS MICROBIOL REV, V30, P243, DOI 10.1111/j.1574-6976.2005.00011.x; O'Sullivan D, 2000, MOL MICROBIOL, V36, P866, DOI 10.1046/j.1365-2958.2000.01901.x; Papadimitriou K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-272; Papadimitriou K, 2012, J BACTERIOL, V194, P1838, DOI 10.1128/JB.06804-11; Popa O, 2011, CURR OPIN MICROBIOL, V14, P615, DOI 10.1016/j.mib.2011.07.027; Schirawski J, 2002, APPL ENVIRON MICROB, V68, P5508, DOI 10.1128/AEM.68.11.5508-5516.2002; Schlegel L, 2000, INT J SYST EVOL MICR, V50, P1425, DOI 10.1099/00207713-50-4-1425; Shareck J, 2004, CRIT REV BIOTECHNOL, V24, P155, DOI 10.1080/07388550490904288; Siezen RJ, 2005, APPL ENVIRON MICROB, V71, P8371, DOI 10.1128/AEM.71.12.8371-8382.2005; Skulj M, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-6; Smith WM, 2012, APPL ENVIRON MICROB, V78, P7753, DOI 10.1128/AEM.02316-12; Strahinic I, 2009, J APPL MICROBIOL, V106, P78, DOI 10.1111/j.1365-2672.2008.03977.x; Tanous C, 2007, MICROBIOL-SGM, V153, P1664, DOI 10.1099/mic.0.2006/002246-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsakalidou E, 1998, INT J SYST BACTERIOL, V48, P519, DOI 10.1099/00207713-48-2-519; Van Domselaar GH, 2005, NUCLEIC ACIDS RES, V33, pW455, DOI 10.1093/nar/gki593	54	9	9	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0116337	10.1371/journal.pone.0116337	http://dx.doi.org/10.1371/journal.pone.0116337			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OG	25584532	Green Published, Green Submitted, gold			2022-12-26	WOS:000348201300008
J	Araki, S; Dairiki, R; Nakayama, Y; Murai, A; Miyashita, R; Iwatani, M; Nomura, T; Nakanishi, O				Araki, Shinsuke; Dairiki, Ryo; Nakayama, Yusuke; Murai, Aiko; Miyashita, Risa; Iwatani, Misa; Nomura, Toshiyuki; Nakanishi, Osamu			Inhibitors of CLK Protein Kinases Suppress Cell Growth and Induce Apoptosis by Modulating Pre-mRNA Splicing	PLOS ONE			English	Article							TARGET; GENE; EXON; SF3B; SPLICEOSTATIN; MECHANISMS; FAMILY; BREAST; CANCER; SRPK1	Accumulating evidence has demonstrated the importance of alternative splicing in various physiological processes, including the development of different diseases. CDC-like kinases (CLKs) and serine-arginine protein kinases (SRPKs) are components of the splicing machinery that are crucial for exon selection. The discovery of small molecule inhibitors against these kinases is of significant value, not only to delineate the molecular mechanisms of splicing, but also to identify potential therapeutic opportunities. Here we describe a series of small molecules that inhibit CLKs and SRPKs and thereby modulate pre-mRNA splicing. Treatment with these small molecules (Cpd-1, Cpd-2, or Cpd-3) significantly reduced the levels of endogenous phosphorylated SR proteins and caused enlargement of nuclear speckles in MDA-MB-468 cells. Additionally, the compounds resulted in splicing alterations of RPS6KB1 (S6K), and subsequent depletion of S6K protein. Interestingly, the activity of compounds selective for CLKs was well correlated with the activity for modulating S6K splicing as well as growth inhibition of cancer cells. A comprehensive mRNA sequencing approach revealed that the inhibitors induced splicing alterations and protein depletion for multiple genes, including those involved in growth and survival pathways such as S6K, EGFR, EIF3D, and PARP. Fluorescence pulse-chase labeling analyses demonstrated that isoforms with premature termination codons generated after treatment with the CLK inhibitors were degraded much faster than canonical mRNAs. Taken together, these results suggest that CLK inhibitors exhibit growth suppression and apoptosis induction through splicing alterations in genes involved in growth and survival. These small molecule inhibitors may be valuable tools for elucidating the molecular machinery of splicing and for the potential development of a novel class of antitumor agents.	[Araki, Shinsuke; Dairiki, Ryo; Nakayama, Yusuke; Murai, Aiko; Miyashita, Risa; Iwatani, Misa; Nomura, Toshiyuki; Nakanishi, Osamu] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd	Araki, S (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan.	shinsuke.araki@takeda.com	Araki, Shinsuke/M-3983-2018	Araki, Shinsuke/0000-0002-9936-1417	Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	Funding: Takeda Pharmaceutical Company Limited provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amin EM, 2011, CANCER CELL, V20, P768, DOI 10.1016/j.ccr.2011.10.016; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Bose P, 2014, PHARMACOL THERAPEUT, V143, P323, DOI 10.1016/j.pharmthera.2014.04.004; Busse D, 2000, J BIOL CHEM, V275, P6987, DOI 10.1074/jbc.275.10.6987; Cazzola M, 2013, BLOOD, V121, P260, DOI 10.1182/blood-2012-09-399725; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Folco EG, 2011, GENE DEV, V25, P440, DOI 10.1101/gad.2009411; GROSSO AR, 2008, EMBO REP; Hayes GM, 2006, CANCER RES, V66, P3819, DOI 10.1158/0008-5472.CAN-05-4065; Hayes GM, 2007, CANCER RES, V67, P2072, DOI 10.1158/0008-5472.CAN-06-2969; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Lai MC, 2003, BIOCHEM J, V371, P937, DOI 10.1042/BJ20021827; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malumbres M, 2014, EXPER OPIN THER TAR, P1; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; MAYEDA A, 1992, P NATL ACAD SCI USA, V89, P1301, DOI 10.1073/pnas.89.4.1301; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Nayler O, 1998, J BIOL CHEM, V273, P34341, DOI 10.1074/jbc.273.51.34341; Neugebauer KM, 1997, GENE DEV, V11, P1148, DOI 10.1101/gad.11.9.1148; Nishida A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1306; Rios J, 2011, ONCOLOGY-NY, V25, P1014; Sinha R, 2010, MOL CELL BIOL, V30, P2762, DOI 10.1128/MCB.01270-09; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Tazi J, 2005, TRENDS BIOCHEM SCI, V30, P469, DOI 10.1016/j.tibs.2005.06.002; TUMA RS, 1993, J CELL BIOL, V122, P767, DOI 10.1083/jcb.122.4.767; Twyffels L, 2011, FEBS J, V278, P3246, DOI 10.1111/j.1742-4658.2011.08274.x; UCHIKAWA O, 2010, Patent No. 20100029619; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Webb TR, 2013, DRUG DISCOV TODAY, V18, P43, DOI 10.1016/j.drudis.2012.07.013; Wong R, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-47; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014	40	79	81	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2015	10	1							e0116929	10.1371/journal.pone.0116929	http://dx.doi.org/10.1371/journal.pone.0116929			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4CF	25581376	gold, Green Published, Green Submitted			2022-12-26	WOS:000348169100007
J	Que, T; Song, Y; Liu, Z; Zheng, S; Long, H; Li, Z; Liu, Y; Wang, G; Liu, Y; Zhou, J; Zhang, X; Fang, W; Qi, S				Que, T.; Song, Y.; Liu, Z.; Zheng, S.; Long, H.; Li, Z.; Liu, Y.; Wang, G.; Liu, Y.; Zhou, J.; Zhang, X.; Fang, W.; Qi, S.			Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1	ONCOGENE			English	Article							HUMAN GLIOBLASTOMA-MULTIFORME; MALIGNANT GLIOMA; NASOPHARYNGEAL CARCINOMA; TUMOR-SUPPRESSOR; EXPRESSION; MICRORNAS; PROLIFERATION; PAKT	Although increasing evidence indicated that the deregulation of microRNAs (miRNAs) contributes to tumorigenesis and invasion, little is known about the role of miR-637 in human gliomas. In the present study, we found that the expression level of miR-637 was significantly reduced in clinical glioma tissues compared with normal brain tissues. Moreover, we revealed that the introduction of miR-637 dramatically suppressed glioma cell growth, migration and invasion in vitro and in vivo. Further studies revealed that Akt1 is a direct target gene of miR-637. Silencing of Akt1 inhibited the growth and invasion of glioma cells by decreasing phosphorylated Akt, beta-catenin, phosphorylated Foxo1 and Cyclin D1 and inducing the expression of Foxo1, which was consistent with the effect of miR-637 overexpression. Suppressed expression of miR-637 and increased Akt1 protein levels were correlated with unfavorable progression and poor prognosis, respectively, and a negative relationship between the miR-637 expression and Akt1 protein levels was observed in gliomas. Our findings provide new insights into the role of miR-637 in the development of gliomas, and implicate the potential application of miR-637 in cancer therapy.	[Que, T.; Song, Y.; Zheng, S.; Long, H.; Li, Z.; Liu, Y.; Wang, G.; Liu, Y.; Zhang, X.; Qi, S.] Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou 510515, Guangdong, Peoples R China; [Que, T.; Liu, Z.; Fang, W.] Southern Med Univ, Canc Res Inst, Guangzhou 510515, Guangdong, Peoples R China; [Liu, Z.] Guangzhou Med Univ, Basic Sch, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Zhou, J.] Luzhou Med Coll, Affiliated Hosp, Dept Neurosurg, Luzhou, Sichuan, Peoples R China; [Fang, W.] Southern Med Univ, TCM Integrated Hosp, Canc Ctr, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Guangzhou Medical University; Southwest Medical University; Southern Medical University - China	Qi, S (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Neurosurg, 1838,North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China.	zhang-xi-an@hotmail.com; fangweiyi1975@163.com; qisongtaosjwk@163.com		Wang, Gang/0000-0003-3827-2653; Que, Tianshi/0000-0002-3838-8253	National Nature Science Fund of China [81372692]; Natural Science Fund of Guangdong Province [S2013010014886]; Medical Scientific Research Fund of Guangdong Province [B2013238]; Scientific Research Initiative Project Fund of Southern Medical University [B1012032]; President Fund of Nanfang Hospital [2011C007, 2012C011]; Science Fund of the Affiliated Hospital of Luzhou Medical College [2013-60]; Science and Technology Project of Luzhou [3-S-48]	National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Guangdong Province(National Natural Science Foundation of Guangdong Province); Medical Scientific Research Fund of Guangdong Province; Scientific Research Initiative Project Fund of Southern Medical University; President Fund of Nanfang Hospital; Science Fund of the Affiliated Hospital of Luzhou Medical College; Science and Technology Project of Luzhou	This study was supported by the National Nature Science Fund of China (NO. 81372692; http://www.nsfc.gov.cn), the Natural Science Fund of Guangdong Province (NO. S2013010014886; http://www.gdstc.gov.cn), the Medical Scientific Research Fund of Guangdong Province (NO. B2013238; http://www.medste.gd.cn), the Scientific Research Initiative Project Fund of Southern Medical University (NO. B1012032; http://www.fimmu.com), the President Fund of Nanfang Hospital (2011C007, 2012C011; http://www.nfyy.com), the Science Fund of the Affiliated Hospital of Luzhou Medical College (2013-60) and Science and Technology Project of Luzhou (3-S-48). The funders had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Al-Harthi L, 2012, J NEUROIMMUNE PHARM, V7, P725, DOI 10.1007/s11481-012-9412-x; Antonelli M, 2012, NEUROPATHOLOGY, V32, P133, DOI 10.1111/j.1440-1789.2011.01252.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Besse A, 2013, TUMOR BIOL, V34, P1969, DOI 10.1007/s13277-013-0772-5; Cai N, 2013, RNA, V19, P85, DOI 10.1261/rna.035295.112; Dontula Ranadheer, 2013, Genes Cancer, V4, P285, DOI 10.1177/1947601913500141; Emdad L, 2012, FUTURE ONCOL, V8, P343, DOI [10.2217/FON.12.16, 10.2217/fon.12.16]; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Guo P, 2013, ONCOL REP, V30, P870, DOI 10.3892/or.2013.2526; Hobert O, 2007, CELL, V131, P22, DOI 10.1016/j.cell.2007.09.031; Jansen M, 2010, LANCET NEUROL, V9, P717, DOI 10.1016/S1474-4422(10)70105-8; Kim KH, 2013, NEURO-ONCOLOGY, V15, P161, DOI 10.1093/neuonc/nos299; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Leivonen SK, 2014, MOL ONCOL, V8, P93, DOI 10.1016/j.molonc.2013.10.001; Li GQ, 2013, MOL CELL BIOCHEM, V372, P221, DOI 10.1007/s11010-012-1463-z; Li T, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-263; Liu Z, 2011, INT J CANCER, V128, P2562, DOI 10.1002/ijc.25595; Liu Z, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-270; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Nan Y, 2010, BRAIN RES, V1359, P14, DOI 10.1016/j.brainres.2010.08.074; Pan SJ, 2012, INT J IMMUNOPATH PH, V25, P871, DOI 10.1177/039463201202500405; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Qi ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038842; Quintavalle C, 2012, ONCOGENE, V31, P858, DOI 10.1038/onc.2011.280; Rodriguez EF, 2011, ACTA NEUROPATHOL, V121, P407, DOI 10.1007/s00401-010-0784-9; Schlegel J, 2000, CANCER LETT, V158, P103, DOI 10.1016/S0304-3835(00)00515-2; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Stokowy T, 2014, HORM METAB RES, V46, P171, DOI 10.1055/s-0033-1363264; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Suzuki Y, 2010, J RADIAT RES, V51, P343, DOI 10.1269/jrr.09109; Wang YY, 2012, J NEURO-ONCOL, V106, P217, DOI 10.1007/s11060-011-0679-1; Wlodarski P, 2006, FOLIA NEUROPATHOL, V44, P214; Wu S, 2012, ONCOGENE, V31, P3866, DOI 10.1038/onc.2011.551; Yin D, 2013, ONCOGENE, V32, P1155, DOI 10.1038/onc.2012.132; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang JF, 2011, HEPATOLOGY, V54, P2137, DOI 10.1002/hep.24595	36	96	100	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 17	2015	34	38					4952	4963		10.1038/onc.2014.419	http://dx.doi.org/10.1038/onc.2014.419			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR9QZ	25597410				2022-12-26	WOS:000361693000005
J	Li, XW; Montine, KS; Keene, CD; Montine, TJ				Li, Xianwu; Montine, Kathleen S.; Keene, C. Dirk; Montine, Thomas J.			Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E-2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia	FASEB JOURNAL			English	Article						apolipoprotein E genotype; PGE(2); Alzheimer disease; neuroinflammation; brain immunity	TARGETED REPLACEMENT; A-BETA; ALZHEIMER-DISEASE; APOE GENOTYPE; CUTTING EDGE; MOUSE MODEL; NSAID USE; E GENE; ALLELE; TLR	Several lines of evidence support immune response in brain as a mechanism of injury in Alzheimer disease (AD). Moreover, immune activation is heightened in apolipoprotein E (APOE) epsilon 4 carriers; inhibitors of prostaglandin (PG) synthesis show a partially protective effect on AD risk from APOE epsilon 4; and genetic variants in triggering receptor expressed on myeloid cells 2 (TREM2) are a rare but potent risk for AD. We tested the hypothesis that APOE epsilon 4 inheritance modulates both the PGE(2) pathway and TREM2 expression using primary murine microglia from targeted replacement (TR) APOE3/3 and APOE4/4 mice. Microglial cyclooxygenase-2, microsomal PGE synthase, and PGE(2) expression were increased 2- to 25-fold in both genotypes by TLR activators; however, this induction was significantly (P < 0.01) greater in TR APOE4/4 microglia with TLR3 and TLR4 activators. Microglial TREM2 expression was reduced approximately 85% by all TLR activators; this reduction was approximately one-third greater in microglia from TR APOE4/4 mice. Importantly, both receptor-associated protein and a nuclear factor -light-chain-enhancer inhibitor blocked TR APOE4/4-dependent effects on the PGE(2) pathway but not on TREM2 expression. These data demonstrate complementary, but mechanistically distinct, regulation of pro- and anti-inflammatory mediators in TR APOE4/4 murine microglia that yields a more proinflammatory state than with TR APOE3/3.Li, X., Montine, K. S., Keene, C. D., Montine, T. J. Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E-2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia.	[Li, Xianwu; Montine, Kathleen S.; Keene, C. Dirk; Montine, Thomas J.] Univ Washington, Dept Pathol, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle	Li, XW (corresponding author), Univ Washington, Dept Pathol, Box 359645, Seattle, WA 98104 USA.	xli@uw.edu	Keene, Christopher D/N-1806-2015	Keene, Christopher/0000-0002-5291-1469; Montine, Kathleen/0000-0003-2110-8363	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences [R01-ES016754]; NIH National Institute on Aging [P50-AG05136]; NIH National Institute of Neurological Disorders and Stroke [P50-NS062684]; Nancy and Buster Alvord Endowment; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS062684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences; NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Nancy and Buster Alvord Endowment; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Samantha Rice and Leanne Hellstern for assistance with animal husbandry, K. Arumuganathan and Jingjing Tang for assistance with flow cytometry, Eiron Cudaback for scientific input, and Aimee Schantz and Carol Arnold for administrative support. This work was funded by the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (Grant R01-ES016754), NIH National Institute on Aging (Grant P50-AG05136), NIH National Institute of Neurological Disorders and Stroke (Grant P50-NS062684) and the Nancy and Buster Alvord Endowment.	Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chouery E, 2008, HUM MUTAT, V29, pE194, DOI 10.1002/humu.20836; Cole GM, 2010, CNS NEUROL DISORD-DR, V9, P140, DOI 10.2174/187152710791011991; Cudaback E, 2014, BIOCHEM PHARMACOL, V88, P565, DOI 10.1016/j.bcp.2013.12.014; Cudaback E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-192; Cudaback E, 2011, FASEB J, V25, P2082, DOI 10.1096/fj.10-176891; Egensperger R, 1998, BRAIN PATHOL, V8, P439; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hayden KM, 2007, NEUROLOGY, V69, P275, DOI 10.1212/01.wnl.0000265223.25679.2a; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Ito H, 2012, EUR J IMMUNOL, V42, P176, DOI 10.1002/eji.201141679; Jiang T, 2014, NEUROBIOL AGING, V35, P1243, DOI 10.1016/j.neurobiolaging.2013.11.026; Jones BM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00094; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Keene CD, 2011, CURR OPIN NEUROBIOL, V21, P920, DOI 10.1016/j.conb.2011.08.002; Klunemann HH, 2005, NEUROLOGY, V64, P1502, DOI 10.1212/01.WNL.0000160304.00003.CA; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Li XW, 2013, J NEUROIMMUNE PHARM, V8, P87, DOI 10.1007/s11481-012-9380-1; Li XW, 2012, FASEB J, V26, P3075, DOI 10.1096/fj.11-200279; Li XW, 2011, GLIA, V59, P569, DOI 10.1002/glia.21125; Lue LF, 2015, BRAIN PATHOL, V25, P469, DOI 10.1111/bpa.12190; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; Maezawa I, 2004, J NEUROCHEM, V91, P1312, DOI 10.1111/j.1471-4159.2004.02818.x; Maezawa I, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-10; Maezawa I, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-21; Maezawa I, 2006, FASEB J, V20, P797, DOI 10.1096/fj.05-5423fje; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; McGeer PL, 2007, NEUROBIOL AGING, V28, P639, DOI 10.1016/j.neurobiolaging.2006.03.013; Melchior B, 2010, ASN NEURO, V2, P157, DOI 10.1042/AN20100010; Moir RD, 1999, BIOCHEMISTRY-US, V38, P4595, DOI 10.1021/bi982437d; Mosconi L, 2008, BIOL PSYCHIAT, V63, P609, DOI 10.1016/j.biopsych.2007.05.030; Ng S, 2013, NEUROTOXICOLOGY, V37, P85, DOI 10.1016/j.neuro.2013.03.012; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paradowska-Gorycka A, 2013, HUM IMMUNOL, V74, P730, DOI 10.1016/j.humimm.2013.02.003; Pasqualetti P, 2009, AGING CLIN EXP RES, V21, P102, DOI 10.1007/BF03325217; Rodriguez GA, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-111; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Saura J, 2003, J NEUROCHEM, V85, P1455, DOI 10.1046/j.1471-4159.2003.01788.x; Schellenberg GD, 2012, ACTA NEUROPATHOL, V124, P305, DOI 10.1007/s00401-012-0996-2; Sessa G, 2004, EUR J NEUROSCI, V20, P2617, DOI 10.1111/j.1460-9568.2004.03729.x; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Sullivan PM, 1998, J CLIN INVEST, V102, P130, DOI 10.1172/JCI2673; Szekely CA, 2008, NEUROLOGY, V70, P17, DOI 10.1212/01.wnl.0000284596.95156.48; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Town T, 2006, J IMMUNOL, V176, P3804, DOI 10.4049/jimmunol.176.6.3804; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Valla J, 2010, J ALZHEIMERS DIS, V22, P307, DOI 10.3233/JAD-2010-100129; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; WISNIEWSKI T, 1994, AM J PATHOL, V145, P1030; Wright RO, 2003, PEDIATR RES, V54, P819, DOI 10.1203/01.PDR.0000090927.53818.DE; Yang Y, 2013, AM J PATHOL, V183, P905, DOI 10.1016/j.ajpath.2013.05.009	56	35	35	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1754	1762		10.1096/fj.14-262683	http://dx.doi.org/10.1096/fj.14-262683			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25593125	Green Published			2022-12-26	WOS:000354114600013
J	Jaeger, C; Sandu, C; Malan, A; Mellac, K; Hicks, D; Felder-Schmittbuhl, MP				Jaeger, Catherine; Sandu, Cristina; Malan, Andre; Mellac, Katell; Hicks, David; Felder-Schmittbuhl, Marie-Paule			Circadian organization of the rodent retina involves strongly coupled, layer-specific oscillators	FASEB JOURNAL			English	Article						clock; circadian rhythms; bioluminescence; period	RAT RETINA; SUPRACHIASMATIC NUCLEUS; CLOCK PROTEIN; DOPAMINE; EXPRESSION; GENE; PHOTORECEPTORS; LOCALIZATION; RECEPTORS; RELEASE	Rhythmic physiology is central to retinal function and survival and adapts vision to daily light intensity changes. Mammalian retina rhythmically releases melatonin when cultured under constant conditions, and the occurrence of clock gene [e.g., Period(Per)] expression has been shown for most cellular layers. However, contribution of the distinct layers to genesis of circadian rhythms within the retina is still debated. To characterize their endogenous oscillatory capacity and their communication at the whole-tissue level, we used a vibratome-based method toisolate individual or paired retina cellular layers from the mPer2(Luc) mouse and Per1-luciferase (Per1-Luc) rat, and real-time recorded bioluminescence. We report that each layer of the mouse retina harbors a self-sustained oscillator whose period is significantly longer (similar to 26 hours) than in whole-retina explants (similar to 22.9 hours), indicating that the period is correlated with the degree of coupling. Accordingly, the maximal period (similar to 29 hours) is reached upon complete enzymatic dissociation of the retina. By using pharmacological approaches, we demonstrate that connection between retina oscillators involves gap junctions but only minor contribution from the main retina neuro-chemicals. Taken together with results from Per1-Luc rats, these data show that mammalian retina consists of a network of layer-specific oscillators whose period is determined by their connectivity.	[Jaeger, Catherine; Sandu, Cristina; Malan, Andre; Hicks, David; Felder-Schmittbuhl, Marie-Paule] Univ Strasbourg, Inst Cellular & Integrat Neurosci, Dept Neurobiol Rhythms, Natl Ctr Sci Res UPR3212, F-67084 Strasbourg, France; [Mellac, Katell] Univ Strasbourg, Unit Math & Comp Sci, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Felder-Schmittbuhl, MP (corresponding author), Univ Strasbourg, Inst Cellular & Integrat Neurosci, Dept Neurobiol Rhythms, UPR 3212,CNRS, 5 Rue Blaise Pascal, F-67084 Strasbourg, France.	feldermp@inci-cnrs.unistra.fr		Jaeger, Catherine/0000-0001-8519-8893	association Retina France; French Research and Education Ministry; Retina France; Fondation Berthe Fouassier; Neurex network (TriNeuron - Program Interreg IV Upper Rhine - European Regional Development Fund	association Retina France; French Research and Education Ministry; Retina France; Fondation Berthe Fouassier; Neurex network (TriNeuron - Program Interreg IV Upper Rhine - European Regional Development Fund	The authors thank Dr. Sophie Reibel, Dr. Dominique Sage, Aurore Senser, Laurence Huck, and Nicolas Lethenet from Chronobiotron Unite Mixte de Service 3415 (Strasbourg, France) for animal care. The authors are grateful to Dr. Michael Menaker for kindly providing the Per1-Luc rats. This work was supported by grants from the association Retina France and fellowships from the French Research and Education Ministry and Retina France (to C.J.) and from the Fondation Berthe Fouassier (to C.S.). Publication costs are supported by the Neurex network (TriNeuron - Program Interreg IV Upper Rhine - European Regional Development Fund; www.neurex.org.	Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; Buonfiglio DC, 2014, MOL VIS, V20, P742; Dkhissi-Benyahya O, 2013, CELL MOL LIFE SCI, V70, P3435, DOI 10.1007/s00018-013-1338-9; Dorenbos R, 2007, VISUAL NEUROSCI, V24, P573, DOI 10.1017/S0952523807070538; Etchegaray JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010303; Feigenspan A, 1998, J NEUROSCI, V18, P6776; Fontaine V, 1998, J NEUROSCI, V18, P9662; Freeman GM, 2013, J NEUROPHYSIOL, V110, P103, DOI 10.1152/jn.00220.2013; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Garbarino-Pico E, 2004, J NEUROSCI RES, V76, P642, DOI 10.1002/jnr.20126; Garcia-Fernandez JA, 2007, NEUROSCI LETT, V419, P55, DOI 10.1016/j.neulet.2007.03.054; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Koinuma S, 2013, EUR J NEUROSCI, V38, P2832, DOI 10.1111/ejn.12308; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050602; McMahon DG, 2014, PROG RETIN EYE RES, V39, P58, DOI 10.1016/j.preteyeres.2013.12.001; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; Namihira M, 1999, NEUROSCI LETT, V271, P1, DOI 10.1016/S0304-3940(99)00407-3; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; Puopolo M, 2001, NEURON, V30, P211, DOI 10.1016/S0896-6273(01)00274-4; Renna JM, 2007, VISUAL NEUROSCI, V24, P503, DOI 10.1017/S0952523807070241; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; Ribelayga C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011020; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; Ruan GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038985; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Sandu C, 2011, EUR J NEUROSCI, V34, P507, DOI 10.1111/j.1460-9568.2011.07772.x; Schneider K, 2010, J NEUROCHEM, V115, P585, DOI 10.1111/j.1471-4159.2010.06953.x; TAMAI M, 1978, INVEST OPHTH VIS SCI, V17, P558; TERMAN JS, 1993, BRAIN RES, V605, P256; Thoreson WB, 1999, PROG RETIN EYE RES, V18, P765, DOI 10.1016/S1350-9462(98)00031-7; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yujnovsky I, 2006, P NATL ACAD SCI USA, V103, P6386, DOI 10.1073/pnas.0510691103	45	30	31	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1493	1504		10.1096/fj.14-261214	http://dx.doi.org/10.1096/fj.14-261214			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25573753	Green Submitted			2022-12-26	WOS:000354115000034
J	Arous, C; Ferreira, PG; Dermitzakis, ET; Halban, PA				Arous, Caroline; Ferreira, Pedro G.; Dermitzakis, Emmanouil T.; Halban, Philippe A.			Short Term Exposure of Beta Cells to Low Concentrations of Interleukin-1 beta Improves Insulin Secretion through Focal Adhesion and Actin Remodeling and Regulation of Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HUMAN PANCREATIC-ISLETS; ISOLATED RAT ISLETS; EXTRACELLULAR-MATRIX; DIABETES-MELLITUS; ACTIVATION; GLUCOSE; RELEASE; PROTEIN; KINASE	Type 2 diabetes involves defective insulin secretion with islet inflammation governed in part by IL-1 beta. Prolonged exposure of islets to high concentrations of IL-1 beta (>24 h, 20 ng/ml) impairs beta cell function and survival. Conversely, exposure to lower concentrations of IL-1 beta for >24 h improves these same parameters. The impact on insulin secretion of shorter exposure times to IL-1 beta and the underlying molecular mechanisms are poorly understood and were the focus of this study. Treatment of rat primary beta cells, as well as rat or human whole islets, with 0.1 ng/ml IL-1 beta for 2 h increased glucose-stimulated (but not basal) insulin secretion, whereas 20 ng/ml was without effect. Similar differential effects of IL-1 beta depending on concentration were observed after 15 min of KCl stimulation but were prevented by diazoxide. Studies on sorted rat beta cells indicated that the enhancement of stimulated secretion by 0.1 ng/ml IL-1 beta was mediated by the NE-KB pathway and c-JUN/JNK pathway acting in parallel to elicit focal adhesion remodeling and the phosphorylation of paxillin independently of upstream regulation by focal adhesion kinase. Because the beneficial effect of IL-1 beta Ivas dependent in part upon transcription, gene expression was analyzed by RNAseq. There were 18 genes regulated uniquely by 0.1 but not 20 ng/ml IL-1 beta, which are mostly involved in transcription and apoptosis. These results indicate that 2 h of exposure of beta cells to a low but not a high concentration of IL-1 beta enhances glucose-stimulated insulin secretion through focal adhesion and actin remodeling, as well as modulation of gene expression.	[Arous, Caroline; Ferreira, Pedro G.; Dermitzakis, Emmanouil T.; Halban, Philippe A.] Univ Geneva, Dept Genet Med & Dev, Univ Med Ctr, CH-1211 Geneva 4, Switzerland	University of Geneva	Arous, C (corresponding author), Univ Med Ctr, Dept Genet Med & Dev, 1 Michel Servet, CH-1211 Geneva 4, Switzerland.	Caroline.Arous@unige.ch	Ferreira, Pedro/HDO-1346-2022; Ferreira, Pedro G/J-6379-2013	Ferreira, Pedro G/0000-0003-3838-8664	JDRF Award [31-2008-416]	JDRF Award	We thank Melanie Cor-nut and Stephane Dupuis for expert technical assistance. We also thank Dr. Samuel W. Lukowski (University Medical Centre, Geneva) for generous help for the transcriptional analysis. Human islets were generously provided through the JDRF Award 31-2008-416 (ECIT Islet for Basic Research Program).	Arous C, 2013, DIABETOLOGIA, V56, P792, DOI 10.1007/s00125-012-2800-1; BENDTZEN K, 1986, SCIENCE, V232, P1545, DOI 10.1126/science.3086977; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; BORG LAH, 1990, IMMUNOL LETT, V26, P253, DOI 10.1016/0165-2478(90)90155-J; Bosco D, 2001, DIABETES, V50, P1039, DOI 10.2337/diabetes.50.5.1039; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; COMENS PG, 1987, DIABETES, V36, P963, DOI 10.2337/diabetes.36.8.963; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Donath MY, 2010, TRENDS ENDOCRIN MET, V21, P261, DOI 10.1016/j.tem.2009.12.010; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Drews G, 2010, ADV EXP MED BIOL, V654, P115, DOI 10.1007/978-90-481-3271-3_7; EIZIRIK DL, 1995, MOL CELL ENDOCRINOL, V111, P159, DOI 10.1016/0303-7207(95)03561-K; EIZIRIK DL, 1993, J CLIN ENDOCR METAB, V76, P399, DOI 10.1210/jc.76.2.399; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1989, DIABETOLOGIA, V32, P769; Eswarappa SM, 2008, INNATE IMMUN-LONDON, V14, P309, DOI 10.1177/1753425908096856; Franco-Barraza J, 2010, ARCH MED RES, V41, P170, DOI 10.1016/j.arcmed.2010.04.010; GEMBAL M, 1992, J CLIN INVEST, V89, P1288, DOI 10.1172/JCI115714; Guo WK, 2011, MED SCI MONITOR, V17, pBR242, DOI 10.12659/MSM.881927; Hammar EB, 2005, J BIOL CHEM, V280, P30630, DOI 10.1074/jbc.M502493200; Henquin JC, 2004, DIABETES, V53, pS48, DOI 10.2337/diabetes.53.suppl_3.S48; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Huang Z, 2008, CELL SIGNAL, V20, P2002, DOI 10.1016/j.cellsig.2008.07.014; Jiang BB, 2004, J BIOL CHEM, V279, P1323, DOI 10.1074/jbc.M307521200; Jiao XM, 2008, MOL BIOL CELL, V19, P1378, DOI 10.1091/mbc.E07-08-0753; JOHNSON RC, 1994, ENDOCRINOLOGY, V135, P1178, DOI 10.1210/en.135.3.1178; Kustermans G, 2005, BIOCHEM J, V387, P531, DOI 10.1042/BJ20041318; Lapierre M, 2007, CANCER RES, V67, P9030, DOI 10.1158/0008-5472.CAN-07-0807; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Lifshitz Y, 2002, SCIENCE, V297, P1531, DOI 10.1126/science.1074551; MacGillivray MK, 2000, J BIOL CHEM, V275, P23509, DOI 10.1074/jbc.M003186200; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2006, DIABETES, V55, P2713, DOI 10.2337/db05-1430; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Mariot P, 1998, DIABETES, V47, P365, DOI 10.2337/diabetes.47.3.365; Matsuda T, 2005, AM J TRANSPLANT, V5, P484, DOI 10.1046/j.1600-6143.2004.00716.x; MCDANIEL ML, 1988, DIABETES, V37, P1311, DOI 10.2337/diabetes.37.10.1311; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Moran A, 2013, LANCET, V381, P1905, DOI 10.1016/S0140-6736(13)60023-9; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Papaccio G, 2005, J CELL PHYSIOL, V204, P124, DOI 10.1002/jcp.20276; Rajshankar D, 2012, FASEB J, V26, P4429, DOI 10.1096/fj.12-207381; Ribaux P, 2007, ENDOCRINOLOGY, V148, P5582, DOI 10.1210/en.2007-0325; Rondas D, 2011, DIABETES, V60, P1146, DOI 10.2337/db10-0946; Sachdev S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-12; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; SPINAS GA, 1986, ACTA ENDOCRINOL-COP, V113, P551, DOI 10.1530/acta.0.1130551; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsuji A, 2003, BBA-PROTEINS PROTEOM, V1645, P95, DOI 10.1016/S1570-9639(02)00532-0; Wang Q, 2011, FASEB J, V25, P3448, DOI 10.1096/fj.11-183459; Weber A., 2010, SCI SIGNAL, V3; WELSH N, 1989, ACTA ENDOCRINOL-COP, V121, P698, DOI 10.1530/acta.0.1210698; ZAWALICH WS, 1989, AM J PHYSIOL, V256, pE19, DOI 10.1152/ajpendo.1989.256.1.E19	66	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6653	6669		10.1074/jbc.M114.611111	http://dx.doi.org/10.1074/jbc.M114.611111			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25586177	Green Published, hybrid			2022-12-26	WOS:000350732500066
J	Bialkowska, K; Byzova, TV; Plow, EF				Bialkowska, Katarzyna; Byzova, Tatiana V.; Plow, Edward F.			Site-specific Phosphorylation of Kindlin-3 Protein Regulates Its Capacity to Control Cellular Responses Mediated by Integrin alpha(IIb)beta(3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN IIB/IIA COMPLEX; FOCAL ADHESION SITES; TALIN HEAD DOMAIN; KINASE-C; LEUKOCYTE ADHESION; MATRIX ADHESION; IIB-IIIA; ACTIVATION; BINDING; RECEPTOR	The contributions of integrins to cellular responses depend upon their activation, which is regulated by binding of proteins to their cytoplasmic tails. Kindlins are integrin cytoplasmic tail binding partners and are essential for optimal integrin activation, and kindlin-3 fulfills this role in hematopoietic cells. Here, we used human platelets and human erythroleukemia (HEL) cells, which express integrin alpha(IIb)beta 3, to investigate whether phosphorylation of kindlin-3 regulates integrin activation. When HEL cells were stimulated with thrombopoietin or phorbol 12-myristate 13-acetate (PMA), alpha(IIb)beta 3 became activated as evidenced by binding of an activation-specific monoclonal antibody and soluble fibrinogen, adherence and spreading on fibrinogen, colocalization of beta(3) integrin and kindlin-3 in focal adhesions, and enhanced beta(3) integrin-kindlin-3 association in immunoprecipitates. Kindlin-3 knockdown impaired adhesion and spreading on fibrinogen. Stimulation of HEL cells with agonists significantly increased kindlin-3 phosphorylation as detected by mass spectrometric sequencing. Thr482 or Ser484 was identified as a phosphorylation site, which resides in a sequence not conserved in kindlin-1 or kindlin-2. These same residues were phosphorylated in kindlin-3 when platelets were stimulated with thrombin. When expressed in HEL cells, T482A/S484A kindlin-3 decreased soluble ligand binding and cell spreading on fibrinogen compared with wild-type kindlin-3. A membrane-permeable peptide containing residues 476-485 of kindlin-3 was introduced into HEL cells and platelets; adhesion and spreading of both cell types were blunted compared with a scrambled control peptide. These data identify a role of kindlin-3 phosphorylation in integrin beta(3) activation and provide a basis for functional differences between kindlin-3 and the two other kindlin paralogs.	[Bialkowska, Katarzyna; Byzova, Tatiana V.; Plow, Edward F.] Cleveland Clin, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Plow, EF (corresponding author), Dept Mol Cardiol, NB5-50,9500 Euclid Ave, Cleveland, OH 44195 USA.	plowe@ccf.org		Byzova, Tatiana/0000-0002-2615-875X	National Institutes of Health from the NHLBI [P01HL073311, R01 HL096062]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096062, P01HL073311] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL073311 and R01 HL096062 from the NHLBI.	Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Bledzka K, 2012, J BIOL CHEM, V287, P24585, DOI 10.1074/jbc.M111.336743; Bledzka K, 2010, J BIOL CHEM, V285, P30370, DOI 10.1074/jbc.C110.134247; BoudignonProudhon C, 1996, BLOOD, V87, P968, DOI 10.1182/blood.V87.3.968.bloodjournal873968; BRASS LF, 1991, J BIOL CHEM, V266, P958; Buensuceso CS, 2005, J BIOL CHEM, V280, P644, DOI 10.1074/jbc.M410229200; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Cifuni SM, 2008, BLOOD, V112, P1696, DOI 10.1182/blood-2008-02-139733; David T, 2006, J THROMB HAEMOST, V4, P2645, DOI 10.1111/j.1538-7836.2006.02198.x; Dowling JJ, 2008, CIRC RES, V102, P423, DOI 10.1161/CIRCRESAHA.107.161489; Ehlers R, 2003, J EXP MED, V198, P1077, DOI 10.1084/jem.20022181; FOX JEB, 1993, J BIOL CHEM, V268, P25973; Gachet C, 2006, ANNU REV PHARMACOL, V46, P277, DOI 10.1146/annurev.pharmtox.46.120604.141207; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; JARVINEN M, 1987, EUR J CELL BIOL, V44, P238; Jobard F, 2003, HUM MOL GENET, V12, P925, DOI 10.1093/hmg/ddg097; Kahner BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034056; Kasirer-Friede A, 2014, BLOOD, V123, P3156, DOI 10.1182/blood-2013-08-520627; Kliche S, 2012, BLOOD, V119, P777, DOI 10.1182/blood-2011-06-362269; KOUNS WC, 1991, J BIOL CHEM, V266, P13891; Kuijpers TW, 2009, BLOOD, V113, P4740, DOI 10.1182/blood-2008-10-182154; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Mattheyses AL, 2010, J CELL SCI, V123, P3621, DOI 10.1242/jcs.056218; Meller J, 2012, J THROMB HAEMOST, V10, P1397, DOI 10.1111/j.1538-7836.2012.04768.x; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Morse EM, 2014, BIOCHEMISTRY-US, V53, P810, DOI 10.1021/bi401596q; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Nakazawa T, 2013, EXP HEMATOL, V41, P79, DOI 10.1016/j.exphem.2012.09.011; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; PHILLIPS DR, 1980, J CELL BIOL, V86, P77, DOI 10.1083/jcb.86.1.77; PLOW EF, 1981, J BIOL CHEM, V256, P9477; PONCZ M, 1987, J BIOL CHEM, V262, P8476; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; Rich S, 1996, J IMMUNOL, V157, P2916; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Ruperez P, 2012, MOL CELL PROTEOMICS, V11, P171, DOI 10.1074/mcp.M112.017863; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Soriani A, 2006, J THROMB HAEMOST, V4, P648, DOI 10.1111/j.1538-7836.2006.01806.x; Sossey-Alaoui K, 2014, FASEB J, V28, P2260, DOI 10.1096/fj.13-244004; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wagner CL, 1996, BLOOD, V88, P907; WARD NE, 1993, BIOCHEMISTRY-US, V32, P11903, DOI 10.1021/bi00095a020; WILLIAMS AG, 1990, BLOOD, V76, P721; WOODS VL, 1984, BLOOD, V63, P368; Xu Z, 2014, ARTERIOSCL THROM VAS, V34, P1961, DOI 10.1161/ATVBAHA.114.303851; Yacoub D, 2006, J BIOL CHEM, V281, P30024, DOI 10.1074/jbc.M604504200; Yates LA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.415208; YLANNE J, 1990, BLOOD, V76, P570; YLANNE J, 1988, BLOOD, V72, P1478; Zauli G, 1997, BLOOD, V89, P883, DOI 10.1182/blood.V89.3.883; Zhao YZ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.380469; Zimman A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084488; ZIMRIN AB, 1988, J CLIN INVEST, V81, P1470, DOI 10.1172/JCI113478	65	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6226	6242		10.1074/jbc.M114.634436	http://dx.doi.org/10.1074/jbc.M114.634436			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25609252	Green Published, hybrid			2022-12-26	WOS:000350732500030
J	Ousingsawat, J; Wanitchakool, P; Schreiber, R; Wuelling, M; Vortkamp, A; Kunzelmann, K				Ousingsawat, Jiraporn; Wanitchakool, Podchanart; Schreiber, Rainer; Wuelling, Manuela; Vortkamp, Andrea; Kunzelmann, Karl			Anoctamin-6 Controls Bone Mineralization by Activating the Calcium Transporter NCX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/CA2+ EXCHANGER ISOFORMS; MEMBRANE CA2+ ATPASE; CHANNEL; PHOSPHATE; TMEM16F; OSTEOCLASTS; INHIBITION; EXPRESSION; DEPOSITION; REGULATOR	Anoctamin-6 (Ano6, TMEM16F) belongs to a family of putative Ca2+-activated Cl- channels and operates as membrane phospholipid scramblase. Deletion of Ano6 leads to reduced skeleton size, skeletal deformities, and mineralization defects in mice. However, it remains entirely unclear how a lack of Ano6 leads to a delay in bone mineralization by osteoblasts. The Na+/Ca2+ exchanger NCX1 was found to interact with Ano6 in a two-hybrid split-ubiquitin screen. Using human osteoblasts and osteoblasts from Ano6(-/-) and WT mice, we demonstrate that NCX1 requires Ano6 to efficiently translocate Ca2+ out of osteoblasts into the calcifying bone matrix. Ca2+-activated anion currents are missing in primary osteoblasts isolated from Ano6 null mice. Our findings demonstrate the importance of NCX1 for bone mineralization and explain why deletion of an ion channel leads to the observed mineralization defect: Ano6 Cl- currents are probably required to operate as a Cl- bypass channel, thereby compensating net Na+ charge movement by NCX1.	[Ousingsawat, Jiraporn; Wanitchakool, Podchanart; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Wuelling, Manuela; Vortkamp, Andrea] Univ Duisburg Essen, Fak Biol, Dept Entwicklungsbiol, D-45141 Essen, Germany	University of Regensburg; University of Duisburg Essen	Kunzelmann, K (corresponding author), Univ Regensburg, Inst Physiol, Univ Str 31, D-93053 Regensburg, Germany.	karl.kunzelmann@ur.de		Wuelling, Manuela/0000-0003-4534-3528	Deutsche Forschungsgemeinschaft [DFG SFB699, DFG KU756/12-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants DFG SFB699 (Project A7/A12) and DFG KU756/12-1.	ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266; Bonucci E, 2009, J BONE MINER METAB, V27, P255, DOI 10.1007/s00774-009-0061-y; Boonrungsiman S, 2012, P NATL ACAD SCI USA, V109, P14170, DOI 10.1073/pnas.1208916109; Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F; Bronckers A, 2010, BONE, V46, P1188, DOI 10.1016/j.bone.2009.12.002; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Ehlen HWA, 2013, J BONE MINER RES, V28, P246, DOI 10.1002/jbmr.1751; Faria D, 2014, KIDNEY INT, V85, P1369, DOI 10.1038/ki.2013.535; Francis MJO, 2002, INT J BIOCHEM CELL B, V34, P459, DOI 10.1016/S1357-2725(01)00142-X; GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041; Go W, 2013, BONE, V54, P48, DOI 10.1016/j.bone.2013.01.026; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Grubb S, 2013, J GEN PHYSIOL, V141, P585, DOI 10.1085/jgp.201210861; Harper MT, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.495; Kmit A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.135; Kornak U, 2011, JOINT BONE SPINE, V78, P561, DOI 10.1016/j.jbspin.2011.03.020; Kunzelmann K, 2014, PFLUG ARCH EUR J PHY, V466, P407, DOI 10.1007/s00424-013-1305-1; Ladilov Y, 1999, AM J PHYSIOL-HEART C, V276, pH1868, DOI 10.1152/ajpheart.1999.276.6.H1868; Le Henaff C, 2012, AM J PATHOL, V180, P2068, DOI 10.1016/j.ajpath.2012.01.039; Li JP, 2007, ENDOCRINOLOGY, V148, P2116, DOI 10.1210/en.2006-1321; Linck B, 1998, AM J PHYSIOL-CELL PH, V274, pC415, DOI 10.1152/ajpcell.1998.274.2.C415; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Lundquist P, 2000, CALCIFIED TISSUE INT, V67, P60, DOI 10.1007/s00223001098; Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105; Mahamid J, 2011, J STRUCT BIOL, V174, P527, DOI 10.1016/j.jsb.2011.03.014; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Rosenberg N, 2012, RAMBAM MAIMONIDES ME, V3, DOI 10.5041/RMMJ.10080; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shimizu T, 2013, AM J PHYSIOL-CELL PH, V304, pC748, DOI 10.1152/ajpcell.00228.2012; Sosnoski DA, 2008, J CELL BIOCHEM, V103, P1101, DOI 10.1002/jcb.21483; Stains JP, 2002, J CELL BIOCHEM, V84, P625, DOI 10.1002/jcb.10050; Stains JP, 2001, J BONE MINER RES, V16, P1434, DOI 10.1359/jbmr.2001.16.8.1434; Stalvey MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080098; Stalvey MS, 2013, CURR OPIN ENDOCRINOL, V20, P547, DOI 10.1097/01.med.0000436191.87727.ec; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; Van der Eerden BCJ, 2012, J CELL PHYSIOL, V227, P1951, DOI 10.1002/jcp.22923; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	41	28	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6270	6280		10.1074/jbc.M114.602979	http://dx.doi.org/10.1074/jbc.M114.602979			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25589784	hybrid, Green Published			2022-12-26	WOS:000350732500033
J	Smith, AM; Brown, WC; Harms, E; Smith, JL				Smith, Amber Marie; Brown, William Clay; Harms, Etti; Smith, Janet L.			Crystal Structures Capture Three States in the Catalytic Cycle of a Pyridoxal Phosphate (PLP) Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5'-PHOSPHATE SYNTHASE; CHROMOPHORIC INTERMEDIATE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; BIOSYNTHESIS; COMPLEX; ENZYMES; REFINEMENT; MECHANISM; INSIGHTS	PLP synthase (PLPS) is a remarkable single-enzyme biosynthetic pathway that produces pyridoxal 5'-phosphate (PLP) from glutamine, ribose 5-phosphate, and glyceraldehyde 3-phosphate. The intact enzyme includes 12 synthase and 12 glutaminase subunits. PLP synthesis occurs in the synthase active site by a complicated mechanism involving at least two covalent intermediates at a catalytic lysine. The first intermediate forms with ribose 5-phosphate. The glutaminase subunit is a glutamine amidotransferase that hydrolyzes glutamine and channels ammonia to the synthase active site. Ammonia attack on the first covalent intermediate forms the second intermediate. Glyceraldehyde 3-phosphate reacts with the second intermediate to form PLP. To investigate the mechanism of the synthase subunit, crystal structures were obtained for three intermediate states of the Geobacillus stearothermophilus intact PLPS or its synthase subunit. The structures capture the synthase active site at three distinct steps in its complicated catalytic cycle, provide insights into the elusive mechanism, and illustrate the coordinated motions within the synthase subunit that separate the catalytic states. In the intact PLPS with a Michaelis-like intermediate in the glutaminase active site, the first covalent intermediate of the synthase is fully sequestered within the enzyme by the ordering of a generally disordered 20-residue C-terminal tail. Following addition of ammonia, the synthase active site opens and admits the Lys-149 side chain, which participates in formation of the second intermediate and PLP. Roles are identified for conserved Asp-24 in the formation of the first intermediate and for conserved Arg-147 in the conversion of the first to the second intermediate.	[Smith, Amber Marie; Smith, Janet L.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Smith, Amber Marie; Brown, William Clay; Smith, Janet L.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Brown, William Clay; Smith, Janet L.] Univ Michigan, Struct Biol Ctr, Ann Arbor, MI 48109 USA; [Harms, Etti] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Smith, JL (corresponding author), Univ Michigan, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	JanetSmith@umich.edu			National Institutes of Health from NIGMS [GM Y1-GM-1104]; National Institutes of Health from NCI, Advanced Photon Source [CA Y1-CO-1020]; United States Department of Energy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042303, R01DK042303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM093461] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health from NCI, Advanced Photon Source(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. Boris Belitsky at Tufts University for a plasmid encoding PdxT. We thank the staff at the GM/CA beamlines (supported by National Institutes of Health Grants GM Y1-GM-1104 from NIGMS and CA Y1-CO-1020 from NCI, Advanced Photon Source (supported by the United States Department of Energy), Argonne National Laboratory).	Bauer JA, 2004, J BIOL CHEM, V279, P2704, DOI 10.1074/jbc.M310311200; Belitsky BR, 2004, J BACTERIOL, V186, P1191, DOI 10.1128/JB.186.4.1191-1196.2004; Bilski P, 2000, PHOTOCHEM PHOTOBIOL, V71, P129, DOI 10.1562/0031-8655(2000)071&lt;0129:SIPVBP&gt;2.0.CO;2; BROSIUS J, 1985, J BIOL CHEM, V260, P3539; Burns KE, 2005, J AM CHEM SOC, V127, P3682, DOI 10.1021/ja042792t; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christen P, 2001, CHEM REC, V1, P436, DOI 10.1002/tcr.10005; Douangamath A, 2002, STRUCTURE, V10, P185, DOI 10.1016/S0969-2126(02)00702-5; Ehrenshaft M, 1998, MOL CELL, V1, P603, DOI 10.1016/S1097-2765(00)80060-X; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzpatrick TB, 2007, BIOCHEM J, V407, P1, DOI 10.1042/BJ20070765; Gengenbacher M, 2006, J BIOL CHEM, V281, P3633, DOI 10.1074/jbc.M508696200; Guedez G, 2012, STRUCTURE, V20, P172, DOI 10.1016/j.str.2011.11.015; Hanes JW, 2008, NAT CHEM BIOL, V4, P425, DOI 10.1038/nchembio.93; Hanes JW, 2008, J AM CHEM SOC, V130, P3043, DOI 10.1021/ja076604l; Hanes JW, 2008, ANGEW CHEM INT EDIT, V47, P2102, DOI 10.1002/anie.200704390; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; Jain SK, 2001, FREE RADICAL BIO MED, V30, P232, DOI 10.1016/S0891-5849(00)00462-7; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Matsuura A, 2012, MOL CELLS, V34, P407, DOI 10.1007/s10059-012-0198-8; MCCARTHY JEG, 1985, EMBO J, V4, P519, DOI 10.1002/j.1460-2075.1985.tb03659.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moccand C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016042; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Raschle T, 2005, J BIOL CHEM, V280, P32291, DOI 10.1074/jbc.M501356200; Raschle T, 2007, J BIOL CHEM, V282, P6098, DOI 10.1074/jbc.M610614200; Raschle T, 2009, J BIOL CHEM, V284, P7706, DOI 10.1074/jbc.M804728200; RINGQUIST S, 1992, MOL MICROBIOL, V6, P1219, DOI 10.1111/j.1365-2958.1992.tb01561.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Smart OS, 2011, GRADE WEB SERVER VER; Strohmeier M, 2006, P NATL ACAD SCI USA, V103, P19284, DOI 10.1073/pnas.0604950103; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zalkin H, 1998, ADV ENZYMOL RAMB, V72, P87; Zein F, 2006, BIOCHEMISTRY-US, V45, P14609, DOI 10.1021/bi061464y; Zhang XA, 2010, BIOCHEM J, V432, P445, DOI 10.1042/BJ20101241; Zhu JH, 2005, J BIOL CHEM, V280, P27914, DOI 10.1074/jbc.M503642200	45	16	15	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5226	5239		10.1074/jbc.M114.626382	http://dx.doi.org/10.1074/jbc.M114.626382			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568319	hybrid, Green Published			2022-12-26	WOS:000350044200001
J	Aykul, S; Ni, W; Mutatu, W; Martinez-Hackert, E				Aykul, Senem; Ni, Wendi; Mutatu, Washington; Martinez-Hackert, Erik			Human Cerberus Prevents Nodal-Receptor Binding, Inhibits Nodal Signaling, and Suppresses Nodal-Mediated Phenotypes	PLOS ONE			English	Article							CRIPTO CFC DOMAIN; EXTRACELLULAR DOMAIN; BETA RECEPTOR; STEM-CELLS; MOUSE NODE; ACTIVIN; BMP; ANTAGONIST; EXPRESSION; ENDODERM	The Transforming Growth Factor-beta (TGF beta) family ligand Nodal is an essential embryonic morphogen that is associated with progression of breast and other cancers. It has therefore been suggested that Nodal inhibitors could be used to treat breast cancers where Nodal plays a defined role. As secreted antagonists, such as Cerberus, tightly regulate Nodal signaling during embryonic development, we undertook to produce human Cerberus, characterize its biochemical activities, and determine its effect on human breast cancer cells. Using quantitative methods, we investigated the mechanism of Nodal signaling, we evaluated binding of human Cerberus to Nodal and other TGF beta family ligands, and we characterized the mechanism of Nodal inhibition by Cerberus. Using cancer cell assays, we examined the ability of Cerberus to suppress aggressive breast cancer cell phenotypes. We found that human Cerberus binds Nodal with high affinity and specificity, blocks binding of Nodal to its signaling partners, and inhibits Nodal signaling. Moreover, we showed that Cerberus profoundly suppresses migration, invasion, and colony forming ability of Nodal expressing and Nodal supplemented breast cancer cells. Taken together, our studies provide mechanistic insights into Nodal signaling and Nodal inhibition with Cerberus and highlight the potential value of Cerberus as anti-Nodal therapeutic.	[Aykul, Senem; Ni, Wendi; Mutatu, Washington; Martinez-Hackert, Erik] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Martinez-Hackert, E (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	emh@msu.edu		Martinez-Hackert, Erik/0000-0002-6182-7023; Mutatu, Washington/0000-0002-1857-0314; AYKUL, SENEM/0000-0001-7250-2913	Michigan State University	Michigan State University	This work was supported by Startup Funds from Michigan State University to EMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins HB, 2003, J CLIN INVEST, V112, P575, DOI 10.1172/JCI200317788; Belo JA, 2000, GENESIS, V26, P265, DOI 10.1002/(SICI)1526-968X(200004)26:4<265::AID-GENE80>3.3.CO;2-W; Bertocchini F, 2002, DEV CELL, V3, P735, DOI 10.1016/S1534-5807(02)00318-0; Bianco C, 2002, MOL CELL BIOL, V22, P2586, DOI 10.1128/MCB.22.8.2586-2597.2002; Brown S, 2011, STEM CELLS, V29, P1176, DOI 10.1002/stem.666; Cai WQ, 2013, GENE DEV, V27, P2332, DOI 10.1101/gad.225144.113; Calvanese L, 2009, J PEPT SCI, V15, P175, DOI 10.1002/psc.1091; Chen CH, 2004, CURR BIOL, V14, P618, DOI 10.1016/j.cub.2004.02.042; Chi LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027676; De Crescenzo G, 2003, J MOL BIOL, V328, P1173, DOI 10.1016/S0022-2836(03)00360-7; Fang R, 2013, CANCER LETT, V333, P66, DOI 10.1016/j.canlet.2013.01.014; Foley AC, 2007, DEV BIOL, V303, P57, DOI 10.1016/j.ydbio.2006.10.033; Fuerer C, 2014, J BIOL CHEM, V289, P17854, DOI 10.1074/jbc.M114.550301; Gray PC, 2003, P NATL ACAD SCI USA, V100, P5193, DOI 10.1073/pnas.0531290100; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Herrera MB, 2006, STEM CELLS, V24, P2840, DOI 10.1634/stemcells.2006-0114; Hinck AP, 2012, FEBS LETT, V586, P1860, DOI 10.1016/j.febslet.2012.05.028; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Humphries B, 2014, CARCINOGENESIS, V35, P2254, DOI 10.1093/carcin/bgu133; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kelber JA, 2008, J BIOL CHEM, V283, P4490, DOI 10.1074/jbc.M704960200; Kumar A, 2001, J BIOL CHEM, V276, P656, DOI 10.1074/jbc.M004649200; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Marques S, 2004, GENE DEV, V18, P2342, DOI 10.1101/gad.306504; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Nolan K, 2013, STRUCTURE, V21, P1417, DOI 10.1016/j.str.2013.06.005; Papageorgiou I, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-122; Petersen M, 2008, KIDNEY INT, V73, P705, DOI 10.1038/sj.ki.5002717; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Quail DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048237; Quail DF, 2012, CANCER RES, V72, P3851, DOI 10.1158/0008-5472.CAN-11-3951; Quail DF, 2013, ONCOGENE; Reissmann E, 2001, GENE DEV, V15, P2010, DOI 10.1101/gad.201801; Sako D, 2010, J BIOL CHEM, V285, P21037, DOI 10.1074/jbc.M110.114959; Sakuma R, 2002, GENES CELLS, V7, P401, DOI 10.1046/j.1365-2443.2002.00528.x; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SOMMERS CL, 1994, BREAST CANCER RES TR, V31, P325, DOI 10.1007/BF00666165; Strizzi L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3185; Strizzi L, 2012, CANCER RES, V72, P1915, DOI 10.1158/0008-5472.CAN-11-3419; Strizzi Luigi, 2008, Breast Dis, V29, P91; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Varlet I, 1997, DEVELOPMENT, V124, P1033; Wu XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071258; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Yu XY, 2008, DEV DYNAM, V237, P3613, DOI 10.1002/dvdy.21769; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang C, 2009, DEV BIOL, V331, P340, DOI 10.1016/j.ydbio.2009.04.016; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0	58	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0114954	10.1371/journal.pone.0114954	http://dx.doi.org/10.1371/journal.pone.0114954			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603319	Green Submitted, Green Published, gold			2022-12-26	WOS:000348203500007
J	Niemeyer, BF; Parrish, JK; Spoelstra, NS; Joyal, T; Richer, JK; Jedlicka, P				Niemeyer, Brian F.; Parrish, Janet K.; Spoelstra, Nicole S.; Joyal, Teresa; Richer, Jennifer K.; Jedlicka, Paul			Variable Expression of PIK3R3 and PTEN in Ewing Sarcoma Impacts Oncogenic Phenotypes	PLOS ONE			English	Article							GROWTH-FACTOR; THERAPEUTIC TARGET; REGULATORY SUBUNIT; MAMMALIAN TARGET; TYROSINE KINASE; NUCLEAR PTEN; CELL; PATHWAY; CANCER; DIFFERENTIATION	Ewing Sarcoma is an aggressive malignancy of bone and soft tissue affecting children and young adults. Ewing Sarcoma is driven by EWS/Ets fusion oncoproteins, which cause widespread alterations in gene expression in the cell. Dysregulation of receptor tyrosine kinase signaling, particularly involving IGF-1R, also plays an important role in Ewing Sarcoma pathogenesis. However, the basis of this dysregulation, including the relative contribution of EWS/Ets-dependent and independent mechanisms, is not well understood. In the present study, we identify variable expression of two modifiers of PI3K signaling activity, PIK3R3 and PTEN, in Ewing Sarcoma, and examine the consequences of this on PI3K pathway regulation and oncogenic phenotypes. Our findings indicate that PIK3R3 plays a growth-promotional role in Ewing Sarcoma, but suggest that this role is not strictly dependent on regulation of PI3K pathway activity. We further show that expression of PTEN, a well-established, potent tumor suppressor, is lost in a subset of Ewing Sarcomas, and that this loss strongly correlates with high baseline PI3K pathway activity in cell lines. In support of functional importance of PTEN loss in Ewing Sarcoma, we show that re-introduction of PTEN into two different PTEN-negative Ewing Sarcoma cell lines results in downregulation of PI3K pathway activity, and sensitization to the IGF-1R small molecule inhibitor OSI-906. Our findings also suggest that PTEN levels may contribute to sensitivity of Ewing Sarcoma cells to the microtubule inhibitor vincristine, a relevant chemotherapeutic agent in this cancer. Our studies thus identify PIK3R3 and PTEN as modifiers of oncogenic phenotypes in Ewing Sarcoma, with potential clinical implications.	[Niemeyer, Brian F.; Parrish, Janet K.; Spoelstra, Nicole S.; Joyal, Teresa; Richer, Jennifer K.; Jedlicka, Paul] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Jedlicka, P (corresponding author), Univ Colorado Denver, Dept Pathol, Anschutz Med Campus, Aurora, CO 80045 USA.	paul.jedlicka@ucdenver.edu		Niemeyer, Brian/0000-0002-2020-2238	Boettcher Foundation's Webb-Waring Biomedical Research Program; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Boettcher Foundation's Webb-Waring Biomedical Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding from Boettcher Foundation's Webb-Waring Biomedical Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benini S, 2004, INT J CANCER, V108, P358, DOI 10.1002/ijc.11576; Chen ZH, 2014, CELL REP, V8, P2003, DOI 10.1016/j.celrep.2014.08.008; Dylla L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00065; Fernandez S, 2014, ONCOGENE, V33, P4114, DOI 10.1038/onc.2013.376; Grohar PJ, 2013, PHARMACOL THERAPEUT, V137, P216, DOI 10.1016/j.pharmthera.2012.10.004; Herrero-Martin D, 2009, BRIT J CANCER, V101, P80, DOI 10.1038/sj.bjc.6605104; Hu JB, 2008, MOL CANCER THER, V7, P3719, DOI 10.1158/1535-7163.MCT-08-0499; Jedlicka P, 2010, INT J CLIN EXP PATHO, V3, P338; Kamura S, 2010, BRIT J CANCER, V103, P370, DOI 10.1038/sj.bjc.6605775; Kang HG, 2007, CANCER RES, V67, P3094, DOI 10.1158/0008-5472.CAN-06-3259; Lawlor ER, 2002, ONCOGENE, V21, P307, DOI 10.1038/sj.onc.1205053; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Linger RMA, 2009, BLOOD, V114, P2678, DOI 10.1182/blood-2009-03-209247; Ludwig JA, 2008, CURR OPIN ONCOL, V20, P412, DOI 10.1097/CCO.0b013e328303ba1d; Ordonez JL, 2009, CANCER RES, V69, P7140, DOI 10.1158/0008-5472.CAN-08-4041; Lynn M, 2013, DIAGN MOL PATHOL, V22, P76, DOI 10.1097/PDM.0b013e31827a47f9; Manara MC, 2010, CLIN CANCER RES, V16, P530, DOI 10.1158/1078-0432.CCR-09-0816; McKinsey EL, 2011, ONCOGENE, V30, P4910, DOI 10.1038/onc.2011.197; Mendoza-Naranjo A, 2013, EMBO MOL MED, V5, P1087, DOI 10.1002/emmm.201202343; NAVARRO S, 1990, VIRCHOWS ARCH A, V416, P383, DOI 10.1007/BF01605142; Neilsen Paul M., 2011, Sarcoma, V2011, P746939, DOI 10.1155/2011/746939; Olmos D, 2010, CANCER J, V16, P183, DOI 10.1097/PPO.0b013e3181dbebf9; Parrish JK, 2015, ONCOGENE, V34, P257, DOI 10.1038/onc.2013.541; Patel M, 2014, MOL CANCER RES, V12, P1610, DOI 10.1158/1541-7786.MCR-14-0006; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Sainz-Jaspeado M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071449; Sangale Z, 2011, APPL IMMUNOHISTO M M, V19, P173, DOI 10.1097/PAI.0b013e3181f1da13; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shukla N, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00141; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Soroceanu L, 2007, P NATL ACAD SCI USA, V104, P3466, DOI 10.1073/pnas.0611271104; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Tsuchiya T, 2000, CANCER GENET CYTOGEN, V120, P91, DOI 10.1016/S0165-4608(99)00255-1; VanderWeele DJ, 2005, MOL CANCER RES, V3, P635, DOI 10.1158/1541-7786.MCR-05-0063; VanderWeele DJ, 2004, MOL CANCER THER, V3, P1605; Wang G, 2012, CELL DEATH DIFFER, V19, P1870, DOI 10.1038/cdd.2012.70; Wang GH, 2013, ANGIOGENESIS, V16, P561, DOI 10.1007/s10456-013-9336-y; Xia XM, 2003, MOL CELL BIOL, V23, P1717, DOI 10.1128/MCB.23.5.1717-1725.2003; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241; Zhang H, 2010, CANCER INVEST, V28, P156, DOI 10.3109/07357900903179641; Zhang L, 2007, CLIN CANCER RES, V13, P5314, DOI 10.1158/1078-0432.CCR-06-2660	43	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116895	10.1371/journal.pone.0116895	http://dx.doi.org/10.1371/journal.pone.0116895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603314	Green Published, gold, Green Submitted			2022-12-26	WOS:000348203500034
J	Haridan, US; Mokhtar, U; Machado, LR; Aziz, AA; Shueb, RH; Zaid, M; Sim, B; Mustafa, M; Yusof, NKN; Lee, CKC; Abu Bakar, S; AbuBakar, S; Hollox, EJ; Peng, HB				Haridan, Umi Shakina; Mokhtar, Umairah; Machado, Lee R.; Aziz, Abu Thalhah Abdul; Shueb, Rafidah Hanim; Zaid, Masliza; Sim, Benedict; Mustafa, Mahiran; Yusof, Nik Khairudin Nik; Lee, Christopher K. C.; Abu Bakar, Suhaili; AbuBakar, Sazaly; Hollox, Edward J.; Peng, Hoh Boon			A Comparison of Assays for Accurate Copy Number Measurement of the Low-Affinity Fc Gamma Receptor Genes FCGR3A and FCGR3B	PLOS ONE			English	Article							DISEASE; EXPRESSION; LOCUS; SUSCEPTIBILITY; AUTOIMMUNITY; GENOME	The FCGR3 locus encoding the low affinity activating receptor FcyRIII, plays a vital role in immunity triggered by cellular effector and regulatory functions. Copy number of the genes FCGR3A and FCGR3B has previously been reported to affect susceptibility to several autoimmune diseases and chronic inflammatory conditions. However, such genetic association studies often yield inconsistent results; hence require assays that are robust with low error rate. We investigated the accuracy and efficiency in estimating FCGR3 CNV by comparing Sequenom MassARRAY and paralogue ratio test-restriction enzyme digest variant ratio (PRT-REDVR). In addition, since many genetic association studies of FCGR3B CNV were carried out using real-time quantitative PCR, we have also included the evaluation of that method's performance in estimating the multi-allelic CNV of FCGR3B. The qPCR assay exhibited a considerably broader distribution of signal intensity, potentially introducing error in estimation of copy number and higher false positive rates. Both Sequenom and PRT-REDVR showed lesser systematic bias, but Sequenom skewed towards copy number normal (CN = 2). The discrepancy between Sequenom and PRT-REDVR might be attributed either to batch effects noise in individual measurements. Our study suggests that PRT-REDVR is more robust and accurate in genotyping the CNV of FCGR3, but highlights the needs of multiple independent assays for extensive validation when performing a genetic association study with multi-allelic CNVs.	[Haridan, Umi Shakina; Mokhtar, Umairah; Aziz, Abu Thalhah Abdul; Peng, Hoh Boon] Univ Teknol MARA, Fac Med, IMMB, Sungai Buloh Campus, Selangor, Malaysia; [Machado, Lee R.; Hollox, Edward J.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Shueb, Rafidah Hanim] Univ Sains Malaysia, Sch Med Sci, Dept Microbiol & Parasitol, Kubang Kerian, Kelantan, Malaysia; [Zaid, Masliza; Sim, Benedict; Lee, Christopher K. C.] Jalan Hosp, Hosp Sungai Buloh, Dept Med, Sungai Buloh, Selangor, Malaysia; [Mustafa, Mahiran; Yusof, Nik Khairudin Nik] Hosp Raja Perempuan Zainab II, Kota Baharu, Kelantan, Malaysia; [Abu Bakar, Suhaili] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Biomed Sci, Serdang 43400, Selangor, Malaysia; [AbuBakar, Sazaly] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [AbuBakar, Sazaly] Univ Malaya, Fac Med, Trop Infect Dis Res & Educ Ctr, Kuala Lumpur, Malaysia	Universiti Teknologi MARA; University of Leicester; Universiti Sains Malaysia; Universiti Putra Malaysia; Universiti Malaya; Universiti Malaya	Peng, HB (corresponding author), Univ Teknol MARA, Fac Med, IMMB, Sungai Buloh Campus, Selangor, Malaysia.	hoh.boonpeng@gmail.com	Shueb, Rafidah Hanim/E-4541-2012; Hoh, Boon-Peng/H-8682-2016; abubakar, sazaly/B-3957-2010; Shueb, Rafidah Hanim/Q-8385-2019; Shueb, Rafidah Hanim/C-8675-2016; Abubakar, Suhaili/ABC-2884-2021	Hoh, Boon-Peng/0000-0001-9249-4965; abubakar, sazaly/0000-0002-9267-1420; Shueb, Rafidah Hanim/0000-0002-1249-5229; Abubakar, Suhaili/0000-0002-2217-4509; Hollox, Edward/0000-0002-0115-2298; Abdul Aziz, Abu Thalhah/0000-0002-1416-7931; Machado, Lee/0000-0001-7974-2178	UITM DANA Kecemerlangan [600-RMI/STDANA5/3/Fst (281/2009)]; FRGS [600-RMI/ST/FRGS5/3/Fst (69/2010)]; Long-term Research Grant Scheme (LRGS) for Infectious Disease [600-RMI/LRGS5/3 (3/2011)]	UITM DANA Kecemerlangan; FRGS; Long-term Research Grant Scheme (LRGS) for Infectious Disease	This study is supported by UITM DANA Kecemerlangan (600-RMI/STDANA5/3/Fst (281/2009)), FRGS 2010 (600-RMI/ST/FRGS5/3/Fst (69/2010)), and Long-term Research Grant Scheme (LRGS) for Infectious Disease 2011 (600-RMI/LRGS5/3 (3/2011)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldhous MC, 2010, HUM MOL GENET, V19, P4930, DOI 10.1093/hmg/ddq411; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Breunis WB, 2009, HUM MUTAT, V30, pE640, DOI 10.1002/humu.20997; Bux J, 2008, VOX SANG, V94, P277, DOI 10.1111/j.1423-0410.2007.01031.x; Cantsilieris S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-329; Carpenter D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-418; Estivill X, 2007, PLOS GENET, V3, P1787, DOI 10.1371/journal.pgen.0030190; Fanciulli M, 2010, CLIN GENET, V77, P201, DOI 10.1111/j.1399-0004.2009.01342.x; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Fode P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016768; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hollox EJ, 2008, CYTOGENET GENOME RES, V123, P148, DOI 10.1159/000184702; Hollox EJ, 2014, HUM GENET, V133, P1217, DOI 10.1007/s00439-014-1457-x; Hollox EJ, 2009, HUM MUTAT, V30, P477, DOI 10.1002/humu.20911; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marques RB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013173; Mueller M, 2013, AM J HUM GENET, V92, P28, DOI 10.1016/j.ajhg.2012.11.013; RAVETCH JV, 1989, J EXP MED, V170, P481, DOI 10.1084/jem.170.2.481; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Walker S, 2009, GENOMICS, V93, P98, DOI 10.1016/j.ygeno.2008.09.004; Willcocks LC, 2008, J EXP MED, V205, P1573, DOI 10.1084/jem.20072413; Willcocks LC, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001161	26	10	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2015	10	1							e0116791	10.1371/journal.pone.0116791	http://dx.doi.org/10.1371/journal.pone.0116791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OS	25594501	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000348202900005
J	Schupp, JC; Binder, H; Jager, B; Cillis, G; Zissel, G; Muller-Quernheim, J; Prasse, A				Schupp, Jonas Christian; Binder, Harald; Jaeger, Benedikt; Cillis, Giuseppe; Zissel, Gernot; Mueller-Quernheim, Joachim; Prasse, Antje			Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ACUTE LUNG INJURY; ALVEOLAR MACROPHAGES; GENE-EXPRESSION; FACTOR-ALPHA; INTERLEUKIN-1-BETA; SARCOIDOSIS; MONOCYTES	Background Acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) is a common cause of disease acceleration in IPF and has a major impact on mortality. The role of macrophage activation in AE of IPF has never been addressed before. Methods We evaluated BAL cell cytokine profiles and BAL differential cell counts in 71 IPF patients w/wo AE and in 20 healthy volunteers. Twelve patients suffered from AE at initial diagnosis while sixteen patients developed AE in the 24 months of follow-up. The levels of IL-1ra, CCL2, CCL17, CCL18, CCL22, TNF-alpha, IL-1 beta, CXCL1 and IL-8 spontaneously produced by BAL-cells were analysed by ELISA. Results In patients with AE, the percentage of BAL neutrophils was significantly increased compared to stable patients. We found an increase in the production rate of the proinflammatory cytokines CXCL1 and IL-8 combined with an increase in all tested M2 cytokines by BAL-cells. An increase in CCL18 levels and neutrophil counts during AE was observed in BAL cells from patients from whom serial lavages were obtained. Furthermore, high baseline levels of CCL18 production by BAL cells were significantly predictive for the development of future AE. Conclusions BAL cell cytokine production levels at acute exacerbation show up-regulation of pro-inflammatory as well as anti-inflammatory/ M2 cytokines. Our data suggest that AE in IPF is not an incidental event but rather driven by cellular mechanisms including M2 macrophage activation.	[Schupp, Jonas Christian; Jaeger, Benedikt; Zissel, Gernot; Mueller-Quernheim, Joachim; Prasse, Antje] Univ Med Ctr, Dept Pneumol, Freiburg, Germany; [Binder, Harald] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Biostat Epidemiol & Informat, D-55122 Mainz, Germany; [Jaeger, Benedikt] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Cillis, Giuseppe] Univ Siena, Dept Clin Med & Immunol Sci, Resp Dis Sect, I-53100 Siena, Italy	University of Freiburg; Johannes Gutenberg University of Mainz; University of Freiburg; University of Siena	Prasse, A (corresponding author), Univ Med Ctr, Dept Pneumol, Freiburg, Germany.	antje.prasse@uniklinik-freiburg.de	Prasse, Antje/AAM-7521-2021; Prasse, Antje/AAY-6279-2020; Binder, Harald/C-7413-2009; Zissel, Gernot/B-1208-2010	Prasse, Antje/0000-0002-7336-7458; Binder, Harald/0000-0002-5666-8662; Zissel, Gernot/0000-0001-8021-9798; Schupp, Jonas/0000-0002-7714-8076; cillis, giuseppe/0000-0001-6927-3363	E-RARE project, JRC IPF-AE [DLR 01GM1210A]; Albert Ludwigs University Freiburg	E-RARE project, JRC IPF-AE; Albert Ludwigs University Freiburg	This study was supported by E-RARE project, JRC 2011 IPF-AE (DLR 01GM1210A), (http://www.erare.eu), AP. The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini V, 2003, EUR RESPIR J, V22, P821, DOI 10.1183/09031936.03.00022703; Armstrong L, 1997, THORAX, V52, P442, DOI 10.1136/thx.52.5.442; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; BRIELAND JK, 1995, AM J RESP CELL MOL, V12, P104, DOI 10.1165/ajrcmb.12.1.7811465; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; DONNELLY SC, 1993, LANCET, V341, P643, DOI 10.1016/0140-6736(93)90416-E; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Ghatol A, 2012, LUNG, V190, P373, DOI 10.1007/s00408-012-9389-5; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; Johannson KA, 2014, EUR RESPIR J, V43, P1124, DOI 10.1183/09031936.00122213; Kim DS, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-86; Kim DS, 2006, EUR RESPIR J, V27, P143, DOI 10.1183/09031936.06.00114004; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Konishi K, 2009, AM J RESP CRIT CARE, V180, P167, DOI 10.1164/rccm.200810-1596OC; Kurosu K, 2008, J IMMUNOL, V181, P756, DOI 10.4049/jimmunol.181.1.756; Lee JS, 2012, EUR RESPIR J, V39, P352, DOI 10.1183/09031936.00050911; Maher TM, 2007, EUR RESPIR J, V30, P835, DOI 10.1183/09031936.00069307; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Mora AL, 2006, AM J RESP CELL MOL, V35, P466, DOI 10.1165/rcmb.2006-0121OC; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Osterholzer JJ, 2013, J IMMUNOL, V190, P3447, DOI 10.4049/jimmunol.1200604; Papiris SA, 2010, CRIT CARE, V14, DOI 10.1186/cc9241; Parambil JG, 2005, CHEST, V128, P3310, DOI 10.1378/chest.128.5.3310; Prasse A, 2000, CLIN EXP IMMUNOL, V122, P241, DOI 10.1046/j.1365-2249.2000.01365.x; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Prasse A, 2007, ARTHRITIS RHEUM-US, V56, P1685, DOI 10.1002/art.22559; Pugin J, 1996, AM J RESP CRIT CARE, V153, P1850, DOI 10.1164/ajrccm.153.6.8665045; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rodenburg RJT, 1998, J LEUKOCYTE BIOL, V63, P606, DOI 10.1002/jlb.63.5.606; Song JW, 2011, EUR RESPIR J, V37, P356, DOI 10.1183/09031936.00159709; Stahl M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081382; STEINBERG KP, 1994, AM J RESP CRIT CARE, V150, P113, DOI 10.1164/ajrccm.150.1.8025736; Stijn W, 2013, ANN THORAC MED, V8, P38, DOI 10.4103/1817-1737.105718; Sun L, 2011, AM J PHYSIOL-LUNG C, V300, pL341, DOI 10.1152/ajplung.00122.2010; Wells AU, 2003, AM J RESP CRIT CARE, V167, P962, DOI 10.1164/rccm.2111053; Ziegenhagen MW, 1998, AM J RESP CRIT CARE, V157, P762, DOI 10.1164/ajrccm.157.3.9705014	39	114	118	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116775	10.1371/journal.pone.0116775	http://dx.doi.org/10.1371/journal.pone.0116775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590613	Green Submitted, Green Published, gold			2022-12-26	WOS:000350679400022
J	Reuland, EA; Halaby, T; Hays, JP; de Jongh, DMC; Snetselaar, HDR; van Keulen, M; Elders, PJM; Savelkoul, PHM; Vandenbroucke-Grauls, CMJE; al Naiemi, N				Reuland, E. Ascelijn; Halaby, Teysir; Hays, John P.; de Jongh, Denise M. C.; Snetselaar, Henrieke D. R.; van Keulen, Marte; Elders, Petra J. M.; Savelkoul, Paul H. M.; Vandenbroucke-Grauls, Christina M. J. E.; al Naiemi, Nashwan			Plasmid-Mediated AmpC: Prevalence in Community-Acquired Isolates in Amsterdam, the Netherlands, and Risk Factors for Carriage	PLOS ONE			English	Article							RESISTANT ESCHERICHIA-COLI; SPECTRUM-BETA-LACTAMASE; KLEBSIELLA-PNEUMONIAE; CTX-M; ENTEROBACTERIACEAE; OUTBREAK; ACC-1; CARBAPENEMASES; EPIDEMIOLOGY; SURVEILLANCE	Objectives The objective of this study was to determine the prevalence of pAmpC beta-lactamases in community-acquired Gram negative bacteria in the Netherlands, and to identify possible risk factors for carriage of these strains. Methods Fecal samples were obtained from community-dwelling volunteers. Participants also returned a questionnaire for analysis of risk factors. Screening for pAmpC was performed with selective enrichment broth and a selective screening agar. Confirmation of AmpC-production was performed with two double disc combination tests: cefotaxime and ceftazidime with either boronic acid or cloxacillin as inhibitor. Multiplex PCR was used as gold standard for detection of pAmpC. 16S rRNA PCR and AFLP were performed as required, plasmids were identified by PCR-based replicon typing. Questionnaire results were analyzed with SPSS, version 20.0. Results Fecal samples were obtained from 550 volunteers; mean age 51 years (range: 18-91), 61% were females. pAmpC was present in seven E. coli isolates (7/550, 1.3%, 0.6-2.7 95% CI): six CMY-2-like pAmpC and one DHA. ESBL-encoding genes were found in 52/550 (9.5%, 7.3-12.2 95% CI) isolates; these were predominantly blaCTX-M genes. Two isolates had both ESBL and pAmpC. Admission to a hospital in the previous year was the only risk factor we identified. Conclusions Our data indicate that the prevalence of pAmpC in the community seems still low. However, since pAmpC-producing isolates were not identified as ESBL producers by routine algorithms, there is consistent risk that further increase of their prevalence might go undetected.	[Reuland, E. Ascelijn; Snetselaar, Henrieke D. R.; van Keulen, Marte; Savelkoul, Paul H. M.; Vandenbroucke-Grauls, Christina M. J. E.; al Naiemi, Nashwan] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Halaby, Teysir; al Naiemi, Nashwan] Lab Med Microbiol & Publ Hlth, Hengelo, Netherlands; [Hays, John P.; de Jongh, Denise M. C.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Elders, Petra J. M.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [al Naiemi, Nashwan] Ziekenhuisgroep Twente, Med Microbiol & Infect Control, Almelo, Netherlands	Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam	Reuland, EA (corresponding author), Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands.	e.reuland@vumc.nl	Hays, J/I-9007-2017; Vandenbroucke-Grauls, Christina/AAO-7953-2020	Hays, J/0000-0001-9183-4497; Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Elders, Petra/0000-0002-5907-7219	European Community [241742]; ZonMw, the Netherlands Organisation for Health Research and Development [125020011]	European Community(European Commission); ZonMw, the Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	The European Community Seventh Framework Program FP7/2007-2013, TEMPOtest-QC, under grant agreement number 241742, supported this study by enabling the multiplex pAmpC PCR investigations. This work was supported by ZonMw, the Netherlands Organisation for Health Research and Development (grant number 125020011 to CMJEV-G and NaN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SF, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-22; Al Naiemi N, 2005, J CLIN MICROBIOL, V43, P4862, DOI 10.1128/JCM.43.9.4862-4864.2005; al Naiemi N, 2008, NVMM GUIDELINE DUTCH; Borjesson S, 2013, CLIN MICROBIOL INFEC, V19, pE309, DOI 10.1111/1469-0691.12192; Bortolaia V, 2014, J ANTIMICROB CHEMOTH, V69, P1492, DOI 10.1093/jac/dku011; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Cejas D, 2012, REV ARGENT MICROBIOL, V44, P182; Corvec S, 2010, DIAGN MICR INFEC DIS, V67, P277, DOI 10.1016/j.diagmicrobio.2010.02.007; Cuzon G, 2012, J ANTIMICROB CHEMOTH, V67, P1865, DOI 10.1093/jac/dks156; Endimiani A, 2010, J CLIN MICROBIOL, V48, P2618, DOI 10.1128/JCM.00568-10; Garrido A, 2014, MICROB DRUG RESIST, V20, P301, DOI 10.1089/mdr.2013.0109; Hanson ND, 2008, ANTIMICROB AGENTS CH, V52, P3814, DOI 10.1128/AAC.00877-08; Huang IF, 2005, J CLIN MICROBIOL, V43, P2608, DOI 10.1128/JCM.43.6.2608-2612.2005; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Ktari S, 2009, MICROB DRUG RESIST, V15, P279, DOI 10.1089/mdr.2009.0035; Lee CH, 2015, J MICROBIOL IMMUNOL, V48, P269, DOI 10.1016/j.jmii.2013.08.010; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mulvey MR, 2005, ANTIMICROB AGENTS CH, V49, P358, DOI 10.1128/AAC.49.1.358-365.2005; Nadjar D, 2000, FEMS MICROBIOL LETT, V187, P35, DOI 10.1016/S0378-1097(00)00166-X; Naseer U, 2010, CLIN MICROBIOL INFEC, V16, P171, DOI 10.1111/j.1469-0691.2009.02861.x; Ohana S, 2005, ANTIMICROB AGENTS CH, V49, P2095, DOI 10.1128/AAC.49.5.2095-2097.2005; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Philippon A, 2002, ANTIMICROB AGENTS CH, V46, P1, DOI 10.1128/AAC.46.1.1-11.2002; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Pitout JDD, 2007, EMERG INFECT DIS, V13, P443, DOI 10.3201/eid1303.060447; Reuland EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091396; Reuland EA, 2012, CLIN MICROBIOL INFEC; Rodriguez-Bano J, 2012, J INFECTION, V64, P176, DOI 10.1016/j.jinf.2011.11.016; Roh KH, 2008, YONSEI MED J, V49, P53, DOI 10.3349/ymj.2008.49.1.53; Savelkoul PHM, 1999, J CLIN MICROBIOL, V37, P3083, DOI 10.1128/JCM.37.10.3083-3091.1999; Stuart JC, 2010, INT J ANTIMICROB AG, V36, P205, DOI 10.1016/j.ijantimicag.2010.05.014; Tan TY, 2009, ANTIMICROB AGENTS CH, V53, P146, DOI 10.1128/AAC.00862-08; Tumbarello M, 2007, ANTIMICROB AGENTS CH, V51, P1987, DOI 10.1128/AAC.01509-06; Wiener J, 1999, JAMA-J AM MED ASSOC, V281, P517, DOI 10.1001/jama.281.6.517; Woodford N, 2007, J ANTIMICROB CHEMOTH, V59, P102, DOI 10.1093/jac/dkl456	35	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0113033	10.1371/journal.pone.0113033	http://dx.doi.org/10.1371/journal.pone.0113033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587716	Green Published, gold, Green Submitted			2022-12-26	WOS:000347928300001
J	Zhao, S; Kurenbekova, L; Gao, Y; Roos, A; Creighton, CJ; Rao, P; Hicks, J; Man, TK; Lau, C; Brown, AMC; Jones, SN; Lazar, AJ; Ingram, D; Lev, D; Donehower, LA; Yustein, JT				Zhao, S.; Kurenbekova, L.; Gao, Y.; Roos, A.; Creighton, C. J.; Rao, P.; Hicks, J.; Man, T-K; Lau, C.; Brown, A. M. C.; Jones, S. N.; Lazar, A. J.; Ingram, D.; Lev, D.; Donehower, L. A.; Yustein, J. T.			NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma	ONCOGENE			English	Article							PROMOTER HYPERMETHYLATION; P53; GENE; PROGRESSION; MEMBRANE; INVASION; PATHWAYS; MUTATION; BIOLOGY; ALPHA	Osteosarcoma (OS) is the most frequent pediatric malignant bone tumor that has a high propensity for metastases. Through osteoblast-specific alteration of p53 status, we developed a genetically engineered mouse model of localized and metastatic OS to gain an understanding into the molecular pathogenesis of OS. Microarray analysis of both localized tumors and metastatic tumors identified the downregulation of the naked cuticle homolog 2 (NKD2) gene, a negative regulator of Wnt signaling. Overexpression of NKD2 in metastatic human and mouse OS cells significantly decreases cell proliferation, migration and invasion ability in vitro and drastically diminishes OS tumor growth and metastasis in vivo, whereas downregulation enhances migratory and invasive potential. Evaluation of NKD2-overexpressing tumors revealed upregulation of tumor-suppressor genes and downregulation of molecules involved in blood vessel formation and cell migration. Furthermore, assessment of primary human OS revealed downregulation of NKD2 in metastatic and recurrent OS. Finally, we provide biological evidence that use of small-molecule inhibitors targeting the Wnt pathway can have therapeutic efficacy in decreasing metastatic properties in OS. Our studies provide compelling evidence that downregulation of NKD2 expression and alterations in associated regulated pathways have a significant role in driving OS tumor growth and metastasis.	[Zhao, S.; Kurenbekova, L.; Gao, Y.; Roos, A.; Rao, P.; Man, T-K; Lau, C.; Donehower, L. A.; Yustein, J. T.] Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Zhao, S.; Kurenbekova, L.; Gao, Y.; Roos, A.; Rao, P.; Man, T-K; Lau, C.; Donehower, L. A.; Yustein, J. T.] Baylor Coll Med, Texas Childrens Hematol Ctr, Dept Pediat, Houston, TX 77030 USA; [Roos, A.; Donehower, L. A.; Yustein, J. T.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Creighton, C. J.] Baylor Coll Med, Dept Med, Div Biostat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Hicks, J.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Brown, A. M. C.] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Jones, S. N.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA USA; [Lazar, A. J.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Lazar, A. J.; Ingram, D.] Univ Texas MD Anderson Canc Ctr, Sarcoma Res Ctr, Houston, TX 77030 USA; [Ingram, D.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Lev, D.] Ohio State Univ, Dept Canc Biol, Columbus, OH 43210 USA; [Donehower, L. A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Cornell University; University of Massachusetts System; University of Massachusetts Worcester; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; Ohio State University; Baylor College of Medicine	Yustein, JT (corresponding author), Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat, One Baylor Plaza,Room 824D, Houston, TX 77030 USA.	yustein@bcm.edu	Lazar, Alexander J/A-3416-2008	Lazar, Alexander J/0000-0002-6395-4499; Man, Tsz-Kwong/0000-0001-5920-5746	Cancer Prevention and Research Institute of Texas; WWWW Foundation, Inc.; St Baldrick's Foundation; Sarcoma Foundation of America; NIH [R01 CA123238]; NCI/NIH [P30 CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123, R01CA123238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008539] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; WWWW Foundation, Inc.; St Baldrick's Foundation; Sarcoma Foundation of America; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Yiqun Zhang for technical assistance and Dr Neha Parikh for her assistance with figure layout and design. This work was supported by The Cancer Prevention and Research Institute of Texas (to SZ, T-KM, CL, PR, JH, LK, CJC, LAD, JTY), WWWW Foundation, Inc. (QuadW) (to JTY), The St Baldrick's Foundation (to JTY), the Sarcoma Foundation of America (to LAD), NIH R01 CA123238 (to AMCB) and NCI/NIH grant P30 CA125123 (to CJC).	Bacci G, 2003, ANN ONCOL, V14, P1126, DOI 10.1093/annonc/mdg286; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Baron Roland, 2007, Curr Osteoporos Rep, V5, P73; Brennecke P, 2014, CLIN EXP METASTAS, V31, P339, DOI 10.1007/s10585-013-9632-3; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Donehower Lawrence A, 2009, Nat Rev Cancer, V9, P831, DOI 10.1038/nrc2731; Dumble Melissa L, 2003, Methods Mol Biol, V234, P29; Edamura K, 2007, CANCER GENE THER, V14, P765, DOI 10.1038/sj.cgt.7701071; Feng W, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1762; Flores RJ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-50; Gotze S, 2010, INT J CANCER, V126, P2584, DOI 10.1002/ijc.24981; Guo Y, 2007, J ORTHOP RES, V25, P964, DOI 10.1002/jor.20356; Hoang BH, 2004, CANCER RES, V64, P2734, DOI 10.1158/0008-5472.CAN-03-1952; Hong SH, 2009, INT J CANCER, V124, P2042, DOI 10.1002/ijc.24169; Hsieh SY, 2004, ONCOGENE, V23, P9183, DOI 10.1038/sj.onc.1208138; Hu TH, 2010, J BIOL CHEM, V285, P13561, DOI 10.1074/jbc.M109.075945; Husmann K, 2013, BBA-MOL BASIS DIS, V1832, P347, DOI 10.1016/j.bbadis.2012.11.006; Johnson AS, 1998, CARCINOGENESIS, V19, P213, DOI 10.1093/carcin/19.1.213; Kager L, 2003, J CLIN ONCOL, V21, P2011, DOI 10.1200/JCO.2003.08.132; Kanda M, 2011, MOL CARCINOGEN, V50, P571, DOI 10.1002/mc.20735; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Kimura R, 2011, BBA-MOL CELL RES, V1813, P1543, DOI 10.1016/j.bbamcr.2011.04.008; Lauvrak SU, 2013, BRIT J CANCER, V109, P2228, DOI 10.1038/bjc.2013.549; Li CX, 2007, MOL BIOL CELL, V18, P3081, DOI 10.1091/mbc.E07-02-0172; Li CX, 2004, P NATL ACAD SCI USA, V101, P5571, DOI 10.1073/pnas.0401294101; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Luu HH, 2005, CLIN EXP METASTAS, V22, P319, DOI 10.1007/s10585-005-0365-9; MEYERS PA, 1993, J CLIN ONCOL, V11, P449, DOI 10.1200/JCO.1993.11.3.449; Miretti S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001828; Mizobuchi Y, 2008, NEURO-ONCOLOGY, V10, P244, DOI 10.1215/15228517-2008-016; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Muff Roman, 2012, Sarcoma, V2012, P937506, DOI 10.1155/2012/937506; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Veeck J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2151; Wang LL, 2005, CANCER J, V11, P294, DOI 10.1097/00130404-200507000-00005; Wlazlinski A, 2007, PROSTATE, V67, P1770, DOI 10.1002/pros.20667; Yan D, 2001, P NATL ACAD SCI USA, V98, P3802, DOI 10.1073/pnas.071041898	46	81	86	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 24	2015	34	39					5069	5079		10.1038/onc.2014.429	http://dx.doi.org/10.1038/onc.2014.429			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR9RC	25579177	Green Accepted			2022-12-26	WOS:000361693300007
J	Mediero, A; Wilder, T; Perez-Aso, M; Cronstein, BN				Mediero, Aranzazu; Wilder, Tuere; Perez-Aso, Miguel; Cronstein, Bruce N.			Direct or indirect stimulation of adenosine A(2A) receptors enhances bone regeneration as well as bone morphogenetic protein-2	FASEB JOURNAL			English	Article						CGS21680; dipyridamole; bone formation; osteoclast; osteoblast	OSTEOCLAST FORMATION; ACTIVATION; DIFFERENTIATION; INFLAMMATION; TRANSPORTER; EXPRESSION; DEFECTS; SAFETY; CELLS; A(1)	Promoting bone regeneration and repair of bone defects is a need that has not been well met to date. We have previously found that adenosine, acting via A(2A) receptors (A2AR) promotes wound healing and inhibits inflammatory osteolysis and hypothesized that A2AR might be a novel target to promote bone regeneration. Therefore, we determined whether direct A2AR stimulation or increasing endogenous adenosine concentrations via purine transport blockade with dipyridamole regulates bone formation. We determined whether coverage of a 3 mm trephine defect in a mouse skull with a collagen scaffold soaked in saline, bone morphogenetic protein-2 (BMP-2; 200 ng), 1 mu M CGS21680 (A2AR agonist, EC50 = 160 nM), or 1 mu M dipyridamole (EC50 = 32 nM) promoted bone regeneration. Microcomputed tomography examination demonstrated that CGS21680 and dipyridamole markedly enhanced bone regeneration as well as BMP-2 8 wk after surgery (60 +/- 2%, 79 +/- 2%, and 75 +/- 1% bone regeneration, respectively, vs. 32 +/- 2% in control, P < 0.001). Blockade by a selective A2AR antagonist (ZM241385, 1 mu M) or deletion of A2AR abrogated the effect of CGS21680 and dipyridamole on bone regeneration. Both CGS21680 and dipyridamole treatment increased alkaline phosphatase-positive osteoblasts and diminished tartrate resistance acid phosphatase-positive osteoclasts in the defects. In vivo imaging with a fluorescent dye for new bone formation revealed a strong fluorescent signal in treated animals that was equivalent to BMP-2. In conclusion, stimulation of A2AR by specific agonists or by increasing endogenous adenosine levels stimulates new bone formation as well as BMP-2 and represents a novel approach to stimulating bone regeneration.	NYU, Langone Med Ctr, Dept Med, Div Translat Med, New York, NY 10016 USA; NYU, Langone Med Ctr, Dept Med, Div Rheumatol, New York, NY 10016 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Cronstein, BN (corresponding author), NYU, Sch Med, Dept Med, Div Translat Med, 550 First Ave,MSB251, New York, NY 10016 USA.	bruce.cronstein@nyumc.org	Mediero, Aranzazu/AAA-8362-2020	Mediero, Aranzazu/0000-0002-5368-574X; Cronstein, Bruce/0000-0002-4295-7383; Pintor, Jesus/0000-0002-9191-7679; Perez-Aso, Miguel/0000-0002-4703-4182	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR56672, AR54897, AR046121]; NIH National Heart, Lung, and Blood Institute [RC1-HL100815]; New York University Health and Hospitals Corporation (NYU-HHC) Clinical and Translational Science Institute [UL1TR000038]; New York University Caregiver Intervention (NYUCI) Center support grant from NIH National Cancer Institute [5-P30CA16087-310]; Takeda; Celgene; AstraZeneca; Gilead Pharmaceuticals; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445, UL1TR000038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR056672, R01AR056672, R01AR054897, P30AR046121] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); New York University Health and Hospitals Corporation (NYU-HHC) Clinical and Translational Science Institute; New York University Caregiver Intervention (NYUCI) Center support grant from NIH National Cancer Institute; Takeda(Takeda Pharmaceutical Company Ltd); Celgene(Bristol-Myers SquibbCelgene Corporation); AstraZeneca(AstraZeneca); Gilead Pharmaceuticals(Gilead Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank the New York University School of Medicine Histology Core for help with immunostainings. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants AR56672, AR54897, AR046121 and NIH National Heart, Lung, and Blood Institute Grant RC1-HL100815; New York University Health and Hospitals Corporation (NYU-HHC) Clinical and Translational Science Institute (Grant UL1TR000038); New York University Caregiver Intervention (NYUCI) Center support grant from NIH National Cancer Institute Grant 5-P30CA16087-310; and grants from Takeda, Celgene, AstraZeneca, and Gilead Pharmaceuticals. A.M. and B.N.C. have filed a patent on the use of dipyridamole-coated matrices to promote bone growth and have received a patent for the use of adenosine A2AR agonists to prevent prosthesis loosening (patent number 8183225). A.M. and B.N.C. have filed a patent on the use of anti-netrin-1 antibodies for the treatment of bone disease (pending). B.N.C. holds patents 5,932,558; 6,020,321; 6,555,545; and 7,795,427-adenosine A1R and A<INF>2B</INF>R antagonists to treat fatty liver (pending). B.N.C. is a consultant for Bristol-Myers Squibb, Novartis, Eli Lilly & Co., CanFite Biopharmaceuticals, Cypress Laboratories, Regeneron (Westat, DSMB), Endocyte, Protalex, Allos, Inc., Savient, Gismo Therapeutics, Antares Pharmaceutical, Medivector, King Pharmaceutical, Celizome, Tap Pharmaceuticals, Prometheus Laboratories, Sepracor, Amgen, Combinatorx, Kyowa Hakka, Hoffman-LaRoche, and Avidimer Therapeutics and has stock in CanFite Biopharmaceuticals. M.P.-A. and T.W. declare no conflicts of interest.	Costa MA, 2011, J CELL PHYSIOL, V226, P1353, DOI 10.1002/jcp.22458; Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Carroll SH, 2012, J BIOL CHEM, V287, P15718, DOI 10.1074/jbc.M112.344994; Cerqueira MD, 2004, AM J CARDIOL, V94, p33D; Chan ESL, 2010, NAT REV RHEUMATOL, V6, P175, DOI 10.1038/nrrheum.2010.5; Chaudary N, 2004, CARDIOVASC RES, V61, P780, DOI 10.1016/j.cardiores.2003.11.031; Cook SD, 2002, J INVEST SURG, V15, P69, DOI 10.1080/08941930290085822; Cooper GM, 2010, PLAST RECONSTR SURG, V125, P1685, DOI 10.1097/PRS.0b013e3181cb63a3; De Mattei M, 1999, BIOELECTROMAGNETICS, V20, P177, DOI 10.1002/(SICI)1521-186X(1999)20:3<177::AID-BEM4>3.0.CO;2-#; den Boer FC, 2003, J ORTHOP RES, V21, P521, DOI 10.1016/S0736-0266(02)00205-X; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Evans BAJ, 2006, J BONE MINER RES, V21, P228, DOI 10.1359/JBMR.051021; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Frey JL, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.5; Gharibi B, 2012, INT J OBESITY, V36, P397, DOI 10.1038/ijo.2011.129; Gharibi B, 2011, J BONE MINER RES, V26, P2112, DOI 10.1002/jbmr.424; Glassman SD, 2011, SPINE, V36, P1849, DOI 10.1097/BRS.0b013e3181d133d0; Harmatys KM, 2013, MOL PHARMACEUT, V10, P4263, DOI 10.1021/mp400357v; He W, 2012, PURINERG SIGNAL, V8, P327, DOI 10.1007/s11302-012-9292-9; He WJ, 2013, FASEB J, V27, P3446, DOI 10.1096/fj.13-231233; Kara FM, 2010, FASEB J, V24, P2325, DOI 10.1096/fj.09-147447; Kara FM, 2010, ARTHRITIS RHEUM-US, V62, P534, DOI 10.1002/art.27219; Katebi M, 2009, J LEUKOCYTE BIOL, V85, P438, DOI 10.1189/jlb.0908520; Khoa ND, 2006, MOL PHARMACOL, V69, P1311, DOI 10.1124/mol.105.016857; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; Knowles HJ, 2010, FASEB J, V24, P4648, DOI 10.1096/fj.10-162230; LAM JYT, 1988, J AM COLL CARDIOL, V11, P585, DOI 10.1016/0735-1097(88)91535-5; Lassailly F, 2010, BLOOD, V115, P5347, DOI 10.1182/blood-2009-05-224030; LETTE J, 1995, J NUCL CARDIOL, V2, P3, DOI 10.1016/S1071-3581(05)80003-0; Li HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002353; Mediero A, 2015, ARTHRITIS RHEUMATOL, V67, P849, DOI 10.1002/art.38971; Mediero A, 2013, BRIT J PHARMACOL, V169, P1372, DOI 10.1111/bph.12227; Mediero A, 2013, TRENDS ENDOCRIN MET, V24, P290, DOI 10.1016/j.tem.2013.02.001; Mediero A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003393; Mediero A, 2012, AM J PATHOL, V180, P775, DOI 10.1016/j.ajpath.2011.10.017; Montesinos MC, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1914; Morote-Garcia JC, 2009, GASTROENTEROLOGY, V136, P607, DOI 10.1053/j.gastro.2008.10.037; Onishi T, 1998, BONE, V22, P605, DOI 10.1016/S8756-3282(98)00056-8; Pape HC, 2010, J ORTHOP TRAUMA, V24, P522, DOI 10.1097/BOT.0b013e3181ed1361; Pennycooke M, 2001, BIOCHEM BIOPH RES CO, V280, P951, DOI 10.1006/bbrc.2000.4205; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299, DOI 10.1097/00003086-198604000-00036; Spiro AS, 2010, J ORTHOP RES, V28, P785, DOI 10.1002/jor.21044; Takedachi M, 2012, J CELL PHYSIOL, V227, P2622, DOI 10.1002/jcp.23001; Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006; Utting JC, 2006, EXP CELL RES, V312, P1693, DOI 10.1016/j.yexcr.2006.02.007; van Gaalen SM, 2010, TISSUE ENG PART B-RE, V16, P209, DOI [10.1089/ten.teb.2009.0503, 10.1089/ten.TEB.2009.0503]; White AP, 2007, INT ORTHOP, V31, P735, DOI 10.1007/s00264-007-0422-x; Yang ZQ, 2006, CIRCULATION, V114, P2056, DOI 10.1161/CIRCULATIONAHA.106.649244; Yang ZQ, 2005, CIRCULATION, V111, P2190, DOI 10.1161/01.CIR.0000163586.62253.A5	53	61	65	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1577	1590		10.1096/fj.14-265066	http://dx.doi.org/10.1096/fj.14-265066			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25573752	Green Published			2022-12-26	WOS:000354115000041
J	Byrd, AK; Raney, KD				Byrd, Alicia K.; Raney, Kevin D.			A Parallel Quadruplex DNA Is Bound Tightly but Unfolded Slowly by Pif1 Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE PIF1; SINGLE-STRANDED-DNA; C-MYC PROMOTER; TELOMERIC G-QUADRUPLEX; GENOMIC STABILITY; CRYSTAL-STRUCTURE; FAMILY HELICASES; MAMMALIAN-CELLS; NUCLEIC-ACIDS; BINDING	DNA sequences that can form intramolecular quadruplex structures are found in promoters of proto-oncogenes. Many of these sequences readily fold into parallel quadruplexes. Here we characterize the ability of yeast Pill to bind and unfold a parallel quadruplex DNA substrate. We found that Pif1 binds more tightly to the parallel quadruplex DNA than single-stranded DNA or tailed duplexes. However, Pif1 unwinding of duplexes occurs at a much faster rate than unfolding of a parallel intramolecular quadruplex. Pill readily unfolds a parallel quadruplex DNA substrate in a multiturnover reaction and also generates some product under single cycle conditions. The rate of ATP hydrolysis by Pill is reduced when bound to a parallel quadruplex compared with single-stranded DNA. ATP hydrolysis occurs at a faster rate than quadruplex unfolding, indicating that some ATP hydrolysis events are non-productive during unfolding of intramolecular parallel quadruplex DNA. However, product eventually accumulates at a slow rate.	[Byrd, Alicia K.; Raney, Kevin D.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Raney, KD (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Slot 516,4301 W Markham, Little Rock, AR 72205 USA.	raneykevind@uams.edu		Byrd, Alicia/0000-0001-5484-0759	National Institutes of Health [R01 GM098922]; Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM098922 (to K. D. R.). This work was also supported by the Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000.	Adrian M, 2014, J AM CHEM SOC, V136, P6297, DOI 10.1021/ja4125274; Ail JA, 1999, J MOL BIOL, V293, P815, DOI 10.1006/jmbi.1999.3185; Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Bachrati CZ, 2006, METHOD ENZYMOL, V409, P86, DOI 10.1016/S0076-6879(05)09005-1; Barranco-Medina S, 2010, BIOCHEMISTRY-US, V49, P8445, DOI 10.1021/bi100984j; Belotserkovskii BP, 2007, J BIOL CHEM, V282, P32433, DOI 10.1074/jbc.M704618200; Bharti SK, 2013, J BIOL CHEM, V288, P28217, DOI 10.1074/jbc.M113.496463; Bhattacharyya B, 2014, PROTEIN SCI, V23, P1498, DOI 10.1002/pro.2533; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Byrd AK, 2012, FRONT BIOSCI-LANDMRK, V17, P2070, DOI 10.2741/4038; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; Carroll SS, 1996, METHOD ENZYMOL, V275, P365; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; Eddy S, 2014, NUCLEIC ACIDS RES, V42, P3272, DOI 10.1093/nar/gkt1314; Eoff RL, 2006, NAT STRUCT MOL BIOL, V13, P242, DOI 10.1038/nsmb1055; Galletto R, 2013, NUCLEIC ACIDS RES, V41, P4613, DOI 10.1093/nar/gkt117; Gavathiotis E, 2003, ORG BIOMOL CHEM, V1, P1650, DOI 10.1039/b300845m; Gilhooly Neville Surain, 2013, Front Biosci (Schol Ed), V5, P206; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; Gray LT, 2014, NAT CHEM BIOL, V10, P313, DOI [10.1038/NCHEMBIO.1475, 10.1038/nchembio.1475]; Gray RD, 2014, J MOL BIOL, V426, P1629, DOI 10.1016/j.jmb.2014.01.009; Halder K, 2005, NUCLEIC ACIDS RES, V33, P4466, DOI 10.1093/nar/gki750; Hatzakis E, 2010, BIOCHEMISTRY-US, V49, P9152, DOI 10.1021/bi100946g; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Inagaki H, 2009, GENOME RES, V19, P191, DOI 10.1101/gr.079244.108; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; LAHAYE A, 1993, J BIOL CHEM, V268, P26155; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Long X, 2013, NUCLEIC ACIDS RES, V41, P2746, DOI 10.1093/nar/gks1341; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Meier M, 2013, J BIOL CHEM, V288, P35014, DOI 10.1074/jbc.M113.512970; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Morris PD, 2001, J BIOL CHEM, V276, P19691, DOI 10.1074/jbc.M010928200; Muller S, 2010, NAT CHEM, V2, P1095, DOI 10.1038/NCHEM.842; Murat P, 2014, CURR OPIN GENET DEV, V25, P22, DOI 10.1016/j.gde.2013.10.012; Narayana N, 2009, J MOL BIOL, V385, P469, DOI 10.1016/j.jmb.2008.10.041; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Piazza A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003033; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; Ramanagoudr-Bhojappa R, 2014, BIOCHEMISTRY-US, V53, P7659, DOI 10.1021/bi500746v; Ramanagoudr-Bhojappa R, 2013, J BIOL CHEM, V288, P16185, DOI 10.1074/jbc.M113.470013; Ramanagoudr-Bhojappa R, 2013, NUCLEIC ACIDS RES, V41, P1029, DOI 10.1093/nar/gks1088; Raney KD, 2013, ADV EXP MED BIOL, V973, P17, DOI 10.1007/978-1-4614-5037-5_2; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Toseland CP, 2009, J MOL BIOL, V392, P1020, DOI 10.1016/j.jmb.2009.07.071; Wang GL, 2006, P NATL ACAD SCI USA, V103, P2677, DOI 10.1073/pnas.0511084103; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Xiao S, 2013, NUCLEIC ACIDS RES, V41, P10379, DOI 10.1093/nar/gkt781; Ying LM, 2003, P NATL ACAD SCI USA, V100, P14629, DOI 10.1073/pnas.2433350100; Zhang AYQ, 2012, J AM CHEM SOC, V134, P19297, DOI 10.1021/ja309851t; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2; Zhou RB, 2014, ELIFE, V3, DOI 10.7554/eLife.02190	68	47	53	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6482	6494		10.1074/jbc.M114.630749	http://dx.doi.org/10.1074/jbc.M114.630749			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25589786	hybrid, Green Published			2022-12-26	WOS:000350732500051
J	Ando, Y; Shinozawa, Y; Iijima, Y; Yu, BC; Sone, M; Ooi, Y; Watanaka, Y; Chida, K; Hakuno, F; Takahashi, SI				Ando, Yasutoshi; Shinozawa, Yusuke; Iijima, Yumi; Yu, Bu-Chin; Sone, Meri; Ooi, Yuko; Watanaka, Yusuke; Chida, Kazuhiro; Hakuno, Fumihiko; Takahashi, Shin-Ichiro			Tumor Necrosis Factor (TNF)-alpha-induced Repression of GKAP42 Protein Levels through cGMP-dependent Kinase (cGK)-I alpha Causes Insulin Resistance in 3T3-L1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; RECEPTOR SUBSTRATE-1; FACTOR-ALPHA; TYROSINE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; GLUT4 TRANSLOCATION; SIGNALING PATHWAYS; PHOSPHORYLATION; OBESITY; DOMAIN	Insulin receptor substrates (IRSs) have been shown to be major mediators of insulin signaling. Recently, we found that IRSs form high-molecular weight complexes, and here, we identify by yeast two-hybrid screening a novel IRS-1-associated protein: a 42-kDa cGMP-dependent protein kinase-anchoring protein (GKAP42). GKAP42 knockdown in 3T3-L1 adipocytes suppressed insulin-dependent IRS-1 tyrosine phosphorylation and downstream signaling, resulting in suppression of GLUT4 translocation to plasma membrane induced by insulin. In addition, GLUT4 translocation was also suppressed in cells overexpressing GKAP42-N (the IRS-1 binding region of GKAP42), which competed with GKAP42 for IRS-1, indicating that GKAP42 binding to IRS-1 is required for insulin-induced GLUT4 translocation. Long term treatment of 3T3-L1 adipocytes with TNF-alpha, which induced insulin resistance, significantly decreased the GKAP42 protein level. We then investigated the roles of cGMP-dependent kinase (cGK)-I alpha, which bound to GKAP42, in these changes. cGK-I alpha knockdown partially rescued TNF-alpha-induced decrease in GKAP42 and impairment of insulin signals. These data indicated that TNF-alpha-induced repression of GKAP42 via cGK-I alpha caused reduction of insulin-induced IRS-1 tyrosine phosphorylation at least in part. The present study describes analysis of the novel TNF-alpha-induced pathway, cGK-I alpha-GKAP42, which regulates insulin-dependent signals and GLUT4 translocation.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Sci, Bunkyo Ku, Tokyo 1138657, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo	Hakuno, F (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Sci, Lab Cell Regulat,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ahakuno@mail.ecc.u-tokyo.ac.jp		Hakuno, Fumihiko/0000-0002-4447-6225; Takahashi, Shin-Ichiro/0000-0002-2323-2010; Ando, Yukio/0000-0001-7115-9105	Japan Society for the Promotion of Science [24380152, 16208028, 22248030, 25221204]; Program for Promotion of Basic Research Activities for Innovative Biosciences; Program for Basic and Applied Research for Innovations in Bio-oriented Industry	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic Research Activities for Innovative Biosciences; Program for Basic and Applied Research for Innovations in Bio-oriented Industry	This work was supported in part by Grant-in-aid for Scientific Research (B) 24380152 (to F. H.) and Grants-in-aid for Scientific Research (A) (2) 16208028, (A) (2) 22248030, and (S) 25221204 (to S.-I. T.); a Grant-in-aid for International Joint Research (to S.-I. T.); and the Core-to-Core Program (to S.-I. T.) from the Japan Society for the Promotion of Science. This work was also supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences (to F. H.) as well as the Program for Basic and Applied Research for Innovations in Bio-oriented Industry (to S.-I. T.).	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Ariga M, 2000, BIOCHEM J, V348, P409, DOI 10.1042/0264-6021:3480409; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f; Ducluzeau PH, 2002, DIABETES METAB, V28, P85; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Elmendorf JS, 1998, J BIOL CHEM, V273, P13289, DOI 10.1074/jbc.273.21.13289; Engelman JA, 2000, MOL ENDOCRINOL, V14, P1557, DOI 10.1210/me.14.10.1557; Farhang-Fallah J, 2002, MOL CELL BIOL, V22, P7325, DOI 10.1128/MCB.22.20.7325-7336.2002; Fischer BM, 1999, AM J RESP CELL MOL, V20, P413, DOI 10.1165/ajrcmb.20.3.3393; Fukushima T, 2011, MOL CELL ENDOCRINOL, V344, P81, DOI 10.1016/j.mce.2011.06.029; Fukushima T, 2011, BIOCHEM BIOPH RES CO, V404, P767, DOI 10.1016/j.bbrc.2010.12.045; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Grigsby RJ, 2001, BIOCHEM BIOPH RES CO, V287, P1121, DOI 10.1006/bbrc.2001.5694; GRONBORG M, 1993, J BIOL CHEM, V268, P23435; Gual P, 2003, DIABETOLOGIA, V46, P1532, DOI 10.1007/s00125-003-1223-4; Hakuno F, 2007, J BIOL CHEM, V282, P37747, DOI 10.1074/jbc.M702472200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Kabuta T, 2002, J BIOL CHEM, V277, P6846, DOI 10.1074/jbc.M107058200; Kanatani Y, 2007, DIABETES, V56, P795, DOI 10.2337/db06-1039; Kapur S, 1999, AM J PHYSIOL-ENDOC M, V276, pE635, DOI 10.1152/ajpendo.1999.276.4.E635; Lee A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055634; Liu YF, 2004, MOL CELL BIOL, V24, P9668, DOI 10.1128/MCB.24.21.9668-9681.2004; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Nawaratne R, 2006, MOL ENDOCRINOL, V20, P1838, DOI 10.1210/me.2005-0536; Nedachi T, 2000, ENDOCRINOLOGY, V141, P2429, DOI 10.1210/en.141.7.2429; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Ribiere C, 1996, BIOCHEM BIOPH RES CO, V222, P706, DOI 10.1006/bbrc.1996.0824; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; TANTI JF, 1994, J BIOL CHEM, V269, P6051; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Watson RT, 2004, EMBO J, V23, P2059, DOI 10.1038/sj.emboj.7600159; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Yoneyama Y, 2013, MOL CELL BIOL, V33, P1991, DOI 10.1128/MCB.01394-12; Yuasa K, 2000, J BIOL CHEM, V275, P4897, DOI 10.1074/jbc.275.7.4897; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4	54	19	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5881	5892		10.1074/jbc.M114.624759	http://dx.doi.org/10.1074/jbc.M114.624759			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25586176	Green Published, hybrid			2022-12-26	WOS:000350044200052
J	Liu, HJ; Yan, PJ; Fanning, E				Liu, Hanjian; Yan, Peijun; Fanning, Ellen			Human DNA Helicase B Functions in Cellular Homologous Recombination and Stimulates Rad51-Mediated 5 '-3 ' Heteroduplex Extension In Vitro	PLOS ONE			English	Article							REPLICATION PROTEIN-A; DOUBLE-STRAND BREAKS; YEAST RAD51 PROTEIN; SACCHAROMYCES-CEREVISIAE; COMPLEX-FORMATION; BINDING PROTEIN; EXCHANGE; REPAIR; CELLS; DAMAGE	Homologous recombination is involved in the repair of DNA damage and collapsed replication fork, and is critical for the maintenance of genomic stability. Its process involves a network of proteins with different enzymatic activities. Human DNA helicase B (HDHB) is a robust 5'-3' DNA helicase which accumulates on chromatin in cells exposed to DNA damage. HDHB facilitates cellular recovery from replication stress, but its role in DNA damage response remains unclear. Here we report that HDHB silencing results in reduced sister chromatid exchange, impaired homologous recombination repair, and delayed RPA late-stage foci formation induced by ionizing radiation. Ectopically expressed HDHB colocalizes with Rad51, Rad52, RPA, and ssDNA. In vitro, HDHB stimulates Rad51-mediated hetero-duplex extension in 5'-3' direction. A helicase-defective mutant HDHB failed to promote this reaction. Our studies implicate HDHB promotes homologous recombination in vivo and stimulates 5'-3' heteroduplex extension during Rad51-mediated strand exchange in vitro.	[Liu, Hanjian; Yan, Peijun; Fanning, Ellen] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Liu, HJ (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	hanjianliu@gmail.com			NIH [GM52948, P30CA68485]; HHMI Professors Program [52003905]; Vanderbilt University; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052948] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI Professors Program; Vanderbilt University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH (www.nih.gov) (GM52948 to E.F. and P30CA68485 to the Vanderbilt-Ingram Cancer Center), HHMI Professors Program (52003905), and by Vanderbilt University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2004, J BIOL CHEM, V279, P37343, DOI 10.1074/jbc.M313910200; Balajee AS, 2004, EXP CELL RES, V300, P320, DOI 10.1016/j.yexcr.2004.07.022; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Ceballos SJ, 2011, BBA-GENE REGUL MECH, V1809, P509, DOI 10.1016/j.bbagrm.2011.06.006; Chi P, 2006, J BIOL CHEM, V281, P26268, DOI 10.1074/jbc.M602983200; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; Dudas A, 2004, MUTAT RES, V566, P131; Gu JM, 2004, MOL BIOL CELL, V15, P3320, DOI 10.1091/mbc.E04-03-0227; Guler GD, 2012, J BIOL CHEM, V287, P6469, DOI 10.1074/jbc.M111.324582; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; KODADEK T, 1987, NATURE, V326, P312, DOI 10.1038/326312a0; Li X, 2009, NUCLEIC ACIDS RES, V37, P638, DOI 10.1093/nar/gkn980; Liu YL, 2004, J MOL BIOL, V337, P817, DOI 10.1016/j.jmb.2004.02.022; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Mazin AV, 2000, EMBO J, V19, P1148, DOI 10.1093/emboj/19.5.1148; Mazina OM, 2004, CELL, V117, P47, DOI 10.1016/S0092-8674(04)00294-6; McHugh PJ, 2001, LANCET ONCOL, V2, P483, DOI 10.1016/S1470-2045(01)00454-5; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Mohindra A, 2002, HUM MOL GENET, V11, P2189, DOI 10.1093/hmg/11.18.2189; Namsaraev E, 1997, MOL CELL BIOL, V17, P5359, DOI 10.1128/MCB.17.9.5359; Namsaraev EA, 1998, P NATL ACAD SCI USA, V95, P10477, DOI 10.1073/pnas.95.18.10477; Namsaraev EA, 2000, J BIOL CHEM, V275, P3970, DOI 10.1074/jbc.275.6.3970; New JH, 2002, J BIOL CHEM, V277, P26171, DOI 10.1074/jbc.M203670200; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; SAITOH A, 1995, NUCLEIC ACIDS RES, V23, P2014, DOI 10.1093/nar/23.11.2014; Shim KS, 2006, DNA REPAIR, V5, P718, DOI 10.1016/j.dnarep.2006.03.006; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Solinger JA, 2001, P NATL ACAD SCI USA, V98, P8447, DOI 10.1073/pnas.121009898; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Tada S, 2001, NUCLEIC ACIDS RES, V29, P3835, DOI 10.1093/nar/29.18.3835; Taneja P, 2002, J BIOL CHEM, V277, P40853, DOI 10.1074/jbc.M208067200; Wang X, 2004, PLOS BIOL, V2, P104, DOI 10.1371/journal.pbio.0020021; Wright WD, 2014, MOL CELL, V53, P420, DOI 10.1016/j.molcel.2013.12.027	42	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116852	10.1371/journal.pone.0116852	http://dx.doi.org/10.1371/journal.pone.0116852			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617833	gold, Green Submitted, Green Published			2022-12-26	WOS:000350336000029
J	Yu, TY; Pang, WJ; Yang, GS				Yu, Tai-yong; Pang, Wei-jun; Yang, Gong-she			Aryl Hydrocarbon Receptors in Osteoclast Lineage Cells Are a Negative Regulator of Bone Mass	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; DIFFERENTIATION FACTOR; ESTROGEN-RECEPTOR; AH-RECEPTOR; IN-UTERO; KAPPA-B; LIGAND; OSTEOPROTEGERIN; ACTIVATION; INDUCTION	Aryl hydrocarbon receptors (AhRs) play a critical role in various pathological and physiological processes. Although recent research has identified AhRs as a key contributor to bone metabolism following studies in systemic AhR knockout (KO) or transgenic mice, the cellular and molecular mechanism(s) in this process remain unclear. In this study, we explored the function of AhR in bone metabolism using AhR(RANK Delta Oc/Delta Oc) (RANK(Cre/+); AhR(flox/flox)) mice. We observed enhanced bone mass together with decreased resorption in both male and female 12 and 24-week-old AhR(RANK Delta Oc/Delta Oc) mice. Control mice treated with 3-methylcholanthrene (3MC), an AhR agonist, exhibited decreased bone mass and increased bone resorption, whereas AhR(Ctsk Delta Oc/Delta Oc) (Ctsk(Cre/+); AhR(flox/flox)) mice injected with 3MC appeared to have a normal bone phenotype. In vitro, bone marrow-derived macrophages (BMDMs) from AhR(RANK Delta Oc/Delta Oc) mice exhibited impaired osteoclastogenesis and repressed differentiation with downregulated expression of B lymphocyte-induced maturation protein 1 (Blimp1), and cytochrome P450 genes Cyp1b1 and Cyp1a2. Collectively, our results not only demonstrated that AhR in osteoclast lineage cells is a physiologically relevant regulator of bone resorption, but also highlighted the need for further studies on the skeletal actions of AhR inhibitors in osteoclast lineage cells commonly associated with bone diseases, especially diseases linked to environmental pollutants known to induce bone loss.	[Yu, Tai-yong] Ehime Univ, Grad Sch Med, Proteosci Ctr, Div Integrat Pathophysiol, Matsuyama, Ehime 7910295, Japan; [Yu, Tai-yong] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Epigenet Skeletal Dis, Tokyo 1130032, Japan; [Pang, Wei-jun; Yang, Gong-she] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi Provinc, Peoples R China	Ehime University; University of Tokyo; Northwest A&F University - China	Yu, TY (corresponding author), Ehime Univ, Grad Sch Med, Proteosci Ctr, Div Integrat Pathophysiol, Matsuyama, Ehime 7910295, Japan.	utaiei310@yahoo.co.jp			Japan Society for the Promotion of Science (JSPS) [12F02106]; Japanese Government doctoral scholarship	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Government doctoral scholarship	This work was supported by a postdoctoral fellowship for foreign researchers (Grant number 12F02106 to TY) from the Japan Society for the Promotion of Science (JSPS), and a Japanese Government doctoral scholarship in 2008 (to TY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuAmer Y, 1997, J CLIN INVEST, V100, P1557, DOI 10.1172/JCI119679; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; EMA M, 1992, BIOCHEM BIOPH RES CO, V184, P246, DOI 10.1016/0006-291X(92)91185-S; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hardy R, 2009, J ENDOCRINOL, V201, P309, DOI 10.1677/JOE-08-0568; Hayashi M, 2010, BIOCHEM BIOPH RES CO, V393, P432, DOI 10.1016/j.bbrc.2010.02.013; He YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024780; Hermsen SAB, 2008, TOXICOLOGY, V253, P147, DOI 10.1016/j.tox.2008.09.005; Hirose J, 2014, J EXP MED, V211, P153, DOI 10.1084/jem.20130538; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Ikuta T, 2010, J DERMATOL SCI, V58, P211, DOI 10.1016/j.jdermsci.2010.04.003; Iqbal J, 2013, P NATL ACAD SCI USA, V110, P11115, DOI 10.1073/pnas.1220919110; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Khosla S, 2009, NEW ENGL J MED, V361, P818, DOI 10.1056/NEJMe0905480; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kondoh S, 2014, BONE, V60, P68, DOI 10.1016/j.bone.2013.12.005; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lind PM, 2009, CHEMOSPHERE, V75, P680, DOI 10.1016/j.chemosphere.2008.12.024; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Miettinen HM, 2005, TOXICOL SCI, V85, P1003, DOI 10.1093/toxsci/kfi136; Miyauchi Y, 2010, J EXP MED, V207, P751, DOI 10.1084/jem.20091957; Nakahama T, 2011, P NATL ACAD SCI USA, V108, P14222, DOI 10.1073/pnas.1111786108; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Nishimura N, 2009, TOXICOL APPL PHARM, V236, P301, DOI 10.1016/j.taap.2009.01.025; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Santiago F, 2012, BIOCHEM BIOPH RES CO, V417, P223, DOI 10.1016/j.bbrc.2011.11.089; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Sato K, 2006, CURR OPIN RHEUMATOL, V18, P419, DOI 10.1097/01.bor.0000231912.24740.a5; Seeman E, 2003, OSTEOPOROSIS INT, V14, pS2, DOI 10.1007/s00198-002-1340-9; Shukla D, 2009, HIGH ALT MED BIOL, V10, P57, DOI 10.1089/ham.2008.1028; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sogawa K, 1997, J BIOCHEM, V122, P1075; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2000, ARTHRITIS RHEUM-US, V43, P259, DOI 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2005, J PERIODONTAL RES, V40, P287, DOI 10.1111/j.1600-0765.2005.00814.x; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Villa A, 2009, CALCIFIED TISSUE INT, V84, P1, DOI 10.1007/s00223-008-9196-4; Wagner EF, 2001, CURR OPIN GENET DEV, V11, P527, DOI 10.1016/S0959-437X(00)00228-8; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Wejheden C, 2010, TOXICOL SCI, V114, P48, DOI 10.1093/toxsci/kfp284; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yu TY, 2014, BIOCHEM BIOPH RES CO, V450, P416, DOI 10.1016/j.bbrc.2014.05.114; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007	55	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117112	10.1371/journal.pone.0117112	http://dx.doi.org/10.1371/journal.pone.0117112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615839	Green Submitted, Green Published, gold			2022-12-26	WOS:000349122100056
J	Zhou, NN; Ding, B; Agler, M; Cockett, M; McPhee, F				Zhou, Nannan; Ding, Bo; Agler, Michele; Cockett, Mark; McPhee, Fiona			Lethality of PAK3 and SGK2 shRNAs to Human Papillomavirus Positive Cervical Cancer Cells Is Independent of PAK3 and SGK2 Knockdown	PLOS ONE			English	Article							SHORT-INTERFERING RNAS; KINASE REQUIREMENTS; MENTAL-RETARDATION; MAMMALIAN-CELLS; PROTEIN-KINASE; GENE-EXPRESSION; INDUCTION; ACTIVATION; REPRESSION; ISOFORMS	The p21-activated kinase 3 (PAK3) and the serum and glucocorticoid-induced kinase 2 (SGK2) have been previously proposed as essential kinases for human papillomavirus positive (HPV+) cervical cancer cell survival. This was established using a shRNA knockdown approach. To validate PAK3 and SGK2 as potential targets for HPV+ cervical cancer therapy, the relationship between shRNA-induced phenotypes in HPV+ cervical cancer cells and PAK3 or SGK2 knockdown was carefully examined. We observed that the phenotypes of HPV+ cervical cancer cells induced by various PAK3 and SGK2 shRNAs could not be rescued by complement expression of respective cDNA constructs. A knockdown-deficient PAK3 shRNA with a single mismatch was sufficient to inhibit HeLa cell growth to a similar extent as wild-type PAK3 shRNA. The HPV+ cervical cancer cells were also susceptible to several non-human target shRNAs. The discrepancy between PAK3 and SGK2 shRNA-induced apoptosis and gene expression knockdown, as well as cell death stimulation, suggested that these shRNAs killed HeLa cells through different pathways that may not be target-specific. These data demonstrated that HPV+ cervical cancer cell death was not associated with RNAi-induced PAK3 and SGK2 knockdown but likely through off-target effects.	[Zhou, Nannan; Ding, Bo; Cockett, Mark; McPhee, Fiona] R&D Bristol Myers Squibb Co, Dept Virol, Wallingford, CT USA; [Agler, Michele] R&D Bristol Myers Squibb Co, Dept Leads Discovery, Wallingford, CT USA	Bristol-Myers Squibb; Bristol-Myers Squibb	McPhee, F (corresponding author), R&D Bristol Myers Squibb Co, Dept Virol, Wallingford, CT USA.	Fiona.McPhee@bms.com			Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	Funding of this study was from Bristol-Myers Squibb. BMS provided support in the form of salaries for authors [NZ, BD, MA, MC and FM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Since Michele Agler became an employee of Boehringer Ingleheim, they have provided support in the form of a salary for her, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Baldwin A, 2010, P NATL ACAD SCI USA, V107, P12463, DOI 10.1073/pnas.1007462107; Bienvenu T, 2000, AM J MED GENET, V93, P294, DOI 10.1002/1096-8628(20000814)93:4<294::AID-AJMG8>3.0.CO;2-F; Boda B, 2004, J NEUROSCI, V24, P10816, DOI 10.1523/JNEUROSCI.2931-04.2004; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Editorial, 2003, NAT CELL BIOL, V5, P489, DOI [10.1038/ncb0603-490, DOI 10.1038/NCB0603-490]; Friedrich B, 2003, PFLUG ARCH EUR J PHY, V445, P693, DOI 10.1007/s00424-002-0993-8; Gamper N, 2002, PFLUG ARCH EUR J PHY, V445, P60, DOI 10.1007/s00424-002-0873-2; Ghittoni R, 2010, VIRUS GENES, V40, P1, DOI 10.1007/s11262-009-0412-8; Grueneberg DA, 2008, P NATL ACAD SCI USA, V105, P16490, DOI 10.1073/pnas.0806578105; Grueneberg DA, 2008, P NATL ACAD SCI USA, V105, P16472, DOI 10.1073/pnas.0808019105; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kreis P, 2008, J NEUROCHEM, V106, P1184, DOI 10.1111/j.1471-4159.2008.05474.x; Lowy DR, 2001, FIELDS VIROLOGY, P2231; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; McPhie DL, 2003, J NEUROSCI, V23, P6914; Pebernard S, 2004, DIFFERENTIATION, V72, P103, DOI 10.1111/j.1432-0436.2004.07202001.x; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Snijders PJF, 2006, J PATHOL, V208, P152, DOI 10.1002/path.1866; Souopgui J, 2002, EMBO J, V21, P6429, DOI 10.1093/emboj/cdf644; Svoboda P, 2007, CURR OPIN MOL THER, V9, P248; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701	34	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117357	10.1371/journal.pone.0117357	http://dx.doi.org/10.1371/journal.pone.0117357			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615606	Green Published, gold, Green Submitted			2022-12-26	WOS:000349122100062
J	Brambert, PR; Kelpsch, DJ; Hameed, R; Desai, CV; Calafiore, G; Godley, LA; Raimondi, SL				Brambert, Patrick R.; Kelpsch, Daniel J.; Hameed, Rabia; Desai, Charmi V.; Calafiore, Gianfranco; Godley, Lucy A.; Raimondi, Stacey L.			DNMT3B7 Expression Promotes Tumor Progression to a More Aggressive Phenotype in Breast Cancer Cells	PLOS ONE			English	Article							BETA-CATENIN; DNA METHYLTRANSFERASES; METHYLATION; METASTASIS; PATHWAYS; SUPPRESSES; INVASION	Epigenetic changes, such as DNA methylation, have been shown to promote breast cancer progression. However, the mechanism by which cancer cells acquire and maintain abnormal DNA methylation is not well understood. We have previously identified an aberrant splice form of a DNA methyltransferase, DNMT3B7, expressed in virtually all cancer cell lines but at very low levels in normal cells. Furthermore, aggressive MDA-MB-231 breast cancer cells have been shown to express increased levels of DNMT3B7 compared to poorly invasive MCF-7 cells, indicating that DNMT3B7 may have a role in promoting a more invasive phenotype. Using data gathered from The Cancer Genome Atlas, we show that DNMT3B7 expression is increased in breast cancer patient tissues compared to normal tissue. To determine the mechanism by which DNMT3B7 was functioning in breast cancer cells, two poorly invasive breast cancer cell lines, MCF-7 and T-47D, were stably transfected with a DNMT3B7 expression construct. Expression of DNMT3B7 led to hypermethylation and down-regulation of E-cadherin, altered localization of beta-catenin, as well as increased adhesion turnover, cell proliferation, and anchorage-independent growth. The novel results presented in this study suggest a role for DNMT3B7 in the progression of breast cancer to a more aggressive state and the potential for future development of novel therapeutics.	[Brambert, Patrick R.; Kelpsch, Daniel J.; Hameed, Rabia; Desai, Charmi V.; Calafiore, Gianfranco; Raimondi, Stacey L.] Elmhurst Coll, Dept Biol, Elmhurst, IL 60126 USA; [Godley, Lucy A.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Chicago	Raimondi, SL (corresponding author), Elmhurst Coll, Dept Biol, Elmhurst, IL 60126 USA.	raimondis@elmhurst.edu		Raimondi, Stacey/0000-0001-7667-6814	Diana Nicholas Loving Trust; Alfred Koplin; Beta Beta Beta Research Foundation; Elmhurst College Biology Department; Elmhurst College Center for Scholarship and Teaching/Faculty Development Committee; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	Diana Nicholas Loving Trust; Alfred Koplin; Beta Beta Beta Research Foundation; Elmhurst College Biology Department; Elmhurst College Center for Scholarship and Teaching/Faculty Development Committee; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Diana Nicholas Loving Trust (SLR), Alfred Koplin (SLR), Beta Beta Beta Research Foundation (RH), the Elmhurst College Biology Department (SLR), and the Elmhurst College Center for Scholarship and Teaching/Faculty Development Committee (SLR, PRB, GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azarschab P, 2003, ONCOL REP, V10, P501; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Graff JR, 2000, J BIOL CHEM, V275, P2727, DOI 10.1074/jbc.275.4.2727; Kelpsch Daniel J., 2012, BIOS, V83, P17; Kudo Y, 2004, CLIN CANCER RES, V10, P5455, DOI 10.1158/1078-0432.CCR-04-0372; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lim SC, 2002, ONCOL REP, V9, P915; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Odero-Marah VA, 2003, CANCER BIOL THER, V2, P398, DOI 10.4161/cbt.2.4.471; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orsulic S, 1999, J CELL SCI, V112, P1237; Ostler K, 2007, ONCOGENE, V26, P5553, DOI 10.1038/sj.onc.1210351; Ostler KR, 2012, CANCER RES, V72, P4714, DOI 10.1158/0008-5472.CAN-12-0886; Payne SL, 2006, J CELL BIOCHEM, V98, P827, DOI 10.1002/jcb.20792; Prasad CP, 2007, ONCOLOGY-BASEL, V73, P112, DOI 10.1159/000120999; Reed KR, 2008, P NATL ACAD SCI USA, V105, P18919, DOI 10.1073/pnas.0805778105; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Semba S, 2000, ENDOCR PATHOL, V11, P243, DOI 10.1385/EP:11:3:243; Shah MY, 2010, CANCER RES, V70, P5840, DOI 10.1158/0008-5472.CAN-10-0847; Siapati EK, 2011, BRIT J HAEMATOL, V152, P164, DOI 10.1111/j.1365-2141.2010.08471.x; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020	26	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0117310	10.1371/journal.pone.0117310	http://dx.doi.org/10.1371/journal.pone.0117310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607950	Green Submitted, gold, Green Published			2022-12-26	WOS:000348205300050
J	Tsuruya, K; Fukuma, S; Wakita, T; Ninomiya, T; Nagata, M; Yoshida, H; Fujimi, S; Kiyohara, Y; Kitazono, T; Uchida, K; Shirota, T; Akizawa, T; Akiba, T; Saito, A; Fukuhara, S				Tsuruya, Kazuhiko; Fukuma, Shingo; Wakita, Takafumi; Ninomiya, Toshiharu; Nagata, Masaharu; Yoshida, Hisako; Fujimi, Satoru; Kiyohara, Yutaka; Kitazono, Takanari; Uchida, Kazuhiro; Shirota, Tomoko; Akizawa, Tadao; Akiba, Takashi; Saito, Akira; Fukuhara, Shunichi			Dietary Patterns and Clinical Outcomes in Hemodialysis Patients in Japan: A Cohort Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; COLORECTAL-CANCER; DIALYSIS PATIENTS; HISTORY QUESTIONNAIRES; CLUSTER-ANALYSIS; MORTALITY; HISAYAMA; METAANALYSIS; GUIDELINES	Background & Objectives Little is known about actual dietary patterns and their associations with clinical outcomes in hemodialysis patients. We identified dietary patterns in hemodialysis patients in Japan and examined associations between dietary patterns and clinical outcomes. Design, setting, participants, measurements We used data from 3,080 general-population participants in the Hisayama study (year 2007), and data from 1,355 hemodialysis patients in the Japan Dialysis Outcomes and Practice Patterns Study (JDOPPS: years 2005-2007). Food intake was measured using a brief self-administered diet-history questionnaire (BDHQ). To identify food groups with the Hisayama population data, we used principal components analysis with Promax rotation. We adjusted the resulting food groups for total daily energy intake, and then we used those adjusted food-group scores to identify dietary patterns in the JDOPPS patients by cluster analysis (Ward's method). We then used Cox regression to examine the association between dietary patterns and a composite of adverse clinical outcomes: hospitalization due to cardiovascular disease or death due to any cause. Results We identified three food groups: meat, fish, and vegetables. Using those groups we then identified three dietary patterns: well-balanced, unbalanced, and other. After adjusting for potential confounders, we found an association between an unbalanced diet and important clinical events (hazard ratio 1.90, 95% C.I. 1.19-3.04). Conclusions Hemodialysis patients whose diet was unbalanced were more likely to have adverse clinical outcomes. Thus hemodialysis patients might benefit not only from portion control, but also from a diet that is well-balanced diet with regard to the food groups identified here as meat, fish, and vegetables.	[Tsuruya, Kazuhiko; Yoshida, Hisako] Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Fukuoka 812, Japan; [Fukuma, Shingo; Fukuhara, Shunichi] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan; [Fukuma, Shingo] Inst Hlth Outcomes & Proc Evaluat Res iHope Int, Tokyo, Japan; [Wakita, Takafumi] Kansai Univ, Fac Sociol, Osaka, Japan; [Ninomiya, Toshiharu; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Nagata, Masaharu] Kyushu Univ, Grad Sch Med Sci, Commun Med Educ Unit, Fukuoka 812, Japan; [Fujimi, Satoru] Fukuoka Renal Clin, Fukuoka, Japan; [Kiyohara, Yutaka] Kyushu Univ, Grad Sch Med Sci, Dept Environm Med, Fukuoka 812, Japan; [Uchida, Kazuhiro; Shirota, Tomoko] Nakamura Gakuen Univ, Sch Hlth & Nutr Sci, Dept Hlth Promot, Fukuoka, Japan; [Akizawa, Tadao] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan; [Akiba, Takashi] Tokyo Womens Med Univ, Kidney Ctr, Dept Blood Purificat & Internal Med, Tokyo, Japan; [Saito, Akira] Shonantobu Gen Hosp, Div Nephrol, Kanagawa, Japan; [Saito, Akira] Shonantobu Gen Hosp, Dialysis Ctr, Kanagawa, Japan; [Fukuhara, Shunichi] Fukushima Med Univ, Ctr Innovat Res Commun & Clin Excellence, Fukushima, Japan	Kyushu University; Kyoto University; Kansai University; Kyushu University; Kyushu University; Kyushu University; Showa University; Tokyo Women's Medical University; Fukushima Medical University	Fukuhara, S (corresponding author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan.	fukuhara.shunichi.6m@kyoto-u.ac.jp		Wakita, Takafumi/0000-0003-2293-5918; Fukuma, Shingo/0000-0002-8379-8761	scientific research grants from Kyowa Hakko Kirin (Japan)	scientific research grants from Kyowa Hakko Kirin (Japan)	This study is supported by scientific research grants from Kyowa Hakko Kirin (Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CATTELL RB, 1965, BIOMETRICS, V21, P405, DOI 10.2307/2528100; Combe C, 2004, AM J KIDNEY DIS, V44, pS39, DOI 10.1053/j.ajkd.2004.08.010; Everitt B. S., 2001, CLUSTER ANAL; Flood A, 2008, AM J CLIN NUTR, V88, P176, DOI 10.1093/ajcn/88.1.176; Fukuhara M, 2012, J HYPERTENS, V30, P893, DOI 10.1097/HJH.0b013e328351d380; Hata J, 2013, CIRCULATION, V128, P1198, DOI 10.1161/CIRCULATIONAHA.113.002424; Heerspink HL, 2009, LANCET, V373, P1009, DOI 10.1016/S0140-6736(09)60212-9; Kalantar-Zadeh K, 2009, CIRCULATION, V119, P671, DOI 10.1161/CIRCULATIONAHA.108.807362; Katsuki S, 1966, Prog Brain Res, V21, P64; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI 10.2188/jea.JE20110075; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Kopple JD, 2001, AM J KIDNEY DIS, V37, pS66, DOI 10.1053/ajkd.2001.20748; Krishnamurthy VMR, 2012, KIDNEY INT, V81, P300, DOI 10.1038/ki.2011.355; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Kuriyama S, 2008, CLIN EXP NEPHROL, V12, P165, DOI 10.1007/s10157-007-0020-7; Kutner NG, 2002, AM J KIDNEY DIS, V39, P1018, DOI 10.1053/ajkd.2002.32775; Mahabir S, 2006, EUR J CLIN NUTR, V60, P561, DOI 10.1038/sj.ejcn.1602359; Mailloux LU, 2000, SEMIN DIALYSIS, V13, P150, DOI 10.1046/j.1525-139x.2000.00040.x; Noori N, 2010, CLIN J AM SOC NEPHRO, V5, P683, DOI 10.2215/CJN.08601209; Okubo H, 2006, AM J CLIN NUTR, V83, P1185, DOI 10.1093/ajcn/83.5.1185; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Pisoni RL, 2004, AM J KIDNEY DIS, V44, pS7, DOI 10.1053/j.ajkd.2004.08.005; Port FK, 2004, AM J KIDNEY DIS, V44, pS1, DOI 10.1053/j.ajkd.2004.08.004; Reedy J, 2010, AM J EPIDEMIOL, V171, P479, DOI 10.1093/aje/kwp393; Sanghavi S, 2013, SEMIN DIALYSIS, V26, P597, DOI 10.1111/sdi.12123; Sasaki S, 2000, J NUTR SCI VITAMINOL, V46, P285, DOI 10.3177/jnsv.46.285; Sasaki S, 1998, J Epidemiol, V8, P203; Sherman RA, 2009, AM J KIDNEY DIS, V54, P18, DOI 10.1053/j.ajkd.2009.01.269; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Wirfalt E, 2009, EUR J CLIN NUTR, V63, P707, DOI 10.1038/ejcn.2008.40	30	14	14	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116677	10.1371/journal.pone.0116677	http://dx.doi.org/10.1371/journal.pone.0116677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607947	Green Submitted, Green Published, gold			2022-12-26	WOS:000348205300031
J	English, S; Pen, I; Shea, N; Uller, T				English, Sinead; Pen, Ido; Shea, Nicholas; Uller, Tobias			The Information Value of Non-Genetic Inheritance in Plants and Animals	PLOS ONE			English	Article							TRANSGENERATIONAL EPIGENETIC INHERITANCE; LOCUST PHASE POLYPHENISM; EVOLUTIONARY CONSEQUENCES; DEVELOPMENTAL PLASTICITY; SCHISTOCERCA-GREGARIA; NATURAL-SELECTION; DESERT LOCUST; ADAPTATION; MECHANISMS; CONFLICT	Parents influence the development of their offspring in many ways beyond the transmission of DNA. This includes transfer of epigenetic states, nutrients, antibodies and hormones, and behavioural interactions after birth. While the evolutionary consequences of such non-genetic inheritance are increasingly well understood, less is known about how inheritance mechanisms evolve. Here, we present a simple but versatile model to explore the adaptive evolution of non-genetic inheritance. Our model is based on a switch mechanism that produces alternative phenotypes in response to different inputs, including genes and non-genetic factors transmitted from parents and the environment experienced during development. This framework shows how genetic and non-genetic inheritance mechanisms and environmental conditions can act as cues by carrying correlational information about future selective conditions. Differential use of these cues is manifested as different degrees of genetic, parental or environmental morph determination. We use this framework to evaluate the conditions favouring non-genetic inheritance, as opposed to genetic determination of phenotype or within-generation plasticity, by applying it to two putative examples of adaptive non-genetic inheritance: maternal effects on seed germination in plants and transgenerational phase shift in desert locusts. Our simulation models show how the adaptive value of non-genetic inheritance depends on its mechanism, the pace of environmental change, and life history characteristics.	[English, Sinead; Uller, Tobias] Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England; [Pen, Ido] Univ Groningen, Theoret Biol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Shea, Nicholas] Kings Coll London, Dept Philosophy, London, England; [Uller, Tobias] Lund Univ, Dept Biol, Lund, Sweden	University of Oxford; University of Groningen; University of London; King's College London; Lund University	Uller, T (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	tobias.uller@zoo.ox.ac.uk	English, Sinead/N-6348-2014	English, Sinead/0000-0003-2898-2301; Novoplansky, Ariel/0000-0003-0988-786X	European Union [259679]; Leverhulme Trust; Royal Society of London; Knut and Alice Wallenberg Foundations	European Union(European Commission); Leverhulme Trust(Leverhulme Trust); Royal Society of London(Royal Society of London); Knut and Alice Wallenberg Foundations(Knut & Alice Wallenberg Foundation)	This research was funded by the European Union's Seventh Framework Programme (FP7/20072011) under grant agreement no 259679 (project IDEAL), and the Leverhulme Trust (both to TU). TU is supported by the Royal Society of London and the Knut and Alice Wallenberg Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 2002, EVOL ECOL, V16, P285, DOI 10.1023/A:1019684612767; [Anonymous], 1988, AM ANTHROPOL; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1169, DOI 10.1098/rstb.2008.0302; Bergstrom CT, 2011, BIOL PHILOS, V26, P159, DOI 10.1007/s10539-009-9180-z; Boerjan B, 2011, GEN COMP ENDOCR, V173, P120, DOI 10.1016/j.ygcen.2011.05.003; Boyd R., 1985, CULTURE EVOLUTIONARY; Burgess SC, 2014, OIKOS, V123, P769, DOI 10.1111/oik.01235; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Cheverud James M., 2009, P11; Crean AJ, 2013, ECOLOGY, V94, P2575, DOI 10.1890/13-0184.1; Curley JP, 2011, HORM BEHAV, V59, P306, DOI 10.1016/j.yhbeh.2010.06.018; Danchin E, 2013, TRENDS ECOL EVOL, V28, P351, DOI 10.1016/j.tree.2013.02.010; Danchin E, 2011, NAT REV GENET, V12, P475, DOI 10.1038/nrg3028; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Day T, 2011, AM NAT, V178, pE18, DOI 10.1086/660911; Donohue K, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P137; Donohue K, 2009, PHILOS T R SOC B, V364, P1059, DOI 10.1098/rstb.2008.0291; Furrow RE, 2014, EVOLUTION, V68, P673, DOI 10.1111/evo.12225; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Galloway LF, 2007, SCIENCE, V318, P1134, DOI 10.1126/science.1148766; Galloway LF, 2005, NEW PHYTOL, V166, P93, DOI 10.1111/j.1469-8137.2004.01314.x; Geoghegan JL, 2013, THEOR POPUL BIOL, V88, P1, DOI 10.1016/j.tpb.2013.05.001; Herman JJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00102; Hinde CA, 2009, P ROY SOC B-BIOL SCI, V276, P2787, DOI 10.1098/rspb.2009.0375; Huestis DL, 2006, OECOLOGIA, V146, P513, DOI 10.1007/s00442-005-0232-z; Jablonka E, 2002, PHILOS SCI, V69, P578, DOI 10.1086/344621; Jablonka E, 2014, LIFE MIND-PHILOS ISS, P1; Jablonka E, 1995, PHILOS T R SOC B, V350, P133, DOI 10.1098/rstb.1995.0147; Jablonka E., 2005, EVOLUTION 4 DIMENSIO; Jablonka E, 2013, PROG BIOPHYS MOL BIO, V111, P99, DOI 10.1016/j.pbiomolbio.2012.08.014; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jacobs BS, 2012, FUNCT ECOL, V26, P588, DOI 10.1111/j.1365-2435.2012.01964.x; KIMURA M, 1961, GENET RES, V2, P127, DOI 10.1017/S0016672300000616; Kuijper B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003550; LACEY EP, 1991, UNITY OF EVOLUTIONARY BIOLOGY, VOLS 1 AND 2, P735; Laland KN, 1996, J EVOLUTION BIOL, V9, P293, DOI 10.1046/j.1420-9101.1996.9030293.x; Leimar O, 2006, AM NAT, V167, P367, DOI 10.1086/499566; Leimar O, 2009, EVOL ECOL, V23, P125, DOI 10.1007/s10682-007-9194-4; LEVINS RICHARD, 1968; Lim JP, 2013, TRENDS GENET, V29, P176, DOI 10.1016/j.tig.2012.12.008; Lind MI, 2007, J EVOLUTION BIOL, V20, P1288, DOI 10.1111/j.1420-9101.2007.01353.x; Lock JE, 2007, AM NAT, V170, P709, DOI 10.1086/521963; Marshall DJ, 2008, ECOLOGY, V89, P418, DOI 10.1890/07-0449.1; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; McElreath R, 2008, CURR ANTHROPOL, V49, P307, DOI 10.1086/524364; McIntyre PJ, 2014, EVOL ECOL, V28, P229, DOI 10.1007/s10682-013-9670-y; Miller GA, 2008, J EXP BIOL, V211, P370, DOI 10.1242/jeb.013458; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Muller W, 2007, AM NAT, V169, pE84, DOI 10.1086/511962; Odling-Smee J, 2010, NICHE INHERITANCE, P175; Parker GA, 2002, PHILOS T R SOC B, V357, P295, DOI 10.1098/rstb.2001.0950; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; PLATENKAMP GAJ, 1993, EVOLUTION, V47, P540, DOI 10.1111/j.1558-5646.1993.tb02112.x; Revardel E, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-217; Richerson PJ., 2005, NOT GENES ALONE CULT; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; Scharf I, 2010, CLIM RES, V43, P115, DOI 10.3354/cr00907; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shea N, 2011, J EVOLUTION BIOL, V24, P1178, DOI 10.1111/j.1420-9101.2011.02235.x; Simpson S. J., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P147; Simpson SJ, 1999, BIOL REV, V74, P461, DOI 10.1017/S000632319900540X; Simpson SJ, 2008, CURR BIOL, V18, pR364, DOI 10.1016/j.cub.2008.02.029; Simpson SJ, 2007, J INSECT PHYSIOL, V53, P869, DOI 10.1016/j.jinsphys.2007.05.011; Slagsvold T, 2011, PHILOS T R SOC B, V366, P969, DOI 10.1098/rstb.2010.0343; Stein LR, 2014, ANIM BEHAV, V95, P165, DOI 10.1016/j.anbehav.2014.07.010; Takahasi K, 1999, THEOR POPUL BIOL, V55, P208, DOI 10.1006/tpbi.1998.1400; Thornton A, 2006, SCIENCE, V313, P227, DOI 10.1126/science.1128727; Topaz CM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002642; Uller T, 2013, J EVOLUTION BIOL, V26, P2161, DOI 10.1111/jeb.12212; Uller T, CHALLENGES EVOLUTION; Uller T, 2014, TRANSGENERATIONAL EP, P175; Uller T, 2008, TRENDS ECOL EVOL, V23, P432, DOI 10.1016/j.tree.2008.04.005; Uller T, 2012, EVOLUTION OF PARENTAL CARE, P247; Uller T, 2011, EVOLUTION, V65, P2075, DOI 10.1111/j.1558-5646.2011.01282.x; Ventura AK, 2013, CURR BIOL, V23, pR401, DOI 10.1016/j.cub.2013.02.037; West-Eberhard Mary Jane, 2003, pi; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238; Zajitschek S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0422	83	61	62	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116996	10.1371/journal.pone.0116996	http://dx.doi.org/10.1371/journal.pone.0116996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603120	Green Submitted, Green Published, gold			2022-12-26	WOS:000348203500040
J	Xu, SZ; Li, DZ; Li, JW; Xiang, XG; Jin, WT; Huang, WC; Jin, XH; Huang, LQ				Xu, Songzhi; Li, Dezhu; Li, Jianwu; Xiang, Xiaoguo; Jin, Weitao; Huang, Weichang; Jin, Xiaohua; Huang, Luqi			Evaluation of the DNA Barcodes in Dendrobium (Orchidaceae) from Mainland Asia	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; PHYLOGENETIC ANALYSIS; SYSTEMATICS; IDENTIFICATION; DISCRIMINATE; SEQUENCES; TAXONOMY; RATES; MATK; LOCI	DNA barcoding has been proposed to be one of the most promising tools for accurate and rapid identification of taxa. However, few publications have evaluated the efficiency of DNA barcoding for the large genera of flowering plants. Dendrobium, one of the largest genera of flowering plants, contains many species that are important in horticulture, medicine and biodiversity conservation. Besides, Dendrobium is a notoriously difficult group to identify. DNA barcoding was expected to be a supplementary means for species identification, conservation and future studies in Dendrobium. We assessed the power of 11 candidate barcodes on the basis of 1,698 accessions of 184 Dendrobium species obtained primarily from mainland Asia. Our results indicated that five single barcodes, i.e., ITS, ITS2, matK, rbcL and trnH-psbA, can be easily amplified and sequenced with the currently established primers. Four barcodes, ITS, ITS2, ITS+matK, and ITS2+matK, have distinct barcoding gaps. ITS+matK was the optimal barcode based on all evaluation methods. Furthermore, the efficiency of ITS+matK was verified in four other large genera including Ficus, Lysimachia, Paphiopedilum, and Pedicularis in this study. Therefore, we tentatively recommend the combination of ITS+ matK as a core DNA barcode for large flowering plant genera.	[Xu, Songzhi; Xiang, Xiaoguo; Jin, Weitao; Jin, Xiaohua] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Li, Dezhu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming 650201, Yunnan, Peoples R China; [Li, Jianwu] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Menglun Township 666303, Yunnan, Peoples R China; [Huang, Weichang] Shanghai Chenshan Bot Garden, Shanghai 201602, Peoples R China; [Huang, Luqi] China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat Med, Beijing 100700, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; China Academy of Chinese Medical Sciences; National Resource Center for Chinese Materia Medica, CACMS	Jin, XH (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China.	xiaohuajin@ibcas.ac.cn; huangluqi01@126.com	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X	National Natural Science Foundation of China [31107176, 31470299, J1310002]; Chinese Special Fund for Medicine Research in the Public Interest [201407003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Special Fund for Medicine Research in the Public Interest	The work was supported by the National Natural Science Foundation of China (31107176, 31470299, J1310002) and the Chinese Special Fund for Medicine Research in the Public Interest (201407003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PB, 2011, BOT J LINN SOC, V166, P105, DOI 10.1111/j.1095-8339.2011.01141.x; Asahina H, 2010, J NAT MED-TOKYO, V64, P133, DOI 10.1007/s11418-009-0379-8; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P573, DOI 10.1111/1755-0998.12089; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Burke JM, 2008, AUST SYST BOT, V21, P1, DOI 10.1071/SB07038; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Clements M. A., 2003, Telopea, V10, P247; Cribb P., 2005, Proceedings of the 18th World Orchid Conference, Dijon, France, 11-20 March, 2005, P161; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Doyle J. J., 1987, PHYTOCHEM B, P11; Farrington L, 2009, AUST J BOT, V57, P276, DOI 10.1071/BT08138; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Goldman DH, 2001, SYST BOT, V26, P670; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; HU SY, 1970, ECON BOT, V24, P165, DOI 10.1007/BF02860596; IBM Corp, 2010, IBM SPSS STAT WIND V; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lau DTW, 2001, PLANTA MED, V67, P456, DOI 10.1055/s-2001-15818; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li HQ, 2012, MOL ECOL RESOUR, V12, P783, DOI 10.1111/j.1755-0998.2012.03147.x; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Morris MW, 1996, BOT J LINN SOC, V120, P89, DOI 10.1111/j.1095-8339.1996.tb00483.x; Parveen I, 2012, MOL ECOL RESOUR, V12, P82, DOI 10.1111/j.1755-0998.2011.03071.x; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; RIESEBERG LH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P70; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rubinoff D, 2006, TRENDS ECOL EVOL, V21, P1, DOI 10.1016/j.tree.2005.10.019; Schuiteman Andre, 2011, Gardens' Bulletin (Singapore), V63, P245; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Singh Hemant Kumar, 2012, BMC Res Notes, V5, P42, DOI 10.1186/1756-0500-5-42; State Pharmacopoeia Committee, 2010, PHARMACOPOEIA PEOPLE; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WOOD HP, 2006, DENDROBIUMS, pR5; Xiang XG, 2013, MOL PHYLOGENET EVOL, V69, P950, DOI 10.1016/j.ympev.2013.06.009; Xiang XG, 2011, MOL ECOL RESOUR, V11, P1012, DOI 10.1111/j.1755-0998.2011.03044.x; XU H, 2005, PLANTA MED, V71, P1; Yang JB, 2012, MOL ECOL RESOUR, V12, P267, DOI 10.1111/j.1755-0998.2011.03095.x; Yao H, 2009, PLANTA MED, V75, P667, DOI 10.1055/s-0029-1185385; Yu WB, 2011, J SYST EVOL, V49, P425, DOI 10.1111/j.1759-6831.2011.00154.x; Yukawa T, 1996, PLANT SYST EVOL, V201, P1, DOI 10.1007/BF00989048; Zhang CY, 2012, MOL ECOL RESOUR, V12, P98, DOI 10.1111/j.1755-0998.2011.03076.x	55	56	68	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0115168	10.1371/journal.pone.0115168	http://dx.doi.org/10.1371/journal.pone.0115168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602282	Green Published, gold, Green Submitted			2022-12-26	WOS:000348203500009
J	Dimitrov, D; Donnell, D; Brown, ER				Dimitrov, Dobromir; Donnell, Deborah; Brown, Elizabeth R.			High Incidence Is Not High Exposure: What Proportion of Prevention Trial Participants Are Exposed to HIV?	PLOS ONE			English	Article							SOUTH-AFRICA; INFECTION; RISK; HETEROGENEITY; TRANSMISSION; METAANALYSIS; ASSOCIATION; PREVALENCE	Objective Randomized clinical trials of HIV prevention in high-risk populations of women often assume that all participants have similar exposure to HIV. However, a substantial fraction of women enrolled in the trial may have no or low exposure to HIV. Our objective was to estimate the proportion of women exposed to HIV throughout a hypothetical high-risk study population. Methods A stochastic individual-based model was developed to simulate the sexual behavior and the risk of HIV acquisition for a cohort of sexually active HIV-uninfected women in high HIV prevalence settings. Key behavior and epidemic assumptions in the model were based on published studies on HIV transmission in South Africa. The prevalence of exposure, defined as the proportion of women who have sex with HIV-infected partner, and HIV incidence were evaluated. Results Our model projects that in communities with HIV incidence rate of 1 per 100 person years, only 5-6% of women are exposed to HIV annually while in communities with an HIV incidence of 5 per 100 person years 20-25% of women are exposed to HIV. Approximately 70% of the new infections are acquired from partners with asymptomatic HIV. Conclusions Mathematical models suggest that a high proportion of women enrolled in HIV prevention trials may be unexposed to HIV even when incidence rates are high. The relationship between HIV exposure and other risk factors should be carefully analyzed when future clinical trials are planned.	[Dimitrov, Dobromir; Donnell, Deborah; Brown, Elizabeth R.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Dimitrov, Dobromir; Donnell, Deborah; Brown, Elizabeth R.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Dimitrov, Dobromir] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Donnell, Deborah] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Brown, Elizabeth R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dimitrov, D (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	dobromir@scharp.org		Donnell, Deborah/0000-0002-0587-7480	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [UM1 AI068617, UM1 AI068615]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068615, UM1AI068617, UM1AI068615, U01AI068617] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number UM1 AI068617 (D. Donnell) and UM1 AI068615 (D. Dimitrov and E. R. Brown). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALEN OO, 1988, STAT MED, V7, P1121, DOI 10.1002/sim.4780071105; Auvert B, 2011, CLIN TRIALS, V8, P144, DOI 10.1177/1740774511398923; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Centers for Disease Control and Prevention, 2011, CDC TRIAL AN MAJ STU; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Foss AM, 2007, SEX TRANSM INFECT, V83, P510, DOI 10.1136/sti.2007.027144; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Jeanne Marrazzo GR, 2013, C RETR OPP INF ATL G; Jewkes R, 2001, SOC SCI MED, V52, P733, DOI 10.1016/S0277-9536(00)00177-5; Johnson LF, 2009, DEMOGR RES, V21, P289, DOI 10.4054/DemRes.2009.21.11; Kalichman SC, 2009, SEX TRANSM INFECT, V85, P411, DOI 10.1136/sti.2008.035287; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Shisana O, 2009, S AFRICAN NATL HIV P	15	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2015	10	1							e0115528	10.1371/journal.pone.0115528	http://dx.doi.org/10.1371/journal.pone.0115528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BT	25569838	Green Published, Green Submitted, gold			2022-12-26	WOS:000348168000002
J	Choi, SJ; Panhelainen, A; Schmitz, Y; Larsen, KE; Kanter, E; Wu, M; Sulzer, D; Mosharov, EV				Choi, Se Joon; Panhelainen, Anne; Schmitz, Yvonne; Larsen, Kristin E.; Kanter, Ellen; Wu, Min; Sulzer, David; Mosharov, Eugene V.			Changes in Neuronal Dopamine Homeostasis following 1-Methyl-4-phenylpyridinium (MPP+) Exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR MONOAMINE TRANSPORTER; PARKINSONISM-INDUCING NEUROTOXIN; MESENCEPHALIC CELL-CULTURES; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP; SYNAPTIC VESICLES; CYTOSOLIC DOPAMINE; REVERSE TRANSPORT; MIDBRAIN NEURONS; OXIDATIVE STRESS; QUANTAL SIZE	1-Methyl-4-phenylpyridinium (MPP+), the active metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, selectively kills dopaminergic neurons in vivo and in vitro via a variety of toxic mechanisms, including mitochondrial dysfunction, generation of peroxynitrite, induction of apoptosis, and oxidative stress due to disruption of vesicular dopamine (DA) storage. To investigate the effects of acute MPP+ exposure on neuronal DA homeostasis, we measured stimulation-dependent DA release and non-exocytotic DA efflux from mouse striatal slices and extracellular, intracellular, and cytosolic DA (DAcyt) levels in cultured mouse ventral midbrain neurons. In acute striatal slices, MPP+ exposure gradually decreased stimulation- dependent DA release, followed by massive DA efflux that was dependent on MPP+ concentration, temperature, and DA uptake transporter activity. Similarly, in mouse midbrain neuronal cultures, MPP+ depleted vesicular DA storage accompanied by an elevation of cytosolic and extracellular DA levels. In neuronal cell bodies, increased DAcyt was not due to transmitter leakage from synaptic vesicles but rather to competitive MPP+-dependent inhibition of monoamine oxidase activity. Accordingly, monoamine oxidase blockers pargyline and L-deprenyl had no effect on DAcyt levels in MPP+-treated cells and produced only a moderate effect on the survival of dopaminergic neurons treated with the toxin. In contrast, depletion of intracellular DA by blocking neurotransmitter synthesis resulted in similar to 30% reduction of MPP+-mediated toxicity, whereas overexpression of VMAT2 completely rescued dopaminergic neurons. These results demonstrate the utility of comprehensive analysis of DA metabolism using various electrochemical methods and reveal the complexity of the effects of MPP+ on neuronal DA homeostasis and neurotoxicity.	[Choi, Se Joon; Schmitz, Yvonne; Larsen, Kristin E.; Kanter, Ellen; Wu, Min; Sulzer, David; Mosharov, Eugene V.] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA; [Sulzer, David] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY 10032 USA; [Sulzer, David] Columbia Univ, Dept Pharmacol, Med Ctr, New York, NY 10032 USA; [Panhelainen, Anne] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland	Columbia University; Columbia University; Columbia University; University of Helsinki	Mosharov, EV (corresponding author), Columbia Univ, Dept Neurol, Black Bldg,Rm 308,650 West 168th St, New York, NY 10032 USA.	em706@columbia.edu		Panhelainen, Anne/0000-0001-5082-4006	National Institutes of Health from NINDS [R01NS075222]; NINDS Morris K. Udall Center of Excellence Research Grant; Parkinson's Disease Foundation; JPB Foundation; Finnish Cultural Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075222] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; NINDS Morris K. Udall Center of Excellence Research Grant; Parkinson's Disease Foundation; JPB Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS075222 from NINDS (to E. V. M.) and the NINDS Morris K. Udall Center of Excellence Research Grant (to D. S.). This work was also supported by the Parkinson's Disease and JPB Foundations (to D. S.) and by a fellowship from the Finnish Cultural Foundation (to A. P.).	Barc S, 2001, NEUROCHEM INT, V38, P243, DOI 10.1016/S0197-0186(00)00083-8; Bezard E, 1999, EXP NEUROL, V155, P268, DOI 10.1006/exnr.1998.6995; Bove J, 2012, NEUROSCIENCE, V211, P51, DOI 10.1016/j.neuroscience.2011.10.057; BROOKS WJ, 1989, J NEURAL TRANSM, V76, P1, DOI 10.1007/BF01244987; Burke RE, 1998, J NEUROCHEM, V71, P517; Burke RE, 2013, EXP NEUROL, V246, P72, DOI 10.1016/j.expneurol.2012.01.011; Cappelletti G, 1999, J NEUROSCI RES, V56, P28, DOI 10.1002/(SICI)1097-4547(19990401)56:1<28::AID-JNR4>3.0.CO;2-2; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chang L, 2007, ADDICTION, V102, P16, DOI 10.1111/j.1360-0443.2006.01782.x; Chen LN, 2008, J NEUROSCI, V28, P425, DOI 10.1523/JNEUROSCI.3602-07.2008; CHIEN JB, 1990, J NEUROCHEM, V54, P633, DOI 10.1111/j.1471-4159.1990.tb01918.x; Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Cui M, 2009, P NATL ACAD SCI USA, V106, P8043, DOI 10.1073/pnas.0900358106; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; DAVIS GC, 1979, PSYCHIAT RES, V1, P249, DOI 10.1016/0165-1781(79)90006-4; EDWARDS RH, 1993, ANN NEUROL, V34, P638, DOI 10.1002/ana.410340504; Feigin A, 2001, NEUROLOGY, V57, P2083, DOI 10.1212/WNL.57.11.2083; Gainetdinov RR, 1998, J NEUROCHEM, V70, P1973; GERLACH M, 1992, EUR J PHARM-MOLEC PH, V226, P97, DOI 10.1016/0922-4106(92)90170-Z; Hasbani DM, 2005, J NEUROSCI, V25, P9428, DOI 10.1523/JNEUROSCI.0130-05.2005; Hastings T. G., 1999, ROLE CATECHOL QUINON, P69; Huguet F, 1997, TOXICOLOGY, V122, P93, DOI 10.1016/S0300-483X(97)00084-X; Inazu M, 2003, J NEUROCHEM, V84, P43, DOI 10.1046/j.1471-4159.2003.01566.x; Jackson-Lewis V, 2005, NEUROTOX RES, V7, P193, DOI 10.1007/BF03036449; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Jenner P, 2011, MOVEMENT DISORD, V26, P2316, DOI 10.1002/mds.23926; Jones SR, 1998, J NEUROSCI, V18, P1979; Karunakaran S, 2008, J NEUROSCI, V28, P12500, DOI 10.1523/JNEUROSCI.4511-08.2008; Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3; Krantz DE, 1997, J BIOL CHEM, V272, P6752, DOI 10.1074/jbc.272.10.6752; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Larsen KE, 2002, J NEUROSCI, V22, P8951; LAU YS, 1991, NEUROTOXICOLOGY, V12, P189; Le WD, 1997, NEUROSCI LETT, V224, P197, DOI 10.1016/S0304-3940(97)00170-5; Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; Lohr KM, 2014, P NATL ACAD SCI USA, V111, P9977, DOI 10.1073/pnas.1402134111; Lotharius J, 2000, J BIOL CHEM, V275, P38581, DOI 10.1074/jbc.M005385200; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Michael DJ, 1999, J PHARMACEUT BIOMED, V19, P33, DOI 10.1016/S0731-7085(98)00145-9; MONTINE TJ, 1995, J NEUROPATH EXP NEUR, V54, P311, DOI 10.1097/00005072-199505000-00004; MORIYAMA Y, 1993, ARCH BIOCHEM BIOPHYS, V305, P271, DOI 10.1006/abbi.1993.1422; Mosharov E.V., 2014, HDB NEUROTOXICITY, P973, DOI [10.1007/978-1-4614-5836-4_2, DOI 10.1007/978-1-4614-5836-4_2]; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Mosharov EV, 2003, J NEUROSCI, V23, P5835; Moszczynska A, 2004, BRAIN, V127, P363, DOI 10.1093/brain/awh046; MYTILINEOU C, 1993, J NEUROCHEM, V61, P1470, DOI 10.1111/j.1471-4159.1993.tb13642.x; Naoi M, 2009, EXPERT REV NEUROTHER, V9, P1233, DOI [10.1586/ern.09.68, 10.1586/ERN.09.68]; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; PARDO B, 1995, BRAIN RES, V682, P133, DOI 10.1016/0006-8993(95)00341-M; Pifl C, 2014, J NEUROSCI, V34, P8210, DOI 10.1523/JNEUROSCI.5456-13.2014; Pothos EN, 2000, J NEUROSCI, V20, P7297; Przedborski S, 1996, P NATL ACAD SCI USA, V93, P4565, DOI 10.1073/pnas.93.10.4565; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Qureshi HY, 2011, J BIOL CHEM, V286, P5055, DOI 10.1074/jbc.M110.178905; RANSOM BR, 1987, NEUROSCI LETT, V75, P323, DOI 10.1016/0304-3940(87)90543-X; RAYPORT S, 1992, J NEUROSCI, V12, P4264; ROSSETTI ZL, 1988, BIOCHEM PHARMACOL, V37, P4573, DOI 10.1016/0006-2952(88)90674-0; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; SCHAPIRA AHV, 1994, MOVEMENT DISORD, V9, P125, DOI 10.1002/mds.870090202; Schmitz Y, 2001, J NEUROSCI, V21, P5916, DOI 10.1523/JNEUROSCI.21-16-05916.2001; Serra Pier Andrea, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS189, DOI 10.1016/j.parkreldis.2008.04.029; Sharma SK, 2003, J NEUROCYTOL, V32, P329, DOI 10.1023/B:NEUR.0000011327.23739.1b; SIRINATHSINGHJI DJS, 1988, BRAIN RES, V443, P101, DOI 10.1016/0006-8993(88)91603-4; Speciale SG, 1998, NEUROSCIENCE, V84, P1177, DOI 10.1016/S0306-4522(97)00570-8; SULZER D, 1993, J NEUROCHEM, V60, P527, DOI 10.1111/j.1471-4159.1993.tb03181.x; SULZER D, 1995, J NEUROSCI, V15, P4102; Sulzer D, 2000, REV NEUROSCIENCE, V11, P159; Sulzer D, 1999, NEUROTOX RES, V1, P181, DOI 10.1007/BF03033289; Sulzer D, 2013, MOVEMENT DISORD, V28, P41, DOI 10.1002/mds.25095; Teismann P, 2003, P NATL ACAD SCI USA, V100, P5473, DOI 10.1073/pnas.0837397100; Uhl GR, 1998, ANN NEUROL, V43, P555, DOI 10.1002/ana.410430503; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Volz TJ, 2006, J NEUROSCI METH, V155, P109, DOI 10.1016/j.jneumeth.2006.01.002; Wang XL, 2011, AGING CELL, V10, P807, DOI 10.1111/j.1474-9726.2011.00721.x; Whitehead RE, 2001, J NEUROCHEM, V76, P1242, DOI 10.1046/j.1471-4159.2001.00125.x; WILLIAMS JT, 1984, NEUROSCIENCE, V13, P137, DOI 10.1016/0306-4522(84)90265-3; Xie T, 2000, J NEUROSCI, V20, P7838; Yi H, 2006, J NEURAL TRANSM, V113, P21, DOI 10.1007/s00702-005-0299-z; Youdim MBH, 2001, BRIT J PHARMACOL, V132, P500, DOI 10.1038/sj.bjp.0703826	84	37	38	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6799	6809		10.1074/jbc.M114.631556	http://dx.doi.org/10.1074/jbc.M114.631556			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25596531	Green Published, hybrid			2022-12-26	WOS:000350991500016
J	Peshenko, IV; Olshevskaya, EV; Dizhoor, AM				Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.			Evaluating the Role of Retinal Membrane Guanylyl Cyclase 1 (RetGC1) Domains in Binding Guanylyl Cyclase-activating Proteins (GCAPs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONE-ROD DYSTROPHY; CAUSES PHOTORECEPTOR DEGENERATION; LEBER CONGENITAL AMAUROSIS; CALCIUM; GENE; MUTATION; IDENTIFICATION; CA2+; SENSITIVITY; CLONING	Retinal membrane guanylyl cyclase 1 (RetGC1) regulated by guanylyl cyclase-activating proteins (GCAPs) controls photoreceptor recovery and when mutated causes blinding disorders. We evaluated the principal models of how GCAP1 and GCAP2 bind RetGC1: through a shared docking interface versus independent binding sites formed by distant portions of the cydase intracellular domain. At near-saturating concentrations, GCAP1 and GCAP2 activated RetGC1 from HEK293 cells and RetGC2(-/-) GCAPs1,2(-/-) mouse retinas in a non-additive fashion. The M26R GCAP1, which binds but does not activate RetGC1, suppressed activation of recombinant and native RetGC1 by competing with both GCAP1 and GCAP2. Untagged GCAP1 displaced both GCAP1-GFP and GCAP2-GFP from the complex with RetGC1 in HEK293 cells. The intracellular segment of a natriuretic peptide receptor A guanylyl cyclase failed to bind GCAPs, but replacing its kinase homology and dimerization domains with those from RetGC1 restored GCAP1 and GCAP2 binding by the hybrid cyclase and its GCAP-dependent regulation. Deletion of the Tyr(1016)-Ser(1103) fragment in RetGC1 did not block GCAP2 binding to the cyclase. In contrast, substitutions in the kinase homology domain, W708R and 17341, linked to Leber congenital amaurosis prevented binding of both GCAP1-GFP and GCAP2-GFP. Our results demonstrate that GCAPs cannot regulate RetGC1 using independent primary binding sites. Instead, GCAP1 and GCAP2 bind with the cyclase molecule in a mutually exclusive manner using a common or overlapping binding site(s) in the Arg(488)-Arg(851) Arel portion of RetGC1, and mutations in that region causing Leber congenital amaurosis blindness disrupt activation of the cyclase by both GCAP1 and GCAP2.	[Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, Dept Res, Elkins Pk, PA 19027 USA		Dizhoor, AM (corresponding author), Salus Univ, Res S416,8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@salus.edu		Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health from the NEI [EY11522]; Commonwealth Universal Research Enhancement formula grant from the Pennsylvania Department of Health; NATIONAL EYE INSTITUTE [R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health from the NEI; Commonwealth Universal Research Enhancement formula grant from the Pennsylvania Department of Health; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY11522 from the NEI. This work was also supported by a Commonwealth Universal Research Enhancement formula grant from the Pennsylvania Department of Health.	[Anonymous], 2012, NEUROSCIENCE; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Duda T, 2005, BIOCHEMISTRY-US, V44, P7336, DOI 10.1021/bi050068x; Duda T, 2012, BIOCHEMISTRY-US, V51, P4650, DOI 10.1021/bi300572w; Duda T, 2011, BIOCHEM BIOPH RES CO, V408, P236, DOI 10.1016/j.bbrc.2011.03.134; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; Garbers DL, 1999, METHODS, V19, P477, DOI 10.1006/meth.1999.0890; Hwang JY, 2003, EUR J BIOCHEM, V270, P3814, DOI 10.1046/j.1432-1033.2003.03770.x; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Jacobson SG, 2013, HUM MOL GENET, V22, P168, DOI 10.1093/hmg/dds421; Jiang L, 2011, P NATL ACAD SCI USA, V108, P18476, DOI 10.1073/pnas.1112758108; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kitiratschky VBD, 2009, HUM MUTAT, V30, pE782, DOI 10.1002/humu.21055; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOCH KW, 1991, J BIOL CHEM, V266, P8634; Laura RP, 1996, J BIOL CHEM, V271, P11646, DOI 10.1074/jbc.271.20.11646; Laura RP, 1998, BIOCHEMISTRY-US, V37, P11264, DOI 10.1021/bi9809674; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Peshenko IV, 2008, J BIOL CHEM, V283, P21747, DOI 10.1074/jbc.M801899200; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2014, J BIOL CHEM, V289, P10140, DOI 10.1074/jbc.M113.540716; Peshenko IV, 2012, J BIOL CHEM, V287, P13972, DOI 10.1074/jbc.M112.341883; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2010, BIOCHEMISTRY-US, V49, P709, DOI 10.1021/bi901495y; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Scholten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023117; Sharma RK, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00056; Sokal I, 1999, BIOCHEMISTRY-US, V38, P1387, DOI 10.1021/bi982512k; Sokal I, 2005, INVEST OPHTH VIS SCI, V46, P1124, DOI 10.1167/iovs.04-1431; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Wen XH, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00045; Wilkie SE, 2001, AM J HUM GENET, V69, P471, DOI 10.1086/323265; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; Yang RB, 1997, J BIOL CHEM, V272, P13738, DOI 10.1074/jbc.272.21.13738; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; Zinchuk V., 2008, CURR PROTOC CELL BIO, V39, P4191	60	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6913	6924		10.1074/jbc.M114.629642	http://dx.doi.org/10.1074/jbc.M114.629642			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25616661	Green Published, hybrid			2022-12-26	WOS:000350991500026
J	Seviour, T; Hansen, SH; Yang, L; Yau, YH; Wang, VB; Stenvang, MR; Christiansen, G; Marsili, E; Givskov, M; Chen, YC; Otzen, DE; Nielsen, PH; Geifman-Shochat, S; Kjelleberg, S; Dueholm, MS				Seviour, Thomas; Hansen, Susan Hove; Yang, Liang; Yau, Yin Hoe; Wang, Victor Bochuan; Stenvang, Marcel R.; Christiansen, Gunna; Marsili, Enrico; Givskov, Michael; Chen, Yicai; Otzen, Daniel E.; Nielsen, Per Halkjaer; Geifman-Shochat, Susana; Kjelleberg, Staffan; Dueholm, Morten S.			Functional Amyloids Keep Quorum-sensing Molecules in Check	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA VIRULENCE; BIOFILM FORMATION; BACTERIAL BIOFILMS; ALPHA-SYNUCLEIN; PYOCYANIN; SIGNAL; EXOPOLYSACCHARIDE; AGGREGATION; EXPRESSION; PROTEIN	The mechanism by which extracellular metabolites, including redox mediators and quorum-sensing signaling molecules, traffic through the extracellular matrix of biofilms is poorly explored. We hypothesize that functional amyloids, abundant in natural biofilms and possessing hydrophobic domains, retain these metabolites. Using surface plasmon resonance, we demonstrate that the quorum-sensing (QS) molecules, 2-heptyl-3-hydroxy-4(1H)quinolone and N-(3-oxododecanoyl)-L-homoserine lactone, and the redox mediator pyocyaruin bind with transient affinity to functional amyloids from Pseudomonas (Fap). Their high hydrophobicity predisposes them to signal-amyloid interactions, but specific interactions also play a role. Transient interactions allow for rapid association and dissociation kinetics, which make the QS molecules bioavailable and at the same time secure within the extracellular matrix as a consequence of serial bindings. Retention of the QS molecules was confirmed using Pseudomonas aeruginosa P A()1based 2-heptyl-3-hydroxy-4(1H)-quinolone and N-(3-oxododecanoyl)-L-homoserine lactone reporter assays, showing that Fap fibrils pretreated with the QS molecules activate the reporters even after sequential washes. Pyocyanin retention was validated by electrochemical analysis of pyocyanin-pretreated Fap fibrils subjected to the same washing process. Results suggest that QS molecule-amyloid interactions are probably important in the turbulent environments commonly encountered in natural habitats.	[Seviour, Thomas; Yang, Liang; Wang, Victor Bochuan; Marsili, Enrico; Givskov, Michael; Chen, Yicai; Nielsen, Per Halkjaer; Kjelleberg, Staffan] Nanyang Technol Univ, SCELSE, Singapore 637551, Singapore; [Yau, Yin Hoe; Geifman-Shochat, Susana] Nanyang Technol Univ, SBS, Singapore 637551, Singapore; [Hansen, Susan Hove; Nielsen, Per Halkjaer; Dueholm, Morten S.] Aalborg Univ, Ctr Microbial Communities, DK-9220 Aalborg, Denmark; [Wang, Victor Bochuan] Nanyang Technol Univ, Sch Mat Sci & Engn MSE, Singapore 639798, Singapore; [Stenvang, Marcel R.; Otzen, Daniel E.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Dept Mol Biol & Genet, Ctr Insoluble Prot Struct inSPIN, DK-8000 Aarhus C, Denmark; [Christiansen, Gunna] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Givskov, Michael] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, DK-1165 Copenhagen, Denmark; [Kjelleberg, Staffan] Univ New S Wales, Ctr Marine Bioinnovat, Mosman, NSW 2088, Australia; [Kjelleberg, Staffan] Univ New S Wales, Sch Biotechnol & Biomol Sci, Mosman, NSW 2088, Australia	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Aalborg University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Aarhus University; Aarhus University; University of Copenhagen; University of New South Wales Sydney; University of New South Wales Sydney	Seviour, T (corresponding author), Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, SBS-B2n-27,50 Nanyang Ave, Singapore 639798, Singapore.	twseviour@ntu.edu.sg	Kjelleberg, Staffan/C-9229-2015; Nielsen, Per Halkjær/T-6796-2018; Marsili, Enrico/A-8652-2008; Hoe, YAU Yin/A-2817-2011; Kjelleberg, Staffan/AAB-4641-2020; Yang, Liang/C-8487-2011; Dueholm, Morten Simonsen/T-6718-2018	Kjelleberg, Staffan/0000-0003-4271-6413; Nielsen, Per Halkjær/0000-0002-6402-1877; Marsili, Enrico/0000-0003-3150-1564; Hoe, YAU Yin/0000-0001-8136-2393; Kjelleberg, Staffan/0000-0003-4271-6413; Yang, Liang/0000-0002-2362-0128; Dueholm, Morten Simonsen/0000-0003-4135-2670; Givskov, Michael/0000-0001-5004-8609; Christiansen, Gunna/0000-0003-0540-1367	Singapore's National Research Foundation; Ministry of Education; Nanyang Technological University (NTU); National University of Singapore (NUS); Sino-Danish Centre for Education and Research	Singapore's National Research Foundation(National Research Foundation, Singapore); Ministry of Education; Nanyang Technological University (NTU)(Nanyang Technological University); National University of Singapore (NUS)(National University of Singapore); Sino-Danish Centre for Education and Research	The Singapore Centre on Environmental Life Sciences Engineering is supported by Singapore's National Research Foundation, Ministry of Education, Nanyang Technological University (NTU), and National University of Singapore (NUS), and hosted by NTU in partnership with NUS. Electrical characterization was performed at the Energy Research Institute at NTU.r Supported by the Sino-Danish Centre for Education and Research.	Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bieler S, 2005, J BIOL CHEM, V280, P26880, DOI 10.1074/jbc.M502031200; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; BRITIGAN BE, 1992, J CLIN INVEST, V90, P2187, DOI 10.1172/JCI116104; Britigan BE, 1999, INFECT IMMUN, V67, P1207, DOI 10.1128/IAI.67.3.1207-1212.1999; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; Calfee MW, 2001, P NATL ACAD SCI USA, V98, P11633, DOI 10.1073/pnas.201328498; Colvin KM, 2012, ENVIRON MICROBIOL, V14, P1913, DOI 10.1111/j.1462-2920.2011.02657.x; Das T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058299; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; del Mercato LL, 2007, P NATL ACAD SCI USA, V104, P18019, DOI 10.1073/pnas.0702843104; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; Diggle SP, 2007, CHEM BIOL, V14, P87, DOI 10.1016/j.chembiol.2006.11.014; Dueholm M. S., 2013, FUNCTIONAL AMYLOIDS, P411; Dueholm MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076630; Dueholm MS, 2013, MICROBIOLOGYOPEN, V2, P365, DOI 10.1002/mbo3.81; Dueholm MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051274; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Ghafoor A, 2011, APPL ENVIRON MICROB, V77, P5238, DOI 10.1128/AEM.00637-11; Gloag ES, 2013, P NATL ACAD SCI USA, V110, P11541, DOI 10.1073/pnas.1218898110; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Haussler S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000166; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Harmsen M, 2010, APPL ENVIRON MICROB, V76, P2271, DOI 10.1128/AEM.02361-09; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Herbst -A, 2014, J PROTEORNE RES, DOI [110.1021/pr500938x, DOI 10.1021/PR500938X]; Herva ME, 2014, J BIOL CHEM, V289, P11897, DOI 10.1074/jbc.M113.542340; Hunter RC, 2012, AM J RESP CELL MOL, V47, P738, DOI 10.1165/rcmb.2012-0088OC; Irie Y, 2012, P NATL ACAD SCI USA, V109, P20632, DOI 10.1073/pnas.1217993109; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Kawatake S, 2006, BIOL PHARM BULL, V29, P927, DOI 10.1248/bpb.29.927; Larsen P, 2008, APPL ENVIRON MICROB, V74, P1517, DOI 10.1128/AEM.02274-07; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lorenzen N, 2014, FEBS LETT, V588, P497, DOI 10.1016/j.febslet.2013.12.015; Malvankar NS, 2011, NAT NANOTECHNOL, V6, P573, DOI [10.1038/nnano.2011.119, 10.1038/NNANO.2011.119]; Mammen Mathai, 1998, Angew Chem Int Ed Engl, V37, P2754, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Mashburn-Warren L, 2008, MOL MICROBIOL, V69, P491, DOI 10.1111/j.1365-2958.2008.06302.x; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Myszka DG, 2004, ANAL BIOCHEM, V329, P316, DOI 10.1016/j.ab.2004.03.028; Ohlson S, 2008, DRUG DISCOV TODAY, V13, P433, DOI 10.1016/j.drudis.2008.02.001; Olsen A, 2002, J BIOL CHEM, V277, P34568, DOI 10.1074/jbc.M206353200; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Passador L, 1996, J BACTERIOL, V178, P5995, DOI 10.1128/jb.178.20.5995-6000.1996; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Pedersen JS, 2006, J MOL BIOL, V355, P501, DOI 10.1016/j.jmb.2005.09.100; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; Purevdorj B, 2002, APPL ENVIRON MICROB, V68, P4457, DOI 10.1128/AEM.68.9.4457-4464.2002; Rabaey K, 2005, ENVIRON SCI TECHNOL, V39, P3401, DOI 10.1021/es048563o; Ramos I, 2010, RES MICROBIOL, V161, P187, DOI 10.1016/j.resmic.2010.01.003; Roden LD, 1996, BIOCHEM BIOPH RES CO, V225, P1073, DOI 10.1006/bbrc.1996.1297; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Seviour T, 2012, WATER RES, V46, P4803, DOI 10.1016/j.watres.2012.06.018; Seviour T, 2012, BIOMACROMOLECULES, V13, P1965, DOI 10.1021/bm3005808; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; Strycharz-Glaven SM, 2011, ENERG ENVIRON SCI, V4, P4366, DOI 10.1039/c1ee01753e; Usher LR, 2002, J IMMUNOL, V168, P1861, DOI 10.4049/jimmunol.168.4.1861; Wang VB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063129; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Yang L, 2007, MICROBIOL-SGM, V153, P1318, DOI 10.1099/mic.0.2006/004911-0; Yang L, 2009, ANTIMICROB AGENTS CH, V53, P2432, DOI 10.1128/AAC.01283-08; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zhang LB, 2013, MICROBIOL-SGM, V159, P1931, DOI 10.1099/mic.0.066266-0	71	55	55	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6457	6469		10.1074/jbc.M114.613810	http://dx.doi.org/10.1074/jbc.M114.613810			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25586180	hybrid, Green Published			2022-12-26	WOS:000350732500049
J	Kwon, MJ; Choi, Y; Yun, JH; Lee, W; Han, IO; Oh, ES				Kwon, Mi-Jung; Choi, Youngsil; Yun, Ji-Hye; Lee, Weontae; Han, Inn-Oc; Oh, Eok-Soo			A Unique Phenylalanine in the Transmembrane Domain Strengthens Homodimerization of the Syndecan-2 Transmembrane Domain and Functionally Regulates Syndecan-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX-HELIX INTERACTIONS; GXXXG MOTIFS; ASSOCIATION; MIGRATION; RECEPTOR; DIMERIZATION; RESIDUES; ADHESION	The syndecans are a type of cell surface adhesion receptor that initiates intracellular signaling events through receptor clustering mediated by their highly conserved transmembrane domains (TMDs). However, the exact function of the syndecan TMD is not yet fully understood. Here, we investigated the specific regulatory role of the syndecan-2 TMD. We found that syndecan-2 mutants in which the TMD had been replaced with that of syndecan-4 were defective in syndecan-2-mediated functions, suggesting that the TMD of syndecan-2 plays one or more specific roles. Interestingly, syndecan-2 has a stronger tendency to form sodium dodecyl sulfate (SDS)-resistant homodimers than syndecan-4. Our structural studies showed that a unique phenylalanine residue (Phe(167)) enables an additional molecular interaction between the TMDs of the syndecan-2 homodimer. The presence of Phe(167) was correlated with a higher tendency toward oligomerization, and its replacement with isoleucine significantly reduced the SDS-resistant dimer formation and cellular functions of syndecan-2 (e. g. cell migration). Conversely, replacement of isoleucine with phenylalanine at this position in the syndecan-4 TMD rescued the defects observed in a mutant syndecan-2 harboring the syndecan-4 TMD. Taken together, these data suggest that Phe(167) in the TMD of syndecan-2 endows the protein with specific functions. Our work offers new insights into the signaling mediated by the TMD of syndecan family members.	[Kwon, Mi-Jung; Choi, Youngsil; Oh, Eok-Soo] Ewha Womans Univ, Dept Life Sci, Res Ctr Cellular Homeostasis, Seoul 120750, South Korea; [Yun, Ji-Hye; Lee, Weontae] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea; [Han, Inn-Oc] Inha Univ, Dept Physiol & Biophys, Coll Med, Inchon 402751, South Korea	Ewha Womans University; Yonsei University; Inha University	Oh, ES (corresponding author), Ewha Womans Univ, Dept Life Sci, 52 Ewhayeodae Gil, Seoul 120750, South Korea.	OhES@ewha.ac.kr	LEE, WEON TAE/AAQ-9088-2021	Lee, Weontae/0000-0003-2347-1262	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2012R1A5A1048236, 2013R1A2A2A01013565]; Mid-career Researcher Program Grant through an NRF grant - Korean Ministry of Education, Science, and Technology (MEST) [NRF-2013R1A2A2A01068963]; Brain Korea Plus (BK+) grant	National Research Foundation of Korea (NRF) - Korean government (MSIP); Mid-career Researcher Program Grant through an NRF grant - Korean Ministry of Education, Science, and Technology (MEST); Brain Korea Plus (BK+) grant	This work was supported by National Research Foundation of Korea (NRF) Grants 2012R1A5A1048236 and 2013R1A2A2A01013565 (to E. S. O.) funded by the Korean government (MSIP) and Mid-career Researcher Program Grant NRF-2013R1A2A2A01068963 through an NRF grant funded by the Korean Ministry of Education, Science, and Technology (MEST) (to W. T. L.).; Recipient of a Brain Korea Plus (BK+) grant.	CALOF AL, 1991, J CELL BIOL, V115, P779, DOI 10.1083/jcb.115.3.779; Carey DJ, 1997, BIOCHEM J, V327, P1; Chen LG, 2002, BIOCHEM J, V366, P481, DOI 10.1042/BJ20020711; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Choi Y, 2008, EUR J CELL BIOL, V87, P807, DOI 10.1016/j.ejcb.2008.04.005; Choi Y, 2011, MATRIX BIOL, V30, P93, DOI 10.1016/j.matbio.2010.10.006; Choi Y, 2010, BIOCHEM BIOPH RES CO, V391, P921, DOI 10.1016/j.bbrc.2009.11.165; Dawson JP, 2003, J MOL BIOL, V331, P255, DOI 10.1016/S0022-2836(03)00714-9; DeMali KA, 1999, J BIOL CHEM, V274, P19551, DOI 10.1074/jbc.274.28.19551; Dews IC, 2007, P NATL ACAD SCI USA, V104, P20782, DOI 10.1073/pnas.0708909105; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Hecker TP, 2002, CANCER RES, V62, P2699; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hienola A, 2006, J CELL BIOL, V174, P569, DOI 10.1083/jcb.200602043; Johnson RM, 2007, BIOCHEMISTRY-US, V46, P9208, DOI 10.1021/bi7008773; Kannan N, 2000, PROTEIN ENG, V13, P753, DOI 10.1093/protein/13.11.753; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Lee H, 2011, BIOCHEM BIOPH RES CO, V409, P148, DOI 10.1016/j.bbrc.2011.04.135; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Melnyk RA, 2004, J BIOL CHEM, V279, P16591, DOI 10.1074/jbc.M313936200; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Rapraeger AC, 2000, J CELL BIOL, V149, P995, DOI 10.1083/jcb.149.5.995; Ryu HY, 2009, J BIOL CHEM, V284, P35692, DOI 10.1074/jbc.M109.054254; Sal-Man N, 2007, J BIOL CHEM, V282, P19753, DOI 10.1074/jbc.M610368200; Schlesinger TK, 1999, BIOCHEM J, V344, P519, DOI 10.1042/0264-6021:3440519; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Unterreitmeier S, 2007, J MOL BIOL, V374, P705, DOI 10.1016/j.jmb.2007.09.056; Waters ML, 2002, CURR OPIN CHEM BIOL, V6, P736, DOI 10.1016/S1367-5931(02)00359-9	31	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5772	5782		10.1074/jbc.M114.599845	http://dx.doi.org/10.1074/jbc.M114.599845			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25572401	Green Published, hybrid			2022-12-26	WOS:000350044200044
J	Kim, SR; Han, K; Choi, JY; Ersek, J; Liu, JX; Jo, SJ; Lee, KS; Yim, HW; Lee, WC; Park, YG; Lee, SH; Park, YM				Kim, So-Ra; Han, Kyungdo; Choi, Jin-Young; Ersek, Jennifer; Liu, Junxiu; Jo, Sun-Jin; Lee, Kang-Sook; Yim, Hyeon Woo; Lee, Won-Chul; Park, Yong Gyu; Lee, Seung-Hwan; Park, Yong-Moon			Age- and Sex-Specific Relationships between Household Income, Education, and Diabetes Mellitus in Korean Adults: The Korea National Health and Nutrition Examination Survey, 2008-2010	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; METABOLIC SYNDROME; RISK-FACTORS; ASSOCIATION; POSITION; PREVALENCE; OBESITY; LIFE; GENDER; DISPARITIES	Background To investigate the effects of age and sex on the relationship between socioeconomic status (SES) and the prevalence and control status of diabetes mellitus (DM) in Korean adults. Methods Data came from 16,175 adults (6,951 men and 9,227 women) over the age of 30 who participated in the 2008-2010 Korea National Health and Nutrition Examination Survey. SES was measured by household income or education level. The adjusted odds ratios (ORs) and corresponding 95% confidence intervals (95% CI) for the prevalence or control status of diabetes were calculated using multiple logistic regression analyses across household income quartiles and education levels. Results The household income-DM and education level-DM relationships were significant in younger age groups for both men and women. The adjusted ORs and 95% CI for diabetes were 1.51 (0.97, 2.34) and 2.28 (1.29, 4.02) for the lowest vs. highest quartiles of household income and education level, respectively, in women younger than 65 years of age (both P for linear trend < 0.05 with Bonferroni adjustment). The adjusted OR and 95% CI for diabetes was 2.28 (1.53, 3.39) for the lowest vs. highest quartile of household income in men younger than 65 (P for linear trend < 0.05 with Bonferroni adjustment). However, in men and women older than 65, no associations were found between SES and the prevalence of DM. No significant association between SES and the status of glycemic control was detected. Conclusions We found age-and sex-specific differences in the relationship of household income and education with the prevalence of DM in Korea. DM preventive care is needed for groups with a low SES, particularly in young or middle-aged populations.	[Kim, So-Ra; Yim, Hyeon Woo; Lee, Won-Chul; Park, Yong-Moon] Catholic Univ Korea, Grad Sch Publ Hlth, Seoul, South Korea; [Han, Kyungdo; Jo, Sun-Jin; Lee, Kang-Sook; Yim, Hyeon Woo; Lee, Won-Chul; Park, Yong-Moon] Catholic Univ Korea, Dept Prevent Med, Coll Med, Seoul, South Korea; [Han, Kyungdo; Park, Yong Gyu] Catholic Univ Korea, Dept Biostat, Coll Med, Seoul, South Korea; [Choi, Jin-Young] Catholic Univ Korea, Catholic Med Ctr, Seoul, South Korea; [Ersek, Jennifer; Liu, Junxiu; Park, Yong-Moon] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA; [Lee, Seung-Hwan] Catholic Univ Korea, Seoul St Marys Hosp, Div Endocrinol & Metab, Dept Internal Med,Coll Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Catholic University of Korea; Seoul St. Mary's Hospital	Lee, SH (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Div Endocrinol & Metab, Dept Internal Med,Coll Med, Seoul, South Korea.	hwanx2@catholic.ac.kr; markYMpark@gmail.com	PARK, YONG-MOON ("MARK")/ABA-2765-2021; Lee, Seung-Hwan/C-7568-2018; Lee, Seung-Hwan/AAG-1361-2019	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879; Lee, Seung-Hwan/0000-0002-3964-3877; Lee, Seung-Hwan/0000-0002-3964-3877; Park, Yong Gyu/0000-0002-8721-3230; Choi, Jin Young/0000-0002-3641-2504	Catholic Medical Center Research Foundation	Catholic Medical Center Research Foundation	This study was supported by the grant from the Catholic Medical Center Research Foundation made in the program year of 2014 (to SHL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Agardh EE, 2007, INT J EPIDEMIOL, V36, P84, DOI 10.1093/ije/dyl269; Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Assari S, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-36; Assari S, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-3; Barbeau EM, 2004, AM J PUBLIC HEALTH, V94, P269, DOI 10.2105/AJPH.94.2.269; Brezinka V, 1996, SOC SCI MED, V42, P1351, DOI 10.1016/0277-9536(95)00284-7; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; Choi BCK, 2001, DIABETOLOGIA, V44, P1221, DOI 10.1007/s001250100648; 박봉숙, 2005, Diabetes and Metabolism Journal, V29, P254; Dallongeville J, 2005, DIABETES CARE, V28, P409, DOI 10.2337/diacare.28.2.409; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Duncan GJ, 1996, INT J HEALTH SERV, V26, P419, DOI 10.2190/1KU0-4Y3K-ACFL-BYU7; Evans JMM, 2000, DIABETIC MED, V17, P478, DOI 10.1046/j.1464-5491.2000.00309.x; Gallegos-Macias Angela R, 2003, Pediatr Diabetes, V4, P19, DOI 10.1034/j.1399-5448.2003.00020.x; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Guariguata L, 2011, DIABETES RES CLIN PR, V94, P322, DOI 10.1016/j.diabres.2011.10.040; Hassan K, 2006, J PEDIATR-US, V149, P526, DOI 10.1016/j.jpeds.2006.05.039; Hosseinpoor AR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-912; Hur Inyoung, 2011, Osong Public Health Res Perspect, V2, P192, DOI 10.1016/j.phrp.2011.11.044; Jeffery RW, 1996, ANN EPIDEMIOL, V6, P263, DOI 10.1016/S1047-2797(96)00070-1; Kautzky-Willer A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-392; Kim DJ, 2011, DIABETES METAB J, V35, P303, DOI 10.4093/dmj.2011.35.4.303; KO MJ, 2012, INT J EPIDEMIOL, P1; Kowall B, 2011, J EPIDEMIOL COMMUN H, V65, P606, DOI 10.1136/jech.2009.094086; Larrimore J, 2011, MILBANK Q, V89, P694, DOI 10.1111/j.1468-0009.2011.00647.x; Lee DS, 2013, PUBLIC HEALTH, V127, P554, DOI 10.1016/j.puhe.2013.02.001; Lee J, 2013, ENDOCRINOL METAB, V28, P180, DOI 10.3803/EnM.2013.28.3.180; Lee TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027670; Loucks EB, 2007, ANN EPIDEMIOL, V17, P19, DOI 10.1016/j.annepidem.2006.07.002; Myong JP, 2012, IND HEALTH, V50, P115, DOI 10.2486/indhealth.MS1328; Park IB, 2013, DIABETES METAB J, V37, P233, DOI 10.4093/dmj.2013.37.4.233; Park YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085068; Ploubidis GB, 2013, INT J PUBLIC HEALTH, V58, P133, DOI 10.1007/s00038-012-0389-2; Rabi DM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-124; Robbins JM, 2001, AM J PUBLIC HEALTH, V91, P76, DOI 10.2105/AJPH.91.1.76; Schooling CM, 2008, AM J EPIDEMIOL, V167, P419, DOI 10.1093/aje/kwm329; SORLIE PD, 1995, AM J PUBLIC HEALTH, V85, P949, DOI 10.2105/AJPH.85.7.949; Tang M, 2003, INT J EPIDEMIOL, V32, P381, DOI 10.1093/ije/dyg075; Turrell G, 2006, PUBLIC HEALTH NUTR, V9, P375, DOI 10.1079/PHN2006850; Wardle J, 2001, J EPIDEMIOL COMMUN H, V55, P185, DOI 10.1136/jech.55.3.185; Wikstrom K, 2011, EUR J PUBLIC HEALTH, V21, P768, DOI 10.1093/eurpub/ckq164; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Yoon YS, 2006, OBESITY, V14, P909, DOI 10.1038/oby.2006.105	44	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117034	10.1371/journal.pone.0117034	http://dx.doi.org/10.1371/journal.pone.0117034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ8MR	25622031	Green Published, Green Submitted, gold			2022-12-26	WOS:000348470400014
J	Hu, P; Luo, BH				Hu, Ping; Luo, Bing-Hao			Integrin alpha(IIb)beta(3) Transmembrane Domain Separation Mediates Bi-Directional Signaling across the Plasma Membrane	PLOS ONE			English	Article							CYTOPLASMIC DOMAIN; OUTSIDE-IN; STRUCTURAL BASIS; ALPHA-SUBUNIT; TYROSINE KINASE; CELL-MIGRATION; ACTIVATION; PAXILLIN; ALPHA-IIB-BETA-3; BINDING	Integrins play an essential role in hemostasis, thrombosis, and cell migration, and they transmit bidirectional signals. Transmembrane/cytoplasmic domains are hypothesized to associate in the resting integrins; whereas, ligand binding and intracellular activating signals induce transmembrane domain separation. However, how this conformational change affects integrin outside-in signaling and whether the a subunit cytoplasmic domain is important for this signaling remain elusive. Using Chinese Hamster Ovary (CHO) cells that stably expressed different integrin alpha(IIb)beta(3) constructs, we discovered that an alpha(IIb) cytoplasmic domain truncation led to integrin activation but not defective outside-in signaling. In contrast, preventing transmembrane domain separation abolished both inside-out and outside-in signaling regardless of removing the alpha(IIb) cytoplasmic tail. Truncation of the alpha(IIb) cytoplasmic tail did not obviously affect adhesion-induced outside-in signaling. Our research revealed that transmembrane domain separation is a downstream conformational change after the cytoplasmic domain dissociation in inside-out activation and indispensable for ligand-induced outside-in signaling. The result implicates that the beta TM helix rearrangement after dissociation is essential for integrin transmembrane signaling. Furthermore, we discovered that the PI3K/Akt pathway is not essential for cell spreading but spreading-induced Erk1/2 activation is PI3K dependent implicating requirement of the kinase for cell survival in outside-in signaling.	[Hu, Ping; Luo, Bing-Hao] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Luo, BH (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	luo@tigers.lsu.edu			American Heart Association [10GRNT3960011]	American Heart Association(American Heart Association)	This work was supported by the American Heart Association (#10GRNT3960011) to BHL (http://www.heart.org/HEARTORG/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; Chua GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055184; de Virgilio M, 2004, J CELL BIOL, V165, P305, DOI 10.1083/jcb.200402064; Gao CJ, 2011, BLOOD, V117, P4946, DOI 10.1182/blood-2010-09-307751; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Gottschalk KE, 2002, PROTEIN SCI, V11, P1800, DOI 10.1110/ps.4120102; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hu P, 2013, J CELL PHYSIOL, V228, P306, DOI 10.1002/jcp.24154; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ishibe S, 2003, MOL CELL, V12, P1275, DOI 10.1016/S1097-2765(03)00406-4; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Liu JL, 2005, BLOOD, V105, P4345, DOI 10.1182/blood-2004-07-2718; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Liu SC, 2001, J BIOL CHEM, V276, P37086, DOI 10.1074/jbc.M105114200; Liu SC, 2000, J BIOL CHEM, V275, P22736, DOI 10.1074/jbc.M000388200; Lu CF, 1997, J IMMUNOL, V159, P268; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mehrbod M, 2013, BIOPHYS J, V105, P1304, DOI 10.1016/j.bpj.2013.07.055; Mehrbod M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002948; Metcalf DG, 2010, P NATL ACAD SCI USA, V107, P22481, DOI 10.1073/pnas.1015545107; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Niu HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047356; O'Brien KA, 2012, ARTERIOSCL THROM VAS, V32, P2232, DOI 10.1161/ATVBAHA.112.254680; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Partridge AW, 2005, J BIOL CHEM, V280, P7294, DOI 10.1074/jbc.M412701200; Pfaff M, 2001, J CELL SCI, V114, P2775; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Romanova LY, 2011, CELL ADHES MIGR, V5, P457, DOI 10.4161/cam.5.6.18219; Stefansson A, 2004, J BIOL CHEM, V279, P21200, DOI 10.1074/jbc.M400771200; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Surya W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074281; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; Wang W, 2010, BIOCHEMISTRY-US, V49, P10158, DOI 10.1021/bi101462h; Wang W, 2010, J CELL BIOCHEM, V109, P447, DOI 10.1002/jcb.22427; Wegener KL, 2008, MOL MEMBR BIOL, V25, P376, DOI 10.1080/09687680802269886; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; WILLIAMS SE, 1994, ANN NY ACAD SCI, V737, P1, DOI 10.1111/j.1749-6632.1994.tb44297.x; Woodside DG, 2001, CURR BIOL, V11, P1799, DOI 10.1016/S0960-9822(01)00565-6; Zeller KS, 2010, CELL SIGNAL, V22, P1838, DOI 10.1016/j.cellsig.2010.07.011; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022	57	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0116208	10.1371/journal.pone.0116208	http://dx.doi.org/10.1371/journal.pone.0116208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617834	Green Published, gold, Green Submitted			2022-12-26	WOS:000350336000009
J	Li, TF; Fan, H; Wang, YX				Li, Teng-Fei; Fan, Hui; Wang, Yong-Xiang			Epidural Sustained Release Ropivacaine Prolongs Anti-Allodynia and Anti-Hyperalgesia in Developing and Established Neuropathic Pain	PLOS ONE			English	Article							C-FOS; LOCAL-ANESTHETICS; OIL SUSPENSIONS; SODIUM-CHANNELS; NERVE INJURY; BUPIVACAINE; LIDOCAINE; RAT; SURGERY; MODEL	Ropivacaine is a local anesthetic widely used for regional anesthesia and epidural analgesia, but its relatively short duration limits its clinical use. A novel sustained release lipid formulation of ropivacaine has been recently developed to prolong its duration. We examined the epidural anti-hypersensitivity and preemptive effects of ropivacaine in mesylate injection and sustained release suspension forms in a rat model of neuropathy produced by peripheral nerve injury. Epidural administration of ropivacaine mesylate injection specifically blocked mechanical allodynia and thermal hyperalgesia by approximately 50% with a biological half-effective duration of approximately 3 hrs. The equivalent dose of ropivacaine free-base in sustained release suspension significantly prolonged the duration of anti-allodynia and anti-hyperalgesia by approximately 2 times. Multiple daily epidural injections of ropivacaine in both the mesylate injection and sustained-release suspension forms did not induce tolerance or potentiation to anti-allodynia or anti-hyperalgesia. Moreover, the single or multiple daily administration of ropivacaine mesylate injection before surgery in particular, markedly blocked the initiation and development of neuropathic pain, increasing the biological half-effective duration from less than 4 hrs up to 1 or 2 days. The single and multiple daily epidural injection of ropivacaine sustained release suspension further delayed the biological half-lives to 2 and 3 days, respectively. Our results indicate that the epidural administration of ropivacaine effectively blocks neuropathic pain without the induction of analgesic tolerance, and significantly delays the development of neuropathy produced by peripheral nerve injury. Epidural ropivacaine sustained release suspension produces much longer blockade effects of mechanical allodynia and heat hyperalgesia, and more significantly delays the development of neuropathic pain.	[Li, Teng-Fei; Fan, Hui; Wang, Yong-Xiang] Shanghai Jiao Tong Univ, Sch Pharm, Kings Lab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wang, YX (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Kings Lab, Shanghai 200030, Peoples R China.	yxwang@sjtu.edu.cn			Xi'an Libang Pharmaceutical Co. (Xi'an, China)	Xi'an Libang Pharmaceutical Co. (Xi'an, China)	This research was financially supported by Xi'an Libang Pharmaceutical Co. (Xi'an, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram SE, 1996, REGION ANESTH, V21, P117; AKERMAN B, 1988, ACTA ANAESTH SCAND, V32, P571, DOI 10.1111/j.1399-6576.1988.tb02788.x; Albi-Feldzer A, 2013, ANESTHESIOLOGY, V118, P318, DOI 10.1097/ALN.0b013e31827d88d8; Amir R, 2006, J PAIN, V7, pS1, DOI 10.1016/j.jpain.2006.01.444; ARNER S, 1990, PAIN, V43, P287, DOI 10.1016/0304-3959(90)90026-A; Avelino A, 1998, J UROLOGY, V159, P567, DOI 10.1016/S0022-5347(01)63985-5; Batoz H, 2009, ANESTH ANALG, V109, P240, DOI 10.1213/ane.0b013e3181a4928d; CHAPLAN SR, 1995, ANESTHESIOLOGY, V83, P775, DOI 10.1097/00000542-199510000-00017; Charlet A, 2011, J PAIN, V12, P246, DOI 10.1016/j.jpain.2010.07.005; Crosby E, 1998, CAN J ANAESTH, V45, P1066, DOI 10.1007/BF03012393; DEVOR M, 1992, PAIN, V48, P261, DOI 10.1016/0304-3959(92)90067-L; DURANT PAC, 1986, ANESTHESIOLOGY, V64, P43, DOI 10.1097/00000542-198601000-00008; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; England JD, 1996, NEUROLOGY, V47, P272, DOI 10.1212/WNL.47.1.272; Gong N, 2014, J NEUROSCI, V34, P5322, DOI 10.1523/JNEUROSCI.4703-13.2014; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; Herbland A, 2006, REGION ANESTH PAIN M, V31, P34, DOI 10.1016/j.rapm.2005.10.008; Hogan QH, 1997, ANESTHESIOLOGY, V86, P216, DOI 10.1097/00000542-199701000-00026; Huang JL, 2012, AMINO ACIDS, V43, P1905, DOI 10.1007/s00726-012-1390-z; Ji Ru-Rong, 2004, Sci STKE, V2004, preE14; Kanai Y, 1999, REGION ANESTH PAIN M, V24, P444, DOI 10.1016/S1098-7339(99)90012-3; Kemp MI, 2010, PROGR MED CHEM, V49, P81, DOI 10.1016/S0079-6468(10)49003-7; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; KOLTZENBURG M, 1994, BRAIN, V117, P579, DOI 10.1093/brain/117.3.579; LANGERMAN L, 1991, ANESTH ANALG, V72, P635; Larsen SW, 2008, EUR J PHARM SCI, V34, P37, DOI 10.1016/j.ejps.2008.02.005; LEUNG JM, 1995, ANESTHESIOLOGY, V83, P1132, DOI 10.1097/00000542-199511000-00034; Lierz P, 2004, EUR J ANAESTH, V21, P32, DOI 10.1017/S0265021504001061; Lin CT, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/921405; LIU S, 1995, ANESTHESIOLOGY, V82, P1474, DOI 10.1097/00000542-199506000-00019; Lu WD, 2013, Patent, Patent No. [103142458A, 103142458]; McClure JH, 1996, BRIT J ANAESTH, V76, P300, DOI 10.1093/bja/76.2.300; Mitchell VA, 1999, ANESTH ANALG, V89, P989, DOI 10.1097/00000539-199910000-00031; Oda A, 2000, ANESTH ANALG, V91, P1213, DOI 10.1097/00000539-200011000-00031; Pedersen BT, 2008, DRUG DELIV, V15, P23, DOI [10.1080/10717540701828657, 10.1080/10717540701828657 ]; Ratajczak-Enselme M, 2009, EUR J PHARM BIOPHARM, V72, P54, DOI 10.1016/j.ejpb.2008.11.003; Rose FX, 2007, ANESTH ANALG, V105, P859, DOI 10.1213/01.ane.0000278129.37099.fa; ROY ML, 1992, J NEUROSCI, V12, P2104; Shin JW, 2008, ANESTH ANALG, V107, P1587, DOI 10.1213/ane.0b013e31818200aa; Shum P, 2001, ADV DRUG DELIVER REV, V53, P273, DOI 10.1016/S0169-409X(01)00232-0; Smith LJ, 2002, PAIN, V97, P267, DOI 10.1016/S0304-3959(02)00028-3; Stenberg C, 2005, BASIC CLIN PHARMACOL, V96, P381, DOI 10.1111/j.1742-7843.2005.pto_07.x; Sun XH, 2004, ANESTH ANALG, V98, P1093, DOI 10.1213/01.ANE.0000104580.89717.A2; Terpstra AHM, 2001, J NUTR, V131, P2067, DOI 10.1093/jn/131.7.2067; Toda S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-2; Wei H, 2007, BRAIN RES, V1148, P105, DOI 10.1016/j.brainres.2007.02.040; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6; Zink W, 2008, CURR OPIN ANESTHESIO, V21, P645, DOI 10.1097/ACO.0b013e32830c214c	48	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117321	10.1371/journal.pone.0117321	http://dx.doi.org/10.1371/journal.pone.0117321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617901	Green Published, Green Submitted, gold			2022-12-26	WOS:000350336000042
J	Dores-Silva, PR; Barbosa, LRS; Ramos, CHI; Borges, JC				Dores-Silva, Paulo R.; Barbosa, Leandro R. S.; Ramos, Carlos H. I.; Borges, Julio C.			Human Mitochondrial Hsp70 (Mortalin): Shedding Light on ATPase Activity, Interaction with Adenosine Nucleotides, Solution Structure and Domain Organization	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONE; SUBSTRATE-BINDING; ANALYTICAL ULTRACENTRIFUGATION; UNFOLDED PROTEINS; CANCER-CELLS; DNAK; FAMILY; IDENTIFICATION; IMPORT	The human mitochondrial Hsp70, also called mortalin, is of considerable importance for mitochondria biogenesis and the correct functioning of the cell machinery. In the mitochondrial matrix, mortalin acts in the importing and folding process of nucleus-encoded proteins. The in vivo deregulation of mortalin expression and/or function has been correlated with age-related diseases and certain cancers due to its interaction with the p53 protein. In spite of its critical biological roles, structural and functional studies on mortalin are limited by its insoluble recombinant production. This study provides the first report of the production of folded and soluble recombinant mortalin when co-expressed with the human Hsp70-escort protein 1, but it is still likely prone to self-association. The monomeric fraction of mortalin presented a slightly elongated shape and basal ATPase activity that is higher than that of its cytoplasmic counterpart Hsp70-1A, suggesting that it was obtained in the functional state. Through small angle X-ray scattering, we assessed the low-resolution structural model of monomeric mortalin that is characterized by an elongated shape. This model adequately accommodated high resolution structures of Hsp70 domains indicating its quality. We also observed that mortalin interacts with adenosine nucleotides with high affinity. Thermally induced unfolding experiments indicated that mortalin is formed by at least two domains and that the transition is sensitive to the presence of adenosine nucleotides and that this process is dependent on the presence of Mg2+ ions. Interestingly, the thermal-induced unfolding assays of mortalin suggested the presence of an aggregation/association event, which was not observed for human Hsp70-1A, and this finding may explain its natural tendency for in vivo aggregation. Our study may contribute to the structural understanding of mortalin as well as to contribute for its recombinant production for antitumor compound screenings.	[Dores-Silva, Paulo R.; Borges, Julio C.] Univ Sao Paulo, Inst Chem Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil; [Barbosa, Leandro R. S.] Univ Sao Paulo, Inst Phys, BR-05508090 Sao Paulo, Brazil; [Ramos, Carlos H. I.] Univ Estadual Campinas, UNICAMP, Inst Chem, BR-13083970 Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas	Borges, JC (corresponding author), Univ Sao Paulo, Inst Chem Sao Carlos, POB 780, BR-13560970 Sao Carlos, SP, Brazil.	borgesjc@iqsc.usp.br	Barbosa, Leandro Ramos Souza/E-6577-2012; Barbosa, L. R. S./AAN-7787-2020; Ramos, CH/C-1571-2012; Barbosa, Leandro Ramos Souza/GRJ-9680-2022; Borges, Julio C/C-6160-2008	Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Ramos, CH/0000-0002-7246-9081; Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Borges, Julio C/0000-0003-4856-748X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (CHIR) [2011/23110-0, 2012/50161-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [471415/2013-8]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (CHIR); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by 2011/23110-0 (JCB); 2012/50161-8, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br/) (CHIR); and 471415/2013-8-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/) (JCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amick J, 2014, PROTEIN SCI, V23, P833, DOI 10.1002/pro.2466; [Anonymous], [No title captured]; Araujo TLS, 2014, BIOCHEMISTRY-US, V53, P2884, DOI 10.1021/bi500004q; BARBOSA LRS, 2013, PROTEINS SOLUTION IN, P49; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; BHATTACHARYYA T, 1995, J BIOL CHEM, V270, P1705, DOI 10.1074/jbc.270.4.1705; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bohnert M, 2007, FEBS LETT, V581, P2802, DOI 10.1016/j.febslet.2007.03.004; Borges JC, 2011, CURR MED CHEM, V18, P1276; Borges JC, 2006, ARCH BIOCHEM BIOPHYS, V452, P46, DOI 10.1016/j.abb.2006.05.006; Borges JC, 2009, BMB REP, V42, P166, DOI 10.5483/BMBRep.2009.42.3.166; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; da Silva KP, 2011, PROTEIN PEPTIDE LETT, V18, P132; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Deocaris CC, 2007, CANCER LETT, V252, P259, DOI 10.1016/j.canlet.2006.12.038; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; DOMANICO SZ, 1993, MOL CELL BIOL, V13, P3598, DOI 10.1128/MCB.13.6.3598; Dores-Silva PR, 2013, INT J BIOL MACROMOL, V56, P140, DOI 10.1016/j.ijbiomac.2013.02.009; Fan ACY, 2011, PROTEIN PEPTIDE LETT, V18, P122; HUANG SP, 1993, J BIOL CHEM, V268, P2063; Jin JH, 2006, MOL CELL PROTEOMICS, V5, P1193, DOI 10.1074/mcp.M500382-MCP200; Kaul SC, 2000, FEBS LETT, V474, P159, DOI 10.1016/S0014-5793(00)01594-5; Kaul SC, 2007, EXP GERONTOL, V42, P263, DOI 10.1016/j.exger.2006.10.020; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Liu Y, 2005, MOL CELL BIOCHEM, V268, P45, DOI 10.1007/s11010-005-2996-1; Londono C, 2012, BIOMOLECULES, V2, P143, DOI 10.3390/biom2010143; Lopez-Buesa P, 1998, P NATL ACAD SCI USA, V95, P15253, DOI 10.1073/pnas.95.26.15253; Luo WI, 2010, PROTEIN EXPRES PURIF, V72, P75, DOI 10.1016/j.pep.2010.02.003; MCCARTY JS, 1991, P NATL ACAD SCI USA, V88, P9513, DOI 10.1073/pnas.88.21.9513; Mokranjac D, 2009, BBA-MOL CELL RES, V1793, P33, DOI 10.1016/j.bbamcr.2008.06.021; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Ortore MG, 2009, J R SOC INTERFACE, V6, pS619, DOI 10.1098/rsif.2009.0163.focus; PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719; PALLEROS DR, 1993, FEBS LETT, V336, P124, DOI 10.1016/0014-5793(93)81624-9; PALLEROS DR, 1992, J BIOL CHEM, V267, P5279; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Popp SL, 2009, FEBS LETT, V583, P573, DOI 10.1016/j.febslet.2008.12.062; Qu MY, 2011, BRAIN RES, V1368, P336, DOI 10.1016/j.brainres.2010.10.068; Ran QT, 2000, BIOCHEM BIOPH RES CO, V275, P174, DOI 10.1006/bbrc.2000.3237; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Rodina A, 2013, CHEM BIOL, V20, P1469, DOI 10.1016/j.chembiol.2013.10.008; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; SADIS S, 1992, BIOCHEMISTRY-US, V31, P9406, DOI 10.1021/bi00154a012; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Sichting M, 2005, EMBO J, V24, P1046, DOI 10.1038/sj.emboj.7600580; Silberg JJ, 2000, J BIOL CHEM, V275, P7779, DOI 10.1074/jbc.275.11.7779; Silva KP, 2013, BBA-PROTEINS PROTEOM, V1834, P351, DOI 10.1016/j.bbapap.2012.08.004; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; Spinozzi F, 2014, J APPL CRYSTALLOGR, V47, P1132, DOI 10.1107/S1600576714005147; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Szklarz LKS, 2005, J MOL BIOL, V351, P206, DOI 10.1016/j.jmb.2005.05.068; Veyel D, 2014, BIOCHEM J, V460, P13, DOI 10.1042/BJ20140001; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vu MT, 2012, PROTEIN SCI, V21, P258, DOI 10.1002/pro.2012; WADHWA R, 1993, J BIOL CHEM, V268, P22239; WADHWA R, 1993, J BIOL CHEM, V268, P6615; WADHWA R, 1993, EXP CELL RES, V207, P442, DOI 10.1006/excr.1993.1213; Wadhwa R, 2005, BIOCHEM J, V391, P185, DOI 10.1042/BJ20050861; Wadhwa R, 2002, EXP CELL RES, V274, P246, DOI 10.1006/excr.2002.5468; Wadhwa R, 2000, CANCER RES, V60, P6818; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; XU LJ, 2009, J CEREBR BLOOD F MET, V29, P365, DOI DOI 10.1038/JCBFM.2008.125; Zhai P, 2008, J BIOL CHEM, V283, P26098, DOI 10.1074/jbc.M803475200; Zhai P, 2011, BIOCHEM BIOPH RES CO, V408, P589, DOI 10.1016/j.bbrc.2011.04.066; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	70	40	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0117170	10.1371/journal.pone.0117170	http://dx.doi.org/10.1371/journal.pone.0117170			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615450	Green Published, Green Submitted, gold			2022-12-26	WOS:000349122100059
J	Jourdan, M; Gagne, S; Dubois-Laurent, C; Maghraoui, M; Huet, S; Suel, A; Hamama, L; Briard, M; Peltier, D; Geoffriau, E				Jourdan, Matthieu; Gagne, Severine; Dubois-Laurent, Cecile; Maghraoui, Mohamed; Huet, Sebastien; Suel, Anita; Hamama, Latifa; Briard, Mathilde; Peltier, Didier; Geoffriau, Emmanuel			Carotenoid Content and Root Color of Cultivated Carrot: A Candidate-Gene Association Study Using an Original Broad Unstructured Population	PLOS ONE			English	Article							PLASTID TERMINAL OXIDASE; DAUCUS-CAROTA; PHYTOENE SYNTHASE; BIOSYNTHESIS; LYCOPENE; FRUIT; ACCUMULATION; ARABIDOPSIS; SOFTWARE; NUMBER	Accumulated in large amounts in carrot, carotenoids are an important product quality attribute and therefore a major breeding trait. However, the knowledge of carotenoid accumulation genetic control in this root vegetable is still limited. In order to identify the genetic variants linked to this character, we performed an association mapping study with a candidate gene approach. We developed an original unstructured population with a broad genetic basis to avoid the pitfall of false positive detection due to population stratification. We genotyped 109 SNPs located in 17 candidate genes - mostly carotenoid biosynthesis genes - on 380 individuals, and tested the association with carotenoid contents and color components. Total carotenoids and beta- carotene contents were significantly associated with genes zeaxanthin epoxydase (ZEP), phytoene desaturase (PDS) and carotenoid isomerase (CRTISO) while alpha-carotene was associated with CRTISO and plastid terminal oxidase (PTOX) genes. Color components were associated most significantly with ZEP. Our results suggest the involvement of the couple PDS/PTOX and ZEP in carotenoid accumulation, as the result of the metabolic and catabolic activities respectively. This study brings new insights in the understanding of the carotenoid pathway in non-photosynthetic organs.	[Jourdan, Matthieu; Gagne, Severine; Dubois-Laurent, Cecile; Maghraoui, Mohamed; Huet, Sebastien; Suel, Anita; Hamama, Latifa; Briard, Mathilde; Peltier, Didier; Geoffriau, Emmanuel] Agrocampus Ouest, UMR1345, Inst Rech Hort & Semences, Angers, France; [Jourdan, Matthieu; Gagne, Severine; Dubois-Laurent, Cecile; Maghraoui, Mohamed; Huet, Sebastien; Suel, Anita; Hamama, Latifa; Briard, Mathilde; Peltier, Didier; Geoffriau, Emmanuel] Univ Angers, UMR1345, Inst Rech Hort & Semences, Angers, France; [Jourdan, Matthieu; Gagne, Severine; Dubois-Laurent, Cecile; Maghraoui, Mohamed; Huet, Sebastien; Suel, Anita; Hamama, Latifa; Briard, Mathilde; Peltier, Didier; Geoffriau, Emmanuel] INRA, UMR1345, Inst Rech Hort & Semences, Beaucouze, France	Institut Agro; Agrocampus Ouest; Universite d'Angers; Universite d'Angers; INRAE	Geoffriau, E (corresponding author), Agrocampus Ouest, UMR1345, Inst Rech Hort & Semences, Angers, France.	emmanuel.geoffriau@agrocampus-ouest.fr	martel, celine/O-6651-2016	martel, celine/0000-0002-1800-4558	French ministry of Research	French ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was funded by the French ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONIO C, 2005, GENETICS MOL BIO, V28, P287; ARANGO J, 2014, PLANT CELL; Auzanneau J, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-183; Baranski R, 2012, FOOD RES INT, V47, P182, DOI 10.1016/j.foodres.2011.05.006; Baranski R, 2012, GENET RESOUR CROP EV, V59, P163, DOI 10.1007/s10722-011-9777-3; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bradeen JM, 1998, THEOR APPL GENET, V97, P960, DOI 10.1007/s001220050977; Brand A, 2012, PLANTA, V235, P579, DOI 10.1007/s00425-011-1530-9; Briard M, 2000, PLANT MOL BIOL REP, V18, P235, DOI 10.1007/BF02823994; BUISHAND JG, 1979, EUPHYTICA, V28, P611, DOI 10.1007/BF00038928; Cardoso S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046021; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; Cavagnaro PF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-386; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Chandler K, 2013, CROP SCI, V53, P189, DOI 10.2135/cropsci2012.02.0129; Clotault J, 2008, J EXP BOT, V59, P3563, DOI 10.1093/jxb/ern210; Clotault J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038724; Clotault J, 2010, THEOR APPL GENET, V121, P659, DOI 10.1007/s00122-010-1338-1; de Rosso VV, 2007, J AGR FOOD CHEM, V55, P5062, DOI 10.1021/jf0705421; Diretto G, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-13; Ehrenreich IM, 2009, GENETICS, V183, P325, DOI 10.1534/genetics.109.105189; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Santos CAF, 2006, EUPHYTICA, V151, P79, DOI 10.1007/s10681-006-9130-7; Galpaz N, 2008, PLANT J, V53, P717, DOI 10.1111/j.1365-313X.2007.03362.x; Gomez R, 1998, J SCI FOOD AGR, V77, P268, DOI 10.1002/(SICI)1097-0010(199806)77:2&lt;268::AID-JSFA35&gt;3.0.CO;2-V; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hirschberg J, 2001, CURR OPIN PLANT BIOL, V4, P210, DOI 10.1016/S1369-5266(00)00163-1; Howitt CA, 2006, PLANT CELL ENVIRON, V29, P435, DOI 10.1111/j.1365-3040.2005.01492.x; Huh JH, 2001, THEOR APPL GENET, V102, P524, DOI 10.1007/s001220051677; Inbaraj BS, 2006, J CHROMATOGR A, V1102, P193, DOI 10.1016/j.chroma.2005.10.055; Josse EM, 2000, PLANT PHYSIOL, V123, P1427, DOI 10.1104/pp.123.4.1427; Just BJ, 2007, THEOR APPL GENET, V114, P693, DOI 10.1007/s00122-006-0469-x; Just BJ, 2009, THEOR APPL GENET, V119, P1155, DOI 10.1007/s00122-009-1117-z; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Le Clerc V, 2003, BIODIVERS CONSERV, V12, P2227, DOI 10.1023/A:1024562701150; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lu S, 2008, J INTEGR PLANT BIOL, V50, P778, DOI 10.1111/j.1744-7909.2008.00708.x; Maass D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006373; McDonald AE, 2011, BBA-BIOENERGETICS, V1807, P954, DOI 10.1016/j.bbabio.2010.10.024; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Paran I, 2007, J EXP BOT, V58, P3841, DOI 10.1093/jxb/erm257; Pogson BJ, 2000, PHILOS T ROY SOC B, V355, P1395, DOI 10.1098/rstb.2000.0701; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012; Ravel C, 2013, MOL BREEDING, V31, P87, DOI 10.1007/s11032-012-9772-1; Rodriguez-Villalon A, 2009, PLANT J, V60, P424, DOI 10.1111/j.1365-313X.2009.03966.x; Roncallo PF, 2012, EUPHYTICA, V185, P77, DOI 10.1007/s10681-012-0628-x; Sandmann G, 2006, METAB ENG, V8, P291, DOI 10.1016/j.ymben.2006.01.005; Santos CAF, 2002, MOL GENET GENOMICS, V268, P122, DOI 10.1007/s00438-002-0735-9; Shahbazi M, 2007, PLANT PHYSIOL, V145, P691, DOI 10.1104/pp.107.106336; Simon PW, 1996, J HERED, V87, P63, DOI 10.1093/oxfordjournals.jhered.a022955; SINGHA S, 1991, J AM SOC HORTIC SCI, V116, P497, DOI 10.21273/JASHS.116.3.497; Soufflet-Freslon V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070801; Surles RL, 2004, J AGR FOOD CHEM, V52, P3417, DOI 10.1021/jf035472m; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Vallabhaneni R, 2009, PLANT PHYSIOL, V150, P562, DOI 10.1104/pp.109.137042; Weber A, 2007, GENETICS, V177, P2349, DOI 10.1534/genetics.107.080424; Wolters AMA, 2010, PLANT MOL BIOL, V73, P659, DOI 10.1007/s11103-010-9647-y; Wu DY, 1999, PLANT CELL, V11, P43, DOI 10.1105/tpc.11.1.43; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Yu BY, 2008, TRANSGENIC RES, V17, P573, DOI 10.1007/s11248-007-9131-x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	66	45	46	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116674	10.1371/journal.pone.0116674	http://dx.doi.org/10.1371/journal.pone.0116674			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25614987	Green Published, gold			2022-12-26	WOS:000349122100036
J	Lin, JC; Ettinger, RA; Schuman, JT; Zhang, AH; Wamiq-Adhami, M; Nguyen, PCT; Nakaya-Fletcher, SM; Puranik, K; Thompson, AR; Pratt, KP				Lin, Jasper C.; Ettinger, Ruth A.; Schuman, Jason T.; Zhang, Ai-Hong; Wamiq-Adhami, Muhammad; Nguyen, Phuong-Cac T.; Nakaya-Fletcher, Shelley M.; Puranik, Komal; Thompson, Arthur R.; Pratt, Kathleen P.			Six Amino Acid Residues in a 1200 angstrom 2 Interface Mediate Binding of Factor VIII to an IgG4 kappa Inhibitory Antibody	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; COAGULATION-FACTOR-VIII; HEMOPHILIA-A MICE; RECOMBINANT FACTOR-VIII; C2 DOMAIN; PHOSPHOLIPID-BINDING; MASS-SPECTROMETRY; THERMODYNAMIC ANALYSIS; BIOSENSOR TECHNOLOGY; VONWILLEBRAND-FACTOR	The development of neutralizing anti-factor VIII (FVIII) antibodies complicates the treatment of many hemophilia A patients. The C-terminal C2 domain is a particularly antigenic FVIII region. A crystal structure of recombinant FVIII-C2 bound to an Fab fragment of the patient-derived monoclonal antibody BO2C11, which recognizes an immunodominant inhibitor epitope on FVIII and blocks its ability to bind von Willebrand factor (VWF) and phospholipids, revealed that 15 amino acids in FVIII contact this antibody. Forty-three recombinant FVIII-C2 proteins, each with a surface-exposed side chain mutated to alanine or another residue, were generated, and surface plasmon resonance studies were carried out to evaluate effects of these substitutions on BO2C11/FVIII-C2 binding affinity. Thermodynamic analysis of experiments carried out at three temperatures indicated that one beta hairpin turn at the antigen-antibody interface (FVIII-F2196, N2198, M2199 and F2200) plus two non-contiguous arginines (FVIII-R2215 and R2220), contributed appreciably to the affinity. B-domain-deleted (BDD) FVIII-F2196A, FVIII-F2196K and FVIII-M2199A were generated and characterized. Their pro-coagulant activities and binding to VWF were similar to those of WT-BDD-FVIII, and FVIII-F2196K avoided neutralization by BO2C11 and murine inhibitory mAb 1B5. This study suggests specific sites for amino acid substitutions to rationally design FVIII variants capable of evading immunodominant neutralizing anti-FVIII antibodies.	[Lin, Jasper C.; Ettinger, Ruth A.; Nguyen, Phuong-Cac T.; Nakaya-Fletcher, Shelley M.; Puranik, Komal; Thompson, Arthur R.; Pratt, Kathleen P.] Puget Sound Blood Ctr Res Inst, Seattle, WA 98102 USA; [Lin, Jasper C.; Thompson, Arthur R.; Pratt, Kathleen P.] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Schuman, Jason T.] Gen Elect GE Healthcare Life Sci, Portland, OR USA; [Zhang, Ai-Hong; Pratt, Kathleen P.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Wamiq-Adhami, Muhammad] Walter Reed Natl Mil Med Ctr, Dept Pathol, Bethesda, MD USA	Puget Sound Blood Center; University of Washington; University of Washington Seattle; General Electric; Uniformed Services University of the Health Sciences - USA; Walter Reed National Military Medical Center	Pratt, KP (corresponding author), Puget Sound Blood Ctr Res Inst, Seattle, WA 98102 USA.	Kathleen.pratt@usuhs.edu	Pratt, Kathleen P/E-9489-2019	Pratt, Kathleen/0000-0001-6837-6133	Pfizer ASPIRE Hemophilia award [NIH-HLT3207093, NIH-1RC2-HL101851, NIH-HLR01-071093]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101851] Funding Source: NIH RePORTER	Pfizer ASPIRE Hemophilia award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Pfizer ASPIRE Hemophilia award, https://www.aspireresearch.org/ASPIRE-Hemophilia/index.html (KPP); NIH-HLT3207093 (JCL); NIH-1RC2-HL101851 (KPP) and NIH-HLR01-071093 (ART). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansong C, 2006, J THROMB HAEMOST, V4, P842, DOI 10.1111/j.1538-7836.2006.01831.x; Barrow RT, 2001, BLOOD, V97, P169, DOI 10.1182/blood.V97.1.169; Berntorp E, 2006, HAEMOPHILIA, V12, P1, DOI 10.1111/j.1365-2516.2006.01359.x; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Collins PW, 2007, BLOOD, V109, P1870, DOI 10.1182/blood-2006-06-029850; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; Deinum J, 2002, ANAL BIOCHEM, V300, P152, DOI 10.1006/abio.2001.5454; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Dimitrov JD, 2010, J THROMB HAEMOST, V8, P1524, DOI 10.1111/j.1538-7836.2010.03878.x; Dimitrov JD, 2012, BIOCHEMISTRY-US, V51, P4108, DOI 10.1021/bi300232d; Dimitrov JD, 2009, MOL IMMUNOL, V47, P290, DOI 10.1016/j.molimm.2009.09.021; EHRENFORTH S, 1992, LANCET, V339, P594, DOI 10.1016/0140-6736(92)90874-3; FOSTER PA, 1990, THROMB HAEMOSTASIS, V63, P403; Fuentes-Prior P, 2002, CURR PROTEIN PEPT SC, V3, P313, DOI 10.2174/1389203023380639; FULCHER CA, 1987, BLOOD, V69, P1475; GILLES JGG, 1993, BLOOD, V82, P2452; Griffiths AE, 2011, J THROMB HAEMOST, V9, P1534, DOI 10.1111/j.1538-7836.2011.04397.x; Hay CRM, 1998, THROMB HAEMOSTASIS, V79, P762; Healey JF, 2007, J THROMB HAEMOST, V5, P512, DOI 10.1111/j.1538-7836.2007.02373.x; Jacquemin MG, 1998, BLOOD, V92, P496, DOI 10.1182/blood.V92.2.496.414k16_496_506; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P612; Kessel C, 2009, CHEMMEDCHEM, V4, P1364, DOI 10.1002/cmdc.200900023; Kuwabara I, 1999, J IMMUNOL METHODS, V224, P89, DOI 10.1016/S0022-1759(99)00012-5; Lewis DA, 2003, THROMB HAEMOSTASIS, V89, P795, DOI 10.1055/s-0037-1613464; Liu ML, 1998, BRIT J HAEMATOL, V103, P1051, DOI 10.1046/j.1365-2141.1998.01122.x; LUBIN IM, 1994, J BIOL CHEM, V269, P8639; Lusher JM, 2003, HAEMOPHILIA, V9, P38, DOI 10.1046/j.1365-2516.2003.00708.x; LUSHER JM, 1993, NEW ENGL J MED, V328, P453, DOI 10.1056/NEJM199302183280701; Meeks SL, 2008, BLOOD, V112, P1151, DOI 10.1182/blood-2008-01-132639; Meeks SL, 2007, BLOOD, V110, P4234, DOI 10.1182/blood-2007-06-096842; Nguyen PCT, 2014, BLOOD, V123, P2732, DOI 10.1182/blood-2013-09-527275; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; Parker ET, 2004, BLOOD, V104, P704, DOI 10.1182/blood-2003-11-3891; Pearce KH, 1997, J BIOL CHEM, V272, P20595, DOI 10.1074/jbc.272.33.20595; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Pratt KP, 2004, THROMB HAEMOSTASIS, V92, P522, DOI 10.1160/TH03-12-0755; Qian JJ, 1999, THROMB HAEMOSTASIS, V81, P240, DOI 10.1055/s-0037-1614450; Roos H, 1998, J MOL RECOGNIT, V11, P204, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<204::AID-JMR424>3.0.CO;2-T; SAENKO EL, 1995, J BIOL CHEM, V270, P13826, DOI 10.1074/jbc.270.23.13826; SAENKO EL, 1994, J BIOL CHEM, V269, P11601; Sandberg H, 2012, THROMB RES, V130, P808, DOI 10.1016/j.thromres.2012.08.311; SCANDELLA D, 1995, BLOOD, V86, P1811, DOI 10.1182/blood.V86.5.1811.bloodjournal8651811; Sevy AM, 2013, J THROMB HAEMOST, V11, P2128, DOI 10.1111/jth.12433; SHIMA M, 1991, INT J HEMATOL, V54, P515; Spiegel PC, 2001, BLOOD, V98, P13, DOI 10.1182/blood.V98.1.13; Takeshima K, 2003, THROMB HAEMOSTASIS, V89, P788, DOI 10.1055/s-0037-1613463; Thompson AR, 2003, SEMIN THROMB HEMOST, V29, P11, DOI 10.1055/s-2003-37935; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; VANCOTT TC, 1994, J IMMUNOL, V153, P449; Voorberg J, 2000, SEMIN THROMB HEMOST, V26, P143, DOI 10.1055/s-2000-9816; Walter JD, 2013, BLOOD, V122, P4270, DOI 10.1182/blood-2013-08-519124; Walter JD, 2013, J BIOL CHEM, V288, P9905, DOI 10.1074/jbc.M112.424564; Wu HY, 2001, THROMB HAEMOSTASIS, V85, P125, DOI 10.1055/s-0037-1612915	54	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116577	10.1371/journal.pone.0116577	http://dx.doi.org/10.1371/journal.pone.0116577			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615825	Green Submitted, Green Published, gold			2022-12-26	WOS:000349122100034
J	Essinger, SD; Reichenberger, E; Morrison, C; Blackwood, CB; Rosen, GL				Essinger, Steven D.; Reichenberger, Erin; Morrison, Calvin; Blackwood, Christopher B.; Rosen, Gail L.			A Toolkit for ARB to Integrate Custom Databases and Externally Built Phylogenies	PLOS ONE			English	Article							SEQUENCE ALIGNMENT	Researchers are perpetually amassing biological sequence data. The computational approaches employed by ecologists for organizing this data (e.g . alignment, phylogeny, etc.) typically scale nonlinearly in execution time with the size of the dataset. This often serves as a bottleneck for processing experimental data since many molecular studies are characterized by massive datasets. To keep up with experimental data demands, ecologists are forced to choose between continually upgrading expensive in-house computer hardware or outsourcing the most demanding computations to the cloud. Outsourcing is attractive since it is the least expensive option, but does not necessarily allow direct user interaction with the data for exploratory analysis. Desktop analytical tools such as ARB are indispensable for this purpose, but they do not necessarily offer a convenient solution for the coordination and integration of datasets between local and outsourced destinations. Therefore, researchers are currently left with an undesirable tradeoff between computational throughput and analytical capability. To mitigate this tradeoff we introduce a software package to leverage the utility of the interactive exploratory tools offered by ARB with the computational throughput of cloud-based resources. Our pipeline serves as middleware between the desktop and the cloud allowing researchers to form local custom databases containing sequences and metadata from multiple resources and a method for linking data outsourced for computation back to the local database. A tutorial implementation of the toolkit is provided in the supporting information,	[Essinger, Steven D.; Morrison, Calvin; Rosen, Gail L.] Drexel Univ, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA; [Reichenberger, Erin] Drexel Univ, Dept Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Blackwood, Christopher B.] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA	Drexel University; Drexel University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Rosen, GL (corresponding author), Drexel Univ, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA.	gailr@ece.drexel.edu	Blackwood, Christopher/B-3839-2010	Blackwood, Christopher/0000-0001-5764-6978; Rosen, Gail/0000-0003-1763-5750	Department of Energy [DE-SC0004335]	Department of Energy(United States Department of Energy (DOE))	This work was supported by Department of Energy Grant DE-SC0004335. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Biomatters Limited, 2014, GEN VERS 6 1; Derbyshire MK, 2012, ANNOTATION FUNCTIONA; Fusaro VA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002147; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller M, 2009, CIPRES; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064	19	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0109277	10.1371/journal.pone.0109277	http://dx.doi.org/10.1371/journal.pone.0109277			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607539	gold, Green Published, Green Submitted			2022-12-26	WOS:000348205300001
J	Ayari-Jeridi, H; Moran, K; Chebbi, A; Bouguila, H; Abbes, I; Charradi, K; Benammar-Elgaaied, A; Ganguly, A				Ayari-Jeridi, Hajer; Moran, Kimberly; Chebbi, Amel; Bouguila, Hedi; Abbes, Imen; Charradi, Khaoula; Benammar-Elgaaied, Amel; Ganguly, Arupa			Mutation Spectrum of RB1 Gene in Unilateral Retinoblastoma Cases from Tunisia and Correlations with Clinical Features	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; HEREDITARY RETINOBLASTOMA; SPORADIC RETINOBLASTOMA; RISK; HETEROZYGOSITY; PREDICTION; DIAGNOSIS; FAMILIES; SEQUENCE; CANCER	Retinoblastoma, an embryonic neoplasm of retinal origin, is the most common primary intra-ocular malignancy in children. Somatic inactivation of both alleles of the RB1 tumor suppressor gene in a retinal progenitor cell through diverse mechanisms including genetic and epigenetic modifications, is the crucial event in initiation of tumorigenesis in most cases of isolated unilateral retinoblastoma. We analyzed DNA from tumor tissue and from peripheral blood to determine the RB1 mutation status and seek correlations with clinical features of 37 unrelated cases of Tunisian origin with sporadic retinoblastoma. All cases were unilateral except one who presented with bilateral disease, in whom no germline coding sequence alteration was identified. A multi-step mutation scanning protocol identified bi-allelic inactivation of RB1 gene in 30 (81%) of the samples tested. A total of 7 novel mutations were identified. There were three tumors without any detectable mutation while a subset contained multiple mutations in RB1 gene. The latter group included tumors collected after treatment with chemotherapy. There were seven individuals with germline mutations and all presented with advanced stage of tumor. There was no difference in age of onset of RB based on the germline mutation status. Thus 20% of the individuals with sporadic unilateral RB in this series carried germline mutations and indicate the importance of genetic testing all children with sporadic retinoblastoma. These findings help to characterize the spectrum of mutations present in the Tunisian population and can improve genetic diagnosis of retinoblastoma.	[Ayari-Jeridi, Hajer; Charradi, Khaoula; Benammar-Elgaaied, Amel] Univ Tunis EL MANAR, Fac Sci Tunis, Lab Genet Immunol & Pathol Humaines, Tunis 2092, Tunisia; [Chebbi, Amel; Bouguila, Hedi] Inst Hedi Rais Ophtalmol Tunis, Tunis, Tunisia; [Abbes, Imen] Inst Salah Azaiez Cancerol, Lab Anatomie Patholog, Tunis, Tunisia; [Moran, Kimberly; Ganguly, Arupa] Univ Pennsylvania, Perelman Sch Med, Dept Genet, Genet Diagnost Lab, Philadelphia, PA USA	Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Universite de Tunis-El-Manar; Institut Hedi Raies d'ophtalmologie de Tunis; University of Pennsylvania; Pennsylvania Medicine	Ganguly, A (corresponding author), Univ Tunis EL MANAR, Fac Sci Tunis, Lab Genet Immunol & Pathol Humaines, Campus Univ, Tunis 2092, Tunisia.	ganguly@mail.med.upenn.edu	Elgaaied, Amel Ben Ammar/AAL-1183-2020	Chebbi, Amel/0000-0002-8661-3160	National Institutes of Health/National Cancer Institute [RO1-CA118580]; NATIONAL CANCER INSTITUTE [R01CA118580] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health/National Cancer Institute (RO1-CA118580). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa RH, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-75; Chen Z, 2014, HUM MUTAT, V35, P384, DOI 10.1002/humu.22488; Choy Kwong Wai, 2002, Hum Mutat, V20, P408, DOI 10.1002/humu.9077; Cowell JK, 1996, EUR J CANCER, V32A, P1749, DOI 10.1016/0959-8049(96)00201-8; Dehainault C, 2007, EUR J HUM GENET, V15, P473, DOI 10.1038/sj.ejhg.5201787; DRAPER GJ, 1992, BRIT J CANCER, V66, P211, DOI 10.1038/bjc.1992.244; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Goodrich DW, 2003, J CELL PHYSIOL, V197, P169, DOI 10.1002/jcp.10358; Gordon GM, 2011, PROTEIN CELL, V2, P864, DOI 10.1007/s13238-011-1117-z; Houdayer C, 2004, HUM MUTAT, V23, P193, DOI 10.1002/humu.10303; Jeridi HA, 2014, EXP EYE RES, V124, P48, DOI 10.1016/j.exer.2014.04.013; KATO MV, 1993, INT J CANCER, V54, P922, DOI 10.1002/ijc.2910540609; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; Lohmann DR, 1999, HUM MUTAT, V14, P283, DOI 10.1002/(SICI)1098-1004(199910)14:4<283::AID-HUMU2>3.0.CO;2-J; Lohmann DR, 2004, AM J MED GENET C, V129C, P23, DOI 10.1002/ajmg.c.30024; Lohmann DR, 1997, AM J HUM GENET, V61, P282, DOI 10.1086/514845; Moll AC, 1996, INT J CANCER, V67, P515, DOI 10.1002/(SICI)1097-0215(19960807)67:4<515::AID-IJC9>3.0.CO;2-V; NAUMOVA A, 1994, AM J HUM GENET, V54, P264; Nichols KE, 2005, HUM MUTAT, V25, P566, DOI 10.1002/humu.20184; Ottaviani D, 2013, OPHTHALMIC GENET, V34, P189, DOI 10.3109/13816810.2012.755553; Palazzi MA, 2003, ACTA OPHTHALMOL SCAN, V81, P396, DOI 10.1034/j.1600-0420.2003.00112.x; Richter S, 2003, AM J HUM GENET, V72, P253, DOI 10.1086/345651; Rizzolio F, 2012, CELL DEATH DIFFER, V19, P1152, DOI 10.1038/cdd.2011.202; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; Schuler A, 2005, EUR J CANCER, V41, P735, DOI 10.1016/j.ejca.2004.12.022; Sippel KC, 1998, AM J HUM GENET, V62, P610, DOI 10.1086/301766; Taylor M, 2007, HUM MUTAT, V28, P284, DOI 10.1002/humu.20443; Valverde JR, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-53; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305; ZHU X, 1992, CYTOGENET CELL GENET, V59, P248, DOI 10.1159/000133261	31	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116615	10.1371/journal.pone.0116615	http://dx.doi.org/10.1371/journal.pone.0116615			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602518	gold, Green Submitted, Green Published			2022-12-26	WOS:000348203500029
J	Lo, YS; Huang, SH; Luo, YC; Lin, CY; Yang, JM				Lo, Yu-Shu; Huang, Sing-Han; Luo, Yong-Chun; Lin, Chun-Yu; Yang, Jinn-Moon			Reconstructing Genome-Wide Protein-Protein Interaction Networks Using Multiple Strategies with Homologous Mapping	PLOS ONE			English	Article							WEB SERVER; GENE ONTOLOGY; CORE COMPLEX; YEAST; DATABASE; IDENTIFICATION; ANNOTATION; RESOURCE; BINDING; MODULES	Background One of the crucial steps toward understanding the biological functions of a cellular system is to investigate protein-protein interaction (PPI) networks. As an increasing number of reliable PPIs become available, there is a growing need for discovering PPIs to reconstruct PPI networks of interesting organisms. Some interolog-based methods and homologous PPI families have been proposed for predicting PPIs from the known PPIs of source organisms. Results Here, we propose a multiple-strategy scoring method to identify reliable PPIs for reconstructing the mouse PPI network from two well-known organisms: human and fly. We firstly identified the PPI candidates of target organisms based on homologous PPIs, sharing significant sequence similarities (joint E-value <= 1 x 10(-40)), from source organisms using generalized interolog mapping. These PPI candidates were evaluated by our multiple-strategy scoring method, combining sequence similarities, normalized ranks, and conservation scores across multiple organisms. According to 106,825 PPI candidates in yeast derived from human and fly, our scoring method can achieve high prediction accuracy and outperform generalized interolog mapping. Experiment results show that our multiple-strategy score can avoid the influence of the protein family size and length to significantly improve PPI prediction accuracy and reflect the biological functions. In addition, the top-ranked and conserved PPIs are often orthologous/ essential interactions and share the functional similarity. Based on these reliable predicted PPIs, we reconstructed a comprehensive mouse PPI network, which is a scale-free network and can reflect the biological functions and high connectivity of 292 KEGG modules, including 216 pathways and 76 structural complexes. Conclusions Experimental results show that our scoring method can improve the predicting accuracy based on the normalized rank and evolutionary conservation from multiple organisms. Our predicted PPIs share similar biological processes and cellular components, and the reconstructed genome-wide PPI network can reflect network topology and modularity. We believe that our method is useful for inferring reliable PPIs and reconstructing a comprehensive PPI network of an interesting organism.	[Lo, Yu-Shu; Huang, Sing-Han; Luo, Yong-Chun; Lin, Chun-Yu; Yang, Jinn-Moon] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Yang, Jinn-Moon] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Yang, Jinn-Moon] Natl Chiao Tung Univ, Ctr Bioinformat Res, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Yang, JM (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.	moon@faculty.nctu.edu.tw	Lin, Chun-Yu/AFK-1793-2022; 黃, 星翰/HDM-4670-2022; Yang, Jinn-Moon/AAU-4400-2021	Lin, Chun-Yu/0000-0003-2901-2681; Huang, Sing Han/0000-0003-0289-2260	National Science Council; Ministry of Education Research Institute; National Health Research Institute [NHRI-EX100-10009PI]; "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University and Ministry of Education, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education Research Institute; National Health Research Institute(National Health Research Institutes - Taiwan); "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University and Ministry of Education, Taiwan	This paper was supported by National Science Council, partial supports of Ministry of Education and National Health Research Institutes (NHRI-EX100-10009PI). This paper is also particularly supported by "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University and Ministry of Education, Taiwan. The authors also thank Core Facility for Protein Structural Analysis supported by National Core Facility Program for Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Blake JA, 2014, NUCLEIC ACIDS RES, V42, pD810, DOI 10.1093/nar/gkt1225; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Camasses A, 1998, MOL CELL BIOL, V18, P1956, DOI 10.1128/MCB.18.4.1956; Campillos M, 2006, GENOME RES, V16, P374, DOI 10.1101/gr.4336406; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chen CC, 2009, NUCLEIC ACIDS RES, V37, pW369, DOI 10.1093/nar/gkp309; Chen YC, 2007, NUCLEIC ACIDS RES, V35, pW561, DOI 10.1093/nar/gkm346; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fury MG, 1997, EXP CELL RES, V237, P63, DOI 10.1006/excr.1997.3750; Grote M, 2010, MOL CELL BIOL, V30, P2105, DOI 10.1128/MCB.01505-09; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kelley BP, 2003, P NATL ACAD SCI USA, V100, P11394, DOI 10.1073/pnas.1534710100; KLUG A, 1987, COLD SPRING HARB SYM, V52, P473, DOI 10.1101/SQB.1987.052.01.054; Koster J, 2004, MOL BIOL CELL, V15, P1211, DOI 10.1091/mbc.E03-09-0697; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lin CY, 2012, NUCLEIC ACIDS RES, V40, pW263, DOI 10.1093/nar/gks541; Lleres D, 2010, EMBO REP, V11, P445, DOI 10.1038/embor.2010.64; Lo YS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S7; Lo YS, 2010, NUCLEIC ACIDS RES, V38, pW516, DOI 10.1093/nar/gkq464; Lu XY, 2007, BIOCHEM BIOPH RES CO, V354, P968, DOI 10.1016/j.bbrc.2007.01.097; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mewes HW, 2008, NUCLEIC ACIDS RES, V36, pD196, DOI 10.1093/nar/gkm980; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; ROSBASH M, 1991, TRENDS BIOCHEM SCI, V16, P187, DOI 10.1016/0968-0004(91)90073-5; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Seyed-allaei H, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046113; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267; Wang HD, 2009, MOL CELL PROTEOMICS, V8, P1361, DOI 10.1074/mcp.M800490-MCP200; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Wu XM, 2006, NUCLEIC ACIDS RES, V34, P2137, DOI 10.1093/nar/gkl219; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu HH, 2001, ONCOGENE, V20, P3995, DOI 10.1038/sj.onc.1204524; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904	49	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116347	10.1371/journal.pone.0116347	http://dx.doi.org/10.1371/journal.pone.0116347			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602759	Green Published, Green Submitted, gold			2022-12-26	WOS:000348203500022
J	Tu, Y; Wei, YX; Sun, K; Zhao, WG; Yu, BW				Tu, Ye; Wei, Yongxu; Sun, Kun; Zhao, Weiguo; Yu, Buwei			Altered Spontaneous Brain Activity in Patients with Hemifacial Spasm: A Resting-State Functional MRI Study	PLOS ONE			English	Article							RESPONSE-INHIBITION; CONNECTIVITY; ORGANIZATION; INVOLVEMENT; HOMOGENEITY; CEREBELLUM; MOVEMENT; CIRCUITS; NUCLEUS; NERVE	Resting-state functional magnetic resonance imaging (fMRI) has been used to detect the alterations of spontaneous neuronal activity in various neurological and neuropsychiatric diseases, but rarely in hemifacial spasm (HFS), a nervous system disorder. We used resting-state fMRI with regional homogeneity (ReHo) analysis to investigate changes in spontaneous brain activity of patients with HFS and to determine the relationship of these functional changes with clinical features. Thirty patients with HFS and 33 age-, sex-, and education-matched healthy controls were included in this study. Compared with controls, HFS patients had significantly decreased ReHo values in left middle frontal gyrus (MFG), left medial cingulate cortex (MCC), left lingual gyrus, right superior temporal gyrus (STG) and right precuneus; and increased ReHo values in left precentral gyrus, anterior cingulate cortex (ACC), right brainstem, and right cerebellum. Furthermore, the mean ReHo value in brainstem showed a positive correlation with the spasm severity (r = 0.404, p = 0.027), and the mean ReHo value in MFG was inversely related with spasm severity in HFS group (r = -0.398, p = 0.028). This study reveals that HFS is associated with abnormal spontaneous brain activity in brain regions most involved in motor control and blinking movement. The disturbances of spontaneous brain activity reflected by ReHo measurements may provide insights into the neurological pathophysiology of HFS.	[Tu, Ye; Yu, Buwei] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Anesthesiol, Shanghai 200030, Peoples R China; [Wei, Yongxu; Zhao, Weiguo] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Neurosurg, Shanghai 200030, Peoples R China; [Sun, Kun] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Radiol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yu, BW (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Anesthesiol, Shanghai 200030, Peoples R China.	buweiyu1997@163.com						ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Baglio F, 2011, NEUROBIOL AGING, V32, P115, DOI 10.1016/j.neurobiolaging.2008.12.009; Cai WD, 2014, HUM BRAIN MAPP, V35, P2119, DOI 10.1002/hbm.22315; Calderon DP, 2011, NAT NEUROSCI, V14, P357, DOI 10.1038/nn.2753; Chhatwal JP, 2013, NEUROLOGY, V81, P736, DOI 10.1212/WNL.0b013e3182a1aafe; Chung JY, 2006, NEUROSCI LETT, V395, P196, DOI 10.1016/j.neulet.2005.10.094; Dambacher F, 2014, J COGNITIVE NEUROSCI, V26, P1775, DOI 10.1162/jocn_a_00595; Fang WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069199; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hanakawa T, 2008, CEREB CORTEX, V18, P930, DOI 10.1093/cercor/bhm129; Jankovic J, 2009, NEUROL CLIN, V27, P821, DOI 10.1016/j.ncl.2009.04.005; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kotterba S, 2000, ACTA NEUROL SCAND, V101, P305, DOI 10.1034/j.1600-0404.2000.90281a.x; Lerner A, 2009, CEREB CORTEX, V19, P218, DOI 10.1093/cercor/bhn074; Li ZJ, 2012, J MAGN RESON IMAGING, V36, P344, DOI 10.1002/jmri.23670; Luo CY, 2014, NEUROBIOL AGING, V35, P431, DOI 10.1016/j.neurobiolaging.2013.08.018; Luppino G, 2000, NEWS PHYSIOL SCI, V15, P219; Machielsen WCM, 2000, HUM BRAIN MAPP, V9, P156, DOI 10.1002/(SICI)1097-0193(200003)9:3<156::AID-HBM4>3.0.CO;2-Q; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; MARTINELLI P, 1992, MOVEMENT DISORD, V7, P181, DOI 10.1002/mds.870070214; Martinelli P, 2012, MOVEMENT DISORD, V27, P927, DOI [10.1002/mds.25013, 10.1002/mds.24986]; MOLLER AR, 1991, ACTA NEUROCHIR, V113, P24, DOI 10.1007/BF01402110; Oge AE, 2005, CLIN NEUROPHYSIOL, V116, P1542, DOI 10.1016/j.clinph.2005.02.021; Pilurzi G, 2013, J PHYSIOL-LONDON, V591, P1889, DOI 10.1113/jphysiol.2012.245746; Ping LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071557; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Robinson OJ, 2012, AM J PSYCHIAT, V169, P152, DOI 10.1176/appi.ajp.2011.11010137; Shimizu M, 2012, MOVEMENT DISORD, V27, P519, DOI 10.1002/mds.24925; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tan EK, 2004, J NEUROL SCI, V219, P151, DOI 10.1016/j.jns.2004.01.010; Tokucoglu F, 2008, ACTA NEUROL BELG, V108, P94; van der Salm SMA, 2013, EXP NEUROL, V247, P623, DOI 10.1016/j.expneurol.2013.02.017; Wang AC, 1998, MUSCLE NERVE, V21, P1740, DOI 10.1002/(SICI)1097-4598(199812)21:12<1740::AID-MUS17>3.0.CO;2-V; Wang L, 2014, PSYCHOL MED, V44, P1417, DOI 10.1017/S0033291713002031; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	40	19	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116849	10.1371/journal.pone.0116849	http://dx.doi.org/10.1371/journal.pone.0116849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603126	Green Published, gold, Green Submitted			2022-12-26	WOS:000348203500033
J	Bhaskar, RV; Mohanty, B; Verma, V; Wijaya, E; Kumar, PP				Bhaskar, Ravindran Vijay; Mohanty, Bijayalaxmi; Verma, Vivek; Wijaya, Edward; Kumar, Prakash P.			A Hormone-Responsive C1-Domain-Containing Protein At5g17960 Mediates Stress Response in Arabidopsis thaliana	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; ABSCISIC-ACID; REGULATORY ELEMENT; GENE; TRANSCRIPTION; RESOURCE; CROSSTALK; FAMILY; SERVER	Phytohormones play a critical role in mediating plant stress response. They employ a variety of proteins for coordinating such processes. In Arabidopsis thaliana, some members of a Cys-rich protein family known as C1-clan proteins were involved in stress response, but the actual function of the protein family is largely unknown. We studied At5g17960, a C1-clan protein member that possesses three unique C1 signature domains viz. C1_2, C1_3 and ZZ/PHD type. Additionally, we identified 72 other proteins in A. thaliana that contain all three unique signature domains. Subsequently, the 73 proteins were phylogenetically classified into IX subgroups. Promoter motif analysis of the 73 genes identified the presence of hormone-responsive and stress-responsive putative cis-regulatory elements. Furthermore, we observed that transcript levels of At5g17960 were induced in response to different hormones and stress treatments. At1g35610 and At3g13760, two other members of subgroup IV, also showed upregulation upon GA3, biotic and abiotic stress treatments. Moreover, seedlings of independent transgenic A. thaliana lines ectopically expressing or suppressing At5g17960 also showed differential regulation of several abiotic stress-responsive marker genes. Thus, our data suggest that C1-domain-containing proteins have a role to play in plant hormone-mediated stress responses, thereby assigning a putative function for the C1-clan protein family.	[Bhaskar, Ravindran Vijay; Verma, Vivek; Kumar, Prakash P.] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore; [Mohanty, Bijayalaxmi] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117548, Singapore; [Wijaya, Edward] Osaka Univ, IFReC, Osaka, Japan; [Kumar, Prakash P.] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Osaka University; National University of Singapore	Kumar, PP (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore.	dbskumar@nus.edu.sg	Mohanty, Bijayalaxmi/AAY-7386-2020; Kumar, Prakash P/A-6236-2009	Mohanty, Bijayalaxmi/0000-0002-8226-2367; Kumar, Prakash P/0000-0002-0963-1664	National University of Singapore; Lee Foundation, Singapore	National University of Singapore(National University of Singapore); Lee Foundation, Singapore	RVB was the recipient of a research scholarship from the National University of Singapore. VV was supported by research funding from The Lee Foundation, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSKA I, 1992, J BIOL CHEM, V267, P24732; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davuluri RV, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-25; Garreton V, 2002, PLANT PHYSIOL, V130, P1516, DOI 10.1104/pp.009886; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hosoda K, 2002, PLANT CELL, V14, P2015, DOI 10.1105/tpc.002733; Huang EL, 2005, SER ADV BIOINFORM, V2, P611; Kohli A, 2013, PLANT CELL REP, V32, P945, DOI 10.1007/s00299-013-1461-y; Kumar PP, 2013, PLANT CELL REP, V32, P731, DOI 10.1007/s00299-013-1435-0; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Li CL, 2010, PLANT PHYSIOL, V154, P211, DOI 10.1104/pp.110.161182; Li Y, 2008, GENOMICS, V92, P488, DOI 10.1016/j.ygeno.2008.08.011; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Navarro L, 2008, CURR BIOL, V18, P650, DOI 10.1016/j.cub.2008.03.060; Priest HD, 2009, CURR OPIN PLANT BIOL, V12, P643, DOI 10.1016/j.pbi.2009.07.016; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Shinya T, 2007, PLANT CELL PHYSIOL, V48, P1404, DOI 10.1093/pcp/pcm115; Stamm P, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-179; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Suesslin C, 2003, PLANT J, V33, P591, DOI 10.1046/j.1365-313X.2003.01649.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Zhang WX, 2005, BIOINFORMATICS, V21, P3074, DOI 10.1093/bioinformatics/bti490	31	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0115418	10.1371/journal.pone.0115418	http://dx.doi.org/10.1371/journal.pone.0115418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590629	Green Published, Green Submitted, gold			2022-12-26	WOS:000350679400009
J	Diez-Fernandez, A; Sanchez-Lopez, M; Gulias-Gonzalez, R; Notario-Pacheco, B; Garcia-Prieto, JC; Arias-Palencia, N; Martinez-Vizcaino, V				Diez-Fernandez, Ana; Sanchez-Lopez, Mairena; Gulias-Gonzalez, Roberto; Notario-Pacheco, Blanca; Canete Garcia-Prieto, Jorge; Arias-Palencia, Natalia; Martinez-Vizcaino, Vicente			BMI as a Mediator of the Relationship between Muscular Fitness and Cardiometabolic Risk in Children: A Mediation Analysis	PLOS ONE			English	Article							METABOLIC SYNDROME; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR RISK; BODY-SIZE; INSULIN-RESISTANCE; BLOOD-PRESSURE; STRENGTH; ADOLESCENTS; OVERWEIGHT; PERFORMANCE	Objective Muscular fitness levels have been associated with cardiometabolic risk in children, although whether body weight acts as a confounder or as an intermediate variable in this relationship remains controversial. The aim of this study was to examine whether the association between muscular fitness and cardiometabolic risk factors is mediated by body mass index (BMI). Design and Methods Cross-sectional study using a sample of 1158 schoolchildren aged 8-11 years from the province of Cuenca, Spain. We measured anthropometrics and biochemical variables and we calculated a muscular fitness index as the sum of z-scores of handgrip dynamometry/weight and standing long jump, and we estimated a previously validated cardiometabolic risk index (CMRI). Linear regression models were fitted for mediation analysis to assess whether the association between muscular fitness and cardiometabolic risk was mediated by BMI. Results Children with normal weight (NW) had a better cardiometabolic risk profile than their overweight (OW) or obese (OB) peers after controlling for muscular fitness. Marginal estimated mean +/- SE values for NW, OW and OB categories of CMRI were -0.75 +/- 0.06<0.84 +/- 0.10<2.18 +/- 0.16 in boys and -0.73 +/- 0.06<0.96 +/- 0.10<2.71 +/- 0.17 in girls, both p<0.001. Children with higher levels of muscular fitness had a better cardiometabolic risk profile (CMRI marginal estimated mean +/- SE 1.04 +/- 0.13>0.05 +/- 0.09>-1.16 +/- 0.13 for lower, middle and upper quartiles of muscular fitness in boys and 1.01 +/- 0.16>0.10 +/- 0.09>-1.02 +/- 0.15 in girls, both p<0.001), but differences disappeared when controlling for BMI. BMI acted as a full mediator between muscular fitness and most cardiometabolic risk factors (Sobel test z=-11.44 for boys; z=-11.83 for girls; p<0.001 in CMRI mediation model) and as a partial mediator in the case of waist circumference (Sobel test z=-14.86 for boys; z=-14.51 for girls; p<0.001). Conclusions BMI mediates the association between muscular fitness and cardiometabolic risk in schoolchildren. Overall, good muscular fitness is associated with lower cardiometabolic risk, but particularly when accompanied by normal weight.	[Diez-Fernandez, Ana; Sanchez-Lopez, Mairena; Notario-Pacheco, Blanca; Canete Garcia-Prieto, Jorge; Arias-Palencia, Natalia; Martinez-Vizcaino, Vicente] Univ Castilla La Mancha, Social & Hlth Care Res Ctr, Cuenca, Spain; [Diez-Fernandez, Ana] Univ Castilla La Mancha, Fac Occupat Therapy Speech Therapy & Nursing, Talavera De La Reina, Toledo, Spain; [Sanchez-Lopez, Mairena; Gulias-Gonzalez, Roberto] Univ Castilla La Mancha, Fac Educ, E-13071 Ciudad Real, Spain; [Martinez-Vizcaino, Vicente] Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad Autonoma de Chile	Martinez-Vizcaino, V (corresponding author), Univ Castilla La Mancha, Social & Hlth Care Res Ctr, Cuenca, Spain.	Vicente.martinez@uclm.es	Palencia, Natalia María Arias/Q-5070-2017; Diez-Fernandez, Ana/Z-3348-2019; VIZCAINO, VICENTE MARTINEZ/AAZ-9034-2021; VIZCAINO, VICENTE MARTINEZ/R-4336-2017; SANCHEZ-LOPEZ, MAIRENA/J-7933-2016; Notario Pacheco, Blanca/G-2583-2016	Palencia, Natalia María Arias/0000-0001-5004-3197; Diez-Fernandez, Ana/0000-0002-7673-986X; VIZCAINO, VICENTE MARTINEZ/0000-0001-6121-7893; VIZCAINO, VICENTE MARTINEZ/0000-0001-6121-7893; Notario Pacheco, Blanca/0000-0001-8406-6952; Sanchez Lopez, Mairena/0000-0002-0217-0623	Ministry of Education and Science-Junta de Comunidades de Castilla-La Mancha [PII1I09-0259-9898, POII10-0208-5325]; Ministry of Health [FIS PI081297]; Research Network on Preventative Activities and Health Promotion [-RD06/0018/0038]	Ministry of Education and Science-Junta de Comunidades de Castilla-La Mancha; Ministry of Health; Research Network on Preventative Activities and Health Promotion	This study was funded by the Ministry of Education and Science-Junta de Comunidades de Castilla-La Mancha (PII1I09-0259-9898 and POII10-0208-5325), and Ministry of Health (FIS PI081297). Additional funding was obtained from the Research Network on Preventative Activities and Health Promotion (Ref. -RD06/0018/0038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LB, 2003, PREV MED, V37, P363, DOI 10.1016/S0091-7435(03)00145-2; Artero EG, 2012, J CARDIOPULM REHABIL, V32, P351, DOI 10.1097/HCR.0b013e3182642688; Artero EG, 2011, PEDIATR DIABETES, V12, P704, DOI 10.1111/j.1399-5448.2011.00769.x; BAO WH, 1994, ARCH INTERN MED, V154, P1842; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Benson AC, 2006, INT J PEDIATR OBES, V1, P222, DOI 10.1080/17477160600962864; Castro-Pinero J, 2010, J STRENGTH COND RES, V24, P1810, DOI 10.1519/JSC.0b013e3181ddb03d; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Committee of Experts on Sports Resarch EUROFIT, 1993, HANDBOOK FOR THE EUR; Diez-Fernandez A, 2014, DIABETES CARE, V37, P855, DOI 10.2337/dc13-0416; Eberly LE, 2006, DIABETES CARE, V29, P123, DOI 10.2337/diacare.29.01.06.dc05-1320; Friedemann C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4759; Garcia-Artero E, 2007, REV ESP CARDIOL, V60, P581, DOI 10.1157/13107114; Grontved A, 2015, BRIT J SPORT MED, V49, P90, DOI 10.1136/bjsports-2012-091907; I'Allemand D, 2008, OBESITY, V16, P1672, DOI 10.1038/oby.2008.259; Jaric S, 2005, J STRENGTH COND RES, V19, P467; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Magnussen CG, 2012, EUR J APPL PHYSIOL, V112, P3167, DOI 10.1007/s00421-011-2286-4; Marcovecchio ML, 2013, CURR DIABETES REP, V13, P56, DOI 10.1007/s11892-012-0331-2; Markovic G, 2004, EUR J APPL PHYSIOL, V92, P139, DOI 10.1007/s00421-004-1076-7; Martinez-Vizcaino V, 2012, REV ESP CARDIOL, V65, P427, DOI [10.1016/j.recesp.2011.12.008, 10.1016/j.rec.2011.12.009]; Martinez-Vizcaino V, 2010, DIABETES CARE, V33, P1370, DOI 10.2337/dc09-2049; Peterson MD, 2014, PEDIATRICS, V133, pE896, DOI 10.1542/peds.2013-3169; Pietrobelli A, 2004, EUR J CLIN NUTR, V58, P1479, DOI 10.1038/sj.ejcn.1601993; Ruiz JR, 2007, J HYPERTENS, V25, P2027, DOI 10.1097/HJH.0b013e328277597f; Ruiz JR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a439; Rutter MK, 2005, DIABETES, V54, P3252, DOI 10.2337/diabetes.54.11.3252; Sinaiko AR, 1999, CIRCULATION, V99, P1471, DOI 10.1161/01.CIR.99.11.1471; Smith JJ, 2014, SPORTS MED, V44, P1209, DOI 10.1007/s40279-014-0196-4; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Steene-Johannessen J, 2009, MED SCI SPORT EXER, V41, P1361, DOI 10.1249/MSS.0b013e31819aaae5; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; TANNER JM, 1985, J PEDIATR-US, V107, P317, DOI 10.1016/S0022-3476(85)80501-1; US Department of Health and Human Service, 2008, PHYS ACT GUID AM; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475	40	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0116506	10.1371/journal.pone.0116506	http://dx.doi.org/10.1371/journal.pone.0116506			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590619	Green Published, gold, Green Submitted			2022-12-26	WOS:000350679400015
J	Xiao, B; Wang, Y; Reinach, PS; Ren, YP; Li, JY; Hua, SS; Lu, HH; Chen, W				Xiao, Bing; Wang, Yu; Reinach, Peter S.; Ren, Yueping; Li, Jinyang; Hua, Shanshan; Lu, Huihui; Chen, Wei			Dynamic Ocular Surface and Lacrimal Gland Changes Induced in Experimental Murine Dry Eye	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MATRIX METALLOPROTEINASES; SJOGRENS-SYNDROME; T-CELLS; KERATOCONJUNCTIVITIS SICCA; CONJUNCTIVAL EPITHELIUM; IMMUNE DEVIATION; TEAR FLUID; IN-VITRO; TGF-BETA	Dry eye disease can be a consequence of lacrimal gland insufficiency in Sjogren's Syndrome or increased tear film evaporation despite normal lacrimal gland function. To determine if there is a correlation between severity effects in these models and underlying pathophysiological responses, we compared the time dependent changes in each of these parameters that occur during a 6 week period. Dry eye was induced in 6-week-old female C57BL/6 mice by exposing them to an Intelligently Controlled Environmental System (ICES). Sixty mice were housed in ICES for 1, 2, 4 and 6 weeks respectively. Twelve were raised in normal environment and received subcutaneous injections of scopolamine hydrobromide (SCOP) 3 times daily for 5 days. Another sixty mice were housed in a normal environment and received no treatment. Corneal fluorescein staining along with corneal MMP-9 and caspase-3 level measurements were performed in parallel with the TUNEL assay. Interleukin-17(IL-17), IL-23, IL-6, IL-1, TNF-alpha, IFN-gamma and TGF-beta 2 levels were estimated by realtime PCR measurements of conjunctival and lacrimal gland samples (LGs). Immunohistochemistry of excised LGs along with flow cytometry in cervical lymph nodes evaluated immune cell infiltration. Light and transmission electron microscopy studies evaluated LGs cytoarchitectural changes. ICES induced corneal epithelial destruction and apoptosis peaked at 2 weeks and kept stable in the following 4 weeks. In the ICES group, lacrimal gland proinflammatory cytokine level increases were much lower than those in the SCOP group. In accord with the lower proinflammatory cytokine levels, in the ICES group, lacrimal gland cytosolic vesicular density and size exceeded that in the SCOP group. ICES and SCOP induced murine dry eye effects became progressively more severe over a two week period. Subsequently, the disease process stabilized for the next four weeks. ICES induced local effects in the ocular surface, but failed to elicit lacrimal gland inflammation and cytoarchitectural changes, which accounts for less dry eye severity in the ICES model than that in the SCOP model.	[Xiao, Bing; Wang, Yu; Reinach, Peter S.; Ren, Yueping; Li, Jinyang; Hua, Shanshan; Lu, Huihui; Chen, Wei] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Reinach, Peter S.] SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA	Wenzhou Medical University; State University of New York (SUNY) System; SUNY Optometry	Chen, W (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	chenweimd@hotmail.com	Reinach, Peter/AAI-3582-2021	Li, Jinyang/0000-0002-5904-3094	National Natural Science Foundation of China [81170820, 81470605]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was only supported by two research grants from National Natural Science Foundation of China (81170820 and 81470605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argueso P, 2001, EXP EYE RES, V73, P281, DOI 10.1006/exer.2001.1045; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Brignole F, 1998, EXP EYE RES, V67, P687, DOI 10.1006/exer.1998.0566; Chauhan SK, 2009, J IMMUNOL, V182, P1247, DOI 10.4049/jimmunol.182.3.1247; Chen W, 2008, INVEST OPHTH VIS SCI, V49, P1386, DOI 10.1167/iovs.07-0744; Chen W, 2013, INVEST OPHTH VIS SCI, V54, P6287, DOI 10.1167/iovs.13-12081; Chen W, 2009, EXP EYE RES, V89, P311, DOI 10.1016/j.exer.2009.03.015; Clark AF, 1998, INVEST OPHTH VIS SCI, V39, P2514; Corrales RM, 2006, INVEST OPHTH VIS SCI, V47, P3293, DOI 10.1167/iovs.05-1382; De Paiva CS, 2009, MUCOSAL IMMUNOL, V2, P243, DOI 10.1038/mi.2009.5; Dursun D, 2002, INVEST OPHTH VIS SCI, V43, P632; FOX RI, 1986, ARTHRITIS RHEUM-US, V29, P577, DOI 10.1002/art.1780290501; Gao JP, 1998, CORNEA, V17, P654, DOI 10.1097/00003226-199811000-00014; GERSHON RK, 1975, TRANSPLANT REV-DENMA, V26, P170; Johnson ME, 2004, PROG RETIN EYE RES, V23, P449, DOI 10.1016/j.preteyeres.2004.04.003; Kamoi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043688; Kang MH, 2011, J KOREAN MED SCI, V26, P938, DOI 10.3346/jkms.2011.26.7.938; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Kezuka T, 2000, INVEST OPHTH VIS SCI, V41, P1410; Kong L, 1998, CLIN EXP RHEUMATOL, V16, P675; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kugler A, 1999, ANTICANCER RES, V19, P1589; Lekhanont K, 2007, CORNEA, V26, P84, DOI 10.1097/01.ico.0000240079.24583.a1; Lemp Michael A., 1995, CLAO Journal, V21, P221; Li JY, 2012, MOL VIS, V18, P317; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Massingale ML, 2009, CORNEA, V28, P1023, DOI 10.1097/ICO.0b013e3181a16578; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; Niederkorn JY, 2006, J IMMUNOL, V176, P3950, DOI 10.4049/jimmunol.176.7.3950; Pflugfelder SC, 1999, CURR EYE RES, V19, P201, DOI 10.1076/ceyr.19.3.201.5309; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Pitcher JD, 2011, INVEST OPHTH VIS SCI, V52, P3221, DOI 10.1167/iovs.09-4212; Schaumberg DA, 2002, ADV EXP MED BIOL, V506, P989; Siemasko KF, 2008, INVEST OPHTH VIS SCI, V49, P5434, DOI 10.1167/iovs.08-2075; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; Stern ME, 2010, MUCOSAL IMMUNOL, V3, P425, DOI 10.1038/mi.2010.26; Stern ME, 1998, CORNEA, V17, P584, DOI 10.1097/00003226-199811000-00002; Takeuchi M, 1997, EUR J IMMUNOL, V27, P1648, DOI 10.1002/eji.1830270709; Takeuchi M, 1998, J IMMUNOL, V160, P1589; Turner K, 2000, CORNEA, V19, P492, DOI 10.1097/00003226-200007000-00018; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; WILBANKS GA, 1992, EUR J IMMUNOL, V22, P165, DOI 10.1002/eji.1830220125; Wolkoff P, 2005, OCCUP ENVIRON MED, V62, P4, DOI 10.1136/oem.2004.016030; Xanthou G, 1999, CLIN EXP IMMUNOL, V118, P154; Yeh S, 2003, INVEST OPHTH VIS SCI, V44, P124, DOI 10.1167/iovs.02-0581; Zheng XF, 2010, INVEST OPHTH VIS SCI, V51, P3083, DOI 10.1167/iovs.09-3838	49	40	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0115333	10.1371/journal.pone.0115333	http://dx.doi.org/10.1371/journal.pone.0115333			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590134	Green Submitted, Green Published, gold			2022-12-26	WOS:000350679400004
J	del Campo, SEM; Latchana, N; Levine, KM; Grignol, VP; Fairchild, ET; Jaime-Ramirez, AC; Dao, TV; Karpa, VI; Carson, M; Ganju, A; Chan, AN; Carson, WE				del Campo, Sara E. Martin; Latchana, Nicholas; Levine, Kala M.; Grignol, Valerie P.; Fairchild, Ene T.; Jaime-Ramirez, Alena Cristina; Thao-Vi Dao; Karpa, Volodymyr I.; Carson, Mary; Ganju, Akaansha; Chan, Anthony N.; Carson, William E., III			MiR-21 Enhances Melanoma Invasiveness via Inhibition of Tissue Inhibitor of Metalloproteinases 3 Expression: In Vivo Effects of MiR-21 Inhibitor	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; PROMOTER METHYLATION; DOWN-REGULATION; INVASION; MICRORNA-21; CANCER; APOPTOSIS; TIMP-3; CELLS; PROGRESSION	Metastatic melanoma is the most aggressive form of this cancer. It is important to understand factors that increase or decrease metastatic activity in order to more effectively research and implement treatments for melanoma. Increased cell invasion through the extracellular matrix is required for metastasis and is enhanced by matrix metalloproteinases (MMPs). Tissue inhibitor of metalloproteinases 3 (TIMP3) inhibits MMP activity. It was previously shown by our group that miR-21, a potential regulator of TIMP3, is over-expressed in cutaneous melanoma. It was therefore hypothesized that increased levels of miR-21 expression would lead to decreased expression of TIMP3 and thereby enhance the invasiveness of melanoma cells. miR-21 over-expression in the melanoma cell lines WM1552c, WM793b, A375 and MEL 39 was accomplished via transfection with pre-miR-21. Immunoblot analysis of miR-21-overexpressing cell lines revealed reduced expression of TIMP3 as compared to controls. This in turn led to a significant increase in the invasiveness of the radial growth phase cell line WM1552c and the vertical growth phase cell line WM793b (p < 0.05), but not in the metastatic cell lines A375 or MEL 39. The proliferation and migration of miR-21 over-expressing cell lines was not affected. Reduced expression of TIMP3 was achieved by siRNA knockdown and significantly enhanced invasion of melanoma cell lines, mimicking the effects of miR-21 over-expression. Treatment of tumor cells with a linked nucleic acid antagomir to miR-21 inhibited tumor growth and increased tumor expression of TIMP3 in vivo in 01B74 Athymic NCr-nu/nu mice. Intra-tumoral injections of anti-miR-21 produced similar effects. This data shows that increased expression of miR-21 enhanced the invasive potential of melanoma cell lines through TIMP3 inhibition. Therefore, inhibition of miR-21 in melanoma may reduce melanoma invasiveness.	[del Campo, Sara E. Martin; Latchana, Nicholas; Grignol, Valerie P.; Carson, Mary; Carson, William E., III] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; [Levine, Kala M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Fairchild, Ene T.; Carson, William E., III] Nationwide Childrens Hosp, Dept Gen Pediat, Columbus, OH USA; [Jaime-Ramirez, Alena Cristina] Ohio State Univ, Arthur Giangiacomo James Canc Hosp, Dept Neurol Surg, Columbus, OH 43210 USA; [Jaime-Ramirez, Alena Cristina; Carson, William E., III] Richard Jack Solove Res Inst, Columbus, OH USA; [Thao-Vi Dao; Karpa, Volodymyr I.; Chan, Anthony N.] Wright State Univ, Sch Med, Dayton, OH 45435 USA; [Carson, William E., III] Ohio State Univ, Arthur Giangiacomo James Canc Hosp, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Ganju, Akaansha] Northeast Ohio Med Univ, Sch Med, Rootstown, OH USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Wright State University Dayton; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Northeast Ohio Medical University (NEOMED)	Carson, WE (corresponding author), Ohio State Univ, Dept Surg, Columbus, OH 43210 USA.	william.carson@osumc.edu	Carson, William E/E-2846-2011	Martin del Campo, Sara/0000-0002-8821-3208; Carson, III, William E./0000-0001-7024-7533; Grignol, Valerie/0000-0002-8574-0715	National Institutes of Health (NIH) [T32 CA090223, T32 CA009338, T32 GM068412, P30 CA16058, P01 CA95426-01A1, K24 CA93670]; NATIONAL CANCER INSTITUTE [T32CA090223, K24CA093670, T32CA009338, P01CA095426, P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068412] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LThis work was supported by National Institutes of Health (NIH) Grants T32 CA090223 (to WEC), T32 CA009338 (to M.A. Caligiuri), T32 GM068412 (to V.M. Sanders), P30 CA16058 (to M.A. Caligiuri), P01 CA95426-01A1 (to M.A. Caligiuri), and K24 CA93670 (to WEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; Ahonen M, 1998, CANCER RES, V58, P2310; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Coit Daniel G, 2012, J Natl Compr Canc Netw, V10, P366; Cruz-Munoz W, 2006, ONCOGENE, V25, P6489, DOI 10.1038/sj.onc.1209663; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; Das AM, 2014, ANGIOGENESIS, V17, P163, DOI 10.1007/s10456-013-9385-2; Feng HC, 2004, GYNECOL ONCOL, V94, P375, DOI 10.1016/j.ygyno.2004.04.019; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gaggioli C, 2007, PIGM CELL RES, V20, P161, DOI 10.1111/j.1600-0749.2007.00378.x; Grignol V, 2011, BRIT J CANCER, V105, P1023, DOI 10.1038/bjc.2011.288; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hofmann UB, 2005, BIOCHIMIE, V87, P307, DOI 10.1016/j.biochi.2005.01.013; HORNER M, 2009, SURVEILLANCE EPIDEMI; Hu SY, 2006, INT J CANCER, V119, P2322, DOI 10.1002/ijc.22110; Karan D, 2003, INT J ONCOL, V23, P1365; Kettunen E, 2004, CANCER GENET CYTOGEN, V149, P98, DOI 10.1016/s0165-4608(03)00300-5; LECO KJ, 1994, J BIOL CHEM, V269, P9352; Lesinski GB, 2007, CLIN CANCER RES, V13, P5010, DOI 10.1158/1078-0432.CCR-06-3092; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Liu SH, 2008, PIGM CELL MELANOMA R, V21, P545, DOI 10.1111/j.1755-148X.2008.00484.x; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Nareyeck G, 2005, OPHTHAL RES, V37, P23, DOI 10.1159/000082940; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Song B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-29; Srinivasan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008283; Storz P, 2009, MOL CELL BIOL, V29, P4906, DOI 10.1128/MCB.00077-09; Van der Velden PA, 2003, INT J CANCER, V106, P472, DOI 10.1002/ijc.11262; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang N, 2013, DIGEST DIS SCI, V58, P1863, DOI 10.1007/s10620-013-2612-2; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200; Zeng ZS, 2001, DIS COLON RECTUM, V44, P1290, DOI 10.1007/BF02234786; Zhang AM, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.03.030; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zhang Z, 2012, WIRES RNA, V3, P593, DOI 10.1002/wrna.1114; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	42	71	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0115919	10.1371/journal.pone.0115919	http://dx.doi.org/10.1371/journal.pone.0115919			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25587717	Green Submitted, Green Published, gold			2022-12-26	WOS:000347928300007
J	Sun, M; Lu, MX; Tang, XT; Du, YZ				Sun, Meng; Lu, Ming-Xing; Tang, Xiao-Tian; Du, Yu-Zhou			Exploring Valid Reference Genes for Quantitative Real-Time PCR Analysis in Sesamia inferens (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							RT-PCR; EXPRESSION ANALYSIS; QUANTIFICATION; NORMALIZATION; WALKER; SELECTION; MODEL; BORER	The pink stem borer, Sesamia inferens, which is endemic in China and other parts of Asia, is a major pest of rice and causes significant yield loss in this host plant. Very few studies have addressed gene expression in S. inferens. Quantitative real-time PCR (qRT-PCR) is currently the most accurate and sensitive method for gene expression analysis. In qRT-PCR, data are normalized using reference genes, which help control for internal differences and reduce error between samples. In this study, seven candidate reference genes, 18S ribosomal RNA (18S rRNA), elongation factor 1 (EF1), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), ribosomal protein S13 (RPS13), ribosomal protein S20 (RPS20), tubulin (TUB), and beta-actin (ACTB) were evaluated for their suitability in normalizing gene expression under different experimental conditions. The results indicated that three genes (RPS13, RPS20, and EF1) were optimal for normalizing gene expression in different insect tissues (head, epidermis, fat body, foregut, midgut, hindgut, Malpighian tubules, haemocytes, and salivary glands). 18S rRNA, EF1, and GAPDH were best for normalizing expression with respect to developmental stages and sex (egg masses; first, second, third, fourth, fifth, and sixth instar larvae; male and female pupae; and one-day-old male and female adults). 18S rRNA, RPS20, and TUB were optimal for fifth instars exposed to different temperatures (-8, -6, -4, -2, 0, and 27 degrees C). To validate this recommendation, the expression profile of a target gene heat shock protein 83 gene (hsp83) was investigated, and results showed the selection was necessary and effective. In conclusion, this study describes reference gene sets that can be used to accurately measure gene expression in S. inferens.	[Sun, Meng; Lu, Ming-Xing; Tang, Xiao-Tian; Du, Yu-Zhou] Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China; [Sun, Meng; Lu, Ming-Xing; Tang, Xiao-Tian; Du, Yu-Zhou] Yangzhou Univ, Inst Appl Entomol, Yangzhou, Jiangsu, Peoples R China; [Sun, Meng] Shangdong Acad Agr Sci, Inst Plant Protect, Jinan, Shandong, Peoples R China	Yangzhou University; Yangzhou University; Shandong Academy of Agricultural Sciences	Du, YZ (corresponding author), Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China.	yzdu@yzu.edu.cn			National Basic Research Program of China (973 Program) [2012CB114100]; National Natural Science Foundation of China [31371937]; Youth Science Foundation of Yangzhou; Testing Center of Yangzhou University	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Science Foundation of Yangzhou; Testing Center of Yangzhou University	This research was funded by the National Basic Research Program of China (973 Program) (2012CB114100), the National Natural Science Foundation of China (31371937), and Youth Science Foundation of Yangzhou. The authors also appreciate the support and help of the Testing Center of Yangzhou University on experimental apparatus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Areekul S., 1973, Kasetsart J, V7, P65; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Han Chao, 2012, Chinese Journal of Applied Entomology, V49, P281; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jiang HB, 2010, MOL BIOL REP, V37, P1019, DOI 10.1007/s11033-009-9803-0; Jiang XF, 2012, CELL STRESS CHAPERON, V17, P67, DOI 10.1007/s12192-011-0286-2; Joshi Gagan, 2009, Annals of Biology (Hissar), V25, P41; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Mahesh P, 2013, SUGAR TECH, V15, P384, DOI 10.1007/s12355-013-0212-2; Mao JJ, 2014, TRANSGENIC RES, V23, P145, DOI 10.1007/s11248-013-9739-y; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rahman Md. Touhidur, 2004, Entomologia Sinica, V11, P47; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Singh Beant, 2012, Journal of Entomology, V9, P368, DOI 10.3923/je.2012.368.374; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026980; Yu H, 2012, J INTEGR AGR, V11, P293, DOI 10.1016/S2095-3119(12)60013-6; Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084730	33	57	62	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2015	10	1							e0115979	10.1371/journal.pone.0115979	http://dx.doi.org/10.1371/journal.pone.0115979			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OG	25585250	Green Published, Green Submitted, gold			2022-12-26	WOS:000348201300005
J	Zhong, WB; Qin, SY; Zhu, BY; Pu, MS; Liu, FP; Wang, L; Ye, GL; Yi, Q; Yan, DG				Zhong, Wenbin; Qin, Shengying; Zhu, Biying; Pu, Miaoshui; Liu, Fupei; Wang, Lin; Ye, Guilin; Yi, Qing; Yan, Daoguang			Oxysterol-binding Protein-related Protein 8 (ORP8) Increases Sensitivity of Hepatocellular Carcinoma Cells to Fas-Mediated Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HUMAN HEPATOMA-CELLS; ENDOPLASMIC-RETICULUM; LIGAND EXPRESSION; ACTIVATION; LIVER; CHOLESTEROL; MECHANISM; CANCER; INITIATION-FACTOR-2	Human hepatoma (HCC) has been reported to be strongly resistant to Fas-mediated apoptosis. However, the underlying mechanisms are poorly understood. In this study the function of oxysterol-binding protein-related protein 8 (ORP8) in human hepatoma cells apoptosis was assessed. We found that ORP8 is down-regulated, whereas miR-143, which controls ORP8 expression, is up-regulated in clinical HCC tissues as compared with liver tissue from healthy subjects. ORP8 overexpression triggered apoptosis in primary HCC cells and cell lines, which coincided with a relocation of cytoplasmic Fas to the cell plasma membrane and FasL up-regulation. Co-culture of HepG2 cells or primary HCC cells with Jurkat T-cells or T-cells, respectively, provided further evidence that ORP8 increases HCC cell sensitivity to Fas-mediated apoptosis. ORP8-induced Fas translocation is p53-dependent, and FasL was induced upon ORP8 overexpression via the endoplasmic reticulum stress response. Moreover, ORP8 overexpression and miR-143 inhibition markedly inhibited tumor growth in a HepG2 cell xenograft model. These results indicate that ORP8 induces HCC cell apoptosis through the Fas/FasL pathway. The role of ORP8 in Fas translocation to the plasma membrane and its down-regulation by miR-143 offer a putative mechanistic explanation for HCC resistance to apoptosis. ORP8 may be a potential target for HCC therapy.	[Zhong, Wenbin; Qin, Shengying; Zhu, Biying; Liu, Fupei; Wang, Lin; Ye, Guilin; Yan, Daoguang] Jinan Univ, Guangdong Higher Educ Inst, Key Lab Funct Prot Res, Guangzhou 510632, Guangdong, Peoples R China; [Zhong, Wenbin; Qin, Shengying; Zhu, Biying; Liu, Fupei; Wang, Lin; Ye, Guilin; Yan, Daoguang] Jinan Univ, Dept Biotechnol, Guangzhou 510632, Guangdong, Peoples R China; [Pu, Miaoshui] Guangzhou Gen Hosp, Dept Hepatobiliary Surg, Guangzhou 510010, Guangdong, Peoples R China; [Yi, Qing] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA	Jinan University; Jinan University; Cleveland Clinic Foundation	Yan, DG (corresponding author), Guangdong Higher Educ Inst, Key Lab Funct Prot Res, Guangzhou 510632, Guangdong, Peoples R China.	tydg@jnu.edu.cn		Zhu, Biying/0000-0003-2358-2739	NSFC (National Natural Science Foundation of China), China [91439122, 30971104]; National Basic Research Program of China [2012CB517502]; Fundamental Research Funds for the Central Universities, China [21610609]	NSFC (National Natural Science Foundation of China), China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the NSFC (National Natural Science Foundation of China), China (91439122 and 30971104 (to D. Y.)), the National Basic Research Program of China (2012CB517502 (to D. Y.), and Fundamental Research Funds for the Central Universities, China (21610609 (to D. Y.)).	Beaslas O, 2012, EXP CELL RES, V318, P1933, DOI 10.1016/j.yexcr.2012.05.026; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; DESSI S, 1994, CANCER, V73, P253, DOI 10.1002/1097-0142(19940115)73:2<253::AID-CNCR2820730204>3.0.CO;2-F; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; ELKHATIB M, 1995, CELL IMMUNOL, V163, P237, DOI 10.1006/cimm.1995.1122; Faubion WA, 1999, HEPATOLOGY, V29, P1, DOI 10.1002/hep.510290101; GALLE PR, 1995, J EXP MED, V182, P1223, DOI 10.1084/jem.182.5.1223; Higaki K, 1996, AM J PATHOL, V149, P429; Hsu SC, 1999, EUR J IMMUNOL, V29, P2948, DOI 10.1002/(SICI)1521-4141(199909)29:09<2948::AID-IMMU2948>3.0.CO;2-0; Ito Y, 2000, BRIT J CANCER, V82, P1211; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lowin B, 1996, INT IMMUNOL, V8, P57, DOI 10.1093/intimm/8.1.57; NATOLI G, 1995, ONCOGENE, V11, P1157; Ogawa K, 2004, J HEPATOL, V40, P278, DOI 10.1016/j.jhep.2003.09.021; PAHL HL, 1995, EMBO J, V14, P2580, DOI 10.1002/j.1460-2075.1995.tb07256.x; Pahl HL, 1997, TRENDS BIOCHEM SCI, V22, P63, DOI 10.1016/S0968-0004(96)10073-6; Pinkoski MJ, 2000, AM J PHYSIOL-GASTR L, V278, pG354, DOI 10.1152/ajpgi.2000.278.3.G354; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Schulze-Bergkamen H, 2004, SEMIN ONCOL, V31, P90, DOI 10.1053/j.seminoncol.2003.11.006; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Trakooljul N, 2010, ANIM GENET, V41, P357, DOI 10.1111/j.1365-2052.2009.02015.x; Wang XD, 2005, HEPATOLOGY, V42, P400, DOI 10.1002/hep.20792; Wang XD, 2007, FREE RADICAL BIO MED, V42, P971, DOI 10.1016/j.freeradbiomed.2006.12.023; Yan D, 2008, J BIOL CHEM, V283, P332, DOI 10.1074/jbc.M705313200; Yano H, 1996, J HEPATOL, V25, P454, DOI 10.1016/S0168-8278(96)80204-2; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008; Zhao X, 2012, SCI CHINA LIFE SCI, V55, P906, DOI 10.1007/s11427-012-4384-x; Zhong WB, 2014, EXP CELL RES, V322, P227, DOI 10.1016/j.yexcr.2014.01.002; Zhou TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021078	33	31	34	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8876	8887		10.1074/jbc.M114.610188	http://dx.doi.org/10.1074/jbc.M114.610188			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25596532	Green Published, hybrid			2022-12-26	WOS:000352207100016
J	King, SM; Patel-King, RS				King, Stephen M.; Patel-King, Ramila S.			The Oligomeric Outer Dynein Arm Assembly Factor CCDC103 Is Tightly Integrated within the Ciliary Axoneme and Exhibits Periodic Binding to Microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Motility; Chlamydomonas; Cilia; Dynein; Microtubule; Flagella	DOCKING COMPLEX; MUTATIONAL ANALYSIS; INTERMEDIATE CHAIN; PROTEIN; SUBUNIT; MECHANISMS; DYSKINESIA; INTERACTS; DEFECTS; DISEASE	Background: CCDC103 is necessary for the assembly of outer dynein arms on ciliary microtubules. Results: CCDC103 is arrayed along the axoneme, self-assembles, and binds microtubules with a 12-nm periodicity. Conclusion: CCDC103 is an integral component of the axoneme that underlies dynein assembly. Significance: Defining how dynein arms are incorporated is necessary to understand the complex patterning of motile cilia. CCDC103 is an approximate to 29-kDa protein consisting of a central RPAP3_C domain flanked by N- and C-terminal coiled coils. Defects in CCDC103 lead to primary ciliary dyskinesia caused by the loss of outer dynein arms. This protein is present along the entire length of the ciliary axoneme and does not require other dynein or docking complex components for its integration. Unlike other known dynein assembly factors within the axoneme, CCDC103 is not solubilized by 0.6 m NaCl and requires more chaotropic conditions, such as 0.5 m KI. Alternatively, it can be extracted using 0.3% sarkosyl. CCDC103 forms stable dimers and other oligomers in solution through interactions involving the central domain. The smallest particle observed by dynamic light scattering has a hydrodynamic diameter of approximate to 25 nm. Furthermore, CCDC103 binds microtubules directly, forming approximate to 9-nm diameter particles that exhibit a 12-nm spacing on the microtubule lattice, suggesting that there may be two CCDC103 units per outer arm dynein repeat. Although the outer dynein arm docking complex is necessary to form arrays of dyneins along microtubules, it is not sufficient to set up a single array in a precise location on each axonemal doublet. We propose that CCDC103 helps generate a high-affinity site on the doublets for outer arm assembly, either through direct interactions or indirectly, perhaps by modifying the underlying microtubule lattice.	[King, Stephen M.; Patel-King, Ramila S.] Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA; [King, Stephen M.] Univ Connecticut, Ctr Hlth, Inst Syst Genom, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut	Patel-King, RS (corresponding author), Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, 263 Farmington Ave, Farmington, CT 06030 USA.	king@uchc.edu			National Institutes of Health [GM051293]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051293] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in whole or in part, by National Institutes of Health Grant GM051293.	Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Austin-Tse C, 2013, AM J HUM GENET, V93, P672, DOI 10.1016/j.ajhg.2013.08.015; Casey DM, 2003, MOL BIOL CELL, V14, P3650, DOI 10.1091/mbc.E03-01-0057; Dean AB, 2013, MOL BIOL CELL, V24, P3689, DOI 10.1091/mbc.E13-06-0310; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; HAIMO LT, 1988, CELL MOTIL CYTOSKEL, V9, P129, DOI 10.1002/cm.970090205; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; HOOPS HJ, 1983, J CELL BIOL, V97, P902, DOI 10.1083/jcb.97.3.902; Inoue M, 2010, BIOCHEM BIOPH RES CO, V403, P340, DOI 10.1016/j.bbrc.2010.11.031; Itsuki Y, 2008, FEBS LETT, V582, P2365, DOI 10.1016/j.febslet.2008.05.041; KAMIYA R, 1988, J CELL BIOL, V107, P2253, DOI 10.1083/jcb.107.6.2253; KING SM, 1995, METHOD CELL BIOL, V47, P9, DOI 10.1016/S0091-679X(08)60783-9; KING SM, 1986, METHOD ENZYMOL, V134, P291; KING SM, 1991, J BIOL CHEM, V266, P8401; King SM, 2012, DYNEINS: STRUCTURE, BIOLOGY AND DISEASE, P209, DOI 10.1016/B978-0-12-382004-4.10007-X; Knowles MR, 2013, AM J HUM GENET, V93, P711, DOI 10.1016/j.ajhg.2013.07.025; Koutoulis A, 1997, J CELL BIOL, V137, P1069, DOI 10.1083/jcb.137.5.1069; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Ni L, 2009, J CELL BIOCHEM, V106, P920, DOI 10.1002/jcb.22073; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Owa M, 2014, P NATL ACAD SCI USA, V111, P9461, DOI 10.1073/pnas.1403101111; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Patel-King RS, 2009, J CELL BIOL, V186, P283, DOI 10.1083/jcb.200905083; Rompolas P, 2007, J CELL SCI, V120, P3653, DOI 10.1242/jcs.012773; Rompolas P, 2012, MOL BIOL CELL, V23, P3554, DOI 10.1091/mbc.E12-04-0287; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; TAILLON BE, 1992, J CELL BIOL, V119, P1613, DOI 10.1083/jcb.119.6.1613; TAKADA S, 1994, J CELL BIOL, V126, P737, DOI 10.1083/jcb.126.3.737; Takada S, 2002, MOL BIOL CELL, V13, P1015, DOI 10.1091/mbc.01-04-0201; Tarkar A, 2013, NAT GENET, V45, P995, DOI 10.1038/ng.2707; Wirschell M, 2004, MOL BIOL CELL, V15, P2729, DOI 10.1091/mbc.E03-11-0820; WITMAN GB, 1972, J CELL BIOL, V54, P507, DOI 10.1083/jcb.54.3.507; Wu HW, 2000, NAT STRUCT BIOL, V7, P575; Zhao L, 2013, P NATL ACAD SCI USA, V110, P12697, DOI 10.1073/pnas.1300968110	35	25	26	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7388	7401		10.1074/jbc.M114.616425	http://dx.doi.org/10.1074/jbc.M114.616425			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25572396	hybrid, Green Published			2022-12-26	WOS:000351613600008
J	Tapryal, N; Vivek, GV; Mukhopadhyay, CK				Tapryal, Nisha; Vivek, Vishnu G.; Mukhopadhyay, Chinmay K.			Catecholamine Stress Hormones Regulate Cellular Iron Homeostasis by a Posttranscriptional Mechanism Mediated by Iron Regulatory Protein IMPLICATION IN ENERGY HOMEOSTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Catecholamine; Ferritin; Gene Regulation; Iron Metabolism; Mitochondria; Reactive Oxygen Species (ROS); Transferrin Receptor	FERRITIN MESSENGER-RNA; HUMAN SKELETAL-MUSCLE; CITRIC-ACID CYCLE; RESPONSIVE ELEMENT; NITRIC-OXIDE; OXIDATIVE STRESS; NOREPINEPHRINE TRANSPORTERS; TRANSLATIONAL REGULATION; 5-UNTRANSLATED REGION; GENE-EXPRESSION	Background: The role of catecholamines in cellular iron homeostasis is not understood. Results: Epinephrine and norepinephrine up-regulate transferrin receptor-1, inhibit ferritin expression, and increase mitochondrial iron content in hepatic and skeletal muscle cells. Conclusion: Catecholamine stress hormones are novel regulators of cellular iron homeostasis. Significance: Catecholamines may act to increase cellular iron content to meet an increased demand during stress. Adequate availability of iron is important for cellular energy metabolism. Catecholamines such as epinephrine and norepinephrine promote energy expenditure to adapt to conditions that arose due to stress. To restore the energy balance, epinephrine/norepinephrine-exposed cells may face higher iron demand. So far, no direct role of epinephrine/norepinephrine in cellular iron homeostasis has been reported. Here we show that epinephrine/norepinephrine regulates iron homeostasis components such as transferrin receptor-1 and ferritin-H in hepatic and skeletal muscle cells by promoting the binding of iron regulatory proteins to iron-responsive elements present in the UTRs of transferrin receptor-1 and ferritin-H transcripts. Increased transferrin receptor-1, decreased ferritin-H, and increased iron-responsive element-iron regulatory protein interaction are also observed in liver and muscle tissues of epinephrine/norepinephrine-injected mice. We demonstrate the role of epinephrine/norepinephrine-induced generation of reactive oxygen species in converting cytosolic aconitase (ACO1) into iron regulatory protein-1 to bind iron-responsive elements present in UTRs of transferrin receptor-1 and ferritin-H. Our study further reveals that mitochondrial iron content and mitochondrial aconitase (ACO2) activity are elevated by epinephrine/norepinephrine that are blocked by the antioxidant N-acetyl cysteine and iron regulatory protein-1 siRNA, suggesting involvement of reactive oxygen species and iron regulatory protein-1 in this mechanism. This study reveals epinephrine and norepinephrine as novel regulators of cellular iron homeostasis.	[Tapryal, Nisha; Vivek, Vishnu G.; Mukhopadhyay, Chinmay K.] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Mukhopadhyay, CK (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India.	ckm2300@mail.jnu.ac.in			Council of Scientific and Industrial Research (CSIR) of India; CSIR	Council of Scientific and Industrial Research (CSIR) of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research (CSIR) of India.; Recipient of a fellowship from the CSIR.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Biswas S, 2013, BBA-MOL BASIS DIS, V1832, P293, DOI 10.1016/j.bbadis.2012.11.003; BLAAK EE, 1993, INT J OBESITY, V17, pS78; Caltagirone A, 2001, J BIOL CHEM, V276, P19738, DOI 10.1074/jbc.M100245200; Das NK, 2009, CELL MICROBIOL, V11, P83, DOI 10.1111/j.1462-5822.2008.01241.x; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; DEBOER SF, 1990, PHYSIOL BEHAV, V47, P1117, DOI 10.1016/0031-9384(90)90361-7; Deugnier Y, 2007, WORLD J GASTROENTERO, V13, P4755, DOI 10.3748/wjg.v13.i35.4755; DIX DJ, 1992, BIOCHEMISTRY-US, V31, P2818, DOI 10.1021/bi00125a024; DRAPIER JC, 1986, J CLIN INVEST, V78, P790, DOI 10.1172/JCI112642; Eisenstein RS, 2003, J NUTR, V133, p1510S, DOI 10.1093/jn/133.5.1510S; ESLER M, 1990, PHYSIOL REV, V70, P963, DOI 10.1152/physrev.1990.70.4.963; Galli A, 1998, P NATL ACAD SCI USA, V95, P13260, DOI 10.1073/pnas.95.22.13260; Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007; Ganz T, 2006, BBA-MOL CELL RES, V1763, P690, DOI 10.1016/j.bbamcr.2006.03.014; Gray NK, 1996, P NATL ACAD SCI USA, V93, P4925, DOI 10.1073/pnas.93.10.4925; Gupta MK, 2006, ANTIOXID REDOX SIGN, V8, P1081, DOI 10.1089/ars.2006.8.1081; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; Kim HY, 1996, J BIOL CHEM, V271, P24226, DOI 10.1074/jbc.271.39.24226; Kohler SA, 1995, J BIOL CHEM, V270, P30781, DOI 10.1074/jbc.270.51.30781; Kvetnansky R, 2009, PHYSIOL REV, V89, P535, DOI 10.1152/physrev.00042.2006; Little R A, 1985, Arch Emerg Med, V2, P46; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; Lymboussaki A, 2003, J HEPATOL, V39, P710, DOI 10.1016/S0168-8278(03)00408-2; Muralidharan B, 2007, FEBS LETT, V581, P4103, DOI 10.1016/j.febslet.2007.07.050; Nonogaki K, 2000, DIABETOLOGIA, V43, P533, DOI 10.1007/s001250051341; Oben JA, 2004, ANAT REC PART A, V280A, P874, DOI 10.1002/ar.a.20081; Oexle H, 1999, BBA-BIOENERGETICS, V1413, P99, DOI 10.1016/S0005-2728(99)00088-2; Pantopoulos K, 1996, MOL CELL BIOL, V16, P3781; Philippe MA, 2007, WORLD J GASTROENTERO, V13, P4746, DOI 10.3748/wjg.v13.i35.4746; Remondino A, 2003, CIRC RES, V92, P136, DOI 10.1161/01.RES.0000054624.03539.B4; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Rouault T A, 1996, EXS, V77, P183; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Sancho-Bru P, 2006, AM J PHYSIOL-GASTR L, V291, pG877, DOI 10.1152/ajpgi.00537.2005; Schwartz JW, 2005, J BIOL CHEM, V280, P19177, DOI 10.1074/jbc.M412923200; Schwartz JW, 2003, J BIOL CHEM, V278, P9768, DOI 10.1074/jbc.M209824200; SIERZPUTOWSKAGRACZ H, 1995, NUCLEIC ACIDS RES, V23, P146, DOI 10.1093/nar/23.1.146; Soum E, 2003, BIOCHEMISTRY-US, V42, P7648, DOI 10.1021/bi030041i; SPENCER MK, 1991, AM J PHYSIOL, V260, pE436, DOI 10.1152/ajpendo.1991.260.3.E436; SYLVIA AL, 1985, BRAIN RES, V338, P281, DOI 10.1016/0006-8993(85)90158-1; TAETLE R, 1987, BLOOD, V70, P852; Tapryal N, 2009, J BIOL CHEM, V284, P1873, DOI 10.1074/jbc.M804079200; Viguerie N, 2004, J CLIN ENDOCR METAB, V89, P2000, DOI 10.1210/jc.2003-031733	47	15	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7634	7646		10.1074/jbc.M114.592519	http://dx.doi.org/10.1074/jbc.M114.592519			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25572399	Green Published, hybrid			2022-12-26	WOS:000351613600026
J	Marinangeli, C; Tasiaux, B; Opsomer, R; Hage, S; Sodero, AO; Dewachter, I; Octave, JN; Smith, SO; Constantinescu, SN; Kienlen-Campard, P				Marinangeli, Claudia; Tasiaux, Bernadette; Opsomer, Remi; Hage, Salim; Sodero, Alejandro O.; Dewachter, Ilse; Octave, Jean Noel; Smith, Steven O.; Constantinescu, Stefan N.; Kienlen-Campard, Pascal			Presenilin Transmembrane Domain 8 Conserved AXXXAXXXG Motifs Are Required for the Activity of the gamma-Secretase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; C-TERMINAL FRAGMENT; ALZHEIMERS-DISEASE; BETA-PROTEIN; GLYCOPHORIN-A; INTRAMEMBRANE CLEAVAGE; MEMBRANE-PROTEINS; SITE CONFORMATION; TRAFFICKING; MUTATIONS	Understanding the molecular mechanisms controlling the physiological and pathological activity of gamma-secretase represents a challenging task in Alzheimer disease research. The assembly and proteolytic activity of this enzyme require the correct interaction of the 19 transmembrane domains (TMDs) present in its four subunits, including presenilin (PS1 or PS2), the gamma-secretase catalytic core. GXXXG and GXXXG-like motifs are critical for TMDs interactions as well as for protein folding and assembly. The GXXXG motifs on gamma-secretase subunits (e. g. APH-1) or on gamma-secretase substrates (e. g. APP) are known to be involved in gamma-secretase assembly and in A beta peptide production, respectively. We identified on PS1 and PS2 TMD8 two highly conserved AXXXAXXXG motifs. The presence of a mutation causing an inherited form of Alzheimer disease (familial Alzheimer disease) in the PS1 motif suggested their involvement in the physiopathological configuration of the gamma-secretase complex. In this study, we targeted the role of these motifs on TMD8 of PSs, focusing on their role in PS assembly and catalytic activity. Each motif was mutated, and the impact on complex assembly, activity, and substrate docking was monitored. Different amino acid substitutions on the same motif resulted in opposite effects on gamma-secretase activity, without affecting the assembly or significantly impairing the maturation of the complex. Our data suggest that AXXXAXXXG motifs in PS TMD8 are key determinants for the conformation of the mature gamma-secretase complex, participating in the switch between the physiological and pathological functional conformations of the gamma-secretase.	[Marinangeli, Claudia; Tasiaux, Bernadette; Opsomer, Remi; Sodero, Alejandro O.; Dewachter, Ilse; Octave, Jean Noel; Kienlen-Campard, Pascal] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Hage, Salim] Catholic Univ Louvain, Louvain Drug Res Inst, B-1200 Brussels, Belgium; [Constantinescu, Stefan N.] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Constantinescu, Stefan N.] Catholic Univ Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Smith, Steven O.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Ludwig Institute for Cancer Research; Universite Catholique Louvain; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kienlen-Campard, P (corresponding author), Catholic Univ Louvain, Inst Neurosci IoNS, Ave Mounier 53 Box B1-53-02, B-1200 Brussels, Belgium.	pascal.kienlen-campard@uclouvain.be	Dewachter, Ilse/AAZ-5661-2020; Smith, Steven/HDM-9496-2022	Dewachter, Ilse/0000-0001-7202-515X; Kienlen-Campard, Pascal/0000-0003-1086-2942; Constantinescu, Stefan N./0000-0002-8599-2699	National Institutes of Health [AG27317]; Fondation Recherche Alzheimer; Foundation for Research on Alzheimer's Disease; Commission du Patrimoine of Universite Catholique de Louvain; Interuniversity Attraction Pole Programme-Belgian Sate-Belgian Science Policy (Belgian Medical Genetics Initiative) [P7/16]; Salus Sanguinis Foundation; Action de Recherche Concertee ARC of the University Catholique de Louvain [10/15-027]; Special Fund for Research (FSR, UCL); NATIONAL INSTITUTE ON AGING [R01AG027317, RF1AG027317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Recherche Alzheimer; Foundation for Research on Alzheimer's Disease; Commission du Patrimoine of Universite Catholique de Louvain; Interuniversity Attraction Pole Programme-Belgian Sate-Belgian Science Policy (Belgian Medical Genetics Initiative); Salus Sanguinis Foundation; Action de Recherche Concertee ARC of the University Catholique de Louvain; Special Fund for Research (FSR, UCL); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG27317 (to S. O. S.). This work was also supported by grants from the Fondation Recherche Alzheimer, the Foundation for Research on Alzheimer's Disease (to C. M. and P. K. C.), the Commission du Patrimoine of Universite Catholique de Louvain (to C. M.), and the Interuniversity Attraction Pole Programme-Belgian Sate-Belgian Science Policy (P7/16-Belgian Medical Genetics Initiative) (to J. N. O., P. K. C., and S. N. C.). This work was also supported by the Salus Sanguinis Foundation, the Action de Recherche Concertee ARC 10/15-027 of the University Catholique de Louvain, and the Special Fund for Research (FSR, UCL) (to S. N. C.).	Adamian L, 2002, PROTEINS, V47, P209, DOI 10.1002/prot.10071; Aldudo J, 1999, HUM MUTAT, V14, P433, DOI 10.1002/(SICI)1098-1004(199911)14:5<433::AID-HUMU10>3.0.CO;2-K; Araki W, 2006, J MOL NEUROSCI, V29, P35, DOI 10.1385/JMN:29:1:35; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Ben Khalifa N, 2012, FASEB J, V26, P855, DOI 10.1096/fj.11-190207; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Berechid BE, 2002, J BIOL CHEM, V277, P8154, DOI 10.1074/jbc.M108238200; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chau DM, 2012, J BIOL CHEM, V287, P17288, DOI 10.1074/jbc.M111.300483; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DESTROOPER B, 1995, EMBO J, V14, P4932, DOI 10.1002/j.1460-2075.1995.tb00176.x; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Eilers M, 2002, BIOPHYS J, V82, P2720, DOI 10.1016/S0006-3495(02)75613-0; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Fukumori A, 2010, J NEUROSCI, V30, P7853, DOI 10.1523/JNEUROSCI.1443-10.2010; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Hage S, 2014, NEURODEGENER DIS, V14, P39, DOI 10.1159/000355557; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Huysseune S, 2007, BIOCHEM BIOPH RES CO, V361, P317, DOI 10.1016/j.bbrc.2007.06.186; Jozwiak K, 2008, CHEMMEDCHEM, V3, P627, DOI 10.1002/cmdc.200700189; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kimberly WT, 2000, J BIOL CHEM, V275, P3173, DOI 10.1074/jbc.275.5.3173; Knappenberger KS, 2004, BIOCHEMISTRY-US, V43, P6208, DOI 10.1021/bi036072v; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kopan R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011213; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Lee SF, 2004, J BIOL CHEM, V279, P4144, DOI 10.1074/jbc.M309745200; Leem JY, 2002, NEUROBIOL DIS, V11, P64, DOI 10.1006/nbdi.2002.0546; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; Liu W, 2004, J MOL BIOL, V337, P713, DOI 10.1016/j.jmb.2004.02.001; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Matsumura N, 2014, J BIOL CHEM, V289, P5109, DOI 10.1074/jbc.M113.510131; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Nyabi O, 2002, NAT CELL BIOL, V4, pE164, DOI 10.1038/ncb0702-e164a; Octave JN, 2000, J BIOL CHEM, V275, P1525, DOI 10.1074/jbc.275.3.1525; Oh YS, 2005, BIOCHEMISTRY-US, V44, P11821, DOI 10.1021/bi0509494; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Salmon Patrick, 2007, Curr Protoc Hum Genet, VChapter 12, DOI 10.1002/0471142905.hg1210s54; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato T, 2009, P NATL ACAD SCI USA, V106, P1421, DOI 10.1073/pnas.0812261106; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shiraishi H, 2006, GENES CELLS, V11, P83, DOI 10.1111/j.1365-2443.2005.00914.x; Smith SO, 2002, BIOPHYS J, V82, P2476, DOI 10.1016/S0006-3495(02)75590-2; Smith SO, 2001, BIOCHEMISTRY-US, V40, P6553, DOI 10.1021/bi010357v; Sobhanifar S, 2010, P NATL ACAD SCI USA, V107, P9644, DOI 10.1073/pnas.1000778107; Spasic D, 2008, J CELL SCI, V121, P413, DOI 10.1242/jcs.015255; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tang TC, 2014, STRUCTURE, V22, P387, DOI 10.1016/j.str.2013.12.012; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Wang LF, 2009, MOLECULES, V14, P3589, DOI 10.3390/molecules14093589; Wanngren J, 2014, FEBS OPEN BIO, V4, P393, DOI 10.1016/j.fob.2014.04.006; Watanabe N, 2010, J BIOL CHEM, V285, P19738, DOI 10.1074/jbc.M110.101287; Weggen S, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt107; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wolfe MS, 2014, CELL, V158, P247, DOI 10.1016/j.cell.2014.06.043; Wolfe MS, 2013, BBA-BIOMEMBRANES, V1828, P2886, DOI 10.1016/j.bbamem.2013.04.015; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P11223, DOI 10.1021/bi991080q; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208	82	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7169	7184		10.1074/jbc.M114.601286	http://dx.doi.org/10.1074/jbc.M114.601286			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25614624	Green Published, hybrid			2022-12-26	WOS:000350991500047
J	Ramezani-Moghadam, M; Wang, JH; Ho, V; Iseli, TJ; Alzahrani, B; Xu, AM; Van der Poorten, D; Qiao, L; George, J; Hebbard, L				Ramezani-Moghadam, Mehdi; Wang, Jianhua; Ho, Vikki; Iseli, Tristan J.; Alzahrani, Badr; Xu, Aimin; Van der Poorten, David; Qiao, Liang; George, Jacob; Hebbard, Lionel			Adiponectin Reduces Hepatic Stellate Cell Migration by Promoting Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; RNA EXPRESSION; FIBROSIS; PROLIFERATION; MECHANISMS; RESOLUTION; APOPTOSIS; CD63; RAT	Hepatic stellate cells (HSC) are central players in liver fibrosis that when activated, proliferate, migrate to sites of liver injury, and secrete extracellular matrix, Obesity, a known risk factor for liver fibrosis is associated with reduced levels of adiponectin, a protein that inhibits liver fibrosis in vivo and limits HSC proliferation and migration in vitro. Adiponectin-mediated activation of adenosine monophosphate-activated kinase (AMPK) inhibits HSC proliferation, but the mechanism by which it limits HSC migration to sites of injury is unknown. Here we sought to elucidate how adiponectin regulates HSC motility. Primary rat HSCs were isolated and treated with adiponectin in migration assays. The in vivo actions of adiponectin were examined by treating mice with carbon tetrachloride for 12 weeks and then injecting them with adiponectin. Cell and tissue samples were collected and analyzed for gene expression, signaling, and histology. Serum from patients with liver fibrosis was examined for adiponectin and tissue inhibitor of metalloproteinase-1 (TIMP-1) protein. Adiponectin administration into mice increased TIMP-1 gene and protein expression. In cultured HSCs, adiponectin promoted TIMP-1 expression and through binding of TIMP-1 to the CD63/beta 1-integrin complex reduced phosphorylation of focal adhesion kinase to limit HS( migration. In mice with liver fibrosis, adiponectin had similar effects and limited focal adhesion kinase phosphorylation. Finally, in patients with advanced fibrosis, there was a positive correlation between serum adiponectin and TIMP-1 levels. In sum, these data show that adiponectin stimulates TIMP-1 secretion by HSCs to retard their migration and contributes to the anti-fibrotic effects of adiponectin.	[Ramezani-Moghadam, Mehdi; Wang, Jianhua; Ho, Vikki; Iseli, Tristan J.; Alzahrani, Badr; Van der Poorten, David; Qiao, Liang; George, Jacob; Hebbard, Lionel] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Storr Liver Ctr, Westmead, NSW 2145, Australia; [Xu, Aimin] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Sydney; Westmead Institute for Medical Research; University of Hong Kong	Hebbard, L (corresponding author), Storr Liver Ctr, Westmead Millennium Inst, POB 412, Westmead, NSW 2145, Australia.	lionel.hebbard@sydney.edu.au	Hebbard, Lionel/W-4057-2019; George, jacob/P-1496-2014; Hebbard, Lionel/O-1489-2017	Hebbard, Lionel/0000-0002-7094-9065	University of Sydney; National Health and Medical Research Council of Australia (NHMRC) Program [1053206]; NHMRC [632630]; Cancer Council NSW Project [1069733]	University of Sydney(University of Sydney); National Health and Medical Research Council of Australia (NHMRC) Program(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW Project(Cancer Council New South Wales)	This project was supported by the Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney, National Health and Medical Research Council of Australia (NHMRC) Program Grant 1053206, NHMRC Project Grant 632630 (to L. H. and J. G.), and Cancer Council NSW Project Grant 1069733 (to L. H.).	Adachi M, 2008, HEPATOLOGY, V47, P677, DOI 10.1002/hep.21991; Akahane T, 2004, EXP CELL RES, V301, P158, DOI 10.1016/j.yexcr.2004.08.002; Benyon RC, 1996, GASTROENTEROLOGY, V110, P821, DOI 10.1053/gast.1996.v110.pm8608892; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; BERDITCHEVSKI F, 1995, J BIOL CHEM, V270, P17784, DOI 10.1074/jbc.270.30.17784; Boeker KHW, 2002, CLIN CHIM ACTA, V316, P71, DOI 10.1016/S0009-8981(01)00730-6; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Ding XK, 2005, AM J PATHOL, V166, P1655, DOI 10.1016/S0002-9440(10)62476-5; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Herbst H, 1997, AM J PATHOL, V150, P1647; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Iredale JP, 1996, HEPATOLOGY, V24, P176, DOI 10.1002/hep.510240129; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kamada Y, 2003, GASTROENTEROLOGY, V125, P1796, DOI 10.1053/j.gastro.2003.08.029; Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Lotersztajn S, 2005, ANNU REV PHARMACOL, V45, P605, DOI 10.1146/annurev.pharmtox.45.120403.095906; Mandal P, 2010, HEPATOLOGY, V51, P1420, DOI 10.1002/hep.23427; Mannion BA, 1996, J IMMUNOL, V157, P2039; Marra F, 2005, Eur Rev Med Pharmacol Sci, V9, P279; Mazzocca A, 2002, J HEPATOL, V37, P322, DOI 10.1016/S0168-8278(02)00175-7; Murawaki Y, 1997, J HEPATOL, V26, P1213, DOI 10.1016/S0168-8278(97)80454-0; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; Parsons CJ, 2004, HEPATOLOGY, V40, P1106, DOI 10.1002/hep.20425; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Safadi Rifaat, 2002, MedGenMed, V4, P27; Salman TA, 2010, HEPATOL INT, V4, P767, DOI 10.1007/s12072-010-9216-0; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stearns ME, 1997, INVAS METAST, V17, P62; Stearns ME, 2003, MOL CANCER RES, V1, P631; Tacke F, 2005, J HEPATOL, V42, P666, DOI 10.1016/j.jhep.2004.12.024; Tietge UJF, 2004, AM J PHYSIOL-ENDOC M, V287, pE82, DOI 10.1152/ajpendo.00494.2003; van der Poorten D, 2013, HEPATOLOGY, V57, P2180, DOI 10.1002/hep.26072; Wang H, 2011, PROTECTING PRIVACY IN CHINA: A RESEARCH ON CHINAS PRIVACY STANDARDS AND THE POSSIBILITY OF ESTABLISHING THE RIGHT TO PRIVACY AND THE INFORMATION PRIVACY PROTECTION LEGISLATION IN MODERN CHINA, P1, DOI 10.1007/978-3-642-21750-0_1; Wang JH, 2009, GASTROENTEROLOGY, V137, P713, DOI 10.1053/j.gastro.2009.04.011; Yoshiji H, 2000, HEPATOLOGY, V32, P1248, DOI 10.1053/jhep.2000.20521; Yoshiji H, 2002, HEPATOLOGY, V36, P850, DOI 10.1053/jhep.2002.35625; Younossi ZM, 2011, OBES SURG, V21, P431, DOI 10.1007/s11695-010-0204-1; ZACHARY I, 1992, CELL, V71, P891, DOI 10.1016/0092-8674(92)90385-P; Zhou XY, 2004, LIVER INT, V24, P492, DOI 10.1111/j.1478-3231.2004.0946.x; Zhou XY, 2004, J BIOL CHEM, V279, P23996, DOI 10.1074/jbc.M311668200	43	40	42	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5533	5542		10.1074/jbc.M114.598011	http://dx.doi.org/10.1074/jbc.M114.598011			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25575598	Green Published, hybrid			2022-12-26	WOS:000350044200025
J	Ermakov, OA; Simonov, E; Surin, VL; Titov, SV; Brandler, OV; Ivanova, NV; Borisenko, AV				Ermakov, Oleg A.; Simonov, Evgeniy; Surin, Vadim L.; Titov, Sergey V.; Brandler, Oleg V.; Ivanova, Natalia V.; Borisenko, Alex V.			Implications of Hybridization, NUMTs, and Overlooked Diversity for DNA Barcoding of Eurasian Ground Squirrels	PLOS ONE			English	Article							SPECIES IDENTIFICATION; MITOCHONDRIAL PSEUDOGENES; MOLECULAR-IDENTIFICATION; MAXIMUM-LIKELIHOOD; SPERMOPHILUS-MAJOR; RIBOSOMAL-RNA; RODENTIA; PHYLOGENY; EVOLUTION; TAXONOMY	The utility of DNA Barcoding for species identification and discovery has catalyzed a concerted effort to build the global reference library; however, many animal groups of economical or conservational importance remain poorly represented. This study aims to contribute DNA barcode records for all ground squirrel species (Xerinae, Sciuridae, Rodentia) inhabiting Eurasia and to test efficiency of this approach for species discrimination. Cytochrome c oxidase subunit 1 (COI) gene sequences were obtained for 97 individuals representing 16 ground squirrel species of which 12 were correctly identified. Taxonomic allocation of some specimens within four species was complicated by geographically restricted mtDNA introgression. Exclusion of individuals with introgressed mtDNA allowed reaching a 91.6% identification success rate. Significant COI divergence (3.5-4.4%) was observed within the most widespread ground squirrel species (Spermophilus erythrogenys, S. pygmaeus, S. suslicus, Urocitellus undulatus), suggesting the presence of cryptic species. A single putative NUMT (nuclear mitochondrial pseudogene) sequence was recovered during molecular analysis; mitochondrial COI from this sample was amplified following re-extraction of DNA. Our data show high discrimination ability of 100 bp COI fragments for Eurasian ground squirrels (84.3%) with no incorrect assessments, underscoring the potential utility of the existing reference librariy for the development of diagnostic 'mini-barcodes'.	[Ermakov, Oleg A.; Titov, Sergey V.] Penza State Univ, Dept Zool & Ecol, Penza, Russia; [Simonov, Evgeniy] Russian Acad Sci, Inst Systemat & Ecol Anim, Siberian Branch, Novosibirsk, Russia; [Simonov, Evgeniy] Tomsk State Univ, Tomsk 634050, Russia; [Surin, Vadim L.] Russian Acad Med Sci, Hematol Res Ctr, Moscow, Russia; [Brandler, Oleg V.] Russian Acad Sci, NK Koltsov Dev Biol Inst, Moscow, Russia; [Ivanova, Natalia V.; Borisenko, Alex V.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	Penza State University; Russian Academy of Sciences; Tomsk State University; Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Russian Academy of Sciences; University of Guelph	Ermakov, OA (corresponding author), Penza State Univ, Dept Zool & Ecol, Penza, Russia.	oaermakov@list.ru	Brandler, Oleg V/R-9535-2017; Surin, Vadim/ABB-5867-2020; Titov, Sergey/P-1744-2015; Borisenko, Alex/GQZ-9054-2022; Borisenko, Alex/G-9107-2014; Simonov, Evgeniy/F-7698-2012; Ermakov, Oleg/S-4634-2019; Titov, Sergey/AAT-8491-2020; Ermakov, Oleg/L-9499-2013	Brandler, Oleg V/0000-0003-0658-9680; Borisenko, Alex/0000-0002-3061-3057; Ermakov, Oleg/0000-0003-1486-6799; Titov, Sergey/0000-0001-9634-1157; Ermakov, Oleg/0000-0003-1486-6799; Simonov, Evgeniy/0000-0003-0194-4487; Surin, V. L./0000-0002-1890-4492				Afonin AN, 2008, INTERACTIVE AGR ECOL; Agadzhanyan A. K., 2006, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V111, P4; Artyushin IV, 2009, ZOOTAXA, P40; Barbosa S, 2013, MOL ECOL RESOUR, V13, P43, DOI 10.1111/1755-0998.12024; Bazanova L. P., 2012, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P115; Bazhanov VS, 1944, DOKL AKAD NAUK SSSR, V12, P321; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bitanyi S, 2011, MOL ECOL RESOUR, V11, P442, DOI 10.1111/j.1755-0998.2011.02980.x; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Brandler OV, 2010, RUSS J GENET+, V46, P283, DOI 10.1134/S102279541003004X; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Chaval Yannick, 2010, Kasetsart Journal Natural Sciences, V44, P590; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Coroiu C, 2008, SPERMOPHILUS CITELLU; Denisov V., 1969, Folia Biologica Krakow, V17, P169; DENISOV V. P., 1963, ZOOL ZHUR, V42, P1887; Eaton MJ, 2010, CONSERV GENET, V11, P1389, DOI 10.1007/s10592-009-9967-0; Enzinger K, 2012, 4 EUR GROUND SQUIRR, P19; Epp LS, 2012, MOL ECOL, V21, P1821, DOI 10.1111/j.1365-294X.2012.05537.x; Ermakov OA, 2006, ZOOL ZH, V85, P1474; Ermakov OA, 2006, RUSS J GENET+, V42, P429, DOI 10.1134/S1022795406040107; Ermakov O. A., 2006, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V111, P30; Ermakov OA, 2002, RUSS J GENET+, V38, P796, DOI 10.1023/A:1016395722664; Ermakov OA, 2011, IZV PENZ GOS PEDAGOG, V25, P176; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Furman A, 2014, ZOOL SCR, V43, P549, DOI 10.1111/zsc.12076; Gromov I.M., 1995, GUIDES RUSSIAN FAUNA, V167, P529; Gromov IG, 1965, GROUND SQUIRRELS MAR, V3; Gunduz I, 2007, MOL PHYLOGENET EVOL, V43, P916, DOI 10.1016/j.ympev.2007.02.021; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harrison Richard G., 2003, Journal of Mammalian Evolution, V10, P249, DOI 10.1023/B:JOMM.0000015105.96065.f0; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Helaers R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-379; Helgen KM, 2009, J MAMMAL, V90, P270, DOI 10.1644/07-MAMM-A-309.1; Herron MD, 2004, MOL PHYLOGENET EVOL, V31, P1015, DOI 10.1016/j.ympev.2003.09.015; Howell A. H., 1938, North American Fauna, Vno. 56, P1, DOI 10.3996/nafa.56.0001; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kapustina SY, 2011, TERIOFAUNA ROSSII I, P197; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Korablev VP, 1997, RARE MAMMAL SPECIES, P50; Koshev Yordan Spasov, 2008, Lynx (Prague), P251; Kruskop SV, 2012, ACTA CHIROPTEROL, V14, P1, DOI 10.3161/150811012X654222; Kucheruk VV, 1977, ADV MODERN THERIOLOG, P75; Lakra WS, 2009, MOL BIOL REP, V36, P831, DOI 10.1007/s11033-008-9252-1; LIAPUNOVA EA, 1970, EXPERIENTIA, V26, P1033, DOI 10.1007/BF02114181; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linetskaya ON, 1989, MODERN APPROACHES ST, P99; Meier R, 2008, NEURAL NETWORKS, V21, P1085, DOI 10.1016/j.neunet.2008.06.019; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Nesi N, 2011, CR BIOL, V334, P544, DOI 10.1016/j.crvi.2011.05.003; Nikolsky AA, 1997, ZOOL ZH, V76, P845; Ozkurt SO, 2007, ZOOTAXA, P1; Ognev SI, 1947, MAMMALS USSR ADJACEN, VV; Oliveira R, 2010, CONSERV GENET, V11, P1023, DOI 10.1007/s10592-009-9947-4; Pages M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-184; Paquin P, 2004, MOL ECOL, V13, P3239, DOI 10.1111/j.1365-294X.2004.02296.x; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A, 2008, FIGTREE V1 4 TREE FI; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Rolo EA, 2013, FORENSIC SCI INT, V228, P160, DOI 10.1016/j.forsciint.2013.02.038; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Shekarova Olga N., 2008, Lynx (Prague), P317; Shilova S. A., 2009, Current Zoology, V55, P81; Sludskiy AA, 1969, MAMMALS KAZACHSTAN R; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Sorenson MD, 1998, AUK, V115, P214, DOI 10.2307/4089130; Spiridonova LN, 2005, RUSS J GENET+, V41, P991, DOI 10.1007/s11177-005-0190-x; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thorington R.W., 2005, MAMMAL SPECIES WORLD; Tokaji K, 2012, 4 EUR GROUND SQUIRR, P17; Tsvirka Marina V., 2012, Vestnik Tomskogo Gosudarstvennogo Universiteta Biologiya, V4, P145; VANDERKUYL AC, 1995, J MOL EVOL, V40, P652, DOI 10.1007/BF00160513; Verzhutsky D.B., 1999, Parazitologiya (St. Petersburg), V33, P242; Vorontsov NN, 1980, GENETICA HAGUE, V52, P229; Zagorodnuk IV, 1995, VESTN ZOOL, V29, P49; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	89	29	33	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117201	10.1371/journal.pone.0117201	http://dx.doi.org/10.1371/journal.pone.0117201			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617768	Green Submitted, Green Published, gold			2022-12-26	WOS:000350336000040
J	Hiyama, Y; Asai, T; Wada, O; Maruno, H; Nitta, S; Mizuno, K; Iwasaki, Y; Okada, S				Hiyama, Yoshinori; Asai, Tsuyoshi; Wada, Osamu; Maruno, Hideto; Nitta, Shingo; Mizuno, Kiyonori; Iwasaki, Yasunobu; Okada, Shuichi			Gait Variability before Surgery and at Discharge in Patients Who Undergo Total Knee Arthroplasty: A Cohort Study	PLOS ONE			English	Article							OLDER-ADULTS; FALLS RISK; REHABILITATION; PAIN; REPLACEMENT; RECOVERY; WOMEN; OSTEOARTHRITIS; RELIABILITY; STRENGTH	This study aimed to determine gait ability at hospital discharge in patients undergoing total knee arthroplasty (TKA) as an indicator of the risk of falling. Fifty-seven patients undergoing primary TKA for knee osteoarthritis participated in this study. Gait variability measured with accelerometers and physical function including knee range of motion (ROM), quadriceps strength, walking speed, and the Timed Up and Go (TUG) test were evaluated preoperatively and at discharge from the hospital (1 month before and 5 days after surgery). All patients were discharged directly home at 5 days after surgery. Knee flexion of ROM, quadriceps strength, walking speed, and the TUG test results were significantly worse at hospital discharge than preoperatively (p < 0.001). However, gait variability was not significantly different before and after TKA. This result indicated that patients following TKA surgery could walk at hospital discharge as stably as preoperatively regardless of the decrease in physical function, including knee ROM, quadriceps strength, and gait speed after surgery.	[Hiyama, Yoshinori; Wada, Osamu; Maruno, Hideto; Nitta, Shingo; Mizuno, Kiyonori; Iwasaki, Yasunobu] Anshin Hosp, Kobe, Hyogo, Japan; [Hiyama, Yoshinori; Okada, Shuichi] Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo 657, Japan; [Asai, Tsuyoshi] Kobegakuin Univ, Fac Rehabil, Dept Phys Therapy, Kobe, Hyogo, Japan	Kobe University; Kobe Gakuin University	Hiyama, Y (corresponding author), Anshin Hosp, Kobe, Hyogo, Japan.	yoshinori.hiyama@gmail.com		Wada, Osamu/0000-0001-6918-3499				BLAKE AJ, 1988, AGE AGEING, V17, P365, DOI 10.1093/ageing/17.6.365; Brach JS, 2007, J GERONTOL A-BIOL, V62, P983, DOI 10.1093/gerona/62.9.983; Brand C, 2005, APLAR J RHEUMATOLOGY, V8, P99, DOI [10.1111/j.1479-8077.2005.00136.x, DOI 10.1111/J.1479-8077.2005.00136.X]; CALLAHAN CM, 1994, JAMA-J AM MED ASSOC, V271, P1349, DOI 10.1001/jama.271.17.1349; Enloe LJ, 1996, J ORTHOP SPORT PHYS, V23, P3, DOI 10.2519/jospt.1996.23.1.3; Foley SJ, 2006, OSTEOARTHR CARTILAGE, V14, P533, DOI 10.1016/j.joca.2005.12.007; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; HAUSDORFF JM, 1995, J BIOMECH, V28, P347, DOI 10.1016/0021-9290(94)00074-E; Hausdorff JM, 2005, EXP BRAIN RES, V164, P541, DOI 10.1007/s00221-005-2280-3; Hausdorff JM, 1997, ARCH PHYS MED REHAB, V78, P278, DOI 10.1016/S0003-9993(97)90034-4; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Herman T, 2005, GAIT POSTURE, V21, P178, DOI 10.1016/j.gaitpost.2004.01.014; Herman T, 2010, J GERONTOL A-BIOL, V65, P1086, DOI 10.1093/gerona/glq077; Kang HG, 2008, GAIT POSTURE, V27, P572, DOI 10.1016/j.gaitpost.2007.07.009; Katoh M, 2009, J PHYS THER SCI, V21, P37, DOI 10.1589/jpts.21.37; Kauppila AM, 2010, CLIN REHABIL, V24, P398, DOI 10.1177/0269215509346089; Kavanagh JJ, 2006, J BIOMECH, V39, P2863, DOI 10.1016/j.jbiomech.2005.09.012; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Lamb SE, 2000, ANN RHEUM DIS, V59, P331, DOI 10.1136/ard.59.5.331; Leveille SG, 2002, J AM GERIATR SOC, V50, P671, DOI 10.1046/j.1532-5415.2002.50161.x; Levinger P, 2011, KNEE SURG SPORT TR A, V19, P1082, DOI 10.1007/s00167-010-1325-8; Lombardi AV, 2006, CLIN ORTHOP RELAT R, P117, DOI 10.1097/01.blo.0000238824.56024.7a; Lord SR, 2003, PHYS THER, V83, P237, DOI 10.1093/ptj/83.3.237; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; MANSKE PR, 1977, PHYS THER, V57, P915, DOI 10.1093/ptj/57.8.915; Matsumoto H, 2012, ARCH ORTHOP TRAUM SU, V132, P555, DOI 10.1007/s00402-011-1418-y; Mizner RL, 2005, J ORTHOP SPORT PHYS, V35, P424, DOI 10.2519/jospt.2005.35.7.424; Munin MC, 1998, JAMA-J AM MED ASSOC, V279, P847, DOI 10.1001/jama.279.11.847; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Reelick MF, 2009, AGE AGEING, V38, P435, DOI 10.1093/ageing/afp066; Reilly KA, 2005, KNEE, V12, P351, DOI 10.1016/j.knee.2005.01.002; Renkawitz T, 2010, CLIN REHABIL, V24, P230, DOI 10.1177/0269215509353267; Labraca NS, 2011, CLIN REHABIL, V25, P557, DOI 10.1177/0269215510393759; Sturnieks DL, 2004, J RHEUMATOL, V31, P2272; Williams SB, 2010, ARCH PHYS MED REHAB, V91, P106, DOI 10.1016/j.apmr.2009.08.150; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; Yeung TSM, 2008, J ORTHOP SPORT PHYS, V38, P410, DOI [10.2519/jospt.2008.2657, 10.519/jospt.2008.2657]	37	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117683	10.1371/journal.pone.0117683	http://dx.doi.org/10.1371/journal.pone.0117683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4PT	25617842	gold, Green Published, Green Submitted			2022-12-26	WOS:000350336000045
J	Shahmanesh, M; Phillips, K; Boothby, M; Tomlinson, JW				Shahmanesh, Mohsen; Phillips, Kenneth; Boothby, Meg; Tomlinson, Jeremy W.			Differential Adipose Tissue Gene Expression Profiles in Abacavir Treated Patients That May Contribute to the Understanding of Cardiovascular Risk: A Microarray Study	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; INTIMA-MEDIA THICKNESS; INDIVIDUAL ANTIRETROVIRAL DRUGS; ENDOTHELIAL ACTIVATION MARKERS; ACUTE MYOCARDIAL-INFARCTION; PLATELET REACTIVITY; ADHERENS JUNCTIONS; INSULIN-RESISTANCE; DISEASE EVENTS; SUPPRESSED HIV	Objective To compare changes in gene expression by microarray from subcutaneous adipose tissue from HIV treatment naive patients treated with efavirenz based regimens containing abacavir (ABC), tenofovir (TDF) or zidovidine (AZT). Design Subcutaneous fat biopsies were obtained before, at 6- and 18-24-months after treatment, and from HIV negative controls. Groups were age, ethnicity, weight, biochemical profile, and pre-treatment CD4 count matched. Microarray data was generated using the Agilent Whole Human Genome Microarray. Identification of differentially expressed genes and genomic response pathways was performed using limma and gene set enrichment analysis. Results There were significant divergences between ABC and the other two groups 6 months after treatment in genes controlling cell adhesion and environmental information processing, with some convergence at 18-24 months. Compared to controls the ABC group, but not AZT or TDF showed enrichment of genes controlling adherence junction, at 6 months and 18-24 months (adjusted p<0.05) and focal adhesions and tight junction at 6 months (p<0.5). Genes controlling leukocyte transendothelial migration (p<0.05) and ECM-receptor interactions (p = 0.04) were over-expressed in ABC compared to TDF and AZT at 6 months but not at 18-24 months. Enrichment of pathways and individual genes controlling cell adhesion and environmental information processing were specifically dysregulated in the ABC group in comparison with other treatments. There was little difference between AZT and TDF. Conclusion After initiating treatment, there is divergence in the expression of genes controlling cell adhesion and environmental information processing between ABC and both TDF and AZT in subcutaneous adipose tissue. If similar changes are also taking place in other tissues including the coronary vasculature they may contribute to the increased risk of cardiovascular events reported in patients recently started on abacavir-containing regimens.	[Shahmanesh, Mohsen] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Phillips, Kenneth] ILS Genom, Morrisville, NC USA; [Boothby, Meg] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Tomlinson, Jeremy W.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England	University of Birmingham; University of Birmingham; University of Oxford	Tomlinson, JW (corresponding author), Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.	jeremy.tomlinson@ocdem.ox.ac.uk	Shahmanesh, Mohsen/B-1183-2013	Shahmanesh, Maryam/0000-0001-7129-8535; Tomlinson, Jeremy/0000-0002-3170-8533	Gilead Sciences; Pharmacia Upjohn; Dupont Pharmaceuticals; Sexually Transmitted Infection Research Foundation; Jo Lee Foundation; Medical Research Council [G0802765] Funding Source: researchfish	Gilead Sciences(Gilead Sciences); Pharmacia Upjohn; Dupont Pharmaceuticals; Sexually Transmitted Infection Research Foundation; Jo Lee Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by an unrestricted educational grant from Gilead Sciences, Pharmacia Upjohn, Dupont Pharmaceuticals, Sexually Transmitted Infection Research Foundation (a UK-based charity, http:/stirf.org) and the Jo Lee Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas JR, 2008, JAIDS-J ACQ IMM DEF, V47, P74, DOI 10.1097/QAI.0b013e31815acab8; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Baum PD, 2011, AIDS, V25, P2243, DOI 10.1097/QAD.0b013e32834d3cc3; Bavinger C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059551; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bedimo RJ, 2011, CLIN INFECT DIS, V53, P84, DOI 10.1093/cid/cir269; Bobryshev YV, 1998, CARDIOVASC RES, V40, P191, DOI 10.1016/S0008-6363(98)00141-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boothby M, 2009, ANTIVIR THER, V14, P1089, DOI 10.3851/IMP1457; Bozzette SA, 2011, CLIN INFECT DIS, V53, P92, DOI 10.1093/cid/cir275; Brothers CH, 2009, JAIDS-J ACQ IMM DEF, V51, P20, DOI 10.1097/QAI.0b013e31819ff0e6; Caron M, 2009, PPAR RES, V2009, DOI 10.1155/2009/507141; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 2003, JAIDS-J ACQ IMM DEF, V34, pS73, DOI 10.1097/00126334-200309011-00011; Choi AI, 2011, AIDS, V25, P1289, DOI 10.1097/QAD.0b013e328347fa16; Cruciani M, 2011, AIDS, V25, P1993, DOI 10.1097/QAD.0b013e328349c6ee; de Gaetano Donati Katleen, 2010, Mediterr J Hematol Infect Dis, V2, pe2010034, DOI 10.4084/MJHID.2010.034; De Pablo C, 2013, J INFECT DIS, V208, P1448, DOI 10.1093/infdis/jit340; De Pablo C, 2010, AIDS, V24, P1259, DOI 10.1097/QAD.0b013e32833a2b02; Donati KD, 2004, LANCET INFECT DIS, V4, P213, DOI 10.1016/S1473-3099(04)00971-5; Durand M, 2011, JAIDS-J ACQ IMM DEF, V57, P245, DOI 10.1097/QAI.0b013e31821d33a5; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Falcinelli E, 2013, THROMB HAEMOSTASIS, V110, P349, DOI 10.1160/TH12-07-0504; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Ford ES, 2010, AIDS, V24, P1509, DOI 10.1097/QAD.0b013e32833ad914; Gentleman R, 2005, BIOINFORMATICS AND C; Giralt M, 2009, PPAR RES, V2009, DOI 10.1155/2009/607902; Hileman CO, 2012, AIDS RES HUM RETROV, V28, P1561, DOI [10.1089/aid.2012.0034, 10.1089/AID.2012.0034]; Hsue PY, 2009, AIDS, V23, P2021, DOI 10.1097/QAD.0b013e32832e7140; Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197; Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Lundgren JD, 2008, AIDS, V22, pF17, DOI 10.1097/QAD.0b013e32830fe35e; Mallon PWG, 2003, AIDS, V17, P971, DOI 10.1097/00002030-200305020-00005; Martin A, 2010, AIDS, V24, P2657, DOI 10.1097/QAD.0b013e32833f147f; Martinez E, 2013, AIDS RES HUM RETROV, V29, P235, DOI [10.1089/aid.2012.0150, 10.1089/AID.2012.0150]; Martinez E, 2010, AIDS, V24, pF1, DOI 10.1097/QAD.0b013e32833562c5; McComsey GA, 2012, AIDS, V26, P1371, DOI 10.1097/QAD.0b013e328354f4fb; McGee KC, 2012, ANTIVIR THER, V17, P495, DOI 10.3851/IMP2017; Obel N, 2010, HIV MED, V11, P130, DOI 10.1111/j.1468-1293.2009.00751.x; Palella FJ, 2010, AIDS, V24, P1657, DOI 10.1097/QAD.0b013e3283389dfa; Resink TJ, 2009, SWISS MED WKLY, V139, P122, DOI smw-12429; Ribaudo HJ, 2011, CLIN INFECT DIS, V52, P929, DOI 10.1093/cid/ciq244; Ross AC, 2010, ATHEROSCLEROSIS, V211, P492, DOI 10.1016/j.atherosclerosis.2010.04.008; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Satchell CS, 2011, J INFECT DIS, V204, P1202, DOI 10.1093/infdis/jir509; Satchell CS, 2010, AIDS, V24, P649, DOI 10.1097/QAD.0b013e328336098c; Servant Nicolas, 2010, BMC Res Notes, V3, P277, DOI 10.1186/1756-0500-3-277; Shlay JC, 2008, JAIDS-J ACQ IMM DEF, V48, P53, DOI 10.1097/QAI.0b013e31816856ed; Smith KY, 2009, AIDS, V23, P1547, DOI 10.1097/QAD.0b013e32832cbcc2; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Tebas P, 2008, JAIDS-J ACQ IMM DEF, V49, pS86, DOI 10.1097/QAI.0b013e31818651e6; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Trevillyan JM, 2013, SEX HEALTH, V10, P97, DOI 10.1071/SH12081; van Vonderen MGA, 2009, J INFECT DIS, V199, P1186, DOI 10.1086/597475; Wohl DA, 2013, COMPARISON OF CARDIO; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897	61	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2015	10	1							e0117164	10.1371/journal.pone.0117164	http://dx.doi.org/10.1371/journal.pone.0117164			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4PT	25617630	Green Submitted, Green Published, gold			2022-12-26	WOS:000350336000039
J	Chen, CY; Huang, KYA; Shen, JH; Tsao, KC; Huang, YC				Chen, Chao-Yu; Huang, Kuan-Ying A.; Shen, Jen-Hsiang; Tsao, Kuo-Chien; Huang, Yhu-Chering			A Large-Scale Seroprevalence of Epstein-Barr Virus in Taiwan	PLOS ONE			English	Article							INFECTIOUS-MONONUCLEOSIS; UNIVERSITY-STUDENTS; RISK-FACTORS; CHILDREN; ANTIBODIES; PREVALENCE; SEX; HERPESVIRUSES; ACQUISITION; POPULATION	Background Epstein-Barr virus (EBV) causes a variety of clinical manifestations from asymptomatic infection to acute infectious mononucleosis in human. Moreover, the EBV infection is associated with malignancies. The large-scale EBV seroepidemiology across all age groups has been lacking in Taiwan. Methods A total of 1411 serum samples were tested to examine the seroprevalence of EBV in 2007. The samples were collected during an island-wide seroepidemiological survey of vaccine preventable diseases in Taiwan. The enzyme-linked immunosorbent assay was performed to detect anti-EBV viral capsid IgG in sera. Demographic and personal health data were obtained by questionnaires. Results The overall weighted seropositive rate of EBV was 88.5% (95% CI, 86.7%-90.1%). The seropositive rate of EBV reached 52.8% (95% CI, 44.0%-61.6%) in children aged 2 years, rapidly rose to 88.7%(95% CI, 79.0%-95.1%) in those aged 5-7 years and 93.0%(95% CI, 83.0%-98.1%) for those aged 14-16 years. Age and higher educational level were associated with the increased EBV seropositive rate. Conclusion In Taiwan, people had the EBV infection early in life. Children under 7 years should be the primary target popution of public health measures in the future.	[Chen, Chao-Yu; Shen, Jen-Hsiang; Tsao, Kuo-Chien; Huang, Yhu-Chering] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chen, Chao-Yu; Huang, Kuan-Ying A.; Shen, Jen-Hsiang; Huang, Yhu-Chering] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Infect Dis, Taoyuan, Taiwan; [Tsao, Kuo-Chien] Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Huang, YC (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	ychuang@cgmh.org.tw	Chen, Chao-Yu/HGE-7352-2022; Shen, Jen-Hsiang/GVS-5543-2022	Chen, Chao-Yu/0000-0003-0302-2347; 	Chang Gung Memorial Hospital [CMRPG470132]; Medical Foundation	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Medical Foundation	This study was support by a grant from Chang Gung Memorial Hospital (CMRPG470132) and partly supported by Medical Foundation in Memory of Dr. Deh-Lin Cheng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-111; Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; Balfour HH, 2013, J INFECT DIS, V208, P1286, DOI 10.1093/infdis/jit321; Balfour HH, 2013, J INFECT DIS, V207, P80, DOI 10.1093/infdis/jis646; Beagley KW, 2003, FEMS IMMUNOL MED MIC, V38, P13, DOI 10.1016/S0928-8244(03)00202-5; BIGGAR RJ, 1981, LANCET, V2, P115; Chen Chih-Jung, 2004, Journal of Microbiology Immunology and Infection, V37, P157; Chen CJ, 2012, VACCINE, V30, P6721, DOI 10.1016/j.vaccine.2012.05.019; Chen CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024440; Cheng Chia-Chi, 2007, Journal of Microbiology Immunology and Infection, V40, P216; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Crawford DH, 2006, CLIN INFECT DIS, V43, P276, DOI 10.1086/505400; Crowcroft NS, 1998, J EPIDEMIOL COMMUN H, V52, P101, DOI 10.1136/jech.52.2.101; Dowd JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064921; EPSTEIN MA, 1985, NATURE, V318, P287, DOI 10.1038/318287a0; Gartner BC, 2003, CLIN DIAGN LAB IMMUN, V10, P78, DOI 10.1128/CDLI.10.1.78-82.2003; GERBER P, 1972, LANCET, V2, P988; Haque T, 1996, J MED VIROL, V48, P17, DOI 10.1002/(SICI)1096-9071(199601)48:1&lt;17::AID-JMV3&gt;3.0.CO;2-O; HEATH CW, 1972, AM J EPIDEMIOL, V95, P46, DOI 10.1093/oxfordjournals.aje.a121369; HENLE G, 1969, J NATL CANCER I, V43, P1147; Hess RD, 2004, J CLIN MICROBIOL, V42, P3381, DOI 10.1128/JCM.42.8.3381-3387.2004; Higgins CD, 2007, J INFECT DIS, V195, P474, DOI 10.1086/510854; HO SPS, 1982, WORLD DEV, V10, P973, DOI 10.1016/0305-750X(82)90036-5; Jenson H, 1999, J INFECT DIS, V179, P1395, DOI 10.1086/314764; Jenson HB, 2011, PEDIATR REV, V32, P375, DOI 10.1542/pir.32-9-375; KANGRO HO, 1994, J MED VIROL, V43, P91, DOI 10.1002/jmv.1890430117; Kimura H, 2001, BLOOD, V98, P280, DOI 10.1182/blood.V98.2.280; LEMON SM, 1977, NATURE, V268, P268, DOI 10.1038/268268a0; Levine N, 2012, ANN EPIDEMIOL, V22, P783, DOI 10.1016/j.annepidem.2012.06.099; Macsween KF, 2010, CLIN INFECT DIS, V50, P699, DOI 10.1086/650456; MILLER G, 1973, NEW ENGL J MED, V288, P229, DOI 10.1056/NEJM197302012880503; Odumade OA, 2011, CLIN MICROBIOL REV, V24, P193, DOI 10.1128/CMR.00044-10; Pancharoen C, 2001, ASIAN PAC J ALLERGY, V19, P135; Rezza G, 2001, EMERG INFECT DIS, V7, P893; Sidorchuk A, 2003, PEDIATR INFECT DIS J, V22, P642, DOI 10.1097/00006454-200307000-00014; Sokal EM, 2007, J INFECT DIS, V196, P1749, DOI 10.1086/523813; SUMAYA CV, 1975, J INFECT DIS, V131, P403, DOI 10.1093/infdis/131.4.403; Svahn A, 2006, J CLIN VIROL, V37, P118, DOI 10.1016/j.jcv.2006.07.012; Takeuchi K, 2006, PATHOL INT, V56, P112, DOI 10.1111/j.1440-1827.2006.01936.x; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Tsai Ming-Han, 2005, Journal of Microbiology Immunology and Infection, V38, P255; Tsai W S, 1989, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V30, P81; UN, 2007, WORLD URB PROSP 2007; VENKITARAMAN AR, 1985, J MED VIROL, V15, P11, DOI 10.1002/jmv.1890150103; WAGNER HJ, 1994, IMMUNOBIOLOGY, V190, P424, DOI 10.1016/S0171-2985(11)80613-3; WANG PS, 1986, J INFECT DIS, V153, P150, DOI 10.1093/infdis/153.1.150; Xiong G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099857	47	31	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0115836	10.1371/journal.pone.0115836	http://dx.doi.org/10.1371/journal.pone.0115836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615611	Green Published, Green Submitted, gold			2022-12-26	WOS:000349122100019
J	Kowalczyk, A; Lukaszewicz, E				Kowalczyk, Artur; Lukaszewicz, Ewa			Simple and Effective Methods of Freezing Capercaillie (Tetrao urogallus L.) Semen	PLOS ONE			English	Article							AVIAN SPERMATOZOA; CRYOPRESERVATION; SPERM; POULTRY; CRYOPROTECTANT; CONSERVATION; FROZEN; FERTILITY; TOLERANCE; CRYOBANK	A continuous decline in the number and range of capercaillie (Tetrao urogallus L.) in many European countries can be observed, mostly due to habitat destruction by human activity, unecological forestry management, and increased density of natural predators. Ex situ in vitro gene banks provide a unique opportunity to preserve the genetic material for future generations. Simple and effective cryopreservation methods for capercaillie semen are discussed. Semen was collected from seven males kept in the Capercaillie Breeding Centre at Forestry Wisla in Poland. Within five minutes after collection, ejaculates were diluted with EK diluent, then divided into two parts, and subjected to two freezing procedures: in pellets and in straws. In fresh semen, ejaculate clearness, viscosity, color and volume, as well as sperm concentration, motility and morphology, were evaluated, while in frozen-thawed semen only motility and morphology of sperm were determined. Fertilizing ability of thawed semen was examined for samples frozen in straws. Significant (P < 0.05) differences between individual males were found in relation to the majority of fresh semen traits: ejaculate volume averaged 102.1 mu L (varying from 49.0 to 205.0); average sperm concentration was 632.5 x 10(6) mL(-1) (178.8-1257.1); percentage of live normal cells varied from 39.2 to 70.3% (58.7% on an average); percentage of motile cells ranged from 76.0 to 85.7%) and motility parameters were male dependent, as well. Both cryopreservation methods had a negative effect on morphology and motility of frozen-thawed semen; however, the straw method yielded 60.7% and the pellet method 42.5% of live cells in total in thawed semen (P < 0.05), while the number of live normal (intact) cells was similar (22.4 and 22.2%, respectively). Egg fertility varied between 77.8 and 91.7% (average 84.4%). Both freezing procedures seem to be effective in obtaining acceptable viability and high fertilizing potency of thawed sperm and can be used to create a gene bank of capercaillie semen.	[Kowalczyk, Artur; Lukaszewicz, Ewa] Wroclaw Univ Environm & Life Sci, Div Poultry Breeding, Inst Anim Breeding, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences	Lukaszewicz, E (corresponding author), Wroclaw Univ Environm & Life Sci, Div Poultry Breeding, Inst Anim Breeding, Wroclaw, Poland.	ewa.lukaszewicz@up.wroc.pl	Kowalczyk, Artur/B-5721-2017; ŁUKASZEWICZ, EWA T./B-4114-2017	Kowalczyk, Artur/0000-0001-7446-0147; ŁUKASZEWICZ, EWA T./0000-0002-9505-0056	National Research Centre [NN 311 081040]; Wroclaw Centre of Biotechnology, program The Leading National Research Centre (KNOW)	National Research Centre(National Research Centre (NRC)); Wroclaw Centre of Biotechnology, program The Leading National Research Centre (KNOW)	This experiment was financially supported by the National Research Centre, Grant NN 311 081040. Publication was supported by Wroclaw Centre of Biotechnology, program The Leading National Research Centre (KNOW) for the years 2014-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanch E, 2014, THERIOGENOLOGY, V81, P1174, DOI 10.1016/j.theriogenology.2014.01.019; Blanco JM, 2009, THERIOGENOLOGY, V71, P200, DOI 10.1016/j.theriogenology.2008.09.019; Blanco JM, 2000, BIOL REPROD, V63, P1164, DOI 10.1095/biolreprod63.4.1164; Blanco JM, 2008, CRYOBIOLOGY, V56, P8, DOI 10.1016/j.cryobiol.2007.09.004; Blanco JM, 2012, ANIM REPROD SCI, V131, P1, DOI 10.1016/j.anireprosci.2012.02.001; Blesbois E, 2007, WORLD POULTRY SCI J, V63, P213, DOI 10.1017/S0043933907001419; Blesbois E, 2008, THERIOGENOLOGY, V69, P252, DOI 10.1016/j.theriogenology.2007.09.019; Blesbois E, 2007, POULTRY SCI, V86, P555, DOI 10.1093/ps/86.3.555; Blesbois E, 2005, REPRODUCTION, V129, P371, DOI 10.1530/rep.1.00454; Blesbois E, 2011, AVIAN BIOL RES, V4, P52, DOI 10.3184/175815511X13069413108523; Chalah T, 1999, CRYOBIOLOGY, V39, P185, DOI 10.1006/cryo.1999.2201; Ciereszko A, 2011, EUR J WILDLIFE RES, V57, P383, DOI 10.1007/s10344-010-0436-3; Gee G.F., 1995, P 1 INT S ART INS PO, P262; KOWALCZYK A, 2012, P 12 INT GROUS S 20; Kowalczyk A, 2008, CRYOLETTERS, V29, P199; Kowalczyk A, 2012, THERIOGENOLOGY, V77, P899, DOI 10.1016/j.theriogenology.2011.09.015; Lukaszewicz E, 2004, ANIM REPROD SCI, V80, P163, DOI 10.1016/S0378-4320(03)00119-2; Lukaszewicz E, 2003, THERIOGENOLOGY, V59, P1627, DOI 10.1016/S0093-691X(02)01209-8; Lukaszewicz E, 2002, THERIOGENOLOGY, V58, P19, DOI 10.1016/S0093-691X(01)00690-2; Lukaszewicz E, 2011, ZOO BIOL, V30, P672, DOI 10.1002/zoo.20367; Lukaszewicz E, 2011, ORNIS FENNICA, V88, P110; Saint Jalme M, 2003, THERIOGENOLOGY, V59, P875, DOI 10.1016/S0093-691X(02)01153-6; Santiago-Moreno J, 2011, POULTRY SCI, V90, P2047, DOI 10.3382/ps.2011-01355; Siudzinska A, 2008, ANIM SCI PAP REP, V26, P331; Storch I, 2007, WILDLIFE BIOL, V13, P5, DOI 10.2981/0909-6396(2007)13[5:CSOGWA]2.0.CO;2; TSELUTIN K, 1995, BRIT POULTRY SCI, V36, P805, DOI 10.1080/00071669508417825; Varadi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062759; Watson PF, 2000, ANIM REPROD SCI, V60, P481, DOI 10.1016/S0378-4320(00)00099-3; Woelders H, 2006, POULTRY SCI, V85, P216, DOI 10.1093/ps/85.2.216; Zaniboni L, 2014, THERIOGENOLOGY, V82, P251, DOI 10.1016/j.theriogenology.2014.04.007	30	21	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116797	10.1371/journal.pone.0116797	http://dx.doi.org/10.1371/journal.pone.0116797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615640	Green Published, gold, Green Submitted			2022-12-26	WOS:000349122100043
J	Vazquez, L; Renton, K				Vazquez, Leopoldo; Renton, Katherine			High Density of Tree-Cavities and Snags in Tropical Dry Forest of Western Mexico Raises Questions for a Latitudinal Gradient	PLOS ONE			English	Article							LILAC-CROWNED PARROT; NESTING BIRDS; ATLANTIC FOREST; PROBOSCIGER-ATERRIMUS; CONSERVATION STATUS; DECIDUOUS FOREST; PALM COCKATOOS; AVAILABILITY; COMMUNITIES; SELECTION	It has been suggested that a latitudinal gradient exists of a low density of snags and high density of naturally-formed tree-cavities in tropical vs. temperate forests, though few cavities may have characteristics suitable for nesting by birds. We determined snag and cavity density, characteristics, and suitability for birds in a tropical dry forest biome of western Mexico, and evaluated whether our data fits the trend of snag and cavity density typically found in tropical moist and wet forests. We established five 0.25-ha transects to survey and measure tree-cavities and snags in each of three vegetation types of deciduous, semi-deciduous, and mono-dominant Piranhea mexicana forest, comprising a total of 3.75 ha. We found a high density of 77 cavities/ha, with 37 cavities suitable for birds/ha, where density, and characteristics of cavities varied significantly among vegetation types. Lowest abundance of cavities occurred in deciduous forest, and these were in smaller trees, at a lower height, and with a narrower entrance diameter. Only 8.6% of cavities were excavated by woodpeckers, and only 11% of cavities were occupied, mainly by arthropods, though 52% of all cavities were unsuitable for birds. We also found a high density of 56 snags/ha, with greatest density in deciduous forest (70 snags/ha), though these were of significantly smaller diameter, and snags of larger diameter were more likely to contain cavities. The Chamela-Cuixmala tropical dry forest had the highest density of snags recorded for any tropical or temperate forest, and while snag density was significantly correlated with mean snag dbh, neither latitude nor mean dbh predicted snag density in ten forest sites. The high spatial aggregation of snag and cavity resources in tropical dry forest may limit their availability, particularly for large-bodied cavity adopters, and highlights the importance of habitat heterogeneity in providing resources for primary and secondary cavity-nesters.	[Vazquez, Leopoldo] Univ Nacl Autonoma Mexico, Inst Biol, Posgrado Ciencia Biol, Mexico City 04510, DF, Mexico; [Renton, Katherine] Univ Nacl Autonoma Mexico, Inst Biol, Estn Biol Chamela, San Patricio Melaque, Jalisco, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Renton, K (corresponding author), Univ Nacl Autonoma Mexico, Inst Biol, Estn Biol Chamela, San Patricio Melaque, Jalisco, Mexico.	krenton@ib.unam.mx			Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) of the Direccion General Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (UNAM) [IN203012]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [83441]; CONACYT at the Posgrado en Ciencias Biologicas, UNAM [220265]	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) of the Direccion General Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (UNAM); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT at the Posgrado en Ciencias Biologicas, UNAM	The study was funded by research grants from the Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT; grant number IN203012 to KR) of the Direccion General Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (UNAM), and Consejo Nacional de Ciencia y Tecnologia (CONACyT; grant number 83441 in collaboration with E. Martinez Meyer). LV was supported by a postgraduate grant from CONACYT (grant number 220265) at the Posgrado en Ciencias Biologicas, UNAM. The Fundacion Ecologica de Cuixmala A.C. provided logistical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken KEH, 2007, J ORNITHOL, V148, pS425, DOI 10.1007/s10336-007-0166-9; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2005, ARBOLES TROPICALES M; Boyle WA, 2008, BIOTROPICA, V40, P241, DOI 10.1111/j.1744-7429.2007.00357.x; BULLOCK SH, 1986, ARCH METEOR GEOPHY B, V36, P297, DOI 10.1007/BF02263135; Cockle K, 2008, ORNITOL NEOTROP, V19, P269; Cockle K, 2011, BIOTROPICA, V43, P228, DOI 10.1111/j.1744-7429.2010.00661.x; Cockle KL, 2012, FOREST ECOL MANAG, V264, P210, DOI 10.1016/j.foreco.2011.10.015; Cockle KL, 2011, FRONT ECOL ENVIRON, V9, P377, DOI 10.1890/110013; Cockle KL, 2010, BIOL CONSERV, V143, P2851, DOI 10.1016/j.biocon.2010.08.002; Escalante P., 1998, DIVERSIDAD BIOL MEXI, P279; Galicia L, 1999, CATENA, V36, P153, DOI 10.1016/S0341-8162(98)00121-0; GENTRY AH, 1982, EVOL BIOL, V15, P1; Gentry Alwyn H., 1995, P146, DOI 10.1017/CBO9780511753398.007; GIBBS JP, 1993, BIOTROPICA, V25, P236, DOI 10.2307/2389188; Heinsohn R, 2003, AUST J ZOOL, V51, P81, DOI 10.1071/ZO02003; Jauregui E, 2003, ATMOSFERA, V16, P193; Koch AJ, 2008, FOREST ECOL MANAG, V255, P3938, DOI 10.1016/j.foreco.2008.03.025; Lesnoff, 2012, AOD ANAL OVERDISPERS; LOTT EJ, 1987, BIOTROPICA, V19, P228, DOI 10.2307/2388340; Lott EJ, 1993, OCCASIONAL PAPERS CA, V148, P1; Maass J. M., 2002, HIST NATURAL CHAMELA, P525; MARTIJENA NE, 1994, J BIOGEOGR, V21, P63, DOI 10.2307/2845604; Martin K, 2004, CONDOR, V106, P5, DOI 10.1650/7482; Martin K, 1999, FOREST ECOL MANAG, V115, P243, DOI 10.1016/S0378-1127(98)00403-4; Masera OR, 1997, CLIMATIC CHANGE, V35, P265, DOI 10.1023/A:1005309908420; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; Miranda A, 1997, DEFORESTACION FRAGME; Monterrubio-Rico TC, 2006, BIOL CONSERV, V128, P67, DOI 10.1016/j.biocon.2005.09.017; MOONEY HA, 1995, SEASONALLY DRY TROPI, P1, DOI DOI 10.1017/CBO9780511753398.001; Murphy S, 2003, J ZOOL, V261, P327, DOI 10.1017/S0952836903004175; Murphy SA, 2007, EMU, V107, P1, DOI 10.1071/MU06012; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pattanavibool A, 1996, J WILDLIFE MANAGE, V60, P67, DOI 10.2307/3802041; Politi N, 2010, FOREST ECOL MANAG, V260, P893, DOI 10.1016/j.foreco.2010.06.009; Politi N, 2009, BIOTROPICA, V41, P354, DOI 10.1111/j.1744-7429.2008.00481.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rayner L, 2011, AUSTRAL ECOL, V36, P252, DOI 10.1111/j.1442-9993.2010.02145.x; Renton K, 2004, CONDOR, V106, P354, DOI 10.1650/7388; Renton K, 2001, CONDOR, V103, P62, DOI 10.1650/0010-5422(2001)103[0062:LCPDAF]2.0.CO;2; Renton K, 1999, WILSON BULL, V111, P488; Rzedowski J., 1978, VEGETACION MEXICO; Salinas-Melgoza A, 2009, CONDOR, V111, P305, DOI 10.1525/cond.2009.090017; Sanchez-Azofeifa GA, 2009, FOREST ECOL MANAG, V258, P907, DOI 10.1016/j.foreco.2008.10.030; Sandoval L, 2006, ORNITOL NEOTROP, V17, P295; Sandoval L, 2009, WILSON J ORNITHOL, V121, P75, DOI 10.1676/07-165.1; SAUNDERS DA, 1984, AUST J ZOOL, V32, P57, DOI 10.1071/ZO9840057; Stojanovic D, 2012, EMU, V112, P350, DOI 10.1071/MU11076; Trejo I, 2000, BIOL CONSERV, V94, P133, DOI 10.1016/S0006-3207(99)00188-3; Watson A, 1970, P167; Wiebe KL, 2011, J FIELD ORNITHOL, V82, P239, DOI 10.1111/j.1557-9263.2011.00327.x; Zar JH, 1999, BIOSTATISTICAL ANAL	53	14	16	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2015	10	1							e0116745	10.1371/journal.pone.0116745	http://dx.doi.org/10.1371/journal.pone.0116745			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7UF	25615612	Green Published, Green Submitted, gold			2022-12-26	WOS:000349122100041
J	Ekizoglu, S; Bulut, P; Karaman, E; Kilic, E; Buyru, N				Ekizoglu, Seda; Bulut, Pelin; Karaman, Emin; Kilic, Erkan; Buyru, Nur			Epigenetic and Genetic Alterations Affect the WWOX Gene in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							GROWTH IN-VITRO; BREAST-CANCER; EXPRESSION; SUPPRESSOR; LUNG; FRA16D; INACTIVATION; RESTORATION; PROGRESSION; REVEALS	Different types of genetic and epigenetic changes are associated with HNSCC. The molecular mechanisms of HNSCC carcinogenesis are still undergoing intensive investigation. WWOX gene expression is altered in many cancers and in a recent work reduced WWOX expression has been associated with miR-134 expression in HNSCC. In this study we investigated the WWOX messenger RNA expression levels in association with the promoter methylation of the WWOX gene and miR-134 expression levels in 80 HNSCC tumor and non-cancerous tissue samples. Our results show that WWOX expression is down-regulated especially in advanced-stage tumor samples or in tumors with SCC. This down-regulation was associated with methylation of the WWOX promoter region but not with miR-134 expression. There was an inverse correlation between the expression level and promoter methylation. We also analyzed whole exons and exon/intron boundries of the WWOX gene by direct sequencing. In our study group we observed 10 different alterations in the coding sequences and 18 different alterations in the non-coding sequences of the WWOX gene in HNSCC tumor samples. These results indicate that the WWOX gene can be functionally inactivated by promoter methylation, epigenetically or by mutations affecting the sequences coding for the enzymatic domain of the gene, functionally. We conclude that inactivation of WWOX gene contributes to the progression of HNSCC.	[Ekizoglu, Seda; Bulut, Pelin; Buyru, Nur] Istanbul Univ, Cerrahpasa Med Fac, Dept Med Biol, Istanbul, Turkey; [Karaman, Emin; Kilic, Erkan] Istanbul Univ, Cerrahpasa Med Fac, Dept Otorhinolaryngol, Istanbul, Turkey	Istanbul University; Istanbul University - Cerrahpasa; Istanbul University; Istanbul University - Cerrahpasa	Buyru, N (corresponding author), Istanbul Univ, Cerrahpasa Med Fac, Dept Med Biol, Istanbul, Turkey.	nbuyru@yahoo.com	Buyru, Nur/D-1810-2019	Buyru, Nur/0000-0002-6920-1455				Abdeen SK, 2011, ONCOGENE, V30, P3900, DOI 10.1038/onc.2011.115; Aldaz CM, 2014, BBA-REV CANCER, V1846, P188, DOI 10.1016/j.bbcan.2014.06.001; Aqeilan RI, 2007, CANCER RES, V67, P5606, DOI 10.1158/0008-5472.CAN-07-1081; Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Aqeilan RI, 2004, CLIN CANCER RES, V10, P3053, DOI 10.1158/1078-0432.CCR-03-0594; Baykara O, 2010, TUMOR BIOL, V31, P315, DOI 10.1007/s13277-010-0039-3; Bednarek AK, 2000, CANCER RES, V60, P2140; Bednarek AK, 2001, CANCER RES, V61, P8068; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Cancemi L, 2011, INT J CANCER, V129, P2816, DOI 10.1002/ijc.25937; Donati V, 2007, CLIN CANCER RES, V13, P884, DOI 10.1158/1078-0432.CCR-06-2016; Ekizoglu S, 2012, MED ONCOL, V29, P1529, DOI 10.1007/s12032-011-0080-0; Fabbri M, 2005, P NATL ACAD SCI USA, V102, P15611, DOI 10.1073/pnas.0505485102; Gale NP, 2005, WHO CLASSIFICATION T, P140; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Guo W, 2013, MOL CARCINOGEN, V52, P265, DOI 10.1002/mc.21853; Guo W, 2013, ENVIRON MOL MUTAGEN, V54, P112, DOI 10.1002/em.21748; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Iliopoulos D, 2005, ONCOGENE, V24, P1625, DOI 10.1038/sj.onc.1208398; Iliopoulos D, 2007, CLIN CANCER RES, V13, P268, DOI 10.1158/1078-0432.CCR-06-2038; Jenner MW, 2007, BLOOD, V110, P3291, DOI 10.1182/blood-2007-02-075069; Kuroki T, 2004, CLIN CANCER RES, V10, P2459, DOI 10.1158/1078-0432.CCR-03-0096; Kuroki T, 2002, CANCER RES, V62, P2258; Liu CJ, 2014, INT J CANCER, V134, P811, DOI 10.1002/ijc.28358; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nunez M, 2005, BREAST CANCER RES TR, V89, P99, DOI 10.1007/s10549-004-1474-x; Nunez MI, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-64; Paige AJW, 2001, P NATL ACAD SCI USA, V98, P11417, DOI 10.1073/pnas.191175898; Pimenta FJ, 2006, INT J CANCER, V118, P1154, DOI 10.1002/ijc.21446; Ramos D, 2008, HISTOPATHOLOGY, V52, P831, DOI 10.1111/j.1365-2559.2008.03033.x; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Yan HC, 2013, BIOMED REP, V1, P375, DOI 10.3892/br.2013.86; Yan HC, 2013, ONCOL LETT, V6, P845, DOI 10.3892/ol.2013.1438	35	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2015	10	1							e0115353	10.1371/journal.pone.0115353	http://dx.doi.org/10.1371/journal.pone.0115353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UU	25612104	Green Published, Green Submitted, gold			2022-12-26	WOS:000348562900008
J	Chen, XQ; Wales, P; Quinti, L; Zuo, FX; Moniot, S; Herisson, F; Rauf, NA; Wang, H; Silverman, RB; Ayata, C; Maxwell, MM; Steegborn, C; Schwarzschild, MA; Outeiro, TF; Kazantsev, AG				Chen, Xiqun; Wales, Pauline; Quinti, Luisa; Zuo, Fuxing; Moniot, Sebastien; Herisson, Fanny; Rauf, Nazifa Abdul; Wang, Hua; Silverman, Richard B.; Ayata, Cenk; Maxwell, Michelle M.; Steegborn, Clemens; Schwarzschild, Michael A.; Outeiro, Tiago F.; Kazantsev, Aleksey G.			The Sirtuin-2 Inhibitor AK7 Is Neuroprotective in Models of Parkinson's Disease but Not Amyotrophic Lateral Sclerosis and Cerebral Ischemia	PLOS ONE			English	Article							MOUSE MODEL; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; SIRT2; DEACETYLASE; PROTEIN; POLYMORPHISM; GENERATION; RS10410544; DESIGN	Sirtuin deacetylases regulate diverse cellular pathways and influence disease processes. Our previous studies identified the brain-enriched sirtuin-2 (SIRT2) deacetylase as a potential drug target to counteract neurodegeneration. In the present study, we characterize SIRT2 inhibition activity of the brain-permeable compound AK7 and examine the efficacy of this small molecule in models of Parkinson's disease, amyotrophic lateral sclerosis and cerebral ischemia. Our results demonstrate that AK7 is neuroprotective in models of Parkinson's disease; it ameliorates alpha-synuclein toxicity in vitro and prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopamine depletion and dopaminergic neuron loss in vivo. The compound does not show beneficial effects in mouse models of amyotrophic lateral sclerosis and cerebral ischemia. These findings underscore the specificity of protective effects observed here in models of Parkinson's disease, and previously in Huntington's disease, and support the development of SIRT2 inhibitors as potential therapeutics for the two neurodegenerative diseases.	[Chen, Xiqun; Quinti, Luisa; Zuo, Fuxing; Herisson, Fanny; Rauf, Nazifa Abdul; Ayata, Cenk; Maxwell, Michelle M.; Schwarzschild, Michael A.; Kazantsev, Aleksey G.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02129 USA; [Wales, Pauline; Outeiro, Tiago F.] Univ Med Ctr Goettingen, Ctr Nanoscale Microscopy & Mol Physiol Brain, Dept NeuroDegenerat & Restorat Res, D-37073 Gottingen, Germany; [Moniot, Sebastien; Steegborn, Clemens] Univ Bayreuth, Dept Biochem, D-95447 Bayreuth, Germany; [Wang, Hua; Silverman, Richard B.] Northwestern Univ, Ctr Mol Innovat & Drug Discovery, Chem Life Proc Inst, Dept Chem,Dept Mol Biosci, Evanston, IL 60208 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Gottingen; University of Bayreuth; Northwestern University	Chen, XQ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02129 USA.	xchen17@mgh.harvard.edu; AKAZANTSEV@mgh.harvard.edu	Outeiro, Tiago/L-7351-2019; Outeiro, Tiago F/C-1067-2008; Outeiro, Tiago/M-8106-2019	Outeiro, Tiago/0000-0003-1679-1727; Outeiro, Tiago F/0000-0003-1679-1727; 	NIH [U01-NS066912]; RJG foundation [2011D004473]; DFG Center of Excellence on Nanoscale Microscopy and Molecular Physiology of the Brain; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS051343, U01NS066912, P01NS055104] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RJG foundation; DFG Center of Excellence on Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the NIH U01-NS066912 (http://grants.nih.gov/grants/funding/ac_search_results.htm?text_curr = u01), RJG foundation 2011D004473 (no website), and DFG Center of Excellence on Nanoscale Microscopy and Molecular Physiology of the Brain (http://grc.unigoettingen.de/89.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beirowski B, 2011, P NATL ACAD SCI USA, V108, pE952, DOI 10.1073/pnas.1104969108; Bobrowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034805; Chen XQ, 2013, P NATL ACAD SCI USA, V110, P300, DOI 10.1073/pnas.1217296110; Chopra V, 2012, CELL REP, V2, P1492, DOI 10.1016/j.celrep.2012.11.001; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Donmez G, 2013, EMBO MOL MED, V5, P344, DOI 10.1002/emmm.201302451; Nguyen GTT, 2013, CHEM BIOL, V20, P1375, DOI 10.1016/j.chembiol.2013.09.019; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Ji SP, 2011, J MOL CELL BIOL, V3, P351, DOI 10.1093/jmcb/mjr009; Kachroo A, 2012, ANN NEUROL, V71, P278, DOI 10.1002/ana.22630; Korner S, 2013, NEURODEGENER DIS, V11, P141, DOI 10.1159/000338048; Lizee G, 2003, HUM GENE THER, V14, P497, DOI 10.1089/104303403764539387; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Luthi-Carter R, 2010, P NATL ACAD SCI USA, V107, P7927, DOI 10.1073/pnas.1002924107; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Maxwell MM, 2011, HUM MOL GENET, V20, P3986, DOI 10.1093/hmg/ddr326; Moniot S, 2013, J STRUCT BIOL, V182, P136, DOI 10.1016/j.jsb.2013.02.012; Narayan N, 2012, NATURE, V492, P199, DOI 10.1038/nature11700; Newton K, 2014, NATURE, V506, pE4, DOI 10.1038/nature13024; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Outeiro TF, 2009, CURR PHARM DESIGN, V15, P3968, DOI 10.2174/138161209789649321; Porcelli S, 2013, J NEURAL TRANSM, V120, P1709, DOI 10.1007/s00702-013-1045-6; Rauh D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3327; Schildknecht S, 2013, ALTEX-ALTERN ANIM EX, V30, P427, DOI 10.14573/altex.2013.4.427; Scholz D, 2011, J NEUROCHEM, V119, P957, DOI 10.1111/j.1471-4159.2011.07255.x; Schutkowski M, 2014, EXPERT OPIN DRUG DIS, V9, P183, DOI 10.1517/17460441.2014.875526; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Spires-Jones TL, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00042; Taes I, 2013, HUM MOL GENET, V22, P1783, DOI 10.1093/hmg/ddt028; Taylor DM, 2008, CELL MOL LIFE SCI, V65, P4000, DOI 10.1007/s00018-008-8357-y; Taylor DM, 2011, ACS CHEM BIOL, V6, P540, DOI 10.1021/cb100376q; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Wei WJ, 2014, NEUROMOL MED, V16, P448, DOI 10.1007/s12017-014-8291-0; Wooley CM, 2005, MUSCLE NERVE, V32, P43, DOI 10.1002/mus.20228; Yamagata K, 2014, STRUCTURE, V22, P345, DOI 10.1016/j.str.2013.12.001	39	83	85	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116919	10.1371/journal.pone.0116919	http://dx.doi.org/10.1371/journal.pone.0116919			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25608039	Green Published, gold, Green Submitted			2022-12-26	WOS:000348205300044
J	Teles, F; da Silva, TM; da Cruz, FP; Honorato, VH; Costa, HD; Barbosa, APF; de Oliveira, SG; Porfirio, Z; Liborio, AB; Borges, RL; Fanelli, C				Teles, Flavio; da Silva, Tarcilo Machado; da Cruz Junior, Francisco Pessoa; Honorato, Vitor Hugo; Costa, Henrique de Oliveira; Fernandes Barbosa, Ana Paula; de Oliveira, Sabrina Gomes; Porfirio, Zenaldo; Liborio, Alexandre Braga; Borges, Raquel Lerner; Fanelli, Camilla			Brazilian Red Propolis Attenuates Hypertension and Renal Damage in 5/6 Renal Ablation Model	PLOS ONE			English	Article							EXPERIMENTAL DIABETIC-NEPHROPATHY; RAT THORACIC AORTA; OXIDATIVE STRESS; REMNANT KIDNEY; GLOMERULAR INJURY; MESANGIAL CELLS; LOSARTAN; INFLAMMATION; FAILURE; RENOPROTECTION	The pathogenic role of inflammation and oxidative stress in chronic kidney disease (CKD) is well known. Anti-inflammatories and antioxidant drugs has demonstrated significant renoprotection in experimental nephropathies. Moreover, the inclusion of natural antioxidants derived from food and herbal extracts (such as polyphenols, curcumin and lycopene) as an adjuvant therapy for slowing CKD progression has been largely tested. Brazilian propolis is a honeybee product, whose anti-inflammatory, antimicrobial and antioxidant effects have been widely shown in models of sepsis, cancer, skin irritation and liver fibrosis. Furthermore, previous studies demonstrated that this compound promotes vasodilation and reduces hypertension. However, potential renoprotective effects of propolis in CKD have never been investigated. The aim of this study was to evaluate the effects of a subtype of Brazilian propolis, the Red Propolis (RP), in the 5/6 renal ablation model (Nx). Adult male Wistar rats underwent Nx and were divided into untreated (Nx) and RP-treated (Nx+RP) groups, after 30 days of surgery; when rats already exhibited marked hypertension and proteinuria. Animals were observed for 90 days from the surgery day, when Nx+RP group showed significant reduction of hypertension, proteinuria, serum creatinine retention, glomerulosclerosis, renal macrophage infiltration and oxidative stress, compared to age-matched untreated Nx rats, which worsened progressively over time. In conclusion, RP treatment attenuated hypertension and structural renal damage in Nx model. Reduction of renal inflammation and oxidative stress could be a plausible mechanism to explain this renoprotection.	[Teles, Flavio; da Silva, Tarcilo Machado; da Cruz Junior, Francisco Pessoa; Honorato, Vitor Hugo; Costa, Henrique de Oliveira; Fernandes Barbosa, Ana Paula; de Oliveira, Sabrina Gomes; Porfirio, Zenaldo] State Univ Hlth Sci, Fac Med, Dept Clin Med, Div Renal, Alagoas, Brazil; [Liborio, Alexandre Braga] Fed Univ, Fac Med, Fortaleza, Ceara, Brazil; [Borges, Raquel Lerner] Univ No Colorado, Sch Sport & Exercise Sci, Greeley, CO 80639 USA; [Fanelli, Camilla] Univ Sao Paulo, Fac Med, Dept Clin Med, Div Renal, Sao Paulo, Brazil	University of Northern Colorado; Universidade de Sao Paulo	Fanelli, C (corresponding author), Univ Sao Paulo, Fac Med, Dept Clin Med, Div Renal, Sao Paulo, Brazil.	camilla.fanelli@usp.br	Fanelli, Camilla/D-6287-2012; de Farias Filho, Flávio Teles/G-9033-2016	Fanelli, Camilla/0000-0003-4425-7708; de Farias Filho, Flávio Teles/0000-0002-6937-5615	Universidade Estadual de Ciencias da Saude de Alagoas	Universidade Estadual de Ciencias da Saude de Alagoas	This study was supported by Universidade Estadual de Ciencias da Saude de Alagoas (http:// www.uncisal.edu.br/) (FT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Salem OM, 2009, PAK J PHARM SCI, V22, P205; Ahn MR, 2004, J AGR FOOD CHEM, V52, P7286, DOI 10.1021/jf048726s; Arias SCA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056215; Banday AA, 2011, HYPERTENSION, V57, P452, DOI 10.1161/HYPERTENSIONAHA.110.162339; Briones AM, 2010, CURR HYPERTENS REP, V12, P135, DOI 10.1007/s11906-010-0100-z; Burdock GA, 1998, FOOD CHEM TOXICOL, V36, P347, DOI 10.1016/S0278-6915(97)00145-2; Cicala C, 2003, LIFE SCI, V73, P73, DOI 10.1016/S0024-3205(03)00235-2; Fanelli C, 2011, HYPERTENSION, V57, P373, DOI 10.1161/HYPERTENSIONAHA.110.167775; Fujihara CK, 1998, AM J PHYSIOL-RENAL, V274, pF573, DOI 10.1152/ajprenal.1998.274.3.F573; Fujihara CK, 2005, KIDNEY INT, V67, P1913, DOI 10.1111/j.1523-1755.2005.00290.x; Fujihara CK, 1998, KIDNEY INT, V54, P1510, DOI 10.1046/j.1523-1755.1998.00138.x; Fujihara CK, 2007, AM J PHYSIOL-RENAL, V292, pF92, DOI 10.1152/ajprenal.00184.2006; Fujihara CK, 2007, AM J PHYSIOL-RENAL, V292, pF1810, DOI 10.1152/ajprenal.00521.2006; Ghosh SS, 2012, AM J PHYSIOL-RENAL, V302, pF439, DOI 10.1152/ajprenal.00356.2010; Goncalves ARR, 2004, AM J PHYSIOL-RENAL, V286, pF945, DOI 10.1152/ajprenal.00238.2003; Grams ME, 2013, AM J KIDNEY DIS, V62, P245, DOI 10.1053/j.ajkd.2013.03.009; GREENAWAY W, 1990, BEE WORLD, V71, P107, DOI 10.1080/0005772X.1990.11099047; Jaimes EA, 1998, KIDNEY INT, V54, P775, DOI 10.1046/j.1523-1755.1998.00068.x; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; KHAYYAL MT, 1993, DRUG EXP CLIN RES, V19, P197; Kitamura H, 2013, ADIPOCYTE, V2, P227, DOI 10.4161/adip.25608; Kliem V, 1996, KIDNEY INT, V49, P666, DOI 10.1038/ki.1996.95; Kubota Yoko, 2004, Clin Exp Pharmacol Physiol, V31 Suppl 2, pS29, DOI 10.1111/j.1440-1681.2004.04113.x; Li YJ, 2005, AM J KIDNEY DIS, V46, DOI 10.1053/j.ajkd.2005.08.028; Lopes AA, 2013, BIOORGAN MED CHEM, V21, P7570, DOI 10.1016/j.bmc.2013.10.044; de Faria JBL, 2011, HYPERTENS RES, V34, P413, DOI 10.1038/hr.2010.263; Maruyama H, 2009, BIOL PHARM BULL, V32, P1244, DOI 10.1248/bpb.32.1244; Mishima S, 2005, BIOL PHARM BULL, V28, P1909, DOI 10.1248/bpb.28.1909; Morello S, 2006, LIFE SCI, V78, P825, DOI 10.1016/j.lfs.2005.05.072; Nagai T, 2003, FOOD CHEM, V80, P29, DOI 10.1016/S0308-8146(02)00231-5; Orsolic N, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-117; Rodriguez-Iturbe B, 2001, KIDNEY INT, V59, P1626, DOI 10.1046/j.1523-1755.2001.0590051626.x; RuizMunoz LM, 1997, NEPHROL DIAL TRANSPL, V12, P456, DOI 10.1093/ndt/12.3.456; Shimizu MHM, 2005, KIDNEY INT, V68, P2208, DOI 10.1111/j.1523-1755.2005.00677.x; Silva BB, 2008, EVID-BASED COMPL ALT, V5, P313, DOI 10.1093/ecam/nem059; SMITH WR, 1989, AM J NEPHROL, V9, P230, DOI 10.1159/000167970; Tain YL, 2007, AM J PHYSIOL-RENAL, V292, pF1404, DOI 10.1152/ajprenal.00260.2006; Teles F, 2009, KIDNEY INT, V75, P72, DOI 10.1038/ki.2008.528; Tohamy AA, 2014, CYTOTECHNOLOGY, V66, P283, DOI 10.1007/s10616-013-9568-0; Toreti VC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/697390; Utimura R, 2003, KIDNEY INT, V63, P209, DOI 10.1046/j.1523-1755.2003.00736.x; Vaziri ND, 2007, J PHARMACOL EXP THER, V323, P85, DOI 10.1124/jpet.107.123638; Vaziri ND, 2003, KIDNEY INT, V63, P179, DOI 10.1046/j.1523-1755.2003.00702.x; VIENET R, 1994, J CARDIOVASC PHARM, V23, pS19, DOI 10.1097/00005344-199400234-00006; Wu LL, 1997, KIDNEY INT, pS221; Yang NS, 1998, NEPHROL DIAL TRANSPL, V13, P1967, DOI 10.1093/ndt/13.8.1967; Zhu W, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq025	47	40	41	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e0116535	10.1371/journal.pone.0116535	http://dx.doi.org/10.1371/journal.pone.0116535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	25607548	Green Published, gold, Green Submitted			2022-12-26	WOS:000348205300028
J	Kamali, A; Price, MA; Lakhi, S; Karita, E; Inambao, M; Sanders, EJ; Anzala, O; Latka, MH; Bekker, LG; Kaleebu, P; Asiki, G; Ssetaala, A; Ruzagira, E; Allen, S; Farmer, P; Hunter, E; Mutua, G; Makkan, H; Tichacek, A; Brill, IK; Fast, P; Stevens, G; Chetty, P; Amornkul, PN; Gilmour, J				Kamali, Anatoli; Price, Matt A.; Lakhi, Shabir; Karita, Etienne; Inambao, Mubiana; Sanders, Eduard J.; Anzala, Omu; Latka, Mary H.; Bekker, Linda-Gail; Kaleebu, Pontiano; Asiki, Gershim; Ssetaala, Ali; Ruzagira, Eugene; Allen, Susan; Farmer, Paul; Hunter, Eric; Mutua, Gaudensia; Makkan, Heeran; Tichacek, Amanda; Brill, Ilene K.; Fast, Pat; Stevens, Gwynn; Chetty, Paramesh; Amornkul, Pauli N.; Gilmour, Jill		IAVI Africa HIV Prevention Partner	Creating an African HIV Clinical Research and Prevention Trials Network: HIV Prevalence, Incidence and Transmission	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; VIRUS ANKARA MVA; NEUTRALIZING ANTIBODIES; DISCORDANT COUPLES; VACCINE; EPIDEMIOLOGY; SAFETY; DNA; IMMUNOGENICITY; SEROCONVERSION	HIV epidemiology informs prevention trial design and program planning. Nine clinical research centers (CRC) in sub-Saharan Africa conducted HIV observational epidemiology studies in populations at risk for HIV infection as part of an HIV prevention and vaccine trial network. Annual HIV incidence ranged from below 2% to above 10% and varied by CRC and risk group, with rates above 5% observed in Zambian men in an HIV-discordant relationship, Ugandan men from Lake Victoria fishing communities, men who have sex with men, and several cohorts of women. HIV incidence tended to fall after the first three months in the study and over calendar time. Among suspected transmission pairs, 28% of HIV infections were not from the reported partner. Volunteers with high incidence were successfully identified and enrolled into large scale cohort studies. Over a quarter of new cases in couples acquired infection from persons other than the suspected transmitting partner.	[Kamali, Anatoli; Price, Matt A.] Uganda Virus Res Inst, Med Res Council, Uganda Res Unit AIDS, Entebbe, Uganda; [Lakhi, Shabir; Karita, Etienne] IAVI, New York, NY USA; [Inambao, Mubiana; Sanders, Eduard J.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Anzala, Omu; Latka, Mary H.] Zambia Emory HIV Res Project, Lusaka, Zambia; [Bekker, Linda-Gail; Kaleebu, Pontiano] Zambia Emory HIV Res Project, Copperbelt, Zambia; [Kaleebu, Pontiano; Asiki, Gershim] Project San Francisco, Kigali, Rwanda; [Ssetaala, Ali; Ruzagira, Eugene] KEMRI, Ctr Geog Med Coast, Kilifi, Kenya; [Ruzagira, Eugene; Allen, Susan] Univ Oxford, Oxford, England; [Allen, Susan; Farmer, Paul] Kenya AIDS Vaccine Inst, Inst Clin Res, Nairobi, Kenya; [Hunter, Eric; Mutua, Gaudensia] Aurum Inst, Rustenburg, South Africa; [Hunter, Eric; Mutua, Gaudensia] Aurum Inst, Johannesburg, South Africa; [Mutua, Gaudensia; Makkan, Heeran; Tichacek, Amanda] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Anzala, Omu; Latka, Mary H.; Bekker, Linda-Gail] Emory Univ, Atlanta, GA 30322 USA; [Latka, Mary H.; Bekker, Linda-Gail] IAVI, Johannesburg, South Africa; [Sanders, Eduard J.; Anzala, Omu] Univ London Imperial Coll Sci Technol & Med, IAVI, Human Immunol Lab, London, England; [Kamali, Anatoli; Price, Matt A.] Univ Alabama Birmingham, Birmingham, AL USA; [Stevens, Gwynn; Chetty, Paramesh] IAVI, UVRI HIV Vaccine Program, Entebbe, Uganda; [Amornkul, Pauli N.; Gilmour, Jill] IAVI, UVRI HIV Vaccine Program, Masaka, Uganda	Uganda Virus Research Institute; International AIDS Vaccine Initiative; University of California System; University of California San Francisco; University of Oxford; University of Cape Town; Emory University; International AIDS Vaccine Initiative; Imperial College London; International AIDS Vaccine Initiative; University of Alabama System; University of Alabama Birmingham; International AIDS Vaccine Initiative; International AIDS Vaccine Initiative	Price, MA (corresponding author), Uganda Virus Res Inst, Med Res Council, Uganda Res Unit AIDS, Entebbe, Uganda.	mprice@iavi.org	Makkan, Heeran/GXI-0465-2022; Price, Matt/AAK-6881-2021; Ssetaala, Ali/AAB-3832-2020; Bekker, Linda-Gail/AAZ-8929-2020; Byabagambi, John/GVU-6682-2022	Price, Matt/0000-0002-2918-1373; Ssetaala, Ali/0000-0003-2156-3024; Byabagambi, John/0000-0002-1456-3387; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Churchyard, Gavin/0000-0002-4269-3699; Makkan, Heeran/0000-0002-4737-7804; Ruzagira, Eugene/0000-0002-7291-1693; Asiki, Gershim/0000-0002-9966-1153	OPEC Fund for International Development (OFID); Rwanda and Zambia, including the Emory CFAR [P30 AI050409, NIH-FIC TW001042, NIH-NIAID R01 AI040951, NIH-NIMH R01 MH066767, NIH-NICHD R01 HD040125, NIH-NIAID R01 AI064060, NIH-NIAID R37 AI51231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, R01AI064060, R37AI051231] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	OPEC Fund for International Development (OFID); Rwanda and Zambia, including the Emory CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	IAVI's work is made possible by generous support from many donors including: the Bill & Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation (NORAD); the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at www.iavi.org This work is made possible by the generous support of the American people through USAID. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. Funding was also provided by the OPEC Fund for International Development (OFID), a development finance institution of the OPEC Member States, established to provide financial support for socio-economic development, particularly for low-income countries. Family Health International (now FHI360) supported some of the cohort study work in Rustenburg, and the European and Developing Countries Clinical Trials Partnership helped fund some of the cohorts in the Ugandan fishing communities. Several grants funded the HIV incidence and early infection studies, particularly in Rwanda and Zambia, including the Emory CFAR: P30 AI050409, NIH-FIC TW001042, NIH-NIAID R01 AI040951, NIH-NIMH R01 MH066767, NIH-NICHD R01 HD040125, NIH-NIAID R01 AI064060, and NIH-NIAID R37 AI51231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2011, J INFECT DIS, V203, P258, DOI 10.1093/infdis/jiq028; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Amornkul PN, 2013, AIDS, V27, P2775, DOI 10.1097/QAD.0000000000000012; Artzrouni M, 2002, AIDS, V16, pW1; Baalwa J, 2013, VIROLOGY, V436, P33, DOI 10.1016/j.virol.2012.10.009; Braunstein SL, 2009, AIDS REV, V11, P140; Brown B, 2011, MEN WHO HAVE SEX MEN; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Centers for Disease Control (CDC), 2007, COUPL HIV COUNS TEST; Chomba E, 2008, JAIDS-J ACQ IMM DEF, V47, P108, DOI 10.1097/QAI.0b013e31815b2d67; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2009, LANCET, V373, P1077, DOI 10.1016/S0140-6736(09)60640-1; Crawford H, 2011, J VIROL, V85, P1384, DOI 10.1128/JVI.01879-10; Curran K, 2012, CURR HIV-AIDS REP, V9, P160, DOI 10.1007/s11904-012-0114-z; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Fast PE, 2010, AIDS, V24, pS50, DOI 10.1097/01.aids.0000390707.58512.5e; Feldblum PJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000626; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; Hara H, 2011, HUM VACCINES, V7, P639, DOI 10.4161/hv.7.6.15408; Hayes R, 2010, AIDS, V24, pS81, DOI 10.1097/01.aids.0000390710.04255.2b; Jaoko W, 2008, VACCINE, V26, P2788, DOI 10.1016/j.vaccine.2008.02.071; Jaoko W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012873; Kamali A, 2002, TROP MED INT HEALTH, V7, P1053, DOI 10.1046/j.1365-3156.2002.00963.x; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429; Lihana RW, 2012, AIDS REV, V14, P83; Lyerla R, 2012, JAIDS-J ACQ IMM DEF, V60, pS57, DOI 10.1097/QAI.0b013e31825d279a; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Ngongo PB, 2012, AIDS CARE, V24, P1277, DOI 10.1080/09540121.2012.656572; Nordling L, 2014, NATURE, V509, P274, DOI 10.1038/509274a; Peters BS, 2007, VACCINE, V25, P2120, DOI 10.1016/j.vaccine.2006.11.016; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Price MA, 2012, JAIDS-J ACQ IMM DEF, V59, P185, DOI 10.1097/QAI.0b013e31823d8693; Roth DL, 2001, INT J STD AIDS, V12, P181, DOI 10.1258/0956462011916992; Ruzagira E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020684; Sanders EJ, 2013, AIDS, V27, P437, DOI 10.1097/QAD.0b013e32835b0f81; Seeley J, 2012, SEX TRANSM DIS, V39, P433, DOI 10.1097/OLQ.0b013e318251555d; Shetty AK, 2013, CURR HIV RES, V11, P81, DOI 10.2174/1570162X11311020002; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; UNAIDS, 2011, WORLD REF DAY 2019 H; *UNAIDS, 2005, UNAIDS REF GROUP EST; Vardas E, 2010, AIDS RES HUM RETROV, V26, P933, DOI 10.1089/aid.2009.0242; Wagner BG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041212; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; World Health Organization, 2012, GUID OR PREEXP PROPH	49	37	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116100	10.1371/journal.pone.0116100	http://dx.doi.org/10.1371/journal.pone.0116100			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602351	Green Submitted, Green Published, gold			2022-12-26	WOS:000348203500019
J	Kant, S; Burch, D; Badenhorst, P; Palanisamy, R; Mason, J; Spangenberg, G				Kant, Surya; Burch, David; Badenhorst, Pieter; Palanisamy, Rajasekaran; Mason, John; Spangenberg, German			Regulated Expression of a Cytokinin Biosynthesis Gene IPT Delays Leaf Senescence and Improves Yield under Rainfed and Irrigated Conditions in Canola (Brassica napus L.)	PLOS ONE			English	Article							ISOPENTENYL TRANSFERASE GENE; TOBACCO PLANTS; DROUGHT TOLERANCE; FOOD SECURITY; WATER-USE; STRESS; PHOTOSYNTHESIS; ARABIDOPSIS; METABOLISM; RESISTANCE	Delay of leaf senescence through genetic modification can potentially improve crop yield, through maintenance of photosynthetically active leaves for a longer period. Plant growth hormones such as cytokinin regulate and delay leaf senescence. Here, the structural gene (IPT) encoding the cytokinin biosynthetic enzyme isopentenyltransferase was fused to a functionally active fragment of the AtMYB32 promoter and was transformed into canola plants. Expression of the AtMYB32xs::IPT gene cassette delayed the leaf senescence in transgenic plants grown under controlled environment conditions and field experiments conducted for a single season at two geographic locations. The transgenic canola plants retained higher chlorophyll levels for an extended period and produced significantly higher seed yield with similar growth and phenology compared to wild type and null control plants under rainfed and irrigated treatments. The yield increase in transgenic plants was in the range of 16% to 23% and 7% to 16% under rainfed and irrigated conditions, respectively, compared to control plants. Most of the seed quality parameters in transgenic plants were similar, and with elevated oleic acid content in all transgenic lines and higher oil content and lower glucosinolate content in one specific transgenic line as compared to control plants. The results suggest that by delaying leaf senescence using the AtMYB32xs:: IPT technology, productivity in crop plants can be improved under water stress and well-watered conditions.	[Kant, Surya; Burch, David] Biosci Res Div, Dept Environm & Primary Ind, Horsham, Vic, Australia; [Badenhorst, Pieter; Palanisamy, Rajasekaran] Dept Environm & Primary Ind, Biosci Res Div, Hamilton, Vic, Australia; [Mason, John; Spangenberg, German] AgriBio, Ctr AgriBiosci, Biosci Res Div, Dept Environm & Primary Ind, Bundoora, Vic, Australia; [Mason, John; Spangenberg, German] La Trobe Univ, Bundoora, Vic, Australia	La Trobe University; La Trobe University	Spangenberg, G (corresponding author), AgriBio, Ctr AgriBiosci, Biosci Res Div, Dept Environm & Primary Ind, Bundoora, Vic, Australia.	german.spangenberg@depi.vic.gov.au		Badenhorst, Pieter/0000-0001-5155-8889; Kant, Surya/0000-0001-6178-7036	Victorian Department of Primary Industries	Victorian Department of Primary Industries	This work was supported by funding from the Victorian Department of Primary Industries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum A, 2009, FIELD CROP RES, V112, P119, DOI 10.1016/j.fcr.2009.03.009; Chang HS, 2003, PLANT PHYSIOL, V132, P2174, DOI 10.1104/pp.103.023945; Cowan AK, 2005, PLANTA, V221, P801, DOI 10.1007/s00425-005-1489-5; Faiss M, 1997, PLANT J, V12, P401, DOI 10.1046/j.1365-313X.1997.12020401.x; GAMON JA, 1995, ECOL APPL, V5, P28, DOI 10.2307/1942049; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; Gan SS, 1996, BIOESSAYS, V18, P557, DOI 10.1002/bies.950180707; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Haberer G, 2002, PLANT PHYSIOL, V128, P354, DOI 10.1104/pp.010773; Jordi W, 2000, PLANT CELL ENVIRON, V23, P279, DOI 10.1046/j.1365-3040.2000.00544.x; Kuppu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064190; LI Y, 1992, DEV BIOL, V153, P386, DOI 10.1016/0012-1606(92)90123-X; Lin YH, 2003, PLANT SCI, V165, P1437, DOI 10.1016/j.plantsci.2003.08.011; LIU XY, 1994, J TEXTURE STUD, V25, P179, DOI 10.1111/j.1745-4603.1994.tb01325.x; Loven KV, 1993, J EXP BOT, V44, P1671; McCabe MS, 2001, PLANT PHYSIOL, V127, P505, DOI 10.1104/pp.010244; MEDFORD JI, 1989, PLANT CELL, V1, P403, DOI 10.1105/tpc.1.4.403; Merewitz EB, 2011, J EXP BOT, V62, P383, DOI 10.1093/jxb/erq285; MILLER CO, 1956, J AM CHEM SOC, V78, P1375, DOI 10.1021/ja01588a032; Peleg Z, 2011, PLANT BIOTECHNOL J, V9, P747, DOI 10.1111/j.1467-7652.2010.00584.x; Qin H, 2011, PLANT CELL PHYSIOL, V52, P1904, DOI 10.1093/pcp/pcr125; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Rivero RM, 2010, PLANT CELL PHYSIOL, V51, P1929, DOI 10.1093/pcp/pcq143; Rivero RM, 2009, PLANT PHYSIOL, V150, P1530, DOI 10.1104/pp.109.139378; Robson PRH, 2004, PLANT BIOTECHNOL J, V2, P101, DOI 10.1046/j.1467-7652.2004.00054.x; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Schoor S, 2011, PLANT PHYSIOL, V157, P659, DOI 10.1104/pp.111.181560; SMIGOCKI AC, 1988, P NATL ACAD SCI USA, V85, P5131, DOI 10.1073/pnas.85.14.5131; SMIGOCKI AC, 1989, PLANT PHYSIOL, V91, P808, DOI 10.1104/pp.91.3.808; Sykorova B, 2008, J EXP BOT, V59, P377, DOI 10.1093/jxb/erm319; Wang R, 2007, PLANT BREEDING, V126, P588, DOI 10.1111/j.1439-0523.2007.01382.x; Zhang P, 2010, J INTEGR PLANT BIOL, V52, P653, DOI 10.1111/j.1744-7909.2010.00956.x	32	47	49	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0116349	10.1371/journal.pone.0116349	http://dx.doi.org/10.1371/journal.pone.0116349			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25602960	Green Published, gold			2022-12-26	WOS:000348203500023
J	Malhotra, R; Burke, MF; Martyn, T; Shakartzi, HR; Thayer, TE; O'Rourke, C; Li, PC; Derwall, M; Spagnolli, E; Kolodziej, SA; Hoeft, K; Mayeur, C; Jiramongkolchai, P; Kumar, R; Buys, ES; Yu, PB; Bloch, KD; Bloch, DB				Malhotra, Rajeev; Burke, Megan F.; Martyn, Trejeeve; Shakartzi, Hannah R.; Thayer, Timothy E.; O'Rourke, Caitlin; Li, Pingcheng; Derwall, Matthias; Spagnolli, Ester; Kolodziej, Starsha A.; Hoeft, Konrad; Mayeur, Claire; Jiramongkolchai, Pawina; Kumar, Ravindra; Buys, Emmanuel S.; Yu, Paul B.; Bloch, Kenneth D.; Bloch, Donald B.			Inhibition of Bone Morphogenetic Protein Signal Transduction Prevents the Medial Vascular Calcification Associated with Matrix Gla Protein Deficiency	PLOS ONE			English	Article							CORONARY-ARTERY CALCIFICATION; SMOOTH-MUSCLE-CELLS; IN-VIVO; MOLECULAR-MECHANISMS; VULNERABLE PLAQUE; ENDOTHELIAL-CELLS; KEUTEL-SYNDROME; ATHEROSCLEROSIS; RUNX2; HYDROXYAPATITE	Objective Matrix Gla protein (MGP) is reported to inhibit bone morphogenetic protein (BMP) signal transduction. MGP deficiency is associated with medial calcification of the arterial wall, in a process that involves both osteogenic transdifferentiation of vascular smooth muscle cells (VSMCs) and mesenchymal transition of endothelial cells (EndMT). In this study, we investigated the contribution of BMP signal transduction to the medial calcification that develops in MGP-deficient mice. Approach and Results MGP-deficient mice (MGP(-/-)) were treated with one of two BMP signaling inhibitors, LDN-193189 or ALK3-Fc, beginning one day after birth. Aortic calcification was assessed in 28-day-old mice by measuring the uptake of a fluorescent bisphosphonate probe and by staining tissue sections with Alizarin red. Aortic calcification was 80% less in MGP(-/-) mice treated with LDN-193189 or ALK3-Fc compared with vehicle-treated control animals (P < 0.001 for both). LDN-193189-treated MGP(-/-) mice survived longer than vehicle-treated MGP(-/-) mice. Levels of phosphorylated Smad1/5 and Id1 mRNA (markers of BMP signaling) did not differ in the aortas from MGP(-/-) and wild-type mice. Markers of EndMT and osteogenesis were increased in MGP(-/-) aortas, an effect that was prevented by LDN-193189. Calcification of isolated VSMCs was also inhibited by LDN-193189. Conclusions Inhibition of BMP signaling leads to reduced vascular calcification and improved survival in MGP(-/-) mice. The EndMT and osteogenic transdifferentiation associated with MGP deficiency is dependent upon BMP signaling. These results suggest that BMP signal transduction has critical roles in the development of vascular calcification in MGP-deficient mice.	[Malhotra, Rajeev; Burke, Megan F.; Thayer, Timothy E.; Bloch, Kenneth D.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02115 USA; [Malhotra, Rajeev; Burke, Megan F.; Thayer, Timothy E.; Bloch, Kenneth D.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Cardiol,Dept Med, Boston, MA 02115 USA; [Martyn, Trejeeve; Shakartzi, Hannah R.; O'Rourke, Caitlin; Li, Pingcheng; Derwall, Matthias; Spagnolli, Ester; Kolodziej, Starsha A.; Hoeft, Konrad; Mayeur, Claire; Jiramongkolchai, Pawina; Buys, Emmanuel S.; Bloch, Kenneth D.; Bloch, Donald B.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Anesthesia Ctr Crit Care Res,Dept Anesthesia Crit, Boston, MA 02115 USA; [Derwall, Matthias] Rhein Westfal TH Aachen, Uniklin Aachen, Dept Anesthesiol, Aachen, Germany; [Kumar, Ravindra] Acceleron Pharma Inc, Cambridge, MA USA; [Yu, Paul B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Bloch, Donald B.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02115 USA; [Bloch, Donald B.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol,Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Acceleron Pharma; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Malhotra, R (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02115 USA.	rmalhotra@partners.org	Thayer, Timothy/AAG-5285-2021; Yu, Paul B./J-7540-2019	Yu, Paul B./0000-0003-2145-4944; Bloch, Donald/0000-0002-6828-4754; Malhotra, Rajeev/0000-0003-0120-4630	American Heart Association [11FTF7290032]; National Heart, Lung, and Blood Institute [K08HL111210]; Howard Hughes Medical Institute; Sarnoff Cardiovascular Research Foundation; START-Program of the Faculty of Medicine at RWTH Aachen (MD); Leducq Foundation; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR057374]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK082971]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007208, K08HL111210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082971] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sarnoff Cardiovascular Research Foundation; START-Program of the Faculty of Medicine at RWTH Aachen (MD); Leducq Foundation(Leducq Foundation); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Heart Association Fellow-to-Faculty Award # 11FTF7290032 (RM); the National Heart, Lung, and Blood Institute (K08HL111210, RM); the Howard Hughes Medical Institute (TM and PJ); the Sarnoff Cardiovascular Research Foundation (MFB and TET); the START-Program of the Faculty of Medicine at RWTH Aachen (MD); the Leducq Foundation (Multidisciplinary Program to Elucidate the Role of Bone Morphogenetic Protein Signaling in the Pathogenesis of Pulmonary and Systemic Vascular Diseases, PBY and KDB); the National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR057374, PBY); and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK082971, KDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Aikawa E, 2007, CIRCULATION, V115, P377, DOI 10.1161/CIRCULATIONAHA.106.654913; Amann K, 2008, CLIN J AM SOC NEPHRO, V3, P1599, DOI 10.2215/CJN.02120508; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; Cassidy-Bushrow AE, 2013, ARTERIOSCL THROM VAS, V33, P645, DOI 10.1161/ATVBAHA.112.300491; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Crosier MD, 2009, J NUTR SCI VITAMINOL, V55, P59, DOI 10.3177/jnsv.55.59; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Derwall M, 2012, ARTERIOSCL THROM VAS, V32, P613, DOI 10.1161/ATVBAHA.111.242594; Goiko M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080344; Hedin Ulf, 1999, Thrombosis and Haemostasis, V82, P23; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Huang H, 2001, CIRCULATION, V103, P1051, DOI 10.1161/01.CIR.103.8.1051; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; KEUTEL J, 1971, DEUT MED WOCHENSCHR, V96, P1676, DOI 10.1055/s-0028-1110200; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lomashvili KA, 2011, J BIOL CHEM, V286, P28715, DOI 10.1074/jbc.M111.251462; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Meier M, 2001, EUR RESPIR J, V17, P566, DOI 10.1183/09031936.01.17305660; Munroe PB, 1999, NAT GENET, V21, P142, DOI 10.1038/5102; Nakagawa Y, 2010, ARTERIOSCL THROM VAS, V30, P1908, DOI 10.1161/ATVBAHA.110.206185; O'Young J, 2011, J AM CHEM SOC, V133, P18406, DOI 10.1021/ja207628k; Otsuka F, 2014, ARTERIOSCL THROM VAS, V34, P724, DOI 10.1161/ATVBAHA.113.302642; Proudfoot D, 2006, NEPHROLOGY, V11, P455, DOI 10.1111/j.1440-1797.2006.00660.x; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; Roy ME, 2002, BONE, V31, P296, DOI 10.1016/S8756-3282(02)00821-9; Rusanescu G, 2008, CURR CARDIOL REV, V4, P148, DOI 10.2174/157340308785160552; Sage AP, 2010, NAT REV CARDIOL, V7, P528, DOI 10.1038/nrcardio.2010.115; Schurgers LJ, 2013, TRENDS MOL MED, V19, P217, DOI 10.1016/j.molmed.2012.12.008; Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20; Speer MY, 2010, J CELL BIOCHEM, V110, P935, DOI 10.1002/jcb.22607; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Speer MY, 2002, J EXP MED, V196, P1047, DOI 10.1084/jem.20020911; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Sun Y, 2012, CIRC RES, V111, P543, DOI 10.1161/CIRCRESAHA.112.267237; Vattikuti R, 2004, AM J PHYSIOL-ENDOC M, V286, pE686, DOI 10.1152/ajpendo.00552.2003; Vengrenyuk Y, 2006, P NATL ACAD SCI USA, V103, P14678, DOI 10.1073/pnas.0606310103; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Wallin R, 2000, THROMB HAEMOSTASIS, V84, P1039; Yagami K, 1999, J CELL BIOL, V147, P1097, DOI 10.1083/jcb.147.5.1097; Yao YC, 2006, J BIOL CHEM, V281, P33921, DOI 10.1074/jbc.M604239200; Yao YC, 2013, CIRC RES, V113, P495, DOI 10.1161/CIRCRESAHA.113.301792; Yao YC, 2010, CIRC RES, V107, P485, DOI 10.1161/CIRCRESAHA.110.219071; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200; Zebboudj AF, 2003, J CELL BIOCHEM, V90, P756, DOI 10.1002/jcb.10669	54	51	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0117098	10.1371/journal.pone.0117098	http://dx.doi.org/10.1371/journal.pone.0117098			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	25603410	Green Submitted, Green Published, gold			2022-12-26	WOS:000348203500042
J	Capdevila-Busquets, E; Badiola, N; Arroyo, R; Alcalde, V; Soler-Lopez, M; Aloy, P				Capdevila-Busquets, Eva; Badiola, Nahuai; Arroyo, Rodrigo; Alcalde, Vctor; Soler-Lopez, Montserrat; Aloy, Patrick			Breast Cancer Genes PSMC3IP and EPSTI1 Play a Role in Apoptosis Regulation	PLOS ONE			English	Article							EPITHELIAL-STROMAL INTERACTION; POLY(ADP-RIBOSE) POLYMERASE; DNA FRAGMENTATION; CELL-LINES; INHIBITION; PROTEIN; IDENTIFICATION; MOUSE; EXPRESSION; INDUCTION	A key element to delineate the biology of individual tumors is the regulation of apoptosis. In this work, we functionally characterize two breast cancer associated genes, the proteasome 26S subunit ATPase 3 interacting protein (PSMC3IP) and the epithelial-stromal interaction 1 (EPSTI1), to explore their potential apoptotic role in breast cancer. We first explore the existence of direct physical interactions with annotated BC-apoptotic genes. Based on the generated interaction network, we examine several apoptotic markers to determine the effect of PSMC3IP and EPSTI1 gene expression modulation in two different human breast cancer cell lines to suggest potential molecular mechanisms to unveil their role in the disease. Our results show that PSMC3IP and EPSTI1 are able to modulate the extrinsic apoptotic pathway in estrogen receptor positive and triple negative breast cancer cell lines, highlighting them as potential therapeutic targets.	[Capdevila-Busquets, Eva; Badiola, Nahuai; Arroyo, Rodrigo; Alcalde, Vctor; Soler-Lopez, Montserrat; Aloy, Patrick] Inst Res Biomed IRB Barcelona, Joint IRB BSC CRG Program Computat Biol, Barcelona, Catalonia, Spain; [Aloy, Patrick] ICREA, Barcelona, Catalonia, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Aloy, P (corresponding author), Inst Res Biomed IRB Barcelona, Joint IRB BSC CRG Program Computat Biol, Barcelona, Catalonia, Spain.	patrick.aloy@irbbarcelona.org	Aloy, Patrick/AAB-3538-2019	Aloy, Patrick/0000-0002-3557-0236; Arroyo, Rodrigo/0000-0003-3540-1173; Alcalde Adell, Victor/0000-0002-7868-2983	Spanish Ministerio de Ciencia e Innovacion [BIO2010-22073]; FPI fellowship; ICREA Funding Source: Custom	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FPI fellowship(Spanish Government); ICREA(ICREA)	This work was partially supported by the Spanish Ministerio de Ciencia e Innovacion (BIO2010-22073). EC-B is a recipient of an FPI fellowship.	Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Buess M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r191; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Collins JA, 1997, J HISTOCHEM CYTOCHEM, V45, P923, DOI 10.1177/002215549704500702; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Neergaard M, 2010, AM J PATHOL, V176, P1229, DOI 10.2353/ajpath.2010.090648; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; GONG JP, 1994, ANAL BIOCHEM, V218, P314, DOI 10.1006/abio.1994.1184; Gudjonsson T, 2003, METHODS, V30, P247, DOI 10.1016/S1046-2023(03)00031-8; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hastak K, 2010, CANCER RES, V70, P7970, DOI 10.1158/0008-5472.CAN-09-4521; Ibrahim YH, 2012, CANCER DISCOV, V2, P1036, DOI 10.1158/2159-8290.CD-11-0348; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Ko L, 2002, MOL CELL BIOL, V22, P357, DOI 10.1128/MCB.22.1.357-369.2002; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lenferink AEG, 2001, CANCER RES, V61, P6583; Li T, 2013, ONCOGENE; Liang F, 2004, NUCLEIC ACIDS RES, V32, pD595, DOI 10.1093/nar/gkh118; Lobenhofer EK, 2000, CELL GROWTH DIFFER, V11, P99; Lord CJ, 2006, CLIN CANCER RES, V12, P4463, DOI 10.1158/1078-0432.CCR-06-1269; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Nielsen HL, 2002, GENOMICS, V79, P703, DOI 10.1006/geno.2002.6755; Nugoli M, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-13; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Peng Min, 2013, Genes Cancer, V4, P15, DOI 10.1177/1947601913486344; Petukhova GV, 2003, DEV CELL, V5, P927, DOI 10.1016/S1534-5807(03)00369-1; Rahman M, 2009, BREAST CANCER RES TR, V113, P217, DOI 10.1007/s10549-008-9924-5; ROMMENS JM, 1995, GENOMICS, V28, P530, DOI 10.1006/geno.1995.1185; Satoh T, 2009, ENDOCRINOLOGY, V150, P3283, DOI 10.1210/en.2008-1122; Sircoulomb F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-539; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; Tsai EM, 2001, CANCER RES, V61, P8390; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; van Agthoven T, 1998, EMBO J, V17, P2799, DOI 10.1093/emboj/17.10.2799; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Xu J, 2007, CANCER RES, V67, P1203, DOI 10.1158/0008-5472.CAN-06-2310; Xu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010226; Yang HY, 2001, ONCOGENE, V20, P3695, DOI 10.1038/sj.onc.1204472; Yang KM, 2013, CANCER RES, V73, P6679, DOI 10.1158/0008-5472.CAN-13-0891; Zanzoni A, 2009, FEBS LETT, V583, P1759, DOI 10.1016/j.febslet.2009.03.001; Zhang QB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009712	48	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2015	10	1							e0115352	10.1371/journal.pone.0115352	http://dx.doi.org/10.1371/journal.pone.0115352			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HN	25590583	Green Submitted, gold, Green Published			2022-12-26	WOS:000350679400007
J	Corte, L; Tiecco, M; Roscini, L; De Vincenzi, S; Colabella, C; Germani, R; Tascini, C; Cardinali, G				Corte, Laura; Tiecco, Matteo; Roscini, Luca; De Vincenzi, Sergio; Colabella, Claudia; Germani, Raimondo; Tascini, Carlo; Cardinali, Gianluigi			FTIR Metabolomic Fingerprint Reveals Different Modes of Action Exerted by Structural Variants of N-Alkyltropinium Bromide Surfactants on Escherichia coli and Listeria innocua Cells	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; INHIBITORY-ACTIVITY; CANDIDA-ALBICANS; STRESS-RESPONSE; MICROSPECTROSCOPY; IDENTIFICATION; ANTIFUNGAL; YEASTS; WATER; TOOL	Surfactants are extremely important agents to clean and sanitize various environments. Their biocidal activity is a key factor determined by the interactions between amphiphile structure and the target microbial cells. The object of this study was to analyze the interactions between four structural variants of N-alkyltropinium bromide surfactants with the Gram negative Escherichia coli and the Gram positive Listeria innocua bacteria. Microbiological and conductometric methods with a previously described FTIR bioassay were used to assess the metabolomic damage exerted by these compounds. All surfactants tested showed more biocidal activity in L. innocua than in E. coli. N-tetradecyltropinium bromide was the most effective compound against both species, while all the other variants had a reduced efficacy as biocides, mainly against E. coli cells. In general, the most prominent metabolomic response was observed for the constituents of the cell envelope in the fatty acids (W1) and amides (W2) regions and at the wavenumbers referred to peptidoglycan (W2 and W3 regions). This response was particularly strong and negative in L. innocua, when cells were challenged by N-tetradecyltropinium bromide, and by the variant with a smaller head and a 12C tail (N-dodecylquinuclidinium bromide). Tail length was critical for microbial inhibition especially when acting against E. coli, maybe due the complex nature of Gram negative cell envelope. Statistical analysis allowed us to correlate the induced mortality with the metabolomic cell response, highlighting two different modes of action. In general, gaining insights in the interactions between fine structural properties of surfactants and the microbial diversity can allow tailoring these compounds for the various operative conditions.	[Corte, Laura; Roscini, Luca; De Vincenzi, Sergio; Colabella, Claudia; Cardinali, Gianluigi] Univ Perugia, Dept Pharmaceut Sci Microbiol, I-06121 Perugia, Italy; [Tiecco, Matteo; Germani, Raimondo; Cardinali, Gianluigi] Univ Perugia, Dept Chem Biol & Biotechnol, Ctr Excellence Nanostruct Innovat Mat, CEMIN, I-06123 Perugia, Italy; [Tascini, Carlo] Univ Pisana, Azienda Osped, UO Malattie Infett, I-56100 Pisa, Italy	University of Perugia; University of Perugia; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Corte, L (corresponding author), Univ Perugia, Dept Pharmaceut Sci Microbiol, Borgo XX Giugno 74, I-06121 Perugia, Italy.	laura.corte@unipg.it	Germani, Raimondo/E-7707-2014; Roscini, Luca/B-8804-2011; Corte, Laura/I-5498-2012; Tascini, Carlo/L-5942-2017; Germani, Raimondo/GMX-0960-2022; Tiecco, Matteo/K-8855-2014	Germani, Raimondo/0000-0001-7076-7475; Roscini, Luca/0000-0003-3706-9936; Corte, Laura/0000-0002-4723-7254; Tascini, Carlo/0000-0001-9625-6024; Germani, Raimondo/0000-0001-7076-7475; Tiecco, Matteo/0000-0002-1867-421X; Colabella, Claudia/0000-0002-2156-4150	ESF "Competitiveness and Employment objective" Umbrian Regional Operational Programme (ROP); project of the Bavicchi company [598/94 - Umbria Region]; FCR [2013.0043.021]; "Green chemistry cluster" project	ESF "Competitiveness and Employment objective" Umbrian Regional Operational Programme (ROP); project of the Bavicchi company; FCR; "Green chemistry cluster" project	MT was supported by 2007-2013 ESF "Competitiveness and Employment objective" Umbrian Regional Operational Programme (ROP), and partially supported by a project of the Bavicchi company (598/94 - Umbria Region). The project was partially supported by the FCR grant 2013.0043.021. The work was partially supported by the "Green chemistry cluster" project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adt I, 2006, ARCH MICROBIOL, V185, P277, DOI 10.1007/s00203-006-0094-8; Bellisola G, 2012, AM J CANCER RES, V2, P1; Breyton C, 2010, METHODS MOL BIOL, V601, P219, DOI 10.1007/978-1-60761-344-2_14; CABRAL JPS, 1992, CAN J MICROBIOL, V38, P115, DOI 10.1139/m92-019; Cao J, 2013, INT J MOL SCI, V14, P17453, DOI 10.3390/ijms140917453; Chaveriat L, 2013, EUR J MED CHEM, V62, P177, DOI 10.1016/j.ejmech.2012.12.032; Cheng J, 2011, ANAL CHIM ACTA, V701, P86, DOI 10.1016/j.aca.2011.04.058; Cornellas A, 2011, J COLLOID INTERF SCI, V355, P164, DOI 10.1016/j.jcis.2010.11.063; Corte L, 2014, COLLOID SURFACE B, V116, P761, DOI 10.1016/j.colsurfb.2014.01.054; Corte L, 2014, J SCI FOOD AGR, V94, P235, DOI 10.1002/jsfa.6239; Corte L, 2012, FOOD CHEM, V134, P1327, DOI 10.1016/j.foodchem.2012.03.025; Corte L, 2011, ANALYST, V136, P2339, DOI 10.1039/c0an00515k; Corte L, 2010, ANAL CHIM ACTA, V659, P258, DOI 10.1016/j.aca.2009.11.035; Del Bove M, 2009, FOOD MICROBIOL, V26, P453, DOI 10.1016/j.fm.2009.03.009; Essendoubi M, 2005, BBA-GEN SUBJECTS, V1724, P239, DOI 10.1016/j.bbagen.2005.04.019; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323; Fernandez MV, 2014, FOOD BIOPROCESS TECH, V7, P2528, DOI 10.1007/s11947-013-1243-0; Hagan EWS, 2010, PROG ORG COAT, V69, P73, DOI 10.1016/j.porgcoat.2010.05.008; Hamouda T, 2000, J APPL MICROBIOL, V89, P397, DOI 10.1046/j.1365-2672.2000.01127.x; Huang WE, 2006, J MICROBIOL METH, V67, P273, DOI 10.1016/j.mimet.2006.04.009; Jarudilokkul S, 2000, BIOSEPARATION, V9, P81, DOI 10.1023/A:1008183828223; Kamnev AA, 2008, MICROB ECOL, V56, P615, DOI 10.1007/s00248-008-9381-z; Kamnev AA, 2008, SPECTROSC-INT J, V22, P83, DOI 10.1155/2008/862085; Kubo I, 2002, J AGR FOOD CHEM, V50, P3992, DOI 10.1021/jf020088v; Kugler R, 2005, MICROBIOL-SGM, V151, P1341, DOI 10.1099/mic.0.27526-0; Kummerle M, 1998, APPL ENVIRON MICROB, V64, P2207; Maillard JY, 2002, J APPL MICROBIOL, V92, p16S, DOI 10.1046/j.1365-2672.92.5s1.3.x; Mandal A, 2012, COLLOID SURFACE B, V90, P191, DOI 10.1016/j.colsurfb.2011.10.021; MENGER FM, 1991, J AM CHEM SOC, V113, P1451, DOI 10.1021/ja00004a077; Nakata K, 2011, J APPL MICROBIOL, V110, P568, DOI 10.1111/j.1365-2672.2010.04912.x; NAUMANN D, 1982, EUR J BIOCHEM, V125, P505, DOI 10.1111/j.1432-1033.1982.tb06711.x; Nazari M, 2012, BIOPHYS J, V102, P498, DOI 10.1016/j.bpj.2011.12.029; Negm NA, 2013, J SURFACTANTS DETERG, V16, P767, DOI 10.1007/s11743-013-1437-5; Ng CKL, 2007, BIOORGAN MED CHEM, V15, P3422, DOI 10.1016/j.bmc.2007.03.018; Noriega E, 2011, FOOD MICROBIOL, V28, P1293, DOI 10.1016/j.fm.2011.05.007; Numata M, 2010, P NATL ACAD SCI USA, V107, P320, DOI 10.1073/pnas.0909361107; Peetla C, 2009, LANGMUIR, V25, P2369, DOI 10.1021/la803361y; Qi L, 2011, VIROLOGY, V412, P426, DOI 10.1016/j.virol.2011.01.029; Roscini L, 2010, ANALYST, V135, P2099, DOI 10.1039/c0an00127a; Singh P, 2004, TRENDS BIOTECHNOL, V22, P142, DOI 10.1016/j.tibtech.2004.01.010; Smaoui S, 2010, APPL BIOCHEM BIOTECH, V162, P1132, DOI 10.1007/s12010-009-8821-7; Szeghalmi A, 2007, ANAL BIOANAL CHEM, V387, P1779, DOI 10.1007/s00216-006-0850-2; Tiecco M, 2014, CHEM-BIOL INTERACT, V218, P20, DOI 10.1016/j.cbi.2014.04.012; Tiecco M, 2013, COLLOID SURFACE B, V111, P407, DOI 10.1016/j.colsurfb.2013.06.033; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Woodhall EW, 2012, US Patent App., Patent No. [13/708,676, 13708676]; Yu CX, 2005, BIOPOLYMERS, V77, P368, DOI 10.1002/bip.20247; Yuan XZ, 2008, COLLOID SURFACE A, V317, P256, DOI 10.1016/j.colsurfa.2007.10.024; Zana R, 2002, ADV COLLOID INTERFAC, V97, P205, DOI 10.1016/S0001-8686(01)00069-0; Zhao HJ, 2004, APPL ENVIRON MICROB, V70, P6619, DOI 10.1128/AEM.70.11.6619-6627.2004	50	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0115275	10.1371/journal.pone.0115275	http://dx.doi.org/10.1371/journal.pone.0115275			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25588017	Green Submitted, Green Published, gold			2022-12-26	WOS:000347928300005
J	Looker, KJ; Magaret, AS; Turner, KME; Vickerman, P; Gottlieb, SL; Newman, LM				Looker, Katharine J.; Magaret, Amalia S.; Turner, Katherine M. E.; Vickerman, Peter; Gottlieb, Sami L.; Newman, Lori M.			Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012	PLOS ONE			English	Article							GENITAL HERPES; UNITED-STATES; SEROPOSITIVE WOMEN; HIV ACQUISITION; HSV-2; RISK; TRANSMISSION; MEN; SEROPREVALENCE; SEROCONVERSION	Background: Herpes simplex virus type 2 (HSV-2) infection causes significant disease globally. Adolescent and adult infection may present as painful genital ulcers. Neonatal infection has high morbidity and mortality. Additionally, HSV-2 likely contributes substantially to the spread of HIV infection. The global burden of HSV-2 infection was last estimated for 2003. Here we present new global estimates for 2012 of the burden of prevalent (existing) and incident (new) HSV-2 infection among females and males aged 15-49 years, using updated methodology to adjust for test performance and estimate by World Health Organization (WHO) region. Methods and Findings: We conducted a literature review of HSV-2 prevalence studies world-wide since 2000. We then fitted a model with constant HSV-2 incidence by age to pooled HSV-2 prevalence values by age and sex. Prevalence values were adjusted for test sensitivity and specificity. The model estimated prevalence and incidence by sex for each WHO region to obtain global burden estimates. Uncertainty bounds were computed by refitting the model to reflect the variation in the underlying prevalence data. In 2012, we estimate that there were 417 million people aged 15-49 years (range: 274-678 million) living with HSV-2 infection world-wide (11.3% global prevalence), of whom 267 million were women. We also estimate that in 2012, 19.2 million (range: 13.0-28.6 million) individuals aged 15-49 years were newly-infected (0.5% of all individuals globally). The highest burden was in Africa. However, despite lower prevalence, South-East Asia and Western Pacific regions also contributed large numbers to the global totals because of large population sizes. Conclusions: The global burden of HSV-2 infection is large, leaving over 400 million people at increased risk of genital ulcer disease, HIV acquisition, and transmission of HSV-2 to partners or neonates. These estimates highlight the critical need for development of vaccines, microbicides, and other new HSV prevention strategies.	[Looker, Katharine J.; Turner, Katherine M. E.; Vickerman, Peter] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Magaret, Amalia S.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Gottlieb, Sami L.; Newman, Lori M.] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	University of Bristol; University of Washington; University of Washington Seattle; World Health Organization	Looker, KJ (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	katharine.looker@bristol.ac.uk	Turner, Katy/R-3853-2019	Turner, Katy/0000-0002-8152-6017; Chen, Yu/0000-0002-1519-4894; Vickerman, Peter/0000-0002-8291-5890	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research; Development and Research Training in Human Reproduction; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731] Funding Source: NIH RePORTER	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research; Development and Research Training in Human Reproduction; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, http://www.who.int/reproductivehealth/hrp/en/. WHO commissioned the study, advised as required during the study, co-ordinated data requests, helped with redrafts, and approved the manuscript submission. KJL had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Abu-Raddad LJ, 2010, EPIDEMICS-NETH, V2, P173, DOI 10.1016/j.epidem.2010.08.003; [Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P456; Ashley RL, 1999, J CLIN MICROBIOL, V37, P1632, DOI 10.1128/JCM.37.5.1632-1633.1999; Ashley RL, 2001, SEX TRANSM INFECT, V77, P232, DOI 10.1136/sti.77.4.232; Ashley-Morrow R, 2004, CLIN MICROBIOL INFEC, V10, P530, DOI 10.1111/j.1469-0691.2004.00836.x; Ashley-Morrow R, 2003, SEX TRANSM DIS, V30, P310, DOI 10.1097/00007435-200304000-00007; AUGENBRAUN M, 1995, ANN INTERN MED, V123, P845, DOI 10.7326/0003-4819-123-11-199512010-00006; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; BENEDETTI J, 1994, ANN INTERN MED, V121, P847, DOI 10.7326/0003-4819-121-11-199412010-00004; Broutet N, 2014, VACCINE, V32, P1630, DOI 10.1016/j.vaccine.2014.01.053; Brown JM, 2007, AIDS, V21, P1515, DOI 10.1097/QAD.0b013e3282004929; Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Genocea website, GEN ANN POS TOP LIN; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gray E, 2008, NEW ZEAL MED J, V121, P43; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Holmes KK, 2008, SEXUALLY TRANSMITTED, V4th; Johnston C, 2014, VACCINE, V32, P1553, DOI 10.1016/j.vaccine.2013.08.066; Kaushic C, 2011, J REPROD IMMUNOL, V88, P204, DOI 10.1016/j.jri.2010.12.004; Kelsey JL, 1986, METHODS OBSERVATIONS; Kenyon C, 2013, INT J STD AIDS, V24, P375, DOI 10.1177/0956462412472816; Lingappa JR, 2010, LANCET, V375, P824, DOI 10.1016/S0140-6736(09)62038-9; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; Morrow R, 2006, CLIN MICROBIOL INFEC, V12, P463, DOI 10.1111/j.1469-0691.2006.01370.x; Muench H., CATALYTIC MODELS EPI, P8928; Pena KC, 2010, J CLIN MICROBIOL, V48, P150, DOI 10.1128/JCM.01336-09; Pinninti SG, 2013, AM J PERINAT, V30, P113, DOI 10.1055/s-0032-1332802; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Roberts CM, 2003, SEX TRANSM DIS, V30, P797, DOI 10.1097/01.OLQ.0000092387.58746.C7; Ryder N, 2009, SEX TRANSM INFECT, V85, P416, DOI 10.1136/sti.2008.033902; Schacker T, 1998, J INFECT DIS, V178, P1616, DOI 10.1086/314486; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Tassiopoulos KK, 2007, J INFECT DIS, V195, P493, DOI 10.1086/510537; Todd J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059037; Tuokko H, 2014, SEX TRANSM INFECT; United Nations, 2013, WORLD POP AG 2013; Wald A, 2002, CLIN INFECT DIS, V35, pS173, DOI 10.1086/342104; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; WHO, 2012, GLOB INC PREV SEL CU; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	49	483	513	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e114989	10.1371/journal.pone.0114989	http://dx.doi.org/10.1371/journal.pone.0114989			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	26510007	gold, Green Submitted, Green Published			2022-12-26	WOS:000348205300007
J	Shi, SW; Han, PF; Zhang, P; Ding, F; Ma, CL				Shi, Sheng-wei; Han, Peng-fei; Zhang, Ping; Ding, Fan; Ma, Cheng-lin			The Impact of Afforestation on Soil Organic Carbon Sequestration on the Qinghai Plateau, China	PLOS ONE			English	Article							LAND-USE CHANGE; VERTICAL-DISTRIBUTION; AGRICULTURAL SOILS; NITROGEN ADDITIONS; STOCKS; FOREST; ACCUMULATION; GRASSLAND; DYNAMICS; MATTER	Afforestation, the conversion of non-forested land into forest, is widespread in China. However, the dynamics of soil organic carbon (SOC) after afforestation are not well understood, especially in plateau climate zones. For a total of 48 shrub- and/or tree-dominated afforestation sites on the Qinghai Plateau, Northwestern China, post-afforestation changes in SOC, total nitrogen (TN), the carbon-to-nitrogen ratio (C/N) and soil bulk density (BD) were investigated to a soil depth of 60 cm using the paired-plots method. SOC and TN accumulated at rates of 138.2 g C m(-2) yr(-1) and 4.6 g N m(-2) yr(-1), respectively, in shrub-dominated afforestation sites and at rates of 113.3 g C m(-2) yr(-1) and 6.7 g N m(-2)yr(-1), respectively, in tree-dominated afforestation sites. Soil BD was slightly reduced in all layers in the shrub-dominated afforestation plots, and significantly reduced in soil layers from 0-40cm in the tree-dominated afforestation plots. The C/N ratio was higher in afforested sites relative to the reference sites. SOC accumulation was closely related to TN accumulation following afforestation, and the inclusion of N-fixing species in tree-dominated afforestation sites additionally increased the soil accumulation capacity for SOC (p < 0.05). Multiple regression models including the age of an afforestation plot and total number of plant species explained 75% of the variation in relative SOC content change at depth of 0-20 cm, in tree-dominated afforestation sites. We conclude that afforestation on the Qinghai Plateau is associated with great capability of SOC and TN sequestration. This study improves our understanding of the mechanisms underlying SOC and TN accumulation in a plateau climate, and provides evidence on the C sequestration potentials associated with forestry projects in China.	[Shi, Sheng-wei; Han, Peng-fei; Zhang, Ping] Chinese Acad Sci, State Key Lab Atmospher Boundary Layer Phys & Atm, Inst Atmospher Phys, Beijing 100083, Peoples R China; [Shi, Sheng-wei; Han, Peng-fei; Ding, Fan; Ma, Cheng-lin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Shi, Sheng-wei] Northwest A&F Univ, Coll Forestry, Yangling 712100, Shaanxi, Peoples R China; [Ding, Fan; Ma, Cheng-lin] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing 100093, Peoples R China	Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Botany, CAS	Shi, SW (corresponding author), Chinese Acad Sci, State Key Lab Atmospher Boundary Layer Phys & Atm, Inst Atmospher Phys, Beijing 100083, Peoples R China.	weiweishi848@gmail.com	LAPC, IAP/AAI-6991-2020; Ding, Fan/A-3049-2015; Han, Pengfei/F-9082-2018	LAPC, IAP/0000-0002-0025-3484; Ding, Fan/0000-0002-7938-1015; Zhang, Min/0000-0001-5812-9518	national key fundamental research program for the Chinese Science and Technology Department [2010CB950604]	national key fundamental research program for the Chinese Science and Technology Department	This research was sponsored by the national key fundamental research program for the Chinese Science and Technology Department (2010CB950604).	Barcena TG, 2014, GLOBAL CHANGE BIOL, V20, P2393, DOI 10.1111/gcb.12576; Berry SL, 2002, GLOBAL ECOL BIOGEOGR, V11, P23, DOI 10.1046/j.1466-822X.2002.00183.x; Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Binkley D, 2005, NATO SCI S SS IV EAR, V55, P155; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; Bowman RA, 2002, COMMUN SOIL SCI PLAN, V33, P1629, DOI 10.1081/CSS-120004304; Chang RY, 2011, ENVIRON MANAGE, V48, P1158, DOI 10.1007/s00267-011-9682-8; Chapin FS., 2011, PRINCIPLES TERRESTRI, V2nd ed.; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; Del Galdo I, 2003, GLOBAL CHANGE BIOL, V9, P1204, DOI 10.1046/j.1365-2486.2003.00657.x; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; [董旭 Dong Xu], 2011, [水土保持通报, Bulletin of Soil and Water Conservation], V31, P45; Eclesia RP, 2012, GLOBAL CHANGE BIOL, V18, P3237, DOI 10.1111/j.1365-2486.2012.02761.x; Ellert BH, 1995, CAN J SOIL SCI, V75, P529, DOI 10.4141/cjss95-075; Fan GH, 2008, QINGHAI SCI TECHNOLO, V1, P17; Fornara DA, 2008, J ECOL, V96, P314, DOI 10.1111/j.1365-2745.2007.01345.x; [高国雄 GAO Guoxiong], 2007, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V21, P104; Giardina CP, 2004, OECOLOGIA, V139, P545, DOI 10.1007/s00442-004-1552-0; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; HANSEN EA, 1993, BIOMASS BIOENERG, V5, P431, DOI 10.1016/0961-9534(93)90038-6; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Hoogmoed M, 2012, AGR ECOSYST ENVIRON, V159, P176, DOI 10.1016/j.agee.2012.07.011; Hoover CM, 2003, POTENTIAL OF U.S. FOREST SOILS TO SEQUESTER CARBON AND MITIGATE THE GREENHOUSE EFFECT, P211; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; [黄玉霞 Huang Yuxia], 2006, [气象, Meteorological Monthly], V32, P18; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Janssens IA, 2003, SCIENCE, V300, P1538, DOI 10.1126/science.1083592; Jarecki MK, 2003, CRIT REV PLANT SCI, V22, P471, DOI 10.1080/713608318; [敬文茂 Jing Wenmao], 2011, [甘肃农业大学学报, Journal of Gansu Agricultural University], V46, P81; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kaye JP, 2000, ECOLOGY, V81, P3267, DOI 10.1890/0012-9658(2000)081[3267:NACDIA]2.0.CO;2; Knops JMH, 2009, SOIL SCI SOC AM J, V73, P2096, DOI 10.2136/sssaj2009.0058; Laganiere J, 2010, GLOBAL CHANGE BIOL, V16, P439, DOI 10.1111/j.1365-2486.2009.01930.x; Li DJ, 2012, NEW PHYTOL, V195, P172, DOI 10.1111/j.1469-8137.2012.04150.x; Lin ZY, 1981, ACTA GEOGRAPHICA SIN, V1, P22; Liu F, 2011, GLOBAL CHANGE BIOL, V17, P1119, DOI 10.1111/j.1365-2486.2010.02251.x; Liu F, 2010, GLOBAL CHANGE BIOL, V16, P2213, DOI 10.1111/j.1365-2486.2009.02099.x; Liu LL, 2010, ECOL LETT, V13, P819, DOI 10.1111/j.1461-0248.2010.01482.x; Lu F, 2007, THESIS BEIJING FORES; Lu CQ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007990; LUGO AE, 1993, PLANT SOIL, V149, P27, DOI 10.1007/BF00010760; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Luo YQ, 2006, ECOLOGY, V87, P3, DOI 10.1890/05-0923; Mao R, 2010, ENVIRON MANAGE, V46, P110, DOI 10.1007/s00267-010-9504-4; McKinley DC, 2011, ECOL APPL, V21, P1902, DOI 10.1890/10-0697.1; Morris SJ, 2007, GLOBAL CHANGE BIOL, V13, P1145, DOI 10.1111/j.1365-2486.2007.01359.x; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Pineiro G, 2006, GLOBAL CHANGE BIOL, V12, P804, DOI 10.1111/j.1365-2486.2006.01139.x; Poeplau C, 2011, GLOBAL CHANGE BIOL, V17, P2415, DOI 10.1111/j.1365-2486.2011.02408.x; Powers JS, 2011, P NATL ACAD SCI USA, V108, P6318, DOI 10.1073/pnas.1016774108; Resh SC, 2002, ECOSYSTEMS, V5, P217, DOI 10.1007/s10021-001-0067-3; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; Saiz G, 2012, GLOBAL CHANGE BIOL, V18, P1670, DOI 10.1111/j.1365-2486.2012.02657.x; Shi SW, 2013, FOREST ECOL MANAG, V296, P53, DOI 10.1016/j.foreco.2013.01.026; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; Smith P, 2012, GLOBAL CHANGE BIOL, V18, P2089, DOI 10.1111/j.1365-2486.2012.02689.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song XZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04460; State Forestry Administration PCC, 2010, CHIN FOR STAT YB, P498; Tang JW, 2009, GLOBAL CHANGE BIOL, V15, P145, DOI 10.1111/j.1365-2486.2008.01741.x; Throop HL, 2008, GLOBAL CHANGE BIOL, V14, P2420, DOI 10.1111/j.1365-2486.2008.01650.x; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Wang SL, 2010, PLANT SOIL, V334, P501, DOI 10.1007/s11104-010-0400-8; Wang WJ, 2011, GLOBAL CHANGE BIOL, V17, P2657, DOI 10.1111/j.1365-2486.2011.02447.x; Yang YH, 2007, BIOGEOCHEMISTRY, V84, P131, DOI 10.1007/s10533-007-9109-z; Yang YH, 2011, NEW PHYTOL, V190, P977, DOI 10.1111/j.1469-8137.2011.03645.x; Zhang K, 2010, LAND DEGRAD DEV, V21, P13, DOI 10.1002/ldr.954; Zhou XH, 2012, TELLUS B, V64, DOI 10.3402/tellusb.v64i0.17223; Zillich AJ, 2006, HYPERTENSION, V48, P219, DOI 10.1161/01.HYP.0000231552.10054.aa	73	27	29	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116591	10.1371/journal.pone.0116591	http://dx.doi.org/10.1371/journal.pone.0116591			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25621996	Green Submitted, Green Published, gold			2022-12-26	WOS:000350662100041
J	Huang, Y; Guo, F; Li, YL; Liu, YF				Huang, Yu; Guo, Feng; Li, Yongling; Liu, Yufeng			Parameter Estimation of Fractional-Order Chaotic Systems by Using Quantum Parallel Particle Swarm Optimization Algorithm	PLOS ONE			English	Article							DIFFERENTIAL EVOLUTION; SYNCHRONIZATION; IDENTIFICATION; EQUATIONS	Parameter estimation for fractional-order chaotic systems is an important issue in fractionalorder chaotic control and synchronization and could be essentially formulated as a multidimensional optimization problem. A novel algorithm called quantum parallel particle swarm optimization (QPPSO) is proposed to solve the parameter estimation for fractional-order chaotic systems. The parallel characteristic of quantum computing is used in QPPSO. This characteristic increases the calculation of each generation exponentially. The behavior of particles in quantum space is restrained by the quantum evolution equation, which consists of the current rotation angle, individual optimal quantum rotation angle, and global optimal quantum rotation angle. Numerical simulation based on several typical fractional-order systems and comparisons with some typical existing algorithms show the effectiveness and efficiency of the proposed algorithm.	[Huang, Yu; Li, Yongling] North China Elect Power Univ, Hebei Engn Res Ctr Simulat & Optimized Control Po, Baoding, Peoples R China; [Guo, Feng] Xiamen Univ, Sch Informat Sci & Engn, Dept Cognit Sci, Xiamen, Peoples R China; [Huang, Yu; Liu, Yufeng] Tsinghua Univ, Dept Thermal Engn, State Key Lab Power Syst, Beijing 100084, Peoples R China	North China Electric Power University; Xiamen University; Tsinghua University	Guo, F (corresponding author), Xiamen Univ, Sch Informat Sci & Engn, Dept Cognit Sci, Xiamen, Peoples R China.	betop@xmu.edu.cn	Shi, Yunliang/AAR-3963-2021; Liu, Xiaoling/HGD-3566-2022	Fang, Xiong/0000-0002-4176-2162	Central Universities Fundamental Research Funds [12MS117]; Natural Science Foundation of Fujian Province of China [2014J01249]	Central Universities Fundamental Research Funds; Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	This work was supported by Central Universities Fundamental Research Funds (12MS117) and the Natural Science Foundation of Fujian Province of China (No. 2014J01249). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhalekar S, 2010, COMMUN NONLINEAR SCI, V15, P2178, DOI 10.1016/j.cnsns.2009.08.015; Caponetto R., 2010, WORLD SCI SERIES NON; Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692; Daftardar-Gejji V, 2010, COMPUT MATH APPL, V59, P1117, DOI 10.1016/j.camwa.2009.07.003; Dai D, 2002, ACTA PHYS SIN-CH ED, V51, P2459, DOI 10.7498/aps.51.2459; Deng WH, 2006, CHAOS, V16, DOI 10.1063/1.2401061; Diethelm K, 2002, J MATH ANAL APPL, V265, P229, DOI 10.1006/jmaa.2000.7194; Dong-Feng W, 2006, PROPORTIONAL INTEGRA; Gandomi AH, 2013, COMMUN NONLINEAR SCI, V18, P327, DOI 10.1016/j.cnsns.2012.07.017; Gao Y, 2014, HYPERSPECTRAL IMAGE; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P4290, DOI 10.1109/TIP.2012.2199502; Grigorenko I, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.034101; He Q, 2007, CHAOS SOLITON FRACT, V34, P654, DOI 10.1016/j.chaos.2006.03.079; Ho WH, 2010, NONLINEAR DYNAM, V61, P29, DOI 10.1007/s11071-009-9629-2; Ji R, 2014, SPECTRAL SPATIAL CON; Ji RR, 2012, IEEE T IMAGE PROCESS, V21, P2282, DOI 10.1109/TIP.2011.2176950; Li CG, 2004, CHAOS SOLITON FRACT, V22, P549, DOI 10.1016/j.chaos.2004.02.035; Li CG, 2004, PHYSICA A, V341, P55, DOI 10.1016/j.physa.2004.04.113; Li LX, 2006, CHAOS SOLITON FRACT, V28, P1204, DOI 10.1016/j.chaos.2005.04.110; Lu JG, 2006, PHYS LETT A, V354, P305, DOI 10.1016/j.physleta.2006.01.068; Nielsen, 2010, QUANTUM COMPUTATION; Odibat ZM, 2010, INT J BIFURCAT CHAOS, V20, P81, DOI 10.1142/S0218127410025429; Peng B, 2009, CHAOS SOLITON FRACT, V39, P2110, DOI 10.1016/j.chaos.2007.06.084; Sheikhan M, 2013, NEURAL COMPUT APPL, V22, P361, DOI 10.1007/s00521-011-0697-0; Sheu LJ, 2008, CHAOS SOLITON FRACT, V36, P98, DOI 10.1016/j.chaos.2006.06.013; Tang YG, 2012, PHYS LETT A, V376, P457, DOI 10.1016/j.physleta.2011.12.008; Tavazoei MS, 2008, PHYSICA D, V237, P2628, DOI 10.1016/j.physd.2008.03.037; Tavazoei MS, 2007, PHYS LETT A, V367, P102, DOI 10.1016/j.physleta.2007.05.081; Tavazoei MS, 2010, NONLINEAR ANAL-REAL, V11, P332, DOI 10.1016/j.nonrwa.2008.11.008; Yassi M, 2014, DISTINGUISHING CLUST, P1	30	150	158	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0114910	10.1371/journal.pone.0114910	http://dx.doi.org/10.1371/journal.pone.0114910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	26132635	Green Published, Green Submitted, gold			2022-12-26	WOS:000348203500006
J	Shi, S; Zhang, M; Guo, R; Miao, Y; Hu, JJ; Xi, Y; Li, B				Shi, Shuo; Zhang, Min; Guo, Rui; Miao, Ying; Hu, Jiajia; Xi, Yun; Li, Biao			In vivo Molecular Imaging and Radionuclide (I-131) Therapy of Human Nasopharyngeal Carcinoma Cells Transfected with a Lentivirus Expressing Sodium Iodide Symporter	PLOS ONE			English	Article							GENE DELIVERY; SODIUM/IODIDE SYMPORTER; VIRAL VECTORS; PROMOTER; EFFICACY; VITRO; LINE	Introduction Despite recent improvements in the survival rates for nasopharyngeal carcinoma (NPC), novel treatment strategies are required to improve distant metastasis-free survival. The sodium iodine symporter (NIS) gene has been applied for in vivo imaging and cancer therapy. In this study, we examined the potential of NIS gene therapy as a therapeutic approach in NPC by performing non-invasive imaging using I-125 and I-131 therapy in vivo. Methods We constructed a lentiviral vector expressing NIS and enhanced green fluorescent protein (EGFP) under the control of the human elongation factor-1 alpha (EF1 alpha) promoter, and stably transfected the vector into CNE-2Z NPC cells to create CNE-2Z-NIS cells. CNE-2Z and CNE-2Z-NIS tumor xenografts were established in nude mice; I-125 uptake, accumulation and efflux were measured using micro-SPECT/CT imaging; the therapeutic effects of treatment with I-131 were assessed over 25 days by measuring tumor volume and immunohistochemical staining of the excised tumors. Results qPCR, immunofluorescence and Western blotting confirmed that CNE-2Z-NIS cells expressed high levels of NIS mRNA and protein. CNE-2Z-NIS cells and xenografts took up and accumulated significantly more I-125 than CNE-2Z cells and xenografts. In vitro, I-131 significantly reduced the clonogenic survival of CNE-2Z-NIS cells. In vivo, I-131 effectively inhibited the growth of CNE-2Z-NIS xenografts. At the end of I-131 therapy, CNE-2Z-NIS xenograft tumor cells expressed higher levels of NIS and caspase-3 and lower levels of Ki-67. Conclusion Lentiviruses effectively delivered and mediated long-lasting expression of NIS in CNE-2Z cells which enabled uptake and accumulation of radioisotopes and provided a significant therapeutic effect in an in vivo model of NPC. NIS-mediated radioiodine treatment merits further investigation as a potentially effective, low toxicity therapeutic strategy for NPC.	[Shi, Shuo; Zhang, Min; Guo, Rui; Miao, Ying; Hu, Jiajia; Xi, Yun; Li, Biao] Shanghai Jiao Tong Univ, Sch Med, Dept Nucl Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Li, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Nucl Med, Shanghai 200030, Peoples R China.	lb10363@rjh.com.cn	LAPC, IAP/AAI-6991-2020; Ding, Fan/A-3049-2015; Han, Pengfei/F-9082-2018	LAPC, IAP/0000-0002-0025-3484; Ding, Fan/0000-0002-7938-1015; Zhang, Min/0000-0001-5812-9518	National Natural Science Foundation of China [81071181]; Shanghai Outstanding Academic Leaders Project [11XD1403700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Outstanding Academic Leaders Project	This work was supported by grants from the National Natural Science Foundation of China (No. 81071181) (http://isisn.nsfc.gov.cn/egrantweb/), Shanghai Outstanding Academic Leaders Project (11XD1403700) (http://www.stcsm.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeciga-Diaz CJ, 2009, MOL BIOL REP, V36, P1863, DOI 10.1007/s11033-008-9392-3; Bosch EH, 2000, J APPL MICROBIOL, V89, P215, DOI 10.1046/j.1365-2672.2000.01098.x; Cockrell AS, 2007, MOL BIOTECHNOL, V36, P184, DOI 10.1007/s12033-007-0010-8; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; De Meyer SF, 2006, BLOOD, V107, P4728, DOI 10.1182/blood-2005-09-3605; Guo R, 2011, NUCL MED COMMUN, V32, P402, DOI 10.1097/MNM.0b013e328344a1ad; Hingorani M, 2010, CURR CANCER DRUG TAR, V10, P242, DOI 10.2174/156800910791054194; Hu YC, 2008, CURR GENE THER, V8, P54, DOI 10.2174/156652308783688509; KAMINSKY SM, 1993, SOC GEN PHY, V48, P251; Li JH, 2000, INT J CANCER, V87, P606; Li JH, 1997, CLIN CANCER RES, V3, P507; Li JH, 2003, MOL THER, V8, P964, DOI 10.1016/j.ymthe.2003.08.018; Li Jia-Xin, 2010, Chin J Cancer, V29, P82; Li XP, 2006, INT J ONCOL, V29, P595; Liu BH, 2004, GENE THER, V11, P52, DOI 10.1038/sj.gt.3302126; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazzaferri EL, 2001, J CLIN ENDOCR METAB, V86, P1447, DOI 10.1210/jc.86.4.1447; Moiani A, 2012, J CLIN INVEST, V122, P1653, DOI 10.1172/JCI61852; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pan Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061305; Petrich T, 2006, CLIN CANCER RES, V12, P1342, DOI 10.1158/1078-0432.CCR-05-1576; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Riesco-Eizaguirre G, 2006, EUR J ENDOCRINOL, V155, P495, DOI 10.1530/eje.1.02257; Sides MD, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-152; Skugor M., 2009, CLEVELAND CLIN GUIDE; Vannucci L, 2013, NEW MICROBIOL, V36, P1; Vigna E, 2000, J GENE MED, V2, P308; Wang GL, 1999, BRIT J CANCER, V81, P1122, DOI 10.1038/sj.bjc.6690818; Weeks AJ, 2011, NUCL MED COMMUN, V32, P98, DOI 10.1097/MNM.0b013e3283419540; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Weinrib L, 2001, CANCER GENE THER, V8, P352, DOI 10.1038/sj.cgt.7700319; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1090, DOI 10.1210/endo-114-4-1090; Xu T, 2013, CURR ONCOL, V20, pE406, DOI 10.3747/co.20.1456; Zhang XJ, 2006, ADV DRUG DELIVER REV, V58, P515, DOI 10.1016/j.addr.2006.03.006	34	27	29	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0116531	10.1371/journal.pone.0116531	http://dx.doi.org/10.1371/journal.pone.0116531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25621996	Green Published, Green Submitted, gold			2022-12-26	WOS:000348470400005
J	Bachmann, D; Gockele, A; Ravenek, JM; Roscher, C; Strecker, T; Weigelt, A; Buchmann, N				Bachmann, Doerte; Gockele, Annette; Ravenek, Janneke M.; Roscher, Christiane; Strecker, Tanja; Weigelt, Alexandra; Buchmann, Nina			No Evidence of Complementary Water Use along a Plant Species Richness Gradient in Temperate Experimental Grasslands	PLOS ONE			English	Article							DIVERSITY-PRODUCTIVITY RELATIONSHIPS; BIODIVERSITY EXPERIMENTS; ECOSYSTEM PROCESSES; CURRENT KNOWLEDGE; STABLE ISOTOPES; COMMUNITIES; DEPTH; NITROGEN; PATTERNS; SPACE	Niche complementarity in resource use has been proposed as a key mechanism to explain the positive effects of increasing plant species richness on ecosystem processes, in particular on primary productivity. Since hardly any information is available for niche complementarity in water use, we tested the effects of plant diversity on spatial and temporal complementarity in water uptake in experimental grasslands by using stable water isotopes. We hypothesized that water uptake from deeper soil depths increases in more diverse compared to low diverse plant species mixtures. We labeled soil water in 8 cm (with O-18) and 28 cm depth (with H-2) three times during the 2011 growing season in 40 temperate grassland communities of varying species richness (2, 4, 8 and 16 species) and functional group number and composition (legumes, grasses, tall herbs, small herbs). Stable isotope analyses of xylem and soil water allowed identifying the preferential depth of water uptake. Higher enrichment in 18O of xylem water than in H-2 suggested that the main water uptake was in the upper soil layer. Furthermore, our results revealed no differences in root water uptake among communities with different species richness, different number of functional groups or with time. Thus, our results do not support the hypothesis of increased complementarity in water use in more diverse than in less diverse communities of temperate grassland species.	[Bachmann, Doerte; Buchmann, Nina] ETH, Inst Agr Sci, Zurich, Switzerland; [Gockele, Annette] Univ Freiburg, Fac Biol, Dept Geobot, D-79106 Freiburg, Germany; [Ravenek, Janneke M.] Radboud Univ Nijmegen, Dept Expt Plant Ecol, Inst Water & Wetland Res, NL-6525 ED Nijmegen, Netherlands; [Roscher, Christiane] Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Halle, Germany; [Strecker, Tanja] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Weigelt, Alexandra] Univ Leipzig, Dept Special Bot & Funct Biodivers, Inst Biol, D-04109 Leipzig, Germany; [Weigelt, Alexandra] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Freiburg; Radboud University Nijmegen; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Gottingen; Leipzig University	Bachmann, D (corresponding author), ETH, Inst Agr Sci, Zurich, Switzerland.	doerte.bachmann@usys.ethz.ch	Buchmann, Nina/E-6095-2011	Buchmann, Nina/0000-0003-0826-2980; Bachmann, Dorte/0000-0003-2171-3838; Segura, Diego Fernando/0000-0003-2927-9028; Fernandez, Patricia C./0000-0002-4360-6761; Juarez, Maria Laura/0000-0002-4563-5080; Vera, Maria Teresa/0000-0002-1446-6042; Ruiz, Maria Josefina/0000-0003-0773-2629	Swiss National Science Foundation [315230E-131194]; German Science Foundation [FOR 456/1451]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Science Foundation(German Research Foundation (DFG))	This study was financially supported by the Swiss National Science Foundation (315230E-131194, www.snf.ch) and the German Science Foundation (FOR 456/1451, www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2013, OECOLOGIA, V173, P223, DOI 10.1007/s00442-012-2589-0; ALLISON GB, 1983, EFFECT CLIMATE VEGET, P105; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barnard RL, 2006, RAPID COMMUN MASS SP, V20, P3799, DOI 10.1002/rcm.2778; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BERENDSE F, 1982, OECOLOGIA, V53, P50, DOI 10.1007/BF00377135; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bessler H, 2012, PLANT SOIL, V358, P301, DOI 10.1007/s11104-012-1181-z; Caldeira MC, 2001, ECOL LETT, V4, P439, DOI 10.1046/j.1461-0248.2001.00238.x; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; Clark I., 1997, ENV ISOTOPES HYDROLO; DANSGAARD W, 1964, TELLUS, V16, P436; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Dimitrakopoulos PG, 2004, ECOL LETT, V7, P574, DOI 10.1111/j.1461-0248.2004.00607.x; Dodd MB, 1998, OECOLOGIA, V117, P504, DOI 10.1007/s004420050686; EHLERINGER JR, 1992, PLANT CELL ENVIRON, V15, P1073, DOI 10.1111/j.1365-3040.1992.tb01657.x; EHLERINGER JR, 1991, OECOLOGIA, V88, P430, DOI 10.1007/BF00317589; Fargione J, 2005, OECOLOGIA, V143, P598, DOI 10.1007/s00442-005-0010-y; Fischer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098987; GORDON DR, 1992, AM J BOT, V79, P967, DOI 10.2307/2444905; Grieu P, 2001, PLANT SOIL, V230, P197, DOI 10.1023/A:1010363532118; Gubsch M, 2011, PLANT CELL ENVIRON, V34, P895, DOI 10.1111/j.1365-3040.2011.02287.x; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Hoekstra NJ, 2014, BIOGEOSCIENCES DISCU, V11, P4151, DOI DOI 10.5194/BGD-11-4151-2014; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Jobbagy EG, 2001, BIOGEOCHEMISTRY, V53, P51, DOI 10.1023/A:1010760720215; Kahmen A, 2006, ECOLOGY, V87, P1244, DOI 10.1890/0012-9658(2006)87[1244:NCFNAE]2.0.CO;2; Kulmatiski A, 2010, NEW PHYTOL, V188, P199, DOI 10.1111/j.1469-8137.2010.03338.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; Moreno-Gutierrez C, 2012, NEW PHYTOL, V196, P489, DOI 10.1111/j.1469-8137.2012.04276.x; Mueller KE, 2013, ECOLOGY, V94, P787, DOI 10.1890/12-1399.1; Muller-Westermeier G, 2000, BERICHTE DTSCH WETTE, V213; Nippert JB, 2007, OIKOS, V116, P1017, DOI [10.1111/j.2007.0030-1299.15630.x, 10.1111/j.0030-1299.2007.15630.x]; Oelmann Y, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003869; Ogle K, 2004, ECOLOGY, V85, P1967, DOI 10.1890/03-0346; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036760; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; Schlapfer F, 1999, ECOL APPL, V9, P893, DOI 10.1890/1051-0761(1999)009[0893:EEOBAC]2.0.CO;2; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Van Peer L, 2004, FUNCT ECOL, V18, P769, DOI 10.1111/j.0269-8463.2004.00901.x; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; Verheyen K, 2008, OECOLOGIA, V156, P351, DOI 10.1007/s00442-008-0998-x; Volaire F, 2014, EUR J AGRON, V52, P81, DOI 10.1016/j.eja.2013.10.002; von Felten S, 2008, J PLANT ECOL, V1, P33, DOI 10.1093/jpe/rtm006; von Felten S, 2009, ECOLOGY, V90, P1389, DOI 10.1890/08-0802.1; Werner RA, 1999, RAPID COMMUN MASS SP, V13, P1237, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1237::AID-RCM633>3.0.CO;2-C; WHITE JWC, 1985, GEOCHIM COSMOCHIM AC, V49, P237, DOI 10.1016/0016-7037(85)90207-8	57	54	57	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116367	10.1371/journal.pone.0116367	http://dx.doi.org/10.1371/journal.pone.0116367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25923584	Green Submitted, Green Published, gold			2022-12-26	WOS:000347928300011
J	Huang, Y; Pang, YH; Wang, H; Tang, ZZ; Zhou, Y; Zhang, WY; Li, XG; Tan, DM; Li, J; Lin, Y; Liu, XL; Huang, WY; Shi, YL				Huang, Yan; Pang, Yiheng; Wang, Hong; Tang, Zhengzhu; Zhou, Yan; Zhang, Weiyu; Li, Xiugui; Tan, Dongmei; Li, Jian; Lin, Ying; Liu, Xiaoling; Huang, Weiyi; Shi, Yunliang			Occurrence and Characterization of Cronobacter spp. in Dehydrated Rice Powder from Chinese Supermarket	PLOS ONE			English	Article							ENTEROBACTER-SAKAZAKII; INFANT FORMULA; GENOTYPIC CHARACTERIZATION; ANTIBIOTIC SUSCEPTIBILITY; NEONATAL MENINGITIS; MILK; FOOD; IDENTIFICATION; INGREDIENTS; PREVALENCE	Cronobacter spp. are emerging food-borne pathogens and have been identified as causative agents of meningitis and necrotizing enterocolitis in infants. Dehydrated rice is popular with a wide range of people and it is frequently used as a substitute for infant milk powder to baby older than four months. The occurrence of Cronobacter spp. was investigated in 1,012 samples of dehydrated rice powder collected from 14 manufacturers in China during 2010 to 2012. The isolates were identified using fusA allele sequencing and subtyped using pulsed-field gel electrophoresis. Seventy-six samples (7.5%) contained Cronobacter spp. The prevalence among manufacturers ranged from 0-28.8%. The 76 isolates included 4 species [Cronobacter sakazakii (52 isolates) Cronobacter malonaticus (14 isolates), Cronobacter dublinensis (7 isolates), and Cronobacter muytjensii (3 isolates)]. Twenty-three unique fusA alleles and sixty-six PFGE-patterns were detected. All isolated strains were observed to be sensitive or to show intermediate susceptibility to eight tested antimicrobial agents. The study revealed serious contamination of dehydrated rice powder by Cronobacter spp., with prevalence varying among manufacturers in China. Identified Cronobacter species, fusA alleles, and subtypes were diverse.	[Huang, Yan; Wang, Hong; Tang, Zhengzhu; Zhou, Yan; Li, Xiugui; Tan, Dongmei; Shi, Yunliang] Guangxi Zhuang Autonomous Reg Ctr Dis Control & P, Nanning, Peoples R China; [Pang, Yiheng] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Li, Jian; Lin, Ying; Liu, Xiaoling; Huang, Weiyi; Shi, Yunliang] Guangxi Univ, Food Qual & Safety Ctr, Nanning 530004, Guangxi, Peoples R China; [Zhang, Weiyu; Huang, Weiyi] Guangxi Univ, Coll Anim Sci & Technol, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi University; Guangxi University	Huang, Y (corresponding author), Guangxi Zhuang Autonomous Reg Ctr Dis Control & P, Nanning, Peoples R China.	huangyangxdx@163.com; syunliang2008@126.com	Shi, Yunliang/AAR-3963-2021; Liu, Xiaoling/HGD-3566-2022	Fang, Xiong/0000-0002-4176-2162	Guangxi Natural Science Foundation [2012GXNSFBA053125]	Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This work was supported by the Guangxi Natural Science Foundation (Grant No. 2012GXNSFBA053125 to HY). The funder played role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Agostoni C, 2004, J PEDIATR GASTR NUTR, V39, P320, DOI 10.1097/00005176-200410000-00002; Baldwin A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-223; Baumgartner A, 2009, INT J FOOD MICROBIOL, V136, P189, DOI 10.1016/j.ijfoodmicro.2009.04.009; BIERING G, 1989, J CLIN MICROBIOL, V27, P2054, DOI 10.1128/JCM.27.9.2054-2056.1989; Brengi SP, 2012, FOODBORNE PATHOG DIS, V9, P861, DOI 10.1089/fpd.2012.1161; Caubilla-Barron J, 2007, J CLIN MICROBIOL, V45, P3979, DOI 10.1128/JCM.01075-07; Chap J, 2009, INT J FOOD MICROBIOL, V136, P185, DOI 10.1016/j.ijfoodmicro.2009.08.005; Clinical and Laboratory Standards Institute, 2006, 26M100S16 CLIN LAB S; Clinical and Laboratory Standards Institute (CLSI), 2010, M100S20 CLSI; Codex Alimentarius Commission, 2008, 66 CACRCP JOINT FAO; Corti G, 2007, J CHEMOTHERAPY, V19, P94, DOI 10.1179/joc.2007.19.1.94; El-Sharoud WM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-24; FAO/WHO, 2008, FAO MICR RISK ASS SE, V15; FAO/WHO, 2006, EXP M ENT SAK SALM P; FAO/WHO, 2004, WORKSH ENT SAK OTH M; FARMER JJ, 1980, INT J SYST BACTERIOL, V30, P569, DOI 10.1099/00207713-30-3-569; Forsythe SJ, 2005, MATERN CHILD NUTR, V1, P44, DOI 10.1111/j.1740-8709.2004.00008.x; Forsythe SJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1121; Friedemann M, 2007, INT J FOOD MICROBIOL, V116, P1, DOI 10.1016/j.ijfoodmicro.2006.12.018; Healy B, 2010, FOODBORNE PATHOG DIS, V7, P339, DOI 10.1089/fpd.2009.0379; Holy O, 2014, J HOSP INFECT, V86, P169, DOI 10.1016/j.jhin.2013.09.011; Iversen C, 2004, FOOD MICROBIOL, V21, P771, DOI 10.1016/j.fm.2004.01.009; Iversen C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-64; Iversen C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-94; Iversen C, 2007, APPL ENVIRON MICROB, V73, P48, DOI 10.1128/AEM.01562-06; Joseph S, 2012, J CLIN MICROBIOL, V50, P3031, DOI 10.1128/JCM.00905-12; Kim JB, 2011, J MICROBIOL BIOTECHN, V21, P509, DOI 10.4014/jmb.1007.07059; Kim K, 2008, INT J FOOD MICROBIOL, V122, P196, DOI 10.1016/j.ijfoodmicro.2007.11.072; Lai KK, 2001, MEDICINE, V80, P113, DOI 10.1097/00005792-200103000-00004; Lee YD, 2012, FOOD CONTROL, V24, P225, DOI 10.1016/j.foodcont.2011.09.023; Lee YD, 2010, J MICROBIOL BIOTECHN, V20, P757, DOI 10.4014/jmb.0912.12004; Miled-Bennour R, 2010, INT J FOOD MICROBIOL, V139, P116, DOI 10.1016/j.ijfoodmicro.2010.01.045; Mullane NR, 2007, INT J FOOD MICROBIOL, V116, P73, DOI 10.1016/j.ijfoodmicro.2006.12.036; MUYTJENS HL, 1983, J CLIN MICROBIOL, V18, P115, DOI 10.1128/JCM.18.1.115-120.1983; MUYTJENS HL, 1988, J CLIN MICROBIOL, V26, P743, DOI 10.1128/JCM.26.4.743-746.1988; Nazarowec-White M, 1999, J MED MICROBIOL, V48, P559, DOI 10.1099/00222615-48-6-559; NazarowecWhite M, 1997, INT J FOOD MICROBIOL, V34, P103, DOI 10.1016/S0168-1605(96)01172-5; Proudy I, 2008, J APPL MICROBIOL, V104, P26, DOI 10.1111/j.1365-2672.2007.03526.x; Restaino L, 2006, J FOOD PROTECT, V69, P315, DOI 10.4315/0362-028X-69.2.315; Richards GM, 2005, J APPL MICROBIOL, V99, P844, DOI 10.1111/j.1365-2672.2005.02656.x; Shaker R, 2007, FOOD CONTROL, V18, P1241, DOI 10.1016/j.foodcont.2006.07.020; Stock I, 2002, CLIN MICROBIOL INFEC, V8, P564, DOI 10.1046/j.1469-0691.2002.00413.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Walsh D, 2011, J APPL MICROBIOL, V110, P697, DOI 10.1111/j.1365-2672.2010.04921.x	44	150	158	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131053	10.1371/journal.pone.0131053	http://dx.doi.org/10.1371/journal.pone.0131053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132635	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000090
